PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tang, HB; Lee, M; Sharpe, O; Salamone, L; Noonan, EJ; Hoang, CD; Levine, S; Robinson, WH; Shrager, JB				Tang, Huibin; Lee, Myung; Sharpe, Orr; Salamone, Louis; Noonan, Emily J.; Hoang, Chuong D.; Levine, Sanford; Robinson, William H.; Shrager, Joseph B.			Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems	FASEB JOURNAL			English	Article						phosphofructokinase; muscle; diaphragm; mechanical ventilation; Warburg effect; Ets	CONTRACTING SKELETAL-MUSCLE; MECHANICAL VENTILATION; BREAST-CANCER; MITOCHONDRIA; CELLS; ANTIOXIDANTS; METASTASIS; STRATEGY; SURVIVAL; ENZYMES	Glycolysis is the initial step of glucose catabolism and is up-regulated in cancer cells (the Warburg Effect). Such shifts toward a glycolytic phenotype have not been explored widely in other biological systems, and the molecular mechanisms underlying the shifts remain unknown. With proteomics, we observed increased glycolysis in disused human diaphragm muscle. In disused muscle, lung cancer, and H2O2-treated myotubes, we show up-regulation of the rate-limiting glycolytic enzyme muscle-type phosphofructokinase (PFKm, >2 fold, P<0.05) and accumulation of lactate (>150%, P<0.05). Using microRNA profiling, we identify miR-320a as a regulator of PFKm expression. Reduced miR-320a levels (to similar to 50% of control, P<0.05) are associated with the increased PFKm in each of these diverse systems. Manipulation of miR-320a levels both in vitro and in vivo alters PFKm and lactate levels in the expected directions. Further, miR-320a appears to regulate oxidative stress-induced PFKm expression, and reduced miR-320a allows greater induction of glycolysis in response to H2O2 treatment. We show that this microRNA-mediated regulation occurs through PFKm's 3' untranslated region and that Ets proteins are involved in the regulation of PFKm via miR-320a. These findings suggest that oxidative stress-responsive microRNA-320a may regulate glycolysis broadly within nature.-Tang, H., Lee, M., Sharpe, O., Salamone, L., Noonan, E. J., Hoang, C. D., Levine, S., Robinson, W. H., Shrager, J. B. Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems. FASEB J. 26, 4710-4721 (2012). www.fasebj.org	[Tang, Huibin; Lee, Myung; Hoang, Chuong D.; Shrager, Joseph B.] Stanford Univ, Sch Med, Div Thorac Surg, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Sharpe, Orr; Salamone, Louis; Robinson, William H.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Sharpe, Orr; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Noonan, Emily J.] Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Tang, Huibin; Lee, Myung; Sharpe, Orr; Noonan, Emily J.; Hoang, Chuong D.; Robinson, William H.; Shrager, Joseph B.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA; [Levine, Sanford] Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Pennsylvania	Shrager, JB (corresponding author), Stanford Univ, Sch Med, Div Thorac Surg, Dept Cardiothorac Surg, 2nd Floor,Falk Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	shrager@stanford.edu		Robinson, William/0000-0003-4385-704X	Veterans Affairs Merit Review grant; U.S. National Institutes of Health [RO1-HL-078834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002022] Funding Source: NIH RePORTER	Veterans Affairs Merit Review grant(US Department of Veterans Affairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The authors are grateful to Dr. Sabah Hussain (McGill University, Montreal, QC, Canada) for sharing MV limb muscle samples and Dr. Marlene Rabinovitch (Stanford University) for sharing the fluorescent dissection scope, Dr. Alejandro Sweet-Cordero (Stanford University) for helpful discussion and advice, and Dr. Xuhuai Ji (Stanford University) for assistance in microarray data analysis. This research was supported by a Veterans Affairs Merit Review grant awarded to J.B.S. and in part by U.S. National Institutes of Health grant RO1-HL-078834 to S.L. The authors disclosed the research results to Stanford Office of Licensing for potential intellectual property.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Crowther GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE67, DOI 10.1152/ajpendo.2002.282.1.E67; Crowther GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE74, DOI 10.1152/ajpendo.2002.282.1.E74; Danshina PV, 2001, IUBMB LIFE, V51, P309; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Fogg Vanessa C, 2011, Chin J Cancer, V30, P526, DOI 10.5732/cjc.011.10018; Fredriksson K, 2005, ACTA ANAESTH SCAND, V49, P1101, DOI 10.1111/j.1399-6576.2005.00718.x; Garcia M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000615; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Goh J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-191; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hockenbery DM, 2010, ENVIRON MOL MUTAGEN, V51, P476, DOI 10.1002/em.20552; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Ishii N, 2007, CORNEA, V26, pS3, DOI 10.1097/ICO.0b013e31812f6745; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Jahnke VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008637; Kauhanen S, 1998, ACTA NEUROPATHOL, V95, P165, DOI 10.1007/s004010050782; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krause U, 1996, AM J PHYSIOL-REG I, V270, pR821, DOI 10.1152/ajpregu.1996.270.4.R821; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Liddell JR, 2009, J NEUROSCI RES, V87, P2696, DOI 10.1002/jnr.22093; Ling HY, 2009, CLIN EXP PHARMACOL P, V36, pe32, DOI 10.1111/j.1440-1681.2009.05207.x; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200; Najafov A, 2010, P NATL ACAD SCI USA, V107, P19135, DOI 10.1073/pnas.1014047107; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; RADY P, 1979, J CANCER RES CLIN, V95, P287, DOI 10.1007/BF00410650; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Shanely RA, 2004, AM J RESP CRIT CARE, V170, P994, DOI 10.1164/rccm.200304-575OC; Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014; Sotgia F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-62; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Tang HB, 2011, FASEB J, V25, P2921, DOI 10.1096/fj.11-183798; Verschoor ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013565; Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Xu RH, 2005, CANCER RES, V65, P613; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808	53	81	87	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4710	4721		10.1096/fj.11-197467	http://dx.doi.org/10.1096/fj.11-197467			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22767230	Green Published			2022-12-25	WOS:000310574200031
J	Steinkellner, T; Yang, JW; Montgomery, TR; Chen, WQ; Winkler, MT; Sucic, S; Lubec, G; Freissmuth, M; Elgersma, Y; Sitte, HH; Kudlacek, O				Steinkellner, Thomas; Yang, Jae-Won; Montgomery, Therese R.; Chen, Wei-Qiang; Winkler, Marie-Therese; Sucic, Sonja; Lubec, Gert; Freissmuth, Michael; Elgersma, Ype; Sitte, Harald H.; Kudlacek, Oliver			Ca2+/Calmodulin-dependent Protein Kinase II alpha (alpha CaMKII) Controls the Activity of the Dopamine Transporter IMPLICATIONS FOR ANGELMAN SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; MOUSE MODEL; AMPHETAMINE; HIPPOCAMPAL; INHIBITION; MECHANISMS; PLASTICITY; TERMINUS; INSIGHTS; DEFICITS	The dopamine transporter (DAT) is a crucial regulator of dopaminergic neurotransmission, controlling the length and brevity of dopaminergic signaling. DAT is also the primary target of psychostimulant drugs such as cocaine and amphetamines. Conversely, methylphenidate and amphetamine are both used clinically in the treatment of attention-deficit hyperactivity disorder and narcolepsy. The action of amphetamines, which induce transport reversal, relies primarily on the ionic composition of the intra-and extracellular milieus. Recent findings suggest that DAT interacting proteins may also play a significant role in the modulation of reverse dopamine transport. The pharmacological inhibition of the serine/threonine kinase alpha CaMKII attenuates amphetamine-triggered DAT-mediated 1-methyl-4-phenylpyridinium (MPP+) efflux. More importantly, alpha CaMKII has also been shown to bind DAT in vitro and is therefore believed to be an important player within the DAT interactome. Herein, we show that alpha CaMKII co-immunoprecipitates with DAT in mouse striatal synaptosomes. Mice, which lack alpha CaMKII or which express a permanently self-inhibited alpha CaMKII (alpha CaMKIIT305D), exhibit significantly reduced amphetamine-triggered DAT-mediated MPP+ efflux. Additionally, we investigated mice that mimic a neurogenetic disease known as Angelman syndrome. These mice possess reduced alpha CaMKII activity. Angelman syndrome mice demonstrated an impaired DAT efflux function, which was comparable with that of the alpha CaMKII mutant mice, indicating that DAT-mediated dopaminergic signaling is affected in Angelman syndrome.	[Sucic, Sonja; Freissmuth, Michael; Sitte, Harald H.; Kudlacek, Oliver] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Chen, Wei-Qiang; Lubec, Gert] Med Univ Vienna, Neuroprote Div, Dept Pediat, A-1090 Vienna, Austria; [Montgomery, Therese R.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Elgersma, Ype] Erasmus Univ, Med Ctr, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands	Medical University of Vienna; Medical University of Vienna; University College Dublin; Erasmus University Rotterdam; Erasmus MC	Sitte, HH (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	harald.sitte@meduniwien.ac.at	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013; Elgersma, Ype/F-5164-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Elgersma, Ype/0000-0002-3758-1297; Montgomery, Therese/0000-0003-2749-5376; Yang, Jae-Won/0000-0001-8928-0130; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765; CHEN, Weiqiang/0000-0002-7720-4816; Lubec, Gert/0000-0002-6333-9461; Steinkellner, Thomas/0000-0003-4591-4992; Kudlacek, Oliver/0000-0002-3086-8551	Austrian Science Foundation/FWF Grants [SFB35, DK W1232-B11]; Health Research Board (HRB)-Marie Curie postdoctoral mobility fellowship; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Austrian Science Foundation/FWF Grants; Health Research Board (HRB)-Marie Curie postdoctoral mobility fellowship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation/FWF Grants SFB35 (to H. H. S. and M. F.) and DK W1232-B11 (to H. H. S.).; Recipient of a Health Research Board (HRB)-Marie Curie postdoctoral mobility fellowship.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Harbord M, 2001, J CLIN NEUROSCI, V8, P421, DOI 10.1054/jocn.2000.0753; Hornykiewicz O, 2006, J NEURAL TRANSM-SUPP, P9; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Mulherkar SA, 2010, NEUROBIOL DIS, V40, P586, DOI 10.1016/j.nbd.2010.08.002; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Owens WA, 2012, J NEUROSCI, V32, P2637, DOI 10.1523/JNEUROSCI.3759-11.2012; Quick MW, 2006, HANDB EXP PHARM, V175, P181; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Scholze P, 2001, NEUROSCI LETT, V309, P173, DOI 10.1016/S0304-3940(01)02058-4; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Steinkellner T, 2011, BIOL CHEM, V392, P103, DOI 10.1515/BC.2011.016; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams CA, 2010, AM J MED GENET C, V154C, P432, DOI 10.1002/ajmg.c.30278; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274	40	45	45	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29627	29635		10.1074/jbc.M112.367219	http://dx.doi.org/10.1074/jbc.M112.367219			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778257	hybrid, Green Published			2022-12-25	WOS:000308286900038
J	Zhou, YY; Zhang, HM; He, B; Du, JT; Lin, HN; Cerione, RA; Hao, Q				Zhou, Yeyun; Zhang, Hongmin; He, Bin; Du, Jintang; Lin, Hening; Cerione, Richard A.; Hao, Quan			The Bicyclic Intermediate Structure Provides Insights into the Desuccinylation Mechanism of Human Sirtuin 5 (SIRT5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIE RESTRICTION; LIFE-SPAN; NICOTINAMIDE; INHIBITION; NAD; GENE; DEACETYLASES; FAMILY; CANCER	Sirtuins are pivotal regulators in various cellular processes, including transcription, DNA repair, genome stability, and energy metabolism. Their functions have been generally attributed to NAD-dependent deacetylase activity. However, human SIRT5 (sirtuin 5), which has been reported to exhibit little deacetylase activity, was recently identified as an NAD-dependent demalonylase and desuccinylase. Biochemical studies suggested that the mechanism of SIRT5-catalyzed demalonylation and desuccinylation is similar to that of deacetylation catalyzed by other sirtuins. Previously, we solved the crystal structure of a SIRT5-succinyl-lysine peptide-NAD complex. Here, we present two more structures: a binary complex of SIRT5 with an H3K9 succinyl peptide and a binary complex of SIRT5 with a bicyclic intermediate obtained by incubating SIRT5-H3K9 thiosuccinyl peptide co-crystals with NAD. To our knowledge, this represents the first bicyclic intermediate for a sirtuin-catalyzed deacylation reaction that has been captured in a crystal structure, thus providing unique insights into the reaction mechanism. The structural information should benefit the design of specific inhibitors for SIRT5 and help in exploring the therapeutic potential of targeting sirtuins for treating human diseases.	[Zhang, Hongmin; Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Yeyun] Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Coll Vet Med, Ithaca, NY 14853 USA; [He, Bin; Du, Jintang; Lin, Hening; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Coll Vet Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	University of Hong Kong; Cornell University; Cornell University; Cornell University	Hao, Q (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	qhao@hku.hk	Zhang, Hongmin/S-9953-2017; Hao, Quan/C-4304-2009; Zhang, Hongmin/C-4503-2009	Zhang, Hongmin/0000-0003-4356-3615; Hao, Quan/0000-0002-9642-0514; Zhang, Hongmin/0000-0001-6357-4106	National Institutes of Health [RR01646, CA163255, DMR-0225180]; Hong Kong Research Grants Council [GRF766510]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA163255] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants RR01646 (to R. A. C. and Q. H.) and CA163255 (to H. L.). This work was also supported by Hong Kong Research Grants Council Grant GRF766510 (to Q. H.).; The crystallographic data were collected at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and National Institutes of Health through Award DMR-0225180.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; de Nigris F, 2002, BRIT J CANCER, V86, P917, DOI 10.1038/sj.bjc.6600156; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Frye R, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600635; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; Garske AL, 2007, ACS CHEM BIOL, V2, P529, DOI 10.1021/cb700160d; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; He B, 2012, J AM CHEM SOC, V134, P1922, DOI 10.1021/ja2090417; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; North BJ, 2005, METHODS, V36, P338, DOI 10.1016/j.ymeth.2005.03.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	43	62	62	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28307	28314		10.1074/jbc.M112.384511	http://dx.doi.org/10.1074/jbc.M112.384511			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22767592	hybrid, Green Published			2022-12-25	WOS:000308074600008
J	Alessandri, S; Sancho, A; Vieths, S; Mills, CEN; Wal, JM; Shewry, PR; Rigby, N; Hoffmann-Sommergruber, K				Alessandri, Stefano; Sancho, Ana; Vieths, Stefan; Mills, Clare E. N.; Wal, Jean-Michel; Shewry, Peter R.; Rigby, Neil; Hoffmann-Sommergruber, Karin			High-Throughput NMR Assessment of the Tertiary Structure of Food Allergens	PLOS ONE			English	Article							ARA H 1; MAJOR PEANUT ALLERGEN; PROTEIN-STRUCTURE MODELS; MOLTEN-GLOBULE STATE; PRU P 3; CRYSTAL-STRUCTURE; ALPHA-LACTALBUMIN; IGE-BINDING; PURIFICATION; QUALITY	Background: In vitro component-resolved diagnosis of food allergy requires purified allergens that have to meet high standards of quality. These include the authentication of their conformation, which is relevant for the recognition by specific IgE antibodies from allergic patients. Therefore, highly sensitive and reliable screening methods for the analysis of proteins/allergens are required to assess their structural integrity. In the present study one-dimensional 1H Nuclear Magnetic Resonance (1D 1H-NMR) analysis was adopted for the assessment of overall structural and dynamic properties and authentication of a set of relevant food allergens, including non-specific lipid transfer proteins from apple, peach and hazelnut, 7/8S seed storage globulins from hazelnut and peanut, 11S seed storage globulins from hazelnut and peanut, caseins from cows' and goats' milk and tropomyosin from shrimp. Methodology/Principal Findings: Two sets of 1D 1H-NMR experiments, using 700 MHz and 600 MHz instruments at 298 K were carried out to determine the presence and the extent of tertiary structure. Structural similarity among members of the individual allergen families was also assessed and changes under thermal stress investigated. The nuclear magnetic resonance (NMR) results were compared with structural information available either from the literature, Protein Data Bank entries, or derived from molecular models. Conclusions/Significance: 1D H-1-NMR analysis of food allergens allowed their classification into molecules with rigid, extended and ordered tertiary structures, molecules without a rigid tertiary structure and molecules which displayed both features. Differences in thermal stability were also detected. In summary, 1D H-1-NMR gives insights into molecular fold of proteins and offers an independent method for assessing structural properties of proteins.	[Alessandri, Stefano] Univ Florence, CERM, Ctr Ric Risonanze Magnet, Florence, Italy; [Alessandri, Stefano] Univ Florence, Dept Agr Biotechnol, Florence, Italy; [Sancho, Ana; Mills, Clare E. N.; Rigby, Neil] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Vieths, Stefan] Paul Ehrlich Inst, D-6070 Langen, Germany; [Wal, Jean-Michel] CEA Saclay, INRA, Immunoallergie Alimentaire UR496, CEA iBiTeC S SPI, F-91191 Gif Sur Yvette, France; [Shewry, Peter R.] Rothamsted Res, Harpenden, Herts, England; [Hoffmann-Sommergruber, Karin] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria	University of Florence; University of Florence; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia; Paul Ehrlich Institute; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Medical University of Vienna	Alessandri, S (corresponding author), Univ Florence, CERM, Ctr Ric Risonanze Magnet, Florence, Italy.	Karin.hoffmann@meduniwien.ac.at	Alessandri, Stefano/Q-6314-2019; Alessandri, Stefano/L-2055-2013	Alessandri, Stefano/0000-0001-8228-7559; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X; Sancho, Ana/0000-0002-6064-6159	EU through the EuroPrevall project [FOOD-CT-2005-514000]; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Austrian (FWF) Science Fund [SFB-F46-B19]; BBSRC [BBS/E/C/00005206] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00041800, BBS/E/C/00005206] Funding Source: researchfish	EU through the EuroPrevall project; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian (FWF) Science Fund(Austrian Science Fund (FWF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the EU through the EuroPrevall project (FOOD-CT-2005-514000). Rothamsted Research and the Institute of Food Research are funded by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. KHS is supported by the Grant SFB-F46-B19 from the Austrian (FWF) Science Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2008, MOL NUTR FOOD RES, V52, pS186, DOI 10.1002/mnfr.200700424; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAUM J, 1989, BIOCHEMISTRY-US, V28, P7, DOI 10.1021/bi00427a002; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Beyer K, 2002, J ALLERGY CLIN IMMUN, V110, P517, DOI 10.1067/mai.2002.127434; Blanc F, 2008, MOL NUTR FOOD RES, V52, pS166, DOI 10.1002/mnfr.200700283; BRERETON IM, 1989, MAGNET RESON MED, V9, P118, DOI 10.1002/mrm.1910090114; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Cabanos C, 2011, MOL IMMUNOL, V49, P115, DOI 10.1016/j.molimm.2011.08.004; Cabanos C, 2010, ACTA CRYSTALLOGR F, V66, P1071, DOI 10.1107/S1744309110029040; Chruszcz M, 2011, J BIOL CHEM, V286, P39318, DOI 10.1074/jbc.M111.270132; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; Fukuda T, 2008, J AGR FOOD CHEM, V56, P4145, DOI 10.1021/jf072667b; Gaier S, 2008, MOL NUTR FOOD RES, V52, pS220, DOI 10.1002/mnfr.200700274; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; Hansen KS, 2009, J ALLERGY CLIN IMMUN, V123, P1134, DOI 10.1016/j.jaci.2009.02.005; Hoffmann-Sommergruber K, 2009, ANAL BIOANAL CHEM, V395, P25, DOI 10.1007/s00216-009-2953-z; Hoffmann-Sommergruber K, 2008, MOL NUTR FOOD RES, V52, pS159, DOI 10.1002/mnfr.200800466; Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026; Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019; Jin TC, 2009, J AGR FOOD CHEM, V57, P8643, DOI 10.1021/jf9017355; Jin T, 2009, MOL IMMUNOL, V46, P1796, DOI 10.1016/j.molimm.2009.01.023; Johnson P, 2011, J AGR FOOD CHEM, V59, P12420, DOI 10.1021/jf203151e; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Lauer I, 2004, BIOCHEM J, V383, P327, DOI 10.1042/BJ20041062; Le TM, 2011, J ALLERGY CLIN IMMUN, V127, P677, DOI 10.1016/j.jaci.2010.10.003; Manjasetty BA, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-21; Marsh J, 2008, MOL NUTR FOOD RES, V52, pS272, DOI 10.1002/mnfr.200700524; Mills ENC, 2008, CURR OPIN ALLERGY CL, V8, P249, DOI 10.1097/ACI.0b013e3282ffb123; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Oberhuber C, 2008, MOL NUTR FOOD RES, V52, pS208, DOI 10.1002/mnfr.200700522; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102; Pasquato N, 2006, J MOL BIOL, V356, P684, DOI 10.1016/j.jmb.2005.11.063; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perrocheau L, 2006, J AGR FOOD CHEM, V54, P3108, DOI 10.1021/jf052910b; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Reese G, 2006, CLIN EXP ALLERGY, V36, P517, DOI 10.1111/j.1365-2222.2006.02454.x; Rehm T, 2002, STRUCTURE, V10, P1613, DOI 10.1016/S0969-2126(02)00894-8; Rigby NM, 2008, MOL NUTR FOOD RES, V52, pS251, DOI 10.1002/mnfr.200800083; Rosner HI, 2009, J MOL BIOL, V394, P351, DOI 10.1016/j.jmb.2009.09.025; Rouge P, 2009, MOL IMMUNOL, V46, P1067, DOI 10.1016/j.molimm.2008.09.030; Sancho AI, 2010, CLIN EXP ALLERGY, V40, P973, DOI 10.1111/j.1365-2222.2010.03534.x; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Toda M, 2011, J ALLERGY CLIN IMMUN, V128, P1022, DOI 10.1016/j.jaci.2011.04.020; Vissers YM, 2011, CLIN EXP ALLERGY, V41, P1631, DOI 10.1111/j.1365-2222.2011.03830.x; Whitby FG, 2000, PROTEINS, V38, P49; Wijesinha-Bettoni R, 2010, BIOCHEMISTRY-US, V49, P2130, DOI 10.1021/bi901939z	52	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39785	10.1371/journal.pone.0039785	http://dx.doi.org/10.1371/journal.pone.0039785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768312	Green Submitted, Green Published, gold			2022-12-25	WOS:000305966500025
J	Acton, JH; Gibson, JM; Cubbidge, RP				Acton, Jennifer H.; Gibson, Jonathan M.; Cubbidge, Robert P.			Quantification of Visual Field Loss in Age-Related Macular Degeneration	PLOS ONE			English	Article							WAVELENGTH AUTOMATED PERIMETRY; BLUE-ON-YELLOW; MULTIFOCAL ELECTRORETINOGRAM; MACULOPATHY; SENSITIVITY; VULNERABILITY; DISEASE; DRUSEN; ACUITY; CLASSIFICATION	Background: An evaluation of standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP) for the central 10-2 visual field test procedure in patients with age-related macular degeneration (AMD) is presented in order to determine methods of quantifying the central sensitivity loss in patients at various stages of AMD. Methods: 10-2 SAP and SWAP Humphrey visual fields and stereoscopic fundus photographs were collected in 27 eyes of 27 patients with AMD and 22 eyes of 22 normal subjects. Results: Mean Deviation and Pattern Standard Deviation (PSD) varied significantly with stage of disease in SAP (both p < 0.001) and SWAP (both p < 0.001), but post hoc analysis revealed overlap of functional values among stages. In SWAP, indices of focal loss were more sensitive to detecting differences in AMD from normal. SWAP defects were greater in depth and area than those in SAP. Central sensitivity (within 1 degrees) changed by -3.9 and -4.9 dB per stage in SAP and SWAP, respectively. Based on defect maps, an AMD Severity Index was derived. Conclusions: Global indices of focal loss were more sensitive to detecting early stage AMD from normal. The SWAP sensitivity decline with advancing stage of AMD was greater than in SAP. A new AMD Severity Index quantifies visual field defects on a continuous scale. Although not all patients are suitable for SWAP examinations, it is of value as a tool in research studies of visual loss in AMD.	[Acton, Jennifer H.] NYU, Dept Ophthalmol, New York, NY 10016 USA; [Acton, Jennifer H.; Gibson, Jonathan M.; Cubbidge, Robert P.] Aston Univ, Sch Life & Hlth Sci, Ophthalm Res Grp, Birmingham B4 7ET, W Midlands, England; [Gibson, Jonathan M.] Birmingham & Midland Eye Ctr, Birmingham, W Midlands, England	New York University; Aston University	Acton, JH (corresponding author), NYU, Dept Ophthalmol, 550 1St Ave, New York, NY 10016 USA.	jenniferhacton@gmail.com	Acton, Jennifer/AAU-3307-2021	Acton, Jennifer/0000-0002-0347-7651; Gibson, Jonathan M/0000-0002-9281-5244; Cubbidge, Robert P/0000-0002-7851-1375	College of Optometrists	College of Optometrists	Presented in part at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Florida, for which the College of Optometrists provided a travel grant to J Acton.	Agardh E, 2006, DIABETOLOGIA, V49, P200, DOI 10.1007/s00125-005-0072-8; Anderson AJ, 2011, OPTOMETRY VISION SCI, V88, P806, DOI 10.1097/OPX.0b013e31821861bd; APPLEGATE RA, 1987, APPL OPTICS, V26, P1458, DOI 10.1364/AO.26.001458; ATCHISON DA, 1990, OPTOMETRY VISION SCI, V67, P179, DOI 10.1097/00006324-199003000-00006; Bengtsson B, 2005, DIABETOLOGIA, V48, P2494, DOI 10.1007/s00125-005-0001-x; Bengtsson B, 2008, ACTA OPHTHALMOL, V86, P170, DOI 10.1111/j.1600-0420.2007.01019.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; CHENG AS, 1993, OPTOMETRY VISION SCI, V70, P89, DOI 10.1097/00006324-199302000-00001; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Conway M, 2008, EPILEPSIA, V49, P108, DOI 10.1111/j.1528-1167.2007.01249.x; CRABB DP, 1995, BRIT J OPHTHALMOL, V79, P213, DOI 10.1136/bjo.79.3.213; Cubbidge RP, 2002, GRAEF ARCH CLIN EXP, V240, P650, DOI 10.1007/s00417-002-0509-4; Durad AC, 1910, J AMER MED ASSOC, V55, P369, DOI 10.1001/jama.1910.04330050007004; EISNER A, 1987, INVEST OPHTH VIS SCI, V28, P1832; Feigl B, 2005, EYE, V19, P1169, DOI 10.1038/sj.eye.6701711; FRENNESSON C, 1995, DOC OPHTHALMOL, V90, P377, DOI 10.1007/BF01268123; Gerth C, 2003, ARCH OPHTHALMOL-CHIC, V121, P1404, DOI 10.1001/archopht.121.10.1404; Goldstein M, 2005, RETINA-J RET VIT DIS, V25, P296; GREENSTEIN VC, 1989, INVEST OPHTH VIS SCI, V30, P1732; HAEGERSTROMPORTNOY G, 1989, CLIN VISION SCI, V4, P165; HART WM, 1983, OPHTHALMOLOGY, V90, P1028; HOOD DC, 1984, INVEST OPHTH VIS SCI, V25, P864; Hudson C, 1998, DIABETOLOGIA, V41, P918, DOI 10.1007/s001250051008; Johnson C A, 1994, J Glaucoma, V3 Suppl 1, pS32; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P645, DOI 10.1001/archopht.1993.01090050079034; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P651, DOI 10.1001/archopht.1993.01090050085035; Li J, 2001, BRIT J OPHTHALMOL, V85, P287, DOI 10.1136/bjo.85.3.287; MAYER MJ, 1992, INVEST OPHTH VIS SCI, V33, P3136; Midena E, 1997, INVEST OPHTH VIS SCI, V38, P469; MIDENA E, 1994, DOC OPHTHALMOL, V88, P179, DOI 10.1007/BF01204616; Owsley C, 2000, INVEST OPHTH VIS SCI, V41, P267; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P3355, DOI 10.1167/iovs.04-0253; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Remky A, 2005, BRIT J OPHTHALMOL, V89, P464, DOI 10.1136/bjo.2004.050260; Remky A, 2001, BRIT J OPHTHALMOL, V85, P1432, DOI 10.1136/bjo.85.12.1432; Remky A, 2000, INVEST OPHTH VIS SCI, V41, P274; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SAMPLE PA, 1994, AM J OPHTHALMOL, V118, P632, DOI 10.1016/S0002-9394(14)76578-X; Scholl HPN, 2004, INVEST OPHTH VIS SCI, V45, P574, DOI 10.1167/iovs.03-0495; STEINMETZ RL, 1993, BRIT J OPHTHALMOL, V77, P549, DOI 10.1136/bjo.77.9.549; SWANN PG, 1991, OPHTHAL PHYSL OPT, V11, P59, DOI 10.1111/j.1475-1313.1991.tb00196.x; TOLENTINO MJ, 1994, VISION RES, V34, P409, DOI 10.1016/0042-6989(94)90099-X; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wild JM, 1998, INVEST OPHTH VIS SCI, V39, P54; WILD JM, 1995, OPHTHALMOLOGY, V102, P911, DOI 10.1016/S0161-6420(95)30935-9	45	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39944	10.1371/journal.pone.0039944	http://dx.doi.org/10.1371/journal.pone.0039944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768178	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305892100148
J	Bauer, M; Goldstein, M; Heylmann, D; Kaina, B				Bauer, Martina; Goldstein, Michael; Heylmann, Daniel; Kaina, Bernd			Human Monocytes Undergo Excessive Apoptosis following Temozolomide Activating the ATM/ATR Pathway While Dendritic Cells and Macrophages Are Resistant	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; DNA-REPLICATION; LIGASE-III; INHIBITOR; CANCER; O-6-METHYLGUANINE; IMMUNOTHERAPY; P53; RECOMBINATION	Immunodeficiency is a severe therapy-limiting side effect of anticancer chemotherapy resulting from sensitivity of immunocompetent cells to DNA damaging agents. A central role in the immune system is played by monocytes that differentiate into macrophages and dendritic cells (DCs). In this study we compared human monocytes isolated from peripheral blood and cytokine matured macrophages and DCs derived from them and assessed the mechanism of toxicity of the DNA methylating anticancer drug temozolomide (TMZ) in these cell populations. We observed that monocytes, but not DCs and macrophages, were highly sensitive to the killing effect of TMZ. Studies on DNA damage and repair revealed that the initial DNA incision was efficient in monocytes while the re-ligation step of base excision repair (BER) can not be accomplished, resulting in an accumulation of DNA single-strand breaks (SSBs). Furthermore, monocytes accumulated DNA double-strand breaks (DSBs) following TMZ treatment, while DCs and macrophages were able to repair DSBs. Monocytes lack the DNA repair proteins XRCC1, ligase III alpha and PARP-1 whose expression is restored during differentiation into macrophages and DCs following treatment with GM-CSF and GM-CSF plus IL-4, respectively. These proteins play a key role both in BER and DSB repair by B-NHEJ, which explains the accumulation of DNA breaks in monocytes following TMZ treatment. Although TMZ provoked an upregulation of XRCC1 and ligase IIIa, BER was not enhanced likely because PARP-1 was not upregulated. Accordingly, inhibition of PARP-1 did not sensitize monocytes, but monocyte-derived DCs in which strong PARP activation was observed. TMZ induced in monocytes the DNA damage response pathways ATM-Chk2 and ATR-Chk1 resulting in p53 activation. Finally, upon activation of the Fas-receptor and the mitochondrial pathway apoptosis was executed in a caspase-dependent manner. The downregulation of DNA repair in monocytes, resulting in their selective killing by TMZ, might impact on the immune response during cancer chemotherapy.	[Bauer, Martina; Goldstein, Michael; Heylmann, Daniel; Kaina, Bernd] Univ Med Ctr, Dept Toxicol, Mainz, Germany	Johannes Gutenberg University of Mainz	Bauer, M (corresponding author), Univ Med Ctr, Dept Toxicol, Mainz, Germany.	kaina@uni-mainz.de	Kaina, Bernd/AAE-4692-2020	Heylmann, Daniel/0000-0002-8335-2313	Deutsche Forschungsgemeinschaft [KA724/13, KA724/14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft, KA724/13 and KA724/14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briegert M, 2007, DNA REPAIR, V6, P1255, DOI 10.1016/j.dnarep.2007.02.008; Briegert M, 2007, CANCER RES, V67, P26, DOI 10.1158/0008-5472.CAN-06-3712; BURKLE A, 1993, CARCINOGENESIS, V14, P559, DOI 10.1093/carcin/14.4.559; Chen D, 2008, J BIOL CHEM, V283, P15381, DOI 10.1074/jbc.M710296200; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; De Vleeschouwer S, 2008, CLIN CANCER RES, V14, P3098, DOI 10.1158/1078-0432.CCR-07-4875; Eich M, 2010, MOL PHARMACOL, V78, P943, DOI 10.1124/mol.110.066076; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldstein M, 2008, TOXICOL APPL PHARM, V229, P20, DOI 10.1016/j.taap.2008.01.001; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hazeki O, 1996, J LIPID MEDIAT CELL, V14, P259, DOI 10.1016/0929-7855(96)00534-2; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Iliakis G, 2009, RADIOTHER ONCOL, V92, P310, DOI 10.1016/j.radonc.2009.06.024; Jiang XX, 2004, MOL CANCER THER, V3, P1221; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Nardin A, 2008, FRONT BIOSCI-LANDMRK, V13, P3494; Nikolova T, 2010, DNA REPAIR, V9, P1050, DOI 10.1016/j.dnarep.2010.07.005; Parchment RE, 1998, ANN ONCOL, V9, P357, DOI 10.1023/A:1008245906772; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Roos W, 2004, ONCOGENE, V23, P359, DOI 10.1038/sj.onc.1207080; Roos WP, 2012, CANC LETT IN PRESS, P8; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Voss CY, 2004, TRANSFUS MED REV, V18, P189, DOI 10.1016/j.tmrv.2004.03.005; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e	40	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39956	10.1371/journal.pone.0039956	http://dx.doi.org/10.1371/journal.pone.0039956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768182	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100153
J	Bilgin, T; Wagner, A				Bilgin, Tugce; Wagner, Andreas			Design Constraints on a Synthetic Metabolism	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; FLUX BALANCE ANALYSIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BIOTECHNOLOGICAL PRODUCTION; ADAPTIVE EVOLUTION; GENE-EXPRESSION; NETWORK MODEL; BIOLOGY; OPTIMIZATION	A metabolism is a complex network of chemical reactions that converts sources of energy and chemical elements into biomass and other molecules. To design a metabolism from scratch and to implement it in a synthetic genome is almost within technological reach. Ideally, a synthetic metabolism should be able to synthesize a desired spectrum of molecules at a high rate, from multiple different nutrients, while using few chemical reactions, and producing little or no waste. Not all of these properties are achievable simultaneously. We here use a recently developed technique to create random metabolic networks with pre-specified properties to quantify trade-offs between these and other properties. We find that for every additional molecule to be synthesized a network needs on average three additional reactions. For every additional carbon source to be utilized, it needs on average two additional reactions. Networks able to synthesize 20 biomass molecules from each of 20 alternative sole carbon sources need to have at least 260 reactions. This number increases to 518 reactions for networks that can synthesize more than 60 molecules from each of 80 carbon sources. The maximally achievable rate of biosynthesis decreases by approximately 5 percent for every additional molecule to be synthesized. Biochemically related molecules can be synthesized at higher rates, because their synthesis produces less waste. Overall, the variables we study can explain 87 percent of variation in network size and 84 percent of the variation in synthesis rate. The constraints we identify prescribe broad boundary conditions that can help to guide synthetic metabolism design.	[Bilgin, Tugce; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland; [Bilgin, Tugce; Wagner, Andreas] Swiss Inst Bioinformat, Zurich, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Bilgin, T (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland.	tugce.bilgin@ieu.uzh.ch			Swiss National Science Foundation [315230-129708]; YeastX project of SystemsX.ch; University Priority Research Program in Systems Biology at University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); YeastX project of SystemsX.ch; University Priority Research Program in Systems Biology at University of Zurich	We acknowledge support through Swiss National Science Foundation grant 315230-129708, as well as through the YeastX project of SystemsX.ch, and the University Priority Research Program in Systems Biology at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Cases I, 2005, INT MICROBIOL, V8, P213; Ciliberti S, 2007, PLOS COMPUTATIONAL B, V3, P10; Cooper GM, 2008, CELL, V77, P67; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Diaconis P, 2009, B AM MATH SOC, V46, P179; Domingues A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-113; Duenas-Sanchez R, 2010, INT J FOOD MICROBIOL, V143, P150, DOI 10.1016/j.ijfoodmicro.2010.08.009; Ebenhoh O, 2001, B MATH BIOL, V63, P21, DOI 10.1006/bulm.2000.0197; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Exposito O, 2009, ANTI-CANCER AGENT ME, V9, P109, DOI 10.2174/187152009787047761; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2003, J BACTERIOL, V185, P6400, DOI 10.1128/JB.185.21.6400-6408.2003; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gonzalez OR, 2007, BIOINFORMATICS, V23, P480, DOI 10.1093/bioinformatics/btl522; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Goto S, 2000, NUCLEIC ACIDS RES, V28, P380, DOI 10.1093/nar/28.1.380; Handorf T, 2008, J THEOR BIOL, V252, P530, DOI 10.1016/j.jtbi.2007.10.036; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Julius AA, 2008, IEEE DECIS CONTR P, P762, DOI 10.1109/CDC.2008.4739111; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; LI XR, 1992, FIRST IEEE CONFERENCE ON CONTROL APPLICATIONS, PROCEEDINGS, VOLS 1 AND 2, P654, DOI 10.1109/CCA.1992.269770; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Liu EK, 2010, BIOCHEM ENG J, V48, P204, DOI 10.1016/j.bej.2009.10.011; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mizoguchi H, 2008, DNA RES, V15, P277, DOI 10.1093/dnares/dsn019; Morot-Gaudry JF, 2001, MED BIOCH, V28, P299; Mukhopadhyay A, 2008, CURR OPIN BIOTECH, V19, P228, DOI 10.1016/j.copbio.2008.05.003; Murtas G, 2007, ORIGINS LIFE EVOL B, V37, P419, DOI 10.1007/s11084-007-9090-5; Nakabachi A, 2008, BACTERIAL ENDOSYMBIO; Neal R. M, 1993, CRGTR931 U TOR DEP C, P144; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Nishikawa T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000236; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Paul G, 2005, BIOINFORMATICS MOL E; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Raab AM, 2011, APPL ENVIRON MICROB, V77, P1981, DOI 10.1128/AEM.02219-10; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rasmussen S, 2004, SCIENCE, V303, P963, DOI 10.1126/science.1093669; Riley M, 1997, NUCLEIC ACIDS RES, V25, P51, DOI 10.1093/nar/25.1.51; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Rocha I, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-45; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; Sanchez RG, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-13; Savage DF, 2008, ACS CHEM BIOL, V3, P13, DOI 10.1021/cb700259j; Schellenberger J, 2007, NATURE PROTOCOLS, V2, P1290; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA118, DOI 10.1289/ehp.118-a118; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Smallbone K, 2009, J THEOR BIOL, V258, P311, DOI 10.1016/j.jtbi.2009.01.027; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; Tomshine J, 2006, BIOPHYS J, V91, P3196, DOI 10.1529/biophysj.106.083485; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; VANDAMME EJ, 1992, J CHEM TECHNOL BIOT, V53, P313; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Weber J, 2005, MICROBIOL-SGM, V151, P707, DOI 10.1099/mic.0.27482-0; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wessely F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.46; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Yang L, 2008, COMPUT CHEM ENG, V32, P2072, DOI 10.1016/j.compchemeng.2007.10.015; Yarmush ML, 2003, ANNU REV BIOMED ENG, V5, P349, DOI 10.1146/annurev.bioeng.5.031003.163247	101	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39903	10.1371/journal.pone.0039903	http://dx.doi.org/10.1371/journal.pone.0039903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768162	Green Published, Green Accepted, gold			2022-12-25	WOS:000305892100131
J	Greco, S; Perfetti, A; Fasanaro, P; Cardani, R; Capogrossi, MC; Meola, G; Martelli, F				Greco, Simona; Perfetti, Alessandra; Fasanaro, Pasquale; Cardani, Rosanna; Capogrossi, Maurizio C.; Meola, Giovanni; Martelli, Fabio			Deregulated MicroRNAs in Myotonic Dystrophy Type 2	PLOS ONE			English	Article							EXPANDED-REPEAT TRANSCRIPTS; SKELETAL-MUSCLE; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; NUCLEAR FOCI; IN-VIVO; RNA; AKT2; DM2; DIFFERENTIATION	Myotonic Dystrophy Type-2 (DM2) is an autosomal dominant disease caused by the expansion of a CCTG tetraplet repeat. It is a multisystemic disorder, affecting skeletal muscles, the heart, the eye, the central nervous system and the endocrine system. Since microRNA (miRNA) expression is disrupted in Myotonic Dystrophy Type-1 and many other myopathies, miRNAs deregulation was studied in skeletal muscle biopsies of 13 DM2 patients and 13 controls. Eleven miRNAs were deregulated: 9 displayed higher levels compared to controls (miR-34a-5p, miR-34b-3p, miR-34c-5p, miR-146b-5p, miR-208a, miR-221-3p and miR-381), while 4 were decreased (miR-125b-5p, miR-193a-3p, miR-193b-3p and miR-378a-3p). To explore the relevance of DM2 miRNA deregulation, the predicted interactions between miRNA and mRNA were investigated. Global gene expression was analyzed in DM2 and controls and bioinformatic analysis identified more than 1,000 miRNA/mRNA interactions. Pathway and function analysis highlighted the involvement of the miRNA-deregulated mRNAs in multiple aspects of DM2 pathophysiology. In conclusion, the observed miRNA dysregulations may contribute to DM2 pathogenetic mechanisms.	[Greco, Simona; Perfetti, Alessandra; Cardani, Rosanna; Meola, Giovanni; Martelli, Fabio] IRCCS, Policlin San Donato, Milan, Italy; [Meola, Giovanni] Univ Milan, Milan, Italy; [Fasanaro, Pasquale; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Rome, Italy	IRCCS Policlinico San Donato; University of Milan; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Greco, S (corresponding author), IRCCS, Policlin San Donato, Milan, Italy.	lcm.psd@grupposandonato.it	Martelli, Fabio/AAL-3788-2020; Perfetti, Alessandra/O-4849-2019; cardani, rosanna/ABH-6525-2020; Perfetti, Alessandra/J-8166-2016; greco, simona/J-5374-2016; Meola, Giovanni/K-4775-2016; greco, simona/AAD-3211-2021	Martelli, Fabio/0000-0002-8624-7738; Perfetti, Alessandra/0000-0001-9514-9032; cardani, rosanna/0000-0001-8858-4327; Perfetti, Alessandra/0000-0001-9514-9032; greco, simona/0000-0002-0275-7221; Meola, Giovanni/0000-0001-6396-717X; greco, simona/0000-0002-0275-7221	Ministero della Salute; FMM-Fondazione Malattie Miotoniche; Association Francaise contre les Myopathies	Ministero della Salute(Ministry of Health, Italy); FMM-Fondazione Malattie Miotoniche; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This research was funded by Ministero della Salute, FMM-Fondazione Malattie Miotoniche, and Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botta A, 2007, GENE EXPRESSION, V13, P339; BROOK, 1992, CELL, V69, P385; Burge JA, 2012, CURR NEUROL NEUROSCI, V12, P62, DOI 10.1007/s11910-011-0238-3; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; ERDREICH LS, 1981, AM J EPIDEMIOL, V114, P649, DOI 10.1093/oxfordjournals.aje.a113236; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fasanaro P, 2010, PHARMACOL THERAPEUT, V125, P92, DOI 10.1016/j.pharmthera.2009.10.003; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Greco S, 2012, DIABETES; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harper P, 2009, MYOTONIC DYSTROPHY; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Le Brigand K, 2010, BIOINFORMATICS, V26, P3131, DOI 10.1093/bioinformatics/btq589; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Schoser BGH, 2004, MUSCLE NERVE, V29, P275, DOI 10.1002/mus.10545; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Toscano A, 2005, FREE RADICAL RES, V39, P771, DOI 10.1080/10715760500138932; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Udd B, 2011, Neuromuscul Disord, V21, P443, DOI 10.1016/j.nmd.2011.03.013; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; Vihola A, 2010, ACTA NEUROPATHOL, V119, P465, DOI 10.1007/s00401-010-0637-6; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299	52	67	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39732	10.1371/journal.pone.0039732	http://dx.doi.org/10.1371/journal.pone.0039732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768114	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100084
J	Hu, QH; Zhu, YY; Tu, J; Yin, YC; Wang, XL; Han, XG; Ding, C; Zhang, BM; Yu, SQ				Hu, Qinghai; Zhu, Yinyu; Tu, Jing; Yin, Yuncong; Wang, Xiaolan; Han, Xiangan; Ding, Chan; Zhang, Beimin; Yu, Shengqing			Identification of the Genes Involved in Riemerella anatipestifer Biofilm Formation by Random Transposon Mutagenesis	PLOS ONE			English	Article							SIGNATURE-TAGGED MUTAGENESIS; FLAVOBACTERIUM-PSYCHROPHILUM; BACTERIAL BIOFILMS; ESCHERICHIA-COLI; GLIDING MOTILITY; IDENTIFY GENES; PATHOGENESIS; INFECTIONS; SURFACES	Riemerella anatipestifer causes epizootics of infectious disease in poultry that result in serious economic losses to the duck industry. Our previous studies have shown that some strains of R. anatipestifer can form a biofilm, and this may explain the intriguing persistence of R. anatipestifer on duck farms post infection. In this study we used strain CH3, a strong producer of biofilm, to construct a library of random Tn4351 transposon mutants in order to investigate the genetic basis of biofilm formation by R. anatipestifer on abiotic surfaces. A total of 2,520 mutants were obtained and 39 of them showed a reduction in biofilm formation of 47%-98% using crystal violet staining. Genetic characterization of the mutants led to the identification of 33 genes. Of these, 29 genes are associated with information storage and processing, as well as basic cellular processes and metabolism; the function of the other four genes is currently unknown. In addition, a mutant strain BF19, in which biofilm formation was reduced by 98% following insertion of the Tn4351 transposon at the dihydrodipicolinate synthase (dhdps) gene, was complemented with a shuttle plasmid pCP-dhdps. The complemented mutant strain was restored to give 92.6% of the biofilm formation of the wild-type strain CH3, which indicates that the dhdp gene is associated with biofilm formation. It is inferred that such complementation applies also to other mutant strains. Furthermore, some biological characteristics of biofilm-defective mutants were investigated, indicating that the genes deleted in the mutant strains function in the biofilm formation of R. anatipestifer. Deletion of either gene will stall the biofilm formation at a specific stage thus preventing further biofilm development. In addition, the tested biofilm-defective mutants had different adherence capacity to Vero cells. This study will help us to understand the molecular mechanisms of biofilm development by R. anatipestifer and to study the pathogenesis of R. anatipestifer further.	[Hu, Qinghai; Zhu, Yinyu; Tu, Jing; Wang, Xiaolan; Han, Xiangan; Ding, Chan; Zhang, Beimin; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Yu, Shengqing] China Natl Engn Technol Res Ctr Poultry, Shanghai, Peoples R China; [Yin, Yuncong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Nanjing Agricultural University	Hu, QH (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.	yus@shvri.ac.cn		Han, Xiangan/0000-0001-5625-637X	Shanghai Nature Science Fund [09ZR1438600]; National Natural Science Foundation of China [31072156, 31072161]; Shanghai Key Project on Agricultural Development through Science and Technology [2009HNG5-3]	Shanghai Nature Science Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Project on Agricultural Development through Science and Technology	This work is supported by Shanghai Nature Science Fund (09ZR1438600), the National Natural Science Foundation of China (31072156 and 31072161), and Shanghai Key Project on Agricultural Development through Science and Technology (2009HNG5-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; Alvarez B, 2004, APPL ENVIRON MICROB, V70, P581, DOI 10.1128/AEM.70.1.581-587.2004; BISGAARD M, 1982, AVIAN PATHOL, V11, P341, DOI 10.1080/03079458208436109; Boddicker JD, 2006, INFECT IMMUN, V74, P4590, DOI 10.1128/IAI.00129-06; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cooper AJ, 1997, J BACTERIOL, V179, P6221, DOI 10.1128/jb.179.20.6221-6227.1997; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hartmann I, 2010, APPL ENVIRON MICROB, V76, P2251, DOI 10.1128/AEM.00930-09; Hu Q., 2002, ANIMAL HUSBANDRY VET, V34, P8; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu QH, 2010, VET MICROBIOL, V144, P429, DOI 10.1016/j.vetmic.2010.02.023; McBride MJ, 1996, J BACTERIOL, V178, P583, DOI 10.1128/jb.178.3.583-590.1996; McBride MJ, 2003, J BACTERIOL, V185, P6648, DOI 10.1128/JB.185.22.6648-6657.2003; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OCHMAN H, 1988, GENETICS, V120, P621; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Pearson MM, 2007, INFECT IMMUN, V75, P4316, DOI 10.1128/IAI.01347-06; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Sambrook J., 2001, MOL CLONING LABORATO, V3; Sandhu T.S., 2008, DIS POULTRY, P758; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Tsai HJ, 2005, AVIAN PATHOL, V34, P55, DOI 10.1080/03079450400025471; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; Wu MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023500; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x	35	33	35	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39805	10.1371/journal.pone.0039805	http://dx.doi.org/10.1371/journal.pone.0039805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768127	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100097
J	Kalajdzic, P; Oehler, S; Reczko, M; Pavlidi, N; Vontas, J; Hatzigeorgiou, AG; Savakis, C				Kalajdzic, Predrag; Oehler, Stefan; Reczko, Martin; Pavlidi, Nena; Vontas, John; Hatzigeorgiou, Artemis G.; Savakis, Charalambos			Use of Mutagenesis, Genetic Mapping and Next Generation Transcriptomics to Investigate Insecticide Resistance Mechanisms	PLOS ONE			English	Article							BARBITAL-INDUCED EXPRESSION; DROSOPHILA-MELANOGASTER; REGULATORY ELEMENTS; PERMETHRIN RESISTANCE; SUSCEPTIBLE STRAINS; OVER-EXPRESSION; MOLECULAR-BASIS; CYP6A2; GENOME; BIOINFORMATICS	Insecticide resistance is a worldwide problem with major impact on agriculture and human health. Understanding the underlying molecular mechanisms is crucial for the management of the phenomenon; however, this information often comes late with respect to the implementation of efficient counter-measures, particularly in the case of metabolism-based resistance mechanisms. We employed a genome-wide insertional mutagenesis screen to Drosophila melanogaster, using a Minos-based construct, and retrieved a line (MiT[w(-)]3R2) resistant to the neonicotinoid insecticide Imidacloprid. Biochemical and bioassay data indicated that resistance was due to increased P450 detoxification. Deep sequencing transcriptomic analysis revealed substantial over-and under-representation of 357 transcripts in the resistant line, including statistically significant changes in mixed function oxidases, peptidases and cuticular proteins. Three P450 genes (Cyp4p2, Cyp6a2 and Cyp6g1) located on the 2R chromosome, are highly up-regulated in mutant flies compared to susceptible Drosophila. One of them (Cyp6g1) has been already described as a major factor for Imidacloprid resistance, which validated the approach. Elevated expression of the Cyp4p2 was not previously documented in Drosophila lines resistant to neonicotinoids. In silico analysis using the Drosophila reference genome failed to detect transcription binding factors or microRNAs associated with the over-expressed Cyp genes. The resistant line did not contain a Minos insertion in its chromosomes, suggesting a hit-and-run event, i.e. an insertion of the transposable element, followed by an excision which caused the mutation. Genetic mapping placed the resistance locus to the right arm of the second chromosome, within a similar to 1 Mb region, where the highly up-regulated Cyp6g1 gene is located. The nature of the unknown mutation that causes resistance is discussed on the basis of these results.	[Kalajdzic, Predrag] Univ Belgrade, Inst Biol Res, Belgrade, Serbia; [Kalajdzic, Predrag; Savakis, Charalambos] Univ Crete, Sch Med, Iraklion, Greece; [Oehler, Stefan; Savakis, Charalambos] Biomed Sci Res Ctr Alexander Fleming, Inst Cellular & Dev Biol, Varkiza, Greece; [Reczko, Martin; Hatzigeorgiou, Artemis G.] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Varkiza, Greece; [Pavlidi, Nena; Vontas, John] Univ Crete, Dept Biol, Iraklion, Greece	University of Belgrade; University of Crete; Alexander Fleming Biomedical Sciences Research Center; Alexander Fleming Biomedical Sciences Research Center; University of Crete	Kalajdzic, P (corresponding author), Univ Belgrade, Inst Biol Res, Belgrade, Serbia.	pedja@ibiss.bg.ac.rs	Vontas, John/X-5112-2018; Hatzigeorgiou, Artemis/Z-1976-2019; Reczko, Martin/O-8935-2019	Vontas, John/0000-0002-8704-2574; Reczko, Martin/0000-0002-0005-8718	Greek State Scholarships Foundation [1021]; Ministry of Education and Science, Republic of Serbia [173012]	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT); Ministry of Education and Science, Republic of Serbia	This project was funded by Greek State Scholarships Foundation (I Delta P gamma MA KRATIK Omega N gamma Pi OTPO Phi I Omega N - IKY program for postgraduate studies (PhD), contract No. 1021 (2006-2010) (www.iky.gr)) and Ministry of Education and Science, Republic of Serbia (Grant No. 173012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; [Anonymous], 1999, SPSS BAS 10 0 WIND U; APPERSON CS, 1975, J ECON ENTOMOL, V68, P153, DOI 10.1093/jee/68.2.153; Araujo RA, 2008, B ENTOMOL RES, V98, P417, DOI 10.1017/S0007485308005737; Arca B, 1997, GENETICS, V145, P267; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Chung H, 2011, INSECT BIOCHEM MOLEC, V41, P863, DOI 10.1016/j.ibmb.2011.07.002; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dombrowski SM, 1998, GENE, V221, P69, DOI 10.1016/S0378-1119(98)00436-3; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Finney D.J., 1971, PROBIT ANAL; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; GOSSEN M, 1993, TRENDS BIOCHEM SCI, V18, P471, DOI 10.1016/0968-0004(93)90009-C; Green CD, 2001, J IMMUNOL METHODS, V250, P67, DOI 10.1016/S0022-1759(01)00306-4; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inceoglu AB, 2009, J MED ENTOMOL, V46, P83, DOI 10.1603/033.046.0111; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Karunker I, 2009, INSECT BIOCHEM MOLEC, V39, P697, DOI 10.1016/j.ibmb.2009.08.006; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koukidou M, 2006, INSECT MOL BIOL, V15, P95, DOI 10.1111/j.1365-2583.2006.00613.x; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Lopes KVG, 2010, J INSECT PHYSIOL, V56, P1050, DOI 10.1016/j.jinsphys.2010.02.020; Maitra S, 2000, GENE, V248, P147, DOI 10.1016/S0378-1119(00)00129-3; Maitra S, 1996, GENE, V180, P165, DOI 10.1016/S0378-1119(96)00446-5; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Morra R, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00954.x; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Mushtaq AS, 2003, PAK J ZOOL, V35, P197; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Pavlopoulos A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S2; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollock DD, 2004, GENETICS, V168, P489, DOI 10.1534/genetics.103.024430; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Saner C, 1996, ENVIRON MOL MUTAGEN, V27, P46, DOI 10.1002/(SICI)1098-2280(1996)27:1<46::AID-EM7>3.0.CO;2-C; SCOTT JG, 1986, BIOCHEM GENET, V24, P25, DOI 10.1007/BF00502976; Scott JG, 2004, PESTIC BIOCHEM PHYS, V78, P171, DOI 10.1016/j.pestbp.2004.01.002; SCOTT JG, 1986, PESTIC SCI, V17, P195, DOI 10.1002/ps.2780170302; Silva LB, 2010, COMP BIOCHEM PHYS B, V155, P12, DOI 10.1016/j.cbpb.2009.09.011; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; Taskin V., 2007, J MOL CELL BIOL, V6, P31; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WATERS LC, 1992, P NATL ACAD SCI USA, V89, P4855, DOI 10.1073/pnas.89.11.4855; Wilson TG, 2001, ANNU REV ENTOMOL, V46, P545, DOI 10.1146/annurev.ento.46.1.545; WILSON TG, 1988, J ECON ENTOMOL, V81, P22, DOI 10.1093/jee/81.1.22	62	20	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40296	10.1371/journal.pone.0040296	http://dx.doi.org/10.1371/journal.pone.0040296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768270	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100244
J	Price, AE; Reinhardt, RL; Liang, HE; Locksley, RM				Price, April E.; Reinhardt, R. Lee; Liang, Hong-Erh; Locksley, Richard M.			Marking and Quantifying IL-17A-Producing Cells In Vivo	PLOS ONE			English	Article							DELTA-T-CELLS; ROR-GAMMA-T; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; KLEBSIELLA-PNEUMONIAE INFECTION; CYTOKINE GM-CSF; HOST-DEFENSE; TH17 CELLS; CUTTING EDGE; T(H)17 CELLS	Interleukin (IL)-17A plays an important role in host defense against a variety of pathogens and may also contribute to the pathogenesis of autoimmune diseases. However, precise identification and quantification of the cells that produce this cytokine in vivo have not been performed. We generated novel IL-17A reporter mice to investigate expression of IL-17A during Klebsiella pneumoniae infection and during experimental autoimmune encephalomyelitis, conditions previously demonstrated to potently induce IL-17A production. In both settings, the majority of IL-17A was produced by non-CD4(+) T cells, particularly gamma delta T cells, but also invariant NKT cells and other CD4(-)CD3 epsilon(+) cells. As measured in dual-reporter mice, IFN-gamma-producing Th1 cells greatly outnumbered IL-17A-producing Th17 cells throughout both challenges. Production of IL-17A by cells from unchallenged mice or by non-T cells under any condition was not evident. Administration of IL-1 beta and/or IL-23 elicited rapid production of IL-17A by gamma delta T cells, invariant NKT cells and other CD4(-)CD3 epsilon(+) cells in vivo, demonstrating that these cells are poised for rapid cytokine production and likely comprise the major sources of this cytokine during acute immunologic challenges.	[Price, April E.; Reinhardt, R. Lee; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Price, April E.; Reinhardt, R. Lee; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Price, AE (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			United States National Institutes of Health [AI30663, AI078869]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078869, R01AI030663] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI30663 and AI078869 from the United States National Institutes of Health, the Howard Hughes Medical Institute, and the Sandler Asthma Basic Research Center at University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croxford AL, 2009, J IMMUNOL, V182, P1237, DOI 10.4049/jimmunol.182.3.1237; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Ferber IA, 1996, J IMMUNOL, V156, P5; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Moore TA, 2002, INFECT IMMUN, V70, P6310, DOI 10.1128/IAI.70.11.6310-6318.2002; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Toh ML, 2009, CYTOKINE, V48, P226, DOI 10.1016/j.cyto.2009.07.013; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	56	63	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39750	10.1371/journal.pone.0039750	http://dx.doi.org/10.1371/journal.pone.0039750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768117	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100087
J	Wang, JN; Teves, ME; Shen, XN; Nagarkatti-Gude, DR; Hess, RA; Henderson, SC; Strauss, JF; Zhang, ZB				Wang, Jiannan; Teves, Maria E.; Shen, Xuening; Nagarkatti-Gude, David R.; Hess, Rex A.; Henderson, Scott C.; Strauss, Jerome F., III; Zhang, Zhibing			Mouse RC/BTB2, a Member of the RCC1 Superfamily, Localizes to Spermatid Acrosomal Vesicles	PLOS ONE			English	Article							MAMMALIAN ORTHOLOGUE; CHLAMYDOMONAS PF16; LIFE-HISTORY; GENE; PROTEINS; SPERMATOGENESIS; SPERMIOGENESIS; ACROPLAXOME; EXPRESSION; MANCHETTE	Mouse RC/BTB2 is an unstudied protein of the RCC1 (Regulator of Chromosome Condensation) superfamily. Because of the significant remodeling of chromatin that occurs during spermiogenesis, we characterized the expression and localization of mouse RC/BTB2 in the testis and male germ cells. The Rc/btb2 gene yields two major transcripts: 2.3 kb Rc/btb2-s, present in most somatic tissues examined; and 2.5 kb Rc/btb2-t, which contains a unique non-translated exon in its 59-UTR that is only detected in the testis. During the first wave of spermatogenesis, Rc/btb2-t mRNA is expressed from day 8 after birth, reaching highest levels of expression at day 30 after birth. The full-length protein contains three RCC1 domains in the N-terminus, and a BTB domain in the C-terminus. In the testis, the protein is detectable from day 12, but is progressively up-regulated to day 30 and day 42 after birth. In spermatids, some of the protein co-localizes with acrosomal markers sp56 and peanut lectin, indicating that it is an acrosomal protein. A GFP-tagged RCC1 domain is present throughout the cytoplasm of transfected CHO cells. However, both GFP-tagged, full-length RC/BTB2 and a GFP-tagged BTB domain localize to vesicles in close proximity to the nuclear membrane, suggesting that the BTB domain might play a role in mediating full-length RC/BTB2 localization. Since RCC1 domains associate with Ran, a small GTPase that regulates molecular trafficking, it is possible that RC/BTB2 plays a role in transporting proteins during acrosome formation.	[Wang, Jiannan; Teves, Maria E.; Shen, Xuening; Nagarkatti-Gude, David R.; Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA; [Nagarkatti-Gude, David R.; Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Henderson, Scott C.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Hess, Rex A.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL 61801 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Illinois System; University of Illinois Urbana-Champaign	Wang, JN (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA.	zzhang4@vcu.edu	Nagarkatti-Gude, David/AAF-6996-2020; Teves, Maria/AAJ-9523-2020; Henderson, Scott/AAP-2785-2021	Teves, Maria/0000-0001-7035-2202; Henderson, Scott/0000-0002-1076-3867; Hess, Rex/0000-0003-2649-3563	Virginia Commonwealth University; National Institutes of Health [HD37416]; National Institute of Child Health and Human Development [IF3IHD0G2314-01]; Fogarty International Center [5D43TW007692]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037416] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW007692] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	Virginia Commonwealth University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by Virginia Commonwealth University Presidential Research Incentive Program (PRIP) (to ZZ), National Institutes of Health grants HD37416 (JFS), National Institute of Child Health and Human Development F31 Predoctoral Fellowship IF3IHD0G2314-01 (to DRNG). MET is a visiting scholar from Centro de Biologia Celulary Molecular, Universidad Nacional de Cordoba, Argentina, and supported by the Fogarty International Center (5D43TW007692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armellini A, 2008, BRIT J HAEMATOL, V141, P212, DOI 10.1111/j.1365-2141.2007.06956.x; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; Garcia-Gonzalo FR, 2005, FEBS LETT, V579, P343, DOI 10.1016/j.febslet.2004.11.095; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; HARTREE EF, 1975, J REPROD FERTIL, V44, P125, DOI 10.1530/jrf.0.0440125; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Hu ZZ, 2007, INT J MASS SPECTROM, V259, P147, DOI 10.1016/j.ijms.2006.09.024; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2004, BIOL REPROD, V70, P1400, DOI 10.1095/biolreprod.103.025346; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; KLUIN PM, 1982, INT J ANDROL, V5, P282, DOI 10.1111/j.1365-2605.1982.tb00257.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latil A, 2003, PROSTATE, V57, P39, DOI 10.1002/pros.10272; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Mabuchi H, 2001, CANCER RES, V61, P2870; Marshall J, 2011, ADV EXP MED BIOL, V717, P115, DOI 10.1007/978-1-4419-9557-5_10; MartinezMenarguez JA, 1996, J HISTOCHEM CYTOCHEM, V44, P313, DOI 10.1177/44.4.8601690; Meistrich ML, 2003, CHROMOSOMA, V111, P483, DOI 10.1007/s00412-002-0227-z; MORTIMER D, 1990, HUM REPROD, V5, P99, DOI 10.1093/oxfordjournals.humrep.a137050; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Rivkin E, 1997, MOL REPROD DEV, V48, P77, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;77::AID-MRD10&gt;3.0.CO;2-T; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Selva DM, 2002, J BIOL CHEM, V277, P45291, DOI 10.1074/jbc.M205903200; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; TANG XM, 1982, AM J ANAT, V163, P283, DOI 10.1002/aja.1001630402; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; Tsuneoka M, 2006, INT J ANDROL, V29, P323, DOI 10.1111/j.1365-2605.2005.00572.x; Xu BF, 2008, DEV BIOL, V319, P201, DOI 10.1016/j.ydbio.2008.03.043; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yatsenko AN, 2010, J ANDROL, V31, P34, DOI 10.2164/jandrol.109.008227; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zhang ZB, 2004, P NATL ACAD SCI USA, V101, P12946, DOI 10.1073/pnas.0404280101; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002; Zhang ZB, 2008, BIOL REPROD, V79, P75, DOI 10.1095/biolreprod.107.066308; Zhang ZB, 2009, P NATL ACAD SCI USA, V106, P17055, DOI 10.1073/pnas.0906414106	48	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39846	10.1371/journal.pone.0039846	http://dx.doi.org/10.1371/journal.pone.0039846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768142	Green Published, gold			2022-12-25	WOS:000305892100111
J	Cleto, S; Matos, S; Kluskens, L; Vieira, MJ				Cleto, Sara; Matos, Sonia; Kluskens, Leon; Vieira, Maria Joao			Characterization of Contaminants from a Sanitized Milk Processing Plant	PLOS ONE			English	Article							SERRATIA-PLYMUTHICA; PASTEURIZED MILK; DAIRY; BIOFILM; BACTERIA; COMPONENT; MULTIPLE; INDUSTRY; REMOVAL; SPP.	Milk processing lines offer a wide variety of microenvironments where a diversity of microorganisms can proliferate. We sampled crevices and junctions where, due to deficient reach by typical sanitizing procedures, bacteria can survive and establish biofilms. The sampling sites were the holding cell, cold storage tank, pasteurizer and storage tank - transfer pump junction. The culturable bacteria that were isolated after the sanitation procedure were predominantly Pseudomonas spp., Serratia spp, Staphylococcus sciuri and Stenotrophomonas maltophilia. We assayed several phenotypic characteristics such as the ability to secrete enzymes and siderophores, as well as the capacity of the strains to form biofilms that might contribute to their survival in a mixed species environment. The Pseudomonas spp. isolates were found to either produce proteases or lecithinases at high levels. Interestingly, protease production showed an inverse correlation with siderophore production. Furthermore, all of the Serratia spp. isolates were strong biofilm formers and spoilage enzymes producers. The organisms identified were not mere contaminants, but also producers of proteins with the potential to lower the quality and shelf-life of milk. In addition, we found that a considerable number of the Serratia and Pseudomonas spp. isolated from the pasteurizer were capable of secreting compounds with antimicrobial properties.	[Cleto, Sara; Matos, Sonia; Kluskens, Leon; Vieira, Maria Joao] Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal	Universidade do Minho	Cleto, S (corresponding author), Univ Minho, Ctr Biol Engn, IBB, Campus Gualtar, Braga, Portugal.	sara.cleto@deb.uminho.pt	Kluskens, Leon/J-3019-2013	Kluskens, Leon/0000-0002-0070-7837; Vieira, Maria Joao/0000-0002-1379-890X; Cleto, Sara/0000-0003-1273-0142	Portuguese Foundation for Science and Technology [CHEMBIO-PTDC/EBB-EBI/104263/2008, SFRH/BD/38298/2007]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	The authors acknowledge the financial support provided by the Portuguese Foundation for Science and Technology (www.fct.pt): Project CHEMBIO-PTDC/EBB-EBI/104263/2008; Ph.D grant SFRH/BD/38298/2007 to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS BW, 1983, J HYG-CAMBRIDGE, V91, P479, DOI 10.1017/S0022172400060526; Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Almeida C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014786; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; AUSTIN JW, 1995, J DAIRY RES, V62, P509, DOI 10.1017/S0022029900031204; Banning N, 2003, MICROBIOL-SGM, V149, P47, DOI 10.1099/mic.0.25938-0; Bore E, 2005, J APPL MICROBIOL, V98, P96, DOI 10.1111/j.1365-2672.2004.02436.x; Bush K, 2009, 29 CLIN LAB STAND I, P29; Coffey A, 1996, APPL ENVIRON MICROB, V62, P1252, DOI 10.1128/AEM.62.4.1252-1256.1996; Dogan B, 2003, APPL ENVIRON MICROB, V69, P130, DOI 10.1128/AEM.69.1.130-138.2003; Eneroth A, 2000, INT DAIRY J, V10, P325, DOI 10.1016/S0958-6946(00)00055-8; Eneroth A, 1998, INT DAIRY J, V8, P829, DOI 10.1016/S0958-6946(98)00123-X; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; ESSELMANN M, 1961, J BACTERIOL, V81, P939, DOI 10.1128/JB.81.6.939-945.1961; INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014, DOI 10.1128/JCM.27.9.2014-2018.1989; Kagkli DM, 2007, INT J FOOD MICROBIOL, V114, P243, DOI 10.1016/j.ijfoodmicro.2006.09.016; Latorre AA, 2010, J DAIRY SCI, V93, P2792, DOI 10.3168/jds.2009-2717; LIU PV, 1964, J BACTERIOL, V88, P1421, DOI 10.1128/JB.88.5.1421-1427.1964; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; MAGWOOD SE, 1967, CAN J COMPARAT MED, V31, P88; Meyer B, 2003, INT BIODETER BIODEGR, V51, P249, DOI 10.1016/S0964-8305(03)00047-7; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Moons P, 2006, APPL ENVIRON MICROB, V72, P7294, DOI 10.1128/AEM.01708-06; Mortimore S. E., 2001, HACCP; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Sabour PM, 2004, J CLIN MICROBIOL, V42, P3449, DOI 10.1128/JCM.42.8.3449-3455.2004; Salustiano VC, 2009, FOOD CONTROL, V20, P439, DOI 10.1016/j.foodcont.2008.07.004; Schlegelova J, 2010, CZECH J FOOD SCI, V28, P450, DOI 10.17221/65/2009-CJFS; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sharma M, 2002, FOOD CONTROL, V13, P469, DOI 10.1016/S0956-7135(01)00068-8; Sharma M, 2002, FOOD MICROBIOL, V19, P627, DOI 10.1006/fmic.2002.0472; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; STEVENS MG, 1993, J IMMUNOL METHODS, V157, P225, DOI 10.1016/0022-1759(93)90091-K; Tang X, 2009, J APPL MICROBIOL, V107, P443, DOI 10.1111/j.1365-2672.2009.04214.x; Van Houdt R, 2005, FEMS MICROBIOL LETT, V246, P265, DOI 10.1016/j.femsle.2005.04.016; WHITTAKER C, 1984, APPL ENVIRON MICROB, V48, P395, DOI 10.1128/AEM.48.2.395-403.1984; WILLIAMS HN, 1995, J AM DENT ASSOC, V126, P1255, DOI 10.14219/jada.archive.1995.0360; Zhao T, 2006, APPL ENVIRON MICROB, V72, P3314, DOI 10.1128/Aem.72.5.3314-3320.2006	42	56	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40189	10.1371/journal.pone.0040189	http://dx.doi.org/10.1371/journal.pone.0040189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761957	Green Published, gold, Green Submitted			2022-12-25	WOS:000305826400058
J	Colizoli, O; Murre, JMJ; Rouw, R				Colizoli, Olympia; Murre, Jaap M. J.; Rouw, Romke			Pseudo-Synesthesia through Reading Books with Colored Letters	PLOS ONE			English	Article							BRAIN STRUCTURE CHANGES; INDIVIDUAL-DIFFERENCES; NEURAL BASIS; GRAY-MATTER; SYNAESTHESIA; INTERFERENCE; ASSOCIATIONS; PERCEPTION; ACTIVATION; FREQUENCY	Background: Synesthesia is a phenomenon where a stimulus produces consistent extraordinary subjective experiences. A relatively common type of synesthesia involves perception of color when viewing letters (e.g. the letter 'a' always appears as light blue). In this study, we examine whether traits typically regarded as markers of synesthesia can be acquired by simply reading in color. Methodology/Principal Findings: Non-synesthetes were given specially prepared colored books to read. A modified Stroop task was administered before and after reading. A perceptual crowding task was administered after reading. Reading one book (>49,000 words) was sufficient to induce effects regarded as behavioral markers for synesthesia. The results of the Stroop tasks indicate that it is possible to learn letter-color associations through reading in color (F(1, 14) = 5.85, p = .030). Furthermore, Stroop effects correlated with subjective reports about experiencing letters in color (r(13) = 0.51, p = .05). The frequency of viewing letters is related to the level of association as seen by the difference in the Stroop effect size between upper-and lower-case letters (t(14) = 2.79, p = .014) and in a subgroup of participants whose Stroop effects increased as they continued to read in color. Readers did not show significant performance advantages on the crowding task compared to controls. Acknowledging the many differences between trainees and synesthetes, results suggest that it may be possible to acquire a subset of synesthetic behavioral traits in adulthood through training. Conclusion/Significance: To our knowledge, this is the first evidence of acquiring letter-color associations through reading in color. Reading in color appears to be a promising avenue in which we may explore the differences and similarities between synesthetes and non-synesthetes. Additionally, reading in color is a plausible method for a long-term 'synesthetic' training program.	[Colizoli, Olympia; Murre, Jaap M. J.; Rouw, Romke] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam	Colizoli, O (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	o.colizoli@uva.nl	Murre, Jaap MJ/A-3813-2010	Colizoli, Olympia/0000-0001-5288-2437; Murre, Jaap/0000-0003-4447-9482	Department of Psychology, University of Amsterdam	Department of Psychology, University of Amsterdam	This research was supported by the Department of Psychology, University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher JE, 2009, AM J HUM GENET, V84, P279, DOI 10.1016/j.ajhg.2009.01.012; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; Beeli G, 2007, PSYCHOL SCI, V18, P788, DOI 10.1111/j.1467-9280.2007.01980.x; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brang D, 2011, J COGNITIVE NEUROSCI, V23, P1681, DOI 10.1162/jocn.2010.21486; Chomsky N., 1957, SYNTACTIC STRUCTURES; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cytowic R. E., 2002, SYNESTHESIA UNION SE; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Elias LJ, 2003, COGNITIVE BRAIN RES, V16, P232, DOI 10.1016/S0926-6410(02)00278-1; Galton F, 1880, SYNAESTHESIA CLASSIC, P43; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Green JAK, 2008, COGNITION, V106, P463, DOI 10.1016/j.cognition.2007.01.013; Hanggi J, 2008, NEUROIMAGE, V43, P192, DOI 10.1016/j.neuroimage.2008.07.018; Halliday M. A. K., 1975, EXPLORATIONS FUNCTIO; Hancock P, 2006, CORTEX, V42, P147, DOI 10.1016/S0010-9452(08)70338-1; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Jancke L, 2009, EUR J NEUROSCI, V29, P1287, DOI 10.1111/j.1460-9568.2009.06673.x; Kadosh RC, 2005, J COGNITIVE NEUROSCI, V17, P1766, DOI 10.1162/089892905774589181; Kwok V, 2011, P NATL ACAD SCI USA, V108, P6686, DOI 10.1073/pnas.1103217108; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Meier B, 2009, NEUROPSYCHOLOGIA, V47, P1208, DOI 10.1016/j.neuropsychologia.2009.01.009; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; Pelli DG, 2004, J VISION, P4; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Rothen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005037; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Rouw R, 2011, J NEUROPSYCHOL, V5, P214, DOI 10.1111/j.1748-6653.2011.02006.x; Rouw R, 2010, J NEUROSCI, V30, P6205, DOI 10.1523/JNEUROSCI.3444-09.2010; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simner J, 2005, COGN NEUROPSYCHOL, V22, P1069, DOI 10.1080/02643290500200122; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Simner J, 2012, BRIT J PSYCHOL, V103, P1, DOI 10.1348/000712610X528305; Simner J, 2009, BRAIN, V132, P57, DOI 10.1093/brain/awn292; Smilek D, 2005, NEUROCASE, V11, P363, DOI 10.1080/13554790500205413; Smilek D, 2002, PSYCHOL SCI, V13, P548, DOI 10.1111/1467-9280.00496; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Smilek D, 2007, PSYCHOL SCI, V18, P793, DOI 10.1111/j.1467-9280.2007.01981.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Wagner K, 2011, PSYCHOL SCI, V22, P1067, DOI 10.1177/0956797611416250; Weiss PH, 2009, BRAIN, V132, P65, DOI 10.1093/brain/awn304; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Wollen KA, 1983, J MENT IMAG, V7, P83; Yaro C, 2007, Q J EXP PSYCHOL, V60, P681, DOI 10.1080/17470210600785208	56	31	32	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39799	10.1371/journal.pone.0039799	http://dx.doi.org/10.1371/journal.pone.0039799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761905	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800071
J	Jourdan, C; Petersen, AK; Gieger, C; Doring, A; Illig, T; Wang-Sattler, R; Meisinger, C; Peters, A; Adamski, J; Prehn, C; Suhre, K; Altmaier, E; Kastenmuller, G; Romisch-Margl, W; Theis, FJ; Krumsiek, J; Wichmann, HE; Linseisen, J				Jourdan, Carolin; Petersen, Ann-Kristin; Gieger, Christian; Doering, Angela; Illig, Thomas; Wang-Sattler, Rui; Meisinger, Christa; Peters, Annette; Adamski, Jerzy; Prehn, Cornelia; Suhre, Karsten; Altmaier, Elisabeth; Kastenmueller, Gabi; Romisch-Margl, Werner; Theis, Fabian J.; Krumsiek, Jan; Wichmann, H. -Erich; Linseisen, Jakob			Body Fat Free Mass Is Associated with the Serum Metabolite Profile in a Population-Based Study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; METABOLOMICS; CONSUMPTION; PHENOTYPES; EQUATION	Objective: To characterise the influence of the fat free mass on the metabolite profile in serum samples from participants of the population-based KORA (Cooperative Health Research in the Region of Augsburg) S4 study. Subjects and Methods: Analyses were based on metabolite profile from 965 participants of the S4 and 890 weight-stable subjects of its seven-year follow-up study (KORA F4). 190 different serum metabolites were quantified in a targeted approach including amino acids, acylcarnitines, phosphatidylcholines (PCs), sphingomyelins and hexose. Associations between metabolite concentrations and the fat free mass index (FFMI) were analysed using adjusted linear regression models. To draw conclusions on enzymatic reactions, intra-metabolite class ratios were explored. Pairwise relationships among metabolites were investigated and illustrated by means of Gaussian graphical models (GGMs). Results: We found 339 significant associations between FFMI and various metabolites in KORA S4. Among the most prominent associations (p-values 4.75 x 10(-16) -8.95 x 10(-06)) with higher FFMI were increasing concentrations of the branched chained amino acids (BCAAs), ratios of BCAAs to glucogenic amino acids, and carnitine concentrations. For various PCs, a decrease in chain length or in saturation of the fatty acid moieties could be observed with increasing FFMI, as well as an overall shift from acyl-alkyl PCs to diacyl PCs. These findings were reproduced in KORA F4. The established GGMs supported the regression results and provided a comprehensive picture of the relationships between metabolites. In a sub-analysis, most of the discovered associations did not exist in obese subjects in contrast to non-obese subjects, possibly indicating derangements in skeletal muscle metabolism. Conclusion: A set of serum metabolites strongly associated with FFMI was identified and a network explaining the relationships among metabolites was established. These results offer a novel and more complete picture of the FFMI effects on serum metabolites in a data-driven network.	[Jourdan, Carolin; Doering, Angela; Wichmann, H. -Erich; Linseisen, Jakob] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Petersen, Ann-Kristin; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Meisinger, Christa; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Illig, Thomas; Wang-Sattler, Rui] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Adamski, Jerzy; Prehn, Cornelia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Chair Expt Genet, Munich, Germany; [Suhre, Karsten; Altmaier, Elisabeth; Kastenmueller, Gabi; Romisch-Margl, Werner; Theis, Fabian J.; Krumsiek, Jan] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Suhre, Karsten] Weill Cornell Med Coll, Dept Physiol & Biophys, Educ City, Qatar; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Munich; University of Munich	Jourdan, C (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	j.linseisen@helmholtz-muenchen.de	Suhre, Karsten/AAF-1778-2020; Meisinger, Christine/B-5358-2014; Krumsiek, Jan/B-3961-2013; Linseisen, Jakob/B-5353-2014; Peters, Annette/A-6117-2011; Wichmann, Heinz Erich/AAA-5695-2022; Wang-Sattler, Rui/B-5354-2014; Theis, Fabian J/ABD-5212-2021; Kastenmüller, Gabi/ABF-5987-2020	Suhre, Karsten/0000-0001-9638-3912; Linseisen, Jakob/0000-0002-9386-382X; Peters, Annette/0000-0001-6645-0985; Wang-Sattler, Rui/0000-0002-8794-8229; Theis, Fabian J/0000-0002-2419-1943; Kastenmuller, Gabi/0000-0002-2368-7322; Meisinger, Christa/0000-0002-9026-6544; Gieger, Christian/0000-0001-6986-9554; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715	German Federal Ministry of Education and Research (BMBF); Helmholtz Zentrum Munchen - German Research Centre for Environmental Health; BMBF; State of Bavaria; German National Genome Research Network (NGFN)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen - German Research Centre for Environmental Health(Helmholtz Association); BMBF(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German National Genome Research Network (NGFN)	This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Centre Diabetes Research (DZD e.V.). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Centre for Environmental Health, which is funded by the BMBF and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN). No additional sources of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Altmaier E, 2011, EUR J EPIDEMIOL, V26, P145, DOI 10.1007/s10654-010-9524-7; Altmaier E, 2009, MOL NUTR FOOD RES, V53, P1357, DOI 10.1002/mnfr.200900116; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; FDA, 2018, BIOANALYTICAL METHOD; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Kyle UG, 2003, CLIN NUTR, V22, P537, DOI 10.1016/S0261-5614(03)00048-7; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Nimptsch K, 2010, PUBLIC HEALTH NUTR, V13, P1636, DOI 10.1017/S1368980009993041; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Tom A, 2006, J NUTR, V136, p324S, DOI 10.1093/jn/136.1.324S; Vinayavekhin N, 2009, ACS CHEM BIOL, V4, P617, DOI 10.1021/cb900075n; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776	28	80	82	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40009	10.1371/journal.pone.0040009	http://dx.doi.org/10.1371/journal.pone.0040009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761945	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800087
J	Tiberio, P; Cavadini, E; Callari, M; Daidone, MG; Appierto, V				Tiberio, Paola; Cavadini, Elena; Callari, Maurizio; Daidone, Maria Grazia; Appierto, Valentina			AF1q: A Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells	PLOS ONE			English	Article							FENRETINIDE-INDUCED APOPTOSIS; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; CARCINOMA CELLS; BREAST-CANCER; FUNCTIONAL-ROLE; ONCOGENE AF1Q; MECHANISMS; INDUCTION; PATHWAY	Background: Fenretinide (4-HPR) is a synthetic retinoid that exhibits potent antitumor and chemopreventive activities against different malignancies, including ovarian tumors. We previously showed that in ovarian cancer cells, 4-HPR induces apoptosis through a signaling cascade starting from reactive oxygen species (ROS) generation and involving endoplasmic reticulum (ER) stress response, Jun N-terminal Kinase (JNK) activation, and induction of the proapoptotic PLAcental Bone morphogenetic protein (PLAB). Since recent studies have shown that the oncogene ALL1-fused from chromosome 1q (AF1q), a retinoic acid target gene, is implicated in apoptosis induction by several therapeutic agents, we investigated its possible involvement in the apoptosis induced by 4-HPR in ovarian cancer cells. Methodology/Principal Findings: Protein expression analysis, performed in ovarian cancer cells and extended to other histotypes (breast, neuroblastoma, and cervical), revealed that 4-HPR enhanced AF1q expression in cancer cells sensitive to the retinoid but not in resistant cells. Through gene silencing, AF1q was found functionally involved in 4-HPR-induced apoptosis in A2780, an ovarian cancer cell line highly sensitive to retinoid growth inhibitory and apoptotic effects. Inhibition of the signaling intermediates of the 4-HPR apoptotic cascade showed that AF1q upregulation was depended on prior generation of ROS, induction of ER stress response, JNK activation, and PLAB upmodulation. Finally, we found that direct overexpression of AF1q, in the absence of external stimuli, increased apoptosis in ovarian cancer cell lines. Conclusions/Significance: The study expands the knowledge of the 4-HPR mechanism of action, which has not yet been completely elucidated, identifying AF1q as a novel mediator of retinoid anticancer activity. In addition, we demonstrate, for the first time, that AF1q plays a role in the onset of basal apoptosis in ovarian cancer cells, thus providing new information about the activity of this protein whose biologic functions are mostly unknown.	[Tiberio, Paola; Cavadini, Elena; Callari, Maurizio; Daidone, Maria Grazia; Appierto, Valentina] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Tiberio, P (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	paola.tiberio@istitutotumori.mi.it	Daidone, Maria Grazia/E-9232-2017; Callari, Maurizio/AAF-7089-2019; Appierto, Valentina/B-9325-2017	Daidone, Maria Grazia/0000-0002-4786-1321; Callari, Maurizio/0000-0001-5239-0918; Appierto, Valentina/0000-0002-8726-6981	Fondazione IRCCS Istituto Nazionale Tumori	Fondazione IRCCS Istituto Nazionale Tumori	This study was funded by funds from Italian citizens who allocated the 5x1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000'; www.lavoro.gov.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appierto V, 2007, ONCOGENE, V26, P3952, DOI 10.1038/sj.onc.1210171; Appierto V, 2004, CELL DEATH DIFFER, V11, P270, DOI 10.1038/sj.cdd.4401349; Appierto V, 2001, BRIT J CANCER, V84, P1528, DOI 10.1054/bjoc.2001.1826; Appierto V, 2009, CARCINOGENESIS, V30, P824, DOI 10.1093/carcin/bgp067; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Chang XZ, 2008, BREAST CANCER RES TR, V111, P65, DOI 10.1007/s10549-007-9761-y; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; Co NN, 2008, MOL CANCER THER, V7, P3160, DOI 10.1158/1535-7163.MCT-08-0416; Co NN, 2010, ONCOL REP, V24, P547, DOI 10.3892/or_00000891; De Palo G, 2002, GYNECOL ONCOL, V86, P24, DOI 10.1006/gyno.2002.6663; Dmitrovsky E, 2004, J NATL CANCER I, V96, P1264, DOI 10.1093/jnci/djh268; Garattini E, 2004, CURR PHARM DESIGN, V10, P433, DOI 10.2174/1381612043453351; Garaventa A, 2003, CLIN CANCER RES, V9, P2032; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Li DQ, 2006, EUR J CANCER, V42, P3274, DOI 10.1016/j.ejca.2006.07.008; Liu T, 2005, BRIT J CANCER, V93, P310, DOI 10.1038/sj.bjc.6602700; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nagy L, 1998, CELL DEATH DIFFER, V5, P11, DOI 10.1038/sj.cdd.4400337; Parcelier A, 2011, BLOOD, V118, P1784, DOI 10.1182/blood-2011-01-333179; Schneider BJ, 2009, INVEST NEW DRUG 0219; Skotheim RI, 2006, CELL ONCOL, V28, P315; Sogno I, 2010, CRIT REV ONCOL HEMAT, V75, P2, DOI 10.1016/j.critrevonc.2009.10.007; Strunk CJ, 2009, AM J HEMATOL, V84, P308, DOI 10.1002/ajh.21396; Supino R, 1996, INT J CANCER, V65, P491, DOI 10.1002/(SICI)1097-0215(19960208)65:4<491::AID-IJC17>3.0.CO;2-D; Tiberio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013362; Tse W, 2005, BRIT J HAEMATOL, V128, P218, DOI 10.1111/j.1365-2141.2004.05306.x; Tse W, 2004, BLOOD, V104, P3058, DOI 10.1182/blood-2003-12-4347; TSE W, 1995, BLOOD, V85, P650, DOI 10.1182/blood.V85.3.650.bloodjournal853650; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Villani MG, 2004, CLIN CANCER RES, V10, P6265, DOI 10.1158/1078-0432.CCR-04-0655; Xiong Y, 2011, BRIT J HAEMATOL, V153, P753, DOI 10.1111/j.1365-2141.2011.08662.x	37	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39968	10.1371/journal.pone.0039968	http://dx.doi.org/10.1371/journal.pone.0039968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761939	Green Submitted, Green Published, gold			2022-12-25	WOS:000305808700055
J	Sayedyahossein, S; Nini, L; Irvine, TS; Dagnino, L				Sayedyahossein, Samar; Nini, Lylia; Irvine, Timothy S.; Dagnino, Lina			Essential role of integrin-linked kinase in regulation of phagocytosis in keratinocytes	FASEB JOURNAL			English	Article						ILK; epidermis; Rac1; particle engulfment; melanosome	PROTEASE-ACTIVATED RECEPTOR-2; GROWTH-FACTOR; MELANOSOME TRANSFER; ADHESION; RAC1; SKIN; DIFFERENTIATION; MORPHOGENESIS; PROLIFERATION; INACTIVATION	Phagocytic melanosome uptake by epidermal keratinocytes is a central protective mechanism against damage induced by ultraviolet radiation. Phagocytosis requires formation of pseudopodia via actin cytoskeleton rearrangements. Integrin-linked kinase (ILK) is an important modulator of actin cytoskeletal dynamics. We have examined the role of ILK in regulation of phagocytosis, using epidermal keratinocytes isolated from mice with epidermis-restricted Ilk gene inactivation. ILK-deficient cells exhibited severely impaired capacity to engulf fluorescent microspheres in response to stimulation of the keratinocyte growth factor (KGF) receptor or the protease-activated receptor-2. KGF induced ERK phosphorylation in ILK-expressing and ILK-deficient cells, suggesting that ILK is not essential for KGF receptor signaling. In contrast, KGF promoted activation of Rac1 and formation of pseudopodia in ILK-expressing, but not in ILK-deficient cells. Rac1-deficient keratinocytes also showed substantially impaired phagocytic ability, underlining the importance of ILK-dependent Rac1 function for particle engulfment. Finally, cross-modulation of KGF receptors by integrins may be another important element, as integrin beta 1-deficient keratinocytes also fail to show significant phagocytosis in response to KGF. Thus, we have identified a novel signaling pathway essential for phagocytosis in keratinocytes, which involves ILK-dependent activation of Rac1 in response to KGF, resulting in the formation of pseudopodia and particle uptake.-Sayedyahossein, S., Nini, L., Irvine, T. S., and Dagnino, L.. Essential role of integrin-linked kinase in regulation of phagocytosis in keratinocytes. FASEB J. 26, 4218-4229 (2012). www.fasebj.org	[Sayedyahossein, Samar; Nini, Lylia; Irvine, Timothy S.; Dagnino, Lina] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Dagnino, Lina] Univ Western Ontario, Dept Paediat, London, ON N6A 5C1, Canada; [Sayedyahossein, Samar; Nini, Lylia; Irvine, Timothy S.; Dagnino, Lina] Childrens Hlth Res Inst, London, ON, Canada; [Sayedyahossein, Samar; Nini, Lylia; Irvine, Timothy S.; Dagnino, Lina] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Dagnino, L (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Med Sci Bldg, London, ON N6A 5C1, Canada.	ldagnino@uwo.ca		Dagnino, Lina/0000-0003-1483-5159; Sayedyahossein, Samar/0000-0003-1773-4740	Canadian Institutes of Health Research; Quality of Life Campaign of the Children's Health Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quality of Life Campaign of the Children's Health Research Institute	The authors thank Dr. M. Glogauer (University of Toronto, Toronto, ON, Canada) for his gift of Rac<SUP>f/f</SUP> mice, and Dr. S. Koval and J. Sholdic for expert help with transmission electron microscopy experiments. The authors also thank Karen Nygaard for help with confocal microscopy imaging. Funding to L.D. for this work was provided by the Canadian Institutes of Health Research. S.S. was supported with funds from the Quality of Life Campaign of the Children's Health Research Institute.	Auriemma C, 2010, CELL MOL BIOL LETT, V15, P496, DOI 10.2478/s11658-010-0019-z; Belleudi F, 2011, FASEB J, V25, P170, DOI 10.1096/fj.10-162156; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Botelho RJ, 2011, CURR BIOL, V21, pR533, DOI 10.1016/j.cub.2011.05.053; Boulter E, 2006, FASEB J, V20, P1489, DOI 10.1096/fj.05-4579fje; Byers HR, 2007, J INVEST DERMATOL, V127, P1736, DOI 10.1038/sj.jid.5700760; Cardinali G, 2005, J INVEST DERMATOL, V125, P1190, DOI 10.1111/j.0022-202X.2005.23929.x; Cardinali G, 2008, J INVEST DERMATOL, V128, P558, DOI 10.1038/sj.jid.5701063; Costa C, 2010, THESCIENTIFICWORLDJO, V10, P1826, DOI 10.1100/tsw.2010.178; Dagnino L, 2010, METHODS MOL BIOL, V585, P93, DOI 10.1007/978-1-60761-380-0_8; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Enomoto A, 2011, AM J PATHOL, V178, P679, DOI 10.1016/j.ajpath.2010.10.021; Fens MHAM, 2012, HAEMATOL-HEMATOL J, V97, P500, DOI 10.3324/haematol.2011.048694; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Guidetti GF, 2009, J THROMB HAEMOST, V7, P1200, DOI 10.1111/j.1538-7836.2009.03444.x; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; Ho E, 2009, MOL BIOL CELL, V20, P3033, DOI 10.1091/mbc.E09-01-0050; Ivanova IA, 2007, ONCOGENE, V26, P1147, DOI 10.1038/sj.onc.1209894; Ivanova IA, 2007, CELL CYCLE, V6, P2186, DOI 10.4161/cc.6.17.4650; Judah D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036704; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Liu E, 2005, MOL CELL BIOL, V25, P11145, DOI 10.1128/MCB.25.24.11145-11155.2005; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Mao YY, 2012, MOL BIOL CELL, V23, P1104, DOI 10.1091/mbc.E11-10-0840; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Nakrieko KA, 2011, MOL BIOL CELL, V22, P2532, DOI 10.1091/mbc.E11-01-0035; Raghavan S, 2003, DEV CELL, V5, P415, DOI 10.1016/S1534-5807(03)00261-2; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rooney N, 2011, FEBS LETT, V585, P1663, DOI 10.1016/j.febslet.2011.05.014; Rosenberger G, 2005, J BIOL CHEM, V280, P6879, DOI 10.1074/jbc.M412119200; Sharlow ER, 2000, J CELL SCI, V113, P3093; Siemens N, 2011, J BIOL CHEM, V286, P21612, DOI 10.1074/jbc.M110.202671; Sindrilaru A, 2009, BLOOD, V113, P5266, DOI 10.1182/blood-2008-07-166702; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Tzircotis G, 2011, J CELL SCI, V124, P2897, DOI 10.1242/jcs.084269; Uliczka F, 2009, CELL MICROBIOL, V11, P1782, DOI 10.1111/j.1462-5822.2009.01371.x; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Virador VM, 2001, FASEB J, V15, P105, DOI 10.1096/fj.01-0518fje; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yoshida H, 1996, DEVELOPMENT, V122, P1207; Zeigler ME, 1999, J CELL PHYSIOL, V180, P271	47	22	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4218	4229		10.1096/fj.12-207852	http://dx.doi.org/10.1096/fj.12-207852			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22767228				2022-12-25	WOS:000309704000027
J	Becker, K; Braune, M; Benderska, N; Buratti, E; Baralle, F; Villmann, C; Stamm, S; Eulenburg, V; Becker, CM				Becker, Kristina; Braune, Marlen; Benderska, Natalya; Buratti, Emanuele; Baralle, Francisco; Villmann, Carmen; Stamm, Stefan; Eulenburg, Volker; Becker, Cord-Michael			A Retroelement Modifies Pre-mRNA Splicing THE MURINE Glrb(spa) ALLELE IS A SPLICING SIGNAL POLYMORPHISM AMPLIFIED BY LONG INTERSPERSED NUCLEAR ELEMENT INSERTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRONIC INSERTION; L1 RETROTRANSPOSON; GLYCINE RECEPTORS; LINE-1 ELEMENT; SPASTIC MOUSE; GENE; DISEASE; EXON; HYPEREKPLEXIA; LOCALIZATION	The glycine receptor-deficient mutant mouse spastic carries a full-length long interspersed nuclear element (LINE1) retrotransposon in intron 6 of the glycine receptor beta subunit gene, Glrb(spa). The mutation arose in the C57BL/6J strain and is associated with skipping of exon 6 or a combination of the exons 5 and 6, thus resulting in a translational frameshift within the coding regions of the GlyR beta subunit. The effect of the Glrb(spa) LINE1 insertion on pre-mRNA splicing was studied using a minigene approach. Sequence comparison as well as motif prediction and mutational analysis revealed that in addition to the LINE1 insertion the inactivation of an exonic splicing enhancer (ESE) within exon 6 is required for skipping of exon 6. Reconstitution of the ESE by substitution of a single residue was sufficient to prevent exon skipping. In addition to the ESE, two regions within the 5' and 3' UTR of the LINE1 were shown to be critical determinants for exon skipping, indicating that LINE1 acts as efficient modifier of subtle endogenous splicing phenotypes. Thus, the spastic allele of the murine glycine receptor beta subunit gene is a two-hit mutation, where the hypomorphic alteration in an ESE is amplified by the insertion of a LINE1 element in the adjacent intron. Conversely, the LINE1 effect on splicing may be modulated by individual polymorphisms, depending on the insertional environment within the host genome.	[Becker, Kristina; Braune, Marlen; Benderska, Natalya; Villmann, Carmen; Stamm, Stefan; Eulenburg, Volker; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Buratti, Emanuele; Baralle, Francisco] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy	University of Erlangen Nuremberg; International Center for Genetic Engineering & Biotechnology (ICGEB)	Eulenburg, V (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	Volker.eulenburg@biochem.uni-erlangen.de	Buratti, Emanuele/K-4691-2016; Eulenburg, Volker/B-7263-2013; Eulenburg, Volker/B-7263-2013	Buratti, Emanuele/0000-0002-1356-9074; Eulenburg, Volker/0000-0002-4878-5746; Eulenburg, Volker/0000-0001-6314-566X	Deutsche Forschungsgemeinschaft [BE 1138/5-3]; Bundesministerium fur Forschung und Bildung/Deutsch Israelische Projektkooperation [BMBF/DIP G3.2]; NIH [GM083187]; Fonds der Chemischen Industrie [160-43]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083187] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Forschung und Bildung/Deutsch Israelische Projektkooperation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft (BE 1138/5-3), the Bundesministerium fur Forschung und Bildung/Deutsch Israelische Projektkooperation (BMBF/DIP G3.2), the NIH (GM083187), and Fonds der Chemischen Industrie (160-43).	Babushok DV, 2007, CELL MOL LIFE SCI, V64, P542, DOI 10.1007/s00018-006-6453-4; BECKER CM, 1986, J NEUROSCI, V6, P1358; Becker Kristina, 2006, Hum Mutat, V27, P1061, DOI 10.1002/humu.9455; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Humeny A, 2002, EUR J HUM GENET, V10, P188, DOI 10.1038/sj.ejhg.5200779; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Oertel J, 2007, J BIOL CHEM, V282, P2798, DOI 10.1074/jbc.M608941200; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030	31	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31185	31194		10.1074/jbc.M112.375691	http://dx.doi.org/10.1074/jbc.M112.375691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782896	Green Published, hybrid			2022-12-25	WOS:000308791300031
J	Cala-De Paepe, D; Layre, E; Giacometti, G; Garcia-Alles, LF; Mori, L; Hanau, D; de Libero, G; de la Salle, H; Puzo, G; Gilleron, M				Cala-De Paepe, Diane; Layre, Emilie; Giacometti, Gaelle; Garcia-Alles, Luis F.; Mori, Lucia; Hanau, Daniel; de Libero, Gennaro; de la Salle, Henri; Puzo, Germain; Gilleron, Martine			Deciphering the Role of CD1e Protein in Mycobacterial Phosphatidyl-myo-inositol Mannosides (PIM) Processing for Presentation by CD1b to T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; ANTIGEN PRESENTATION; ACTIVATOR PROTEIN; DENDRITIC CELLS; ACYLATION STATE; LIPID TRANSFER; SAPOSIN-B; MOLECULES; MEMBRANES; PURIFICATION	Lipids are important antigens that induce T cell-mediated specific immune responses. They are presented to T lymphocytes by a specific class of MHC-Ilike proteins, termed CD1. The majority of the described CD1-presented mycobacterial antigens are presented by the CD1b isoform. We previously demonstrated that the stimulation of CD1b-restricted T cells by the hexamannosylated phosphatidyl-myo-inositol (PIM6), a family of mycobacterial antigens, requires a prior partial digestion of the antigen oligomannoside moiety by alpha-mannosidase and that CD1e is an accessory protein absolutely required for the generation of the lipid immunogenic form. Here, we show that CD1e behaves as a lipid transfer protein influencing lipid immunoediting and membrane transfer of PIM lipids. CD1e selectively assists the alpha-mannosidase-dependent digestion of PIM6 species according to their degree of acylation. Moreover, CD1e transfers only diacylated PIM from donor to acceptor liposomes and also from membranes to CD1b. This study provides new insight into the molecular mechanisms by which CD1e contributes to lipid immunoediting and CD1-restricted presentation to T cells.	[Gilleron, Martine] CNRS, UMR5089, Dept Mol Mech Mycobacterial Infect, Inst Pharmacol & Biol Struct, F-31077 Toulouse 4, France; [Cala-De Paepe, Diane; Layre, Emilie; Garcia-Alles, Luis F.; Puzo, Germain; Gilleron, Martine] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Giacometti, Gaelle; Hanau, Daniel; de la Salle, Henri] INSERM, U725, Etab Francais Sang Alsace, Strasbourg, France; [Giacometti, Gaelle; Hanau, Daniel; de la Salle, Henri] Univ Strasbourg, F-67000 Strasbourg, France; [Mori, Lucia; de Libero, Gennaro] Univ Basel Hosp, Dept Biomed, Div Expt Immunol, CH-4031 Basel, Switzerland; [Mori, Lucia; de Libero, Gennaro] Singapore Immunol Network Agcy Sci Technol & Res, Singapore 138648, Singapore	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Gilleron, M (corresponding author), CNRS, UMR5089, Dept Mol Mech Mycobacterial Infect, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse 4, France.	martine.gilleron@ipbs.fr	De La Salle, Henri/H-9353-2016; De Libero, Gennaro/P-2694-2017	De La Salle, Henri/0000-0001-5136-0776; Layre, Emilie/0000-0003-3044-1299; Garcia-Alles, Luis/0000-0002-1141-0393; GILLERON, Martine/0000-0002-2581-3302; De Libero, Gennaro/0000-0003-0853-7868	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche Emergence [ANR-05-MIIM-006]; Etablissement Francais du Sang-Alsace; European Community's Seventh Framework Program [241745]; Swiss National Foundation [3100AO-122464/1]; Sinergia [CRS133-124819]; Association de Recherche et de Developpement en Medecine et Sante Publique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche Emergence(French National Research Agency (ANR)); Etablissement Francais du Sang-Alsace; European Community's Seventh Framework Program; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Sinergia; Association de Recherche et de Developpement en Medecine et Sante Publique	This work was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche Emergence (ANR-05-MIIM-006), the Etablissement Francais du Sang-Alsace, European Community's Seventh Framework Program Grant 241745, and Swiss National Foundation Grants 3100AO-122464/1 and Sinergia CRS133-124819.; Supported by an Association de Recherche et de Developpement en Medecine et Sante Publique grant.	Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Ciaffoni F, 2001, J BIOL CHEM, V276, P31583, DOI 10.1074/jbc.M102736200; Ciaffoni F, 2006, J LIPID RES, V47, P1045, DOI 10.1194/jlr.M500547-JLR200; CONZELMANN E, 1979, H-S Z PHYSIOL CHEM, V360, P1837, DOI 10.1515/bchm2.1979.360.2.1837; CONZELMANN E, 1982, EUR J BIOCHEM, V123, P455, DOI 10.1111/j.1432-1033.1982.tb19789.x; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; De Libero G, 2009, EUR J IMMUNOL, V39, P2648, DOI 10.1002/eji.200939425; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Facciotti F, 2011, P NATL ACAD SCI USA, V108, P14228, DOI 10.1073/pnas.1108809108; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Alles LF, 2011, P NATL ACAD SCI USA, V108, P13230, DOI 10.1073/pnas.1105627108; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Leon L, 2012, P NATL ACAD SCI USA, V109, P4357, DOI 10.1073/pnas.1200764109; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; VACCARO AM, 1993, FEBS LETT, V336, P159, DOI 10.1016/0014-5793(93)81631-9; Vaccaro AM, 1995, J BIOL CHEM, V270, P30576, DOI 10.1074/jbc.270.51.30576; VOGEL A, 1991, EUR J BIOCHEM, V200, P591, DOI 10.1111/j.1432-1033.1991.tb16222.x; Wendeler M, 2006, FEBS J, V273, P982, DOI 10.1111/j.1742-4658.2006.05126.x; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	30	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31494	31502		10.1074/jbc.M112.386300	http://dx.doi.org/10.1074/jbc.M112.386300			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782895	Green Published, hybrid			2022-12-25	WOS:000308791300062
J	Friederich-Persson, M; Aslam, S; Nordquist, L; Welch, WJ; Wilcox, CS; Palm, F				Friederich-Persson, Malou; Aslam, Shakil; Nordquist, Lina; Welch, William J.; Wilcox, Christopher S.; Palm, Fredrik			Acute Knockdown of Uncoupling Protein-2 Increases Uncoupling via the Adenine Nucleotide Transporter and Decreases Oxidative Stress in Diabetic Kidneys	PLOS ONE			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; PROXIMAL TUBULAR CELLS; PROTON CONDUCTANCE; ENDOTHELIAL-CELLS; OXYGEN; MEMBRANE; NEPHROPATHY; SUPEROXIDE; ISOFORMS; TRENDS	Increased O-2 metabolism resulting in chronic hypoxia is common in models of endstage renal disease. Mitochondrial uncoupling increases O-2 consumption but the ensuing reduction in mitochondrial membrane potential may limit excessive oxidative stress. The present study addressed the hypothesis that mitochondrial uncoupling regulates mitochondria function and oxidative stress in the diabetic kidney. Isolated mitochondria from kidney cortex of control and streptozotocin-induced diabetic rats were studied before and after siRNA knockdown of uncoupling protein-2 (UCP-2). Diabetes resulted in increased UCP-2 protein expression and UCP-2-mediated uncoupling, but normal mitochondria membrane potential. This uncoupling was inhibited by GDP, which also increased the membrane potential. siRNA reduced UCP-2 protein expression in controls and diabetics (-30-50%), but paradoxically further increased uncoupling and markedly reduced the membrane potential. This siRNA mediated uncoupling was unaffected by GDP but was blocked by ADP and carboxyatractylate (CAT). Mitochondria membrane potential after UCP-2 siRNA was unaffected by GDP but increased by CAT. This demonstrated that further increased mitochondria uncoupling after siRNA towards UCP-2 is mediated through the adenine nucleotide transporter (ANT). The increased oxidative stress in the diabetic kidney, manifested as increased thiobarbituric acids, was reduced by knocking down UCP-2 whereas whole-body oxidative stress, manifested as increased circulating malondialdehyde, remained unaffected. All parameters investigated were unaffected by scrambled siRNA. In conclusion, mitochondrial uncoupling via UCP-2 regulates mitochondria membrane potential in diabetes. However, blockade of the diabetes-induced upregulation of UCP-2 results in excessive uncoupling and reduced oxidative stress in the kidney via activation of ANT.	[Friederich-Persson, Malou; Nordquist, Lina; Palm, Fredrik] Uppsala Univ, Dept Med Cell Biol, Div Integrat Physiol, Uppsala, Sweden; [Friederich-Persson, Malou; Aslam, Shakil; Welch, William J.; Wilcox, Christopher S.] Georgetown Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens,Kidney & Vasc Res Ctr, Washington, DC 20007 USA; [Palm, Fredrik] Linkoping Univ, Dept Med Hlth Sci, Linkoping, Sweden	Uppsala University; Georgetown University; Linkoping University	Friederich-Persson, M (corresponding author), Uppsala Univ, Dept Med Cell Biol, Div Integrat Physiol, Uppsala, Sweden.	Malou.Friederich@mcb.uu.se		Nordquist, Lina/0000-0002-8552-5388	Swedish Research Council; Swedish Society for Medical Research; Lars Hierta Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; NIH/NIDDK K99/R00 [DK077858]; NHLBI [HL-68686]; NIDDK [DK-49870]; George E. Schreiner Chair of Nephrology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049870, K99DK077858, R00DK077858] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Lars Hierta Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; NIH/NIDDK K99/R00; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); George E. Schreiner Chair of Nephrology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Fredrik Palm was funded by the Swedish Research Council, the Swedish Society for Medical Research, the Lars Hierta Foundation, the Magnus Bergvall Foundation, the Ake Wiberg Foundation and NIH/NIDDK K99/R00 grant (DK077858). Christopher S. Wilcox and William J. Welch were funded by grants from the NHLBI (HL-68686) and NIDDK (DK-49870) and by the George E. Schreiner Chair of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Bevilacqua L, 2010, BBA-BIOENERGETICS, V1797, P1389, DOI 10.1016/j.bbabio.2010.02.018; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Dorner A, 1999, BBA-BIOMEMBRANES, V1417, P16, DOI 10.1016/S0005-2736(98)00245-4; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Friederich M, 2008, BBA-BIOENERGETICS, V1777, P935, DOI 10.1016/j.bbabio.2008.03.030; Harvey JN, 2003, CURR OPIN NEPHROL HY, V12, P317, DOI 10.1097/00041552-200305000-00015; Klingenberg M, 1999, J BIOENERG BIOMEMBR, V31, P419, DOI 10.1023/A:1005440221914; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; NICHOLLS DG, 1976, EUR J BIOCHEM, V62, P223, DOI 10.1111/j.1432-1033.1976.tb10151.x; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Palm F, 2006, CLIN EXP PHARMACOL P, V33, P997, DOI 10.1111/j.1440-1681.2006.04473.x; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010	24	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39635	10.1371/journal.pone.0039635	http://dx.doi.org/10.1371/journal.pone.0039635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768304	Green Published, gold, Green Submitted			2022-12-25	WOS:000305966500017
J	Kohler, S; Bausch, AR				Koehler, Simone; Bausch, Andreas R.			Contraction Mechanisms in Composite Active Actin Networks	PLOS ONE			English	Article							FRACTIONAL DYNAMICS APPROACH; RABBIT SKELETAL-MUSCLE; BUNDLING PROTEINS; ALPHA-ACTININ; IN-VITRO; MYOSIN; CYTOKINESIS; DIFFUSION; CELLS	Simplified in vitro systems are ideally suited for studying the principle mechanisms of the contraction of cytoskeletal actin systems. To shed light on the dependence of the contraction mechanism on the nature of the crosslinking proteins, we study reconstituted in vitro active actin networks on different length scales ranging from the molecular organization to the macroscopic contraction. Distinct contraction mechanisms are observed in polar and apolar crosslinked active gels whereas composite active gels crosslinked in a polar and apolar fashion at the same time exhibit both mechanisms simultaneously. In polar active actin/fascin networks initially bundles are formed which are then rearranged. In contrast, apolar cortexillin-I crosslinked active gels are bundled only after reorganization of actin filaments by myosin-II motor filaments.	[Koehler, Simone; Bausch, Andreas R.] Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany	Technical University of Munich	Kohler, S (corresponding author), Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany.	abausch@mytum.de		Kohler, Simone/0000-0002-1119-8855	European Research Council under the European Union [279476]	European Research Council under the European Union(European Research Council (ERC))	Financial support from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC CompNet (279476) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2011, MOL BIOL CELL, V22, P1330, DOI 10.1091/mbc.E10-11-0891; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; FERAMISCO JR, 1979, P NATL ACAD SCI USA, V76, P3967, DOI 10.1073/pnas.76.8.3967; Field CM, 2011, J CELL SCI, V124, P2086, DOI 10.1242/jcs.082263; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; KANE RE, 1983, J CELL BIOL, V97, P1745, DOI 10.1083/jcb.97.6.1745; Kohler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023798; Kohler S, 2011, NAT MATER, V10, P462, DOI [10.1038/NMAT3009, 10.1038/nmat3009]; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Metzler R, 2000, EUROPHYS LETT, V51, P492, DOI 10.1209/epl/i2000-00364-5; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; POLLARD TD, 1981, J CELL BIOL, V91, pS156, DOI 10.1083/jcb.91.3.156s; Reichl EM, 2008, CURR BIOL, V18, P471, DOI 10.1016/j.cub.2008.02.056; Reymann AC, 2010, NAT MATER, V9, P827, DOI 10.1038/nmat2855; Schaller V, 2011, P NATL ACAD SCI USA, V108, P19183, DOI 10.1073/pnas.1107540108; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Thoresen T, 2011, BIOPHYS J, V100, P2698, DOI 10.1016/j.bpj.2011.04.031; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; WANG K, 1975, P NATL ACAD SCI USA, V72, P4483, DOI 10.1073/pnas.72.11.4483	30	39	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39869	10.1371/journal.pone.0039869	http://dx.doi.org/10.1371/journal.pone.0039869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768316	gold, Green Submitted, Green Published			2022-12-25	WOS:000305966500029
J	Villanueva, S; Suazo, C; Santapau, D; Perez, F; Quiroz, M; Carreno, JE; Illanes, S; Lavandero, S; Michea, L; Irarrazabal, CE				Villanueva, Sandra; Suazo, Cristian; Santapau, Daniela; Perez, Francisco; Quiroz, Mariana; Carreno, Juan E.; Illanes, Sebastian; Lavandero, Sergio; Michea, Luis; Irarrazabal, Carlos E.			NFAT5 Is Activated by Hypoxia: Role in Ischemia and Reperfusion in the Rat Kidney	PLOS ONE			English	Article							OSMOTIC RESPONSE ELEMENT; ENHANCER-BINDING PROTEIN; ACUTE-RENAL-FAILURE; TRANSCRIPTION FACTOR TONEBP/OREBP; OXYGEN SPECIES CONTRIBUTE; NACL-INDUCED ACTIVATION; ALDOSE REDUCTASE GENE; CELLULAR-RESPONSE; OXIDATIVE STRESS; NITRIC-OXIDE	The current hypothesis postulates that NFAT5 activation in the kidney's inner medulla is due to hypertonicity, resulting in cell protection. Additionally, the renal medulla is hypoxic (10-18 mmHg); however there is no information about the effect of hypoxia on NFAT5. Using in vivo and in vitro models, we evaluated the effect of reducing the partial pressure of oxygen (PO2) on NFAT5 activity. We found that 1) Anoxia increased NFAT5 expression and nuclear translocation in primary cultures of IMCD cells from rat kidney. 2) Anoxia increased transcriptional activity and nuclear translocation of NFAT5 in HEK293 cells. 3) The dose-response curve demonstrated that HIF-1 alpha peaked at 2.5% and NFAT5 at 1% of O-2. 4) At 2.5% of O-2, the time-course curve of hypoxia demonstrated earlier induction of HIF-1 alpha gene expression than NFAT5. 5) siRNA knockdown of NFAT5 increased the hypoxia-induced cell death. 6) siRNA knockdown of HIF-1 alpha did not affect the NFAT5 induction by hypoxia. Additionally, HIF-1 alpha was still induced by hypoxia even when NFAT5 was knocked down. 7) NFAT5 and HIF-1 alpha expression were increased in kidney (cortex and medulla) from rats subjected to an experimental model of ischemia and reperfusion (I/R). 7) Experimental I/R increased the NFAT5-target gene aldose reductase (AR). 8) NFAT5 activators (ATM and PI3K) were induced in vitro (HEK293 cells) and in vivo (I/R kidneys) with the same timing of NFAT5. 8) Wortmannin, which inhibits ATM and PI3K, reduces hypoxia-induced NFAT5 transcriptional activation in HEK293 cells. These results demonstrate for the first time that NFAT5 is induced by hypoxia and could be a protective factor against ischemic damage.	[Villanueva, Sandra; Suazo, Cristian; Santapau, Daniela; Quiroz, Mariana; Carreno, Juan E.; Illanes, Sebastian; Irarrazabal, Carlos E.] Univ Los Andes, Fac Med, Lab Mol Physiol, Santiago, Chile; [Perez, Francisco; Michea, Luis] Univ Chile, Lab Integrat Physiol, ICBM, Santiago, Chile; [Perez, Francisco; Lavandero, Sergio; Michea, Luis] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 7, Chile; [Lavandero, Sergio] Univ Chile, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Lavandero, Sergio] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA	Universidad de los Andes - Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; University of Texas System; University of Texas Southwestern Medical Center Dallas	Villanueva, S (corresponding author), Univ Los Andes, Fac Med, Lab Mol Physiol, Santiago, Chile.	cirarrazabal@uandes.cl	Lavandero, Sergio/B-6001-2013	Lavandero, Sergio/0000-0003-4258-1483; Irarrazabal, Carlos Ernesto/0000-0002-6538-5314; Illanes, Sebastian/0000-0001-5433-9315	Fondecyt [1100885, 1090223]; FAI-Med [001-08, 003-09]; Fondecyt-FONDAP [15010006]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FAI-Med; Fondecyt-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP)	This work was supported by the following grants: Fondecyt 1100885 (National Fund for Science and Technology Development-Chile); FAI-Med 001-08-(Research Fund, University of Los Andes); FAI-Med 003-09 (Research Fund, University of Los Andes); and Fondecyt-FONDAP 15010006 (National Fund for Science and Technology Development-Chile); FONDECYT 1090223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo M, 2006, CURR OPIN NEPHROL HY, V15, P72, DOI 10.1097/01.mnh.0000191912.65281.e9; Bhoumik A, 2007, PIGM CELL RES, V20, P498, DOI 10.1111/j.1600-0749.2007.00414.x; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; BREZIS M, 1993, ANNU REV MED, V44, P27, DOI 10.1146/annurev.me.44.020193.000331; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cai Q, 2005, AM J PHYSIOL-RENAL, V289, pF803, DOI 10.1152/ajprenal.00448.2004; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Colla E, 2006, BIOCHEM J, V393, P411, DOI 10.1042/BJ20051082; Cristol JP, 1996, J LIPID MEDIAT CELL, V13, P9, DOI 10.1016/0929-7855(95)00010-0; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; FERRARIS JD, 1994, P NATL ACAD SCI USA, V91, P10742, DOI 10.1073/pnas.91.22.10742; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 1996, J BIOL CHEM, V271, P18318, DOI 10.1074/jbc.271.31.18318; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gong H, 2004, KIDNEY INT, V66, P683, DOI 10.1111/j.1523-1755.2004.00791.x; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Irarrazabal CE, 2008, J BIOL CHEM, V283, P2554, DOI 10.1074/jbc.M703490200; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Irarrazabal CE, 2010, P NATL ACAD SCI USA, V107, P906, DOI 10.1073/pnas.0913415107; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kuper C, 2009, AM J PHYSIOL-RENAL, V296, pF1100, DOI 10.1152/ajprenal.90402.2008; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF413, DOI 10.1152/ajprenal.1999.277.3.F413; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; LOPEZNEBLINA F, 1994, CIRC SHOCK, V44, P91; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Priyadarshi A, 2002, KIDNEY INT, V61, P542, DOI 10.1046/j.1523-1755.2002.00140.x; Rosas-Rodriguez JA, 2010, LIFE SCI, V87, P515, DOI 10.1016/j.lfs.2010.08.003; SADOWSKI J, 1985, Acta Physiologica Polonica, V36, P339; SCHRAMM L, 1994, RENAL FAILURE, V16, P555, DOI 10.3109/08860229409044885; Sykes E, 2007, ANN ROY COLL SURG, V89, P22, DOI 10.1308/003588407X155536; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Woo SK, 2000, BIOCHEM BIOPH RES CO, V278, P269, DOI 10.1006/bbrc.2000.3798; Xue Y, 2011, AM J PHYSIOL-HEART C, V300, pH2169, DOI 10.1152/ajpheart.00970.2010; Yuan K, 2010, PEPTIDES, V31, P1319, DOI 10.1016/j.peptides.2010.04.008; Zhou BY, 2007, AM J PHYSIOL-CELL PH, V292, pC1280, DOI 10.1152/ajpcell.00070.2006; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005; Zhou XM, 2005, AM J PHYSIOL-RENAL, V289, pF377, DOI 10.1152/ajprenal.00463.2004	47	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39665	10.1371/journal.pone.0039665	http://dx.doi.org/10.1371/journal.pone.0039665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768306	Green Published, gold			2022-12-25	WOS:000305966500019
J	Chen-An, PP; Andreassen, KV; Henriksen, K; Li, YD; Karsdal, MA; Bay-Jensen, AC				Chen-An, Pingping; Andreassen, Kim Vietz; Henriksen, Kim; Li, Yadong; Karsdal, Morten Asser; Bay-Jensen, Anne-Christine			The Inhibitory Effect of Salmon Calcitonin on Tri-Iodothyronine Induction of Early Hypertrophy in Articular Cartilage	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; GROWTH-PLATE CHONDROCYTES; OSTEOARTHRITIC CARTILAGE; ENDOCHONDRAL OSSIFICATION; TERMINAL DIFFERENTIATION; BONE CHANGES; EX-VIVO; RECEPTOR; EXPRESSION; DEGRADATION	Objective: Salmon calcitonin has chondroprotective effect both in vitro and in vivo, and is therefore being tested as a candidate drug for cartilage degenerative diseases. Recent studies have indicated that different chondrocyte phenotypes may express the calcitonin receptor (CTR) differentially. We tested for the presence of the CTR in chondrocytes from tri-iodothyronin (T3)-induced bovine articular cartilage explants. Moreover, investigated the effects of human and salmon calcitonin on the explants. Methods: Early chondrocyte hypertrophy was induced in bovine articular cartilage explants by stimulation over four days with 20 ng/mL T3. The degree of hypertrophy was investigated by molecular markers of hypertrophy (ALP, IHH, COLX and MMP13), by biochemical markers of cartilage turnover (C2M, P2NP and AGNxII) and histology. The expression of the CTR was detected by qPCR and immunohistochemistry. T3-induced explants were treated with salmon or human calcitonin. Calcitonin down-stream signaling was measured by levels of cAMP, and by the molecular markers. Results: Compared with untreated control explants, T3 induction increased expression of the hypertrophic markers (p<0.05), of cartilage turnover (p<0.05), and of CTR (p<0.01). Salmon, but not human, calcitonin induced cAMP release (p<0.001). Salmon calcitonin also inhibited expression of markers of hypertrophy and cartilage turnover (p<0.05). Conclusions: T3 induced early hypertrophy of chondrocytes, which showed an elevated expression of the CTR and was thus a target for salmon calcitonin. Molecular marker levels indicated salmon, but not human, calcitonin protected the cartilage from hypertrophy. These results confirm that salmon calcitonin is able to modulate the CTR and thus have chondroprotective effects.	[Chen-An, Pingping; Karsdal, Morten Asser; Bay-Jensen, Anne-Christine] Nord Biosci AS, Cartilage Biol & Biomarkers, Herlev, Denmark; [Andreassen, Kim Vietz; Henriksen, Kim] Nord Biosci AS, Bone Biol & Pharmacol, Herlev, Denmark; [Li, Yadong] Beijing Friendship Hosp, Orthoped Surg Unit, Beijing, Peoples R China	Nordic Bioscience; Nordic Bioscience; Capital Medical University	Chen-An, PP (corresponding author), Nord Biosci AS, Cartilage Biol & Biomarkers, Herlev, Denmark.	acbj@nordicbioscience.com	Bay-Jensen, Anne-Christine/AEQ-7281-2022	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Karsdal, Morten/0000-0001-5026-8740	Danish Research Foundation (Den Danske Forskningsfond); university of Southern Denmark; Nordic Bioscience	Danish Research Foundation (Den Danske Forskningsfond); university of Southern Denmark; Nordic Bioscience	The authors gratefully acknowledge the funding from the Danish Research Foundation (Den Danske Forskningsfond) supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nordic Bioscience is involved in the development of oral salmon calcitonin for the treatment of osteoporosis and osteoarthritis. ACBJ, KH and MAK are full-time employees of Nordic Bioscience. PCA and KAN are PhD students funded by the university of Southern Denmark and Nordic Bioscience. MAK owns stock in Nordic Bioscience. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. YL has no competing interest to declare. There are no patents, products in development or marketed products to declare related to the presented FDC model nor the expression of the CTR.	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Bay-Jensen AC, 2010, ASSAY DRUG DEV TECHN, V8, P118, DOI 10.1089/adt.2009.0199; Bay-Jensen AC, 2010, RHEUMATOL INT, V30, P435, DOI 10.1007/s00296-009-1183-1; Behets C, 2004, J BONE MINER RES, V19, P1821, DOI 10.1359/JBMR.040609; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Born W, 2002, RECEPTOR CHANNEL, V8, P201, DOI 10.1080/10606820213683; Bos SD, 2008, CURR OPIN RHEUMATOL, V20, P553, DOI 10.1097/BOR.0b013e32830aba48; Brondello Jean-Marc, 2010, Open Rheumatol J, V4, P10, DOI 10.2174/1874312901004010010; BURCH WM, 1984, ENDOCRINOLOGY, V114, P1196, DOI 10.1210/endo-114-4-1196; Chen PY, 2012, J ELECTROANALYTICAL, V675, P1, DOI [10.1109/ RSETE.2012.6260647, DOI 10.1109/RSETE.2012.6260647]; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Cranney A, 2002, ENDOCR REV, V23, P540, DOI 10.1210/er.2001-6002; Di Nino DL, 2003, ENDOCRINOLOGY, V144, P1979, DOI 10.1210/en.2002-220905; ELIMA K, 1989, FEBS LETT, V258, P195, DOI 10.1016/0014-5793(89)81651-5; Felson DT, 2004, ARTHRITIS RHEUM-US, V50, P341, DOI 10.1002/art.20051; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; Hajjaji HE, 2004, OSTEOARTHR CARTILAGE, V12, P904, DOI 10.1016/j.joca.2004.08.005; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Henriksen K, 2010, EXPERT OPIN BIOL TH, V10, P1617, DOI 10.1517/14712598.2010.526104; Ishikawa Y, 1998, J BONE MINER RES, V13, P1398, DOI 10.1359/jbmr.1998.13.9.1398; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Kawaguchi H, 2008, MOL CELLS, V25, P1; Lassova L, 2009, J CELL PHYSIOL, V219, P595, DOI 10.1002/jcp.21704; Lin Z, 2008, OSTEOARTHR CARTILAGE, V16, P450, DOI 10.1016/j.joca.2007.08.003; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Madsen SH, 2009, SCAND J RHEUMATOL, V38, P222, DOI 10.1080/03009740802464186; MARTIN TJ, 1993, OSTEOPOROSIS INT, V3, pS121, DOI 10.1007/BF01621884; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; NICHOLSON GC, 1986, J CLIN INVEST, V78, P355, DOI 10.1172/JCI112584; Nielsen RH, 2011, OSTEOARTHR CARTILAGE, V19, P466, DOI 10.1016/j.joca.2011.01.008; Pullig O, 2000, CALCIFIED TISSUE INT, V67, P230, DOI 10.1007/s002230001108; Purdue BW, 2002, RECEPTOR CHANNEL, V8, P243, DOI 10.1080/10606820213681; Segovia-Silvestre Toni, 2011, BMC Res Notes, V4, P407, DOI 10.1186/1756-0500-4-407; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Sondergaard BC, 2007, ANN RHEUM DIS, V66, P116; Sondergaard BC, 2006, OSTEOARTHR CARTILAGE, V14, P759, DOI 10.1016/j.joca.2006.01.014; Sondergaard BC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-62; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Sumer EU, 2007, OSTEOARTHR CARTILAGE, V15, P212, DOI 10.1016/j.joca.2006.07.009; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Udawela M, 2004, SEMIN CELL DEV BIOL, V15, P299, DOI 10.1016/j.semcdb.2003.12.019; Wang Bijue, 2009, BMC Res Notes, V2, P259, DOI 10.1186/1756-0500-2-259; Wang L, 2007, J BONE MINER RES, V22, P1988, DOI 10.1359/JBMR.070806; Wookey PJ, 2008, HISTOPATHOLOGY, V52, P605, DOI 10.1111/j.1365-2559.2008.02979.x	50	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40081	10.1371/journal.pone.0040081	http://dx.doi.org/10.1371/journal.pone.0040081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768225	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100197
J	Franke, AG; Lieb, K; Hildt, E				Franke, Andreas G.; Lieb, Klaus; Hildt, Elisabeth			What Users Think about the Differences between Caffeine and Illicit/Prescription Stimulants for Cognitive Enhancement	PLOS ONE			English	Article							PRESCRIPTION STIMULANTS; ILLICIT USE; MODAFINIL; NEUROENHANCEMENT; METHYLPHENIDATE; AMPHETAMINE; PERFORMANCE; PREVALENCE; STUDENTS; MOTIVES	Pharmacological cognitive enhancement (CE) is a topic of increasing public awareness. In the scientific literature on student use of CE as a study aid for academic performance enhancement, there are high prevalence rates regarding the use of caffeinated substances (coffee, caffeinated drinks, caffeine tablets) but remarkably lower prevalence rates regarding the use of illicit/prescription stimulants such as amphetamines or methylphenidate. While the literature considers the reasons and mechanisms for these different prevalence rates from a theoretical standpoint, it lacks empirical data to account for healthy students who use both, caffeine and illicit/prescription stimulants, exclusively for the purpose of CE. Therefore, we extensively interviewed a sample of 18 healthy university students reporting non-medical use of caffeine as well as illicit/prescription stimulants for the purpose of CE in a face-to-face setting about their opinions regarding differences in general and morally-relevant differences between caffeine and stimulant use for CE. 44% of all participants answered that there is a general difference between the use of caffeine and illicit/prescription stimulants for CE, 28% did not differentiate, 28% could not decide. Furthermore, 39% stated that there is a moral difference, 56% answered that there is no moral difference and one participant was not able to comment on moral aspects. Participants came to their judgements by applying three dimensions: medical, ethical and legal. Weighing the medical, ethical and legal aspects corresponded to the students' individual preferences of substances used for CE. However, their views only partly depicted evidence-based medical aspects and the ethical issues involved. This result shows the need for well-directed and differentiated information to prevent the potentially harmful use of illicit or prescription stimulants for CE.	[Franke, Andreas G.; Lieb, Klaus] Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany; [Hildt, Elisabeth] Johannes Gutenberg Univ Mainz, Dept Philosophy, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Franke, AG (corresponding author), Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany.	afranke@uni-mainz.de			German Ministry of Education and Research (BMBF) [01GP0807]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (BMBF) (Project No. 01GP0807) which has supported the work until September 2011. The BMBF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; Bramstedt KA, 2007, SUBST USE MISUSE, V42, P1237, DOI 10.1080/10826080701208962; Bryant A, 2007, SAGE HDB GROUNDED TH; Bublitz JC, 2009, BIOETHICS, V23, P360, DOI 10.1111/j.1467-8519.2009.01725.x; CAPLAN A, 2002, NEUROETHICS MAPPING, P95; Caplan JP, 2007, NEUROPSYCHOL REV, V17, P363, DOI 10.1007/s11065-007-9037-7; Corbin J., 2015, BASICS QUALITATIVE R; Elliott C, 2000, HASTINGS CENT REP, V30, P7, DOI 10.2307/3528306; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Ferre S, 2008, FRONT BIOSCI-LANDMRK, V13, P2391, DOI 10.2741/2852; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2010, BUNDESGESUNDHEITSBLA, V53, P853, DOI 10.1007/s00103-010-1105-0; Franke AG, 2012, PSYCHIAT PR IN PRESS; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hildt E, 2011, NERVENHEILKUNDE, V30, P833; HUGHES JR, 1992, AM J PSYCHIAT, V149, P33; Juengst Eric T., 1998, ENHANCING HUMAN TRAI, P29; Kass LR, 2003, PRESIDENTS COUNCIL B; Killgore WDS, 2008, J SLEEP RES, V17, P309, DOI 10.1111/j.1365-2869.2008.00654.x; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; Mayring P., 2010, QUALITATIVE INHALTSA, V2nd Aufl, DOI [10.1007/978-3-531-92052-8_42, DOI 10.1007/978-3-531-92052-8_42]; Metzinger T., 2011, OXFORD HDB NEUROETHI, P245; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; Oades RD, 2005, DEVELOPMENTAL SCI, V8, P122, DOI 10.1111/j.1467-7687.2005.00399.x; Prince J, 2008, J CLIN PSYCHOPHARM, V28, pS39, DOI 10.1097/JCP.0b013e318174f92a; Racine E, 2009, J MED ETHICS, V35, P469, DOI 10.1136/jme.2009.030460; Racine E, 2010, NEUROETHICS-NETH, V3, P1, DOI 10.1007/s12152-008-9023-7; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Satel S, 2006, AM J DRUG ALCOHOL AB, V32, P493, DOI 10.1080/00952990600918965; SCHREIBER GB, 1988, PREV MED, V17, P280, DOI 10.1016/0091-7435(88)90004-7; Sententia W, 2004, ANN NY ACAD SCI, V1013, P221, DOI 10.1196/annals.1305.014; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; Teter CJ, 2005, J AM COLL HEALTH, V53, P253, DOI 10.3200/JACH.53.6.253-262; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x; Wilens TE, 2008, J CLIN PSYCHOPHARM, V28, pS46, DOI 10.1097/JCP.0b013e318173312f; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1	40	55	56	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40047	10.1371/journal.pone.0040047	http://dx.doi.org/10.1371/journal.pone.0040047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768218	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100190
J	Lee, SM; Park, JW; Park, CW; Yoon, BH				Lee, Seung Mi; Park, Jeong Woo; Park, Chan-Wook; Yoon, Bo Hyun			"Early Rupture of Membranes" during Induced Labor as a Risk Factor for Cesarean Delivery in Term Nulliparas	PLOS ONE			English	Article							ELECTIVE INDUCTION; WOMEN; PREDICTION; SECTION	Objective: To determine if "early rupture of membranes" (early ROM) during induction of labor is associated with an increased risk of cesarean section in term nulliparas. Study Design: The rate of cesarean section and the timing of ROM during the course of labor were examined in term singleton nulliparas whose labor was induced. Cases were divided into 2 groups according the timing of ROM: 1)"early ROM", defined as ROM at a cervical dilatation <4 cm during labor; and 2) "late ROM", ROM at a cervical dilatation >= 4 cm during labor. Nonparametric techniques were used for statistical analysis. Results: 1) In a total of 500 cases of study population, "early ROM" occurred in 43% and the overall cesarean section rate was 15.8%; 2) patients with "early ROM" had a higher rate of cesarean section and cesarean section due to failure to progress than did those with "late ROM'' (overall cesarean section rate: 24%[51/215] vs. 10%[28/285], p<0.01; cesarean section rate due to failure to progress: 18%[38/215] vs. 8%[22/285], p<0.01 for each) and this difference remained significant after adjusting for confounding variables. Conclusion: "Early ROM" during the course of induced labor is a risk factor for cesarean section in term singleton nulliparas.	[Lee, Seung Mi; Park, Jeong Woo; Park, Chan-Wook; Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	yoonbh@snu.ac.kr	Park, Chan-Wook/J-5498-2012; PARK, Chan-Wook/G-3663-2013; Yoon, Bo Hyun/H-6344-2011	PARK, Chan-Wook/0000-0002-1290-6438; Park, Jeong Woo/0000-0001-6499-0814				ACOG technical bulletin, 1996, INT J GYNECOL OBSTET, V53, P73; Al Housseini A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.001; [Anonymous], 2009, OBSTET GYNECOL, V114, P386, DOI [10.1097/AOG.0b013e3181b48ef5, DOI 10.1097/AOG.0B013E3181B48EF5]; [Anonymous], 2003, OBSTET GYNECOL; Boulvain M, 2001, PAEDIATR PERINAT EP, V15, P131; Bueno B, 2007, J PERINATOL, V27, P4, DOI 10.1038/sj.jp.7211619; Cammu H, 2002, AM J OBSTET GYNECOL, V186, P240, DOI 10.1067/mob.2002.119643; Cunningham FG, 2010, WILLIAMS OBSTET; DUFF P, 1983, AM J OBSTET GYNECOL, V147, P391, DOI 10.1016/S0002-9378(16)32231-1; Edris FE, 2006, SAUDI MED J, V27, P1167; Feinstein U, 2002, INT J GYNECOL OBSTET, V77, P7, DOI 10.1016/S0020-7292(02)00007-3; Hin LY, 1999, STAT MED, V18, P1101, DOI 10.1002/(SICI)1097-0258(19990515)18:9<1101::AID-SIM99>3.3.CO;2-H; Hin LY, 1997, OBSTET GYNECOL, V90, P183, DOI 10.1016/S0029-7844(97)00238-X; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Isono W, 2011, J OBSTET GYNAECOL RE, V37, P1784, DOI 10.1111/j.1447-0756.2011.01607.x; Johnson DP, 2003, AM J OBSTET GYNECOL, V188, P1565, DOI 10.1067/mob.2003.458; Kim LH, 2010, J MATERN-FETAL NEO M, V23, P383, DOI 10.3109/14767050903168432; Lee SM, 2011, J MATERN-FETAL NEO M, V24, P37, DOI 10.3109/14767058.2010.482622; Lee SM, 2010, EUR J OBSTET GYN R B, V148, P152, DOI 10.1016/j.ejogrb.2009.10.031; Luthy DA, 2004, AM J OBSTET GYNECOL, V191, P1511, DOI 10.1016/j.ajog.2004.07.001; Manzanares S, 2007, J MATERN-FETAL NEO M, V20, P221, DOI 10.1080/14767050601127391; Maslow AS, 2000, OBSTET GYNECOL, V95, P917, DOI 10.1016/S0029-7844(00)00794-8; Moore LE, 2006, CLIN OBSTET GYNECOL, V49, P698, DOI 10.1097/00003081-200609000-00026; Park HS, 2010, PLACENTA, V31, P792, DOI 10.1016/j.placenta.2010.06.013; Park KH, 2006, J OBSTET GYNAECOL RE, V32, P482, DOI 10.1111/j.1447-0756.2006.00443.x; Peregrine E, 2006, OBSTET GYNECOL, V107, P227, DOI 10.1097/01.AOG.0000196508.11431.c0; SATIN AJ, 1992, OBSTET GYNECOL, V79, P913; Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4; Sheiner E, 2002, ACTA OBSTET GYN SCAN, V81, P222, DOI 10.1034/j.1600-0412.2002.810306.x; SILVER RK, 1986, OBSTET GYNECOL, V68, P587; Vahratian A, 2005, OBSTET GYNECOL, V105, P698, DOI 10.1097/01.AOG.0000157436.68847.3b; Venturini P, 2005, J MATERN-FETAL NEO M, V17, P129, DOI 10.1080/14767050400029566; Verhoeven CJM, 2009, ULTRASOUND OBST GYN, V34, P316, DOI 10.1002/uog.7315; Vrouenraets FPJM, 2005, OBSTET GYNECOL, V105, P690, DOI 10.1097/01.AOG.0000152338.76759.38; Yeast JD, 1999, AM J OBSTET GYNECOL, V180, P628, DOI 10.1016/S0002-9378(99)70265-6; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	36	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39883	10.1371/journal.pone.0039883	http://dx.doi.org/10.1371/journal.pone.0039883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768153	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100122
J	Levesque, D; Reymond, C; Perreault, JP				Levesque, Dominique; Reymond, Cedric; Perreault, Jean-Pierre			Characterization of the Trans Watson-Crick GU Base Pair Located in the Catalytic Core of the Antigenomic HDV Ribozyme	PLOS ONE			English	Article							HEPATITIS-DELTA-VIRUS; SELF-CLEAVING RIBOZYMES; METAL-ION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CLEAVAGE ACTIVITY; RNA; SEQUENCE; SUBSTRATE; SPECIFICITY	The HDV ribozyme's folding pathway is, by far, the most complex folding pathway elucidated to date for a small ribozyme. It includes 6 different steps that have been shown to occur before the chemical cleavage. It is likely that other steps remain to be discovered. One of the most critical of these unknown steps is the formation of the trans Watson-Crick GU base pair within loop III. The U-23 and G(28) nucleotides that form this base pair are perfectly conserved in all natural variants of the HDV ribozyme, and therefore are considered as being part of the signature of HDV-like ribozymes. Both the formation and the transformation of this base pair have been studied mainly by crystal structure and by molecular dynamic simulations. In order to obtain physical support for the formation of this base pair in solution, a set of experiments, including direct mutagenesis, the site-specific substitution of chemical groups, kinetic studies, chemical probing and magnesium-induced cleavage, were performed with the specific goal of characterizing this trans Watson-Crick GU base pair in an antigenomic HDV ribozyme. Both U-23 and G(28) can be substituted for nucleotides that likely preserve some of the H-bond interactions present before and after the cleavage step. The formation of the more stable trans Watson-Crick base pair is shown to be a post-cleavage event, while a possibly weaker trans Watson-Crick/Hoogsteen interaction seems to form before the cleavage step. The formation of this unusually stable post-cleavage base pair may act as a driving force on the chemical cleavage by favouring the formation of a more stable ground state of the product-ribozyme complex. To our knowledge, this represents the first demonstration of a potential stabilising role of a post-cleavage conformational switch event in a ribozyme-catalyzed reaction.	[Levesque, Dominique; Reymond, Cedric; Perreault, Jean-Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Levesque, D (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Pierre.Perreault@usherbrooke.ca			Canadian Institute of Health Research (CIHR) [MOP-44022]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (CIHR; grant number MOP-44022) to JPP. JPP holds the Canada Research Chairs in genomics and catalytic RNAs, and is a member of the Centre de Recherche Clinique Etienne Lebel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Been MD, 2006, CURR TOP MICROBIOL, V307, P47; Chen JH, 2010, BIOCHEMISTRY-US, V49, P6508, DOI 10.1021/bi100670p; Chen JH, 2009, BIOCHEMISTRY-US, V48, P1498, DOI 10.1021/bi8020108; Deschenes P, 2000, ANTISENSE NUCLEIC A, V10, P53, DOI 10.1089/oli.1.2000.10.53; Deschenes P, 2003, NUCLEIC ACIDS RES, V31, P2087, DOI 10.1093/nar/gkg307; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fiola K, 2002, J BIOL CHEM, V277, P26508, DOI 10.1074/jbc.M203468200; Gopinath SCB, 2009, ANAL CHIM ACTA, V636, P117, DOI 10.1016/j.aca.2009.01.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KAZAKOV S, 1991, P NATL ACAD SCI USA, V88, P9193, DOI 10.1073/pnas.88.20.9193; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Krasovska MV, 2005, J MOL BIOL, V351, P731, DOI 10.1016/j.jmb.2005.06.016; Lafontaine DA, 1999, NUCLEIC ACIDS RES, V27, P3236, DOI 10.1093/nar/27.15.3236; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Nehdi A, 2006, NUCLEIC ACIDS RES, V34, P584, DOI 10.1093/nar/gkj463; Nehdi A, 2007, NUCLEIC ACIDS RES, V35, P6820, DOI 10.1093/nar/gkm674; Ouellet J, 2004, RNA, V10, P1059, DOI 10.1261/rna.7230604; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Perrotta AT, 1996, NUCLEIC ACIDS RES, V24, P1314, DOI 10.1093/nar/24.7.1314; Reymond C, 2010, STRUCTURE, V18, P1608, DOI 10.1016/j.str.2010.09.024; Reymond C, 2009, CELL MOL LIFE SCI, V66, P3937, DOI 10.1007/s00018-009-0124-1; Reymond C, 2009, BIOPHYS J, V96, P132, DOI 10.1016/j.bpj.2008.09.033; Rocheleau L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-24; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; Tanaka Y, 2002, GENES CELLS, V7, P567, DOI 10.1046/j.1365-2443.2002.00541.x; TANNER NK, 1994, CURR BIOL, V4, P488, DOI 10.1016/S0960-9822(00)00109-3; THILL G, 1993, BIOCHEMISTRY-US, V32, P4254, DOI 10.1021/bi00067a013; Veeraraghavan N, 2011, J PHYS CHEM B, V115, P8346, DOI 10.1021/jp203202e; Veeraraghavan N, 2011, BIOCHEMISTRY-US, V50, P2672, DOI 10.1021/bi2000164; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Wrzesinski J, 2001, NUCLEIC ACIDS RES, V29, P4482, DOI 10.1093/nar/29.21.4482	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40309	10.1371/journal.pone.0040309	http://dx.doi.org/10.1371/journal.pone.0040309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768274	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100248
J	Cerbone, A; Toaldo, C; Minelli, R; Ciamporcero, E; Pizzimenti, S; Pettazzoni, P; Roma, G; Dianzani, MU; Ullio, C; Ferretti, C; Dianzani, C; Barrera, G				Cerbone, Angelo; Toaldo, Cristina; Minelli, Rosalba; Ciamporcero, Eric; Pizzimenti, Stefania; Pettazzoni, Piergiorgio; Roma, Guglielmo; Dianzani, Mario Umberto; Ullio, Chiara; Ferretti, Carlo; Dianzani, Chiara; Barrera, Giuseppina			Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; PROLIFERATOR; METALLOTHIONEIN; INHIBITION; LIGAND; THIAZOLIDINEDIONE; DIFFERENTIATION; IDENTIFICATION; GROWTH	PPARs are nuclear receptors activated by ligands. Activation of PPAR gamma leads to a reduction of adhesion and motility in some cancer models. PPAR gamma transcriptional activity can be negatively regulated by JNK-mediated phosphorylation. We postulated that the use of agents able to inhibit JNK activity could increase the effectiveness of PPAR gamma ligands. We analysed the effects of rosiglitazone (PPAR gamma ligand) and AS601245 (a selective JNK inhibitor) alone or in association on adhesion and migration of CaCo-2, HT29, and SW480 human colon cancer cells and investigated, through microarray analysis, the genes involved in these processes. Cell adhesion and migration was strongly inhibited by rosiglitazone and AS601245. Combined treatment with the two compounds resulted in a greater reduction of the adhesion and migration capacity. Affymetrix analysis in CaCo-2 cells revealed that some genes which were highly modulated by the combined treatment could be involved in these biological responses. Rosiglitazone, AS601245 and combined treatment down-regulated the expression of fibrinogen chains in all three cell lines. Moreover, rosiglitazone, alone or in association with AS601245, caused a decrease in the fibrinogen release. ARHGEF7/beta-PIX gene was highly down-regulated by combined treatment, and western blot analysis revealed that beta-PIX protein is down-modulated in CaCo-2, HT29 and SW480 cells, also. Transfection of cells with beta-PIX gene completely abrogated the inhibitory effect on cell migration, determined by rosiglitazone, AS601245 and combined treatment. Results demonstrated that beta-PIX protein is involved in the inhibition of cell migration and sustaining the positive interaction between PPAR gamma ligands and anti-inflammatory agents in humans.	[Cerbone, Angelo; Roma, Guglielmo] Ist Ric Biomed A Marxer, MerckSerono Ivrea RBM SpA, Turin, Italy; [Toaldo, Cristina; Ciamporcero, Eric; Pizzimenti, Stefania; Pettazzoni, Piergiorgio; Dianzani, Mario Umberto; Ullio, Chiara; Barrera, Giuseppina] Univ Turin, Dept Med & Expt Oncol, Sect Gen Pathol, Turin, Italy; [Minelli, Rosalba; Ferretti, Carlo; Dianzani, Chiara] Univ Turin, Dept Sci & Pharmaceut Technol, Turin, Italy	University of Turin; University of Turin	Cerbone, A (corresponding author), Ist Ric Biomed A Marxer, MerckSerono Ivrea RBM SpA, Turin, Italy.	giuseppina.barrera@unito.it	Ciamporcero, Eric/M-6580-2017; Pizzimenti, Stefania/AAB-8250-2022; Pettazzoni, Piergiorgio/GRJ-3011-2022	Ciamporcero, Eric/0000-0002-3856-6435; Pizzimenti, Stefania/0000-0001-6937-8632; Dianzani, Chiara/0000-0002-2246-3183	Regione Piemonte; Universita degli Studi di Torino	Regione Piemonte(Regione Piemonte); Universita degli Studi di Torino	This work was supported by grants from Regione Piemonte (http://www.ricerca-sanitaria-finalizzata.it/) and Universita degli Studi di Torino (http://www.unito.it/unitoWAR/page/istituzionale/ricerca1/Ricerca_601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atrian S, 2009, METALLOTHIONEINS REL; Barrera G, 2008, PPAR RES, V2008, DOI 10.1155/2008/524671; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Carter JC, 2011, J ONCOL, V2011, DOI 10.1155/2011/594258; Chacko BK, 2011, J BIOL CHEM, V286, P38738, DOI 10.1074/jbc.M111.247981; Chintharlapalli S, 2006, MOL CANCER THER, V5, P1362, DOI 10.1158/1535-7163.MCT-06-0002; Cimini AM, 2005, INT J CANCER, V117, P923, DOI 10.1002/ijc.21272; Dianzani C, 2003, BRIT J PHARMACOL, V139, P1103, DOI 10.1038/sj.bjp.0705344; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Farnesi-de-Assuncao TS, 2012, CELL IMMUNOL, V273, P23, DOI 10.1016/j.cellimm.2011.11.010; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Genini D, 2006, J RECEPT SIG TRANSD, V26, P679, DOI 10.1080/10799890600928202; Hsu HH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-61; Jackson L, 2003, GUT, V52, P1317, DOI 10.1136/gut.52.9.1317; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Janssen AML, 2002, CLIN CANCER RES, V8, P1889; Kaoud TS, 2011, ACS CHEM BIOL, V6, P658, DOI 10.1021/cb200017n; KARIN M, 1979, SCIENCE, V204, P176, DOI 10.1126/science.432639; Koh SH, 2011, STEM CELLS IN PRESS; Kumari MVR, 1998, FREE RADICAL RES, V29, P93, DOI 10.1080/10715769800300111; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Marin HE, 2006, CANCER RES, V66, P4394, DOI 10.1158/0008-5472.CAN-05-4277; McAlpine CA, 2006, INT J CANCER, V119, P2339, DOI 10.1002/ijc.22115; Nakajima A, 2008, CANCER SCI, V99, P1892, DOI 10.1111/j.1349-7006.2008.00904.x; Ogino S, 2009, GASTROENTEROLOGY, V136, P1242, DOI 10.1053/j.gastro.2008.12.048; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P29, DOI 10.1016/j.proghi.2008.10.001; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Staton CA, 2003, EXPERT OPIN BIOL TH, V3, P1105, DOI 10.1517/eobt.3.7.1105.21272; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; SUMMER KH, 1989, BIOL TRACE ELEM RES, V21, P165, DOI 10.1007/BF02917248; Takayama T, 2009, J MED INVESTIG, V56, P1, DOI 10.2152/jmi.56.1; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Theocharis S, 2007, DIGEST DIS SCI, V52, P2305, DOI 10.1007/s10620-007-9794-4; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yoshizumi T, 2004, INT J ONCOL, V25, P631	43	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40149	10.1371/journal.pone.0040149	http://dx.doi.org/10.1371/journal.pone.0040149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761953	gold, Green Published, Green Submitted			2022-12-25	WOS:000305826400057
J	Flores, R; Shi, JX; Gail, MH; Gajer, P; Ravel, J; Goedert, JJ				Flores, Roberto; Shi, Jianxin; Gail, Mitchell H.; Gajer, Pawel; Ravel, Jacques; Goedert, James J.			Association of Fecal Microbial Diversity and Taxonomy with Selected Enzymatic Functions	PLOS ONE			English	Article							BETA-GLUCURONIDASE; GUT MICROBIOME; HUMAN FECES; GLUCOSIDASE; EXPRESSION; BACTERIA; ENZYMES	Few microbial functions have been compared to a comprehensive survey of the human fecal microbiome. We evaluated determinants of fecal microbial beta-glucuronidase and beta-glucosidase activities, focusing especially on associations with microbial alpha and beta diversity and taxonomy. We enrolled 51 healthy volunteers (26 female, mean age 39) who provided questionnaire data and multiple aliquots of a stool, from which proteins were extracted to quantify beta-glucuronidase and beta-glucosidase activities, and DNA was extracted to amplify and pyrosequence 16S rRNA gene sequences to classify and quantify microbiome diversity and taxonomy. Fecal beta-glucuronidase was elevated with weight loss of at least 5 lb. (P = 0.03), whereas beta-glucosidase was marginally reduced in the four vegetarians (P = 0.06). Both enzymes were correlated directly with microbiome richness and alpha diversity measures, directly with the abundance of four Firmicutes Clostridia genera, and inversely with the abundance of two other genera (Firmicutes Lactobacillales Streptococcus and Bacteroidetes Rikenellaceae Alistipes) (all P = 0.05-0.0001). Beta diversity reflected the taxonomic associations. These observations suggest that these enzymatic functions are performed by particular taxa and that diversity indices may serve as surrogates of bacterial functions. Independent validation and deeper understanding of these associations are needed, particularly to characterize functions and pathways that may be amenable to manipulation.	[Flores, Roberto; Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Flores, Roberto] NCI, Canc Prevent Fellowship Program, Rockville, MD USA; [Shi, Jianxin; Gail, Mitchell H.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; [Gajer, Pawel; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Flores, R (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA.	floresr2@mail.nih.gov	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233	National Cancer Institute, National Institutes of Health [Z01-CP010214]; NATIONAL CANCER INSTITUTE [ZIACP010214] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project (Z01-CP010214) was funded by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone Michele, 2012, J Gastrointest Cancer, V43, P13, DOI 10.1007/s12029-011-9332-7; COLE CB, 1985, J APPL BACTERIOL, V59, P549, DOI 10.1111/j.1365-2672.1985.tb03359.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Flores R, 2012, EUR J CLIN INVEST, V42, P855, DOI 10.1111/j.1365-2362.2012.02659.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Koning CJM, 2008, AM J GASTROENTEROL, V103, P178, DOI 10.1111/j.1572-0241.2007.01547.x; LING WH, 1992, J NUTR, V122, P924, DOI 10.1093/jn/122.4.924; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; McIntosh FM, 2012, ENVIRON MICROBIOL, V14, P1876, DOI 10.1111/j.1462-2920.2012.02711.x; Mroczynska M, 2010, POL J MICROBIOL, V59, P265; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P487, DOI 10.1111/j.1348-0421.2002.tb02723.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940; Tryland I, 1998, APPL ENVIRON MICROB, V64, P1018; Turnbaugh PJ, 2010, ACTA CRYSTALLOGR F, V66, P1261, DOI 10.1107/S1744309110029088; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z	22	39	41	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39745	10.1371/journal.pone.0039745	http://dx.doi.org/10.1371/journal.pone.0039745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761886	gold, Green Submitted, Green Published			2022-12-25	WOS:000305826400034
J	Feig, JE; Vengrenyuk, Y; Reiser, V; Wu, CW; Statnikov, A; Aliferis, CF; Garabedian, MJ; Fisher, EA; Puig, O				Feig, Jonathan E.; Vengrenyuk, Yuliya; Reiser, Vladimir; Wu, Chaowei; Statnikov, Alexander; Aliferis, Constantin F.; Garabedian, Michael J.; Fisher, Edward A.; Puig, Oscar			Regression of Atherosclerosis Is Characterized by Broad Changes in the Plaque Macrophage Transcriptome	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; MARKOV BLANKET INDUCTION; MONOCYTE-DERIVED CELLS; APOE-DEFICIENT MICE; APOLIPOPROTEIN-E; GENE-EXPRESSION; FEATURE-SELECTION; CAUSAL DISCOVERY; RAPID REGRESSION; LOCAL CAUSAL	We have developed a mouse model of atherosclerotic plaque regression in which an atherosclerotic aortic arch from a hyperlipidemic donor is transplanted into a normolipidemic recipient, resulting in rapid elimination of cholesterol and monocyte-derived macrophage cells (CD68+) from transplanted vessel walls. To gain a comprehensive view of the differences in gene expression patterns in macrophages associated with regressing compared with progressing atherosclerotic plaque, we compared mRNA expression patterns in CD68+ macrophages extracted from plaque in aortic aches transplanted into normolipidemic or into hyperlipidemic recipients. In CD68+ cells from regressing plaque we observed that genes associated with the contractile apparatus responsible for cellular movement (e. g. actin and myosin) were up-regulated whereas genes related to cell adhesion (e.g. cadherins, vinculin) were down-regulated. In addition, CD68+ cells from regressing plaque were characterized by enhanced expression of genes associated with an anti-inflammatory M2 macrophage phenotype, including arginase I, CD163 and the C-lectin receptor. Our analysis suggests that in regressing plaque CD68+ cells preferentially express genes that reduce cellular adhesion, enhance cellular motility, and overall act to suppress inflammation.	[Feig, Jonathan E.; Vengrenyuk, Yuliya; Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY 10012 USA; [Feig, Jonathan E.; Vengrenyuk, Yuliya; Fisher, Edward A.] NYU, Sch Med, Dept Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA; [Reiser, Vladimir] Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ USA; [Wu, Chaowei; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Statnikov, Alexander; Aliferis, Constantin F.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Statnikov, Alexander] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY USA; [Aliferis, Constantin F.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Puig, Oscar] Merck Res Labs, Informat & Anal, Kenilworth, NJ USA	New York University; New York University; Merck & Company; New York University; New York University; New York University; New York University; Merck & Company	Feig, JE (corresponding author), NYU, Sch Med, Dept Med, Div Cardiol, New York, NY 10012 USA.	edward.fisher@nyumc.org; oscar.puig@roche.com	Puig, Oscar/ABG-3370-2021; Fisher, Edward/ABE-7469-2020; Puig, Oscar/GVR-8557-2022	Puig, Oscar/0000-0003-0918-2528; Fisher, Edward/0000-0001-9802-143X	National Institutes of Heatlh [HL-084312, AG-029748, T32HL098129, R56 LM007948-04A1, 1UL1RR029893]; Philip Morris USA; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098129, R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG029748] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R56LM007948] Funding Source: NIH RePORTER	National Institutes of Heatlh; Philip Morris USA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Heatlh grant HL-084312 (EAF), NIH fellowship AG-029748 (JEF), NIH training grant T32HL098129 (YV), NIH grant R56 LM007948-04A1 (AS and CFA), NIH grant 1UL1RR029893 (AS and CFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Vladimir Reiser and Oscar Puig worked for Merck at the time the research was carried out. Dr Garabedian has previously received research funds from Philip Morris USA, for research projects not related to the study reported in the manuscript. The remaining authors do not have any competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Aliferis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004922; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen SN, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-111; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Choudhury RP, 2004, ARTERIOSCL THROM VAS, V24, P1904, DOI 10.1161/01.ATV.0000142808.34602.25; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; GRUNDY SM, 1986, JAMA-J AM MED ASSOC, V256, P2849, DOI 10.1001/jama.256.20.2849; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, P1329, DOI 10.1161/01.ATV.0000139012.45265.e0; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; McMahan CA, 2007, ATHEROSCLEROSIS, V190, P370, DOI 10.1016/j.atherosclerosis.2006.02.008; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; OTTO JJ, 1990, CELL MOTIL CYTOSKEL, V16, P1, DOI 10.1002/cm.970160102; Puig O, 2010, PHYSIOL GENOMICS, V42A, P24, DOI 10.1152/physiolgenomics.00010.2010; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Skogsberg J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000036; Sugiura Y, 2010, J BIOL CHEM, V285, P7135, DOI 10.1074/jbc.M109.082545; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; Trogan E, 2004, ARTERIOSCL THROM VAS, V24, P1714, DOI 10.1161/01.ATV.0000139313.69015.1c; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; Williams KJ, 2007, CURR OPIN LIPIDOL, V18, P443, DOI 10.1097/MOL.0b013e32823bcb15; Winrow CJ, 2009, BRAIN RES, V1271, P1, DOI 10.1016/j.brainres.2009.02.083; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	34	85	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39790	10.1371/journal.pone.0039790	http://dx.doi.org/10.1371/journal.pone.0039790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761902	Green Submitted, Green Published, gold			2022-12-25	WOS:000305825800070
J	Giri, PK; Jing-Song, F; Shanmugam, MK; Ding, JL; Sethi, G; Swaminathan, K; Sivaraman, J				Giri, Pankaj Kumar; Jing-Song, Fan; Shanmugam, Muthu K.; Ding, Jeak Ling; Sethi, Gautam; Swaminathan, Kunchithapadam; Sivaraman, J.			NMR Structure of Carcinoscorpius rotundicauda Thioredoxin-related Protein 16 and Its Role in Regulating Transcription Factor NF-kappa B Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; REDOX REGULATION; PHYSIOLOGICAL FUNCTIONS; BIOLOGICAL-ACTIVITIES; LIPID-PEROXIDATION; DNA-DAMAGE; ACTIVATION; ANTIOXIDANT; HOMODIMER; DISULFIDE	Thioredoxins (Trxs), which play a key role in maintaining a redox environment in the cell, are found in almost all organisms. Trxs act as potential reducing agents of disulfide bonds and contain two vicinal cysteines in a CXXC motif at the active site. Trx is also known to activate the DNA binding activity of NF-kappa B, an important transcription factor. Previously, Trx-related protein 16 from Carcinoscorpius rotundicauda (Cr-TRP16), a 16-kDa Trx-like protein that contains a WCPPC motif, was reported. Here we present the NMR structure of the reduced form of Cr-TRP16, along with its regulation of NF-kappa B activity. Unlike other 16-kDa Trx-like proteins, Cr-TRP16 contains an additional Cys residue (Cys-15, at the N terminus), through which it forms a homodimer. Moreover, we have explored the molecular basis of Cr-TRP16-mediated activation of NF-kappa B and showed that Cr-TRP16 exists as a dimer under physiological conditions, and only the dimeric form binds to NF-kappa B and enhances its DNA binding activity by directly reducing the cysteines in the DNA-binding motif of NF-kappa B. The C15S mutant of Cr-TRP16 was unable to dimerize and hence does not bind to NF-kappa B. Based on our finding and combined with the literature, we propose a model of how Cr-TRP16 is likely to bind to NF-kappa B. These findings elucidate the molecular mechanism by which NF-kappa B activation is regulated through Cr-TRP16.	[Giri, Pankaj Kumar; Jing-Song, Fan; Ding, Jeak Ling; Swaminathan, Kunchithapadam; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Shanmugam, Muthu K.; Sethi, Gautam] Natl Univ Singapore, Dept Pharmacol, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsks@nus.edu.sg; dbsjayar@nus.edu.sg	Sivaraman, J/H-8028-2012; Ding, Jeak/H-8057-2012; Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council, Singapore [R154000461305, R154-000-424-305]; Singapore Ministry of Health National Medical Research Council; National University of Singapore	Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National University of Singapore(National University of Singapore)	This work was supported in part by a grant from the Biomedical Research Council, Singapore, Grants R154000461305 (to J. S.) and R154-000-424-305 (to K. S.). This project was also supported in part by a grant from Singapore Ministry of Health National Medical Research Council (to. G. S.) under its Individual Research Grant (IRG) funding scheme.; Supported by a graduate research scholarship from the National University of Singapore.	Ahn KS, 2007, CURR MOL MED, V7, P619, DOI 10.2174/156652407782564363; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Aviram M, 2000, FREE RADICAL RES, V33, pS85; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Carvalho AP, 2006, PROG BIOPHYS MOL BIO, V91, P229, DOI 10.1016/j.pbiomolbio.2005.06.012; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FESIK SW, 1990, J AM CHEM SOC, V112, P886, DOI 10.1021/ja00158a069; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; FUJII S, 1991, CANCER, V68, P1583, DOI 10.1002/1097-0142(19911001)68:7<1583::AID-CNCR2820680720>3.0.CO;2-N; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; GASDASKA PY, 1994, BBA-GENE STRUCT EXPR, V1218, P292, DOI 10.1016/0167-4781(94)90180-5; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Goddard T.D., SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hirota K, 2002, ANN NY ACAD SCI, V957, P189, DOI 10.1111/j.1749-6632.2002.tb02916.x; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Matsuo Y, 2002, DRUG NEWS PERSPECT, V15, P575, DOI 10.1358/dnp.2002.15.9.840062; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MENON SD, 1995, J BIOL CHEM, V270, P18881; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Montemartini Marisa, 2000, Biofactors, V11, P65; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; OCHMAN H, 1988, GENETICS, V120, P621; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wang XW, 2008, FREE RADICAL BIO MED, V45, P336, DOI 10.1016/j.freeradbiomed.2008.04.028; Wang XW, 2007, FREE RADICAL BIO MED, V42, P247, DOI 10.1016/j.freeradbiomed.2006.10.040; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	61	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29417	29428		10.1074/jbc.M112.379859	http://dx.doi.org/10.1074/jbc.M112.379859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22763700	hybrid, Green Published			2022-12-25	WOS:000308286900020
J	Moretti, J; Chastagner, P; Liang, CC; Cohn, MA; Israel, A; Brou, C				Moretti, Julien; Chastagner, Patricia; Liang, Chih-Chao; Cohn, Martin A.; Israel, Alain; Brou, Christel			The Ubiquitin-specific Protease 12 (USP12) Is a Negative Regulator of Notch Signaling Acting on Notch Receptor Trafficking toward Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA; LIGAND; ENDOCYTOSIS; ACTIVATION; CLEAVAGE; PATHWAY; DOMAIN; RNAI	Notch signaling is critical for development and adult tissue physiology, controlling cell fate in a context-dependent manner. Upon ligand binding, the transmembrane Notch receptor undergoes two ordered proteolytic cleavages releasing Notch intracellular domain, which regulates the transcription of Notch target genes. The strength of Notch signaling is of crucial importance and depends notably on the quantity of Notch receptor at the cell surface. Using an shRNA library screen monitoring Notch trafficking and degradation in the absence of ligand, we identified mammalian USP12 and its Drosophila melanogaster homolog as novel negative regulators of Notch signaling. USP12 silencing specifically interrupts Notch trafficking to the lysosomes and, as a consequence, leads to an increased amount of receptor at the cell surface and to a higher Notch activity. At the biochemical level, USP12 with its activator UAF1 deubiquitinate the nonactivated form of Notch in cell culture and in vitro. These results characterize a new level of conserved regulation of Notch signaling by the ubiquitin system.	[Moretti, Julien; Chastagner, Patricia; Israel, Alain; Brou, Christel] Inst Pasteur, F-75724 Paris 15, France; [Moretti, Julien; Chastagner, Patricia; Israel, Alain; Brou, Christel] CNRS, Unite Rech Associee URA Signalisat Mol & Activat, F-75724 Paris 15, France; [Moretti, Julien] Univ Paris 06, Cellule Pasteur UPMC, F-75724 Paris 15, France; [Liang, Chih-Chao; Cohn, Martin A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Oxford	Brou, C (corresponding author), Inst Pasteur, 25 Rue Docteur Roux, F-75724 Paris 15, France.	christel.brou@pasteur.fr		Cohn, Martin/0000-0002-2988-3009; Moretti, Julien/0000-0002-3415-9058; Liang, Chih-Chao/0000-0001-5039-7008	Institut Pasteur; CNRS; Association pour la Recherche sur le Cancer [SFI20101201664]; Ligue Nationale Contre le Cancer [LNCC RS11/75-21]; European Community [018683]; French Ministry of Research	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Community(European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported in part by the Institut Pasteur, CNRS, Association pour la Recherche sur le Cancer (Grant SFI20101201664, to C. B.), Ligue Nationale Contre le Cancer (Grant LNCC RS11/75-21, to C. B.), and the European Community (Grant 018683, Network of Excellence RUBICON, to A. I.).; Recipient of fellowships from the French Ministry of Research and from the Association pour la Recherche sur le Cancer.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Babaoglan AB, 2009, DEVELOPMENT, V136, P4089, DOI 10.1242/dev.040386; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brou C, 2009, EXP CELL RES, V315, P1549, DOI 10.1016/j.yexcr.2008.09.010; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Couturier L, 2012, NAT CELL BIOL, V14, P131, DOI 10.1038/ncb2419; Dirac AMG, 2005, METHOD ENZYMOL, V398, P554, DOI 10.1016/S0076-6879(05)98045-2; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vodovar Nicolas, 2008, J Biol, V7, P7, DOI 10.1186/jbiol68	30	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29429	29441		10.1074/jbc.M112.366807	http://dx.doi.org/10.1074/jbc.M112.366807			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778262	Green Published, hybrid			2022-12-25	WOS:000308286900021
J	Onal, M; Xiong, JH; Chen, XR; Thostenson, JD; Almeida, M; Manolagas, SC; O'Brien, CA				Onal, Melda; Xiong, Jinhu; Chen, Xinrong; Thostenson, Jeff D.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.			Receptor Activator of Nuclear Factor kappa B Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; OSTEOCLAST FORMATION; ESTROGEN DEFICIENCY; T-CELLS; ACCELERATED OSTEOCLASTOGENESIS; MESSENGER-RNA; MICE; OSTEOPROTEGERIN; LYMPHOPOIESIS; MARROW	Production of the cytokine receptor activator of NF kappa B ligand (RANKL) by lymphocytes has been proposed as a mechanism by which sex steroid deficiency causes bone loss. However, there have been no studies that functionally link RANKL expression in lymphocytes with bone loss in this condition. Herein, we examined whether RANKL expression in either B or T lymphocytes contributes to ovariectomy-induced bone loss in mice. Mice harboring a conditional RANKL allele were crossed with CD19-Cre or Lck-Cre mice to delete RANKL in B or T lymphocytes, respectively. Deletion of RANKL from either cell type had no impact on bone mass in estrogen-replete mice up to 7 months of age. However, mice lacking RANKL in B lymphocytes were partially protected from the bone loss caused by ovariectomy. This protection occurred in cancellous, but not cortical, bone and was associated with a failure to increase osteoclast numbers in the conditional knock-out mice. Deletion of RANKL from T lymphocytes had no impact on ovariectomy-induced bone loss. These results demonstrate that lymphocyte RANKL is not involved in basal bone remodeling, but B cell RANKL does contribute to the increase in osteoclasts and cancellous bone loss that occurs after loss of estrogen.	[Onal, Melda; Xiong, Jinhu; Chen, Xinrong; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Onal, Melda; Xiong, Jinhu; Chen, Xinrong; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Thostenson, Jeff D.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, 4301 W Markham St,MS 587, Little Rock, AR 72205 USA.	caobrien@uams.edu	O'Brien, Charles A./AAL-5078-2020; xiong, jinhu/E-1849-2011; Liu, Juan/J-5155-2015	Warren, Aaron D./0000-0002-0042-9021; Almeida, Maria/0000-0002-6722-9200	Central Arkansas Veterans Healthcare System [5I01BX000294-04]; National Institutes of Health [AR049794, AG13918]; University of Arkansas for Medical Sciences (UAMS) Translational Research Institute [UL1 RR029884]; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	Central Arkansas Veterans Healthcare System(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences (UAMS) Translational Research Institute; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the Central Arkansas Veterans Healthcare System, Merit Review 5I01BX000294-04 (to C. A. O.). This work was also supported by National Institutes of Health Grants AR049794 (to C. A. O.) and AG13918 (to S. C. M.), by the University of Arkansas for Medical Sciences (UAMS) Translational Research Institute Grant UL1 RR029884, and UAMS tobacco settlement funds.	Ammann P, 1997, J CLIN INVEST, V99, P1699, DOI 10.1172/JCI119333; Blin-Wakkach C, 2004, J BONE MINER RES, V19, P1137, DOI 10.1359/JBMR.040318; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Farrugia AN, 2003, CANCER RES, V63, P5438; Han XZ, 2006, J IMMUNOL, V176, P625, DOI 10.4049/jimmunol.176.1.625; Heider U, 2004, J CANCER RES CLIN, V130, P469, DOI 10.1007/s00432-004-0578-3; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Horowitz MC, 2010, BONE, V47, P472, DOI 10.1016/j.bone.2010.06.011; Ikeda T, 2001, J BONE MINER RES, V16, P1416, DOI 10.1359/jbmr.2001.16.8.1416; Ishimi Y, 1999, ENDOCRINOLOGY, V140, P1893, DOI 10.1210/en.140.4.1893; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5; Kanematsu M, 2000, J BONE MINER RES, V15, P1321, DOI 10.1359/jbmr.2000.15.7.1321; Katavic V, 2003, BONE, V32, P581, DOI 10.1016/S8756-3282(03)00097-8; KIMBLE RB, 1995, ENDOCRINOLOGY, V136, P3054, DOI 10.1210/en.136.7.3054; KINCADE PW, 1994, IMMUNOL REV, V137, P119, DOI 10.1111/j.1600-065X.1994.tb00661.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SK, 2006, J BONE MINER RES, V21, P695, DOI 10.1359/JBMR.060117; Lee SK, 2006, J BONE MINER RES, V21, P1704, DOI 10.1359/JBMR.060726; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Li XD, 2009, BONE, V45, P669, DOI 10.1016/j.bone.2009.06.011; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo JA, 1998, ENDOCRINOLOGY, V139, P3022, DOI 10.1210/en.139.6.3022; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; Onoe Y, 2000, J BONE MINER RES, V15, P541, DOI 10.1359/jbmr.2000.15.3.541; Pacifici R, 2012, J BONE MINER RES, V27, P231, DOI 10.1002/jbmr.1500; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perlot T, 2012, J IMMUNOL, V188, P1201, DOI 10.4049/jimmunol.1102063; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Proell V, 2009, BONE, V45, P677, DOI 10.1016/j.bone.2009.05.024; Pugliese LS, 2012, IMMUNOBIOLOGY, V217, P336, DOI 10.1016/j.imbio.2011.07.014; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sato T, 2001, J BONE MINER RES, V16, P2215, DOI 10.1359/jbmr.2001.16.12.2215; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Taxel P, 2008, OSTEOPOROSIS INT, V19, P193, DOI 10.1007/s00198-007-0452-7; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	53	161	172	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29851	29860		10.1074/jbc.M112.377945	http://dx.doi.org/10.1074/jbc.M112.377945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782898	Green Published, hybrid			2022-12-25	WOS:000308286900059
J	Raynes, R; Leckey, BD; Nguyen, K; Westerheide, SD				Raynes, Rachel; Leckey, Bruce D., Jr.; Kevin Nguyen; Westerheide, Sandy D.			Heat Shock and Caloric Restriction Have a Synergistic Effect on the Heat Shock Response in a sir2.1-dependent Manner in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; DIETARY RESTRICTION; MESSENGER-RNA; DECREASED EXPRESSION; GENE-TRANSCRIPTION; CELL-SURVIVAL; FACTOR-I; PROTEIN; STRESS; HEAT-SHOCK-PROTEIN-70	The heat shock response (HSR) is responsible for maintaining cellular and organismal health through the regulation of proteostasis. Recent data demonstrating that the mammalian HSR is regulated by SIRT1 suggest that this response may be under metabolic control. To test this hypothesis, we have determined the effect of caloric restriction in Caenorhabditis elegans on activation of the HSR and have found a synergistic effect on the induction of hsp70 gene expression. The homolog of mammalian SIRT1 in C. elegans is Sir2.1. Using a mutated C. elegans strain with a sir2.1 deletion, we show that heat shock and caloric restriction cooperate to promote increased survivability and fitness in a sir2.1-dependent manner. Finally, we show that caloric restriction increases the ability of heat shock to preserve movement in a polyglutamine toxicity neurodegenerative disease model and that this effect is dependent on sir2.1.	[Raynes, Rachel; Leckey, Bruce D., Jr.; Kevin Nguyen; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, 4202 E Fowler Ave,ISA2015, Tampa, FL 33620 USA.	swesterheide@usf.edu			Department of Cell Biology, Microbiology and Molecular of the University of South Florida; National Institutes of Health; Canadian Institutes of Health Research; Genome Canada; Genome BC; Michael Smith Foundation; National Institutes of Health National Center for Research Resources	Department of Cell Biology, Microbiology and Molecular of the University of South Florida; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Genome BC; Michael Smith Foundation(Michael Smith Foundation for Health Research); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a departmental start-up grant from the Department of Cell Biology, Microbiology and Molecular of the University of South Florida (to S. D. W.).; We thank Dr. R. I. Morimoto (Northwestern University, Evanston, IL) for providing the C. elegans C12C8.1::GFP, Q0-YFP, Q24-YFP, and Q35-YFP strains. The sir2.1(ok434) IV and sir2.3(ok444) X strains were provided by the C. elegans Gene Knockout Consortium (C. elegans Gene Knockout Facility at the Oklahoma Medical Research Foundation, which is funded by the National Institutes of Health, and the C. elegans Reverse Genetics Core Facility at the University of British Columbia, which is funded by the Canadian Institutes of Health Research, Genome Canada, Genome BC, the Michael Smith Foundation, and the National Institutes of Health). Other strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We thank Dr. C. Voisine (Northwestern University) and Dr. James West (College of Wooster, Wooster, OH) for helpful comments and advice.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; ANGELIDIS CE, 1991, EUR J BIOCHEM, V199, P35, DOI 10.1111/j.1432-1033.1991.tb16088.x; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; CAMPANINI C, 1992, ANN NY ACAD SCI, V663, P442, DOI 10.1111/j.1749-6632.1992.tb38695.x; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; DEGUCHI Y, 1988, BIOCHEM BIOPH RES CO, V157, P580, DOI 10.1016/S0006-291X(88)80289-4; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Ehrenfried JA, 1996, ANN SURG, V223, P592, DOI 10.1097/00000658-199605000-00015; FAASSEN AE, 1989, EXP CELL RES, V183, P326, DOI 10.1016/0014-4827(89)90393-5; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Heydari AR, 1996, DEV GENET, V18, P114, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;114::AID-DVG4&gt;3.0.CO;2-C; HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909; Johnson TE, 2008, EXP GERONTOL, V43, P1, DOI 10.1016/j.exger.2007.09.008; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LEE BS, 1995, P NATL ACAD SCI USA, V92, P7207, DOI 10.1073/pnas.92.16.7207; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LIU AYC, 1989, J BIOL CHEM, V264, P12037; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MCCAY CM, 1989, NUTRITION, V5, P155; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; PAHLAVANI MA, 1995, EXP CELL RES, V218, P310, DOI 10.1006/excr.1995.1160; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Torok Z, 2003, P NATL ACAD SCI USA, V100, P3131, DOI 10.1073/pnas.0438003100; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	54	48	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29045	29053		10.1074/jbc.M112.353714	http://dx.doi.org/10.1074/jbc.M112.353714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22778258	hybrid, Green Published			2022-12-25	WOS:000308074600071
J	Finan, K; Torella, JP; Kapanidis, AN; Cook, PR				Finan, Kieran; Torella, Joseph P.; Kapanidis, Achillefs N.; Cook, Peter R.			T7 RNA Polymerase Functions In Vitro without Clustering	PLOS ONE			English	Article							ELONGATION COMPLEXES; TRANSCRIPTION ELONGATION; REPLICATION FACTORIES; ESCHERICHIA-COLI; STRUCTURAL BASIS; STATE KINETICS; DNA-POLYMERASE; INITIATION; BACTERIOPHAGE-T7; VISUALIZATION	Many nucleic acid polymerases function in clusters known as factories. We investigate whether the RNA polymerase ( RNAP) of phage T7 also clusters when active. Using 'pulldowns' and fluorescence correlation spectroscopy we find that elongation complexes do not interact in vitro with a K-d < 1 mu M. Chromosome conformation capture also reveals that genes located 100 kb apart on the E. coli chromosome do not associate more frequently when transcribed by T7 RNAP. We conclude that if clustering does occur in vivo, it must be driven by weak interactions, or mediated by a phage-encoded protein.	[Finan, Kieran; Cook, Peter R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Torella, Joseph P.; Kapanidis, Achillefs N.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford; University of Oxford	Finan, K (corresponding author), Univ Wurzburg, Dept Biotechnol & Biophys, Wurzburg, Germany.	peter.cook@path.ox.ac.uk		Cook, Peter/0000-0002-6639-188X	E.P. Abraham Trust; University of Oxford; UK government; European Commission [FP7/2007-2013 HEALTH-F4-2008-201418]; UK BBSRC [BB/H01795X/1]; BBSRC [BB/H01795X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01795X/1] Funding Source: researchfish	E.P. Abraham Trust; University of Oxford; UK government; European Commission(European CommissionEuropean Commission Joint Research Centre); UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	K.F. was supported by the E.P. Abraham Trust, a Clarendon Fund award from the University of Oxford, and an Overseas Research Student Award from the UK government. J.P.T. was supported by a Clarendon Award from the University of Oxford. A.N.K. was supported by a European Commission Seventh Framework Program grant (FP7/2007-2013 HEALTH-F4-2008-201418) and a UK BBSRC grant (BB/H01795X/1). P.R.C. is E.P. Abraham Professor of Cell Biology and a Professorial Fellow of Lincoln College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Choudhry MA, 2004, BIOCHEM SOC T, V32, P1103, DOI 10.1042/BST0321103; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; COOK PR, 1992, NUCLEIC ACIDS RES, V20, P3591, DOI 10.1093/nar/20.14.3591; Cseresnyes Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-88; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Jung G, 2007, MODERN RES ED TOPICS, V1, P855; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; MASLAK M, 1994, BIOCHEMISTRY-US, V33, P6918, DOI 10.1021/bi00188a022; MCCLELLAND M, 1988, NUCLEIC ACIDS RES, V16, P364, DOI 10.1093/nar/16.1.364; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Miele A, 2006, CURR PROTOC MOL BIOL, V21, P1; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Muller C, 2008, EPL, V83, DOI [10.1209/0295-5075/1283/46001, DOI 10.1209/0295-5075/1283/46001]; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Papantonis A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000419; PATA JD, 1995, RNA, V1, P466; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; Santoso Y, 2009, ANAL CHEM, V81, P9561, DOI 10.1021/ac901423e; Sastry SS, 1997, J BIOL CHEM, V272, P8644, DOI 10.1074/jbc.272.13.8644; Skinner GM, 2004, J BIOL CHEM, V279, P3239, DOI 10.1074/jbc.M310471200; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; TENHEGGELERBORDIER B, 1992, EMBO J, V11, P667, DOI 10.1002/j.1460-2075.1992.tb05098.x; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; ZAWADZKI V, 1991, NUCLEIC ACIDS RES, V19, P1948, DOI 10.1093/nar/19.8.1948; Zhou Y, 2006, J BIOL CHEM, V281, P24441, DOI 10.1074/jbc.M604369200	47	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40207	10.1371/journal.pone.0040207	http://dx.doi.org/10.1371/journal.pone.0040207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768341	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500054
J	Vasanthakumar, B; Ravishankar, H; Subramanian, S				Vasanthakumar, Balasubramanian; Ravishankar, Honnavar; Subramanian, Sankaran			A Novel Property of DNA - As a Bioflotation Reagent in Mineral Processing	PLOS ONE			English	Article							SPHALERITE; FLOTATION; ACID	Environmental concerns regarding the use of certain chemicals in the froth flotation of minerals have led investigators to explore biological entities as potential substitutes for the reagents in vogue. Despite the fact that several microorganisms have been used for the separation of a variety of mineral systems, a detailed characterization of the biochemical molecules involved therein has not been reported so far. In this investigation, the selective flotation of sphalerite from a sphalerite-galena mineral mixture has been achieved using the cellular components of Bacillus species. The key constituent primarily responsible for the flotation of sphalerite has been identified as DNA, which functions as a bio-collector. Furthermore, using reconstitution studies, the obligatory need for the presence of non-DNA components as bio-depressants for galena has been demonstrated. A probable model involving these entities in the selective flotation of sphalerite from the mineral mixture has been discussed.	[Vasanthakumar, Balasubramanian; Ravishankar, Honnavar; Subramanian, Sankaran] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Vasanthakumar, B (corresponding author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.	ssmani@materials.iisc.ernet.in						Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; BROMFIELD SM, 1954, J GEN MICROBIOL, V11, P1; Chandraprabha MN, 2010, MIN PROC EXT MET REV, V31, P1, DOI 10.1080/08827500903404682; Draghi JA, 2006, MICROBIOL-SGM, V152, P2683, DOI 10.1099/mic.0.29013-0; DUGUID J, 1993, BIOPHYS J, V65, P1916, DOI 10.1016/S0006-3495(93)81263-3; FELSENFE.G, 1967, ANNU REV BIOCHEM, V36, P407, DOI 10.1146/annurev.bi.36.070167.002203; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fuerstenau D.W., 1957, ENG MIN J, V158, P93; Gaudin A.M., 1957, FLOTATION, P573; HARRISON STL, 1991, BIOTECHNOL ADV, V9, P217, DOI 10.1016/0734-9750(91)90005-G; Holmes DS, 1995, MINERAL BIOPROCESSIN, VII; HUANG PC, 1966, ANAL BIOCHEM, V16, P107, DOI 10.1016/0003-2697(66)90085-6; IZATT RM, 1971, CHEM REV, V71, P439, DOI 10.1021/cr60273a002; Kuyucak N, 1998, 3 INT C MIN BIOPR BI; Pelta J, 1996, J BIOL CHEM, V271, P5656, DOI 10.1074/jbc.271.10.5656; Perks B, 2000, AM J RESP CRIT CARE, V162, P1767, DOI 10.1164/ajrccm.162.5.9908107; Rao KH, 2010, HYDROMETALLURGY, V104, P465, DOI 10.1016/j.hydromet.2010.01.016; Rao KH, 2001, INT J MINER PROCESS, V62; RAO KH, 2007, MICR PROC MET SULF, P267; RASANEN L, 1982, IMMUNOLOGY, V46, P481; Rath RK, 1999, INT J MINER PROCESS, V57, P265, DOI 10.1016/S0301-7516(99)00028-9; RUBIN RL, 1977, J BACTERIOL, V129, P916, DOI 10.1128/JB.129.2.916-925.1977; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santhiya D, 2002, J COLLOID INTERF SCI, V256, P237, DOI 10.1006/jcis.2002.8681; Santhiya D, 2001, J COLLOID INTERF SCI, V235, P289, DOI 10.1006/jcis.2000.7374; Smith R.W., 1991, MINERAL BIOPROCESSIN; Smith RW, 2006, MINER ENG, V19, P548, DOI 10.1016/j.mineng.2005.09.007; STOLL VS, 1990, METHOD ENZYMOL, V182, P24; Vollmer W, 2012, NAT CHEM BIOL, V8, P14, DOI 10.1038/nchembio.748; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Xia F, 2010, J AM CHEM SOC, V132, P1252, DOI 10.1021/ja908890q	32	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39316	10.1371/journal.pone.0039316	http://dx.doi.org/10.1371/journal.pone.0039316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768298	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500011
J	Bi, Q; Tang, SH; Xia, L; Du, R; Fan, R; Gao, LC; Jin, J; Liang, SH; Chen, Z; Xu, GH; Nie, YZ; Wu, KC; Liu, J; Shi, YQ; Ding, J; Fan, DM				Bi, Qian; Tang, Shanhong; Xia, Lin; Du, Rui; Fan, Rui; Gao, Liucun; Jin, Jiang; Liang, Shuhui; Chen, Zheng; Xu, Guanghui; Nie, Yongzhan; Wu, Kaichun; Liu, Jie; Shi, Yongquan; Ding, Jie; Fan, Daiming			Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL; INVASION; CANCER; HSA-MIR-125A-5P; MODULATION; LIVER	Background: Studies have been shown that miR-125a plays an important role in carcinogenesis, however, the role of miR-125a in hepatocellular carcinoma (HCC) remains elusive. Methodology/Principal: Real time-PCR (qRT-PCR) was performed to test the significance of miR-125a in HCC. Ectopic expression of miR-125a was used to test the influences of miR-125a on proliferation and metastasis of HCC cells in vitro and in vivo. Predicted target genes of miR-125a were determined by dual-luciferase reporting, qRT-PCR, and western blot (WB) analyses. Then immunohistochemical staining (IHC) was used to detect the expression of target genes, and the correlations and prognostic values of miR-125a and its target genes were also investigated. Conclusions/Significance: Decreased miR-125a was observed in both HCC tissues and cell lines, and associated with patients' aggressive pathologic features. Up-regulating miR-125a significantly inhibited the malignant phenotypes by repressing the expression of matrix metalloproteinase 11 (MMP11) and vascular endothelial growth factor A (VEGF-A) both in vitro and in vivo. Furthermore, miR-125a expression was inversely correlated with both MMP11 and VEGF-A expression in HCC tissues. Inhibiting miR-125a could increase both MMP11 and VEGF-A expression, and RNA interference targeting MMP11 or VEGF-A mRNA could rescue the loss of miR-125a functions. MiR-125a inhibits the proliferation and metastasis of HCC by targeting MMP11 and VEGF-A. Up-regulation of miR-125a might be a promising approach and a prognostic marker for HCC.	[Bi, Qian; Tang, Shanhong; Xia, Lin; Du, Rui; Fan, Rui; Gao, Liucun; Jin, Jiang; Liang, Shuhui; Chen, Zheng; Xu, Guanghui; Nie, Yongzhan; Wu, Kaichun; Liu, Jie; Shi, Yongquan; Ding, Jie; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200433, Peoples R China	Air Force Military Medical University; Fudan University	Bi, Q (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China.	shiyquan@fmmu.edu.cn; dingjie@fmmu.edu.cn	Shi, Yongquan/AAE-3954-2020; BI, QIAN/GWV-4943-2022; gao, Liu/AAH-5970-2019		National Basic Research Program of China [2010CB732400]; National Natural Science Foundation of China [30973428, 30900674, 30970149]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (No. 2010CB732400) and National Natural Science Foundation of China (No. 30973428, 30900674 and 30970149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chow NH, 1997, HUM PATHOL, V28, P698, DOI 10.1016/S0046-8177(97)90179-9; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Fan R, 2011, INT J CANCER, V128, P2980, DOI 10.1002/ijc.25624; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; He XX, 2011, ONCOGENE; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li XM, 1998, J EXP CLIN CANC RES, V17, P13; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Liang S, 2011, PLOS ONE, V18; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Meng F, 2009, GASTROENTEROLOGY, V133, P647; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Raskop E, 2011, CURR PHARM BIOTECHNO, V24; Raskopf E, 2008, J HEPATOL, V49, P977, DOI 10.1016/j.jhep.2008.07.022; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Tang SH, 2010, CANCER BIOL THER, V9, P88, DOI 10.4161/cbt.9.2.10283; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Yang F, 2011, NEOPLASIA, V13, P590, DOI 10.1593/neo.11422; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002; Zhao YM, 2011, CANCER	29	150	159	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40169	10.1371/journal.pone.0040169	http://dx.doi.org/10.1371/journal.pone.0040169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768249	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100222
J	Frezzato, F; Gattazzo, C; Martini, V; Trimarco, V; Teramo, A; Carraro, S; Cabrelle, A; Ave, E; Facco, M; Zambello, R; Tibaldi, E; Brunati, AM; Semenzato, G; Trentin, L				Frezzato, Federica; Gattazzo, Cristina; Martini, Veronica; Trimarco, Valentina; Teramo, Antonella; Carraro, Samuela; Cabrelle, Anna; Ave, Elisa; Facco, Monica; Zambello, Renato; Tibaldi, Elena; Brunati, Anna Maria; Semenzato, Gianpietro; Trentin, Livio			HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen	PLOS ONE			English	Article							VARIABLE-REGION MUTATIONS; PROTEIN-TYROSINE KINASE; HEMATOPOIETIC LINEAGE; MEDIATED APOPTOSIS; ACTIN-BINDING; CELL; SRC; PHOSPHORYLATION; COMPLEX; ACTIVATION	In B-Chronic Lymphocytic Leukemia (B-CLL) kinase Lyn is overexpressed, active, abnormally distributed, and part of a cytosolic complex involving hematopoietic lineage cell-specific protein 1 (HS1). These aberrant properties of Lyn could partially explain leukemic cells' defective apoptosis, directly or through its substrates, for example, HS1 that has been associated to apoptosis in different cell types. To verify the hypothesis of HS1 involvement in Lyn-mediated leukemic cell survival, we investigated HS1 protein in 71 untreated B-CLL patients and 26 healthy controls. We found HS1 overexpressed in leukemic as compared to normal B lymphocytes (1.38 +/- 0.54 vs 0.86 +/- 0.29, p < 0.01), and when HS1 levels were correlated to clinical parameters we found a higher expression of HS1 in poor-prognosis patients. Moreover, HS1 levels significantly decreased in ex vivo leukemic cells of patients responding to a fludarabine-containing regimen. We also observed that HS1 is partially localized in the nucleus of neoplastic B cells. All these data add new information on HS1 study, hypothesizing a pivotal role of HS1 in Lyn-mediated modulation of leukemic cells' survival and focusing, one more time, the attention on the BCR-Lyn axis as a putative target for new therapeutic strategies in this disorder.	[Frezzato, Federica; Gattazzo, Cristina; Martini, Veronica; Trimarco, Valentina; Teramo, Antonella; Cabrelle, Anna; Ave, Elisa; Facco, Monica; Zambello, Renato; Semenzato, Gianpietro; Trentin, Livio] Ctr Eccellenza Ric Biomed, Venetian Inst Mol Med, Padua, Italy; [Frezzato, Federica; Gattazzo, Cristina; Martini, Veronica; Trimarco, Valentina; Teramo, Antonella; Carraro, Samuela; Ave, Elisa; Facco, Monica; Zambello, Renato; Semenzato, Gianpietro; Trentin, Livio] Univ Padua, Sch Med, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy; [Tibaldi, Elena; Brunati, Anna Maria] Univ Padua, Dept Mol Med, Padua, Italy	Veneto Institute Molecular Medicine; University of Padua; University of Padua	Frezzato, F (corresponding author), Ctr Eccellenza Ric Biomed, Venetian Inst Mol Med, Padua, Italy.	g.semenzato@unipd.it	TERAMO, ANTONELLA/AFR-2599-2022; SEMENZATO, GIANPIETRO C/J-7727-2016; Martini, Veronica/AAV-6339-2020; Zambello, Renato/AAB-5280-2022; Facco, Monica/F-7732-2017; TRENTIN, LIVIO/J-7676-2016; Martini, Veronica/J-8656-2016; Teramo, Antonella/K-1988-2016; Frezzato, Federica/J-7260-2016; FREZZATO, Federica/V-5802-2019; Brunati, Anna Maria/I-8136-2018; TRENTIN, LIVIO/L-6678-2019	TERAMO, ANTONELLA/0000-0002-2754-699X; SEMENZATO, GIANPIETRO C/0000-0002-6061-4595; Zambello, Renato/0000-0002-8799-5324; Facco, Monica/0000-0003-0100-5789; TRENTIN, LIVIO/0000-0003-1222-6149; Martini, Veronica/0000-0002-0887-4082; Teramo, Antonella/0000-0002-2754-699X; Frezzato, Federica/0000-0001-7093-2493; FREZZATO, Federica/0000-0001-7093-2493; Brunati, Anna Maria/0000-0002-3481-9503; TRENTIN, LIVIO/0000-0003-1222-6149	Ministero dell'Istruzione dell'Universita e della Ricerca; University of Padova (Progetto di Ateneo); Associazione Italiana per la Ricerca sul Cancro (Milan); Regione Veneto on chronic lymphocytic leukemia	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Padova (Progetto di Ateneo); Associazione Italiana per la Ricerca sul Cancro (Milan)(Fondazione AIRC per la ricerca sul cancro); Regione Veneto on chronic lymphocytic leukemia(Regione Veneto)	This work was supported by grants (Prin 2008) from Ministero dell'Istruzione dell'Universita e della Ricerca and University of Padova (Progetto di Ateneo 2005), Associazione Italiana per la Ricerca sul Cancro (Milan), and Regione Veneto on chronic lymphocytic leukemia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunati AM, 1999, J BIOL CHEM, V274, P7557, DOI 10.1074/jbc.274.11.7557; Chen YR, 2001, BIOCHEM BIOPH RES CO, V288, P981, DOI 10.1006/bbrc.2001.5862; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Danilov AV, 2006, CURR MOL MED, V6, P665, DOI 10.2174/156652406778195008; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; FUKUDA T, 1995, P NATL ACAD SCI USA, V92, P7302, DOI 10.1073/pnas.92.16.7302; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1997, BLOOD REV, V11, P119, DOI 10.1016/S0268-960X(97)90007-2; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; He H, 1998, MOL CELL BIOL, V18, P3829, DOI 10.1128/MCB.18.7.3829; Hussein K, 2009, ANN HEMATOL, V88, P1059, DOI 10.1007/s00277-009-0727-5; KITAMURA D, 1989, NUCLEIC ACIDS RES, V17, P9367; Lee F, 2008, INT J BIOCHEM CELL B, V40, P334, DOI 10.1016/j.biocel.2007.10.001; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pugh-Bernard AE, 2006, CURR OPIN RHEUMATOL, V18, P451, DOI 10.1097/01.bor.0000240353.99808.5f; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Ruzzene M, 2000, EUR J BIOCHEM, V267, P3065, DOI 10.1046/j.1432-1327.2000.01333.x; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Scielzo C, 2005, J CLIN INVEST, V115, P1644, DOI 10.1172/JCI24276; Scielzo C, 2010, BLOOD, V116, P3537, DOI 10.1182/blood-2009-12-258814; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Trentin L, 2008, BLOOD, V112, P4665, DOI 10.1182/blood-2008-02-139139; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Warr MR, 2008, CURR MOL MED, V8, P138; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387	34	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39902	10.1371/journal.pone.0039902	http://dx.doi.org/10.1371/journal.pone.0039902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768161	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100130
J	Havermann, K; Volcic, R; Lappe, M				Havermann, Katharina; Volcic, Robert; Lappe, Markus			Saccadic Adaptation to Moving Targets	PLOS ONE			English	Article							PURSUIT EYE-MOVEMENTS; ADAPTIVE MODIFICATIONS; ERROR SIGNALS; VISUAL ERROR; SHORT-TERM; MECHANISMS; MEMORY	Saccades are so called ballistic movements which are executed without online visual feedback. After each saccade the saccadic motor plan is modified in response to post-saccadic feedback with the mechanism of saccadic adaptation. The post-saccadic feedback is provided by the retinal position of the target after the saccade. If the target moves after the saccade, gaze may follow the moving target. In that case, the eyes are controlled by the pursuit system, a system that controls smooth eye movements. Although these two systems have in the past been considered as mostly independent, recent lines of research point towards many interactions between them. We were interested in the question if saccade amplitude adaptation is induced when the target moves smoothly after the saccade. Prior studies of saccadic adaptation have considered intra-saccadic target steps as learning signals. In the present study, the intra-saccadic target step of the McLaughlin paradigm of saccadic adaptation was replaced by target movement, and a post-saccadic pursuit of the target. We found that saccadic adaptation occurred in this situation, a further indication of an interaction of the saccadic system and the pursuit system with the aim of optimized eye movements.	[Havermann, Katharina; Lappe, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Dept Psychol, Munster, Germany; [Volcic, Robert] Ist Italiano Tecnol, UniTn, Ctr Neurosci & Cognit Syst, Rovereto, Italy	University of Munster; Istituto Italiano di Tecnologia - IIT	Havermann, K (corresponding author), Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Dept Psychol, Munster, Germany.	k.havermann@wwu.de	Volcic, Robert/B-4944-2009	Volcic, Robert/0000-0002-0170-4136	German Science Foundation DFG [LA-952/3]; German Federal Ministry of Education and Research	German Science Foundation DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	ML is supported by the German Science Foundation DFG LA-952/3, the German Federal Ministry of Education and Research project Visuo-spatial Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1772, DOI 10.1152/jn.00621.2001; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; Eggert T, 2005, ANN NY ACAD SCI, V1039, P149, DOI 10.1196/annals.1325.014; Etchells PJ, 2010, J VISION, V10, DOI 10.1167/10.6.7; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Ethier V, 2008, J NEUROSCI, V28, P13929, DOI 10.1523/JNEUROSCI.3470-08.2008; Fuchs AF, 1996, J NEUROPHYSIOL, V76, P2522, DOI 10.1152/jn.1996.76.4.2522; Fujita M, 2002, COGNITIVE BRAIN RES, V13, P41, DOI 10.1016/S0926-6410(01)00088-X; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; Havermann K, 2010, J NEUROPHYSIOL, V103, P3302, DOI 10.1152/jn.00970.2009; HEYWOOD S, 1981, VISION RES, V21, P479, DOI 10.1016/0042-6989(81)90094-8; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Nagao S, 1998, NEUROSCI RES, V32, P157, DOI 10.1016/S0168-0102(98)00079-0; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Ogawa T, 1997, EXP BRAIN RES, V116, P83, DOI 10.1007/PL00005747; Panouilleres M, 2009, J NEUROPHYSIOL, V101, P1550, DOI 10.1152/jn.90988.2008; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; Schnier F, 2011, J NEUROPHYSIOL, V106, P1399, DOI 10.1152/jn.00236.2011; Schutz AC, 2011, EXP BRAIN RES, V209, P537, DOI 10.1007/s00221-011-2581-7; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; Shafer JL, 2000, J NEUROPHYSIOL, V84, P88, DOI 10.1152/jn.2000.84.1.88; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	30	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39708	10.1371/journal.pone.0039708	http://dx.doi.org/10.1371/journal.pone.0039708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768109	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100079
J	Keshvari, S; van den Berg, R; Ma, WJ				Keshvari, Shaiyan; van den Berg, Ronald; Ma, Wei Ji			Probabilistic Computation in Human Perception under Variability in Encoding Precision	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; ATTENTION; INFERENCE; RESPONSES; BRAIN; DISCRIMINATION; UNCERTAINTY; INFORMATION; PERFORMANCE; CAPACITY	A key function of the brain is to interpret noisy sensory information. To do so optimally, observers must, in many tasks, take into account knowledge of the precision with which stimuli are encoded. In an orientation change detection task, we find that encoding precision does not only depend on an experimentally controlled reliability parameter (shape), but also exhibits additional variability. In spite of variability in precision, human subjects seem to take into account precision near-optimally on a trial-to-trial and item-to-item basis. Our results offer a new conceptualization of the encoding of sensory information and highlight the brain's remarkable ability to incorporate knowledge of uncertainty during complex perceptual decision-making.	[Keshvari, Shaiyan; van den Berg, Ronald; Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Keshvari, S (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	wjma@bcm.edu		/0000-0002-5907-6259; Ma, Wei Ji/0000-0002-9835-9083; van den Berg, Ronald/0000-0001-7353-5960	National Eye Institute [R01EY020958]; Netherlands Organisation for Scientific Research; NATIONAL EYE INSTITUTE [R01EY020958] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	WJM is supported by award number R01EY020958 from the National Eye Institute (http://www.nei.nih.gov/). RvdB is supported by the Netherlands Organisation for Scientific Research (http://www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Baldassi S, 2002, J VISION, V2, DOI 10.1167/2.8.3; Brady TF, 2010, COGNITION IN FLUX, P411; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Eng HY, 2005, PSYCHON B REV, V12, P1127, DOI 10.3758/BF03206454; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FRENCH RS, 1953, J EXP PSYCHOL, V46, P1, DOI 10.1037/h0059543; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Girshick AR, 2009, J VISION, V9, DOI 10.1167/9.9.8; Goris RLT, 2012, USING DOUBLY STOCHAS; Green DM, 1966, SIGNAL DETECTION THE; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Ma WJ, 2010, VISION RES, V50, P2308, DOI 10.1016/j.visres.2010.08.035; Ma WJ, 2009, J VISION, V9, DOI 10.1167/9.11.3; MacKay D. J. C., 2003, INFORM THEORY INFERE; Matthias E, 2009, NEUROPSYCHOLOGIA, V47, P3255, DOI 10.1016/j.neuropsychologia.2009.08.004; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Natarajan R, 2009, ADV NEURAL INFORM PR, V21; NOLTE LW, 1967, J ACOUST SOC AM, V41, P497, DOI 10.1121/1.1910360; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Reddy L, 2006, CURR BIOL, V2006, P20; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Saproo S, 2010, J NEUROPHYSIOL, V104, P885, DOI 10.1152/jn.00369.2010; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Van den Berg R, 2012, P NATL ACAD SCI US, V109; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P3178, DOI 10.1073/pnas.1108790109; Whiteley L, 2008, J VISION, V8, DOI 10.1167/8.3.2; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Yule GU, 1902, BIOMETRIKA, V2, P121	49	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40216	10.1371/journal.pone.0040216	http://dx.doi.org/10.1371/journal.pone.0040216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768258	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100231
J	Le Vu, S; Velter, A; Meyer, L; Peytavin, G; Guinard, J; Pillonel, J; Barin, F; Semaille, C				Le Vu, Stephane; Velter, Annie; Meyer, Laurence; Peytavin, Gilles; Guinard, Jerome; Pillonel, Josiane; Barin, Francis; Semaille, Caroline			Biomarker-Based HIV Incidence in a Community Sample of Men Who Have Sex with Men in Paris, France	PLOS ONE			English	Article							SEROLOGIC TESTING ALGORITHM; UNDIAGNOSED INFECTION; GAY MEN; EPIDEMIC; IMMUNOASSAY; PREVALENCE; BIAS	Background: Population-based estimates of HIV incidence in France have revealed that men who have sex with men (MSM) are the most affected population and contribute to nearly half of new infections each year. We sought to estimate HIV incidence among sexually active MSM in Paris gay community social venues. Methodology/Principal Findings: A cross-sectional survey was conducted in 2009 in a sample of commercial venues such as bars, saunas and backrooms. We collected a behavioural questionnaire and blood sample. Specimens were tested for HIV infection and positive specimens then tested for recent infection by the enzyme immunoassay for recent HIV-1 infection (EIA-RI). We assessed the presence of antiretroviral therapy among infected individuals to rule out treated patients in the algorithm that determined recent infection. Biomarker-based cross-sectional incidence estimates were calculated. We enrolled 886 MSM participants among which 157 (18%) tested HIV positive. In positive individuals who knew they were infected, 75% of EIA-RI positive results were due to ART. Of 157 HIV positive specimens, 15 were deemed to be recently infected. The overall HIV incidence was estimated at 3.8% person-years(py) [95% CI: 1.5-6.2]. Although differences were not significant, incidence was estimated to be 3.5% py [0.1-6.1] in men having had a negative HIV test in previous year and 4.8% py [0.1-10.6] in men having had their last HIV test more than one year before the survey, or never tested. Incidence was estimated at 4.1% py [0-8.3] in men under 35 years and 2.5% py [0-5.4] in older men. Conclusions/Significance: This is the first community-based survey to estimate HIV incidence among MSM in France. It includes ART detection and reveals a high level of HIV transmission in sexually active individuals, despite a high uptake of HIV testing. These data call for effective prevention programs targeting MSM engaged in high-risk behaviours.	[Le Vu, Stephane; Velter, Annie; Pillonel, Josiane; Barin, Francis; Semaille, Caroline] Inst Veille Sanit, St Maurice, France; [Meyer, Laurence] Univ Paris Sud, Ctr Res Epidemiol & Populat Hlth, F-94275 Le Kremlin Bicetre, France; [Peytavin, Gilles] Paris VII Diderot Univ, Clin Pharmacokinet Dept, Bichat Claude Bernard Hosp, APHP, Paris, France; [Guinard, Jerome] Univ Tours, Univ Hosp Bretonneau, Natl HIV Reference Ctr, Natl Inst Hlth & Med Res,INSERM, Tours, France	Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Le Vu, S (corresponding author), Inst Veille Sanit, St Maurice, France.	s.levu@invs.sante.fr		Le Vu, Stephane/0000-0002-1303-8281	French National Institute for Public Health Surveillance (InVS); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Institute for Public Health Surveillance (InVS); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	The Prevagay survey was funded by the French National Institute for Public Health Surveillance (InVS) and the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Chaillon A, 2011, 18 C RETR OPP INF BO; Dodds JP, 2007, SEX TRANSM INFECT, V83, P392, DOI 10.1136/sti.2006.021782; Folch C, 2009, Euro Surveill, V14; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jung BH, 2007, BIOMED CHROMATOGR, V21, P1095, DOI 10.1002/bmc.865; Le Vu S, 2008, Euro Surveill, V13; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Le Vu S, 2009, AIDS, V23, P1771, DOI 10.1097/QAD.0b013e32832d8754; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; Pedrana AE, 2012, JAIDS-J ACQ IMM DEF, V59, P94, DOI 10.1097/QAI.0b013e3182396869; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Stall R, 2009, AIDS BEHAV, V13, P615, DOI 10.1007/s10461-008-9509-7; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Vanden Berghe W, 2011, EUROSURVEILLANCE, V16, P10; Velter A., 2010, Bulletin Epidemiologique Hebdomadaire, P464; Velter A, 2009, Euro Surveill, V14; Velter A, 2006, B EPIDEMIOLOGIQUE HE, P178; Velter A, 2007, ENQUETE PRESSE GAY 2; White E, 2010, SEX TRANSM INFECT, V86, P254, DOI 10.1136/sti.2009.037291; Williamson LM, 2007, JAIDS-J ACQ IMM DEF, V45, P224, DOI 10.1097/QAI.0b013e318058a01e; Yeni P, 2010, PRISE CHARGE MED PER	28	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39872	10.1371/journal.pone.0039872	http://dx.doi.org/10.1371/journal.pone.0039872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768150	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100119
J	Poole, B; Markowitz, JE; Gardner, TJ				Poole, Barish; Markowitz, Jeffrey E.; Gardner, Timothy J.			The Song Must Go On: Resilience of the Songbird Vocal Motor Pathway	PLOS ONE			English	Article							MALE ZEBRA FINCHES; SEQUENCE GENERATION; VISUAL-CORTEX; SLEEP; PLASTICITY; NEURONS; NETWORKS; REPLAY	Stereotyped sequences of neural activity underlie learned vocal behavior in songbirds; principle neurons in the cortical motor nucleus HVC fire in stereotyped sequences with millisecond precision across multiple renditions of a song. The geometry of neural connections underlying these sequences is not known in detail though feed-forward chains are commonly assumed in theoretical models of sequential neural activity. In songbirds, a well-defined cortical-thalamic motor circuit exists but little is known the fine-grain structure of connections within each song nucleus. To examine whether the structure of song is critically dependent on long-range connections within HVC, we bilaterally transected the nucleus along the anterior-posterior axis in normal-hearing and deafened birds. The disruption leads to a slowing of song as well as an increase in acoustic variability. These effects are reversed on a time-scale of days even in deafened birds or in birds that are prevented from singing post-transection. The stereotyped song of zebra finches includes acoustic details that span from milliseconds to seconds-one of the most precise learned behaviors in the animal kingdom. This detailed motor pattern is resilient to disruption of connections at the cortical level, and the details of song variability and duration are maintained by offline homeostasis of the song circuit.	[Poole, Barish; Gardner, Timothy J.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Markowitz, Jeffrey E.] Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; [Markowitz, Jeffrey E.; Gardner, Timothy J.] Ctr Excellence Learning Educ Sci & Technol, Boston, MA USA	Boston University; Boston University	Poole, B (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	timothyg@bu.edu	Markowitz, Jeffrey/GQP-3708-2022		National Science Foundation Science of Learning Center CELEST [SBE-0354378]; Burroughs Wellcome Fund; Smith family award	National Science Foundation Science of Learning Center CELEST(National Science Foundation (NSF)NSF - Office of the Director (OD)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Smith family award	This work is supported by the National Science Foundation Science of Learning Center CELEST (SBE-0354378) and by a Career Award at the Scientific Interface to TG from the Burroughs Wellcome Fund and a Smith family award to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Foster EF, 1998, J COMP NEUROL, V397, P118; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hebb D.O., 2002, ORG BEHAV NEUROPSYCH; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Lashley K, 1951, PSYCHOLINGUISTICS BO; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Lim Y, 2011, IEEE WORKSH APPL SIG; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; MOONEY R, 1991, P NATL ACAD SCI USA, V88, P4075, DOI 10.1073/pnas.88.10.4075; O'Keefe J., 1971, BRAIN RES; Schmidt M, 2003, J NEUROPHYSIOLOGY; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	29	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38173	10.1371/journal.pone.0038173	http://dx.doi.org/10.1371/journal.pone.0038173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768040	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100011
J	Shoham, DA; Tong, LP; Lamberson, PJ; Auchincloss, AH; Zhang, J; Dugas, L; Kaufman, JS; Cooper, RS; Luke, A				Shoham, David A.; Tong, Liping; Lamberson, Peter J.; Auchincloss, Amy H.; Zhang, Jun; Dugas, Lara; Kaufman, Jay S.; Cooper, Richard S.; Luke, Amy			An Actor-Based Model of Social Network Influence on Adolescent Body Size, Screen Time, and Playing Sports	PLOS ONE			English	Article							US CHILDREN; OBESITY; OVERWEIGHT; SPREAD; PREVALENCE; CONTAGION; SELECTION; EPIDEMIC; SMOKING	Recent studies suggest that obesity may be "contagious" between individuals in social networks. Social contagion (influence), however, may not be identifiable using traditional statistical approaches because they cannot distinguish contagion from homophily (the propensity for individuals to select friends who are similar to themselves) or from shared environmental influences. In this paper, we apply the stochastic actor-based model (SABM) framework developed by Snijders and colleagues to data on adolescent body mass index (BMI), screen time, and playing active sports. Our primary hypothesis was that social influences on adolescent body size and related behaviors are independent of friend selection. Employing the SABM, we simultaneously modeled network dynamics (friendship selection based on homophily and structural characteristics of the network) and social influence. We focused on the 2 largest schools in the National Longitudinal Study of Adolescent Health (Add Health) and held the school environment constant by examining the 2 school networks separately (N = 624 and 1151). Results show support in both schools for homophily on BMI, but also for social influence on BMI. There was no evidence of homophily on screen time in either school, while only one of the schools showed homophily on playing active sports. There was, however, evidence of social influence on screen time in one of the schools, and playing active sports in both schools. These results suggest that both homophily and social influence are important in understanding patterns of adolescent obesity. Intervention efforts should take into consideration peers' influence on one another, rather than treating "high risk" adolescents in isolation.	[Shoham, David A.; Tong, Liping; Zhang, Jun; Dugas, Lara; Cooper, Richard S.; Luke, Amy] Loyola Univ Chicago, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Tong, Liping] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [Lamberson, Peter J.] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL USA; [Auchincloss, Amy H.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kaufman, Jay S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Loyola University Chicago; Loyola University Chicago; Northwestern University; Drexel University; McGill University	Shoham, DA (corresponding author), Loyola Univ Chicago, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA.	dshoham@lumc.edu		Dugas, Lara/0000-0002-0692-8585; Kaufman, Jay/0000-0003-1606-401X	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01-HD061978]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061978, P01HD031921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061978] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, under grant number U01-HD061978, "Modeling Obesity through Simulation (MOTS)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Add Health program project was funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. No direct support was received from grant P01-HD31921 for this analysis.	Alexander C, 2001, J ADOLESCENT HEALTH, V29, P22, DOI 10.1016/S1054-139X(01)00210-5; [Anonymous], SAS PROGR CDC GROWTH; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; Field AE, 2007, OBESITY, V15, P2357, DOI 10.1038/oby.2007.279; Fletcher A, 2011, J EPIDEMIOL COMMUN H, V65, P548, DOI 10.1136/jech.2010.113936; Gillum RF, 2005, NUTR J WEBSITE; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Halliday TJ, 2009, ECON HUM BIOL, V7, P181, DOI 10.1016/j.ehb.2009.05.002; Harris K. M., 2009, NATL LONGITUDINAL ST; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Johns D, 2010, SLATE; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mercken L, 2010, ADDICTION, V105, P1280, DOI 10.1111/j.1360-0443.2010.02930.x; Merrill RM, 2009, VALIDITY SELF REPORT; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Moore S, 2009, J PUBLIC HEALTH-UK, V31, P175, DOI 10.1093/pubmed/fdn104; O'Malley AJ, 2011, STAT MED, V30, P950, DOI 10.1002/sim.4190; Ogden C.L., 2010, OBESITY SOCIOECONOMI; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Ripley R.M., 2022, MANUAL RSIENA; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Snijders TAB, 2001, SOCIOL METHODOL, V31, P361, DOI 10.1111/0081-1750.00099; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Sturm R, 2008, PUBLIC HEALTH, V122, P739, DOI 10.1016/j.puhe.2008.01.004; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Valente T, 1995, NETWORK MODELS DIFFU; Valente T. W., 2009, SOCIAL NETWORKS HLTH; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wasserman S., 1994, SOCIAL NETWORK ANAL; Woodard GA, 2011, ARCH SURG-CHICAGO, V146, P1185, DOI 10.1001/archsurg.2011.244; Yakusheva O, 2009, ECON HUM BIOL, V9, P119	51	85	86	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39795	10.1371/journal.pone.0039795	http://dx.doi.org/10.1371/journal.pone.0039795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768124	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100094
J	Skelly, LR; Decety, J				Skelly, Laurie R.; Decety, Jean			Passive and Motivated Perception of Emotional Faces: Qualitative and Quantitative Changes in the Face Processing Network	PLOS ONE			English	Article							PREFRONTAL CORTEX; SOCIAL-PERCEPTION; ORBITOFRONTAL CORTEX; FACIAL EXPRESSIONS; NEURAL ACTIVATION; AMYGDALA ACTIVITY; FUSIFORM GYRUS; HUMAN BRAIN; AUTISM; FMRI	Emotionally expressive faces are processed by a distributed network of interacting sub-cortical and cortical brain regions. The components of this network have been identified and described in large part by the stimulus properties to which they are sensitive, but as face processing research matures interest has broadened to also probe dynamic interactions between these regions and top-down influences such as task demand and context. While some research has tested the robustness of affective face processing by restricting available attentional resources, it is not known whether face network processing can be augmented by increased motivation to attend to affective face stimuli. Short videos of people expressing emotions were presented to healthy participants during functional magnetic resonance imaging. Motivation to attend to the videos was manipulated by providing an incentive for improved recall performance. During the motivated condition, there was greater coherence among nodes of the face processing network, more widespread correlation between signal intensity and performance, and selective signal increases in a task-relevant subset of face processing regions, including the posterior superior temporal sulcus and right amygdala. In addition, an unexpected task-related laterality effect was seen in the amygdala. These findings provide strong evidence that motivation augmentsco-activity among nodes of the face processing network and the impact of neural activity on performance. These within-subject effects highlight the necessity to consider motivation when interpreting neural function in special populations, and to further explore the effect of task demands on face processing in healthy brains.	[Skelly, Laurie R.; Decety, Jean] Univ Chicago, Dept Psychol, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Decety, Jean] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Skelly, LR (corresponding author), Univ Chicago, Dept Psychol, Dept Psychiat & Behav Neurosci, 5848 S Univ Ave, Chicago, IL 60637 USA.	lskelly@uchicago.edu			NSF [BCS-0718480]	NSF(National Science Foundation (NSF))	This study was supported by an NSF grant (BCS-0718480) awarded to Dr. Jean Decety. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anderson AK, 2003, J NEUROSCI, V23, P5627; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Baker KB, 2004, BEHAV NEUROSCI, V118, P15, DOI 10.1037/0735-7044.118.1.15; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Berntson GG, 2003, EUR J NEUROSCI, V18, P2103, DOI 10.1046/j.1460-9568.2003.02967.x; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dadds MR, 2008, J AM ACAD CHILD PSY, V47, P455, DOI 10.1097/CHI.0b013e31816407f1; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; DAVIDSON RA, 1992, NEUROPSYCHOLOGIA, V30, P1053, DOI 10.1016/0028-3932(92)90098-7; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Elliott R, 2003, J NEUROSCI, V23, P303; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Foley E, 2012, J COGNITIVE NEUROSCI, V24, P507, DOI 10.1162/jocn_a_00120; Furl N, 2011, J COGNITIVE NEUROSCI, V23, P1723, DOI 10.1162/jocn.2010.21545; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Glascher J, 2003, J NEUROSCI, V23, P10274; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Grelotti DJ, 2005, NEUROPSYCHOLOGIA, V43, P373, DOI 10.1016/j.neuropsychologia.2004.06.015; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Harenski CL, 2010, J ABNORM PSYCHOL, V119, P863, DOI 10.1037/a0020979; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Herrington JD, 2011, NEUROIMAGE, V56, P2348, DOI 10.1016/j.neuroimage.2011.03.072; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Kadosh KC, 2010, J COGNITIVE NEUROSCI, V22, P903, DOI 10.1162/jocn.2009.21224; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kleinhans NM, 2011, NEUROIMAGE, V54, P697, DOI 10.1016/j.neuroimage.2010.07.037; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Muller JL, 2003, BIOL PSYCHIAT, V54, P152, DOI 10.1016/S0006-3223(02)01749-3; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Newman JP, 2003, SER AFFECTIVE SCI, P904; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Pessoa L, 2010, NEUROPSYCHOLOGIA, V48, P3416, DOI 10.1016/j.neuropsychologia.2010.06.038; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Reinhardt I, 2010, EUR ARCH PSY CLIN N, V260, P443, DOI 10.1007/s00406-010-0099-9; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Van Bavel JJ, 2011, J COGNITIVE NEUROSCI, V23, P3343, DOI 10.1162/jocn_a_00016; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Weng SJ, 2011, J CHILD PSYCHOL PSYC, V52, P296, DOI 10.1111/j.1469-7610.2010.02317.x; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039	78	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40371	10.1371/journal.pone.0040371	http://dx.doi.org/10.1371/journal.pone.0040371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768287	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100261
J	Takada, A; Miki, T; Kuno, A; Kouzu, H; Sunaga, D; Itoh, T; Tanno, M; Yano, T; Sato, T; Ishikawa, S; Miura, T				Takada, Akifumi; Miki, Takayuki; Kuno, Atsushi; Kouzu, Hidemichi; Sunaga, Daisuke; Itoh, Takahito; Tanno, Masaya; Yano, Toshiyuki; Sato, Tatsuya; Ishikawa, Satoko; Miura, Tetsuji			Role of ER Stress in Ventricular Contractile Dysfunction in Type 2 Diabetes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HEART-FAILURE; MYOCARDIAL-INFARCTION; TAUROURSODEOXYCHOLIC ACID; CARDIAC-FUNCTION; GENE-TRANSFER; CA2+ ATPASE; CARDIOMYOPATHY; RAT; MODEL	Background: Diabetes mellitus (DM) is associated with an increased risk of ischemic heart disease and of adverse outcomes following myocardial infarction (MI). Here we assessed the role of endoplasmic reticulum (ER) stress in ventricular dysfunction and outcomes after MI in type 2 DM (T2DM). Methodology and Principal Findings: In hearts of OLETF, a rat model of T2DM, at 25 similar to 30 weeks of age, GRP78 and GRP94, markers of ER stress, were increased and sarcoplasmic reticulum calcium ATPase (SERCA) 2a protein was reduced by 35% compared with those in LETO, a non-diabetic control. SERCA2a mRNA levels were similar, but SERCA2a protein was more ubiquitinated in OLETF than in LETO. Left ventricular (LV) end-diastolic elastance (Eed) was higher in OLETF than in LETO (53.9 +/- 5.2 vs. 20.2 +/- 5.6 mmHg/mu l), whereas LV end-systolic elastance and positive inotropic responses to beta-adrenergic stimulation were similar in OLETF and LETO. 4-Phenylbutyric acid (4-PBA), an ER stress modulator, suppressed both GRP up-regulation and SERCA2a ubiquitination and normalized SERCA2a protein level and Eed in OLETF. Sodium tauroursodeoxycholic acid, a structurally different ER stress modulator, also restored SERCA2a protein level in OLETF. Though LV dysfunction was modest, mortality within 48 h after coronary occlusion was markedly higher in OLETF than in LETO (61.3% vs. 7.7%). Telemetric recording showed that rapid progression of heart failure was responsible for the high mortality rate in OLETF. ER stress modulators failed to reduce the mortality rate after MI in OLETF. Conclusions: ER stress reduces SERCA2a protein via its augmented ubiquitination and degradation, leading to LV diastolic dysfunction in T2DM. Even at a stage without systolic LV dysfunction, susceptibility to lethal heart failure after infarction is markedly increased, which cannot be explained by ER stress or change in myocardial response to sympathetic nerve activation.	[Takada, Akifumi; Miki, Takayuki; Kuno, Atsushi; Kouzu, Hidemichi; Sunaga, Daisuke; Itoh, Takahito; Tanno, Masaya; Yano, Toshiyuki; Sato, Tatsuya; Ishikawa, Satoko; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan; [Kuno, Atsushi] Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Sato, Tatsuya] Sapporo Med Univ, Sch Med, Dept Cellular Physiol & Signal Transduct, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Takada, A (corresponding author), Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan.	miura@sapmed.ac.jp	Kouzu, Hidemichi/AAZ-3810-2020	Kouzu, Hidemichi/0000-0001-7815-1464; KUNO, ATSUSHI/0000-0001-6873-1297	Japanese Society for Promotion of Science, Tokyo, Japan [3591086]; Suhara Memorial Foundation, Sapporo, Japan	Japanese Society for Promotion of Science, Tokyo, Japan; Suhara Memorial Foundation, Sapporo, Japan	This study was supported by a Grant-in-Aid for Scientific Research (#3591086; T. Miura) from the Japanese Society for the Promotion of Science, Tokyo, Japan, and a grant from the Suhara Memorial Foundation (T. Miki), Sapporo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Bidasee KR, 2004, DIABETES, V53, P463, DOI 10.2337/diabetes.53.2.463; Bonito P, 2005, DIABETIC MED, V22, P1720, DOI 10.1111/j.1464-5491.2005.01685.x; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chandler MP, 2007, AM J PHYSIOL-HEART C, V293, pH1609, DOI 10.1152/ajpheart.01338.2006; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; George I, 2011, CARDIOVASC RES, V91, P447, DOI 10.1093/cvr/cvr106; Greer JJM, 2006, AM J PHYSIOL-HEART C, V290, pH146, DOI 10.1152/ajpheart.00583.2005; Gwathmey JK, 2011, J MOL CELL CARDIOL, V50, P803, DOI 10.1016/j.yjmcc.2010.11.011; Hotta H, 2010, CIRC RES, V106, P129, DOI 10.1161/CIRCRESAHA.109.205385; Karakikes I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006474; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Lujan HL, 2009, J CARDIOVASC PHARM T, V14, P199, DOI 10.1177/1074248409340160; Mariani JA, 2011, EUR J HEART FAIL, V13, P247, DOI 10.1093/eurjhf/hfq234; Matsushima S, 2009, AM J PHYSIOL-HEART C, V297, pH409, DOI 10.1152/ajpheart.01332.2008; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Radovits T, 2009, AM J PHYSIOL-HEART C, V297, pH125, DOI 10.1152/ajpheart.00165.2009; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH1204, DOI 10.1152/ajpheart.00892.2006; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Shah AM, 2010, EUR J HEART FAIL, V12, P1229, DOI 10.1093/eurjhf/hfq179; Shiomi T, 2003, J AM COLL CARDIOL, V42, P165, DOI 10.1016/S0735-1097(03)00509-6; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Smith HM, 2005, J MOL CELL CARDIOL, V39, P657, DOI 10.1016/j.yjmcc.2005.07.004; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Temsah RM, 1999, AM J PHYSIOL-HEART C, V277, pH584, DOI 10.1152/ajpheart.1999.277.2.H584; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Vahtola E, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-5; Vetter R, 2002, FASEB J, V16, P1657, DOI 10.1096/fj.01-1019fje; Xu JC, 2009, J CELL MOL MED, V13, P1499, DOI 10.1111/j.1582-4934.2009.00833.x; Yano T, 2006, J AM COLL CARDIOL, V47, P626, DOI 10.1016/j.jacc.2005.09.037; Zhang L, 2008, DIABETES, V57, P2158, DOI 10.2337/db08-0140; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977	43	52	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39893	10.1371/journal.pone.0039893	http://dx.doi.org/10.1371/journal.pone.0039893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768157	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100126
J	Onate, B; Vilahur, G; Ferrer-Lorente, R; Ybarra, J; Diez-Caballero, A; Ballesta-Lopez, C; Moscatiello, F; Herrero, J; Badimon, L				Onate, Blanca; Vilahur, Gemma; Ferrer-Lorente, Raquel; Ybarra, Juan; Diez-Caballero, Alberto; Ballesta-Lopez, Carlos; Moscatiello, Fabrizio; Herrero, Javier; Badimon, Lina			The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients	FASEB JOURNAL			English	Article						thrombospondin 1; cardiovascular risk factors; hypoxia; proliferation; angiogenesis; differentiation	ENDOTHELIAL PROGENITOR CELLS; CORONARY-ARTERY-DISEASE; STROMAL CELLS; BONE-MARROW; PREADIPOCYTE DIFFERENTIATION; HYPOXIA; TRANSPLANTATION; PROLIFERATION; AGE; THERAPY	It has been demonstrated that the adipose tissue, a highly functional metabolic tissue, is a reservoir of mesenchymal stem cells. The potential use of adipose-derived stem cells (ADSCs) from white adipose tissue (WAT) for organ repair and regeneration has been considered because of their obvious benefits in terms of accessibility and quantity of available sample. However, the functional capability of ADSCs from subjects with different adiposity has not been investigated. It has been our hypothesis that ADSCs from adipose tissue of patients with metabolic syndrome and high adiposity may be functionally impaired. We report that subcutaneous WAT stromal vascular fraction (SVF) from nonobese individuals had a significantly higher number of CD90(+) cells than SVF from obese patients. The isolated ADSCs from WAT of obese patients had reduced differentiation potential and were less proangiogenic. Therefore, ADSCs in adipose tissue of obese patients have lower capacity for spontaneous or therapeutic repair than ADSCs from nonobese metabolically normal individuals.-Onate, B., Vilahur, G., Ferrer-Lorente, R., Ybarra, J., Diez-Caballero, A., Ballesta-Lopez, C., Moscatiello, F., Herrero, J., Badimon, L. The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients. FASEB J. 26, 4327-4336 (2012). www.fasebj.org	[Onate, Blanca; Vilahur, Gemma; Ferrer-Lorente, Raquel; Badimon, Lina] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr, Barcelona 08025, Spain; [Onate, Blanca; Vilahur, Gemma; Ferrer-Lorente, Raquel; Badimon, Lina] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Ybarra, Juan] Resistencia Insulina SL, Barcelona, Spain; [Diez-Caballero, Alberto] Quirurg Cirujanos Asociados, Barcelona, Spain; [Moscatiello, Fabrizio; Herrero, Javier] Ctr Med Teknon, Dept Plast Surg, Barcelona, Spain; [Ballesta-Lopez, Carlos] Ctr Laparoscop Doctor Ballesta SLU, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Badimon, L (corresponding author), Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr CSIC ICCC, Av S Antoni M Claret 167, Barcelona 08025, Spain.	lbadimon@csic-iccc.org	Ferrer-Lorente, Raquel/M-4416-2014; BADIMON, LINA/O-4711-2014; BADIMON, LINA/S-2950-2019	Ferrer-Lorente, Raquel/0000-0002-2052-9011; BADIMON, LINA/0000-0002-9162-2459; 	Instituto Salud Carlos III (Madrid, Spain) [SAF2010/16549, CIBERobn-CB06/03, Retic-TERCEL RD06/0010/0017]; Fundacion Jesus Serra (Barcelona, Spain); Instituto Salud Carlos III; Spanish Ministry of Science and Innovation (MICINN) [RyC-2009-5495]; Instituto Salud Carlos III, MICINN	Instituto Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Fundacion Jesus Serra (Barcelona, Spain); Instituto Salud Carlos III(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto Salud Carlos III, MICINN	This work was supported by grants SAF2010/16549, CIBERobn-CB06/03, and Retic-TERCEL RD06/0010/0017 from Instituto Salud Carlos III (Madrid, Spain) and Fundacion Jesus Serra (Barcelona, Spain). L.B. is the Cardiovascular Research Chair, Universitat Autonoma de Barcelona (Barcelona, Spain). B.O. was the recipient of a predoctoral fellowship from Instituto Salud Carlos III. G.V. is a recipient of a contract from the Spanish Ministry of Science and Innovation (MICINN; RyC-2009-5495). R.F.-L. is a recipient of a Sara Borrell contract from Instituto Salud Carlos III, MICINN. The authors thank Marta Sanchez and Vanesa Rodriguez for their technical support. The authors declare no conflicts of interest.	Casteilla L, 2011, METHODS MOL BIOL, V702, P269, DOI 10.1007/978-1-61737-960-4_20; Casteilla L, 2010, CURR STEM CELL RES T, V5, P141, DOI 10.2174/157488810791268546; Chen JZ, 2004, CLIN SCI, V107, P273, DOI 10.1042/CS20030389; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Garcia-Diaz DF, 2011, J PHYSIOL BIOCHEM, V67, P453, DOI 10.1007/s13105-011-0081-7; Garcia-Olmo D, 2003, INT J COLORECTAL DIS, V18, P451, DOI 10.1007/s00384-003-0490-3; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Gupta V, 2008, MOL CELL ENDOCRINOL, V296, P32, DOI 10.1016/j.mce.2008.08.019; Heida NM, 2010, J AM COLL CARDIOL, V55, P357, DOI 10.1016/j.jacc.2009.09.031; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim JH, 2011, EXP DERMATOL, V20, P383, DOI 10.1111/j.1600-0625.2010.01221.x; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Madonna R, 2011, EUR J CLIN INVEST, V41, P126, DOI 10.1111/j.1365-2362.2010.02384.x; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Permana PA, 2004, AM J PHYSIOL-ENDOC M, V286, pE958, DOI 10.1152/ajpendo.00544.2003; Pilgaard L, 2009, EXP CELL RES, V315, P1937, DOI 10.1016/j.yexcr.2009.01.020; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Potier E, 2007, TISSUE ENG, V13, P1325, DOI 10.1089/ten.2006.0325; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Ramis JM, 2002, CELL MOL LIFE SCI, V59, P1960, DOI 10.1007/PL00012518; Ramunni A, 2010, BLOOD PURIFICAT, V29, P383, DOI 10.1159/000314650; Rasmussen JG, 2011, CYTOTHERAPY, V13, P318, DOI 10.3109/14653249.2010.506505; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Schipper BM, 2008, ANN PLAS SURG, V60, P538, DOI 10.1097/SAP.0b013e3181723bbe; Sheng LL, 2011, TOHOKU J EXP MED, V224, P229, DOI 10.1620/tjem.224.229; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Thangarajah H, 2009, STEM CELLS, V27, P266, DOI 10.1634/stemcells.2008-0276; van Harmelen V, 2003, INT J OBESITY, V27, P889, DOI 10.1038/sj.ijo.0802314; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yang Z, 2010, CLIN EXP HYPERTENS, V32, P444, DOI 10.3109/10641961003686435; Yue WS, 2010, AM J CARDIOL, V106, P1248, DOI 10.1016/j.amjcard.2010.06.045; Zhang DZ, 2007, CHINESE MED J-PEKING, V120, P300, DOI 10.1097/00029330-200702020-00009; Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	55	84	86	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4327	4336		10.1096/fj.12-207217	http://dx.doi.org/10.1096/fj.12-207217			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22772162				2022-12-25	WOS:000309704000037
J	Emberley, ED; Mosadeghi, R; Deshaies, RJ				Emberley, Ethan D.; Mosadeghi, Ruzbeh; Deshaies, Raymond J.			Deconjugation of Nedd8 from Cul1 Is Directly Regulated by Skp1-F-box and Substrate, and the COP9 Signalosome Inhibits Deneddylated SCF by a Noncatalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; COMPLEX; CANCER; ACTIVATION; DEGRADATION; INSIGHTS; CLEAVAGE; MOTIF; CONJUGATION; PROGRESSION	COP9 signalosome (CSN) mediates deconjugation of the ubiquitin-like protein Nedd8 from the cullin subunits of SCF and other cullin-RING ubiquitin ligases (CRLs). This process is essential to maintain the proper activity of CRLs in cells. Here, we report a detailed kinetic characterization of CSN-mediated deconjugation of Nedd8 from SCF. CSN is an efficient enzyme, with a k(cat) of similar to 1 s(-1) and K-m for neddylated Cul1-Rbx1 of similar to 200 nM, yielding a k(cat)/K-m near the anticipated diffusion-controlled limit. Assembly with an F-box-Skp1 complex markedly inhibited deneddylation, although the magnitude varied considerably, with Fbw7-Skp1 inhibiting by similar to 5-fold but Skp2-Cks1-Skp1 by only similar to 15%. Deneddylation of both SCFFbw7 and SCFSkp2-Cks1 was further inhibited similar to 2.5-fold by the addition of substrate. Combined, the inhibition by Fbw7-Skp1 plus its substrate cyclin E was greater than 10-fold. Unexpectedly, our results also uncover significant product inhibition by deconjugated Cul1, which results from the ability of Cul1 to bind tightly to CSN. Reciprocally, CSN inhibits the ubiquitin ligase activity of deneddylated Cul1. We propose a model in which assembled CRL complexes engaged with substrate are normally refractory to deneddylation. Upon consumption of substrate and subsequent deneddylation, CSN can remain stably bound to the CRL and hold it in low state of reduced activity.	[Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	National Institutes of Health [GM065997]; Canadian Institutes of Health Research postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA164803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065997.; Supported in part by a Canadian Institutes of Health Research postdoctoral fellowship.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bandau S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-36; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Choo YY, 2011, MOL BIOL CELL, V22, P4706, DOI 10.1091/mbc.E11-03-0251; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Helmstaedt K, 2011, MOL BIOL CELL, V22, P153, DOI 10.1091/mbc.E10-08-0732; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Min KW, 2005, BIOCHEM BIOPH RES CO, V334, P867, DOI 10.1016/j.bbrc.2005.06.188; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SPILBURG CA, 1977, BIOCHEMISTRY-US, V16, P1142, DOI 10.1021/bi00625a018; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Yamoah K, 2005, METHOD ENZYMOL, V398, P509, DOI 10.1016/S0076-6879(05)98042-7; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712	55	84	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29679	29689		10.1074/jbc.M112.352484	http://dx.doi.org/10.1074/jbc.M112.352484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767593	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000308286900044
J	Spooner, PM; Bonner, J; Maricq, AV; Benian, GM; Norman, KR				Spooner, Patrick M.; Bonner, Jennifer; Maricq, Andres V.; Benian, Guy M.; Norman, Kenneth R.			Large Isoforms of UNC-89 (Obscurin) Are Required for Muscle Cell Architecture and Optimal Calcium Release in Caenorhabditis elegans	PLOS ONE			English	Article							BODY-WALL MUSCLE; C-ELEGANS; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; STRIATED-MUSCLES; RNA INTERFERENCE; LOCALIZATION; ORGANIZATION; SARCOMERES; CA2+	Calcium, a ubiquitous intracellular signaling molecule, controls a diverse array of cellular processes. Consequently, cells have developed strategies to modulate the shape of calcium signals in space and time. The force generating machinery in muscle is regulated by the influx and efflux of calcium ions into the muscle cytoplasm. In order for efficient and effective muscle contraction to occur, calcium needs to be rapidly, accurately and reliably regulated. The mechanisms underlying this highly regulated process are not fully understood. Here, we show that the Caenorhabditis elegans homolog of the giant muscle protein obscurin, UNC-89, is required for normal muscle cell architecture. The large immunoglobulin domain-rich isoforms of UNC-89 are critical for sarcomere and sarcoplasmic reticulum organization. Furthermore, we have found evidence that this structural organization is crucial for excitation-contraction coupling in the body wall muscle, through the coordination of calcium signaling. Thus, our data implicates UNC-89 in maintaining muscle cell architecture and that this precise organization is essential for optimal calcium mobilization and efficient and effective muscle contraction.	[Spooner, Patrick M.; Bonner, Jennifer; Norman, Kenneth R.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Benian, Guy M.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Bonner, Jennifer] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Maricq, Andres V.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Albany Medical College; Emory University; Skidmore College; Utah System of Higher Education; University of Utah	Spooner, PM (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	NormanK@mail.amc.edu			American Heart Association; Alzheimer's Association; National Institutes of Health [GM088213, AR051466]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070280, R01NS035812] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association (www.heart.org), the Alzheimer's Association (www.alz.org), and National Institutes of Health grant GM088213 (www.nigms.nih.gov) to KRN, and NIH grant AR051466 (www.niams.nih.gov) to GMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Borisov AB, 2006, HISTOCHEM CELL BIOL, V125, P227, DOI 10.1007/s00418-005-0069-x; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; Borisov AB, 2008, J CELL BIOCHEM, V103, P1621, DOI 10.1002/jcb.21551; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; BRENNER S, 1974, GENETICS, V77, P71; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; Carlsson L, 2008, HISTOCHEM CELL BIOL, V130, P91, DOI 10.1007/s00418-008-0413-z; Coisy-Quivy M, 2009, J CELL SCI, V122, P947, DOI 10.1242/jcs.040121; Etheridge T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002471; Ferrara TM, 2005, J MUSCLE RES CELL M, V26, P435, DOI 10.1007/s10974-005-9027-4; Ford-Speelman DL, 2009, MOL BIOL CELL, V20, P3905, DOI 10.1091/mbc.E08-10-1029; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Liu Q, 2005, J NEUROSCI, V25, P6745, DOI 10.1523/JNEUROSCI.1730-05.2005; Mariol MC, 2001, CURR BIOL, V11, P1691, DOI 10.1016/S0960-9822(01)00528-0; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maryon EB, 1998, J CELL SCI, V111, P2885; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; Moerman Donald G., 1997, Cold Spring Harbor Monograph Series, V33, P417; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Qadota H, 2008, J MOL BIOL, V383, P747, DOI 10.1016/j.jmb.2008.08.083; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Sakube Y, 1997, J MOL BIOL, V267, P849, DOI 10.1006/jmbi.1997.0910; Shephard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024686; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; Small TM, 2004, J MOL BIOL, V342, P91, DOI 10.1016/j.jmb.2004.07.006; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons Lisa, 2006, V351, P119; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yishi J, 1999, C ELEGANS PRACTICAL, P69; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	55	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40182	10.1371/journal.pone.0040182	http://dx.doi.org/10.1371/journal.pone.0040182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768340	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500053
J	Bagavathiannan, MV; Begg, GS; Gulden, RH; Van Acker, RC				Bagavathiannan, Muthukumar V.; Begg, Graham S.; Gulden, Robert H.; Van Acker, Rene C.			Modelling the Dynamics of Feral Alfalfa Populations and Its Management Implications	PLOS ONE			English	Article							TRAITS PROMOTE PERSISTENCE; MEDICAGO-SATIVA L.; DENSITY-DEPENDENCE; GLYPHOSATE RESISTANCE; SEEDLING RECRUITMENT; GM CROPS; EVOLUTION; SPREAD	Background: Feral populations of cultivated crops can pose challenges to novel trait confinement within agricultural landscapes. Simulation models can be helpful in investigating the underlying dynamics of feral populations and determining suitable management options. Methodology/Principal Findings: We developed a stage-structured matrix population model for roadside feral alfalfa populations occurring in southern Manitoba, Canada. The model accounted for the existence of density-dependence and recruitment subsidy in feral populations. We used the model to investigate the long-term dynamics of feral alfalfa populations, and to evaluate the effectiveness of simulated management strategies such as herbicide application and mowing in controlling feral alfalfa. Results suggest that alfalfa populations occurring in roadside habitats can be persistent and less likely to go extinct under current roadverge management scenarios. Management attempts focused on controlling adult plants alone can be counterproductive due to the presence of density-dependent effects. Targeted herbicide application, which can achieve complete control of seedlings, rosettes and established plants, will be an effective strategy, but the seedbank population may contribute to new recruits. In regions where roadside mowing is regularly practiced, devising a timely mowing strategy (early-to mid-August for southern Manitoba), one that can totally prevent seed production, will be a feasible option for managing feral alfalfa populations. Conclusions/Significance: Feral alfalfa populations can be persistent in roadside habitats. Timely mowing or regular targeted herbicide application will be effective in managing feral alfalfa populations and limit feral-population-mediated gene flow in alfalfa. However, in the context of novel trait confinement, the extent to which feral alfalfa populations need to be managed will be dictated by the tolerance levels established by specific production systems for specific traits. The modelling framework outlined in this paper could be applied to other perennial herbaceous plants with similar life-history characteristics.	[Bagavathiannan, Muthukumar V.; Gulden, Robert H.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Begg, Graham S.] James Hutton Inst, Dundee, Scotland; [Van Acker, Rene C.] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Manitoba; James Hutton Institute; University of Guelph	Bagavathiannan, MV (corresponding author), Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA.	muthu@uark.edu		Begg, Graham/0000-0003-3590-2699	Agri-Food Research and Development Initiative of the government of Manitoba; Agri-Food Research and Development Initiative of the government of Canada; Natural Sciences and Engineering Research Council of Canada; Scottish Government; University of Manitoba	Agri-Food Research and Development Initiative of the government of Manitoba; Agri-Food Research and Development Initiative of the government of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Scottish Government; University of Manitoba	Funding was provided by the Agri-Food Research and Development Initiative of the governments of Manitoba and Canada, the Natural Sciences and Engineering Research Council of Canada, the Scottish Government (work package 1.7 Sustainable Crop Systems), and by a University of Manitoba Graduate Fellowship and Manitoba Graduate Scholarship for MVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker R. C. van, 2007, The first decade of herbicide-resistant crops in Canada. 'Transgenic herbicide-resistant crops: agronomy, environment and beyond', a symposium held on November 28, 2005, in Niagara, Canada., P153; Bagavathiannan MV, 2011, WEED SCI, V59, P314, DOI 10.1614/WS-D-10-00144.1; Bagavathiannan MV, 2011, TRANSGENIC RES, V20, P397, DOI 10.1007/s11248-010-9425-2; Bagavathiannan MV, 2010, ENVIRON SCI POLLUT R, V17, P1448, DOI 10.1007/s11356-010-0330-2; Bagavathiannan MV, 2009, CRIT REV PLANT SCI, V28, P69, DOI 10.1080/07352680902753613; Bass L. N., 1988, Alfalfa and alfalfa improvement, P961; Begg GS, 2006, ECOL MODEL, V198, P195, DOI 10.1016/j.ecolmodel.2006.04.025; Buckley YM, 2001, ECOL LETT, V4, P551, DOI 10.1046/j.1461-0248.2001.00264.x; Bullock JM, 2008, ECOL APPL, V18, P945, DOI 10.1890/07-1128.1; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell H, 2008, DEMOGR RES, V18, P59, DOI 10.4054/DemRes.2008.18.3; Claessen D, 2005, OIKOS, V110, P30, DOI 10.1111/j.0030-1299.2005.13668.x; Claessen D, 2005, OIKOS, V110, P20, DOI 10.1111/j.0030-1299.2005.13667.x; Crawley MJ, 2004, P ROY SOC B-BIOL SCI, V271, P1909, DOI 10.1098/rspb.2004.2814; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Davis AS, 2004, ECOL APPL, V14, P655, DOI 10.1890/02-5385; Davis AS, 2003, WEED SCI, V51, P919, DOI 10.1614/P2002-133A; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Garnier A, 2006, ECOL MODEL, V194, P141, DOI 10.1016/j.ecolmodel.2005.10.009; Garnier A, 2006, ECOL MODEL, V197, P373, DOI 10.1016/j.ecolmodel.2006.03.031; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Jenczewski E, 1999, AM J BOT, V86, P677, DOI 10.2307/2656577; Jennings JA, 2002, AGRON J, V94, P1104, DOI 10.2134/agronj2002.1104; KENDRICK D, 2005, P N CENTR WEED SCI S, P124; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Menges E.S., 2000, ECOLOGICAL B, V48, P73; MMPP, 2011, VAR YIELD DAT; Neve P, 2011, WEED RES, V51, P99, DOI 10.1111/j.1365-3180.2010.00838.x; Pardini EA, 2008, AM MIDL NAT, V160, P310, DOI 10.1674/0003-0031(2008)160[310:CODDFM]2.0.CO;2; Pardini EA, 2009, ECOL APPL, V19, P387, DOI 10.1890/08-0845.1; PUTNAM DH, 2006, PUBLICATION U CALIFO, V8193; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramula S, 2010, METHODS ECOL EVOL, V1, P158, DOI 10.1111/j.2041-210X.2010.00022.x; ROLSTON MP, 1978, BOT REV, V44, P365, DOI 10.1007/BF02957854; RUMBAUGH MD, 1982, J RANGE MANAGE, V35, P84, DOI 10.2307/3898526; Thornby DF, 2009, ANN BOT-LONDON, V104, P747, DOI 10.1093/aob/mcp152; Ugarcovici I, 2004, NONLINEARITY, V17, P1689, DOI 10.1088/0951-7715/17/5/007; Uriarte M, 2005, J ECOL, V93, P291, DOI 10.1111/j.0022-0477.2005.00984.x; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; WATKINSON AR, 1989, J ECOL, V77, P162, DOI 10.2307/2260923; Williams JL, 2011, J ECOL, V99, P1171, DOI 10.1111/j.1365-2745.2011.01845.x; Wright SJ, 2005, ECOLOGY, V86, P848, DOI 10.1890/03-0750; Zhang TJ, 2008, CROP SCI, V48, P794, DOI 10.2135/cropsci2007.06.0340	44	16	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39440	10.1371/journal.pone.0039440	http://dx.doi.org/10.1371/journal.pone.0039440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768079	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100050
J	Csaba, K; Kiss, G; Torocsik, B; Adam-Vizi, V; Chinopoulos, C				Csaba Konrad; Kiss, Gergely; Torocsik, Beata; Adam-Vizi, Vera; Chinopoulos, Christos			Absence of Ca2+-Induced Mitochondrial Permeability Transition but Presence of Bongkrekate-Sensitive Nucleotide Exchange in C. crangon and P. serratus	PLOS ONE			English	Article							CA-2&-INDUCED MEMBRANE TRANSITION; MULTIPLE SEQUENCE ALIGNMENTS; CRAB CALLINECTES-SAPIDUS; CYCLOPHILIN-D; CYCLOSPORINE-A; CELL-DEATH; ARTEMIA-FRANCISCANA; BRAIN MITOCHONDRIA; ADP/ATP CARRIER; PORE	Mitochondria from the embryos of brine shrimp (Artemia franciscana) do not undergo Ca2+-induced permeability transition in the presence of a profound Ca2+ uptake capacity. Furthermore, this crustacean is the only organism known to exhibit bongkrekate-insensitive mitochondrial adenine nucleotide exchange, prompting the conjecture that refractoriness to bongkrekate and absence of Ca2+-induced permeability transition are somehow related phenomena. Here we report that mitochondria isolated from two other crustaceans, brown shrimp (Crangon crangon) and common prawn (Palaemon serratus) exhibited bongkrekate-sensitive mitochondrial adenine nucleotide transport, but lacked a Ca2+-induced permeability transition. Ca2+ uptake capacity was robust in the absence of adenine nucleotides in both crustaceans, unaffected by either bongkrekate or cyclosporin A. Transmission electron microscopy images of Ca2+-loaded mitochondria showed needle-like formations of electron-dense material strikingly similar to those observed in mitochondria from the hepatopancreas of blue crab (Callinectes sapidus) and the embryos of Artemia franciscana. Alignment analysis of the partial coding sequences of the adenine nucleotide translocase (ANT) expressed in Crangon crangon and Palaemon serratus versus the complete sequence expressed in Artemia franciscana reappraised the possibility of the 208-214 amino acid region for conferring sensitivity to bongkrekate. However, our findings suggest that the ability to undergo Ca2+-induced mitochondrial permeability transition and the sensitivity of adenine nucleotide translocase to bongkrekate are not necessarily related phenomena.	[Csaba Konrad; Kiss, Gergely; Torocsik, Beata; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, Budapest, Hungary	Semmelweis University	Csaba, K (corresponding author), Semmelweis Univ, Dept Med Biochem, Budapest, Hungary.	chinopoulos.christos@eok.sote.hu		Chinopoulos, Christos/0000-0003-0183-4149; Adam-Vizi, Vera/0000-0002-8350-8701; Torocsik, Beata/0000-0002-9838-3710	Orszagos Tudomanyos Kutatasi Alapprogram [OTKA NK81983]; Magyar Tudomanyos Akademia (MTA); OTKA-NKTH (Nemzeti Kutatasies Technologiai Hivatal) [NF 68294]; Egeszsegugyi Tudomanyos Tanacs (ETT) [55160]; European Community [227799]; OTKA [NNF 78905, NNF2 85658, K 100918]	Orszagos Tudomanyos Kutatasi Alapprogram; Magyar Tudomanyos Akademia (MTA); OTKA-NKTH (Nemzeti Kutatasies Technologiai Hivatal); Egeszsegugyi Tudomanyos Tanacs (ETT); European Community(European Commission); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by grants from Orszagos Tudomanyos Kutatasi Alapprogram (OTKA NK81983), and Magyar Tudomanyos Akademia (MTA) to Dr. Adam-Vizi, and OTKA-NKTH (Nemzeti Kutatasies Technologiai Hivatal) NF 68294, OTKA NNF 78905, OTKA NNF2 85658, OTKA K 100918 and Egeszsegugyi Tudomanyos Tanacs (ETT) grant 55160 and the European Community grant ASSEMBLE (project agreement no. 227799, BKA binding on ANT) to Dr. Chinopoulos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Azzolin L, 2010, FEBS LETT, V584, P2504, DOI 10.1016/j.febslet.2010.04.023; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BECKER GL, 1974, J CELL BIOL, V61, P316, DOI 10.1083/jcb.61.2.316; Belyaeva EA, 2002, ARCH BIOCHEM BIOPHYS, V405, P252, DOI 10.1016/S0003-9861(02)00400-9; BUBEL A, 1976, CELL TISSUE RES, V167, P65; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; CHEN CH, 1974, J CELL BIOL, V61, P301, DOI 10.1083/jcb.61.2.301; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Chinopoulos C, 2012, MITOCHONDRION, V12, P41, DOI 10.1016/j.mito.2011.04.007; Chinopoulos C, 2011, FEBS J, V278, P1112, DOI 10.1111/j.1742-4658.2011.08026.x; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031; Doczi J, 2011, J BIOL CHEM, V286, P6345, DOI 10.1074/jbc.M110.196600; Forte M, 2005, J BIOENERG BIOMEMBR, V37, P121, DOI 10.1007/s10863-005-6565-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Holman JD, 2009, J EXP MAR BIOL ECOL, V376, P85, DOI 10.1016/j.jembe.2009.06.008; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; KEMP A JR, 1970, Biochimica et Biophysica Acta, V223, P460, DOI 10.1016/0005-2728(70)90210-0; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Konrad C, 2011, FEBS J, V278, P822, DOI 10.1111/j.1742-4658.2010.08001.x; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Lei WW, 2011, CHEMOSPHERE, V84, P689, DOI 10.1016/j.chemosphere.2011.03.023; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Mcgee AM, 2012, BIOCHEM J, V443, P185, DOI 10.1042/BJ20111881; Menze MA, 2005, AM J PHYSIOL-REG I, V289, pR68, DOI 10.1152/ajpregu.00844.2004; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; MUNDAY KA, 1962, COMP BIOCHEM PHYSIOL, V5, P95, DOI 10.1016/0010-406X(62)90122-6; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; POWERS MF, 1994, J BIOL CHEM, V269, P10614; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TSOKOS J, 1983, ARCH BIOCHEM BIOPHYS, V224, P707, DOI 10.1016/0003-9861(83)90259-X; Tyler D. D., 1967, METHOD ENZYMOL, V10, P75, DOI DOI 10.1016/0076-6879(67)10014-1; Vajda S, 2009, FEBS J, V276, P2713, DOI 10.1111/j.1742-4658.2009.06995.x; Yamada A, 2009, BBA-BIOENERGETICS, V1787, P1486, DOI 10.1016/j.bbabio.2009.07.001; Zolkiewska Anna, 1993, Acta Biochimica Polonica, V40, P241	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39839	10.1371/journal.pone.0039839	http://dx.doi.org/10.1371/journal.pone.0039839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768139	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100109
J	Harrison, LEA; Burton, JO; Szeto, CC; Li, PKT; McIntyre, CW				Harrison, Laura E. A.; Burton, James O.; Szeto, Cheuk-Chun; Li, Philip K. T.; McIntyre, Christopher W.			Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PERITONEAL-DIALYSIS PATIENTS; CHRONIC HEART-FAILURE; RECEIVING HEMODIALYSIS; SYSTEMIC INFLAMMATION; BACTERIAL-ENDOTOXIN; DARBEPOETIN ALPHA; ANEMIA; HEMOGLOBIN	Background/Objectives: Translocated endotoxin derived from intestinal bacteria is a driver of systemic inflammation and oxidative stress. Severe endotoxaemia is an underappreciated, but characteristic finding in haemodialysis (HD) patients, and appears to be driven by acute repetitive dialysis induced circulatory stress. Resistance to erythropoietin (EPO) has been identified as a predictor of mortality risk, and associated with inflammation and malnutrition. This study aims to explore the potential link between previously unrecognised endotoxaemia and EPO Resistance Index (ERI) in HD patients. Methodology/Principal Findings: 50 established HD patients were studied at a routine dialysis session. Data collection included weight, BMI, ultrafiltration volume, weekly EPO dose, and blood sampling pre and post HD. ERI was calculated as ratio of total weekly EPO dose to body weight (U/kg) to haemoglobin level (g/dL). Mean haemoglobin (Hb) was 11.3 +/- 1.3 g/dL with a median EPO dose of 10,000 [IQR 7,500-20,000] u/wk and ERI of 13.7 [IQR 6.9-23.3] ((U/Kg)/(g/dL)). Mean pre-HD serum ET levels were significantly elevated at 0.69 +/- 0.30 EU/ml. Natural logarithm (Ln) of ERI correlated to predialysis ET levels (r = 0.324, p = 0.03) with a trend towards association with hsCRP (r = 0.280, p = 0.07). Ln ERI correlated with ultrafiltration volume, a driver of circulatory stress (r = 0.295, p = 0.046), previously identified to be associated with increased intradialytic endotoxin translocation. Both serum ET and ultrafiltration volume corrected for body weight were independently associated with Ln ERI in multivariable analysis. Conclusions: This study suggests that endotoxaemia is a significant factor in setting levels of EPO requirement. It raises the possibility that elevated EPO doses may in part merely be identifying patients subjected to significant circulatory stress and suffering the myriad of negative biological consequences arising from sustained systemic exposure to endotoxin.	[Harrison, Laura E. A.; Burton, James O.; McIntyre, Christopher W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [Szeto, Cheuk-Chun; Li, Philip K. T.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [McIntyre, Christopher W.] Univ Nottingham, Sch Grad Entry Med & Hlth, Derby, England	University of Nottingham; Chinese University of Hong Kong; University of Nottingham	Harrison, LEA (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.	chris.mcintyre@nottingham.ac.uk	Burton, James O/AAQ-7361-2021; Szeto, Cheuk Chun/N-4954-2015; Li, Philip K. T./D-4051-2017; McIntyre, Christopher W/O-8927-2014	Burton, James O/0000-0003-1176-7592; Szeto, Cheuk Chun/0000-0002-8898-8505; 				Anker SD, 1997, AM J CARDIOL, V79, P1426, DOI 10.1016/S0002-9149(97)00159-8; Badve SV, 2011, NEPHROLOGY, V16, P144, DOI 10.1111/j.1440-1797.2010.01407.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brendt P, 2009, ANESTH ANALG, V109, P705, DOI 10.1213/ane.0b013e3181adc80f; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Chan CT, 2002, KIDNEY INT, V61, P2235, DOI 10.1046/j.1523-1755.2002.00362.x; Charalambous BM, 2007, SHOCK, V28, P15, DOI 10.1097/shk.0b013e318033ebc5; DIEBEL L, 1993, SURGERY, V113, P520; Drueke T, 2001, NEPHROL DIAL TRANSPL, V16, P25, DOI 10.1093/ndt/16.suppl_7.25; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Feng SYS, 2010, AM J PHYSIOL-REG I, V298, pR760, DOI 10.1152/ajpregu.00398.2009; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gunnell J, 1999, AM J KIDNEY DIS, V33, P63, DOI 10.1016/S0272-6386(99)70259-3; Jakob SM, 2001, CRIT CARE MED, V29, P1393, DOI 10.1097/00003246-200107000-00015; John SG, 2011, CLIN J AM SOC NEPHRO, V6, P2389, DOI 10.2215/CJN.11211210; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P761, DOI 10.1016/S0272-6386(03)00915-6; Khanna A, 2001, J SURG RES, V99, P114, DOI 10.1006/jsre.2001.6103; Kotanko P, 2006, NEPHROL DIAL TRANSPL, V21, P2057, DOI 10.1093/ndt/gfl281; Krack A, 2005, EUR HEART J, V26, P2368, DOI 10.1093/eurheartj/ehi389; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Macdougall IC, 2010, NEPHROL DIAL TRANSPL, V25, P914, DOI 10.1093/ndt/gfp550; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; MAXWELL A, 1986, LANCET, V1, P1148; McIntyre CW, 2008, CLIN J AM SOC NEPHRO, V3, P19, DOI 10.2215/CJN.03170707; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Molina M, 2007, NEFROLOGIA, V27, P196; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Peschel T, 2003, EUR J HEART FAIL, V5, P609, DOI 10.1016/S1388-9842(03)00104-1; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; RAIJ L, 1973, KIDNEY INT, V4, P57, DOI 10.1038/ki.1973.79; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Richardson D, 2002, NEPHROL DIAL TRANSPL, V17, P53, DOI 10.1093/ndt/17.suppl_1.53; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; STIVELMAN JC, 1989, SEMIN NEPHROL, V9, P8; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6	41	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40209	10.1371/journal.pone.0040209	http://dx.doi.org/10.1371/journal.pone.0040209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768256	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100229
J	Hartig, G; Peters, RS; Borner, J; Etzbauer, C; Misof, B; Niehuis, O				Hartig, Gerrit; Peters, Ralph S.; Borner, Janus; Etzbauer, Claudia; Misof, Bernhard; Niehuis, Oliver			Oligonucleotide Primers for Targeted Amplification of Single-Copy Nuclear Genes in Apocritan Hymenoptera	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EUKARYOTIC GENOMES; PARASITIC WASPS; DRAFT GENOME; PHYLOGENY; EVOLUTION; INSIGHTS; INSECTS; LIFE; DNA	Background: Published nucleotide sequence data from the mega-diverse insect order Hymenoptera (sawflies, bees, wasps, and ants) are taxonomically scattered and still inadequate for reconstructing a well-supported phylogenetic tree for the order. The analysis of comprehensive multiple gene data sets obtained via targeted PCR could provide a cost-effective solution to this problem. However, oligonucleotide primers for PCR amplification of nuclear genes across a wide range of hymenopteran species are still scarce. Findings: Here we present a suite of degenerate oligonucleotide primer pairs for PCR amplification of 154 single-copy nuclear protein-coding genes from Hymenoptera. These primers were inferred from genome sequence data from nine Hymenoptera (seven species of ants, the honeybee, and the parasitoid wasp Nasonia vitripennis). We empirically tested a randomly chosen subset of these primer pairs for amplifying target genes from six Hymenoptera, representing the families Chrysididae, Crabronidae, Gasteruptiidae, Leucospidae, Pompilidae, and Stephanidae. Based on our results, we estimate that these primers are suitable for studying a large number of nuclear genes across a wide range of apocritan Hymenoptera (i.e., all hymenopterans with a wasp-waist) and of aculeate Hymenoptera in particular (i.e., apocritan wasps with stingers). Conclusions: The amplified nucleotide sequences are (a) with high probability from single-copy genes, (b) easily generated at low financial costs, especially when compared to phylogenomic approaches, (c) easily sequenced by means of an additionally provided set of sequencing primers, and (d) suitable to address a wide range of phylogenetic questions and to aid rapid species identification via barcoding, as many amplicons contain both exonic and fast-evolving intronic nucleotides.	[Hartig, Gerrit; Etzbauer, Claudia; Misof, Bernhard; Niehuis, Oliver] Zentrum Mol Biodiversitatsforsch, Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Hartig, Gerrit] Univ Munster, Inst Bioinformat, Munster, Germany; [Peters, Ralph S.] Abt Arthropoda, Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Borner, Janus] Univ Hamburg, Biozentrum Grindel & Zool Museum, Hamburg, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Munster; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Hamburg	Hartig, G (corresponding author), Zentrum Mol Biodiversitatsforsch, Zool Forsch Museum Alexander Koenig, Bonn, Germany.	o.niehuis.zfmk@uni-bonn.de	Borner, Janus/E-1430-2012	Borner, Janus/0000-0001-9612-6668	German Research Foundation [DFG NI 1387/1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by a grant of the German Research Foundation to ON (DFG NI 1387/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; BROWER AVZ, 1994, ANN ENTOMOL SOC AM, V87, P702, DOI 10.1093/aesa/87.6.702; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Desjardins CA, 2007, MOL PHYLOGENET EVOL, V45, P454, DOI 10.1016/j.ympev.2007.08.004; Dowton M, 2001, BIOL J LINN SOC, V74, P87, DOI 10.1006/bijl.2001.0577; DOWTON M, 1994, P NATL ACAD SCI USA, V91, P9911, DOI 10.1073/pnas.91.21.9911; Drummond AJ., 2011, GENEIOUS PRO 5 4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Feau N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018803; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grimaldi David, 2005, pi; Heraty J, 2011, MOL PHYLOGENET EVOL, V60, P73, DOI 10.1016/j.ympev.2011.04.003; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Peters RS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-55; Pilgrim EM, 2008, ZOOL SCR, V37, P539, DOI 10.1111/j.1463-6409.2008.00340.x; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Sharanowski BJ, 2010, MOL PHYLOGENET EVOL, V57, P101, DOI 10.1016/j.ympev.2010.07.006; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	33	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39826	10.1371/journal.pone.0039826	http://dx.doi.org/10.1371/journal.pone.0039826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768134	Green Published, gold			2022-12-25	WOS:000305892100104
J	Hoflehner, E; Hufnagl, K; Schabussova, I; Jasinska, J; Hoffmann-Sommergruber, K; Bohle, B; Maizels, RM; Wiedermann, U				Hoflehner, Elisabeth; Hufnagl, Karin; Schabussova, Irma; Jasinska, Joanna; Hoffmann-Sommergruber, Karin; Bohle, Barbara; Maizels, Rick M.; Wiedermann, Ursula			Prevention of Birch Pollen-Related Food Allergy by Mucosal Treatment with Multi-Allergen-Chimers in Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; TGF-BETA; TOLERANCE INDUCTION; IMMUNE-RESPONSES; IGA PRODUCTION; I ALLERGY; IMMUNOTHERAPY; CELLS; INTRANASAL; APPLE	Background: Among birch pollen allergic patients up to 70% develop allergic reactions to Bet v 1-homologue food allergens such as Api g 1 (celery) or Dau c 1 (carrot), termed as birch pollen-related food allergy. In most cases, specific immunotherapy with birch pollen extracts does not reduce allergic symptoms to the homologue food allergens. We therefore genetically engineered a multi-allergen chimer and tested if mucosal treatment with this construct could represent a novel approach for prevention of birch pollen-related food allergy. Methodology: BALB/c mice were poly-sensitized with a mixture of Bet v 1, Api g 1 and Dau c 1 followed by a sublingual challenge with carrot, celery and birch pollen extracts. For prevention of allergy sensitization an allergen chimer composed of immunodominant T cell epitopes of Api g 1 and Dau c 1 linked to the whole Bet v 1 allergen, was intranasally applied prior to sensitization. Results: Intranasal pretreatment with the allergen chimer led to significantly decreased antigen-specific IgE-dependent beta-hexosaminidase release, but enhanced allergen-specific IgG2a and IgA antibodies. Accordingly, IL-4 levels in spleen cell cultures and IL-5 levels in restimulated spleen and cervical lymph node cell cultures were markedly reduced, while IFN-gamma levels were increased. Immunomodulation was associated with increased IL-10, TGF-beta and Foxp3 mRNA levels in NALT and Foxp3 in oral mucosal tissues. Treatment with anti-TGF-beta, anti-IL10R or anti-CD25 antibodies abrogated the suppression of allergic responses induced by the chimer. Conclusion: Our results indicate that mucosal application of the allergen chimer led to decreased Th2 immune responses against Bet v 1 and its homologue food allergens Api g 1 and Dau c 1 by regulatory and Th1-biased immune responses. These data suggest that mucosal treatment with a multi-allergen vaccine could be a promising treatment strategy to prevent birch pollen-related food allergy.	[Hoflehner, Elisabeth; Hufnagl, Karin; Schabussova, Irma; Jasinska, Joanna; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Hoffmann-Sommergruber, Karin; Bohle, Barbara] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	Medical University of Vienna; Medical University of Vienna; University of Edinburgh	Hoflehner, E (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at		Wiedermann, Ursula/0000-0002-1302-3223; Bohle, Barbara/0000-0002-5105-7985; Schabussova, Irma/0000-0002-2109-2640; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X; Jasinska, Joanna/0000-0002-0822-2084	Austrian Science Fund [F01814, P14634-PAT, Y0784GEN, FWF T163]; Wellcome Trust	Austrian Science Fund(Austrian Science Fund (FWF)); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was funded by grants from the Austrian Science Fund (F01814, P14634-PAT, Y0784GEN, FWF T163). RMM is supported by a Wellcome Trust Programme Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x; Bohle B, 2007, ALLERGY, V62, P3, DOI 10.1111/j.1398-9995.2006.01258.x; Bohle B, 2003, EUR J IMMUNOL, V33, P3303, DOI 10.1002/eji.200324321; Bublin M, 2003, FASEB J, V17, P1697, DOI 10.1096/fj.02-0872fje; Bucher X, 2004, ALLERGY, V59, P1272, DOI 10.1111/j.1398-9995.2004.00626.x; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Hansen KS, 2004, MOL NUTR FOOD RES, V48, P441, DOI 10.1002/mnfr.200400037; Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P155, DOI 10.1159/000024392; Hufnagl K, 2008, CLIN EXP ALLERGY, V38, P1192, DOI 10.1111/j.1365-2222.2008.02992.x; Hufnagl K, 2005, J ALLERGY CLIN IMMUN, V116, P370, DOI 10.1016/j.jaci.2005.04.002; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Mauro M, 2011, INT ARCH ALLERGY IMM, V156, P416, DOI 10.1159/000323909; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Pilette C, 2007, J IMMUNOL, V178, P4658, DOI 10.4049/jimmunol.178.7.4658; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Scadding GW, 2010, CLIN EXP ALLERGY, V40, P598, DOI 10.1111/j.1365-2222.2010.03462.x; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Steinman H, 2009, CURRENT ALLERGY CLIN, V22; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Verhagen J, 2006, J ALLERGY CLIN IMMUN, V117, P176, DOI 10.1016/j.jaci.2005.10.040; Walker SM, 2011, CLIN EXP ALLERGY, V41, P1177, DOI 10.1111/j.1365-2222.2011.03794.x; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Wiedermann U, 2001, INT ARCH ALLERGY IMM, V126, P68, DOI 10.1159/000049496; Wild C, 2007, ALLERGY, V62, P33, DOI 10.1111/j.1398-9995.2006.01245.x; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Winkler B, 2006, ALLERGY, V61, P173, DOI 10.1111/j.1398-9995.2006.01014.x; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39409	10.1371/journal.pone.0039409	http://dx.doi.org/10.1371/journal.pone.0039409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768077	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100048
J	Lokk, K; Vooder, T; Kolde, R; Valk, K; Vosa, U; Roosipuu, R; Milani, L; Fischer, K; Koltsina, M; Urgard, E; Annilo, T; Metspalu, A; Tonisson, N				Lokk, Kaie; Vooder, Tonu; Kolde, Raivo; Vaelk, Kristjan; Vosa, Urmo; Roosipuu, Retlav; Milani, Lili; Fischer, Krista; Koltsina, Marina; Urgard, Egon; Annilo, Tarmo; Metspalu, Andres; Tonisson, Neeme			Methylation Markers of Early-Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DNA METHYLATION; TUMOR-SUPPRESSOR; EPIGENETIC INACTIVATION; DOWN-REGULATION; GENE; EXPRESSION; SUPPORTS; RECEPTOR; TISSUE	Background: Despite of intense research in early cancer detection, there is a lack of biomarkers for the reliable detection of malignant tumors, including non-small cell lung cancer (NSCLC). DNA methylation changes are common and relatively stable in various types of cancers, and may be used as diagnostic or prognostic biomarkers. Methods: We performed DNA methylation profiling of samples from 48 patients with stage I NSCLC and 18 matching cancer-free lung samples using microarrays that cover the promoter regions of more than 14,500 genes. We correlated DNA methylation changes with gene expression levels and performed survival analysis. Results: We observed hypermethylation of 496 CpGs in 379 genes and hypomethylation of 373 CpGs in 335 genes in NSCLC. Compared to adenocarcinoma samples, squamous cell carcinoma samples had 263 CpGs in 223 hypermethylated genes and 513 CpGs in 436 hypomethylated genes. 378 of 869 (43.5%) CpG sites discriminating the NSCLC and control samples showed an inverse correlation between CpG site methylation and gene expression levels. As a result of a survival analysis, we found 10 CpGs in 10 genes, in which the methylation level differs in different survival groups. Conclusions: We have identified a set of genes with altered methylation in NSCLC and found that a minority of them showed an inverse correlation with gene expression levels. We also found a set of genes that associated with the survival of the patients. These newly-identified marker candidates for the molecular screening of NSCLC will need further analysis in order to determine their clinical utility.	[Lokk, Kaie; Vooder, Tonu; Vaelk, Kristjan; Vosa, Urmo; Koltsina, Marina; Urgard, Egon; Annilo, Tarmo; Metspalu, Andres; Tonisson, Neeme] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Lokk, Kaie; Tonisson, Neeme] Tartu Univ Hosp, United Labs, Dept Genet, Tartu, Estonia; [Vooder, Tonu] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Kolde, Raivo] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia; [Roosipuu, Retlav] Tartu Univ Hosp, Dept Pathol, Tartu, Estonia; [Milani, Lili; Fischer, Krista; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu	Lokk, K (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	neeme.tonisson@ut.ee	Võsa, Urmo/AAJ-5928-2020; Kolde, Raivo/AAB-8149-2022; Milani, Lili/C-8759-2011; Milani, Lili/N-1097-2019; Annilo, Tarmo/J-2900-2013; Tonisson, Neeme/H-2783-2015	Võsa, Urmo/0000-0003-3476-1652; Kolde, Raivo/0000-0003-2886-6298; Milani, Lili/0000-0002-5323-3102; Milani, Lili/0000-0002-5323-3102; Annilo, Tarmo/0000-0002-9588-3058; 	European Union [MJD71]; Centre of Excellence in Genomics; Estonian Ministry of Education and Science [SF0180142s08]; Estonian Science Foundation [7473, 9293]; University of Tartu; Alexander von Humboldt Foundation; Kristjan-Jaak Foundation;  [245536 OpenGene]	European Union(European Commission); Centre of Excellence in Genomics; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian Science Foundation; University of Tartu; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Kristjan-Jaak Foundation; 	The study was supported by the European Union through European Regional Development Fund, Centre of Excellence in Genomics and project 245536 OpenGene. Additional support was obtained from Estonian Ministry of Education and Science core grant SF0180142s08, Estonian Science Foundation grants 7473, 9293 and University of Tartu Development Fund Project of Translational Genomics. LM has been supported by the European Union through the European Social Fund, fellowship MJD71. NT has been supported by the fellowship from Alexander von Humboldt Foundation. KL, MK and NT have received travel stipends from Kristjan-Jaak Foundation. Website of OpenGene project: www.geenivaramu.ee/opengene/. Website of Estonian Science Foundation: www.etf.ee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki J, 2005, EUR J CANCER, V41, P2360, DOI 10.1016/j.ejca.2005.04.043; Bartling B, 2005, CARCINOGENESIS, V26, P293, DOI 10.1093/carcin/bgh333; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bertazza L, 2010, CURR MED CHEM, V17, P3337, DOI 10.2174/092986710793176339; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chu XY, 2011, CANC BIOL THER, V11; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Faller WJ, 2010, MELANOMA RES, V20, P392, DOI 10.1097/CMR.0b013e32833d32a6; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Foley DL, 2009, AM J EPIDEMIOL, V169, P389, DOI 10.1093/aje/kwn380; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Hirai K, 2005, ANN THORAC SURG, V79, P248, DOI 10.1016/j.athoracsur.2004.06.118; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jin MJ, 2009, CANCER SCI, V100, P2325, DOI 10.1111/j.1349-7006.2009.01321.x; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Khattar NH, 2005, J BIOMED SCI, V12, P65, DOI 10.1007/s11373-004-8185-5; Kim H, 2005, CANCER RES, V65, P8118, DOI 10.1158/0008-5472.CAN-04-4562; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Mountain CF, 2000, SEMIN SURG ONCOL, V18, P106, DOI 10.1002/(SICI)1098-2388(200003)18:2<106::AID-SSU4>3.0.CO;2-P; Muller-Hagen G, 2004, CURR OPIN DRUG DISC, V7, P290; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strassburg CP, 1999, BIOCHEM J, V338, P489, DOI 10.1042/0264-6021:3380489; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tekpli X, 2011, INT J CANC; Uribe-Lewis S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001717; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200; Ye YW, 2011, CANC LETT; Yoo KH, 2010, PATHOL INT, V60, P661, DOI 10.1111/j.1440-1827.2010.02578.x	38	52	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39813	10.1371/journal.pone.0039813	http://dx.doi.org/10.1371/journal.pone.0039813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768131	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100101
J	Ota, S; Ishikawa, S; Takazawa, Y; Goto, A; Fujii, T; Ohashi, K; Fukayama, M				Ota, Satoshi; Ishikawa, Shumpei; Takazawa, Yutaka; Goto, Akiteru; Fujii, Takeshi; Ohashi, Ken-ichi; Fukayama, Masashi			Quantitative Analysis of Viral Load per Haploid Genome Revealed the Different Biological Features of Merkel Cell Polyomavirus Infection in Skin Tumor	PLOS ONE			English	Article							T-ANTIGEN; SIMIAN VIRUS-40; ABERRANT METHYLATION; DNA REPLICATION; CARCINOMA; EXPRESSION; TRANSFORMATION; ASSOCIATION; SEQUENCES; MUTANTS	Merkel cell polyomavirus (MCPyV) has recently been identified in Merkel cell carcinoma (MCC), an aggressive cancer that occurs in sun-exposed skin. Conventional technologies, such as polymerase chain reaction (PCR) and immunohistochemistry, have produced conflicting results for MCPyV infections in non-MCC tumors. Therefore, we performed quantitative analyses of the MCPyV copy number in various skin tumor tissues, including MCC (n = 9) and other sun exposure-related skin tumors (basal cell carcinoma [BCC, n = 45], actinic keratosis [AK, n = 52], Bowen's disease [n = 34], seborrheic keratosis [n = 5], primary cutaneous anaplastic large-cell lymphoma [n = 5], malignant melanoma [n = 5], and melanocytic nevus [n = 6]). In a conventional PCR analysis, MCPyV DNA was detected in MCC (9 cases; 100%), BCC (1 case; 2%), and AK (3 cases; 6%). We then used digital PCR technology to estimate the absolute viral copy number per haploid human genome in these tissues. The viral copy number per haploid genome was estimated to be around 1 in most MCC tissues, and there were marked differences between the MCC (0.119-42.8) and AK (0.02-0.07) groups. PCR-positive BCC tissue showed a similar viral load as MCC tissue (0.662). Immunohistochemistry with a monoclonal antibody against the MCPyV T antigen (CM2B4) demonstrated positive nuclear localization in most of the high-viral-load tumor groups (8 of 9 MCC and 1 BCC), but not in the low-viral-load or PCR-negative tumor groups. These results demonstrated that MCPyV infection is possibly involved in a minority of sun-exposed skin tumors, including BCC and AK, and that these tumors display different modes of infection.	[Ota, Satoshi] Chiba Univ, Chiba Univ Hosp, Dept Pathol, Chuo Ku, Chiba, Japan; [Ota, Satoshi; Ishikawa, Shumpei; Takazawa, Yutaka; Goto, Akiteru; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Fujii, Takeshi; Ohashi, Ken-ichi] Toranomon Gen Hosp, Dept Pathol, Minato Ku, Tokyo, Japan	Chiba University; University of Tokyo; Toranomon Hospital	Ota, S (corresponding author), Chiba Univ, Chiba Univ Hosp, Dept Pathol, Chuo Ku, Chiba, Japan.	isikawas-tky@umin.org	Goto, Akiteru/P-5775-2014; Fujii, Takeshi/D-5877-2014	Fujii, Takeshi/0000-0001-7237-1183; Goto, Akiteru/0000-0001-8776-9004	New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23590389] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Industrial Technology Research Grant Program of the New Energy and Industrial Technology Development Organization (NEDO) of Japan (S. I.) and Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2010, J CUTAN PATHOL, V37, P28, DOI 10.1111/j.1600-0560.2009.01352.x; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Bhatia K, 2010, INT J CANCER, V126, P2240, DOI 10.1002/ijc.24676; Busam KJ, 2009, AM J SURG PATHOL, V33, P1378, DOI 10.1097/PAS.0b013e3181aa30a5; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Duncavage EJ, 2009, MODERN PATHOL, V22, P516, DOI 10.1038/modpathol.2009.3; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fischer N, 2010, INT J CANCER, V126, P2133, DOI 10.1002/ijc.24877; Foulongne V, 2010, BRIT J DERMATOL, V162, P59, DOI 10.1111/j.1365-2133.2009.09381.x; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Helmbold P, 2009, MOL CARCINOGEN, V48, P903, DOI 10.1002/mc.20540; Houben R, 2010, INT J CANCER, V126, P796, DOI 10.1002/ijc.24790; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Kassem A, 2009, INT J CANCER, V125, P356, DOI 10.1002/ijc.24323; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Kuwamoto S, 2011, HUM PATHOL, V42, P632, DOI 10.1016/j.humpath.2010.09.011; LANIA L, 1981, J VIROL, V39, P422, DOI 10.1128/JVI.39.2.422-431.1981; LeBoit PE, 2006, WHO CLASSIFICATION T; Loyo M, 2010, INT J CANCER, V126, P2991, DOI 10.1002/ijc.24737; Mangana J, 2010, DERMATOLOGY, V221, P184, DOI 10.1159/000315067; MANOS MM, 1984, MOL CELL BIOL, V4, P1125, DOI 10.1128/MCB.4.6.1125; Nakajima H, 2009, J DERMATOL SCI, V56, P210, DOI 10.1016/j.jdermsci.2009.07.013; Neumann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029112; Paulson KG, 2009, J INVEST DERMATOL, V129, P1547, DOI 10.1038/jid.2008.365; PRIVES C, 1983, MOL CELL BIOL, V3, P1958, DOI 10.1128/MCB.3.11.1958; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Reisinger DM, 2010, J AM ACAD DERMATOL, V63, P400, DOI 10.1016/j.jaad.2009.08.064; Ridd K, 2009, J INVEST DERMATOL, V129, P250, DOI 10.1038/jid.2008.215; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Sihto H, 2009, JNCI-J NATL CANCER I, V101, P938, DOI 10.1093/jnci/djp139; SMALL MB, 1982, NATURE, V296, P671, DOI 10.1038/296671a0; Touze A, 2009, EMERG INFECT DIS, V15, P960, DOI 10.3201/eid1506.081463; Toyooka S, 2002, ONCOGENE, V21, P4340, DOI 10.1038/sj.onc.1205381; Toyooka S, 2001, CANCER RES, V61, P5727; Varga E, 2009, BRIT J DERMATOL, V161, P930, DOI 10.1111/j.1365-2133.2009.09221.x; Wetzels CTAH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004958; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575; Woo KJ, 2010, J PLAST RECONSTR AES, V63, P2064, DOI 10.1016/j.bjps.2010.01.020	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39954	10.1371/journal.pone.0039954	http://dx.doi.org/10.1371/journal.pone.0039954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768181	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100152
J	Qiu, HY; KuoLee, R; Harris, G; Van Rooijen, N; Patel, GB; Chen, WX				Qiu, Hongyu; KuoLee, Rhonda; Harris, Greg; Van Rooijen, Nico; Patel, Girishchandra B.; Chen, Wangxue			Role of Macrophages in Early Host Resistance to Respiratory Acinetobacter baumannii Infection	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; NITRIC-OXIDE; ALVEOLAR MACROPHAGES; BACTERIAL CLEARANCE; MICE; EPIDEMIOLOGY; PHAGOCYTOSIS; ELIMINATION; NEUTROPHILS; DEFENSES	Acinetobacter baumannii is an emerging bacterial pathogen that causes nosocomial pneumonia and other infections. Although it is recognized as an increasing threat to immunocompromised patients, the mechanism of host defense against A. baumannii infection remains poorly understood. In this study, we examined the potential role of macrophages in host defense against A. baumannii infection using in vitro macrophage culture and the mouse model of intranasal (i.n.) infection. Large numbers of A. baumannii were taken up by alveolar macrophages in vivo as early as 4 h after i.n. inoculation. By 24 h, the infection induced significant recruitment and activation (enhanced expression of CD80, CD86 and MHC-II) of macrophages into bronchoalveolar spaces. In vitro cell culture studies showed that A. baumannii were phagocytosed by J774A.1 (J774) macrophage-like cells within 10 minutes of co-incubation, and this uptake was microfilament-and microtubule-dependent. Moreover, the viability of phagocytosed bacteria dropped significantly between 24 and 48 h after co-incubation. Infection of J774 cells by A. baumannii resulted in the production of large amounts of proinflammatory cytokines and chemokines, and moderate amounts of nitric oxide (NO). Prior treatment of J774 cells with NO inhibitors significantly suppressed their bactericidal efficacy (P<0.05). Most importantly, in vivo depletion of alveolar macrophages significantly enhanced the susceptibility of mice to i.n. A. baumannii challenge (P<0.01). These results indicate that macrophages may play an important role in early host defense against A. baumannii infection through the efficient phagocytosis and killing of A. baumannii to limit initial pathogen replication and the secretion of proinflammatory cytokines and chemokines for the rapid recruitment of other innate immune cells such as neutrophils.	[Qiu, Hongyu; KuoLee, Rhonda; Harris, Greg; Patel, Girishchandra B.; Chen, Wangxue] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Chen, Wangxue] Brock Univ, Dept Biol, St Catharines, ON L2S 3A1, Canada	National Research Council Canada; Vrije Universiteit Amsterdam; Brock University	Qiu, HY (corresponding author), Cangene Corp, Winnipeg, MB, Canada.	HQiu@Cangene.com; wangxue.chen@nrc.gc.ca	Van Rooijen, Nico/Z-1578-2019					Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; CHEN WX, 1992, J EXP MED, V176, P713, DOI 10.1084/jem.176.3.713; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; de Roux A, 2006, CHEST, V129, P1219, DOI 10.1378/chest.129.5.1219; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dugas N, 1996, BLOOD, V88, P3528, DOI 10.1182/blood.V88.9.3528.bloodjournal8893528; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; JolyGuillou MC, 1997, ANTIMICROB AGENTS CH, V41, P345, DOI 10.1128/AAC.41.2.345; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Kuo LC, 2007, CLIN MICROBIOL INFEC, V13, P196, DOI 10.1111/j.1469-0691.2006.01601.x; Leemans JC, 2005, J INFECT DIS, V191, P65, DOI 10.1086/426395; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; March C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010033; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Qiu HY, 2009, INFECT IMMUN, V77, P1015, DOI 10.1128/IAI.01029-08; Renckens R, 2006, J INFECT DIS, V193, P187, DOI 10.1086/498876; ROSE RM, 1989, EUR J CLIN MICROBIOL, V8, P25, DOI 10.1007/BF01964116; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P923, DOI 10.1164/ajrccm.160.3.9901107; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Tsai WC, 1997, INFECT IMMUN, V65, P1870, DOI 10.1128/IAI.65.5.1870-1875.1997; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WILEMAN T, 1985, BIOCHEM J, V232, P1; Yan HB, 2009, BIOCHEM BIOPH RES CO, V387, P581, DOI 10.1016/j.bbrc.2009.07.061	43	72	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40019	10.1371/journal.pone.0040019	http://dx.doi.org/10.1371/journal.pone.0040019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768201	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100173
J	Sampath, R; Mulholland, N; Blyn, LB; Massire, C; Whitehouse, CA; Waybright, N; Harter, C; Bogan, J; Miranda, MS; Smith, D; Baldwin, C; Wolcott, M; Norwood, D; Kreft, R; Frinder, M; Lovari, R; Yasuda, I; Matthews, H; Toleno, D; Housley, R; Duncan, D; Li, F; Warren, R; Eshoo, MW; Hall, TA; Hofstadler, SA; Ecker, DJ				Sampath, Rangarajan; Mulholland, Niveen; Blyn, Lawrence B.; Massire, Christian; Whitehouse, Chris A.; Waybright, Nicole; Harter, Courtney; Bogan, Joseph; Miranda, Mary Sue; Smith, David; Baldwin, Carson; Wolcott, Mark; Norwood, David; Kreft, Rachael; Frinder, Mark; Lovari, Robert; Yasuda, Irene; Matthews, Heather; Toleno, Donna; Housley, Roberta; Duncan, David; Li, Feng; Warren, Robin; Eshoo, Mark W.; Hall, Thomas A.; Hofstadler, Steven A.; Ecker, David J.			Comprehensive Biothreat Cluster Identification by PCR/Electrospray-Ionization Mass Spectrometry	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; YERSINIA-PESTIS; GENETIC-RELATIONSHIPS; RAPID IDENTIFICATION; UNIVERSAL BIOSENSOR; GENOME SEQUENCE; BACILLUS; PLAGUE; VIRUS; PSEUDOTUBERCULOSIS	Technology for comprehensive identification of biothreats in environmental and clinical specimens is needed to protect citizens in the case of a biological attack. This is a challenge because there are dozens of bacterial and viral species that might be used in a biological attack and many have closely related near-neighbor organisms that are harmless. The biothreat agent, along with its near neighbors, can be thought of as a biothreat cluster or a biocluster for short. The ability to comprehensively detect the important biothreat clusters with resolution sufficient to distinguish the near neighbors with an extremely low false positive rate is required. A technological solution to this problem can be achieved by coupling biothreat group-specific PCR with electrospray ionization mass spectrometry (PCR/ESI-MS). The biothreat assay described here detects ten bacterial and four viral biothreat clusters on the NIAID priority pathogen and HHS/USDA select agent lists. Detection of each of the biothreat clusters was validated by analysis of a broad collection of biothreat organisms and near neighbors prepared by spiking biothreat nucleic acids into nucleic acids extracted from filtered environmental air. Analytical experiments were carried out to determine breadth of coverage, limits of detection, linearity, sensitivity, and specificity. Further, the assay breadth was demonstrated by testing a diverse collection of organisms from each biothreat cluster. The biothreat assay as configured was able to detect all the target organism clusters and did not misidentify any of the near-neighbor organisms as threats. Coupling biothreat cluster-specific PCR to electrospray ionization mass spectrometry simultaneously provides the breadth of coverage, discrimination of near neighbors, and an extremely low false positive rate due to the requirement that an amplicon with a precise base composition of a biothreat agent be detected by mass spectrometry.	[Sampath, Rangarajan; Blyn, Lawrence B.; Massire, Christian; Kreft, Rachael; Frinder, Mark; Lovari, Robert; Yasuda, Irene; Matthews, Heather; Toleno, Donna; Housley, Roberta; Duncan, David; Li, Feng; Warren, Robin; Eshoo, Mark W.; Hall, Thomas A.; Hofstadler, Steven A.; Ecker, David J.] Abbott, Ibis Biosci, Carlsbad, CA 92008 USA; [Mulholland, Niveen; Waybright, Nicole; Harter, Courtney; Bogan, Joseph] MRIGlobal, Rockville, MD USA; [Whitehouse, Chris A.; Baldwin, Carson; Wolcott, Mark; Norwood, David] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Miranda, Mary Sue; Smith, David] Pentagon Force Protect Agcy, Lab Div, Chem Biol Radiol Nucl & Explos Directorate, Washington, DC USA		Sampath, R (corresponding author), Abbott, Ibis Biosci, Carlsbad, CA 92008 USA.	rangarajan.sampath@abbott.com		Smith, David/0000-0002-9465-988X; Kreft, Rachael/0000-0001-9817-8584; Ecker, David/0000-0003-4350-9037	Defense Advanced Research Projects Agency (DARPA) [MDA972-00-C-0053]; Centers for Disease Control and Prevention (CDC) [1R01-C1000099]; Department of Homeland Security (DHS) [NBCHC070019]; Ibis; Department of Homeland Security	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Homeland Security (DHS)(United States Department of Homeland Security (DHS)); Ibis; Department of Homeland Security(United States Department of Homeland Security (DHS))	The authors acknowledge the Defense Advanced Research Projects Agency (DARPA: Contract MDA972-00-C-0053) and the Centers for Disease Control and Prevention (CDC: Contract 1R01-C1000099) for financial support to develop the hardware platform, and the Department of Homeland Security (DHS: Contract NBCHC070019) for support of the biothreat assay validation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.S. and other authors with affiliation listed as Ibis Biosciences Inc., are employees of Ibis Biosciences, a subsidiary of Abbott Molecular, Inc., which manufactures the instruments and reagents used in this study. N.M. and other authors with affiliations listed as MRIGlobal are employees of MRIGlobal, an independent, not-for-profit contract research organization that was funded by Ibis and the Department of Homeland Security to carry out the validation studies. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States Army or the Pentagon Force Protection Agency.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; BERCOVIER H, 1980, CURR MICROBIOL, V4, P225, DOI 10.1007/BF02605861; Brenner DJ, 1984, BERGEYS MANUAL SYSTE, P408; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chen KF, 2011, J VIROL METH; Chen KF, 2011, DIAGN MICR INFEC DIS, V69, P179, DOI 10.1016/j.diagmicrobio.2010.10.010; Cowan G, 2000, POSTGRAD MED J, V76, P269, DOI 10.1136/pmj.76.895.269; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Denison AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-91; Deyde VM, 2011, EXPERT REV MOL DIAGN, V11, P41, DOI [10.1586/erm.10.107, 10.1586/ERM.10.107]; Deyde VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013293; Ecker D, 2006, J ASS LAB AUTOM, P341; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Ecker DJ, 2005, J FORENSIC SCI, V50, P1380, DOI 10.1520/JFS2004462; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Eshoo MW, 2011, MICROBIAL FORENSICS, 2ND EDITION, P155, DOI 10.1016/B978-0-12-382006-8.00010-4; Eshoo MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006342; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Grunow R, 2012, PLOS ONE, V7, pe39928, DOI [10.1371/journal.pone.0039928, DOI 10.1371/JOURNAL.PONE.0039928]; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Janda J. M., 2003, MANUAL CLIN MICROBIO, P706; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kaper J.B., 1998, ESCHERICHIA COLI 015; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Leslie T, 2010, EPIDEMIOL INFECT, P1; Lindler LE, 2004, INFECT DIS BIOL WEAP, P453; Metzgar D, 2010, J CLIN MICROBIOL, V48, P4228, DOI 10.1128/JCM.01336-10; Morens DM, 2010, CLIN INFECT DIS, V51, P1442, DOI 10.1086/657429; Morens DM, 2009, J INFECT DIS, V200, P1018, DOI 10.1086/644537; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Rocke TE, 1998, J WILDLIFE DIS, V34, P744, DOI 10.7589/0090-3558-34.4.744; Roux V, 1997, INT J SYST BACTERIOL, V47, P1255, DOI 10.1099/00207713-47-4-1255; Sampath R, 2005, EMERG INFECT DIS, V11, P373, DOI 10.3201/eid1103.040629; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Simonet M, 1996, INFECT IMMUN, V64, P375, DOI 10.1128/IAI.64.1.375-379.1996; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Whitehouse CA, 2010, APPL ENV MICROBIOL	48	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e36528	10.1371/journal.pone.0036528	http://dx.doi.org/10.1371/journal.pone.0036528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768032	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100003
J	Galimberti, A; Spada, M; Russo, D; Mucedda, M; Agnelli, P; Crottini, A; Ferri, E; Martinoli, A; Casiraghi, M				Galimberti, Andrea; Spada, Martina; Russo, Danilo; Mucedda, Mauro; Agnelli, Paolo; Crottini, Angelica; Ferri, Emanuele; Martinoli, Adriano; Casiraghi, Maurizio			Integrated Operational Taxonomic Units (IOTUs) in Echolocating Bats: A Bridge between Molecular and Traditional Taxonomy	PLOS ONE			English	Article							TIME-EXPANDED RECORDINGS; MYOTIS-MYOTIS CHIROPTERA; MITOCHONDRIAL PSEUDOGENES; SPECIES IDENTIFICATION; GENETIC CONSEQUENCES; CRYPTIC DIVERSITY; ICE AGES; DNA; VESPERTILIONIDAE; PIPISTRELLUS	Background: Nowadays, molecular techniques are widespread tools for the identification of biological entities. However, until very few years ago, their application to taxonomy provoked intense debates between traditional and molecular taxonomists. To prevent every kind of disagreement, it is essential to standardize taxonomic definitions. Along these lines, we introduced the concept of Integrated Operational Taxonomic Unit (IOTU). IOTUs come from the concept of Operational Taxonomic Unit (OTU) and paralleled the Molecular Operational Taxonomic Unit (MOTU). The latter is largely used as a standard in many molecular-based works (even if not always explicitly formalized). However, while MOTUs are assigned solely on molecular variation criteria, IOTUs are identified from patterns of molecular variation that are supported by at least one more taxonomic characteristic. Methodology/Principal Findings: We tested the use of IOTUs on the widest DNA barcoding dataset of Italian echolocating bats species ever assembled (i.e. 31 species, 209 samples). We identified 31 molecular entities, 26 of which corresponded to the morphologically assigned species, two MOTUs and three IOTUs. Interestingly, we found three IOTUs in Myotis nattereri, one of which is a newly described lineage found only in central and southern Italy. In addition, we found a level of molecular variability within four vespertilionid species deserving further analyses. According to our scheme two of them (i.e. M. bechsteinii and Plecotus auritus) should be ranked as unconfirmed candidate species (UCS). Conclusions/Significance: From a systematic point of view, IOTUs are more informative than the general concept of OTUs and the more recent MOTUs. According to information content, IOTUs are closer to species, although it is important to underline that IOTUs are not species. Overall, the use of a more precise panel of taxonomic entities increases the clarity in the systematic field and has the potential to fill the gaps between modern and traditional taxonomy.	[Galimberti, Andrea; Crottini, Angelica; Ferri, Emanuele; Casiraghi, Maurizio] Univ Milano Bicocca, Dipartimento Biotecnol Biosci, ZooPlantLab, Milan, Italy; [Spada, Martina; Martinoli, Adriano] Univ Insubria, Dipartimento Ambiente Salute Sicurezza, Varese, Italy; [Russo, Danilo] Univ Naples Federico II, Fac Agr, Dipartimento ArBoPaVe, Lab Ecol Applicata, Naples, Italy; [Mucedda, Mauro] Grp Speleolog Sassarese, Sassari, Italy; [Mucedda, Mauro] Ctr Pipistrelli Sardegna, Sassari, Italy; [Agnelli, Paolo] Univ Florence, Sez Zool Specola, Museo Storia Nat, Florence, Italy; [Crottini, Angelica] Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal	University of Milano-Bicocca; University of Insubria; University of Naples Federico II; University of Florence; Universidade do Porto	Galimberti, A (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol Biosci, ZooPlantLab, Milan, Italy.	maurizio.casiraghi@unimib.it	Galimberti, Andrea/ABF-7019-2020; Casiraghi, Maurizio/E-7273-2011; Crottini, Angelica/I-7680-2013; Martinoli, Adriano/L-4924-2016	Galimberti, Andrea/0000-0003-3140-3024; Casiraghi, Maurizio/0000-0002-2733-2094; Crottini, Angelica/0000-0002-8505-3050; Martinoli, Adriano/0000-0003-0298-0869; AGNELLI, PAOLO/0000-0002-0004-8325; Russo, Danilo/0000-0002-1934-7130	Fondazione Cariplo "Dai geni all'ecosistema: il DNA barcoding come supporto innovativo per la protezione della biodiversita e l'analisi della funzionalita delle reti ecologiche'' [H71J08000600003]; Portuguese "Fundacao para a Ciencia e Tecnologia'' (FCT) [SFRH/BPD/72908/2010]	Fondazione Cariplo "Dai geni all'ecosistema: il DNA barcoding come supporto innovativo per la protezione della biodiversita e l'analisi della funzionalita delle reti ecologiche''; Portuguese "Fundacao para a Ciencia e Tecnologia'' (FCT)(Portuguese Foundation for Science and Technology)	The study was carried out with financial support of Fondazione Cariplo "Dai geni all'ecosistema: il DNA barcoding come supporto innovativo per la protezione della biodiversita e l'analisi della funzionalita delle reti ecologiche'', project number: H71J08000600003. AC was supported by a postdoctoral grant from the Portuguese "Fundacao para a Ciencia e Tecnologia'' (FCT): SFRH/BPD/72908/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli P, 2006, GUIDELINES BAT MONIT; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; Artyushin IV, 2009, ZOOTAXA, P40; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baron B, 2010, HYSTRIX, V21, P65; Barratt EM, 1997, NATURE, V387, P138, DOI 10.1038/387138b0; Benda Petr, 2000, Acta Societatis Zoologicae Bohemicae, V64, P331; Benda Petr, 2005, Lynx (Prague), P9; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Blant M, 2010, HOLOCENE, V20, P711, DOI 10.1177/0959683609358912; Boero Ferdinando, 2010, Diversity, V2, P115; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Boston ESM, 2010, ACTA CHIROPTEROL, V12, P457, DOI 10.3161/150811010X538025; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brower AVZ, 2010, SYST BIODIVERS, V8, P485, DOI 10.1080/14772000.2010.534512; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Cabrera A, 1904, MEMORIAS SOC ESPANOL, V2, P249; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021460; Claridge MF, 1997, SPECIES UNITS BIODIV; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dietz C, 2004, ILLUSTRATED IDENTIFI; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Garcia-Mudarra JL, 2009, BIOL J LINN SOC, V96, P434, DOI 10.1111/j.1095-8312.2008.01128.x; GERLOFF U, 1995, MOL ECOL, V4, P515, DOI 10.1111/j.1365-294X.1995.tb00247.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holynski RB, 2010, ARTHROPOD SYST PHYLO, V68, P143; Hutson A, 2001, MICROCHIROPTERAN BAT; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jaarola M, 2004, HEREDITY, V92, P228, DOI 10.1038/sj.hdy.6800400; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Juste J, 2004, MOL PHYLOGENET EVOL, V31, P1114, DOI 10.1016/j.ympev.2003.10.005; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kiefer Andreas, 2001, Myotis, V39, P5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Mayr E, 2002, WHAT EVOLUTION LONDO; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mucedda M, 2002, ACTA CHIROPTEROL, V4, P121, DOI 10.3161/001.004.0202; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Page TJ, 2011, ZOOTAXA, P65; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Preatoni DG, 2005, J WILDLIFE MANAGE, V69, P1601, DOI 10.2193/0022-541X(2005)69[1601:IBFTRO]2.0.CO;2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Ruedi M, 2003, MOL ECOL, V12, P1527, DOI 10.1046/j.1365-294X.2003.01828.x; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Ruedi M, 2008, MOL ECOL, V17, P1801, DOI 10.1111/j.1365-294X.2008.03702.x; Russo D, 2000, MAMMALIA, V64, P187, DOI 10.1515/mamm.2000.64.2.187; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Salicini I, 2011, MOL PHYLOGENET EVOL, V61, P888, DOI 10.1016/j.ympev.2011.08.010; Santos LM, 2011, ZOOTAXA, P66, DOI 10.11646/zootaxa.3025.1.5; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spitzenberger Friederike, 2003, Natura Croatica, V12, P39; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trizio Ilaria, 2003, Hystrix, V14, P113; Veith M, 2011, ACTA CHIROPTEROL, V13, P89, DOI 10.3161/150811011X578642; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; VOLLETH M, 1987, CYTOGENET CELL GENET, V44, P186, DOI 10.1159/000132371; von Helversen O, 2001, NATURWISSENSCHAFTEN, V88, P217, DOI 10.1007/s001140100225; Wicht B, 2003, REV SUISSE ZOOL, V110, P411, DOI 10.5962/bhl.part.80191	81	52	53	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40122	10.1371/journal.pone.0040122	http://dx.doi.org/10.1371/journal.pone.0040122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761951	gold, Green Published, Green Submitted			2022-12-25	WOS:000305826400055
J	Lazarczyk, M; Dalard, C; Hayder, M; Dupre, L; Pignolet, B; Majewski, S; Vuillier, F; Favre, M; Liblau, RS				Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Majewski, Slawomir; Vuillier, Francoise; Favre, Michel; Liblau, Roland S.			EVER Proteins, Key Elements of the Natural Anti-Human Papillomavirus Barrier, Are Regulated upon T-Cell Activation	PLOS ONE			English	Article							EPIDERMODYSPLASIA-VERRUCIFORMIS; ZINC TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; MEDIATED-IMMUNITY; IONS; GENE; PATHOGENESIS; MECHANISMS; EXPRESSION; INFECTION	Human papillomaviruses (HPV) cause a variety of mucosal and skin lesions ranging from benign proliferations to invasive carcinomas. The clinical manifestations of infection are determined by host-related factors that define the natural anti-HPV barrier. Key elements of this barrier are the EVER1 and EVER2 proteins, as deficiency in either one of the EVER proteins leads to Epidermodysplasia Verruciformis (EV), a genodermatosis associated with HPV-induced skin carcinoma. Although EVERs have been shown to regulate zinc homeostasis in keratinocytes, their expression and function in other cell types that may participate to the anti-HPV barrier remain to be investigated. In this work, we demonstrate that EVER genes are expressed in different tissues, and most notably in lymphocytes. Interestingly, in contrast to the skin, where EVER2 transcripts are hardly detectable, EVER genes are both abundantly expressed in murine and human T cells. Activation of CD4+ and CD8+ T cells via the TCR triggers a rapid and profound decrease in EVER expression, accompanied by an accumulation of free Zn2+ ions. Thus, EVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytes. Consistent with this hypothesis, we show that the concentration of Zn2+ ions is elevated in lymphoblastoid cells or primary T cells from EVER2-deficient patients. Interestingly, we also show that Zn2+ excess blocks T-cell activation and proliferation. Therefore, EVER proteins appear as key components of the activation-dependent regulation of Zn2+ concentration in T cells. However, the impact of EVER-deficiency in T cells on EV pathogenesis remains to be elucidated.	[Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Liblau, Roland S.] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Liblau, Roland S.] CNRS, UMR5282, Toulouse, France; [Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Liblau, Roland S.] Univ Toulouse, UPS, CPTP, Toulouse, France; [Majewski, Slawomir] Med Univ Warsaw, Dept Dermatol & Venereol, Warsaw, Poland; [Vuillier, Francoise; Favre, Michel] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Warsaw; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lazarczyk, M (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	roland.liblau@inserm.fr	Liblau, Roland/J-3530-2014; Vuillier, Françoise/T-4699-2019; dupre, loic/L-8174-2014	dupre, loic/0000-0002-7278-6503; LIBLAU, Roland/0000-0001-5477-5475; Vuillier, Francoise/0000-0002-5551-9876	Institut national de la sante et de la recherche medicale (INSERM); Agence de Recherche contre le Cancer (ARC); Agence Nationale de la Recherche (ANR-MIE); Region Midi-Pyrenees	Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence de Recherche contre le Cancer (ARC); Agence Nationale de la Recherche (ANR-MIE)(French National Research Agency (ANR)); Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	This work was supported by Institut national de la sante et de la recherche medicale (INSERM), Agence de Recherche contre le Cancer (ARC), Agence Nationale de la Recherche (ANR-MIE 2009), and Region Midi-Pyrenees. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Barthel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P175, DOI 10.1016/j.abb.2007.04.015; Barzegar C, 1998, BRIT J DERMATOL, V139, P122; CSERMELY P, 1989, ACTA PHYSIOL HUNG, V74, P195; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; GLINSKI W, 1976, DERMATOLOGICA, V153, P218, DOI 10.1159/000251060; Haase H, 2006, ANAL BIOCHEM, V352, P222, DOI 10.1016/j.ab.2006.02.009; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; HAFTEK M, 1985, DERMATOLOGICA, V170, P213, DOI 10.1159/000249535; Kaler P, 2007, AM J PHYSIOL-RENAL, V292, pF217, DOI 10.1152/ajprenal.00014.2006; Kaltenberg J, 2010, EUR J IMMUNOL, V40, P1496, DOI 10.1002/eji.200939574; Kawai K, 2009, DERMATOLOGY, V219, P274, DOI 10.1159/000235743; Kim YM, 2006, AM J PHYSIOL-LUNG C, V290, pL1028, DOI 10.1152/ajplung.00479.2005; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Landini MM, 2012, J INVEST DERMATOL, V132, P1305, DOI 10.1038/jid.2011.399; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lazarczyk M, 2008, J VIROL, V82, P11486, DOI 10.1128/JVI.01314-08; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Lin RS, 1998, J BIOL CHEM, V273, P32878, DOI 10.1074/jbc.273.49.32878; Majewski S, 1997, CLIN DERMATOL, V15, P321, DOI 10.1016/S0738-081X(96)00169-1; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; Orth G, 2008, CURR TOP MICROBIOL, V321, P59; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; PRAWER SE, 1977, ARCH DERMATOL, V113, P495, DOI 10.1001/archderm.113.4.495; PULIDO P, 1966, BIOCHEMISTRY-US, V5, P1768, DOI 10.1021/bi00869a046; PYRHONEN S, 1980, BRIT J DERMATOL, V102, P247, DOI 10.1111/j.1365-2133.1980.tb08136.x; Ramoz N, 2000, J INVEST DERMATOL, V114, P1148, DOI 10.1046/j.1523-1747.2000.00996.x; Ramoz N, 1999, J INVEST DERMATOL, V112, P259, DOI 10.1046/j.1523-1747.1999.00536.x; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Rogers HD, 2009, J AM ACAD DERMATOL, V60, P315, DOI 10.1016/j.jaad.2008.08.035; Romir J, 2007, J MOL BIOL, V365, P1417, DOI 10.1016/j.jmb.2006.10.058; Saxena A, 2008, J IMMUNOL, V181, P1617, DOI 10.4049/jimmunol.181.3.1617; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Seo SR, 2001, J NEUROCHEM, V78, P600, DOI 10.1046/j.1471-4159.2001.00438.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanaka S, 2005, BIOCHEM BIOPH RES CO, V335, P162, DOI 10.1016/j.bbrc.2005.07.059; Tobin E, 2003, BRIT J DERMATOL, V149, P627, DOI 10.1046/j.1365-2133.2003.05543.x; Vizler C, 2000, J IMMUNOL, V165, P6314, DOI 10.4049/jimmunol.165.11.6314; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yu MC, 2011, J EXP MED, V208, P775, DOI 10.1084/jem.20100031	44	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39995	10.1371/journal.pone.0039995	http://dx.doi.org/10.1371/journal.pone.0039995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761942	Green Submitted, Green Published, gold			2022-12-25	WOS:000305826400051
J	Gao, JZ; Faraggi, E; Zhou, YQ; Ruan, JS; Kurgan, L				Gao, Jianzhao; Faraggi, Eshel; Zhou, Yaoqi; Ruan, Jishou; Kurgan, Lukasz			BEST: Improved Prediction of B-Cell Epitopes from Antigen Sequences	PLOS ONE			English	Article							SOLVENT ACCESSIBILITY; PROTEIN; RESIDUES; PROGRAM; SERVER; DETERMINANTS; ACCURACY; LOCATION; REGIONS; TOOLS	Accurate identification of immunogenic regions in a given antigen chain is a difficult and actively pursued problem. Although accurate predictors for T-cell epitopes are already in place, the prediction of the B-cell epitopes requires further research. We overview the available approaches for the prediction of B-cell epitopes and propose a novel and accurate sequence-based solution. Our BEST (B-cell Epitope prediction using Support vector machine Tool) method predicts epitopes from antigen sequences, in contrast to some method that predict only from short sequence fragments, using a new architecture based on averaging selected scores generated from sliding 20-mers by a Support Vector Machine (SVM). The SVM predictor utilizes a comprehensive and custom designed set of inputs generated by combining information derived from the chain, sequence conservation, similarity to known (training) epitopes, and predicted secondary structure and relative solvent accessibility. Empirical evaluation on benchmark datasets demonstrates that BEST outperforms several modern sequence-based B-cell epitope predictors including ABCPred, method by Chen et al. (2007), BCPred, COBEpro, BayesB, and CBTOPE, when considering the predictions from antigen chains and from the chain fragments. Our method obtains a cross-validated area under the receiver operating characteristic curve (AUC) for the fragment-based prediction at 0.81 and 0.85, depending on the dataset. The AUCs of BEST on the benchmark sets of full antigen chains equal 0.57 and 0.6, which is significantly and slightly better than the next best method we tested. We also present case studies to contrast the propensity profiles generated by BEST and several other methods.	[Gao, Jianzhao; Ruan, Jishou] Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China; [Gao, Jianzhao; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Faraggi, Eshel; Zhou, Yaoqi] Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA; [Faraggi, Eshel; Zhou, Yaoqi] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada	Nankai University; Nankai University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Nankai University; University of Alberta	Gao, JZ (corresponding author), Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.	gaojz@nankai.edu.cn; lkurgan@ece.ualberta.ca	Zhou, Yaoqi/B-3284-2009; Kurgan, Lukasz/B-5721-2009	Zhou, Yaoqi/0000-0002-9958-5699; Kurgan, Lukasz/0000-0002-7749-0314; Gao, Jianzhao/0000-0002-9943-4786	National Science Foundation of China (NSFC) [31050110432, 31150110577]; National Institutes of Health [GM R01 085003]; NSERC (National Science and Engineering Research Council) Canada [298328]; International Development Research Center, Ottawa, Canada [104519-010]; Tianjin science and technology support project [08ZCHHZ00200]; Fundamental Research Funds for the Central Universities [65011491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085003] Funding Source: NIH RePORTER	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC (National Science and Engineering Research Council) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); International Development Research Center, Ottawa, Canada; Tianjin science and technology support project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation of China (NSFC) grants 31050110432 and 31150110577 to LK and JR, National Institutes of Health grant GM R01 085003 to YZ, and by the Discovery grant 298328 from NSERC (National Science and Engineering Research Council) Canada to LK. JR was also supported by the International Development Research Center, Ottawa, Canada (No. 104519-010) and Tianjin science and technology support project 08ZCHHZ00200. JG was supported by the Fundamental Research Funds for the Central Universities grant 65011491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Beck A, 2007, J PEPT SCI, V13, P588, DOI 10.1002/psc.852; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657; Chen K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S4; Chen Ping, 2011, Virologica Sinica, V26, P1, DOI 10.1007/s12250-011-3159-4; Dor O, 2007, PROTEINS, V66, P838, DOI 10.1002/prot.21298; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Flower Darren R., 2007, V409, P1, DOI 10.1007/978-1-60327-118-9_1; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Kurgan L, 2011, CURR PROTEIN PEPT SC, V12, P470, DOI 10.2174/138920311796957711; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; LIU R, 2011, J PROTEOM BIOINFORM, V4; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miri Disfani F, 2012, BIOINFORMAT IN PRESS; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Mizianty MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-414; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176; PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341; Zhao L, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S6	53	65	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40104	10.1371/journal.pone.0040104	http://dx.doi.org/10.1371/journal.pone.0040104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761950	Green Submitted, Green Published, gold			2022-12-25	WOS:000305825800088
J	Coleman, BM; Hanssen, E; Lawson, VA; Hill, AF				Coleman, Bradley M.; Hanssen, Eric; Lawson, Victoria A.; Hill, Andrew F.			Prion-infected cells regulate the release of exosomes with distinct ultrastructural features	FASEB JOURNAL			English	Article						cryo-electron microscopy; tomography; vesicle	PROTEIN; INFECTIVITY; ASSOCIATION; VESICLES; AMPLIFICATION; TRANSMISSION; PROPAGATION; BIOGENESIS; ASSAY; HIV-1	Exosomes are small membrane-bound vesicles released from cells and found in vivo in most biological fluids. Functions reported for exosomes include cell-cell communication, roles in modulating immune responses, and roles in the transfer of pathogens such as prions. Here we investigated the molecular characteristics of the structure of exosomes that harbor prion infectivity to determine the native structure of exosomes and whether infected exosomes have a distinct structure. Cryo-electron tomography revealed the previously unidentified ultrastructural detail of exosomes with high resolution. Exosomes were found to be naturally spherical in shape and to have a diverse population that varies in size and internal structure, such as differences in the number of membrane structures. Exosomes isolated from prion-infected cells contained a significantly different population of exosomes with distinct structural features compared to control vesicles from mock-infected cells. Exosomes are highly structured vesicles that can modify their structure on altering their protein cargo. This finding provides further insight into the role that the exosomal protein cargo plays on influencing the structure of the vesicles as well as highlighting the diversity of exosomes and their relationship to biological processes.-Coleman, B. M., Hanssen, E., Lawson, V. A., Hill, A. F. Prion-infected cells regulate the release of exosomes with distinct ultrastructural features FASEB J. 26, 4160-4173 (2012). www.fasebj.org	[Coleman, Bradley M.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Coleman, Bradley M.; Lawson, Victoria A.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Hanssen, Eric] Univ Melbourne, Electron Microscopy Unit Bio21, Parkville, Vic 3010, Australia; [Lawson, Victoria A.; Hill, Andrew F.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hill, AF (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.	a.hill@unimelb.edu.au	Hill, Andrew F./GZL-4124-2022; Lawson, Victoria/AAJ-7392-2021; Hill, Andrew F./AAH-2854-2020; Hanssen, Eric/A-7217-2013; Hill, Andrew F/B-4527-2009	Hill, Andrew F./0000-0001-5581-2354; Hanssen, Eric/0000-0002-4064-1844; Hill, Andrew F/0000-0001-5581-2354; Lawson, Victoria/0000-0002-7362-7176	Australian National Health and Medical Research Council (NHMRC) [628946, 400202]; NHMRC Postgraduate Scholarship [628959]; Australian Research Council Future Fellowship [FT100100560]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	The authors thank Dr. Percy Chu (Department of Biochemistry and Molecular Biology, The University of Melbourne) for kindly providing mouse brain tissue used in this study, and Dr. David Cullis-Hill (Biopharm Australia, Sydney, NSW, Australia) for kindly providing PPS. This study was funded by grants from the Australian National Health and Medical Research Council (NHMRC; grants 628946 and 400202; www.nhmrc.gov.au). B.M.C. is supported by an NHMRC Postgraduate Scholarship (grant 628959), and A.F.H. is supported by an Australian Research Council (www.arc.gov.au) Future Fellowship (grant FT100100560). A.F.H., B.M.C., and V.A.L. designed research; B.M.C. and E.G. performed research; B.M.C., A.F.H., E.G., and V.A.L. analyzed data; B.M.C. and A.F.H. wrote the paper. The authors declare no conflicts of interest.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bess JW, 1997, VIROLOGY, V230, P134, DOI 10.1006/viro.1997.8499; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0; GABIZON R, 1988, J BIOL CHEM, V263, P4950; Gluschankof P, 1997, VIROLOGY, V230, P125, DOI 10.1006/viro.1997.8453; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Harrison CF, 2010, J BIOL CHEM, V285, P20213, DOI 10.1074/jbc.M109.093310; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Larramendy-Gozalo C, 2007, J GEN VIROL, V88, P1062, DOI 10.1099/vir.0.82286-0; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Mahal Sukhvir P., 2008, V459, P49, DOI 10.1007/978-1-59745-234-2_4; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mattei V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005057; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rasband W., 2006, IMAGEJ; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Schatzl HM, 1997, J VIROL, V71, P8821; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	57	111	115	1	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4160	4173		10.1096/fj.11-202077	http://dx.doi.org/10.1096/fj.11-202077			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22767229				2022-12-25	WOS:000309704000022
J	Crespo, R; Rocha, FA; Damas, AM; Martins, PM				Crespo, Rosa; Rocha, Fernando A.; Damas, Ana M.; Martins, Pedro M.			A Generic Crystallization-like Model That Describes the Kinetics of Amyloid Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; ATOMIC-FORCE MICROSCOPY; PROTEIN AGGREGATION; APOLIPOPROTEIN-E; CRYSTAL-GROWTH; PRION PROTEIN; LAG TIME; NUCLEATION; MECHANISM; BETA(2)-MICROGLOBULIN	Associated with neurodegenerative disorders such as Alzheimer, Parkinson, or prion diseases, the conversion of soluble proteins into amyloid fibrils remains poorly understood. Extensive "in vitro" measurements of protein aggregation kinetics have been reported, but no consensus mechanism has emerged until now. This contribution aims at overcoming this gap by proposing a theoretically consistent crystallization-like model (CLM) that is able to describe the classic types of amyloid fibrillization kinetics identified in our literature survey. Amyloid conversion represented as a function of time is shown to follow different curve shapes, ranging from sigmoidal to hyperbolic, according to the relative importance of the nucleation and growth steps. Using the CLM, apparently unrelated data are deconvoluted into generic mechanistic information integrating the combined influence of seeding, nucleation, growth, and fibril breakage events. It is notable that this complex assembly of interdependent events is ultimately reduced to a mathematically simple model, whose two parameters can be determined by little more than visual inspection. The good fitting results obtained for all cases confirm the CLM as a good approximation to the generalized underlying principle governing amyloid fibrillization. A perspective is presented on possible applications of the CLM during the development of new targets for amyloid disease therapeutics.	[Damas, Ana M.; Martins, Pedro M.] Univ Porto, ICBAS, P-4050313 Oporto, Portugal; [Crespo, Rosa; Rocha, Fernando A.; Martins, Pedro M.] Univ Porto, Fac Engn, Dept Engn Quim, LEPAE, P-4200465 Oporto, Portugal; [Damas, Ana M.] Univ Porto, IBMC, P-4150180 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Martins, PM (corresponding author), Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.	pmmartins@icbas.up.pt	Martins, Pedro M/J-3765-2013; Rocha, Fernando A/D-4324-2014; Martins, Pedro/GWC-7702-2022	Rocha, Fernando A/0000-0002-2778-8374; Crespo Rodriguez, Rosa/0000-0003-4980-2074; Martins, Pedro Miguel/0000-0002-6908-1828	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-PRO/101260/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Project PTDC/BIA-PRO/101260/2008 from the Fundacao para a Ciencia e a Tecnologia, Portugal.	Auer S, 2010, PROTEINS, V78, P2412, DOI 10.1002/prot.22762; Ban T, 2006, METHOD ENZYMOL, V413, P91, DOI 10.1016/S0076-6879(06)13005-0; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bernacki JP, 2009, BIOPHYS J, V96, P2871, DOI 10.1016/j.bpj.2008.12.3903; Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; Bhak G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004177; Bondos SE, 2006, CURR ANAL CHEM, V2, P157, DOI 10.2174/157341106776359140; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Fandrich M, 2007, J MOL BIOL, V365, P1266, DOI 10.1016/j.jmb.2006.11.009; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Heldt CL, 2011, PROTEINS, V79, P92, DOI 10.1002/prot.22861; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ionescu-Zanetti C, 1999, P NATL ACAD SCI USA, V96, P13175, DOI 10.1073/pnas.96.23.13175; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kamihira M, 2000, PROTEIN SCI, V9, P867, DOI 10.1110/ps.9.5.867; Kashchiev D., 2000, NUCL BASIC THEORY AP; Kashchiev D, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3447891; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; Kim HJ, 2007, J MICROBIOL BIOTECHN, V17, P2027; Knowles TPJ, 2007, P NATL ACAD SCI USA, V104, P10016, DOI 10.1073/pnas.0610659104; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Konuma T, 2011, J MOL BIOL, V405, P851, DOI 10.1016/j.jmb.2010.11.029; Markov I. V., 2003, CRYSTAL GROWTH BEGGI; Martins PM, 2007, SURF SCI, V601, P5466, DOI 10.1016/j.susc.2007.09.008; Martins PM, 2007, SURF SCI, V601, P3400, DOI 10.1016/j.susc.2007.06.016; Martins PM, 2008, CRYST RES TECHNOL, V43, P1258, DOI 10.1002/crat.200800301; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Naiki H, 1998, BIOCHEMISTRY-US, V37, P17882, DOI 10.1021/bi980550y; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Patil SM, 2011, BIOCHEMISTRY-US, V50, P2808, DOI 10.1021/bi101908m; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; Radford SE, 2005, BBA-PROTEINS PROTEOM, V1753, P51, DOI 10.1016/j.bbapap.2005.07.006; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Schmidt H, 2008, BIOINFORMATICS, V24, P848, DOI 10.1093/bioinformatics/btn035; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Watzky MA, 1997, J AM CHEM SOC, V119, P10382, DOI 10.1021/ja9705102; Watzky MA, 2008, BIOCHEMISTRY-US, V47, P10790, DOI 10.1021/bi800726m; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zhang TH, 2009, ANGEW CHEM INT EDIT, V48, P1308, DOI 10.1002/anie.200804743	69	66	66	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30585	30594		10.1074/jbc.M112.375345	http://dx.doi.org/10.1074/jbc.M112.375345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22767606	Green Published, hybrid			2022-12-25	WOS:000308579800050
J	Cairns, DM; Liu, RJ; Sen, M; Canner, JP; Schindeler, A; Little, DG; Zeng, L				Cairns, Dana M.; Liu, Renjing; Sen, Manpreet; Canner, James P.; Schindeler, Aaron; Little, David G.; Zeng, Li			Interplay of Nkx3.2, Sox9 and Pax3 Regulates Chondrogenic Differentiation of Muscle Progenitor Cells	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; SKELETAL-MUSCLE; SATELLITE CELLS; STEM-CELLS; IN-VITRO; FRACTURE REPAIR; AXIAL SKELETON; BONE-MARROW; MYOGENIC DIFFERENTIATION; CHONDROCYTE MATURATION	Muscle satellite cells make up a stem cell population that is capable of differentiating into myocytes and contributing to muscle regeneration upon injury. In this work we investigate the mechanism by which these muscle progenitor cells adopt an alternative cell fate, the cartilage fate. We show that chick muscle satellite cells that normally would undergo myogenesis can be converted to express cartilage matrix proteins in vitro when cultured in chondrogenic medium containing TGF beta 3 or BMP2. In the meantime, the myogenic program is repressed, suggesting that muscle satellite cells have undergone chondrogenic differentiation. Furthermore, ectopic expression of the myogenic factor Pax3 prevents chondrogenesis in these cells, while chondrogenic factors Nkx3.2 and Sox9 act downstream of TGF beta 3 or BMP2 to promote this cell fate transition. We found that Nkx3.2 and Sox9 repress the activity of the Pax3 promoter and that Nkx3.2 acts as a transcriptional repressor in this process. Importantly, a reverse function mutant of Nkx3.2 blocks the ability of Sox9 to both inhibit myogenesis and induce chondrogenesis, suggesting that Nkx3.2 is required for Sox9 to promote chondrogenic differentiation in satellite cells. Finally, we found that in an in vivo mouse model of fracture healing where muscle progenitor cells were lineage-traced, Nkx3.2 and Sox9 are significantly upregulated while Pax3 is significantly downregulated in the muscle progenitor cells that give rise to chondrocytes during fracture repair. Thus our in vitro and in vivo analyses suggest that the balance of Pax3, Nkx3.2 and Sox9 may act as a molecular switch during the chondrogenic differentiation of muscle progenitor cells, which may be important for fracture healing.	[Cairns, Dana M.; Canner, James P.; Zeng, Li] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA; [Liu, Renjing; Schindeler, Aaron; Little, David G.] Childrens Hosp Westmead, Orthopaed Res & Biotechnol Unit, Westmead, NSW, Australia; [Liu, Renjing; Schindeler, Aaron; Little, David G.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Sen, Manpreet; Zeng, Li] Tufts Univ, Sch Med, Bldg Divers Biomed Res Program BDBS, Boston, MA 02111 USA; [Sen, Manpreet; Zeng, Li] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Zeng, Li] Tufts Med Ctr, Dept Orthopaed Surg, Boston, MA USA	Tufts University; University of Sydney; University of Sydney; Tufts University; Tufts University; Tufts Medical Center	Cairns, DM (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA.	li.zeng@tufts.edu		Cairns, Dana/0000-0003-0574-8395; Schindeler, Aaron/0000-0002-7757-6281	NSF [CBET-0966920]; NIH [R01AR059106, 5R25HL007786]; Sackler Dean's Fellowship from Tufts University; Australian Orthopaedic Research Fund (AORF); National Health and Medical Research Council (NH MRC) [457245]; Peter Bega scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL007786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059106, R03AR054611] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Dean's Fellowship from Tufts University; Australian Orthopaedic Research Fund (AORF); National Health and Medical Research Council (NH MRC)(National Health and Medical Research Council (NHMRC) of Australia); Peter Bega scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	L.Z. was supported by a grant from NSF (CBET-0966920, www.nsf.gov) and NIH (R01AR059106, www.nih.gov). D.C. was supported by the Sackler Dean's Fellowship from Tufts University (sackler.tufts.edu). A.S. and D.G.L. were supported by the Australian Orthopaedic Research Fund (AORF, www.aoa.org.au) and the National Health and Medical Research Council (NH& MRC, grant no. 457245, www.nhmrc.gov.au). R.S. was supported by a Peter Bega scholarship (www.chw.edu.au). M.S. was supported by NIH (5R25HL007786, www.nih.gov), which funds the Building Diversity in Biomedical Sciences program (BDBS) at Tufts University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BETTEXGALLAND M, 1987, EXPERIENTIA, V43, P610, DOI 10.1007/BF02126349; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022; Brammer KS, 2010, MAT SCI ENG C-MATER, V30, P518, DOI 10.1016/j.msec.2010.01.013; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Burton N M, 2000, Methods Cell Sci, V22, P51, DOI 10.1023/A:1009830114804; Cairns DM, 2008, DEV BIOL, V323, P152, DOI 10.1016/j.ydbio.2008.08.024; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; Clark CA, 2009, J ORTHOP RES, V27, P785, DOI 10.1002/jor.20805; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Espina Virginia, 2006, V319, P213; Evans CH, 2009, EUR CELLS MATER, V18, P96, DOI 10.22203/eCM.v018a09; Evans CH, 2007, TISSUE ENG, V13, P1987, DOI 10.1089/ten.2006.0302; Fenwick SA, 1997, INT J EXP PATHOL, V78, P187, DOI 10.1046/j.1365-2613.1997.210355.x; Han HS, 2010, J ORTHOP RES, V28, P1283, DOI 10.1002/jor.21129; Harry LE, 2008, J ORTHOP RES, V26, P1238, DOI 10.1002/jor.20649; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; Hashimoto N, 2008, MECH DEVELOP, V125, P257, DOI 10.1016/j.mod.2007.11.004; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hellemans J, 2009, AM J HUM GENET, V85, P916, DOI 10.1016/j.ajhg.2009.11.005; Herbrand H, 2002, MECH DEVELOP, V117, P217, DOI 10.1016/S0925-4773(02)00207-1; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Holzmann P, 2010, ALTEX-ALTERN ANIM EX, V27, P97; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kaback LA, 2008, J CELL BIOCHEM, V105, P219, DOI 10.1002/jcb.21816; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Lettice L, 2001, J ANAT, V199, P181, DOI 10.1046/j.1469-7580.2001.19910181.x; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Li G, 2004, P 50 ANN M ORTH RES; Lissenberg-Thunnissen SN, 2011, INT ORTHOP; Liu R, 2010, J MUSCULOSKEL NEURON, V10, P71; Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lu Chuanyong, 2006, Iowa Orthop J, V26, P17; Machida S, 2004, CELL PROLIFERAT, V37, P267, DOI 10.1111/j.1365-2184.2004.00311.x; Maeda Y, 2003, BONE, V32, P27, DOI 10.1016/S8756-3282(02)00917-1; Magnaghi P, 1998, NAT GENET, V20, P74, DOI 10.1038/1739; Hernandez-Hernandez JM, 2009, J MOL BIOL, V394, P1, DOI 10.1016/j.jmb.2009.08.057; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meech R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011612; Mello MA, 1999, IN VITRO CELL DEV-AN, V35, P262; Minear S, 2010, J BONE MINER RES, V25, P1196, DOI 10.1002/jbmr.29; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; NATHANSON MA, 1983, J BIOL CHEM, V258, P325; NATHANSON MA, 1986, CURR TOP DEV BIOL, V20, P39, DOI 10.1016/S0070-2153(08)60653-5; Natoli TA, 1997, DEVELOPMENT, V124, P617; Nehlin JO, 2011, BIOGERONTOLOGY, V12, P349, DOI 10.1007/s10522-011-9336-5; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294; Schindeler A, 2008, BONE, V42, P616, DOI 10.1016/j.bone.2007.11.006; Schindeler A, 2008, J ORTHOP RES, V26, P1053, DOI 10.1002/jor.20628; Schindeler A, 2009, DIFFERENTIATION, V77, P12, DOI 10.1016/j.diff.2008.09.007; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Secreto Frank J, 2009, Curr Osteoporos Rep, V7, P64; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Takahata M, 2011, CELL TISSUE RES; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wang LH, 2007, CRYOBIOLOGY, V55, P138, DOI 10.1016/j.cryobiol.2007.06.005; Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022; WHITLEY CB, 1989, CLIN CHEM, V35, P374; Wiggan O, 1998, ONCOGENE, V16, P227, DOI 10.1038/sj.onc.1201534; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Yi SE, 2000, DEVELOPMENT, V127, P621; Yu YY, 2010, BONE, V46, P841, DOI 10.1016/j.bone.2009.11.005; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zhao YM, 2012, CELLS TISSUES ORGANS, V195, P414, DOI 10.1159/000329254	101	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39642	10.1371/journal.pone.0039642	http://dx.doi.org/10.1371/journal.pone.0039642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768305	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500018
J	Morairty, SR; Revel, FG; Malherbe, P; Moreau, JL; Valladao, D; Wettstein, JG; Kilduff, TS; Borroni, E				Morairty, Stephen R.; Revel, Florent G.; Malherbe, Pari; Moreau, Jean-Luc; Valladao, Daniel; Wettstein, Joseph G.; Kilduff, Thomas S.; Borroni, Edilio			Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone	PLOS ONE			English	Article							HYPOTHALAMIC OREXIN NEURONS; BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; PHARMACOLOGICAL CHARACTERIZATION; RAT-BRAIN; REM-SLEEP; MICE; WAKEFULNESS; NARCOLEPSY; DISCOVERY	The hypocretin (orexin) system is involved in sleep/wake regulation, and antagonists of both hypocretin receptor type 1 (HCRTR1) and/or HCRTR2 are considered to be potential hypnotic medications. It is currently unclear whether blockade of either or both receptors is more effective for promoting sleep with minimal side effects. Accordingly, we compared the properties of selective HCRTR1 (SB-408124 and SB-334867) and HCRTR2 (EMPA) antagonists with that of the dual HCRTR1/R2 antagonist almorexant in the rat. All 4 antagonists bound to their respective receptors with high affinity and selectivity in vitro. Since in vivo pharmacokinetic experiments revealed poor brain penetration for SB-408124, SB-334867 was selected for subsequent in vivo studies. When injected in the mid-active phase, SB-334867 produced small increases in rapid-eye-movement (REM) and non-REM (NR) sleep. EMPA produced a significant increase in NR only at the highest dose studied. In contrast, almorexant decreased NR latency and increased both NR and REM proportionally throughout the subsequent 6 h without rebound wakefulness. The increased NR was due to a greater number of NR bouts; NR bout duration was unchanged. At the highest dose tested (100 mg/kg), almorexant fragmented sleep architecture by increasing the number of waking and REM bouts. No evidence of cataplexy was observed. HCRTR1 occupancy by almorexant declined 4-6 h post-administration while HCRTR2 occupancy was still elevated after 12 h, revealing a complex relationship between occupancy of HCRT receptors and sleep promotion. We conclude that dual HCRTR1/R2 blockade is more effective in promoting sleep than blockade of either HCRTR alone. In contrast to GABA receptor agonists which induce sleep by generalized inhibition, HCRTR antagonists seem to facilitate sleep by reducing waking "drive".	[Morairty, Stephen R.; Valladao, Daniel; Kilduff, Thomas S.] SRI Int, Ctr Neurosci & Metab Dis Res, Menlo Pk, CA 94025 USA; [Revel, Florent G.; Malherbe, Pari; Moreau, Jean-Luc; Wettstein, Joseph G.; Borroni, Edilio] F Hoffmann La Roche Ltd, Neurosci Res, Basel, Switzerland	SRI International; Roche Holding	Morairty, SR (corresponding author), SRI Int, Ctr Neurosci & Metab Dis Res, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	stephen.morairty@sri.com	Kilduff, Thomas S/K-3127-2012	Kilduff, Thomas S/0000-0002-6823-0094	United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH-09-2-0081]; Roche	United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Roche(Roche Holding)	Work at SRI International was supported in part by United States Army Medical Research and Materiel Command (USAMRMC) grant W81XWH-09-2-0081 (http://cdmrp.army.mil/default.shtml) and in part by institutional funds. Work at Roche was funded by Roche. USAMRMC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche partly contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adamantidis A, 2009, J PHYSIOL-LONDON, V587, P33, DOI 10.1113/jphysiol.2008.164400; Akanmu MA, 2005, BRAIN RES, V1048, P138, DOI 10.1016/j.brainres.2005.04.064; Baker DE, 2007, REV GASTROENTEROL DI, V7, pS11; Ballard TM, 2009, PSYCHOPHARMACOLOGY, V202, P207, DOI 10.1007/s00213-008-1357-7; Bingham S, 2001, PAIN, V92, P81, DOI 10.1016/S0304-3959(00)00470-X; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Coleman PJ, 2010, BIOORG MED CHEM LETT, V20, P4201, DOI 10.1016/j.bmcl.2010.05.047; Coleman PJ, 2012, CHEMMEDCHEM; Cox CD, 2010, J MED CHEM, V53, P5320, DOI 10.1021/jm100541c; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Di Fabio R, 2011, BIOORG MED CHEM LETT, V21, P5562, DOI 10.1016/j.bmcl.2011.06.086; DUGOVIC C, 2009, J PHARM EXP THER; Emerich DF, 1998, BRAIN RES, V801, P259, DOI 10.1016/S0006-8993(98)00571-X; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Gozzi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016406; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Hirose M, 2003, BIOORG MED CHEM LETT, V13, P4497, DOI 10.1016/j.bmcl.2003.08.038; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; Kajiyama S, 2005, BRAIN RES, V1044, P76, DOI 10.1016/j.brainres.2005.03.007; KALINER MA, 1992, AM FAM PHYSICIAN, V45, P1337; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; Kilduff TS, 2005, SLEEP MED REV, V9, P227, DOI 10.1016/j.smrv.2005.04.002; Kuwaki T, 2010, RESP PHYSL NEUROBIOL; Kuwaki T, 2008, RESP PHYSIOL NEUROBI, V164, P204, DOI 10.1016/j.resp.2008.03.011; Langmead CJ, 2004, BRIT J PHARMACOL, V141, P340, DOI 10.1038/sj.bjp.0705610; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Linnet K, 2008, EUR NEUROPSYCHOPHARM, V18, P157, DOI 10.1016/j.euroneuro.2007.06.003; Malherbe P, 2009, BRIT J PHARMACOL, V156, P1326, DOI 10.1111/j.1476-5381.2009.00127.x; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McAtee LC, 2004, BIOORG MED CHEM LETT, V14, P4225, DOI 10.1016/j.bmcl.2004.06.032; Mieda M, 2011, J NEUROSCI, V31, P6518, DOI 10.1523/JNEUROSCI.6506-10.2011; Mobarakeh JI, 2005, PEPTIDES, V26, P767, DOI 10.1016/j.peptides.2005.01.001; Morairty SR, 2008, SLEEP, V31, P34, DOI 10.1093/sleep/31.1.34; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Nattie E, 2010, J APPL PHYSIOL, V108, P1417, DOI 10.1152/japplphysiol.01261.2009; NORMAN PS, 1985, J ALLERGY CLIN IMMUN, V76, P366, DOI 10.1016/0091-6749(85)90655-4; Sadeque AJM, 2000, CLIN PHARMACOL THER, V68, P231, DOI 10.1067/mcp.2000.109156; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Samson WK, 2005, SLEEP MED REV, V9, P243, DOI 10.1016/j.smrv.2004.07.006; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Siegel JM, 2004, ANNU REV PSYCHOL, V55, P125, DOI 10.1146/annurev.psych.55.090902.141545; Smart D, 2001, BRIT J PHARMACOL, V132, P1179, DOI 10.1038/sj.bjp.0703953; Smith MI, 2003, NEUROSCI LETT, V341, P256, DOI 10.1016/S0304-3940(03)00066-1; SNYDER SH, 1987, ANN ALLERGY, V59, P4; Thuerauf N, 2006, EUR ARCH PSY CLIN N, V256, P281, DOI 10.1007/s00406-006-0662-6; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Weller T., 2005, [No title captured], Patent No. [WO2005118548, 2005118548, WO 2005/118548]; Whitman DB, 2009, CHEMMEDCHEM, V4, P1069, DOI 10.1002/cmdc.200900069; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Winrow CJ, 2012, NEUROPHARMACOLOGY, V62, P978, DOI 10.1016/j.neuropharm.2011.10.003; Winrow CJ, 2011, J NEUROGENET, V25, P52, DOI 10.3109/01677063.2011.566953; Winsky-Sommerer R, 2004, J NEUROSCI, V24, P11439, DOI 10.1523/JNEUROSCI.3459-04.2004; Xie XM, 2008, J CLIN INVEST, V118, P2471, DOI 10.1172/JCI35115; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	63	95	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39131	10.1371/journal.pone.0039131	http://dx.doi.org/10.1371/journal.pone.0039131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768296	Green Published, gold, Green Submitted			2022-12-25	WOS:000305966500009
J	Nirantharakumar, K; Marshall, T; Hodson, J; Narendran, P; Deeks, J; Coleman, JJ; Ferner, RE				Nirantharakumar, Krishnarajah; Marshall, Tom; Hodson, James; Narendran, Parth; Deeks, Jon; Coleman, Jamie J.; Ferner, Robin E.			Hypoglycemia in Non-Diabetic In-Patients: Clinical or Criminal?	PLOS ONE			English	Article							MILD HYPOGLYCEMIA; PREVALENCE; MANAGEMENT; MORTALITY; INSULIN; MURDER	Background and Aim: We wished to establish the frequency of unexpected hypoglycemia observed in non diabetic patients outside the intensive care unit and to determine if they have a plausible clinical explanation. Methods: We analysed data for 2010 from three distinct sources to identify non diabetic hypoglycaemic patients: bedside and laboratory blood glucose measurements; medication records for those treatments (high-strength glucose solution and glucagon) commonly given to reverse hypoglycemia; and diagnostic codes for hypoglycemia. We excluded from the denominator admissions of patients with a diagnosis of diabetes or prescribed diabetic medication. Case notes of patients identified were reviewed. We used capture-recapture methods to establish the likely frequency of hypoglycemia in nondiabetic in-patients outside intensive care unit at different cut-off points for hypoglycemia. We also recorded co-morbidities that might have given rise to hypoglycemia. Results: Among the 37,898 admissions, the triggers identified 71 hypoglycaemic episodes at a cut-off of 3.3 mmol/l. Estimated frequency at 3.3 mmol/l was 50(CI 33-93), at 3.0 mmol/l, 36(CI 24-64), at 2.7 mmol/l, 13(CI 11-19), at 2.5 mmol/l, 11(CI 9-15) and at 2.2 mmol/l, 8(CI 7-11) per 10,000 admissions. Admissions of patients aged above 65 years were approximately 50% more likely to have an episode of hypoglycemia. Most were associated with important co-morbidities. Conclusion: Significant non-diabetic hypoglycemia in hospital in-patients (at or below 2.7 mmol/l) outside critical care is rare. It is sufficiently rare for occurrences to merit case-note review and diagnostic blood tests, unless an obvious explanation is found.	[Nirantharakumar, Krishnarajah; Narendran, Parth; Coleman, Jamie J.; Ferner, Robin E.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Nirantharakumar, Krishnarajah; Hodson, James; Coleman, Jamie J.] Univ Hosp Birmingham, EPrescribing Res Team, Birmingham, W Midlands, England; [Narendran, Parth] Univ Hosp Birmingham, Dept Diabet, Birmingham, W Midlands, England; [Coleman, Jamie J.; Ferner, Robin E.] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Nirantharakumar, K (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England.	k.nirantharan@bham.ac.uk	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971; Hodson, James/0000-0003-3487-0090; Marshall, Tom/0000-0001-9277-5214; Ferner, Robin/0000-0003-3769-1346; Narendran, Parth/0000-0002-4583-8793; Coleman, Jamie/0000-0002-7512-5153	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme.	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme.(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The funders also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anabtawi A, 2010, DIABETES TECHNOL THE, V12, P635, DOI 10.1089/dia.2010.0009; Arinzon Z, 2007, ARCH GERONTOL GERIAT, V45, P191, DOI 10.1016/j.archger.2006.10.010; Becker C, 2001, MODERN HEALTHCARE, V33, P6; Ben Salem C, 2011, DRUG SAFETY, V34, P21, DOI 10.2165/11538290-000000000-00000; Berger B, 1998, DIABETES CARE, V21, P546, DOI 10.2337/diacare.21.4.546; Childs BP, 2005, DIABETES CARE, V28, P1245; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; FLETCHER SM, 1983, J FORENSIC SCI SOC, V23, P5, DOI 10.1016/S0015-7368(83)71537-9; Ford Steve, 2008, Nurs Times, V104, P8; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; Gamble JM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.11.021; Griffiths MJ, 2005, HOSP MED, V66, P277; Hart SP, 1998, QJM-MON J ASSOC PHYS, V91, P505, DOI 10.1093/qjmed/91.7.505; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Hook EB, J CLIN EPIDEMIOLOGY, V52, P917; Hunt J, 1997, MED SCI LAW, V37, P189, DOI 10.1177/002580249703700302; Joint British Diabetes Society, 2010, HOSP MAN HYP AD DIAB; Kagansky N, 2003, ARCH INTERN MED, V163, P1825, DOI 10.1001/archinte.163.15.1825; Krinsley J, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-49; Krinsley JS, 2011, CRIT CARE, V15, DOI 10.1186/cc10322; Lanoy E, 2011, INT J CANCER, V129, P467, DOI 10.1002/ijc.25903; Lupsa BC, 2009, MEDICINE, V88, P141, DOI 10.1097/MD.0b013e3181a5b42e; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Mannucci E, 2006, AGING CLIN EXP RES, V18, P446; MARKS V, 2006, DIABETES VASC DIS, V6, P281; Marks V, 2009, MED LEG J, V77; Marks V, 2008, J ROY SOC MED, V101, P110, DOI 10.1258/jrsm.2008.071002; Marks V, 2009, DRUG TEST ANAL, V1, P162, DOI 10.1002/dta.38; Missliwetz J, 1994, ARCH KRIMINOLOGIE, V194; REGAL RR, 1984, STAT MED, V3, P287, DOI 10.1002/sim.4780030310; Reurings MCB, 2011, ANN EPIDEMIOL, V21, P648, DOI 10.1016/j.annepidem.2011.05.007; Samardzic M, 2010, PEDIATR DIABETES, V11, P412, DOI 10.1111/j.1399-5448.2009.00617.x; Service FJ, 1995, NEW ENGLAND J MED, V332; Shilo S, 1998, J AM GERIATR SOC, V46, P978, DOI 10.1111/j.1532-5415.1998.tb02752.x; StataCorp, 2011, STAT STAT SOFTW REL; Teo S. K., 1997, SMJ, V38, P432; Thornley S, 2010, NEW ZEAL MED J, V123, P76; Turchin A, 2009, DIABETES CARE, V32, P1153, DOI 10.2337/dc08-2127; Virally ML, 1999, DIABETES METAB, V25, P477; Wise J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4707; Yorker BC, 2006, J FORENSIC SCI, V51, P1362, DOI 10.1111/j.1556-4029.2006.00273.x	42	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40384	10.1371/journal.pone.0040384	http://dx.doi.org/10.1371/journal.pone.0040384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768352	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500065
J	Alvarez-Rueda, N; Albassier, M; Allain, S; Deknuydt, F; Altare, F; Le Pape, P				Alvarez-Rueda, Nidia; Albassier, Marjorie; Allain, Sophie; Deknuydt, Florence; Altare, Frederic; Le Pape, Patrice			First Human Model of In Vitro Candida albicans Persistence within Granuloma for the Reliable Study of Host-Fungi Interactions	PLOS ONE			English	Article							POLYMORPHONUCLEAR NEUTROPHILS; VAGINAL CANDIDIASIS; TISSUE-REACTIONS; ACUTE-LEUKEMIA; CELLS; INFECTION; GENE; INFLAMMATION; DEGRADATION; MACROPHAGES	Backgound: The balance between human innate immune system and Candida albicans virulence signaling mechanisms ultimately dictates the outcome of fungal invasiveness and its pathology. To better understand the pathophysiology and to identify fungal virulence-associated factors in the context of persistence in humans, complex models are indispensable. Although fungal virulence factors have been extensively studied in vitro and in vivo using different immune cell subsets and cell lines, it is unclear how C. albicans survives inside complex tissue granulomas. Methodology/Principal Finding: We developed an original model of in vitro human granuloma, reproducing the natural granulomatous response to C. albicans. Persistent granulomas were obtained when the ratio of phagocytes to fungi was high. This in vitro fungal granuloma mimics natural granulomas, with infected macrophages surrounded by helper and cytotoxic T lymphocytes. A small proportion of granulomas exhibited C. albicans hyphae. Histological and time-lapse analysis showed that C. albicans blastoconidia were located within the granulomas before hyphae formation. Using staining techniques, fungal load calculations, as well as confocal and scanning electron microscopy, we describe the kinetics of fungal granuloma formation. We provide the first direct evidence that C. albicans are not eliminated by immunocompetent cells inside in vitro human granulomas. In fact, after an initial candicidal period, the remaining yeast proliferate and persist under very complex immune responses. Conclusions/Significance: Using an original in vitro model of human fungal granuloma, we herein present the evidence that C. albicans persist and grow into immunocompetent granulomatous structures. These results will guide us towards a better understanding of fungal invasiveness and, henceforth, will also help in the development of better strategies for its control in human physiological conditions.	[Alvarez-Rueda, Nidia; Albassier, Marjorie; Le Pape, Patrice] Nantes Atlantique Univ, Univ Nantes, Fac Pharm Nantes, Dept Parasitol & Mycol Med,CiMed EA1155 2, Nantes, France; [Le Pape, Patrice] CHU Nantes, Lab Parasitol Mycol, F-44035 Nantes 01, France; [Allain, Sophie; Deknuydt, Florence; Altare, Frederic] Univ Nantes, CNRS 6299, Inserm, CRCNA,U892, Nantes, France	Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Alvarez-Rueda, N (corresponding author), Nantes Atlantique Univ, Univ Nantes, Fac Pharm Nantes, Dept Parasitol & Mycol Med,CiMed EA1155 2, Nantes, France.	nidia.alvarez-rueda@univ-nantes.fr; patrice.le-pape@univ-nantes.fr	Le Pape, Patrice/W-1472-2019; Le Pape, Patrice/AAY-3632-2021; altare, frederic/K-8664-2015	Le Pape, Patrice/0000-0001-5059-6402; altare, frederic/0000-0002-5077-4616; ALVAREZ RUEDA, Nidia/0000-0002-5629-1930; Allain, Sophie/0000-0003-2241-5736				Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021239; Andres RH, 2007, ACTA NEUROCHIR, V149, P953, DOI 10.1007/s00701-007-1260-8; Bachh AA, 2008, LUNG INDIA, V25, P165, DOI 10.4103/0970-2113.45285; Banuprakash S, 2009, J NEURORADIOLOGY, V36, P233, DOI 10.1016/j.neurad.2009.06.003; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; Beattie L, 2011, CELL MICROBIOL; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Calderone R, 2000, MED MYCOL, V38, P125, DOI 10.1080/mmy.38.s1.125.137; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Calera JA, 2000, YEAST, V16, P1053, DOI 10.1002/1097-0061(200008)16:11&lt;1053::AID-YEA598&gt;3.0.CO;2-H; Collins CD, 2011, PATIENT PREFER ADHER, V5, P369, DOI 10.2147/PPA.S14047; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Crawford CL, 2011, INT J DERMATOL, V50, P255, DOI 10.1111/j.1365-4632.2010.04805.x; Diniz SN, 2001, HUM IMMUNOL, V62, P799, DOI 10.1016/S0198-8859(01)00268-3; Dubey A, 2005, SURG NEUROL, V63, P254, DOI 10.1016/j.surneu.2004.04.020; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P266, DOI 10.1093/jac/dkl246; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; Franco MVG, 1997, MYCOPATHOLOGIA, V137, P129, DOI 10.1023/A:1006883313078; Glittenberg MT, 2011, DIS MODEL MECH, V4, P515, DOI 10.1242/dmm.006627; Hanna S, 2011, J ALLERGY CLIN IMMUN, V127, P1433, DOI 10.1016/j.jaci.2011.03.026; Heinemann DEH, 1997, SCAND J IMMUNOL, V45, P596, DOI 10.1046/j.1365-3083.1997.d01-435.x; Iking-Konert C, 2008, RHEUMATOLOGY, V47, P609, DOI 10.1093/rheumatology/ken028; Iking-Konert C, 2005, ANN RHEUM DIS, V64, P1436, DOI 10.1136/ard.2004.034132; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Jain V, 2009, SURV OPHTHALMOL, V54, P286, DOI 10.1016/j.survophthal.2008.12.008; Jouault T, 2009, CELL MICROBIOL, V11, P1007, DOI 10.1111/j.1462-5822.2009.01318.x; Lalla RV, 2010, SUPPORT CARE CANCER, V18, P985, DOI 10.1007/s00520-010-0892-z; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Marcil A, 2002, INFECT IMMUN, V70, P6319, DOI 10.1128/IAI.70.11.6319-6329.2002; Masood A, 2005, LEUKEMIA RES, V29, P493, DOI 10.1016/j.leukres.2004.10.003; MEISTER H, 1977, J INFECT DIS, V135, P224, DOI 10.1093/infdis/135.2.224; MEISTER H, 1977, J INFECT DIS, V135, P235, DOI 10.1093/infdis/135.2.235; Montejo Miguel, 2011, Enferm Infecc Microbiol Clin, V29 Suppl 2, P15, DOI 10.1016/S0213-005X(11)70004-0; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Panjabi C, 2009, J BRAS PNEUMOL, V35, P480, DOI 10.1590/S1806-37132009000500015; Pankhurst CL, 2009, CLIN EVID ONLINE; Park TH, 2012, J PLAST RECONSTR AES; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pietrella D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022770; Poulain D, 2009, DIGEST DIS, V27, P104, DOI 10.1159/000268129; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Sallah S, 2001, CANCER-AM CANCER SOC, V92, P1349, DOI 10.1002/1097-0142(20010915)92:6<1349::AID-CNCR1457>3.0.CO;2-E; Saunus JM, 2008, FRONT BIOSCI-LANDMRK, V13, P5345, DOI 10.2741/3085; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Spellberg BJ, 2005, J LEUKOCYTE BIOL, V78, P338, DOI 10.1189/jlb.0205072; Srikantha T, 2008, MICROBIOL-SGM, V154, P3309, DOI 10.1099/mic.0.2008/020578-0; Tsiodras S, 2000, MAYO CLIN PROC, V75, P1039, DOI 10.4065/75.10.1039; Turgut M, 2010, CHILD NERV SYST, V26, P733, DOI 10.1007/s00381-010-1149-3; Vazquez JA, 2010, SEMIN RESP CRIT CARE, V31, P79, DOI 10.1055/s-0029-1246289; VONEIFF M, 1990, MYCOSES, V33, P283; Wagner C, 2006, CLIN EXP IMMUNOL, V143, P70, DOI 10.1111/j.1365-2249.2005.02963.x; Yumoto E, 2008, LARYNGOSCOPE, V118, P932, DOI 10.1097/MLG.0b013e318163819b	63	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40185	10.1371/journal.pone.0040185	http://dx.doi.org/10.1371/journal.pone.0040185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768252	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100225
J	Baker, SE; Ellwood, SA; Tagarielli, VL; Macdonald, DW				Baker, Sandra E.; Ellwood, Stephen A.; Tagarielli, Vito L.; Macdonald, David W.			Mechanical Performance of Rat, Mouse and Mole Spring Traps, and Possible Implications for Welfare Performance	PLOS ONE			English	Article							THRESHOLDS; MOMENTUM; PEST	Lethal spring traps are widely used for killing small mammals in the UK. Many require government approval, based primarily on humaneness. However, mole traps and break-back traps for rats and mice are exempt; those available vary widely in price and apparent quality. The EU is considering implementing a Trapping Directive that would alter UK legislation, and a recent report advised the EU that trapping legislation should cover all trapped species and encourage improvement of traps. Mechanical trap performance is often used as an indicator of welfare impact. We examined the mechanical evidence for scope to improve the welfare standards of rat, mouse and mole spring traps. We measured mechanical performance among a range of rat, mouse and mole traps. Impact momentum values varied 6-8 fold, and clamping force values 4-5.5 fold, among traps for killing each species. There was considerable overlap in the performance of rat and mouse traps. Trap-opening angle and spring type were related to impact momentum and clamping force in traps for both species. There was no relationship between price and mechanical performance in traps for any species, except talpa mole traps. We are unable to judge the direct welfare impact of the traps tested, but rather the potential welfare threat associated with their exemption from approval. The wide variation in mechanical performance in traps for each species, overlap in performance between rat and mouse traps and increasing availability of weaker plastic rodent traps indicate considerable scope for improving the humaneness of spring traps for rats, mice and moles. We conclude that all such traps should be subject to the UK approval process. New welfare categories might improve trap standards further. Our results could also help improve rodent trap design and assist consumers in selecting more powerful traps. Many thousands of rats, mice and moles might benefit.	[Baker, Sandra E.; Ellwood, Stephen A.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; [Tagarielli, Vito L.] Univ London Imperial Coll Sci Technol & Med, Dept Aeronaut, London, England	University of Oxford; Imperial College London	Baker, SE (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford OX1 3PS, England.	sandra.baker@zoo.ox.ac.uk	Tagarielli, Vito/K-3612-2013	Tagarielli, Vito/0000-0002-6696-676X	Royal Society for the Prevention of Cruelty to Animals [WLD 49/06-8S25]	Royal Society for the Prevention of Cruelty to Animals	This study was funded by the Royal Society for the Prevention of Cruelty to Animals (www.rspca.org.uk); Project WLD 49/06-8S25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, 109904 ISO; ATKINSON RPD, 1994, MAMMAL REV, V24, P73, DOI 10.1111/j.1365-2907.1994.tb00136.x; Benn DM, 1980, EFFECT CLAMPIN UNPUB; Cassidy D. C., 2002, UNDERSTANDING PHYS; Defra, 2010, WILDL MAN ENGL POL M; LLOYD HG, 1963, ANN APPL BIOL, V51, P329; Macdonald D., 1993, MAMMALS BRITAIN EURO; Mason G, 2003, ANIM WELFARE, V12, P1; Newcombe WR, 1981, WORLDWIDE FURBEARER, P1612; QUY R, 2004, REV METHODS USED EUR; SAS Institute, 2002, SAS STAT SOFTW VERS; Scott Henderson J, 1951, CMD8266; Talling JC, 2009, IMPROVEMENTS TRAPPIN; Warburton B, 2008, ANIM WELFARE, V17, P111; WARBURTON B, 1995, NEW ZEAL J ZOOL, V22, P39, DOI 10.1080/03014223.1995.9518022; Warburton B, 2006, LC0607039 LANDC RES; ZELIN S, 1983, J WILDLIFE MANAGE, V47, P863, DOI 10.2307/3808628	17	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39334	10.1371/journal.pone.0039334	http://dx.doi.org/10.1371/journal.pone.0039334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768073	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100044
J	Brunenberg, EJL; Moeskops, P; Backes, WH; Pollo, C; Cammoun, L; Vilanova, A; Janssen, MLF; Visser-Vandewalle, VERM; Romeny, BMT; Thiran, JP; Platel, B				Brunenberg, Ellen J. L.; Moeskops, Pim; Backes, Walter H.; Pollo, Claudio; Cammoun, Leila; Vilanova, Anna; Janssen, Marcus L. F.; Visser-Vandewalle, Veerle E. R. M.; Romeny, Bart M. ter Haar; Thiran, Jean-Philippe; Platel, Bram			Structural and Resting State Functional Connectivity of the Subthalamic Nucleus: Identification of Motor STN Parts and the Hyperdirect Pathway	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ADVANCED PARKINSON-DISEASE; DIFFUSION-WEIGHTED MRI; BASAL GANGLIA; STRIATAL CONNECTIONS; EFFERENT CONNECTIONS; EXTERNAL PALLIDUM; THALAMIC NUCLEI; FIBER TRACKING; CORTEX	Deep brain stimulation (DBS) for Parkinson's disease often alleviates the motor symptoms, but causes cognitive and emotional side effects in a substantial number of cases. Identification of the motor part of the subthalamic nucleus (STN) as part of the presurgical workup could minimize these adverse effects. In this study, we assessed the STN's connectivity to motor, associative, and limbic brain areas, based on structural and functional connectivity analysis of volunteer data. For the structural connectivity, we used streamline counts derived from HARDI fiber tracking. The resulting tracks supported the existence of the so-called "hyperdirect" pathway in humans. Furthermore, we determined the connectivity of each STN voxel with the motor cortical areas. Functional connectivity was calculated based on functional MRI, as the correlation of the signal within a given brain voxel with the signal in the STN. Also, the signal per STN voxel was explained in terms of the correlation with motor or limbic brain seed ROI areas. Both right and left STN ROIs appeared to be structurally and functionally connected to brain areas that are part of the motor, associative, and limbic circuit. Furthermore, this study enabled us to assess the level of segregation of the STN motor part, which is relevant for the planning of STN DBS procedures.	[Brunenberg, Ellen J. L.; Moeskops, Pim; Vilanova, Anna; Romeny, Bart M. ter Haar] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Backes, Walter H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Backes, Walter H.; Janssen, Marcus L. F.] Maastricht Univ, Sch Mental Hlth & NeuroSci, Maastricht, Netherlands; [Pollo, Claudio; Cammoun, Leila; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Inst, Lausanne, Switzerland; [Pollo, Claudio] Lausanne Univ Hosp CHUV, Dept Neurosurg, Lausanne, Switzerland; [Janssen, Marcus L. F.; Visser-Vandewalle, Veerle E. R. M.] Maastricht Univ, Med Ctr, Dept Neurosurg, Maastricht, Netherlands; [Janssen, Marcus L. F.; Visser-Vandewalle, Veerle E. R. M.] Maastricht Univ, Med Ctr, MIND, Maastricht, Netherlands; [Platel, Bram] Fraunhofer MEVIS, Bremen, Germany	Eindhoven University of Technology; Maastricht University; Maastricht University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Maastricht University; Maastricht University	Brunenberg, EJL (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	ellenbrunenberg@gmail.com	Romenij, Bart M. ter Haar/A-5323-2013; Moeskops, Pim/K-6728-2017; Brunenberg, Ellen JL/M-6651-2015; Janssen, Mark/AAX-5137-2021; Platel, Bram/D-2132-2009; Janssen, Mark/ABE-3031-2021	Moeskops, Pim/0000-0002-8733-6716; Platel, Bram/0000-0002-1936-6825; Janssen, Mark/0000-0003-0030-7224; Backes, Walter H/0000-0001-7905-0681; Thiran, Jean-Philippe/0000-0003-2938-9657	Netherlands Organization for Scientific Research [021.001.055]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	EB is supported by the Netherlands Organization for Scientific Research (www.nwo.nl, grant number 021.001.055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Ahrens James, 2005, VISUALIZATION HDB, V717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amtage F, 2009, CLIN NEUROPHYSIOL, V120, P1755, DOI 10.1016/j.clinph.2009.06.018; Andersson J, 2008, P HUM BRAIN MAPP, V14; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Barnes KA, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00018; Baudrexel S, 2010, P INT SOC MAGN RES M, V18, P440; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2005, PHILOS T R SOC B, V360, P903, DOI 10.1098/rstb.2005.1640; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18; Brunenberg E, 2010, LECT NOTES COMPUT SC, V6361, P175, DOI 10.1007/978-3-642-15705-9_22; CARPENTER MB, 1981, BRAIN RES, V224, P1, DOI 10.1016/0006-8993(81)91113-6; Cho ZH, 2011, MOVEMENT DISORD, V26, P713, DOI 10.1002/mds.23465; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cook PA, 2005, LECT NOTES COMPUT SC, V3749, P164; Cook PA, 2006, P INT SOC MAGNETIC R, V14, P2759; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guehl D, 2007, J NEUROSURG, V106, P101, DOI 10.3171/jns.2007.106.1.101; Haegelen C, 2009, MED HYPOTHESES, V72, P421, DOI 10.1016/j.mehy.2008.07.065; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; HARTMANNVONMONAKOW K, 1978, EXP BRAIN RES, V33, P395; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Joel D, 1997, BRAIN RES REV, V23, P62, DOI 10.1016/S0165-0173(96)00018-5; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; KUNZLE H, 1978, BRAIN BEHAV EVOLUT, V15, P185, DOI 10.1159/000123779; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Le Jeune F, 2010, EUR J NUCL MED MOL I, V37, P1512, DOI 10.1007/s00259-010-1436-y; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; Loucif KC, 2005, J PHYSIOL-LONDON, V567, P977, DOI 10.1113/jphysiol.2005.093807; Marrakchi-Kacem L, 2010, LECT NOTES COMPUT SC, V6362, P217; Nakano K, 2000, BRAIN DEV-JPN, V22, pS5; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nambu A, 1997, NEUROSCI LETT, V239, P13, DOI 10.1016/S0304-3940(97)00877-X; Nambu A, 1996, J NEUROSCI, V16, P2671; Nioche C, 2009, AM J NEURORADIOL, V30, P396, DOI 10.3174/ajnr.A1375; Nisino Y, 1940, Z MIKR ANAT FORSCH, V47, P401; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Peron J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009919; Piasecki SD, 2004, J CLIN PSYCHIAT, V65, P845; POLLAK P, 1993, REV NEUROL, V149, P175; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Rodriguez-Oroz MC, 2004, J NEUROL NEUROSUR PS, V75, P1382, DOI 10.1136/jnnp.2003.031294; SADIKOT AF, 1992, J COMP NEUROL, V315, P137, DOI 10.1002/cne.903150203; Seunarine KK, 2007, IEEE I CONF COMP VIS, P2649; Shink E, 1996, NEUROSCIENCE, V73, P335, DOI 10.1016/0306-4522(96)00022-X; Smeding HMM, 2006, NEUROLOGY, V66, P1830, DOI 10.1212/01.wnl.0000234881.77830.66; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strafella AP, 2005, IEEE IJCNN, P1525; Talairach J., 1988, COPLANAR STEREOTAXIC; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Temel Y, 2006, PARKINSONISM RELAT D, V12, P265, DOI 10.1016/j.parkreldis.2006.01.004; Tsai ST, 2007, NEUROSURGERY, V61, P1024, DOI 10.1227/01.NEU-0000280085.60995.95; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; Wassermann D, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/526906; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	81	85	90	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39061	10.1371/journal.pone.0039061	http://dx.doi.org/10.1371/journal.pone.0039061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768059	Green Published, gold			2022-12-25	WOS:000305892100029
J	Bustamante, C; Lamilla, J; Concha, F; Ebert, DA; Bennett, MB				Bustamante, Carlos; Lamilla, Julio; Concha, Francisco; Ebert, David A.; Bennett, Michael B.			Morphological Characters of the Thickbody Skate Amblyraja frerichsi (Krefft 1968) (Rajiformes: Rajidae), with Notes on Its Biology	PLOS ONE			English	Article							EGG CAPSULES; CHONDRICHTHYES; BIODIVERSITY; ELASMOBRANCHII; SYSTEMATICS; STRATEGIES; MATURITY; PACIFIC; SIZE; KEY	Detailed descriptions of morphological features, morphometrics, neurocranium anatomy, clasper structure and egg case descriptions are provided for the thickbody skate Amblyraja frerichsi; a rare, deep-water species from Chile, Argentina and Falkland Islands. The species diagnosis is complemented from new observations and aspects such as colour, size and distribution are described. Geographic and bathymetric distributional ranges are discussed as relevant features of this taxons biology. Additionally, the conservation status is assessed including bycatch records from Chilean fisheries.	[Bustamante, Carlos; Bennett, Michael B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Bustamante, Carlos; Lamilla, Julio] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Elasmobranquios ELASMOLAB, Valdivia, Chile; [Concha, Francisco] Valparaiso Univ, Fac Ciencias Mar & Recursos Nat, Lab Biol & Conservac Condrictios, Renaca, Vina Del Mar, Chile; [Ebert, David A.] Pacific Shark Res Ctr, Moss Landing Marine Labs, Moss Landing, CA USA; [Ebert, David A.] S African Inst Aquat Biodivers, Grahamstown, South Africa; [Ebert, David A.] Calif Acad Sci, Dept Ichthyol, San Francisco, CA 94118 USA	University of Queensland; Universidad Austral de Chile; Moss Landing Marine Laboratories; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; California Academy of Sciences	Bustamante, C (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	c.bustamantediaz@uq.edu.au	Concha, Francisco/AAN-1529-2021; Bustamante, Carlos/A-7893-2011; Bennett, Michael/A-7218-2012; Bennett, Michael/L-4483-2019	Bustamante, Carlos/0000-0002-0816-6406; Bennett, Michael/0000-0001-8051-0040	Direccion de Investigacion of Universidad Austral de Chile (DID-UACH); Fondo de Investigacion Pesquera [FIP 2006-31/2008-60]	Direccion de Investigacion of Universidad Austral de Chile (DID-UACH); Fondo de Investigacion Pesquera	This contribution was supported by Direccion de Investigacion of Universidad Austral de Chile (DID-UACH) and Fondo de Investigacion Pesquera (FIP 2006-31/2008-60). The funders had no role in study design data collection and analysis decision to publish or preparation of the manuscript.	Acua E, 1987, 7 JORN CIENC MAR CON; [Anonymous], 2005, OCEANA; Bizikov V.A., 2004, IDENTIFICATION GUIDE; Cedrola PV, 2005, FISH RES, V71, P141, DOI 10.1016/j.fishres.2004.08.031; Compagno LJV, 1999, T ROY SOC S AFR, V54, P75, DOI 10.1080/00359199909520406; Concha F, 2010, J FISH BIOL, V77, P963, DOI 10.1111/j.1095-8649.2010.02736.x; Concha F, 2009, REV BIOL MAR OCEANOG, V44, P253, DOI 10.4067/S0718-19572009000100026; Cousseau MB, 2007, RAYAS CHUCHOS OTROS; Delpiani G, 2012, ZOOTAXA, P57; Dulvy NK, 2010, CRC MAR BIOL SER, P639; Ebert DA, 2007, BIOL SKATES; Ebert DA, 2008, ICES J MAR SCI, V65, P81, DOI 10.1093/icesjms/fsm169; Ebert DA, 2007, ENVIRON BIOL FISH, V80, P111, DOI 10.1007/s10641-007-9247-0; Ebert DA, 2010, CRC MAR BIOL SER, P115; Francis MP, 2001, NEW ZEAL J MAR FRESH, V35, P831, DOI 10.1080/00288330.2001.9517045; Frisk MG, 2010, CRC MAR BIOL SER, P283; Gomes U.L., 2010, GUIA IDENTIFICACAO T, V1st ed.; González H E, 2006, Gayana (Concepc.), V70, P26; Gravendeel R, 2002, INT J OSTEOARCHAEOL, V12, P420, DOI 10.1002/oa.645; Guerrero A, 2009, LAT AM J AQUAT RES, V37, P361, DOI 10.3856/vol37-issue3-fulltext-7; HOENIG J M, 1990, NOAA Technical Report NMFS, P1; Hulley P. A., 1970, Ann. S. Afr. Mus., V55, P151; Hulley PA, 1972, ANN S AFR MUS, V60, P1; ISHIYAMA REIZO, 1958, JOUR SHIMONOSEKI COLL FISH, V7, P193; KREFFT G, 1968, ARCH FISCHEREIWISS, V19, P1; Kyne PM, 2010, CRC MAR BIOL SER, P37; Lamilla J., 2010, ESTIMACION DESCARTE; Lamilla Julio, 2003, Investigaciones Marinas Universidad Catolica de Valparaiso, V31, P3; Last PR, 2007, ZOOTAXA, P45; Last Peter R., 2008, CSIRO Marine and Atmospheric Research Paper, V021, P1; Leible M.D., 1988, Gayana Zoologia, V52, P15; McEachran JD, 1998, COPEIA, P271; MCEACHRAN JD, 1990, NOAA TECH REP, V90, P305; Menni Roberto C., 2000, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V2, P69; Oddone MC, 2004, ZOOTAXA, P1; Oddone MC, 2004, ICES J MAR SCI, V61, P293, DOI 10.1016/j.icesjms.2003.11.004; Parent S, 2008, ZOO BIOL, V27, P145, DOI 10.1002/zoo.20170; Pequeno German, 1997, Revista de Biologia Marina y Oceanografia, V32, P77; PEQUENO-R G, 1985, Revista de Biologia Marina, V21, P225; Pequeno-R. German, 1993, Revista de Biologia Marina, V28, P203; Reyes PR, 2009, REV BIOL MAR OCEANOG, V44, P243, DOI 10.4067/S0718-19572009000100025; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; Sosebee Katherine A., 2005, Journal of Northwest Atlantic Fishery Science, V35, P141, DOI 10.2960/J.v35.m499; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; STEHMANN M, 1970, ARCH FISCHEREIWISS, V21, P73; Thiel R, 2009, J APPL ICHTHYOL, V25, P9, DOI 10.1111/j.1439-0426.2009.01296.x; Treloar MA, 2006, ZOOTAXA, P53, DOI 10.11646/zootaxa.1231.1.3; Vargas M, 1989, 9 JORN CIENC MAR ANT; Walsh JH, 2007, ZOOTAXA, P31; ZORZI GD, 1988, CALIF FISH GAME, V74, P87	51	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39963	10.1371/journal.pone.0039963	http://dx.doi.org/10.1371/journal.pone.0039963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768186	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100158
J	Edwards, NC; Hing, ZA; Perry, A; Blaisdell, A; Kopelman, DB; Fathke, R; Plum, W; Newell, J; Allen, CE; Geetha, S; Shapiro, A; Okunji, C; Kosti, I; Shomron, N; Grigoryan, V; Przytycka, TM; Sauna, ZE; Salari, R; Mandel-Gutfreund, Y; Komar, AA; Kimchi-Sarfaty, C				Edwards, Nathan C.; Hing, Zachary A.; Perry, Avital; Blaisdell, Adam; Kopelman, David B.; Fathke, Robert; Plum, William; Newell, Jordan; Allen, Courtni E.; Geetha, S.; Shapiro, Aaron; Okunji, Chinyere; Kosti, Idit; Shomron, Noam; Grigoryan, Vahan; Przytycka, Teresa M.; Sauna, Zuben E.; Salari, Raheleh; Mandel-Gutfreund, Yael; Komar, Anton A.; Kimchi-Sarfaty, Chava			Characterization of Coding Synonymous and Non-Synonymous Variants in ADAMTS13 Using Ex Vivo and In Silico Approaches	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; CODON USAGE; SECONDARY STRUCTURE; ENDOPLASMIC-RETICULUM; PROTEIN DISLOCATION; GENE-EXPRESSION; QUALITY-CONTROL; MUTATIONS; SEQUENCE; EVOLUTION	Synonymous variations, which are defined as codon substitutions that do not change the encoded amino acid, were previously thought to have no effect on the properties of the synthesized protein(s). However, mounting evidence shows that these "silent" variations can have a significant impact on protein expression and function and should no longer be considered "silent". Here, the effects of six synonymous and six non-synonymous variations, previously found in the gene of ADAMTS13, the von Willebrand Factor (VWF) cleaving hemostatic protease, have been investigated using a variety of approaches. The ADAMTS13 mRNA and protein expression levels, as well as the conformation and activity of the variants have been compared to that of wild-type ADAMTS13. Interestingly, not only the non-synonymous variants but also the synonymous variants have been found to change the protein expression levels, conformation and function. Bioinformatic analysis of ADAMTS13 mRNA structure, amino acid conservation and codon usage allowed us to establish correlations between mRNA stability, RSCU, and intracellular protein expression. This study demonstrates that variants and more specifically, synonymous variants can have a substantial and definite effect on ADAMTS13 function and that bioinformatic analysis may allow development of predictive tools to identify variants that will have significant effects on the encoded protein.	[Edwards, Nathan C.; Hing, Zachary A.; Perry, Avital; Blaisdell, Adam; Kopelman, David B.; Fathke, Robert; Plum, William; Newell, Jordan; Allen, Courtni E.; Geetha, S.; Shapiro, Aaron; Okunji, Chinyere; Sauna, Zuben E.; Kimchi-Sarfaty, Chava] US FDA, Lab Hemostasis, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Kosti, Idit; Mandel-Gutfreund, Yael] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Shomron, Noam] Tel Aviv Univ, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Grigoryan, Vahan; Przytycka, Teresa M.; Salari, Raheleh] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Komar, Anton A.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	US Food & Drug Administration (FDA); Technion Israel Institute of Technology; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University System of Ohio; Cleveland State University	Edwards, NC (corresponding author), US FDA, Lab Hemostasis, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	a.komar@csuohio.edu; chava.kimchi-sarfaty@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019; Mandel-Gutfreund, Yael/AAI-4365-2021	Mandel-Gutfreund, Yael/0000-0002-8946-8237; Kosti, Idit/0000-0003-2212-5472; Komar, Anton/0000-0003-4188-0633; Kopelman, David/0000-0002-7950-2390; Przytycka, Teresa/0000-0002-6261-277X; Kimchi-Sarfaty, Chava/0000-0002-9355-8585	Food and Drug Administration, Intramural Research Program of the National Institutes of Health, National Library of Medicine; HFSP [RGP0024]; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	Food and Drug Administration, Intramural Research Program of the National Institutes of Health, National Library of Medicine; HFSP(Human Frontier Science Program); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the Food and Drug Administration, Intramural Research Program of the National Institutes of Health, National Library of Medicine and by HFSP RGP0024 to AAK. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bauer AP, 2010, NUCLEIC ACIDS RES, V38, P3891, DOI 10.1093/nar/gkq115; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bohm M, 2002, ANN HEMATOL, V81, P430, DOI 10.1007/s00277-002-0502-3; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Calcagno AM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-29; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chen L, 1997, HUM GENE THER, V8, P125, DOI 10.1089/hum.1997.8.2-125; COLEMAN TA, 1991, MOL CELL ENDOCRINOL, V75, P91, DOI 10.1016/0303-7207(91)90223-F; Czech A, 2010, MOL BIOSYST, V6, P1767, DOI 10.1039/c004796c; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Franchini M, 2008, BLOOD TRANSFUS-ITALY, V6, P127, DOI 10.2450/2008.0055-07; Galtier N, 2001, GENETICS, V159, P907; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hovinga JAK, 2006, J THROMB HAEMOST, V4, P1146, DOI 10.1111/j.1538-7836.2006.01904.x; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Kelley LA, 1999, RECOGNITION REMOTE P; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; LIEBHABER SA, 1984, J BIOL CHEM, V259, P5597; Mahdian R, 2006, THROMB HAEMOSTASIS, V95, P1049, DOI 10.1160/TH06-03-0166; Mannucci PM, 2004, BRIT J HAEMATOL, V126, P213, DOI 10.1111/j.1365-2141.2004.05009.x; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Plaimauer B, 2006, BLOOD, V107, P118, DOI 10.1182/blood-2005-06-2482; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sauna ZE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006506; Schettert IT, 2010, THROMB RES, V125, P61, DOI 10.1016/j.thromres.2009.03.008; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shomron N, 2010, THROMB HAEMOSTASIS, V104, P531, DOI 10.1160/TH09-12-0860; Tao Z, 2006, J THROMB HAEMOST, V4, P1931, DOI 10.1111/j.1538-7836.2006.02098.x; Tripodi A, 2004, J THROMB HAEMOST, V2, P1601, DOI 10.1111/j.1538-7836.2004.00879.x; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Wildman KAH, 2002, BIOPOLYMERS, V64, P246, DOI 10.1002/bip.10180; Xayaphoummine A, 2005, NUCL ACIDS RES, V33; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zhou WH, 2004, THROMB HAEMOSTASIS, V91, P806, DOI 10.1160/TH03-11-0675; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	75	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38864	10.1371/journal.pone.0038864	http://dx.doi.org/10.1371/journal.pone.0038864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768050	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100020
J	Lourenco, A; Ferreira, A; Veiga, N; Machado, I; Pereira, MO; Azevedo, NF				Lourenco, Analia; Ferreira, Andreia; Veiga, Nuno; Machado, Idalina; Pereira, Maria Olivia; Azevedo, Nuno F.			BiofOmics: A Web Platform for the Systematic and Standardized Collection of High-Throughput Biofilm Data	PLOS ONE			English	Article							HELICOBACTER-PYLORI; MINIMUM INFORMATION; QUANTIFICATION; MICROBES; STRESS	Background: Consortia of microorganisms, commonly known as biofilms, are attracting much attention from the scientific community due to their impact in human activity. As biofilm research grows to be a data-intensive discipline, the need for suitable bioinformatics approaches becomes compelling to manage and validate individual experiments, and also execute inter-laboratory large-scale comparisons. However, biofilm data is widespread across ad hoc, non-standardized individual files and, thus, data interchange among researchers, or any attempt of cross-laboratory experimentation or analysis, is hardly possible or even attempted. Methodology/Principal Findings: This paper presents BiofOmics, the first publicly accessible Web platform specialized in the management and analysis of data derived from biofilm high-throughput studies. The aim is to promote data interchange across laboratories, implementing collaborative experiments, and enable the development of bioinformatics tools in support of the processing and analysis of the increasing volumes of experimental biofilm data that are being generated. BiofOmics' data deposition facility enforces data structuring and standardization, supported by controlled vocabulary. Researchers are responsible for the description of the experiments, their results and conclusions. BiofOmics' curators interact with submitters only to enforce data structuring and the use of controlled vocabulary. Then, BiofOmics' search facility makes publicly available the profile and data associated with a submitted study so that any researcher can profit from these standardization efforts to compare similar studies, generate new hypotheses to be tested or even extend the conditions experimented in the study. Significance: BiofOmics' novelty lies in its support to standardized data deposition, the availability of computerizable data files and the free-of-charge dissemination of biofilm studies across the community. Hopefully, this will open promising research possibilities, namely the comparison of results between different laboratories, the reproducibility of methods within and between laboratories, and the development of guidelines and standardized protocols for biofilm formation operating procedures and analytical methods.	[Lourenco, Analia; Ferreira, Andreia; Veiga, Nuno; Machado, Idalina; Pereira, Maria Olivia] Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal; [Azevedo, Nuno F.] Univ Porto, Fac Engn, Dept Chem Engn, LEPAE Lab Proc Environm & Energy Engn, P-4100 Oporto, Portugal	Universidade do Minho; Universidade do Porto	Lourenco, A (corresponding author), Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal.	nazevedo@fe.up.pt	Lourenço, Anália/Y-9447-2019; Azevedo, Nuno/I-4915-2013; Machado, Idalina/J-2892-2013; Pereira, Maria O/O-4859-2015; Lourenço, Anália/G-8879-2013	Lourenço, Anália/0000-0001-8401-5362; Machado, Idalina/0000-0003-0546-4915; Pereira, Maria O/0000-0002-4307-3985; Lourenço, Anália/0000-0001-8401-5362; Azevedo, Nuno/0000-0001-5864-3250	Institute of Biotechnology and Bioengineering - Center of Biological Engineering (IBB-CEB); Fundacao para a Ciencia e Tecnologia (FCT); European Community; Idalina Machado [SFRH/BD/31065/2006];  [PTDC/SAU-ESA/646091/2006/FCOMP-01-0124-FEDER-007480]	Institute of Biotechnology and Bioengineering - Center of Biological Engineering (IBB-CEB); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); Idalina Machado; 	The financial support from the Institute of Biotechnology and Bioengineering - Center of Biological Engineering (IBB-CEB), Fundacao para a Ciencia e Tecnologia (FCT) and European Community fund FEDER (Program COMPETE), project PTDC/SAU-ESA/646091/2006/FCOMP-01-0124-FEDER-007480 and PhD grant of Idalina Machado (SFRH/BD/31065/2006) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014786; Azevedo NF, 2006, APPL ENVIRON MICROB, V72, P2936, DOI 10.1128/AEM.72.4.2936-2941.2006; Azevedo NF, 2009, BIOTECHNOL LETT, V31, P477, DOI 10.1007/s10529-008-9901-4; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Coenye T, 2010, FEMS IMMUNOL MED MIC, V59, P239, DOI 10.1111/j.1574-695X.2010.00682.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; Di Cagno R, 2011, J PROTEOMICS, V74, P19, DOI 10.1016/j.jprot.2010.09.003; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Giao MS, 2008, APPL ENVIRON MICROB, V74, P5898, DOI 10.1128/AEM.00827-08; Gibbons JG, 2012, EUKARYOT CELL, V11, P68, DOI 10.1128/EC.05102-11; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lourenco A, 2012, ADV INTEL SOFT COMPU, V154, P113; Machado I, 2011, BIOFOULING, V27, P1151, DOI 10.1080/08927014.2011.636148; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sousa AM, 2012, ADV INTEL SOFT COMPU, V154, P181; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Wilmes P, 2010, MBIO, V1, DOI 10.1128/mBio.00246-10; Wood TK, 2011, TRENDS BIOTECHNOL, V29, P87, DOI 10.1016/j.tibtech.2010.11.001; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813	25	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39960	10.1371/journal.pone.0039960	http://dx.doi.org/10.1371/journal.pone.0039960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768184	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100156
J	Lucas, S; Taront, S; Magnan, C; Fauconnier, L; Delacre, M; Macia, L; Delanoye, A; Verwaerde, C; Spriet, C; Saule, P; Goormachtigh, G; Heliot, L; Ktorza, A; Movassat, J; Polakowska, R; Auriault, C; Poulain-Godefroy, O; Di Santo, J; Froguel, P; Wolowczuk, I				Lucas, Stephanie; Taront, Solenne; Magnan, Christophe; Fauconnier, Laurence; Delacre, Myriam; Macia, Laurence; Delanoye, Anne; Verwaerde, Claudie; Spriet, Corentin; Saule, Pasquine; Goormachtigh, Gautier; Heliot, Laurent; Ktorza, Alain; Movassat, Jamileh; Polakowska, Renata; Auriault, Claude; Poulain-Godefroy, Odile; Di Santo, James; Froguel, Philippe; Wolowczuk, Isabelle			Interleukin-7 Regulates Adipose Tissue Mass and Insulin Sensitivity in High-Fat Diet-Fed Mice through Lymphocyte-Dependent and Independent Mechanisms	PLOS ONE			English	Article							CENTRAL LEPTIN; IMMUNE CELLS; CRUCIAL ROLE; STEM-CELLS; T-CELLS; INFLAMMATION; OBESITY; IL-7; ACTIVATION; RESISTANCE	Although interleukin (IL)-7 is mostly known as a key regulator of lymphocyte homeostasis, we recently demonstrated that it also contributes to body weight regulation through a hypothalamic control. Previous studies have shown that IL-7 is produced by the human obese white adipose tissue (WAT) yet its potential role on WAT development and function in obesity remains unknown. Here, we first show that transgenic mice overexpressing IL-7 have reduced adipose tissue mass associated with glucose and insulin resistance. Moreover, in the high-fat diet (HFD)-induced obesity model, a single administration of IL-7 to C57BL/6 mice is sufficient to prevent HFD-induced WAT mass increase and glucose intolerance. This metabolic protective effect is accompanied by a significant decreased inflammation in WAT. In lymphocyte-deficient HFD-fed SCID mice, IL-7 injection still protects from WAT mass gain. However, IL-7-triggered resistance against WAT inflammation and glucose intolerance is lost in SCID mice. These results suggest that IL-7 regulates adipose tissue mass through a lymphocyte-independent mechanism while its protective role on glucose homeostasis would be relayed by immune cells that participate to WAT inflammation. Our observations establish a key role for IL-7 in the complex mechanisms by which immune mediators modulate metabolic functions.	[Lucas, Stephanie; Delacre, Myriam; Macia, Laurence; Delanoye, Anne; Verwaerde, Claudie] Univ Lille Nord France, Inst Pasteur, Lab Neuroimmunoendocrinol, IFR 142, Lille, France; [Taront, Solenne; Poulain-Godefroy, Odile; Froguel, Philippe; Wolowczuk, Isabelle] Univ Lille Nord France, Inst Pasteur, UMR 8199, CNRS,Lab Genom & Metab Dis, Lille, France; [Magnan, Christophe; Ktorza, Alain] Univ Paris 07, CNRS, UMR 7059, Lab Physiopathol Nutr, Paris, France; [Fauconnier, Laurence; Saule, Pasquine; Goormachtigh, Gautier; Auriault, Claude] Inst Pasteur, Inst Biol, CNRS, UMR 8527,Lab Cellular Immunopathol Infect Dis, F-59019 Lille, France; [Spriet, Corentin; Heliot, Laurent] Univ Lille Nord France, USR 3078, CNRS, Interdisciplinary Res Inst, Villeneuve Dascq, France; [Movassat, Jamileh] Univ Paris 07, CNRS, EAC 4413, Lab Biol & Pathol Endocrine Pancreas, Paris, France; [Polakowska, Renata] Univ Lille Nord France, CHU, U837, Inserm, Lille, France; [Polakowska, Renata] Univ Lille Nord France, CHU, Jean Pierre Aubert Res Ctr, Lille, France; [Di Santo, James] Inst Pasteur, Innate Immun Unit, Paris, France; [Di Santo, James] Inserm, U668, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lucas, S (corresponding author), Univ Lille Nord France, Inst Pasteur, Lab Neuroimmunoendocrinol, IFR 142, Lille, France.	Isabelle.Wolowczuk@good.ibl.fr	FROGUEL, Philippe/O-6799-2017; magnan, christophe/AAJ-7622-2021; Macia, laurence/D-5983-2016; Poulain-Godefroy, Odile/AAF-5474-2021; Spriet, Corentin/ABE-4215-2021; Di Santo, James P/M-4298-2014; DEZITTER, Solenne/N-5219-2018	FROGUEL, Philippe/0000-0003-2972-0784; magnan, christophe/0000-0002-7044-2571; Macia, laurence/0000-0003-0835-851X; Spriet, Corentin/0000-0002-5805-3426; Di Santo, James P/0000-0002-7146-1862; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; Goormachtigh, Gautier/0000-0003-1736-8269; DEZITTER, Solenne/0000-0001-5850-7291; wolowczuk, isabelle/0000-0001-6692-6904; LUCAS, Stephanie/0000-0001-7530-7486	Pasteur Institute in Lille; Institut Federatif de Recherche 142; Centre National de la Recherche Scientifique; French Region Nord/Pas-de-Calais	Pasteur Institute in Lille; Institut Federatif de Recherche 142; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Region Nord/Pas-de-Calais(Region Hauts-de-France)	The work was supported by the Pasteur Institute in Lille, the Institut Federatif de Recherche 142 and the Centre National de la Recherche Scientifique. S. L. was supported by a post-doctoral grant from the French Region Nord/Pas-de-Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; ALDERSON MR, 1991, J EXP MED, V173, P923, DOI 10.1084/jem.173.4.923; Alvehus M, 2010, OBESITY, V18, P879, DOI 10.1038/oby.2010.22; Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; ARNER P, 1995, ANN MED, V27, P435, DOI 10.3109/07853899709002451; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Brown LM, 2010, J STEROID BIOCHEM, V122, P65, DOI 10.1016/j.jsbmb.2009.12.005; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Eckel LA, 2011, PHYSIOL BEHAV, V104, P517, DOI 10.1016/j.physbeh.2011.04.014; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; FOXWELL BMJ, 1995, EUR J IMMUNOL, V25, P3041, DOI 10.1002/eji.1830251109; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Jan V, 2004, ANTIVIR THER, V9, P555; Kelly EAB, 2009, J IMMUNOL, V182, P1404, DOI 10.4049/jimmunol.182.3.1404; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kim S, 2000, J NUTR, V130, p3110S; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lee SK, 2005, IMMUNOL REV, V208, P169, DOI 10.1111/j.0105-2896.2005.00339.x; Lolmede K, 2011, DIABETES METAB, V37, P283, DOI 10.1016/j.diabet.2011.03.002; Lucas S., 2009, IMMUNOL IMMUNOGENET, V1, P3, DOI [10.4137/III.S2145., DOI 10.4137/III.S2145]; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Macia L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009953; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 2000, CURR OPIN IMMUNOL, V12, P468, DOI 10.1016/S0952-7915(00)00122-9; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams IR, 1997, J IMMUNOL, V159, P3044; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	58	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40351	10.1371/journal.pone.0040351	http://dx.doi.org/10.1371/journal.pone.0040351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768283	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100257
J	Luo, JH; Cai, QQ; Wang, W; Huang, H; Zeng, H; He, W; Deng, WX; Yu, H; Chan, ED; Ng, CF; Huang, J; Lin, TX				Luo, Junhua; Cai, Qingqing; Wang, Wei; Huang, Hui; Zeng, Hong; He, Wang; Deng, Weixi; Yu, Hao; Chan, Eddie; Ng, Chi-fai; Huang, Jian; Lin, Tianxin			A MicroRNA-7 Binding Site Polymorphism in HOXB5 Leads to Differential Gene Expression in Bladder Cancer	PLOS ONE			English	Article							CYSTIC ADENOMATOID MALFORMATION; HOMEOBOX GENES; IN-VIVO; CELLS; OVEREXPRESSION; CARCINOMAS	Purpose: To investigate the biological function of HOXB5 in human bladder cancer and explore whether the HOXB5 3'-UTR SNP (1010A/G), which is located within the microRNA-7 binding site, was correlated with clinical features of bladder cancer. Methods: Expression of HOXB5 in 35 human bladder cancer tissues and 8 cell lines were examined using real-time PCR and immunohistochemistry. Next, we explored the biological function of HOXB5 in vitro using cell proliferation, migration and colony formation assays. Using bioinformatics, a SNP (1010A/G) was found located within the microRNA-7 binding site in the 3'-UTR of HOXB5. Real-time PCR was used to test HOXB5 expression affected by different alleles. Finally, multivariate logistic regression analysis was used to determine the relationship between SNP (1010A/G) frequency and clinical features in 391 cases. Results: HOXB5 was frequently over-expressed both in bladder cancer tissues and cell lines. Inhibition of HOXB5 suppressed the oncogenic function of cancer cells. Next, we demonstrated that a SNP (1010A/G), located within the microRNA-7 binding site in the 3'-UTR of HOXB5, could affect HOXB5 expression in bladder cancer mainly by differential binding activity of microRNA-7 and SNP-related mRNA stability. Finally, we also showed the frequency of 1010G genotype was higher in cancer group compared to normal controls and correlated with the risk of high grade and high stage. Conclusion: HOXB5 is overexpressed in bladder cancer. A miRNA-binding SNP (1010A/G) located within 3'-UTR of HOXB5 is associated with gene expression and may be a promising prognostic factor for bladder cancer.	[Luo, Junhua; He, Wang; Yu, Hao; Huang, Jian; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Qingqing] Sun Yat Sen Univ, Ctr Canc, Dept Internal Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] Guangzhou Gen Hosp Guangzhou Mil Command, Guangzhou Liuhuaqiao Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Hong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Weixi; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Lin Bai Xin Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chan, Eddie; Ng, Chi-fai] Chinese Univ Hong Kong, Dept Surg, Div Urol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Theater Command General Hospital; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong	Luo, JH (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	yehjn@yahoo.com.cn; tianxinl@sina.com	Ng, Chi-Fai/E-5134-2011; Chi-fai, NG/AAV-8270-2021; Luo, Junhua/AAS-3339-2020	Ng, Chi-Fai/0000-0002-1723-9646; Luo, Junhua/0000-0002-3179-7652	National Natural Science Foundation of China [81071688, 30972983, 81172431, 91029742]; Guangdong province Natural Scientific Foundation [07117366, 6104605]; Yat-sen Scholarship for Young Scientists; Public Health Ministry; Program for New Century Excellent Talents in University [NCET-10-0852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong province Natural Scientific Foundation; Yat-sen Scholarship for Young Scientists; Public Health Ministry; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (81071688, 30972983, 81172431, 91029742), Guangdong province Natural Scientific Foundation (07117366, 6104605), Yat-sen Scholarship for Young Scientists (For Tianxin Lin), Clinical Key Project of Public Health Ministry (for Jian Huang), and the Program for New Century Excellent Talents in University (NCET-10-0852, for Tianxin Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantile M, 2003, ONCOGENE, V22, P6462, DOI 10.1038/sj.onc.1206808; CILLO C, 1992, INT J CANCER, V51, P892, DOI 10.1002/ijc.2910510610; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GIAMPAOLO A, 1994, BLOOD, V84, P3637, DOI 10.1182/blood.V84.11.3637.bloodjournal84113637; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Lu JW, 2006, J HUM GENET, V51, P155, DOI 10.1007/s10038-005-0339-4; Messing E, 2007, CAMPBELL WALSH UROLO, P2407; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Stein S, 1996, MECH DEVELOP, V55, P91, DOI 10.1016/0925-4773(95)00494-7; Tsai FJ, 2002, UROLOGY, V59, P458, DOI 10.1016/S0090-4295(01)01576-X; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Volpe MV, 2009, AM J PHYSIOL-LUNG C, V297, pL143, DOI 10.1152/ajplung.90618.2008; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Volpe MV, 1997, HISTOCHEM CELL BIOL, V108, P495, DOI 10.1007/s004180050190; Wang W, 2009, INT J CANCER, V125, P2836, DOI 10.1002/ijc.24721; Wang XY, 2011, FETAL DIAGN THER, V29, P315, DOI 10.1159/000322738; Winnik S, 2009, CARDIOVASC RES, V83, P558, DOI 10.1093/cvr/cvp133; Wu XF, 2009, CANCER METAST REV, V28, P269, DOI 10.1007/s10555-009-9190-y; Wu YX, 2003, MOL CELL BIOL, V23, P5680, DOI 10.1128/MCB.23.16.5680-5691.2003; YU S, 2004, UROLOGY, P959; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480	30	37	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40127	10.1371/journal.pone.0040127	http://dx.doi.org/10.1371/journal.pone.0040127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768238	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100210
J	Park, YN; Zhao, XH; Norton, M; Taylor, JP; Eisenberg, E; Greene, LE				Park, Yang-Nim; Zhao, Xiaohong; Norton, Mark; Taylor, J. Paul; Eisenberg, Evan; Greene, Lois E.			Huntingtin Fragments and SOD1 Mutants Form Soluble Oligomers in the Cell	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FLUORESCENCE CORRELATION SPECTROSCOPY; INCLUSION-BODY FORMATION; WILD-TYPE SOD1; POLYGLUTAMINE PROTEIN; SUPEROXIDE-DISMUTASE; MAMMALIAN-CELLS; NEURONAL DEATH; MOUSE MODELS; LIVING CELLS	Diffusion coefficients of huntingtin (Htt) fragments and SOD1 mutants expressed in cells were measured using fluorescence correlation spectroscopy. The diffusion mobilities of both non-pathological Htt fragments (25 polyQs) and pathological Htt fragments (103 polyQs) were much slower than expected for monomers suggesting that they oligomerize. The mobility of these fragments was unaffected by duration of expression or by over-expression of Hsp70 and Hsp40. However in cells with HttQ103 inclusions, diffusion measurements showed that the residual cytosolic HttQ103 was monomeric. These results suggest that both non-pathological and pathological Htt fragments form soluble oligomers in the cytosol with the properties of the oligomers determining whether they cause pathology. SOD1 with point mutations (A4V, G37R, and G85R) also had slower diffusional mobility than the wild-type protein whose mobility was consistent with that of a dimer. However, the decrease in mobility of the different SOD1 mutantsdid not correlate with their known pathology. Therefore, while soluble oligomers always seem to be present under conditions where cell pathology occurs, the presence of the oligomers, in itself, does not determine the extent of neuropathology.	[Park, Yang-Nim; Zhao, Xiaohong; Norton, Mark; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Taylor, J. Paul] St Jude Childrens Hosp, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); St Jude Children's Research Hospital	Park, YN (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	greenel@helix.nih.gov	Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the National Institutes of Health (intramural program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; BLUSZTAJN JK, 1992, J NEUROSCI, V12, P793; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Brock R, 1999, P NATL ACAD SCI USA, V96, P10123, DOI 10.1073/pnas.96.18.10123; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Chai YH, 1999, J NEUROSCI, V19, P10338; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Hackam AS, 1999, HUM MOL GENET, V8, P25, DOI 10.1093/hmg/8.1.25; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Juneja T, 1997, NEUROLOGY, V48, P55, DOI 10.1212/WNL.48.1.55; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Krishnan U, 2006, MOL CELL BIOCHEM, V287, P201, DOI 10.1007/s11010-005-9112-4; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Weisshart K, 2004, CURR PHARM BIOTECHNO, V5, P135, DOI 10.2174/1389201043376913; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	60	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40329	10.1371/journal.pone.0040329	http://dx.doi.org/10.1371/journal.pone.0040329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768276	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100250
J	Peeters, MW; Claessens, AL				Peeters, Maarten W.; Claessens, Albrecht L.			The Left Hand Second to Fourth Digit Ratio (2D:4D) Does Not Discriminate World-Class Female Gymnasts from Age Matched Sedentary Girls	PLOS ONE			English	Article							SPORTING SUCCESS; 4TH-DIGIT RATIO; 2D4D; PREDICTS; WOMEN; STRENGTH; FINGER; ELITE; TESTOSTERONE; METAANALYSIS	Introduction: The second to fourth-digit-ratio (2D:4D), a putative marker of prenatal androgen action and a sexually dimorphic trait, has been suggested to be related with sports performance, although results are not univocal. If this relation exists, it is most likely to be detected by comparing extreme groups on the continuum of sports performance. Methods: In this study the 2D:4D ratio of world-class elite female artistic gymnasts (n = 129), competing at the 1987 Rotterdam World-Championships was compared to the 2D:4D ratio of sedentary age-matched sedentary girls (n = 129), alongside with other anthropometric characteristics including other sexually dimorphic traits such as an androgyny index (Bayer & Bayley) and Heath-Carter somatotype components (endomorphy, mesomorphy, ectomorphy) using AN(C)OVA. 2D:4D was measured on X-rays of the left hand. Results: Left hand 2D:4D digit ratio in world class elite female gymnasts (0.921 +/- 0.020) did not differ significantly from 2D:4D in age-matched sedentary girls (0.924 +/- 0.018), either with or without inclusion of potentially confounding covariates such as skeletal age, height, weight, somatotype components or androgyny index. Height (161.9 +/- 6.4 cm vs 155.4 +/- 6.6 cm p < 0.01), weight (53.9 +/- 7.6 kg vs 46.2 6.3 kg p < 0.01), BMI (20.51 +/- 2.41 kg/m(2) vs 19.05 +/- 1.56 kg/m(2)), skeletal age (15.2 +/- 1.1 y vs 14.5 +/- 1.2 y p > 0.01), somatotype components (4.0/3.0/2.9 vs 1.7/3.7/3.2 for endomorphy (p < 0.01), mesomorphy (p < 0.01) and ectomorphy (p < 0.05) respectively) all differed significantly between sedentary girls and elite gymnasts. As expressed by the androgyny index, gymnasts have, on average, broader shoulders relative to their hips, compared to the reference sample. Correlations between the 2D:4D ratio and chronological age, skeletal age, and the anthropometric characteristics are low and not significant. Conclusion: Although other anthropometric characteristics of sexual dimorphism were significantly different between the two samples, the present study cannot discriminate sedentary girls from world-class female gymnasts by means of the left hand 2D:4D ratio.	[Peeters, Maarten W.; Claessens, Albrecht L.] Katholieke Univ Leuven, Dept Kinesiol, Louvain, Belgium	KU Leuven	Peeters, MW (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Louvain, Belgium.	Maarten.Peeters@faber.kuleuven.be			Research Foundation Flanders	Research Foundation Flanders(FWO)	MWP is supported by the Research Foundation Flanders as a post doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allaway HC, 2009, AM J HUM BIOL, V21, P365, DOI 10.1002/ajhb.20892; [Anonymous], 2003, SCI ASPECTS WOMENS G; Bayley N, 1946, AM J PHYS ANTHROP-NE, V4, P433, DOI 10.1002/ajpa.1330040406; Bennett M, 2010, J SPORT SCI, V28, P1415, DOI 10.1080/02640414.2010.510143; Bescos R, 2009, J SPORT SCI, V27, P625, DOI 10.1080/02640410802707029; Brown J., 2001, SPORTS TALENT IDENTI; Claessens AL, 1991, J SPORT SCI, V9, P53, DOI 10.1080/02640419108729855; Claessens A. L., 1990, GROWTH FITNESS FLEMI, P21; CLAESSENS AL, 1992, MED SCI SPORT EXER, V24, P755; CLAESSENS AL, 1990, INT CONGR SER, V921, P725; CLAESSENS AL, 2008, PAEDIAT EXERCISE SCI, P23; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Fink B, 2006, INT J OBESITY, V30, P711, DOI 10.1038/sj.ijo.0803154; Fink B, 2003, ANN HUM BIOL, V30, P728, DOI 10.1080/03014460310001620153; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; Giffin NA, 2012, J SPORT SCI, V30, P135, DOI 10.1080/02640414.2011.630744; Helle S, 2010, AM J HUM BIOL, V22, P418, DOI 10.1002/ajhb.21000; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Kemper CJ, 2009, AM J HUM BIOL, V21, P188, DOI 10.1002/ajhb.20843; Longman D, 2011, AM J PHYS ANTHROPOL, V144, P337, DOI 10.1002/ajpa.21407; Malina R.M., 1995, PHYSL ASSESSMENT HUM, P205; Manning JT, 2009, AM J HUM BIOL, V21, P210, DOI 10.1002/ajhb.20855; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2010, AM J HUM BIOL, V22, P604, DOI 10.1002/ajhb.21051; Manning JT, 2000, LATERALITY, V5, P121, DOI 10.1080/135765000396744; Manning JT, 2005, ARCH SEX BEHAV, V34, P329, DOI 10.1007/s10508-005-3121-y; Manning JT., 2002, DIGIT RATIO POINTER; Matchock RL, 2008, AM J HUM BIOL, V20, P487, DOI 10.1002/ajhb.20763; Paul SN, 2006, BRIT J SPORT MED, V40, P981, DOI 10.1136/bjsm.2006.027193; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Pokrywka L, 2005, AM J HUM BIOL, V17, P796, DOI 10.1002/ajhb.20449; SIMONS J, 1990, GROWTH FITNESS FLEMI; Stein AD, 2010, AM J HUM BIOL, V22, P801, DOI 10.1002/ajhb.21085; Tester N, 2007, J PERS, V75, P663, DOI 10.1111/j.1467-6494.2007.00452.x; van Anders SM, 2007, AM J HUM BIOL, V19, P437, DOI 10.1002/ajhb.20634; Voracek M, 2010, SCAND J MED SCI SPOR, V20, P853, DOI 10.1111/j.1600-0838.2009.01031.x	41	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40270	10.1371/journal.pone.0040270	http://dx.doi.org/10.1371/journal.pone.0040270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768268	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100242
J	Soltani, A; Sohal, SS; Reid, D; Weston, S; Wood-Baker, R; Walters, EH				Soltani, Amir; Sohal, Sukhwinder Singh; Reid, David; Weston, Steve; Wood-Baker, Richard; Walters, E. Haydn			Vessel-Associated Transforming Growth Factor-Beta1 (TGF-beta 1) Is Increased in the Bronchial Reticular Basement Membrane in COPD and Normal Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FACTOR-BETA; MAST-CELLS; ANGIOGENESIS; EXPRESSION; ASTHMA; INFLAMMATION; MACROPHAGES; RECEPTORS; PATHOLOGY	Background: Transforming growth factor-beta1 (TGF-beta 1) is a multipotential cytokine with angiogenic activity. There are only limited data about its role in airway remodeling in COPD. We have previously shown that the reticular basement membrane (Rbm) is hypervascular in the airways of current smokers either with or without chronic obstructive pulmonary disease (COPD). This study evaluated TGF-beta 1 immunostaining in the Rbm and its relationship to vascularity in smokers with or without COPD. Methodology/Principal Findings: Bronchial biopsies from 15 smokers with normal lung function, 19 current and 14 ex-smokers with COPD were immunostained for TGF-beta 1 antibody and compared to 17 healthy controls. The percentage area of tissue and also number and area of vessels staining positively for TGF-beta 1 were measured and compared between groups. Some bronchial biopsies from current smoking COPD subjects were also stained for phosphorylated (active) Smad2/3. Epithelial TGF-beta 1 staining was not different between COPD current smokers and normal controls. TGF-beta 1 stained vessels in the Rbm were increased in smokers with normal lung function, current smoking COPD and ex-smokers with COPD compared to controls [median (range) for number of vessels/mm Rbm 2.5 (0.0-12.7), 3.4 (0.0-8.1) and 1.0 (0.0-6.3) vs. 0.0 (0.0-7.0), p<0.05]. Percentage of vessels stained was also increased in these clinical groups. Preliminary data suggest that in current smoking COPD subjects endothelial cells and cells in the Rbm stain positively for phosphorylated Smad2/3 suggesting TGF-beta 1 is functionally active in this situation. Conclusions/Significance: Vessel-associated TGF-beta 1 activity is increased in the bronchial Rbm in smokers and especially those with COPD.	[Soltani, Amir; Sohal, Sukhwinder Singh; Reid, David; Weston, Steve; Wood-Baker, Richard; Walters, E. Haydn] Univ Tasmania, Sch Med, NHMRC Natl Ctr Res Excellence Chron Resp Dis, Hobart, Tas, Australia	University of Tasmania	Soltani, A (corresponding author), Univ Tasmania, Sch Med, NHMRC Natl Ctr Res Excellence Chron Resp Dis, Hobart, Tas, Australia.	Haydn.Walters@utas.edu.au	Reid, David W/Y-2343-2018; WALTERS, Eugene/AAL-2264-2021	Reid, David W/0000-0001-9517-8212; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Walters, Eugene/0000-0002-0993-4374	NHMRC (National Health Medical Research Council) Australia [490023]	NHMRC (National Health Medical Research Council) Australia	This study was supported by NHMRC (National Health Medical Research Council) Australia (grant number 490023). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Boulet LP, 2007, EUR RESPIR J, V30, P831, DOI 10.1183/09031936.00110107; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; Feltis BN, 2006, AM J RESP CRIT CARE, V173, P1201, DOI 10.1164/rccm.200507-1105OC; Global Initiative for Chronic Obstructive Lung Disease, 2022, GLOBAL STRATEGY DIAG; Gong Y, 2011, LUNG, V189, P213, DOI 10.1007/s00408-011-9294-3; Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684; Hogg JC, 2008, INT J TUBERC LUNG D, V12, P467; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Knox AJ, 2005, THORAX, V60, P88, DOI 10.1136/thx.2004.030544; Konigshoff M, 2009, SWISS MED WKLY, V139, P554, DOI smw-12528; Kokturk N, 2003, J ASTHMA, V40, P887, DOI 10.1081/JAS-120023580; Kranenburg AR, 2005, THORAX, V60, P106, DOI 10.1136/thx.2004.023986; Levi-Schaffer F, 2001, CLIN EXP ALLERGY, V31, P521, DOI 10.1046/j.1365-2222.2001.01041.x; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; MAGNAN A, 1994, THORAX, V49, P789, DOI 10.1136/thx.49.8.789; Makinde T, 2006, CURR MOL MED, V6, P831, DOI 10.2174/156652406779010795; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Puxeddu I, 2005, J ALLERGY CLIN IMMUN, V116, P531, DOI 10.1016/j.jaci.2005.06.007; Reid DW, 2008, RESPIROLOGY, V13, P799, DOI 10.1111/j.1440-1843.2008.01380.x; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sohal Sukhwinder S, 2011, Respir Res, V12, P130, DOI 10.1186/1465-9921-12-130; Sohal SS, 2010, RESPIROLOGY, V15, P930, DOI 10.1111/j.1440-1843.2010.01808.x; Soltani A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-105; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Walters EH, 2008, PHARMACOL THERAPEUT, V118, P128, DOI 10.1016/j.pharmthera.2008.01.007; Zandvoort A, 2006, EUR RESPIR J, V28, P533, DOI 10.1183/09031936.06.00078405; Zanini A, 2009, THORAX, V64, P1019, DOI 10.1136/thx.2009.114629	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39736	10.1371/journal.pone.0039736	http://dx.doi.org/10.1371/journal.pone.0039736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768115	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100085
J	Wu, PR; Kuo, CC; Yet, SF; Liou, JY; Wu, KK; Chen, PF				Wu, Pei-Rung; Kuo, Cheng-Chin; Yet, Shaw-Fang; Liou, Jun-Yang; Wu, Kenneth K.; Chen, Pei-Feng			Lobe-Specific Calcium Binding in Calmodulin Regulates Endothelial Nitric Oxide Synthase Activation	PLOS ONE			English	Article							ELECTRON-TRANSFER; BIDOMAIN STRUCTURE; REDUCTASE DOMAIN; STRUCTURAL BASIS; NO SYNTHASE; SITES; SUBUNIT; PURIFICATION; OXYGENASE; KINASE	Background: Human endothelial nitric oxide synthase (eNOS) requires calcium-bound calmodulin (CaM) for electron transfer but the detailed mechanism remains unclear. Methodology/Principal Findings: Using a series of CaM mutants with E to Q substitution at the four calcium-binding sites, we found that single mutation at any calcium-binding site (B1Q, B2Q, B3Q and B4Q) resulted in similar to 2-3 fold increase in the CaM concentration necessary for half-maximal activation (EC50) of citrulline formation, indicating that each calcium-binding site of CaM contributed to the association between CaM and eNOS. Citrulline formation and cytochrome c reduction assays revealed that in comparison with nNOS or iNOS, eNOS was less stringent in the requirement of calcium binding to each of four calcium-binding sites. However, lobe-specific disruption with double mutations in calcium-binding sites either at N-(B12Q) or at C-terminal (B34Q) lobes greatly diminished both eNOS oxygenase and reductase activities. Gel mobility shift assay and flavin fluorescence measurement indicated that N- and C-lobes of CaM played distinct roles in regulating eNOS catalysis; the C-terminal EF-hands in its calcium-bound form was responsible for the binding of canonical CaM-binding domain, while N-terminal EF-hands in its calcium-bound form controlled the movement of FMN domain. Limited proteolysis studies further demonstrated that B12Q and B34Q induced different conformational change in eNOS. Conclusions: Our results clearly demonstrate that CaM controls eNOS electron transfer primarily through its lobe-specific calcium binding.	[Wu, Pei-Rung; Kuo, Cheng-Chin; Yet, Shaw-Fang; Liou, Jun-Yang; Wu, Kenneth K.; Chen, Pei-Feng] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Wu, PR (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan.	kkgo@nhri.org.tw; 990419@nhri.org.tw	Liou, Jun-Yang/B-1065-2010; Yet, Shaw-Fang/B-1067-2010; Wu, Kenneth Kun-Yu/B-1070-2010; Yet, Shaw-Fang/O-8583-2019; Kuo, Cheng-Chin/B-1064-2010	Yet, Shaw-Fang/0000-0001-9097-3962	National Health Research Institutes at Taiwan [99A1-CSAP01-014]	National Health Research Institutes at Taiwan	The work was supported by the Grant of National Health Research Institutes (99A1-CSAP01-014) at Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chen PF, 2009, ARCH BIOCHEM BIOPHYS, V486, P132, DOI 10.1016/j.abb.2009.03.015; Chen PF, 1996, J BIOL CHEM, V271, P14631, DOI 10.1074/jbc.271.24.14631; CHEN PF, 1994, J BIOL CHEM, V269, P25062; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; GHOSH DK, 1995, BIOCHEMISTRY-US, V34, P801, DOI 10.1021/bi00003a013; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gribovskaja I, 2005, BIOCHEMISTRY-US, V44, P7593, DOI 10.1021/bi0474517; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jama AM, 2011, J BIOL CHEM, V276; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; LIU JW, 1994, J BIOL CHEM, V269, P11691; LIU JW, 1995, BIOCHEMISTRY-US, V34, P12333, DOI 10.1021/bi00038a029; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; PERSECHINI A, 1994, J BIOL CHEM, V269, P16148; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Rodney GG, 2001, BIOCHEMISTRY-US, V40, P12430, DOI 10.1021/bi011078a; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; SCHMIDT HHH, 1989, BIOCHEM BIOPH RES CO, V165, P813; SHETA EA, 1994, J BIOL CHEM, V269, P15147; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Spratt DE, 2007, BBA-PROTEINS PROTEOM, V1774, P1351, DOI 10.1016/j.bbapap.2007.07.019; StevensTruss R, 1997, BIOCHEMISTRY-US, V36, P12337, DOI 10.1021/bi970973k; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; WANG CLA, 1985, BIOCHEM BIOPH RES CO, V130, P426, DOI 10.1016/0006-291X(85)90434-6; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39851	10.1371/journal.pone.0039851	http://dx.doi.org/10.1371/journal.pone.0039851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768143	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100112
J	Xu, ZW; Wan, SQ; Ren, HY; Han, XG; Li, MH; Cheng, WX; Jiang, Y				Xu, Zhuwen; Wan, Shiqiang; Ren, Haiyan; Han, Xingguo; Li, Mai-He; Cheng, Weixin; Jiang, Yong			Effects of Water and Nitrogen Addition on Species Turnover in Temperate Grasslands in Northern China	PLOS ONE			English	Article							OLD-FIELD SUCCESSION; MINNESOTA SAND PLAIN; ELEVATED CO2; LAND-USE; DEPOSITION; RICHNESS; DIVERSITY; ECOSYSTEM; DYNAMICS; CLIMATE	Global nitrogen (N) deposition and climate change have been identified as two of the most important causes of current plant diversity loss. However, temporal patterns of species turnover underlying diversity changes in response to changing precipitation regimes and atmospheric N deposition have received inadequate attention. We carried out a manipulation experiment in a steppe and an old-field in North China from 2005 to 2009, to test the hypothesis that water addition enhances plant species richness through increase in the rate of species gain and decrease in the rate of species loss, while N addition has opposite effects on species changes. Our results showed that water addition increased the rate of species gain in both the steppe and the old field but decreased the rates of species loss and turnover in the old field. In contrast, N addition increased the rates of species loss and turnover in the steppe but decreased the rate of species gain in the old field. The rate of species change was greater in the old field than in the steppe. Water interacted with N to affect species richness and species turnover, indicating that the impacts of N on semi-arid grasslands were largely mediated by water availability. The temporal stability of communities was negatively correlated with rates of species loss and turnover, suggesting that water addition might enhance, but N addition would reduce the compositional stability of grasslands. Experimental results support our initial hypothesis and demonstrate that water and N availabilities differed in the effects on rate of species change in the temperate grasslands, and these effects also depend on grassland types and/or land-use history. Species gain and loss together contribute to the dynamic change of species richness in semi-arid grasslands under future climate change.	[Xu, Zhuwen; Ren, Haiyan; Han, Xingguo; Li, Mai-He; Cheng, Weixin; Jiang, Yong] Chinese Acad Sci, State Key Lab Forest & Soil Ecol, Inst Appl Ecol, Shenyang, Peoples R China; [Wan, Shiqiang] Henan Univ, Coll Life Sci, Key Lab Plant Stress Biol, Kaifeng, Peoples R China; [Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Cheng, Weixin] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Henan University; Chinese Academy of Sciences; Institute of Botany, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of California System; University of California Santa Cruz	Xu, ZW (corresponding author), Chinese Acad Sci, State Key Lab Forest & Soil Ecol, Inst Appl Ecol, Shenyang, Peoples R China.	jiangyong@iae.ac.cn	Li, Mai-He/L-6390-2013; Wan, Shiqiang/L-9166-2019; Xu, ZhuWen/O-3635-2015; Wan, Shiqiang/B-5799-2009; Han, Xingguo/K-7552-2016; Ren, Haiyan/I-1863-2019; Jiang, Yong/A-2263-2012; Cheng, Weixin/F-4968-2011; Xu, Zhuwen/GLS-8029-2022	Li, Mai-He/0000-0002-7029-2841; Wan, Shiqiang/0000-0003-0631-1232; Xu, ZhuWen/0000-0002-8898-6577; Wan, Shiqiang/0000-0003-0631-1232; Han, Xingguo/0000-0002-1836-975X; Ren, Haiyan/0000-0002-2008-9626; Jiang, Yong/0000-0001-7518-5810; Cheng, Weixin/0000-0003-2964-2376; 	National Basic Research Program of China [2011CB403204]; National Natural Science Foundation of China [31000200]; Knowledge Innovation Project of CAS [KZCX2-YW-T06]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was financially supported by the National Basic Research Program of China (2011CB403204) and by the National Natural Science Foundation of China (31000200) and the Knowledge Innovation Project of CAS (No. KZCX2-YW-T06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2007, AM NAT, V169, P780, DOI 10.1086/516653; Anderson TM, 2008, OIKOS, V117, P675, DOI [10.1111/j.2008.0030-1299.16516.x, 10.1111/j.0030-1299.2008.16516.x]; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Britton AJ, 2001, J VEG SCI, V12, P797, DOI 10.2307/3236867; CARSON WP, 1988, ECOLOGY, V69, P984, DOI 10.2307/1941253; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Chen HYH, 2012, GLOBAL ECOL BIOGEOGR, V21, P441, DOI 10.1111/j.1466-8238.2011.00689.x; Cholaw B, 2003, ADV ATMOS SCI, V20, P755, DOI 10.1007/BF02915400; Clark CM, 2010, ECOLOGY, V91, P3620, DOI 10.1890/09-1268.1; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Dickson TL, 2008, J ECOL, V96, P937, DOI 10.1111/j.1365-2745.2008.01420.x; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gaudnik C, 2011, GLOBAL CHANGE BIOL, V17, P3351, DOI 10.1111/j.1365-2486.2011.02463.x; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; HULBERT L C, 1969, Ecology (Washington D C), V50, P874, DOI 10.2307/1933702; INOUYE RS, 1994, B TORREY BOT CLUB, V121, P266, DOI 10.2307/2997181; INOUYE RS, 1987, ECOLOGY, V68, P12, DOI 10.2307/1938801; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028601; [刘全友 Liu Quanyou], 2003, [生态学报, Acta Ecologica Sinica], V23, P1025; MAC ARTHUR ROBERT H., 1967; MAJOR J, 1974, HDB VEGETATION SCI, V8, P7; MCINTYRE S, 1994, J VEG SCI, V5, P373, DOI 10.2307/3235861; MCLENDON T, 1991, ECOLOGY, V72, P2016, DOI 10.2307/1941556; MYSTER RW, 1994, ECOLOGY, V75, P387, DOI 10.2307/1939542; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; PRACH K, 1993, OIKOS, V66, P343, DOI 10.2307/3544823; Price JN, 2007, PLANT ECOL, V188, P29, DOI 10.1007/s11258-006-9145-0; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Ren HY, 2011, ANN BOT-LONDON, V107, P145, DOI 10.1093/aob/mcq219; SHUGART HH, 1973, SCIENCE, V180, P1379, DOI 10.1126/science.180.4093.1379; Stevens CJ, 2010, ENVIRON POLLUT, V158, P2940, DOI 10.1016/j.envpol.2010.06.006; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens MHH, 2006, PLANT ECOL, V183, P27, DOI 10.1007/s11258-005-9003-5; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1993, COMMUNITY DIVERSITY, P327; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wijesinghe DK, 2005, J ECOL, V93, P99, DOI 10.1111/j.0022-0477.2004.00934.x; WOOD DM, 1987, ECOLOGY, V68, P780, DOI 10.2307/1938349; Xu ZW, 2010, RESTOR ECOL, V18, P217, DOI 10.1111/j.1526-100X.2009.00595.x; Yahdjian L, 2010, ECOSYSTEMS, V13, P575, DOI 10.1007/s10021-010-9341-6; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; [尤联元 You Lianyuan], 2003, [地理研究, Geographical Research], V22, P680; Yurkonis KA, 2006, PLANT ECOL, V184, P325, DOI 10.1007/s11258-005-9076-1; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x	52	55	64	14	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39762	10.1371/journal.pone.0039762	http://dx.doi.org/10.1371/journal.pone.0039762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768119	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100089
J	Zhang, M; Lu, J; Tao, K; Ye, WW; Li, AN; Liu, XY; Kong, L; Dong, SM; Zheng, XB; Wang, YC				Zhang, Meng; Lu, Jing; Tao, Kai; Ye, Wenwu; Li, Aining; Liu, Xiaoyun; Kong, Liang; Dong, Suomeng; Zheng, Xiaobo; Wang, Yuanchao			A Myb Transcription Factor of Phytophthora sojae, Regulated by MAP Kinase PsSAK1, Is Required for Zoospore Development	PLOS ONE			English	Article							GENE-EXPRESSION; OOMYCETE PHYTOPHTHORA; PROTEIN-KINASE; INFESTANS; CELL; PATHOGENICITY; PARASITICA; RESISTANCE; BIOLOGY	PsSAK1, a mitogen-activated protein (MAP) kinase from Phytophthora sojae, plays an important role in host infection and zoospore viability. However, the downstream mechanism of PsSAK1 remains unclear. In this study, the 3'-tag digital gene expression (DGE) profiling method was applied to sequence the global transcriptional sequence of PsSAK1-silenced mutants during the cysts stage and 1.5 h after inoculation onto susceptible soybean leaf tissues. Compared with the gene expression levels of the recipient P. sojae strain, several candidates of Myb family were differentially expressed (up or down) in response to the loss of PsSAK1, including of a R2R3-type Myb transcription factor, PsMYB1. qRT-PCR indicated that the transcriptional level of PsMYB1 decreased due to PsSAK1 silencing. The transcriptional level of PsMYB1 increased during sporulating hyphae, in germinated cysts, and early infection. Silencing of PsMYB1 results in three phenotypes: a) no cleavage of the cytoplasm into uninucleate zoospores or release of normal zoospores, b) direct germination of sporangia, and c) afunction in zoospore-mediated plant infection. Our data indicate that the PsMYB1 transcription factor functions downstream of MAP kinase PsSAK1 and is required for zoospore development of P. sojae.	[Zhang, Meng; Lu, Jing; Tao, Kai; Ye, Wenwu; Li, Aining; Liu, Xiaoyun; Kong, Liang; Dong, Suomeng; Zheng, Xiaobo; Wang, Yuanchao] Nanjing Agr Univ, Minist Educ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, M (corresponding author), Nanjing Agr Univ, Minist Educ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	wangyc@njau.edu.cn	Kong, Liang/AGE-7498-2022; Ye, Wenwu/AAE-4961-2022; wang, yuanchao/G-9667-2011; Ye, Wenwu/J-5624-2014	Ye, Wenwu/0000-0001-7347-8935; wang, yuanchao/0000-0001-5803-5343; Ye, Wenwu/0000-0001-7347-8935	National Natural Science Foundation of China [30900932]; Special Fund for Agro-scientific Research in the Public Interest from China; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest from China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (30900932) to S.D., the Special Fund for Agro-scientific Research in the Public Interest (3 20) from China to Y.W., and Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Brett M, 1995, MOL PLANT MICROBE IN, V8, P515; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Dong SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020172; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Erwin DC, 1985, PHYTOPHTHORA; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; HEMMES DE, 1969, AM J BOT, V56, P300, DOI 10.2307/2440853; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hua CL, 2008, EUKARYOT CELL, V7, P2133, DOI 10.1128/EC.00286-08; HYDE GJ, 1991, MYCOL RES, V95, P577, DOI 10.1016/S0953-7562(09)80072-5; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Judelson HS, 2002, EUKARYOT CELL, V1, P687, DOI 10.1128/EC.1.5.687-695.2002; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Li AN, 2010, MOL PLANT MICROBE IN, V23, P1022, DOI 10.1094/MPMI-23-8-1022; Moriwaki A, 2007, MICROBIOL RES, V162, P108, DOI 10.1016/j.micres.2006.01.014; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Schmitthenner AF, 1999, PLANT HLTH PROGR; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Vega-Sanchez ME, 2005, PHYSIOL MOL PLANT P, V66, P175, DOI 10.1016/j.pmpp.2005.07.001; vonBroembsen SL, 1997, PHYTOPATHOLOGY, V87, P522, DOI 10.1094/PHYTO.1997.87.5.522; Walker Claire A., 2007, Fungal Biology Reviews, V21, P10, DOI 10.1016/j.fbr.2007.02.001; Xiang QJ, 2010, GENE, V453, P1, DOI 10.1016/j.gene.2009.12.006; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Ye WW, 2011, MOL PLANT MICROBE IN, V24, P1530, DOI 10.1094/MPMI-05-11-0106; Yoshioka S, 2004, PLANT CELL, V16, P1466, DOI 10.1105/tpc.021162; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x	35	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40246	10.1371/journal.pone.0040246	http://dx.doi.org/10.1371/journal.pone.0040246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768262	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100236
J	Ayele, FT; Hailu, E; Finan, C; Aseffa, A; Davey, G; Newport, MJ; Rotimi, CN; Adeyemo, A				Ayele, Fasil Tekola; Hailu, Elena; Finan, Chris; Aseffa, Abraham; Davey, Gail; Newport, Melanie J.; Rotimi, Charles N.; Adeyemo, Adebowale			Prediction of HLA Class II Alleles Using SNPs in an African Population	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SYMPATRIC ETHNIC-GROUPS; TYPING IDENTIFIED 2; EXTENDED HUMAN MHC; ASSOCIATION ANALYSIS; KENYAN POPULATION; GENOME-WIDE; GENE MAP; PODOCONIOSIS; SEQUENCE	Background: Despite the importance of the human leukocyte antigen (HLA) gene locus in research and clinical practice, direct HLA typing is laborious and expensive. Furthermore, the analysis requires specialized software and expertise which are unavailable in most developing country settings. Recently, in silico methods have been developed for predicting HLA alleles using single nucleotide polymorphisms (SNPs). However, the utility of these methods in African populations has not been systematically evaluated. Methodology/Principal Findings: In the present study, we investigate prediction of HLA class II (HLA-DRB1 and HLA-DQB1) alleles using SNPs in the Wolaita population, southern Ethiopia. The subjects comprised 297 Ethiopians with genome-wide SNP data, of whom 188 had also been HLA typed and were used for training and testing the model. The 109 subjects with SNP data alone were used for empirical prediction using the multi-allelic gene prediction method. We evaluated accuracy of the prediction, agreement between predicted and HLA typed alleles, and discriminative ability of the prediction probability supplied by the model. We found that the model predicted intermediate (two-digit) resolution for HLA-DRB1 and HLA-DQB1 alleles at accuracy levels of 96% and 87%, respectively. All measures of performance showed high accuracy and reliability for prediction. The distribution of the majority of HLA alleles in the study was similar to that previously reported for the Oromo and Amhara ethnic groups from Ethiopia. Conclusions/Significance: We demonstrate that HLA class II alleles can be predicted from SNP genotype data with a high level of accuracy at intermediate (two-digit) resolution in an African population. This finding offers new opportunities for HLA studies of disease epidemiology and population genetics in developing countries.	[Ayele, Fasil Tekola; Rotimi, Charles N.; Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Hailu, Elena; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Finan, Chris; Davey, Gail; Newport, Melanie J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Brighton; University of Sussex	Ayele, FT (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.	ayeleft@mail.nih.gov	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Newport, Melanie/0000-0002-8946-7525; Adeyemo, Adebowale/0000-0002-3105-3231; Tekola-Ayele, Fasil/0000-0003-4194-9370; Davey, Gail/0000-0003-2796-7468	Wellcome Trust [079791]; National Human Genome Research Institute, National Institutes of Health, in the Center for Research on Genomics and Global Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Human Genome Research Institute, National Institutes of Health, in the Center for Research on Genomics and Global Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the Wellcome Trust [grant number 079791]; and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, in the Center for Research on Genomics and Global Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001184; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; Cesbron-Gautier A, 2004, ANN BIOL CLIN-PARIS, V62, P93; CSA, 2007, 2007 POPULATION HOUS; Davey G, 2007, T ROY SOC TROP MED H, V101, P1175, DOI 10.1016/j.trstmh.2007.08.013; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; [Department DPaC Federal Ministry of Health], 2006, NAT 5 YEAR STRAT PLA, P3; Destas K, 2003, TROP DOCT, V33, P217, DOI 10.1177/004947550303300410; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fort M, 1998, TISSUE ANTIGENS, V51, P327; Geshere G, 2009, IDENTIFICATION ETIOL; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall M., 2009, SIGKDD EXPLORATIONS, V11; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li SYS, 2011, GENET EPIDEMIOL, V35, P85, DOI 10.1002/gepi.20549; Lulli P, 2009, HUM IMMUNOL, V70, P903, DOI 10.1016/j.humimm.2009.07.025; Luo M, 2005, TISSUE ANTIGENS, V65, P120, DOI 10.1111/j.1399-0039.2005.00339.x; Luo M, 2004, TISSUE ANTIGENS, V63, P609, DOI 10.1111/j.0001-2815.2004.00231.x; Luo M, 2003, TISSUE ANTIGENS, V62, P182, DOI 10.1034/j.1399-0039.2003.00066.x; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P193; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Peterson TA, 2008, HUM IMMUNOL, V69, P885, DOI 10.1016/j.humimm.2008.09.001; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Setty MN, 2011, J COMPUT BIOL, V18, P483, DOI 10.1089/cmb.2010.0258; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; World Health Organization, 2008, GLOB BURD DIS 2004 U; Xie MZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S10; Zhang XC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-39	47	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40206	10.1371/journal.pone.0040206	http://dx.doi.org/10.1371/journal.pone.0040206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761960	Green Published, Green Accepted, gold			2022-12-25	WOS:000305826400061
J	Chen, WG; Liu, FL; Ling, ZX; Tong, XJ; Xiang, C				Chen, Weiguang; Liu, Fanlong; Ling, Zongxin; Tong, Xiaojuan; Xiang, Charlie			Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; ULCERATIVE-COLITIS; COMMENSAL BACTERIA; COLONIC MUCOSA; DIVERSITY; MECHANISMS; INDUCTION; ECOLOGY; UNIFRAC; OBESITY	Recent reports have suggested the involvement of gut microbiota in the progression of colorectal cancer (CRC). We utilized pyrosequencing based analysis of 16S rRNA genes to determine the overall structure of microbiota in patients with colorectal cancer and healthy controls; we investigated microbiota of the intestinal lumen, the cancerous tissue and matched noncancerous normal tissue. Moreover, we investigated the mucosa-adherent microbial composition using rectal swab samples because the structure of the tissue-adherent bacterial community is potentially altered following bowel cleansing. Our findings indicated that the microbial structure of the intestinal lumen and cancerous tissue differed significantly. Phylotypes that enhance energy harvest from diets or perform metabolic exchange with the host were more abundant in the lumen. There were more abundant Firmicutes and less abundant Bacteroidetes and Proteobacteria in lumen. The overall microbial structures of cancerous tissue and noncancerous tissue were similar; howerer the tumor microbiota exhibited lower diversity. The structures of the intestinal lumen microbiota and mucosa-adherent microbiota were different in CRC patients compared to matched microbiota in healthy individuals. Lactobacillales was enriched in cancerous tissue, whereas Faecalibacterium was reduced. In the mucosa-adherent microbiota, Bifidobacterium, Faecalibacterium, and Blautia were reduced in CRC patients, whereas Fusobacterium, Porphyromonas, Peptostreptococcus, and Mogibacterium were enriched. In the lumen, predominant phylotypes related to metabolic disorders or metabolic exchange with the host, Erysipelotrichaceae, Prevotellaceae, and Coriobacteriaceae were increased in cancer patients. Coupled with previous reports, these results suggest that the intestinal microbiota is associated with CRC risk and that intestinal lumen microflora potentially influence CRC risk via cometabolism or metabolic exchange with the host. However, mucosa-associated microbiota potentially affects CRC risk primarily through direct interaction with the host.	[Chen, Weiguang; Ling, Zongxin; Tong, Xiaojuan; Xiang, Charlie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Infect Dis Diagnost & Treatment, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Fanlong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Anus & Intestine, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, WG (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Infect Dis Diagnost & Treatment, Hangzhou 310003, Zhejiang, Peoples R China.	cxiang@zju.edu.cn	Ling, Zongxin/M-1657-2018; Chen, Weiguang/D-7467-2012; Ling, Zongxin/AAM-4059-2021	Ling, Zongxin/0000-0001-9662-099X; Chen, Weiguang/0000-0003-0859-8118; 	Chinese National Programs for Fundamental Research and Development [2007CB513001]	Chinese National Programs for Fundamental Research and Development	This work was supported by Project 2007CB513001 of Chinese National Programs for Fundamental Research and Development ( 973 program, http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Atarashi K, 2010, VACCINE, V28, P8036, DOI 10.1016/j.vaccine.2010.09.026; Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Benus RF, 2010, INTENS CARE MED, V36, P1394, DOI 10.1007/s00134-010-1826-4; Brown K R, 1977, Trop Doct, V7, P111; Brown Nat F, 2011, Mob Genet Elements, V1, P118; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Castellarin M, 2011, GENOME RES; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Davis CD, 2009, J NUTR BIOCHEM, V20, P743, DOI 10.1016/j.jnutbio.2009.06.001; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JI, 2002, ORAL MICROBIOL IMMUN, V17, P224, DOI 10.1034/j.1399-302X.2002.170404.x; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Kostic AD, 2011, GENOME RES; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2005, SCIENCE, V310, P1118, DOI 10.1126/science.310.5751.1118; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Paillard D, 2007, ANTON LEEUW INT J G, V91, P417, DOI 10.1007/s10482-006-9121-7; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208; Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Strauss J, 2011, INFLAMM BOWEL DIS; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van der Waaij LA, 2005, INFLAMM BOWEL DIS, V11, P865, DOI 10.1097/01.mib.0000179212.80778.d3; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Wang T, 2011, ISME J; Wei H, 2010, FEMS MICROBIOL ECOL, V73, P577, DOI 10.1111/j.1574-6941.2010.00924.x; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	61	415	458	10	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39743	10.1371/journal.pone.0039743	http://dx.doi.org/10.1371/journal.pone.0039743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761885	Green Published, Green Submitted, gold			2022-12-25	WOS:000305826400033
J	Dai, AY; Yan, GJ; He, QY; Jiang, Y; Zhang, Q; Fang, T; Ding, LJ; Sun, JX; Sun, HX; Hu, YL				Dai, Anyi; Yan, Guijun; He, Qinyuan; Jiang, Yue; Zhang, Qun; Fang, Ting; Ding, Lijun; Sun, Jianxin; Sun, Haixiang; Hu, Yali			Orphan Nuclear Receptor Nur77 Regulates Androgen Receptor Gene Expression in Mouse Ovary	PLOS ONE			English	Article							INDUCED STAR TRANSCRIPTION; ENDOMETRIAL STROMAL CELLS; NGFI-B NUR77; KIT-LIGAND; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; COACTIVATOR RECRUITMENT; FOLLICLE DEVELOPMENT; HORMONE RECEPTOR; GRANULOSA-CELLS; DEFICIENT MICE	The androgen receptor (AR) is a nuclear receptor that is expressed in growing follicles and involved in folliculogenesis and follicle growth. The orphan nuclear receptor, Nur77, also has an important role in steroid signaling and follicle maturation. We hypothesized that AR levels and androgen signaling through AR are regulated by Nur77 in the ovary. In the ovaries of Nur77 knockout mice (n = 5), real-time PCR results showed that the mRNA levels of AR and an androgen signaling target gene, Kitl, were decreased by 35% and 24%, respectively, relative to wild-type mice (n = 5), which suggested transcriptional regulation of AR by Nur77 in vivo. In cultured mouse granulosa cells and a steroidogenic human ovarian granulosa-like tumor cell line, KGN, mRNA and protein expression levels of AR were increased by overexpressing Nur77 but decreased by knocking down endogenous Nur77. Consistent with increased AR expression, chromatin immunoprecipitation showed that Nur77 bound to the NGFI-B response element (NBRE) in the AR promoter sequence. AR promoter activity was stimulated by Nur77 in HEK293T cells and attenuated in Nur77 knockout mouse granulosa cells (luciferase assay). Overexpression of Nur77 enhanced the androgenic induction of Kitl (200 nM; 48h), while knockout of Nur77 attenuated this induction. These results demonstrate that AR is regulated by Nur77 in the ovaries, and they suggest that the participation of Nur77 in androgen signaling may be essential for normal follicular development.	[Dai, Anyi; Yan, Guijun; He, Qinyuan; Jiang, Yue; Zhang, Qun; Fang, Ting; Ding, Lijun; Sun, Haixiang; Hu, Yali] Nanjing Univ, Affiliated Drum Tower Hosp, Reprod Med Ctr, Sch Med, Nanjing, Jiangsu, Peoples R China; [Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA	Nanjing University; Jefferson University	Dai, AY (corresponding author), Nanjing Univ, Affiliated Drum Tower Hosp, Reprod Med Ctr, Sch Med, Nanjing, Jiangsu, Peoples R China.	stevensunz@163.com; yali_hu@hotmail.com		Sun, Jianxin/0000-0001-5319-912X	State Key Development Program of Basic Research of China [2010CB945104]; National Natural Science Foundation of China [81070508, 30900727, 81070492, 81170570]; Health Department of Jiangsu Province of PR China [XK201102, LJ201102, RC2011005]; Natural Science Foundation of Jiangsu Province Grant of PR China [BK2009038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER	State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Jiangsu Province of PR China; Natural Science Foundation of Jiangsu Province Grant of PR China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the State Key Development Program of Basic Research of China Grant (973 Project No. 2010CB945104), the National Natural Science Foundation of China (No. 81070508, No. 30900727, No. 81070492, No. 81170570), the Special Grant for Principal Investigators from the Health Department of Jiangsu Province of PR China (No. XK201102, No. LJ201102, No. RC2011005), and the Natural Science Foundation of Jiangsu Province Grant of PR China (No. BK2009038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bassett MH, 2004, J BIOL CHEM, V279, P37622, DOI 10.1074/jbc.M405431200; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; CRAWFORD PA, 1995, MOL CELL BIOL, V15, P4331; Ding LJ, 2011, FEBS LETT, V585, P2437, DOI 10.1016/j.febslet.2011.06.013; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gill A, 2004, MOL ENDOCRINOL, V18, P97, DOI 10.1210/me.2003-0326; Havelock JC, 2005, MOL HUM REPROD, V11, P79, DOI 10.1093/molehr/gah139; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Hickey TE, 2004, BIOL REPROD, V71, P45, DOI 10.1095/biolreprod.103.026484; HILDPETITO S, 1991, BIOL REPROD, V44, P561, DOI 10.1095/biolreprod44.3.561; Hutt KJ, 2006, BIOL REPROD, V75, P421, DOI 10.1095/biolreprod.106.051516; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Jiang Y, 2011, BIOCHEM BIOPH RES CO, V404, P628, DOI 10.1016/j.bbrc.2010.12.027; Kelly SN, 2004, J ENDOCRINOL, V181, P355, DOI 10.1677/joe.0.1810355; Kipp JL, 2009, METHODS MOL BIOL, V590, P177, DOI 10.1007/978-1-60327-378-7_11; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li M, 2009, MOL HUM REPROD, V15, P149, DOI 10.1093/molehr/gap006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Martin LJ, 2008, J MOL ENDOCRINOL, V41, P165, DOI 10.1677/JME-07-0145; Martin LJ, 2008, MOL ENDOCRINOL, V22, P2021, DOI 10.1210/me.2007-0370; Maruyama K, 1998, INT J ONCOL, V12, P1237; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Mei L, 2010, MOL CELL ENDOCRINOL, V319, P39, DOI 10.1016/j.mce.2010.01.014; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Murphy EP, 2001, ARTHRITIS RHEUM-US, V44, P782, DOI 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.3.CO;2-8; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; PACKER AI, 1994, DEV BIOL, V161, P194, DOI 10.1006/dbio.1994.1020; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Sen A, 2010, MOL ENDOCRINOL, V24, P1393, DOI 10.1210/me.2010-0006; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Sun HX, 2009, BIOCHEM BIOPH RES CO, V379, P16, DOI 10.1016/j.bbrc.2008.11.144; TETSUKA M, 1995, J ENDOCRINOL, V145, P535, DOI 10.1677/joe.0.1450535; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Walters KA, 2007, ENDOCRINOLOGY, V148, P3674, DOI 10.1210/en.2007-0248; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; Wu YM, 2005, ENDOCRINOLOGY, V146, P237, DOI 10.1210/en.2004-0889; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963; Ye YH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-26; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891	49	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39950	10.1371/journal.pone.0039950	http://dx.doi.org/10.1371/journal.pone.0039950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761936	Green Published, gold			2022-12-25	WOS:000305826400050
J	Feng, J; Zhang, XS; Zhu, HJ; Wang, XD; Ni, SS; Huang, JF				Feng, Jian; Zhang, Xuesong; Zhu, Huijun; Wang, Xudong; Ni, Songshi; Huang, Jianfei			FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; PROTEIN EXPRESSION; BREAST-CARCINOMA; GROWTH	Background: We determined the expression of forkhead box Q1 (FoxQ1), E-cadherin (E-cad), Mucin 1 (MUC1), vimentin (VIM) and S100 calcium binding protein A4 (S100A4), all epithelial-mesenchymal transition (EMT) indicator proteins in non-small cell lung cancer (NSCLC) tissue samples. We also investigated the relationship between these five proteins expression and other clinicopathologic factors in NSCLC. Finally, we assessed the potential value of these markers as prognostic indicators of survival in NSCLC's patients. Methods: Quantitative real-time PCR and immunohistochemistry were used to characterize the expression of the FoxQ1 mRNA and protein in NSCLC. Expression of transcripts and translated products for the other four EMT indicator proteins was assessed by immunohistochemistry in the same clinical NSCLC samples. Results: FoxQ1 mRNA and protein were up-regulated in NSCLC compared with normal tissues (P = 0.015 and P<0.001, respectively). Expression of FoxQ1 in adenocarcinoma was higher than in squamous cell carcinoma (P = 0.005), and high expression of FoxQ1 correlated with loss of E-cad expression (P = 0.012), and anomalous positivity of VIM (P = 0.024) and S100A4 (P = 0.004). Additional survival analysis showed that high expression of FoxQ1 (P = 0.047) and E-cad (P = 0.021) were independent prognostic factors. Conclusion: FoxQ1 maybe plays a specific role in the EMT of NSCLC, and could be used as a prognostic factor for NSCLC.	[Feng, Jian; Zhang, Xuesong; Ni, Songshi] Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong, Jiangsu, Peoples R China; [Zhu, Huijun; Huang, Jianfei] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong, Jiangsu, Peoples R China; [Wang, Xudong] Nantong Univ, Affiliated Hosp, Dept Lab Med, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University	Feng, J (corresponding author), Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong, Jiangsu, Peoples R China.	ntyydoctor@126.com		Huang, Jianfei/0000-0002-1276-5962	Nantong government, China [S2010041]; Department of Health Jiangsu; Affiliated Hospital of Nantong University, Nantong, China	Nantong government, China; Department of Health Jiangsu; Affiliated Hospital of Nantong University, Nantong, China	This study was supported by grants from the Social Development and Applied Research Projects (S2010041) of Nantong government, China; International Cooperation and Exchanges (2011) from the Department of Health Jiangsu; and the Doctoral Fund (2010) of the Affiliated Hospital of Nantong University, Nantong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Cagle PT, 2011, ARCH PATHOL LAB MED, V135, P110, DOI 10.1043/2010-0567-RA.1; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chai JY, 2010, BIOSCI TRENDS, V4, P130; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Feuerborn A, 2011, J CELL PHYSIOL, V226, P710, DOI 10.1002/jcp.22385; Gao W, 2011, CLIN LUNG CANCER, V12, P14, DOI 10.3816/CLC.2011.n.001; Ghoul A, 2009, CANCER RES, V69, P4260, DOI 10.1158/0008-5472.CAN-08-2837; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Huang JF, 2011, J MOL HISTOL, V42, P597, DOI 10.1007/s10735-011-9355-1; Huang JF, 2011, J CLIN PATHOL, V64, P343, DOI 10.1136/jcp.2010.085142; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Lee KW, 2012, ANN SURG ONCOL, V19, P326, DOI 10.1245/s10434-011-1867-0; Li LP, 2011, PROTEOMICS, V11, P429, DOI 10.1002/pmic.200900819; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Okamoto S, 2009, ONCOL REP, V21, P1209, DOI 10.3892/or_00000343; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; Sloan JA, 2011, CANCER J, V17, P63, DOI 10.1097/PPO.0b013e31820e15dc; Smith CB, 2010, SEMIN THORAC CARDIOV, V22, P193, DOI 10.1053/j.semtcvs.2010.10.002; Soini Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-73; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Tsuna M, 2009, ANTICANCER RES, V29, P2547; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; van Zijl F, 2011, MOL CANCER THER, V10, P850, DOI 10.1158/1535-7163.MCT-10-0917; Wang GH, 2011, EUR J CARDIO-THORAC, V39, P1028, DOI 10.1016/j.ejcts.2011.01.023; Wang XX, 2011, HUM PATHOL, V42, P1410, DOI 10.1016/j.humpath.2010.12.007; Wen CH, 2011, LANCET ONCOL, V12, P15, DOI 10.1016/S1470-2045(10)70303-X; Yi ZY, 2011, J INVEST SURG, V24, P67, DOI 10.3109/08941939.2010.542272; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	40	68	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39937	10.1371/journal.pone.0039937	http://dx.doi.org/10.1371/journal.pone.0039937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761930	Green Submitted, gold, Green Published			2022-12-25	WOS:000305826400046
J	Tao, Q; Li, DY; Zhang, L; Luo, SQ				Tao, Qiang; Li, Dongyue; Zhang, Lu; Luo, Shuqian			Using X-Ray In-Line Phase-Contrast Imaging for the Investigation of Nude Mouse Hepatic Tumors	PLOS ONE			English	Article								The purpose of this paper is to report the noninvasive imaging of hepatic tumors without contrast agents. Both normal tissues and tumor tissues can be detected, and tumor tissues in different stages can be classified quantitatively. We implanted BEL-7402 human hepatocellular carcinoma cells into the livers of nude mice and then imaged the livers using X-ray in-line phase-contrast imaging (ILPCI). The projection images' texture feature based on gray level co-occurrence matrix (GLCM) and dual-tree complex wavelet transforms (DTCWT) were extracted to discriminate normal tissues and tumor tissues. Different stages of hepatic tumors were classified using support vector machines (SVM). Images of livers from nude mice sacrificed 6 days after inoculation with cancer cells show diffuse distribution of the tumor tissue, but images of livers from nude mice sacrificed 9, 12, or 15 days after inoculation with cancer cells show necrotic lumps in the tumor tissue. The results of the principal component analysis (PCA) of the texture features based on GLCM of normal regions were positive, but those of tumor regions were negative. The results of PCA of the texture features based on DTCWT of normal regions were greater than those of tumor regions. The values of the texture features in low-frequency coefficient images increased monotonically with the growth of the tumors. Different stages of liver tumors can be classified using SVM, and the accuracy is 83.33%. Noninvasive and micron-scale imaging can be achieved by X-ray ILPCI. We can observe hepatic tumors and small vessels from the phase-contrast images. This new imaging approach for hepatic cancer is effective and has potential use in the early detection and classification of hepatic tumors.	[Tao, Qiang; Li, Dongyue; Zhang, Lu; Luo, Shuqian] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Li, Dongyue] Tianjin Med Univ, Sch Med Image, Tianjin, Peoples R China	Capital Medical University; Tianjin Medical University	Tao, Q (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	shuqian_luo@yahoo.com.cn			National Natural Science Foundation of China [60532090, 30770593]; European Community [PIRSES-GA-2009-269124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Community(European Commission)	This study was supported by National Natural Science Foundation of China, Grant Nos. 60532090 and 30770593, and by the 7th Framework Programme of the European Community, Grant Agreement Number: PIRSES-GA-2009-269124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajdub M, 2007, CONTRAST MEDIA MOL I, V2, P88, DOI 10.1002/cmmi.130; Astrid L, 2009, EUR J RADIOL EXTRA, V72, pe9; Carvalho ML, 2001, X-RAY SPECTROM, V30, P397, DOI 10.1002/xrs.517; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Elshemey WM, 2003, PHYS MED BIOL, V48, pN239, DOI 10.1088/0031-9155/48/17/401; Furlan A, 2008, AM J ROENTGENOL, V191, P1430, DOI 10.2214/AJR.07.3419; Giuseppetti GM, 1998, EUR J RADIOL, V27, pS254, DOI 10.1016/S0720-048X(98)00076-X; Hatfield MK, 2008, AM J ROENTGENOL, V190, P413, DOI 10.2214/AJR.07.2676; Hong Y, 2009, APPL PHYS LETT, V95; Iwazawa J, 2009, AM J ROENTGENOL, V192, P1057, DOI 10.2214/AJR.08.1285; Killi RM, 1999, EUR J RADIOL, V32, P21, DOI 10.1016/S0720-048X(99)00112-6; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Li ST, 2003, PATTERN RECOGN, V36, P2883, DOI 10.1016/S0031-3203(03)00219-X; Lucia M, 2011, PLOS ONE, V6; Luo W, 2009, AM J ROENTGENOL, V192, P165, DOI 10.2214/AJR.08.1107; Masato H, 2011, PLOS ONE, V6; Rand D, 2011, NANO LETT, V11, P2678, DOI 10.1021/nl200858y; Raty J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449127; Rod DB, 2012, PLOS ONE, V7; Sarah WI, 2009, EUR J RADIOL EXTRA, V71, pe25; Shuqian L, 2010, MED IMAGE PROCESSING, P39; Simone CC, 2011, PLOS ONE, V6; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Tabuchi A, 2009, EUR J RADIOL, V71, P506, DOI 10.1016/j.ejrad.2008.06.001; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu J, 2009, KIDNEY INT, V75, P945, DOI 10.1038/ki.2009.42; Wu XZ, 2003, MED PHYS, V30, P2169, DOI 10.1118/1.1593836; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006	29	6	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39936	10.1371/journal.pone.0039936	http://dx.doi.org/10.1371/journal.pone.0039936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761929	Green Submitted, Green Published, gold			2022-12-25	WOS:000305826400045
J	Butenko, O; Dzamba, D; Benesova, J; Honsa, P; Benfenati, V; Rusnakova, V; Ferroni, S; Anderova, M				Butenko, Olena; Dzamba, David; Benesova, Jana; Honsa, Pavel; Benfenati, Valentina; Rusnakova, Vendula; Ferroni, Stefano; Anderova, Miroslava			The Increased Activity of TRPV4 Channel in the Astrocytes of the Adult Rat Hippocampus after Cerebral Hypoxia/Ischemia	PLOS ONE			English	Article							BERGMANN GLIAL-CELLS; CORTICAL ASTROCYTES; CATION CHANNEL; IN-SITU; CALCIUM OSCILLATIONS; NA+-CA2+ EXCHANGER; GLUTAMATE RELEASE; MEMBRANE CURRENTS; NEURONAL-ACTIVITY; OXIDATIVE STRESS	The polymodal transient receptor potential vanilloid 4 (TRPV4) channel, a member of the TRP channel family, is a calcium-permeable cationic channel that is gated by various stimuli such as cell swelling, low pH and high temperature. Therefore, TRPV4-mediated calcium entry may be involved in neuronal and glia pathophysiology associated with various disorders of the central nervous system, such as ischemia. The TRPV4 channel has been recently found in adult rat cortical and hippocampal astrocytes; however, its role in astrocyte pathophysiology is still not defined. In the present study, we examined the impact of cerebral hypoxia/ischemia (H/I) on the functional expression of astrocytic TRPV4 channels in the adult rat hippocampal CA1 region employing immunohistochemical analyses, the patch-clamp technique and microfluorimetric intracellular calcium imaging on astrocytes in slices as well as on those isolated from sham-operated or ischemic hippocampi. Hypoxia/ischemia was induced by a bilateral 15-minute occlusion of the common carotids combined with hypoxic conditions. Our immunohistochemical analyses revealed that 7 days after H/I, the expression of TRPV4 is markedly enhanced in hippocampal astrocytes of the CA1 region and that the increasing TRPV4 expression coincides with the development of astrogliosis. Additionally, adult hippocampal astrocytes in slices or cultured hippocampal astrocytes respond to the TRPV4 activator 4-alpha-phorbol-12,-13-didecanoate (4 alpha PDD) by an increase in intracellular calcium and the activation of a cationic current, both of which are abolished by the removal of extracellular calcium or exposure to TRP antagonists, such as Ruthenium Red or RN1734. Following hypoxic/ischemic injury, the responses of astrocytes to 4 alpha PDD are significantly augmented. Collectively, we show that TRPV4 channels are involved in ischemia-induced calcium entry in reactive astrocytes and thus, might participate in the pathogenic mechanisms of astroglial reactivity following ischemic insult.	[Butenko, Olena; Dzamba, David; Benesova, Jana; Honsa, Pavel; Anderova, Miroslava] Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Butenko, Olena; Dzamba, David; Benesova, Jana; Honsa, Pavel] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Benfenati, Valentina] CNR, Inst Study Nanostruct Mat, Bologna, Italy; [Rusnakova, Vendula] Acad Sci Czech Republic, Inst Biotechnol, Gene Express Lab, Prague, Czech Republic; [Ferroni, Stefano] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Bologna	Butenko, O (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Novosadova, Vendula/G-6388-2014; Benfenati, Valentina/AAD-1821-2019; Novosadova, Vendula/AAJ-1449-2021; Butenko, Olena/AAL-3766-2021; Benfenati, Valentina/D-4579-2016; Anderova, Miroslava/H-2249-2014	Benfenati, Valentina/0000-0002-2858-8497; Butenko, Olena/0000-0003-2959-559X; Benfenati, Valentina/0000-0002-2858-8497; Anderova, Miroslava/0000-0002-9030-4571	Grant Agency of the Czech Republic [GA CR:P303/10/1338, GA CR:309/08/H079]; Academy of Sciences of the Czech Republic [AVOZ50390512]; Ministry of Education, Youth and Sports of the Czech Republic [LC554]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the grants GA CR:P303/10/1338 and GA CR:309/08/H079 from the Grant Agency of the Czech Republic, AVOZ50390512 from the Academy of Sciences of the Czech Republic, and LC554 from the Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bae CYJ, 2011, ACTA PHARMACOL SIN, V32, P725, DOI 10.1038/aps.2011.60; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Balazsi G, 2003, CHAOS, V13, P515, DOI 10.1063/1.1567652; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Bond CE, 2006, EUR J NEUROSCI, V24, P381, DOI 10.1111/j.1460-9568.2006.04898.x; Cali C, 2009, INT REV NEUROBIOL, V85, P261, DOI 10.1016/S0074-7742(09)85020-4; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Cao X, 2010, NEUROSCI LETT, V479, P118, DOI 10.1016/j.neulet.2010.05.040; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Chvatal A, 2008, PHYSIOL RES, V57, pS101, DOI 10.33549/physiolres.931604; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Clemens JA, 1996, STROKE, V27, P527, DOI 10.1161/01.STR.27.3.527; Cotrina ML, 2009, PURINERG SIGNAL, V5, P223, DOI 10.1007/s11302-009-9138-2; Evanko DS, 2004, GLIA, V47, P233, DOI 10.1002/glia.20050; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Guler AD, 2002, J NEUROSCI, V22, P6408; Hill K, 2006, NEUROPHARMACOLOGY, V50, P89, DOI 10.1016/j.neuropharm.2005.08.021; Honsa P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036816; Jia YL, 2004, AM J PHYSIOL-LUNG C, V287, pL272, DOI 10.1152/ajplung.00393.2003; Jung C, 2009, PFLUG ARCH EUR J PHY, V459, P105, DOI 10.1007/s00424-009-0706-7; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kirischuk S, 1997, FASEB J, V11, P566, DOI 10.1096/fasebj.11.7.9212080; Kirischuk S, 2007, PFLUG ARCH EUR J PHY, V454, P245, DOI 10.1007/s00424-007-0207-5; Krebs C, 2003, J NEUROSCI, V23, P3364; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lanciotti A, 2012, HUM MOL GENET, V21, P2166, DOI 10.1093/hmg/dds032; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Liedtke W, 2006, J ENDOCRINOL, V191, P515, DOI 10.1677/joe.1.07000; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makara JK, 2003, MOL CELL NEUROSCI, V23, P521, DOI 10.1016/S1044-7431(03)00080-0; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; Manning TJ, 1997, GLIA, V21, P332; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Meng F, 2008, RESP PHYSIOL NEUROBI, V164, P386, DOI 10.1016/j.resp.2008.09.002; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Neprasova H, 2007, PFLUG ARCH EUR J PHY, V453, P839, DOI 10.1007/s00424-006-0151-9; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Paluzzi S, 2007, J NEUROCHEM, V103, P1196, DOI 10.1111/j.1471-4159.2007.04826.x; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Plant T. D., 2007, V179, P189; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; Rao SP, 2006, GLIA, V53, P817, DOI 10.1002/glia.20341; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Rojas H, 2007, J NEUROCHEM, V100, P1188, DOI 10.1111/j.1471-4159.2006.04303.x; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shirakawa H, 2010, J NEUROSCI, V30, P13116, DOI 10.1523/JNEUROSCI.1890-10.2010; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; TAKUMA K, 1994, GLIA, V12, P336, DOI 10.1002/glia.440120410; Verkhratsky A, 2009, FRONT BIOSCI-LANDMRK, V14, P2004, DOI 10.2741/3359; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635; Zhou M, 2000, J NEUROPHYSIOL, V84, P2746, DOI 10.1152/jn.2000.84.6.2746	82	112	117	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39959	10.1371/journal.pone.0039959	http://dx.doi.org/10.1371/journal.pone.0039959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761937	Green Submitted, Green Published, gold			2022-12-25	WOS:000305825800082
J	Guessous, I; Bochud, M; Theler, JM; Gaspoz, JM; Pechere-Bertschi, A				Guessous, Idris; Bochud, Murielle; Theler, Jean-Marc; Gaspoz, Jean-Michel; Pechere-Bertschi, Antoinette			1999-2009 Trends in Prevalence, Unawareness, Treatment and Control of Hypertension in Geneva, Switzerland	PLOS ONE			English	Article							BLOOD-PRESSURE LEVELS; RISK-FACTORS; ARTERIAL-HYPERTENSION; EUROPEAN COUNTRIES; ADULT-POPULATION; CZECH POPULATION; AWARENESS; CANADA; PREVENTION; DISEASE	Background: There are no time trends in prevalence, unawareness, treatment, and control of hypertension in Switzerland. The objective of this study was to analyze these trends and to determine the associated factors. Methods/Findings: Population-based study conducted in the Canton of Geneva, Switzerland, between 1999 and 2009. Blood pressure was measured thrice using a standard protocol. Hypertension was defined as mean systolic or diastolic blood pressure >= 140/90 mmHg or self-reported hypertension or anti-hypertensive medication. Unawareness, untreated and uncontrolled hypertension was determined by questionnaires/blood pressure measurements. Yearly age-standardized prevalences and adjusted associations for the 1999-2003 and 2004-2009 survey periods were reported. The 10-year survey included 9,215 participants aged 35 to 74 years. Hypertension remained stable (34.4%). Hypertension unawareness decreased from 35.9% to 17.7% (P < 0.001). The decrease in hypertension unawareness was not paralleled by a concomitant absolute increase in hypertension treatment, which remained low (38.2%). A larger proportion of all hypertensive participants were aware but not treated in 2004-2009 (43.7%) compared to 1999-2003 (33.1%). Uncontrolled hypertension improved from 62.2% to 40.6% between 1999 and 2009 (P = 0.02). In 1999-2003 period, factors associated with hypertension unawareness were current smoking (OR = 1.27, 95% CI, 1.02-1.59), male gender (OR = 1.56, 1.27-1.92), hypercholesterolemia (OR = 1.31, 1.20-1.44), and older age (OR 65-74yrs vs 35-49yrs = 1.56, 1.21-2.02). In 1999-2003 and 2004-2009, obesity and diabetes were negatively associated with hypertension unawareness, high education was associated with untreated hypertension (OR = 1.45, 1.12-1.88 and 1.42, 1.02-1.99, respectively), and male gender with uncontrolled hypertension (OR = 1.49, 1.03-2.17 and 1.65, 1.08-2.50, respectively). Sedentarity was associated with higher risk of hypertension and uncontrolled hypertension in 1999-2003. Conclusions: Hypertension prevalence remained stable since 1999 in the canton of Geneva. Although hypertension unawareness substantially decreased, more than half of hypertensive subjects still remained untreated or uncontrolled in 2004-2009. This study identified determinants that should guide interventions aimed at improving hypertension treatment and control.	[Guessous, Idris; Theler, Jean-Marc; Gaspoz, Jean-Michel] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Unit Populat Epidemiol, Div Primary Care Med, Geneva, Switzerland; [Guessous, Idris; Bochud, Murielle] Univ Lausanne Hosp, Univ Inst Social & Prevent Med, Community Prevent Unit, Lausanne, Switzerland; [Guessous, Idris; Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Hypertens Unit, Dept Med Specialties, Geneva, Switzerland; [Guessous, Idris; Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Hypertens Unit, Dept Community Med & Primary Care & Emergency Med, Geneva, Switzerland	University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva	Guessous, I (corresponding author), Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Unit Populat Epidemiol, Div Primary Care Med, Geneva, Switzerland.	Idris.Guessous@hcuge.ch	Bochud, Murielle/A-3981-2010	Bochud, Murielle/0000-0002-5727-0218	Geneva University Hospitals through the General Directorate of Health (Canton of Geneva); Swiss Foundation for Science [33CM30-124087]; Swiss School of Public Health Plus	Geneva University Hospitals through the General Directorate of Health (Canton of Geneva); Swiss Foundation for Science; Swiss School of Public Health Plus	The Bus Sante study is funded by the Geneva University Hospitals through the General Directorate of Health (Canton of Geneva) http://ge.ch/dares/sante/accueil.html. IG is supported by a grant from the Swiss Foundation for Science, http://www.snf.ch/E/Pages/default.aspx (33CM30-124087). MB is supported by the Swiss School of Public Health Plus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, J HUM HYPERTENS, V20, P874, DOI 10.1038/sj.jhh.1002073; ASSMANN G, 1988, AM HEART J, V116, P1713, DOI 10.1016/0002-8703(88)90220-7; Beer-Borst S, 2009, EUR J CLIN NUTR, V63, P155, DOI 10.1038/sj.ejcn.1602922; BERNSTEIN M, 1994, SOZ PRAVENTIV MED, V39, P333, DOI 10.1007/BF01299665; Bernstein M, 1998, AM J EPIDEMIOL, V147, P147; Bersamin A, 2009, J GEN INTERN MED, V24, P521, DOI 10.1007/s11606-009-1094-6; Bielecka-Dabrowa A, 2011, CURR CARDIOVASC RISK, V5, P174, DOI 10.1007/s12170-010-0152-2; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Brindel P, 2006, J HYPERTENS, V24, P51, DOI 10.1097/01.hjh.0000198028.84353.86; Centers for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V282, P724, DOI DOI 10.1001/JAMA.282.8.724; Chalmers J, 1999, J HYPERTENS, V17, P151; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cifkova R, 2004, J HYPERTENS, V22, P1479, DOI 10.1097/01.hjh.0000133737.77866.3e; Cifkova R, 2004, J HUM HYPERTENS, V18, P571, DOI 10.1038/sj.jhh.1001686; Cifkova R, 2010, J HYPERTENS, V28, P2196, DOI 10.1097/HJH.0b013e32833d4451; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Danon-Hersch N, 2009, EUR J CARDIOV PREV R, V16, P66, DOI 10.1097/HJR.0b013e32831e9511; Dorobantu M, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/970694; Efstratopoulos AD, 2006, AM J HYPERTENS, V19, P53, DOI 10.1016/j.amjhyper.2005.07.011; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Ferrari P, 2004, J HYPERTENS, V22, P1221, DOI 10.1097/00004872-200406000-00024; Gaolbardes B, 2003, ANN EPIDEMIOL, V13, P537, DOI 10.1016/S1047-2797(03)00055-3; Gaspoz JM, 2009, SUIVI FACTEURS RISQU; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kronborg CN, 2009, J AM SOC HYPERTENS, V3, P19, DOI 10.1016/j.jash.2008.08.001; Leenen FHH, 2008, CAN MED ASSOC J, V178, P1441, DOI 10.1503/cmaj.071340; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; Macedo ME, 2005, J HYPERTENS, V23, P1661, DOI 10.1097/01.hjh.0000179908.51187.de; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 1997, LANCET, V349, P454, DOI 10.1016/S0140-6736(96)07099-7; Mancia Giuseppe, 2008, Ther Adv Cardiovasc Dis, V2, P5, DOI 10.1177/1753944707087409; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mohan S, 2008, CAN MED ASSOC J, V178, P1458, DOI 10.1503/cmaj.080296; MORABIA A, 1994, SOZ PRAVENTIV MED, V39, P345, DOI 10.1007/BF01299666; Morabia A, 1997, PREV MED, V26, P311, DOI 10.1006/pmed.1997.0146; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; Ordunez-Garcia P, 2006, J HYPERTENS, V24, P845, DOI 10.1097/01.hjh.0000222753.67572.28; Reinhardt UE, 2004, JAMA-J AM MED ASSOC, V292, P1227, DOI 10.1001/jama.292.10.1227; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; Wagner A, 2011, J HYPERTENS, V29, P43, DOI 10.1097/HJH.0b013e32833f9c4d; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Wang YR, 2007, ARCH INTERN MED, V167, P141, DOI 10.1001/archinte.167.2.141; Whelton PK, 2004, J HUM HYPERTENS, V18, P545, DOI 10.1038/sj.jhh.1001701; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wolff H, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13165; Zdrojewski T, 2004, J HUM HYPERTENS, V18, P557, DOI 10.1038/sj.jhh.1001739	55	91	93	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39877	10.1371/journal.pone.0039877	http://dx.doi.org/10.1371/journal.pone.0039877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761919	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800077
J	Siedner, MJ; Lankowski, A; Haberer, JE; Kembabazi, A; Emenyonu, N; Tsai, AC; Muzoora, C; Geng, E; Martin, JN; Bangsberg, DR				Siedner, Mark J.; Lankowski, Alexander; Haberer, Jessica E.; Kembabazi, Annet; Emenyonu, Nneka; Tsai, Alexander C.; Muzoora, Conrad; Geng, Elvin; Martin, Jeffrey N.; Bangsberg, David R.			Rethinking the "Pre" in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; SOUTH-AFRICA; HIV CARE; PROGRAMS; BARRIERS; EFFICACY; DURBAN; ART; INTERVENTION	Background: Many guidelines recommend adherence counseling prior to initiating antiretrovirals (ARVs), however the additional benefit of pre-therapy counseling visits on early adherence is not known. We sought to assess for a benefit of adherence counseling visits prior to ARV initiation versus adherence counseling during the early treatment period. Methods: We performed a secondary analysis of data from a prospective cohort of HIV-infected patients in Mbarara, Uganda. Adults were enrolled upon initiation of ARVs. Our primary exposure of interest was ARV adherence counseling prior to initiating therapy (versus concurrent with initiation of therapy). Our outcomes of interest were: 1) average adherence >90% in first three months; 2) absence of treatment interruptions >72 hours in first three months; and 3) Viral load >400 copies/ml at the three month visit. We fit univariable and multivariable regression models, adjusted for predictors of ARV adherence, to estimate the association between additional pre-therapy counseling visits and our outcomes. Results: 300 participants had records of counseling, of whom 231 (77%) completed visits prior to initiation of ARVs and 69 (23%) on or shortly after initiation. Median age was 33, 71% were female, and median CD4 was 133 cell/ml. Median 90-day adherence was 95%. Participants who completed pre-therapy counseling visits had longer delays from ARV eligibility to initiation (median 49 vs 14 days, p<0.01). In multivariable analyses, completing adherence counseling prior to ARV initiation was not associated with average adherence >90% (AOR 0.8, 95% CI 0.4-1.5), absence of treatment gaps (AOR 0.7, 95% CI 0.2-1.9), or HIV viremia (AOR 1.1, 95% CI 0.4-3.1). Conclusions: Completion of adherence counseling visits prior to ARV therapy was not associated with higher adherence in this cohort of HIV-infected patients in Uganda. Because mortality and loss-to-follow-up remain high in the pre-ARV period, policy makers should reconsider whether counseling can be delivered with ARV initiation, especially in patients with advanced disease.	[Siedner, Mark J.; Lankowski, Alexander; Haberer, Jessica E.; Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Lankowski, Alexander; Kembabazi, Annet; Emenyonu, Nneka; Muzoora, Conrad] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Tsai, Alexander C.; Bangsberg, David R.] Harvard Univ, Robert Wood Johnson Hlth & Soc Scholars Program, Boston, MA 02115 USA; [Geng, Elvin; Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bangsberg, David R.] Massahusetts Gen Hosp, Ctr Global Hlth, Boston, MA USA; [Bangsberg, David R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Mbarara University of Science & Technology; Harvard University; Robert Wood Johnson Foundation (RWJF); University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Siedner, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA.	msiedner@partners.org	Lankowski, Alexander/AAE-6094-2020; Tsai, Alexander C./F-4247-2015; Haberer, Jessica/AAH-7976-2019; Muzoora, Conrad/AAV-7023-2021	Lankowski, Alexander/0000-0002-4769-7242; Tsai, Alexander C./0000-0001-6397-7917; Haberer, Jessica/0000-0001-5845-3190; Muzoora, Conrad/0000-0002-7866-5198	National Institutes of Health [R01 MH054907, K24 MH87227, P30 AI027793]; Mark and Lisa Schwartz Family Foundation; Robert Wood Johnson Health and Society Scholars Program; Doris Duke Charitable Foundation Clinical Research Fellowship at Harvard Medical School; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907, K23MH087228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mark and Lisa Schwartz Family Foundation; Robert Wood Johnson Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); Doris Duke Charitable Foundation Clinical Research Fellowship at Harvard Medical School; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by the National Institutes of Health (R01 MH054907, K24 MH87227, and P30 AI027793), and the Mark and Lisa Schwartz Family Foundation. Dr. Tsai received salary support from the Robert Wood Johnson Health and Society Scholars Program. Dr. Siedner received additional support from the Harvard Institute for Global Health and from the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. Mr. Lankowski received support from the Doris Duke Charitable Foundation Clinical Research Fellowship at Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2010, NAT GUID HIV AIDS CA; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; *BOTSW MIN HLTH DE, 2008, BOTSW NAT HIV AIDS T; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Geng E, 2009, J ACQUIR IMMUNE DEFI; Geng E, 2011, FAILURE INITIATE ART; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Goujard C, 2003, JAIDS-J ACQ IMM DEF, V34, P191, DOI 10.1097/00126334-200310010-00009; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; McGrath N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-601; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; *MIN HLTH SOC WELF, 2008, NAT GUID MAN HIV AID; Ministerio de Saude, 2006, TRAT ANT INF OP AD A; Ministry of Health and Social Services Namibia, 2010, NAT GUID ANT THER; Ministry of Health Republic of Uganda, 2009, NAT ANT TREATM GUID; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Pradier C, 2003, HIV CLIN TRIALS, V4, P121; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Tuldra A, 2000, J ACQ IMMUN DEF SYND, V25, P221, DOI 10.1097/00126334-200011010-00003; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Zachariah R, 2011, T ROY SOC TROP MED H, V105, P421, DOI 10.1016/j.trstmh.2011.04.014	37	38	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39894	10.1371/journal.pone.0039894	http://dx.doi.org/10.1371/journal.pone.0039894			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966AK	22761924	Green Published, gold, Green Submitted			2022-12-25	WOS:000305808700053
J	Tang, Y; Horikawa, I; Ajiro, M; Robles, AI; Fujita, K; Mondal, AM; Stauffer, JK; Zheng, ZM; Harris, CC				Tang, Y.; Horikawa, I.; Ajiro, M.; Robles, A. I.; Fujita, K.; Mondal, A. M.; Stauffer, J. K.; Zheng, Z-M; Harris, C. C.			Downregulation of splicing factor SRSF3 induces p53 beta, an alternatively spliced isoform of p53 that promotes cellular senescence	ONCOGENE			English	Article						SRSF3; p53; isoform; cellular senescence; alternative splicing	PRE-MESSENGER-RNA; SR PROTEIN-PHOSPHORYLATION; ONCOGENE-INDUCED SENESCENCE; FACTOR SRP20; EXPRESSION; GENE; SF2/ASF; BINDING; PLURIPOTENCY; REQUIRES	Most human pre-mRNA transcripts are alternatively spliced, but the significance and fine-tuning of alternative splicing in different biological processes is only starting to be understood. SRSF3 (SRp20) is a member of a highly conserved family of splicing factors that have critical roles in key biological processes, including tumor progression. Here, we show that SRSF3 regulates cellular senescence, a p53-mediated process to suppress tumorigenesis, through TP53 alternative splicing. Downregulation of SRSF3 was observed in normal human fibroblasts undergoing replicative senescence, and was associated with the upregulation of p53 beta, an alternatively spliced isoform of p53 that promotes p53-mediated senescence. Knockdown of SRSF3 by short interfering RNA ( siRNA) in early-passage fibroblasts induced senescence, which was associated with elevated expression of p53 beta at mRNA and protein levels. Knockdown of p53 partially rescued SRSF3-knockdown-induced senescence, suggesting that SRSF3 acts on p53-mediated cellular senescence. RNA pulldown assays demonstrated that SRSF3 binds to an alternatively spliced exon uniquely included in p53b mRNA through the consensus SRSF3-binding sequences. RNA crosslinking and immunoprecipitation assays ( CLIP) also showed that SRSF3 in vivo binds to endogenous p53 pre-mRNA at the region containing the p53 beta-unique exon. Splicing assays using a transfected TP53 minigene in combination with siRNA knockdown of SRSF3 showed that SRSF3 functions to inhibit the inclusion of the p53 beta-unique exon in splicing of p53 pre-mRNA. These data suggest that downregulation of SRSF3 represents an endogenous mechanism for cellular senescence that directly regulates the TP53 alternative splicing to generate p53 beta. This study uncovers the role for general splicing machinery in tumorigenesis, and suggests that SRSF3 is a direct regulator of p53.	[Tang, Y.; Horikawa, I.; Robles, A. I.; Fujita, K.; Mondal, A. M.; Harris, C. C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ajiro, M.; Zheng, Z-M] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stauffer, J. K.] NCI, Canc & Inflammat Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37,Room 3068,37 Convent Dr, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov	Tang, Yizhe/A-8682-2014	Tang, Yizhe/0000-0001-5354-478X; Zheng, Zhi-Ming/0000-0001-5547-7912; Robles, Ana/0000-0001-5019-4374	Intramural Research Program of the NIH; NCI; NATIONAL CANCER INSTITUTE [ZIABC011496, ZIASC010357, ZIABC005795] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, NCI. We thank the NIH Fellows Editorial Board for improving the readability of the manuscript.	Anko ML, 2010, NAT STRUCT MOL BIOL, V17, P962, DOI 10.1038/nsmb.1862; Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Aubol BE, 2011, BIOCHEMISTRY-US, V50, P6888, DOI 10.1021/bi2007993; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Celotto AM, 2001, GENETICS, V159, P599; Chen WY, 2001, GENE CHROMOSOME CANC, V32, P281, DOI 10.1002/gcc.1191; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ebrahimi M, 2008, ORAL ONCOL, V44, P156, DOI 10.1016/j.oraloncology.2007.01.014; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; Fujita K, 2010, NAT CELL BIOL, V12, P1205, DOI 10.1038/ncb2123; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Garcia-Alai MM, 2008, PROTEIN SCI, V17, P1671, DOI 10.1110/ps.036996.108; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; He X, 2011, ONCOGENE, V30, P356, DOI 10.1038/onc.2010.426; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jia R, 2010, INT J BIOL SCI, V6, P806; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jumaa H, 1997, MOL CELL BIOL, V17, P3116, DOI 10.1128/MCB.17.6.3116; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kang JG, 2011, J VIROL, V85, P2620, DOI 10.1128/JVI.02144-10; Kanj SS, 2006, VIROLOGY, V345, P280, DOI 10.1016/j.virol.2005.09.060; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Majerciak V, 2006, J BIOL CHEM, V281, P28365, DOI 10.1074/jbc.M603095200; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Olshavsky NA, 2010, CANCER RES, V70, P3975, DOI 10.1158/0008-5472.CAN-09-3468; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Rajan P, 2008, BIOCHEM SOC T, V36, P505, DOI 10.1042/BST0360505; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Sanford JR, 1999, GENE DEV, V13, P1513, DOI 10.1101/gad.13.12.1513; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaw SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000854; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; Tacke R, 1997, P NATL ACAD SCI USA, V94, P1148, DOI 10.1073/pnas.94.4.1148; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; WynfordThomas D, 1996, J PATHOL, V180, P118, DOI 10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO;2-I; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	75	99	101	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2792	2798		10.1038/onc.2012.288	http://dx.doi.org/10.1038/onc.2012.288			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22777358	Green Accepted			2022-12-25	WOS:000319808000010
J	Mizuno, N; Varkey, J; Kegulian, NC; Hegde, BG; Cheng, NQ; Langen, R; Steven, AC				Mizuno, Naoko; Varkey, Jobin; Kegulian, Natalie C.; Hegde, Balachandra G.; Cheng, Naiqian; Langen, Ralf; Steven, Alasdair C.			Remodeling of Lipid Vesicles into Cylindrical Micelles by alpha-Synuclein in an Extended alpha-Helical Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE STRUCTURES; NEURONAL DYSFUNCTION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BROKEN HELIX; BINDING; PROTEIN; CELLS; CURVATURE; PHOSPHATIDYLCHOLINE	alpha-Synuclein (alpha S) is a protein with multiple conformations and interactions. Natively unfolded in solution, alpha S accumulates as amyloid in neurological tissue in Parkinson disease and interacts with membranes under both physiological and pathological conditions. Here, we used cryoelectron microscopy in conjunction with electron paramagnetic resonance (EPR) and other techniques to characterize the ability of alpha S to remodel vesicles. At molar ratios of 1: 5 to 1: 40 for protein/lipid (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol), large spherical vesicles are converted into cylindrical micelles similar to 50 angstrom in diameter. Other lipids of the same charge (negative) exhibit generally similar behavior, although bilayer tubes of 150-500 angstrom in width are also produced, depending on the lipid acyl chains. At higher protein/lipid ratios, discoid particles, 70-100 angstrom across, are formed. EPR data show that, on cylindrical micelles, alpha S adopts an extended amphipathic alpha-helical conformation, with its long axis aligned with the tube axis. The observed geometrical relationship between alpha S and the micelle suggests that the wedging of its long alpha-helix into the outer leaflet of a membrane may cause curvature and an anisotropic partition of lipids, leading to tube formation.	[Mizuno, Naoko; Cheng, Naiqian; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Varkey, Jobin; Kegulian, Natalie C.; Hegde, Balachandra G.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Southern California	Mizuno, N (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	mizuno@biochem.mpg.de; langen@med.usc.edu; stevena@mail.nih.gov	Hegde, Balachandra/GPS-6028-2022; Mizuno, Naoko/AAY-1926-2021; Varkey, Jobin/I-5845-2019; Kegulian, Natalie/AFF-8981-2022	Mizuno, Naoko/0000-0002-1594-2821; Kegulian, Natalie/0000-0002-8574-1099	National Institutes of Health [2 R01 GM063915]; Intramural Research Program of NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 GM063915 (to R. L.) and the Intramural Research Program of NIAMS.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Dickey A, 2008, BIOPHYS J, V95, P2636, DOI 10.1529/biophysj.107.128074; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; EDWARDS K, 1993, J COLLOID INTERF SCI, V161, P299, DOI 10.1006/jcis.1993.1470; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Kanazawa T, 2012, BRAIN PATHOL, V22, P67, DOI 10.1111/j.1750-3639.2011.00509.x; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lewy F.H., 2017, HDB NEUROLOGIE, V3, P920; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rieker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024834; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SHIBAYAMAIMAZU T, 1993, BRAIN RES, V622, P17, DOI 10.1016/0006-8993(93)90796-P; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	71	85	85	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29301	29311		10.1074/jbc.M112.365817	http://dx.doi.org/10.1074/jbc.M112.365817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767608	hybrid, Green Published			2022-12-25	WOS:000308286900010
J	Monteferrante, CG; Miethke, M; van der Ploeg, R; Glasner, C; van Dijl, JM				Monteferrante, Carmine G.; Miethke, Marcus; van der Ploeg, Rene; Glasner, Corinna; van Dijl, Jan Maarten			Specific Targeting of the Metallophosphoesterase YkuE to the Bacillus Cell Wall Requires the Twin-arginine Translocation System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CYTOPLASMIC MEMBRANE; SUBTILIS TAT PATHWAY; PROTEIN SECRETION; ESCHERICHIA-COLI; SIGNAL PEPTIDES; ALKALINE-PHOSPHATASE; STREPTOCOCCUS-PNEUMONIAE; STREPTOMYCES-COELICOLOR; FOLDED PROTEINS; EXPORT PATHWAY	The twin-arginine translocation (Tat) pathway is dedicated to the transport of fully folded proteins across the cytoplasmic membranes of many bacteria and the chloroplast thylakoidal membrane. Accordingly, Tat-dependently translocated proteins are known to be delivered to the periplasm of Gram-negative bacteria, the growth medium of Gram-positive bacteria, and the thylakoid lumen. Here, we present the first example of a protein, YkuE of Bacillus subtilis, that is specifically targeted by the Tat pathway to the cell wall of a Gram-positive bacterium. The cell wall binding of YkuE is facilitated by electrostatic interactions. Interestingly, under particular conditions, YkuE can also be targeted to the cell wall in a Tat-independent manner. The biological function of YkuE was so far unknown. Our present studies show that YkuE is a metal-dependent phosphoesterase that preferentially binds manganese and zinc.	[Monteferrante, Carmine G.; van der Ploeg, Rene; Glasner, Corinna; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [Monteferrante, Carmine G.; van der Ploeg, Rene; Glasner, Corinna; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Miethke, Marcus] Univ Marburg, Dept Chem Biochem, D-35032 Marburg, Germany	University of Groningen; University of Groningen; Philipps University Marburg	van Dijl, JM (corresponding author), Univ Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	j.m.van.dijl01@umcg.nl	van Dijl, Jan Maarten/G-1205-2013	van der Ploeg, Rene/0000-0003-2490-9262	Commission of the European Union [LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469, PITN-GA-2008-215524, PITN-GA-2008-244093]; Transnational SysMO Initiative Projects BACELL SysMO1 and -2 through the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research; LOEWE Center for Synthetic Microbiology (Synmikro), Germany	Commission of the European Union(European Commission); Transnational SysMO Initiative Projects BACELL SysMO1 and -2 through the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research; LOEWE Center for Synthetic Microbiology (Synmikro), Germany	This work was supported in part by Commission of the European Union Projects LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469, PITN-GA-2008-215524, and -244093 and Transnational SysMO Initiative Projects BACELL SysMO1 and -2 through the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (to C. G. M., R. v. d. P., C. G., and J. M. v. D.).; Supported by the LOEWE Center for Synthetic Microbiology (Synmikro), Germany.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Albrecht AG, 2011, CHEMBIOCHEM, V12, P2052, DOI 10.1002/cbic.201100190; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Antelmann H, 2002, PROTEOMICS, V2, P591, DOI 10.1002/1615-9861(200205)2:5<591::AID-PROT591>3.0.CO;2-8; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eickhorst T, 2004, J CHROMATOGR A, V1050, P103, DOI 10.1016/j.chroma.2004.04.084; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; GASSON MJ, 1983, J BACTERIOL, V154, P1; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; HATEFI Y, 1969, P NATL ACAD SCI USA, V62, P1129, DOI 10.1073/pnas.62.4.1129; HULL WE, 1976, BIOCHEMISTRY-US, V15, P1547, DOI 10.1021/bi00652a028; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Joshi MV, 2010, MOL MICROBIOL, V77, P252, DOI 10.1111/j.1365-2958.2010.07206.x; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Li HM, 2005, MICROBIOL-SGM, V151, P2189, DOI 10.1099/mic.0.27893-0; Muller JP, 1997, MICROBIOL-SGM, V143, P947, DOI 10.1099/00221287-143-3-947; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; Novak R, 2000, MOL MICROBIOL, V36, P1504, DOI 10.1046/j.1365-2958.2000.01959.x; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Sambrook J., 2002, MOL CLONING LAB MANU; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Taylor PD, 2006, BIOINFORMATION, V1, P184, DOI 10.6026/97320630001184; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; van Dijl JM, 2012, J BACTERIOL, V194, P2779, DOI 10.1128/JB.00270-12; van Dijl JM, 2002, J BIOTECHNOL, V98, P243, DOI 10.1016/S0168-1656(02)00135-9; Vavrova L, 2010, RES MICROBIOL, V161, P791, DOI 10.1016/j.resmic.2010.09.004; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Widdick DA, 2008, J MOL BIOL, V375, P595, DOI 10.1016/j.jmb.2007.11.002; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Zweers JC, 2009, APPL ENVIRON MICROB, V75, P7356, DOI 10.1128/AEM.01560-09	70	19	22	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29789	29800		10.1074/jbc.M112.378190	http://dx.doi.org/10.1074/jbc.M112.378190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767609	Green Published, hybrid			2022-12-25	WOS:000308286900054
J	Barrio, MM; Abes, R; Colombo, M; Pizzurro, G; Boix, C; Roberti, MP; Gelize, E; Rodriguez-Zubieta, M; Mordoh, J; Teillaud, JL				Marcela Barrio, Maria; Abes, Riad; Colombo, Marina; Pizzurro, Gabriela; Boix, Charlotte; Paula Roberti, Maria; Gelize, Emmanuelle; Rodriguez-Zubieta, Mariana; Mordoh, Jose; Teillaud, Jean-Luc			Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8(+) T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells	PLOS ONE			English	Article							HUMAN TUMOR-ANTIGEN; CROSS-PRESENTATION; IN-VIVO; APOPTOTIC CELLS; METASTATIC MELANOMA; HLA-A2 MELANOMAS; B16 MELANOMA; PHASE-II; LYMPHOCYTES; VACCINATION	Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have previously used gamma-irradiated MART-1 expressing melanoma cells as a source of antigens to vaccinate melanoma patients by injecting irradiated cells with BCG and GM-CSF or to load immature DC and use them as a vaccine. Other clinical trials have used IFN-gamma activated macrophage killer cells (MAK) to treat cancer patients. However, the clinical use of MAK has been based on their direct tumoricidal activity rather than on their ability to act as antigen-presenting cells to stimulate an adaptive antitumor response. Thus, in the present work, we compared the fate of MART-1 after phagocytosis of gamma-irradiated cells by clinical grade DC or MAK as well as the ability of these cells to cross present MART-1 to CD8(+) T cells. Using a high affinity antibody against MART-1, 2A9, which specifically stains melanoma tumors, melanoma cell lines and normal melanocytes, the expression level of MART-1 in melanoma cell lines could be related to their ability to stimulate IFN-gamma production by a MART-1 specific HLA-A*0201-restricted CD8(+) T cell clone. Confocal microscopy with Alexa Fluor (R) 647-labelled 2A9 also showed that MART-1 could be detected in tumor cells attached and/or fused to phagocytes and even inside these cells as early as 1 h and up to 24 h or 48 h after initiation of co-cultures between gamma-irradiated melanoma cells and MAK or DC, respectively. Interestingly, MART-1 was cross-presented to MART-1 specific T cells by both MAK and DC co-cultured with melanoma gamma-irradiated cells for different time-points. Thus, naturally occurring MART-1 melanoma antigen can be taken-up from dying melanoma cells into DC or MAK and both cell types can induce specific CD8(+) T cell cross-presentation thereafter.	[Marcela Barrio, Maria; Pizzurro, Gabriela; Paula Roberti, Maria; Mordoh, Jose] Fdn Canc FUCA, Ctr Invest Oncol, Buenos Aires, DF, Argentina; [Abes, Riad; Boix, Charlotte; Gelize, Emmanuelle; Teillaud, Jean-Luc] INSERM, UMR S 872, Paris, France; [Abes, Riad; Boix, Charlotte; Gelize, Emmanuelle; Teillaud, Jean-Luc] Univ Paris 06, UMR S 872, Ctr Rech Cordeliers, Paris, France; [Abes, Riad; Boix, Charlotte; Gelize, Emmanuelle; Teillaud, Jean-Luc] Univ Paris 05, UMR S 872, Paris, France; [Colombo, Marina; Rodriguez-Zubieta, Mariana; Mordoh, Jose] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Inst Invest Bioquim Buenos Aires, RA-1033 Buenos Aires, DF, Argentina	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Barrio, MM (corresponding author), Fdn Canc FUCA, Ctr Invest Oncol, Buenos Aires, DF, Argentina.	jean-luc.teillaud@crc.jussieu.fr		Teillaud, Jean-Luc/0000-0003-4442-9565	INSERM (INSERM - Institut National de la Sante et de la Recherche Medicale (France)), Paris Descartes; UPMC (Universite Pierre et Marie Curie) universities; Evaluation-orientation de la Cooperation Scientifique Sud (ECOS Sud)/Secretaria de Promocion Cientifica y Tecnologica (SEPCyT) exchange program from Argentine SEPCyT [A03S03]; French Ministere des Affaires Etrangeres; INSERM/Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) exchange program; CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Fundacion Sales; Fundacion Cancer (FUCA); Fundacion Pedro F. Mosoteguy; Fundacion Maria Calderon de la Barca, Argentina; Laboratoire Francais du Fractionnement et des Biotechnologies (LFB)-Agence Nationale de la Recherche et de la Technologie (ANRT) (Conventions Industrielles de Formation par la Recherche (CIFRE) fellowship [173/2006]; Pole de Competitivite Meditech Sante, Ile-de-France (Immucan project)	INSERM (INSERM - Institut National de la Sante et de la Recherche Medicale (France)), Paris Descartes; UPMC (Universite Pierre et Marie Curie) universities; Evaluation-orientation de la Cooperation Scientifique Sud (ECOS Sud)/Secretaria de Promocion Cientifica y Tecnologica (SEPCyT) exchange program from Argentine SEPCyT; French Ministere des Affaires Etrangeres; INSERM/Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) exchange program; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Fundacion Sales; Fundacion Cancer (FUCA); Fundacion Pedro F. Mosoteguy; Fundacion Maria Calderon de la Barca, Argentina; Laboratoire Francais du Fractionnement et des Biotechnologies (LFB)-Agence Nationale de la Recherche et de la Technologie (ANRT) (Conventions Industrielles de Formation par la Recherche (CIFRE) fellowship; Pole de Competitivite Meditech Sante, Ile-de-France (Immucan project)	This work was supported by INSERM (INSERM - Institut National de la Sante et de la Recherche Medicale (France)), Paris Descartes and UPMC (Universite Pierre et Marie Curie) universities, by an Evaluation-orientation de la Cooperation Scientifique Sud (ECOS Sud)/Secretaria de Promocion Cientifica y Tecnologica (SEPCyT) exchange program grant (A03S03) from the Argentine SEPCyT and the French Ministere des Affaires Etrangeres, by a grant from an INSERM/Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) exchange program and by grants from the CONICET, the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), the Fundacion Sales, the Fundacion Cancer (FUCA), the Fundacion Pedro F. Mosoteguy and the Fundacion Maria Calderon de la Barca, Argentina. JM and MMB are members of CONICET, and MPR is a fellow of the same Institution. GP is a fellow from the ANPCyT. MC and MRZ were supported by fellowships from CONICET. JLT and EG are members of INSERM. RA was supported by Laboratoire Francais du Fractionnement et des Biotechnologies (LFB)-Agence Nationale de la Recherche et de la Technologie (ANRT) (Conventions Industrielles de Formation par la Recherche (CIFRE) fellowship # 173/2006. CB was supported by a grant from the Pole de Competitivite Meditech Sante, Ile-de-France (Immucan project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2000, NAT REV IMMUNOL, V1, P387; Baron-Bodo W, 2005, IMMUNOBIOLOGY, V210, P267, DOI 10.1016/j.imbio.2005.05.021; Barrio MM, 2006, J IMMUNOTHER, V29, P444, DOI 10.1097/01.cji.0000208258.79005.5f; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; BOVER L, 1991, BREAST CANCER RES TR, V19, P47, DOI 10.1007/BF01975204; Boyer A, 1999, EXP HEMATOL, V27, P751, DOI 10.1016/S0301-472X(98)00070-8; Brayer J, 2010, IMMUNOL LETT, V131, P126, DOI 10.1016/j.imlet.2010.03.004; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Brusa D, 2008, VACCINE, V26, P6422, DOI 10.1016/j.vaccine.2008.08.063; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; De Maziere AM, 2002, TRAFFIC, V3, P678, DOI 10.1034/j.1600-0854.2002.30909.x; Gaipl US, 2003, IMMUNOBIOLOGY, V207, P73, DOI 10.1078/0171-2985-00217; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; GUERRA L, 1989, PIGM CELL RES, V2, P504, DOI 10.1111/j.1600-0749.1989.tb00246.x; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Lesterhuis WJ, 2011, CANCER IMMUNOL IMMUN, V60, P249, DOI 10.1007/s00262-010-0942-x; Mac Keon S, 2010, VACCINE, V28, P8162, DOI 10.1016/j.vaccine.2010.09.095; Moehler MH, 2005, HUM GENE THER, V16, P996, DOI 10.1089/hum.2005.16.996; Monnet I, 2002, CHEST, V121, P1921, DOI 10.1378/chest.121.6.1921; Mordoh J, 1997, MEDICINA-BUENOS AIRE, V57, P421; Motta I, 2001, J IMMUNOL, V167, P1795, DOI 10.4049/jimmunol.167.3.1795; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Olazabal IM, 2008, MOL BIOL CELL, V19, P701, DOI 10.1091/mbc.E07-07-0650; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slingluff CL, 2008, J CLIN ONCOL, V26, P4973, DOI 10.1200/JCO.2008.17.3161; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Speiser DE, 2004, J IMMUNOTHER, V27, P298, DOI 10.1097/00002371-200407000-00006; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Thiounn N, 2002, J UROLOGY, V168, P2373, DOI 10.1016/S0022-5347(05)64148-1; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vely F, 1997, HYBRIDOMA, V16, P519, DOI 10.1089/hyb.1997.16.519; Vingert B, 2006, EUR J IMMUNOL, V36, P1124, DOI 10.1002/eji.200535443; Von Euw EM, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-6; von Euw EM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-19; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; Yee C, 1999, J IMMUNOL, V162, P2227	53	40	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40311	10.1371/journal.pone.0040311	http://dx.doi.org/10.1371/journal.pone.0040311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768350	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500063
J	Berkman, ET; Falk, EB; Lieberman, MD				Berkman, Elliot T.; Falk, Emily B.; Lieberman, Matthew D.			Interactive Effects of Three Core Goal Pursuit Processes on Brain Control Systems: Goal Maintenance, Performance Monitoring, and Response Inhibition	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL GYRUS; PREFRONTAL CORTEX; COGNITIVE CONTROL; NEURAL BASIS; COMMON; TASKS; FMRI; REPRESENTATION; METAANALYSIS	Goal attainment relies in part on one's ability to maintain a cognitive representation of the desired goal (goal maintenance), monitor the current state vis-a-vis the targeted end state and remain vigilant for lapses in progress (performance monitoring), and inhibit counter-goal behaviors (response inhibition). Because neurocognitive studies have typically examined these three processes in isolation from one another, little is known regarding if and how they interact during goal pursuit. However, these processes frequently co-occur during online, real-world goal pursuit. The present study employed a novel task to investigate how goal maintenance, performance monitoring, and response inhibition interact with one another. We identified functional activations distinct to each of the processes that correspond to results of prior investigations. In addition, we report interactive effects between response inhibition and goal maintenance in the dorsal anterior cingulate cortex and between performance monitoring and goal maintenance in the superior frontal gyrus and supramarginal gyrus. Implications for studying the neural systems of in situ goals include the need for both experimental designs that distinguish between process, but also more complex, realistic tasks to begin to map interactions among these neurocognitive processes and how they are altered by the presence or absence of one another.	[Berkman, Elliot T.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Falk, Emily B.] Univ Michigan, Dept Commun Studies, Inst Social Res, Ann Arbor, MI USA; [Falk, Emily B.] Univ Michigan, Dept Psychol, Inst Social Res, Ann Arbor, MI USA; [Lieberman, Matthew D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of Oregon; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles	Berkman, ET (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	berkman@uoregon.edu	Berkman, Elliot T./Q-5233-2016; Lieberman, Matthew/ABD-8197-2020	Berkman, Elliot T./0000-0002-7113-5792; Lieberman, Matthew/0000-0002-4447-7359	National Institutes of Health [F31DA 024904-01]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for this work was provided by the National Institutes of Health to ETB (F31DA 024904-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonovich E, 2003, DRUG ALCOHOL DEPEN, V71, P207, DOI 10.1016/S0376-8716(03)00092-9; Aron AR, 2008, CURR DIR PSYCHOL SCI, V17, P124, DOI 10.1111/j.1467-8721.2008.00561.x; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Baker SC, 1996, CEREB CORTEX, V6, P612, DOI 10.1093/cercor/6.4.612; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Berkman E. T., 2009, PSYCHOL GOALS, P98; Berkman ET, 2011, PSYCHOL SCI, V22, P498, DOI 10.1177/0956797611400918; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown SM, 2006, EMOTION, V6, P239, DOI 10.1037/1528-3542.6.2.239; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Dikman ZV, 2000, PSYCHOPHYSIOLOGY, V37, P43, DOI 10.1017/S0048577200980983; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Herd SA, 2006, J COGNITIVE NEUROSCI, V18, P22, DOI 10.1162/089892906775250012; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD C, 1991, BEHAV RES THER, V29, P599, DOI 10.1016/0005-7967(91)90009-R; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muraven M, 2010, J EXP SOC PSYCHOL, V46, P465, DOI 10.1016/j.jesp.2009.12.011; Oettingen G, 2001, J PERS SOC PSYCHOL, V80, P736, DOI 10.1037//0022-3514.80.5.736; Oettingen G., 2000, INT J EDUC RES, V33, P705, DOI [10.1016/S0883-0355(00)00046-X, DOI 10.1016/S0883-0355(00)00046-X]; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pham LB, 1999, PERS SOC PSYCHOL B, V25, P250, DOI 10.1177/0146167299025002010; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Shulman GL, 2007, CEREB CORTEX, V17, P2625, DOI 10.1093/cercor/bhl170; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stroop JR, 1935, AM J PSYCHOL, V47, P499, DOI 10.2307/1416349; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Venkatraman V, 2009, J NEUROSCI, V29, P13158, DOI 10.1523/JNEUROSCI.2708-09.2009; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220; ZIMMERMAN BJ, 1992, AM EDUC RES J, V29, P663, DOI 10.2307/1163261	55	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40334	10.1371/journal.pone.0040334	http://dx.doi.org/10.1371/journal.pone.0040334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768277	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100251
J	Delucchi, F; Berni, R; Frati, C; Cavalli, S; Graiani, G; Sala, R; Chaponnier, C; Gabbiani, G; Calani, L; Del Rio, D; Bocchi, L; Lagrasta, C; Quaini, F; Stilli, D				Delucchi, Francesca; Berni, Roberta; Frati, Caterina; Cavalli, Stefano; Graiani, Gallia; Sala, Roberto; Chaponnier, Christine; Gabbiani, Giulio; Calani, Luca; Del Rio, Daniele; Bocchi, Leonardo; Lagrasta, Costanza; Quaini, Federico; Stilli, Donatella			Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats	PLOS ONE			English	Article							ALPHA-SKELETAL ACTIN; OXIDATIVE STRESS; STEM-CELLS; MOLECULAR-MECHANISMS; RED WINE; VASCULAR INJURY; PROTEIN; HEART; EXPRESSION; CARDIOMYOPATHY	Emerging evidence suggests that both adult cardiac cell and the cardiac stem/progenitor cell (CSPC) compartments are involved in the patho-physiology of diabetic cardiomyopathy (DCM). We evaluated whether early administration of Resveratrol, a natural antioxidant polyphenolic compound, in addition to improving cardiomyocyte function, exerts a protective role on (i) the progenitor cell pool, and (ii) the myocardial environment and its impact on CSPCs, positively interfering with the onset of DCM phenotype. Adult Wistar rats (n = 128) with streptozotocin-induced type-1 diabetes were either untreated (D group; n = 54) or subjected to administration of trans-Resveratrol (i. p. injection: 2.5 mg/Kg/day; DR group; n = 64). Twenty-five rats constituted the control group (C). After 1, 3 or 8 weeks of hyperglycemia, we evaluated cardiac hemodynamic performance, and cardiomyocyte contractile properties and intracellular calcium dynamics. Myocardial remodeling and tissue inflammation were also assessed by morphometry, immunohistochemistry and immunoblotting. Eventually, the impact of the diabetic "milieu" on CSPC turnover was analyzed in co-cultures of healthy CSPCs and cardiomyocytes isolated from D and DR diabetic hearts. In untreated animals, cardiac function was maintained during the first 3 weeks of hyperglycemia, although a definite ventricular remodeling was already present, mainly characterized by a marked loss of CSPCs and adult cardiac cells. Relevant signs of ventricular dysfunction appeared after 8 weeks of diabetes, and included: 1) a significant reduction in +/- dP/dt in comparison with C group, 2) a prolongation of isovolumic contraction/relaxation times, 3) an impaired contraction of isolated cardiomyocytes associated with altered intracellular calcium dynamics. Resveratrol administration reduced atrial CSPC loss, succeeded in preserving the functional abilities of CSPCs and mature cardiac cells, improved cardiac environment by reducing inflammatory state and decreased unfavorable ventricular remodeling of the diabetic heart, leading to a marked recovery of ventricular function. These findings indicate that RSV can constitute an adjuvant therapeutic option in DCM prevention.	[Delucchi, Francesca; Berni, Roberta; Bocchi, Leonardo; Stilli, Donatella] Univ Parma, Dipartimento Biol Evolutiva & Funz, I-43100 Parma, Italy; [Frati, Caterina; Cavalli, Stefano; Graiani, Gallia; Lagrasta, Costanza] Univ Parma, Dipartimento Patol & Med Lab, I-43100 Parma, Italy; [Sala, Roberto] Univ Parma, Dipartimento Med Sperimentale, I-43100 Parma, Italy; [Chaponnier, Christine; Gabbiani, Giulio] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Calani, Luca; Del Rio, Daniele] Univ Parma, Dipartimento Sanita Pubbl, I-43100 Parma, Italy; [Quaini, Federico] Univ Parma, Dipartimento Med Interna & Sci Biomed, I-43100 Parma, Italy; [Lagrasta, Costanza; Quaini, Federico; Stilli, Donatella] Univ Parma, Ctr Interdipartimentale Cellule Staminali Cardiac, I-43100 Parma, Italy	University of Parma; University of Parma; University of Parma; University of Geneva; University of Parma; University of Parma; University of Parma	Delucchi, F (corresponding author), Univ Parma, Dipartimento Biol Evolutiva & Funz, I-43100 Parma, Italy.	donatella.stilli@unipr.it	Stilli, Donatella/M-5630-2018; Sala, Roberto/B-9736-2013; Del Rio, Daniele/E-8696-2010	Sala, Roberto/0000-0002-9167-0020; Del Rio, Daniele/0000-0001-5394-1259; Quaini, Federico/0000-0003-2377-4810; BOCCHI, Leonardo/0000-0003-4799-2804; Frati, Caterina/0000-0002-3343-6471; Graiani, Gallia/0000-0003-1926-7568	Italian Ministry of Education, University and Research; European Commission CORDIS; Italian Ministry of Health "Regenerative Medicine THEAPLL"; Swiss National Science Foundation (SNSF) [310030_125320]; Fondazione Cassa di Risparmio di Parma; National Institute for Cardiovascular Research (INRC);  [NMP-214539 2007]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission CORDIS; Italian Ministry of Health "Regenerative Medicine THEAPLL"; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Fondazione Cassa di Risparmio di Parma(Fondazione Cariparma); National Institute for Cardiovascular Research (INRC); 	This study was supported by the following grants: Italian Ministry of Education, University and Research PRIN2007, European Commission CORDIS FP7-BIOSCENT, NMP-214539 2007, Italian Ministry of Health "Regenerative Medicine 2007 THEAPLL", Swiss National Science Foundation (SNSF) grant #310030_125320 (CC), funding by "Fondazione Cassa di Risparmio di Parma" and from the National Institute for Cardiovascular Research (INRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero M, 2011, DIABETOLOGIA, V54, P945, DOI 10.1007/s00125-010-2007-2; Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Balestrieri ML, 2008, J BIOCHEM, V143, P179, DOI 10.1093/jb/mvm209; Balestrieri ML, 2008, BBA-PROTEINS PROTEOM, V1784, P936, DOI 10.1016/j.bbapap.2008.03.004; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Cohen BH, 2001, EXPLAINING PSYCHOLOG, P324; Das M, 2010, MOL ASPECTS MED, V31, P503, DOI 10.1016/j.mam.2010.09.001; DODGE HT, 1969, AM J CARDIOL, V23, P528, DOI 10.1016/0002-9149(69)90006-X; Driesen RB, 2009, J CELL MOL MED, V13, P896, DOI 10.1111/j.1582-4934.2008.00523.x; Dudley J, 2009, J NUTR BIOCHEM, V20, P443, DOI 10.1016/j.jnutbio.2008.05.003; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gurusamy N, 2010, J CELL MOL MED, V14, P2235, DOI 10.1111/j.1582-4934.2010.01140.x; HEWETT TE, 1994, CIRC RES, V74, P740, DOI 10.1161/01.RES.74.4.740; Jian BX, 2012, MOL MED, V18, P209, DOI 10.2119/molmed.2011.00365; Khullar M, 2010, CAN J PHYSIOL PHARM, V88, P233, DOI 10.1139/Y10-016; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Lin JF, 2008, LIFE SCI, V83, P313, DOI 10.1016/j.lfs.2008.06.016; Lu NH, 2010, FREE RADICAL BIO MED, V48, P873, DOI 10.1016/j.freeradbiomed.2010.01.010; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Madonna R, 2011, VASC PHARMACOL, V54, P75, DOI 10.1016/j.vph.2011.03.007; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; MYRENG Y, 1990, CIRCULATION, V81, P260, DOI 10.1161/01.CIR.81.1.260; Orlandi A, 2010, BASIC RES CARDIOL, V105, P703, DOI 10.1007/s00395-010-0109-0; Palsamy P, 2009, CHEM-BIOL INTERACT, V179, P356, DOI 10.1016/j.cbi.2008.11.008; Park DW, 2009, EXP MOL MED, V41, P171, DOI 10.3858/emm.2009.41.3.020; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Picchi A, 2010, WORLD J CARDIOL, V2, P377, DOI 10.4330/wjc.v2.i11.377; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Stilli D, 2007, BASIC RES CARDIOL, V102, P488, DOI 10.1007/s00395-007-0665-0; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Volz HC, 2010, BASIC RES CARDIOL, V105, P805, DOI 10.1007/s00395-010-0114-3; Westermann D, 2007, DIABETES, V56, P1834, DOI 10.2337/db06-1662; Yar AS, 2010, MOL BIOL REP, V37, P2323, DOI 10.1007/s11033-009-9737-6; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Yu W, 2009, J CELL BIOCHEM, V107, P741, DOI 10.1002/jcb.22169; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; Zhang HR, 2010, AM J PHYSIOL-HEART C, V299, pH985, DOI 10.1152/ajpheart.00489.2010	55	56	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39836	10.1371/journal.pone.0039836	http://dx.doi.org/10.1371/journal.pone.0039836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768138	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100108
J	Gramlich, HS; Reisbig, T; Schatz, DG				Gramlich, Hillary Selle; Reisbig, Tara; Schatz, David G.			AID-Targeting and Hypermutation of Non-Immunoglobulin Genes Does Not Correlate with Proximity to Immunoglobulin Genes in Germinal Center B Cells	PLOS ONE			English	Article							C-MYC ONCOGENE; HEAVY-CHAIN LOCUS; CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; BURKITT-LYMPHOMA; CHROMOSOMAL TRANSLOCATIONS; IN-VIVO; SEQUENCING REVEALS; KAPPA-GENE	Upon activation, B cells divide, form a germinal center, and express the activation induced deaminase (AID), an enzyme that triggers somatic hypermutation of the variable regions of immunoglobulin (Ig) loci. Recent evidence indicates that at least 25% of expressed genes in germinal center B cells are mutated or deaminated by AID. One of the most deaminated genes, c-Myc, frequently appears as a translocation partner with the Ig heavy chain gene (Igh) in mouse plasmacytomas and human Burkitt's lymphomas. This indicates that the two genes or their double-strand break ends come into close proximity at a biologically relevant frequency. However, the proximity of c-Myc and Igh has never been measured in germinal center B cells, where many such translocations are thought to occur. We hypothesized that in germinal center B cells, not only is c-Myc near Igh, but other mutating non-Ig genes are deaminated by AID because they are near Ig genes, the primary targets of AID. We tested this "collateral damage" model using 3D-fluorescence in situ hybridization (3D-FISH) to measure the distance from non-Ig genes to Ig genes in germinal center B cells. We also made mice transgenic for human MYC and measured expression and mutation of the transgenes. We found that there is no correlation between proximity to Ig genes and levels of AID targeting or gene mutation, and that c-Myc was not closer to Igh than were other non-Ig genes. In addition, the human MYC transgenes did not accumulate mutations and were not deaminated by AID. We conclude that proximity to Ig loci is unlikely to be a major determinant of AID targeting or mutation of non-Ig genes, and that the MYC transgenes are either missing important regulatory elements that allow mutation or are unable to mutate because their new nuclear position is not conducive to AID deamination.	[Gramlich, Hillary Selle] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Reisbig, Tara; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Schatz, David G.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Yale University; Howard Hughes Medical Institute	Gramlich, HS (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	Howard Hughes Medical Institute; National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF))	Funding sources were Howard Hughes Medical Institute: http://www.hhmi.org/ and National Science Foundation (predoctoral fellowship to HSG): http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Cario G, 2000, BRIT J HAEMATOL, V110, P537, DOI 10.1046/j.1365-2141.2000.02241.x; Carter RH, 2008, SEMIN IMMUNOL, V20, P43, DOI 10.1016/j.smim.2007.12.007; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chowdhury M, 2008, P NATL ACAD SCI USA, V105, P15872, DOI 10.1073/pnas.0808462105; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; DENNY CT, 1985, MOL CELL BIOL, V5, P3199, DOI 10.1128/MCB.5.11.3199; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gong H, 2009, BIOCHEM BIOPH RES CO, V383, P11, DOI 10.1016/j.bbrc.2009.03.122; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Hakim O, NATURE; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; HARTL P, 1987, MOL CELL BIOL, V7, P2037, DOI 10.1128/MCB.7.6.2037; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Inlay MA, 2006, J IMMUNOL, V177, P1146, DOI 10.4049/jimmunol.177.2.1146; Jeevan-Raj BP, J EXP MED, V208, P1649; KATO S, 1991, GENE, V97, P239; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; KLOBECK HG, 1987, NUCLEIC ACIDS RES, V15, P4877, DOI 10.1093/nar/15.12.4877; Kozubek S, 1997, BLOOD, V89, P4537, DOI 10.1182/blood.V89.12.4537; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; RAPPOLD GA, 1984, EMBO J, V3, P2951, DOI 10.1002/j.1460-2075.1984.tb02239.x; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Ronai D, 2005, P NATL ACAD SCI USA, V102, P11829, DOI 10.1073/pnas.0505449102; Roschke V, 1997, ONCOGENE, V14, P3011, DOI 10.1038/sj.onc.1201156; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; TumasBrundage KM, 1997, MOL IMMUNOL, V34, P367, DOI 10.1016/S0161-5890(97)00065-5; Upton DC, IMMUNOL RES, V49, P14; van der Stoep N, 1998, IMMUNITY, V8, P743, DOI 10.1016/S1074-7613(00)80579-8; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang LL, 2006, J EXP MED, V203, P215, DOI 10.1084/jem.20051774; Yamane A, NAT IMMUNOL, V12, P62; YELAMOS J, 1995, NATURE, V376, P225; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	82	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39601	10.1371/journal.pone.0039601	http://dx.doi.org/10.1371/journal.pone.0039601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768095	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100065
J	Kaitu'u-Lino, TJ; Palmer, K; Tuohey, L; Ye, L; Tong, S				Kaitu'u-Lino, Tu'uhevaha J.; Palmer, Kirsten; Tuohey, Laura; Ye, Louie; Tong, Stephen			MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin	PLOS ONE			English	Article							METALLOPROTEINASES MT-MMPS; MEMBRANE-TYPE 1; MATRIX METALLOPROTEINASES; HUMAN PLACENTA; EXPRESSION; MT1-MMP; IDENTIFICATION; INVASION; MT2-MMP; GENE	Preeclampsia is a major pregnancy complication, characterized by severe endothelial dysfunction, hypertension and maternal end-organ damage. Soluble endoglin is an anti-angiogenic protein released from placenta and thought to play a central role in causing the endothelial dysfunction and maternal organ injury seen in severe preeclampsia. We recently reported MMP-14 was the protease producing placentally-derived soluble endoglin by cleaving full-length endoglin present on the syncytiotrophoblast surface. This find identifies a specific drug target for severe preeclampsia; interfering with MMP-14 mediated cleavage of endoglin could decrease soluble endoglin production, ameliorating clinical disease. However, experimental MMP-14 inhibition alone only partially repressed soluble endoglin production, implying other proteases might have a role in producing soluble endoglin. Here we investigated whether MMP-15-phylogenetically the closest MMP relative to MMP-14 with 66% sequence similarity-also cleaves endoglin to produce soluble endoglin. MMP-15 was localized to the syncytiotrophoblast layer of the placenta, the same site where endoglin was localized. Interestingly, it was significantly (p = 0.03) up-regulated in placentas from severe early-onset preeclamptic pregnancies (n = 8) compared to gestationally matched preterm controls (n = 8). However, siRNA knockdown of MMP-15 yielded no significant decrease of soluble endoglin production from either HUVECs or syncytialised BeWo cells in vitro. Importantly, concurrent siRNA knockdown of both MMP-14 and MMP-15 in HUVECS did not yield further decrease in soluble endoglin production compared to MMP-14 siRNA alone. We conclude MMP-15 is up-regulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.	[Kaitu'u-Lino, Tu'uhevaha J.; Palmer, Kirsten; Tuohey, Laura; Ye, Louie; Tong, Stephen] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia	University of Melbourne	Kaitu'u-Lino, TJ (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia.	t.klino@unimelb.edu.au	Palmer, Kirsten/X-2299-2018	Tong, Stephen/0000-0002-2319-0586; Tuohey, Laura/0000-0002-4255-0196; Palmer, Kirsten/0000-0001-7421-6291; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737	Victorian Government; National Health and Medical Research Council of Australia [490970, 490995]	Victorian Government; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Victorian Government's Operational Infrastructure Support Program. The National Health and Medical Research Council of Australia provided salary support (#490970 to S.T.; #490995 to T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; BioGPS, 2012, GEN PORT SYST; Bjorn SF, 2000, PLACENTA, V21, P170, DOI 10.1053/plac.1999.0447; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; GOUGOS A, 1992, INT IMMUNOL, V4, P83, DOI 10.1093/intimm/4.1.83; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Kaitu'u-Lino TJ, 2012, AM J PATHOL IN PRESS; Lafleur MA, 2002, J CELL SCI, V115, P3427; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Myers JE, 2005, HYPERTENS PREGNANCY, V24, P103, DOI 10.1081/PRG-200059836; Nakada M, 1999, AM J PATHOL, V154, P417, DOI 10.1016/S0002-9440(10)65288-1; Ohnishi Y, 2001, EUR J DERMATOL, V11, P420; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sato H, 1997, THROMB HAEMOSTASIS, V78, P497; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Szabova L, 2010, BLOOD, V116, P5752, DOI 10.1182/blood-2009-10-249847; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Theret N, 1998, AM J PATHOL, V153, P945, DOI 10.1016/S0002-9440(10)65636-2; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429	25	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39864	10.1371/journal.pone.0039864	http://dx.doi.org/10.1371/journal.pone.0039864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768148	Green Published, gold			2022-12-25	WOS:000305892100117
J	Li, XK; Qi, WB; He, J; Ning, ZY; Hu, Y; Tian, J; Jiao, PR; Xu, CG; Chen, JX; Richt, J; Ma, WJ; Liao, M				Li, Xiaokang; Qi, Wenbao; He, Jun; Ning, Zhangyong; Hu, Yue; Tian, Jin; Jiao, Peirong; Xu, Chenggang; Chen, Jianxin; Richt, Juergen; Ma, Wenjun; Liao, Ming			Molecular Basis of Efficient Replication and Pathogenicity of H9N2 Avian Influenza Viruses in Mice	PLOS ONE			English	Article							A VIRUSES; HONG-KONG; GENETIC-CHARACTERIZATION; SOUTHEASTERN CHINA; CONTINUING EVOLUTION; HUMAN INFECTION; CELL TROPISM; AMINO-ACID; HOST-RANGE; POULTRY	H9N2 subtype avian influenza viruses (AIVs) have shown expanded host range and can infect mammals, such as humans and swine. To date the mechanisms of mammalian adaptation and interspecies transmission of H9N2 AIVs remain poorly understood. To explore the molecular basis determining mammalian adaptation of H9N2 AIVs, we compared two avian field H9N2 isolates in a mouse model: one (A/chicken/Guangdong/TS/2004, TS) is nonpathogenic, another one (A/chicken/Guangdong/V/2008, V) is lethal with efficient replication in mouse brains. In order to determine the basis of the differences in pathogenicity and brain tropism between these two viruses, recombinants with a single gene from the TS (or V) virus in the background of the V (or TS) virus were generated using reverse genetics and evaluated in a mouse model. The results showed that the PB2 gene is the major factor determining the virulence in the mouse model although other genes also have variable impacts on virus replication and pathogenicity. Further studies using PB2 chimeric viruses and mutated viruses with a single amino acid substitution at position 627 [glutamic acid (E) to lysine, (K)] in PB2 revealed that PB2 627K is critical for pathogenicity and viral replication of H9N2 viruses in mouse brains. All together, these results indicate that the PB2 gene and especially position 627 determine virus replication and pathogenicity in mice. This study provides insights into the molecular basis of mammalian adaptation and interspecies transmission of H9N2 AIVs.	[Li, Xiaokang; Qi, Wenbao; He, Jun; Ning, Zhangyong; Hu, Yue; Tian, Jin; Jiao, Peirong; Xu, Chenggang; Chen, Jianxin; Liao, Ming] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Richt, Juergen; Ma, Wenjun] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Li, Xiaokang] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Peoples R China	South China Agricultural University; Kansas State University; Henan University of Science & Technology	Li, XK (corresponding author), S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	wma@vet.k-state.edu; mliao@scau.edu.cn	Jiao, Peirong/R-3060-2019; Xu, Cheng/GXH-4815-2022; Richt, Juergen/AAL-3632-2020	Jiao, Peirong/0000-0001-7750-239X; Xu, Cheng/0000-0003-1000-733X; 	National Science Foundation of China [81001375]; Program for National Broiler Industry [nycytx-42-G3-03]; Natural Science Foundation of Guangdong Province [10251064201000004]; Science and Technology Projects of Guangdong Province [20100206]; National Key Technology R&D Program in the 11th Five-Year Plan [2006BAD06A16]; CEEZAD program of the Department of Homeland Security [2010-ST-061-AG0001-02]; Kansas State University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for National Broiler Industry; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province; National Key Technology R&D Program in the 11th Five-Year Plan(National Key Technology R&D Program); CEEZAD program of the Department of Homeland Security(United States Department of Homeland Security (DHS)); Kansas State University	This work was partially supported by the National Science Foundation of China (No. 81001375), Program for National Broiler Industry (nycytx-42-G3-03), Natural Science Foundation of Guangdong Province (No. 10251064201000004), Science and Technology Projects of Guangdong Province (No. 20100206), National Key Technology R&D Program in the 11th Five-Year Plan(2006BAD06A16), CEEZAD program of the Department of Homeland Security, under the cooperative Agreement number 2010-ST-061-AG0001-02 and start-up fund (SRO#001) from Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER P, 2009, CAN J INFECT DIS MED, V20, P35; Amonsin A, 2006, VIROLOGY, V344, P480, DOI 10.1016/j.virol.2005.08.032; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Cong YL, 2008, VIRUS GENES, V36, P461, DOI 10.1007/s11262-008-0227-z; Dong G, 2010, PLOS ONE, V6; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kim JA, 2006, VET MICROBIOL, V118, P169, DOI 10.1016/j.vetmic.2006.07.007; Lee YJ, 2007, VIROLOGY, V359, P313, DOI 10.1016/j.virol.2006.09.025; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2003, AVIAN DIS, V47, P828, DOI 10.1637/0005-2086-47.s3.828; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Yu H, 2011, VET MICROBIOL, V149, P254, DOI 10.1016/j.vetmic.2010.11.008	42	38	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40118	10.1371/journal.pone.0040118	http://dx.doi.org/10.1371/journal.pone.0040118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768236	gold, Green Published			2022-12-25	WOS:000305892100208
J	Naatsaari, L; Mistlberger, B; Ruth, C; Hajek, T; Hartner, FS; Glieder, A				Naeaetsaari, Laura; Mistlberger, Beate; Ruth, Claudia; Hajek, Tanja; Hartner, Franz S.; Glieder, Anton			Deletion of the Pichia pastoris KU70 Homologue Facilitates Platform Strain Generation for Gene Expression and Synthetic Biology	PLOS ONE			English	Article							YEAST PICHIA-PASTORIS; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; BREAK REPAIR; RECOMBINANT PROTEINS; V(D)J RECOMBINATION; TARGETING SYSTEM; GENOME SEQUENCE; KU PROTEIN; TRANSFORMATION	Targeted gene replacement to generate knock-outs and knock-ins is a commonly used method to study the function of unknown genes. In the methylotrophic yeast Pichia pastoris, the importance of specific gene targeting has increased since the genome sequencing projects of the most commonly used strains have been accomplished, but rapid progress in the field has been impeded by inefficient mechanisms for accurate integration. To improve gene targeting efficiency in P. pastoris, we identified and deleted the P. pastoris KU70 homologue. We observed a substantial increase in the targeting efficiency using the two commonly known and used integration loci HIS4 and ADE1, reaching over 90% targeting efficiencies with only 250-bp flanking homologous DNA. Although the ku70 deletion strain was noted to be more sensitive to UV rays than the corresponding wild-type strain, no lethality, severe growth retardation or loss of gene copy numbers could be detected during repetitive rounds of cultivation and induction of heterologous protein production. Furthermore, we demonstrated the use of the ku70 deletion strain for fast and simple screening of genes in the search of new auxotrophic markers by targeting dihydroxyacetone synthase and glycerol kinase genes. Precise knock-out strains for the well-known P. pastoris AOX1, ARG4 and HIS4 genes and a whole series of expression vectors were generated based on the wild-type platform strain, providing a broad spectrum of precise tools for both intracellular and secreted production of heterologous proteins utilizing various selection markers and integration strategies for targeted or random integration of single and multiple genes. The simplicity of targeted integration in the ku70 deletion strain will further support protein production strain generation and synthetic biology using P. pastoris strains as platform hosts.	[Naeaetsaari, Laura; Ruth, Claudia; Hajek, Tanja; Hartner, Franz S.; Glieder, Anton] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria; [Mistlberger, Beate; Ruth, Claudia; Hajek, Tanja; Hartner, Franz S.; Glieder, Anton] Austrian Ctr Ind Biotechnol ACIB GmbH, Graz, Austria	Graz University of Technology; Austrian Centre of Industrial Biotechnology	Naatsaari, L (corresponding author), Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria.	glieder@glieder.com		glieder, anton/0000-0002-5986-9689	Austrian Science Fund "Fonds zur Forderung der wissenschaftlichen Forschung" [W901]; VTU Technology GmbH; Fonds zur Forderung der wissenschaftlichen Forschung; VTU Technology; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund "Fonds zur Forderung der wissenschaftlichen Forschung"(Austrian Science Fund (FWF)); VTU Technology GmbH; Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); VTU Technology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund "Fonds zur Forderung der wissenschaftlichen Forschung" [W901 DK Molecular Enzymology] and VTU Technology GmbH. Funding for the open access charge: Fonds zur Forderung der wissenschaftlichen Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: Construction of plasmid vectors and Pichia auxotrophy strains was co-financed by VTU Technology. VTU Technology is one of many international groups employing the described strains and vectors in their labs and all described strains and materials are available from Graz University of Technology for a modest fee covering costs for production and distribution of the materials. Some of the vectors are distributed by DNA2.0 as vector backbones with synthetic genes cloned into these expression plasmids which were designed for general FTO. However, there was no financial support by DNA2.0 in any means to the development of the described strains and vectors. There is no dependency from DNA2.0. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abad S, 2010, BIOTECHNOL J, V5, P413, DOI 10.1002/biot.200900233; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Clikeman JA, 2001, GENETICS, V157, P579; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; FELDMANN H, 1993, J BIOL CHEM, V268, P12895; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gravel S, 2002, MOL CELL BIOL, V22, P2182, DOI 10.1128/MCB.22.7.2182-2193.2002; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Higgins D. R., 1998, PICHIA PROTOCOLS; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Inan M, 2001, J BIOSCI BIOENG, V92, P585, DOI 10.1263/jbb.92.585; Klinner U, 2004, FEMS MICROBIOL REV, V28, P201, DOI 10.1016/j.femsre.2003.10.002; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Kuberl A, 2011, J BIOTECHNOL, V154, P312, DOI 10.1016/j.jbiotec.2011.04.014; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Milne GT, 1996, MOL CELL BIOL, V16, P4189; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Pastwa E, 2003, ACTA BIOCHIM POL, V50, P891; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Raschke WC, 1996, GENE, V177, P163, DOI 10.1016/0378-1119(96)00293-4; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Ruth C, 2010, Syst Synth Biol, V4, P181, DOI 10.1007/s11693-010-9057-0; Scharer OD, 2003, ANGEW CHEM INT EDIT, V42, P2946, DOI 10.1002/anie.200200523; Schroer K, 2010, METAB ENG, V12, P8, DOI 10.1016/j.ymben.2009.08.006; SOUTHERN EM, 1974, ANAL BIOCHEM, V62, P317, DOI 10.1016/0003-2697(74)90395-9; Takahashi T, 2006, BIOSCI BIOTECH BIOCH, V70, P135, DOI 10.1271/bbb.70.135; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Yamana Y, 2005, MOL GENET GENOMICS, V273, P167, DOI 10.1007/s00438-005-1108-y; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7; Zhu TC, 2009, BIOTECHNOL LETT, V31, P679, DOI 10.1007/s10529-009-9917-4	59	156	171	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39720	10.1371/journal.pone.0039720	http://dx.doi.org/10.1371/journal.pone.0039720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768112	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100082
J	Rose, SB; Wei, Z; Cooper, AJ; Lawton, BA				Rose, Sally B.; Wei, Zhang; Cooper, Annette J.; Lawton, Beverley A.			Peri-Abortion Contraceptive Choices of Migrant Chinese Women: A Retrospective Review of Medical Records	PLOS ONE			English	Review							DISCONTINUATION	Background: Migrant Asian women reportedly have low levels of contraceptive use and high rates of abortion in New Zealand. Chinese make up the largest proportion of migrant Asian in New Zealand. This study aimed to describe the contraceptive choices of Chinese women seeking abortion; to examine method choice in relation to demographic characteristics (including length of stay) and to determine whether Chinese women were over-represented among abortion clinic attendees. Methods: Retrospective review of medical records at a public hospital abortion clinic involving 305 Chinese women. Previously collected data for European (n = 277) and Maori women (n = 128) were used for comparative analyses. Regression analyses explored correlates of contraceptive method choice. Population census data were used to calculate rates of clinic attendance across ethnic groups. Results: Chinese women were not over-represented among clinic attendees, and had similar rates of contraceptive non-use pre-abortion as women in comparison groups. Use of the oral contraceptive pill by Chinese was lower pre-abortion than for other ethnic groups, but choice of this method post-abortion was similar for Chinese (46.9%, 95% CI 41-52.7) and European women (43.7%, 95% CI 37.8-49.7). Post-abortion choice of an intrauterine device did not differ significantly between Chinese (28.9%, 95% CI 23.8-34.3) and Maori women (37%, 95% CI 28.4-45.7), but was higher than uptake of this method by European women (21.7%, 95% CI 17-27.0). Age, parity and previous abortion were significant predictors of post-abortion method choice by Chinese women (p<0.05). Conclusions: Following contraceptive counseling at the clinic, Chinese women chose more effective contraceptive methods for use post-abortion than they had used previously. As the population of migrant Chinese in New Zealand continues to increase, strategies are urgently needed to provide new arrivals with appropriate information and advice about contraception and where to access it, so women can be better prepared to avoid unplanned pregnancy.	[Rose, Sally B.; Wei, Zhang; Cooper, Annette J.; Lawton, Beverley A.] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand	University of Otago	Rose, SB (corresponding author), Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand.	sally.rose@otago.ac.nz		Lawton, Beverley/0000-0003-2447-8386	New Zealand Lotteries Health Research Grant [276188]	New Zealand Lotteries Health Research Grant	This research was funded by a New Zealand Lotteries Health Research Grant (Ref 276188) (http://www.communitymatters.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ETHNIC DIFFERENTIALS; [Anonymous], 2005, LONG ACT REV CONTR E; Crampton Peter, 2007, N Z Med J, V120, pU2582; DeSouza R., 2005, ACCESS ISSUES CHINES; Goodyear-Smith Felicity A, 2003, N Z Med J, V116, pU683; Ministry of Health, 2006, AS HLTH CHART BOOK 2; National Ethics Advisory Committee, 2006, ETH GUID OBS STUD OB; Reid W, 2008, BUILDING HLTH COMMUN; Rose SB, 2010, CONTRACEPTION, V82, P345, DOI 10.1016/j.contraception.2010.04.021; Salmond C., 2007, NZDEP2006 INDEX DEPR; Scragg R., 2010, ASIAN HLTH AOTEAROA; Simon-Kumar R, 2005, CULT HEALTH SEX, V11, P1; Statistics New Zealand, 2007, 2006 NZ CENS DAT; Statistics New Zealand, 2006, NZ CENS ETHN DAT CHI; Statistics New Zealand, 2007, PROJ ETHN POP NZ SEX; Statistics New Zealand, 2001, BIRTHS; Statistics New Zealand, 2006, ETHN DEF; Trussell J., 2018, CONTRACEPTIVE TECHNO, V21st, P26; Ursin G, 1999, AM J EPIDEMIOL, V150, P561; Vaughan B, 2008, CONTRACEPTION, V78, P271, DOI 10.1016/j.contraception.2008.05.007; Vitzthum VJ, 2005, STUD FAMILY PLANN, V36, P13, DOI 10.1111/j.1728-4465.2005.00038.x; Wiebe ER, 2008, CONTRACEPTION, V78, P405, DOI 10.1016/j.contraception.2008.06.007; Wiebe ER, 2004, CONTRACEPTION, V69, P493, DOI 10.1016/j.contraception.2004.01.006; Wiebe ER, 2002, CONTRACEPTION, V65, P159, DOI 10.1016/S0010-7824(01)00297-9	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40103	10.1371/journal.pone.0040103	http://dx.doi.org/10.1371/journal.pone.0040103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768231	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100203
J	Terabayashi, T; Sakaguchi, M; Shinmyozu, K; Ohshima, T; Johjima, A; Ogura, T; Miki, H; Nishinakamura, R				Terabayashi, Takeshi; Sakaguchi, Masaji; Shinmyozu, Kaori; Ohshima, Toshio; Johjima, Ai; Ogura, Teru; Miki, Hiroaki; Nishinakamura, Ryuichi			Phosphorylation of Kif26b Promotes Its Polyubiquitination and Subsequent Proteasomal Degradation during Kidney Development	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; UBIQUITIN LIGASE NEDD4-1; BRANCHING MORPHOGENESIS; DEACETYLASE COMPLEX; EPITHELIAL-CELLS; PROTEIN; CDK5; KINESIN; DOMAINS; SALL1	Kif26b, a member of the kinesin superfamily proteins (KIFs), is essential for kidney development. Kif26b expression is restricted to the metanephric mesenchyme, and its transcription is regulated by a zinc finger transcriptional regulator Sall1. However, the mechanism(s) by which Kif26b protein is regulated remain unknown. Here, we demonstrate phosphorylation and subsequent polyubiquitination of Kif26b in the developing kidney. We find that Kif26b interacts with an E3 ubiquitin ligase, neural precursor cell expressed developmentally down-regulated protein 4 (Nedd4) in developing kidney. Phosphorylation of Kif26b at Thr-1859 and Ser-1962 by the cyclin-dependent kinases (CDKs) enhances the interaction of Kif26b with Nedd4. Nedd4 polyubiquitinates Kif26b and thereby promotes degradation of Kif26b via the ubiquitin-proteasome pathway. Furthermore, Kif26b lacks ATPase activity but does associate with microtubules. Nocodazole treatment not only disrupts the localization of Kif26b to microtubules but also promotes phosphorylation and polyubiquitination of Kif26b. These results suggest that the function of Kif26b is microtubule-based and that Kif26b degradation in the metanephric mesenchyme via the ubiquitin-proteasome pathway may be important for proper kidney development.	[Terabayashi, Takeshi; Sakaguchi, Masaji; Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan; [Terabayashi, Takeshi; Sakaguchi, Masaji; Johjima, Ai; Ogura, Teru; Nishinakamura, Ryuichi] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Honjo, Kumamoto, Japan; [Shinmyozu, Kaori] RIKEN, Ctr Dev Biol, Prote Lab, Kobe, Hyogo, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Johjima, Ai; Ogura, Teru] Kumamoto Univ, Dept Mol Cell Biol, Inst Mol Embryol & Genet, Kumamoto, Japan; [Miki, Hiroaki] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Osaka, Japan	Kumamoto University; Kumamoto University; RIKEN; Waseda University; Kumamoto University; Osaka University	Terabayashi, T (corresponding author), Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan.	ryuichi@gpo.kumamoto-u.ac.jp		Terabayashi, Takeshi/0000-0001-7102-784X; Ogura, Teru/0000-0003-3784-0970	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and by the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Grindstaff KK, 1998, MOL BIOL CELL, V9, P685, DOI 10.1091/mbc.9.3.685; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiefer SM, 2002, J BIOL CHEM, V277, P14869, DOI 10.1074/jbc.M200052200; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Lauberth SM, 2007, J BIOL CHEM, V282, P34858, DOI 10.1074/jbc.M703702200; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lazaro JB, 1997, J CELL SCI, V110, P1251; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lillie SH, 1998, J CELL BIOL, V140, P873, DOI 10.1083/jcb.140.4.873; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Negash S, 2002, J CELL SCI, V115, P2109; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Park SK, 1997, KIDNEY INT, V51, P762, DOI 10.1038/ki.1997.107; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Terabayashi T, 2009, J BIOL CHEM, V284, P26716, DOI 10.1074/jbc.M109.039313; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Yoshimura Y, 2010, MOL CELL BIOL, V30, P2206, DOI 10.1128/MCB.01181-09; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	58	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39714	10.1371/journal.pone.0039714	http://dx.doi.org/10.1371/journal.pone.0039714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768111	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100081
J	Pabian, SE; Ermer, NM; Tzilkowski, WM; Brittingham, MC				Pabian, Sarah E.; Ermer, Nathan M.; Tzilkowski, Walter M.; Brittingham, Margaret C.			Effects of Liming on Forage Availability and Nutrient Content in a Forest Impacted by Acid Rain	PLOS ONE			English	Article							WHITE-TAILED DEER; NORWAY SPRUCE; SUGAR MAPLE; GROUND VEGETATION; BODY-MASS; SOIL; GROWTH; LIME; FERTILIZATION; RESPONSES	Acidic deposition and subsequent forest soil acidification and nutrient depletion can affect negatively the growth, health and nutrient content of vegetation, potentially limiting the availability and nutrient content of forage for white-tailed deer (Odocoileus virginianus) and other forest herbivores. Liming is a mitigation technique that can be used to restore forest health in acidified areas, but little is known about how it affects the growth or nutrient content of deer forage. We examined the effects of dolomitic limestone application on the growth and chemical composition of understory plants in an acidified forest in central Pennsylvania, with a focus on vegetative groups included as white-tailed deer forage. We used a Before-After-Control-Impact study design with observations 1 year before liming and up to 5 years post-liming on 2 treated and 2 untreated 100-ha sites. Before liming, forage availability and several nutrients were below levels considered optimal for white-tailed deer, and many vegetative characteristics were related to soil chemistry. We observed a positive effect of liming on forb biomass, with a 2.7 fold increase on limed sites, but no biomass response in other vegetation groups. We observed positive effects of liming on calcium and magnesium content and negative effects on aluminum and manganese content of several plant groups. Responses to liming by forbs and plant nutrients show promise for improving vegetation health and forage quality and quantity for deer.	[Pabian, Sarah E.; Ermer, Nathan M.; Tzilkowski, Walter M.; Brittingham, Margaret C.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pabian, SE (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	sarah.pabian@colostate.edu	Pabian, Sarah/K-4831-2012		Pennsylvania's Wild Resources Conservation Program; Pennsylvania Department of Environmental Protection [41000155481ME352917]	Pennsylvania's Wild Resources Conservation Program; Pennsylvania Department of Environmental Protection	Funding was provided by Pennsylvania's Wild Resources Conservation Program, http://www.dcnr.state.pa.us/conservationscience/wrcp/index.htm, and an Environmental Stewardship and Watershed Protection Grant from the Pennsylvania Department of Environmental Protection, Grant no. 41000155481ME352917, http://www.portal.state.pa.us/portal/server.pt/community/growing_greener/13958/watershed_grants/588895. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MB, 2000, FOREST ECOL MANAG, V138, P301, DOI 10.1016/S0378-1127(00)00421-7; ANDERSSON F, 1986, WATER AIR SOIL POLL, V30, P17, DOI 10.1007/BF00305173; ANDERSSON M, 1988, WATER AIR SOIL POLL, V39, P439; [Anonymous], 2010, NSRP3 NADP PROGR OFF; [Anonymous], 1985, NUTR GRAZING RUMINAN; Baker TT, 1998, FOREST ECOL MANAG, V109, P21, DOI 10.1016/S0378-1127(98)00259-X; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BELOVSKY GE, 1981, J MAMMAL, V62, P613, DOI 10.2307/1380408; BLAIR RM, 1977, J WILDLIFE MANAGE, V41, P667, DOI 10.2307/3799988; CONROY MJ, 1982, J WILDLIFE MANAGE, V46, P719, DOI 10.2307/3808564; CRAWFORD H S, 1989, Southern Journal of Applied Forestry, V13, P12; CRAWFORD HS, 1982, J WILDLIFE MANAGE, V46, P974, DOI 10.2307/3808230; Demchik M. C., 2000, Journal of Sustainable Forestry, V11, P69, DOI 10.1300/J091v11n04_04; Demchik MC, 2001, FOREST ECOL MANAG, V144, P239, DOI 10.1016/S0378-1127(00)00388-1; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Duliere JF, 1999, ANN FOR SCI, V56, P361, DOI 10.1051/forest:19990501; Eckert D, 1995, NE REGIONAL B, V493, P11; FALKENGRENGRERUP U, 1995, ENVIRON EXP BOT, V35, P9, DOI 10.1016/0098-8472(94)00039-8; FRENCH C. E., 1956, JOUR WILDLIFE MANAGEMENT, V20, P221, DOI 10.2307/3796954; Gaillard JM, 1996, J WILDLIFE MANAGE, V60, P29, DOI 10.2307/3802036; GILL JOHN, 1956, JOUR WILDLIFE MANAGEMENT, V20, P286, DOI 10.2307/3796964; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; GRASMAN BT, 1993, ECOLOGY, V74, P2279, DOI 10.2307/1939581; Gronflaten LK, 2005, FOREST ECOL MANAG, V213, P261, DOI 10.1016/j.foreco.2005.03.060; Gunn J, 2001, WATER AIR SOIL POLL, V130, P1439, DOI 10.1023/A:1013908913162; Hamburg SP, 2003, ECOSYSTEMS, V6, P399, DOI 10.1007/s10021-002-0174-9; HAYNES RJ, 1982, PLANT SOIL, V68, P289, DOI 10.1007/BF02197935; HEALY WM, 1971, J WILDLIFE MANAGE, V35, P717, DOI 10.2307/3799777; Herfindal I, 2006, J ANIM ECOL, V75, P1110, DOI 10.1111/j.1365-2656.2006.01138.x; Hindar A, 2003, FOREST ECOL MANAG, V180, P509, DOI 10.1016/S0378-1127(02)00647-3; Horsley SB, 2000, CAN J FOREST RES, V30, P1365, DOI 10.1139/cjfr-30-9-1365; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; HUANG CYL, 1985, COMMUN SOIL SCI PLAN, V16, P943, DOI 10.1080/00103628509367657; HUETTL RF, 1993, FOREST ECOL MANAG, V61, P325, DOI 10.1016/0378-1127(93)90209-6; Jones PD, 2010, WILDLIFE BIOL, V16, P430, DOI 10.2981/10-041; Jones PD, 2008, SOUTHEAST NAT, V7, P595, DOI 10.1656/1528-7092-7.4.595; Juice SM, 2006, ECOLOGY, V87, P1267, DOI 10.1890/0012-9658(2006)87[1267:ROSMTC]2.0.CO;2; Lehoczki R, 2011, BIOL TRACE ELEM RES, V139, P168, DOI 10.1007/s12011-010-8655-8; LJUNGSTROM M, 1995, FOREST ECOL MANAG, V74, P133, DOI 10.1016/0378-1127(94)03494-H; Long RP, 1997, CAN J FOREST RES, V27, P1560, DOI 10.1139/cjfr-27-10-1560; Lyon J, 1996, TREE PHYSIOL, V16, P923; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MCCULLOUGH DR, 1985, J MAMMAL, V66, P682, DOI 10.2307/1380794; McDonald TL, 2000, J AGRIC BIOL ENVIR S, V5, P262, DOI 10.2307/1400453; McEWEN L. C, 1957, TRANS N AMER WILDLIFE CONF, V22-No. 91, P119; MCNAUGHTON SJ, 1988, NATURE, V334, P343, DOI 10.1038/334343a0; MEYER MW, 1984, J WILDLIFE MANAGE, V48, P527, DOI 10.2307/3801185; Misson L, 2001, ANN FOR SCI, V58, P699, DOI 10.1051/forest:2001157; Mizel NL, 2005, THESIS PENNSYLVANIA; Murphy D. A., 1966, Transactions of the North American Wildlife Conference, V31, P129; NYHOLM NEI, 1981, ENVIRON RES, V26, P363, DOI 10.1016/0013-9351(81)90212-7; Olsson BA, 2002, FOREST ECOL MANAG, V158, P127, DOI 10.1016/S0378-1127(00)00713-1; Pabian SE, 2007, ECOL APPL, V17, P2184, DOI 10.1890/07-0394.1; Pabian SE, 2012, INT J FORESTRY RES, V2012; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plummer M, 2009, CODA OUTPUT ANAL DIA; RODENKIRCHEN H, 1992, WATER AIR SOIL POLL, V61, P279, DOI 10.1007/BF00482611; ROY AK, 1988, BOT REV, V54, P145, DOI 10.1007/BF02858527; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Rummel SM, 2006, THESIS PENNSYLVANIA; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Schreffler AM, 2003, FOREST ECOL MANAG, V177, P471, DOI 10.1016/S0378-1127(02)00452-8; Sharpe W.E., 2006, EVALUATION WHOLE WAT; Sharpe WE, 2004, P 14 CENTR HARDW FOR, P265; Sharpe WE, 2006, P 15 CENTR HARDW FOR, P702; Simkiss K., 1967, CALCIUM REPROD PHYSL; SMITH F. H., 1956, Journal of Wildlife Management, V20, P359, DOI 10.2307/3797145; SMITH SH, 1975, J WILDLIFE MANAGE, V39, P582, DOI 10.2307/3800401; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; Strickland BK, 2000, J WILDLIFE MANAGE, V64, P903, DOI 10.2307/3803198; Traaen TS, 1997, WHOLE CATCHMENT LIMI; ULLREY DE, 1967, J WILDLIFE MANAGE, V31, P679, DOI 10.2307/3797970; VANGILDER LD, 1982, J WILDLIFE MANAGE, V46, P711, DOI 10.2307/3808563; WALLMO OC, 1977, J RANGE MANAGE, V30, P122, DOI 10.2307/3897753; WEBB WILLIAM L., 1959, JOUR WILDLIFE MANAGEMENT, V23, P455, DOI 10.2307/3796497; Wherry ET, 1920, P ACAD NAT SCI PHILA, V72, P84; Wolf AM, 1995, NE REGIONAL B, V493, P25; Wolt JD, 1990, MECH FOREST RESPONSE, P62	78	14	15	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39755	10.1371/journal.pone.0039755	http://dx.doi.org/10.1371/journal.pone.0039755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761890	Green Submitted, Green Published, gold			2022-12-25	WOS:000305826400036
J	Orubu, T; Alharbi, NK; Lambe, T; Gilbert, SC; Cottingham, MG				Orubu, Toritse; Alharbi, Naif Khalaf; Lambe, Teresa; Gilbert, Sarah C.; Cottingham, Matthew G.			Expression and Cellular Immunogenicity of a Transgenic Antigen Driven by Endogenous Poxviral Early Promoters at Their Authentic Loci in MVA	PLOS ONE			English	Article							RECOMBINANT VACCINIA VIRUS; GENETICALLY-ENGINEERED POXVIRUSES; BACTERIAL ARTIFICIAL CHROMOSOME; GENE-EXPRESSION; INFECTIOUS-DISEASES; BIOLOGICAL-ACTIVITY; ESCHERICHIA-COLI; IMMUNE-RESPONSES; LIVE VACCINES; GROWTH-FACTOR	CD8(+) T cell responses to vaccinia virus are directed almost exclusively against early gene products. The attenuated strain modified vaccinia virus Ankara (MVA) is under evaluation in clinical trials of new vaccines designed to elicit cellular immune responses against pathogens including Plasmodium spp., M. tuberculosis and HIV-1. All of these recombinant MVAs (rMVA) utilize the well-established method of linking the gene of interest to a cloned poxviral promoter prior to insertion into the viral genome at a suitable locus by homologous recombination in infected cells. Using BAC recombineering, we show that potent early promoters that drive expression of non-functional or non-essential MVA open reading frames (ORFs) can be harnessed for immunogenic expression of recombinant antigen. Precise replacement of the MVA orthologs of C11R, F11L, A44L and B8R with a model antigen positioned to use the same translation initiation codon allowed early transgene expression similar to or slightly greater than that achieved by the commonly-used p7.5 or short synthetic promoters. The frequency of antigen-specific CD8(+) T cells induced in mice by single shot or adenovirus-prime, rMVA-boost vaccination were similarly equal or marginally enhanced using endogenous promoters at their authentic genomic loci compared to the traditional constructs. The enhancement in immunogenicity observed using the C11R or F11L promoters compared with p7.5 was similar to that obtained with the mH5 promoter compared with p7.5. Furthermore, the growth rates of the viruses were unimpaired and the insertions were genetically stable. Insertion of a transgenic ORF in place of a viral ORF by BAC recombineering can thus provide not only a potent promoter, but also, concomitantly, a suitable insertion site, potentially facilitating development of MVA vaccines expressing multiple recombinant antigens.	[Orubu, Toritse; Alharbi, Naif Khalaf; Lambe, Teresa; Gilbert, Sarah C.; Cottingham, Matthew G.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Orubu, T (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	matt.cottingham@ndm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019; Lambe, Teresa/E-5733-2016	Gilbert, Sarah C./0000-0002-6823-9750; Lambe, Teresa/0000-0001-7711-897X; Cottingham, Matthew/0000-0003-0766-6465; Alharbi, Naif/0000-0002-6049-3383	Grand Challenges in Global Health grant; Jenner Institute, University of Oxford; Oxford Martin School; Wellcome Trust	Grand Challenges in Global Health grant; Jenner Institute, University of Oxford; Oxford Martin School; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by a Grand Challenges in Global Health grant to Prof. Adrian V. S. Hill, Jenner Institute, University of Oxford administered by the Foundation for the National Institutes of Health. MGC and TL are supported by the Oxford Martin School. SCG is a Jenner Investigator. The authors are grateful to the Jenner Institute's Vector Core Facility, funded by the Wellcome Trust, for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI A, 1995, J VIROL, V69, P4633; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Baur K, 2010, J VIROL, V84, P8743, DOI 10.1128/JVI.00604-10; BENNINK JR, 1984, NATURE, V311, P578, DOI 10.1038/311578a0; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; BULLER RML, 1988, J VIROL, V62, P866, DOI 10.1128/JVI.62.3.866-874.1988; BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Cottingham MG, 2010, J VIROL METHODS, V168, P233, DOI 10.1016/j.jviromet.2010.04.012; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Cottingham MG, 2012, METHODS MOL IN PRESS; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; Domi A, 2005, NAT METHODS, V2, P95, DOI 10.1038/NMETH734; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Earl PL, 1998, CURRENT PROTOCOLS MO; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2001, ARCH VIROL, V146, P875, DOI 10.1007/s007050170122; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Krauss O, 2002, J GEN VIROL, V83, P2347, DOI 10.1099/0022-1317-83-10-2347; Kreijtz JHCM, 2010, J GEN VIROL, V91, P2745, DOI 10.1099/vir.0.024885-0; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; Manuel ER, 2010, VIROLOGY, V403, P155, DOI 10.1016/j.virol.2010.04.015; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; MOSS B, 1984, NATURE, V311, P67, DOI 10.1038/311067a0; Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; PANICALI D, 1983, P NATL ACAD SCI-BIOL, V80, P5364, DOI 10.1073/pnas.80.17.5364; PAOLETTI E, 1984, P NATL ACAD SCI-BIOL, V81, P193, DOI 10.1073/pnas.81.1.193; PERKUS ME, 1985, SCIENCE, V229, P981, DOI 10.1126/science.2992092; PERKUS ME, 1989, J VIROL, V63, P3829, DOI 10.1128/JVI.63.9.3829-3836.1989; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J EXP MED, V197, P1269, DOI 10.1084/jem.20022201; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; ROMERO P, 1990, IMMUNOL LETT, V25, P27, DOI 10.1016/0165-2478(90)90086-6; Rubins KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002628; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sette A, 2009, VACCINE, V27, pG21, DOI 10.1016/j.vaccine.2009.10.011; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Skinner MA, 2005, EXPERT REV VACCINES, V4, P63, DOI 10.1586/14760584.4.1.63; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SMITH GL, 1983, P NATL ACAD SCI-BIOL, V80, P7155, DOI 10.1073/pnas.80.23.7155; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wyatt LS, 2008, VIROLOGY, V372, P260, DOI 10.1016/j.virol.2007.10.033; Wyatt LS, 2008, VACCINE, V26, P486, DOI 10.1016/j.vaccine.2007.11.036; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107	65	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40167	10.1371/journal.pone.0040167	http://dx.doi.org/10.1371/journal.pone.0040167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761956	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800092
J	Hunemeier, T; Amorim, CEG; Azevedo, S; Contini, V; Acuna-Alonzo, V; Rothhammer, F; Dugoujon, JM; Mazieres, S; Barrantes, R; Villarreal-Molina, MT; Paixao-Cortes, VR; Salzano, FM; Canizales-Quinteros, S; Ruiz-Linares, A; Bortolini, MC				Huenemeier, Tabita; Guerra Amorim, Carlos Eduardo; Azevedo, Soledad; Contini, Veronica; Acuna-Alonzo, Victor; Rothhammer, Francisco; Dugoujon, Jean-Michel; Mazieres, Stephane; Barrantes, Ramiro; Teresa Villarreal-Molina, Maria; Paixao-Cortes, Vanessa Rodrigues; Salzano, Francisco M.; Canizales-Quinteros, Samuel; Ruiz-Linares, Andres; Bortolini, Maria Catira			Evolutionary Responses to a Constructed Niche: Ancient Mesoamericans as a Model of Gene-Culture Coevolution	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; LACTASE-PERSISTENCE; LACTOSE DIGESTION; FRENCH-GUIANA; HUMAN GENOME; ALLELE; MAIZE; DOMESTICATION; POPULATIONS; VARIANT	Culture and genetics rely on two distinct but not isolated transmission systems. Cultural processes may change the human selective environment and thereby affect which individuals survive and reproduce. Here, we evaluated whether the modes of subsistence in Native American populations and the frequencies of the ABCA1*Arg230Cys polymorphism were correlated. Further, we examined whether the evolutionary consequences of the agriculturally constructed niche in Mesoamerica could be considered as a gene-culture coevolution model. For this purpose, we genotyped 229 individuals affiliated with 19 Native American populations and added data for 41 other Native American groups (n = 1905) to the analysis. In combination with the SNP cluster of a neutral region, this dataset was then used to unravel the scenario involved in 230Cys evolutionary history. The estimated age of 230Cys is compatible with its origin occurring in the American continent. The correlation of its frequencies with the archeological data on Zea pollen in Mesoamerica/Central America, the neutral coalescent simulations, and the F-ST-based natural selection analysis suggest that maize domestication was the driving force in the increase in the frequencies of 230Cys in this region. These results may represent the first example of a gene-culture coevolution involving an autochthonous American allele.	[Huenemeier, Tabita; Guerra Amorim, Carlos Eduardo; Contini, Veronica; Paixao-Cortes, Vanessa Rodrigues; Salzano, Francisco M.; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Azevedo, Soledad] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Argentina; [Acuna-Alonzo, Victor] Escuela Nacl Antropol & Hist, Mol Genet Lab, Mexico City, DF, Mexico; [Rothhammer, Francisco] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile; [Rothhammer, Francisco] Univ Tarapaca, Inst Alta Invest, Arica, Chile; [Dugoujon, Jean-Michel] Univ Toulouse 3, Lab Anthropol Mol & Imagerie Synth, CNRS, UMR 5288, Toulouse, France; [Mazieres, Stephane] Aix Marseille Univ, CNRS, UMR 7268, EFS, Marseille, France; [Barrantes, Ramiro] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Teresa Villarreal-Molina, Maria] Inst Nacl Med Genom, Lab Genom Enfermedades Cardiovasc, Mexico City, DF, Mexico; [Canizales-Quinteros, Samuel] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unit Mol Biol & Genom Med, Mexico City, DF, Mexico; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico; [Ruiz-Linares, Andres] UCL, Galton Lab, Dept Biol, London, England	Universidade Federal do Rio Grande do Sul; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Chile; Universidad de Tarapaca; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Universidad Costa Rica; Instituto Nacional de Medicina Genomica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; University of London; University College London	Hunemeier, T (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	maria.bortolini@ufrgs.br	Hünemeier, Tábita/F-4181-2011; Salzano, Francisco M/L-7916-2015; Paixão-Côrtes, Vanessa R/H-3564-2011; Acuna Alonzo, Victor/E-2312-2013; Ruiz-Linares, Andres/AAR-1104-2021; Mazieres, Stephane/G-1702-2010; Mazières, Stéphane/R-2061-2019	Paixão-Côrtes, Vanessa R/0000-0003-2677-0903; Acuna Alonzo, Victor/0000-0003-2205-7625; Ruiz-Linares, Andres/0000-0001-8372-1011; Mazieres, Stephane/0000-0003-1266-4659; Hunemeier, Tabita/0000-0002-3156-2079; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); PRONEX (Brazil); Programme Interdisciplinaire CNRS: Amazonie-Analyse, Modelisation et Ingenierie des Systemes Amazoniens (France); Convenio de Desempeno Mecesup 2/UTA (Chile)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); PRONEX (Brazil); Programme Interdisciplinaire CNRS: Amazonie-Analyse, Modelisation et Ingenierie des Systemes Amazoniens (France); Convenio de Desempeno Mecesup 2/UTA (Chile)	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), PRONEX (Brazil); Programme Interdisciplinaire CNRS: Amazonie-Analyse, Modelisation et Ingenierie des Systemes Amazoniens (France); and Convenio de Desempeno Mecesup 2/UTA (Chile). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; [Anonymous], 1988, AM ANTHROPOL; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; Benedict FG, 1936, FOOD PRESENT DAY MAY; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Blake Michael, 2006, HIST MAIZE MULTIDISC, P55; Bocquet-Appel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P35, DOI 10.1007/978-1-4020-8539-0_3; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bortolini MC, 2002, ANN HUM GENET, V66, P255, DOI 10.1017/S0003480002001148; Brown CH, 2010, PRE-COLUMBIAN FOODWAYS: INTERDISCIPLINARY APPROACHES TO FOOD, CULTURE, AND MARKETS IN ANCIENT MESOAMERICA, P273, DOI 10.1007/978-1-4419-0471-3_11; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; CHISHOLM B, 2006, HIST MAIZE MULTIDISC, P161; Cohen MN, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P481, DOI 10.1007/978-1-4020-8539-0_18; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dull Robert A., 2006, HIST MAIZE MULTIDISC, P357; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gerbault P, 2011, PHILOS T R SOC B, V366, P863, DOI 10.1098/rstb.2010.0268; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Gonzalez-Martin A, 2008, AM J HUM BIOL, V20, P605, DOI 10.1002/ajhb.20787; HEYJ, 2005, PLOS BIOL, V3, pE193; Holden C, 1997, HUM BIOL, V69, P605; Holden C, 2009, HUM BIOL, V81, P597, DOI 10.3378/027.081.0609; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Jaenicke-Despres Viviane, 2006, HIST MAIZE, P83; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Kennett DJ, 2006, ORIG HUM BEHAV, V1, P103; KIMURA M, 1973, GENETICS, V75, P199; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lesure RG, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P107, DOI 10.1007/978-1-4020-8539-0_6; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; Lia VV, 2007, P ROY SOC B-BIOL SCI, V274, P545, DOI 10.1098/rspb.2006.3747; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mazieres S, 2008, ANN HUM GENET, V72, P145, DOI 10.1111/j.1469-1809.2007.00392.x; Mazieres S, 2009, AM J HUM BIOL, V21, P113, DOI 10.1002/ajhb.20835; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEEL JV, 1967, AM J HUM GENET, V19, P554; Odling-Smee F.J., 1988, P73; Parsons JR, 2010, PRE-COLUMBIAN FOODWAYS: INTERDISCIPLINARY APPROACHES TO FOOD, CULTURE, AND MARKETS IN ANCIENT MESOAMERICA, P109, DOI 10.1007/978-1-4419-0471-3_4; Pavlidis P, 2010, MOL ECOL RESOUR, V10, P723, DOI 10.1111/j.1755-0998.2010.02832.x; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Piperno DR, 2007, P NATL ACAD SCI USA, V104, P11874, DOI 10.1073/pnas.0703442104; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; Rannala B, 2008, PACIFIC S BIOCOMP, V8, P526; Raymond J. S., 2006, HIST MAIZE MULTIDISC, P337; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Romero-Hidalgo S, 2012, J NUTR, V142, P278, DOI 10.3945/jn.111.152421; Rowley-Conwy P, 2011, PHILOS T R SOC B, V366, P849, DOI 10.1098/rstb.2010.0307; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schroeder KB, 2009, MOL BIOL EVOL, V26, P995, DOI 10.1093/molbev/msp024; Schwarcz H, 2006, HIST MAIZE MULTIDISC, P315; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Steckel RH, 2002, EVOL ANTHROPOL, V11, P142, DOI 10.1002/evan.10030; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tovo-Rodrigues L, 2010, AM J PHYS ANTHROPOL, V143, P458, DOI 10.1002/ajpa.21358; Tykot RH, 2006, HIST MAIZE MULTIDISC, P187; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Vargas-Alarcon G, 2007, MOL IMMUNOL, V44, P747, DOI 10.1016/j.molimm.2006.04.014; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Zarrillo S, 2009, P NATL ACAD SCI USA, V106, P9979	74	29	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38862	10.1371/journal.pone.0038862	http://dx.doi.org/10.1371/journal.pone.0038862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22768049	Green Published, gold			2022-12-25	WOS:000305695100021
J	Kim, JH; Tonelli, M; Frederick, RO; Chow, DCF; Markley, JL				Kim, Jin Hae; Tonelli, Marco; Frederick, Ronnie O.; Chow, Darius C. -F.; Markley, John L.			Specialized Hsp70 Chaperone (HscA) Binds Preferentially to the Disordered Form, whereas J-protein (HscB) Binds Preferentially to the Structured Form of the Iron-Sulfur Cluster Scaffold Protein (IscU)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DEPENDENT REACTION; NMR-SPECTROSCOPY; UNFOLDING STORY; REACTION CYCLE; SYSTEM; DNAK; SUBSTRATE; MECHANISM; MYOPATHY	The Escherichia coli protein IscU serves as the scaffold for Fe-S cluster assembly and the vehicle for Fe-S cluster transfer to acceptor proteins, such as apoferredoxin. IscU populates two conformational states in solution, a structured conformation (S) that resembles the conformation of the holoproteinIsc U-[2Fe-2S] and a dynamically disordered conformation (D) that does not bind metal ions. NMR spectroscopic results presented here show that the specialized Hsp70 chaperone (HscA), alone or as the HscA-ADP complex, preferentially binds to and stabilizes the D-state of IscU. IscU is released when HscA binds ATP. By contrast, the J-protein HscB binds preferentially to the S-state of IscU. Consistent with these findings, we propose a mechanism in which cluster transfer is coupled to hydrolysis of ATP bound to HscA, conversion of IscU to the D-state, and release of HscB.	[Kim, Jin Hae; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Frederick, Ronnie O.; Chow, Darius C. -F.; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	jmarkley@wisc.edu		Kim, Jin Hae/0000-0002-6776-2451	National Institutes of Health [R01 GM58667, U01 GM94622]; National Magnetic Resonance Facility at Madison; NIH grants from the National Center for Research Resources [5P41RR002301-27, RR02301-26S1]; National Institute for General Medical Sciences [8 P41 GM103399-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, U01GM094622, R01GM058667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Magnetic Resonance Facility at Madison; NIH grants from the National Center for Research Resources; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM58667 and U01 GM94622 in collaboration with the National Magnetic Resonance Facility at Madison, which is supported by NIH grants from the National Center for Research Resources (5P41RR002301-27 and RR02301-26S1) and the National Institute for General Medical Sciences (8 P41 GM103399-27).	Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Bonomi F, 2005, J BIOL CHEM, V280, P29513, DOI 10.1074/jbc.M504344200; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chylla RA, 2011, ANAL CHEM, V83, P4871, DOI 10.1021/ac200536b; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fuzery AK, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-3; Goddard T. D., 2008, SPARKY 3; Hoff KG, 2003, J BIOL CHEM, V278, P37582, DOI 10.1074/jbc.M305292200; Hoff KG, 2002, J BIOL CHEM, V277, P27353, DOI 10.1074/jbc.M202814200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kim JH, 2012, P NATL ACAD SCI USA, V109, P454, DOI 10.1073/pnas.1114372109; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Kuloglu ES, 2002, J BIOL CHEM, V277, P17863, DOI 10.1074/jbc.M200402200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Slepenkov SV, 2002, MOL MICROBIOL, V45, P1197, DOI 10.1046/j.1365-2958.2002.03093.x; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Taneva SG, 2010, BIOCHEMISTRY-US, V49, P1338, DOI 10.1021/bi901847q; Tyler RC, 2011, BIOCHEMISTRY-US, V50, P7077, DOI 10.1021/bi200750k; Vickery LE, 1997, PROTEIN SCI, V6, P1047, DOI 10.1002/pro.5560060511; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	42	38	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31406	31413		10.1074/jbc.M112.352617	http://dx.doi.org/10.1074/jbc.M112.352617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782893	Green Published, hybrid			2022-12-25	WOS:000308791300051
J	Wang, L; Jia, Y; Rogers, H; Wu, YP; Huang, SM; Noguchi, CT				Wang, Li; Jia, Yi; Rogers, Heather; Wu, Yun-Ping; Huang, Suming; Noguchi, Constance Tom			GATA-binding Protein 4 (GATA-4) and T-cell Acute Leukemia 1 (TAL1) Regulate Myogenic Differentiation and Erythropoietin Response via Cross-talk with Sirtuin1 (Sirt1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART TUBE FORMATION; SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; VENTRAL MORPHOGENESIS; HISTONE DEACETYLASES; GENE DISRUPTION; SATELLITE CELLS; MYOD; EXPRESSION; RECEPTOR	Erythropoietin (EPO), the cytokine required for erythrocyte production, contributes to muscle progenitor cell proliferation and delay myogenic differentiation. However, the underlying mechanism is not yet fully understood. Here, we report that EPO changes the skeletal myogenic regulatory factor expression program and delays differentiation via induction of GATA-4 and the basic helix-loop-helix TAL1 and that knockdown of both factors promotes differentiation. EPO increases the Sirt1 level, a NAD(+)-dependent deacetylase, and also induces the NAD(+)/NADH ratio that further increases Sirt1 activity. Sirt1 knockdown reduced GATA-4 and TAL1 expression, impaired EPO effect on delayed myogenic differentiation, and the Sirt1 knockdown effect was abrogated when combined with overexpression of GATA-4 or TAL1. GATA-4 interacts with Sirt1 and targets Sirt1 to the myogenin promoter and represses myogenin expression, whereas TAL1 inhibits myogenin expression by decreasing MyoD binding to and activation of the myogenin promoter. Sirt1 was found to bind to the GATA-4 promoter to directly regulate GATA-4 expression and GATA-4 binds to the TAL1 promoter to regulate TAL1 expression positively. These data suggest that GATA-4, TAL1, and Sirt1 cross-talk each other to regulate myogenic differentiation and mediate EPO activity during myogenic differentiation with Sirt1 playing a role upstream of GATA-4 and TAL1. Taken together, our findings reveal a novel role for GATA-4 and TAL1 to affect skeletal myogenic differentiation and EPO response via cross-talk with Sirt1.	[Wang, Li; Jia, Yi; Rogers, Heather; Noguchi, Constance Tom] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Wu, Yun-Ping] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Noguchi, CT (corresponding author), Bldg 10,Rm 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@niddk.nih.gov			National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025061] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDDK.	ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Das M, 2007, NAT PROTOC, V2, P1795, DOI 10.1038/nprot.2007.229; Dey S, 2010, MOL CELL BIOL, V30, P2181, DOI 10.1128/MCB.01441-09; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GOLDFARB AN, 1995, BLOOD, V85, P465; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Hofmann TJ, 1996, ONCOGENE, V13, P617; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Hu X, 2009, EPIGENETICS-US, V4, P257, DOI 10.4161/epi.4.6.9711; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jia Y, 2012, FASEB J, V26, P2847, DOI 10.1096/fj.11-196618; Jia Y, 2009, FASEB J, V23, P3089, DOI 10.1096/fj.09-130237; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LECOINTE N, 1994, ONCOGENE, V9, P2623; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Ravet E, 2004, BLOOD, V103, P3326, DOI 10.1182/blood-2003-05-1689; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sinclair AM, 1999, DEV BIOL, V209, P128, DOI 10.1006/dbio.1999.9236; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Suzuki YJ, 2004, LIFE SCI, V74, P1829, DOI 10.1016/j.lfs.2003.10.002; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; von Salisch S, 2011, J CELL MOL MED, V15, P1963, DOI 10.1111/j.1582-4934.2010.01193.x; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wen J, 2005, J BIOL CHEM, V280, P12956, DOI 10.1074/jbc.M412721200; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144	55	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30157	30169		10.1074/jbc.M112.376640	http://dx.doi.org/10.1074/jbc.M112.376640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773876	Green Published, hybrid			2022-12-25	WOS:000308579800011
J	Pastar, I; Khan, AA; Stojadinovic, O; Lebrun, EA; Medina, MC; Brem, H; Kirsner, RS; Jimenez, JJ; Leslie, C; Tomic-Canic, M				Pastar, Irena; Khan, Aly Azeem; Stojadinovic, Olivera; Lebrun, Elizabeth A.; Medina, Mayrin Correa; Brem, Harold; Kirsner, Robert S.; Jimenez, Joaquin J.; Leslie, Christina; Tomic-Canic, Marjana			Induction of Specific MicroRNAs Inhibits Cutaneous Wound Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTORS; KERATINOCYTE MIGRATION; PROTEIN-SYNTHESIS; HUMAN GENES; SKIN; TARGET; LEPTIN; PROLIFERATION; BIOGENESIS; EXPRESSION	Chronic nonhealing wounds, such as venous ulcers (VUs), are a widespread and serious medical problem with high morbidity and mortality. The molecular pathology of VUs remains poorly understood, impeding the development of effective treatment strategies. Using mRNA expression profiling of VUs biopsies and computational analysis, we identified a candidate set of microRNAs with lowered target gene expression. Among these candidates, miR-16, -20a, -21, -106a -130a, and -203 were confirmed to be aberrantly overexpressed in a cohort study of 10 VU patients by quantitative PCR and in situ hybridizations. These microRNAs were predicted to target multiple genes important for wound healing, including early growth response factor 3, vinculin, and leptin receptor (LepR). Overexpression of the top up-regulated miRNAs, miR-21 and miR-130a, in primary human keratinocytes down-regulated expression of the endogenous LepR and early growth response factor 3. The luciferase reporter assay verified LepR as a direct target for miR-21 and miR-130a. Both miR-21 and miR-130a delayed epithelialization in an acute human skin wound model. Furthermore, in vivo overexpression of miR-21 inhibited epithelialization and granulation tissue formation in a rat wound model. Our results identify a novel mechanism in which overexpression of specific set of microRNAs inhibits wound healing, resulting in new potential molecular markers and targets for therapeutic intervention.	[Pastar, Irena; Stojadinovic, Olivera; Lebrun, Elizabeth A.; Kirsner, Robert S.; Jimenez, Joaquin J.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Medina, Mayrin Correa] Univ Miami, Miller Sch Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Khan, Aly Azeem; Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Brem, Harold] Winthrop Univ Hosp, Div Wound Healing & Regenerat Med, Mineola, NY 11501 USA	University of Miami; University of Miami; Memorial Sloan Kettering Cancer Center; Winthrop University Hospital	Tomic-Canic, M (corresponding author), 1600 NW 10th Ave,RMSB,Rm 2023-A, Miami, FL 33136 USA.	MTCanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	National Institutes of Health [NR013881, ULIRR024996, 1-U24-CA143840]; Starr Cancer Consortium [I4-A411]; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grants NR013881 (to M. T.-C.) and ULIRR024996 Clinical and Translational Science Center pilot grant (to M. T.-C.) and Grant 1-U24-CA143840 (to C. L.). This work was also supported by Starr Cancer Consortium Grant I4-A411 (to C. L.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019; Bertero T, 2011, FASEB J, V25, P3092, DOI 10.1096/fj.10-168401; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Brem H, 2007, EXP GERONTOL, V42, P523, DOI 10.1016/j.exger.2006.11.018; Brem H, 2007, MOL MED, V13, P30, DOI 10.2119/2006-00054.Brem; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Brem H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-75; BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Herschthal Jordana, 2008, Surg Technol Int, V17, P77; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Larcher F, 2001, FASEB J, V15, P1529, DOI 10.1096/fj.01-0082com; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Meisgen F, 2012, EXP DERMATOL, V21, P312, DOI 10.1111/j.1600-0625.2012.01462.x; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pastar I., 2012, SURG TECHNOL INT, VXXI, P51; Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Robson M. C., 1995, Wound Repair and Regeneration, V3, P157, DOI 10.1046/j.1524-475X.1995.30207.x; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shilo S, 2007, DNA CELL BIOL, V26, P227, DOI 10.1089/dna.2006.0568; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; SPORN MB, 1993, J CLIN INVEST, V92, P2565, DOI 10.1172/JCI116868; Stallmeyer B, 2001, J INVEST DERMATOL, V117, P98, DOI 10.1046/j.0022-202x.2001.01387.x; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2008, J CELL MOL MED, V12, P2675, DOI 10.1111/j.1582-4934.2008.00321.x; TAKAHASHI K, 1995, J BIOL CHEM, V270, P18581, DOI 10.1074/jbc.270.31.18581; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P673; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105	63	96	98	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29324	29335		10.1074/jbc.M112.382135	http://dx.doi.org/10.1074/jbc.M112.382135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773832	hybrid, Green Published			2022-12-25	WOS:000308286900012
J	Di Camillo, CG; Luna, GM; Bo, M; Giordano, G; Corinaldesi, C; Bavestrello, G				Di Camillo, Cristina Gioia; Luna, Gian Marco; Bo, Marzia; Giordano, Giuseppe; Corinaldesi, Cinzia; Bavestrello, Giorgio			Biodiversity of Prokaryotic Communities Associated with the Ectoderm of Ectopleura crocea (Cnidaria, Hydrozoa)	PLOS ONE			English	Article							MICROBIAL DIVERSITY; GEN. NOV.; BACTERIA; HYDRA; ALGAE; SEA	The surface of many marine organisms is colonized by complex communities of microbes, yet our understanding of the diversity and role of host-associated microbes is still limited. We investigated the association between Ectopleura crocea (a colonial hydroid distributed worldwide in temperate waters) and prokaryotic assemblages colonizing the hydranth surface. We used, for the first time on a marine hydroid, a combination of electron and epifluorescence microscopy and 16S rDNA tag pyrosequencing to investigate the associated prokaryotic diversity. Dense assemblages of prokaryotes were associated with the hydrant surface. Two microbial morphotypes were observed: one horseshoe-shaped and one fusiform, worm-like. These prokaryotes were observed on the hydrozoan epidermis, but not in the portions covered by the perisarcal exoskeleton, and their abundance was higher in March while decreased in late spring. Molecular analyses showed that assemblages were dominated by Bacteria rather than Archaea. Bacterial assemblages were highly diversified, with up to 113 genera and 570 Operational Taxonomic Units (OTUs), many of which were rare and contributed to <0.4%. The two most abundant OTUs, likely corresponding to the two morphotypes present on the epidermis, were distantly related to Comamonadaceae (genus Delftia) and to Flavobacteriaceae (genus Polaribacter). Epibiontic bacteria were found on E. crocea from different geographic areas but not in other hydroid species in the same areas, suggesting that the host-microbe association is species-specific. This is the first detailed report of bacteria living on the hydrozoan epidermis, and indeed the first study reporting bacteria associated with the epithelium of E. crocea. Our results provide a starting point for future studies aiming at clarifying the role of this peculiar hydrozoan-bacterial association.	[Di Camillo, Cristina Gioia; Giordano, Giuseppe; Corinaldesi, Cinzia] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [Luna, Gian Marco] Natl Res Council CNR, Inst Marine Sci, Venice, Italy; [Bo, Marzia; Bavestrello, Giorgio] Univ Genoa, Dept Study Land & Resources, Genoa, Italy	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Genoa	Di Camillo, CG (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.	c.dicamillo@univpm.it	Luna, Gian Marco/G-9129-2012; Luna, Gian Marco/AAY-5262-2020; Di Camillo, Cristina/AAI-5960-2021	Di Camillo, Cristina/0000-0002-4031-8158; Bavestrello, Giorgio/0000-0002-5428-2344; Bo, Marzia/0000-0001-8400-6722; LUNA, GIAN MARCO/0000-0002-8303-3400	programme FIRB Futuro in ricerca; MIUR [I31J10000060001]	programme FIRB Futuro in ricerca; MIUR(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by the programme FIRB Futuro in ricerca 2008 funded by the MIUR (contract n. I31J10000060001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Altincicek B, 2009, ISJ-INVERT SURVIV J, V6, P106; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Bavestrello G, 2008, J MAR BIOL ASSOC UK, V88, P1611, DOI 10.1017/S0025315408001665; Bowman JP, 1998, MICROBIOL-UK, V144, P1601, DOI 10.1099/00221287-144-6-1601; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins AG, 2005, ZOOL SCR, V34, P91, DOI 10.1111/j.1463-6409.2005.00172.x; Di Camillo C, 2008, J MAR BIOL ASSOC UK, V88, P485, DOI 10.1017/S0025315408001045; Di Camillo C, 2005, J MAR BIOL ASSOC UK, V85, P1373, DOI 10.1017/S0025315405012555; Di Camillo CG, MAR ECOL; Di Camillo C, 2006, J MAR BIOL ASSOC UK, V86, P1285, DOI 10.1017/S0025315406014305; Dobretsov S, 2004, J EXP MAR BIOL ECOL, V299, P35, DOI 10.1016/j.jembe.2003.08.011; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Gnanambal KME, 2005, INDIAN J MAR SCI, V34, P316; Gorelova O.A., 2009, MOSC U BIOL SCI B, V64, P16, DOI [10.3103/S0096392509010040, DOI 10.3103/S0096392509010040]; Gravili C, 2011, J MAR BIOL IN PRESS; HUFNAGEL LA, 1977, T AM MICROSC SOC, V96, P406, DOI 10.2307/3225874; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; MARGULIS L, 1978, CURR MICROBIOL, V1, P227, DOI 10.1007/BF02602848; Neave MJ, 2012, MICROB ECOL, V63, P639, DOI 10.1007/s00248-011-9966-9; Nedashkovskaya OI, 2005, CURR MICROBIOL, V51, P408, DOI 10.1007/s00284-005-0105-z; Ostman C, 2000, SCI MAR, V64, P31; Proksch P, 2002, APPL MICROBIOL BIOT, V59, P125, DOI 10.1007/s00253-002-1006-8; RAHAT M, 1982, SCIENCE, V216, P67, DOI 10.1126/science.7063873; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Romagnoli T, 2007, MAR BIOL, V151, P537, DOI 10.1007/s00227-006-0487-x; Santiago-Vazquez LZ, 2007, ISME J, V1, P654, DOI 10.1038/ismej.2007.77; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Sharon G, 2008, CURR MICROBIOL, V56, P481, DOI 10.1007/s00284-008-9100-5; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stabili L, 2008, MICROB ECOL, V56, P625, DOI 10.1007/s00248-008-9382-y; Stabili L, 2006, MICROB ECOL, V52, P603, DOI 10.1007/s00248-006-9010-7; Stachowicz JJ, 2000, OECOLOGIA, V124, P280, DOI 10.1007/s004420000372; SVOBODA A, 1991, ZOOLOGISCHE VERHANDE, V274, P1; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wen AM, 1999, INT J SYST BACTERIOL, V49, P567, DOI 10.1099/00207713-49-2-567; WILKERSON FP, 1980, MICROB ECOL, V6, P85, DOI 10.1007/BF02020377	37	20	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39926	10.1371/journal.pone.0039926	http://dx.doi.org/10.1371/journal.pone.0039926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768172	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100142
J	Idh, J; Mekonnen, M; Abate, E; Wedajo, W; Werngren, J; Angeby, K; Lerm, M; Elias, D; Sundqvist, T; Aseffa, A; Stendahl, O; Schon, T				Idh, Jonna; Mekonnen, Mekidim; Abate, Ebba; Wedajo, Wassihun; Werngren, Jim; Angeby, Kristian; Lerm, Maria; Elias, Daniel; Sundqvist, Tommy; Aseffa, Abraham; Stendahl, Olle; Schon, Thomas			Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis	PLOS ONE			English	Article							INTERMEDIATES IN-VITRO; REACTIVE NITROGEN; PULMONARY TUBERCULOSIS; ALVEOLAR MACROPHAGES; GENETIC DIVERSITY; HOST-DEFENSE; STRAINS; SYNTHASE; COMPLEX; EPIDEMIOLOGY	Background and Objective: The relative contribution of nitric oxide (NO) to the killing of Mycobacterium tuberculosis in human tuberculosis (TB) is controversial, although this has been firmly established in rodents. Studies have demonstrated that clinical strains of M. tuberculosis differ in susceptibility to NO, but how this correlates to drug susceptibility and clinical outcome is not known. Methods: In this study, 50 sputum smear-and culture-positive patients with pulmonary TB in Gondar, Ethiopia were included. Clinical parameters were recorded and drug susceptibility profile and spoligotyping patterns were investigated. NO susceptibility was studied by exposing the strains to the NO donor DETA/NO. Results: Clinical isolates of M. tuberculosis showed a dose-and time-dependent response when exposed to NO. The most frequent spoligotypes found were CAS1-Delhi and T3_ETH in a total of nine known spoligotypes and four orphan patterns. There was a significant association between reduced susceptibility to NO (>10% survival after exposure to 1 mM DETA/NO) and resistance against first-line anti-TB drugs, in particular isoniazid (INH). Patients infected with strains of M. tuberculosis with reduced susceptibility to NO showed no difference in cure rate or other clinical parameters but a tendency towards lower rate of weight gain after two months of treatment, independent of antibiotic resistance. Conclusion:: There is a correlation between resistance to first-line anti-TB drugs and reduced NO susceptibility in clinical strains of M. tuberculosis. Further studies including the mechanisms of reduced NO susceptibility are warranted and could identify targets for new therapeutic interventions.	[Idh, Jonna; Abate, Ebba; Lerm, Maria; Sundqvist, Tommy; Stendahl, Olle] Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Linkoping, Sweden; [Mekonnen, Mekidim] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Debre Zeit, Ethiopia; [Mekonnen, Mekidim; Abate, Ebba; Wedajo, Wassihun; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Abate, Ebba] Gondar Univ Hosp, Dept Microbiol & Parasitol, Gondar, Ethiopia; [Werngren, Jim] Swedish Inst Communicable Dis Control, Dept Preparedness, Unit Highly Pathogen Microorganisms, Solna, Sweden; [Angeby, Kristian] Karolinska Univ Hosp, Karolinska Inst, MTC, Stockholm, Sweden; [Elias, Daniel] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat, Odense, Denmark; [Schon, Thomas] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol, Kalmar, Sweden	Linkoping University; Addis Ababa University; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska University Hospital; University of Southern Denmark	Idh, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Linkoping, Sweden.	jonna.idh@liu.se	Aseffa, Abraham/J-3248-2016; Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Aseffa, Abraham/0000-0002-8028-1150; Lerm, Maria/0000-0002-5092-9892; Aragaw, Wassihun/0000-0002-4199-2224	Swedish Research Council; Swedish International Development Agency (Sida); Swedish Heart-Lung Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency (Sida); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	The study was supported by grants from the Swedish Research Council, Swedish International Development Agency (Sida) and the Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 2001, EUR J CLIN MICROBIOL, V20, P329, DOI 10.1007/PL00011272; American ST, 1961, NAT TUB ASS US DIAGN; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Choi HS, 2002, AM J RESP CRIT CARE, V166, P178, DOI 10.1164/rccm.2201023; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; DOI T, 1993, INFECT IMMUN, V61, P1980, DOI 10.1128/IAI.61.5.1980-1989.1993; Firmani MA, 2002, INFECT IMMUN, V70, P3965, DOI 10.1128/IAI.70.7.3965-3968.2002; Friedman CR, 1997, J INFECT DIS, V176, P478, DOI 10.1086/514067; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07; Gurumurthy M, 2012, FEBS J, V279, P113, DOI 10.1111/j.1742-4658.2011.08404.x; (HPA). HPA, 2003, STAND OP PROC INV SP; Idh J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-146; Institut GldP, 2011, SITVITWEB; Inumaru VTG, 2009, INT J TUBERC LUNG D, V13, P665; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Mekonen Mekdem, 2010, Ethiop Med J, V48, P203; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2008, SCIENCE, V322, P1337, DOI 10.1126/science.1167452; NCCLS NCfCLS, 2000, M24T2 NCCLS NCFCLS; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Rhoades ER, 1997, INFECT IMMUN, V65, P1189, DOI 10.1128/IAI.65.4.1189-1195.1997; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001; Schon T, 2004, INT J TUBERC LUNG D, V8, P1134; Schon T, 2011, TUBERCULOSIS, V91, P370, DOI 10.1016/j.tube.2011.06.002; Schon T, 2003, EUR RESPIR J, V21, P483, DOI 10.1183/09031936.03.00090702; Sherman DR, 1999, BIOFACTORS, V10, P211, DOI 10.1002/biof.5520100219; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; Timmins GS, 2004, ANTIMICROB AGENTS CH, V48, P3006, DOI 10.1128/AAC.48.8.3006-3009.2004; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	47	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39891	10.1371/journal.pone.0039891	http://dx.doi.org/10.1371/journal.pone.0039891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768155	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100124
J	Kumar, A; Zhang, M; Zhu, LY; Liao, RLP; Mutai, C; Hafsat, S; Sherman, DR; Wang, MW				Kumar, Anuradha; Zhang, Meng; Zhu, Linyun; Liao, Reiling P.; Mutai, Charles; Hafsat, Shittu; Sherman, David R.; Wang, Ming-Wei			High-throughput Screening and Sensitized Bacteria Identify an M. tuberculosis Dihydrofolate Reductase Inhibitor with Whole Cell Activity	PLOS ONE			English	Article							EXPRESSION; TARGETS; DESIGN; DNA	Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is a bacterial pathogen that claims roughly 1.4 million lives every year. Current drug regimens are inefficient at clearing infection, requiring at least 6 months of chemotherapy, and resistance to existing agents is rising. There is an urgent need for new drugs that are more effective and faster acting. The folate pathway has been successfully targeted in other pathogens and diseases, but has not yielded a lead drug against tuberculosis. We developed a high-throughput screening assay against Mtb dihydrofolate reductase (DHFR), a critical enzyme in the folate pathway, and screened a library consisting of 32,000 synthetic and natural product-derived compounds. One potent inhibitor containing a quinazoline ring was identified. This compound was active against the wildtype laboratory strain H37Rv (MIC99 = 207 mu M). In addition, an Mtb strain with artificially lowered DHFR levels showed increased sensitivity to this compound (MIC99 = 70.7 mu M), supporting that the inhibition was target-specific. Our results demonstrate the potential to identify Mtb DHFR inhibitors with activity against whole cells, and indicate the power of using a recombinant strain of Mtb expressing lower levels of DHFR to facilitate the discovery of antimycobacterial agents. With these new tools, we highlight the folate pathway as a potential target for new drugs to combat the tuberculosis epidemic.	[Kumar, Anuradha; Liao, Reiling P.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Zhang, Meng; Zhu, Linyun; Mutai, Charles; Hafsat, Shittu; Wang, Ming-Wei] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai, Peoples R China; [Zhang, Meng; Zhu, Linyun; Mutai, Charles; Hafsat, Shittu; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Center for Infectious Disease Research; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Kumar, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org; wangmw@mail.shcnc.ac.cn	Mutai, Prof. Charles/GNH-5259-2022; Mutai, Prof. Charles/AAP-1084-2021	Mutai, Prof. Charles/0000-0002-9354-006X	World Health Organization [A80533]; Ministry of Science and Technology of China [2009ZX09302-001, 2010DFB73280, 2012ZX09304-011]; Novo Nordisk-CAS Research Fund; Paul G. Allen Family Foundation	World Health Organization(World Health Organization); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Novo Nordisk-CAS Research Fund; Paul G. Allen Family Foundation	This study was supported in part by grants from World Health Organization (A80533), the Ministry of Science and Technology of China (2009ZX09302-001, 2010DFB73280 and 2012ZX09304-011), Novo Nordisk-CAS Research Fund, and the Paul G. Allen Family Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	[Anonymous], 2011, 2011 TB ALL ANN REP; Argyrou A, 2006, NAT STRUCT MOL BIOL, V13, P408, DOI 10.1038/nsmb1089; BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x; Dhople AM, 2002, INT J ANTIMICROB AG, V19, P71, DOI 10.1016/S0924-8579(01)00470-8; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; El-Hamamsy MHRI, 2007, BIOORGAN MED CHEM, V15, P4552, DOI 10.1016/j.bmc.2007.04.011; Gangjee A, 2001, BIOORGAN MED CHEM, V9, P2929, DOI 10.1016/S0968-0896(01)00223-1; Gerum AB, 2002, ANTIMICROB AGENTS CH, V46, P3362, DOI 10.1128/AAC.46.11.3362-3369.2002; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Hitchings G H, 1980, Adv Enzyme Regul, V18, P349, DOI 10.1016/0065-2571(80)90025-4; Kompis IM, 2005, CHEM REV, V105, P593, DOI 10.1021/cr0301144; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Li RB, 2000, J MOL BIOL, V295, P307, DOI 10.1006/jmbi.1999.3328; Nerlich AG, 1997, LANCET, V350, P1404, DOI 10.1016/S0140-6736(05)65185-9; ROSOWSKY A, 1995, ANTIMICROB AGENTS CH, V39, P79, DOI 10.1128/AAC.39.1.79; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; White EL, 2004, FEMS MICROBIOL LETT, V232, P101, DOI 10.1016/S0378-1097(04)00038-2; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2011, GLOB TUB CONTR REP 2; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	25	39	39	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39961	10.1371/journal.pone.0039961	http://dx.doi.org/10.1371/journal.pone.0039961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768185	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100157
J	Podhajska, A; Musso, A; Trancikova, A; Stafa, K; Moser, R; Sonnay, S; Glauser, L; Moore, DJ				Podhajska, Agata; Musso, Alessandra; Trancikova, Alzbeta; Stafa, Klodjan; Moser, Roger; Sonnay, Sarah; Glauser, Liliane; Moore, Darren J.			Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism	PLOS ONE			English	Article							KUFOR-RAKEB SYNDROME; ALPHA-SYNUCLEIN; PROTEINS; DISEASE; CELLS; DEGRADATION; HOMEOSTASIS; TRANSPORT	Mutations in the ATP13A2 gene (PARK9) cause autosomal recessive, juvenile-onset Kufor-Rakeb syndrome (KRS), a neurodegenerative disease characterized by parkinsonism. KRS mutations produce truncated forms of ATP13A2 with impaired protein stability resulting in a loss-of-function. Recently, homozygous and heterozygous missense mutations in ATP13A2 have been identified in subjects with early-onset parkinsonism. The mechanism(s) by which missense mutations potentially cause parkinsonism are not understood at present. Here, we demonstrate that homozygous F182L, G504R and G877R missense mutations commonly impair the protein stability of ATP13A2 leading to its enhanced degradation by the proteasome. ATP13A2 normally localizes to endosomal and lysosomal membranes in neurons and the F182L and G504R mutations disrupt this vesicular localization and promote the mislocalization of ATP13A2 to the endoplasmic reticulum. Heterozygous T12M, G533R and A746T mutations do not obviously alter protein stability or subcellular localization but instead impair the ATPase activity of microsomal ATP13A2 whereas homozygous missense mutations disrupt the microsomal localization of ATP13A2. The overexpression of ATP13A2 missense mutants in SH-SY5Y neural cells does not compromise cellular viability suggesting that these mutant proteins lack intrinsic toxicity. However, the overexpression of wild-type ATP13A2 may impair neuronal integrity as it causes a trend of reduced neurite outgrowth of primary cortical neurons, whereas the majority of disease-associated missense mutations lack this ability. Finally, ATP13A2 overexpression sensitizes cortical neurons to neurite shortening induced by exposure to cadmium or nickel ions, supporting a functional interaction between ATP13A2 and heavy metals in post-mitotic neurons, whereas missense mutations influence this sensitizing effect. Collectively, our study provides support for common loss-of-function effects of homozygous and heterozygous missense mutations in ATP13A2 associated with early-onset forms of parkinsonism.	[Podhajska, Agata; Musso, Alessandra; Trancikova, Alzbeta; Stafa, Klodjan; Moser, Roger; Sonnay, Sarah; Glauser, Liliane; Moore, Darren J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Podhajska, A (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland.	darren.moore@epfl.ch	Trancikova, Alzbeta Kralova/X-7402-2018	Trancikova, Alzbeta Kralova/0000-0002-4743-4952; Moore, Darren/0000-0003-2359-5679	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation [310030_127478]; Ecole Polytechnique Federale de Lausanne	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by funding from the Michael J. Fox Foundation for Parkinson's Research (D. J. M.), Swiss National Science Foundation (grant no. 310030_127478 to D. J. M.), and the Ecole Polytechnique Federale de Lausanne (D. J. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDIN ASN, 1994, ACTA NEUROL SCAND, V89, P347; Behrens MI, 2010, MOVEMENT DISORD, V25, P1929, DOI 10.1002/mds.22996; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Crosiers D, 2011, PARKINSONISM RELAT D, V17, P135, DOI 10.1016/j.parkreldis.2010.10.011; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grunewald A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.035; Gusdon AM, 2012, NEUROBIOL DIS, V45, P962, DOI 10.1016/j.nbd.2011.12.015; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Leitch S, 2011, BIOMETALS, V24, P159, DOI 10.1007/s10534-010-9384-3; Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Ning YP, 2008, NEUROLOGY, V70, P1491, DOI 10.1212/01.wnl.0000310427.72236.68; Park JS, 2011, HUM MUTAT, V32, P956, DOI 10.1002/humu.21527; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Santoro L, 2011, NEUROGENETICS, V12, P33, DOI 10.1007/s10048-010-0259-0; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schneider SA, 2010, MOVEMENT DISORD, V25, P979, DOI 10.1002/mds.22947; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Ton VK, 2004, AM J PHYSIOL-CELL PH, V287, pC580, DOI 10.1152/ajpcell.00135.2004; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Usenovic M, 2012, J NEUROSCI, V32, P4240, DOI 10.1523/JNEUROSCI.5575-11.2012; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Williams DR, 2005, MOVEMENT DISORD, V20, P1264, DOI 10.1002/mds.20511	36	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39942	10.1371/journal.pone.0039942	http://dx.doi.org/10.1371/journal.pone.0039942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768177	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100147
J	Tamura, H; Ohgami, N; Yajima, I; Iida, M; Ohgami, K; Fujii, N; Itabe, H; Kusudo, T; Yamashita, H; Kato, M				Tamura, Haruka; Ohgami, Nobutaka; Yajima, Ichiro; Iida, Machiko; Ohgami, Kyoko; Fujii, Noriko; Itabe, Hiroyuki; Kusudo, Tastuya; Yamashita, Hitoshi; Kato, Masashi			Chronic Exposure to Low Frequency Noise at Moderate Levels Causes Impaired Balance in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; HEARING; BRAIN; CELLS; LIPOPROTEIN; PERFORMANCE; DEPRESSION; AUTOPHAGY	We are routinely exposed to low frequency noise (LFN; below 0.5 kHz) at moderate levels of 60-70 dB sound pressure level (SPL) generated from various sources in occupational and daily environments. LFN has been reported to affect balance in humans. However, there is limited information about the influence of chronic exposure to LFN at moderate levels for balance. In this study, we investigated whether chronic exposure to LFN at a moderate level of 70 dB SPL affects the vestibule, which is one of the organs responsible for balance in mice. Wild-type ICR mice were exposed for 1 month to LFN (0.1 kHz) and high frequency noise (HFN; 16 kHz) at 70 dB SPL at a distance of approximately 10-20 cm. Behavior analyses including rotarod, beam-crossing and footprint analyses showed impairments of balance in LFN-exposed mice but not in non-exposed mice or HFN-exposed mice. Immunohistochemical analysis showed a decreased number of vestibular hair cells and increased levels of oxidative stress in LFN-exposed mice compared to those in non-exposed mice. Our results suggest that chronic exposure to LFN at moderate levels causes impaired balance involving morphological impairments of the vestibule with enhanced levels of oxidative stress. Thus, the results of this study indicate the importance of considering the risk of chronic exposure to LFN at a moderate level for imbalance.	[Tamura, Haruka; Ohgami, Nobutaka; Yajima, Ichiro; Iida, Machiko; Ohgami, Kyoko; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 59004, Japan; [Itabe, Hiroyuki] Showa Univ, Sch Pharm, Dept Biol Chem, Shinagawa Ku, Tokyo, Japan; [Kusudo, Tastuya; Yamashita, Hitoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Mol Biol Unit, Kasugai, Aichi 487, Japan	Chubu University; Kyoto University; Showa University; Chubu University	Tamura, H (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@isc.chubu.ac.jp	KATO, Masashi/I-7250-2014; YAJIMA, Ichiro/I-7467-2014; Ohgami, Nobutaka/I-4572-2014; 板部板部, 洋之/ABC-7746-2020	Yamashita, Hitoshi/0000-0002-5785-5208	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19390168, 20406003, 23650241, 18790738]; Center of Excellence (COE) Project; MEXT; Chubu University [S0801055]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS); Mitsui Co., Ltd. [R08-C097]; Tokyo Biochemical Research Foundation (TBRF); Research Foundation from the Institute of Science and Technology Research in Chubu University; Chubu University	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Excellence (COE) Project; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University; Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS); Mitsui Co., Ltd.(Mitsui & Co., LTD.); Tokyo Biochemical Research Foundation (TBRF); Research Foundation from the Institute of Science and Technology Research in Chubu University; Chubu University	This study was supported in part by Grants-in-Aid for Scientific Research (B) (No. 19390168 and 20406003), Grant-in-Aid for Challenging Exploratory Research (No. 23650241), Grants-in-Aid for Young Scientists (B) (No. 18790738) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Center of Excellence (COE) Project (Health Science Hills) for Private Universities form MEXT and Chubu University (No. S0801055), Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency, AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS), Mitsui & Co., Ltd. Environment Fund (No. R08-C097), Research Grant from the Tokyo Biochemical Research Foundation (TBRF), Research Foundation from the Institute of Science and Technology Research in Chubu University and Chubu University grants A, B and CG. The authors also declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishima Y, 2005, MODERN PATHOL, V18, P365, DOI 10.1038/modpathol.3800249; Al Deeb S, 2000, NEUROTOXICOL TERATOL, V22, P213, DOI 10.1016/S0892-0362(99)00075-6; Bartolami S, 2011, J NEUROSCI, V31, P16541, DOI 10.1523/JNEUROSCI.2430-11.2011; DANIELSSON A, 1985, ACTA MED SCAND, V217, P531; Doroshenko PN, 1983, NOISE VIBRATION  NOV, P192; DOUGHERTY JD, 1966, NEW ENGL J MED, V275, P759, DOI 10.1056/NEJM196610062751405; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; Gerhardt KJ, 1996, SEMIN PERINATOL, V20, P11, DOI 10.1016/S0146-0005(96)80053-X; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Heffner HE, 2007, J AM ASSOC LAB ANIM, V46, P20; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Ising Hartmut, 2002, Noise Health, V4, P13; ITABE H, 1994, J BIOL CHEM, V269, P15274; Karpova N., 1970, NOISE VIBRATION B, V11, P100; Kaur G, 2002, BRAIN RES, V943, P206, DOI 10.1016/S0006-8993(02)02624-0; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Lalwani A. K., 2008, CURRENT DIAGNOSIS TR, P683; Landstrom U, 1983, J LOW FREQ NOISE VIB, V2, P1; Leventhall Geoff, 2003, REV PUBLISHED RES LO; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Matsumura BA, 2006, CLIN GERIATR MED, V22, P395, DOI 10.1016/j.cger.2005.12.007; Miller LJ, 2009, WOMENS HEALTH, V5, P577, DOI 10.2217/WHE.09.44; Ohgami N, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.002; Ohgami N, 2011, TOXICOL IND HEALTH, V27, P143, DOI 10.1177/0748233710382539; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Patel RS, 2012, TOXICOLOGY, V293, P41, DOI 10.1016/j.tox.2011.12.005; Pei ZH, 2007, ENVIRON TOXICOL, V22, P169, DOI 10.1002/tox.20244; Pienkowski M, 2012, EAR HEAR IN PRESS; Prasher D, 2009, NOISE HEALTH, V11, P141, DOI 10.4103/1463-1741.53358; PRIEVE BA, 1984, ACTA OTO-LARYNGOL, V98, P428, DOI 10.3109/00016488409107584; ROTHENBERG SJ, 1994, NEUROTOXICOLOGY, V15, P695; Samson J, 2007, NEUROSCI RES, V57, P143, DOI 10.1016/j.neures.2006.09.019; Samson J, 2007, NEUROTOXICOLOGY, V28, P679, DOI 10.1016/j.neuro.2007.02.011; Schust M, 2004, Noise Health, V6, P73; Takigawa H., 1988, Journal of Low Frequency Noise & Vibration, V7, P66; Wallenius MA, 2004, J ENVIRON PSYCHOL, V24, P167, DOI 10.1016/j.jenvp.2003.12.002; Waye KP, 2002, LIFE SCI, V70, P745, DOI 10.1016/S0024-3205(01)01450-3; Wijayanto Titis, 2009, Journal of Physiological Anthropology, V28, P253, DOI 10.2114/jpa2.28.253; Yamauchi Daisuke, 2010, BMC Physiology, V10, P1, DOI 10.1186/1472-6793-10-1; Zakon H, 1998, J NEUROSCI, V18, P2581; Zhao X, 2008, NEUROSCIENCE, V153, P289, DOI 10.1016/j.neuroscience.2008.01.055	42	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39807	10.1371/journal.pone.0039807	http://dx.doi.org/10.1371/journal.pone.0039807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768129	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100099
J	Lee, KM; Ahn, KH; Keller, EL				Lee, Kyoung-Min; Ahn, Kyung-Ha; Keller, Edward L.			Saccade Generation by the Frontal Eye Fields in Rhesus Monkeys Is Separable from Visual Detection and Bottom-Up Attention Shift	PLOS ONE			English	Article							SPATIAL ATTENTION; NEURAL ACTIVITY; MOVEMENTS; INACTIVATION; SEARCH; RESPONSES; SELECTION; NEURONS; LESIONS; CHOICE	The frontal eye fields (FEF), originally identified as an oculomotor cortex, have also been implicated in perceptual functions, such as constructing a visual saliency map and shifting visual attention. Further dissecting the area's role in the transformation from visual input to oculomotor command has been difficult because of spatial confounding between stimuli and responses and consequently between intermediate cognitive processes, such as attention shift and saccade preparation. Here we developed two tasks in which the visual stimulus and the saccade response were dissociated in space (the extended memory-guided saccade task), and bottom-up attention shift and saccade target selection were independent (the four-alternative delayed saccade task). Reversible inactivation of the FEF in rhesus monkeys disrupted, as expected, contralateral memory-guided saccades, but visual detection was demonstrated to be intact at the same field. Moreover, saccade behavior was impaired when a bottom-up shift of attention was not a prerequisite for saccade target selection, indicating that the inactivation effect was independent of the previously reported dysfunctions in bottom-up attention control. These findings underscore the motor aspect of the area's functions, especially in situations where saccades are generated by internal cognitive processes, including visual short-term memory and long-term associative memory.	[Lee, Kyoung-Min; Ahn, Kyung-Ha] Seoul Natl Univ, Dept Neurol, Seoul, South Korea; [Lee, Kyoung-Min; Keller, Edward L.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Seoul National University (SNU); The Smith-Kettlewell Eye Research Institute	Lee, KM (corresponding author), Seoul Natl Univ, Dept Neurol, Seoul, South Korea.	kminlee@snu.ac.kr	Lee, Kyoung Min/J-2775-2012		National Research Foundation of Korea; Korean Government (MEST) (Global Research Network Project) [2008-H00004]; Smith-Kettlewell Eye Research Foundation	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST) (Global Research Network Project); Smith-Kettlewell Eye Research Foundation	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (Global Research Network Project, 2008-H00004 to KML) and by the Smith-Kettlewell Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BIZZI E, 1967, SCIENCE, V157, P1588, DOI 10.1126/science.157.3796.1588; BRUCE CJ, 1984, TRENDS NEUROSCI, V7, P436, DOI 10.1016/S0166-2236(84)80149-6; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Deng S.-Y., 1986, ADAPTIVE PROCESSES V, P201; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744, DOI 10.1152/jn.1995.74.6.2744; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Karnath HO, 2003, NEUROREPORT, V14, P437, DOI 10.1097/01.wnr.0000059778.23521.88; Keller EL, 2008, J NEUROPHYSIOL, V100, P2726, DOI 10.1152/jn.90673.2008; LATTO R, 1971, BRAIN RES, V30, P1, DOI 10.1016/0006-8993(71)90002-3; Lee KM, 2008, J NEUROSCI, V28, P2242, DOI 10.1523/JNEUROSCI.3596-07.2008; Monosov IE, 2009, J NEUROPHYSIOL, V102, P3656, DOI 10.1152/jn.00750.2009; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schiller PH, 1998, NAT NEUROSCI, V1, P248, DOI 10.1038/693; SCHILLER PH, 1979, SCIENCE, V206, P590, DOI 10.1126/science.115091; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; WYSZECKI G, 1982, COLOR SCI CONCEPTS M, P164; Zhou HH, 2011, NEURON, V70, P1205, DOI 10.1016/j.neuron.2011.04.032	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39886	10.1371/journal.pone.0039886	http://dx.doi.org/10.1371/journal.pone.0039886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761923	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800078
J	Lara, H; Wang, YH; Beltran, AS; Juarez-Moreno, K; Yuan, XN; Kato, S; Leisewitz, AV; Fredes, MC; Licea, AF; Connolly, DC; Huang, L; Blancafort, P				Lara, Haydee; Wang, Yuhua; Beltran, Adriana S.; Juarez-Moreno, Karla; Yuan, Xinni; Kato, Sumie; Leisewitz, Andrea V.; Cuello Fredes, Mauricio; Licea, Alexei F.; Connolly, Denise C.; Huang, Leaf; Blancafort, Pilar			Targeting Serous Epithelial Ovarian Cancer with Designer Zinc Finger Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MASPIN EXPRESSION; FUNCTIONAL-CHARACTERIZATION; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; C/EBP-DELTA; CHROMATIN; MAMMARY; CELLS; MRP-1/CD9	Ovarian cancer is the leading cause of death among gynecological malignancies. It is detected at late stages when the disease is spread through the abdominal cavity in a condition known as peritoneal carcinomatosis. Thus, there is an urgent need to develop novel therapeutic interventions to target advanced stages of ovarian cancer. Mammary serine protease inhibitor (Maspin) represents an important metastasis suppressor initially identified in breast cancer. Herein we have generated a sequence-specific zinc finger artificial transcription factor (ATF) to up-regulate the Maspin promoter in aggressive ovarian cancer cell lines and to interrogate the therapeutic potential of Maspin in ovarian cancer. We found that although Maspin was expressed in some primary ovarian tumors, the promoter was epigenetically silenced in cell lines derived from ascites. Transduction of the ATF in MOVCAR 5009 cells derived from ascitic cultures of a TgMISIIR-TAg mouse model of ovarian cancer resulted in tumor cell growth inhibition, impaired cell invasion, and severe disruption of actin cytoskeleton. Systemic delivery of lipid-protamine-RNA nanoparticles encapsulating a chemically modified ATF mRNA resulted in inhibition of ovarian cancer cell growth in nude mice accompanied with Maspin re-expression in the treated tumors. Gene expression microarrays of ATF-transduced cells revealed an exceptional specificity for the Maspin promoter. These analyses identified novel targets co-regulated with Maspin in human short-term cultures derived from ascites, such as TSPAN12, that could mediate the anti-metastatic phenotype of the ATF. Our work outlined the first targeted, non-viral delivery of ATFs into tumors with potential clinical applications for metastatic ovarian cancers.	[Blancafort, Pilar] Univ N Carolina, UNC Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Wang, Yuhua; Huang, Leaf] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Beltran, Adriana S.; Blancafort, Pilar] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lara, Haydee; Licea, Alexei F.] Ctr Invest Cient & Educ Super Ensenada, Dept Biotecnol Marina, Ensenada 22860, Baja California, Mexico; [Lara, Haydee] Univ Autonoma Baja California, Programa Doctorado Ecol Mol & Biotecnol, Ensenada 22860, Baja California, Mexico; [Kato, Sumie; Cuello Fredes, Mauricio] Pontificia Univ Catolica Chile 686 3409, Fac Med, Lab Obstet & Ginecol, Ctr Invest Med, Santiago, Chile; [Leisewitz, Andrea V.] Pontificia Univ Catolica Chile 686 3409, Fac Med, Dept Hematol Oncol, Santiago, Chile; [Connolly, Denise C.] Fox Chase Canc Ctr, Dev Therapeut Program, Philadelphia, PA 19111 USA; [Juarez-Moreno, Karla] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada 22860, Baja California, Mexico	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California; Fox Chase Cancer Center; Universidad Nacional Autonoma de Mexico	Blancafort, P (corresponding author), Univ N Carolina, UNC Sch Med, Dept Pharmacol, 4009 Genet Med Bldg,Campus Box 7365, Chapel Hill, NC 27599 USA.	pilar_blancafort@med.unc.edu	Cuello, Mauricio A/M-9817-2015; Navaro, Alexei Fedorovish Licea/B-4106-2016; Juarez-Moreno, Karla Oyuky/E-2730-2016; Blancafort, Pilar/K-9029-2012	Cuello, Mauricio A/0000-0003-2812-0015; Navaro, Alexei Fedorovish Licea/0000-0003-4022-7405; Juarez-Moreno, Karla Oyuky/0000-0002-6171-8601; Blancafort, Pilar/0000-0002-3881-7396	National Institutes of Health [1R01CA125273, 3R01CA125273-03S1, CA129835, CA136596, CA083638, CA006927]; Department of of Defense [W81XWH-10-1-0265]; Fondo Nacional de Ciencia y Tecnologia [1080163]; National Council of Science and Technology of Mexico; Baja California Sur State Government; Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; NATIONAL CANCER INSTITUTE [R01CA170370, R01CA125273, P30CA006927, R01CA136596, P50CA083638, R01CA129835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of of Defense(United States Department of Defense); Fondo Nacional de Ciencia y Tecnologia; National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Baja California Sur State Government; Centro de Investigacion Cientifica y de Educacion Superior de Ensenada(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA125273 and 3R01CA125273-03S1 (NCI; to P. B.), CA129835 (to L. H.), and CA136596, CA083638, and CA006927 (NCI; to D. C. C.). This work was also supported by Department of of Defense Grant W81XWH-10-1-0265 (to P. B.), Fondo Nacional de Ciencia y Tecnologia Grant 1080163 (to M. C. F.), the National Council of Science and Technology of Mexico, and The Baja California Sur State Government and Centro de Investigacion Cientifica y de Educacion Superior de Ensenada (to H. L.).	Aydar E, 2006, CANCER LETT, V242, P245, DOI 10.1016/j.canlet.2005.11.011; Banerjee R, 2004, INT J CANCER, V112, P693, DOI 10.1002/ijc.20452; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beltran A, 2007, ONCOGENE, V26, P2791, DOI 10.1038/sj.onc.1210072; Beltran A, 2006, ASSAY DRUG DEV TECHN, V4, P317, DOI 10.1089/adt.2006.4.317; Beltran AS, 2008, MOL CANCER THER, V7, P1080, DOI 10.1158/1535-7163.MCT-07-0526; Beltran AS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3019; Beltran AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024595; Beltran AS, 2011, EPIGENETICS-US, V6, P224, DOI 10.4161/epi.6.2.13700; Beltran AS, 2010, METHODS MOL BIOL, V649, P163, DOI 10.1007/978-1-60761-753-2_10; Berkenblit A, 2005, J REPROD MED, V50, P426; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; Blancafort P, 2008, COMB CHEM HIGH T SCR, V11, P146, DOI 10.2174/138620708783744453; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Connolly DC, 2009, CANCER TREAT RES, V149, P353, DOI 10.1007/978-0-387-98094-2_17; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Endsley MP, 2011, METHOD ENZYMOL, V499, P149, DOI 10.1016/B978-0-12-386471-0.00008-0; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Furuya M, 2005, CANCER RES, V65, P2617, DOI 10.1158/0008-5472.CAN-04-3123; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gardner GJ, 2011, CANCER CONTROL, V18, P44, DOI 10.1177/107327481101800106; Goulet B, 2011, LAB INVEST, V91, P1181, DOI 10.1038/labinvest.2011.66; Havrilesky L, 2003, J CLIN ONCOL, V21, P3814, DOI 10.1200/JCO.2003.11.052; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Herrera FJ, 2004, J VIROL, V78, P9689, DOI 10.1128/JVI.78.18.9689-9696.2004; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Higashiyama M, 1997, INT J CANCER, V74, P205, DOI 10.1002/(SICI)1097-0215(19970422)74:2<205::AID-IJC12>3.0.CO;2-C; Holzer RG, 2003, BREAST CANCER RES TR, V77, P65, DOI 10.1023/A:1021175931177; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang CI, 1998, AM J PATHOL, V153, P973, DOI 10.1016/S0002-9440(10)65639-8; Huang CL, 2004, ONCOGENE, V23, P7475, DOI 10.1038/sj.onc.1208063; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Liu J, 2010, ONCOLOGY-NY, V24, P721; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525; Lonardo F, 2006, LUNG CANCER, V51, P31, DOI 10.1016/j.lungcan.2005.07.011; Lonardo F, 2010, CURR PHARM DESIGN, V16, P1877, DOI 10.2174/138161210791208974; Lu YC, 2006, J BIOL CHEM, V281, P39081, DOI 10.1074/jbc.M606687200; MacLachlan Timothy K, 2003, Methods Mol Biol, V223, P129; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Min Y, 2011, ONCOGENE, V30, P4901, DOI 10.1038/onc.2011.187; Miosge N, 2001, HISTOCHEM J, V33, P523, DOI 10.1023/A:1014995523521; Mohsin SK, 2003, J PATHOL, V199, P432, DOI 10.1002/path.1319; Mussolino C., 2012, CURR OPIN B IN PRESS; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Quinn BA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-24; Rice JC, 2000, NUCLEIC ACIDS RES, V28, P3233, DOI 10.1093/nar/28.17.3233; Richardson MM, 2011, CLIN EXP METASTAS, V28, P261, DOI 10.1007/s10585-010-9365-5; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Rose SL, 2006, GYNECOL ONCOL, V102, P319, DOI 10.1016/j.ygyno.2005.12.025; Rosen DG, 2009, FRONT BIOSCI-LANDMRK, V14, P2089, DOI 10.2741/3364; Seftor REB, 1998, CANCER RES, V58, P5681; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Solomon LA, 2006, GYNECOL ONCOL, V101, P385, DOI 10.1016/j.ygyno.2005.11.049; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Sopel M, 2010, FOLIA MORPHOL, V69, P204; Suehara Y, 2008, CLIN CANCER RES, V14, P1707, DOI 10.1158/1078-0432.CCR-07-1478; Svirshchevskaya EV, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-176; Wang HX, 2011, BIOCHEM SOC T, V39, P547, DOI 10.1042/BST0390547; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wright MH, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-29; WU H, 1995, P NATL ACAD SCI USA, V92, P344, DOI 10.1073/pnas.92.2.344; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200; Zou ZQ, 2002, CLIN CANCER RES, V8, P1172; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	76	34	35	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29873	29886		10.1074/jbc.M112.360768	http://dx.doi.org/10.1074/jbc.M112.360768			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782891	Green Published, hybrid			2022-12-25	WOS:000308286900061
J	Rostovtseva, TK; Gurnev, PA; Chen, MY; Bezrukov, SM				Rostovtseva, Tatiana K.; Gurnev, Philip A.; Chen, Meng-Yang; Bezrukov, Sergey M.			Membrane Lipid Composition Regulates Tubulin Interaction with Mitochondrial Voltage-dependent Anion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-VESICLES; BIOLOGICAL-MEMBRANES; PROTEIN INTERACTIONS; VDAC; APOPTOSIS; MICROTUBULES; CONDUCTANCE; CARDIOLIPIN; CURVATURE; ROLES	Elucidating molecular mechanisms by which lipids regulate protein function within biological membranes is critical for understanding the many cellular processes. Recently, we have found that dimeric alpha beta-tubulin, a subunit of microtubules, regulates mitochondrial respiration by blocking the voltage-dependent anion channel (VDAC) of mitochondrial outer membrane. Here, we show that the mechanism of VDAC blockage by tubulin involves tubulin interaction with the membrane as a critical step. The on-rate of the blockage varies up to 100-fold depending on the particular lipid composition used for bilayer formation in reconstitution experiments and increases with the increasing content of dioleoylphosphatidylethanolamine (DOPE) in dioleoylphosphatidylcholine (DOPC) bilayers. At physiologically low salt concentrations, the on-rate is decreased by the charged lipid. The off-rate of VDAC blockage by tubulin does not depend on the lipid composition. Using confocal fluorescence microscopy, we compared tubulin binding to the membranes of giant unilamellar vesicles (GUVs) made from DOPC and DOPC/DOPE mixtures. We found that detectable binding of the fluorescently labeled dimeric tubulin to GUV membranes requires the presence of DOPE. We propose that prior to the characteristic blockage of VDAC, tubulin first binds to the membrane in a lipid-dependent manner. We thus reveal a new potent regulatory role of the mitochondrial lipids in control of the mitochondrial outer membrane permeability and hence mitochondrial respiration through tuning VDAC sensitivity to blockage by tubulin. More generally, our findings give an example of the lipid-controlled protein-protein interaction where the choice of lipid species is able to change the equilibrium binding constant by orders of magnitude.	[Rostovtseva, Tatiana K.; Gurnev, Philip A.; Chen, Meng-Yang; Bezrukov, Sergey M.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rostovtseva, TK (corresponding author), NICHD, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov			National Institutes of Health Intramural Research Program, Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, Eunice Kennedy Shriver NICHD.	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; BERNIERVALENTIN F, 1983, J CELL BIOL, V97, P209, DOI 10.1083/jcb.97.1.209; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Bezrukov SM, 1998, FARADAY DISCUSS, V111, P173; BEZRUKOV SM, 1993, BIOPHYS J, V64, P16, DOI 10.1016/S0006-3495(93)81336-5; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; CARON JM, 1979, J CELL BIOL, V81, P665, DOI 10.1083/jcb.81.3.665; CARON JM, 1987, BIOCHEMISTRY-US, V26, P3681, DOI 10.1021/bi00386a063; CARON JM, 1980, J CELL BIOL, V87, pA255; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Crimi M, 2011, BBA-MOL CELL RES, V1813, P551, DOI 10.1016/j.bbamcr.2010.09.014; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Furt F, 2009, INT J BIOCHEM CELL B, V41, P1828, DOI 10.1016/j.biocel.2009.02.005; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; HARGREAVES AJ, 1988, INT J BIOCHEM, V20, P1133, DOI 10.1016/0020-711X(88)90259-5; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; KELLER SL, 1993, BIOPHYS J, V65, P23, DOI 10.1016/S0006-3495(93)81040-3; KLAUSNER RD, 1981, J BIOL CHEM, V256, P5879; KUMAR N, 1981, J BIOL CHEM, V256, P5886; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Monge C., 2008, MOL CELL BIOCHEM, V318, P94; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2008, BIOPHYS J, V94, pL23, DOI 10.1529/biophysj.107.120261; Rostovtseva TK, 2007, BIOPHYS J, p436A; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2009, J BIOL CHEM, V284, P34390, DOI 10.1074/jbc.M109.021873; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Sheldon KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025539; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Smith AW, 2012, BBA-BIOMEMBRANES, V1818, P172, DOI 10.1016/j.bbamem.2011.06.015; Sobko AA, 2004, FEBS LETT, V576, P205, DOI 10.1016/j.febslet.2004.09.016; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus	56	53	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29589	29598		10.1074/jbc.M112.378778	http://dx.doi.org/10.1074/jbc.M112.378778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22763701	hybrid, Green Published			2022-12-25	WOS:000308286900034
J	Komori, H; Nitta, Y; Ueno, H; Higuchi, Y				Komori, Hirofumi; Nitta, Yoko; Ueno, Hiroshi; Higuchi, Yoshiki			Structural Study Reveals That Ser-354 Determines Substrate Specificity on Human Histidine Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DECARBOXYLASE; DOPA DECARBOXYLASE; LOCOMOTOR-ACTIVITY; IMPORTANT RESIDUES; BRAIN HISTAMINE; PURIFICATION; COENZYME; LIVER; MICE	Histamine is an important chemical mediator for a wide variety of physiological reactions. L-Histidine decarboxylase (HDC) is the primary enzyme responsible for histamine synthesis and produces histamine from histidine in a one-step reaction. In this study, we determined the crystal structure of human HDC (hHDC) complexed with the inhibitor histidine methyl ester. This structure shows the detailed features of the pyridoxal-5'-phosphate inhibitor adduct (external aldimine) at the active site of HDC. Moreover, a comparison of the structures of hHDC and aromatic L-amino acid (L-DOPA) decarboxylase showed that Ser-354 was a key residue for substrate specificity. The S354G mutation at the active site enlarged the size of the hHDC substrate-binding pocket and resulted in a decreased affinity for histidine, but an acquired ability to bind and act on L-DOPA as a substrate. These data provide insight into the molecular basis of substrate recognition among the group II pyridoxal-5'-phosphate-dependent decarboxylases.	[Komori, Hirofumi; Higuchi, Yoshiki] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Komori, Hirofumi; Higuchi, Yoshiki] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795248, Japan; [Nitta, Yoko] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan; [Ueno, Hiroshi] Nara Womens Univ, Lab Appl Microbiol & Biochem, Kitauoyanishi, Nara 6308506, Japan	University of Hyogo; RIKEN; University of Hyogo; Nara Womens University	Komori, H (corresponding author), Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	komori@sci.u-hyogo.ac.jp; nitta@shse.u-hyogo.ac.jp	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; Higuchi, Yoshiki/0000-0001-8284-5709	Kawanishi Memorial ShinMaywa Education Foundation; Japan Society for the Promotion of Science; Academia Sinica; National Synchrotron Radiation Research Center (Hsinchu City, Taiwan); Grants-in-Aid for Scientific Research [24650495] Funding Source: KAKEN	Kawanishi Memorial ShinMaywa Education Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Hsinchu City, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Kawanishi Memorial ShinMaywa Education Foundation and a grant-in-aid for young scientists (B) from the Japan Society for the Promotion of Science.; We thank the staff at beamline BL44XU at SPring-8 (Harima, Japan). The MX225-HE (Rayonix) CCD detector at BL44XU was financially supported by Academia Sinica and by the National Synchrotron Radiation Research Center (Hsinchu City, Taiwan).	Andersson K, 1998, YALE J BIOL MED, V71, P183; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Bertoldi M, 2000, BIOCHEM J, V352, P533, DOI 10.1042/0264-6021:3520533; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fleming JV, 2004, BIOCHEM J, V379, P253, DOI 10.1042/BJ20031525; Furuta K, 2007, J BIOL CHEM, V282, P13438, DOI 10.1074/jbc.M609943200; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011; Ishii S, 1996, J BIOCHEM, V120, P369; KELLEY JL, 1977, J MED CHEM, V20, P506, DOI 10.1021/jm00214a009; KIYONO S, 1985, PHYSIOL BEHAV, V34, P615, DOI 10.1016/0031-9384(85)90057-5; KOLLONITSCH J, 1978, NATURE, V274, P906, DOI 10.1038/274906a0; Komori H, 2012, ACTA CRYSTALLOGR F, V68, P675, DOI 10.1107/S1744309112015692; Kubota Y, 2002, J NEUROCHEM, V83, P837, DOI 10.1046/j.1471-4159.2002.01189.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Montioli R, 2011, J INHERIT METAB DIS, V34, P1213, DOI 10.1007/s10545-011-9340-6; Morimoto T, 1999, PHYSIOL BEHAV, V67, P679, DOI 10.1016/S0031-9384(99)00123-7; Moya-Garcia AA, 2008, J BIOL CHEM, V283, P12393, DOI 10.1074/jbc.M707434200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitta Y, 2010, J BIOL MACROMOL, V10, P73; Nitta Y, 2007, J AGR FOOD CHEM, V55, P299, DOI 10.1021/jf062392k; Nuutinen S, 2010, ADV EXP MED BIOL, V709, P95; OHMORI E, 1990, J BIOCHEM, V107, P834, DOI 10.1093/oxfordjournals.jbchem.a123134; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Okigami H., 2006, J BIOL MACROMOL, V6, P11; Olmo M, 2002, J BIOCHEM, V132, P433, DOI 10.1093/oxfordjournals.jbchem.a003240; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parmentier R, 2002, J NEUROSCI, V22, P7695; Pino-Angeles A, 2010, PROTEINS, V78, P154, DOI 10.1002/prot.22587; Rodriguez-Caso C, 2003, CELL MOL LIFE SCI, V60, P1760, DOI 10.1007/s00018-003-3135-3; SAKAI N, 1992, LIFE SCI, V51, P397, DOI 10.1016/0024-3205(92)90406-F; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; TAGUCHI Y, 1984, J BIOL CHEM, V259, P5214; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wu F, 2008, FASEB J, V22, P890, DOI 10.1096/fj.07-9566com; Yatsunami K, 1995, J BIOL CHEM, V270, P30813, DOI 10.1074/jbc.270.51.30813	45	54	58	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29175	29183		10.1074/jbc.M112.381897	http://dx.doi.org/10.1074/jbc.M112.381897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22767596	hybrid, Green Published			2022-12-25	WOS:000308074600083
J	Cai, QC; Zhao, ZW; Antalis, C; Yan, LB; Del Priore, G; Hamed, AH; Stehman, FB; Schilder, JM; Xu, Y				Cai, Qingchun; Zhao, Zhenwen; Antalis, Caryl; Yan, Libo; Del Priore, Giuseppe; Hamed, Ali Hassan; Stehman, Frederick B.; Schilder, Jeanne M.; Xu, Yan			Elevated and secreted phospolidase A(2) activities as new potential therapeutic targets in human epithelial ovarian cancer	FASEB JOURNAL			English	Article						ascites; migration; autotaxin; methyl arachidonyl fluorophosphonate	LYSOPHOSPHATIDIC ACID PRODUCTION; PHOSPHOLIPASE A(2); CELL-MIGRATION; TUMOR-CELLS; LYSOPHOSPHOLIPIDS; CARCINOMA; INVASION; ENZYMES; GROWTH; PROLIFERATION	Ascites in epithelial ovarian cancer (EOC) promotes tumor development by mechanisms that are incompletely understood. Lysophosphatidic acid (LPA), a major tumor-promoting factor in EOC ascites, is an enzymatic product of autotaxin (ATX) and phospholipase A(2) (PLA(2)) enzymes. The contribution of PLA(2) activities to ovarian tumorigenesis was investigated. The quantitative measurement of PLA(2) activities in ascites and tissues, as well as assay conditions selective for PLA(2) subtypes, were optimized and validated. PLA(2) activities correlated with tumor-promoting activates in cell-based and in vivo assays. High activities consistent with both cytosolic and calcium-independent PLA(2) were found in human EOC ascites for the first time. Elevated PLA(2) and ATX activities were also observed in EOC compared to benign tumors and normal tissues. Cell-free and vesicle-free (S4) human EOC ascites potently promoted proliferation, migration, and invasion of human EOC cells in a PLA(2)-dependent manner. LPA mediated a significant part of the cell-stimulating effects of ascites. S4 ascites stimulated tumorigenesis/metastasis in vivo, and methyl arachidonyl fluorophosphonate was highly effective in inhibiting EOC metastasis in mouse xenograft models. PLA(2) activity was found in conditioned media from both EOC cells and macrophages. Collectively, our work implies that PLA(2) activity is a potential marker and therapeutic target in EOC.- Cai, Q., Zhao, Z., Antalis, C., Yan, L., Del Priore, G., Hamed, A. H., Stehman, F. B., Schilder, J. M., Xu, Y. Elevated and secreted phospholipase A(2) activities as new potential therapeutic targets in human epithelial ovarian cancer. FASEB J. 26, 3306-3320 (2012). www.fasebj.org	[Cai, Qingchun; Zhao, Zhenwen; Antalis, Caryl; Yan, Libo; Del Priore, Giuseppe; Hamed, Ali Hassan; Stehman, Frederick B.; Schilder, Jeanne M.; Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Xu, Y (corresponding author), Indiana Univ Sch Med, Dept Obstet & Gynecol, 975 W Walnut St,IB355A, Indianapolis, IN 46202 USA.	xu2@iupui.edu	yan, libo/H-9533-2013; Cai, Qingchun/B-6211-2015; Yan, Libo/H-2328-2012	Yan, Libo/0000-0002-4204-3397; Antalis, Caryl/0000-0002-5305-4139	National Cancer Institute [P30 CA082709]; U.S. National Institutes of Health [R01CA95042]; Mary Fendrich Hulman Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA095042, P30CA082709] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Fendrich Hulman Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Lipid analytical work was performed by the Clinical Pharmacology Analytical Core laboratory, a core laboratory of the Indiana University Melvin and Bren Simon Cancer Center, supported by the National Cancer Institute, grant P30 CA082709. This work was supported in part by the U.S. National Institutes of Health, grant R01CA95042 to Y.X., and by the Mary Fendrich Hulman Charitable Trust. The authors report no conflicts of interest.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Brown DPG, 2007, PROTEOM CLIN APPL, V1, P18, DOI 10.1002/prca.200600171; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Colin-Santana CC, 2011, BBA-GEN SUBJECTS, V1810, P1170, DOI 10.1016/j.bbagen.2011.08.016; Cummings BS, 2007, BIOCHEM PHARMACOL, V74, P949, DOI 10.1016/j.bcp.2007.04.021; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Goetzl EJ, 2000, ANN NY ACAD SCI, V905, P177; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; INOUE S, 1991, J VET MED SCI, V53, P521, DOI 10.1292/jvms.53.521; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Li H, 2011, AM J PATHOL, V179, P452, DOI 10.1016/j.ajpath.2011.03.027; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; MILLS GB, 1990, J CLIN INVEST, V86, P851, DOI 10.1172/JCI114784; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murph MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005583; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Scott KF, 2010, BIOCHIMIE, V92, P601, DOI 10.1016/j.biochi.2010.03.019; Sengupta S, 2007, ONCOGENE, V26, P2894, DOI 10.1038/sj.onc.1210093; Sengupta S, 2003, FASEB J, V17, P1570, DOI 10.1096/fj.02-1145fje; Snider AJ, 2010, AM J PHYSIOL-CELL PH, V298, pC163, DOI 10.1152/ajpcell.00001.2009; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Wang GC, 1997, BIOCHEM J, V328, P897, DOI 10.1042/bj3280897; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y., 2006, CELL SCI REV, V3, P168; Xu Yan, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P23, DOI 10.2174/1568008033340414; Xu Y, 2009, CANCER TREAT RES, V149, P241, DOI 10.1007/978-0-387-98094-2_12; YU L, 1990, J BIOL CHEM, V265, P2657; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503; Zhao ZW, 2009, J CHROMATOGR B, V877, P3739, DOI 10.1016/j.jchromb.2009.08.032	46	35	37	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3306	3320		10.1096/fj.12-207597	http://dx.doi.org/10.1096/fj.12-207597			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22767227	Green Published			2022-12-25	WOS:000307162800021
J	Dean, ED; Mexas, LM; Capiro, NL; McKeon, JE; DeLong, MR; Pennell, KD; Doorn, JA; Tangpricha, V; Miller, GW; Evatt, ML				Dean, E. Danielle; Mexas, Lydia M.; Capiro, Natalie L.; McKeon, Jeanne E.; DeLong, Mahlon R.; Pennell, Kurt D.; Doorn, Jonathan A.; Tangpricha, Vin; Miller, Gary W.; Evatt, Marian L.			25-Hydroxyvitamin D Depletion Does Not Exacerbate MPTP-Induced Dopamine Neuron Damage in Mice	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; D-RECEPTOR GENE; PARKINSONS-DISEASE; 1,25-DIHYDROXYVITAMIN D-3; HIGH PREVALENCE; ANIMAL-MODEL; ADULT-RAT; D HORMONE; EXPRESSION; BRAIN	Recent clinical evidence supports a link between 25-hydroxyvitamin D insufficiency (serum 25-hydroxyvitamin D [25(OH)D] levels <30 ng/mL) and Parkinson's disease. To investigate the effect of 25(OH)D depletion on neuronal susceptibility to toxic insult, we induced a state of 25(OH)D deficiency in mice and then challenged them with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We found there was no significant difference between control and 25(OH)D-deficient animals in striatal dopamine levels or dopamine transporter and tyrosine hydroxylase expression after lesioning with MPTP. Additionally, we found no difference in tyrosine hydroxylase expression in the substantia nigra pars compacta. Our data suggest that reducing 25(OH)D serum levels in mice has no effect on the vulnerability of nigral dopaminergic neurons in vivo in this model system of parkinsonism.	[Dean, E. Danielle; Miller, Gary W.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Dean, E. Danielle; DeLong, Mahlon R.; Miller, Gary W.; Evatt, Marian L.] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Mexas, Lydia M.; Doorn, Jonathan A.] Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA; [Capiro, Natalie L.; Pennell, Kurt D.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [McKeon, Jeanne E.; DeLong, Mahlon R.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [DeLong, Mahlon R.; Evatt, Marian L.] Dept Vet Affairs Med Ctr, Neurol Serv, Atlanta Vet Adm, Atlanta, GA USA; [Tangpricha, Vin] Dept Vet Affairs Med Ctr, Serv Endocrinol, Atlanta Vet Adm, Atlanta, GA USA; [Tangpricha, Vin] Emory Univ, Dept Med, Div Endocrinol Diabet & Lipids, Atlanta, GA 30322 USA; [Evatt, Marian L.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Evatt, Marian L.] Emory Univ, Div Movement Disorders, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; University of Iowa; Tufts University; Emory University; Emory University; Emory University; Emory University	Dean, ED (corresponding author), Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Nashville, TN 37203 USA.	mevatt@emory.edu	Tangpricha, Vin/A-8645-2009; Capiro, Natalie/G-5955-2010; Pennell, Kurt D/F-6862-2010; Pennell, Kurt/ABD-8337-2020	Tangpricha, Vin/0000-0002-4021-5853; Capiro, Natalie/0000-0002-8125-1658; Pennell, Kurt D/0000-0002-5788-6397; Miller, Gary/0000-0001-8984-1284	Atlanta Veterans Affairs Medical Center; National Institutes of Health [P01 ES 016731, T32 ES 012870, K23 AR054334]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR054334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870, P01ES016731] Funding Source: NIH RePORTER	Atlanta Veterans Affairs Medical Center(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This material is the result of work supported with resources and the use of facilities at the Atlanta Veterans Affairs Medical Center. Drs. Evatt and Tangpricha receive salary support from Atlanta Veterans Affairs Medical Center. This study was funded by grants from the National Institutes of Health (P01 ES 016731 and T32 ES 012870). Dr. Tangpricha is supported by grant K23 AR054334 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	BALLARD PA, 1985, NEUROLOGY, V35, P949, DOI 10.1212/WNL.35.7.949; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Butler MW, 2011, ANN HUM GENET, V75, P201, DOI 10.1111/j.1469-1809.2010.00631.x; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Evatt ML, 2011, ARCH NEUROL-CHICAGO, V68, P314, DOI 10.1001/archneurol.2011.30; Evatt ML, 2010, ARCH NEUROL-CHICAGO, V67, P795, DOI 10.1001/archneurol.2010.123; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Guillot TS, 2008, J MOTOR BEHAV, V40, P568, DOI 10.3200/JMBR.40.6.568-577; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Kesby JP, 2010, PSYCHOPHARMACOLOGY, V208, P159, DOI 10.1007/s00213-009-1717-y; Kim JS, 2005, J KOREAN MED SCI, V20, P495, DOI 10.3346/jkms.2005.20.3.495; Knekt P, 2010, ARCH NEUROL-CHICAGO, V67, P808, DOI 10.1001/archneurol.2010.120; Lim LS, 2005, AGE AGEING, V34, P504, DOI 10.1093/ageing/afi133; Lin AMY, 2005, ANN NY ACAD SCI, V1053, P319, DOI 10.1196/annals.1344.028; Masoumi A, 2009, J ALZHEIMERS DIS, V17, P703, DOI 10.3233/JAD-2009-1080; Miller GW, 1997, ANN NEUROL, V41, P530, DOI 10.1002/ana.410410417; Misharin A, 2009, ENDOCRINOLOGY, V150, P1051, DOI 10.1210/en.2008-1191; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; Newmark HL, 2007, MOVEMENT DISORD, V22, P461, DOI 10.1002/mds.21317; Richardson JR, 2008, NEUROTOXICOLOGY, V29, P855, DOI 10.1016/j.neuro.2008.05.007; Richardson JR, 2006, FASEB J, V20, P1695, DOI 10.1096/fj.06-5864fje; Sanchez B, 2009, J NEUROSCI RES, V87, P723, DOI 10.1002/jnr.21878; Sato Y, 2005, MOVEMENT DISORD, V20, P1598, DOI 10.1002/mds.20658; Sato Y, 1997, NEUROLOGY, V49, P1273, DOI 10.1212/WNL.49.5.1273; Shinpo K, 2000, J NEUROSCI RES, V62, P374, DOI 10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Tangpricha V, 2005, J NUTR, V135, P2350, DOI 10.1093/jn/135.10.2350; Tekes K, 2009, HORM METAB RES, V41, P277, DOI 10.1055/s-0028-1103287; Tekes K, 2009, BRAIN DEV-JPN, V31, P666, DOI 10.1016/j.braindev.2008.10.007; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wergeland S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026262; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39227	10.1371/journal.pone.0039227	http://dx.doi.org/10.1371/journal.pone.0039227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768297	gold, Green Published, Green Submitted			2022-12-25	WOS:000305966500010
J	Kroes, T; Post, FH; Botha, CP				Kroes, Thomas; Post, Frits H.; Botha, Charl P.			Exposure Render: An Interactive Photo-Realistic Volume Rendering Framework	PLOS ONE			English	Article							OCCLUSION SHADING MODEL; AMBIENT OCCLUSION; ILLUMINATION	The field of volume visualization has undergone rapid development during the past years, both due to advances in suitable computing hardware and due to the increasing availability of large volume datasets. Recent work has focused on increasing the visual realism in Direct Volume Rendering (DVR) by integrating a number of visually plausible but often effect-specific rendering techniques, for instance modeling of light occlusion and depth of field. Besides yielding more attractive renderings, especially the more realistic lighting has a positive effect on perceptual tasks. Although these new rendering techniques yield impressive results, they exhibit limitations in terms of their exibility and their performance. Monte Carlo ray tracing (MCRT), coupled with physically based light transport, is the de-facto standard for synthesizing highly realistic images in the graphics domain, although usually not from volumetric data. Due to the stochastic sampling of MCRT algorithms, numerous effects can be achieved in a relatively straight-forward fashion. For this reason, we have developed a practical framework that applies MCRT techniques also to direct volume rendering (DVR). With this work, we demonstrate that a host of realistic effects, including physically based lighting, can be simulated in a generic and flexible fashion, leading to interactive DVR with improved realism. In the hope that this improved approach to DVR will see more use in practice, we have made available our framework under a permissive open source license.	[Kroes, Thomas; Post, Frits H.; Botha, Charl P.] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Kroes, Thomas] Leiden Univ, Med Ctr, Dept Orthopaed, NL-2300 RA Leiden, Netherlands; [Botha, Charl P.] Leiden Univ, Med Ctr, Dept Radiol, LKEB, NL-2300 RA Leiden, Netherlands	Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kroes, T (corresponding author), Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands.	t.kroes@tudelft.nl	Botha, Charl P./E-9506-2010		Dutch Technology Foundation project [10812]	Dutch Technology Foundation project	This work was partly supported by the Dutch Technology Foundation project 10812 Novel pre-operative planning and intra-operative guidance system for shoulder replacement surgery. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikhmin M, 2000, COMP GRAPH, P65, DOI 10.1145/344779.344814; Banks DC, 2009, IEEE T VIS COMPUT GR, V15, P1595, DOI 10.1109/TVCG.2009.137; Barsky B, 2003, COMPUTATIONAL SCI IT, P983; Beason K., 2006, P SOC PHOTO-OPT INS, P98; Behrens U, 1998, IEEE SYMPOSIUM ON VOLUME VISUALIZATION, P39, DOI 10.1109/SVV.1998.729583; Blasi P., 1993, Computer Graphics Forum, V12, pC201, DOI 10.1111/1467-8659.1230201; Blinn J F, 1977, ACM SIGGRAPH COMPUTE, V11, P192, DOI DOI 10.1145/563858.563893; Buades A, 2006, IEEE T IMAGE PROCESS, V15, P1499, DOI 10.1109/TIP.2006.871137; Csebfalvi B, 2003, P 14 IEEE VIS 2003 V, P59; Hadwiger M., 2006, P 21 ACM SIGGRAPHEUR, P49, DOI [10.1145/1283900.1283908, DOI 10.1145/1283900.1283908]; Kniss J, 2003, IEEE T VIS COMPUT GR, V9, P150, DOI 10.1109/TVCG.2003.1196003; Kniss J, 2002, IEEE T VIS COMPUT GR, V8, P270, DOI 10.1109/TVCG.2002.1021579; Knuth D.E., 1997, FUNDAMENTAL ALGORITH, VI; Kontkanen J, 2006, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2004, P259, DOI 10.1007/3-540-31186-6_16; Kronander J., 2011, IEEE T VISUALIZATION, V99; Lindemann F., 2010, IEEE EG INT S VOL GR, P101; Lindemann F, 2011, IEEE T VIS COMPUT GR, V17, P1922, DOI 10.1109/TVCG.2011.161; Lokovic T, 2000, COMP GRAPH, P385, DOI 10.1145/344779.344958; MAX N, 1995, IEEE T VIS COMPUT GR, V1, P99, DOI 10.1109/2945.468400; McCool MD, 1999, ACM T GRAPHIC, V18, P171, DOI 10.1145/318009.318015; Mendez-Feliu A, 2009, VISUAL COMPUT, V25, P181, DOI 10.1007/s00371-008-0213-4; Novak J., 2010, P EUROGRAPHICS; Penner E., 2008, P 5 EUR IEEE VGTC C, P57, DOI [10.2312/VG/VG-PBG08/057-064, DOI 10.2312/VG/VG-PBG08/057-064]; Ritschel T., 2007, P EUR, P17; Ropinski T, 2008, COMPUT GRAPH FORUM, V27, P567, DOI 10.1111/j.1467-8659.2008.01154.x; Ropinski T, 2010, IEEE PAC VIS SYMP, P169, DOI 10.1109/PACIFICVIS.2010.5429594; Ropinski T, 2008, WSCG 2008, FULL PAPERS, P17; Salama CR, 2007, PACIFIC GRAPHICS 2007: 15TH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, P411, DOI 10.1109/PG.2007.27; Schlegel P, 2011, IEEE T VIS COMPUT GR, V17, P1795, DOI 10.1109/TVCG.2011.198; Schott M, 2011, COMPUT GRAPH FORUM, V30, P941, DOI 10.1111/j.1467-8659.2011.01943.x; Schott M, 2009, COMPUT GRAPH FORUM, V28, P855, DOI 10.1111/j.1467-8659.2009.01464.x; Solteszova V, 2010, COMPUT GRAPH FORUM, V29, P883, DOI 10.1111/j.1467-8659.2009.01695.x; Stewart A. J., 2003, P 2003 IEEE S VIS I, P47; Suykens F., 2000, WSCG 2000 C P; Szirmay-Kalos L, 2011, COMPUT GRAPH FORUM, V30, P85, DOI 10.1111/j.1467-8659.2010.01831.x; van Antwerpen D, 2011, P HIGH PERF GRAPH 20; Veach E, 1997, THESIS CITESEER; WANGER LR, 1992, IEEE COMPUT GRAPH, V12, P44, DOI 10.1109/38.135913; Woodcock E, 1965, P C APPL COMP METH R, P557; Wyman C, 2006, IEEE T VIS COMPUT GR, V12, P186, DOI 10.1109/TVCG.2006.33; Xu RF, 2005, IEEE COMPUT GRAPH, V25, P31, DOI 10.1109/MCG.2005.31; Zhukov S., 1998, Rendering Techniques '98. Proceedings of the Eurographics Workshop, P45	42	70	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e38586	10.1371/journal.pone.0038586	http://dx.doi.org/10.1371/journal.pone.0038586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768292	gold, Green Published			2022-12-25	WOS:000305966500005
J	Miedel, MT; Graf, NJ; Stephen, KE; Long, OS; Pak, SC; Perlmutter, DH; Silverman, GA; Luke, CJ				Miedel, Mark T.; Graf, Nathan J.; Stephen, Kate E.; Long, Olivia S.; Pak, Stephen C.; Perlmutter, David H.; Silverman, Gary A.; Luke, Cliff J.			A Pro-Cathepsin L Mutant Is a Luminal Substrate for Endoplasmic-Reticulum-Associated Degradation in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN-DEGRADATION; RETRO-TRANSLOCATION; MEMBRANE-PROTEIN; PROTEASOME; ERAD; PROTEOSTASIS; EXPRESSION; DISEASE; EMBRYOGENESIS	Endoplasmic-reticulum associated degradation (ERAD) is a major cellular misfolded protein disposal pathway that is well conserved from yeast to mammals. In yeast, a mutant of carboxypeptidase Y (CPY*) was found to be a luminal ER substrate and has served as a useful marker to help identify modifiers of the ERAD pathway. Due to its ease of genetic manipulation and the ability to conduct a genome wide screen for modifiers of molecular pathways, C. elegans has become one of the preferred metazoans for studying cell biological processes, such as ERAD. However, a marker of ERAD activity comparable to CPY* has not been developed for this model system. We describe a mutant of pro-cathepsin L fused to YFP that no longer targets to the lysosome, but is efficiently eliminated by the ERAD pathway. Using this mutant pro-cathepsin L, we found that components of the mammalian ERAD system that participate in the degradation of ER luminal substrates were conserved in C. elegans. This transgenic line will facilitate high-throughput genetic or pharmacological screens for ERAD modifiers using widefield epifluorescence microscopy.	[Miedel, Mark T.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA; UPMC, Magee Womens Hosp, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Miedel, MT (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA.	cliff.luke@chp.edu	Silverman, Gary/AAJ-1269-2020	Miedel, Mark/0000-0002-0132-6032; Pak, Stephen/0000-0002-8089-3237	National Institutes of Health [F32DK086112, DK0854512, DK076918, DK079806, DK081422]; Hartwell Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076918, R01DK079806, F32DK086112, R01DK081422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (F32DK086112 to MTM, DK0854512 and DK076918 to DHP, DK079806 and DK081422 to GAS) (http://www.nih.gov) and The Hartwell Foundation (http://www.thehartwellfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bhatia SR, 2011, METHOD ENZYMOL, V499, P283, DOI 10.1016/B978-0-12-386471-0.00014-6; Britton C, 2004, J CELL SCI, V117, P5133, DOI 10.1242/jcs.01387; Campbell EM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-40; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chapman RL, 1997, J BIOL CHEM, V272, P8808, DOI 10.1074/jbc.272.13.8808; Chi Woo, 2006, Development, V133, P3147, DOI 10.1242/dev.02490; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishida Y, 2009, AUTOPHAGY, V5, P1217, DOI 10.4161/auto.5.8.10168; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kipreos E. T., 2005, WORMBOOK, V1, P24, DOI [10.1895/wormbook.1.36.1, DOI 10.1895/WORMBOOK.1.7.1]; Kreusch S, 2000, EUR J BIOCHEM, V267, P2965; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Mailhes John B, 2002, Cell Chromosome, V1, P2, DOI 10.1186/1475-9268-1-2; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; Naganawa Y, 1999, BIOCHEM J, V340, P467, DOI 10.1042/0264-6021:3400467; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Sasagawa Y, 2007, GENES CELLS, V12, P1063, DOI 10.1111/j.1365-2443.2007.01108.x; Sasagawa Y, 2007, BIOCHEM BIOPH RES CO, V358, P920, DOI 10.1016/j.bbrc.2007.05.022; Schaheen B, 2009, J CELL SCI, V122, P2228, DOI 10.1242/jcs.048892; Segref A, 2011, GENETICS, V187, P1235, DOI 10.1534/genetics.111.126797; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yamamoto M, 2010, BIOCHEM BIOPH RES CO, V393, P384, DOI 10.1016/j.bbrc.2010.02.001; Yamauchi S, 2006, BIOCHEM BIOPH RES CO, V345, P746, DOI 10.1016/j.bbrc.2006.04.160; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	55	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40145	10.1371/journal.pone.0040145	http://dx.doi.org/10.1371/journal.pone.0040145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768338	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305966500051
J	Ahn, HJ; Cha, Y; Moon, SH; Jung, JE; Park, KS				Ahn, Hee-Jin; Cha, Young; Moon, Seok-Ho; Jung, Jee-Eun; Park, Kyung-Soon			Ell3 Enhances Differentiation of Mouse Embryonic Stem Cells by Regulating Epithelial-Mesenchymal Transition and Apoptosis	PLOS ONE			English	Article							DEVELOPMENTAL REGULATORS; EXPRESSION; P53; GENE; IDENTIFICATION; SPECIFICATION; POLYCOMB; MAINTAIN; CANCER; STAT3	Ell3 is a testis-specific RNA polymerase II elongation factor whose cellular function is not clear. The present study shows that Ell3 is activated during the differentiation of mouse embryonic stem cells (mESCs). Furthermore, Ell3 plays a critical role in stimulating lineage differentiation of mESCs by promoting epithelial-mesenchymal transition (EMT) and suppressing apoptosis. Mouse ESCs engineered to stably express Ell3 were rapidly differentiated compared with control cells either under spontaneous differentiation or neural lineage-specific differentiation conditions. Gene expression profile and quantitative RT-PCR analysis showed that the expression of EMT markers, such as Zeb1 and Zeb2, two major genes that regulate EMT, was upregulated in Ell3-overexpressing mESCs. Remarkably, knockdown of Zeb1 attenuated the enhanced differentiation capacity of Ell3-overexpressing mESCs, which indicates that Ell3 plays a role in the induction of mESC differentiation by inducing EMT. In contrast to Ell3-overexpressing mESCs, Ell3-knock down mESCs could not differentiate under differentiation conditions and, instead, underwent caspase-dependent apoptosis. In addition, apoptosis of differentiating Ell3-knock out mESCs was associated with enhanced expression of p53. The present results suggest that Ell3 promotes the differentiation of mESCs by activating the expression of EMT-related genes and by suppressing p53 expression.	[Ahn, Hee-Jin; Cha, Young; Moon, Seok-Ho; Jung, Jee-Eun; Park, Kyung-Soon] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea	Pochon Cha University	Ahn, HJ (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea.	kspark@cha.ac.kr	Cha, Young/AAI-3460-2020	Cha, Young/0000-0001-7647-0699	Korea Science and Engineering Foundation (KOSEF) of the Korean government (MOST) [2010-0003254, 2011-0014084]; Ministry of Health Welfare [A091087-0911-0000200]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0093821]	Korea Science and Engineering Foundation (KOSEF) of the Korean government (MOST)(Korea Science and Engineering Foundation); Ministry of Health Welfare; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) of the Korean government (MOST) (2010-0003254, 2011-0014084) and Korea Health Technology R&D project, Ministry of Health & Welfare (A091087-0911-0000200). This work was also supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cha Y, FEBS LETT, V584, P4241; Cha Y, 2010, STEM CELLS, V28, P1476, DOI 10.1002/stem.470; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Johnstone RW, 2001, MOL CELL BIOL, V21, P1672, DOI 10.1128/MCB.21.5.1672-1681.2001; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Tanaka H, NAT MED, V16, P1414; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamada Y, CELL STEM CELL, V6, P10; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037	34	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40293	10.1371/journal.pone.0040293	http://dx.doi.org/10.1371/journal.pone.0040293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768269	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100243
J	Bakst, RL; Lee, N; He, SB; Chernichenko, N; Chen, CH; Linkov, G; Le, HC; Koutcher, J; Vakiani, E; Wong, RJ				Bakst, Richard L.; Lee, Nancy; He, Shuangba; Chernichenko, Natalya; Chen, Chun-Hao; Linkov, Gary; Le, H. Carl; Koutcher, Jason; Vakiani, Efsevia; Wong, Richard J.			Radiation Impairs Perineural Invasion by Modulating the Nerve Microenvironment	PLOS ONE			English	Article							ADENOID CYSTIC CARCINOMA; SQUAMOUS-CELL CARCINOMA; NEUROTROPHIC FACTOR; PANCREATIC-CANCER; PROSTATE-CANCER; RET PROTOONCOGENE; SALIVARY-GLANDS; AXON GUIDANCE; HEAD; NECK	Purpose: Perineural invasion (PNI) by cancer cells is an ominous clinical event that is associated with increased local recurrence and poor prognosis. Although radiation therapy (RT) may be delivered along the course of an invaded nerve, the mechanisms through which radiation may potentially control PNI remain undefined. Experimental Design: An in vitro co-culture system of dorsal root ganglia (DRG) and pancreatic cancer cells was used as a model of PNI. An in vivo murine sciatic nerve model was used to study how RT to nerve or cancer affects nerve invasion by cancer. Results: Cancer cell invasion of the DRG was partially dependent on DRG secretion of glial-derived neurotrophic factor (GDNF). A single 4 Gy dose of radiation to the DRG alone, cultured with non-radiated cancer cells, significantly inhibited PNI and was associated with decreased GDNF secretion but intact DRG viability. Radiation of cancer cells alone, co-cultured with non-radiated nerves, inhibited PNI through predominantly compromised cancer cell viability. In a murine model of PNI, a single 8 Gy dose of radiation to the sciatic nerve prior to implantation of non-radiated cancer cells resulted in decreased GDNF expression, decreased PNI by imaging and histology, and preservation of sciatic nerve motor function. Conclusions: Radiation may impair PNI through not only direct effects on cancer cell viability, but also an independent interruption of paracrine mechanisms underlying PNI. RT modulation of the nerve microenvironment may decrease PNI, and hold significant therapeutic implications for RT dosing and field design for patients with cancers exhibiting PNI.	[Bakst, Richard L.; Lee, Nancy] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [He, Shuangba; Chernichenko, Natalya; Chen, Chun-Hao; Linkov, Gary; Wong, Richard J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Le, H. Carl; Koutcher, Jason] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Koutcher, Jason] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Vakiani, Efsevia] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bakst, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.	wongr@mskcc.org		He, Shuangba/0000-0002-5171-8819; Linkov, Gary/0000-0001-8584-5851	National Cancer Institute from National Institutes of Health [1R01CA157686-01]; NATIONAL CANCER INSTITUTE [R01CA157686, T32CA009685] Funding Source: NIH RePORTER	National Cancer Institute from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Richard J. Wong is funded by National Cancer Institute, from the National Institutes of Health grant no. 1R01CA157686-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERT K, 1976, CELL TISSUE RES, V165, P281; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Bapat AA, 2011, NAT REV CANCER, V11, P695, DOI 10.1038/nrc3131; Batchelor PE, 1999, J NEUROSCI, V19, P1708; BATSAKIS JG, 1985, ANN OTO RHINOL LARYN, V94, P426; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chen AM, 2007, INT J RADIAT ONCOL, V67, P982, DOI 10.1016/j.ijrobp.2006.10.043; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Cornell RJ, 2003, UROLOGY, V61, P870, DOI 10.1016/S0090-4295(02)02426-3; Dawson DM, 1998, J NATL CANCER I, V90, P519, DOI 10.1093/jnci/90.7.519; Fagan JJ, 1998, ARCH OTOLARYNGOL, V124, P637, DOI 10.1001/archotol.124.6.637; GARDEN AS, 1995, INT J RADIAT ONCOL, V32, P619, DOI 10.1016/0360-3016(95)00122-F; GARDEN AS, 1994, CANCER, V73, P2563, DOI 10.1002/1097-0142(19940515)73:10<2563::AID-CNCR2820731018>3.0.CO;2-X; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; GOEPFERT H, 1984, AM J SURG, V148, P542, DOI 10.1016/0002-9610(84)90385-4; Gomez DR, 2008, INT J RADIAT ONCOL, V70, P1365, DOI 10.1016/j.ijrobp.2007.08.008; Ito Y, 2005, SURGERY, V138, P788, DOI 10.1016/j.surg.2005.07.007; LARSON DL, 1966, AM J SURG, V112, P488, DOI 10.1016/0002-9610(66)90309-6; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Okada Y, 1999, INT J CANCER, V81, P67, DOI 10.1002/(SICI)1097-0215(19990331)81:1<67::AID-IJC13>3.0.CO;2-V; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Singh B, 2001, CANCER RES, V61, P4506; SOO KC, 1986, LARYNGOSCOPE, V96, P1145; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004	24	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39925	10.1371/journal.pone.0039925	http://dx.doi.org/10.1371/journal.pone.0039925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768171	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100141
J	Champiat, S; Raposo, RAS; Maness, NJ; Lehman, JL; Purtell, SE; Hasenkrug, AM; Miller, JC; Dean, H; Koff, WC; Hong, MA; Martin, JN; Deeks, SG; Spotts, GE; Pilcher, CD; Hecht, FM; Kallas, EG; Garrison, KE; Nixon, DF				Champiat, Stephane; Raposo, Rui Andre Saraiva; Maness, Nicholas J.; Lehman, John L.; Purtell, Sean E.; Hasenkrug, Aaron M.; Miller, Jacob C.; Dean, Hansi; Koff, Wayne C.; Hong, Marisa Ailin; Martin, Jeffrey N.; Deeks, Steven G.; Spotts, Gerald E.; Pilcher, Christopher D.; Hecht, Fredrick M.; Kallas, Esper G.; Garrison, Keith E.; Nixon, Douglas F.			Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS TYPE-1 PROTEASE; VIRAL LOAD; CTL EPITOPES; TRANSLATION INITIATION; SELECTION PRESSURE; SUBTYPE-C; LYMPHOCYTES; GENE; RNA	Background: Translational errors can result in bypassing of the main viral protein reading frames and the production of alternate reading frame (ARF) or cryptic peptides. Within HIV, there are many such ARFs in both sense and the antisense directions of transcription. These ARFs have the potential to generate immunogenic peptides called cryptic epitopes (CE). Both antiretroviral drug therapy and the immune system exert a mutational pressure on HIV-1. Immune pressure exerted by ARF CD8(+) T cells on the virus has already been observed in vitro. HAART has also been described to select HIV-1 variants for drug escape mutations. Since the mutational pressure exerted on one location of the HIV-1 genome can potentially affect the 3 reading frames, we hypothesized that ARF responses would be affected by this drug pressure in vivo. Methodology/Principal findings: In this study we identified new ARFs derived from sense and antisense transcription of HIV-1. Many of these ARFs are detectable in circulating viral proteins. They are predominantly found in the HIV-1 env nucleotide region. We measured T cell responses to 199 HIV-1 CE encoded within 13 sense and 34 antisense HIV-1 ARFs. We were able to observe that these ARF responses are more frequent and of greater magnitude in chronically infected individuals compared to acutely infected patients, and in patients on HAART, the breadth of ARF responses increased. Conclusions/Significance: These results have implications for vaccine design and unveil the existence of potential new epitopes that could be included as vaccine targets.	[Champiat, Stephane; Raposo, Rui Andre Saraiva; Lehman, John L.; Hasenkrug, Aaron M.; Miller, Jacob C.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Maness, Nicholas J.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Dean, Hansi; Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY USA; [Hong, Marisa Ailin; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Hong, Marisa Ailin] Adolfo Lutz Inst, Sao Paulo, Brazil; [Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA USA; [Deeks, Steven G.; Spotts, Gerald E.; Pilcher, Christopher D.; Hecht, Fredrick M.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Posit Hlth Program, San Francisco, CA USA; [Lehman, John L.; Purtell, Sean E.; Garrison, Keith E.] St Marys Coll Calif, Dept Biol, Moraga, CA USA	University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; International AIDS Vaccine Initiative; Universidade de Sao Paulo; Instituto Adolfo Lutz; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Saint Mary's College of California	Champiat, S (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	douglas.nixon@ucsf.edu	Nixon, Douglas/AAU-5734-2020; Champiat, Stephane/O-4780-2014	Nixon, Douglas/0000-0002-2801-1786; Raposo, R. Andre/0000-0001-5435-0290; Champiat, Stephane/0000-0002-0741-2118; Hecht, Frederick/0000-0002-5782-1171; Kallas, Esper/0000-0003-2026-6925	International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K24AI069994] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the International AIDS Vaccine Initiative (IAVI), a not for profit organization focused on helping facilitate the discovery of an effective AIDS vaccine. Two scientists from IAVI were involved in the design, analysis and writing of the paper and are included as co-authors. The funders had no role in data collection or decision to publish the manuscript.	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Berger CT, 2010, J EXP MED, V207, P61, DOI 10.1084/jem.20091808; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BRUCE AG, 1986, P NATL ACAD SCI USA, V83, P5062, DOI 10.1073/pnas.83.14.5062; Bullock TNJ, 1996, J EXP MED, V184, P1319, DOI 10.1084/jem.184.4.1319; Bullock TNJ, 1997, J EXP MED, V186, P1051, DOI 10.1084/jem.186.7.1051; Cardinaud S, 2004, J EXP MED, V199, P1053, DOI 10.1084/jem.20031869; FETTEN JV, 1991, J IMMUNOL, V147, P2697; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Garrison KE, 2009, CLIN VACCINE IMMUNOL, V16, P1369, DOI 10.1128/CVI.00410-08; Gatanaga H, 2010, AIDS, V24, pF15, DOI 10.1097/QAD.0b013e328337b010; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Ho O, 2006, J IMMUNOL, V176, P2470, DOI 10.4049/jimmunol.176.4.2470; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; John M, 2005, ANTIVIR THER, V10, P551; Karlsson AC, 2003, J VIROL, V77, P6743, DOI 10.1128/JVI.77.12.6743-6752.2003; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Landry S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-71; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Ludwig LB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-80; Mahnke Lisa, 2006, AIDS Res Ther, V3, P21, DOI 10.1186/1742-6405-3-21; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Maness NJ, 2010, J IMMUNOL, V184, P67, DOI 10.4049/jimmunol.0903118; Maness NJ, 2009, J VIROL, V83, P10280, DOI 10.1128/JVI.00138-09; Manosuthi W, 2010, AIDS, V24, P411, DOI 10.1097/QAD.0b013e3283350eef; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Mason RA, 2004, J IMMUNOL, V172, P7212, DOI 10.4049/jimmunol.172.11.7212; Mayrand SM, 1998, IMMUNOL TODAY, V19, P551, DOI 10.1016/S0167-5699(98)01342-5; McBratney S, 1993, CURR OPIN CELL BIOL, V5, P961, DOI 10.1016/0955-0674(93)90077-4; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Meiklejohn DA, 2004, J IMMUNOL METHODS, V288, P135, DOI 10.1016/j.jim.2004.03.006; MICHAEL NL, 1994, J VIROL, V68, P979, DOI 10.1128/JVI.68.2.979-987.1994; Mueller SM, 2007, J VIROL, V81, P2887, DOI 10.1128/JVI.01547-06; Mueller SM, 2011, JAIDS-J ACQ IMM DEF, V56, P109, DOI 10.1097/QAI.0b013e3181fe946e; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Probst-Kepper M, 2001, J EXP MED, V193, P1189, DOI 10.1084/jem.193.10.1189; Rimoldi D, 2000, J IMMUNOL, V165, P7253, DOI 10.4049/jimmunol.165.12.7253; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; Samri A, 2000, J VIROL, V74, P9306, DOI 10.1128/JVI.74.19.9306-9312.2000; Saulquin X, 2002, J EXP MED, V195, P353, DOI 10.1084/jem.20011399; Schmitt M, 2000, AIDS, V14, P653, DOI 10.1097/00002030-200004140-00004; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; WEISS RB, 1987, COLD SPRING HARB SYM, V52, P687, DOI 10.1101/SQB.1987.052.01.078; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39311	10.1371/journal.pone.0039311	http://dx.doi.org/10.1371/journal.pone.0039311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768072	Green Published, gold			2022-12-25	WOS:000305892100043
J	Kirchhoff, T; Gaudet, MM; Antoniou, AC; McGuffog, L; Humphreys, MK; Dunning, AM; Bojesen, SE; Nordestgaard, BG; Flyger, H; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Dork, T; Schurmann, P; Karstens, JH; Hillemanns, P; Couch, FJ; Olson, J; Vachon, C; Wang, XS; Cox, A; Brock, I; Elliott, G; Reed, MWR; Burwinkel, B; Meindl, A; Brauch, H; Hamann, U; Ko, YD; Broeks, A; Schmidt, MK; van 't Veer, LJ; Braaf, LM; Johnson, N; Fletcher, O; Gibson, L; Peto, J; Turnbull, C; Seal, S; Renwick, A; Rahman, N; Wu, PE; Yu, JC; Hsiung, CN; Shen, CY; Southey, MC; Hopper, JL; Hammet, F; Van Dorpe, T; Dieudonne, AS; Hatse, S; Lambrechts, D; Andrulis, IL; Bogdanova, N; Antonenkova, N; Rogov, JI; Prokofieva, D; Bermisheva, M; Khusnutdinova, E; van Asperen, CJ; Tollenaar, RAEM; Hooning, MJ; Devilee, P; Margolin, S; Lindblom, A; Milne, RL; Arias, JI; Zamora, MP; Benitez, J; Severi, G; Baglietto, L; Giles, GG; Spurdle, AB; Beesley, J; Chen, XQ; Holland, H; Healey, S; Wang-Gohrke, S; Chang-Claude, J; Mannermaa, A; Kosma, VM; Kauppinen, J; Kataja, V; Agnarsson, BA; Caligo, MA; Godwin, AK; Nevanlinna, H; Heikkinen, T; Fredericksen, Z; Lindor, N; Nathanson, KL; Domchek, SM; Loman, N; Karlsson, P; Askmalm, MS; Melin, B; von Wachenfeldt, A; Hogervorst, FBL; Verheus, M; Rookus, MA; Seynaeve, C; Oldenburg, RA; Ligtenberg, MJ; Ausems, MGEM; Aalfs, CM; Gille, HJP; Wijnen, JT; Garcia, EBG; Peock, S; Cook, M; Oliver, CT; Frost, D; Luccarini, C; Pichert, G; Davidson, R; Chu, C; Eccles, D; Ong, KR; Cook, J; Douglas, F; Hodgson, S; Evans, DG; Eeles, R; Gold, B; Pharoah, PDP; Offit, K; Chenevix-Trench, G; Easton, DF				Kirchhoff, Tomas; Gaudet, Mia M.; Antoniou, Antonis C.; McGuffog, Lesley; Humphreys, Manjeet K.; Dunning, Alison M.; Bojesen, Stig E.; Nordestgaard, Borge G.; Flyger, Henrik; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Dork, Thilo; Schuermann, Peter; Karstens, Johann H.; Hillemanns, Peter; Couch, Fergus J.; Olson, Janet; Vachon, Celine; Wang, Xianshu; Cox, Angela; Brock, Ian; Elliott, Graeme; Reed, Malcolm W. R.; Burwinkel, Barbara; Meindl, Alfons; Brauch, Hiltrud; Hamann, Ute; Ko, Yon-Dschun; Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.; Johnson, Nichola; Fletcher, Olivia; Gibson, Lorna; Peto, Julian; Turnbull, Clare; Seal, Sheila; Renwick, Anthony; Rahman, Nazneen; Wu, Pei-Ei; Yu, Jyh-Cherng; Hsiung, Chia-Ni; Shen, Chen-Yang; Southey, Melissa C.; Hopper, John L.; Hammet, Fleur; Van Dorpe, Thijs; Dieudonne, Anne-Sophie; Hatse, Sigrid; Lambrechts, Diether; Andrulis, Irene L.; Bogdanova, Natalia; Antonenkova, Natalia; Rogov, Juri I.; Prokofieva, Daria; Bermisheva, Marina; Khusnutdinova, Elza; van Asperen, Christi J.; Tollenaar, Robert A. E. M.; Hooning, Maartje J.; Devilee, Peter; Margolin, Sara; Lindblom, Annika; Milne, Roger L.; Ignacio Arias, Jose; Pilar Zamora, M.; Benitez, Javier; Severi, Gianluca; Baglietto, Laura; Giles, Graham G.; Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Holland, Helene; Healey, Sue; Wang-Gohrke, Shan; Chang-Claude, Jenny; Mannermaa, Arto; Kosma, Veli-Matti; Kauppinen, Jaana; Kataja, Vesa; Agnarsson, Bjarni A.; Caligo, Maria A.; Godwin, Andrew K.; Nevanlinna, Heli; Heikkinen, Tuomas; Fredericksen, Zachary; Lindor, Noralane; Nathanson, Katherine L.; Domchek, Susan M.; Loman, Niklas; Karlsson, Per; Askmalm, Marie Stenmark; Melin, Beatrice; von Wachenfeldt, Anna; Hogervorst, Frans B. L.; Verheus, Martijn; Rookus, Matti A.; Seynaeve, Caroline; Oldenburg, Rogier A.; Ligtenberg, Marjolijn J.; Ausems, Margreet G. E. M.; Aalfs, Cora M.; Gille, Hans J. P.; Wijnen, Juul T.; Garcia, Encarna B. Gomez; Peock, Susan; Cook, Margaret; Oliver, Clare T.; Frost, Debra; Luccarini, Craig; Pichert, Gabriella; Davidson, Rosemarie; Chu, Carol; Eccles, Diana; Ong, Kai-Ren; Cook, Jackie; Douglas, Fiona; Hodgson, Shirley; Evans, D. Gareth; Eeles, Rosalind; Gold, Bert; Pharoah, Paul D. P.; Offit, Kenneth; Chenevix-Trench, Georgia; Easton, Douglas F.		GENICA Network; kConFab; AOCS Study Grp; SWE-BRCA; HEBON; EMBRACE; BCAC-CIMBA	Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; VARIANTS; ALLELES; FGFR2; GENE	Recently, a locus on chromosome 6q22.33 (rs2180341) was reported to be associated with increased breast cancer risk in the Ashkenazi Jewish (AJ) population, and this association was also observed in populations of non-AJ European ancestry. In the present study, we performed a large replication analysis of rs2180341 using data from 31,428 invasive breast cancer cases and 34,700 controls collected from 25 studies in the Breast Cancer Association Consortium (BCAC). In addition, we evaluated whether rs2180341 modifies breast cancer risk in 3,361 BRCA1 and 2,020 BRCA2 carriers from 11 centers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Based on the BCAC data from women of European ancestry, we found evidence for a weak association with breast cancer risk for rs2180341 (per-allele odds ratio (OR) = 1.03, 95% CI 1.00-1.06, p = 0.023). There was evidence for heterogeneity in the ORs among studies (I-2 = 49.3%; p = <0.004). In CIMBA, we observed an inverse association with the minor allele of rs2180341 and breast cancer risk in BRCA1 mutation carriers (per-allele OR = 0.89, 95% CI 0.80-1.00, p = 0.048), indicating a potential protective effect of this allele. These data suggest that that 6q22.33 confers a weak effect on breast cancer risk.	[Kirchhoff, Tomas; Gaudet, Mia M.; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, New York, NY 10021 USA; [Kirchhoff, Tomas] NYU, Inst Canc, Dept Environm Med, New York, NY USA; [Gaudet, Mia M.] Amer Canc Soc, Atlanta, GA 30329 USA; [Antoniou, Antonis C.; McGuffog, Lesley; Humphreys, Manjeet K.; Dunning, Alison M.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Studies Epidemiol & Risk Factors Canc Hered SEARC, Dept Oncol, Cambridge, England; [Antoniou, Antonis C.; McGuffog, Lesley; Humphreys, Manjeet K.; Dunning, Alison M.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Dept Clin Biochem, Copenhagen Breast Canc Study, DK-1168 Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Dept Clin Biochem, Copenhagen Gen Populat Study, DK-1168 Copenhagen, Denmark; [Flyger, Henrik] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, DK-1168 Copenhagen, Denmark; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun] Seoul Natl Univ, Coll Med, Seoul Breast Canc Study SEBCS, Seoul, South Korea; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun] Natl Canc Ctr, Seoul, South Korea; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun] Univ Ulsan, Coll Med, Dept Surg, Ulsan 680749, South Korea; [Dork, Thilo; Schuermann, Peter; Karstens, Johann H.; Hillemanns, Peter] Hannover Med Sch, Hannover Breast Canc Study HABCS, Clin Obstet & Gynecol, D-3000 Hannover, Germany; [Dork, Thilo; Schuermann, Peter; Karstens, Johann H.; Hillemanns, Peter] Hannover Med Sch, Hannover Breast Canc Study HABCS, Clin Radiat Oncol, D-3000 Hannover, Germany; [Couch, Fergus J.; Olson, Janet; Vachon, Celine; Wang, Xianshu] Mayo Clin, MCBCS, Rochester, MN USA; [Cox, Angela; Brock, Ian; Elliott, Graeme; Reed, Malcolm W. R.] Univ Sheffield, Sch Med, Dept Oncol, SBCS, Sheffield, S Yorkshire, England; [Burwinkel, Barbara] German Canc Res Ctr, Inst Human Genet, GC HBOC, D-6900 Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Div Tumor Genet, Dept Obstet & Gynecol, Munich, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Gene Environm Interact & Breast Canc Germany GENI, D-7000 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Hamann, Ute] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Ko, Yon-Dschun] Evangel Kliniken Bonn gGmbH, Johanniter Krankenhaus, Dept Internal Med, Bonn, Germany; Univ Bonn, Fac Med, Inst Pathol, Bonn, Germany; German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany; [Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.] Netherlands Canc Inst, ABCS, Dept Expt Therapy, Amsterdam, Netherlands; [Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.] Netherlands Canc Inst, ABCS, Dept Epidemiol, Amsterdam, Netherlands; [Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.] Netherlands Canc Inst, ABCS, Dept Mol Pathol, Amsterdam, Netherlands; [Johnson, Nichola; Fletcher, Olivia] Inst Canc Res, Breakthrough Breast Canc Res Ctr, BBCS, London SW3 6JB, England; [Gibson, Lorna; Peto, Julian] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Turnbull, Clare; Seal, Sheila; Renwick, Anthony; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, ICR Familial Breast Canc Study FBCS, Sutton, Surrey, England; [Hsiung, Chia-Ni; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwanese Breast Canc Study TWBCS, Taipei, Taiwan; [Wu, Pei-Ei] Acad Sinica, Taiwan Biobank, Taipei, Taiwan; [Yu, Jyh-Cherng] Tri Serv Gen Hosp, Dept Surg, Taipei, Taiwan; [Southey, Melissa C.; Hammet, Fleur] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, ABCFS, Melbourne, Vic 3010, Australia; [Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Van Dorpe, Thijs; Dieudonne, Anne-Sophie; Hatse, Sigrid] Katholieke Univ Leuven, Multidisciplinary Breast Clin, LMBC, Louvain, Belgium; [Lambrechts, Diether] Vesalius Res Ctr, Louvain, Belgium; [Andrulis, Irene L.] Canc Care Ontario, Ontario Canc Genet Network, OFBCR, Toronto, ON, Canada; [Andrulis, Irene L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bogdanova, Natalia; Antonenkova, Natalia; Rogov, Juri I.] NN Alexandrov Res Inst Oncol & Med Radiol, HMBCS, Minsk, BELARUS; [Prokofieva, Daria; Bermisheva, Marina; Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, HUBCS, Ufa, Russia; [Hooning, Maartje J.] Erasmus MC, Dept Med Oncol, Leiden Univ Med Ctr Breast Canc Study ORIGO, Rotterdam, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet & Pathol, Leiden, Netherlands; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Karolinska Breast Canc Study KARBAC, S-10401 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, S-10401 Stockholm, Sweden; [Margolin, Sara] Karolinska Univ, Stockholm, Sweden; [Milne, Roger L.] Spanish Natl Canc Ctr, Genet & Mol Epidemiol Grp, Spanish Natl Canc Ctr Breast Canc Study CNIO BCS, Madrid, Spain; [Benitez, Javier] Spanish Natl Canc Ctr, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Ctr Invest Biomed Red Enfermedades Rares, Valencia, Spain; [Ignacio Arias, Jose] Monte Naranco Hosp, Oviedo, Spain; [Pilar Zamora, M.] La Paz Univ Hosp, Madrid, Spain; [Southey, Melissa C.; Severi, Gianluca; Baglietto, Laura; Giles, Graham G.] Canc Council, Canc Epidemiol Ctr, MCCS, Melbourne, Vic, Australia; [Southey, Melissa C.; Severi, Gianluca; Baglietto, Laura; Giles, Graham G.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Holland, Helene; Healey, Sue; Chenevix-Trench, Georgia] Queensland Inst Med Res, Kathleen Cuningham Fdn Consortium Res Familial Br, Brisbane, Qld 4006, Australia; [Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Holland, Helene; Healey, Sue; Chenevix-Trench, Georgia] Peter MacCallum Canc Ctr, Australian Ovarian Canc Study Grp, Melbourne, Vic, Australia; [Chang-Claude, Jenny] German Canc Res Ctr DFKZ, Div Canc Epidemiol, Genet Epidemiol Study Breast Canc Age 50 GESBC, Heidelberg, Germany; [Wang-Gohrke, Shan] Univ Ulm, Dept Gynecol & Obstet, Mol Biol Lab, Ulm, Germany; [Mannermaa, Arto; Kosma, Veli-Matti; Kauppinen, Jaana] Univ Eastern Finland, Dept Pathol, Inst Clin Med, KBCP, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Kauppinen, Jaana] Kuopio Univ Hosp, Bioctr Kuopio, SF-70210 Kuopio, Finland; [Kataja, Vesa] Vaasa Cent Hosp, Dept Oncol, Vaasa, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Dept Oncol, SF-70210 Kuopio, Finland; [Agnarsson, Bjarni A.] Landspitali Univ Hosp, Dept Pathol, ILUH, Reykjavik, Iceland; [Agnarsson, Bjarni A.] Univ Iceland, Sch Med, Reykjavik, Iceland; [Caligo, Maria A.] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastruct Pathol, Pisa, Italy; [Caligo, Maria A.] Pisa Univ Hosp, Pisa, Italy; [Godwin, Andrew K.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Nevanlinna, Heli; Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki Breast Canc Study HEBCS, FIN-00290 Helsinki, Finland; [Couch, Fergus J.; Fredericksen, Zachary; Lindor, Noralane] Mayo Clin, Mayo Clin Familial Breast & Ovarian Canc Study MA, Rochester, MN USA; [Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Dept Med, Univ Penn UPENN, Philadelphia, PA 19104 USA; [Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Loman, Niklas] Univ Lund Hosp, Dept Oncol, Swedish BRCA1 & BRCA2 Study Collaborators SWE BRC, S-22185 Lund, Sweden; [Karlsson, Per] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden; [Askmalm, Marie Stenmark] Linkoping Univ Hosp, Dept Oncol, S-58185 Linkoping, Sweden; [Melin, Beatrice] Umea Univ, Dept Radiat Sci, Umea, Sweden; [von Wachenfeldt, Anna] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Hogervorst, Frans B. L.; Verheus, Martijn; Rookus, Matti A.] Netherlands Canc Inst, Coordinating Ctr, Hereditary Breast & Ovarian Canc Res Grp Netherla, Amsterdam, Netherlands; [Seynaeve, Caroline; Oldenburg, Rogier A.] Erasmus MC, Rotterdam, Netherlands; [Ligtenberg, Marjolijn J.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Ausems, Margreet G. E. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Aalfs, Cora M.] Amsterdam Med Ctr, Amsterdam, Netherlands; [Gille, Hans J. P.] Vrije Univ, Univ Med Ctr, Amsterdam, Netherlands; [Garcia, Encarna B. Gomez] Univ Hosp Maastricht, Maastricht, Netherlands; [Peock, Susan; Cook, Margaret; Oliver, Clare T.; Frost, Debra; Luccarini, Craig] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Epidemiol Study BRCA1 & BRCA2 Mutat Carriers EMBR, Cambridge, England; [Evans, D. Gareth] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Eeles, Rosalind] Inst Canc Res, Oncogenet Team, London SW3 6JB, England; [Eeles, Rosalind] Royal Marsden NHS Fdn Trust, London, England; [Pichert, Gabriella] Guys & St Thomas NHS Fdn Trust, London, England; [Davidson, Rosemarie] Yorkhill Hosp, Ferguson Smith Ctr Clin Genet, Glasgow, Lanark, Scotland; [Chu, Carol] Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Eccles, Diana] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Ong, Kai-Ren] Birmingham Womens Hosp Healthcare NHS Trust, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Cook, Jackie] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England; [Douglas, Fiona] Newcastle Tyne Hosp NHS Trust, Ctr Life, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Hodgson, Shirley] Univ London, St Georges Hosp, Dept Clin Genet, London, England; [Gold, Bert] NCI, Clin Genet Branch, Rockville, MD USA	Memorial Sloan Kettering Cancer Center; New York University; American Cancer Society; University of Cambridge; University of Cambridge; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Ulsan; Hannover Medical School; Hannover Medical School; Mayo Clinic; University of Sheffield; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; Ruhr University Bochum; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Tri-Service General Hospital; University of Melbourne; University of Melbourne; KU Leuven; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of Melbourne; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Vaasa Central Hospital; Kuopio University Hospital; University of Eastern Finland; Landspitali National University Hospital; University of Iceland; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Fox Chase Cancer Center; University of Helsinki; Helsinki University Central Hospital; Mayo Clinic; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Lund University; Skane University Hospital; Sahlgrenska University Hospital; Linkoping University; Umea University; Karolinska Institutet; Karolinska University Hospital; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC); University of Cambridge; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; St Georges University London; University of London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kirchhoff, T (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org	Reed, Malcolm Walter/AAG-9219-2020; Ligtenberg, Marjolijn/N-9666-2013; Caligo, Adelaide Maria/K-4289-2018; Margolin, Sara/AAX-9034-2020; Noh, Dong-Young/G-5531-2011; Shen, CY/F-6271-2010; Bowtell, David/H-1007-2016; friedlander, michael l/G-3490-2013; Zeps, Nikolajs/C-4180-2013; Tobias, Edward/D-4246-2009; Devilee, Peter/GXV-8005-2022; Ehrencrona, Hans/Q-4621-2019; DEVILEE, PETER/ABR-2140-2022; Lambrechts, Diether/AAJ-3167-2020; Oosterwijk, Jan C./G-5770-2011; Turnbull, Clare/AAA-6596-2019; Flyger, Henrik/AAM-6494-2021; Dörk, Thilo/J-8620-2012; Evans, D Gareth/AAB-4308-2022; Spurdle, Amanda B/A-4978-2011; Hoogerbrugge, Nicoline/O-1016-2013; Brüning, Thomas/G-8120-2015; Pharoah, Paul/V-6658-2019; Haviv, Izhak/E-3782-2015; Schmidt, Marjanka K/G-9058-2011; Nordestgaard, Borge Gronne/ABF-1310-2020; van Asperen, Christi J/D-3970-2012; Yoo, Keun-Young/J-5548-2012; Khusnutdinova, Elza Kamilevna/A-4810-2013; Severi, Gianluca/H-3774-2018; Hartikainen, Jaana M/E-6256-2015; Baglietto, Laura/AAB-9051-2019; Eccles, Diana/K-6327-2019; Ehrencrona, Hans/M-5619-2014; Severi, Gianluca/Q-1824-2019; Chenevix-Trench, Georgia/AAV-2014-2020; Verdrengh, Evelien/H-4571-2012; Bogdanova, Natalia V./Y-2205-2019; Rahman, Nazneen/D-2802-2013; Lucassen, Anneke/D-7764-2017; Wyld, David/B-8893-2015	Reed, Malcolm Walter/0000-0001-7442-2132; Ligtenberg, Marjolijn/0000-0003-1290-1474; Caligo, Adelaide Maria/0000-0003-0589-1829; Bowtell, David/0000-0001-9089-7525; friedlander, michael l/0000-0002-6488-0604; Zeps, Nikolajs/0000-0002-6404-6839; Tobias, Edward/0000-0003-2649-7695; Ehrencrona, Hans/0000-0002-5589-3622; Lambrechts, Diether/0000-0002-3429-302X; Dörk, Thilo/0000-0002-9458-0282; Evans, D Gareth/0000-0002-8482-5784; Spurdle, Amanda B/0000-0003-1337-7897; Hoogerbrugge, Nicoline/0000-0003-2393-8141; Brüning, Thomas/0000-0001-9560-5464; Pharoah, Paul/0000-0001-8494-732X; Haviv, Izhak/0000-0002-0837-5005; Schmidt, Marjanka K/0000-0002-2228-429X; van Asperen, Christi J/0000-0002-1436-7650; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Severi, Gianluca/0000-0001-7157-419X; Hartikainen, Jaana M/0000-0001-8267-1905; Eccles, Diana/0000-0002-9935-3169; Ehrencrona, Hans/0000-0002-5589-3622; Severi, Gianluca/0000-0001-7157-419X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Southey, Melissa/0000-0002-6313-9005; Beesley, Jonathan/0000-0003-1942-325X; Bojesen, Stig/0000-0002-4061-4133; Brauch, Hiltrud/0000-0001-7531-2736; Heikkinen, Tuomas/0000-0003-1154-6204; Thorne, Heather/0000-0003-3610-2511; Dunning, Alison Margaret/0000-0001-6651-7166; Rahman, Nazneen/0000-0003-4376-0440; Kataja, Vesa/0000-0003-4846-4843; Nathanson, Katherine/0000-0002-6740-0901; Nevanlinna, Heli/0000-0002-0916-2976; Bancroft, Elizabeth/0000-0002-5482-5660; Giles, Graham/0000-0003-4946-9099; Cox, Angela/0000-0002-5138-1099; Turnbull, Clare/0000-0002-1734-5772; Jacobs, Chris/0000-0002-9557-9080; Margolin, Sara/0000-0002-5526-5570; Baglietto, Laura/0000-0002-8193-7529; Nordestgaard, Borge/0000-0002-1954-7220; Gomez-Garcia, Encarna/0000-0003-4999-8847; Kirchhoff, Tomas/0000-0002-9055-2364; Lucassen, Anneke/0000-0003-3324-4338; Vasen, Hans/0000-0003-2682-2603; Kang, Daehee/0000-0003-4031-5878; Eeles, Rosalind/0000-0002-3698-6241; Gille, Johan/0000-0003-4526-298X; van der Luijt, Rob/0000-0002-0018-1089; Nordling, Margareta/0000-0002-4047-4994; Wyld, David/0000-0001-9523-4333	Cancer Research UK [15106, 15007] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0700491] Funding Source: UKRI; Cancer Research UK [10124, 11174, 10118, 11022] Funding Source: Medline; Medical Research Council [G0700491] Funding Source: Medline	Cancer Research UK(Cancer Research UK); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Broeks A, 2011, HUM MOL GENET, V20, P3289, DOI 10.1093/hmg/ddr228; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Dai JC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3101; Dizin E, 2010, INT J BIOCHEM CELL B, V42, P693, DOI 10.1016/j.biocel.2009.12.025; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hemminki K, 2010, INT J CANCER, V126, P2858, DOI 10.1002/ijc.24986; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kirchhoff T, 2009, CANCER EPIDEM BIOMAR, V18, P2468, DOI 10.1158/1055-9965.EPI-09-0151; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang Z, 2012, GENES DEV; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	24	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e35706	10.1371/journal.pone.0035706	http://dx.doi.org/10.1371/journal.pone.0035706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768030	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100001
J	Lizier, NF; Kerkis, A; Gomes, CM; Hebling, J; Oliveira, CF; Caplan, AI; Kerkis, I				Lizier, Nelson F.; Kerkis, Alexandre; Gomes, Cicera M.; Hebling, Josimeri; Oliveira, Camila F.; Caplan, Arnold I.; Kerkis, Irina			Scaling-Up of Dental Pulp Stem Cells Isolated from Multiple Niches	PLOS ONE			English	Article							IN-VITRO; POPULATION; TEETH; DIFFERENTIATION; EXPRESSION; DPSCS	Dental pulp (DP) can be extracted from child's primary teeth (deciduous), whose loss occurs spontaneously by about 5 to 12 years. Thus, DP presents an easy accessible source of stem cells without ethical concerns. Substantial quantities of stem cells of an excellent quality and at early (2-5) passages are necessary for clinical use, which currently is a problem for use of adult stem cells. Herein, DPs were cultured generating stem cells at least during six months through multiple mechanical transfers into a new culture dish every 3-4 days. We compared stem cells isolated from the same DP before (early population, EP) and six months after several mechanical transfers (late population, LP). No changes, in both EP and LP, were observed in morphology, expression of stem cells markers (nestin, vimentin, fibronectin, SH2, SH3 and Oct3/4), chondrogenic and myogenic differentiation potential, even after cryopreservation. Six hours after DP extraction and in vitro plating, rare 5-bromo-2'-deoxyuridine (BrdU) positive cells were observed in pulp central part. After 72 hours, BrdU positive cells increased in number and were found in DP periphery, thus originating a multicellular population of stem cells of high purity. Multiple stem cell niches were identified in different zones of DP, because abundant expression of nestin, vimentin and Oct3/4 proteins was observed, while STRO-1 protein localization was restricted to perivascular niche. Our finding is of importance for the future of stem cell therapies, providing scaling-up of stem cells at early passages with minimum risk of losing their "stemness".	[Lizier, Nelson F.; Kerkis, Alexandre; Gomes, Cicera M.; Oliveira, Camila F.; Kerkis, Irina] Butantan Inst, Genet Lab, Sao Paulo, Brazil; [Lizier, Nelson F.; Kerkis, Irina] Fed Univ Sao Paulo UNIFESP, Dept Morphol, Sao Paulo, Brazil; [Hebling, Josimeri] State Univ Sao Paulo UNESP, Dept Orthodont & Pediat Dent, Araraquara, SP, Brazil; [Caplan, Arnold I.] Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Case Western Reserve University	Lizier, NF (corresponding author), Butantan Inst, Genet Lab, Sao Paulo, Brazil.	nelson_lizier@yahoo.com.br	Kerkis, Irina/AAD-1006-2019; Hebling, Josimeri/C-7738-2012; Hebling, Josimeri/AAH-1737-2019	Hebling, Josimeri/0000-0002-2846-2325; Caplan, Arnold/0000-0002-8677-6621	FAPESP (Sao Paulo Research Foundation) [2010/51051-6]	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant 2010/51051-6 from FAPESP (Sao Paulo Research Foundation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Arora V, 2009, J CLIN PEDIATR DENT, V33, P289, DOI 10.17796/jcpd.33.4.y887672r0j703654; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Bari C, 2006, CURR OPIN ORTHOP, V17, P398; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x; Jo YY, 2007, TISSUE ENG, V13, P767, DOI 10.1089/ten.2006.0192; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kerkis I., 2009, STEM CELLS BASIC APP, P426; Kerkis I, 2011, TISSUE ENG B    1228; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nam H, 2009, BIOCHEM BIOPH RES CO, V386, P135, DOI 10.1016/j.bbrc.2009.05.141; Pal R, 2009, J TISSUE ENG REGEN M, V3, P163, DOI 10.1002/term.143; Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667; Gomes JAP, 2010, INVEST OPHTH VIS SCI, V51, P1408, DOI 10.1167/iovs.09-4029; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; da Fonseca SAS, 2009, CELL PROLIFERAT, V42, P132, DOI 10.1111/j.1365-2184.2008.00578.x; Spath L, 2010, J CELL MOL MED, V14, P1635, DOI 10.1111/j.1582-4934.2009.00848.x; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zhang WB, 2006, TISSUE ENG, V12, P2813, DOI 10.1089/ten.2006.12.2813	39	74	80	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39885	10.1371/journal.pone.0039885	http://dx.doi.org/10.1371/journal.pone.0039885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768154	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100123
J	Piana, S; Lindorff-Larsen, K; Dirks, RM; Salmon, JK; Dror, RO; Shaw, DE				Piana, Stefano; Lindorff-Larsen, Kresten; Dirks, Robert M.; Salmon, John K.; Dror, Ron O.; Shaw, David E.			Evaluating the Effects of Cutoffs and Treatment of Long-range Electrostatics in Protein Folding Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FORCE-FIELD; FORMULATION; TRUNCATION; EWALD	The use of molecular dynamics simulations to provide atomic-level descriptions of biological processes tends to be computationally demanding, and a number of approximations are thus commonly employed to improve computational efficiency. In the past, the effect of these approximations on macromolecular structure and stability has been evaluated mostly through quantitative studies of small-molecule systems or qualitative observations of short-timescale simulations of biological macromolecules. Here we present a quantitative evaluation of two commonly employed approximations, using a test system that has been the subject of a number of previous protein folding studies-the villin headpiece. In particular, we examined the effect of (i) the use of a cutoff-based force-shifting technique rather than an Ewald summation for the treatment of electrostatic interactions, and (ii) the length of the cutoff used to determine how many pairwise interactions are included in the calculation of both electrostatic and van der Waals forces. Our results show that the free energy of folding is relatively insensitive to the choice of cutoff beyond 9 angstrom, and to whether an Ewald method is used to account for long-range electrostatic interactions. In contrast, we find that the structural properties of the unfolded state depend more strongly on the two approximations examined here.	[Piana, Stefano; Lindorff-Larsen, Kresten; Dirks, Robert M.; Salmon, John K.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	D. E. Shaw Research; Columbia University	Piana, S (corresponding author), DE Shaw Res, New York, NY 10036 USA.	Stefano.Piana-Agostinetti@DEShawResearch.com; David.Shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Dror, Ron/0000-0002-6418-2793	D.E. Shaw Research	D.E. Shaw Research	All the authors are affiliated with D.E. Shaw Research, the funder of this study. This research was conducted within D. E. Shaw Research, of which DES is the sole beneficial owner and Chief Scientist. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Beauchamp KA, 2011, P NATL ACAD SCI USA, V108, P12734, DOI 10.1073/pnas.1010880108; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; Bowman GR, 2011, J AM CHEM SOC, V133, P664, DOI 10.1021/ja106936n; Buchete NV, 2008, J PHYS CHEM B, V112, P6057, DOI 10.1021/jp0761665; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ensign DL, 2007, J MOL BIOL, V374, P806, DOI 10.1016/j.jmb.2007.09.069; Feller SE, 1996, J PHYS CHEM-US, V100, P17011, DOI 10.1021/jp9614658; Fennell CJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206581; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; KARASAWA N, 1989, J PHYS CHEM-US, V93, P7320, DOI 10.1021/j100358a012; Klauda JB, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2354486; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2012, J AM CHEM SOC, V134, P3787, DOI 10.1021/ja209931w; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lippert RA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431176; Maritan A, 2000, NATURE, V406, P287, DOI 10.1038/35018538; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mobley DL, 2012, J COMPUT AID MOL DES, V26, P93, DOI 10.1007/s10822-011-9497-y; NORTHRUP SH, 1980, J CHEM PHYS, V73, P2700, DOI 10.1063/1.440484; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pronk S, 2011, P INT C HIGH PERF CO; Robertson A, 2008, J COMPUT CHEM, V29, P694, DOI 10.1002/jcc.20828; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw D. E, 2009, P ACM IEEE C SUP SC0; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shirts MR, 2007, J PHYS CHEM B, V111, P13052, DOI 10.1021/jp0735987; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Stone JE, 2010, J MOL GRAPH MODEL, V29, P116, DOI 10.1016/j.jmgm.2010.06.010; Toxvaerd S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3558787; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137	39	64	64	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39918	10.1371/journal.pone.0039918	http://dx.doi.org/10.1371/journal.pone.0039918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768169	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100138
J	Schoville, SD; Flowers, JM; Burton, RS				Schoville, Sean D.; Flowers, Jonathan M.; Burton, Ronald S.			Diversifying Selection Underlies the Origin of Allozyme Polymorphism at the Phosphoglucose Isomerase Locus in Tigriopus californicus	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; POPULATION-STRUCTURE; BALANCING SELECTION; STATISTICAL TESTS; GENETIC-VARIATION; RECOMBINATION; EVOLUTIONARY; ADAPTATION; DIFFERENTIATION; FITNESS	The marine copepod Tigriopus californicus lives in intertidal rock pools along the Pacific coast, where it exhibits strong, temporally stable population genetic structure. Previous allozyme surveys have found high frequency private alleles among neighboring subpopulations, indicating that there is limited genetic exchange between populations. Here we evaluate the factors responsible for the diversification and maintenance of alleles at the phosphoglucose isomerase (Pgi) locus by evaluating patterns of nucleotide variation underlying previously identified allozyme polymorphism. Copepods were sampled from eleven sites throughout California and Baja California, revealing deep genetic structure among populations as well as genetic variability within populations. Evidence of recombination is limited to the sample from Pescadero and there is no support for linkage disequilibrium across the Pgi locus. Neutrality tests and codon-based models of substitution suggest the action of natural selection due to elevated non-synonymous substitutions at a small number of sites in Pgi. Two sites are identified as the charge-changing residues underlying allozyme polymorphisms in T. californicus. A reanalysis of allozyme variation at several focal populations, spanning a period of 26 years and over 200 generations, shows that Pgi alleles are maintained without notable frequency changes. Our data suggest that diversifying selection accounted for the origin of Pgi allozymes, while McDonald-Kreitman tests and the temporal stability of private allozyme alleles suggests that balancing selection may be involved in the maintenance of amino acid polymorphisms within populations.	[Schoville, Sean D.; Flowers, Jonathan M.; Burton, Ronald S.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Schoville, SD (corresponding author), Univ Grenoble 1, CNRS, Equipe Biol Computat & Math, Grenoble, France.	sschoville@ucsd.edu	Schoville, Sean D./J-8061-2012; Schoville, Sean D./AAY-5324-2020; Burton, R/F-7694-2010	Schoville, Sean D./0000-0001-7364-434X; Schoville, Sean D./0000-0001-7364-434X; Burton, R/0000-0002-6995-5329	National Science Foundation [DEB 0521176, DEB 0717178]; Direct For Biological Sciences [1051057] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors gratefully acknowledge financial support from National Science Foundation grants to R.S.B. (DEB 0521176 and DEB 0717178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2003, GENETICS, V164, P1229; Beaumont MA, 2003, GENETICS, V164, P1139; BURTON RS, 1984, OECOLOGIA, V65, P108, DOI 10.1007/BF00384471; BURTON RS, 1990, EVOLUTION, V44, P1814, DOI 10.1111/j.1558-5646.1990.tb05252.x; Burton RS, 1997, EVOLUTION, V51, P993, DOI 10.1111/j.1558-5646.1997.tb03681.x; BURTON RS, 1981, EVOLUTION, V35, P1192, DOI 10.1111/j.1558-5646.1981.tb04989.x; BURTON RS, 1994, P NATL ACAD SCI USA, V91, P5197, DOI 10.1073/pnas.91.11.5197; BURTON RS, 1979, MAR ECOL PROG SER, V1, P29, DOI 10.3354/meps001029; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond A. J., 2009, TRACER MCMC TRACE AN; DYBDAHL MF, 1994, EVOL ECOL, V8, P113, DOI 10.1007/BF01238245; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; FU YX, 1993, GENETICS, V133, P693; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; GILLESPIE JH, 1978, THEOR POPUL BIOL, V14, P1, DOI 10.1016/0040-5809(78)90002-3; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; JUKES T H, 1969, P21; Katz LA, 1997, GENETICS, V147, P609; Kelly JK, 1997, GENETICS, V146, P1197; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; MORGAN K, 1979, NATURE, V277, P383, DOI 10.1038/277383a0; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Nylander J. A. A., 2004, MRMODELTEST V2; PATARNELLO T, 1992, EVOLUTION, V46, P1568, DOI 10.1111/j.1558-5646.1992.tb01148.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; R Development Core Team, 2011, R VERS 2 13 2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2001, GENETICS, V158, P1147; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Storz JF, 2010, EVOLUTION, V64, P2489, DOI 10.1111/j.1558-5646.2010.01044.x; TAJIMA F, 1989, GENETICS, V123, P585; Vittor B.A, 1971, EFFECTS ENV FITNESS; Wakeley J, 2001, THEOR POPUL BIOL, V59, P133, DOI 10.1006/tpbi.2000.1495; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; Wang B., 2012, J MOL EVOL; WATT WB, 1983, GENETICS, V103, P691; Wheat CW, 2010, CONSERV GENET, V11, P387, DOI 10.1007/s10592-009-0042-7; Wheat CW, 2010, MOL BIOL EVOL, V27, P267, DOI 10.1093/molbev/msp227; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431	52	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40035	10.1371/journal.pone.0040035	http://dx.doi.org/10.1371/journal.pone.0040035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768211	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100183
J	Sheik, CS; Mitchell, TW; Rizvi, FZ; Rehman, Y; Faisal, M; Hasnain, S; McInerney, MJ; Krumholz, LR				Sheik, Cody S.; Mitchell, Tyler W.; Rizvi, Fariha Z.; Rehman, Yasir; Faisal, Muhammad; Hasnain, Shahida; McInerney, Michael J.; Krumholz, Lee R.			Exposure of Soil Microbial Communities to Chromium and Arsenic Alters Their Diversity and Structure	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BACTERIAL COMMUNITY; CHROMATE-RESISTANT; REDUCTION; PATTERNS; PROTEIN; GENES; ACR3; MICROORGANISMS; POPULATIONS	Extensive use of chromium (Cr) and arsenic (As) based preservatives from the leather tanning industry in Pakistan has had a deleterious effect on the soils surrounding production facilities. Bacteria have been shown to be an active component in the geochemical cycling of both Cr and As, but it is unknown how these compounds affect microbial community composition or the prevalence and form of metal resistance. Therefore, we sought to understand the effects that long-term exposure to As and Cr had on the diversity and structure of soil microbial communities. Soils from three spatially isolated tanning facilities in the Punjab province of Pakistan were analyzed. The structure, diversity and abundance of microbial 16S rRNA genes were highly influenced by the concentration and presence of hexavalent chromium (Cr (VI)) and arsenic. When compared to control soils, contaminated soils were dominated by Proteobacteria while Actinobacteria and Acidobacteria (which are generally abundant in pristine soils) were minor components of the bacterial community. Shifts in community composition were significant and revealed that Cr (VI)-containing soils were more similar to each other than to As contaminated soils lacking Cr (VI). Diversity of the arsenic resistance genes, arsB and ACR3 were also determined. Results showed that ACR3 becomes less diverse as arsenic concentrations increase with a single OTU dominating at the highest concentration. Chronic exposure to either Cr or As not only alters the composition of the soil bacterial community in general, but affects the arsenic resistant individuals in different ways.	[Sheik, Cody S.; Mitchell, Tyler W.; McInerney, Michael J.; Krumholz, Lee R.] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Sheik, Cody S.; Mitchell, Tyler W.; Krumholz, Lee R.] Univ Oklahoma, Inst Energy & Environm, Norman, OK 73019 USA; [Rizvi, Fariha Z.; Rehman, Yasir; Faisal, Muhammad; Hasnain, Shahida] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Punjab	Sheik, CS (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	krumholz@ou.edu	Hasnain, Shahida/I-6924-2015; Rehman, Yasir/Y-8730-2019	Hasnain, Shahida/0000-0002-5916-7759; Rehman, Yasir/0000-0002-4787-275X; Sheik, Cody/0000-0003-0413-1924	National Academy of Sciences, USA [PGA-P280292]	National Academy of Sciences, USA	Funding was from the National Academy of Sciences, USA under grant # PGA-P280292. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour-Rokbani A, 2010, APPL ENVIRON MICROB, V76, P948, DOI 10.1128/AEM.01738-09; Agency EP, 1998, IN ARS; Aguilar-Barajas E, 2008, FEMS MICROBIOL LETT, V285, P97, DOI 10.1111/j.1574-6968.2008.01220.x; Alvarez AH, 1999, J BACTERIOL, V181, P7398, DOI 10.1128/JB.181.23.7398-7400.1999; Atlas RM., 2004, HDB MICROBIOLOGICAL; BAATH E, 1989, WATER AIR SOIL POLL, V47, P335, DOI 10.1007/BF00279331; Badar U, 2000, BIOTECHNOL LETT, V22, P829, DOI 10.1023/A:1005649113190; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Bouskill NJ, 2010, ECOTOXICOLOGY, V19, P317, DOI 10.1007/s10646-009-0414-2; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; CAMPOS J, 1995, ANTON LEEUW INT J G, V68, P203, DOI 10.1007/BF00871816; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Faith DP, 2009, INT J MOL SCI, V10, P4723, DOI 10.3390/ijms10114723; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fu HL, 2009, J BIOL CHEM, V284, P19887, DOI 10.1074/jbc.M109.011882; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Giller KE, 1997, APPL SOIL ECOL, V6, P3, DOI 10.1016/S0929-1393(96)00149-7; Giller KE, 2009, SOIL BIOL BIOCHEM, V41, P2031, DOI 10.1016/j.soilbio.2009.04.026; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Gough HL, 2011, ISME J, V5, P543, DOI 10.1038/ismej.2010.132; Gough HL, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000566; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; He MY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-221; Hugenholtz P, 2002, GENOME BIOL, V3; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kamaludeen SPB, 2003, REV ENVIRON CONTAM T, V178, P93, DOI 10.1007/0-387-21728-2_4; Knight BP, 1997, APPL ENVIRON MICROB, V63, P39, DOI 10.1128/AEM.63.1.39-43.1997; Kothe E, 2010, SOIL BIOL, V19, P225, DOI 10.1007/978-3-642-02436-8_10; Kourtev PS, 2006, APPL ENVIRON MICROB, V72, P628, DOI 10.1128/AEM.72.1.628-637.2006; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Liu CR, 2007, POPUL ECOL, V49, P89, DOI 10.1007/s10144-006-0026-0; Lloyd JR, 2001, CURR OPIN BIOTECH, V12, P248, DOI 10.1016/S0958-1669(00)00207-X; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Margesin R, 2011, CHEMOSPHERE, V82, P1583, DOI 10.1016/j.chemosphere.2010.11.056; Marsh TL, 2001, APPL ENVIRON MICROB, V67, P1517, DOI 10.1128/AEM.67.4.1517-1521.2001; MCCARTHY AJ, 1992, GENE, V115, P189, DOI 10.1016/0378-1119(92)90558-7; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Okansen J, 2011, VEGAN COMMUNITY ECOL; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2004, FEMS MICROBIOL ECOL, V48, P15, DOI 10.1016/j.femsec.2003.12.016; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Roesch LFW, 2007, ISME J; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sheik CS, 2011, ISME J; Sokal RR, 2003, BIOMETRY; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Tamura K., 2011, MOL BIOL EVOL, DOI [10.1093/molbev/msr121, DOI 10.1093/MOLBEV/MSR121]; URONE PF, 1955, ANAL CHEM, V27, P1354, DOI 10.1021/ac60104a048; USEPA, 1998, TOX REV HEX CHROM; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; WU JH, 1992, J BIOL CHEM, V267, P12570; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106	70	178	202	14	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40059	10.1371/journal.pone.0040059	http://dx.doi.org/10.1371/journal.pone.0040059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768219	gold, Green Published			2022-12-25	WOS:000305892100191
J	Voges, M; Bachmann, V; Naujoks, J; Kopp, K; Hauck, CR				Voges, Maike; Bachmann, Verena; Naujoks, Jan; Kopp, Kathrin; Hauck, Christof R.			Extracellular Ig(C2) Constant Domains of CEACAMs Mediate PI3K Sensitivity during Uptake of Pathogens	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; NEISSERIA-GONORRHOEAE; ADHESION MOLECULE; CELL-ADHESION; PHOSPHOINOSITIDE 3-KINASE; DIFFERENTIAL RECOGNITION; BACTERIAL PATHOGENS; SIGNAL-TRANSDUCTION; OPA PROTEINS; N-DOMAIN	Background: Several pathogenic bacteria utilize receptors of the CEACAM family to attach to human cells. Binding to different members of this receptor family can result in uptake of the bacteria. Uptake of Neisseria gonorrhoeae, a Gram-negative human pathogen, via CEACAMs found on epithelial cells, such as CEACAM1, CEA or CEACAM6, differs mechanistically from phagocytosis mediated by CEACAM3, a CEACAM family member expressed selectively by human granulocytes. Principal Findings: We find that CEACAM1- as well as CEACAM3-mediated bacterial internalization are accompanied by a rapid increase in phosphatidylinositol-3,4,5 phosphate (PI(3,4,5) P) at the site of bacterial entry. However, pharmacological inhibition of phosphatidylinositol-3' kinase (PI3K) selectively affects CEACAM1-mediated uptake of Neisseria gonorrhoeae. Accordingly, overexpression of the PI(3,4,5) P phosphatase SHIP diminishes and expression of a constitutive active PI3K increases CEACAM1-mediated internalization of gonococci, without influencing uptake by CEACAM3. Furthermore, bacterial uptake by GPI-linked members of the CEACAM family (CEA and CEACAM6) and CEACAM1-mediated internalization of N. meningitidis by endothelial cells require PI3K activity. Sensitivity of CEACAM1-mediated uptake toward PI3K inhibition is independent of receptor localization in cholesterol-rich membrane microdomains and does not require the cytoplasmic or the transmembrane domain of CEACAM1. However, PI3K inhibitor sensitivity requires the Ig(C2)-like domains of CEACAM1, which are also present in CEA and CEACAM6, but which are absent from CEACAM3. Accordingly, overexpression of CEACAM1 Ig(C2) domains blocks CEACAM1-mediated internalization. Conclusions: Our results provide novel mechanistic insight into CEACAM1-mediated endocytosis and suggest that epithelial CEACAMs associate in cis with other membrane receptor(s) via their extracellular domains to trigger bacterial uptake in a PI3K-dependent manner.	[Voges, Maike; Bachmann, Verena; Naujoks, Jan; Kopp, Kathrin; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany; [Voges, Maike; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany	University of Konstanz; University of Konstanz	Voges, M (corresponding author), Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany.	christof.hauck@uni-konstanz.de			DFG (Deutsche Forschungsgemeinschaft) [Ha2856/6-1]; Ministry of Science, Research and Arts of Baden-Wurttemberg	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Ministry of Science, Research and Arts of Baden-Wurttemberg	This study was supported by funds from the DFG (Deutsche Forschungsgemeinschaft),(Ha2856/6-1) and by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg to C. R. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Balla Tamas, 2002, Sci STKE, V2002, ppl3, DOI 10.1126/stke.2002.125.pl3; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; Billker O, 2002, EMBO J, V21, P560, DOI 10.1093/emboj/21.4.560; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Brumell JH, 2003, CELL MICROBIOL, V5, P287, DOI 10.1046/j.1462-5822.2003.00273.x; Buntru A, 2012, ARCH BIOCHEM BIOPHYS, V524, P77, DOI 10.1016/j.abb.2012.03.020; Buntru A, 2011, J BIOL CHEM, V286, P9555, DOI 10.1074/jbc.M110.216085; Buntru A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-81; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Choice CV, 1998, J BIOL CHEM, V273, P22194, DOI 10.1074/jbc.273.35.22194; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kuespert K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014609; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Pils S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032808; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Robert J, 1999, J IMMUNOL, V163, P4133; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Rowe HA, 2007, CELL MICROBIOL, V9, P154, DOI 10.1111/j.1462-5822.2006.00775.x; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sarantis H, 2012, CELL HOST MICROBE, V11, P117, DOI 10.1016/j.chom.2012.01.010; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; Slanina H, 2010, INFECT IMMUN, V78, P1905, DOI 10.1128/IAI.01267-09; Soni P, 2000, MOL CELL BIOL, V20, P3896, DOI 10.1128/MCB.20.11.3896-3905.2000; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Wang JA, 2008, INT J MED MICROBIOL, V298, P209, DOI 10.1016/j.ijmm.2007.05.004; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	64	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39908	10.1371/journal.pone.0039908	http://dx.doi.org/10.1371/journal.pone.0039908			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768164	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100133
J	Wernike, K; Hoffmann, B; Dauber, M; Lange, E; Schirrmeier, H; Beer, M				Wernike, Kerstin; Hoffmann, Bernd; Dauber, Malte; Lange, Elke; Schirrmeier, Horst; Beer, Martin			Detection and Typing of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus by Multiplex Real-Time RT-PCR	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE-PCR; MOUTH-DISEASE VIRUS; NORTH-AMERICAN; RAPID DETECTION; LELYSTAD VIRUS; UNITED-STATES; CHINA; PRRSV; ASSAY; DIFFERENTIATION	Porcine reproductive and respiratory syndrome (PRRS) causes economic losses in the pig industry worldwide, and PRRS viruses (PRRSV) are classified into the two distinct genotypes "North American (NA, type 2)" and "European (EU, type 1)". In 2006, a highly pathogenic NA strain of PRRSV (HP-PRRSV), characterized by high fever as well as high morbidity and mortality, emerged in swine farms in China. Therefore, a real-time reverse transcription polymerase chain reaction (RT-qPCR) assay specific for HP-PRRSV was developed and combined with type 1- and type 2-specific RT-qPCR systems. Furthermore, an internal control, based on a heterologous RNA, was successfully introduced. This final multiplex PRRSV RT-qPCR, detecting and typing PRRSV, had an analytical sensitivity of less than 200 copies per mu l for the type 1-assay and 20 copies per mu l for the type 2- and HP assays and a high diagnostic sensitivity. A panel of reference strains and field isolates was reliably detected and samples from an animal trial with a Chinese HP-PRRS strain were used for test validation. The new multiplex PRRSV RT-qPCR system allows for the first time the highly sensitive detection and rapid differentiation of PRRSV of both genotypes as well as the direct detection of HP-PRRSV.	[Wernike, Kerstin; Hoffmann, Bernd; Schirrmeier, Horst; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Dauber, Malte; Lange, Elke] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute	Wernike, K (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	martin.beer@fli.bund.de			SAB, Sachsische Aufbaubank - Forderbank; SAB	SAB, Sachsische Aufbaubank - Forderbank; SAB	The authros have read the journal's policy and have the following conflicts: MB is a PLoS ONE Editorial Board member (Academic Editor). The study was funded by the SAB, Sachsische Aufbaubank - Forderbank, as a collaboration project with the company Labor Diagnostik Leipzig. KW was funded by the SAB. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chen NH, 2009, J VIROL METHODS, V161, P192, DOI 10.1016/j.jviromet.2009.06.007; Darwich L, 2011, VET MICROBIOLOGY; Egli C, 2001, J VIROL METHODS, V98, P63, DOI 10.1016/S0166-0934(01)00358-5; Fang Y, 2004, VIRUS RES, V100, P229, DOI 10.1016/j.virusres.2003.12.026; Feng YJ, 2008, EMERG INFECT DIS, V14, P1774, DOI 10.3201/eid1411.071676; Gao ZQ, 2004, ARCH VIROL, V149, P1341, DOI 10.1007/s00705-004-0292-0; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Key KF, 2001, VET MICROBIOL, V83, P249, DOI 10.1016/S0378-1135(01)00427-8; Kleiboeker SB, 2005, J VET DIAGN INVEST, V17, P165, DOI 10.1177/104063870501700211; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Lurchachaiwong W, 2008, LETT APPL MICROBIOL, V46, P55, DOI 10.1111/j.1472-765X.2007.02259.x; Lv J, 2008, J GEN VIROL, V89, P2075, DOI 10.1099/vir.0.2008/001529-0; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Moniwa M, 2007, J VET DIAGN INVEST, V19, P9, DOI 10.1177/104063870701900103; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Normile D, 2007, SCIENCE, V317, P1017, DOI 10.1126/science.317.5841.1017; Oleksiewicz MB, 1998, VET MICROBIOL, V64, P7, DOI 10.1016/S0378-1135(98)00254-5; Oleksiewicz MB, 2001, J VIROL METHODS, V92, P23, DOI 10.1016/S0166-0934(00)00265-2; Pesch S, 2005, VET MICROBIOL, V107, P31, DOI 10.1016/j.vetmic.2005.01.028; R Development Core Team, 2009, R FDN STAT COMP; Ropp SL, 2004, J VIROL, V78, P3684, DOI 10.1128/JVI.78.7.3684-3703.2004; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Shi M, 2010, J VIROL, V84, P8700, DOI 10.1128/JVI.02551-09; Stadejek T, 2006, J GEN VIROL, V87, P1835, DOI 10.1099/vir.0.81782-0; Stadejek T, 2008, ARCH VIROL, V153, P1479, DOI 10.1007/s00705-008-0146-2; Thanawongnuwech R, 2004, VET MICROBIOL, V101, P9, DOI 10.1016/j.vetmic.2004.03.005; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Wakeley PR, 2005, J CLIN MICROBIOL, V43, P2786, DOI 10.1128/JCM.43.6.2786-2792.2005; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Xiao XL, 2008, J VIROL METHODS, V149, P49, DOI 10.1016/j.jviromet.2008.01.009; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x	38	36	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38251	10.1371/journal.pone.0038251	http://dx.doi.org/10.1371/journal.pone.0038251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768042	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100013
J	Cruz-Machado, SD; Pinato, L; Tamura, EK; Carvalho-Sousa, CE; Markus, RP				Cruz-Machado, Sanseray da Silveira; Pinato, Luciana; Tamura, Eduardo Koji; Carvalho-Sousa, Claudia Emanuele; Markus, Regina P.			Glia-Pinealocyte Network: The Paracrine Modulation of Melatonin Synthesis by Tumor Necrosis Factor (TNF)	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; CELL-WALL COMPONENTS; TOLL-LIKE RECEPTOR-4; GLAND; RAT; SYSTEM; LIPOPOLYSACCHARIDE; ACTIVATION; INCREASE	The pineal gland, a circumventricular organ, plays an integrative role in defense responses. The injury-induced suppression of the pineal gland hormone, melatonin, which is triggered by darkness, allows the mounting of innate immune responses. We have previously shown that cultured pineal glands, which express toll-like receptor 4 (TLR4) and tumor necrosis factor receptor 1 (TNFR1), produce TNF when challenged with lipopolysaccharide (LPS). Here our aim was to evaluate which cells present in the pineal gland, astrocytes, microglia or pinealocytes produced TNF, in order to understand the interaction between pineal activity, melatonin production and immune function. Cultured pineal glands or pinealocytes were stimulated with LPS. TNF content was measured using an enzyme-linked immunosorbent assay. TLR4 and TNFR1 expression were analyzed by confocal microscopy. Microglial morphology was analyzed by immunohistochemistry. In the present study, we show that although the main cell types of the pineal gland (pinealocytes, astrocytes and microglia) express TLR4, the production of TNF induced by LPS is mediated by microglia. This effect is due to activation of the nuclear factor kappa B (NF-kB) pathway. In addition, we observed that LPS activates microglia and modulates the expression of TNFR1 in pinealocytes. As TNF has been shown to amplify and prolong inflammatory responses, its production by pineal microglia suggests a glia-pinealocyte network that regulates melatonin output. The current study demonstrates the molecular and cellular basis for understanding how melatonin synthesis is regulated during an innate immune response, thus our results reinforce the role of the pineal gland as sensor of immune status.	[Cruz-Machado, Sanseray da Silveira; Tamura, Eduardo Koji; Carvalho-Sousa, Claudia Emanuele; Markus, Regina P.] Univ Sao Paulo, Inst Biosci, Lab Chronopharmacol, Sao Paulo, Brazil; [Pinato, Luciana] Univ Estadual Paulista UNESP, Dept Speech Language & Hearing Therapy, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Cruz-Machado, SD (corresponding author), Univ Sao Paulo, Inst Biosci, Lab Chronopharmacol, Sao Paulo, Brazil.	rpmarkus@usp.br	Tamura, Eduardo Koji/F-7068-2012; Markus, Regina P./AAC-1505-2021; Tamura, Eduardo Koji/L-4360-2019; Markus, Regina P/K-2954-2012; Pinato, luciana/A-8314-2018	Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P./0000-0003-4606-6120; Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P/0000-0003-4606-6120; da Silveira Cruz-Machado, Sanseray/0000-0002-6937-7207; Pinato, luciana/0000-0001-7788-9205	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [07/07871-6]; Conselho Nacional de Pesquisa - CNPq [305378/2009-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this study was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP - (07/07871-6) to RPM; Conselho Nacional de Pesquisa - CNPq - 305378/2009-0 - to RPM; and RPM senior fellow CNPq, LP and EKT - post-doc fellows FAPESP, and SSCM and CECS - PhD fellows FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORJIGIN J, 1995, NATURE, V378, P783, DOI 10.1038/378783a0; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Carrillo-Vico A, 2004, FASEB J, V18, P537, DOI 10.1096/fj.03-0694fje; CARVALHOSOUSA CE, 2011, FR ENDOCRINOL, V2, P1, DOI DOI 10.3389/FENDO.2011.00010; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2003, PHARMACOLOGY, V69, P33, DOI 10.1159/000071264; FERREIRA ZS, 1994, BRIT J PHARMACOL, V112, P107, DOI 10.1111/j.1476-5381.1994.tb13037.x; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Gomez-Corvera A, 2009, J PINEAL RES, V47, P15, DOI 10.1111/j.1600-079X.2009.00683.x; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Ho AK, 2006, MOL CELL ENDOCRINOL, V252, P34, DOI 10.1016/j.mce.2006.03.022; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jiang-Shieh YF, 2005, J PINEAL RES, V38, P17, DOI 10.1111/j.1600-079X.2004.00170.x; Kaltschmidt B, 2000, EXP BRAIN RES, V130, P100, DOI 10.1007/s002210050011; Konturek SJ, 2007, J PHYSIOL PHARMACOL, V58, P23; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Lardone PJ, 2006, J CELL PHYSIOL, V206, P273, DOI 10.1002/jcp.20461; Liu YJ, 2007, J PINEAL RES, V43, P232, DOI 10.1111/j.1600-079X.2007.00466.x; Lotufo CMC, 2006, EUR J PHARMACOL, V534, P258, DOI 10.1016/j.ejphar.2006.01.050; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Majewski P, 2005, J PINEAL RES, V39, P66, DOI 10.1111/j.1600-079X.2005.00214.x; Maldonado MD, 2010, PHARMACOL RES, V62, P282, DOI 10.1016/j.phrs.2009.11.014; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; Markus RP, 2011, ADV NEUROIMMUNE BIOL, V1, P95, DOI 10.3233/NIB-2011-009; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PAULSEN RE, 1987, J NEUROCHEM, V48, P1377, DOI 10.1111/j.1471-4159.1987.tb05674.x; Pedron T, 2003, J BIOL CHEM, V278, P20555, DOI 10.1074/jbc.M203551200; Perras B, 2006, INTENS CARE MED, V32, P624, DOI 10.1007/s00134-006-0069-x; Pontes GN, 2007, J PINEAL RES, V43, P365, DOI 10.1111/j.1600-079X.2007.00487.x; Pontes GN, 2006, J PINEAL RES, V41, P136, DOI 10.1111/j.1600-079X.2006.00345.x; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Skwarlo-Sonta K, 2003, CAN J PHYSIOL PHARM, V81, P342, DOI 10.1139/Y03-026; Srinivasan V, 2010, J PINEAL RES, V48, P1, DOI 10.1111/j.1600-079X.2009.00728.x; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Tsai SY, 2001, HISTOL HISTOPATHOL, V16, P1135, DOI 10.14670/HH-16.1135; Tsai SY, 2001, CELL TISSUE RES, V303, P423, DOI 10.1007/s004410000330; Tsai SY, 1999, J PINEAL RES, V27, P42, DOI 10.1111/j.1600-079X.1999.tb00595.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Wuchert F, 2008, J NEUROIMMUNOL, V204, P66, DOI 10.1016/j.jneuroim.2008.07.017; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309	46	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40142	10.1371/journal.pone.0040142	http://dx.doi.org/10.1371/journal.pone.0040142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768337	gold, Green Published, Green Submitted			2022-12-25	WOS:000305966500050
J	Homolka, S; Projahn, M; Feuerriegel, S; Ubben, T; Diel, R; Nubel, U; Niemann, S				Homolka, Susanne; Projahn, Michaela; Feuerriegel, Silke; Ubben, Tanja; Diel, Roland; Nuebel, Ulrich; Niemann, Stefan			High Resolution Discrimination of Clinical Mycobacterium tuberculosis Complex Strains Based on Single Nucleotide Polymorphisms	PLOS ONE			English	Article							ETHAMBUTOL RESISTANCE; VARIABLE-NUMBER; MIRU-VNTRPLUS; LINEAGE; GENE; RECOMMENDATIONS; PHYLOGEOGRAPHY; IDENTIFICATION; DIVERSITY; EVOLUTION	Recently, the diversity of the Mycobacterium tuberculosis complex (MTBC) population structure has been described in detail. Based on geographical separation and specific host pathogen co-evolution shaping MTBC virulence traits, at least 20 major lineages/genotypes have evolved finally leading to a clear influence of strain genetic background on transmissibility, clinical presentation/outcome, and resistance development. Therefore, high resolution genotyping for characterization of strains in larger studies is mandatory for understanding mechanisms of host-pathogen-interaction and to improve tuberculosis (TB) control. Single nucleotide polymorphisms (SNPs) represent the most reliable markers for lineage classification of clinical isolates due to the low levels of homoplasy, however their use is hampered either by low discriminatory power or by the need to analyze a large number of genes to achieve higher resolution. Therefore, we carried out de novo sequencing of 26 genes (approx. 20000 bp per strain) in a reference collection of MTBC strains including all major genotypes to define a highly discriminatory gene set. Overall, 161 polymorphisms were detected of which 59 are genotype-specific, while 13 define deeper branches such as the Euro-American lineage. Unbiased investigation of the most variable set of 11 genes in a population based strain collection (one year, city of Hamburg, Germany) confirmed the validity of SNP analysis as all strains were classified with high accuracy. Taken together, we defined a diagnostic algorithm which allows the identification of 17 MTBC phylogenetic lineages with high confidence for the first time by sequencing analysis of just five genes. In conclusion, the diagnostic algorithm developed in our study is likely to open the door for a low cost high resolution sequence/SNP based differentiation of the MTBC with a very high specificity. High throughput assays can be established which will be needed for large association studies that are mandatory for detailed investigation of host-pathogen-interaction during TB infection.	[Homolka, Susanne; Projahn, Michaela; Feuerriegel, Silke; Ubben, Tanja; Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Diel, Roland] Med Sch Hannover MHH, Dept Pneumol, Hannover, Germany; [Nuebel, Ulrich] Robert Koch Inst, Wernigerrode, Germany	Forschungszentrum Borstel; Hannover Medical School; Robert Koch Institute	Homolka, S (corresponding author), Res Ctr Borstel, Borstel, Germany.	sniemann@fz-borstel.de	Projahn, Michaela/O-7430-2018; Projahn, Michaela/GSD-6357-2022; Niemann, Stefan/C-9327-2011	Projahn, Michaela/0000-0002-3896-3561; Niemann, Stefan/0000-0002-6604-0684	Germany Ministry of Health; German Federal Ministry for Education and Research (BMBF) within the PathoGenomikPlus network [0313801J]; German Federal Ministry for Education and Research (BMBF) within the "TB or not TB'' network [01KI0784]; European Union TB-PAN-NET [FP7-223681]	Germany Ministry of Health; German Federal Ministry for Education and Research (BMBF) within the PathoGenomikPlus network; German Federal Ministry for Education and Research (BMBF) within the "TB or not TB'' network; European Union TB-PAN-NET	Parts of this work were were supported by the Germany Ministry of Health and the German Federal Ministry for Education and Research (BMBF) within the PathoGenomikPlus (0313801J) and "TB or not TB'' (01KI0784) networks and by the European Union TB-PAN-NET (FP7-223681) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2011, GLOB TUB CONTR; Baker S, 2010, CURR OPIN MICROBIOL, V13, P640, DOI 10.1016/j.mib.2010.08.002; Beisiegel M, 2009, EUR J IMMUNOL, V39, P3369, DOI 10.1002/eji.200939615; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Choi GE, 2011, KOREAN J LAB MED, V31, P37, DOI 10.3343/kjlm.2011.31.1.37; Chuang PC, 2010, J CLIN MICROBIOL, V48, P4245, DOI 10.1128/JCM.00970-10; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Douglas JT, 2003, J CLIN MICROBIOL, V41, P2723, DOI 10.1128/JCM.41.6.2723-2726.2003; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Plinke C, 2006, ANTIMICROB AGENTS CH, V50, P1900, DOI 10.1128/AAC.50.5.1900-1902.2006; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thye T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020908; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	38	86	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39855	10.1371/journal.pone.0039855	http://dx.doi.org/10.1371/journal.pone.0039855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768315	gold, Green Published			2022-12-25	WOS:000305966500028
J	Chang, YH; Lee, CP; Su, MT; Wang, JT; Chen, JY; Lin, SF; Tsai, CH; Hsieh, MJ; Takada, K; Chen, MR				Chang, Yu-Hsin; Lee, Chung-Pei; Su, Mei-Tzu; Wang, Jiin-Tarng; Chen, Jen-Yang; Lin, Su-Fang; Tsai, Ching-Hwa; Hsieh, Min-Jei; Takada, Kenzo; Chen, Mei-Ru			Epstein-Barr Virus BGLF4 Kinase Retards Cellular S-Phase Progression and Induces Chromosomal Abnormality	PLOS ONE			English	Article							RETINOBLASTOMA GENE-PRODUCT; CONSERVED PROTEIN-KINASES; DNA-DAMAGE RESPONSE; LYTIC REPLICATION; PHOSPHORYLATION; CYCLE; INHIBITION; EXPRESSION; TARGET; COMPLEX	Epstein-Barr virus (EBV) induces an uncoordinated S-phase-like cellular environment coupled with multiple prophase-like events in cells replicating the virus. The EBV encoded Ser/Thr kinase BGLF4 has been shown to induce premature chromosome condensation through activation of condensin and topoisomerase II and reorganization of the nuclear lamina to facilitate the nuclear egress of nucleocapsids in a pathway mimicking Cdk1. However, the observation that RB is hyperphosphorylated in the presence of BGLF4 raised the possibility that BGLF4 may have a Cdk2-like activity to promote S-phase progression. Here, we investigated the regulatory effects of BGLF4 on cell cycle progression and found that S-phase progression and DNA synthesis were interrupted by BGLF4 in mammalian cells. Expression of BGLF4 did not compensate Cdk1 defects for DNA replication in S. cerevisiae. Using time-lapse microscopy, we found the fate of individual HeLa cells was determined by the expression level of BGLF4. In addition to slight cell growth retardation, BGLF4 elicits abnormal chromosomal structure and micronucleus formation in 293 and NCP-TW01 cells. In Saos-2 cells, BGLF4 induced the hyperphosphorylation of co-transfected RB, while E2F1 was not released from RB-E2F1 complexes. The E2F1 regulated activities of the cyclin D1 and ZBRK1 promoters were suppressed by BGLF4 in a dose dependent manner. Detection with phosphoamino acid specific antibodies revealed that, in addition to Ser780, phosphorylation of the DNA damage-responsive Ser612 on RB was enhanced by BGLF4. Taken together, our study indicates that BGLF4 may directly or indirectly induce a DNA damage signal that eventually interferes with host DNA synthesis and delays S-phase progression.	[Chang, Yu-Hsin; Lee, Chung-Pei; Su, Mei-Tzu; Wang, Jiin-Tarng; Chen, Jen-Yang; Tsai, Ching-Hwa; Chen, Mei-Ru] Natl Taiwan Univ, Coll Med, Grad Inst, Taipei 10764, Taiwan; [Chang, Yu-Hsin; Lee, Chung-Pei; Su, Mei-Tzu; Wang, Jiin-Tarng; Chen, Jen-Yang; Tsai, Ching-Hwa; Chen, Mei-Ru] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Lee, Chung-Pei] Natl Taipei Univ Nursing & Hlth Sci, Gen Educ Ctr, Taipei, Taiwan; [Chen, Jen-Yang; Lin, Su-Fang; Hsieh, Min-Jei] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Taiwan; [Takada, Kenzo] Hokkaido Univ, Inst Genet Med, Dept Tumor Virol, Sapporo, Hokkaido, Japan	National Taiwan University; National Taiwan University; National Taipei University of Nursing & Health Science (NTUNHS); National Health Research Institutes - Taiwan; Hokkaido University	Chang, YH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst, Taipei 10764, Taiwan.	mrc@ntu.edu.tw	Chen, Jen-Yang/D-2085-2010; Lin, Su-Fang/B-2666-2010	CHEN, MEI-RU/0000-0002-7007-8036; Lin, Su-Fang/0000-0001-8706-2439	National Health Research Institute [NHRI-EX100-9928BI]; National Science National Science Council [NSC98-2320B002-54 MY3]; National Taiwan University, Taiwan [99R71423]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science National Science Council; National Taiwan University, Taiwan(National Taiwan University)	This study was supported by National Health Research Institute, (NHRI-EX100-9928BI, http://www.nhri.org.tw/) and partially supported by National Science National Science Council (NSC98-2320B002-54 MY3, http://web1.nsc.gov.tw/) and National Taiwan University, Taiwan (99R71423, http://www.ntu.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplan PD, 1996, BLOOD, V87, P2649, DOI 10.1182/blood.V87.7.2649.bloodjournal8772649; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Depowski PL, 2000, MODERN PATHOL, V13, P542, DOI 10.1038/modpathol.3880094; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Iwahori S, 2009, J BIOL CHEM, V284, P18923, DOI 10.1074/jbc.M109.015123; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kato K, 2001, J GEN VIROL, V82, P1457, DOI 10.1099/0022-1317-82-6-1457; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2004, J VIROL, V78, P104, DOI 10.1128/JVI.78.1.104-115.2004; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Kudoh A, 2006, J VIROL, V80, P10064, DOI 10.1128/JVI.00678-06; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Liao CC, 2010, J BIOL CHEM, V285, P33134, DOI 10.1074/jbc.M110.143461; LIN CT, 1990, LAB INVEST, V62, P713; LORINCZ AT, 1986, MOL CELL BIOL, V6, P4099; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Mauser A, 2002, J VIROL, V76, P12543, DOI 10.1128/JVI.76.24.12543-12552.2002; McClendon H, 2007, DIMENS CRIT CARE NUR, V26, P199, DOI 10.1097/01.DCC.0000286824.11861.74; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; SUPER HJG, 1993, BLOOD, V82, P3705; Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008; Tsai CH, 1997, J BIOMED SCI, V4, P69, DOI 10.1007/BF02255596; Wang JT, 2005, J GEN VIROL, V86, P3215, DOI 10.1099/vir.0.81313-0; Yang PW, 2008, J GEN VIROL, V89, P884, DOI 10.1099/vir.0.83546-0; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08	50	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39217	10.1371/journal.pone.0039217	http://dx.doi.org/10.1371/journal.pone.0039217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768064	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100034
J	Heller, EA; Zhang, WZ; Selimi, F; Earnheart, JC; Slimak, MA; Santos-Torres, J; Ibanez-Tallon, I; Aoki, C; Chait, BT; Heintz, N				Heller, Elizabeth A.; Zhang, Wenzhu; Selimi, Fekrije; Earnheart, John C.; Slimak, Marta A.; Santos-Torres, Julio; Ibanez-Tallon, Ines; Aoki, Chiye; Chait, Brian T.; Heintz, Nathaniel			The Biochemical Anatomy of Cortical Inhibitory Synapses	PLOS ONE			English	Article							POSTSYNAPTIC DENSITY FRACTION; GABA(A) RECEPTOR TRAFFICKING; ADULT-RAT BRAIN; GLUTAMATERGIC SYNAPSES; SIGNALING COMPLEXES; GABAERGIC SYNAPSES; MASS-SPECTROMETRY; ADHESION PROTEIN; GAMMA-2 SUBUNIT; CEREBRAL-CORTEX	Classical electron microscopic studies of the mammalian brain revealed two major classes of synapses, distinguished by the presence of a large postsynaptic density (PSD) exclusively at type 1, excitatory synapses. Biochemical studies of the PSD have established the paradigm of the synapse as a complex signal-processing machine that controls synaptic plasticity. We report here the results of a proteomic analysis of type 2, inhibitory synaptic complexes isolated by affinity purification from the cerebral cortex. We show that these synaptic complexes contain a variety of neurotransmitter receptors, neural cell-scaffolding and adhesion molecules, but that they are entirely lacking in cell signaling proteins. This fundamental distinction between the functions of type 1 and type 2 synapses in the nervous system has far reaching implications for models of synaptic plasticity, rapid adaptations in neural circuits, and homeostatic mechanisms controlling the balance of excitation and inhibition in the mature brain.	[Heller, Elizabeth A.; Earnheart, John C.; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; [Zhang, Wenzhu; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Selimi, Fekrije] Coll France, CIRB, Paris, France; [Slimak, Marta A.; Santos-Torres, Julio; Ibanez-Tallon, Ines] Max Delbruck Ctr Mol Med, Mol Neurobiol Grp, Berlin, Germany; [Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; UDICE-French Research Universities; PSL Research University Paris; College de France; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University	Heller, EA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA.	heintz@rockefeller.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Slimak-Mastrobuoni, Marta/0000-0003-3203-2309; Heller, Elizabeth A/0000-0002-2984-8705	Irma L. & Abram S. Croll Charitable Trust; Simons Foundation; Howard Hughes Medical Institute; National Eye Institute [EY13079]; National Institutes of Health (NIH) [5 R01 DA009618-09, RR00862, RR022220]; Klarman Family Foundation; NYU Research Challenge Fund; Helmholtz Association [31-002];  [MH091445-01];  [Sonderforschungsbereich SFB 665]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY013079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	Irma L. & Abram S. Croll Charitable Trust; Simons Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Family Foundation; NYU Research Challenge Fund; Helmholtz Association(Helmholtz Association); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by Irma L. & Abram S. Croll Charitable Trust, Simons Foundation and Howard Hughes Medical Institute to NH; National Eye Institute Core grant EY13079, National Institutes of Health (NIH) 5 R01 DA009618-09, Klarman Family Foundation grant, NYU Research Challenge Fund Grant, and MH091445-01 to CA; NIH RR00862 and NIH RR022220 to WZ and BTC; Helmholtz Association 31-002 and Sonderforschungsbereich SFB 665 to IIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki C, 2000, METH MOL B, V136, P535; Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Auer S, 2010, NAT METHODS, V7, P229, DOI [10.1038/NMETH.1425, 10.1038/nmeth.1425]; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Beavis Ronald C., 2006, V328, P217; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BLOMBERG F, 1977, J CELL BIOL, V74, P204, DOI 10.1083/jcb.74.1.204; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Burli T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011507; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Chen ZW, 2007, J NEUROSCI, V27, P6655, DOI 10.1523/JNEUROSCI.0919-07.2007; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; ECCLES JC, 1959, ANN NY ACAD SCI, V81, P247, DOI 10.1111/j.1749-6632.1959.tb49312.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; GRAY EG, 1959, J ANAT, V93, P420; Hjelmeland LM, 1990, METHOD ENZYMOL, P253; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Levinson JN, 2010, NEUROSCIENCE, V165, P782, DOI 10.1016/j.neuroscience.2009.11.016; Li X, 2007, J NEUROCHEM, V102, P1329, DOI 10.1111/j.1471-4159.2007.04635.x; Li XJ, 2009, J BIOL CHEM, V284, P17253, DOI 10.1074/jbc.M109.008870; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; McBain CJ, 2009, CURR OPIN NEUROBIOL, V19, P254, DOI 10.1016/j.conb.2009.05.008; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; Medrihan L, 2009, J PHYSIOL-LONDON, V587, P5095, DOI 10.1113/jphysiol.2009.178236; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Nusser Z, 1998, J NEUROSCI, V18, P1693; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Saiepour L., 2010, J BIOL CHEM; Selimi F, 2009, PLOS BIOL, V7, P948, DOI 10.1371/journal.pbio.1000083; Shen H, 2010, SCIENCE, V327, P1515, DOI 10.1126/science.1184245; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; SIEKEVITZ P, 1985, P NATL ACAD SCI USA, V82, P3494, DOI 10.1073/pnas.82.10.3494; Sturzebecher AS, 2010, J PHYSIOL-LONDON, V588, P1695, DOI 10.1113/jphysiol.2010.187112; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang XL, 2000, J NEUROSCI, V20, P8551; WEHNER JM, 1993, PHARMACOL BIOCHEM BE, V44, P133, DOI 10.1016/0091-3057(93)90290-A; Wisniewski, 2009, NAT METH, V6, P1	73	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39572	10.1371/journal.pone.0039572	http://dx.doi.org/10.1371/journal.pone.0039572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768092	gold, Green Published, Green Accepted			2022-12-25	WOS:000305892100062
J	Kaundun, SS; Hutchings, SJ; Dale, RP; McIndoe, E				Kaundun, Shiv Shankhar; Hutchings, Sarah-Jane; Dale, Richard Paul; McIndoe, Eddie			Broad Resistance to ACCase Inhibiting Herbicides in a Ryegrass Population Is Due Only to a Cysteine to Arginine Mutation in the Target Enzyme	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; COENZYME-A CARBOXYLASE; LOLIUM-RIGIDUM; ACETOLACTATE-SYNTHASE; CARBOXYLTRANSFERASE DOMAIN; MULTIPLE-RESISTANCE; RAPID EVOLUTION; ENDOWING RESISTANCE; MOLECULAR-BASIS; GENETIC-CONTROL	Background: The design of sustainable weed management strategies requires a good understanding of the mechanisms by which weeds evolve resistance to herbicides. Here we have conducted a study on the mechanism of resistance to ACCase inhibiting herbicides in a Lolium multiflorum population (RG3) from the UK. Methodology/Principal Findings: Analysis of plant phenotypes and genotypes showed that all the RG3 plants (72%) that contained the cysteine to arginine mutation at ACCase codon position 2088 were resistant to ACCase inhibiting herbicides. Whole plant dose response tests on predetermined wild and mutant 2088 genotypes from RG3 and a standard sensitive population indicated that the C2088R mutation is the only factor conferring resistance to all ten ACCase herbicides tested. The associated resistance indices ranged from 13 for clethodim to over 358 for diclofop-methyl. Clethodim, the most potent herbicide was significantly affected even when applied on small mutant plants at the peri-emergence and one leaf stages. Conclusion/Significance: This study establishes the clear and unambiguous importance of the C2088R target site mutation in conferring broad resistance to ten commonly used ACCase inhibiting herbicides. It also demonstrates that low levels "creeping", multigenic, non target site resistance, is not always selected before single gene target site resistance appears in grass weed populations subjected to herbicide selection pressure.	[Kaundun, Shiv Shankhar; Hutchings, Sarah-Jane; Dale, Richard Paul; McIndoe, Eddie] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	Syngenta	Kaundun, SS (corresponding author), Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England.	deepak.kaundun@syngenta.com	Kaundun, Shiv/AIB-0473-2022					Beckie HJ, 2004, WEED TECHNOL, V18, P853, DOI 10.1614/WT-03-124R; BURNET MWM, 1994, WEED SCI, V42, P369, DOI 10.1017/S0043174500076645; Busi R, 2011, HEREDITY, V106, P817, DOI 10.1038/hdy.2010.124; Cocker KM, 2001, PEST MANAG SCI, V57, P587, DOI 10.1002/ps.330; de Prado JL, 2005, J AGR FOOD CHEM, V53, P2185, DOI 10.1021/jf049481m; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, WEED RES, V45, P323, DOI 10.1111/j.1365-3180.2005.00467.x; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; Delye C, 2009, WEED RES, V49, P326, DOI 10.1111/j.1365-3180.2009.00700.x; Delye C, 2011, PLANT SCI, V180, P333, DOI 10.1016/j.plantsci.2010.10.007; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; HEAP J, 1982, J AUST I AGR SCI, V48, P156; Hofer U, 2006, J PLANT DIS PROTECT, P989; Kaundun SS, 2010, PEST MANAG SCI, V66, P1249, DOI 10.1002/ps.2003; KONISHI T, 1994, P NATL ACAD SCI USA, V91, P3598, DOI 10.1073/pnas.91.9.3598; Kotoula-Syka E, 2000, PEST MANAG SCI, V56, P1054, DOI 10.1002/1526-4998(200012)56:12<1054::AID-PS267>3.0.CO;2-M; Kuk YI, 2008, WEED SCI, V56, P614, DOI 10.1614/WS-08-003.1; Manalil S, 2011, WEED SCI, V59, P210, DOI 10.1614/WS-D-10-00111.1; Maxwell Bruce D., 1994, P1; Neve P, 2005, THEOR APPL GENET, V110, P1154, DOI 10.1007/s00122-005-1947-2; Owen MJ, 2007, AUST J AGR RES, V58, P711, DOI 10.1071/AR06283; Petit C, 2010, PLANT SCI, V178, P501, DOI 10.1016/j.plantsci.2010.03.007; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; RENDINA AR, 1990, J AGR FOOD CHEM, V38, P1282, DOI 10.1021/jf00095a029; Ruegg WT, 2007, WEED RES, V47, P271, DOI 10.1111/j.1365-3180.2007.00572.x; Sammons RD, 2007, WEED TECHNOL, V21, P347, DOI 10.1614/WT-04-150.1; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Scarabel L, 2011, PEST MANAG SCI, V67, P932, DOI 10.1002/ps.2133; SECOR J, 1988, PLANT PHYSIOL, V86, P10, DOI 10.1104/pp.86.1.10; Tan MK, 2007, WEED RES, V47, P534, DOI 10.1111/j.1365-3180.2007.00591.x; TARDIF FJ, 1994, PHYSIOL PLANTARUM, V91, P488, DOI 10.1111/j.1399-3054.1994.tb02978.x; WRUBEL RP, 1994, WEED TECHNOL, V8, P635, DOI 10.1017/S0890037X00039828; Xiang S, 2009, P NATL ACAD SCI USA, V106, P20723, DOI 10.1073/pnas.0908431106; Yu LPC, 2010, P NATL ACAD SCI USA, V107, P22072, DOI 10.1073/pnas.1012039107; Yu Q, 2008, PEST MANAG SCI, V64, P1229, DOI 10.1002/ps.1624; Yu Q, 2007, PLANT PHYSIOL, V145, P547, DOI 10.1104/pp.107.105262; Zhang HL, 2004, P NATL ACAD SCI USA, V101, P5910, DOI 10.1073/pnas.0400891101; Zhang XQ, 2006, PLANTA, V223, P550, DOI 10.1007/s00425-005-0095-x	38	31	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39759	10.1371/journal.pone.0039759	http://dx.doi.org/10.1371/journal.pone.0039759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768118	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100088
J	Kroidl, I; Clowes, P; Mwalongo, W; Maganga, L; Maboko, L; Kroidl, AL; Geldmacher, C; Machibya, H; Hoelscher, M; Saathoff, E				Kroidl, Inge; Clowes, Petra; Mwalongo, Wolfram; Maganga, Lucas; Maboko, Leonard; Kroidl, Arne L.; Geldmacher, Christof; Machibya, Harun; Hoelscher, Michael; Saathoff, Elmar			Low Specificity of Determine HIV1/2 RDT Using Whole Blood in South West Tanzania	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TESTING ALGORITHMS; ASSAYS; AFRICA; IMMUNOASSAYS; DISEASES; UGANDA; CAPE	Objective: To evaluate the diagnostic performance of two rapid detection tests (RDTs) for HIV 1/2 in plasma and in whole blood samples. Methods: More than 15,000 study subjects above the age of two years participated in two rounds of a cohort study to determine the prevalence of HIV. HIV testing was performed using the Determine HIV 1/2 test (Abbott) in the first (2006/2007) and the HIV 1/2 STAT-PAK Dipstick Assay (Chembio) in the second round (2007/2008) of the survey. Positive results were classified into faint and strong bands depending on the visual appearance of the test strip and confirmed by ELISA and Western blot. Results: The sensitivity and specificity of the Determine RDT were 100% (95% confidence interval = 86.8 to 100%) and 96.8% (95.9 to 97.6%) in whole blood and 100% (99.7 to 100%) and 97.9% (97.6 to 98.1%) in plasma respectively. Specificity was highly dependent on the tested sample type: when using whole blood, 67.1% of positive results were false positive, as opposed to 17.4% in plasma. Test strips with only faint positive bands were more often false positive than strips showing strong bands and were more common in whole blood than in plasma. Evaluation of the STAT-PAK RDT in plasma during the second year resulted in a sensitivity of 99.7% (99.1 to 99.9%) and a specificity of 99.3% (99.1 to 99.4%) with 6.9% of the positive results being false. Conclusions: Our study shows that the Determine HIV 1/2 strip test with its high sensitivity is an excellent tool to screen for HIV infection, but that - at least in our setting - it can not be recommended as a confirmatory test in VCT campaigns where whole blood is used.	[Kroidl, Inge; Kroidl, Arne L.; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Clowes, Petra; Mwalongo, Wolfram; Maganga, Lucas; Maboko, Leonard; Kroidl, Arne L.] NIMR Mbeya Med Res Programme, Mbeya, Tanzania; [Kroidl, Arne L.; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] LMU, German Ctr Infect Res, Munich, Germany; [Machibya, Harun] Mbeya Reg Med Off, Mbeya, Tanzania	University of Munich; German Center for Infection Research; University of Munich	Kroidl, I (corresponding author), Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany.	ikroidl@lrz.uni-muenchen.de	Hoelscher, Michael/D-3436-2012		European Commission as part of EuropAid [SANTE/2004/078-545, SANTE/2006/129-931]	European Commission as part of EuropAid	This study was funded by the European Commission as part of EuropAid (SANTE/2004/078-545 and SANTE/2006/129-931). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, Wkly Epidemiol Rec, V67, P145; [Anonymous], 2010, CLEARVIEW HIV1 2 STA; [Anonymous], 2009, DETERMINE HIV 1 2 PR; Claassen M, 2006, J CLIN VIROL, V37, P68, DOI 10.1016/j.jcv.2006.06.008; Dax EM, 1999, J VIROL METHODS, V82, P113, DOI 10.1016/S0166-0934(99)00082-8; Eller LA, 2007, J CLIN MICROBIOL, V45, P3281, DOI 10.1128/JCM.00894-07; Everett DB, 2010, J CLIN MICROBIOL, V48, P1570, DOI 10.1128/JCM.02264-09; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Granade TC, 2005, CLIN DIAGN LAB IMMUN, V12, P855, DOI 10.1128/CDLI.12.7.855-860.2005; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Halkin A, 1998, QJM-INT J MED, V91, P247, DOI 10.1093/qjmed/91.4.247; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Koblavi-Deme S, 2001, J CLIN MICROBIOL, V39, P1808, DOI 10.1128/JCM.39.5.1808-1812.2001; Lyamuya EF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-19; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; McKenna SL, 1997, AIDS, V11, pS103; Menard D, 2005, J VIROL METHODS, V126, P75, DOI 10.1016/j.jviromet.2005.01.023; National AIDS Control Program website. Standard Operating Procedures for HIV testing and counselling (HTC) services, STAND OP PROC HIV TE; Respess RA, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200104003-00007; SELLERS RF, 1980, J HYG-CAMBRIDGE, V85, P65, DOI 10.1017/S0022172400027108; Singer DE, 2005, J CLIN MICROBIOL, V43, P5312, DOI 10.1128/JCM.43.10.5312-5315.2005; van den Berk GEL, 2003, J CLIN MICROBIOL, V41, P3868, DOI 10.1128/JCM.41.8.3868-3869.2003; World Health Organization Dept. of essential health technologies, 2002, 12 WHO DEP ESS HLTH; 1998, WKLY EPIDEMIOL REC, V73, P321	27	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39529	10.1371/journal.pone.0039529	http://dx.doi.org/10.1371/journal.pone.0039529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768086	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100057
J	Nam, D; Mau, E; Wang, YF; Wright, D; Silkstone, D; Whetstone, H; Whyne, C; Alman, B				Nam, Diane; Mau, Elaine; Wang, Yufa; Wright, David; Silkstone, David; Whetstone, Heather; Whyne, Cari; Alman, Benjamin			T-Lymphocytes Enable Osteoblast Maturation via IL-17F during the Early Phase of Fracture Repair	PLOS ONE			English	Article							TNF-ALPHA; BONE; DIFFERENTIATION; INTERLEUKIN-6; CELLS; SYSTEM; MICE	While it is well known that the presence of lymphocytes and cytokines are important for fracture healing, the exact role of the various cytokines expressed by cells of the immune system on osteoblast biology remains unclear. To study the role of inflammatory cytokines in fracture repair, we studied tibial bone healing in wild-type and Rag1(-/-) mice. Histological analysis, mu CT stereology, biomechanical testing, calcein staining and quantitative RNA gene expression studies were performed on healing tibial fractures. These data provide support for Rag1(-/-) mice as a model of impaired fracture healing compared to wild-type. Moreover, the pro-inflammatory cytokine, IL-17F, was found to be a key mediator in the cellular response of the immune system in osteogenesis. In vitro studies showed that IL-17F alone stimulated osteoblast maturation. We propose a model in which the Th17 subset of T-lymphocytes produces IL-17F to stimulate bone healing. This is a pivotal link in advancing our current understanding of the molecular and cellular basis of fracture healing, which in turn may aid in optimizing fracture management and in the treatment of impaired bone healing.	[Nam, Diane; Mau, Elaine; Wang, Yufa; Wright, David; Whyne, Cari] Univ Toronto, Sunnybrook Res Inst, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada; [Silkstone, David; Whetstone, Heather; Alman, Benjamin] Univ Toronto, Hosp Sick Children, Dept Dev Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Nam, D (corresponding author), Univ Toronto, Sunnybrook Res Inst, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada.	diane.nam@sunnybrook.ca			Holland Musculoskeletal Program, Sunnybrook Research Institute; Department of Surgery, University of Toronto; Division of Orthopaedic Surgery, Department of Surgery, University of Toronto [489200]; Canadian Institutes of Health Research	Holland Musculoskeletal Program, Sunnybrook Research Institute; Department of Surgery, University of Toronto(University of Toronto); Division of Orthopaedic Surgery, Department of Surgery, University of Toronto; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was generously supported by the Holland Musculoskeletal Program, Sunnybrook Research Institute (Internal funding sources); Roscoe Reid Surgical Science Scholarship Award (scholarship), Department of Surgery, University of Toronto; Division of Orthopaedic Surgery, Department of Surgery, University of Toronto (489200) (http://www.medresearch.utoronto.ca/fmro_deans_fund.html) and Canadian Institutes of Health Research (http://www.cihrirsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW JG, 1994, ACTA ORTHOP SCAND, V65, P462, DOI 10.3109/17453679408995493; ASKALONOV AA, 1981, J HYG EPID MICROB IM, V25, P307; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Boyce BF, 2009, CRIT REV EUKAR GENE, V19, P171, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.10; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cho TJ, 2001, CURR OPIN ORTHOP, V12, P403; Colburn NT, 2009, ARTHRITIS RHEUM-US, V60, P1694, DOI 10.1002/art.24520; Entezari V, 2011, J BIOMECH, V44, P552, DOI 10.1016/j.jbiomech.2010.09.022; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Huang H, 2009, CELL DEATH DIFFER, V16, P1332, DOI 10.1038/cdd.2009.74; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Kabelitz D, 2011, CELL MOL LIFE SCI, V68, P2331, DOI 10.1007/s00018-011-0696-4; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kitami S, 2010, BIOCHIMIE, V92, P398, DOI 10.1016/j.biochi.2009.12.011; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Le AX, 2001, J ORTHOPAED RES, V19, P78, DOI 10.1016/S0736-0266(00)00006-1; Le Goff B, 2010, JOINT BONE SPINE, V77, P201, DOI 10.1016/j.jbspin.2010.03.002; Lorenzo J, 2011, OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS, P1; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; MARVEL J, 1988, EUR J IMMUNOL, V18, P825, DOI 10.1002/eji.1830180526; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Nakashima T, 2009, J CLIN IMMUNOL, V29, P555, DOI 10.1007/s10875-009-9316-6; Nazarian A, 2010, CALCIFIED TISSUE INT, V86, P397, DOI 10.1007/s00223-010-9353-4; Nepal RM, 2008, ONCOGENE, V27, P4752, DOI 10.1038/onc.2008.111; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Richardson J, 2008, J BONE JOINT SURG BR, V90B, P988, DOI 10.1302/0301-620X.90B8.20861; Shoji K, 2008, OSTEOPOROSIS INT, V19, P1193, DOI 10.1007/s00198-007-0558-y; Terpos Evangelos, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P94; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; van Gaalen SM, 2010, TISSUE ENG PART B-RE, V16, P209, DOI [10.1089/ten.teb.2009.0503, 10.1089/ten.TEB.2009.0503]; Wallace A, 2011, J ORTHOP RES, V29, P1437, DOI 10.1002/jor.21367; Xing ZQ, 2010, J ORTHOP RES, V28, P1000, DOI 10.1002/jor.21087; Yago T, 2009, J CELL BIOCHEM, V108, P947, DOI 10.1002/jcb.22326; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022	46	117	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40044	10.1371/journal.pone.0040044	http://dx.doi.org/10.1371/journal.pone.0040044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768215	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100187
J	Papa, E; Docktor, M; Smillie, C; Weber, S; Preheim, SP; Gevers, D; Giannoukos, G; Ciulla, D; Tabbaa, D; Ingram, J; Schauer, DB; Ward, DV; Korzenik, JR; Xavier, RJ; Bousvaros, A; Alm, EJ				Papa, Eliseo; Docktor, Michael; Smillie, Christopher; Weber, Sarah; Preheim, Sarah P.; Gevers, Dirk; Giannoukos, Georgia; Ciulla, Dawn; Tabbaa, Diana; Ingram, Jay; Schauer, David B.; Ward, Doyle V.; Korzenik, Joshua R.; Xavier, Ramnik J.; Bousvaros, Athos; Alm, Eric J.			Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; ACTIVITY INDEX; MANAGEMENT; APPRAISAL; THERAPY; UTILITY; TWINS	Background: Pediatric inflammatory bowel disease (IBD) is challenging to diagnose because of the non-specificity of symptoms; an unequivocal diagnosis can only be made using colonoscopy, which clinicians are reluctant to recommend for children. Diagnosis of pediatric IBD is therefore frequently delayed, leading to inappropriate treatment plans and poor outcomes. We investigated the use of 16S rRNA sequencing of fecal samples and new analytical methods to assess differences in the microbiota of children with IBD and other gastrointestinal disorders. Methodology/Principal Findings: We applied synthetic learning in microbial ecology (SLiME) analysis to 16S sequencing data obtained from i) published surveys of microbiota diversity in IBD and ii) fecal samples from 91 children and young adults who were treated in the gastroenterology program of Children's Hospital (Boston, USA). The developed method accurately distinguished control samples from those of patients with IBD; the area under the receiver-operating-characteristic curve (AUC) value was 0.83 (corresponding to 80.3% sensitivity and 69.7% specificity at a set threshold). The accuracy was maintained among data sets collected by different sampling and sequencing methods. The method identified taxa associated with disease states and distinguished patients with Crohn's disease from those with ulcerative colitis with reasonable accuracy. The findings were validated using samples from an additional group of 68 patients; the validation test identified patients with IBD with an AUC value of 0.84 (e. g. 92% sensitivity, 58.5% specificity). Conclusions/Significance: Microbiome-based diagnostics can distinguish pediatric patients with IBD from patients with similar symptoms. Although this test can not replace endoscopy and histological examination as diagnostic tools, classification based on microbial diversity is an effective complementary technique for IBD detection in pediatric patients.	[Papa, Eliseo] Harvard MIT Hlth Sci & Technol Inst, Cambridge, MA USA; [Docktor, Michael; Weber, Sarah; Ingram, Jay; Bousvaros, Athos] Childrens Hosp Boston, Ctr Inflammatory Bowel Dis, Boston, MA USA; [Smillie, Christopher] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Preheim, Sarah P.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Gevers, Dirk; Giannoukos, Georgia; Ciulla, Dawn; Tabbaa, Diana; Ward, Doyle V.; Xavier, Ramnik J.; Alm, Eric J.] 7 Cambridge Ctr, Broad Inst, Cambridge, MA USA; [Schauer, David B.; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Schauer, David B.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Korzenik, Joshua R.; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Ctr Inflammatory Bowel Dis, Boston, MA USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA	Harvard University; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Papa, E (corresponding author), Harvard MIT Hlth Sci & Technol Inst, Cambridge, MA USA.	athos.bousvaros@childrens.harvard.edu; ejalm@mit.edu	Preheim, Sarah P/B-3432-2010; Gevers, Dirk/C-1451-2009	Preheim, Sarah P/0000-0001-7365-2382; Papa, Eliseo/0000-0002-2467-7759; Smillie, Chris/0000-0002-7606-3433	NSERC PGS D award; NIH [1-R21-A1084032-01A1]; MacInnes Friends and Family Fund; Rasmussen Family Fund; NCBI BioProject [82109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092405, P30DK043351] Funding Source: NIH RePORTER	NSERC PGS D award(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacInnes Friends and Family Fund; Rasmussen Family Fund; NCBI BioProject; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by philantropic donations from the MacInnes Friends and Family Fund and by the Rasmussen Family Fund. EP was supported by a NSERC PGS D award. EJA was supported by the NIH award 1-R21-A1084032-01A1. ALPCO diagnostics/Buhlmann laboratories kindly provided calprotectin kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sequencing data is publicly available as a NCBI BioProject, with BioProjectID 82109.	Andersen K, 2006, EUR J RADIOL, V58, P140, DOI 10.1016/j.ejrad.2005.11.004; Arseneau Kristen O, 2007, Curr Gastroenterol Rep, V9, P508, DOI 10.1007/s11894-007-0067-3; Austin GL, 2007, CLIN GASTROENTEROL H, V5, P545, DOI 10.1016/j.cgh.2007.03.006; BALDI P, 2001, BIOINFORMATICS MACHI; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Bohm SK, 2006, ANN NY ACAD SCI, V1072, P339, DOI 10.1196/annals.1326.005; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cabrera-Abreu JC, 2004, ARCH DIS CHILD, V89, P69; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DEVROEDE GJ, 1971, NEW ENGL J MED, V285, P17, DOI 10.1056/NEJM197107012850103; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dubinsky MC, 2001, AM J GASTROENTEROL, V96, P758; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Griffiths AM, 2005, INFLAMM BOWEL DIS, V11, P185, DOI 10.1097/00054725-200502000-00013; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Heikenen JB, 1999, INFLAMM BOWEL DIS, V5, P158, DOI 10.1097/00054725-199908000-00002; Kappelman MD, 2008, MOL NUTR FOOD RES, V52, P867, DOI 10.1002/mnfr.200700156; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Knights D, 2010, FEMS MICROBIOLOGY RE, P1; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Loffler M, 2006, ANN NY ACAD SCI, V1072, P379, DOI 10.1196/annals.1326.014; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peeters M, 2001, AM J GASTROENTEROL, V96, P730, DOI 10.1111/j.1572-0241.2001.03613.x; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sartor R Balfour, 2007, Curr Gastroenterol Rep, V9, P497; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Spray C, 2001, ACTA PAEDIATR, V90, P400, DOI 10.1080/080352501750126230; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Team R. D. C, 2011, R LANG ENV STAT COMP; Tomas G, 2012, ONCOGENE; Turner D, 2010, AM J GASTROENTEROL, V105, P2085, DOI 10.1038/ajg.2010.143; Turner D, 2009, INFLAMM BOWEL DIS, V15, P1218, DOI 10.1002/ibd.20867; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yantiss RK, 2006, HISTOPATHOLOGY, V48, P116, DOI 10.1111/j.1365-2559.2005.02248.x	49	191	209	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39242	10.1371/journal.pone.0039242	http://dx.doi.org/10.1371/journal.pone.0039242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768065	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100036
J	Tamura, M; Moriguchi, Y; Higuchi, S; Hida, A; Enomoto, M; Umezawa, J; Mishima, K				Tamura, Miyuki; Moriguchi, Yoshiya; Higuchi, Shigekazu; Hida, Akiko; Enomoto, Minori; Umezawa, Jun; Mishima, Kazuo			Neural Network Development in Late Adolescents during Observation of Risk-Taking Action	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR CINGULATE CORTEX; SOCIAL-ANXIETY-DISORDER; AGE-RELATED-CHANGES; BRAIN-DEVELOPMENT; PHYSIOLOGICAL CONDITION; REJECTION SENSITIVITY; DEPRESSIVE-DISORDERS; PERSONALITY-FACTORS; FACIAL EXPRESSIONS	Emotional maturity and social awareness are important for adolescents, particularly college students beginning to face the challenges and risks of the adult world. However, there has been relatively little research into personality maturation and psychological development during late adolescence and the neural changes underlying this development. We investigated the correlation between psychological properties (neuroticism, extraversion, anxiety, and depression) and age among late adolescents (n = 25, from 18 years and 1 month to 22 years and 8 months). The results revealed that late adolescents became less neurotic, less anxious, less depressive and more extraverted as they aged. Participants then observed video clips depicting hand movements with and without a risk of harm (risk-taking or safe actions) during functional magnetic resonance imaging (fMRI). The results revealed that risk-taking actions elicited significantly stronger activation in the bilateral inferior parietal lobule, temporal visual regions (superior/middle temporal areas), and parieto-occipital visual areas (cuneus, middle occipital gyri, precuneus). We found positive correlations of age and extraversion with neural activation in the insula, middle temporal gyrus, lingual gyrus, and precuneus. We also found a negative correlation of age and anxiety with activation in the angular gyrus, precentral gyrus, and red nucleus/substantia nigra. Moreover, we found that insula activation mediated the relationship between age and extraversion. Overall, our results indicate that late adolescents become less anxious and more extraverted with age, a process involving functional neural changes in brain networks related to social cognition and emotional processing. The possible neural mechanisms of psychological and social maturation during late adolescence are discussed.	[Tamura, Miyuki] Univ Human Arts & Sci, Fac Human Arts & Sci, Saitama, Japan; [Tamura, Miyuki; Moriguchi, Yoshiya; Higuchi, Shigekazu; Hida, Akiko; Enomoto, Minori; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Dept Psychophysiol, Natl Inst Mental Hlth, Tokyo, Japan; [Moriguchi, Yoshiya; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Dept Clin Neuroimaging, Integrat Brain Imaging Ctr, Tokyo, Japan; [Higuchi, Shigekazu] Kyushu Univ, Fac Design, Fukuoka 812, Japan; [Umezawa, Jun] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Kyushu University; National Cancer Center - Japan	Tamura, M (corresponding author), Univ Human Arts & Sci, Fac Human Arts & Sci, Saitama, Japan.	m-tamura@human.ac.jp	HIGUCHI, Shigekazu/AAM-5800-2020	MISHIMA, KAZUO/0000-0003-1182-1181; higuchi, shigekazu/0000-0001-7131-0792	KAKENHI [21770269]; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Young Scientists (B), KAKENHI (21770269) (http://www.jsps.go.jp/english/e-grants/index.html). This study was supported in part by a Research Grant for a Health Science Grant from the Ministry of Health, Labor and Welfare of Japan, and the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2010, CORTEX, V46, P425, DOI 10.1016/j.cortex.2009.04.011; Arnett J.J., 2004, EMERGING ADULTHOOD W; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Azmitia M, 2008, NEW DIR CHILD ADOLES, V120, P1, DOI 10.1002/cd.212; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; Bienvenu OJ, 2007, AM J PSYCHIAT, V164, P1714, DOI 10.1176/appi.ajp.2007.06101667; Bienvenu OJ, 2001, J NERV MENT DIS, V189, P154, DOI 10.1097/00005053-200103000-00003; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Branje SJT, 2007, EUR J PERSONALITY, V21, P45, DOI 10.1002/per.596; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Buchweitz Augusto, 2009, Psychol. Neurosci., V2, P111, DOI 10.3922/j.psns.2009.2.003; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Butler T, 2007, NEUROSCIENCE, V150, P1, DOI 10.1016/j.neuroscience.2007.09.048; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cheng YW, 2007, CEREB CORTEX, V17, P1979, DOI 10.1093/cercor/bhl107; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Cohen JD, 2010, J PSYCHIATR RES, V44, P81, DOI 10.1016/j.jpsychires.2009.07.001; Corfield DR, 1999, J APPL PHYSIOL, V86, P1468, DOI 10.1152/jappl.1999.86.5.1468; Costa P.T., 1992, NEO FFI PERSONALITY; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Davis N, 2009, MAGN RESON IMAGING, V27, P1187, DOI 10.1016/j.mri.2009.05.010; De Moor MHM, 2006, PREV MED, V42, P273, DOI 10.1016/j.ypmed.2005.12.002; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Eccles J, 2003, CROSS CONT, P383; Erikson E. H., 1994, IDENTITY YOUTH CRISI; Erikson Erik, 1994, IDENTITY LIFE CYCLE; Eysenk HansJ., 1967, BIOL BASIS PERSONALI; Eysenk HJ, 1959, MANUAL MAUDSLEY PERS; Eysenk HJ, 1990, BIOL DIMENSIONS PERS; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; Feinstein JS, 2002, NEUROREPORT, V13, P1255, DOI 10.1097/00001756-200207190-00007; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; French SE, 2000, J ADOLESCENT RES, V15, P587, DOI 10.1177/0743558400155004; Fukuda K, 1983, SDS SELF RATING DEPR; Gamma A, 2000, NEUROPSYCHOPHARMACOL, V23, P388, DOI 10.1016/S0893-133X(00)00130-5; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goodwin RD, 2004, PSYCHIAT RES, V126, P135, DOI 10.1016/j.psychres.2003.12.024; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hanby MS, 2012, J INTERPERS VIOLENCE; Harper MS, 2006, J YOUTH ADOLESCENCE, V35, P459, DOI 10.1007/s10964-006-9048-3; Hurtado Aida., 2003, VOICING CHICANA FEMI; Iwawaki S, 1969, MAUDSLEY PERSONALITY; John Oliver P., 1999, BIG 5 TRAIT TAXONOMY; Johnson DL, 1999, AM J PSYCHIAT, V156, P252; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [10.1037/1089-2680.2.3.320, DOI 10.1037/1089-2680.2.3.320]; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Kobayashi C, 2007, NEUROPSYCHOLOGIA, V45, P1522, DOI 10.1016/j.neuropsychologia.2006.11.017; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lee TMC, 2008, SOC COGN AFFECT NEUR, V3, P7, DOI 10.1093/scan/nsm033; Lieb R, 2000, ACTA PSYCHIAT SCAND, V101, P194, DOI 10.1034/j.1600-0447.2000.101003194.x; Lieb R, 2007, PSYCHOSOM MED, V69, P860, DOI 10.1097/PSY.0b013e31815b0103; Ludtke O, 2011, J PERS SOC PSYCHOL, V101, P620, DOI 10.1037/a0023743; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Marston EG, 2010, J RES ADOLESCENCE, V20, P959, DOI 10.1111/j.1532-7795.2010.00675.x; Mason MJ, 2009, J CLIN PSYCHOL MED S, V16, P346, DOI 10.1007/s10880-009-9169-4; Matthews G, 1999, PERS INDIV DIFFER, V26, P583, DOI 10.1016/S0191-8869(98)00158-5; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCrae RR, 1999, DEV PSYCHOL, V35, P466, DOI 10.1037/0012-1649.35.2.466; Mizuguchi T, 1982, STATE TRAIT ANXIETY; Monk CS, 2003, NEUROIMAGE, V20, P420, DOI 10.1016/S1053-8119(03)00355-0; Moriguchi Y, 2011, J COGNITIVE NEUROSCI, V23, P1027, DOI 10.1162/jocn.2010.21527; Newman B., 2009, DEV LIFE PSYCHOSOCIA; Newman B. M., 2016, THEORIES HUMAN DEV; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Okonogi K, 1981, HUMAN MORATORIUM PER; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2005, COGN AFFECT BEHAV NE, V5, P252, DOI 10.3758/CABN.5.2.252; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Phillips ML, 2004, NEUROIMAGE, V21, P1484, DOI 10.1016/j.neuroimage.2003.12.013; Poropat AE, 2011, BRIT J EDUC PSYCHOL, V81, P41, DOI 10.1348/000709910X497671; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAUCH SL, 1995, ARCH GEN PSYCHIAT, V52, P20; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Sakurai Y, 2010, J NEUROL SCI, V288, P25, DOI 10.1016/j.jns.2009.10.015; Schulenberg JE, 2004, DEV PSYCHOPATHOL, V16, P1119, DOI 10.1017/S0954579404040167; Shaver Phillip, 1985, UNDERSTANDING PERSON, P193; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tabachnik SE, 2006, USING MULTIVARIATE S; TALAIRACH J, 1988, COPLANAR STEREOAXIC; Tanaka E, 1998, J CLIN PSYCHOL, V54, P1043, DOI 10.1002/(SICI)1097-4679(199812)54:8<1043::AID-JCLP4>3.0.CO;2-A; Tanum L, 2001, J PSYCHOSOM RES, V50, P139, DOI 10.1016/S0022-3999(00)00219-1; Terracciano A, 2005, PSYCHOL AGING, V20, P493, DOI 10.1037/0882-7974.20.3.493; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; Vaidya JG, 2002, J PERS SOC PSYCHOL, V83, P1469, DOI 10.1037//0022-3514.83.6.1469; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Watson KK, 2008, ANN NY ACAD SCI, V1128, P8, DOI 10.1196/annals.1399.002; Williams PG, 2002, J CONSULT CLIN PSYCH, V70, P828, DOI 10.1037//0022-006X.70.3.828; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	142	14	14	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39527	10.1371/journal.pone.0039527	http://dx.doi.org/10.1371/journal.pone.0039527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768085	gold, Green Published			2022-12-25	WOS:000305892100056
J	Tomlinson, GS; Booth, H; Petit, SJ; Potton, E; Towers, GJ; Miller, RF; Chain, BM; Noursadeghi, M				Tomlinson, Gillian S.; Booth, Helen; Petit, Sarah J.; Potton, Elspeth; Towers, Greg J.; Miller, Robert F.; Chain, Benjamin M.; Noursadeghi, Mahdad			Adherent Human Alveolar Macrophages Exhibit a Transient Pro-Inflammatory Profile That Confounds Responses to Innate Immune Stimulation	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; ACTIVATION; EXPRESSION; RECEPTOR; DIFFERENTIATION; SARCOIDOSIS; INFECTION; SUPPRESS; BINDING; ALPHA	Alveolar macrophages (AM) are thought to have a key role in the immunopathogenesis of respiratory diseases. We sought to test the hypothesis that human AM exhibit an anti-inflammatory bias by making genome-wide comparisons with monocyte derived macrophages (MDM). Adherent AM obtained by bronchoalveolar lavage of patients under investigation for haemoptysis, but found to have no respiratory pathology, were compared to MDM from healthy volunteers by whole genome transcriptional profiling before and after innate immune stimulation. We found that freshly isolated AM exhibited a marked pro-inflammatory transcriptional signature. High levels of basal pro-inflammatory gene expression gave the impression of attenuated responses to lipopolysaccharide (LPS) and the RNA analogue, poly IC, but in rested cells pro-inflammatory gene expression declined and transcriptional responsiveness to these stimuli was restored. In comparison to MDM, both freshly isolated and rested AM showed upregulation of MHC class II molecules. In most experimental paradigms ex vivo adherent AM are used immediately after isolation. Therefore, the confounding effects of their pro-inflammatory profile at baseline need careful consideration. Moreover, despite the prevailing view that AM have an anti-inflammatory bias, our data clearly show that they can adopt a striking pro-inflammatory phenotype, and may have greater capacity for presentation of exogenous antigens than MDM.	[Tomlinson, Gillian S.] UCL, Ctr Resp Res, London, England; [Booth, Helen] Univ Coll London Hosp NHS Trust, Dept Thorac Med, London, England; [Miller, Robert F.] UCL, Res Dept Infect & Populat Hlth, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Tomlinson, GS (corresponding author), UCL, Ctr Resp Res, London, England.	m.noursadeghi@ucl.ac.uk	Towers, Greg J/H-8892-2012	Tomlinson, Gillian/0000-0003-4342-3161; Towers, Gregory/0000-0002-7707-0264; Miller, Robert/0000-0003-2067-4291; Chain, Benny/0000-0002-7417-3970; Noursadeghi, Mahdad/0000-0002-4774-0853	UK Medical Research Council [G0700569]; Wellcome Trust [WT077161, WT090940]; UK NIHR Comprehensive Biomedical Research Centre; Medical Research Council [G0801172, G0900950B, G9721629, G0700569, G0900950] Funding Source: researchfish; MRC [G0700569, G0900950, G0801172, G9721629] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK NIHR Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a UK Medical Research Council fellowship to GT (G0700569), Wellcome Trust fellowships to MN (WT077161) and to GJT (WT090940), and UK NIHR Comprehensive Biomedical Research Centre funding to UCLH/UCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa KS, 2006, RESPIROLOGY, V11, pS32, DOI 10.1111/j.1440-1843.2006.00805.x; ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; Armstrong L, 1996, THORAX, V51, P143, DOI 10.1136/thx.51.2.143; Bonfield TL, 2003, AM J PHYSIOL-LUNG C, V285, pL1132, DOI 10.1152/ajplung.00216.2003; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; Chain B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-344; Chain BM, 2011, PLOS ONE, V6; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davies John Q, 2005, Methods Mol Biol, V290, P105; Garcia JEL, 1999, MEDIAT INFLAMM, V8, P43, DOI 10.1080/09629359990711; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Hoppstadter J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-124; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; LIPSCOMB MF, 1986, J IMMUNOL, V136, P497; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Prior C, 1996, EUR RESPIR J, V9, P47, DOI 10.1183/09031936.96.09010047; ROTH MD, 1993, J LEUKOCYTE BIOL, V53, P366, DOI 10.1002/jlb.53.4.366; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; STANDIFORD TJ, 1991, AM J RESP CELL MOL, V5, P579, DOI 10.1165/ajrcmb/5.6.579; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tazelaar HD, 2011, HISTOPATHOLOGY, V58, P509, DOI 10.1111/j.1365-2559.2010.03649.x; Thirumaran M, 2009, THORAX, V64, P854, DOI 10.1136/thx.2008.108795; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xu F, 2008, AM J RESP CELL MOL, V39, P522, DOI 10.1165/rcmb.2007-0328OC; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	30	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40348	10.1371/journal.pone.0040348	http://dx.doi.org/10.1371/journal.pone.0040348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768282	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100256
J	Tzertzinis, G; Schildkraut, E; Schildkraut, I				Tzertzinis, George; Schildkraut, Ezra; Schildkraut, Ira			Substrate Cooperativity in Marine Luciferases	PLOS ONE			English	Article							RENILLA-RENIFORMIS LUCIFERASE; COPEPOD METRIDIA-LONGA; GAUSSIA-PRINCEPS; CDNA; BIOLUMINESCENCE; EXPRESSION; DOMAINS; NOCTILUCA; CLONING; GENE	Marine luciferases are increasingly used as reporters to study gene regulation. These luciferases have utility in bioluminescent assay development, although little has been reported on their catalytic properties in response to substrate concentration. Here, we report that the two marine luciferases from the copepods, Gaussia princeps (GLuc) and Metridia longa (MLuc) were found, surprisingly, to produce light in a cooperative manner with respect to their luciferin substrate concentration; as the substrate concentration was decreased 10 fold the rate of light production decreased 1000 fold. This positive cooperative effect is likely a result of allostery between the two proposed catalytic domains found in Gaussia and Metridia. In contrast, the marine luciferases from Renilla reniformis (RLuc) and Cypridina noctiluca (CLuc) demonstrate a linear relationship between the concentration of their respective luciferin and the rate of light produced. The consequences of these enzyme responses are discussed.	[Tzertzinis, George] New England Biolabs Inc, Ipswich, MA USA; [Schildkraut, Ezra; Schildkraut, Ira] CerroSci LLC, Ipswich, MA USA	New England Biolabs	Tzertzinis, G (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	schildkraut@neb.com			New England Biolabs; CerroSci	New England Biolabs; CerroSci	George Tzertzinis was employed by New England Biolabs, Inc. and Ezra Schildkraut and Ira Schildkraut by CerroSci LLC while performing this research. New England Biolabs and CerroSci funded this work. Coelenterazine, cypridina luciferin and Biolux GLuc Flex Assay Buffer were obtained from New England Biolabs. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderson J, 1978, METHOD ENZYMOL, V55, P244; Bryan B., 2001, United States Patent, Patent No. 6232107; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Li LM, 2001, BIOCHEMISTRY-US, V40, P1844, DOI 10.1021/bi002094v; Liu L, 2004, PNAS, V101; Liu LY, 2007, P NATL ACAD SCI USA, V104, P696, DOI 10.1073/pnas.0607816103; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; Markova SV, 2004, J BIOL CHEM, V279, P3212, DOI 10.1074/jbc.M309639200; Markova SV, 2012, BIOCHEM BIOPH RES CO, V417, P98, DOI 10.1016/j.bbrc.2011.11.063; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; Rathnayaka T, 2010, BBA-PROTEINS PROTEOM, V1804, P1902, DOI 10.1016/j.bbapap.2010.04.014; Segel IH., 1993, ENZYME KINETICS BEHA; STANLEY PE, 1975, ANAL BIOCHEM, V67, P540, DOI 10.1016/0003-2697(75)90330-9; Szent-Gyorgyi C, 1999, P SPIE; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; Woo J, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-23	25	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40099	10.1371/journal.pone.0040099	http://dx.doi.org/10.1371/journal.pone.0040099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768230	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100202
J	Banki, NF; Ver, A; Wagner, LJ; Vannay, A; Degrell, P; Prokai, A; Gellai, R; Lenart, L; Szakal, DN; Kenesei, E; Rosta, K; Reusz, G; Szabo, AJ; Tulassay, T; Baylis, C; Fekete, A				Banki, Nora F.; Ver, Agota; Wagner, Laszlo J.; Vannay, Adam; Degrell, Peter; Prokai, Agnes; Gellai, Renata; Lenart, Lilla; Szakal, Dorottya-Nagy; Kenesei, Eva; Rosta, Klara; Reusz, Gyorgy; Szabo, Attila J.; Tulassay, Tivadar; Baylis, Chris; Fekete, Andrea			Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR BLOCKADE; ANGIOTENSIN-II; KIDNEY; HEART; SPIRONOLACTONE; GLUCOSE; SYSTEM; ATPASE; NA+,K+-ATPASE; METABOLISM	Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are the standard clinical therapy of diabetic nephropathy (DN), while aldosterone antagonists are only used as adjuncts. Previously in experimental DN we showed that Na/K ATPase (NKA) is mislocated and angiotensin II leads to superimposed renal progression. Here we investigated the monotherapeutic effect of aldosterone blockers on the progression of DN and renal NKA alteration in comparison to ACEi and ARBs. Streptozotocin-diabetic rats developing DN were treated with aldosterone antagonists; ACEi and ARB. Renal function, morphology, protein level and tubular localization of NKA were analyzed. To evaluate the effect of high glucose per se; HK-2 proximal tubular cells were cultured in normal or high concentration of glucose and treated with the same agents. Aldosterone antagonists were the most effective in ameliorating functional and structural kidney damage and they normalized diabetes induced bradycardia and weight loss. Aldosterone blockers also prevented hyperglycemia and diabetes induced increase in NKA protein level and enzyme mislocation. A monotherapy with aldosterone antagonists might be as, or more effective than ACEi or ARBs in the prevention of STZ-induced DN. Furthermore the alteration of the NKA could represent a novel pathophysiological feature of DN and might serve as an additional target of aldosterone blockers.	[Banki, Nora F.; Prokai, Agnes; Gellai, Renata; Lenart, Lilla; Szakal, Dorottya-Nagy; Kenesei, Eva; Reusz, Gyorgy; Szabo, Attila J.; Tulassay, Tivadar; Fekete, Andrea] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Banki, Nora F.; Gellai, Renata; Lenart, Lilla; Fekete, Andrea] Hungarian Acad Sci, SE MTA Lendulet Diabet Res Grp, Budapest, Hungary; [Ver, Agota; Rosta, Klara] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Wagner, Laszlo J.] Semmelweis Univ, Dept Transplantat & Surg, H-1085 Budapest, Hungary; [Vannay, Adam; Tulassay, Tivadar] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary; [Degrell, Peter] Dept Med 2, Pecs, Hungary; [Degrell, Peter] Ctr Nephrol Res & Training, Pecs, Hungary; [Baylis, Chris] Univ Florida, Dept Physiol, Gainesville, FL USA; [Baylis, Chris] Univ Florida, Dept Funct Genom & Med, Gainesville, FL USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Banki, NF (corresponding author), Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary.	fekete.andrea@med.semmelweis-univ.hu	Reusz, George S/N-7918-2017	Reusz, George S/0000-0003-0396-043X; Vannay, Adam/0000-0001-7412-4733; Rosta, Klara/0000-0002-3502-3734	Lendulet Research Grant [LP2011-008/2011]; NIH [R01 DK56843]; Pfizer; TAMOP [TAMOP-4.2.3-08/1/KMR-2008-0003];  [OTKA PD83431-84087-T71730];  [ETT 05-180-06-066-057-123/2009];  [REG_KM_09-1-2009-0016]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056843] Funding Source: NIH RePORTER	Lendulet Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); TAMOP; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by LP2011-008/2011 Lendulet Research Grant; NIH grant R01 DK56843 and a Pfizer Scholarship for Young investigators. It was also supported by grants of OTKA PD83431-84087-T71730, ETT 05-180-06-066-057-123/2009, REG_KM_09-1-2009-0016 and TAMOP (TAMOP-4.2.3-08/1/KMR-2008-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Achi A, 2001, DRUG DEV IND PHARM, V27, P465, DOI 10.1081/DDC-100104322; ANDERSON S, 1993, AM J PHYSIOL, V265, pF477, DOI 10.1152/ajprenal.1993.265.4.F477; Attman PO, 1998, NEPHROL DIAL TRANSPL, V13, P2833, DOI 10.1093/ndt/13.11.2833; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; BELL RC, 1994, ENDOCRINOLOGY, V135, P2681, DOI 10.1210/en.135.6.2681; Bomback AS, 2012, BLOOD PURIFICAT, V33, P119, DOI 10.1159/000334161; BURNS KD, 1993, SEMIN NEPHROL, V13, P13; Coppey LJ, 2006, DIABETES, V55, P341, DOI 10.2337/diabetes.55.02.06.db05-0885; De Angelis K, 2009, AUTON NEUROSCI-BASIC, V145, P3, DOI 10.1016/j.autneu.2008.10.013; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; EWING DJ, 1981, LANCET, V1, P183; Failli P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-32; Fekete A, 2008, J PHYSIOL-LONDON, V586, P5337, DOI 10.1113/jphysiol.2008.156703; Galuska D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028294; Giacchetti G, 2005, TRENDS ENDOCRIN MET, V16, P120, DOI 10.1016/j.tem.2005.02.003; Goyal BR, 2009, J CARDIOVASC PHARM, V54, P502, DOI 10.1097/FJC.0b013e3181be75cc; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Harris KPG, 2006, DIABETIC MED, V23, P13, DOI 10.1111/j.1464-5491.2006.1930_4.x; Hashimoto M, 2001, J ELECTROCARDIOL, V34, P243, DOI 10.1054/jelc.2001.25130; Isenovic ER, 2004, INT J MOL MED, V13, P915; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Jarman PR, 2003, BRIT MED J, V327, P812, DOI 10.1136/bmj.327.7418.812; Karnib HH, 2010, DIABETES RES CLIN PR, V89, P201, DOI 10.1016/j.diabres.2010.05.022; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; National Institutes of Heath National Institute of Diabetes and Digestive and Kidney Diseases, 2010, US REN DAT SYST USRD; Navar LG, 1999, J AM SOC NEPHROL, V10, pS189; NAVAR LG, 1994, J AM SOC NEPHROL, V5, P1153; Neeli H, 2009, CURR DIABETES REP, V9, P11, DOI 10.1007/s11892-009-0004-y; Ohtomo S, 2010, J OBES, V2010, DOI 10.1155/2010/136502; Ottlecz A, 1996, INVEST OPHTH VIS SCI, V37, P1633; Ribeiro-Oliveira A, 2008, VASC HEALTH RISK MAN, V4, P787; Rosta K, 2009, ACTA PHARMACOL SIN, V30, P1616, DOI 10.1038/aps.2009.162; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Setacci C, 2009, J CARDIOVASC SURG, V50, P263; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; Titan SM, 2011, CLIN NEPHROL, V76, P273, DOI 10.5414/CN107013; Ueno H, 2010, INT J CARDIOL, V138, P174, DOI 10.1016/j.ijcard.2008.08.011; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; WANG W, 1994, HYPERTENSION, V24, P571, DOI 10.1161/01.HYP.24.5.571; Woroniecki R, 2003, AM J PHYSIOL-RENAL, V284, pF358, DOI 10.1152/ajprenal.00100.2002; Zimpelmann J, 2000, KIDNEY INT, V58, P2320, DOI 10.1046/j.1523-1755.2000.00416.x	44	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39938	10.1371/journal.pone.0039938	http://dx.doi.org/10.1371/journal.pone.0039938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761931	Green Published, Green Submitted, gold			2022-12-25	WOS:000305826400047
J	Scribner, KC; Behbod, F; Porter, WW				Scribner, K. C.; Behbod, F.; Porter, W. W.			Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s)	ONCOGENE			English	Article						SIM2s; breast cancer; DCIS; differentiation	CARCINOMA IN-SITU; MAMMARY-GLAND DEVELOPMENT; GENE-EXPRESSION PROFILES; LUMINAL CELL FATE; SINGLE-MINDED 2S; ABERRANT ACTIVATION; SONIC HEDGEHOG; DIFFERENTIATION; PATHWAY; NOTCH	Singleminded-2s (SIM2s) is a member of the bHLH/ PAS family of transcription factors and a key regulator of mammary epithelial cell differentiation. SIM2s is highly expressed in mammary epithelial cells and downregulated in human breast cancer. Loss of Sim2s causes aberrant mouse mammary ductal development, with features suggestive of malignant transformation, whereas overexpression of SIM2s promotes precocious alveolar differentiation in nulliparous mouse mammary glands, suggesting that SIM2s is required for establishing and enhancing mammary gland differentiation. To test the hypothesis that SIM2s regulates tumor cell differentiation, we analyzed SIM2s expression in human primary breast ductal carcinoma in situ (DCIS) samples and found that SIM2s is lost with progression from DCIS to invasive ductal cancer (IDC). Using a MCF10DCIS. COM progression model, we have shown that SIM2s expression is decreased in MCF10DCIS. COM cells compared with MCF10A cells, and reestablishment of SIM2s in MCF10DCIS. COM cells significantly inhibits growth and invasion both in vitro and in vivo. Analysis of SIM2s-MCF10DCIS. com tumors showed that SIM2s promoted a more differentiated tumor phenotype including the expression of a broad range of luminal markers (CSN2 (beta-casein), CDH1 (E-cadherin), and KER18 (keratin-18)) and suppressed genes associated with stem cell maintenance and a basal phenotype (SMO (smoothened), p63, SLUG (snail-2), KER14 (keratin-14) and VIM (vimentin)). Furthermore, loss of SIM2s expression in MCF10DCIS. COM xenografts resulted in a more invasive phenotype and increased lung metastasis likely due to an increase in Hedgehog signaling and matrix metalloproteinase expression. Together, these exciting new data support a role for SIM2s in promoting human breast tumor differentiation and maintaining epithelial integrity.	[Scribner, K. C.; Porter, W. W.] Texas A&M Univ, Coll Vet Med, Dept Integrat Biosci, College Stn, TX 77843 USA; [Behbod, F.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Texas A&M University System; Texas A&M University College Station; University of Kansas; University of Kansas Medical Center	Porter, WW (corresponding author), Texas A&M Univ, Coll Vet Med, Depertment Integrat Biosci, Mail Stop 4458, College Stn, TX 77843 USA.	wporter@cvm.tamu.edu			National Cancer Institute (NCI) [R01CA111551]; Department of Defence (DOD-CDMRP) [W81XWH-11-1-0158]; NCI [5R00CA127462-06]; NATIONAL CANCER INSTITUTE [R00CA127462, R01CA111551] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defence (DOD-CDMRP); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Daniel Medina (Baylor College of Medicine, Houston, TX, USA) for providing the MCF10DCIS.com cell line and the Histology Core Facility at Texas A&M University College of Veterinary Medicine & Biomedical Sciences for tissue preparation and hematoxylin and eosin staining. DCIS and IDC tissue sections were provided by the University of KansasCancer Center Biospecimen Share Resources at the University of KansasMedical Center. This work was supported by grants R01CA111551 from the National Cancer Institute (NCI) to WWP, W81XWH-11-1-0158 from the Department of Defence (DOD-CDMRP) to KCS and 5R00CA127462-06 from the NCI to FB.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bond J, 1996, ONCOGENE, V13, P2097; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cocker R, 2007, MED HYPOTHESES, V69, P57, DOI 10.1016/j.mehy.2006.11.042; Cody HS, 2007, ANN SURG ONCOL, V14, P2179, DOI 10.1245/s10434-006-9300-9; de Biase D, 2010, VIRCHOWS ARCH, V456, P395, DOI 10.1007/s00428-010-0900-1; Du ZJ, 2010, CANCER SCI, V101, P2417, DOI 10.1111/j.1349-7006.2010.01700.x; Dubois-Marshall S, 2011, CLIN EXP METASTASIS; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Gustafson TL, 2009, ONCOGENE; Hettinger AM, 2001, BIOL REPROD, V65, P507, DOI 10.1095/biolreprod65.2.507; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Ioachim EE, 1998, ANTICANCER RES, V18, P1665; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maffuz A, 2006, J EXP CLIN CANC RES, V25, P223; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McDaniel SM, 2006, AM J PATHOL, V168, P608, DOI 10.2353/ajpath.2006.050677; Mendes O, 2005, CLIN EXP METASTAS, V22, P237, DOI 10.1007/s10585-005-8115-6; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Politi K, 2004, SEMIN CANCER BIOL, V14, P341, DOI 10.1016/j.semcancer.2004.04.013; Porter D, 2003, MOL CANCER RES, V1, P362; Schedin P, 2004, MOL CARCINOGEN, V41, P207, DOI 10.1002/mc.20058; Scribner KC, 2011, MOL ENDOCRINOL; Shekhar MPV, 2008, CANCER BIOL THER, V7, P1774, DOI 10.4161/cbt.7.11.6781; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Visbal AP, 2011, DEV BIOL, V352, P116, DOI 10.1016/j.ydbio.2011.01.025; Walsh LA, 2012, J CELL COMMUN SIGNAL, V6, P87, DOI 10.1007/s12079-011-0157-8; Wang C, 2011, J CANCER RES CLIN, V137, P985, DOI 10.1007/s00432-010-0963-z; Wellberg E, 2010, DEVELOPMENT, V137, P945, DOI 10.1242/dev.041657; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Witty Jean P., 1995, Molecular Biology of the Cell, V6, P1287; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538; Zuo SG, 2012, J CANCER RES CLIN, V138, P1045, DOI 10.1007/s00432-012-1153-y	64	20	21	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 23	2013	32	21					2631	2639		10.1038/onc.2012.286	http://dx.doi.org/10.1038/onc.2012.286			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FH	22777354	Green Accepted			2022-12-25	WOS:000319806700004
J	Herglotz, J; Kuvardina, ON; Kolodziej, S; Kumar, A; Hussong, H; Grez, M; Lausen, J				Herglotz, J.; Kuvardina, O. N.; Kolodziej, S.; Kumar, A.; Hussong, H.; Grez, M.; Lausen, J.			Histone arginine methylation keeps RUNX1 target genes in an intermediate state	ONCOGENE			English	Article						epigenetics; stem cell; histone modifications; poised state; RUNX1	HEMATOPOIETIC STEM-CELLS; CHROMATIN SIGNATURES; H3K4 METHYLATION; TRANSCRIPTION; POLYCOMB; LEUKEMIA; AML1; EXPRESSION; COMPLEX; BINDING	The coordinated recruitment of epigenetic regulators of gene expression by transcription factors such as RUNX1 (AML1, acute myeloid leukemia 1) is crucial for hematopoietic differentiation. Here, we identify protein arginine methyltransferase 6 (PRMT6) as a central functional component of a RUNX1 corepressor complex containing Sin3a and HDAC1 in human hematopoietic progenitor cells. PRMT6 is recruited by RUNX1 and mediates asymmetric histone H3 arginine-2 dimethylation (H3R2me2a) at megakaryocytic genes in progenitor cells. H3R2me2a keeps RUNX1 target genes in an intermediate state with concomitant H3K27me3 and H3K4me2 but not H3K4me3. Upon megakaryocytic differentiation PRMT6 binding is lost, the H3R2me2a mark decreases and a coactivator complex containing WDR5/MLL and p300/pCAF is recruited. This leads to an increase of H3K4me3 and H3K9ac, which result in augmented gene expression. Our results provide novel mechanistic insight into how RUNX1 activity in hematopoietic progenitor cells maintains differentiation genes in a suppressed state but poised for rapid transcriptional activation.	[Herglotz, J.; Kuvardina, O. N.; Kolodziej, S.; Kumar, A.; Hussong, H.; Grez, M.; Lausen, J.] Georg Speyer Haus, Inst Biomed Res, D-60596 Frankfurt, Hessen, Germany	Octapharma	Lausen, J (corresponding author), Georg Speyer Haus, Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Hessen, Germany.	lausen@em.uni-frankfurt.de			LOEWE initiatives Onkogene Signaltransduktion Frankfurt (OSF); LOEWE Center for Cell and Gene Therapy Frankfurt (CGT), Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK) [III L 4-518/55.004, III L 4-518/17004]; institutional funds of the Georg-Speyer-Haus; German Federal Ministry of Health (BMG); HMWK; Deutsche Forschungsgemeinschaft [SPP-1463, LA 1389/5-1]	LOEWE initiatives Onkogene Signaltransduktion Frankfurt (OSF); LOEWE Center for Cell and Gene Therapy Frankfurt (CGT), Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK); institutional funds of the Georg-Speyer-Haus; German Federal Ministry of Health (BMG); HMWK; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Reinhard Henschler of the Institute for Transfusion Medicine Frankfurt for providing hCD34+ cells. JL is supported by the LOEWE initiatives Onkogene Signaltransduktion Frankfurt (OSF), the LOEWE Center for Cell and Gene Therapy Frankfurt (CGT), Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK), III L 4-518/55.004 and III L 4-518/17004 and institutional funds of the Georg-Speyer-Haus. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (BMG) and the HMWK. This project was supported by the Deutsche Forschungsgemeinschaft (SPP-1463, LA 1389/5-1).	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Elagib KE, 2007, CRIT REV EUKAR GENE, V17, P271, DOI 10.1615/CritRevEukarGeneExpr.v17.i4.20; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Goldfarb AN, 2009, J CELL BIOCHEM, V107, P377, DOI 10.1002/jcb.22142; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hannah R, 2011, EXP HEMATOL, V39, P531, DOI 10.1016/j.exphem.2011.02.009; Harada Y, 2009, J CELL PHYSIOL, V220, P16, DOI 10.1002/jcp.21769; Hoogenkamp M, 2007, MOL CELL BIOL, V27, P7425, DOI 10.1128/MCB.00905-07; Hoogenkamp M, 2009, BLOOD, V114, P299, DOI 10.1182/blood-2008-11-191890; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Jiang HM, 2005, MOL CELL BIOL, V25, P10675, DOI 10.1128/MCB.25.24.10675-10683.2005; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Lausen J, 2004, J BIOL CHEM, V279, P49281, DOI 10.1074/jbc.M407239200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mahajan MC, 2009, EXP HEMATOL, V37, P1143, DOI 10.1016/j.exphem.2009.07.001; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; O'Malley BW, 2008, CURR OPIN CELL BIOL, V20, P310, DOI 10.1016/j.ceb.2008.04.005; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Owen CJ, 2008, BLOOD, V112, P4639, DOI 10.1182/blood-2008-05-156745; Pencovich N, 2011, BLOOD, V117, pE1, DOI 10.1182/blood-2010-07-295113; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Satoh Y, 2008, J BIOL CHEM, V283, P30045, DOI 10.1074/jbc.M804768200; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Wang L, 2009, BLOOD CELL MOL DIS, V43, P30, DOI 10.1016/j.bcmd.2009.03.005; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wang W, 2010, BLOOD, V116, P254, DOI 10.1182/blood-2009-11-254664; Wilson NK, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt47; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xu G, 2006, LEUKEMIA, V20, P1002, DOI 10.1038/sj.leu.2404223; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	56	39	39	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2013	32	20					2565	2575		10.1038/onc.2012.274	http://dx.doi.org/10.1038/onc.2012.274			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	148UY	22777353				2022-12-25	WOS:000319274300008
J	Yao, Z; Jones, AWE; Fassone, E; Sweeney, MG; Lebiedzinska, M; Suski, JM; Wieckowski, MR; Tajeddine, N; Hargreaves, IP; Yasukawa, T; Tufo, G; Brenner, C; Kroemer, G; Rahman, S; Szabadkai, G				Yao, Z.; Jones, A. W. E.; Fassone, E.; Sweeney, M. G.; Lebiedzinska, M.; Suski, J. M.; Wieckowski, M. R.; Tajeddine, N.; Hargreaves, I. P.; Yasukawa, T.; Tufo, G.; Brenner, C.; Kroemer, G.; Rahman, S.; Szabadkai, G.			PGC-1 beta mediates adaptive chemoresistance associated with mitochondrial DNA mutations	ONCOGENE			English	Article						CDDP; chemoresistance; mitochondrial biogenesis; PGC-1; Complex-I; mitochondrial DNA	CANCER; COACTIVATORS; RESISTANCE; FAMILY; NEURODEGENERATION; PGC-1-ALPHA; BIOGENESIS; REGULATOR; CISPLATIN; APOPTOSIS	Primary mitochondrial dysfunction commonly leads to failure in cellular adaptation to stress. Paradoxically, however, nonsynonymous mutations of mitochondrial DNA (mtDNA) are frequently found in cancer cells and may have a causal role in the development of resistance to genotoxic stress induced by common chemotherapeutic agents, such as cis-diammine-dichloroplatinum(II) (cisplatin, CDDP). Little is known about how these mutations arise and the associated mechanisms leading to chemoresistance. Here, we show that the development of adaptive chemoresistance in the A549 non-small-cell lung cancer cell line to CDDP is associated with the hetero- to homoplasmic shift of a nonsynonymous mutation in MT-ND2, encoding the mitochondrial Complex-I subunit ND2. The mutation resulted in a 50% reduction of the NADH: ubiquinone oxidoreductase activity of the complex, which was compensated by increased biogenesis of respiratory chain complexes. The compensatory mitochondrial biogenesis was most likely mediated by the nuclear co-activators peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) and PGC-1 beta, both of which were significantly upregulated in the CDDP-resistant cells. Importantly, both transient and stable silencing of PGC-1 beta re-established the sensitivity of these cells to CDDP-induced apoptosis. Remarkably, the PGC-1 beta-mediated CDDP resistance was independent of the mitochondrial effects of the co-activator. Altogether, our results suggest that partial respiratory chain defects because of mtDNA mutations can lead to compensatory upregulation of nuclear transcriptional co-regulators, in turn mediating resistance to genotoxic stress.	[Yao, Z.; Jones, A. W. E.; Szabadkai, G.] UCL, Consortium Mitochondrial Res, Dept Cell & Dev Biol, London WC1E 6BT, England; [Fassone, E.; Rahman, S.] UCL Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Fassone, E.] Univ Milan, IRCCS Fdn Ca Granda, Osped Maggiore Policlin, Dino Ferrari Ctr,Dept Neurol Sci, Milan, Italy; [Sweeney, M. G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London, England; [Lebiedzinska, M.; Suski, J. M.; Wieckowski, M. R.] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland; [Tajeddine, N.; Kroemer, G.] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Hargreaves, I. P.] UCL, Inst Neurol, London, England; [Yasukawa, T.] UCL, Wolfson Inst Biomed Res, London, England; [Tufo, G.; Brenner, C.] Univ Paris 11, INSERM, UMR S 769, Chatenay Malabry, France; [Kroemer, G.] Inst Gustave Roussy, Villejuif, France; [Kroemer, G.] Ctr Rech Cordeliers, Paris, France; [Kroemer, G.] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, G.] Univ Paris 05, Fac Med, Paris, France	University of London; University College London; University of London; University College London; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; University of London; University College London; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Szabadkai, G (corresponding author), UCL, Consortium Mitochondrial Res, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	g.szabadkai@ucl.ac.uk	Lebiedzińska-Arciszewska, Magdalena/AAC-5956-2021; Hargreaves, Iain/AAJ-6757-2020; YAO, Zhi/C-6096-2009; Yasukawa, Takehiro/AAP-1335-2020; KROEMER, Guido/B-4263-2013; Yao, Zhi/B-9047-2013; Rahman, Shamima/M-7904-2019; Suski, Jan/AAP-9727-2021; Lebiedzińska-Arciszewska, Magdalena/AAA-3279-2022; Rahman, Shamima/C-5232-2008; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; Yao, Zhi/0000-0001-6432-5734; Lebiedzińska-Arciszewska, Magdalena/0000-0002-2725-5551; Rahman, Shamima/0000-0003-2088-730X; Wieckowski, Mariusz/0000-0003-0789-4521; Yasukawa, Takehiro/0000-0001-9531-8780; Szabadkai, Gyorgy/0000-0002-3006-3577; Suski, Jan/0000-0001-5657-2655	Parkinson's UK [G-0905]; Medical Research Council (MRC-DTA); Polish Ministry of Science and Higher Education [NN407075137]; National Science Centre [DEC-2011/01/M/NZ3/02128]; Foundation for Polish Science; EU; European Regional Development Fund; Operational Programme "Innovative economy"; L'Oreal fellowship; Great Ormond Street Hospital Children's Charity; European Union (ApoSys); European Union (ArtForce); European Union (ChemoRes); Ligue contre le Cancer (Laboratoire labellise); Parkinson&quot;s UK [G-0905] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1220] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); Medical Research Council (MRC-DTA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); EU(European Commission); European Regional Development Fund(European Commission); Operational Programme "Innovative economy"; L'Oreal fellowship(L'Oreal Group); Great Ormond Street Hospital Children's Charity; European Union (ApoSys)(European CommissionEuropean Commission Joint Research Centre); European Union (ArtForce); European Union (ChemoRes); Ligue contre le Cancer (Laboratoire labellise); Parkinson&quot;s UK(Parkinson&apos;s UK); Great Ormond Street Hospital Childrens Charity	We thank the excellent technical help of M Rahman (UCL Biosciences Molecular Biology Unit), K Pearce (UCL Genomics), the access to the Arrayscan VTI HCS Reader and the help of G Keen, M Elrayess and J Staddon from Eisai Europe Ltd; Professors M Duchen, C Boshoff and JM Funes for reagents and advice; JW Taanman for providing the A549 rho0 cell line, and D Housenloy for the Akt antibodies. The work was supported by Parkinson's UK (G-0905) and the Medical Research Council (MRC-DTA) to GS, ZY and AJ MRW is supported by the Polish Ministry of Science and Higher Education under Grant NN407075137 and by the grant from the National Science Centre-decision number DEC-2011/01/M/NZ3/02128. JMS is a recipient of a PhD fellowship from the Foundation for Polish Science, EU, European Regional Development Fund and Operational Programme "Innovative economy". ML is recipient of a fellowship from the Foundation for Polish Science (Programme Start) and the L'Oreal fellowship (For Women in Science). SR is supported by Great Ormond Street Hospital Children's Charity. GK is supported by the European Union (ApoSys, ArtForce, ChemoRes) and the Ligue contre le Cancer (Laboratoire labellise).	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bianchi K, 2006, CELL DEATH DIFFER, V13, P586, DOI 10.1038/sj.cdd.4401784; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; Cullen KJ, 2007, J BIOENERG BIOMEMBR, V39, P43, DOI 10.1007/s10863-006-9059-5; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Guerra F, 2011, HUM MOL GENET, V20, P2394, DOI 10.1093/hmg/ddr146; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kulawiec M, 2010, ENVIRON MOL MUTAGEN, V51, P427, DOI 10.1002/em.20582; Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Lane N, 2011, BIOESSAYS, V16, P1; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lo S, 2005, INT J ONCOL, V27, P337; Mizutani S, 2009, CANCER SCI, V100, P1680, DOI 10.1111/j.1349-7006.2009.01238.x; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Ohta S, 2006, ONCOGENE, V25, P4768, DOI 10.1038/sj.onc.1209602; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Ragan CI, 1988, MITOCHONDRIA PRACTIC, P79; Rahman S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000411; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sen T, 2011, CANCER RES, V71, P1167, DOI 10.1158/0008-5472.CAN-10-1481; Spinazzola A, 2009, ADV EXP MED BIOL, V652, P69, DOI 10.1007/978-90-481-2813-6_6; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	43	28	28	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2013	32	20					2592	2600		10.1038/onc.2012.259	http://dx.doi.org/10.1038/onc.2012.259			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	148UY	22777349				2022-12-25	WOS:000319274300011
J	Chen, YL; Wu, XM; Yu, SS; Lin, XM; Wu, JX; Li, L; Zhao, J; Zhao, Y				Chen, Yanlin; Wu, Xuemei; Yu, Shanshan; Lin, Xuemei; Wu, Jingxian; Li, Lan; Zhao, Jing; Zhao, Yong			Neuroprotection of Tanshinone IIA against Cerebral Ischemia/Reperfusion Injury through Inhibition of Macrophage Migration Inhibitory Factor in Rats	PLOS ONE			English	Article							NF-KAPPA-B; ARTERY OCCLUSION; ISCHEMIA; INFLAMMATION; ACTIVATION; STROKE	Background: Ischemia/reperfusion (I/R) injury is associated with systemic inflammatory response. Macrophage migration inhibitory factor (MIF) has been implicated in many inflammatory processes. Tanshinone IIA (TSA) is one of the active ingredients in danshen, which derived from the dried root or rhizome of Salviae miltiorrhizae Bge. Recent studies have demonstrated that TSA has protective effects against focal cerebral I/R injury. However, little is known about the underlying mechanisms. Here we put forward the hypothesis that TSA acts through inhibition of MIF expression during focal cerebral I/R injury in rats. Methodology/Principal Findings: Rats were subjected to middle cerebral artery occlusion (MCAO) for 2 hours. This was followed by reperfusion. We measured neurological deficits, brain water content, and infarct volume, and found that neurological dysfunction, brain edema, and brain infarction were significantly attenuated by TSA 6 hours after reperfusion. We also measured myeloperoxidase (MPO) activity at 6 and 24 hours, and found that neutrophil infiltration was significantly higher in the vehicle+I/R group than in the TSA+I/R group. ELISA demonstrated that TSA could inhibit MIF expression and the release of TNF-alpha and IL-6 induced by I/R injury. Western blot analysis and immunofluorescence staining showed that MIF expression was significantly lower in the TSA+I/R group than in the vehicle+I/R group. MIF was found almost all located in neurons and hardly any located in astrocytes in the cerebral cortex. Western blot analysis and EMSA demonstrated that NF-kappa B expression and activity were significantly increased in the vehicle+I/R group. However, these changes were attenuated by TSA. Conclusion/Significance: Our results suggest that TSA helps alleviate the proinflammatory responses associated with I/R-induced injury and that this neuroprotective effect may occur through down-regulation of MIF expression in neurons.	[Chen, Yanlin; Wu, Xuemei; Yu, Shanshan; Lin, Xuemei; Wu, Jingxian; Zhao, Yong] Chongqing Med Univ, Dept Pathol, Chongqing, Peoples R China; [Li, Lan; Zhao, Jing] Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, YL (corresponding author), Chongqing Med Univ, Dept Pathol, Chongqing, Peoples R China.	yangyang741022@sina.com; blys01@163.com			National Nature Science Foundation of China [30900457, 81070917]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Nature Science Foundation of China (No. 30900457 and No. 81070917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; [Anonymous], 1977, CHINESE MED J-PEKING, V3, P224; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chen YL, 2012, BIOL PHARM BULL, V35, P164, DOI 10.1248/bpb.35.164; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Clemens JA, 1998, STROKE, V29, P677, DOI 10.1161/01.STR.29.3.677; Dong KN, 2009, PHYTOTHER RES, V23, P608, DOI 10.1002/ptr.2615; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Elango C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-97; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; Inacio AR, 2011, NEUROBIOL DIS, V41, P270, DOI 10.1016/j.nbd.2010.09.015; Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Kim JS, 1996, J NEUROL SCI, V137, P69, DOI 10.1016/0022-510X(95)00338-3; Lam BYH, 2003, PHYTOMEDICINE, V10, P286, DOI 10.1078/094471103322004776; Liesz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021312; Liu LL, 2010, BRAIN RES BULL, V82, P228, DOI 10.1016/j.brainresbull.2010.04.005; Liu Y, 2009, BRAIN RES, V1268, P174, DOI 10.1016/j.brainres.2009.02.069; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Phillips JB, 2000, STROKE, V31, P1686, DOI 10.1161/01.STR.31.7.1686; Tang C, 2010, PHYTOMEDICINE, V17, P1145, DOI 10.1016/j.phymed.2010.03.017; Tripathy D, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-10; Wang LJ, 2009, STROKE, V40, P973, DOI 10.1161/STROKEAHA.108.530535; Yu SS, 2010, BRAIN RES, V1308, P167, DOI 10.1016/j.brainres.2009.10.037; Zhang Y, 2011, BIOL PHARM BULL, V34, P1052, DOI 10.1248/bpb.34.1052; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	34	68	77	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40165	10.1371/journal.pone.0040165	http://dx.doi.org/10.1371/journal.pone.0040165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768247	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100220
J	Marsh, AK; Willer, DO; Skokovets, O; Iwajomo, OH; Chan, JK; MacDonald, KS				Marsh, Angie K.; Willer, David O.; Skokovets, Olena; Iwajomo, Oluwadamilola H.; Chan, Jacqueline K.; MacDonald, Kelly S.			Evaluation of Cynomolgus Macaque (Macaca fascicularis) Endogenous Retrovirus Expression Following Simian Immunodeficiency Virus Infection	PLOS ONE			English	Article							HERV-K; RHESUS-MONKEYS; CHINESE RHESUS; RNA TITERS; HIV; SEQUENCES; GENOME; VACCINE; INDIVIDUALS; PRIMATES	Human endogenous retrovirus type K (HERV-K) transcripts are upregulated in the plasma of HIV-infected individuals and have been considered as targets for an HIV vaccine. We evaluated cynomolgus macaque endogenous retrovirus (CyERV) mRNA expression by RT-qPCR in PBMCs isolated from a cohort of animals previously utilized in a live attenuated SIV vaccine trial. CyERV env transcript levels decreased following vaccination (control and vaccine groups) and CyERV env and gag mRNA expression was decreased following acute SIV-infection, whereas during chronic SIV infection, CyERV transcript levels were indistinguishable from baseline. Reduced susceptibility to initial SIV infection, as measured by the number of SIV challenges required for infection, was associated with increased CyERV transcript levels in PBMCs. In vitro analysis revealed that SIV infection of purified CD4(+) T-cells did not alter CyERV gene expression. This study represents the first evaluation of ERV expression in cynomolgus macaques following SIV infection, in an effort to assess the utility of cynomolgus macaques as an animal model to evaluate ERVs as a target for an HIV/SIV vaccine. This non-human primate model system does not recapitulate what has been observed to date in the plasma of HIV-infected humans suggesting that further investigation at the cellular level is required to elucidate the impact of HIV/SIV infection on endogenous retrovirus expression.	[Marsh, Angie K.; MacDonald, Kelly S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Willer, David O.; Skokovets, Olena; Iwajomo, Oluwadamilola H.; Chan, Jacqueline K.; MacDonald, Kelly S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Marsh, Angie K.; Willer, David O.; Iwajomo, Oluwadamilola H.; Chan, Jacqueline K.; MacDonald, Kelly S.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Marsh, AK (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	kmacdonald@mtsinai.on.ca	MacDonald, Kelly S/L-3315-2019		OHTN [JIDA109, SCI G654]; CIHR [HOP90180, VSR-107743]	OHTN; CIHR(Canadian Institutes of Health Research (CIHR))	OHTN (#JIDA109, #SCI G654; www.ohtn.on.ca), CIHR (#HOP90180, #VSR-107743; http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P1083, DOI 10.1089/aid.2007.0054; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2006, J VIROL METHODS, V136, P51, DOI 10.1016/j.jviromet.2006.03.029; Denner J, 1995, J CANC RES CLIN ONCO, P121; Drummond A., 2011, GENEIOUS V5 5; Ebeling M, 2011, GENOME RES, V21, P1746, DOI 10.1101/gr.123117.111; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Greenwood AD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-44; Guan YJ, 2000, J VIROL, V74, P8854, DOI 10.1128/JVI.74.19.8854-8860.2000; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Hu Shiu-Lok, 2005, Current Drug Targets - Infectious Disorders, V5, P193, DOI 10.2174/1568005054201508; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Katzourakis A, 2005, MOL B INT U, P186; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Kurth R, 2010, INT J CANCER, V126, P306, DOI 10.1002/ijc.24902; Lefebvre G, 2011, J VIROL, V85, P6205, DOI 10.1128/JVI.00252-11; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Mayer J, 1998, J VIROL, V72, P1870, DOI 10.1128/JVI.72.3.1870-1875.1998; MEDSTRAND P, 1992, J GEN VIROL, V73, P2463, DOI 10.1099/0022-1317-73-9-2463; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; O'Connor DH, 2006, FUTURE VIROL, V1, P165, DOI 10.2217/17460794.1.2.165; Romano CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001026; Sacha JB, 2010, NAT PROTOC, V5, P239, DOI 10.1038/nprot.2009.227; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; STEINHUBER S, 1995, HUM GENET, V96, P188, DOI 10.1007/BF00207377; Tonjes RR, 1999, J VIROL, V73, P9187; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Vogt P. K., 1997, P1; Willer DO, 2010, J VIROL, V84, P2304, DOI 10.1128/JVI.01995-09; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40158	10.1371/journal.pone.0040158	http://dx.doi.org/10.1371/journal.pone.0040158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768246	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100219
J	Noor, S; Taylor, MC; Russell, RJ; Jermiin, LS; Jackson, CJ; Oakeshott, JG; Scott, C				Noor, Sajid; Taylor, Matthew C.; Russell, Robyn J.; Jermiin, Lars S.; Jackson, Colin J.; Oakeshott, John G.; Scott, Colin			Intramolecular Epistasis and the Evolution of a New Enzymatic Function	PLOS ONE			English	Article							ATRAZINE CHLOROHYDROLASE; PSEUDOMONAS SP; PROTEIN; ENZYMES	Atrazine chlorohydrolase (AtzA) and its close relative melamine deaminase (TriA) differ by just nine amino acid substitutions but have distinct catalytic activities. Together, they offer an informative model system to study the molecular processes that underpin the emergence of new enzymatic function. Here we have constructed the potential evolutionary trajectories between AtzA and TriA, and characterized the catalytic activities and biophysical properties of the intermediates along those trajectories. The order in which the nine amino acid substitutions that separate the enzymes could be introduced to either enzyme, while maintaining significant catalytic activity, was dictated by epistatic interactions, principally between three amino acids within the active site: namely, S331C, N328D and F84L. The mechanistic basis for the epistatic relationships is consistent with a model for the catalytic mechanisms in which protonation is required for hydrolysis of melamine, but not atrazine.	[Noor, Sajid; Taylor, Matthew C.; Russell, Robyn J.; Jermiin, Lars S.; Oakeshott, John G.; Scott, Colin] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia; [Jermiin, Lars S.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Jermiin, Lars S.] Univ Roma La Sapienza, Dept Biochem Sci Rossi Fanelli, Rome, Italy; [Noor, Sajid; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Sapienza University Rome; Australian National University	Noor, S (corresponding author), Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia.	colin.scott@csiro.au	Jackson, Colin J/C-1500-2008; Taylor, Matthew/B-5903-2009; Jermiin, Lars Sommer/AAQ-7033-2020; Russell, Robyn/C-5449-2008; Oakeshott, John G/B-5365-2009; Jermiin, Lars Sommer/C-2458-2009; Scott, Colin/A-4682-2009	Jackson, Colin J/0000-0001-6150-3822; Taylor, Matthew/0000-0001-9576-1555; Jermiin, Lars Sommer/0000-0002-9619-3809; Russell, Robyn/0000-0001-5600-3305; Oakeshott, John G/0000-0001-8324-7874; Jermiin, Lars Sommer/0000-0002-9619-3809; Scott, Colin/0000-0001-6110-6982	Australian National University; CSIRO's Synthetic Enzymes Emerging Science Initiative	Australian National University(Australian National University); CSIRO's Synthetic Enzymes Emerging Science Initiative	SN was supported by an Australian National University Postgraduate Scholarship and CSIRO's Synthetic Enzymes Emerging Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; COOK AM, 1981, J AGR FOOD CHEM, V29, P1135, DOI 10.1021/jf00108a009; Copley SD, 2009, NAT CHEM BIOL, V5, P560, DOI 10.1038/nchembio.197; Costanzo MS, 2011, J GENET, V90, P187, DOI 10.1007/s12041-011-0072-z; Costanzo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019636; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; deSouza ML, 1996, J BACTERIOL, V178, P4894, DOI 10.1128/jb.178.16.4894-4900.1996; EATON RW, 1991, J BACTERIOL, V173, P1215, DOI 10.1128/jb.173.3.1215-1222.1991; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Raillard S, 2001, CHEM BIOL, V8, P891, DOI 10.1016/S1074-5521(01)00061-8; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Scott C, 2009, APPL ENVIRON MICROB, V75, P2184, DOI 10.1128/AEM.02634-08; Seffernick JL, 2001, J BACTERIOL, V183, P2405, DOI 10.1128/JB.183.8.2405-2410.2001; Seffernick JL, 2001, BIOCHEMISTRY-US, V40, P12747, DOI 10.1021/bi011293r; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Wackett LP, 2009, CURR OPIN MICROBIOL, V12, P244, DOI 10.1016/j.mib.2009.05.001; Wackett LP, 2004, J BIOL CHEM, V279, P41259, DOI 10.1074/jbc.R400014200; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	28	38	39	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39822	10.1371/journal.pone.0039822	http://dx.doi.org/10.1371/journal.pone.0039822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768133	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100103
J	Pfeifer, M; Burgess, ND; Swetnam, RD; Platts, PJ; Willcock, S; Marchant, R				Pfeifer, Marion; Burgess, Neil D.; Swetnam, Ruth D.; Platts, Philip J.; Willcock, Simon; Marchant, Robert			Protected Areas: Mixed Success in Conserving East Africa's Evergreen Forests	PLOS ONE			English	Article							TROPICAL FORESTS; LAND-COVER; CONSERVATION; BIODIVERSITY; DEFORESTATION; DEGRADATION; TANZANIA; LOCATION; POVERTY; GROWTH	In East Africa, human population growth and demands for natural resources cause forest loss contributing to increased carbon emissions and reduced biodiversity. Protected Areas (PAs) are intended to conserve habitats and species. Variability in PA effectiveness and 'leakage' (here defined as displacement of deforestation) may lead to different trends in forest loss within, and adjacent to, existing PAs. Here, we quantify spatial variation in trends of evergreen forest coverage in East Africa between 2001 and 2009, and test for correlations with forest accessibility and environmental drivers. We investigate PA effectiveness at local, landscape and national scales, comparing rates of deforestation within park boundaries with those detected in park buffer zones and in unprotected land more generally. Background forest loss (BFL) was estimated at -9.3% (17,167 km(2)), but varied between countries (range: -0.9% to -85.7%; note: no BFL in South Sudan). We document high variability in PA effectiveness within and between PA categories. The most successful PAs were National Parks, although only 26 out of 48 parks increased or maintained their forest area (i.e. Effective parks). Forest Reserves (Ineffective parks, i.e. parks that lose forest from within boundaries: 204 out of 337), Nature Reserves (six out of 12) and Game Parks (24 out of 26) were more likely to lose forest cover. Forest loss in buffer zones around PAs exceeded background forest loss, in some areas indicating leakage driven by Effective National Parks. Human pressure, forest accessibility, protection status, distance to fires and long-term annual rainfall were highly significant drivers of forest loss in East Africa. Some of these factors can be addressed by adjusting park management. However, addressing close links between livelihoods, natural capital and poverty remains a fundamental challenge in East Africa's forest conservation efforts.	[Pfeifer, Marion; Marchant, Robert] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Burgess, Neil D.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Burgess, Neil D.] WWF US Conservat Sci, Washington, DC USA; [Swetnam, Ruth D.; Platts, Philip J.] Univ Cambridge, Dept Zool, Cambridge, England; [Willcock, Simon] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of York - UK; University of Copenhagen; World Wildlife Fund; University of Cambridge; University of Leeds	Pfeifer, M (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	marion.pfeifer@googlemail.com	Platts, Philip J./C-2002-2009; Swetnam, Ruth D/I-2848-2017	Platts, Philip J./0000-0002-0153-0121; Swetnam, Ruth D/0000-0002-5199-9622; Marchant, Robert/0000-0001-5013-4056; Pfeifer, Marion/0000-0002-6775-3141	Marie Curie Intra-European fellowship IEF Programme (EU FP7-People-IEF) [234394]; Leverthulme Trust through the Valuing the Arc Programme	Marie Curie Intra-European fellowship IEF Programme (EU FP7-People-IEF); Leverthulme Trust through the Valuing the Arc Programme	Marion Pfeifer was supported by the Marie Curie Intra-European fellowship IEF Programme (EU FP7-People-IEF-2008 Grant Agreement no234394). Ruth Swetnam, Philip Platts and Simon Willcock were funded by the Leverthulme Trust through the Valuing the Arc Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2010, P NATL ACAD SCI USA, V107, P14556, DOI 10.1073/pnas.0914471107; Andrew G., 2010, Journal of Sustainable Development in Africa, V12, P122; [Anonymous], 2007, FORESTRY GOVERNANCE; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Baranga D, 2009, AFR J ECOL, V47, P664, DOI 10.1111/j.1365-2028.2009.01037.x; Blomley T., 2009, PARTICIPATORY FOREST; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burgess N, 2005, BIODIVERS CONSERV, V14, P1877, DOI 10.1007/s10531-004-1299-2; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Caro T, 2009, DIVERS DISTRIB, V15, P178, DOI 10.1111/j.1472-4642.2008.00522.x; Cotula Lorenzo., 2009, LAND GRAB DEV OPPORT; Cropper M, 2001, LAND ECON, V77, P172, DOI 10.2307/3147088; Davis A., 2011, Conservation and Society, V9, P25, DOI 10.4103/0972-4923.79184; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; Enawgaw AC, 2011, EXISTING CHALLENGES; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Ewers RM, 2006, BIOL CONSERV, V133, P312, DOI 10.1016/j.biocon.2006.06.018; FAO, 2005, STAT WORLDS FOR 2005; Fearnside PM, 2009, MITIG ADAPT STRAT GL, V14, P557, DOI 10.1007/s11027-009-9174-9; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Fisher B, 2011, NAT CLIM CHANGE, V1, P161, DOI 10.1038/NCLIMATE1119; Freitas SR, 2010, FOREST ECOL MANAG, V259, P410, DOI 10.1016/j.foreco.2009.10.036; Gardner TA, 2007, CONSERV BIOL, V21, P1516, DOI 10.1111/j.1523-1739.2007.00794.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Hall J, 2009, BIOL CONSERV, V142, P2510, DOI 10.1016/j.biocon.2009.05.028; Harris Dan, 2011, POLITICAL EC SOCIAL; IUCN UNEP, 2009, WORLD DAT PROT AR WD; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lilieholm RJ, 2010, CONSERV BIOL, V24, P924, DOI 10.1111/j.1523-1739.2010.01527.x; Linkie M, 2004, BIODIVERS CONSERV, V13, P1809, DOI 10.1023/B:BIOC.0000035867.90891.ea; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Lung T, 2010, ENVIRON MONIT ASSESS, V161, P531, DOI 10.1007/s10661-009-0766-3; Masozera MK, 2004, SCAND J FOREST RES, V19, P85, DOI 10.1080/14004080410034164; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; Naughton-Treves L, 2011, P NATL ACAD SCI USA, V108, P13919, DOI 10.1073/pnas.1013332108; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pfeifer M, 2012, GLOBAL ECOL BIOGEOGR, V21, P603, DOI 10.1111/j.1466-8238.2011.00712.x; Pfund JL, 2011, ENVIRON MANAGE, V48, P334, DOI 10.1007/s00267-011-9689-1; Rutagarama E, 2006, GEOGR J, V172, P291, DOI 10.1111/j.1475-4959.2006.00217.x; Swetnam RD, 2011, J ENVIRON MANAGE, V92, P563, DOI 10.1016/j.jenvman.2010.09.007; Tabor Karyn, 2010, Journal of East African Natural History, V99, P19, DOI 10.2982/028.099.0102; Tallis H, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P278; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Timberlake J, 2011, PLANT ECOL EVOL, V144, P126, DOI 10.5091/plecevo.2011.539; Tumusiime DM, 2011, FOREST POLICY ECON, V13, P273, DOI 10.1016/j.forpol.2011.02.001; United Nations, 2011, WORLD POP PROSP 2010; Wass P, 1995, KENYAS INDIGENEOUS F; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wunder S, 2001, WORLD DEV, V29, P1817, DOI 10.1016/S0305-750X(01)00070-5	59	87	90	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39337	10.1371/journal.pone.0039337	http://dx.doi.org/10.1371/journal.pone.0039337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768074	gold, Green Published, Green Accepted			2022-12-25	WOS:000305892100045
J	Stone, W; Bousema, T; Jones, S; Gesase, S; Hashim, R; Gosling, R; Carneiro, I; Chandramohan, D; Theander, T; Ronca, R; Modiano, D; Arca, B; Drakeley, C				Stone, Will; Bousema, Teun; Jones, Sophie; Gesase, Samwel; Hashim, Rhamadhan; Gosling, Roly; Carneiro, Ilona; Chandramohan, Daniel; Theander, Thor; Ronca, Raffaele; Modiano, David; Arca, Bruno; Drakeley, Chris			IgG Responses to Anopheles gambiae Salivary Antigen gSG6 Detect Variation in Exposure to Malaria Vectors and Disease Risk	PLOS ONE			English	Article							ANTIBODY-RESPONSE; EPIDEMIOLOGIC TOOL; INOCULATION RATES; TRANSMISSION; MOSQUITO; MARKER; CHILDREN; PROTEIN; HETEROGENEITY; IMMUNITY	Assessment of exposure to malaria vectors is important to our understanding of spatial and temporal variations in disease transmission and facilitates the targeting and evaluation of control efforts. Recently, an immunogenic Anopheles gambiae salivary protein (gSG6) was identified and proposed as the basis of an immuno-assay determining exposure to Afrotropical malaria vectors. In the present study, IgG responses to gSG6 and 6 malaria antigens (CSP, AMA-1, MSP-1, MSP-3, GLURP R1, and GLURP R2) were compared to Anopheles exposure and malaria incidence in a cohort of children from Korogwe district, Tanzania, an area of moderate and heterogeneous malaria transmission. Anti-gSG6 responses above the threshold for seropositivity were detected in 15% (96/636) of the children, and were positively associated with geographical variations in Anopheles exposure (OR 1.25, CI 1.01-1.54, p = 0.04). Additionally, IgG responses to gSG6 in individual children showed a strong positive association with household level mosquito exposure. IgG levels for all antigens except AMA-1 were associated with the frequency of malaria episodes following sampling. gSG6 seropositivity was strongly positively associated with subsequent malaria incidence (test for trend p = 0.004), comparable to malaria antigens MSP-1 and GLURP R2. Our results show that the gSG6 assay is sensitive to micro-epidemiological variations in exposure to Anopheles mosquitoes, and provides a correlate of malaria risk that is unrelated to immune protection. While the technique requires further evaluation in a range of malaria endemic settings, our findings suggest that the gSG6 assay may have a role in the evaluation and planning of targeted and preventative anti-malaria interventions.	[Stone, Will; Bousema, Teun; Jones, Sophie; Carneiro, Ilona; Chandramohan, Daniel; Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immun & Infect, London WC1, England; [Stone, Will; Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gesase, Samwel; Hashim, Rhamadhan] Natl Inst Med Res, Tanga, Tanzania; [Gosling, Roly] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Theander, Thor] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Theander, Thor] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Ronca, Raffaele; Arca, Bruno] Univ Federico II, Dept Struct & Funct Biol, Naples, Italy; [Modiano, David; Arca, Bruno] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Parasitol Sect, Rome, Italy	University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen; University of California System; University of California San Francisco; University of Copenhagen; University of Copenhagen; University of Naples Federico II; Sapienza University Rome	Stone, W (corresponding author), London Sch Hyg & Trop Med, Dept Immun & Infect, London WC1, England.	chris.drakeley@lshtm.ac.uk	Bousema, Teun/N-3574-2014; Stone, Will/F-9416-2016; Theander, Thor/F-6714-2015; Arca, Bruno/C-8383-2012	Bousema, Teun/0000-0003-2666-094X; Theander, Thor/0000-0002-3509-7514; Ronca, Raffaele/0000-0003-2217-3378; Arca, Bruno/0000-0002-4029-0984; Stone, William/0000-0002-6647-0166	Intermittent Preventive Treatment in Infants (IPTi) Consortium by the Bill and Melinda Gates Foundation; Gates Malaria Partnership by the Bill and Melinda Gates Foundation; Gates Grand Challenges Exploration Grant [51991]; Wellcome Trust [078925]	Intermittent Preventive Treatment in Infants (IPTi) Consortium by the Bill and Melinda Gates Foundation; Gates Malaria Partnership by the Bill and Melinda Gates Foundation; Gates Grand Challenges Exploration Grant; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Intermittent Preventive Treatment in Infants (IPTi) Consortium and the Gates Malaria Partnership, both of which are supported by the Bill and Melinda Gates Foundation. T. B. is supported by a Gates Grand Challenges Exploration Grant (grant 51991); C. D. is supported by a grant from the Wellcome Trust (grant 078925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2011, J INFECT DIS, V204, P1, DOI 10.1093/infdis/jir225; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; BRUMMERKORVENKONTIO H, 1994, J ALLERGY CLIN IMMUN, V93, P551, DOI 10.1016/S0091-6749(94)70066-4; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drame PM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-72; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; GREENWOOD BM, 1990, B WORLD HEALTH ORGAN, V68, P184; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hii JLK, 2000, B ENTOMOL RES, V90, P211, DOI 10.1017/S000748530000033X; Hommel M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S1; King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552; Kinyanjui SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-242; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Marzouki S, 2011, AM J TROP MED HYG, V84, P653, DOI 10.4269/ajtmh.2011.10-0598; Matsuoka H, 2002, PARASITOL INT, V51, P17, DOI 10.1016/S1383-5769(01)00095-2; MBOGO CNM, 1993, J AM MOSQUITO CONTR, V9, P260; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; MENDIS C, 1992, PARASITE IMMUNOL, V14, P75, DOI 10.1111/j.1365-3024.1992.tb00007.x; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Palosuo K, 1997, INT ARCH ALLERGY IMM, V114, P367, DOI 10.1159/000237696; Peng ZK, 2007, CURR OPIN ALLERGY CL, V7, P350, DOI 10.1097/ACI.0b013e328259c313; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rizzo C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-206; Rizzo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017980; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; SCHWARTZ BS, 1991, AM J EPIDEMIOL, V134, P86, DOI 10.1093/oxfordjournals.aje.a115996; Schwarz A, 2009, INT J PARASITOL, V39, P1021, DOI 10.1016/j.ijpara.2009.01.010; Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Theisen M, 2004, VACCINE, V22, P1188, DOI 10.1016/j.vaccine.2003.09.017; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2007, MAL EL FIELD MAN LOW	70	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40170	10.1371/journal.pone.0040170	http://dx.doi.org/10.1371/journal.pone.0040170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768250	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305892100223
J	Teng, L; Kerbiriou, M; Taiya, M; Le Hir, S; Mignen, O; Benz, N; Trouve, P; Ferec, C				Teng, Ling; Kerbiriou, Mathieu; Taiya, Mehdi; Le Hir, Sophie; Mignen, Olivier; Benz, Nathalie; Trouve, Pascal; Ferec, Claude			Proteomic Identification of Calumenin as a G551D-CFTR Associated Protein	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR CHLORIDE CHANNELS; CYSTIC-FIBROSIS GENE; KINASE-A; ANNEXIN A5; ATP; EXPRESSION; DOMAIN; MECHANISMS; MUTATIONS	Cystic fibrosis (CF) is the most common lethal autosomal recessive disease in the Caucasian population. It is due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. To date, over 1910 mutations have been identified in the CFTR gene. Among these mutations, the CF-causing missense mutation G551D-CFTR (approx. 5% of cases) encodes for a CFTR chloride channel with normal expression on the cell surface. Nevertheless, it is associated with severe disease due to its altered channel activation. The aim of the present study was to identify specific interacting proteins of G551D-CFTR. Co-immunoprecipitated proteins with G551D-CFTR were resolved by 2D-gel electrophoresis (2-DE). Mass Spectrometry revealed that calumenin was present in the protein complex linked to G551D-CFTR. Despite its basal expression was not modified in G551D-CFTR expressing cells when compared to Wt-CFTR expressing cells, it was more abundant in the G551D-CFTR complex detected by immunoprecipitation. The calumenin-CFTR interaction was also shown by Surface Plasmon Resonance and further confirmed by computational analysis of the predicted calumenin's partners. Because in our cellular model calumenin was found in the endoplasmic reticulum (ER) by immunofluorescence experiments, we suggest that calumenin is likely involved in the mutated CFTR's maturation. In conclusion, we showed for the first time that calumenin binds to CFTR and that it is increased in the G551D-CFTR complex. We suggest that it may be involved in the physiopathology of G551D-CFTR and that G551D-CFTR may follow a specific maturation and trafficking pathway. We also hypothesize that UPR may be triggered independently of the retention of G551D-CFTR in the ER because Grp78/Bip expression is increased in the cells. Finally, we propose here that Calumenin is a new CFTR chaperone.	[Teng, Ling; Kerbiriou, Mathieu; Le Hir, Sophie; Mignen, Olivier; Benz, Nathalie; Trouve, Pascal; Ferec, Claude] Inserm, UMR1078, Brest, France; [Teng, Ling; Kerbiriou, Mathieu; Mignen, Olivier; Trouve, Pascal; Ferec, Claude] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Taiya, Mehdi] Univ Bretagne Occidentale, Serv Commun Spectrometrie Masse, Brest, France; [Le Hir, Sophie; Ferec, Claude] CHRU Morvan, Genet Mol Lab, Brest, France; [Ferec, Claude] Etab Francais Sang, Brest, France; [Benz, Nathalie] Assoc Biogenet Gaetan Salaun, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest	Teng, L (corresponding author), Inserm, UMR1078, Brest, France.	pascal.trouve@univ-brest.fr; claude.ferec@univ-brest.fr	Ferec, Claude/ABG-9699-2020; MIGNEN, Olivier/M-3258-2019	Ferec, Claude/0000-0002-2325-0710; MIGNEN, Olivier/0000-0001-7913-6119	association Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose"	association Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose"	This work was supported by grants from the association Gaetan Salaun, the "Etablissement Francais du Sang'' and the French CF foundation "Vaincre la Mucoviscidose''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Caputo A, 2009, J PHARMACOL EXP THER, V330, P783, DOI 10.1124/jpet.109.154146; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Gomes-Alves P, 2010, BBA-PROTEINS PROTEOM, V1804, P856, DOI 10.1016/j.bbapap.2009.12.013; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Le Drevo MA, 2008, BBA-MOL BASIS DIS, V1782, P605, DOI 10.1016/j.bbadis.2008.08.002; Leblais V, 1999, J BIOL CHEM, V274, P6107, DOI 10.1074/jbc.274.10.6107; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 2000, NEWS PHYSIOL SCI, V15, P57; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; Ramjeesingh M, 2003, BIOCHEM J, V375, P633, DOI 10.1042/BJ20030774; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sahoo SK, 2008, MOL CELLS, V26, P265; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Szellas T, 2003, FEBS LETT, V535, P141, DOI 10.1016/S0014-5793(02)03892-9; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Trouve P, 2007, BBA-MOL BASIS DIS, V1772, P1121, DOI 10.1016/j.bbadis.2007.06.006; Trouve P, 2012, TALANTA, V93, P219, DOI 10.1016/j.talanta.2012.02.017; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253	37	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40173	10.1371/journal.pone.0040173	http://dx.doi.org/10.1371/journal.pone.0040173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768251	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100224
J	Torcia, MG; Nencioni, L; Clemente, AM; Civitelli, L; Celestino, I; Limongi, D; Fadigati, G; Perissi, E; Cozzolino, F; Garaci, E; Palamara, AT				Torcia, Maria Gabriella; Nencioni, Lucia; Clemente, Ann Maria; Civitelli, Livia; Celestino, Ignacio; Limongi, Dolores; Fadigati, Giulia; Perissi, Eloisa; Cozzolino, Federico; Garaci, Enrico; Palamara, Anna Teresa			Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; H1N1 VIRUS-INFECTION; IFN-ALPHA PRODUCTION; REGULATORY T-CELLS; INFLUENZA-VIRUS; DENDRITIC CELLS; GENERAL-POPULATION; HEPATITIS-C; INTERLEUKIN-10; GENDER	Background: Susceptibility to viral infections as well as their severity are higher in men than in women. Heightened antiviral responses typical of women are effective for rapid virus clearance, but if excessively high or prolonged, can result in chronic/inflammatory pathologies. We investigated whether this variability could be in part attributable to differences in the response to the Toll-Like Receptors (TLR) more involved in the virus recognition. Methods: Cytokine production by peripheral blood mononuclear cells (PBMCs) from male and female healthy donors after stimulation with Toll-like receptors (TLR) 3, 7, 8, 9 ligands or with viruses (influenza and Herpes-simplex-1) was evaluated. Results: Compared to females, PBMCs from males produced not only lower amounts of IFN-alpha in response to TLR7 ligands but also higher amounts of the immunosuppressive cytokine IL10 after stimulation with TLR8 and TLR9 ligands or viruses. IL10 production after TLR9 ligands or HSV-1 stimulation was significantly related with plasma levels of sex hormones in both groups, whereas no correlation was found in cytokines produced following TLR7 and TLR8 stimulation. Conclusions: Given the role of an early production of IL10 by cells of innate immunity in modulating innate and adaptive immune response to viruses, we suggest that sex-related difference in its production following viral nucleic acid stimulation of TLRs may be involved in the sex-related variability in response to viral infections.	[Torcia, Maria Gabriella; Clemente, Ann Maria; Fadigati, Giulia; Perissi, Eloisa; Cozzolino, Federico] Univ Florence, Dept Clin Physiopathol, Florence, Italy; [Limongi, Dolores; Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Palamara, Anna Teresa] Sapienza Univ Rome, Inst Pasteur Cenci Bolognetti Fdn, Dept Publ Hlth & Infect Dis, Rome, Italy; [Palamara, Anna Teresa] San Raffaele Pisana Sci Inst Res Hospitalizat & H, Rome, Italy	University of Florence; University of Rome Tor Vergata; Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Torcia, MG (corresponding author), Univ Florence, Dept Clin Physiopathol, Florence, Italy.	g.torcia@dfc.unifi.it	Nencioni, Lucia/K-5988-2016; Limongi, Dolores/F-7296-2010; GARACI, ENRICO/AAB-3349-2021; Limongi, Dolores/O-9189-2019; Torcia, Maria Gabriella G/K-1840-2018	Nencioni, Lucia/0000-0003-4427-4823; Limongi, Dolores/0000-0003-2095-8112; Limongi, Dolores/0000-0003-2095-8112; Torcia, Maria Gabriella G/0000-0003-4740-4646; Civitelli, Livia/0000-0003-2399-1436; PALAMARA, ANNA TERESA/0000-0001-8330-4381; Cozzolino, Federico/0000-0002-2800-640X	Italian Ministry of Health; Italian Ministry of Instruction, University, and Research; Istituto Superiore di Sanita; University of Roma "Sapienza"; University of Firenze	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Instruction, University, and Research(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; University of Roma "Sapienza"; University of Firenze	This work was supported by: Italian Ministry of Health (Progetto donna); Italian Ministry of Instruction, University, and Research (Progetto PON); grants from Istituto Superiore di Sanita -2012; grants from University of Roma "Sapienza" (Progetto Ateneo); and grants from University of Firenze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2010, PLOS ONE, V1, ppii; Barchet W, 2005, EUR J IMMUNOL, V35, P236, DOI 10.1002/eji.200425583; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bouman A, 2004, AM J REPROD IMMUNOL, V52, P19, DOI 10.1111/j.1600-0897.2004.00177.x; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Choi Won-Il, 2011, BMC Res Notes, V4, P351, DOI 10.1186/1756-0500-4-351; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hyodo N, 2004, CLIN EXP IMMUNOL, V135, P462, DOI 10.1111/j.1365-2249.2003.02376.x; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Jukkola-Vuorinen A, 2009, J INNATE IMMUN, V1, P59, DOI 10.1159/000151602; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khan N, 2010, HUM IMMUNOL, V71, P372, DOI 10.1016/j.humimm.2010.01.018; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; Killington R, 1991, GROWTH ASSAY PURIFIC, P212; Klein S., 2010, SEX GENDER INFLUENZA, P1; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Ru A, 2010, VACCINE, V28, P3661, DOI 10.1016/j.vaccine.2010.03.029; Li XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-272; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Lorenzo ME, 2011, VACCINE, V29, P9246, DOI 10.1016/j.vaccine.2011.09.110; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Panchanadeswaran S, 2006, SEX TRANSM INFECT, V82, P491, DOI 10.1136/sti.2006.020768; Puchhammer-Stockl E, 2012, J CLIN VIROL, V53, P356, DOI 10.1016/j.jcv.2011.12.015; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Roriz-Cruz M, 2010, J AM GERIATR SOC, V58, P1813, DOI 10.1111/j.1532-5415.2010.03045.x; Sarangi PP, 2008, J IMMUNOL, V180, P6297, DOI 10.4049/jimmunol.180.9.6297; Schmidt A, 2012, EUR J CELL BIOL, V91, P78, DOI 10.1016/j.ejcb.2011.01.015; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; Solomon L, 2003, SEX TRANSM INFECT, V79, P456, DOI 10.1136/sti.79.6.456; Sousa H, 2011, ACTA MEDICA PORT, V 24, P707; Stepanova M, 2012, J VIRAL HEPATITIS, V19, P341, DOI 10.1111/j.1365-2893.2011.01554.x; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Xiao H, 2010, CHINESE MED J-PEKING, V123, P401, DOI 10.3760/cma.j.issn.0366-6999.2010.04.004; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	53	88	89	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39853	10.1371/journal.pone.0039853	http://dx.doi.org/10.1371/journal.pone.0039853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768144	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100113
J	Li, ZR; Ptak, D; Zhang, LY; Walls, EK; Zhong, WX; Leung, YF				Li, Zeran; Ptak, Devon; Zhang, Liyun; Walls, Elwood K.; Zhong, Wenxuan; Leung, Yuk Fai			Phenylthiourea Specifically Reduces Zebrafish Eye Size	PLOS ONE			English	Article							GENE-EXPRESSION; THYROID PEROXIDASE; IN-VIVO; SODIUM/IODIDE SYMPORTER; EMBRYONIC-DEVELOPMENT; TRANSGENIC ZEBRAFISH; DANIO-RERIO; CELL FATE; TYROSINASE; MELANOGENESIS	Phenylthiourea (PTU) is commonly used for inhibiting melanization of zebrafish embryos. In this study, the standard treatment with 0.2 mM PTU was demonstrated to specifically reduce eye size in larval fish starting at three days postfertilization. This effect is likely the result of a reduction in retinal and lens size of PTU-treated eyes and is not related to melanization inhibition. This is because the eye size of tyr, a genetic mutant of tyrosinase whose activity is inhibited in PTU treatment, was not reduced. As PTU contains a thiocarbamide group which is presented in many goitrogens, suppressing thyroid hormone production is a possible mechanism by which PTU treatment may reduce eye size. Despite the fact that thyroxine level was found to be reduced in PTU-treated larvae, thyroid hormone supplements did not rescue the eye size reduction. Instead, treating embryos with six goitrogens, including inhibitors of thyroid peroxidase (TPO) and sodium-iodide symporter (NIS), suggested an alternative possibility. Specifically, three TPO inhibitors, including those that do not possess thiocarbamide, specifically reduced eye size; whereas none of the NIS inhibitors could elicit this effect. These observations indicate that TPO inhibition rather than a general suppression of thyroid hormone synthesis is likely the underlying cause of PTU-induced eye size reduction. Furthermore, the tissue-specific effect of PTU treatment might be mediated by an eye-specific TPO expression. Compared with treatment with other tyrosinase inhibitors or bleaching to remove melanization, PTU treatment remains the most effective approach. Thus, one should use caution when interpreting results that are obtained from PTU-treated embryos.	[Li, Zeran; Ptak, Devon; Zhang, Liyun; Walls, Elwood K.; Leung, Yuk Fai] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Li, Zeran] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Walls, Elwood K.] Indiana Univ Sch Med Lafayette, Dept Cellular & Integrat Physiol, W Lafayette, IN USA; [Zhong, Wenxuan] Univ Illinois, Dept Stat, Champaign, IL USA; [Leung, Yuk Fai] Indiana Univ Sch Med Lafayette, Dept Biochem & Mol Biol, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign	Li, ZR (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	yfleung@purdue.edu	Zhang, Liyun/F-6193-2016; Ptak, Devon/A-5699-2013; Li, Zeran/AAZ-5312-2020	Li, Zeran/0000-0002-7434-6499	Sigma Xi; Zippy Ostroy Research Experience for Undergraduates award; Phillips Undergraduate Research Internship; Knights Templar Eye Foundation; Charles D. Kelman, MD Scholar award; office of Science (BER), U.S. Department of Energy and an NSF [DMS 1120256]; Indiana Academy of Science; Hope for Vision & Showalter Research Trust	Sigma Xi; Zippy Ostroy Research Experience for Undergraduates award; Phillips Undergraduate Research Internship; Knights Templar Eye Foundation; Charles D. Kelman, MD Scholar award; office of Science (BER), U.S. Department of Energy and an NSF; Indiana Academy of Science; Hope for Vision & Showalter Research Trust	This work was supported by Sigma Xi Grant-in-Aid awards for vision-related research to Z.L. and D. P., a Sandy and Zippy Ostroy Research Experience for Undergraduates award and a Dr. William H. Phillips Undergraduate Research Internship to Z.L., a Pediatric Ophthalmology Research Grant from Knights Templar Eye Foundation and a Charles D. Kelman, MD Scholar award to L.Z., a grant from the office of Science (BER), U.S. Department of Energy and an NSF grant DMS 1120256 to WZ, and a Senior Research Grant from Indiana Academy of Science and awards from Hope for Vision & Showalter Research Trust to Y.F.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga Junko, 2010, J Vis Exp, DOI 10.3791/2093; BELL LGE, 1955, NATURE, V175, P1001, DOI 10.1038/1751001a0; Bentley PJ, 1980, ENDOCRINE PHARM PHYS, Vxvi; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991; BYWATER WG, 1945, J PHARMACOL EXP THER, V85, P14; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Chen QX, 2003, J PROTEIN CHEM, V22, P481, DOI 10.1023/B:JOPC.0000005464.36961.9c; Choi TY, 2007, PIGM CELL RES, V20, P120, DOI 10.1111/j.1600-0749.2007.00365.x; Criton M, 2008, BIOORG MED CHEM LETT, V18, P3607, DOI 10.1016/j.bmcl.2008.04.079; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; DE la Vieja A, 2000, PHYSIOL REV, V80, P1083, DOI 10.1152/physrev.2000.80.3.1083; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; DIEKE SH, 1947, ENDOCRINOLOGY, V40, P123, DOI 10.1210/endo-40-3-123; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Draelos ZD, 2007, DERMATOL THER, V20, P308, DOI 10.1111/j.1529-8019.2007.00144.x; Easter SS, 1996, DEV BIOL, V180, P646; Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3; FRIEDERS F., 1954, CATHOLIC UNIV AMER BIOL STUD, V31, P1; Gaitan E., 1989, ENV GOITROGENESIS; Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480; HARBOTTLE R, 1984, BIOCHEM J, V217, P485, DOI 10.1042/bj2170485; Hensley MR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-45; Hensley MR, 2010, ZEBRAFISH, V7, P219, DOI 10.1089/zeb.2010.0652; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hornung MW, 2011, 7 INT S AMPH END NEU; JENKINS MM, 1959, BIOL BULL, V116, P106, DOI 10.2307/1539160; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIRSCHBAUM F, 1975, ROUX ARCH DEV BIOL, V177, P129; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kuliawat R, 2005, J BIOL CHEM, V280, P27713, DOI 10.1074/jbc.M503804200; Lawrence C, 2011, METHOD CELL BIOL, V104, P431, DOI 10.1016/B978-0-12-374814-0.00023-9; Leung YF, 2008, P NATL ACAD SCI USA, V105, P12909, DOI 10.1073/pnas.0806038105; Leung YF, 2005, ZEBRAFISH, V2, P269, DOI 10.1089/zeb.2005.2.269; Leung YF, 2007, INVEST OPHTH VIS SCI, V48, P881, DOI 10.1167/iovs.06-0723; Lister JA, 1999, DEVELOPMENT, V126, P3757; Liu SH, 2007, BIOL PHARM BULL, V30, P1135, DOI 10.1248/bpb.30.1135; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYNN WG, 1957, BIOL BULL-US, V113, P160, DOI 10.2307/1538810; LYNN WG, 1947, BIOL BULL, V93, P199; LYNN WG, 1948, BIOL BULL-US, V94, P1, DOI 10.2307/1538202; MELIUS ME, 1969, J MORPHOL, V129, P1, DOI 10.1002/jmor.1051290102; Messier N, 2001, MOL CELL ENDOCRINOL, V174, P59, DOI 10.1016/S0303-7207(00)00446-9; MILLOT N, 1966, NATURE, V209, P99, DOI 10.1038/209099b0; MINGANTI A, 1957, ACTA EMBRYOL MORPHOL, V1, P37; Neter J, 1996, APPL LINEAR STAT MOD, Vxv; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Nusslein-Volhard C, 2002, ZEBRAFISH PRACTICAL, Vxviii, P303; Ohtaki S, 1996, ENDOCR J, V43, P1, DOI 10.1507/endocrj.43.1; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Pinazo-Duran MD, 2011, BRAIN RES, V1392, P16, DOI 10.1016/j.brainres.2011.04.005; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Richter CP, 1942, ARCH PATHOL, V33, P46; Richter CP, 1941, P SOC EXP BIOL MED, V48, P684; SIMS RT, 1962, Q J MICROSC SCI, V103, P439; Stenkamp D L, 1998, Mol Vis, V4, P26; Takabayashi S, 2006, MOL ENDOCRINOL, V20, P2584, DOI 10.1210/me.2006-0099; Tingaud-Sequeira A, 2006, DEV DYNAM, V235, P3071, DOI 10.1002/dvdy.20921; VanDunk C, 2011, J NEUROSCI, V31, P6457, DOI 10.1523/JNEUROSCI.5385-10.2011; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Wang WD, 2004, BIOCHEM PHARMACOL, V68, P63, DOI 10.1016/j.bcp.2004.03.010; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; WHITTAKE.JR, 1966, DEV BIOL, V14, P1, DOI 10.1016/0012-1606(66)90003-0; WINKLER AW, 1946, YALE J BIOL MED, V18, P527; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x	70	45	47	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40132	10.1371/journal.pone.0040132	http://dx.doi.org/10.1371/journal.pone.0040132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761952	Green Submitted, Green Published, gold			2022-12-25	WOS:000305825800089
J	Chen, N; Eritja, N; Lock, R; Debnath, J				Chen, N.; Eritja, N.; Lock, R.; Debnath, J.			Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture	ONCOGENE			English	Article						autophagy; oncogenic PI3K; proliferation; 3D culture	SIGNALING PATHWAYS; RAT HEPATOCYTES; CANCER; TUMORIGENESIS; MUTATIONS; BECLIN-1; CELLS; GENE; ACTIVATION; INDUCTION	Autophagy is a tightly regulated lysosomal self-digestion process that can both promote and impede tumorigenesis. Here, we utilize a three-dimensional (3D) culture model to address how interactions between autophagy and the phosphatidylinositol 3-kinase(PI3K)/Akt/mammalian target of rapamycin pathway impact the malignant behavior of cells carrying a tumor-derived, activating mutation in PI3K (PI3K-H1047R). In this model, autophagy simultaneously mediates tumor-suppressive and -promoting functions within individual glandular structures. In 3D culture, constitutive PI3K activation overcomes proliferation arrest and promotes resistance to anoikis in the luminal space, resulting in aberrant structures with filled lumen. Inhibiting autophagy in PI3K-H1047R structures triggers luminal cell apoptosis, resulting in lumen clearance. At the same time, autophagy gene depletion strongly enhances PI3K-H1047R cell proliferation during 3D morphogenesis, revealing an unexpected role for autophagy in restricting proliferation driven by PI3K activation. Intriguingly, overexpression of the autophagy cargo receptor p62/SQSTM1 in PI3K-H1047R cells is sufficient to enhance cell proliferation, activate the extracellular signal-related kinase/mitogen-activated protein kinase pathway and to promote epidermal growth factor-independent proliferation in 3D culture. Overall, these results indicate that autophagy antagonizes specific aspects of oncogenic PI3K transformation, with the loss of autophagy promoting proliferation.	[Chen, N.; Eritja, N.; Lock, R.; Debnath, J.] Univ Calif San Francisco, Dept Pathol, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Chen, N.; Eritja, N.; Lock, R.; Debnath, J.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Eritja, N.] Univ Lleida, IRBLleida, Inst Recerca Biomed Lleida, Oncol Pathol Grp, Lleida, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Debnath, J (corresponding author), Univ Calif San Francisco, Dept Pathol, Biomed Sci Grad Program, 513 Parnassus Ave,HSW 450B Box 0502, San Francisco, CA 94143 USA.	Jayanta.Debnath@ucsf.edu	Eritja, Nuria/M-1347-2015; Eritja, Núria/S-3700-2019	Eritja, Nuria/0000-0003-1018-6649; Eritja, Núria/0000-0003-2131-7915; Debnath, Jayanta/0000-0002-8745-4069	NIH [RO1 CA126792, CA126792-S1]; DOD BCRP [W81XWH-11-1-0130]; Spanish Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA126792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP(United States Department of Defense); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs William Weiss, Qiwen Fan and members of the Debnath lab for critically reading the manuscript, and Drs William Weiss and Terge Johansen for generously providing constructs. Grant support to JD includes the NIH (RO1 CA126792 and ARRA supplement CA126792-S1) and the DOD BCRP (W81XWH-11-1-0130). NE received a Short-Term Stay Fellowship from the Spanish Ministry of Health. RL is a DOD BCRP Predoctoral Scholar (W81XWH-08-1-0759).	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Debnath J, 2009, METHOD ENZYMOL, V452, P423, DOI 10.1016/S0076-6879(08)03625-2; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Luiken JJFP, 1996, EUR J BIOCHEM, V235, P564; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	34	32	32	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 16	2013	32	20					2543	2554		10.1038/onc.2012.277	http://dx.doi.org/10.1038/onc.2012.277			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	148UY	22777351	Green Submitted, Green Accepted			2022-12-25	WOS:000319274300006
J	Yang, JC; Xu, XL				Yang, Jingchun; Xu, Xiaolei			alpha-Actinin2 is required for the lateral alignment of Z discs and ventricular chamber enlargement during zebrafish cardiogenesis	FASEB JOURNAL			English	Article						cardiac contraction; mechanical force; cardiomyocyte; myofibrillogenesis	ALPHA-ACTININ; HYPERTROPHIC CARDIOMYOPATHY; SEVERE FORM; PROTEINS; MYOFIBRILLOGENESIS; EXPRESSION; TITIN; DEPLETION; CYPHER; MUTATIONS	alpha-Actinin2 (Actn2) is a predominant protein in the sarcomere Z disc whose mutation can lead to cardiomyopathy. However, the function of Actn2 in Z-disc assembly and cardiomyopathy in vertebrates remains elusive. We leveraged genetic tools in zebrafish embryos to elucidate the function of Actn2. We identified a single Actn2 homologue expressed in the zebrafish heart and conducted loss-of-function studies by antisense morpholino technology. Although zebrafish Actn2 assembles early into the Z disc, depletion of actn2 did not affect the early steps of sarcomere assembly. Instead, Actn2 is required for Z bodies to register laterally, forming well-aligned Z discs. Presumably as a consequence to this structural defect in the sarcomere, the depletion of Actn2 resulted in reduced cardiac function, primarily characterized as a reduced end-diastolic diameter. The depletion of actn2 also significantly reduced the ventricle chamber size, due to both reduced cardiomyocyte (CM) size and CM number. Interestingly, reduced CM size can be rescued by the cessation of heart contractions. The genetic studies of zebrafish uncovered a function for actn2 in lateral registration of Z body. In actn2 morphant fish, the Z-disc defect sequentially affects cardiac function, which leads to morphological changes in the ventricle through a mechanical force-dependent mechanism.-Yang, J., Xu, X. alpha-Actinin2 is required for the lateral alignment of Z discs and ventricular chamber enlargement during zebrafish cardiogenesis. FASEB J. 26, 4230-4242 (2012). www.fasebj.org	[Yang, Jingchun; Xu, Xiaolei] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Div Cardiovasc Dis,Dept Med, Rochester, MN 55905 USA	Mayo Clinic	Xu, XL (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Div Cardiovasc Dis,Dept Med, 200 1st St SW, Rochester, MN 55905 USA.	xu.xiaolei@mayo.edu		Yang, Jingchun/0000-0002-9122-2367	Mayo Foundation; U.S. National Institutes of Health grant [HL81753]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081753] Funding Source: NIH RePORTER	Mayo Foundation; U.S. National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Yu-huan Shih (Mayo Clinic College of Medicine) for his contributions in conducting the RT-PCR experiments. The authors thank Dr. Chi-Bin Chien (University of Utah, Salt Lake City, UT, USA) for sharing the following plasmids: p5E-MCS, pME-megfp, p3E-poly(A), and pDestTol2pA. The authors thank Dr. Carol Gregorio (University of Arizona, Tucson, AZ, USA) and Dr. Joseph Sanger (SUNY Upstate Medical University, Syracuse, NY, USA) for sharing the LASP2 and MYOTILIN cDNAs, respectively. The authors also thank Beninio Jomok for his help with zebrafish husbandry. This study was supported by the Mayo Foundation and by a U.S. National Institutes of Health grant (HL81753) to X.X. The authors declare no conflicts of interest.	Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Bartman T, 2005, DEV DYNAM, V233, P373, DOI 10.1002/dvdy.20367; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Chen ZY, 2008, CARDIOVASC RES, V79, P97, DOI 10.1093/cvr/cvn073; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; Du AP, 2008, DEV BIOL, V318, P236, DOI 10.1016/j.ydbio.2008.03.011; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Freeman JLR, 2000, FEBS LETT, V473, P280, DOI 10.1016/S0014-5793(00)01543-X; Garvey SM, 2006, HUM MOL GENET, V15, P2348, DOI 10.1093/hmg/ddl160; Gupta V, 2012, FASEB J, V26, P1892, DOI 10.1096/fj.11-194548; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Holterhoff CK, 2009, DEV DYNAM, V238, P2936, DOI 10.1002/dvdy.22123; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Jou CJ, 2010, CELL PHYSIOL BIOCHEM, V25, P419, DOI 10.1159/000303046; Keren A, 2008, NAT CLIN PRACT CARD, V5, P158, DOI 10.1038/ncpcardio1110; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Lin YF, 2012, DEV BIOL, V362, P242, DOI 10.1016/j.ydbio.2011.12.005; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Moncman CL, 2002, EXP CELL RES, V273, P204, DOI 10.1006/excr.2001.5423; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Moulder GL, 2010, J MOL BIOL, V403, P516, DOI 10.1016/j.jmb.2010.08.055; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Poss KD, 2002, DEVELOPMENT, V129, P5141; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; ROULIER EM, 1992, J CELL BIOL, V116, P911, DOI 10.1083/jcb.116.4.911; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Seeley M, 2007, CIRC RES, V100, P238, DOI 10.1161/01.RES.0000255758.69821.b5; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Stout AL, 2008, CELL MOTIL CYTOSKEL, V65, P353, DOI 10.1002/cm.20265; Sun XJ, 2008, CIRC RES, V102, P831, DOI 10.1161/CIRCRESAHA.107.166488; Sun XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006596; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Yang JC, 2012, JOVE-J VIS EXP, DOI 10.3791/3510; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362; Zhang RL, 2009, DEV DYNAM, V238, P1564, DOI 10.1002/dvdy.21929; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	52	27	28	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4230	4242		10.1096/fj.12-207969	http://dx.doi.org/10.1096/fj.12-207969			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22767232	Bronze, Green Published			2022-12-25	WOS:000309704000028
J	Jang, YJ; Soekmadji, C; Mitchell, JM; Thomas, WG; Thorn, P				Jang, Yujin; Soekmadji, Carolina; Mitchell, Justin M.; Thomas, Walter G.; Thorn, Peter			Real-Time Measurement of F-Actin Remodelling during Exocytosis Using Lifeact-EGFP Transgenic Animals	PLOS ONE			English	Article							PANCREATIC ACINAR-CELLS; FUSION PORE; COMPENSATORY ENDOCYTOSIS; ZYMOGEN GRANULES; DYNAMICS; RELEASE; BODIES; COAT	F-actin remodelling is essential for a wide variety of cell processes. It is important in exocytosis, where F-actin coats fusing exocytic granules. The purpose of these F-actin coats is unknown. They may be important in stabilizing the fused granules, they may play a contractile role and promote expulsion of granule content and finally may be important in endocytosis. To elucidate these functions of F-actin remodelling requires a reliable method to visualize F-actin dynamics in living cells. The recent development of Lifeact-EGFP transgenic animals offers such an opportunity. Here, we studied the characteristics of exocytosis in pancreatic acinar cells obtained from the Lifeact-EGFP transgenic mice. We show that the time-course of agonist-evoked exocytic events and the kinetics of each single exocytic event are the same for wild type and Lifeact-EGFP transgenic animals. We conclude that Lifeact-EGFP animals are a good model to study of exocytosis and reveal that F-actin coating is dependent on the de novo synthesis of F-actin and that development of actin polymerization occurs simultaneously in all regions of the granule. Our insights using the Lifeact-EGFP mice demonstrate that F-actin coating occurs after granule fusion and is a granule-wide event.	[Jang, Yujin; Mitchell, Justin M.; Thomas, Walter G.; Thorn, Peter] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Soekmadji, Carolina] Princess Alexandra Hosp, Australian Prostate Res Ctr Queensland, Buranda, Qld, Australia	University of Queensland	Jang, YJ (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	p.thorn@uq.edu.au	Thorn, Peter/F-7030-2010; Mitchell, justin M/D-2061-2017; Soekmadji, Carolina/M-2757-2016; Thomas, Walter/I-2208-2015	Thorn, Peter/0000-0002-3228-770X; Mitchell, justin M/0000-0001-8391-5959; Soekmadji, Carolina/0000-0002-6920-6627; Thomas, Walter/0000-0003-0685-2952	Australian Research Council [DP110100642]; National Health and Medical Research Council [APP1021764]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council Grant DP110100642 to PT and WGT, and a National Health and Medical Research Council Grant APP1021764 to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendorff N, 2011, J BIOL CHEM, V286, P29627, DOI 10.1074/jbc.M111.265199; Bhat P, 2009, MOL BIOL CELL, V20, P1795, DOI 10.1091/mbc.E08-10-1048; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Larina O, 2007, MOL BIOL CELL, V18, P3502, DOI 10.1091/mbc.E07-01-0024; Masedunskas A, 2011, P NATL ACAD SCI USA, V108, P13552, DOI 10.1073/pnas.1016778108; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Nightingale TD, 2011, J CELL BIOL, V194, P613, DOI 10.1083/jcb.201011119; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Schell MJ, 2006, EUR J NEUROSCI, V24, P2491, DOI 10.1111/j.1460-9568.2006.05125.x; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Thorn P, 2005, J PHYSIOL-LONDON, V563, P433, DOI 10.1113/jphysiol.2004.077230; Thorn P, 2004, P NATL ACAD SCI USA, V101, P6774, DOI 10.1073/pnas.0400336101; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Turvey MR, 2005, J CELL SCI, V118, P971, DOI 10.1242/jcs.01693; Turvey MR, 2004, PFLUG ARCH EUR J PHY, V448, P552, DOI 10.1007/s00424-004-1288-z; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993; Yu HYE, 2007, NAT CELL BIOL, V9, P149, DOI 10.1038/ncb1527	26	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39815	10.1371/journal.pone.0039815	http://dx.doi.org/10.1371/journal.pone.0039815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768313	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500026
J	Kim, J; Di Vizio, D; Kim, TK; Kim, J; Kim, M; Pelton, K; Clinton, SK; Hai, T; Hwang, D; Solomon, KR; Freeman, MR				Kim, Jayoung; Di Vizio, Dolores; Kim, Taek-Kyun; Kim, Jonghwan; Kim, Minjung; Pelton, Kristine; Clinton, Steven K.; Hai, Tsonwin; Hwang, Daehee; Solomon, Keith R.; Freeman, Michael R.			The Response of the Prostate to Circulating Cholesterol: Activating Transcription Factor 3 (ATF3) as a Prominent Node in a Cholesterol-Sensing Network	PLOS ONE			English	Article							STRESS-INDUCIBLE GENE; EPITHELIAL-CELLS; GROWTH-FACTOR; NEGATIVE REGULATOR; SYSTEMS BIOLOGY; CANCER; HYPERPLASIA; INFLAMMATION; EXPRESSION; RISK	Elevated circulating cholesterol is a systemic risk factor for cardiovascular disease and metabolic syndrome, however the manner in which the normal prostate responds to variations in cholesterol levels is poorly understood. In this study we addressed the molecular and cellular effects of elevated and suppressed levels of circulating cholesterol on the normal prostate. Integrated bioinformatic analysis was performed using DNA microarray data from two experimental formats: (1) ventral prostate from male mice with chronically elevated circulating cholesterol and (2) human prostate cells exposed acutely to cholesterol depletion. A cholesterol-sensitive gene expression network was constructed from these data and the transcription factor ATF3 was identified as a prominent node in the network. Validation experiments confirmed that elevated cholesterol reduced ATF3 expression and enhanced proliferation of prostate cells, while cholesterol depletion increased ATF3 levels and inhibited proliferation. Cholesterol reduction in vivo alleviated dense lymphomononuclear infiltrates in the periprostatic adipose tissue, which were closely associated with nerve tracts and blood vessels. These findings open new perspectives on the role of cholesterol in prostate health, and provide a novel role for ATF3, and associated proteins within a large signaling network, as a cholesterol-sensing mechanism.	[Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Surg, Div Canc Biol & Therapeut, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Canc Biol & Therapeut, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kim, Jayoung; Di Vizio, Dolores; Solomon, Keith R.; Freeman, Michael R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, South Korea; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Jonghwan] Univ Texas Austin, Austin, TX 78712 USA; [Kim, Minjung] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Oncol Dept, Tampa, FL 33682 USA; [Pelton, Kristine; Solomon, Keith R.] Harvard Univ, Dept Orthopaed Surg, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Clinton, Steven K.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Hai, Tsonwin] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Texas System; University of Texas Austin; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Harvard University; Boston Children's Hospital; Harvard Medical School; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kim, J (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Canc Biol & Therapeut, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	Jayoung.Kim@cshs.org; Jayoung.Kim@cshs.org; Michael.Freeman@cshs.org	Hai, Tsonwin/E-3185-2011; Hai, Tsonwin/H-4480-2011; Kim, Jonghwan/AAR-2815-2021; Kim, Taekkyun/A-9810-2017	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315; Kim, Taekkyun/0000-0002-3703-6790; Kim, Minjung/0000-0002-5682-6640; Kim, Jonghwan/0000-0002-9919-9843	National Institutes of Health [R01 DK087806, R01 CA143777, P50 DK65298, R01 CA101046, NCI K99 CA131472]; Fishbein Family IC Research Foundation/Interstitial Cystitis Association (ICA); Pilot Research Program/ICA; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE [K99CA131472, R01CA143777, R01CA101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087806, P50DK065298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fishbein Family IC Research Foundation/Interstitial Cystitis Association (ICA); Pilot Research Program/ICA; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following funding sources: National Institutes of Health grants R01 DK087806, R01 CA143777 and P50 DK65298 (to MRF); R01 CA101046 (to KRS); and NCI K99 CA131472 (to DDV); the Fishbein Family IC Research Foundation/Interstitial Cystitis Association (ICA), Pilot Research Program/ICA, New York Academy of Medicine, and Children's Hospital Boston Faculty Development (to Jayoung Kim). Jayoung Kim is an American Urological Association Foundation Research Scholar and a Harvard Medical School Eleanor and Miles Shore Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RM, 2003, CANCER RES, V63, P484; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Castro P, 2004, PROSTATE, V60, P153, DOI 10.1002/pros.20051; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Dong P, 2010, J CELL BIOCH; Fibbi B, 2010, INT J ANDROL, V33, P475, DOI 10.1111/j.1365-2605.2009.00972.x; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Ishiguro T, 2000, ONCOL RES, V12, P343, DOI 10.3727/096504001108747792; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Kim J, 2009, ENDOCRINOLOGY, V150, P3576, DOI 10.1210/en.2008-1782; Konig JE, 2004, PROSTATE, V58, P121, DOI 10.1002/pros.10317; Kramer G, 2006, CURR OPIN UROL, V16, P25; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Marcovecchio M, 2005, J ENDOCRINOL INVEST, V28, P853, DOI 10.1007/BF03347581; Morote J, 2000, EUR UROL, V37, P537, DOI 10.1159/000020190; Mostaghel EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030062; Moyad MA, 2008, AM J MED, V121, pS34, DOI 10.1016/j.amjmed.2008.05.025; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Nickel JC, 2005, BJU INT, V95, P571, DOI 10.1111/j.1464-410X.2005.05341.x; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Parsons JK, 2008, BJU INT, V101, P313, DOI 10.1111/j.1464-410X.2007.07332.x; Pelton K, 2010, J UROLOGY, V184, P1555, DOI 10.1016/j.juro.2010.05.083; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Penna G, 2009, J IMMUNOL, V182, P4056, DOI 10.4049/jimmunol.0801875; Platz EA, 2008, INT J CANCER, V123, P1693, DOI 10.1002/ijc.23715; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Saslowsky DE, 2003, J MEMBRANE BIOL, V194, P153, DOI 10.1007/s00232-003-2035-7; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Wang J, 2003, J BIOL CHEM, V278, P32899, DOI 10.1074/jbc.M305456200; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Zhuang LY, 2005, J CLIN INVEST, V115, P959	56	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39448	10.1371/journal.pone.0039448	http://dx.doi.org/10.1371/journal.pone.0039448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768301	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500014
J	Aguilar, LF; Pino, JA; Soto-Arriaza, MA; Cuevas, FJ; Sanchez, S; Sotomayor, CP				Aguilar, Luis F.; Pino, Jose A.; Soto-Arriaza, Marco A.; Cuevas, Francisco J.; Sanchez, Susana; Sotomayor, Carlos P.			Differential Dynamic and Structural Behavior of Lipid-Cholesterol Domains in Model Membranes	PLOS ONE			English	Article							GIANT UNILAMELLAR VESICLES; SPIN-LABELED LIPIDS; WATER-PENETRATION; FLUORESCENCE; PHASE; POLARIZATION; MICROSCOPY; PRESSURE; BILAYERS; RAFTS	Changes in the cholesterol (Chol) content of biological membranes are known to alter the physicochemical properties of the lipid lamella and consequently the function of membrane-associated enzymes. To characterize these changes, we used steady-state and time resolved fluorescence spectroscopy and two photon-excitation microscopy techniques. The membrane systems were chosen according to the techniques that were used: large unilamellar vesicles (LUVs) for cuvette and giant unilamellar vesicles (GUVs) for microscopy measurements; they were prepared from dipalmitoyl phosphatidylcholine (DPPC) and dioctadecyl phosphatidylcholine (DOPC) in mixtures that are well known to form lipid domains. Two fluorescent probes, which insert into different regions of the bilayer, were selected: 1,6-diphenyl-1,3,5-hexatriene (DPH) was located at the deep hydrophobic core of the acyl chain regions and 2-dimethylamino-6-lauroylnaphthalene (Laurdan) at the hydrophilic-hydrophobic membrane interface. Our spectroscopy results show that (i) the changes induced by cholesterol in the deep hydrophobic phospholipid acyl chain domain are different from the ones observed in the superficial region of the hydrophilic-hydrophobic interface, and these changes depend on the state of the lamella and (ii) the incorporation of cholesterol into the lamella induces an increase in the orientation dynamics in the deep region of the phospholipid acyl chains with a corresponding decrease in the orientation at the region close to the polar lipid headgroups. The microscopy data from DOPC/DPPC/Chol GUVs using Laurdan generalized polarization (Laurdan GP) suggest that a high cholesterol content in the bilayer weakens the stability of the water hydrogen bond network and hence the stability of the liquid-ordered phase (Lo).	[Aguilar, Luis F.; Pino, Jose A.; Sotomayor, Carlos P.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Soto-Arriaza, Marco A.] Pontificia Univ Catolica Chile, Fac Quim, Santiago, Chile; [Cuevas, Francisco J.] Univ Santo Tomas, Dept Ciencias Basicas, Vina Del Mar, Chile; [Sanchez, Susana] Natl Ctr Cardiovasc Res CNIC, Microscopy & Dynam Imaging Unit, Madrid, Spain; [Sanchez, Susana] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA USA	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Chile; Universidad Santo Tomas; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of California System; University of California Irvine	Aguilar, LF (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	luis.aguilar@ucv.cl	Cuevas, Francisco/AAE-2898-2021; Sánchez, Susana/HII-3113-2022; Pino, José/AAF-4359-2021; Soto-Arriaza, Marco/J-8918-2017	Pino, José/0000-0002-1542-0660; Aguilar, Luis/0000-0002-6038-3475; Cuevas, Francisco/0000-0002-0863-4652; Soto-Arriaza, Marco/0000-0003-4502-6960	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile [1070320]	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile, grant no 1070320. Also acknowledged are Vicerrectoria de Investigacion y Estudios Avanzados and Direccion de Investigacion, Pontificia Universidad Catolica de Valparaiso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Barenholz Y, 2002, PROG LIPID RES, V41, P1, DOI 10.1016/S0163-7827(01)00016-9; Bartucci R, 2006, CHEM PHYS LIPIDS, V141, P142, DOI 10.1016/j.chemphyslip.2006.02.009; Bernsdorff C, 1995, BER BUNSEN PHYS CHEM, V99, P1479, DOI 10.1002/bbpc.199500112; Bernsdorff C, 1997, BIOPHYS J, V72, P1264, DOI 10.1016/S0006-3495(97)78773-3; Bhattacharya S, 2000, BBA-BIOMEMBRANES, V1467, P39, DOI 10.1016/S0005-2736(00)00196-6; Chong PLG, 2009, BBA-BIOMEMBRANES, V1788, P2, DOI 10.1016/j.bbamem.2008.10.010; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Erilov DA, 2004, BIOPHYS J, V87, P3873, DOI 10.1529/biophysj.104.046631; GRATTON E, 1984, ANNU REV BIOPHYS BIO, V13, P105; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; HO C, 1992, BIOPHYS J, V63, P897, DOI 10.1016/S0006-3495(92)81671-5; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; Isaev NP, 2010, APPL MAGN RESON, V37, P405, DOI 10.1007/s00723-009-0096-1; KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LENTZ BR, 1980, BIOCHEMISTRY-US, V19, P1943, DOI 10.1021/bi00550a034; LEVI M, 1990, J CLIN INVEST, V85, P231, DOI 10.1172/JCI114417; Marsh D, 2002, EUR BIOPHYS J BIOPHY, V31, P559, DOI 10.1007/s00249-002-0245-z; Martinez-Cabrera H. I., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/journal.pone.0011162]; MCELHANEY RN, 1982, CHEM PHYS LIPIDS, V30, P229, DOI 10.1016/0009-3084(82)90053-6; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Nielsen M, 1999, PHYS REV E, V59, P5790, DOI 10.1103/PhysRevE.59.5790; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Pasenkiewicz-Gierula M, 2000, BIOPHYS J, V78, P1376, DOI 10.1016/S0006-3495(00)76691-4; PASENKIEWICZGIERULA M, 1990, BIOCHEMISTRY-US, V29, P4059, DOI 10.1021/bi00469a006; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; ROBINSON AJ, 1995, BIOPHYS J, V68, P164, DOI 10.1016/S0006-3495(95)80171-2; Sanchez S.A., 2007, APPL PHYS CHEM SCI, P1007; Sanchez SA, 2002, BIOPHYS J, V82, P2232, DOI 10.1016/S0006-3495(02)75569-0; Sanchez SA, 2007, J LIPID RES, V48, P1689, DOI 10.1194/jlr.M600457-JLR200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPENCER RD, 1969, ANN NY ACAD SCI, V158, P361, DOI 10.1111/j.1749-6632.1969.tb56231.x; Tu KC, 1998, BIOPHYS J, V75, P2147, DOI 10.1016/S0006-3495(98)77657-X; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; ZANNONI C, 1983, CHEM PHYS LIPIDS, V32, P179, DOI 10.1016/0009-3084(83)90037-3	45	39	39	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40254	10.1371/journal.pone.0040254	http://dx.doi.org/10.1371/journal.pone.0040254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768264	Green Published, gold			2022-12-25	WOS:000305892100238
J	Ammosova, T; Platonov, M; Yedavalli, VRK; Obukhov, Y; Gordeuk, VR; Jeang, KT; Kovalskyy, D; Nekhai, S				Ammosova, Tatiana; Platonov, Maxim; Yedavalli, Venkat R. K.; Obukhov, Yuri; Gordeuk, Victor R.; Jeang, Kuan-Teh; Kovalskyy, Dmytro; Nekhai, Sergei			Small Molecules Targeted to a Non-Catalytic "RVxF" Binding Site of Protein Phosphatase-1 Inhibit HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; P-TEFB; DEPENDENT TRANSACTIVATION; TAT; TRANSCRIPTION; TYPE-1; PHOSPHORYLATION; ACTIVATION; MACHINERY; COMPLEX	HIV-1 Tat protein recruits host cell factors including CDK9/cyclin T1 to HIV-1 TAR RNA and thereby induces HIV-1 transcription. An interaction with host Ser/Thr protein phosphatase-1 (PP1) is critical for this function of Tat. PP1 binds to a Tat sequence, Q(35)VCF(38), which resembles the PP1-binding "RVxF" motif present on PP1-binding regulatory subunits. We showed that expression of PP1 binding peptide, a central domain of Nuclear Inhibitor of PP1, disrupted the interaction of HIV-1 Tat with PP1 and inhibited HIV-1 transcription and replication. Here, we report small molecule compounds that target the "RVxF"-binding cavity of PP1 to disrupt the interaction of PP1 with Tat and inhibit HIV-1 replication. Using the crystal structure of PP1, we virtually screened 300,000 compounds and identified 262 small molecules that were predicted to bind the "RVxF"-accommodating cavity of PP1. These compounds were then assayed for inhibition of HIV-1 transcription in CEM T cells. One of the compounds, 1H4, inhibited HIV-1 transcription and replication at non-cytotoxic concentrations. 1H4 prevented PP1-mediated dephosphorylation of a substrate peptide containing an RVxF sequence in vitro. 1H4 also disrupted the association of PP1 with Tat in cultured cells without having an effect on the interaction of PP1 with the cellular regulators, NIPP1 and PNUTS, or on the cellular proteome. Finally, 1H4 prevented the translocation of PP1 to the nucleus. Taken together, our study shows that HIV-inhibition can be achieved through using small molecules to target a non-catalytic site of PP1. This proof-of-principle study can serve as a starting point for the development of novel antiviral drugs that target the interface of HIV-1 viral proteins with their host partners.	[Ammosova, Tatiana; Gordeuk, Victor R.; Nekhai, Sergei] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Ammosova, Tatiana; Obukhov, Yuri; Nekhai, Sergei] Howard Univ, RCMI Prote Core Facil, Washington, DC 20059 USA; [Ammosova, Tatiana; Nekhai, Sergei] Howard Univ, Dept Med, Washington, DC 20059 USA; [Platonov, Maxim; Kovalskyy, Dmytro] Natl Taras Shevchenko Univ, ChemBio Ctr, Kiev, Ukraine; [Platonov, Maxim; Kovalskyy, Dmytro] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Yedavalli, Venkat R. K.; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Gordeuk, Victor R.] Univ Illinois, Sickle Cell Ctr, Chicago, IL USA	Howard University; Howard University; Howard University; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ammosova, T (corresponding author), Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA.	snekhai@howard.edu	Ammosova, Tatiana/HIA-0704-2022; Gordeuk, Victor/AAG-6577-2019; Platonov, Maxim/D-3238-2015; , nekhai/AFO-2652-2022; Ammosova, Tatiana/J-7564-2018; , nekhai/AAW-3105-2021	Platonov, Maxim/0000-0002-3205-3305; Ammosova, Tatiana/0000-0001-8777-1032; 	Civilian Research and Development Foundation [UKB2-2927-KV-07]; National Institutes of Health (NIH) [2 R25 HL003679-08]; Office of Research on Minority Health [2MO1 RR10284, 1SC1GM082325-01, K25GM097501]; Howard University; RCMI-NIH from the Research Centers in Minority Institutions (RCMI) Program (Division of Research Infrastructure, National Center for Research Resources, NIH) [RCMI-NIH 2G12RR003048]; National Heart, Lung, and Blood Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010284, G12RR003048] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM082325, K25GM097501] Funding Source: NIH RePORTER	Civilian Research and Development Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Howard University; RCMI-NIH from the Research Centers in Minority Institutions (RCMI) Program (Division of Research Infrastructure, National Center for Research Resources, NIH); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Civilian Research and Development Foundation [Grant UKB2-2927-KV-07] (to SN and DK), National Institutes of Health (NIH) Research grants [Grant 2 R25 HL003679-08] (to VRG) funded by the National Heart, Lung, and Blood Institute and The Office of Research on Minority Health [Grant 2MO1 RR10284] (to VRG), [Grant 1SC1GM082325-01] (to SN); [Grant K25GM097501] (to YO); by Howard University Seed Grant (to SN) and RCMI-NIH grant [Grant RCMI-NIH 2G12RR003048] (to SN) from the Research Centers in Minority Institutions (RCMI) Program (Division of Research Infrastructure, National Center for Research Resources, NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2005, VIROLOGY, V341, P171, DOI 10.1016/j.virol.2005.06.041; Ammosova T, 2003, J BIOL CHEM, V278, P32189, DOI 10.1074/jbc.M300521200; Ammosova Tatiana, 2011, PLoS One, V6, pe18985, DOI 10.1371/journal.pone.0018985; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; He MZ, 2005, BIOORG MED CHEM LETT, V15, P3978, DOI 10.1016/j.bmcl.2005.01.068; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Huang C C, 1998, Pac Symp Biocomput, P349; Iguchi Takashi, 2005, Nucleic Acids Symp Ser (Oxf), P169; Ivanova G, 2007, OLIGONUCLEOTIDES, V17, P54, DOI 10.1089/oli.2006.0046; Jerebtsova M, 2011, MOL CELL BIOCHEM, V347, P79, DOI 10.1007/s11010-010-0614-3; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Massari S, 2010, J MED CHEM, V53, P641, DOI 10.1021/jm901211d; McMartin C, 1997, J COMPUT AID MOL DES, V11, P333, DOI 10.1023/A:1007907728892; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nekhai S, 2007, ONCOGENE, V26, P3899, DOI 10.1038/sj.onc.1210158; Nekhai S, 2009, HUMAN IMMUNODEFICIEN; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Okamoto H, 2000, VIROLOGY, V272, P402, DOI 10.1006/viro.2000.0396; Pan CF, 2007, J MED CHEM, V50, P2285, DOI 10.1021/jm070014g; Parolin C, 2003, ANTIMICROB AGENTS CH, V47, P889, DOI 10.1128/AAC.47.3.889-896.2003; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Richter S, 2004, ANTIMICROB AGENTS CH, V48, P1895, DOI 10.1128/AAC.48.5.1895-1899.2004; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Stevens M, 2007, VIROLOGY, V365, P220, DOI 10.1016/j.virol.2007.03.036; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Woldehawariat G, 1999, MOL CELL BIOCHEM, V198, P7, DOI 10.1023/A:1006978622240; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yuan DK, 2007, BIOORGAN MED CHEM, V15, P265, DOI 10.1016/j.bmc.2006.09.062; Zeng L, 2005, J AM CHEM SOC, V127, P2376, DOI 10.1021/ja044885g; Zhang Y, 2008, PEPTIDES, V29, P465, DOI 10.1016/j.peptides.2007.07.015	46	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39481	10.1371/journal.pone.0039481	http://dx.doi.org/10.1371/journal.pone.0039481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768081	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100052
J	Bagamian, KH; Douglass, RJ; Alvarado, A; Kuenzi, AJ; Amman, BR; Waller, LA; Mills, JN				Bagamian, Karoun H.; Douglass, Richard J.; Alvarado, Arlene; Kuenzi, Amy J.; Amman, Brian R.; Waller, Lance A.; Mills, James N.			Population Density and Seasonality Effects on Sin Nombre Virus Transmission in North American Deermice (Peromyscus maniculatus) in Outdoor Enclosures	PLOS ONE			English	Article							CREEK CANAL VIRUS; PUUMALA-HANTAVIRUS; TEMPORAL DYNAMICS; BANK VOLES; CLETHRIONOMYS-GLAREOLUS; NEPHROPATHIA-EPIDEMICA; DEPENDENT PREVALENCE; INFECTIOUS-DISEASES; ANTIBODY PREVALENCE; HEMORRHAGIC-FEVER	Surveys of wildlife host-pathogen systems often document clear seasonal variation in transmission; conclusions concerning the relationship between host population density and transmission vary. In the field, effects of seasonality and population density on natural disease cycles are challenging to measure independently, but laboratory experiments may poorly reflect what happens in nature. Outdoor manipulative experiments are an alternative that controls for some variables in a relatively natural environment. Using outdoor enclosures, we tested effects of North American deermouse (Peromyscus maniculatus) population density and season on transmission dynamics of Sin Nombre hantavirus. In early summer, mid-summer, late summer, and fall 2007-2008, predetermined numbers of infected and uninfected adult wild deermice were released into enclosures and trapped weekly or bi-weekly. We documented 18 transmission events and observed significant seasonal effects on transmission, wounding frequency, and host breeding condition. Apparent differences in transmission incidence or wounding frequency between high-and low-density treatments were not statistically significant. However, high host density was associated with a lower proportion of males with scrotal testes. Seasonality may have a stronger influence on disease transmission dynamics than host population density, and density effects cannot be considered independent of seasonality.	[Bagamian, Karoun H.; Mills, James N.] Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA; [Bagamian, Karoun H.; Amman, Brian R.; Mills, James N.] US Ctr Dis Control & Prevent, Med Ecol Unit, Viral Special Pathogens Branch, Atlanta, GA USA; [Bagamian, Karoun H.; Douglass, Richard J.; Kuenzi, Amy J.] Univ Montana, Montana Tech, Dept Biol, Butte, MT USA; [Alvarado, Arlene] Univ Montana, Montana Tech, Inst Educ Opportun, Cfwep Org, Butte, MT USA; [Waller, Lance A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University; Centers for Disease Control & Prevention - USA; University of Montana System; Montana Technological University; University of Montana; University of Montana System; Montana Technological University; University of Montana; Emory University; Rollins School Public Health	Bagamian, KH (corresponding author), Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA.	karoun11@gmail.com	Waller, Lance A./AAA-1012-2021		NIH-CDC [R-36]; NIH from the INBRE-BRIN program of the National Center for Research Resources [P20RR16455-06, P20RR16455-07]; CDC Medical Ecology Unit; Viral Special Pathogens Branch; Montana Tech, University of Montana; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015525] Funding Source: NIH RePORTER	NIH-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institutes of Health (NIH) - USA); NIH from the INBRE-BRIN program of the National Center for Research Resources; CDC Medical Ecology Unit; Viral Special Pathogens Branch; Montana Tech, University of Montana; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was funded by the NIH-CDC Public Health Dissertation Research Grant R-36, NIH Grant P20RR16455-06,07 from the INBRE-BRIN program of the National Center for Research Resources, CDC Medical Ecology Unit, Viral Special Pathogens Branch, and Montana Tech, University of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2008, B MATH BIOL, V70, P236, DOI 10.1007/s11538-007-9251-8; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Begon M, 2009, P ROY SOC B-BIOL SCI, V276, P1603, DOI 10.1098/rspb.2008.1732; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; Botten J, 2002, J VIROL, V76, P7587, DOI 10.1128/JVI.76.15.7587-7594.2002; Burthe S, 2006, J ANIM ECOL, V75, P1416, DOI 10.1111/j.1365-2656.2006.01166.x; Calisher CH, 2007, J WILDLIFE DIS, V43, P1, DOI 10.7589/0090-3558-43.1.1; Cantoni G, 2001, TROP MED INT HEALTH, V6, P811, DOI 10.1046/j.1365-3156.2001.00788.x; Carver S, 2011, J WILDLIFE DIS, V47, P56, DOI 10.7589/0090-3558-47.1.56; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; CHRISTIAN J, 1961, P NATL ACAD SCI USA, V47, P428, DOI 10.1073/pnas.47.4.428; Clay CA, 2009, P R SOC B, V276, P1305, DOI 10.1098/rspb.2008.1693; Dearing MD, 2009, J WILDLIFE DIS, V45, P430, DOI 10.7589/0090-3558-45.2.430; Dobson A., 1995, ECOLOGY INFECT DIS N; Douglass RJ, 2007, J WILDLIFE DIS, V43, P12, DOI 10.7589/0090-3558-43.1.12; Douglass RJ, 2001, AM J TROP MED HYG, V65, P33, DOI 10.4269/ajtmh.2001.65.33; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; FELDMANN H, 1993, VIRUS RES, V30, P351, DOI 10.1016/0168-1702(93)90101-R; Fichet-Calvet E, 2007, VECTOR-BORNE ZOONOT, V7, P119, DOI 10.1089/vbz.2006.0520; Fuller CA, 1996, ECOLOGY, V77, P2196, DOI 10.2307/2265712; GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hardestam J, 2008, EMERG INFECT DIS, V14, P1209, DOI 10.3201/eid1408.080221; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hutchinson KL, 2000, J MED VIROL, V60, P70, DOI 10.1002/(SICI)1096-9071(200001)60:1<70::AID-JMV12>3.0.CO;2-1; Hutchinson KL, 1998, AM J TROP MED HYG, V59, P58, DOI 10.4269/ajtmh.1998.59.58; Kallio ER, 2006, J GEN VIROL, V87, P2127, DOI 10.1099/vir.0.81643-0; KAUFMAN GA, 1989, J MAMMAL, V70, P656, DOI 10.2307/1381445; Kuenzi AJ, 2005, J WILDLIFE DIS, V41, P473, DOI 10.7589/0090-3558-41.3.473; Kuenzi AJ, 2001, AM J TROP MED HYG, V64, P137, DOI 10.4269/ajtmh.2001.64.137; LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106; Lonner BN, 2008, VECTOR-BORNE ZOONOT, V8, P433, DOI 10.1089/vbz.2007.0232; Madhav NK, 2007, VECTOR-BORNE ZOONOT, V7, P353, DOI 10.1089/vbz.2006.0605; Millar J.S., 1989, P169; Mills J.N., 1995, METHODS TRAPPING SAM, P61; Mills JN, 2010, VECTOR-BORNE ZOONOT, V10, P563, DOI 10.1089/vbz.2009.0018; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; MILLS JN, 1992, AM J TROP MED HYG, V47, P749, DOI 10.4269/ajtmh.1992.47.749; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Pearce-Duvet JMC, 2006, J WILDLIFE DIS, V42, P819, DOI 10.7589/0090-3558-42.4.819; PETERS C. J., 2006, TROPICAL INFECT DIS, P762; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Schauber EM, 1997, ECOL APPL, V7, P143, DOI 10.1890/1051-0761(1997)007[0143:IEOSMI]2.0.CO;2; Schountz T, 2007, EMERG INFECT DIS, V13, P1604, DOI 10.3201/eid1310.070383; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Tagliapietra V, 2009, EMERG INFECT DIS, V15, P1019, DOI 10.3201/eid1507.081524; YANAGIHARA R, 1985, J VIROL, V55, P34, DOI 10.1128/JVI.55.1.34-38.1985; YIN Z, 1995, FISH SHELLFISH IMMUN, V5, P519, DOI 10.1016/S1050-4648(95)80052-2	50	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37254	10.1371/journal.pone.0037254	http://dx.doi.org/10.1371/journal.pone.0037254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768034	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100005
J	Fu, SB; Yang, Y; Tirtha, D; Yen, Y; Zhou, BS; Zhou, MM; Ohlmeyer, M; Ko, EC; Cagan, R; Rosenstein, BS; Chen, SH; Kao, J				Fu, Shibo; Yang, Ying; Tirtha, Das; Yen, Yun; Zhou, Bing-sen; Zhou, Ming-Ming; Ohlmeyer, Michael; Ko, Eric C.; Cagan, Ross; Rosenstein, Barry S.; Chen, Shu-hsia; Kao, Johnny			gamma-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers	PLOS ONE			English	Article							HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE RESPONSE; TARGET; ACTIVATION; EFFICACY; ATM	Background: Persistence of gamma-H2AX after ionizing radiation (IR) or drug therapy is a robust reporter of unrepaired DNA double strand breaks in treated cells. Methods: DU-145 prostate cancer cells were treated with a chemical library +/- IR and assayed for persistence of gamma-H2AX using an automated 96-well immunocytochemistry assay at 4 hours after treatment. Hits that resulted in persistence of gamma-H2AX foci were tested for effects on cell survival. The molecular targets of hits were validated by molecular, genetic and biochemical assays and in vivo activity was tested in a validated Drosophila cancer model. Results: We identified 2 compounds, MS0019266 and MS0017509, which markedly increased persistence of gamma-H2AX, apoptosis and radiosensitization in DU-145 cells. Chemical evaluation demonstrated that both compounds exhibited structurally similar and biochemical assays confirmed that these compounds inhibit ribonucleotide reductase. DNA microarray analysis and immunoblotting demonstrates that MS0019266 significantly decreased polo-like kinase 1 gene and protein expression. MS0019266 demonstrated in vivo antitumor activity without significant whole organism toxicity. Conclusions: MS0019266 and MS0017509 are promising compounds that may be candidates for further development as radiosensitizing compounds as inhibitors of ribonucleotide reductase.	[Fu, Shibo; Ko, Eric C.; Rosenstein, Barry S.; Kao, Johnny] Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA; [Fu, Shibo] Jilin Univ, Sch Publ Hlth, Dept Radiat Biol, Changchun 130023, Peoples R China; [Yang, Ying] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Tirtha, Das; Cagan, Ross] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA; [Yen, Yun; Zhou, Bing-sen] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Zhou, Ming-Ming; Ohlmeyer, Michael] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA; [Chen, Shu-hsia] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Kao, Johnny] Good Samaritan Hosp Med Ctr, Dept Radiat Oncol, W Islip, NY USA	Icahn School of Medicine at Mount Sinai; Jilin University; Columbia University; Icahn School of Medicine at Mount Sinai; City of Hope; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fu, SB (corresponding author), Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA.	Johnny.kao@chsli.org	Ko, Eric/AAB-7870-2019; Fu, Shi-bo/ABE-1277-2020; Cagan, Ross Leigh/AAV-9528-2021	Ko, Eric/0000-0003-2308-115X; Cagan, Ross/0000-0001-5297-450X	DOD [W81XWH-05-1-0199]; National Center for Minority Health and Health Disparities Scholar; Katz Foundation; William Harris Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA109322, R01CA127483] Funding Source: NIH RePORTER	DOD(United States Department of Defense); National Center for Minority Health and Health Disparities Scholar; Katz Foundation; William Harris Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by DOD grant W81XWH-05-1-0199, National Center for Minority Health and Health Disparities Scholar, Katz Foundation Award, and William Harris Research Fellowship to J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banath JP, 2003, CANCER RES, V63, P4347; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Connell PP, 2004, DNA REPAIR, V3, P1245, DOI 10.1016/j.dnarep.2004.04.004; CORY JG, 1994, ANTICANCER RES, V14, P875; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Easmon J, 1997, J MED CHEM, V40, P4420, DOI 10.1021/jm970255w; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gerster K, 2010, INT J RADIAT ONCOL, V77, P253, DOI 10.1016/j.ijrobp.2009.11.027; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hou YN, 2009, RADIAT RES, V171, P360, DOI 10.1667/RR1349.1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janzen WP, 2001, HIGH THROUGHPUT SCRE, pix; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kainkaryam RM, 2009, CURR OPIN DRUG DISC, V12, P339; Kao J, 2006, CURR CANCER DRUG TAR, V6, P197, DOI 10.2174/156800906776842957; Kao J, 2005, ANN NY ACAD SCI, V1066, P243, DOI 10.1196/annals.1363.012; Katz D, 2008, BIOTECHNIQUES, V44, pIX, DOI 10.2144/000112757; Katz D, 2009, INT J RADIAT ONCOL, V73, P988, DOI 10.1016/j.ijrobp.2008.12.002; Kunos CA, 2009, RADIAT RES, V172, P666, DOI 10.1667/RR1858.1; Lally BE, 2007, CANCER RES, V67, P8791, DOI 10.1158/0008-5472.CAN-07-0477; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sarkaria JN, 2001, SEMIN RADIAT ONCOL, V11, P316, DOI 10.1053/srao.2001.26030; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P86, DOI 10.1038/ncponc0714; Shiloh Y, 2004, NAT CELL BIOL, V6, P923, DOI 10.1038/ncb1004-923; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Stucki M, 2004, NAT CELL BIOL, V6, P1150, DOI 10.1038/ncb1204-1150; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Tannock IF, 1998, LANCET, V351, P9; Taylor DL, 2006, HIGH CONTENT SCREENI; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vidal M, 2005, CANCER RES, V65, P3538, DOI 10.1158/0008-5472.CAN-04-4561; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r	38	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38465	10.1371/journal.pone.0038465	http://dx.doi.org/10.1371/journal.pone.0038465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768044	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100015
J	Jensen, GS; Haswell, ES				Jensen, Gregory S.; Haswell, Elizabeth S.			Functional Analysis of Conserved Motifs in the Mechanosensitive Channel Homolog MscS-Like2 from Arabidopsis thaliana	PLOS ONE			English	Article							SENSITIVE ION-CHANNEL; ESCHERICHIA-COLI MSCS; HYPOOSMOTIC STRESS; BACILLUS-SUBTILIS; PATCH-CLAMP; IDENTIFICATION; MEMBRANE; TENSION; DOMAIN; ACTIVATION	The Mechanosensitive channel of Small conductance (MscS) of Escherichia coli has become an excellent model system for the structural, biophysical, and functional study of mechanosensitive ion channels. MscS, a complex channel with multiple states, contributes to protection against lysis upon osmotic downshock. MscS homologs are widely and abundantly dispersed among the bacterial and plant lineages, but are not found in animals. Investigation into the eukaryotic branch of the MscS family is in the beginning stages, and it remains unclear how much MscS homologs from eukaryotes resemble E. coli MscS with respect to structure, function, and regulation. Here we test the effect of mutating three conserved motifs on the function of MscS-Like (MSL) 2, a MscS homolog localized to the plastids of Arabidopsis thaliana. We show that 1) a motif at the top of the cytoplasmic domain, referred to here as the PN(X)(9)N motif, is essential for MSL2 function and for its proper intraplastidic localization; 2) substituting polar residues for two large hydrophobic residues located in the predicted pore-lining transmembrane helix of MSL2 produces a likely gain-of-function allele, as previously shown for MscS; and 3) mis-expression of this allele causes severe defects in leaf growth, loss of chloroplast integrity, and abnormal starch accumulation. Thus, two of the three conserved motifs we analyzed are critical for MSL2 function, consistent with the conservation of structure and function between MscS family members in bacteria and plants. These results underscore the importance of plastidic mechanosensitive channels in the maintenance of normal plastid and leaf morphology.	[Jensen, Gregory S.; Haswell, Elizabeth S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jensen, GS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	ehaswell@wustl.edu	Haswell, Elizabeth/AAE-9370-2021	Haswell, Elizabeth/0000-0002-4246-065X	National Science Foundation [MCB0816627]; National Institutes of Health [R01GM084211-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084211] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (MCB0816627) and the National Institutes of Health (R01GM084211-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Anishkin A, 2008, J GEN PHYSIOL, V132, P67, DOI 10.1085/jgp.200810000; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Bent A, 2006, METH MOL B, V343, P87; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; BERRIER C, 1989, FEBS LETT, V259, P27, DOI 10.1016/0014-5793(89)81486-3; Booth IR, 2011, BIOCHEM SOC T, V39, P733, DOI 10.1042/BST0390733; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Booth IR, 2007, MECHANOSENSITIVE I A; CUI C, 1995, J MEMBRANE BIOL, V144, P31; DELCOUR AH, 1989, J MEMBRANE BIOL, V112, P267, DOI 10.1007/BF01870957; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Folgering JHA, 2005, J BIOL CHEM, V280, P8784, DOI 10.1074/jbc.M411732200; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Haswell ES, 2007, MECHANOSENSITIVE I A; Hoffmann T, 2008, APPL ENVIRON MICROB, V74, P2454, DOI 10.1128/AEM.01573-07; Kloda A, 2001, BIOPHYS J, V80, P229, DOI 10.1016/S0006-3495(01)76009-2; Kloda Anna, 2002, Archaea, V1, P35, DOI 10.1155/2002/419261; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Koprowski P, 2001, BIOESSAYS, V23, P1148, DOI 10.1002/bies.10017; Koprowski P, 2011, J BIOL CHEM, V286, P877, DOI 10.1074/jbc.M110.176131; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li C, 2007, MOL MICROBIOL, V64, P560, DOI 10.1111/j.1365-2958.2007.05672.x; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Malcolm HR, 2012, BIOCHEM BIOPH RES CO, V417, P972, DOI 10.1016/j.bbrc.2011.12.049; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; McLaggan D, 2002, MOL MICROBIOL, V43, P521, DOI 10.1046/j.1365-2958.2002.02764.x; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Nottebrock D, 2003, FEMS MICROBIOL LETT, V218, P305, DOI 10.1111/j.1574-6968.2003.tb11533.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Osanai T, 2005, J BIOL CHEM, V280, P34684, DOI 10.1074/jbc.M507489200; Peyronnet R, 2008, PLANT SIGNAL BEHAV, V3, P726, DOI 10.4161/psb.3.9.6487; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Schumann U, 2004, FEBS LETT, V572, P233, DOI 10.1016/j.febslet.2004.07.045; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Steinbacker S, 2007, MECHANOSENSITIVE I A; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Veley KM, 2012, CURR BIOL, V22, P408, DOI 10.1016/j.cub.2012.01.027; Wahome PG, 2008, ARCH MICROBIOL, V189, P49, DOI 10.1007/s00203-007-0292-z; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Wilson M, 2012, PLANT SIGNAL BEHAV, V7; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Zhang M, 2009, CELL RES, V19, P877, DOI 10.1038/cr.2009.78	63	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40336	10.1371/journal.pone.0040336	http://dx.doi.org/10.1371/journal.pone.0040336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768278	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100252
J	Pilbrow, AP; Folkersen, L; Pearson, JF; Brown, CM; McNoe, L; Wang, NM; Sweet, WE; Tang, WHW; Black, MA; Troughton, RW; Richards, AM; Franco-Cereceda, A; Gabrielsen, A; Eriksson, P; Moravec, CS; Cameron, VA				Pilbrow, Anna P.; Folkersen, Lasse; Pearson, John F.; Brown, Chris M.; McNoe, Les; Wang, Nancy M.; Sweet, Wendy E.; Tang, W. H. Wilson; Black, Michael A.; Troughton, Richard W.; Richards, A. Mark; Franco-Cereceda, Anders; Gabrielsen, Anders; Eriksson, Per; Moravec, Christine S.; Cameron, Vicky A.			The Chromosome 9p21.3 Coronary Heart Disease Risk Allele Is Associated with Altered Gene Expression in Normal Heart and Vascular Tissues	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ARTERY-DISEASE; 4 SNPS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; SUSCEPTIBILITY LOCI; COMMON VARIANT; NONCODING RNA	Genome-wide association studies have identified a coronary artery disease (CAD) risk locus in a non-coding region at 9p21.3, the nearest genes being CDKN2A and CDKN2B. To understand the pathways by which this locus might influence CAD susceptibility, we investigated associations between the 9p21.3 risk genotype and global gene expression in heart tissue from donors with no diagnosed heart disease (n = 108, predominant cause of death, cerebral vascular accident) and in carotid plaque (n = 106), aorta (n = 104) and mammary artery (n = 88) tissues from heart valve and carotid endarterectomy patients. Genotyping was performed with Taqman assays and Illumina arrays, and gene expression profiles generated with Affymetrix microarrays. Associations were analyzed with an additive genetic model. In heart tissue, 46 genes were putatively altered in association with the 9p21.3 risk allele (70% down-regulated, fold-change >1.1 per allele, p<0.05 adjusted for age, gender, ethnicity, cause of death). These genes were enriched for biomarkers of myocardial infarction (p = 1.53x10(-9)), response to wounding (p = 2.65x10(-10)) and inflammatory processes (p<1.97x10(-7)). Among the top 10 most down-regulated genes, 7 genes shared a set of transcription factor binding sites within conserved promoter regions (p<1.14x10(-5)), suggesting they may be co-regulated. Canonical pathway modelling of the most differentially expressed transcripts across all tissues (154 genes, 60% down-regulated, fold-change > 1.1 per allele, p < 0.01) showed that 75% of the genes could be transcriptionally regulated through the cell cycle G1 phase progression pathway (p < 1.08x10(-258)), in which CDKN2A and CDKN2B play a regulatory role. These data suggest that the cell cycle G1 phase progression pathway is activated in individuals with the 9p21.3 risk allele. This may contribute to a proliferative phenotype that promotes adverse cardiac hypertrophy and vascular remodeling, leading to an increased CAD risk.	[Pilbrow, Anna P.; Troughton, Richard W.; Richards, A. Mark; Cameron, Vicky A.] Univ Otago, Christchurch Cardioendocrine Res Grp, Dept Med, Christchurch, New Zealand; [Folkersen, Lasse; Gabrielsen, Anders; Eriksson, Per] Karolinska Inst, Dept Med, Stockholm, Sweden; [Pearson, John F.] Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; [Brown, Chris M.; McNoe, Les; Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Sweet, Wendy E.; Tang, W. H. Wilson; Moravec, Christine S.] Cleveland Clin, Dept Cardiovasc Med, Kaufman Ctr Heart Failure, Cleveland, OH 44106 USA; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Otago; Karolinska Institutet; University of Otago; University of Otago; Cleveland Clinic Foundation; Karolinska Institutet	Pilbrow, AP (corresponding author), Univ Otago, Christchurch Cardioendocrine Res Grp, Dept Med, Christchurch, New Zealand.	anna.pilbrow@otago.ac.nz	Pearson, John F/D-7428-2012; Pilbrow, Anna P/B-9969-2011; Cameron, Vicky A/L-4046-2019; Black, Michael/F-1484-2010; Tang, Wai Hong Wilson/I-1238-2013	Pearson, John F/0000-0001-5607-4517; Pilbrow, Anna P/0000-0003-1949-9449; Folkersen, Lasse/0000-0003-0708-9530; Brown, Chris M/0000-0003-0079-7067; Cameron, Vicky/0000-0003-3147-683X; Tang, W. H. Wilson/0000-0002-8335-735X; Troughton, Richard/0000-0001-7484-4036; Eriksson, Per/0000-0002-5635-2692; Black, Michael/0000-0003-1174-6054	Cleveland Clinic Foundation; Heart Foundation of New Zealand; Ministry of Science and Innovation; Health Research Council of New Zealand; Maurice and Phyllis Paykel Trust; Lotteries Health New Zealand; Swedish Research Council; Swedish Heart-Lung Foundation; European Commission; Danish Agency for Science, Technology and Innovation	Cleveland Clinic Foundation; Heart Foundation of New Zealand; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Health Research Council of New Zealand(Health Research Council of New Zealand); Maurice and Phyllis Paykel Trust; Lotteries Health New Zealand; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Agency for Science, Technology and Innovation	This work was funded by the Cleveland Clinic Foundation (www.clevelandclinic.org), the Heart Foundation of New Zealand (www.heartfoundation.org.nz), the New Zealand Foundation of Research, Science and Technology (now the Ministry of Science and Innovation, www.msi.govt.nz), the Health Research Council of New Zealand (www.hrc.govt.nz), the Maurice and Phyllis Paykel Trust (www.paykeltrust.co.nz), Lotteries Health New Zealand (www.dia.govt.nz/Services-Lottery-Grants-Health-Research), the Swedish Research Council (www.vr.se), the Swedish Heart-Lung Foundation (www.hjart-lungfonden.se), the European Commission (www.ec.europa.eu), the Danish Agency for Science, Technology and Innovation (en.fi.dk) and a donation by Fredrik Lundberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Almontashiri N, 2011, AM HEART ASS SCI SES; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen JY, 2007, CLIN CANCER RES, V13, P3100, DOI 10.1158/1078-0432.CCR-06-2319; Chen M, 2002, CIRCULATION, V106, P2707, DOI 10.1161/01.CIR.0000038706.30661.86; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Debniak T, 2005, J MED GENET, V42, P763, DOI 10.1136/jmg.2005.031476; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Driver KE, 2008, CARCINOGENESIS, V29, P333, DOI 10.1093/carcin/bgm284; Ellmers LJ, 2007, J MOL ENDOCRINOL, V38, P245, DOI 10.1677/jme.1.02138; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isumi Y, 2011, BIOCHEM BIOPH RES CO, V405, P216, DOI 10.1016/j.bbrc.2011.01.012; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kumar R, 2001, INT J CANCER, V95, P388, DOI 10.1002/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-449; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39574	10.1371/journal.pone.0039574	http://dx.doi.org/10.1371/journal.pone.0039574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768093	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100063
J	Song, JP; Sun, RJ; Li, DZ; Tan, FJ; Li, X; Jiang, PP; Huang, XJ; Lin, L; Deng, ZI; Zhang, Y				Song, Jiaping; Sun, Renjie; Li, Dazhi; Tan, Fengji; Li, Xin; Jiang, Pingping; Huang, Xinjie; Lin, Liang; Deng, Ziniu; Zhang, Yong			An Improvement of Shotgun Proteomics Analysis by Adding Next-Generation Sequencing Transcriptome Data in Orange	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; MAP	Background: Shotgun proteomics data analysis usually relies on database search. Because commonly employed protein sequence databases of most species do not contain sufficient protein information, the application of shotgun proteomics to the research of protein sequence profile remains a big challenge, especially to the species whose genome has not been sequenced yet. Methodology/Principal Findings: In this paper, we present a workflow with integrated database to partly address this problem. First, we downloaded the homologous species database. Next, we identified the transcriptome of the sample, created a protein sequence database based on the transcriptome data, and integtrated it with homologous species database. Lastly, we developed a workflow for identifying peptides simultaneously from shotgun proteomics data. Conclusions/Significance: We used datasets from orange leaves samples to demonstrate our workflow. The results showed that the integrated database had great advantage on orange shotgun proteomics data analysis compared to the homologous species database, an 18.5% increase in number of proteins identification.	[Song, Jiaping; Sun, Renjie; Tan, Fengji; Li, Xin; Jiang, Pingping; Huang, Xinjie; Lin, Liang; Zhang, Yong] BGI Shenzhen, Shenzhen Proteome Engn Lab, Shenzhen, Peoples R China; [Li, Dazhi; Deng, Ziniu] Hunan Agr Univ, Natl Ctr Citrus Improvement, Changsha, Hunan, Peoples R China	Beijing Genomics Institute (BGI); Hunan Agricultural University	Song, JP (corresponding author), BGI Shenzhen, Shenzhen Proteome Engn Lab, Shenzhen, Peoples R China.	zhangy@genomics.org.cn						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brechenmacher L, 2009, PLANT PHYSIOL, V149, P670, DOI 10.1104/pp.108.131649; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Hughes MA, 2006, J PROTEOME RES, V5, P54, DOI 10.1021/pr050248t; Katz E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-68; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Ma W, 2010, J PROTEOME RES, V9, P2968, DOI 10.1021/pr901168v; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shen Z, 2009, MOL CELL PROTEOMICS, V8, P2443, DOI 10.1074/mcp.M900187-MCP200; Sigdel TK, 2010, PROTEOM CLIN APPL, V4, P32, DOI 10.1002/prca.200900124; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	19	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39494	10.1371/journal.pone.0039494	http://dx.doi.org/10.1371/journal.pone.0039494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768084	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100055
J	Wood, JR; Wilmshurst, JM; Wagstaff, SJ; Worthy, TH; Rawlence, NJ; Cooper, A				Wood, Jamie R.; Wilmshurst, Janet M.; Wagstaff, Steven J.; Worthy, Trevor H.; Rawlence, Nicolas J.; Cooper, Alan			High-Resolution Coproecology: Using Coprolites to Reconstruct the Habits and Habitats of New Zealand's Extinct Upland Moa (Megalapteryx didinus)	PLOS ONE			English	Article							CLOVIS HUMAN COPROLITES; ANCIENT DNA; SOUTH ISLAND; HOLOCENE VEGETATION; POLLEN CONTENT; DIET; ECOLOGY; CLIMATE; RATITE; AVES	Knowledge about the diet and ecology of extinct herbivores has important implications for understanding the evolution of plant defence structures, establishing the influences of herbivory on past plant community structure and composition, and identifying pollination and seed dispersal syndromes. The flightless ratite moa (Aves: Dinornithiformes) were New Zealand's largest herbivores prior to their extinction soon after initial human settlement. Here we contribute to the knowledge of moa diet and ecology by reporting the results of a multidisciplinary study of 35 coprolites from a subalpine cave (Euphrates Cave) on the South Island of New Zealand. Ancient DNA analysis and radiocarbon dating revealed the coprolites were deposited by the extinct upland moa (Megalapteryx didinus), and span from at least 6,368 +/- 31 until 694 +/- 30 C-14 years BP; the approximate time of their extinction. Using pollen, plant macrofossil, and ancient DNA analyses, we identified at least 67 plant taxa from the coprolites, including the first evidence that moa fed on the nectar-rich flowers of New Zealand flax (Phormium) and tree fuchsia (Fuchsia excorticata). The plant assemblage from the coprolites reflects a highly-generalist feeding ecology for upland moa, including browsing and grazing across the full range of locally available habitats (spanning southern beech (Nothofagus) forest to tussock (Chionochloa) grassland). Intact seeds in the coprolites indicate that upland moa may have been important dispersal agents for several plant taxa. Plant taxa with putative anti-browse adaptations were also identified in the coprolites. Clusters of coprolites (based on pollen assemblages, moa haplotypes, and radiocarbon dates), probably reflect specimens deposited at the same time by individual birds, and reveal the necessity of suitably large sample sizes in coprolite studies to overcome potential biases in diet interpretation.	[Wood, Jamie R.; Wilmshurst, Janet M.; Wagstaff, Steven J.] Landcare Res, Canterbury, New Zealand; [Worthy, Trevor H.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Rawlence, Nicolas J.; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia	Landcare Research - New Zealand; University of New South Wales Sydney; University of Adelaide	Wood, JR (corresponding author), Landcare Res, Canterbury, New Zealand.	woodj@landcareresearch.co.nz	Wood, Jamie/A-9393-2008; Wilmshurst, Janet/O-8611-2019; Cooper, Alan/E-8171-2012; Wagstaff, Steven J./E-3847-2014; Wilmshurst, Janet M/C-2209-2009; Wood, Jamie/AAU-5530-2021; Worthy, Trevor/B-3781-2012	Wood, Jamie/0000-0001-8008-6083; Wilmshurst, Janet/0000-0002-4474-8569; Cooper, Alan/0000-0002-7738-7851; Wagstaff, Steven J./0000-0002-9066-8869; Wilmshurst, Janet M/0000-0002-4474-8569; Worthy, Trevor/0000-0001-7047-4680	Royal Society of New Zealand [08-LCR-012]	Royal Society of New Zealand(Royal Society of New Zealand)	This research was funded by the Royal Society of New Zealand Marsden Fund (08-LCR-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2012, ANN ANAT, V194, P36, DOI 10.1016/j.aanat.2011.04.002; Alloway BV, 2007, J QUATERNARY SCI, V22, P9, DOI 10.1002/jqs.1079; Antonelli A., 2010, P ROYAL SOC B, V278, P662; ATKINSON IAE, 1989, NEW ZEAL J ECOL, V12, P67; Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; BATCHELER CL, 1989, NEW ZEAL J ECOL, V12, P57; Bengtsson L, 1986, HDB HOLOCENE PALAEOE, P423; Bjune AE, 2005, GRANA, V44, P45, DOI 10.1080/00173130410005564; Bond WJ, 2004, OIKOS, V104, P500, DOI 10.1111/j.0030-1299.2004.12720.x; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; BURROWS C J, 1981, Records of the Canterbury Museum, V9, P309; Cochrane CH, 2003, NEW ZEAL J ECOL, V27, P61; Cooper A, 2000, SCIENCE, V289, P1139; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Day JS, 1998, NEW ZEAL J ECOL, V22, P43; DRUCE AP, 1987, NEW ZEAL J BOT, V25, P41, DOI 10.1080/0028825X.1987.10409956; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eisen M, 1998, GENE CLUSTER; Flannery TF, 1990, FUTURE EATERS ECOLOG; Forsyth DM, 2010, NEW ZEAL J ECOL, V34, P48; Forsyth DM, 2002, NEW ZEAL J ZOOL, V29, P323, DOI 10.1080/03014223.2002.9518316; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Gill B.J., 2010, CHECKLIST BIRDS NZ N, V4th edition; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; GREGG D, 1972, Records of the Canterbury Museum, V9, P151; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Hester Alison J., 2006, Conservation Biology Series (Cambridge), V11, P97; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HOLECHEK JL, 1985, J RANGE MANAGE, V38, P350, DOI 10.2307/3899420; Horrocks M, 2004, EMU, V104, P149, DOI 10.1071/MU03019; Howell CJ, 2002, FUNCT ECOL, V16, P232, DOI 10.1046/j.1365-2435.2002.00613.x; Janis C.M., 1990, P241; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; JANZEN DH, 1984, AM NAT, V123, P338, DOI 10.1086/284208; Johnson CN, 2009, P ROY SOC B-BIOL SCI, V276, P2509, DOI 10.1098/rspb.2008.1921; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Kelso GK, 2006, PALAEOGEOGR PALAEOCL, V237, P80, DOI 10.1016/j.palaeo.2005.11.036; Koch PL, 1998, CHEM GEOL, V152, P119, DOI 10.1016/S0009-2541(98)00101-6; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee WG, 2010, NEW ZEAL J ECOL, V34, P28; MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McGlone M.S., 1993, Tuatara, V32, P1; McGlone MS, 2004, QUATERNARY RES, V62, P267, DOI 10.1016/j.yqres.2004.09.003; McGlone MS, 1999, J QUATERNARY SCI, V14, P239, DOI 10.1002/(SICI)1099-1417(199905)14:3<239::AID-JQS438>3.0.CO;2-9; MILLS JA, 1977, J ANIM ECOL, V46, P939, DOI 10.2307/3651; Moar NT, 2011, NEW ZEAL J BOT, V49, P201, DOI 10.1080/0028825X.2010.526617; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Pollock ML, 2007, NEW ZEAL J ECOL, V31, P68; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A., 2007, TRACER V1 5; Rambaut A, 2009, MOL BIOL EVOL, V26, P245, DOI 10.1093/molbev/msn256; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rawlence NJ, 2011, J ROY SOC NEW ZEAL, V41, P217, DOI 10.1080/03036758.2011.559663; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Rowe P, 1994, NZ SPELEOL B, V9, P271; Rule S, 2012, SCIENCE, V335, P1483, DOI 10.1126/science.1214261; Shulmeister J, 2003, NEW ZEAL J BOT, V41, P503, DOI 10.1080/0028825X.2003.9512867; SLATER J, 1971, J AUST I AGR SCI, V37, P238; STEVENS EJ, 1987, J RANGE MANAGE, V40, P187, DOI 10.2307/3899218; Tennyson A.J.D., 2006, EXTINCT BIRDS NZ; Urlich SC, 2005, NEW ZEAL J ECOL, V29, P299; Webb C. J., 2001, SEEDS NZ GYMNOSPERMS; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilmshurst J. M., 2003, Science for Conservation; Wilmshurst JM, 2002, J QUATERNARY SCI, V17, P653, DOI 10.1002/jqs.689; Wood Jamie R., 2007, Records of the Canterbury Museum, V21, P27; Wood JR, 2012, NEW ZEAL J ECOL, V36, P164; Wood JR, 2008, QUATERNARY SCI REV, V27, P2593, DOI 10.1016/j.quascirev.2008.09.019; Wood JR, 2008, THESIS U OTAGO DUNED; WORTHY TH, 2002, LOST WORLD MOA	73	69	71	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40025	10.1371/journal.pone.0040025	http://dx.doi.org/10.1371/journal.pone.0040025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768206	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100178
J	Zhan, HY; Moore, CS; Chen, BJ; Zhou, X; Ma, XM; Ijichi, K; Bennett, MVL; Li, XJ; Crocker, SJ; Wang, ZW				Zhan, Haiying; Moore, Craig S.; Chen, Bojun; Zhou, Xin; Ma, Xin-Ming; Ijichi, Kumiko; Bennett, Michael V. L.; Li, Xue-Jun; Crocker, Stephen J.; Wang, Zhao-Wen			Stomatin Inhibits Pannexin-1-Mediated Whole-Cell Currents by Interacting with Its Carboxyl Terminal	PLOS ONE			English	Article							GAP-JUNCTION HEMICHANNELS; CAENORHABDITIS-ELEGANS; PANNEXIN 1; ATP RELEASE; VOLATILE ANESTHETICS; GENETIC-ANALYSIS; NERVOUS-SYSTEM; ION CHANNELS; ACTIVATION; SENSITIVITY	The pannexin-1 (Panx1) channel (often referred to as the Panx1 hemichannel) is a large-conductance channel in the plasma membrane of many mammalian cells. While opening of the channel is potentially detrimental to the cell, little is known about how it is regulated under physiological conditions. Here we show that stomatin inhibited Panx1 channel activity. In transfected HEK-293 cells, stomatin reduced Panx1-mediated whole-cell currents without altering either the total or membrane surface Panx1 protein expression. Stomatin coimmunoprecipitated with full-length Panx1 as well as a Panx1 fragment containing the fourth membrane-spanning domain and the cytosolic carboxyl terminal. The inhibitory effect of stomatin on Panx1-mediated whole-cell currents was abolished by truncating Panx1 at a site in the cytosolic carboxyl terminal. In primary culture of mouse astrocytes, inhibition of endogenous stomatin expression by small interfering RNA enhanced Panx1-mediated outward whole-cell currents. These observations suggest that stomatin may play important roles in astrocytes and other cells by interacting with Panx1 carboxyl terminal to limit channel opening.	[Zhan, Haiying; Moore, Craig S.; Chen, Bojun; Ma, Xin-Ming; Ijichi, Kumiko; Li, Xue-Jun; Crocker, Stephen J.; Wang, Zhao-Wen] Univ Connecticut Hlth Ctr, Dept Neurosci, Farmington, CT 06032 USA; [Zhou, Xin] Univ Connecticut Hlth Ctr, Ctr Aging, Farmington, CT USA; [Bennett, Michael V. L.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	University of Connecticut; University of Connecticut; Yeshiva University; Albert Einstein College of Medicine	Zhan, HY (corresponding author), Univ Connecticut Hlth Ctr, Dept Neurosci, Farmington, CT 06032 USA.	zwwang@uchc.edu	Moore, Craig/I-9205-2014	Moore, Craig/0000-0003-3333-435X; LI, XUEJUN/0000-0003-1899-9134	National Institutes of Health [5R01GM083049, 1R01MH085927]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (5R01GM083049, ZWW and 1R01MH085927) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; BRENNER S, 1974, GENETICS, V77, P71; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bunse S, 2009, FEBS J, V276, P6258, DOI 10.1111/j.1742-4658.2009.07334.x; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen BJ, 2007, CURR BIOL, V17, P1334, DOI 10.1016/j.cub.2007.06.060; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; GALLAGHER PG, 1995, J BIOL CHEM, V270, P26358, DOI 10.1074/jbc.270.44.26358; Garre JM, 2010, P NATL ACAD SCI US; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Iwabuchi S, 2011, NEUROCHEM INT, V58, P376, DOI 10.1016/j.neuint.2010.12.013; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Lapatsina L, 2011, EUR J CELL BIOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Mannsfeldt AG, 1999, MOL CELL NEUROSCI, V13, P391, DOI 10.1006/mcne.1999.0761; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; PARK EC, 1986, GENETICS, V113, P821; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Qiu F, 2011, PURINERGIC SIGNAL; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; SEDENSKY MM, 1987, SCIENCE, V236, P952, DOI 10.1126/science.3576211; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; STARICH TA, 1993, GENETICS, V133, P527; STEWART GW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P15, DOI 10.1016/0925-4439(93)90116-I; STEWART GW, 2003, NEPHRON PHYSIOL, V93, P29; Suadicani SO, 2012, GLIA; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; VEENSTRA RD, 1995, CIRC RES, V77, P1156, DOI 10.1161/01.RES.77.6.1156; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Wang Y, 2011, J NEUROCHEM, V116, P374, DOI 10.1111/j.1471-4159.2010.07117.x; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707	52	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39489	10.1371/journal.pone.0039489	http://dx.doi.org/10.1371/journal.pone.0039489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768083	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100054
J	Zhang, ZH; Ma, XT; Zhang, MQ				Zhang, Zhihua; Ma, Xiaotu; Zhang, Michael Q.			Bivalent-Like Chromatin Markers Are Predictive for Transcription Start Site Distribution in Human	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; NUCLEOSOME ORGANIZATION; HUMAN-CELLS; IN-VIVO; DNA HYPERMETHYLATION; SILENT CHROMATIN; HISTONE H4; CHIP-SEQ; INITIATION; PROMOTERS	Deep sequencing of 5' capped transcripts has revealed a variety of transcription initiation patterns, from narrow, focused promoters to wide, broad promoters. Attempts have already been made to model empirically classified patterns, but virtually no quantitative models for transcription initiation have been reported. Even though both genetic and epigenetic elements have been associated with such patterns, the organization of regulatory elements is largely unknown. Here, linear regression models were derived from a pool of regulatory elements, including genomic DNA features, nucleosome organization, and histone modifications, to predict the distribution of transcription start sites (TSS). Importantly, models including both active and repressive histone modification markers, e. g. H3K4me3 and H4K20me1, were consistently found to be much more predictive than models with only single-type histone modification markers, indicating the possibility of "bivalent-like" epigenetic control of transcription initiation. The nucleosome positions are proposed to be coded in the active component of such bivalent-like histone modification markers. Finally, we demonstrated that models trained on one cell type could successfully predict TSS distribution in other cell types, suggesting that these models may have a broader application range.	[Zhang, Zhihua; Ma, Xiaotu; Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol Cell Biol, Richardson, TX 75083 USA; [Zhang, Zhihua] Chinese Acad Sci, Beijing Inst Genom, Ctr Computat Biol, Beijing, Peoples R China; [Zhang, Zhihua] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Personalized Med, Beijing, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China	University of Texas System; University of Texas Dallas; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Tsinghua University	Zhang, ZH (corresponding author), Univ Texas Dallas, Ctr Syst Biol, Dept Mol Cell Biol, Richardson, TX 75083 USA.	michael.zhang@utdallas.edu			National Institutes of Health [HG001696]; National Natural Science Foundation of China [91131012]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a National Institutes of Health R01 grant (HG001696) to MQZ (http://www.ncbi.nlm.nih.gov) and a National Natural Science Foundation of China grant (91131012) to ZZ (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD., 2007, EPIGENETICS 2007 COL; Antos A, 2001, RANDOM STRUCT ALGOR, V19, P163, DOI 10.1002/rsa.10019; Balakrishnan L, 2010, CRIT REV BIOCHEM MOL, V45, P440, DOI 10.3109/10409238.2010.504700; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jensen ST, 2008, J AM STAT ASSOC, V103, P188, DOI 10.1198/016214507000000365; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Megraw M, 2009, GENOME RES, V19, P644, DOI 10.1101/gr.085449.108; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Schurmann T, 2004, J PHYS A-MATH GEN, V37, pL295, DOI 10.1088/0305-4470/37/27/L02; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Spektor TM, 2009, P NATL ACAD SCI USA, V106, P14808, DOI 10.1073/pnas.0907799106; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-155	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38112	10.1371/journal.pone.0038112	http://dx.doi.org/10.1371/journal.pone.0038112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768038	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100009
J	Preobrazhenska, O; Wright, JL; Churg, A				Preobrazhenska, Olena; Wright, Joanne L.; Churg, Andrew			Regional Heterogeneity in Murine Lung Fibroblasts from Normal Mice or Mice Exposed Once to Cigarette Smoke	PLOS ONE			English	Article							TGF-BETA; EXPRESSION; DECORIN; EMPHYSEMA; DIFFERENTIATION; SURVIVAL; DISEASE	Chronic obstructive lung disease (COPD) is characterized by matrix deposition in the small airways but matrix loss from the parenchyma, phenomena which must depend on the ability of local fibroblasts to produce matrix after smoke exposure. To investigate this idea, we exposed C57Bl/6 mice once to cigarette smoke or to air (control) and prepared primary cultures of lung fibroblasts by microdissecting large airways (trachea, LAF), medium size airways (major bronchi, MAF) and parenchyma (PF). Control PF showed the lowest rate of wound closure and wound closure was depressed in all lines by a single in vivo smoke exposure. Gene expression of matrix proteins differed considerably among the sites; decorin, which may sequester TGF beta, was markedly higher in PF. PF showed higher intrinsic ratios of pSmad2/Smad2. Smoke caused much greater increases in secreted and matrix deposited collagens 1 and 3 in PF than in LAF or MAF. Expression of Thy-1, a gene that suppresses myofibroblast differentiation, was increased by smoke in PF. We conclude that there is considerable regional heterogeneity in murine lung fibroblasts in terms of matrix production, either basally or after in vivo smoke exposure; that PF have lower ability to repair wounds and higher intrinsic TGF beta signaling; and that a single exposure to smoke produces lasting changes in the pattern of matrix production and wound repair, changes that may be mediated in part by smoke-induced release of TGF beta. However, PF still retain the ability to repair by producing new matrix after a single in vivo smoke exposure.	[Preobrazhenska, Olena; Wright, Joanne L.; Churg, Andrew] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada	University of British Columbia	Preobrazhenska, O (corresponding author), Univ British Columbia, Dept Pathol, Vancouver, BC, Canada.	achurg@interchange.ubc.ca			Canadian Institutes of Health Research [42539]; AstraZeneca RD	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca RD(AstraZeneca)	Supported in part by grant 42539 from the Canadian Institutes of Health Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AC and JLW have received grants from AstraZeneca R&D, but they were not specific to this particular study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Churg A, 2003, AM J RESP CRIT CARE, V168, P199, DOI 10.1164/rccm.200302-203OC; HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Koenders MMJF, 2009, J PATHOL, V218, P446, DOI 10.1002/path.2548; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4; Nihlberg K, 2010, THORAX, V65, P670, DOI 10.1136/thx.2009.129320; Noordhoek Jacobien A, 2005, COPD, V2, P17; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; Rennard Stephen I, 2011, Proc Am Thorac Soc, V8, P368, DOI 10.1513/pats.201102-019RM; Robbesom AA, 2008, MODERN PATHOL, V21, P297, DOI 10.1038/modpathol.3801004; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Sanders YY, 2007, AM J RESP CELL MOL, V36, P226, DOI 10.1165/rcmb.2006-0178OC; Sugiura H, 2007, AM J RESP CELL MOL, V37, P424, DOI 10.1165/rcmb.2007-0089OC; Wang RD, 2005, AM J RESP CELL MOL, V33, P387, DOI 10.1165/rcmb.2005-0203OC; Zhou XX, 2011, AM J RESP CELL MOL, V45, P1256, DOI 10.1165/rcmb.2011-0065OC	18	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39761	10.1371/journal.pone.0039761	http://dx.doi.org/10.1371/journal.pone.0039761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761892	Green Published, Green Submitted, gold			2022-12-25	WOS:000305826400037
J	Salazar, E; Bank, EM; Ramsey, N; Hess, KC; Deitsch, KW; Levin, LR; Buck, J				Salazar, Eric; Bank, Erin M.; Ramsey, Nicole; Hess, Kenneth C.; Deitsch, Kirk W.; Levin, Lonny R.; Buck, Jochen			Characterization of Plasmodium falciparum Adenylyl Cyclase-beta and Its Role in Erythrocytic Stage Parasites	PLOS ONE			English	Article							MALARIA PARASITE; V-ATPASE; CYCLIC-AMP; BICARBONATE; PH; CALCIUM; EXPRESSION; EXTRUSION; SENSOR; DIFFER	The most severe form of human malaria is caused by the parasite Plasmodium falciparum. The second messenger cAMP has been shown to be important for the parasite's ability to infect the host's liver, but its role during parasite growth inside erythrocytes, the stage responsible for symptomatic malaria, is less clear. The P. falciparum genome encodes two adenylyl cyclases, the enzymes that synthesize cAMP, PfAC alpha and PfAC beta. We now show that one of these, PfAC beta, plays an important role during the erythrocytic stage of the P. falciparum life cycle. Biochemical characterization of PfAC beta revealed a marked pH dependence, and sensitivity to a number of small molecule inhibitors. These inhibitors kill parasites growing inside red blood cells. One particular inhibitor is selective for PfAC beta relative to its human ortholog, soluble adenylyl cyclase (sAC); thus, PfAC beta represents a potential target for development of safe and effective antimalarial therapeutics.	[Salazar, Eric; Ramsey, Nicole] Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10021 USA; [Salazar, Eric; Bank, Erin M.; Ramsey, Nicole; Hess, Kenneth C.; Deitsch, Kirk W.; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA; [Salazar, Eric; Bank, Erin M.; Ramsey, Nicole; Hess, Kenneth C.; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Deitsch, Kirk W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University	Salazar, E (corresponding author), Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10021 USA.	llevin@med.cornell.edu	Hess, Kenneth/K-6546-2019	Hess, Kenneth/0000-0003-1377-6070; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [AI064842, AI052390]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064842, R01AI052390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546, T32GM007739, R01GM062328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to LRL & JB (AI064842) and to KWD (AI052390). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; ALEY SB, 1984, J EXP MED, V160, P1585, DOI 10.1084/jem.160.5.1585; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Boron WF, 2010, BBA-PROTEINS PROTEOM, V1804, P410, DOI 10.1016/j.bbapap.2009.10.021; BOSIA A, 1993, J CELL PHYSIOL, V154, P527, DOI 10.1002/jcp.1041540311; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Epp C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-86; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; JENSEN MD, 1983, J PARASITOL, V69, P1060, DOI 10.2307/3280864; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee YS, 2011, J BIOL CHEM, V286, P41353, DOI 10.1074/jbc.M111.284679; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; Ono T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000008; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; READ LK, 1991, MOL BIOCHEM PARASIT, V45, P109, DOI 10.1016/0166-6851(91)90032-2; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Syin C, 2001, EUR J BIOCHEM, V268, P4842, DOI 10.1046/j.1432-1327.2001.02403.x; Taussig Ronald, 2003, V237, P77; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Tresguerres M, 2010, AM J PHYSIOL-REG I, V299, pR62, DOI 10.1152/ajpregu.00761.2009; Tresguerres M, 2010, P NATL ACAD SCI USA, V107, P442, DOI 10.1073/pnas.0911790107; Weber JH, 2004, CELL SIGNAL, V16, P115, DOI 10.1016/S0898-6568(03)00129-3; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39769	10.1371/journal.pone.0039769	http://dx.doi.org/10.1371/journal.pone.0039769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761895	Green Published, gold			2022-12-25	WOS:000305808700047
J	Liu, KN; Meng, HX; Hou, JX				Liu, Kaining; Meng, Huanxin; Hou, Jianxia			Characterization of the Autocrine/Paracrine Function of Vitamin D in Human Gingival Fibroblasts and Periodontal Ligament Cells	PLOS ONE			English	Article							D HYDROXYLASE EXPRESSION; D ENDOCRINE SYSTEM; AGGRESSIVE PERIODONTITIS; 25-HYDROXYVITAMIN D-3; SERUM CONCENTRATIONS; PARATHYROID-HORMONE; MEDIATED INDUCTION; GENE-EXPRESSION; D-RECEPTOR; IN-VITRO	Background: We previously demonstrated that 25-hydroxyvitamin D-3, the precursor of 1 alpha,25-dihydroxyvitamin D-3, is abundant around periodontal soft tissues. Here we investigate whether 25-hydroxyvitamin D-3 is converted to 1 alpha,25-dihydroxyvitamin D-3 in periodontal soft tissue cells and explore the possibility of an autocrine/paracrine function of 1 alpha,25-dihydroxyvitamin D-3 in periodontal soft tissue cells. Methodology/Principal Findings: We established primary cultures of human gingival fibroblasts and human periodontal ligament cells from 5 individual donors. We demonstrated that 1 alpha-hydroxylase was expressed in human gingival fibroblasts and periodontal ligament cells, as was cubilin. After incubation with the 1 alpha-hydroxylase substrate 25-hydroxyvitamin D-3, human gingival fibroblasts and periodontal ligament cells generated detectable 1 alpha,25-dihydroxyvitamin D-3 that resulted in an up-regulation of CYP24A1 and RANKL mRNA. A specific knockdown of 1 alpha-hydroxylase in human gingival fibroblasts and periodontal ligament cells using siRNA resulted in a significant reduction in both 1 alpha, 25-dihydroxyvitamin D-3 production and mRNA expression of CYP24A1 and RANKL. The classical renal regulators of 1 alpha-hydroxylase (parathyroid hormone, calcium and 1 alpha,25-dihydroxyvitamin D-3) and Porphyromonas gingivalis lipopolysaccharide did not influence 1 alpha-hydroxylase expression significantly, however, interleukin-1 beta and sodium butyrate strongly induced 1 alpha-hydroxylase expression in human gingival fibroblasts and periodontal ligament cells. Conclusions/Significance: In this study, the expression, activity and functionality of 1 alpha-hydroxylase were detected in human gingival fibroblasts and periodontal ligament cells, raising the possibility that vitamin D acts in an autocrine/paracrine manner in these cells.	[Liu, Kaining] Peking Univ, Sch Stomatol, Dept Periodontol, Beijing 100871, Peoples R China; Peking Univ, Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, KN (corresponding author), Peking Univ, Sch Stomatol, Dept Periodontol, Beijing 100871, Peoples R China.	kqhxmeng@bjmu.edu.cn	hou, joye/AAT-9545-2020		National Natural Science Foundations of China [30772420, 81100749]; Beijing Natural Science Foundation [7102164]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research was funded by National Natural Science Foundations of China (http://www.nsfc.gov.cn/Portal0/default152.htm) (30772420, 81100749) and Beijing Natural Science Foundation (http://www.bjkw.gov.cn/n1143/n1240/n1465/n2276/index.html) (7102164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Bashutski JD, 2011, J DENT RES, V90, P1007, DOI 10.1177/0022034511407771; Bland R, 1999, ENDOCRINOLOGY, V140, P2027, DOI 10.1210/en.140.5.2027; Bland R, 2001, KIDNEY INT, V60, P1277, DOI 10.1046/j.1523-1755.2001.00966.x; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Cross HS, 2007, NUTR REV, V65, pS108, DOI 10.1111/j.1753-4887.2007.tb00334.x; Dietrich T, 2005, AM J CLIN NUTR, V82, P575, DOI 10.1093/ajcn/82.3.575; Dietrich T, 2004, AM J CLIN NUTR, V80, P108; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Garcia MN, 2011, J PERIODONTOL, V82, P25, DOI 10.1902/jop.2010.100207; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HENRY HL, 1985, ENDOCRINOLOGY, V116, P503, DOI 10.1210/endo-116-2-503; Hewison M, 2000, J MOL ENDOCRINOL, V25, P141, DOI 10.1677/jme.0.0250141; Huang DC, 2002, MOL CANCER RES, V1, P56; Ivanovski S, 2001, J PERIODONTAL RES, V36, P131, DOI 10.1034/j.1600-0765.2001.360301.x; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Khorchide M, 2005, J STEROID BIOCHEM, V93, P167, DOI 10.1016/j.jsbmb.2004.12.022; Kitazawa S, 2003, J CELL BIOCHEM, V89, P771, DOI 10.1002/jcb.10567; Kramer C, 2009, J STEROID BIOCHEM, V113, P9, DOI 10.1016/j.jsbmb.2008.10.010; Kurita-Ochiai T, 2002, INFECT IMMUN, V70, P2361, DOI 10.1128/IAI.70.5.2361-2367.2002; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Li Qi-qiang, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P208; Liu KN, 2010, J PERIODONTOL, V81, P260, DOI 10.1902/jop.2009.090355; Liu KN, 2009, J PERIODONTOL, V80, P1114, DOI 10.1902/jop.2009.080675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Rui-fang, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P664; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Overbergh L, 2006, J CLIN ENDOCR METAB, V91, P3566, DOI 10.1210/jc.2006-0678; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; ROST CR, 1981, ENDOCRINOLOGY, V108, P1002, DOI 10.1210/endo-108-3-1002; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Tang X, 2008, J PERIODONTAL RES, V43, P311, DOI 10.1111/j.1600-0765.2007.01031.x; Tang XL, 2009, ARCH ORAL BIOL, V54, P625, DOI 10.1016/j.archoralbio.2009.04.009; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Xu Yan, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P743; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587	44	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39878	10.1371/journal.pone.0039878	http://dx.doi.org/10.1371/journal.pone.0039878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761920	Green Published, Green Submitted, gold			2022-12-25	WOS:000305781700070
J	Foller, M; Jaumann, M; Dettling, J; Saxena, A; Pakladok, T; Munoz, C; Ruth, P; Sopjani, M; Seebohm, G; Ruttiger, L; Knipper, M; Lang, F				Foeller, Michael; Jaumann, Mirko; Dettling, Juliane; Saxena, Ambrish; Pakladok, Tatsiana; Munoz, Carlos; Ruth, Peter; Sopjani, Mentor; Seebohm, Guiscard; Ruettiger, Lukas; Knipper, Marlies; Lang, Florian			AMP-activated protein kinase in BK-channel regulation and protection against hearing loss following acoustic overstimulation	FASEB JOURNAL			English	Article						energy depletion; Ca2+; activated K+ channels; inner ear; acoustic trauma	OUTER HAIR-CELLS; CA2+-ACTIVATED K+ CHANNEL; GUINEA-PIG COCHLEA; GLUCOSE-UPTAKE; POTASSIUM CHANNELS; SKELETAL-MUSCLE; NITRIC-OXIDE; DIFFERENTIAL EXPRESSION; FUNCTIONAL-SIGNIFICANCE; GLUT4 TRANSLOCATION	The energy-sensing AMP-activated serine/threonine protein kinase (AMPK) confers cell survival in part by stimulation of cellular energy production and limitation of cellular energy utilization. AMPK-sensitive functions further include activities of epithelial Na+ channel ENaC and voltage-gated K+ channel KCNE1/KCNQ1. AMPK is activated by an increased cytosolic Ca2+ concentration. The present study explored whether AMPK regulates the Ca2+-sensitive large conductance and voltage-gated potassium (BK) channel. cRNA encoding BK channel was injected into Xenopus oocytes with and without additional injection of wild-type AMPK (AMPK alpha 1 + AMPK beta 1 + AMPK gamma 1), constitutively active AMPK(gamma R70Q), or inactive AMPK(alpha K45R). BK-channel activity was determined utilizing the 2-electrode voltage-clamp. Moreover, BK-channel protein abundance in the cell membrane was determined by confocal immunomicroscopy. As BK channels are expressed in outer hair cells (OHC) of the inner ear and lack of BK channels increases noise vulnerability, OHC BK-channel expression was examined by immunohistochemistry and hearing function analyzed by auditory brain stem response measurements in AMPK alpha 1-deficient mice (ampk(-/-)) and in wild-type mice (ampk(+/+)). As a result, coexpression of AMPK or AMPK(gamma R70Q) but not of AMPK(alpha K45R) significantly enhanced BK-channel-mediated currents and BK-channel protein abundance in the oocyte cell membrane. BK-channel expression in the inner ear was lower in ampk(-/-) mice than in ampk(+/+) mice. The hearing thresholds prior to and immediately after an acoustic overexposure were similar in ampk(-/-) and ampk(+/+) mice. However, the recovery from the acoustic trauma was significantly impaired in ampk(-/-) mice compared to ampk(+/+) mice. In summary, AMPK is a potent regulator of BK channels. It may thus participate in the signaling cascades that protect the inner ear from damage following acoustic overstimulation.-Fuller, M., Jaumann, M., Dettling, J., Saxena, A., Pakladok, T., Munoz, C., Ruth, P., Sopjani, M., Seebohm, G., Ruttiger, L., Knipper, M., Lang, F. AMP-activated protein kinase in BK-channel regulation and protection against hearing loss following acoustic overstimulation. FASEB J. 26, 4243-4253 (2012). www.fasebj.org	[Foeller, Michael; Saxena, Ambrish; Pakladok, Tatsiana; Munoz, Carlos; Sopjani, Mentor; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen Hearing Res Ctr, D-72076 Tubingen, Germany; [Jaumann, Mirko; Dettling, Juliane; Ruettiger, Lukas; Knipper, Marlies] Univ Tubingen, Dept Otolaryngol, Tubingen Hearing Res Ctr, D-72076 Tubingen, Germany; [Ruth, Peter] Univ Tubingen, Dept Pharmacol & Toxicol, Inst Pharm, D-72076 Tubingen, Germany; [Foeller, Michael] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Sopjani, Mentor] Univ Pristina, Fac Med, Pristina, Kosovo, Serbia; [Seebohm, Guiscard] Univ Klin Munster, Inst Genet Herzerkrankungen, Munster, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universiteti i Prishtines; University of Munster	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Tubingen Hearing Res Ctr, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Saxena, Ambrish/AAQ-5984-2020	Sopjani, Mentor/0000-0002-4187-7218	Deutsche Forschungsgemeinschaft; Interdisziplin res Zentrum fur Klinische Forschung of the University of Tubingen (Nachwuchsgruppe)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplin res Zentrum fur Klinische Forschung of the University of Tubingen (Nachwuchsgruppe)	The authors gratefully acknowledge the generosity of Benoit Viollet (Institut Cochin, Universite Paris Descartes, Centre National de la Recherche Scientifique Unite Mixte de Recherche 8104, Paris, France), who provided the AMPK alpha 1-deficient mice. The authors acknowledge the experimental support of Ioana Alesutan and Wibke Singer and the technical assistance of E. Faber. The manuscript was meticulously prepared by L. Subasic. Isolated hair cells were kindly provided by J. Engel (University of Tubingen; current address: Saarland University, Homburg/Saar, Germany). This study was supported by the Deutsche Forschungsgemeinschaft and the Interdisziplin res Zentrum fur Klinische Forschung of the University of Tubingen (Nachwuchsgruppe to M.F.).	Albert AP, 2008, AM J PHYSIOL-LUNG C, V295, pL837, DOI 10.1152/ajplung.90353.2008; Alesutan I, 2011, BIOCHEM BIOPH RES CO, V408, P505, DOI 10.1016/j.bbrc.2011.04.015; Alesutan I, 2011, MOL MEMBR BIOL, V28, P79, DOI 10.3109/09687688.2010.520037; Almaca J, 2009, PFLUG ARCH EUR J PHY, V458, P713, DOI 10.1007/s00424-009-0660-4; Andersen MN, 2012, TRAFFIC, V13, P143, DOI 10.1111/j.1600-0854.2011.01295.x; Armstrong CE, 2001, J PHYSIOL-LONDON, V536, P49, DOI 10.1111/j.1469-7793.2001.00049.x; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Becker S, 2007, CELL PHYSIOL BIOCHEM, V19, P89, DOI 10.1159/000099197; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Bohmer C, 2010, CELL PHYSIOL BIOCHEM, V25, P723, DOI 10.1159/000315092; BOITEUX A, 1981, PHILOS T ROY SOC B, V293, P5, DOI 10.1098/rstb.1981.0056; Borchert GH, 2011, AM J PHYSIOL-HEART C, V300, pH507, DOI 10.1152/ajpheart.00594.2010; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Carling David, 2007, Novartis Found Symp, V286, P72; Dal-Cim T, 2011, NEUROSCIENCE, V183, P212, DOI 10.1016/j.neuroscience.2011.03.022; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; DULON D, 1995, PFLUG ARCH EUR J PHY, V430, P365, DOI 10.1007/BF00373911; Eckey K, 2010, CELL PHYSIOL BIOCHEM, V26, P503, DOI 10.1159/000322318; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Foller M, 2006, CELL PHYSIOL BIOCHEM, V17, P201, DOI 10.1159/000094125; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; FUCHS PA, 1988, J NEUROSCI, V8, P2460; Grimes WN, 2009, NAT NEUROSCI, V12, P585, DOI 10.1038/nn.2302; Guan F, 2008, ARCH MED RES, V39, P52, DOI 10.1016/j.arcmed.2007.06.022; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hirschler-Laszkiewicz I, 2011, J BIOL CHEM, V286, P30636, DOI 10.1074/jbc.M111.238360; Holtzclaw JD, 2011, CURR OPIN NEPHROL HY, V20, P512, DOI 10.1097/MNH.0b013e3283488889; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; IKEDA K, 1987, HEARING RES, V26, P117, DOI 10.1016/0378-5955(87)90040-2; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Kim T, 2009, BIOCHEM BIOPH RES CO, V388, P377, DOI 10.1016/j.bbrc.2009.08.018; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Kohan AB, 2009, BIOCHEM BIOPH RES CO, V388, P117, DOI 10.1016/j.bbrc.2009.07.130; Kohler R, 2010, PFLUG ARCH EUR J PHY, V459, P969, DOI 10.1007/s00424-010-0819-z; KROS CJ, 1990, J PHYSIOL-LONDON, V421, P263, DOI 10.1113/jphysiol.1990.sp017944; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; LANG F, 1992, PHYSIOL REV, V72, P1, DOI 10.1152/physrev.1992.72.1.1; LANG F, 1986, AM J PHYSIOL, V250, pF953, DOI 10.1152/ajprenal.1986.250.6.F953; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Lei BA, 2005, P NATL ACAD SCI USA, V102, P6966, DOI 10.1073/pnas.0500768102; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Li SJ, 2011, DIABETES-METAB RES, V27, P461, DOI 10.1002/dmrr.1196; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015601; Lira VA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1062, DOI 10.1152/ajpendo.00045.2007; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Luiken JJFP, 2004, PFLUG ARCH EUR J PHY, V448, P1, DOI 10.1007/s00424-003-1199-4; Lupescu A, 2009, CELL PHYSIOL BIOCHEM, V23, P211, DOI 10.1159/000204110; Mace OJ, 2008, J PHYSIOL-LONDON, V586, P4541, DOI 10.1113/jphysiol.2008.158253; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; Malerba M, 2010, J BIOL REG HOMEOS AG, V24, P123; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Mohamed MR, 2010, CELL PHYSIOL BIOCHEM, V26, P959, DOI 10.1159/000324004; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; N'Gouemo P, 2011, EXPERT OPIN THER TAR, V15, P1283, DOI 10.1517/14728222.2011.620607; NAKAZAWA K, 1995, J HISTOCHEM CYTOCHEM, V43, P981, DOI 10.1177/43.10.7560888; Natsuizaka M, 2007, EXP CELL RES, V313, P3337, DOI 10.1016/j.yexcr.2007.06.013; Ningaraj NS, 2009, CANCER BIOL THER, V8, P1924, DOI 10.4161/cbt.8.20.9490; Nurbaeva MK, 2012, FASEB J, V26, P3049, DOI 10.1096/fj.12-204024; Ojuka EO, 2000, J APPL PHYSIOL, V88, P1072, DOI 10.1152/jappl.2000.88.3.1072; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; Park S, 2009, AM J PHYSIOL-CELL PH, V296, pC106, DOI 10.1152/ajpcell.00114.2008; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Sausbier M, 2007, FASEB J, V21, P812, DOI 10.1096/fj.06-7167com; Schimmang T, 2003, DEVELOPMENT, V130, P4741, DOI 10.1242/dev.00676; Schneider J, 2007, CELL PHYSIOL BIOCHEM, V20, P35, DOI 10.1159/000104151; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Schug N, 2006, EUR J NEUROSCI, V24, P3372, DOI 10.1111/j.1460-9568.2006.05225.x; Shimizu T, 2006, CELL PHYSIOL BIOCHEM, V18, P295, DOI 10.1159/000097607; Skinner LJ, 2003, J NEUROPHYSIOL, V90, P320, DOI 10.1152/jn.01155.2002; Song HY, 2010, BIOCHEM BIOPH RES CO, V396, P961, DOI 10.1016/j.bbrc.2010.05.033; Sopjani M, 2010, MOL MEMBR BIOL, V27, P137, DOI 10.3109/09687681003616870; Spreadbury IC, 2004, HEARING RES, V190, P115, DOI 10.1016/S0378-5955(03)00376-9; Summermatter S, 2008, FASEB J, V22, P774, DOI 10.1096/fj.07-8972com; SUNOSE H, 1993, JPN J PHYSIOL, V43, pS175; Taub M, 2010, BIOCHEM BIOPH RES CO, V393, P339, DOI 10.1016/j.bbrc.2010.02.037; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vingtdeux V, 2011, FASEB J, V25, P219, DOI 10.1096/fj.10-167361; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; WANGEMANN P, 1993, HEARING RES, V66, P123, DOI 10.1016/0378-5955(93)90133-L; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yoshida H, 2012, J MOL CELL CARDIOL, V52, P410, DOI 10.1016/j.yjmcc.2011.08.013; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073; Zygmunt K, 2010, BIOCHEM BIOPH RES CO, V398, P178, DOI 10.1016/j.bbrc.2010.06.048	119	35	35	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2012	26	10					4243	4253		10.1096/fj.12-208132	http://dx.doi.org/10.1096/fj.12-208132			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22767231				2022-12-25	WOS:000309704000029
J	Rathmann, D; Lindner, D; DeLuca, SH; Kaufmann, KW; Meiler, J; Beck-Sickinger, AG				Rathmann, Daniel; Lindner, Diana; DeLuca, Stephanie H.; Kaufmann, Kristian W.; Meiler, Jens; Beck-Sickinger, Annette G.			Ligand-mimicking Receptor Variant Discloses Binding and Activation Mode of Prolactin-releasing Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; NEUROPEPTIDE-Y RECEPTOR; TOGGLE SWITCH MODEL; CONSTITUTIVE ACTIVITY; THYROTROPIN RECEPTOR; RFAMIDE PEPTIDES; TRANSMEMBRANE DOMAIN; TISSUE DISTRIBUTION; DRUG DISCOVERY	The prolactin-releasing peptide receptor and its bioactive RFamide peptide (PrRP20) have been investigated to explore the ligand binding mode of peptide G-protein-coupled receptors (GPCRs). By receptor mutagenesis, we identified the conserved aspartate in the upper transmembrane helix 6 (Asp(6.59)) of the receptor as the first position that directly interacts with arginine 19 of the ligand (Arg(19)). Replacement of Asp(6.59) with Arg(19) of PrRP20 led to D6.59R, which turned out to be a constitutively active receptor mutant (CAM). This suggests that the mutated residue at the top of transmembrane helix 6 mimics Arg(19) by interacting with additional binding partners in the receptor. Next, we generated an initial comparative model of this CAM because no ligand docking was required, and we selected the next set of receptor mutants to find the engaged partners of the binding pocket. In an iterative process, we identified two acidic residues and two hydrophobic residues that form the peptide ligand binding pocket. As all residues are localized on top or in the upper part of the transmembrane domains, we clearly can show that the extracellular surface of the receptor is sufficient for full signal transduction for prolactin-releasing peptide, rather than a deep, membrane-embedded binding pocket. This contributes to the knowledge of the binding of peptide ligands to GPCRs and might facilitate the development of GPCR ligands, but it also provides new targeting of CAMs involved in hereditary diseases.	[Rathmann, Daniel; Lindner, Diana; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04103 Leipzig, Germany; [DeLuca, Stephanie H.; Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Leipzig University; Vanderbilt University	Beck-Sickinger, AG (corresponding author), Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.	beck-sickinger@uni-leipzig.de	Lindner, Diana/AAL-9856-2021	Lindner, Diana/0000-0001-5477-769X; Meiler, Jens/0000-0001-8945-193X	National Institutes of Health [R01 MH090192, R01 GM080403]; Deutsche Forschungsgemeinschaft [SFB 610, BE 1264-11]; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH090192 and R01 GM080403 (to J. M.) and Deutsche Forschungsgemeinschaft Grant SFB 610, BE 1264-11 (to A. B. S.).	ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; Arsenault J, 2010, BIOCHEM PHARMACOL, V80, P990, DOI 10.1016/j.bcp.2010.06.004; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bohme I, 2008, CELL SIGNAL, V20, P1740, DOI 10.1016/j.cellsig.2008.05.017; Bohme I, 2007, PEPTIDES, V28, P226, DOI 10.1016/j.peptides.2006.08.042; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Boyle RG, 2005, J PEPT SCI, V11, P161, DOI 10.1002/psc.612; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conner AC, 2011, METHODS MOL BIOL, V746, P85, DOI 10.1007/978-1-61779-126-0_5; Cotecchia S, 2003, ASSAY DRUG DEV TECHN, V1, P311, DOI 10.1089/15406580360545125; D'Antona AM, 2006, BRAIN RES, V1108, P1, DOI 10.1016/j.brainres.2006.05.042; D'Ursi AM, 2002, J MED CHEM, V45, P5483, DOI 10.1021/jm020975p; Danho W., 2003, 18 AM PEPT S BOST MA; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Donohue PJ, 1999, BIOCHEMISTRY-US, V38, P9366, DOI 10.1021/bi990544h; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Findeisen M, 2011, PHARMACEUTICALS, V4, P1248, DOI 10.3390/ph4091248; Findeisen M, 2011, CHEMMEDCHEM, V6, P1081, DOI 10.1002/cmdc.201100089; Flanagan CA, 2000, BIOCHEMISTRY-US, V39, P8133, DOI 10.1021/bi000085g; Ford DJ, 2002, J PHARMACOL EXP THER, V300, P810, DOI 10.1124/jpet.300.3.810; Fujii R, 1999, REGUL PEPTIDES, V83, P1, DOI 10.1016/S0167-0115(99)00028-2; Fukusumi S, 2006, PEPTIDES, V27, P1073, DOI 10.1016/j.peptides.2005.06.031; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gromoll J, 1996, MOL CELL ENDOCRINOL, V125, P177, DOI 10.1016/S0303-7207(96)03949-4; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Hofliger MM, 2003, J RECEPT SIG TRANSD, V23, P351, DOI 10.1081/RRS-120026974; HOGGER P, 1995, J BIOL CHEM, V270, P7405; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Kleinau G, 2008, CELL MOL LIFE SCI, V65, P3664, DOI 10.1007/s00018-008-8450-2; Koglin N, 2003, J MED CHEM, V46, P4369, DOI 10.1021/jm0341251; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lagerstrom MC, 2005, GENOMICS, V85, P688, DOI 10.1016/j.ygeno.2005.02.007; Lang M, 2006, J PEPT SCI, V12, P258, DOI 10.1002/psc.716; Langmead CJ, 2000, BRIT J PHARMACOL, V131, P683, DOI 10.1038/sj.bjp.0703617; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lin Steven H., 2008, V46, P57, DOI 10.1007/400_2007_048; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; Madsen KL, 2012, J BIOL CHEM, V287, P12293, DOI 10.1074/jbc.M111.294702; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; McAllister SD, 2002, BIOCHEM PHARMACOL, V63, P2121, DOI 10.1016/S0006-2952(02)01031-6; Merten N, 2007, J BIOL CHEM, V282, P7543, DOI 10.1074/jbc.M608902200; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okzaki R, 1999, J CLIN ENDOCR METAB, V84, P363; Osugi T, 2006, FEBS J, V273, P1731, DOI 10.1111/j.1742-4658.2006.05187.x; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; Rohl CA, 2005, METHOD ENZYMOL, V394, P244, DOI 10.1016/S0076-6879(05)94009-3; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sanger F, 1992, Biotechnology, V24, P104; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Spalding TA, 1995, J PHARMACOL EXP THER, V275, P1274; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ukena K, 2011, CELL TISSUE RES, V343, P475, DOI 10.1007/s00441-010-1116-z; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WELCH SK, 1995, BIOCHEM BIOPH RES CO, V209, P606, DOI 10.1006/bbrc.1995.1543	70	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32181	32194		10.1074/jbc.M112.349852	http://dx.doi.org/10.1074/jbc.M112.349852			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22778259	hybrid, Green Published			2022-12-25	WOS:000309059400055
J	Moon, SH; Jenkins, CM; Kiebish, MA; Sims, HF; Mancuso, DJ; Gross, RW				Moon, Sung Ho; Jenkins, Christopher M.; Kiebish, Michael A.; Sims, Harold F.; Mancuso, David J.; Gross, Richard W.			Genetic Ablation of Calcium-independent Phospholipase A(2)gamma (iPLA(2)gamma) Attenuates Calcium-induced Opening of the Mitochondrial Permeability Transition Pore and Resultant Cytochrome c Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; ARACHIDONIC-ACID RELEASE; CYCLOPHILIN-D; CELL-DEATH; CYCLOSPORINE-A; LIVER-MITOCHONDRIA; HEART-MITOCHONDRIA; INSULIN-RESISTANCE; OXIDATIVE-PHOSPHORYLATION; MEMBRANE-PERMEABILITY	Herein, we demonstrate that calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) is a critical mechanistic participant in the calcium-induced opening of the mitochondrial permeability transition pore (mPTP). Liver mitochondria from iPLA(2)gamma(-/-) mice were markedly resistant to calcium-induced swelling in the presence or absence of phosphate in comparison with wild-type littermates. Furthermore, the iPLA(2)gamma enantioselective inhibitor (R)-(E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one ((R)-BEL) was markedly more potent than (S)-BEL in inhibiting mPTP opening in mitochondria from wild-type liver in comparison with hepatic mitochondria from iPLA(2)gamma(-/-) mice. Intriguingly, low micromolar concentrations of long chain fatty acyl-CoAs and the non-hydrolyzable thioether analog of palmitoyl-CoA markedly accelerated Ca2+-induced mPTP opening in liver mitochondria from wild-type mice. The addition of L-carnitine enabled the metabolic channeling of acyl-CoA through carnitine palmitoyltransferases (CPT-1/2) and attenuated the palmitoyl-CoA-mediated amplification of calcium-induced mPTP opening. In contrast, mitochondria from iPLA(2)gamma(-/-) mice were insensitive to fatty acyl-CoA-mediated augmentation of calcium-induced mPTP opening. Moreover, mitochondria from iPLA(2)gamma(-/-) mouse liver were resistant to Ca2+/t-butyl hydroperoxide-induced mPTP opening in comparison with wild-type littermates. In support of these findings, cytochrome c release from iPLA(2)gamma(-/-) mitochondria was dramatically decreased in response to calcium in the presence or absence of either t-butyl hydroperoxide or phenylarsine oxide in comparison with wild-type littermates. Collectively, these results identify iPLA(2)gamma as an important mechanistic component of the mPTP, define its downstream products as potent regulators of mPTP opening, and demonstrate the integrated roles of mitochondrial bioenergetics and lipidomic flux in modulating mPTP opening promoting the activation of necrotic and necroapoptotic pathways of cell death.	[Moon, Sung Ho; Jenkins, Christopher M.; Kiebish, Michael A.; Sims, Harold F.; Mancuso, David J.; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278, RO1HL41250]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041250, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE678, DOI 10.1152/ajpendo.90287.2008; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BEATRICE MC, 1980, J BIOL CHEM, V255, P8663; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Blum JL, 2011, TOXICOL IN VITRO, V25, P1001, DOI 10.1016/j.tiv.2011.03.014; Bradley JM, 2011, J AM CHEM SOC, V133, P19676, DOI 10.1021/ja209144h; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Ciapaite J, 2005, DIABETES, V54, P944, DOI 10.2337/diabetes.54.4.944; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Cooney GJ, 2002, ANN NY ACAD SCI, V967, P196; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1988, BIOCHEM J, V255, P357; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Di Paola M, 2006, FEBS LETT, V580, P775, DOI 10.1016/j.febslet.2005.12.090; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Dube H, 2012, BIOCHEM J, V441, P901, DOI 10.1042/BJ20111301; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; HANSFORD RG, 1985, BIOCHEM J, V227, P129, DOI 10.1042/bj2270129; Hanske J, 2012, P NATL ACAD SCI USA, V109, P125, DOI 10.1073/pnas.1112312108; Huang YX, 2006, BBA-GEN SUBJECTS, V1760, P1827, DOI 10.1016/j.bbagen.2006.08.013; IMBERTI R, 1993, J PHARMACOL EXP THER, V265, P392; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Jullig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; KIM DK, 1991, AM J PHYSIOL, V260, pH1767, DOI 10.1152/ajpheart.1991.260.6.H1767; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; LERNER E, 1972, J BIOL CHEM, V247, P1513; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; MCCORMACK JG, 1993, DEV NEUROSCI-BASEL, V15, P165, DOI 10.1159/000111332; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; MITTNACHT S, 1981, J BIOL CHEM, V256, P3199; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; ONTKO JA, 1983, BIOCHEM BIOPH RES CO, V116, P173, DOI 10.1016/0006-291X(83)90397-2; OTTO DA, 1978, J BIOL CHEM, V253, P789; Oyanagi E, 2011, BIOCHEM BIOPH RES CO, V412, P61, DOI 10.1016/j.bbrc.2011.07.039; Palomba L, 2001, J NEUROSCI RES, V65, P387, DOI 10.1002/jnr.1165; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Qian T, 1999, TOXICOL APPL PHARM, V154, P117, DOI 10.1006/taap.1998.8580; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Schonfeld P, 1997, FEBS LETT, V420, P167, DOI 10.1016/S0014-5793(97)01511-1; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; Sinibaldi F, 2008, BIOCHEMISTRY-US, V47, P6928, DOI 10.1021/bi800048v; Sinibaldi F, 2010, J BIOL INORG CHEM, V15, P689, DOI 10.1007/s00775-010-0636-z; Sultan A, 2001, ARCH BIOCHEM BIOPHYS, V386, P37, DOI 10.1006/abbi.2000.2194; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tanveer A, 1996, EUR J BIOCHEM, V238, P166, DOI 10.1111/j.1432-1033.1996.0166q.x; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Vay L, 2009, CELL CALCIUM, V45, P243, DOI 10.1016/j.ceca.2008.10.007; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22	83	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29837	29850		10.1074/jbc.M112.373654	http://dx.doi.org/10.1074/jbc.M112.373654			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778252	Green Published, hybrid			2022-12-25	WOS:000308286900058
J	Robal, T; Larsson, M; Martin, M; Olivecrona, G; Lookene, A				Robal, Terje; Larsson, Mikael; Martin, Miina; Olivecrona, Gunilla; Lookene, Aivar			Fatty Acids Bind Tightly to the N-terminal Domain of Angiopoietin-like Protein 4 and Modulate Its Interaction with Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; ADIPOSE-TISSUE; SERUM-ALBUMIN; RISK-FACTORS; TARGET GENE; PLASMA; ANGPTL4; TRIGLYCERIDES; LIPOLYSIS; INSIGHTS	Angiopoietin-like protein 4 (Angptl4), a potent regulator of plasma triglyceride metabolism, binds to lipoprotein lipase (LPL) through its N-terminal coiled-coil domain (ccd-Angptl4) inducing dissociation of the dimeric enzyme to inactive monomers. In this study, we demonstrate that fatty acids reduce the inactivation of LPL by Angptl4. This was the case both with ccd-Angptl4 and full-length Angptl4, and the effect was seen in human plasma or in the presence of albumin. The effect decreased in the sequence oleic acid > palmitic acid > myristic acid > linoleic acid > linolenic acid. Surface plasmon resonance, isothermal titration calorimetry, fluorescence, and chromatography measurements revealed that fatty acids bind with high affinity to ccd-Angptl4. The interactions were characterized by fast association and slow dissociation rates, indicating formation of stable complexes. The highest affinity for ccd-Angptl4 was detected for oleic acid with a subnanomolar equilibrium dissociation constant (K-d). The K-d values for palmitic and myristic acid were in the nanomolar range. Linoleic and linolenic acid bound with much lower affinity. On binding of fatty acids, ccd-Angptl4 underwent conformational changes resulting in a decreased helical content, weakened structural stability, dissociation of oligomers, and altered fluorescence properties of the Trp-38 residue that is located close to the putative LPL-binding region. Based on these results, we propose that fatty acids play an important role in modulating the effects of Angptl4.	[Robal, Terje; Martin, Miina; Lookene, Aivar] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Larsson, Mikael; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci, SE-90187 Umea, Sweden	Tallinn University of Technology; Umea University	Lookene, A (corresponding author), Tallinn Univ Technol, Dept Chem, Akad Tee 15, EE-12618 Tallinn, Estonia.	aivar.lookene@ttu.ee			Estonian Ministry of Education and Research; Estonian Science Foundation [8300]; Swedish Research Council [12203]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Estonian Ministry of Education and Research, Estonian Science Foundation Grant 8300, and by the Swedish Research Council Grant 12203.	AKI H, 1994, J PHARM SCI, V83, P1712, DOI 10.1002/jps.2600831213; Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P557, DOI 10.1111/j.1432-1033.1980.tb04603.x; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; Bergo M, 2002, J BIOL CHEM, V277, P11927, DOI 10.1074/jbc.M200325200; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Bojesen E, 1996, J PHYS CHEM-US, V100, P17981, DOI 10.1021/jp962141m; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33; De Caterina R, 2010, J AM COLL CARDIOL, V55, P198, DOI 10.1016/j.jacc.2009.07.062; Demant EJF, 2002, BIOCHEM J, V363, P809, DOI 10.1042/0264-6021:3630809; Dutton S, 2008, BRIT J NUTR, V100, P18, DOI 10.1017/S0007114507882961; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; Fruchart JC, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000131513.33892.5b; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hultin M, 1996, J LIPID RES, V37, P1022; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Kim YJ, 2006, ANN NY ACAD SCI, V1086, P11, DOI 10.1196/annals.1377.021; Kleinfeld AM, 1996, AM J CARDIOL, V78, P1350, DOI 10.1016/S0002-9149(96)00651-0; Labreuche J, 2010, ATHEROSCLEROSIS, V212, P9, DOI 10.1016/j.atherosclerosis.2010.02.011; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4]; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Nakayama T, 2011, ONCOL REP, V25, P929, DOI 10.3892/or.2011.1176; Nilsson S. K, 2009, 15 INT S ATH BOST MA, pe238; RICHIERI GV, 1995, J LIPID RES, V36, P229; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; SAXENA U, 1989, J BIOL CHEM, V264, P4349; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; SHIMADA K, 1982, BIOCHIM BIOPHYS ACTA, V710, P117, DOI 10.1016/0005-2760(82)90140-0; Smart-Halajko MC, 2010, ARTERIOSCL THROM VAS, V30, P2277, DOI 10.1161/ATVBAHA.110.212209; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	60	22	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29739	29752		10.1074/jbc.M111.303529	http://dx.doi.org/10.1074/jbc.M111.303529			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773878	Green Published, hybrid			2022-12-25	WOS:000308286900050
J	Wang, YG; Tang, RT; Tao, J; Wang, XN; Zheng, BS; Feng, Y				Wang, Yuguo; Tang, Rentao; Tao, Jin; Wang, Xiaonan; Zheng, Baisong; Feng, Yan			Chimeric Cellulase Matrix for Investigating Intramolecular Synergism between Non-hydrolytic Disruptive Functions of Carbohydrate-binding Modules and Catalytic Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-HYDROLYSIS; DOMAINS; PROTEIN; SIMULATIONS; RESIDUES; SMART; CEL5A	The conversion of renewable cellulosic biomass is of considerable interest for the production of biofuels and materials. The bottleneck in the efficient conversion is the compactness and resistance of crystalline cellulose. Carbohydrate-binding modules (CBMs), which disrupt crystalline cellulose via non-hydrolytic mechanisms, are expected to overcome this bottleneck. However, the lack of convenient methods for quantitative analysis of the disruptive functions of CBMs have hindered systematic studies and molecular modifications. Here we established a practical and systematic platform for quantifying and comparing the non-hydrolytic disruptive activities of CBMs via the synergism of CBMs and a catalytic module within designed chimeric cellulase molecules. Bioinformatics and computational biology were also used to provide a deeper understanding. A convenient vector was constructed to serve as a cellulase matrix into which heterologous CBM sequences can be easily inserted. The resulting chimeric cellulases were suitable for studying disruptive functions, and their activities quantitatively reflected the disruptive functions of CBMs on crystalline cellulose. In addition, this cellulase matrix can be used to construct novel chimeric cellulases with high hydrolytic activities toward crystalline cellulose.	[Feng, Yan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Feng, Yan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Wang, Yuguo; Tang, Rentao; Tao, Jin; Wang, Xiaonan; Zheng, Baisong; Feng, Yan] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Jilin University	Feng, Y (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yfeng2009@mail.sjtu.edu.cn			National Basic Research Program of China (973 Program) [2012CB721000, 2011CBA00800]; Natural Science Foundation of China; Science and Technology Commission of the Shanghai Municipality	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of the Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program of China ( 973 Program, No. 2012CB721000 and 2011CBA00800), Natural Science Foundation of China, and Science and Technology Commission of the Shanghai Municipality.	Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Bae HJ, 2003, FEMS MICROBIOL LETT, V227, P175, DOI 10.1016/S0378-1097(03)00593-7; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Case D.A., 2022, AMBER 2020; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Chhabra SR, 2002, FEBS LETT, V531, P375, DOI 10.1016/S0014-5793(02)03493-2; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Doi RH, 2003, J BACTERIOL, V185, P5907, DOI 10.1128/JB.185.20.5907-5914.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mahadevan SA, 2008, FEMS MICROBIOL LETT, V287, P205, DOI 10.1111/j.1574-6968.2008.01324.x; Mattinen ML, 1997, PROTEIN SCI, V6, P294; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; United States Department of Energy, 2006, US DEP EN PUBL; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; WEINER MP, 1994, PCR METH APPL, V4, pS131; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	49	10	11	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29568	29578		10.1074/jbc.M111.320358	http://dx.doi.org/10.1074/jbc.M111.320358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778256	Green Published, hybrid			2022-12-25	WOS:000308286900032
J	Yuan, MS; Pino, E; Wu, LF; Kacergis, M; Soukas, AA				Yuan, Minsheng; Pino, Elizabeth; Wu, Lianfeng; Kacergis, Michael; Soukas, Alexander A.			Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; MOTIF PHOSPHORYLATION; TRANSCRIPTION FACTORS; DIABETES-MELLITUS; LIPID-METABOLISM; KINASE-B; RICTOR; MICE; AKT/PKB; LIVER	Mammalian target of rapamycin complex 2 (mTORC2) is a key activator of protein kinases that act downstream of insulin and growth factor signaling. Here we report that mice lacking the essential mTORC2 component rictor in liver (Lrictor(KO)) are unable to respond normally to insulin. In response to insulin, Lrictor(KO) mice failed to inhibit hepatic glucose output. Lrictor(KO) mice also fail to develop hepatic steatosis on a high fat diet and manifest half-normal serum cholesterol levels. This is accompanied by lower levels of expression of SREBP-1c and SREBP-2 and genes of fatty acid and cholesterol biosynthesis. Lrictor(KO) mice had defects in insulin-stimulated Akt Ser-473 and Thr-308 phosphorylation, leading to decreased phosphorylation of Akt substrates FoxO, GSK-3 beta, PRAS40, AS160, and Tsc2. Lrictor(KO) mice also manifest defects in insulin-activated mTORC1 activity, evidenced by decreased S6 kinase and Lipin1 phosphorylation. Glucose intolerance and insulin resistance of Lrictor(KO) mice could be fully rescued by hepatic expression of activated Akt2 or dominant negative FoxO1. However, in the absence of mTORC2, forced Akt2 activation was unable to drive hepatic lipogenesis. Thus, we have identified an Akt-independent relay from mTORC2 to hepatic lipogenesis that separates the effects of insulin on glucose and lipid metabolism.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet & Diabet Unit,Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Soukas, AA (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN6224, Boston, MA 02114 USA.	asoukas@chgr.mgh.harvard.edu		Pino, Elizabeth/0000-0003-0626-5221	National Institutes of Health Career Development Award through NIDDK [K08DK087941]; Charles H. Hood Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK087941] Funding Source: NIH RePORTER	National Institutes of Health Career Development Award through NIDDK; Charles H. Hood Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by National Institutes of Health Career Development Award K08DK087941 through the NIDDK ( to A. A. S.). This work was also supported by a Child Health Research Award from the Charles H. Hood Foundation ( to A. A. S).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	41	122	125	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29579	29588		10.1074/jbc.M112.386854	http://dx.doi.org/10.1074/jbc.M112.386854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773877	Green Published, hybrid			2022-12-25	WOS:000308286900033
J	Kawamura, I; Maeda, S; Imamura, K; Setoguchi, T; Yokouchi, M; Ishidou, Y; Komiya, S				Kawamura, Ichiro; Maeda, Shingo; Imamura, Katsuyuki; Setoguchi, Takao; Yokouchi, Masahiro; Ishidou, Yasuhiro; Komiya, Setsuro			SnoN Suppresses Maturation of Chondrocytes by Mediating Signal Cross-talk between Transforming Growth Factor-beta and Bone Morphogenetic Protein Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X COLLAGEN GENE; ARTICULAR-CARTILAGE; HYPERTROPHIC DIFFERENTIATION; MURINE CHONDROCYTES; STEM-CELLS; IN-VIVO; EXPRESSION; OSTEOARTHRITIS; CHONDROGENESIS; SMAD3	Hypertrophic maturation of chondrocytes is a crucial step in endochondral ossification, whereas abnormally accelerated differentiation of hypertrophic chondrocytes in articular cartilage is linked to pathogenesis of osteoarthritis. This cellular process is promoted or inhibited by bone morphogenetic protein (BMP) or transforming growth factor-beta (TGF-beta) signaling, respectively, suggesting that these signaling pathways cross-talk during chondrocyte maturation. Here, we demonstrated that expression of Tgfb1 was increased, followed by phosphorylation of Smad2, during BMP-2-induced hypertrophic maturation of ATDC5 chondrocytes. Application of a TGF-beta type I receptor inhibitor compound, SB431542, increased the expression of Id1, without affecting the phosphorylation status of Smad1/5/8, indicating that the activated endogenous TGF-beta pathway inhibited BMP signaling downstream of the Smad activation step. We searched for TGF-beta-inducible effectors that are able to inhibit BMP signaling in ATDC5 cells and identified SnoN. Overexpression of SnoN suppressed the activity of a BMP-responsive luciferase reporter in COS-7 cells as well as expression of Id1 in ATDC5 cells and, subsequently, the expression of Col10a1, a hallmark of hypertrophic chondrocyte maturation. siRNA-mediated loss of SnoN showed opposite effects in BMP-treated ATDC5 cells. In adult mice, we found the highest level of SnoN expression in articular cartilage. Importantly, SnoN was expressed, in combination with phosphorylated Smad2/3, in prehypertrophic chondrocytes in the growth plate of mouse embryo bones and in chondrocytes around the ectopically existing hypertrophic chondrocytes of human osteoarthritis cartilage. Our results indicate that SnoN mediates a negative feedback mechanism evoked by TGF-beta to inhibit BMP signaling and, subsequently, hypertrophic maturation of chondrocytes.	[Kawamura, Ichiro; Maeda, Shingo; Imamura, Katsuyuki; Ishidou, Yasuhiro; Komiya, Setsuro] Kagoshima Univ, Dept Med Joint Mat, Kagoshima 8908544, Japan; [Kawamura, Ichiro; Imamura, Katsuyuki; Yokouchi, Masahiro; Komiya, Setsuro] Kagoshima Univ, Dept Orthoped Surg, Kagoshima 8908544, Japan; [Setoguchi, Takao] Kagoshima Univ, Near Future Locomotor Organ Med Creat Course, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Maeda, S (corresponding author), Kagoshima Univ, Dept Med Joint Mat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	s-maeda@m3.kufm.kagoshima-u.ac.jp			Japan Orthopedics and Traumatology Foundation, Inc. [254];  [23592221];  [23592222]	Japan Orthopedics and Traumatology Foundation, Inc.; ; 	This work was supported by Grants-in-Aid for Scientific Research (Scientific Research (C) (General)) 23592221 (to S. M.) and 23592222 (to Y.I.) and Japan Orthopedics and Traumatology Foundation, Inc., Grant 254.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Bobick BE, 2004, J BIOL CHEM, V279, P4588, DOI 10.1074/jbc.M309805200; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Jahchan NS, 2010, CANCER RES, V70, P4204, DOI 10.1158/0008-5472.CAN-10-0135; Kempf H, 2007, DEV DYNAM, V236, P1954, DOI 10.1002/dvdy.21205; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Kuroki H, 2004, ARTHRITIS RES THER, V6, pR492, DOI 10.1186/ar1219; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Li TF, 2006, J BONE MINER RES, V21, P4, DOI 10.1359/JBMR.050911; Li TF, 2010, ARTHRITIS RHEUM-US, V62, P2359, DOI 10.1002/art.27537; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Nelea V, 2005, J BIOMED MATER RES A, V75A, P216, DOI 10.1002/jbm.a.30402; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Pullig O, 2000, CALCIFIED TISSUE INT, V67, P230, DOI 10.1007/s002230001108; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Takeda M, 2004, MOL BIOL CELL, V15, P963, DOI 10.1091/mbc.E03-07-0478; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van Beuningen HM, 1998, OSTEOARTHR CARTILAGE, V6, P306, DOI 10.1053/joca.1998.0129; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	53	39	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29101	29113		10.1074/jbc.M112.349415	http://dx.doi.org/10.1074/jbc.M112.349415			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22767605	hybrid, Green Published			2022-12-25	WOS:000308074600076
J	Butte, MJ; Lee, SJ; Jesneck, J; Keir, ME; Haining, WN; Sharpe, AH				Butte, Manish J.; Lee, Sun Jung; Jesneck, Jonathan; Keir, Mary E.; Haining, W. Nicholas; Sharpe, Arlene H.			CD28 Costimulation Regulates Genome-Wide Effects on Alternative Splicing	PLOS ONE			English	Article							T-CELLS; EXON ARRAYS; EXPRESSION; CTLA-4; RIBONUCLEOPROTEIN; NAIVE; CD45; AGE	CD28 is the major costimulatory receptor required for activation of naive T cells, yet CD28 costimulation affects the expression level of surprisingly few genes over those altered by TCR stimulation alone. Alternate splicing of genes adds diversity to the proteome and contributes to tissue-specific regulation of genes. Here we demonstrate that CD28 costimulation leads to major changes in alternative splicing during activation of naive T cells, beyond the effects of TCR alone. CD28 costimulation affected many more genes through modulation of alternate splicing than by modulation of transcription. Different families of biological processes are over-represented among genes alternatively spliced in response to CD28 costimulation compared to those genes whose transcription is altered, suggesting that alternative splicing regulates distinct biological effects. Moreover, genes dependent upon hnRNPLL, a global regulator of splicing in activated T cells, were enriched in T cells activated through TCR plus CD28 as compared to TCR alone. We show that hnRNPLL expression is dependent on CD28 signaling, providing a mechanism by which CD28 can regulate splicing in T cells and insight into how hnRNPLL can influence signal-induced alternative splicing in T cells. The effects of CD28 on alternative splicing provide a newly appreciated means by which CD28 can regulate T cell responses.	[Butte, Manish J.; Lee, Sun Jung; Keir, Mary E.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Jesneck, Jonathan; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Jesneck, Jonathan; Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Butte, MJ (corresponding author), Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.	arlene_sharpe@hms.harvard.edu	Butte, Manish/AAM-8604-2020; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595	NIH [BAA-05-011, P01 AI39671, P01 AI065687]; NIAID/NIH [K08AI079268];  [R01 AI091493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079268, P01AI065687, P01AI039671, R01AI091493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH BAA-05-011, P01 AI39671 and P01 AI065687 to AHS, K08AI079268 from the NIAID/NIH to MJB, and R01 AI091493 to WNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chang SY, 2007, NEUROSCIENCE, V145, P1026, DOI 10.1016/j.neuroscience.2006.12.054; DELLAVEDOVA F, 1992, MOL BRAIN RES, V12, P357, DOI 10.1016/0169-328X(92)90140-7; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Ishunina TA, 2005, J CLIN ENDOCR METAB, V90, P3757, DOI 10.1210/jc.2004-1858; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lin L, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp420; Linton PJ, 1997, IMMUNOL REV, V160, P9, DOI 10.1111/j.1600-065X.1997.tb01023.x; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Xing Y, 2008, RNA, V14, P1470, DOI 10.1261/rna.1070208; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088; Yabas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026440; Zikherman J, 2008, IMMUNITY, V29, P839, DOI 10.1016/j.immuni.2008.12.005	36	26	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40032	10.1371/journal.pone.0040032	http://dx.doi.org/10.1371/journal.pone.0040032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768209	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100181
J	Ge, XL; Lv, X; Feng, LL; Liu, XQ; Gao, JM; Chen, N; Wang, X				Ge, Xueling; Lv, Xiao; Feng, Lili; Liu, Xiaoqian; Gao, Junming; Chen, Na; Wang, Xin			Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma	PLOS ONE			English	Article							ASTROCYTE-ELEVATED GENE-1; FLOW-CYTOMETRIC DETECTION; NON-HODGKINS-LYMPHOMA; BREAST-CANCER; PHOSPHATIDYLSERINE EXPRESSION; CLINICAL-SIGNIFICANCE; SIGNALING PATHWAYS; BETA-CATENIN; ANNEXIN-V; IN-VITRO	Background: Metadherin (MTDH) has been demonstrated as a potentially crucial mediator of various types of human malignancies. However, the expression and role of MTDH in diffuse large-B-cell lymphoma (DLBCL) have not been reported yet. This study aimed to illuminate the role of MTDH in the pathogenesis of DLBCL. Methodology/Principal Findings: A remarkable elevation of MTDH on mRNA level was detected in DLBCL tissues by quantitative polymerase chain reaction (PCR). Using Western-blot analysis we found that the expression of MTDH protein was significantly upregulated in DLBCL cell lines and DLBCL tissues compared with peripheral blood mononuclear cells (PBMCs) from healthy samples and tissues from patients of reactive hyperplasia of lymph node. The results showed high expression of MTDH in 23 of 30 (76.67%) DLBCL tissues by using immunohistochemical analysis and the over expression of MTDH was strongly correlated to the clinical staging of patients with DLBCL (P<0.05). Furthermore, the finding suggested that the increase of MTDH in DLBCL cells could distinctly enhance cell proliferation and inhibit cell apoptosis; meanwhile, inhibition of MTDH expression by specific siRNA clearly enhanced LY8 cell apoptosis. Upregulation of MTDH elevated the protein level of total beta-catenin and translocation of beta-catenin to the nucleus directly or indirectly. Knockdown of MTDH decreased the level of total, cytoplasmic beta-catenin and reduced nuclear accumulation of beta-catenin protein. This indicated that the function of MTDH on the development of DLBCL was mediated through regulation of Wnt/beta-catenin signaling pathway. Conclusions/Significance: Our results suggest that MTDH contributes to the pathogenesis of DLBCL mediated by activation of Wnt/beta-catenin pathway. This novel study may contribute to further investigation on the useful biomarkers and potential therapeutic target in the DLBCL patients.	[Ge, Xueling; Lv, Xiao; Feng, Lili; Chen, Na; Wang, Xin] Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250100, Peoples R China; [Liu, Xiaoqian] Qingdao Univ, Dept Hematol, Yantai Yuhuangding Hosp, Affiliated Hosp Med Coll, Yantai, Peoples R China; [Gao, Junming] Shandong Police Officer Gen Hosp, Dept Internal Med, Jinan, Peoples R China; [Wang, Xin] Shandong Univ, Inst Diagnost, Jinan 250100, Peoples R China	Shandong University; Qingdao University; Shandong University	Ge, XL (corresponding author), Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250100, Peoples R China.	xinwang55@yahoo.com.cn			Natural Science Foundation of Shandong Province, China [Y2007C053, ZR2009CM059]; Project of Scientific and Technological Development of Shandong Province, China [2007GG10002008]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Project of Scientific and Technological Development of Shandong Province, China	This study was supported by the grants from the Natural Science Foundation of Shandong Province, China (No. Y2007C053 and No. ZR2009CM059) and the Project of Scientific and Technological Development of Shandong Province, China (No. 2007GG10002008) to Prof. Xin Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid Muhammad Bilal, 2005, Asian Pac J Cancer Prev, V6, P531; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Bellei B, 2004, MODERN PATHOL, V17, P1275, DOI 10.1038/modpathol.3800181; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chan WC, 1997, BLOOD, V89, P3909; Chen W, 2010, NEOPLASMA, V57, P522, DOI 10.4149/neo_2010_06_522; Chung R, 2010, INT J CLIN EXP PATHO, V3, P244; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Coiffier B, 2005, J CLIN ONCOL, V23, P6387, DOI 10.1200/JCO.2005.05.015; Coiffier B, 2001, CURR OPIN ONCOL, V13, P325, DOI 10.1097/00001622-200109000-00003; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Flowers CR, 2010, CA-CANCER J CLIN, V60, P393, DOI 10.3322/caac.20087; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Ge XL, 2012, MOL MED REP IN PRESS; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kawahara T, 2009, ANTICANCER RES, V29, P4629; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Koivula S, 2011, ONCOL REP, V25, P1183, DOI 10.3892/or.2011.1179; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li C, 2011, J SURG ONCOL, V103, P184, DOI 10.1002/jso.21788; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liu HY, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-19; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Meng FL, 2011, INT J GYNECOL PATHOL, V30, P145, DOI 10.1097/PGP.0b013e3181ffd2f7; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020920; Moon R.T., 2005, SCI SIGNAL, V2005, pCM1, DOI [10.1126/stke.2712005cm1, DOI 10.1126/STKE.2712005CM1]; Muris JJF, 2005, BLOOD, V105, P2916, DOI 10.1182/blood-2004-07-2716; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2009, CANCER RES, V69, P8529, DOI 10.1158/0008-5472.CAN-09-1846; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Stein H, 2008, WHO CLASSIFICATION T, P233; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Xu JB, 2011, MED ONCOL, V28, P455, DOI 10.1007/s12032-010-9475-6; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Zhang D, 2010, LEUKEMIA LYMPHOMA, V51, P906, DOI 10.3109/10428191003695645	51	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39449	10.1371/journal.pone.0039449	http://dx.doi.org/10.1371/journal.pone.0039449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768080	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100051
J	Kreft, ME; Robenek, H				Kreft, Mateja Erdani; Robenek, Horst			Freeze-Fracture Replica Immunolabelling Reveals Urothelial Plaques in Cultured Urothelial Cells	PLOS ONE			English	Article							PRIMARY EXPLANT OUTGROWTHS; RAT URINARY-BLADDER; TRANSITIONAL EPITHELIUM; MEMBRANE-STRUCTURE; LUMINAL MEMBRANE; BARRIER FUNCTION; GOLGI-APPARATUS; UROPLAKIN-I; DIFFERENTIATION; MECHANISM	The primary function of the urothelium is to provide the tightest and most impermeable barrier in the body, i.e. the blood-urine barrier. Urothelial plaques are formed and inserted into the apical plasma membrane during advanced stages of urothelial cell differentiation. Currently, it is supposed that differentiation with the final formation of urothelial plaques is hindered in cultured urothelial cells. With the aid of the high-resolution imaging technique of freeze-fracture replica immunolabelling, we here provide evidence that urothelial cells in vitro form uroplakin-positive urothelial plaques, localized in fusiform-shaped vesicles and apical plasma membranes. With the establishment of such an in vitro model of urothelial cells with fully developed urothelial plaques and functional properties equivalent to normal bladder urothelium, new perspectives have emerged which challenge prevailing concepts of apical plasma membrane biogenesis and blood-urine barrier development. This may hopefully provide a timely impulse for many ongoing studies and open up new questions for future research.	[Kreft, Mateja Erdani] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Robenek, Horst] Univ Munster, Leibniz Inst Arteriosclerosis Res, Munster, Germany	University of Ljubljana; University of Munster	Kreft, ME (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	mateja.erdani@mf.uni-lj.si		Kreft, Mateja Erdani/0000-0001-6486-165X	Slovenian Ministry of Higher Education, Science and Technology [P3-0108]; Deutsche Forschungsgemeinschaft [SFB 492]	Slovenian Ministry of Higher Education, Science and Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Slovenian Ministry of Higher Education, Science and Technology (grant number P3-0108) and Deutsche Forschungsgemeinschaft, SFB 492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hudoklin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023636; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; KOSS LG, 1969, LAB INVEST, V21, P154; Kreft ME, 2010, BIOL CELL, V102, P593, DOI 10.1042/BC20100024; Kreft ME, 2009, DIFFERENTIATION, V77, P48, DOI 10.1016/j.diff.2008.09.011; Kreft ME, 2006, HISTOCHEM CELL BIOL, V125, P475, DOI 10.1007/s00418-005-0104-y; Kreft ME, 2005, HISTOCHEM CELL BIOL, V123, P529, DOI 10.1007/s00418-005-0770-9; Kreft ME, 2002, CELL BIOL INT, V26, P63, DOI 10.1006/cbir.2001.0829; Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013; Robenek H, 2009, J CELL MOL MED, V13, P1381, DOI 10.1111/j.1582-4934.2008.00407.x; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; Severs NJ, 2008, METHOD CELL BIOL, V88, P181, DOI 10.1016/S0091-679X(08)00411-1; SEVERS NJ, 1978, J ULTRA MOL STRUCT R, V64, P124, DOI 10.1016/S0022-5320(78)80031-8; SEVERS NJ, 1979, J ULTRA MOL STRUCT R, V69, P279, DOI 10.1016/S0022-5320(79)90117-5; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; SURYA B, 1990, J CELL SCI, V97, P419; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068; Visnjar T, 2012, HISTOCHEM CELL BIOL, V137, P177, DOI 10.1007/s00418-011-0893-0; WU XR, 1990, J BIOL CHEM, V265, P19170	22	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38509	10.1371/journal.pone.0038509	http://dx.doi.org/10.1371/journal.pone.0038509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768045	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100016
J	Ma, WX; Gutierrez, A; Goff, DJ; Geron, I; Sadarangani, A; Jamieson, CAM; Court, AC; Shih, AY; Jiang, QF; Wu, CC; Li, K; Smith, KM; Crews, LA; Gibson, NW; Deichaite, I; Morris, SR; Wei, P; Carson, DA; Look, AT; Jamieson, CHM				Ma, Wenxue; Gutierrez, Alejandro; Goff, Daniel J.; Geron, Ifat; Sadarangani, Anil; Jamieson, Christina A. M.; Court, Angela C.; Shih, Alice Y.; Jiang, Qingfei; Wu, Christina C.; Li, Kang; Smith, Kristen M.; Crews, Leslie A.; Gibson, Neil W.; Deichaite, Ida; Morris, Sheldon R.; Wei, Ping; Carson, Dennis A.; Look, A. Thomas; Jamieson, Catriona H. M.			NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; PROGENITOR CELLS; SELF-RENEWAL; CORD BLOOD; MUTATIONS; MAINTENANCE; EXPRESSION; DIFFERENTIATION; INACTIVATION	Background: Leukemia initiating cells (LIC) contribute to therapeutic resistance through acquisition of mutations in signaling pathways, such as NOTCH1, that promote self-renewal and survival within supportive niches. Activating mutations in NOTCH1 occur commonly in T cell acute lymphoblastic leukemia (T-ALL) and have been implicated in therapeutic resistance. However, the cell type and context specific consequences of NOTCH1 activation, its role in human LIC regeneration, and sensitivity to NOTCH1 inhibition in hematopoietic microenvironments had not been elucidated. Methodology and Principal Findings: We established humanized bioluminescent T-ALL LIC mouse models transplanted with pediatric T-ALL samples that were sequenced for NOTCH1 and other common T-ALL mutations. In this study, CD34(+) cells from NOTCH1(Mutated) T-ALL samples had higher leukemic engraftment and serial transplantation capacity than NOTCH1(Wild-type) CD34(+) cells in hematopoietic niches, suggesting that self-renewing LIC were enriched within the NOTCH1(Mutated) CD34(+) fraction. Humanized NOTCH1 monoclonal antibody treatment reduced LIC survival and self-renewal in NOTCH1(Mutated) T-ALL LIC-engrafted mice and resulted in depletion of CD34(+)CD2(+)CD7(+) cells that harbor serial transplantation capacity. Conclusions: These results reveal a functional hierarchy within the LIC population based on NOTCH1 activation, which renders LIC susceptible to targeted NOTCH1 inhibition and highlights the utility of NOTCH1 antibody targeting as a key component of malignant stem cell eradication strategies.	[Ma, Wenxue; Goff, Daniel J.; Geron, Ifat; Sadarangani, Anil; Jamieson, Christina A. M.; Court, Angela C.; Shih, Alice Y.; Jiang, Qingfei; Wu, Christina C.; Smith, Kristen M.; Crews, Leslie A.; Deichaite, Ida; Morris, Sheldon R.; Carson, Dennis A.; Jamieson, Catriona H. M.] Univ Calif San Diego, Dept Med, Stem Cell Program, La Jolla, CA 92093 USA; [Ma, Wenxue; Goff, Daniel J.; Geron, Ifat; Sadarangani, Anil; Jamieson, Christina A. M.; Court, Angela C.; Shih, Alice Y.; Jiang, Qingfei; Wu, Christina C.; Smith, Kristen M.; Crews, Leslie A.; Deichaite, Ida; Morris, Sheldon R.; Carson, Dennis A.; Jamieson, Catriona H. M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gutierrez, Alejandro; Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gutierrez, Alejandro; Look, A. Thomas] Childrens Hosp, Boston, MA 02115 USA; [Li, Kang; Gibson, Neil W.; Wei, Ping] La Jolla Labs, Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Pfizer	Ma, WX (corresponding author), Univ Calif San Diego, Dept Med, Stem Cell Program, La Jolla, CA 92093 USA.	cjamieson@ucsd.edu	Ma, Wenxue/D-5383-2019; JIANG, QINGFEI/K-3492-2012; Ma, Wenxue/A-6344-2012; Crews, Leslie/B-7584-2014	Ma, Wenxue/0000-0001-9228-6162; Ma, Wenxue/0000-0001-9228-6162; Crews, Leslie/0000-0003-0704-0067; Gutierrez, Alejandro/0000-0002-0249-9007; Goff, Daniel/0000-0003-2109-1696; Deichaite, Ida/0000-0001-8839-0573; Smith, Kristen/0000-0003-0960-0937; JIANG, QINGFEI/0000-0002-9072-8032	Ratner Family Foundation; Leichtag Family Foundation; Moores Cancer Center; NIH [1K08CA133103, 5P01CA68484]; William Lawrence Foundation; American Society of Hematology-Amos Medical Faculty Development program; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) program; CIRM New Faculty Award; CIRM; CIRM Early Translational II grants; Pfizer [Pfizer/28-1076]; NATIONAL CANCER INSTITUTE [K08CA133103, P01CA068484] Funding Source: NIH RePORTER	Ratner Family Foundation; Leichtag Family Foundation; Moores Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence Foundation; American Society of Hematology-Amos Medical Faculty Development program; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) program; CIRM New Faculty Award; CIRM(California Institute for Regenerative Medicine); CIRM Early Translational II grants; Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ratner Family Foundation, the Leichtag Family Foundation, and Moores Cancer Center Donor Funds. Dr. Gutierrez's work is supported by the NIH (grant 1K08CA133103), the William Lawrence Foundation, and the American Society of Hematology-Amos Medical Faculty Development program. Dr. Look's work was funded by the NIH (grant 5P01CA68484). Dr. Jamieson's work was supported by the California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) program, a CIRM New Faculty Award, and CIRM Disease Team and CIRM Early Translational II grants. A portion of this research study was funded by a sponsored research agreement with Pfizer (Pfizer/28-1076), and the antibody utilized in this study was provided by Pfizer. Authors Li, Gibson, and Wei were employees of Pfizer during the study, and these authors provided reagents for use in this study and contributed to data collection and analysis for antibody validation experiments.	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chessells JM, 2003, BRIT J HAEMATOL, V123, P396, DOI 10.1046/j.1365-2141.2003.04584.x; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Clappier E, 2010, LEUKEMIA, V24, P2023, DOI 10.1038/leu.2010.205; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cox CV, 2007, BLOOD, V109, P674, DOI 10.1182/blood-2006-06-030445; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Ferrando A, 2010, LEUKEMIA, V24, P2003, DOI 10.1038/leu.2010.237; Gerby B, 2011, LEUKEMIA, V25, P1249, DOI 10.1038/leu.2011.93; Geron I, 2008, CANCER CELL, V13, P321, DOI 10.1016/j.ccr.2008.02.017; Gutierrez A, 2010, J CLIN ONCOL, V28, P3816, DOI 10.1200/JCO.2010.28.3390; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sanda T, 2010, BLOOD, V115, P1735, DOI 10.1182/blood-2009-07-235143; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; van Delft FW, 2011, BLOOD; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	43	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39725	10.1371/journal.pone.0039725	http://dx.doi.org/10.1371/journal.pone.0039725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768113	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100083
J	Mijaljica, D; Prescott, M; Devenish, RJ				Mijaljica, Dalibor; Prescott, Mark; Devenish, Rodney J.			A Late Form of Nucleophagy in Saccharomyces cerevisiae	PLOS ONE			English	Article							NUCLEUS-VACUOLE JUNCTIONS; PIECEMEAL MICROAUTOPHAGY; AUTOPHAGOSOME FORMATION; SELECTIVE AUTOPHAGY; FLUORESCENT PROTEIN; BUDDING YEAST; MEMBRANE; COMPLEX; ATG9; DEGRADATION	Autophagy encompasses several processes by which cytosol and organelles can be delivered to the vacuole/lysosome for breakdown and recycling. We sought to investigate autophagy of the nucleus (nucleophagy) in the yeast Saccharomyces cerevisiae by employing genetically encoded fluorescent reporters. The use of such a nuclear reporter, n-Rosella, proved the basis of robust assays based on either following its accumulation (by confocal microscopy), or degradation (by immunoblotting), within the vacuole. We observed the delivery of n-Rosella to the vacuole only after prolonged periods of nitrogen starvation. Dual labeling of cells with Nvj1p-EYFP, a nuclear membrane reporter of piecemeal micronucleophagy of the nucleus (PMN), and the nucleoplasm-targeted NAB35-DsRed. T3 allowed us to detect PMN soon after the commencement of nitrogen starvation whilst delivery to the vacuole of the nucleoplasm reporter was observed only after prolonged periods of nitrogen starvation. This later delivery of nuclear components to the vacuole has been designated LN (late nucleophagy). Only a very few cells showed simultaneous accumulation of both reporters (Nvj1p-EYFP and NAB35-DsRed.T3) in the vacuole. We determined, therefore, that delivery of the two respective nuclear reporters to the vacuole is temporally and spatially separated. Furthermore, our data suggest that LN is mechanistically distinct from PMN because it can occur in nvj1 Delta and vac8 Delta cells, and does not require ATG11. Nevertheless, a subset of the components of the core macroautophagic machinery is required for LN as it is efficiently inhibited in null mutants of several autophagy-related genes (ATG) specifying such components. Moreover, the inhibition of LN in some mutants is accompanied by alterations in nuclear morphology.	[Mijaljica, Dalibor; Prescott, Mark; Devenish, Rodney J.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia	Monash University	Mijaljica, D (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia.	Rodney.Devenish@monash.edu		MIJALJICA, DALIBOR/0000-0002-8519-286X	Australian Research Council [DP0986937]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP0986937. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer C, 2001, MICROSC MICROANAL, V7, P530, DOI 10.1007/s10005-001-0020-4; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Devenish RJ, 2008, METHOD ENZYMOL, V451, P109, DOI 10.1016/S0076-6879(08)03209-6; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Epple UD, 2003, J BIOL CHEM, V278, P7810, DOI 10.1074/jbc.M209309200; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; Kiel JAKW, 2010, PHILOS T R SOC B, V365, P819, DOI 10.1098/rstb.2009.0237; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Krick R, 2009, AUTOPHAGY, V5, P270, DOI 10.4161/auto.5.2.7639; Kvam E, 2005, MOL BIOL CELL, V16, P3987, DOI 10.1091/mbc.e05-04-0290; Kvam E, 2004, J CELL SCI, V117, P4959, DOI 10.1242/jcs.01372; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Mijaljica D, 2010, NUCLEUS-PHILA, V1, P213, DOI 10.4161/nucl.1.3.11738; Millen JI, 2009, AUTOPHAGY, V5, P75, DOI 10.4161/auto.5.1.7181; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pereira C, 2010, MOL MICROBIOL, V76, P1398, DOI 10.1111/j.1365-2958.2010.07122.x; PRESCOTT M, 1995, BIOCHEM BIOPH RES CO, V207, P943, DOI 10.1006/bbrc.1995.1276; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sattler T, 2000, J CELL BIOL, V151, P529, DOI 10.1083/jcb.151.3.529; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; Subramani S, 2007, CELL, V130, P18, DOI 10.1016/j.cell.2007.06.041; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Tang FS, 2006, TRAFFIC, V7, P1368, DOI 10.1111/j.1600-0854.2006.00458.x; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Uttenweiler Andreas, 2008, V445, P245, DOI 10.1007/978-1-59745-157-4_16; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612	50	39	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40013	10.1371/journal.pone.0040013	http://dx.doi.org/10.1371/journal.pone.0040013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768199	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100171
J	Neant-Fery, M; Peres, E; Nasrallah, C; Kessner, M; Gribaudo, S; Greer, C; Didier, A; Trembleau, A; Caille, I				Neant-Fery, Marie; Peres, Eleonore; Nasrallah, Carole; Kessner, Monica; Gribaudo, Simona; Greer, Charles; Didier, Anne; Trembleau, Alain; Caille, Isabelle			A Role for Dendritic Translation of CaMKII alpha mRNA in Olfactory Plasticity	PLOS ONE			English	Article							PROTEIN-KINASE-II; MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; CYTOPLASMIC POLYADENYLATION; DEPENDENT TRANSLATION; SYNAPTIC PLASTICITY; MOUSE MODEL; BULB; MEMORY; STIMULATION	Local protein synthesis in dendrites contributes to the synaptic modifications underlying learning and memory. The mRNA encoding the alpha subunit of the calcium/calmodulin dependent Kinase II (CaMKII alpha) is dendritically localized and locally translated. A role for CaMKII alpha local translation in hippocampus-dependent memory has been demonstrated in mice with disrupted CaMKII alpha dendritic translation, through deletion of CaMKII alpha 3'UTR. We studied the dendritic localization and local translation of CaMKII alpha in the mouse olfactory bulb (OB), the first relay of the olfactory pathway, which exhibits a high level of plasticity in response to olfactory experience. CaMKII alpha is expressed by granule cells (GCs) of the OB. Through in situ hybridization and synaptosome preparation, we show that CaMKII alpha mRNA is transported in GC dendrites, synaptically localized and might be locally translated at GC synapses. Increases in the synaptic localization of CaMKII alpha mRNA and protein in response to brief exposure to new odors demonstrate that they are activity-dependent processes. The activity-induced dendritic transport of CaMKII alpha mRNA can be inhibited by an NMDA receptor antagonist and mimicked by an NMDA receptor agonist. Finally, in mice devoid of CaMKII alpha 3'UTR, the dendritic localization of CaMKII alpha mRNA is disrupted in the OB and olfactory associative learning is severely impaired. Our studies thus reveal a new functional modality for CaMKII alpha local translation, as an essential determinant of olfactory plasticity.	[Neant-Fery, Marie; Nasrallah, Carole; Kessner, Monica; Gribaudo, Simona; Trembleau, Alain; Caille, Isabelle] UPMC Univ Paris 06, CNRS, UMR 7102, Team Dev & Plast Neural Networks, Paris, France; [Peres, Eleonore; Didier, Anne] Univ Lyon 1, Neuroplast & Neuropathol Olfactory Percept Team, Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Peres, Eleonore; Didier, Anne] INSERM, UMR 1028, F-69008 Lyon, France; [Peres, Eleonore; Didier, Anne] CNRS, UMR5292, Lyon, France; [Greer, Charles] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Caille, Isabelle] Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Yale University; UDICE-French Research Universities; Universite Paris Cite	Neant-Fery, M (corresponding author), UPMC Univ Paris 06, CNRS, UMR 7102, Team Dev & Plast Neural Networks, Paris, France.	isabelle.caille@snv.jussieu.fr	Caillé, Isabelle/AAC-9575-2021; DIDIER, Anne/H-4413-2017	DIDIER, Anne/0000-0003-3118-9961; Caille, Isabelle/0000-0002-9054-2641; Gribaudo, Simona/0000-0002-9361-3855; Trembleau, Alain/0000-0002-8290-0795	Centre National de la Recherche Scientifique, UPMC; Institut National Scientifique d'Etudes et de Recherches Medicales [R06496DS]; ANR [06-NEUR-039-01]; FRM [INE20071110908, DEQ20071210561]; Fondation Lejeune; Region I le de France (DIM Stem-Pole and NeRF)	Centre National de la Recherche Scientifique, UPMC(Centre National de la Recherche Scientifique (CNRS)); Institut National Scientifique d'Etudes et de Recherches Medicales; ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); Fondation Lejeune; Region I le de France (DIM Stem-Pole and NeRF)	This work was supported by Centre National de la Recherche Scientifique, UPMC, Institut National Scientifique d'Etudes et de Recherches Medicales Avenir program (R06496DS), ANR (06-NEUR-039-01), FRM (INE20071110908 & DEQ20071210561) and Fondation Lejeune Grants. The "Development and Plasticity of Neural Networks'' team is affiliated with the Paris School of Neuroscience. MNF and SG were supported by fellowships from Region I le de France (DIM Stem-Pole and NeRF respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alves-Sampaio A, 2010, J NEUROSCI, V30, P13537, DOI 10.1523/JNEUROSCI.3457-10.2010; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Burton S, 2000, J NEUROSCI, V20, P5468, DOI 10.1523/JNEUROSCI.20-14-05468.2000; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Havik B, 2003, EUR J NEUROSCI, V17, P2679, DOI 10.1046/j.1460-9568.2003.02712.x; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Jonasson Z, 2004, HIPPOCAMPUS, V14, P28, DOI 10.1002/hipo.10146; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kermen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012118; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Martin C, 2004, J NEUROSCI, V24, P389, DOI 10.1523/JNEUROSCI.3433-03.2004; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Paradies MA, 1997, J NEUROBIOL, V33, P473, DOI 10.1002/(SICI)1097-4695(199710)33:4<473::AID-NEU10>3.0.CO;2-D; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Scotto-Lomassese S, 2011, J NEUROSCI, V31, P2205, DOI 10.1523/JNEUROSCI.5514-10.2011; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WHITTAKER VP, 1959, BIOCHEM J, V72, P694, DOI 10.1042/bj0720694; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zou DJ, 2002, J COMP NEUROL, V443, P226, DOI 10.1002/cne.10125	48	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40133	10.1371/journal.pone.0040133	http://dx.doi.org/10.1371/journal.pone.0040133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768241	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100213
J	Ravin, R; Blank, PS; Steinkamp, A; Rappaport, SM; Ravin, N; Bezrukov, L; Guerrero-Cazares, H; Quinones-Hinojosa, A; Bezrukov, SM; Zimmerberg, J				Ravin, Rea; Blank, Paul S.; Steinkamp, Alex; Rappaport, Shay M.; Ravin, Nitay; Bezrukov, Ludmila; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Bezrukov, Sergey M.; Zimmerberg, Joshua			Shear Forces during Blast, Not Abrupt Changes in Pressure Alone, Generate Calcium Activity in Human Brain Cells	PLOS ONE			English	Article							IN-VITRO; INJURY; MECHANISMS; MODEL; WAVE; RESPONSES	Blast-Induced Traumatic Brain Injury (bTBI) describes a spectrum of injuries caused by an explosive force that results in changes in brain function. The mechanism responsible for primary bTBI following a blast shockwave remains unknown. We have developed a pneumatic device that delivers shockwaves, similar to those known to induce bTBI, within a chamber optimal for fluorescence microscopy. Abrupt changes in pressure can be created with and without the presence of shear forces at the surface of cells. In primary cultures of human central nervous system cells, the cellular calcium response to shockwaves alone was negligible. Even when the applied pressure reached 15 atm, there was no damage or excitation, unless concomitant shear forces, peaking between 0.3 to 0.7 Pa, were present at the cell surface. The probability of cellular injury in response to a shockwave was low and cell survival was unaffected 20 hours after shockwave exposure.	[Ravin, Rea; Blank, Paul S.; Steinkamp, Alex; Rappaport, Shay M.; Ravin, Nitay; Bezrukov, Ludmila; Bezrukov, Sergey M.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Blank, Paul S.; Rappaport, Shay M.; Bezrukov, Sergey M.; Zimmerberg, Joshua] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Ravin, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	zimmerbj@mail.nih.gov	Blank, Paul/Q-9673-2019	Guerrero-Cazares, Hugo/0000-0003-1307-719X	Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409, ZIAHD000072] Funding Source: NIH RePORTER	Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this work included funding from Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM) and the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; BRODE HL, 1959, PHYS FLUIDS, V2, P217, DOI 10.1063/1.1705911; Center DaVBI, 2011, DEP DEF NUMB TRAUM B; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; LaPlaca MC, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P5882; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Shin HS, 2009, J NANOSCI NANOTECHNO, V9, P7330, DOI 10.1166/jnn.2009.1769; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; WHITTAKER VP, 1993, J NEUROCYTOL, V22, P735, DOI 10.1007/BF01181319; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215	27	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39421	10.1371/journal.pone.0039421	http://dx.doi.org/10.1371/journal.pone.0039421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768078	gold, Green Published			2022-12-25	WOS:000305892100049
J	Simonsen, TG; Gaustad, JV; Leinaas, MN; Rofstad, EK				Simonsen, Trude G.; Gaustad, Jon-Vidar; Leinaas, Marit N.; Rofstad, Einar K.			High Interstitial Fluid Pressure Is Associated with Tumor-Line Specific Vascular Abnormalities in Human Melanoma Xenografts	PLOS ONE			English	Article							SOLID TUMORS; CANCER-THERAPY; BLOOD-FLOW; ANGIOGENESIS; HYPERTENSION; METASTASIS; MACROMOLECULES; HETEROGENEITY; CARCINOMA; DELIVERY	Purpose: Interstitial fluid pressure (IFP) is highly elevated in many solid tumors. High IFP has been associated with low radiocurability and high metastatic frequency in human melanoma xenografts and with poor survival after radiation therapy in cervical cancer patients. Abnormalities in tumor vascular networks have been identified as an important cause of elevated tumor IFP. The aim of this study was to investigate the relationship between tumor IFP and the functional and morphological properties of tumor vascular networks. Materials and Methods: A-07-GFP and R-18-GFP human melanomas growing in dorsal window chambers in BALB/c nu/nu mice were used as preclinical tumor models. Functional and morphological parameters of the vascular network were assessed from first-pass imaging movies and vascular maps recorded after intravenous bolus injection of 155-kDa tetramethylrhodamine isothiocyanate-labeled dextran. IFP was measured in the center of the tumors using a Millar catheter. Angiogenic profiles of A-07-GFP and R-18-GFP cells were obtained with a quantitative PCR array. Results: High IFP was associated with low growth rate and low vascular density in A-07-GFP tumors, and with high growth rate and high vascular density in R-18-GFP tumors. A-07-GFP tumors showed chaotic and highly disorganized vascular networks, while R-18-GFP tumors showed more organized vascular networks with supplying arterioles in the tumor center and draining venules in the tumor periphery. Furthermore, A-07-GFP and R-18-GFP cells differed substantially in angiogenic profiles. A-07-GFP tumors with high IFP showed high geometric resistance to blood flow due to high vessel tortuosity. R-18-GFP tumors with high IFP showed high geometric resistance to blood flow due to a large number of narrow tumor capillaries. Conclusions: High IFP in A-07-GFP and R-18-GFP human melanoma xenografts was primarily a consequence of high blood flow resistance caused by tumor-line specific vascular abnormalities.	[Simonsen, Trude G.; Gaustad, Jon-Vidar; Leinaas, Marit N.; Rofstad, Einar K.] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Grp Radiat Biol & Tumor Physiol, Oslo, Norway	University of Oslo	Simonsen, TG (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Grp Radiat Biol & Tumor Physiol, Oslo, Norway.	Trude.Golimo.Simonsen@rr-research.no			Norwegian Cancer Society; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority	This work was supported by the Norwegian Cancer Society and the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Olama M, 2011, ACTA ONCOL, V50, P1098, DOI 10.3109/0284186X.2011.562240; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; Bjornaes I, 2001, MAGN RESON IMAGING, V19, P723, DOI 10.1016/S0730-725X(01)00377-0; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOUCHER Y, 1991, CANCER RES, V51, P6691; BOUCHER Y, 1992, CANCER RES, V52, P5110; Boucher Y, 1996, CANCER RES, V56, P4264; Brown JM, 1998, CANCER RES, V58, P1408; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CURTI BD, 1993, CANCER RES, V53, P2204; Ferretti S, 2009, NEOPLASIA, V11, P874, DOI 10.1593/neo.09554; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gaustad JV, 2008, NEOPLASIA, V10, P354, DOI 10.1593/neo.08162; Gaustad JV, 2009, NEOPLASIA, V11, P277, DOI 10.1593/neo.81400; Gulliksrud K, 2009, RADIOTHER ONCOL, V91, P107, DOI 10.1016/j.radonc.2008.08.015; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; Klosowska-Wardega A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008149; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1992, CANCER RES, V52, P6371; Lunt SJ, 2008, FUTURE ONCOL, V4, P793, DOI 10.2217/14796694.4.6.793; Milosevic M, 2001, CANCER RES, V61, P6400; Milosevic MF, 1998, CANCER, V82, P2418, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2418::AID-CNCR16>3.0.CO;2-S; NETTI PA, 1995, CANCER RES, V55, P5451; Netti PA, 1999, P NATL ACAD SCI USA, V96, P3137, DOI 10.1073/pnas.96.6.3137; Oye KS, 2008, MICROVASC RES, V75, P179, DOI 10.1016/j.mvr.2007.06.009; Ozerdem U, 2005, MICROVASC RES, V70, P116, DOI 10.1016/j.mvr.2005.07.003; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Rofstad EK, 2010, NEOPLASIA, V12, P889, DOI 10.1593/neo.10712; Rofstad EK, 2010, CLIN CANCER RES, V16, P936, DOI 10.1158/1078-0432.CCR-09-2718; Rofstad EK, 2009, NEOPLASIA, V11, P1243, DOI 10.1593/neo.91152; ROFSTAD EK, 1986, CELL TISSUE KINET, V19, P205, DOI 10.1111/j.1365-2184.1986.tb00731.x; Rofstad EK, 2000, CANCER RES, V60, P4932; Rofstad EK, 1999, INT J RADIAT BIOL, V75, P1377; Rofstad EK, 2002, CANCER RES, V62, P661; ROFSTAD EK, 1994, BRIT J CANCER, V70, P804, DOI 10.1038/bjc.1994.403; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Sen A, 2011, CANCER RES, V71, P3872, DOI 10.1158/0008-5472.CAN-10-4482; SEVICK EM, 1991, CANCER RES, V51, P1352; Tailor TD, 2010, MOL CANCER THER, V9, P1798, DOI 10.1158/1535-7163.MCT-09-0856; Tozer GM, 2005, ADV DRUG DELIVER REV, V57, P135, DOI 10.1016/j.addr.2004.07.015; Tufto I, 1998, CANCER LETT, V123, P159, DOI 10.1016/S0304-3835(97)00424-2; Vajkoczy P, 2000, NEOPLASIA, V2, P53, DOI 10.1038/sj.neo.7900062; VAUPEL P, 1989, CANCER RES, V49, P6449; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Yeo SG, 2009, CLIN CANCER RES, V15, P6201, DOI 10.1158/1078-0432.CCR-09-0560	48	51	52	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40006	10.1371/journal.pone.0040006	http://dx.doi.org/10.1371/journal.pone.0040006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768196	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100168
J	Su, HL; Liu, XY; Yan, WC; Shi, TY; Zhao, XX; Blake, DP; Tomley, FM; Suo, X				Su, Huali; Liu, Xianyong; Yan, Wenchao; Shi, Tuanyuan; Zhao, Xinxin; Blake, Damer P.; Tomley, Fiona M.; Suo, Xun			piggyBac Transposon-Mediated Transgenesis in the Apicomplexan Parasite Eimeria tenella	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS VIRUSES; STABLE TRANSFECTION; FLUORESCENT PROTEIN; BACULOVIRUS GENOME; IN-VITRO; TRANSFORMATION; EXPRESSION; SEQUENCES; SPOROZOITES; MUTAGENESIS	piggyBac, a type II transposon that is useful for efficient transgenesis and insertional mutagenesis, has been used for effective and stable transfection in a wide variety of organisms. In this study we investigate the potential use of the piggyBac transposon system for forward genetics studies in the apicomplexan parasite Eimeria tenella. Using the restriction enzyme-mediated integration (REMI) method, E. tenella sporozoites were electroporated with a donor plasmid containing the enhanced yellow fluorescent protein (EYFP) gene flanked by piggyBac inverted terminal repeats (ITRs), an Asc I-linearized helper plasmid containing the transposase gene and the restriction enzyme Asc I. Subsequently, electroporated sporozoites were inoculated into chickens via the cloacal route and transfected progeny oocysts expressing EYFP were sorted by flow cytometry. A transgenic E. tenella population was selected by successive in vivo passage. Southern-blotting analysis showed that exogenous DNA containing the EYFP gene was integrated into the parasite genome at a limited number of integration sites and that the inserted part of the donor plasmid was the fragment located between the 5' and 3' ITRs as indicated by primer-specific PCR screening. Genome walking revealed that the insertion sites were TTAA-specific, which is consistent with the transposition characteristics of piggyBac.	[Su, Huali; Liu, Xianyong; Yan, Wenchao; Shi, Tuanyuan; Zhao, Xinxin; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China; [Su, Huali; Liu, Xianyong; Yan, Wenchao; Shi, Tuanyuan; Zhao, Xinxin; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Blake, Damer P.; Tomley, Fiona M.] Inst Anim Hlth, Compton, Berks, England; [Blake, Damer P.; Tomley, Fiona M.] Royal Vet Coll, N Mymms, Herts, England	China Agricultural University; China Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of London; University of London Royal Veterinary College	Su, HL (corresponding author), China Agr Univ, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China.	suoxun@cau.edu.cn	Tomley, Fiona/GWM-9070-2022; Su, Huali/AAD-3755-2021; Yan, Wenchao/R-1234-2019	Tomley, Fiona/0000-0003-2188-8013; Zhao, Xin-Xin/0000-0002-1901-1784; LIU, XIANYONG/0000-0001-9425-6784; Blake, Damer/0000-0003-1077-2306	Ministry of Education Academic Awards for Excellent PhD Students in China; National Key Programs of China [2009ZX08009-152B]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001142] Funding Source: researchfish	Ministry of Education Academic Awards for Excellent PhD Students in China; National Key Programs of China; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Ministry of Education Academic Awards for Excellent PhD Students in China and the National Key Programs of China (Project Nos. 2009ZX08009-152B). Interactions between the authors' laboratories have been facilitated by BBSRC China Partnering Award 1340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Black M, 1995, MOL BIOCHEM PARASIT, V74, P55, DOI 10.1016/0166-6851(95)02483-2; Blake DP, 2006, INT J PARASITOL, V36, P97, DOI 10.1016/j.ijpara.2005.09.011; Bromley E, 2003, PROTEOMICS, V3, P1553, DOI 10.1002/pmic.200300479; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Clark JD, 2008, MOL BIOCHEM PARASIT, V162, P77, DOI 10.1016/j.molbiopara.2008.07.006; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Fonager J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-155; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Hao LL, 2007, MOL BIOCHEM PARASIT, V153, P213, DOI 10.1016/j.molbiopara.2007.02.005; Kelleher M, 1998, MOL BIOCHEM PARASIT, V97, P21, DOI 10.1016/S0166-6851(98)00128-5; Kurth M, 2009, PARASITOL RES, V104, P303, DOI 10.1007/s00436-008-1192-0; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Ling KH, 2007, GENOME RES, V17, P311, DOI 10.1101/gr.5823007; Liu XY, 2008, MOL BIOCHEM PARASIT, V161, P72, DOI 10.1016/j.molbiopara.2008.06.006; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; SCHMATZ DM, 1984, J PROTOZOOL, V31, P181, DOI 10.1111/j.1550-7408.1984.tb04314.x; Shi TY, 2008, J PARASITOL, V94, P978, DOI 10.1645/GE-1412.1; Shi TY, 2009, PARASITOL RES, V104, P315, DOI 10.1007/s00436-008-1194-y; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; Suo X, 2006, VET PARASITOL, V142, P63, DOI 10.1016/j.vetpar.2006.06.020; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Williams RB, 1998, INT J PARASITOL, V28, P1089, DOI 10.1016/S0020-7519(98)00066-6; Yan WC, 2009, INT J PARASITOL, V39, P109, DOI 10.1016/j.ijpara.2008.06.013	27	12	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40075	10.1371/journal.pone.0040075	http://dx.doi.org/10.1371/journal.pone.0040075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768223	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100195
J	Taya, S; Windridge, D; Osman, M				Taya, Shuichiro; Windridge, David; Osman, Magda			Looking to Score: The Dissociation of Goal Influence on Eye Movement and Meta-Attentional Allocation in a Complex Dynamic Natural Scene	PLOS ONE			English	Article							SALIENCY; TASK; OVERT; STRATEGIES; DIRECTION; MEMORY; SHIFTS	Several studies have reported that task instructions influence eye-movement behavior during static image observation. In contrast, during dynamic scene observation we show that while the specificity of the goal of a task influences observers' beliefs about where they look, the goal does not in turn influence eye-movement patterns. In our study observers watched short video clips of a single tennis match and were asked to make subjective judgments about the allocation of visual attention to the items presented in the clip (e. g., ball, players, court lines, and umpire). However, before attending to the clips, observers were either told to simply watch clips (non-specific goal), or they were told to watch the clips with a view to judging which of the two tennis players was awarded the point (specific goal). The results of subjective reports suggest that observers believed that they allocated their attention more to goal-related items (e. g. court lines) if they performed the goal-specific task. However, we did not find the effect of goal specificity on major eye-movement parameters (i.e., saccadic amplitudes, inter-saccadic intervals, and gaze coherence). We conclude that the specificity of a task goal can alter observer's beliefs about their attention allocation strategy, but such task-driven meta-attentional modulation does not necessarily correlate with eye-movement behavior.	[Taya, Shuichiro; Osman, Magda] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Taya, Shuichiro; Windridge, David; Osman, Magda] Univ Surrey, Ctr Vis Speech & Signal Proc, Guildford GU2 5XH, Surrey, England	University of London; Queen Mary University London; University of Surrey	Taya, S (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	m.osman@qmul.ac.uk		osman, magda/0000-0003-1480-6657; Windridge, David/0000-0001-5507-8516	Engineering and Physical Sciences Research Council [EP/F069626/1]; EPSRC [EP/F069421/1, EP/F069626/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F069421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study is supported by grants from the Engineering and Physical Sciences Research Council (EP/F069626/1; http://www.epsrc.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Betz T, 2010, J VISION, V10, DOI 10.1167/10.3.15; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Carmi R, 2006, J VISION, V6, P898, DOI 10.1167/6.9.4; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Chun MM, 2000, VIS COGN, V7, P65, DOI 10.1080/135062800394685; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Foulsham T, 2007, PERCEPTION, V36, P1123, DOI 10.1068/p5659; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Hegarty M, 2010, J EXP PSYCHOL LEARN, V36, P37, DOI 10.1037/a0017683; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Henderson JM, 2007, CURR DIR PSYCHOL SCI, V16, P219, DOI 10.1111/j.1467-8721.2007.00507.x; Henderson JM, 2009, PSYCHON B REV, V16, P850, DOI 10.3758/PBR.16.5.850; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kawahara J, 2010, CONSCIOUS COGN, V19, P107, DOI 10.1016/j.concog.2009.10.004; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Levin DT, 2000, VIS COGN, V7, P397, DOI 10.1080/135062800394865; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Lleras A, 2004, SPATIAL VISION, V17, P465, DOI 10.1163/1568568041920113; Malcolm GL, 2010, J VISION, V10, DOI 10.1167/10.2.4; Marat S, 2009, INT J COMPUT VISION, V82, P231, DOI 10.1007/s11263-009-0215-3; Mills M, 2011, J VISION, V11, DOI 10.1167/11.8.17; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Noesselt T, 2008, BRAIN RES, V1220, P157, DOI 10.1016/j.brainres.2007.12.060; Nuthmann A, 2010, J VISION, V10, DOI 10.1167/10.8.20; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Peters RJ, 2005, VISION RES, V45, P2397, DOI 10.1016/j.visres.2005.03.019; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Shinoda H, 2001, VISION RES, V41, P3535, DOI 10.1016/S0042-6989(01)00199-7; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Turano KA, 2003, VISION RES, V43, P333, DOI 10.1016/S0042-6989(02)00498-4; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Welchman AE, 2003, J VISION, V3, P817, DOI 10.1167/3.11.15; Wolfe JM, 1999, MIT BRAD COGN PSYCH, P71; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	46	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39060	10.1371/journal.pone.0039060	http://dx.doi.org/10.1371/journal.pone.0039060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768058	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100028
J	Xie, X; Ma, YT; Yang, YN; Li, XM; Fu, ZY; Zheng, YY; Ma, X; Chen, BD; Liu, F; Huang, Y; Yu, ZX; Chen, Y				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Fu, Zhen-Yan; Zheng, Ying-Ying; Ma, Xiang; Chen, Bang-Dang; Liu, Fen; Huang, Ying; Yu, Zi-Xiang; Chen, You			Serum Uric Acid Levels Are Associated with Polymorphism in the SAA1 Gene in Chinese Subjects	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HEALTHY-SUBJECTS; HYPERTENSION; DISEASE; INFLAMMATION; MECHANISMS; PROTEINS; OBESITY; CELLS; RISK	Objective: Serum uric acid (SUA) is a cardiovascular risk marker associated with inflammation. The serum amyloid A protein (SAA) is an inflammatory factor and is associated with cardiovascular disease (CVD). However, the relationship between genetic polymorphisms of SAA and SUA levels has not been studied. The objective of this study was to investigate the association between SUA levels and SAA genetic polymorphisms. Methods: All participants were selected from subjects participating in the Cardiovascular Risk Survey (CRS) study. The single nucleotide polymorphism (SNP) rs12218 of the SAA1 gene was genotyped by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The association of SUA levels with genotypes was assessed by using the general liner mode. Results: The SNP rs12218 was associated with SUA levels by analyses of a dominate model (P = 0.002) and additive model (P = 0.005), and the difference remained significant after adjustment of sex, age, obesity, ethnicity, HDL-C, alcohol intake, smoking, and creatinine (P = 0.006 and P = 0.023, respectively). The TT genotype was associated with an increased SUA concentration of 39.34 mmol/L (95% confidence interval [CI], 3.61-75.06, P = 0.031) compared with the CC genotype, and the TT genotype was associated with an increased SUA concentration of 2.48 mmol/L (95% CI, 6.86-38.10; P = 0.005) compared with the CT genotype. Conclusions: The rs12218 SNP in the SAA1 gene was associated with SUA levels in Chinese subjects, indicating that carriers of the T allele of rs12218 have a high risk of hyperuricemia.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Fu, Zhen-Yan; Zheng, Ying-Ying; Ma, Xiang; Huang, Ying; Yu, Zi-Xiang; Chen, You] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Fu, Zhen-Yan; Zheng, Ying-Ying; Ma, Xiang; Chen, Bang-Dang; Liu, Fen; Huang, Ying; Yu, Zi-Xiang; Chen, You] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Xinjiang Medical University [2010YFY08]; National Natural Science Foundation of China [81160017]; Natural Science Foundation of Xinjiang [2011211D32]	Xinjiang Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang	Encouraged Fund for Research of Xinjiang Medical University (2010YFY08) on the basis of the National Natural Science Foundation of China (81160017) and Natural Science Foundation of Xinjiang (2011211D32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; Bonora E, 1996, INT J OBESITY, V20, P975; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; KIRWAN J, 1993, BRIT J RHEUMATOL, V32, P729; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; LEVIN M, 1972, J CLIN INVEST, V51, P2773, DOI 10.1172/JCI107098; Leyva F, 1998, EUR HEART J, V19, P1814, DOI 10.1053/euhj.1998.1188; Manzato E, 2007, INTERN EMERG MED, V2, P1, DOI 10.1007/s11739-007-0001-6; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Montalcini T, 2007, INTERN EMERG MED, V2, P19, DOI 10.1007/s11739-007-0004-3; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Patel S, 2008, EUR HEART J, V29, P386, DOI 10.1093/eurheartj/ehm526; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Xie X, 2011, BLOOD PRESSURE, V20, P232, DOI 10.3109/08037051.2011.566244; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Xie Xiang, 2010, Zhonghua Yi Xue Za Zhi, V90, P1824; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078; Yamada T, 1999, AMYLOID, V6, P199, DOI 10.3109/13506129909007327	31	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40263	10.1371/journal.pone.0040263	http://dx.doi.org/10.1371/journal.pone.0040263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768267	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100241
J	Zhang, SL; Wang, YC; Mao, JH; Hsieh, D; Kim, IJ; Hu, LM; Xu, ZD; Long, H; Jablons, DM; You, L				Zhang, Shulin; Wang, Yucheng; Mao, Jian-Hua; Hsieh, David; Kim, Il-Jin; Hu, Li-Min; Xu, Zhidong; Long, Hao; Jablons, David M.; You, Liang			Inhibition of CK2 alpha Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE CK2; PROSTATE-CANCER; THERAPEUTIC INHIBITION; PATHWAY; TARGET; ABCG2; WNT; DIVERGENCE; CARCINOMAS; SUPPRESSOR	Protein kinase CK2 is frequently elevated in a variety of human cancers. The Hedgehog (Hh) signaling pathway has been implicated in stem cell maintenance, and its aberrant activation has been indicated in several types of cancer, including lung cancer. In this study, we show that CK2 is positively involved in Hh/Gli signaling in lung cancer cell lines A549 and H1299. First, we found a correlation between CK2 alpha and Gli1 mRNA levels in 100 primary lung cancer tissues. Down-regulation of Gli1 expression and transcriptional activity were demonstrated after the silencing of CK2 alpha in lung cancer cells. In addition, CK2 alpha siRNA down-regulated the expression of Hh target genes. Furthermore, two small-molecule CK2 alpha inhibitors led to a dose-dependent inhibition of Gli1 expression and transcriptional activity in lung cancer cells. Reversely, forced overexpression of CK2 alpha resulted in an increase both in Gli1 expression and transcriptional activity in A549 cells. Finally, the inhibition of Hh/Gli by CK2 alpha siRNA led to a reduction of a cancer stem cell-like side population that shows higher ABCG2 expression level. Thus, we report that the inhibition of CK2 alpha down-regulates Hh/Gli signaling and subsequently reduces stem-like side population in human lung cancer cells.	[Zhang, Shulin; Hsieh, David; Kim, Il-Jin; Xu, Zhidong; Long, Hao; Jablons, David M.; You, Liang] Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Zhang, Shulin] Sun Yat Sen Univ, Lung Canc Inst, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Shulin] Guangzhou Med Univ, Affiliated Hosp 3, Dept Surg Oncol, Guangzhou, Guangdong, Peoples R China; [Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hu, Li-Min] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Sun Yat Sen University; Guangzhou Medical University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Zhang, SL (corresponding author), Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, Thorac Oncol Lab, San Francisco, CA 94143 USA.	longhao@mail.sysu.edu.cn; Liang.You@ucsfmedctr.org	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021	National Institutes of Health [R01 CA140654-01A1]; Natural Science Foundation of Guangdong Province, P.R.C. [9451008901003072]; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation, Inc; Estate of Robert Griffiths; Jeffrey and Karen Peterson Family Foundation; Paul and Michelle Zygielbaum; Estate of Norman Mancini; Barbara Isackson Lung Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA140654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Guangdong Province, P.R.C.; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation, Inc; Estate of Robert Griffiths; Jeffrey and Karen Peterson Family Foundation; Paul and Michelle Zygielbaum; Estate of Norman Mancini; Barbara Isackson Lung Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by National Institutes of Health grant R01 CA140654-01A1 (LY) and Natural Science Foundation of Guangdong Province, P.R.C. 2009 (9451008901003072). We are also grateful for support from the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation, Inc; the Estate of Robert Griffiths; the Jeffrey and Karen Peterson Family Foundation; Paul and Michelle Zygielbaum; the Estate of Norman Mancini; and the Barbara Isackson Lung Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Balbuena J, 2011, CYTOM PART A, V79A, P672, DOI 10.1002/cyto.a.21103; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Cozza G, 2011, CURR MED CHEM, V18, P2867, DOI 10.2174/092986711796150423; Cozza G, 2010, MED RES REV, V30, P419, DOI 10.1002/med.20164; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guerra B, 2006, INT J ONCOL, V28, P685; Guo CH, 1999, CANCER RES, V59, P1146; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Hung MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011418; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mizuarai S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-44; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Perea SE, 2011, MOL CELL BIOCHEM, V356, P45, DOI 10.1007/s11010-011-0950-y; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Pierre F, 2011, J MED CHEM, V54, P635, DOI 10.1021/jm101251q; Raaf J, 2011, BIOCHEMISTRY-US, V50, P512, DOI 10.1021/bi1013563; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tian F, 2012, CLIN EXP MED, V12, P25, DOI 10.1007/s10238-011-0135-8; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang GX, 2008, MOL CELL BIOCHEM, V316, P91, DOI 10.1007/s11010-008-9810-9; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860	58	51	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38996	10.1371/journal.pone.0038996	http://dx.doi.org/10.1371/journal.pone.0038996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768056	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100026
J	Gangwar, SP; Dey, S; Saxena, AK				Gangwar, Shanti P.; Dey, Sharmistha; Saxena, Ajay K.			Structural Modeling and DNA Binding Autoinhibition Analysis of Ergp55, a Critical Transcription Factor in Prostate Cancer	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; ETS-DOMAIN; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; COMPLEX; FAMILY; RECOGNITION; PEA3; TRANSACTIVATION; EXPRESSION	Background: The Ergp55 protein belongs to Ets family of transcription factor. The Ets proteins are highly conserved in their DNA binding domain and involved in various development processes and regulation of cancer metabolism. To study the structure and DNA binding autoinhibition mechanism of Ergp55 protein, we have produced full length and smaller polypeptides of Ergp55 protein in E. coli and characterized using various biophysical techniques. Results: The Ergp55 polypeptides contain large amount of alpha-helix and random coil structures as measured by circular dichorism spectroscopy. The full length Ergp55 forms a flexible and elongated molecule as revealed by molecular modeling, dynamics simulation and structural prediction algorithms. The binding analyses of Ergp55 polypeptides with target DNA sequences of E74 and cfos promoters indicate that longer fragments of Ergp55 (beyond the Ets domain) showed the evidence of auto-inhibition. This study also revealed the parts of Ergp55 protein that mediate auto-inhibition. Significance: The current study will aid in designing the compounds that stabilize the inhibited form of Ergp55 and inhibit its binding to promoter DNA. It will contribute in the development of drugs targeting Ergp55 for the prostate cancer treatment.	[Gangwar, Shanti P.; Saxena, Ajay K.] Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India; [Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Gangwar, SP (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India.	ajaysaxena@mail.jnu.ac.in	Gangwar, Shanti Pal/AAE-8163-2021	Gangwar, Shanti Pal/0000-0003-1024-7608	Department of Science and Technology (DST) New Delhi, India [No-SR/SO/HS-05/2009]	Department of Science and Technology (DST) New Delhi, India(Department of Science & Technology (India))	The work was supported by grant from the Department of Science and Technology (DST) New Delhi, India (No-SR/SO/HS-05/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkar VB, 2010, J MOL BIOL, V397, P278, DOI 10.1016/j.jmb.2010.01.017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Laget MP, 1996, ONCOGENE, V12, P1325; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Mackereth CD, 2004, J MOL BIOL, V342, P1249, DOI 10.1016/j.jmb.2004.07.094; Mauen S, 2006, BBA-GEN SUBJECTS, V1760, P1192, DOI 10.1016/j.bbagen.2006.03.007; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Pio F, 1996, J BIOL CHEM, V271, P23329, DOI 10.1074/jbc.271.38.23329; PRASAD DDK, 1992, CANCER RES, V52, P5833; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; SIDDIQUE HR, 1993, ONCOGENE, V8, P1751; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Verger A, 2001, J BIOL CHEM, V276, P17181, DOI 10.1074/jbc.M010208200; Wang YZ, 2005, BIOCHEMISTRY-US, V44, P7095, DOI 10.1021/bi047352t; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251	41	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39850	10.1371/journal.pone.0039850	http://dx.doi.org/10.1371/journal.pone.0039850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761914	gold, Green Submitted, Green Published			2022-12-25	WOS:000305826400042
J	Rutgen, BC; Willenbrock, S; Reimann-Berg, N; Walter, I; Fuchs-Baumgartinger, A; Wagner, S; Kovacic, B; Essler, SE; Schwendenwein, I; Nolte, I; Saalmuller, A; Escobar, HM				Ruetgen, Barbara C.; Willenbrock, Saskia; Reimann-Berg, Nicola; Walter, Ingrid; Fuchs-Baumgartinger, Andrea; Wagner, Siegfried; Kovacic, Boris; Essler, Sabine E.; Schwendenwein, Ilse; Nolte, Ingo; Saalmueller, Armin; Escobar, Hugo Murua			Authentication of Primordial Characteristics of the CLBL-1 Cell Line Prove the Integrity of a Canine B-Cell Lymphoma in a Murine In Vivo Model	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; MALIGNANT-LYMPHOMA; CHROMOSOMAL-ABERRATIONS; DOGS; RECEPTOR; CANCER; TUMORS; CLASSIFICATION; ABNORMALITIES; EXPRESSION	Cell lines are key tools in cancer research allowing the generation of neoplasias in animal models resembling the initial tumours able to mimic the original neoplasias closely in vivo. Canine lymphoma is the major hematopoietic malignancy in dogs and considered as a valuable spontaneous large animal model for human Non-Hodgkin's Lymphoma (NHL). Herein we describe the establishment and characterisation of an in vivo model using the canine B-cell lymphoma cell line CLBL-1 analysing the stability of the induced tumours and the ability to resemble the original material. CLBL-1 was injected into Rag2(-/-)gamma(-/-)(c) mice. The generated tumor material was analysed by immunophenotyping and histopathology and used to establish the cell line CLBL-1M. Both cell lines were karyotyped for detection of chromosomal aberrations. Additionally, CLBL-1 was stimulated with IL-2 and DSP30 as described for primary canine B-cell lymphomas and NHL to examine the stimulatory effect on cell proliferation. CLBL-1 in vivo application resulted in lymphoma-like disease and tumor formation. Immunophenotypic analysis of tumorous material showed expression of CD45(+), MHCII+, CD11a(+) and CD79 alpha cy(+). PARR analysis showed positivity for IgH indicating a monoclonal character. These cytogenetic, molecular, immunophenotypical and histological characterisations of the in vivo model reveal that the induced tumours and thereof generated cell line resemble closely the original material. After DSP30 and IL-2 stimulation, CLBL-1 showed to respond in the same way as primary material. The herein described CLBL-1 in vivo model provides a highly stable tool for B-cell lymphoma research in veterinary and human medicine allowing various further in vivo studies.	[Ruetgen, Barbara C.; Schwendenwein, Ilse] Univ Vet Med Vienna, Dept Pathobiol, Cent Lab, Vienna, Austria; [Willenbrock, Saskia; Reimann-Berg, Nicola; Wagner, Siegfried; Nolte, Ingo; Escobar, Hugo Murua] Univ Vet Med Hannover, Small Anim Clin & Res Cluster Excellence REBIRTH, Hannover, Lower Saxony, Germany; [Walter, Ingrid] Univ Vet Med Vienna, VetCore Facil Res, VetBioBank, Vienna, Austria; [Fuchs-Baumgartinger, Andrea] Univ Vet Med Vienna, Dept Pathobiol, Inst Pathol, Vienna, Austria; [Kovacic, Boris] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Dept Biomed Sci, Vienna, Austria; [Essler, Sabine E.; Saalmueller, Armin] Univ Vet Med Vienna, Inst Immunol, Dept Pathobiol, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Rutgen, BC (corresponding author), Univ Vet Med Vienna, Dept Pathobiol, Cent Lab, Vienna, Austria.	hescobar@tiho-hannover.de	Kovacic, Boris/J-1871-2016; Saalmüller, Armin/AAN-9058-2020; Rütgen, Barbara/ADM-6510-2022	Kovacic, Boris/0000-0002-1148-4149; Saalmuller, Armin/0000-0002-7703-3252	German Research Foundation within the excellence cluster REBIRTH; collaborative research cluster Transregio 37 'Micro- und Nanosysteme in der Medizin'	German Research Foundation within the excellence cluster REBIRTH; collaborative research cluster Transregio 37 'Micro- und Nanosysteme in der Medizin'	The work was funded in part by the German Research Foundation within the excellence cluster REBIRTH. Further parts were funded by the collaborative research cluster Transregio 37 'Micro- und Nanosysteme in der Medizin'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTNITZKE S, 1992, CYTOGENET CELL GENET, V60, P135, DOI 10.1159/000133323; BLOOMFIELD CD, 1983, CANCER RES, V43, P2975; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Decker T, 2000, EXP HEMATOL, V28, P558, DOI 10.1016/S0301-472X(00)00144-2; Devitt JJ, 2009, CYTOGENET GENOME RES, V124, P12, DOI 10.1159/000200083; Fosmire SP, 2007, VET PATHOL, V44, P467, DOI 10.1354/vp.44-4-467; FournelFleury C, 1997, J COMP PATHOL, V117, P35, DOI 10.1016/S0021-9975(97)80065-5; GREENLEE PG, 1990, CANCER-AM CANCER SOC, V66, P480, DOI 10.1002/1097-0142(19900801)66:3&lt;480::AID-CNCR2820660314&gt;3.0.CO;2-X; Haferlach C, 2007, LEUKEMIA, V21, P2442, DOI 10.1038/sj.leu.2404935; HAHN KA, 1994, VET PATHOL, V31, P528, DOI 10.1177/030098589403100504; Joetzke AE, 2010, VET COMP ONCOL, V8, P87, DOI 10.1111/j.1476-5829.2010.00207.x; JOHNSON RE, 1969, RADIOLOGY, V93, P395, DOI 10.1148/93.2.395; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kisseberth WC, 2007, LEUKEMIA RES, V31, P1709, DOI 10.1016/j.leukres.2007.04.003; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Milner RJ, 1996, ONDERSTEPOORT J VET, V63, P309; Mitsiades CS, 2003, CANCER RES, V63, P6689; Pastor M, 2009, J VET INTERN MED, V23, P301, DOI 10.1111/j.1939-1676.2008.0255.x; Reimann N, 1996, CYTOGENET CELL GENET, V73, P140, DOI 10.1159/000134326; Reimann-Berg N, 2011, CYTOGENET GENOME RES, V135, P79, DOI 10.1159/000330126; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Rutgen BC, 2011, TUMORGENICITY GROWTH, P56; Saalmuller A, 2005, CELL IMMUNOL, V236, P51, DOI 10.1016/j.cellimm.2005.08.009; Starkey Mike P., 2005, Briefings in Functional Genomics & Proteomics, V4, P112; Sterenczak KA, 2010, ANTICANCER RES, V30, P5043; Struski S, 2009, LEUKEMIA, V23, P617, DOI 10.1038/leu.2008.252; TESKE E, 1994, VET QUART, V16, P209, DOI 10.1080/01652176.1994.9694451; Thomas R, 2003, BRIT J CANCER, V89, P1530, DOI 10.1038/sj.bjc.6601275; Upanal N, 2011, AUST NZ J OBSTET GYN, V51, P559, DOI 10.1111/j.1479-828X.2011.01365.x; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vang R, 2000, MODERN PATHOL, V13, P19, DOI 10.1038/modpathol.3880005; Winkler S, 2005, ANTICANCER RES, V25, P3995; Withrow SJ, 2001, SMALL ANIMAL CLIN ON, V3rd	36	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40078	10.1371/journal.pone.0040078	http://dx.doi.org/10.1371/journal.pone.0040078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761949	Green Submitted, Green Published, gold			2022-12-25	WOS:000305826400054
J	Gil-Henn, H; Patsialou, A; Wang, Y; Warren, MS; Condeelis, JS; Koleske, AJ				Gil-Henn, H.; Patsialou, A.; Wang, Y.; Warren, M. S.; Condeelis, J. S.; Koleske, A. J.			Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo	ONCOGENE			English	Article						breast cancer; metastasis; invasion; proliferation; Arg kinase	ABL-FAMILY KINASES; TYROSINE-KINASE; C-ABL; TUMOR SIZE; METASTASIS; CELLS; ARG; EXPRESSION; GENE; T(1/12)(Q25,P13)	Tumor progression is a complex, multistep process involving accumulation of genetic aberrations and alterations in gene expression patterns leading to uncontrolled cell division, invasion into surrounding tissue and finally dissemination and metastasis. We have previously shown that the Arg/Abl2 non-receptor tyrosine kinase acts downstream of the EGF receptor and Src tyrosine kinases to promote invadopodium function in breast cancer cells, thereby promoting their invasiveness. However, whether and how Arg contributes to tumor development and dissemination in vivo has never been investigated. Using a mouse xenograft model, we show that knocking down Arg in breast cancer cells leads to increased tumor cell proliferation and significantly enlarged tumor size. Despite having larger tumors, the Arg-knockdown (Arg KD) tumor-bearing mice exhibit significant reductions in tumor cell invasion, intravasation into blood vessels and spontaneous metastasis to lungs. Interestingly, we found that proliferationassociated genes in the Ras-MAPK (mitogen-activated protein kinase) pathway are upregulated in Arg KD breast cancer cells, as is Ras-MAPK signaling, while invasion-associated genes are significantly downregulated. These data suggest that Arg promotes tumor cell invasion and dissemination, while simultaneously inhibiting tumor growth. We propose that Arg acts as a switch in metastatic cancer cells that governs the decision to 'grow or go' (divide or invade).	[Gil-Henn, H.; Warren, M. S.; Koleske, A. J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Patsialou, A.; Wang, Y.; Condeelis, J. S.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Condeelis, J. S.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA	Yale University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Condeelis, JS (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	john.condeelis@einstein.yu.edu; anthony.koleske@yale.edu			Breast Cancer Alliance [CA133346];  [CA100324]; NATIONAL CANCER INSTITUTE [R01CA133346, R01CA164468, P01CA100324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100411] Funding Source: NIH RePORTER	Breast Cancer Alliance; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the Einstein Histotechnology and Comparative Pathology Facility for their excellent service, and Dr Rani Sellers for helpful advice and suggestions. This work was supported by PHS grant CA133346 and an Exceptional Project Award from the Breast Cancer Alliance (AJK) and CA100324 (JSC).	Advani AS, 2002, LEUKEMIA RES, V26, P713, DOI 10.1016/S0145-2126(01)00197-7; Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Cazzaniga G, 1999, BLOOD, V94, P4370, DOI 10.1182/blood.V94.12.4370.424k34_4370_4373; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; Chopra R, 1999, BLOOD REV, V13, P211, DOI 10.1054/blre.1999.0119; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iijima Y, 2000, BLOOD, V95, P2126; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Podtcheko A, 2003, J CLIN ENDOCR METAB, V88, P1889, DOI 10.1210/jc.2002-021230; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wo JY, 2011, J CLIN ONCOL, V29, P2619, DOI 10.1200/JCO.2010.29.5907; Wyckoff JB, 2000, CANCER RES, V60, P5401; Wyckoff JB, 2000, CANCER RES, V60, P2504	38	89	92	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2013	32	21					2622	2630		10.1038/onc.2012.284	http://dx.doi.org/10.1038/onc.2012.284			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FH	22777352	Green Accepted			2022-12-25	WOS:000319806700003
J	Bonet, C; Giuliano, S; Ohanna, M; Bille, K; Allegra, M; Lacour, JP; Bahadoran, P; Rocchi, S; Ballotti, R; Bertolotto, C				Bonet, Caroline; Giuliano, Sandy; Ohanna, Mickael; Bille, Karine; Allegra, Maryline; Lacour, Jean-Philippe; Bahadoran, Philippe; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine			Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; MALIGNANT-MELANOMA; INHIBITOR; EXPRESSION; OVEREXPRESSION; CENTROMERE; APOPTOSIS; MITF; RAF	Metastatic melanoma is a deadly skin cancer and is resistant to almost all existing treatment. Vemurafenib, which targets the BRAFV600E mutation, is one of the drugs that improves patient outcome, but the patients next develop secondary resistance and a return to cancer. Thus, new therapeutic strategies are needed to treat melanomas and to increase the duration of v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) inhibitor response. The ERK pathway controls cell proliferation, and Aurora B plays a pivotal role in cell division. Here, we confirm that Aurora B is highly expressed in metastatic melanoma cells and that Aurora B inhibition triggers both senescence-like phenotypes and cell death in melanoma cells. Furthermore, we show that the BRAF/ERK axis controls Aurora B expression at the transcriptional level, likely through the transcription factor FOXM1. Our results provide insight into the mechanism of Aurora B regulation and the first molecular basis of Aurora B regulation in melanoma cells. The inhibition of Aurora B expression that we observed in vemurafenib-sensitive melanoma cells was rescued in cells resistant to this drug. Consistently, these latter cells remain sensitive to the effect of the Aurora B inhibitor. Noteworthy, wild-type BRAF melanoma cells are also sensitive to Aurora B inhibition. Collectively, our findings, showing that Aurora B is a potential target in melanoma cells, particularly in those vemurafenib-resistant, may open new avenues to improve the treatment of metastatic melanoma.	[Bonet, Caroline; Giuliano, Sandy; Ohanna, Mickael; Bille, Karine; Allegra, Maryline; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine] INSERM, Ctr Mediterraneen Med Mol, Equipe 1, Biol & Pathol Melanocytes Pigmentat Cutanee Melan, F-06204 Nice, France; [Bonet, Caroline; Giuliano, Sandy; Ohanna, Mickael; Bille, Karine; Allegra, Maryline; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine] Univ Nice Sophia Antipolis, UFR Med, F-06107 Nice, France; [Lacour, Jean-Philippe; Bahadoran, Philippe; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine] Ctr Hosp Univ Nice, Serv Dermatol, F-06204 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Bertolotto, C (corresponding author), INSERM, Ctr Mediterraneen Med Mol, Equipe 1, Biol & Pathol Melanocytes Pigmentat Cutanee Melan, F-06204 Nice, France.	bertolot@unice.fr	BALLOTTI, Robert/F-8825-2013; Ohanna, Mickael/O-5784-2016; Rocchi, Stephane/O-4152-2016; Bertolotto, Corine/AAF-6634-2021; Giuliano, Sandy/U-2498-2019; Bertolotto-Ballotti, Corine/O-2155-2016	Ohanna, Mickael/0000-0002-7751-9164; Rocchi, Stephane/0000-0002-0943-1304; Bertolotto, Corine/0000-0001-6971-7753; Bahadoran, Philippe/0000-0002-2481-0556; Lacour, Jean-Philippe/0000-0001-7663-2053; BALLOTTI, Robert/0000-0002-7322-4908	INSERM; Fondation de France; Societe Francaise de Dermatologie; Fondation pour la Recherche Medicale; La Ligue Nationale Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France); Societe Francaise de Dermatologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by INSERM, the "Fondation de France," and the "Societe Francaise de Dermatologie."; Supported by the Fondation pour la Recherche Medicale.; Supported by La Ligue Nationale Contre le Cancer.	Arbitrario JP, 2010, CANCER CHEMOTH PHARM, V65, P707, DOI 10.1007/s00280-009-1076-8; Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Boone B, 2011, J CUTAN PATHOL, V38, P492, DOI 10.1111/j.1600-0560.2011.01673.x; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Cui YP, 2010, CANCER RES, V70, P675, DOI 10.1158/0008-5472.CAN-09-1491; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon NK, 2003, GENES IMMUN, V4, P336, DOI 10.1038/sj.gene.6363973; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jani JP, 2010, MOL CANCER THER, V9, P883, DOI 10.1158/1535-7163.MCT-09-0915; Kimura M, 2004, BIOCHEM BIOPH RES CO, V316, P930, DOI 10.1016/j.bbrc.2004.01.178; Kurai M, 2005, HUM PATHOL, V36, P1281, DOI 10.1016/j.humpath.2005.09.014; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Larribere L, 2004, CELL DEATH DIFFER, V11, P1084, DOI 10.1038/sj.cdd.4401475; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Otsuka T, 1998, CANCER RES, V58, P5157; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Pirker C, 2010, EXP DERMATOL, V19, P1040, DOI 10.1111/j.1600-0625.2010.01182.x; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Song LP, 2007, CELL BIOL INT, V31, P1184, DOI 10.1016/j.cellbi.2007.04.002; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Tomonaga T, 2007, HISTOL HISTOPATHOL, V22, P191, DOI 10.14670/HH-22.191; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Wakahara K, 2008, MOL CANCER RES, V6, P1937, DOI 10.1158/1541-7786.MCR-08-0054; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang Xiaolei, 2010, Genes Cancer, V1, P952, DOI 10.1177/1947601910388936; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	41	59	61	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29887	29898		10.1074/jbc.M112.371682	http://dx.doi.org/10.1074/jbc.M112.371682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767597	Green Published, hybrid			2022-12-25	WOS:000308286900062
J	Bulus, N; Feral, C; Pozzi, A; Zent, R				Bulus, Nada; Feral, Chloe; Pozzi, Ambra; Zent, Roy			CD98 Increases Renal Epithelial Cell Proliferation by Activating MAPKs	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; 4F2 HEAVY-CHAIN; CYCLIN D1 EXPRESSION; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; SUBSTRATE SELECTIVITY; SLC3A2 INTERACTION; MEMBRANE-PROTEIN; CO-EXPRESSES; IDENTIFICATION	CD98 heavy chain (CD98hc) is a multifunctional transmembrane spanning scaffolding protein whose extracellular domain binds with light chain amino acid transporters (Lats) to form the heterodimeric amino acid transporters (HATs). It also interacts with beta 1 and beta 3 integrins by its transmembrane and cytoplasmic domains. This interaction is proposed to be the mechanism whereby CD98 mediates cell survival and growth via currently undefined signaling pathways. In this study, we determined whether the critical function of CD98-dependent amino acid transport also plays a role in cell proliferation and defined the signaling pathways that mediate CD98-dependent proliferation of murine renal inner medullary collecting duct (IMCD) cells. We demonstrate that downregulating CD98hc expression resulted in IMCD cell death. Utilizing overexpression studies of CD98hc mutants that either lacked a cytoplasmic tail or were unable to bind to Lats we showed that CD98 increases serum-dependent cell proliferation by a mechanism that requires the CD98hc cytoplasmic tail. We further demonstrated that CD98-dependent amino acid transport increased renal tubular epithelial cell proliferation by a mechanism that does not require the CD98hc cytoplasmic tail. Both these mechanisms of increased renal tubular epithelial cell proliferation are mediated by Erk and p38 MAPK signaling. Although increased amino transport markedly activated mTor signaling, this pathway did not alter cell proliferation. Thus, these studies demonstrate that in IMCD cells, the cytoplasmic and extracellular domains of CD98hc regulate cell proliferation by distinct mechanisms that are mediated by common MAPK signaling pathways.	[Bulus, Nada; Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Div Nephrol, Dept Med, Nashville, TN 37235 USA; [Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Pozzi, Ambra; Zent, Roy] Vet Affairs Hosp, Dept Med, Nashville, TN USA; [Feral, Chloe] Univ Nice Sophia Antipolis, Ctr Antoine Lacassagne, Inst Res Canc & Aging, Nice, France	Vanderbilt University; Vanderbilt University; Vanderbilt University; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne	Bulus, N (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, Dept Med, Nashville, TN 37235 USA.	roy.zent@vanderbilt.edu	FERAL, Chloe/AAB-6111-2020; Feral, Chloe C/O-5781-2016	FERAL, Chloe/0000-0001-9756-2082; Feral, Chloe C/0000-0001-9756-2082	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; Cantor J, 2011, J IMMUNOL, V187, P851, DOI 10.4049/jimmunol.1100002; Cantor J, 2009, NAT IMMUNOL, V10, P412, DOI 10.1038/ni.1712; Cantor JM, 2008, IMMUNOL REV, V223, P236, DOI 10.1111/j.1600-065X.2008.00640.x; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chrostowski MK, 2010, PLACENTA, V31, P528, DOI 10.1016/j.placenta.2009.12.010; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Estevez R, 1998, FASEB J, V12, P1319, DOI 10.1096/fasebj.12.13.1319; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; Fogelstrand P, 2009, J EXP MED, V206, P2397, DOI 10.1084/jem.20082845; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Hang TTN, 2011, J CLIN INVEST, V121, P1733, DOI 10.1172/JCI44631; Hara K, 2000, ONCOGENE, V19, P6209, DOI 10.1038/sj.onc.1204019; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; HUSTED RF, 1988, AM J PHYSIOL, V255, pF1160, DOI 10.1152/ajprenal.1988.255.6.F1160; Imai H, 2009, HISTOPATHOLOGY, V54, P804, DOI 10.1111/j.1365-2559.2009.03300.x; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kaira K, 2008, PATHOL RES PRACT, V204, P553, DOI 10.1016/j.prp.2008.02.003; Kaira K, 2009, ANN SURG ONCOL, V16, P3473, DOI 10.1245/s10434-009-0685-0; Kaira K, 2009, LUNG CANCER, V66, P120, DOI 10.1016/j.lungcan.2008.12.015; Kaira K, 2009, CANCER SCI, V100, P249, DOI 10.1111/j.1349-7006.2008.01029.x; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Nelsen CJ, 2003, J BIOL CHEM, V278, P25853, DOI 10.1074/jbc.M302360200; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Prager GW, 2007, J BIOL CHEM, V282, P24477, DOI 10.1074/jbc.M702877200; Prasad PD, 1999, BIOCHEM BIOPH RES CO, V255, P283, DOI 10.1006/bbrc.1999.0206; QUACKENBUSH E, 1987, P NATL ACAD SCI USA, V84, P8618; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Sato Y, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-7; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Tomiya T, 2004, HEPATOL RES, V30, pS14, DOI 10.1016/j.hepres.2004.08.010; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; WELLS RG, 1992, J BIOL CHEM, V267, P15285; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059; Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269	65	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40026	10.1371/journal.pone.0040026	http://dx.doi.org/10.1371/journal.pone.0040026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768207	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100179
J	Duca, FA; Swartz, TD; Sakar, Y; Covasa, M				Duca, Frank A.; Swartz, Timothy D.; Sakar, Yassine; Covasa, Mihai			Increased Oral Detection, but Decreased Intestinal Signaling for Fats in Mice Lacking Gut Microbiota	PLOS ONE			English	Article							FLAVOR PREFERENCES; TASTE; OBESITY; ACIDS; CD36; ABSORPTION; ADIPOSITY; SECRETION; GERMFREE; RECEPTOR	Germ-free (GF) mice lacking intestinal microbiota are significantly leaner than normal (NORM) control mice despite consuming more calories. The contribution of microbiota on the recognition and intake of fats is not known. Thus, we investigated the preference for, and acceptance of, fat emulsions in GF and NORM mice, and associated changes in lingual and intestinal fatty acid receptors, intestinal peptide content, and plasma levels of gut peptides. GF and NORM C57Bl/6J mice were given 48-h two-bottle access to water and increasing concentrations of intralipid emulsions. Gene expression of the lingual fatty acid translocase CD36 and protein expression of intestinal satiety peptides and fatty-acid receptors from isolated intestinal epithelial cells were determined. Differences in intestinal enteroendocrine cells along the length of the GI tract were quantified. Circulating plasma satiety peptides reflecting adiposity and biochemical parameters of fat metabolism were also examined. GF mice had an increased preference and intake of intralipid relative to NORM mice. This was associated with increased lingual CD36 (P<0.05) and decreased intestinal expression of fatty acid receptors GPR40 (P<0.0001), GPR41 (P<0.0001), GPR43 (P<0.05), and GPR120 (P<0.0001) and satiety peptides CCK (P<0.0001), PYY (P<0.001), and GLP-1 (P<0.001). GF mice had fewer enteroendocrine cells in the ileum (P<0.05), and more in the colon (P<0.05), relative to NORM controls. Finally, GF mice had lower levels of circulating leptin and ghrelin (P<0.001), and altered plasma lipid metabolic markers indicative of energy deficits. Increased preference and caloric intake from fats in GF mice are associated with increased oral receptors for fats coupled with broad and marked decreases in expression of intestinal satiety peptides and fatty-acid receptors.	[Duca, Frank A.; Swartz, Timothy D.; Sakar, Yassine; Covasa, Mihai] MICALIS, UMR 1319, Ctr Rech Jouy En Josas, Inst Natl Rech Agron, Jouy En Josas, France; [Duca, Frank A.; Swartz, Timothy D.] Univ Paris 06, Paris, France; [Covasa, Mihai] Western Univ Hlth Sci, Coll Osteopath Med, Basic Med Sci Dept, Pomona, CA USA	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Western University of Health Sciences	Duca, FA (corresponding author), MICALIS, UMR 1319, Ctr Rech Jouy En Josas, Inst Natl Rech Agron, Jouy En Josas, France.	mcovasa@jouy.inra.fr		Swartz, Timothy/0000-0002-9801-8756	institution (INRA, French National Institute for Agricultural Research)	institution (INRA, French National Institute for Agricultural Research)	The study was supported by the institution (INRA, French National Institute for Agricultural Research) scientific package awarded to Mihai Covasa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKROFF K, 1991, PHYSIOL BEHAV, V50, P815, DOI 10.1016/0031-9384(91)90023-H; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Degrace-Passilly P, 2012, CURR OPIN CLIN NUTR, V15, P107, DOI 10.1097/MCO.0b013e32834ff19c; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; DEMARNE Y, 1972, ANN BIOL ANIM BIOCH, V12, P509, DOI 10.1051/rnd:19720313; DEMARNE Y, 1982, GUT, V23, P49, DOI 10.1136/gut.23.1.49; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gilbertson TA, 1998, ANN NY ACAD SCI, V855, P165, DOI 10.1111/j.1749-6632.1998.tb10560.x; Gilbertson TA, 2005, PHYSIOL BEHAV, V86, P681, DOI 10.1016/j.physbeh.2005.08.057; Glendinning JI, 2010, AM J PHYSIOL-REG I, V299, pR1333, DOI 10.1152/ajpregu.00331.2010; GOODLAD RA, 1989, Q J EXP PHYSIOL CMS, V74, P437, DOI 10.1113/expphysiol.1989.sp003291; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Lucas F, 1996, PHYSIOL BEHAV, V60, P1151, DOI 10.1016/0031-9384(96)00136-9; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; MINDELL S, 1990, PHYSIOL BEHAV, V48, P283, DOI 10.1016/0031-9384(90)90314-T; Rabot S, 2010, FASEB J; REED DR, 1991, AM J PHYSIOL, V261, pR1084, DOI 10.1152/ajpregu.1991.261.5.R1084; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Sclafani A, 2005, AM J PHYSIOL-REG I, V289, pR712, DOI 10.1152/ajpregu.00176.2005; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Swartz TD, 2010, PHYSIOL BEHAV, V99, P109, DOI 10.1016/j.physbeh.2009.10.016; Swartz T. D., 2011, BR J NUTR, P1; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Theodorakis MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE550, DOI 10.1152/ajpendo.00326.2004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WOSTMANN BS, 1964, J NUTR, V84, P277, DOI 10.1093/jn/84.3.277; Zhang XJ, 2011, ACTA HISTOCHEM, V113, P663, DOI 10.1016/j.acthis.2010.09.007	40	111	120	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39748	10.1371/journal.pone.0039748	http://dx.doi.org/10.1371/journal.pone.0039748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768116	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100086
J	Orekhova, EV; Tsetlin, MM; Butorina, AV; Novikova, SI; Gratchev, VV; Sokolov, PA; Elam, M; Stroganova, TA				Orekhova, Elena V.; Tsetlin, Marina M.; Butorina, Anna V.; Novikova, Svetlana I.; Gratchev, Vitaliy V.; Sokolov, Pavel A.; Elam, Mikael; Stroganova, Tatiana A.			Auditory Cortex Responses to Clicks and Sensory Modulation Difficulties in Children with Autism Spectrum Disorders (ASD)	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; REDUCED THALAMIC VOLUME; EVOKED MAGNETIC-FIELDS; SURFACE-BASED ANALYSIS; YOUNG-CHILDREN; FUNCTIONAL NEUROANATOMY; INFANTILE-AUTISM; BRAIN SIZE; MEG; ABNORMALITIES	Auditory sensory modulation difficulties are common in autism spectrum disorders (ASD) and may stem from a faulty arousal system that compromises the ability to regulate an optimal response. To study neurophysiological correlates of the sensory modulation difficulties, we recorded magnetic field responses to clicks in 14 ASD and 15 typically developing (TD) children. We further analyzed the P100m, which is the most prominent component of the auditory magnetic field response in children and may reflect preattentive arousal processes. The P100m was rightward lateralized in the TD, but not in the ASD children, who showed a tendency toward P100m reduction in the right hemisphere (RH). The atypical P100m lateralization in the ASD subjects was associated with greater severity of sensory abnormalities assessed by Short Sensory Profile, as well as with auditory hypersensitivity during the first two years of life. The absence of right-hemispheric predominance of the P100m and a tendency for its right-hemispheric reduction in the ASD children suggests disturbance of the RH ascending reticular brainstem pathways and/or their thalamic and cortical projections, which in turn may contribute to abnormal arousal and attention. The correlation of sensory abnormalities with atypical, more leftward, P100m lateralization suggests that reduced preattentive processing in the right hemisphere and/or its shift to the left hemisphere may contribute to abnormal sensory behavior in ASD.	[Orekhova, Elena V.; Elam, Mikael] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Tsetlin, Marina M.; Butorina, Anna V.; Novikova, Svetlana I.; Stroganova, Tatiana A.] Moscow State Univ Psychol & Educ, Moscow, Russia; [Gratchev, Vitaliy V.] Moscow Pediat Ctr, Moscow, Russia; [Sokolov, Pavel A.] Acad Med Sci, Mental Hlth Res Ctr Russian, Clin Dept Study Adolescent Psychiat, Moscow, Russia	University of Gothenburg; Moscow State University of Psychology & Education; Russian Academy of Medical Sciences	Orekhova, EV (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden.	Elena.orekhova@neuro.gu.se	Stroganova, Tatiana T.A./C-5773-2014; Orekhova, Elena V/S-9043-2018; Butorina, Anna/V-6995-2018	Orekhova, Elena V/0000-0003-0950-1613; Stroganova, Tatiana/0000-0003-3750-9890	Swedish Research Council [2009-3765]; Russian Ministry of Science and Education [16.518.11.7088]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation)	This research was supported by grant # 2009-3765 from the Swedish Research Council and by grant # 16.518.11.7088 from the Russian Ministry of Science and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Ben-Sasson A, 2008, J CHILD PSYCHOL PSYC, V49, P817, DOI 10.1111/j.1469-7610.2008.01899.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Bishop DVM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018993; Blumenfeld LD, 2001, CLIN NEUROPHYSIOL, V112, P1650, DOI 10.1016/S1388-2457(01)00604-6; Boutros NN, 2011, BIOL PSYCHIAT, V69, P883, DOI 10.1016/j.biopsych.2010.12.011; Brugge JF, 2008, HEARING RES, V238, P12, DOI 10.1016/j.heares.2007.11.012; BUCHWALD JS, 1991, ELECTROEN CLIN NEURO, V80, P303, DOI 10.1016/0168-5597(91)90114-D; BUCHWALD JS, 1992, ELECTROEN CLIN NEURO, V84, P164, DOI 10.1016/0168-5597(92)90021-3; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Cardy JEO, 2008, INT J PSYCHOPHYSIOL, V68, P170, DOI 10.1016/j.ijpsycho.2007.10.015; Cardy JEO, 2004, NEUROREPORT, V15, P1867, DOI 10.1097/00001756-200408260-00006; Cheon KA, 2011, BRAIN RES, V1417, P77, DOI 10.1016/j.brainres.2011.08.020; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Crane L, 2009, AUTISM, V13, P215, DOI 10.1177/1362361309103794; DAHLGREN SO, 1989, EUR ARCH PSY CLIN N, V238, P169; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dunn W, 1999, SENSORY PROFILE USER, Vxiv; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hardan AY, 2008, PSYCHIAT RES-NEUROIM, V163, P97, DOI 10.1016/j.pscychresns.2007.12.002; Hardan AY, 2008, J AUTISM DEV DISORD, V38, P390, DOI 10.1007/s10803-007-0385-1; Hardan AY, 2006, PSYCHIAT RES-NEUROIM, V147, P145, DOI 10.1016/j.pscychresns.2005.12.009; Harrison J, 2004, J AUTISM DEV DISORD, V34, P727, DOI 10.1007/s10803-004-5293-z; HARRISON JB, 1990, BRAIN RES, V520, P43, DOI 10.1016/0006-8993(90)91690-I; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Howard MF, 2009, HEARING RES, V257, P41, DOI 10.1016/j.heares.2009.07.010; Huang MX, 2003, CLIN NEUROPHYSIOL, V114, P835, DOI 10.1016/S1388-2457(03)00041-5; Jou RJ, 2009, PSYCHOL MED, V39, P1347, DOI 10.1017/S0033291708004376; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; Kotecha R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004811; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Liss M, 2006, AUTISM, V10, P155, DOI 10.1177/1362361306062021; Moore JK, 2007, INT J AUDIOL, V46, P460, DOI 10.1080/14992020701383019; Moore JK, 2001, JARO-J ASSOC RES OTO, V2, P297, DOI 10.1007/s101620010052; Okon-Singer N, 2011, NEUROIMAGE, V54, P3010, DOI 10.1016/j.neuroimage.2010.10.078; Orekhova EV, 2009, CLIN NEUROPHYSIOL, V120, P520, DOI 10.1016/j.clinph.2008.12.034; ORNITZ EM, 1983, INT J NEUROSCI, V19, P85, DOI 10.3109/00207458309148648; PAETAU R, 1995, J CLIN NEUROPHYSIOL, V12, P177, DOI 10.1097/00004691-199503000-00008; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Ray MA, 2005, NEUROBIOL DIS, V19, P366, DOI 10.1016/j.nbd.2005.01.017; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Romanski LM, 1997, J COMP NEUROL, V379, P313; Ruhnau P, 2011, NEUROIMAGE, V58, P630, DOI 10.1016/j.neuroimage.2011.06.050; Spencer MD, 2006, NEUROIMAGE, V33, P1136, DOI 10.1016/j.neuroimage.2006.08.011; Stiegler LN, 2010, FOCUS AUTISM DEV DIS, V25, P67, DOI 10.1177/1088357610364530; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sussman E, 2008, HEARING RES, V236, P61, DOI 10.1016/j.heares.2007.12.001; Tamura R, 2010, PSYCHIAT RES-NEUROIM, V184, P186, DOI 10.1016/j.pscychresns.2010.07.001; Thoma RJ, 2003, AM J PSYCHIAT, V160, P1595, DOI 10.1176/appi.ajp.160.9.1595; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; Tsatsanis KD, 2003, BIOL PSYCHIAT, V53, P121, DOI 10.1016/S0006-3223(02)01530-5; VANENGELAND H, 1984, J AUTISM DEV DISORD, V14, P261, DOI 10.1007/BF02409578; Waiter GD, 2004, NEUROIMAGE, V22, P619, DOI 10.1016/j.neuroimage.2004.02.029; Weiland BJ, 2008, NEUROIMAGE, V42, P827, DOI 10.1016/j.neuroimage.2008.05.042; Wiggins LD, 2009, J AUTISM DEV DISORD, V39, P1087, DOI 10.1007/s10803-009-0711-x; Zilbovicius M, 2000, AM J PSYCHIAT, V157, P1988, DOI 10.1176/appi.ajp.157.12.1988	70	37	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39906	10.1371/journal.pone.0039906	http://dx.doi.org/10.1371/journal.pone.0039906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768163	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100132
J	Tsukuda, Y; Iwasaki, N; Seito, N; Kanayama, M; Fujitani, N; Shinohara, Y; Kasahara, Y; Onodera, T; Suzuki, K; Asano, T; Minami, A; Yamashita, T				Tsukuda, Yukinori; Iwasaki, Norimasa; Seito, Naoki; Kanayama, Masashi; Fujitani, Naoki; Shinohara, Yasuro; Kasahara, Yasuhiko; Onodera, Tomohiro; Suzuki, Koji; Asano, Tsuyoshi; Minami, Akio; Yamashita, Tadashi			Ganglioside GM3 Has an Essential Role in the Pathogenesis and Progression of Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; PROINFLAMMATORY CYTOKINES; MONOCYTE MIGRATION; IMMUNE-RESPONSE; C57BL/6 MICE; T-CELLS; INTERLEUKIN-17; INFLAMMATION; IL-17; DESTRUCTION	Rheumatoid arthritis (RA), a chronic systemic inflammatory disorder that principally attacks synovial joints, afflicts over 2 million people in the United States. Interleukin (IL)-17 is considered to be a master cytokine in chronic, destructive arthritis. Levels of the ganglioside GM3, one of the most primitive glycosphingolipids containing a sialic acid in the structure, are remarkably decreased in the synovium of patients with RA. Based on the increased cytokine secretions observed in in vitro experiments, GM3 might have an immunologic role. Here, to clarify the association between RA and GM3, we established a collagen-induced arthritis mouse model using the null mutation of the ganglioside GM3 synthase gene. GM3 deficiency exacerbated inflammatory arthritis in the mouse model of RA. In addition, disrupting GM3 induced T cell activation in vivo and promoted overproduction of the cytokines involved in RA. In contrast, the amount of the GM3 synthase gene transcript in the synovium was higher in patients with RA than in those with osteoarthritis. These findings indicate a crucial role for GM3 in the pathogenesis and progression of RA. Control of glycosphingolipids such as GM3 might therefore provide a novel therapeutic strategy for RA.	[Tsukuda, Yukinori; Iwasaki, Norimasa; Seito, Naoki; Kasahara, Yasuhiko; Onodera, Tomohiro; Asano, Tsuyoshi; Minami, Akio] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan; [Fujitani, Naoki; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Med & Funct Glyc, Sapporo, Hokkaido, Japan; [Suzuki, Koji] Hokkaido Orthopaed Mem Hosp, Sapporo, Hokkaido, Japan; [Yamashita, Tadashi] Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Yamashita, Tadashi] Kyungpook Natl Univ, Sch Med, World Class Univ Program, Taegu, South Korea	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Kyungpook National University	Tsukuda, Y (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan.	niwasaki@med.hokudai.ac.jp; ty11106@sci.hokudai.ac.jp	Fujitani, Naoki/A-4072-2012; Onodera, Tomohiro/G-1686-2012	Fujitani, Naoki/0000-0002-4035-7317; Kanayama, Masashi/0000-0001-8366-5275	Ministry of Health, Labor, and Welfare in Japan [7263000119]; Uehara Memorial Foundation; World Class University through the National Research Foundation of Korea; Ministry of Education, Science, and Technology of Korea [R32-10064]	Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Health and Labor Sciences Research Grants "Comprehensive Research on Aging and Health" (7263000119) from the Ministry of Health, Labor, and Welfare in Japan (http://www.mhlw.go.jp/english/) and the Uehara Memorial Foundation (http://www.ueharazaidan.com/) to N.I., and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology of Korea (R32-10064) (http://wcu.nrf.go.kr/english/e_about/about_5.jsp) to T.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND WP, 1990, ARTHRITIS RHEUM-US, V33, P305, DOI 10.1002/art.1780330302; Awasthi A, 2009, NAT IMMUNOL, V10, P568, DOI 10.1038/ni0609-568; Bankhurst Arthur D, 2008, Arthritis Rheum, V58, pS58, DOI 10.1002/art.23359; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Drolet AM, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/913802; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hashiramoto A, 2006, ONCOGENE, V25, P3948, DOI 10.1038/sj.onc.1209416; IKEDA T, 1992, LIFE SCI, V51, P847, DOI 10.1016/0024-3205(92)90612-S; ITO M, 1989, J BIOL CHEM, V264, P9510; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; LADISCH S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P180, DOI 10.1016/0005-2760(92)90043-U; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Niimi K, 2011, BIOCHEM BIOPH RES CO, V406, P524, DOI 10.1016/j.bbrc.2011.02.071; Okuzawa C, 2008, BIOCHEM BIOPH RES CO, V371, P561, DOI 10.1016/j.bbrc.2008.04.124; Pan M, 2004, J CLIN IMMUNOL, V24, P481, DOI 10.1023/B:JOCI.0000040919.16739.44; Rampersad RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025833; Saouaf SJ, 2009, EXP MOL PATHOL, V87, P99, DOI 10.1016/j.yexmp.2009.06.003; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Shevchuk NA, 2007, BBA-MOL CELL BIOL L, V1771, P1226, DOI 10.1016/j.bbalip.2007.05.008; Shu LM, 2002, J BIOL CHEM, V277, P18447, DOI 10.1074/jbc.M111363200; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Toledo MS, 2004, J BIOL CHEM, V279, P34655, DOI 10.1074/jbc.M403857200; Tran CN, 2007, AM J PATHOL, V171, P1588, DOI 10.2353/ajpath.2007.070004; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Zhu YX, 2011, J BIOL CHEM, V286, P14787, DOI 10.1074/jbc.M111.218610	38	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40136	10.1371/journal.pone.0040136	http://dx.doi.org/10.1371/journal.pone.0040136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768242	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100214
J	Xiao, R; Teng, M; Zhang, Q; Shi, XH; Huang, YS				Xiao, Rong; Teng, Miao; Zhang, Qiong; Shi, Xiao-hua; Huang, Yue-sheng			Myocardial Autophagy after Severe Burn in Rats	PLOS ONE			English	Article							ANGIOTENSIN-II TYPE-1; CELL-DEATH; CARDIAC MYOCYTES; ISCHEMIA/REPERFUSION INJURY; CARDIOMYOCYTE AUTOPHAGY; REPERFUSION; APOPTOSIS; ISCHEMIA; HEART; PATHOGENESIS	Background: Autophagy plays a major role in myocardial ischemia and hypoxia injury. The present study investigated the effects of autophagy on cardiac dysfunction in rats after severe burn. Methods: Protein expression of the autophagy markers LC3 and Beclin 1 were determined at 0, 1, 3, 6, and 12 h post-burn in Sprague Dawley rats subjected to 30% total body surface area 3rd degree burns. Autophagic, apoptotic, and oncotic cell death were evaluated in the myocardium at each time point by immunofluorescence. Changes of cardiac function were measured in a Langendorff model of isolated heart at 6 h post-burn, and the autophagic response was measured following activation by Rapamycin and inhibition by 3-methyladenine (3-MA). The angiotensin converting enzyme inhibitor enalaprilat, the angiotensin receptor I blocker losartan, and the reactive oxygen species inhibitor diphenylene iodonium (DPI) were also applied to the ex vivo heart model to examine the roles of these factors in post-burn cardiac function. Results: Autophagic cell death was first observed in the myocardium at 3 h post-burn, occurring in 0.008 +/- 0.001% of total cardiomyocytes, and continued to increase to a level of 0.022 +/- 0.005% by 12 h post-burn. No autophagic cell death was observed in control hearts. Compared with apoptosis, autophagic cell death occurred earlier and in larger quantities. Rapamycin enhanced autophagy and decreased cardiac function in isolated hearts 6 h post-burn, while 3-MA exerted the opposite response. Enalaprilat, losartan, and DPI all inhibited autophagy and enhanced heart function. Conclusion: Myocardial autophagy is enhanced in severe burns and autophagic cell death occurred early at 3 h post-burn, which may contribute to post-burn cardiac dysfunction. Angiotensin II and reactive oxygen species may play important roles in this process by regulating cell signaling transduction.	[Xiao, Rong; Teng, Miao; Zhang, Qiong; Shi, Xiao-hua; Huang, Yue-sheng] Third Mil Med Univ, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Xiao, R (corresponding author), Third Mil Med Univ, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Southwest Hosp, Chongqing, Peoples R China.	yshuang.tmmu@gmail.com			State Key Laboratory of Trauma, Burns and Combined injury [SKLZZ200806]; National Key Technology Research and Development Program [2009BAI87B03]; Key Project of China National Basic Research and Development Program [2012CB518101]; National Natural Science Foundation of China [81071547]	State Key Laboratory of Trauma, Burns and Combined injury; National Key Technology Research and Development Program(National Key Technology R&D Program); Key Project of China National Basic Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Key Grant from the State Key Laboratory of Trauma, Burns and Combined injury (SKLZZ200806), National Key Technology Research and Development Program (2009BAI87B03), Key Project of China National Basic Research and Development Program (2012CB518101), and National Natural Science Foundation of China (81071547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018; Dong Y, 2010, J CARDIOVASC PHARM T, V15, P220, DOI 10.1177/1074248410370327; Ferreira MAS, 1998, J CLIN PATHOL, V51, P548, DOI 10.1136/jcp.51.7.548; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Huang YS, 1998, BURNS, V24, P706, DOI 10.1016/S0305-4179(98)00123-5; Jin Yulan, 2010, Front Biosci (Elite Ed), V2, P1147; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Narula Jagat, 2001, Cardiology Clinics, V19, P113, DOI 10.1016/S0733-8651(05)70198-3; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Porrello ER, 2009, AUTOPHAGY, V5, P1215, DOI 10.4161/auto.5.8.10153; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Sheng Zhiyong, 2002, Chin J Traumatol, V5, P195; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Wang GQ, 2001, BURNS, V27, P250, DOI 10.1016/S0305-4179(00)00105-4; Xiang F, 2010, FEBS J, V277, P1929, DOI 10.1111/j.1742-4658.2010.07615.x; Xiao R, 2011, J TRAUMA, V71, P663, DOI 10.1097/TA.0b013e31822175f6; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yang J, 1999, Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi, V15, P102; Yin Ze-gang, 2010, Zhonghua Shao Shang Za Zhi, V26, P10; Zhang JP, 2008, J TRAUMA, V65, P401, DOI 10.1097/TA.0b013e31817cf732	35	29	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39488	10.1371/journal.pone.0039488	http://dx.doi.org/10.1371/journal.pone.0039488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768082	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100053
J	van Oosterhout, F; Lucassen, EA; Houben, T; vanderLeest, HT; Antle, MC; Meijer, JH				van Oosterhout, Floor; Lucassen, Eliane A.; Houben, Thijs; vanderLeest, Henk Tjebbe; Antle, Michael C.; Meijer, Johanna H.			Amplitude of the SCN Clock Enhanced by the Behavioral Activity Rhythm	PLOS ONE			English	Article							HAMSTER SUPRACHIASMATIC NUCLEUS; HUMAN CIRCADIAN-RHYTHMS; PHASE DELAYS; NOCTURNAL EXERCISE; PHYSICAL-EXERCISE; MELATONIN RHYTHM; BODY-TEMPERATURE; CONTROLLED-TRIAL; RESPONSE CURVES; SYRIAN-HAMSTERS	Circadian rhythms are regulated by the suprachiasmatic nucleus (SCN), a small structure at the base of the hypothalamus. While light effects on the SCN are well established, little is known of behavioral effects. This study elucidates direct modulating action of behavioral activity on the SCN by use of in vivo electrophysiology recordings, assessments of general locomotor behavior, and video-tracking of mice. The results show suppression of SCN neuronal activity by spontaneous behavior, the magnitude being dependent on the intensity, duration and type of behavioral activity. The suppression was moderate (32% of circadian amplitude) for low-intensity behavior and considerable (59%) for locomotor activity. Mild manipulation of the animals had reversed effects on the SCN indicating that different mechanisms are involved in the regulatory effect of spontaneous versus induced activity. The results indicate that exercise at the proper time of the cycle can boost the amplitude of the rhythm of the SCN clock itself. This has potentially beneficial effects for other rhythmic functions that are under the control of the SCN.	[van Oosterhout, Floor; Lucassen, Eliane A.; Houben, Thijs; vanderLeest, Henk Tjebbe; Antle, Michael C.; Meijer, Johanna H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands; [Antle, Michael C.] Univ Calgary, Dept Psychol, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Calgary	van Oosterhout, F (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands.	J.H.Meijer@lumc.nl		Antle, Michael/0000-0001-5178-4683	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [425-20-403]; EU [018741]; CONACYT (Consejo Nacional de Ciencia y Tecnologia) [91984]; FONCICYT (Fondo de Cooperacion Internacional para el fomento de la investigacion cientifica y tecnologica), Mexico	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); EU(European Commission); CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FONCICYT (Fondo de Cooperacion Internacional para el fomento de la investigacion cientifica y tecnologica), Mexico	This research was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (425-20-403), the EU-funded "Entrainment of the circadian clock"-EUCLOCK (018741), and grant #91984 from CONACYT (Consejo Nacional de Ciencia y Tecnologia) and FONCICYT (Fondo de Cooperacion Internacional para el fomento de la investigacion cientifica y tecnologica), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antle MC, 2000, J NEUROSCI, V20, P9326; Atkinson G, 2007, EUR J APPL PHYSIOL, V99, P331, DOI 10.1007/s00421-006-0361-z; Barger LK, 2004, AM J PHYSIOL-REG I, V286, pR1077, DOI 10.1152/ajpregu.00397.2003; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bobrzynska KJ, 1998, J COMP PHYSIOL A, V182, P251, DOI 10.1007/s003590050175; Brown TM, 2008, NEUROSCI LETT, V448, P273, DOI 10.1016/j.neulet.2008.10.058; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Buxton OM, 1997, AM J PHYSIOL-ENDOC M, V273, pE536, DOI 10.1152/ajpendo.1997.273.3.E536; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Deboer T, 2000, J COMP PHYSIOL A, V186, P969, DOI 10.1007/s003590000150; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Dudley TE, 1998, J NEUROSCI, V18, P5045; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Ehlen JC, 2006, EUR J NEUROSCI, V23, P3328, DOI 10.1111/j.1460-9568.2006.04857.x; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Glass JD, 2010, EUR J NEUROSCI, V31, P1117, DOI 10.1111/j.1460-9568.2010.07139.x; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; Kas MJH, 2001, J BIOL RHYTHM, V16, P66, DOI 10.1177/074873040101600108; Klein D.C., 1991, SUPRACHIASMATIC NUCL; McCurry SM, 2005, J AM GERIATR SOC, V53, P793, DOI 10.1111/j.1532-5415.2005.53252.x; Meerlo P, 1997, J BIOL RHYTHM, V12, P80, DOI 10.1177/074873049701200109; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Mistlberger RE, 2005, J BIOL RHYTHM, V20, P339, DOI 10.1177/0748730405277982; Mistlberger RE, 2003, AM J PHYSIOL-REG I, V285, pR917, DOI 10.1152/ajpregu.00222.2003; Miyazaki T, 2001, AM J PHYSIOL-REG I, V281, pR197; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Power A, 2010, J BIOL RHYTHM, V25, P235, DOI 10.1177/0748730410374446; REEBS SG, 1989, J COMP PHYSIOL A, V165, P811, DOI 10.1007/BF00610879; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; ROSENFELD P, 1988, DEV BRAIN RES, V42, P119, DOI 10.1016/0165-3806(88)90207-6; Rosenwasser AM, 2009, BRAIN RES REV, V61, P281, DOI 10.1016/j.brainresrev.2009.08.001; Schaap J, 2001, EUR J NEUROSCI, V13, P1955, DOI 10.1046/j.0953-816x.2001.01561.x; SHIOIRI T, 1991, PHYSIOL BEHAV, V49, P779, DOI 10.1016/0031-9384(91)90318-I; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Teri L, 2011, J AM GERIATR SOC, V59, P1188, DOI 10.1111/j.1532-5415.2011.03454.x; van Oosterhout F, 2008, ANN NEUROL, V64, P315, DOI 10.1002/ana.21418; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; VANEEKELEN JAM, 1987, BRAIN RES, V436, P120, DOI 10.1016/0006-8993(87)91563-0; VANREETH O, 1989, NATURE, V339, P49, DOI 10.1038/339049a0; VANREETH O, 1994, AM J PHYSIOL, V266, pE964, DOI 10.1152/ajpendo.1994.266.6.E964; VanSomeren EJW, 1997, J BIOL RHYTHM, V12, P146, DOI 10.1177/074873049701200206; Webb IC, 2008, EUR J NEUROSCI, V27, P828, DOI 10.1111/j.1460-9568.2008.06074.x; Yamakawa GR, 2010, EUR J NEUROSCI, V31, P1974, DOI 10.1111/j.1460-9568.2010.07228.x; Yamanaka Y, 2010, AM J PHYSIOL-REG I, V298, pR681, DOI 10.1152/ajpregu.00345.2009; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Youngstedt SD, 2005, CLIN SPORT MED, V24, P355, DOI 10.1016/j.csm.2004.12.003	51	63	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39693	10.1371/journal.pone.0039693	http://dx.doi.org/10.1371/journal.pone.0039693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761873	Green Submitted, gold, Green Published			2022-12-25	WOS:000305826400028
J	Perez-Aso, M; Chiriboga, L; Cronstein, BN				Perez-Aso, Miguel; Chiriboga, Luis; Cronstein, Bruce N.			Pharmacological blockade of adenosine A(2A) receptors diminishes scarring	FASEB JOURNAL			English	Article						ZM241385; collagen; splinted wounds	ENDOTHELIAL GROWTH-FACTOR; DERMAL FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; MURINE MODEL; FACTOR-BETA; EXPRESSION; COLLAGEN; ANGIOGENESIS; AGONISTS; PLASMINOGEN	Adenosine A2A receptor (A(2A)R) stimulation promotes wound healing and is required for the development of fibrosis in murine models of scleroderma and cirrhosis. Nonetheless, the role of A2AR in the formation of scars following skin trauma has not been explored. Here, we examined the effect of pharmacological blockade of A2AR, with the selective adenosine A(2A)R-antagonist ZM241385 (2.5 mg/ml), in a murine model of scarring that mimics human scarring. We found that application of the selective adenosine A(2A)R antagonist ZM241385 decreased scar size and enhanced the tensile strength of the scar. Within the scar itself, collagen alignment and composition (marked reduction in collagen 3), but not periostin, biglycan, or fibronectin accumulation, was improved by application of ZM241385. Moreover, A(2A)R blockade reduced the number of myofibroblasts and angiogenesis but not macrophage infiltration in the scar. Taken together, our work strongly suggests that pharmacological A(2A)R blockade can be used to diminish scarring while improving the collagen composition and tensile strength of the healed wound.-Perez-Aso, M., Chiriboga, L., Cronstein, B. N. Pharmacological blockade of adenosine A(2A) receptors diminishes scarring. FASEB J. 26, 4254-4263 (2012). www.fasebj.org	[Perez-Aso, Miguel; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY 10016 USA; [Chiriboga, Luis] NYU, Sch Med, Expt Pathol Core Lab, New York, NY 10016 USA	New York University; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 1st Ave,MSB255, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Cronstein, Bruce N/D-4678-2011	Cronstein, Bruce N/0000-0002-4295-7383; Chiriboga, Luis/0000-0002-2028-6873	U.S. National Institutes of Health [AR56672, AR56672S1, AR54897]; NYU-Health and Hospitals Corp. Clinical and Translational Science Institute [UL1TR000038]; NYU Cancer Institute Center [5P30CA0016087-33]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054897, R01AR056672, R56AR056672] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU-Health and Hospitals Corp. Clinical and Translational Science Institute; NYU Cancer Institute Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the Histopathology Core of the New York University (NYU) Langone Medical Center. This work was supported by grants from the U.S. National Institutes of Health (AR56672, AR56672S1, and AR54897) and the NYU-Health and Hospitals Corp. Clinical and Translational Science Institute (UL1TR000038), and by the NYU Cancer Institute Center support grant (U.S. National Cancer Institute grant 5P30CA0016087-33). B.N.C. holds patents on use of A<INF>2A</INF>R agonists to promote wound healing and use of A<INF>2A</INF>R antagonists to inhibit fibrosis, use of adenosine A1 receptor antagonists to treat osteoporosis and other diseases of bone, use of adenosine A1 and A<INF>2B</INF>R antagonists to treat fatty liver, and use of A<INF>2A</INF>R agonists to prevent prosthesis loosening. B.N.C. is a consultant for Bristol-Myers Squibb, Novartis, CanFite Biopharmaceuticals, Cypress Laboratories, Regeneron (Westat, Data and Safety Monitoring Board), Endocyte, Protalex, Allos, Inc., Savient, Gismo Therapeutics, Antares Pharmaceutical, and Medivector.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Abe K, 2000, NEPHROL DIAL TRANSPL, V15, P529, DOI 10.1093/ndt/15.4.529; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bellemare J, 2005, J PATHOL, V206, P1, DOI 10.1002/path.1737; Bloch W, 2000, FASEB J, V14, P2373; Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002; Chan ESL, 2006, ARTHRITIS RHEUM-US, V54, P2632, DOI 10.1002/art.21974; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Desai A, 2005, MOL PHARMACOL, V67, P1406, DOI 10.1124/mol.104.007807; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Feoktistov Igor, 2009, Handb Exp Pharmacol, P383, DOI 10.1007/978-3-540-89615-9_13; Fernandez P, 2008, AM J PATHOL, V172, P1675, DOI 10.2353/ajpath.2008.070952; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Gibson SE, 2006, ARCH PATHOL LAB MED, V130, P209; Gira AK, 2004, J AM ACAD DERMATOL, V50, P850, DOI 10.1016/j.jaad.2003.11.061; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; IHARA S, 1990, DEVELOPMENT, V110, P671; JUNQUEIRA LCU, 1979, CELL TISSUE RES, V202, P453, DOI 10.1007/BF00220437; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; Kozma EM, 2000, MOL CELL BIOCHEM, V203, P103, DOI 10.1023/A:1007012321333; Leibovich SJ, 2002, AM J PATHOL, V160, P2231, DOI 10.1016/S0002-9440(10)61170-4; MADDEN JW, 1968, SURGERY, V64, P288; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mignatti P., 1996, MOL CELLULAR BIOL WO, P427; MONTES GS, 1980, HISTOCHEMISTRY, V65, P131, DOI 10.1007/BF00493161; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Montesinos MC, 2002, AM J PATHOL, V160, P2009, DOI 10.1016/S0002-9440(10)61151-0; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; PIERCE GF, 1995, ANNU REV MED, V46, P467; Poucher SM, 1996, J PHARM PHARMACOL, V48, P601, DOI 10.1111/j.2042-7158.1996.tb05981.x; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Romer J, 1996, NAT MED, V2, P725, DOI 10.1038/nm0796-725a; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Sheridan RL, 2004, J AM COLL SURGEONS, V198, P243, DOI 10.1016/j.jamcollsurg.2003.11.007; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Tredget EE, 1998, PLAST RECONSTR SURG, V102, P1317, DOI 10.1097/00006534-199810000-00001; Valls MD, 2009, BIOCHEM PHARMACOL, V77, P1117, DOI 10.1016/j.bcp.2008.11.002; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wetterau M, 2011, WOUND REPAIR REGEN, V19, P481, DOI 10.1111/j.1524-475X.2011.00697.x; WHITBY DJ, 1991, DEV BIOL, V147, P207, DOI 10.1016/S0012-1606(05)80018-1; Wilgus TA, 2008, LAB INVEST, V88, P579, DOI 10.1038/labinvest.2008.36; Wu YD, 2004, AM J PHYSIOL-CELL PH, V286, pC905, DOI 10.1152/ajpcell.00200.2003; Yates CC, 2010, AM J PATHOL, V176, P1743, DOI 10.2353/ajpath.2010.090564	57	30	31	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4254	4263		10.1096/fj.12-209627	http://dx.doi.org/10.1096/fj.12-209627			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22767233	Green Published			2022-12-25	WOS:000309704000030
J	Kakiya, N; Saito, T; Nilsson, P; Matsuba, Y; Tsubuki, S; Takei, N; Nawa, H; Saido, TC				Kakiya, Naomasa; Saito, Takashi; Nilsson, Per; Matsuba, Yukio; Tsubuki, Satoshi; Takei, Nobuyuki; Nawa, Hiroyuki; Saido, Takaomi C.			Cell Surface Expression of the Major Amyloid-beta Peptide (A beta)-degrading Enzyme, Neprilysin, Depends on Phosphorylation by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK) and Dephosphorylation by Protein Phosphatase 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; PRECURSOR PROTEIN; A-BETA; NEUTRAL ENDOPEPTIDASE; PLAQUE-FORMATION; IN-VIVO; BRAIN; RECEPTOR; IDENTIFICATION	Neprilysin is one of the major amyloid-beta peptide (A beta)-degrading enzymes, the expression of which declines in the brain during aging. The decrease in neprilysin leads to a metabolic A beta imbalance, which can induce the amyloidosis underlying Alzheimer disease. Pharmacological activation of neprilysin during aging therefore represents a potential strategy to prevent the development of Alzheimer disease. However, the regulatory mechanisms mediating neprilysin activity in the brain remain unclear. To address this issue, we screened for pharmacological regulators of neprilysin activity and found that the neurotrophic factors brain-derived neurotrophic factor, nerve growth factor, and neurotrophins 3 and 4 reduce cell surface neprilysin activity. This decrease was mediated by MEK/ERK signaling, which enhanced phosphorylation at serine 6 in the neprilysin intracellular domain (S6-NEP-ICD). Increased phosphorylation of S6-NEP-ICD in primary neurons reduced the levels of cell surface neprilysin and led to a subsequent increase in extracellular A beta levels. Furthermore, a specific inhibitor of protein phosphatase-1a, tautomycetin, induced extensive phosphorylation of the S6-NEP-ICD, resulting in reduced cell surface neprilysin activity. In contrast, activation of protein phosphatase-1a increased cell surface neprilysin activity and lowered A beta levels. Taken together, these results indicate that the phosphorylation status of S6-NEP-ICD influences the localization of neprilysin and affects extracellular A beta levels. Therefore, maintaining S6-NEP-ICD in a dephosphorylated state, either by inhibition of protein kinases involved in its phosphorylation or by activation of phosphatases catalyzing its dephosphorylation, may represent a new approach to prevent reduction of cell surface neprilysin activity during aging and to maintain physiological levels of A beta in the brain.	[Kakiya, Naomasa; Saito, Takashi; Nilsson, Per; Matsuba, Yukio; Tsubuki, Satoshi; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Kakiya, Naomasa; Takei, Nobuyuki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata 9518585, Japan	RIKEN; Niigata University	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Saito, Takashi/G-2563-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan; Junior Research Associate Program of RIKEN	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Junior Research Associate Program of RIKEN	This study was supported by research grants from RIKEN Brain Science Institute; the Ministry of Education, Culture, Sports, Science, and Technology; and the Ministry of Health, Labor, and Welfare of Japan. This study was also supported by the Junior Research Associate Program of RIKEN.	BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Carter TL, 2006, NEUROSCI LETT, V392, P235, DOI 10.1016/j.neulet.2005.09.022; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Pagans S, 2011, METHODS, V53, P91, DOI 10.1016/j.ymeth.2010.07.001; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009; Rajput PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024467; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Reilly CE, 2001, J NEUROL, V248, P159; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Siepmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013134; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zheng ZQ, 2010, J BIOL CHEM, V285, P34708, DOI 10.1074/jbc.M110.150821	46	30	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29362	29372		10.1074/jbc.M112.340372	http://dx.doi.org/10.1074/jbc.M112.340372			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767595	Green Published, hybrid			2022-12-25	WOS:000308286900015
J	Wang, L; Liu, J; Zhang, AS; Cheng, P; Zhang, X; Lv, S; Wu, L; Yu, J; Di, WJ; Zha, JM; Kong, XC; Qi, HM; Zhong, Y; Ding, GX				Wang, Long; Liu, Juan; Zhang, Aisen; Cheng, Peng; Zhang, Xiao; Lv, Shan; Wu, Lin; Yu, Jing; Di, Wenjuan; Zha, Juanmin; Kong, Xiaocen; Qi, Hanmei; Zhong, Yi; Ding, Guoxian			BVT.2733, a Selective 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; CORTISOL METABOLISM; VISCERAL OBESITY; FATTY-ACIDS; GLUCOCORTICOIDS; MACROPHAGE; EXPRESSION; HYPERGLYCEMIA; SENSITIVITY; ADIPOCYTES	Background: Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) is being pursued as a new therapeutic approach for the treatment of obesity and metabolic syndrome. Therefore, there is an urgent need to determine the effect of 11 beta-HSD1 inhibitor, which suppresses glucocorticoid action, on adipose tissue inflammation. The purpose of the present study was to examine the effect of BVT.2733, a selective 11 beta-HSD1 inhibitor, on expression of pro-inflammatory mediators and macrophage infiltration in adipose tissue in C57BL/6J mice. Methodology/Principal Findings: C57BL/6J mice were fed with a normal chow diet (NC) or high fat diet (HFD). HFD treated mice were then administrated with BVT.2733 (HFD+BVT) or vehicle (HFD) for four weeks. Mice receiving BVT.2733 treatment exhibited decreased body weight and enhanced glucose tolerance and insulin sensitivity compared to control mice. BVT.2733 also down-regulated the expression of inflammation-related genes including monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor alpha (TNF-alpha) and the number of infiltrated macrophages within the adipose tissue in vivo. Pharmacological inhibition of 11 beta-HSD1 and RNA interference against 11 beta-HSD1 reduced the mRNA levels of MCP-1 and interleukin-6 (IL-6) in cultured J774A.1 macrophages and 3T3-L1 preadipocyte in vitro. Conclusions/Significance: These results suggest that BVT.2733 treatment could not only decrease body weight and improve metabolic homeostasis, but also suppress the inflammation of adipose tissue in diet-induced obese mice. 11 beta-HSD1 may be a very promising therapeutic target for obesity and associated disease.	[Wang, Long; Liu, Juan; Zhang, Aisen; Cheng, Peng; Lv, Shan; Wu, Lin; Yu, Jing; Di, Wenjuan; Zha, Juanmin; Kong, Xiaocen; Qi, Hanmei; Ding, Guoxian] Nanjing Med Univ, Affiliated Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiao] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Zhong, Yi] China Pharmaceut Univ, Dept Pharmaceut Chem, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Northwestern University; Feinberg School of Medicine; China Pharmaceutical University	Wang, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China.	dinggx@njmu.edu.cn	zhang, xiao/B-3947-2010; Yu, Jing/AAL-5498-2021	Yu, Jing/0000-0002-5062-7069	First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China [3057087]; National Natural Science Youth Foundation of China [30900506]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Youth Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, grants from the National Natural Science Foundation of China (3057087) to Guoxian Ding, grants from the National Natural Science Youth Foundation of China (30900506) to Juan Liu and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Ishii-Yonemoto T, 2010, AM J PHYSIOL-ENDOC M, V298, pE930, DOI 10.1152/ajpendo.00320.2009; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lenz A, 2008, CURR OPIN ENDOCRINOL, V15, P9, DOI 10.1097/MED.0b013e3282f43a5b; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Staab CA, 2010, J STEROID BIOCHEM, V119, P56, DOI 10.1016/j.jsbmb.2009.12.013; Stewart PM, 2009, DIABETES, V58, P14, DOI 10.2337/db08-1404; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Wang SJY, 2006, DIABETOLOGIA, V49, P1333, DOI 10.1007/s00125-006-0239-y; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang TY, 2007, J IMMUNOL, V179, P6325, DOI 10.4049/jimmunol.179.9.6325	37	20	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40056	10.1371/journal.pone.0040056	http://dx.doi.org/10.1371/journal.pone.0040056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768329	gold, Green Published, Green Submitted			2022-12-25	WOS:000305966500042
J	Wei, J; Cheng, JM; Li, WJ; Liu, WG				Wei, Jie; Cheng, Jimin; Li, Weijun; Liu, Weiguo			Comparing the Effect of Naturally Restored Forest and Grassland on Carbon Sequestration and Its Vertical Distribution in the Chinese Loess Plateau	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; LAND-USE CHANGE; ISOTOPE FRACTIONATION; CLIMATE-CHANGE; DYNAMICS; VEGETATION; MATTER; DECOMPOSITION; NITROGEN; STORAGE	Vegetation restoration has been conducted in the Chinese Loess Plateau (CLP) since the 1950s, and large areas of farmland have been converted to forest and grassland, which largely results in SOC change. However, there has been little comparative research on SOC sequestration and distribution between secondary forest and restored grassland. Therefore, we selected typical secondary forest (SF-1 and SF-2) and restored grassland (RG-1 and RG-2) sites and determined the SOC storage. Moreover, to illustrate the factors resulting in possible variance in SOC sequestration, we measured the soil delta C-13 value. The average SOC content was 6.8, 9.9, 17.9 and 20.4 g kg(-1) at sites SF-1, SF-2, RG-1 and RG-2, respectively. Compared with 0-100 cm depth, the percentage of SOC content in the top 20 cm was 55.1%, 55.3%, 23.1%, and 30.6% at sites SF-1, SF-2, RG-1 and RG-2, suggesting a higher SOC content in shallow layers in secondary forest and in deeper layers in restored grassland. The variation of soil delta C-13 values with depth in this study might be attributed to the mixing of new and old carbon and kinetic fractionation during the decomposition of SOM by microbes, whereas the impact of the Suess effect (the decline of C-13 atmospheric CO2 values with the burning of fossil fuel since the Industrial Revolution) was minimal. The soil delta C-13 value increased sharply in the top 20 cm, which then increased slightly in deeper layers in secondary forest, indicating a main carbon source of surface litter. However the soil delta C-13 values exhibited slow increases in the whole profile in the restored grasslands, suggesting that the contribution of roots to soil carbon in deeper layers played an important role. We suggest that naturally restored grassland would be a more effective vegetation type for SOC sequestration due to higher carbon input from roots in the CLP.	[Wei, Jie; Liu, Weiguo] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary, Xian, Shaanxi, Peoples R China; [Wei, Jie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cheng, Jimin] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Cheng, Jimin] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Li, Weijun] Adm Off Yunwu Mt, Ningxia, Peoples R China; [Liu, Weiguo] Xi An Jiao Tong Univ, Sch Human Settlement & Civil Engn, Xian 710049, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Xi'an Jiaotong University	Wei, J (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary, Xian, Shaanxi, Peoples R China.	liuwg@loess.llqg.ac.cn	Liu, Weiguo/J-1824-2014		Chinese Academy of Science [kzcx2-yw-149]; National Natural Science Foundation of China [40673012]	Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was co-funded by the Knowledge Innovation Program of the Chinese Academy of Science (kzcx2-yw-149) (URL: http://www.cas.cn/) and the National Natural Science Foundation of China (40673012)(URL: http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewell C, 2011, BIOGEOSCIENCES, V8, P1769, DOI 10.5194/bg-8-1769-2011; Amundson R, 2000, METHODS IN ECOSYSTEM SCIENCE, P117; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; Arai H, 2010, GEODERMA, V159, P425, DOI 10.1016/j.geoderma.2010.09.009; BALDOCK JA, 1992, BIOGEOCHEMISTRY, V16, P1, DOI 10.1007/BF02402261; Bostrom B, 2007, OECOLOGIA, V153, P89, DOI 10.1007/s00442-007-0700-8; Chen LD, 2010, FOREST ECOL MANAG, V259, P1291, DOI 10.1016/j.foreco.2009.10.025; Chen QQ, 2005, PLANT SOIL, V273, P115, DOI 10.1007/s11104-004-7245-y; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Dirnbock T, 2002, APPL VEG SCI, V5, P147, DOI 10.1111/j.1654-109X.2002.tb00544.x; Dube F, 2009, FOREST ECOL MANAG, V257, P1695, DOI 10.1016/j.foreco.2009.01.044; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Fearnside Philip M., 1998, Forest Ecology and Management, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Fu B.J., 2002, LAND USE STRUCTURE E, P1; Garten CT, 2009, ACTA OECOL, V35, P218, DOI 10.1016/j.actao.2008.10.004; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Han FP, 2010, GEODERMA, V154, P261, DOI 10.1016/j.geoderma.2009.10.011; Hobbie EA, 2004, PLANT SOIL, V259, P331, DOI 10.1023/B:PLSO.0000020975.75850.ca; Huygens D, 2005, BIOGEOSCIENCES, V2, P159, DOI 10.5194/bg-2-159-2005; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Katterer T, 2011, AGR ECOSYST ENVIRON, V141, P184, DOI 10.1016/j.agee.2011.02.029; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2002, LAND DEGRAD DEV, V13, P469, DOI 10.1002/ldr.531; Li JF, 2009, CONTENT DISTRIBUTION; Li YY, 2006, J ARID ENVIRON, V64, P77, DOI 10.1016/j.jaridenv.2005.04.005; Liu WG, 2005, GLOBAL CHANGE BIOL, V11, P1094, DOI 10.1111/j.1365-2486.2005.00969.x; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Maia SMF, 2010, GLOBAL CHANGE BIOL, V16, P2775, DOI 10.1111/j.1365-2486.2009.02105.x; Marin-Spiotta E, 2009, GLOBAL CHANGE BIOL, V15, P1584, DOI 10.1111/j.1365-2486.2008.01805.x; Matamala R, 2008, ECOL APPL, V18, P1470, DOI 10.1890/07-1609.1; McLauchlan KK, 2006, GEODERMA, V136, P289, DOI 10.1016/j.geoderma.2006.03.053; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; O'Brien SL, 2010, GLOBAL CHANGE BIOL, V16, P2573, DOI 10.1111/j.1365-2486.2009.02114.x; Parfitt RL, 1997, PLANT SOIL, V191, P279, DOI 10.1023/A:1004266000509; Porporato A, 2002, ADV WATER RESOUR, V25, P1335, DOI 10.1016/S0309-1708(02)00058-1; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Ruiz-Navarro A, 2009, GEODERMA, V153, P353, DOI 10.1016/j.geoderma.2009.08.024; Schweizer M, 1999, RAPID COMMUN MASS SP, V13, P1284, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1284::AID-RCM578>3.0.CO;2-0; Steinbeiss S, 2008, GLOBAL CHANGE BIOL, V14, P2937, DOI 10.1111/j.1365-2486.2008.01697.x; Tate KR, 2000, AUST J SOIL RES, V38, P685, DOI 10.1071/SR99092; Wang G.A., 2008, BIOGEOSCIENCES DISCU, V5, P1795; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wei J, 2011, ACTA ECOL SINICA, V31, P271, DOI DOI 10.1016/j.chnaes.2011.06.009; Wynn JG, 2006, GEODERMA, V131, P89, DOI 10.1016/j.geoderma.2005.03.005; Wynn JG, 2005, GEOCHIM COSMOCHIM AC, V69, P1961, DOI 10.1016/j.gca.2004.09.003; Wynn JG, 2007, PALAEOGEOGR PALAEOCL, V251, P437, DOI 10.1016/j.palaeo.2007.04.009; Zhang X.B., 1994, B SOIL WATER CONSERV, V14, P1, DOI DOI 10.13961/JI.CNKI.STBCTB.1994.06.001	52	37	42	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40123	10.1371/journal.pone.0040123	http://dx.doi.org/10.1371/journal.pone.0040123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768335	Green Submitted, Green Published, gold			2022-12-25	WOS:000305966500048
J	An, SJ; Chen, ZH; Su, J; Zhang, XC; Zhong, WZ; Yang, JJ; Zhou, Q; Yang, XN; Huang, L; Guan, JL; Nie, Q; Yan, HH; Mok, TS; Wu, YL				An, She-Juan; Chen, Zhi-Hong; Su, Jian; Zhang, Xu-Chao; Zhong, Wen-Zhao; Yang, Jin-Ji; Zhou, Qing; Yang, Xue-Ning; Huang, Ling; Guan, Ji-Lin; Nie, Qiang; Yan, Hong-Hong; Mok, Tony S.; Wu, Yi-Long			Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status	PLOS ONE			English	Article							JAPANESE PATIENTS; MUTATIONS; EGFR; ADENOCARCINOMA; THERAPY; KRAS; BRAF; GEFITINIB	Background: Appropriate patient selection is needed for targeted therapies that are efficacious only in patients with specific genetic alterations. We aimed to define subgroups of patients with candidate driver genes in patients with non-small cell lung cancer. Methods: Patients with primary lung cancer who underwent clinical genetic tests at Guangdong General Hospital were enrolled. Driver genes were detected by sequencing, high-resolution melt analysis, qPCR, or multiple PCR and RACE methods. Results: 524 patients were enrolled in this study, and the differences in driver gene alterations among subgroups were analyzed based on histology and smoking status. In a subgroup of non-smokers with adenocarcinoma, EGFR was the most frequently altered gene, with a mutation rate of 49.8%, followed by EML4-ALK (9.3%), PTEN (9.1%), PIK3CA (5.2%), c-Met (4.8%), KRAS (4.5%), STK11 (2.7%), and BRAF (1.9%). The three most frequently altered genes in a subgroup of smokers with adenocarcinoma were EGFR (22.0%), STK11 (19.0%), and KRAS (12.0%). We only found EGFR (8.0%), c-Met (2.8%), and PIK3CA (2.6%) alterations in the non-smoker with squamous cell carcinoma (SCC) subgroup. PTEN (16.1%), STK11 (8.3%), and PIK3CA (7.2%) were the three most frequently enriched genes in smokers with SCC. DDR2 and FGFR2 only presented in smokers with SCC (4.4% and 2.2%, respectively). Among these four subgroups, the differences in EGFR, KRAS, and PTEN mutations were statistically significant. Conclusion: The distinct features of driver gene alterations in different subgroups based on histology and smoking status were helpful in defining patients for future clinical trials that target these genes. This study also suggests that we may consider patients with infrequent alterations of driver genes as having rare or orphan diseases that should be managed with special molecularly targeted therapies.	[An, She-Juan; Chen, Zhi-Hong; Su, Jian; Zhang, Xu-Chao; Huang, Ling; Guan, Ji-Lin; Yan, Hong-Hong; Wu, Yi-Long] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Zhong, Wen-Zhao; Yang, Jin-Ji; Zhou, Qing; Yang, Xue-Ning; Huang, Ling; Guan, Ji-Lin; Nie, Qiang; Wu, Yi-Long] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Div Pulm Oncol, Guangzhou, Guangdong, Peoples R China; [Mok, Tony S.] Chinese Univ Hong Kong, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China; [Mok, Tony S.] Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	An, SJ (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China.	tony@clo.cuhk.edu.hk; syylwu@live.cn	Wu, Yi-Long/GRJ-9238-2022; Wu, Yi-Long/AAB-9137-2022; Mok, Tony Shu Kam/B-2310-2019; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/C-3396-2008	Wu, Yi-Long/0000-0002-3611-0258; Mok, Tony Shu Kam/0000-0002-8251-0551; Wu, Yi-Long/0000-0002-3611-0258	National Natural Science Foundation of China [30772531, 81071699, 30871126, 81172090, 81001031, 81101549]; Foundation of Guangdong Science and Technology Department [2006B60101010, 2007A032000002]; Chinese Lung Cancer Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Guangdong Science and Technology Department; Chinese Lung Cancer Research Foundation	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30772531, 81071699, 30871126, 81172090, 81001031, and 81101549), Foundation of Guangdong Science and Technology Department (2006B60101010 and 2007A032000002), and the Chinese Lung Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Cadranel J, 2011, EUR RESPIR J, V37, P183, DOI 10.1183/09031936.00179409; Chen HJ, 2009, PATHOL ONCOL RES, V15, P651, DOI 10.1007/s12253-009-9167-8; Gao YJ, 2011, PROTEIN CELL, V2, P99, DOI 10.1007/s13238-011-1021-6; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hata A, 2010, J THORAC ONCOL, V5, P1197, DOI 10.1097/JTO.0b013e3181e2a2bc; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Kalikaki A, 2010, LUNG CANCER, V69, P110, DOI 10.1016/j.lungcan.2009.09.010; Kris MG, 2011, J CLIN ONCOL, V29; Loriot Y, 2009, NAT REV CLIN ONCOL, V6, P528, DOI 10.1038/nrclinonc.2009.106; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Byrne KJ, 2011, LANCET ONCOL, V12, P795, DOI 10.1016/S1470-2045(11)70189-9; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Sanchez-Cespedes M, 2011, FAM CANCER, V10, P447, DOI 10.1007/s10689-011-9443-0; Sasaki H, 2006, J SURG RES, V133, P203, DOI 10.1016/j.jss.2005.10.022; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Shepherd FA, 2011, J CLIN ONCOL, V29, P2843, DOI 10.1200/JCO.2011.35.9208; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Sonobe M, 2007, J SURG ONCOL, V95, P63, DOI 10.1002/jso.20547; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Thunnissen FB, 2012, LUNG CANCER, V75, P156, DOI 10.1016/j.lungcan.2011.07.013; Vakiani E, 2011, J PATHOL, V223, P219, DOI 10.1002/path.2796; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; West H, 2009, CHEST, V136, P1112, DOI 10.1378/chest.08-2484; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757; Zhou Wei, 2011, Chin J Cancer, V30, P287	32	114	131	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40109	10.1371/journal.pone.0040109	http://dx.doi.org/10.1371/journal.pone.0040109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768234	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100206
J	Carriere, Y; Goodell, PB; Ellers-Kirk, C; Larocque, G; Dutilleul, P; Naranjo, SE; Ellsworth, PC				Carriere, Yves; Goodell, Peter B.; Ellers-Kirk, Christa; Larocque, Guillaume; Dutilleul, Pierre; Naranjo, Steven E.; Ellsworth, Peter C.			Effects of Local and Landscape Factors on Population Dynamics of a Cotton Pest	PLOS ONE			English	Article							HEMIPTERA-MIRIDAE; HOST PLANTS; LYGUS; ALFALFA; MODELS; SAFFLOWER; STRATEGY; SCALE; SINKS; CROP	Background: Many polyphagous pests sequentially use crops and uncultivated habitats in landscapes dominated by annual crops. As these habitats may contribute in increasing or decreasing pest density in fields of a specific crop, understanding the scale and temporal variability of source and sink effects is critical for managing landscapes to enhance pest control. Methodology/Principal Findings: We evaluated how local and landscape characteristics affect population density of the western tarnished plant bug, Lygus hesperus (Knight), in cotton fields of the San Joaquin Valley in California. During two periods covering the main window of cotton vulnerability to Lygus attack over three years, we examined the associations between abundance of six common Lygus crops, uncultivated habitats and Lygus population density in these cotton fields. We also investigated impacts of insecticide applications in cotton fields and cotton flowering date. Consistent associations observed across periods and years involved abundances of cotton and uncultivated habitats that were negatively associated with Lygus density, and abundance of seed alfalfa and cotton flowering date that were positively associated with Lygus density. Safflower and forage alfalfa had variable effects, possibly reflecting among-year variation in crop management practices, and tomato, sugar beet and insecticide applications were rarely associated with Lygus density. Using data from the first two years, a multiple regression model including the four consistent factors successfully predicted Lygus density across cotton fields in the last year of the study. Conclusions/Significance: Our results show that the approach developed here is appropriate to characterize and test the source and sink effects of various habitats on pest dynamics and improve the design of landscape-level pest management strategies.	[Carriere, Yves; Ellers-Kirk, Christa; Ellsworth, Peter C.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Goodell, Peter B.] Univ Calif Cooperat Extens, Kearney Agr Ctr, Parlier, CA USA; [Larocque, Guillaume; Dutilleul, Pierre] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Naranjo, Steven E.] USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ USA	University of Arizona; University of California System; McGill University; United States Department of Agriculture (USDA)	Carriere, Y (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	ycarrier@ag.arizona.edu	Ellsworth, Peter C./I-2524-2019	Ellsworth, Peter C./0000-0002-2485-0830; Larocque, Guillaume/0000-0002-5967-9156	USDA-CSREES RAMP [0207436]	USDA-CSREES RAMP(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was funded by USDA-CSREES RAMP, Developing and Implementing Field and Landscape Level Reduced-Risk Management Strategies for Lygus in Western Cropping Systems (Project #0207436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpargu G, 2006, COMMUN STAT-SIMUL C, V35, P79, DOI 10.1080/03610910500416082; [Anonymous], 2008, JMP 8 0; Barman AK, 2010, INSECT SCI, V17, P542, DOI 10.1111/j.1744-7917.2010.01334.x; Bianchi FJJA, 2010, ECOL APPL, V20, P2322, DOI 10.1890/09-1278.1; Bommarco R, 2003, OIKOS, V102, P440, DOI 10.1034/j.1600-0579.2003.12578.x; Brodt SB, 2007, CALIF AGR, V61, P24, DOI 10.3733/ca.v061n01p24; Carriere Y, 2006, ENTOMOL EXP APPL, V118, P203, DOI 10.1111/j.1570-7458.2006.00384.x; Carriere Y, 2004, ECOL APPL, V14, P1615, DOI 10.1890/03-5268; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Dutilleul P, 2008, J STAT PLAN INFER, V138, P1402, DOI 10.1016/j.jspi.2007.06.022; Dutilleul PRL., 2011, SPATIO TEMPORAL HETE; ESRI, 2011, ARCGIS DESKT REL 10; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GODFREY LD, 1994, ENVIRON ENTOMOL, V23, P1106, DOI 10.1093/ee/23.5.1106; Goodell P.B., 2006, Proceedings Beltwide Cotton Conferences, V2006, P1375; Goodell PB, 2002, P BELT COTT PROD RES; Goodell PB, 2010, P CAL PLANT SOIL C V, P26; Goodell PB, 2009, PEST MANAG SCI, V65, P1293, DOI 10.1002/ps.1859; [Google Earth web site http://earth.google.com], GOOGL EARTH VERS 6; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hagler JR, 2006, ANN APPL BIOL, V149, P153, DOI 10.1111/j.1744-7348.2006.00076.x; Hanski I., 1999, METAPOPULATION ECOLO; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Jonsson M, 2010, BIOL INVASIONS, V12, P2933, DOI 10.1007/s10530-010-9737-4; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Layton MB, 2000, SOUTHWEST ENTOMOL, P7; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; MUELLER AJ, 1974, J ECON ENTOMOL, V67, P77, DOI 10.1093/jee/67.1.77; Pickett CH, 2009, BIOL CONTROL, V49, P27, DOI 10.1016/j.biocontrol.2008.09.009; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ruberson JR, 2000, SOUTHWEST ENTOMOL, P96; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; SEVACHERIAN V, 1977, J ECON ENTOMOL, V70, P399, DOI 10.1093/jee/70.4.399; SEVACHERIAN V, 1975, ENVIRON ENTOMOL, V4, P163, DOI 10.1093/ee/4.1.163; Snodgrass GL, 2006, ENVIRON ENTOMOL, V35, P1417, DOI 10.1603/0046-225X(2006)35[1417:SOTPBH]2.0.CO;2; STERN VM, 1969, CALIF AGR, V23, P8; The Mathworks Inc, 2008, MATLAB VERS R2008A; Thomas CD, 1999, J ANIM ECOL, V68, P647, DOI 10.1046/j.1365-2656.1999.00330.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; UC IPM Online website, STAT INT PEST MAN PR; University of CA Cotton Web Site, COTT GUID HEAT UN AV; USDA Farm Service Agency website. Aerial Photography Field Office, AER PHOT FIELD OFF I; WILSON LT, 1984, J ECON ENTOMOL, V77, P1313, DOI 10.1093/jee/77.5.1313; Zaller JG, 2008, BASIC APPL ECOL, V9, P682, DOI 10.1016/j.baae.2007.10.004; Zink AG, 2008, ENTOMOL EXP APPL, V126, P61, DOI 10.1111/j.1570-7458.2007.00634.x; [No title captured]	48	45	45	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39862	10.1371/journal.pone.0039862	http://dx.doi.org/10.1371/journal.pone.0039862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768147	Green Published, gold			2022-12-25	WOS:000305892100116
J	Linder, K; Wagner, R; Hatziagelaki, E; Ketterer, C; Heni, M; Machicao, F; Stefan, N; Staiger, H; Haring, HU; Fritsche, A				Linder, Katarzyna; Wagner, Robert; Hatziagelaki, Erifili; Ketterer, Caroline; Heni, Martin; Machicao, Fausto; Stefan, Norbert; Staiger, Harald; Haering, Hans-Ulrich; Fritsche, Andreas			Allele Summation of Diabetes Risk Genes Predicts Impaired Glucose Tolerance in Female and Obese Individuals	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; INSULIN-SECRETION; TYPE-2; ASSOCIATION; POLYMORPHISMS; SENSITIVITY; WOMEN; METAANALYSIS; DETERMINES; DEFINITION	Introduction: Single nucleotide polymorphisms (SNPs) in approximately 40 genes have been associated with an increased risk for type 2 diabetes (T2D) in genome-wide association studies. It is not known whether a similar genetic impact on the risk of prediabetes (impaired glucose tolerance [IGT] or impaired fasting glycemia [IFG]) exists. Methods: In our cohort of 1442 non-diabetic subjects of European origin (normal glucose tolerance [NGT] n = 1046, isolated IFG n = 142, isolated IGT n = 140, IFG+IGT n = 114), an impact on glucose homeostasis has been shown for 9 SNPs in previous studies in this specific cohort. We analyzed these SNPs (within or in the vicinity of the genes TCF7L2, KCNJ11, HHEX, SLC30A8, WFS1, KCNQ1, MTNR1B, FTO, PPARG) for association with prediabetes. Results: The genetic risk load was significantly associated with the risk for IGT (p = 0.0006) in a model including gender, age, BMI and insulin sensitivity. To further evaluate potential confounding effects, we stratified the population on gender, BMI and insulin sensitivity. The association of the risk score with IGT was present in female participants (p = 0.008), but not in male participants. The risk score was significantly associated with IGT (p = 0.008) in subjects with a body mass index higher than 30 kg/m(2) but not in non-obese individuals. Furthermore, only in insulin resistant subjects a significant association between the genetic load and the risk for IGT (p = 0.01) was found. Discussion: We found that T2D genetic risk alleles cause an increased risk for IGT. This effect was not present in male, lean and insulin sensitive subjects, suggesting a protective role of beneficial environmental factors on the genetic risk.	[Linder, Katarzyna; Wagner, Robert; Ketterer, Caroline; Heni, Martin; Machicao, Fausto; Stefan, Norbert; Staiger, Harald; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, D-7400 Tubingen, Germany; [Hatziagelaki, Erifili] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Internal Med 2,Res Inst, GR-11527 Athens, Greece; [Hatziagelaki, Erifili] Univ Athens, Sch Med, Attikon Univ Hosp, Ctr Diabet, GR-11527 Athens, Greece; [Fritsche, Andreas] Univ Hosp Tubingen, Div Nutr & Prevent Med, Dept Internal Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Linder, K (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, D-7400 Tubingen, Germany.	Andreas.Fritsche@med.uni-tuebingen.de	Wagner, Robert/B-3689-2012; Staiger, Harald/N-5871-2014	Wagner, Robert/0000-0002-6120-0191; Stefan, Norbert/0000-0002-2186-9595; Staiger, Harald/0000-0002-9507-5333; Heni, Martin/0000-0002-8462-3832	German Federal Ministry of Education and Research; German Research Foundation [FR 1561/5-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	This study was supported in part by a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD e.V.) and by a grant from the German Research Foundation to AF (FR 1561/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Ershow Abby G, 2009, J Diabetes Sci Technol, V3, P727; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Haupt A, 2009, J CLIN ENDOCR METAB, V94, P1775, DOI 10.1210/jc.2008-1876; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heni M, 2010, DIABETES, V59, P3247, DOI 10.2337/db10-0674; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Mussig K, 2009, DIABETES, V58, P1715, DOI 10.2337/db08-1589; MYKKANEN L, 1990, DIABETES CARE, V13, P1099, DOI 10.2337/diacare.13.11.1099; Perry JRB, 2010, HUM MOL GENET, V19, P535, DOI 10.1093/hmg/ddp522; Peter A, 2010, DIABETES, V59, P3167, DOI 10.2337/db10-0179; Qiao Q, 2003, DIABETES CARE, V26, P688; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Schafer SA, 2009, DIABETOLOGIA, V52, P1075, DOI 10.1007/s00125-009-1344-5; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003962; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38224	10.1371/journal.pone.0038224	http://dx.doi.org/10.1371/journal.pone.0038224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768041	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100012
J	Roy, A; Lara, A; Guimaraes, D; Pires, R; Gomes, ER; Carter, DE; Gomez, MV; Guatimosim, S; Prado, VF; Prado, MAM; Gros, R				Roy, Ashbeel; Lara, Aline; Guimaraes, Diogo; Pires, Rita; Gomes, Eneas R.; Carter, David E.; Gomez, Marcus V.; Guatimosim, Silvia; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert			An Analysis of the Myocardial Transcriptome in a Mouse Model of Cardiac Dysfunction with Decreased Cholinergic Neurotransmission	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; FATTY-ACID OXIDATION; METABOLISM; REPERFUSION; XANTHINE; STRESS; ACETYLCHOLINE; ENDOTHELIUM; TRANSPORTER; EXPRESSION	Autonomic dysfunction is observed in many cardiovascular diseases and contributes to cardiac remodeling and heart disease. We previously reported that a decrease in the expression levels of the vesicular acetylcholine transporter (VAChT) in genetically-modified homozygous mice (VAChT KDHOM) leads to decreased cholinergic tone, autonomic imbalance and a phenotype resembling cardiac dysfunction. In order to further understand the molecular changes resulting from chronic long-term decrease in parasympathetic tone, we undertook a transcriptome-based, microarray-driven approach to analyze gene expression changes in ventricular tissue from VAChT KDHOM mice. We demonstrate that a decrease in cholinergic tone is associated with alterations in gene expression in mutant hearts, which might contribute to increased ROS levels observed in these cardiomyocytes. In contrast, in another model of cardiac remodeling and autonomic imbalance, induced through chronic isoproterenol treatment to increase sympathetic drive, these genes did not appear to be altered in a pattern similar to that observed in VAChT KDHOM hearts. These data suggest the importance of maintaining a fine balance between the two branches of the autonomic nervous system and the significance of absolute levels of cholinergic tone in proper cardiac function.	[Roy, Ashbeel; Pires, Rita; Carter, David E.; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [Roy, Ashbeel; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Western Univ, Schulich Sch Med & Dent, Dept Physiol, London, ON, Canada; [Roy, Ashbeel; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Western Univ, Schulich Sch Med & Dent, Dept Pharmacol, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Western Univ, Schulich Sch Med & Dent, Dept Anat, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Western Univ, Schulich Sch Med & Dent, Dept Cell Biol, London, ON, Canada; [Gros, Robert] Western Univ, Schulich Sch Med & Dent, Dept Med Clin Pharmacol, London, ON, Canada; [Lara, Aline; Gomes, Eneas R.; Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol, Belo Horizonte, MG, Brazil; [Lara, Aline; Gomes, Eneas R.; Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biophys, Belo Horizonte, MG, Brazil; [Guimaraes, Diogo; Gomez, Marcus V.] Grad Program Santa Casa, Belo Horizonte, MG, Brazil	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Roy, A (corresponding author), Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada.	rgros@robarts.ca	Gros, Robert/AAV-2237-2020; Gomez, Marcus Vinicius/I-4081-2012; Guatimosim, Silvia/AAN-7441-2021; Gomes, Eneas RM/G-3153-2010; Prado, Marco Antonio Maximo/K-7638-2013; Gros, Robert/A-3010-2009; Prado, Vania Ferreira/K-7630-2013	Gros, Robert/0000-0002-3667-8011; Gomez, Marcus Vinicius/0000-0002-6082-930X; Guatimosim, Silvia/0000-0001-8386-3722; Gomes, Eneas RM/0000-0001-8528-8741; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Gros, Robert/0000-0002-3667-8011; Prado, Vania Ferreira/0000-0003-4994-6393	Heart and Stroke Foundation of Ontario [NA 6656]; Canadian Institutes for Health Research [MOP-82756, MOP-89919]; Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); NIH from Fogarty International Center [R03TW008425]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Programa de Apoio a Nucleos de Excelencia [PRONEX-CBB APQ-04334-10, APQ-00746-09]; Queen Elizabeth II Graduate Scholarship in Science and Technology (QEIIGSST); CNPq; Heart and Stroke Foundation of Canada; FOGARTY INTERNATIONAL CENTER [R03TW008425] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); NIH from Fogarty International Center; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia; Queen Elizabeth II Graduate Scholarship in Science and Technology (QEIIGSST); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Heart and Stroke Foundation of Ontario (Grant NA 6656), Canadian Institutes for Health Research (Grant MOP-82756 and MOP-89919), Canadian Foundation for Innovation (CFI), and the Ontario Research Fund (ORF), NIH R03TW008425 from the Fogarty International Center (SG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (SG) and Programa de Apoio a Nucleos de Excelencia (PRONEX-CBB APQ-04334-10 and APQ-00746-09). AR is supported by the Queen Elizabeth II Graduate Scholarship in Science and Technology (QEIIGSST). AL is a recipient of the CNPq PhD fellowship at the Post-graduation Program in Biological Science: Physiology and Pharmacology at UFMG. D G is a PhD student at the Graduate Program Santa Casa, Belo Horizonte, MG, Brazil. RG is supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELFATTAH AS, 1988, CIRCULATION, V78, P224; Arch J R, 1978, Essays Biochem, V14, P82; Beetsch JW, 1998, BRAIN RES, V786, P89, DOI 10.1016/S0006-8993(97)01407-8; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bone DBJ, 2010, AM J PHYSIOL-HEART C, V299, pH847, DOI 10.1152/ajpheart.00018.2010; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; DEUTICKE B, 1966, PFLUG ARCH GES PHYS, V292, P239, DOI 10.1007/BF00362739; FLORAS JS, 1993, J AM COLL CARDIOL, V22, pA72, DOI 10.1016/0735-1097(93)90466-E; GERLACH E, 1985, BASIC RES CARDIOL, V80, P459, DOI 10.1007/BF01907911; Guatimosim S, 2001, AM J PHYSIOL-CELL PH, V280, pC1327, DOI 10.1152/ajpcell.2001.280.5.C1327; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Hunt MJ, 2002, AM J PHYSIOL-LUNG C, V283, pL239, DOI 10.1152/ajplung.00001.2002; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Kanazawa H, 2010, J CLIN INVEST, V120, P408, DOI 10.1172/JCI39778; KATZ AM, 1993, CARDIOSCIENCE, V4, P199; Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0; Kinugasa Y, 2003, CIRC J, V67, P781; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; NEES S, 1985, BASIC RES CARDIOL, V80, P515, DOI 10.1007/BF01907915; NOLAN J, 1992, BRIT HEART J, V67, P482; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; OLSON RE, 1951, MEDICINE, V30, P21, DOI 10.1097/00005792-195102000-00002; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rana OR, 2010, AUTON NEUROSCI-BASIC, V156, P82, DOI 10.1016/j.autneu.2010.04.011; Rocha-Resende C, 2012, J MOL CELL CARDIOL; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Shizukuda Y, 2002, AM J PHYSIOL-LUNG C, V283, pL237, DOI 10.1152/ajplung.00111.2002; Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2; Sommerschild HT, 2000, ACTA ANAESTH SCAND, V44, P1038, DOI 10.1034/j.1399-6576.2000.440903.x; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; YAMAMOTO M, 1978, JPN CIRC J, V42, P1385; Zhang JY, 2000, J CARDIOVASC MAGN R, V2, P23, DOI 10.3109/10976640009148670; ZIMMERMAN TP, 1970, P AM ASSOC CANC RES, V11, P87	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39997	10.1371/journal.pone.0039997	http://dx.doi.org/10.1371/journal.pone.0039997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768193	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100165
J	Sun, YE; Peng, LY; Sun, XF; Bo, JH; Yang, D; Zheng, YG; Liu, CL; Zhu, BB; Ma, ZL; Gu, XP				Sun, Yu-e; Peng, Liangyu; Sun, Xiaofeng; Bo, Jinhua; Yang, Dong; Zheng, Yaguo; Liu, Chenglong; Zhu, Beibei; Ma, Zhengliang; Gu, Xiaoping			Intrathecal Injection of Spironolactone Attenuates Radicular Pain by Inhibition of Spinal Microglia Activation in a Rat Model	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; CENTRAL GLUCOCORTICOID-RECEPTORS; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; DORSAL-ROOT GANGLION; KAPPA-B-ALPHA; PROINFLAMMATORY CYTOKINES; CHRONIC COMPRESSION; NEUROPATHIC PAIN; MINERALOCORTICOID RECEPTOR	Background: Microglia might play an important role in nociceptive processing and hyperalgesia by neuroinflammatory process. Mineralocorticoid receptor (MR) expressed on microglia might play a central role in the modulation of microglia activity. However the roles of microglia and MR in radicular pain were not well understood. This study sought to investigate whether selective MR antagonist spironolactone develop antinociceptive effects on radicular pain by inhibition neuroinflammation induced by spinal microglia activation. Results: Radicular pain was produced by chronic compression of the dorsal root ganglia with SURGIFLO (TM). The expression of microglia, interleukin beta (IL-1 beta), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), NR1 subunit of the NMDA receptor (t-NR1), and NR1 subunit phosphorylated at Ser896 (p-NR1) were also markedly up-regulated. Intrathecal injection of spironolactone significantly attenuated pain behaviors as well as the expression of microglia, IL-1 beta, TNF-alpha, t-NR1, and p-NR1, whereas the production of IL-6 wasn't affected. Conclusion: These results suggest that intrathecal delivery spironolactone has therapeutic effects on radicular pain in rats. Decreasing the activation of glial cells, the production of proinflammatory cytokines and down-regulating the expression and phosphorylation of NMDA receptors in the spinal dorsal horn and dorsal root ganglia are the main mechanisms contributing to its beneficial effects.	[Sun, Yu-e; Peng, Liangyu; Sun, Xiaofeng; Bo, Jinhua; Yang, Dong; Zheng, Yaguo; Liu, Chenglong; Zhu, Beibei; Ma, Zhengliang; Gu, Xiaoping] Nanjing Univ, Coll Med, Drum Tower Hosp, Dept Anaesthesiol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Sun, YE (corresponding author), Nanjing Univ, Coll Med, Drum Tower Hosp, Dept Anaesthesiol, Nanjing, Jiangsu, Peoples R China.	mazhengliang1964@yahoo.com.cn; xiaopinggu1@gmail.com			National Natural Foundation of China [30872439/C16060202, 81171047/H0903]; National Natural Foundation of Jiangsu Province, China [BK2010105, 2010117, RC2011006, H200943]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Foundation of Jiangsu Province, China	This research was supported by the National Natural Foundation of China (30872439/C16060202, 81171047/H0903) and the National Natural Foundation of Jiangsu Province, China (BK2010105, 2010117, RC2011006, H200943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2010, EXCLI J, V9; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Avital A, 2006, J NEUROSCI, V26, P9130, DOI 10.1523/JNEUROSCI.1628-06.2006; Bendtzen K, 2003, CLIN EXP IMMUNOL, V134, P151, DOI 10.1046/j.1365-2249.2003.02249.x; Bursztajn S, 2004, NEUROSCIENCE, V125, P269, DOI 10.1016/j.neuroscience.2004.01.024; Doggrell SA, 2001, EXPERT OPIN INV DRUG, V10, P943, DOI 10.1517/13543784.10.5.943; Frieler RA, 2011, STROKE, V42, P179, DOI 10.1161/STROKEAHA.110.598441; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Gu XP, 2008, ANESTHESIOLOGY, V108, P113, DOI 10.1097/01.anes.0000296073.16972.13; Gu XP, 2011, BRAIN RES, V1396, P88, DOI 10.1016/j.brainres.2011.04.012; Gu XP, 2010, EUR J PAIN, V14, P496, DOI 10.1016/j.ejpain.2009.09.001; Gu XP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-76; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hansen PR, 2004, IMMUNOL LETT, V91, P87, DOI 10.1016/j.imlet.2003.11.008; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jaggi AS, 2010, EUR J PHARMACOL, V648, P102, DOI 10.1016/j.ejphar.2010.08.050; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; Liou JT, 2011, ANESTHESIOLOGY, V114, P660, DOI 10.1097/ALN.0b013e31820b8b1e; Ma ZL, 2007, ANN CLIN LAB SCI, V37, P349; MAO J, 1992, BRAIN RES, V576, P254, DOI 10.1016/0006-8993(92)90688-6; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Miura R, 2006, J PHARMACOL SCI, V101, P256, DOI 10.1254/jphs.SC0060049; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Quan N, 1997, P NATL ACAD SCI USA, V94, P10985, DOI 10.1073/pnas.94.20.10985; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Sonder SUS, 2006, APOPTOSIS, V11, P2159, DOI 10.1007/s10495-006-0286-3; Sonder SUS, 2006, BRIT J PHARMACOL, V148, P46, DOI 10.1038/sj.bjp.0706700; Su DS, 2010, ANESTH ANALG, V111, P768, DOI 10.1213/ANE.0b013e3181e9e897; Syngle A, 2009, SCAND J RHEUMATOL, V38, P15, DOI 10.1080/03009740802279709; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Tanaka J, 1997, GLIA, V20, P23, DOI 10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.3.CO;2-U; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang SX, 2006, PAIN, V120, P78, DOI 10.1016/j.pain.2005.10.015; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wang SX, 2004, J NEUROSCI, V24, P8595, DOI 10.1523/JNEUROSCI.3058-04.2004; Wang X, 2004, MOL PSYCHIATR, V9, P65, DOI 10.1038/sj.mp.4001339; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Woods AG, 1999, NEUROSCIENCE, V91, P1277, DOI 10.1016/S0306-4522(98)00685-X; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; YAMAMOTO T, 1992, PAIN, V49, P121, DOI 10.1016/0304-3959(92)90198-K; Zhang RX, 2008, NEUROSCIENCE, V154, P1533, DOI 10.1016/j.neuroscience.2008.04.072; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang W, 2009, ANESTH ANALG, V108, P1015, DOI 10.1213/ane.0b013e318193ffd2	50	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39897	10.1371/journal.pone.0039897	http://dx.doi.org/10.1371/journal.pone.0039897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768159	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100128
J	van Winden, JF; Reichart, GJ; McNamara, NP; Benthien, A; Damste, JSS				van Winden, Julia F.; Reichart, Gert-Jan; McNamara, Niall P.; Benthien, Albert; Damste, Jaap S. Sinninghe			Temperature-Induced Increase in Methane Release from Peat Bogs: A Mesocosm Experiment	PLOS ONE			English	Article							CARBON; PEATLANDS; CH4	Peat bogs are primarily situated at mid to high latitudes and future climatic change projections indicate that these areas may become increasingly wetter and warmer. Methane emissions from peat bogs are reduced by symbiotic methane oxidizing bacteria (methanotrophs). Higher temperatures and increasing water levels will enhance methane production, but also methane oxidation. To unravel the temperature effect on methane and carbon cycling, a set of mesocosm experiments were executed, where intact peat cores containing actively growing Sphagnum were incubated at 5, 10, 15, 20, and 25 degrees C. After two months of incubation, methane flux measurements indicated that, at increasing temperatures, methanotrophs are not able to fully compensate for the increasing methane production by methanogens. Net methane fluxes showed a strong temperature-dependence, with higher methane fluxes at higher temperatures. After removal of Sphagnum, methane fluxes were higher, increasing with increasing temperature. This indicates that the methanotrophs associated with Sphagnum plants play an important role in limiting the net methane flux from peat. Methanotrophs appear to consume almost all methane transported through diffusion between 5 and 15 degrees C. Still, even though methane consumption increased with increasing temperature, the higher fluxes from the methane producing microbes could not be balanced by methanotrophic activity. The efficiency of the Sphagnum-methanotroph consortium as a filter for methane escape thus decreases with increasing temperature. Whereas 98% of the produced methane is retained at 5 degrees C, this drops to approximately 50% at 25 degrees C. This implies that warming at the mid to high latitudes may be enhanced through increased methane release from peat bogs.	[van Winden, Julia F.; Reichart, Gert-Jan; Damste, Jaap S. Sinninghe] Univ Utrecht, Dept Geosci, Utrecht, Netherlands; [Reichart, Gert-Jan; Benthien, Albert] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [McNamara, Niall P.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, England; [Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, Den Burg, Netherlands	Utrecht University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	van Winden, JF (corresponding author), Univ Utrecht, Dept Geosci, Utrecht, Netherlands.	damste@nioz.nl	Reichart, Gert-Jan/N-6308-2018; Damste, Jaap S Sinninghe/F-6128-2011; McNamara, Niall P/B-4907-2008	Reichart, Gert-Jan/0000-0002-7256-2243; Damste, Jaap S Sinninghe/0000-0002-8683-1854; McNamara, Niall P/0000-0002-5143-5819; Benthien, Albert/0000-0002-9159-3109	Darwin Centre for Biogeosciences [142.16.1062]; Natural Environment Research Council [ceh010023] Funding Source: researchfish	Darwin Centre for Biogeosciences; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was partially supported by the Darwin Centre for Biogeosciences (grant no. 142.16.1062). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basiliko N, 2004, WETLANDS, V24, P178, DOI 10.1672/0277-5212(2004)024[0178:ROMSAH]2.0.CO;2; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Bohn TJ, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045015; Borren W, 2007, THESIS UTRECHT U NET; Boucher O, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044007; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Frenzel P, 2000, BIOGEOCHEMISTRY, V51, P91, DOI 10.1023/A:1006351118347; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Larmola T, 2010, ECOLOGY, V91, P2356, DOI 10.1890/09-1343.1; McNamara NP, 2008, SCI TOTAL ENVIRON, V404, P354, DOI 10.1016/j.scitotenv.2008.03.015; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Smith A.J.E., 2004, MOSS FLORA BRITAIN I, DOI [10.1017/cbo9780511541858, DOI 10.1017/CBO9780511541858]; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; WILLIAMS RT, 1984, APPL ENVIRON MICROB, V47, P1266, DOI 10.1128/AEM.47.6.1266-1271.1984	17	48	51	5	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39614	10.1371/journal.pone.0039614	http://dx.doi.org/10.1371/journal.pone.0039614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768100	Green Published, Green Accepted, gold			2022-12-25	WOS:000305892100070
J	Wang, CH; Hung, CP; Chen, MT; Shih, YH; Lin, YY				Wang, Chi-Han; Hung, Chou P.; Chen, Ming-Teh; Shih, Yang-Hsin; Lin, Yung-Yang			Hippocampal Desynchronization of Functional Connectivity Prior to the Onset of Status Epilepticus in Pilocarpine-Treated Rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PRIMARY VISUAL-CORTEX; IN-VIVO; NEURONAL CORRELATION; SPONTANEOUS SEIZURES; ENTORHINAL CORTEX; CROSS-CORRELATION; EPILEPTOGENESIS; DISCHARGES; MODEL	Status epilepticus (SE), a pro-epileptogenic brain insult in rodent models of temporal lobe epilepsy, is successfully induced by pilocarpine in some, but not all, rats. This study aimed to identify characteristic alterations within the hippocampal neural network prior to the onset of SE. Sixteen microwire electrodes were implanted into the left hippocampus of male Sprague-Dawley rats. After a 7-day recovery period, animal behavior, hippocampal neuronal ensemble activities, and local field potentials (LFP) were recorded before and after an intra-peritoneal injection of pilocarpine (350 mg/kg). The single-neuron firing, population neuronal correlation, and coincident firing between neurons were compared between SE (n = 9) and nonSE rats (n = 12). A significant decrease in the strength of functional connectivity prior to the onset of SE, as measured by changes in coincident spike timing between pairs of hippocampal neurons, was exclusively found in SE rats. However, single-neuron firing and LFP profiles did not show a significant difference between SE and nonSE rats. These results suggest that desynchronization in the functional circuitry of the hippocampus, likely associated with a change in synaptic strength, may serve as an electrophysiological marker prior to SE in pilocarpine-treated rats.	[Wang, Chi-Han; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan; [Wang, Chi-Han] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Hung, Chou P.; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Hung, Chou P.; Lin, Yung-Yang] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Hung, Chou P.] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Chen, Ming-Teh] Natl Yang Ming Univ, Dept Neurosurg, Taipei 112, Taiwan; [Hung, Chou P.] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Wang, Chi-Han; Lin, Yung-Yang] Taipei Vet Gen Hosp, Neurophysiol Lab, Taipei, Taiwan; [Chen, Ming-Teh; Shih, Yang-Hsin] Taipei Vet Gen Hosp, Dept Neurosurg, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Georgetown University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Wang, CH (corresponding author), Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan.	g2000kev@gmail.com			Taipei Veterans General Hospital [V96C1-123, V96ER3-004, V96S4-010, V97C1-034, V97ER3-006, V97S4-011, VGHUST97-P6-24, V98C1-095, V98ER3-002, V98S4-001, V98S4-006, V98S4-018, V99C1-156, V99ER3-006, V99S4-004, V101C-023, V100C-146, V100E6-003]; National Science Council [NSC-95-2314-B-010-030-MY3, NSC-96-2628-B-010-030-MY3, NSC98-2321-B-010-007, NSC-99-2321-B-010-004, NSC-99-2628-B-010-011-MY3, NSC 100-2321-B-010 -004]; Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan	The study was supported in part by research grants from the Taipei Veterans General Hospital (V96C1-123, V96ER3-004, V96S4-010, V97C1-034, V97ER3-006, V97S4-011, V97S4-011, VGHUST97-P6-24, V98C1-095, V98ER3-002, V98S4-001, V98S4-006, V98S4-018, V99C1-156, V99ER3-006, V99S4-004, V101C-023, V100C-146, V100E6-003), the National Science Council (NSC-95-2314-B-010-030-MY3; NSC-96-2628-B-010-030-MY3; NSC98-2321-B-010-007; NSC-99-2321-B-010-004, NSC-99-2628-B-010-011-MY3, NSC 100-2321-B-010 -004), and the Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; Bower MR, 2008, J NEUROPHYSIOL, V99, P2431, DOI 10.1152/jn.01369.2007; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chen MT, 2001, EXP NEUROL, V171, P72, DOI 10.1006/exnr.2001.7730; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Goldberg JA, 2003, J NEUROSCI, V23, P10058; Gorter JA, 2001, EUR J NEUROSCI, V13, P657, DOI 10.1046/j.1460-9568.2001.01428.x; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Hung CP, 2007, NAT NEUROSCI, V10, P1185, DOI 10.1038/nn1948; Hung YW, 2012, EPILEPSY RES, V98, P206, DOI 10.1016/j.eplepsyres.2011.09.015; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; LEMOS T, 1995, EXP BRAIN RES, V102, P423; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; Liu XZ, 2003, J NEUROSCI, V23, P11505; LIU Z, 1994, EPILEPSY RES, V17, P237; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mora GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005759; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Popova IY, 2008, NEUROSCI LETT, V442, P228, DOI 10.1016/j.neulet.2008.07.016; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Shi LH, 2007, EPILEPSY RES, V73, P85, DOI 10.1016/j.eplepsyres.2006.08.008; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Stoop R, 2000, EUR J NEUROSCI, V12, P3651, DOI 10.1046/j.1460-9568.2000.00253.x; Swanson L.W, 2004, BRAIN MAPS; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Tsai ML, 2003, J NEUROSCI METH, V131, P107, DOI 10.1016/S0165-0270(03)00235-8; TSO DY, 1986, J NEUROSCI, V6, P1160; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; Williams PA, 2002, J NEUROPHYSIOL, V88, P2075, DOI 10.1152/jn.2002.88.4.2075; Zhou JL, 2007, EPILEPSIA, V48, P720, DOI 10.1111/j.1528-1167.2006.00972.x	41	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39763	10.1371/journal.pone.0039763	http://dx.doi.org/10.1371/journal.pone.0039763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768120	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100090
J	Quitschke, WW				Quitschke, Wolfgang W.			Curcuminoid Binding to Embryonal Carcinoma Cells: Reductive Metabolism, Induction of Apoptosis, Senescence, and Inhibition of Cell Proliferation	PLOS ONE			English	Article							GROWTH SUPPRESSIVE ACTIVITY; HUMAN SERUM-ALBUMIN; VITAMIN-D-RECEPTOR; IN-VITRO; SIGNALING PATHWAYS; DNA FRAGMENTATION; COLORECTAL-CARCINOMA; GENE-EXPRESSION; AGENT CURCUMIN; MELANOMA-CELLS	Curcumin preparations typically contain a mixture of polyphenols, collectively referred to as curcuminoids. In addition to the primary component curcumin, they also contain smaller amounts of the co-extracted derivatives demethoxycurcumin and bisdemethoxycurcumin. Curcuminoids can be differentially solubilized in serum, which allows for the systematic analysis of concentration-dependent cellular binding, biological effects, and metabolism. Technical grade curcumin was solubilized in fetal calf serum by two alternative methods yielding saturated preparations containing either predominantly curcumin (60%) or bisdemethoxycurcumin (55%). Continual exposure of NT2/D1 cells for 4-6 days to either preparation in cell culture media reduced cell division (1-5 mu M), induced senescence (6-7 mu M) or comprehensive cell death (8-10 mu M) in a concentration-dependent manner. Some of these effects could also be elicited in cells transiently exposed to higher concentrations of curcuminoids (47 mu M) for 0.5-4 h. Curcuminoids induced apoptosis by generalized activation of caspases but without nucleosomal fragmentation. The equilibrium binding of serum-solubilized curcuminoids to NT2/D1 cells incubated with increasing amounts of curcuminoid-saturated serum occurred with apparent overall dissociation constants in the 6-10 mu M range. However, the presence of excess free serum decreased cellular binding in a hyperbolic manner. Cellular binding was overwhelmingly associated with membrane fractions and bound curcuminoids were metabolized in NT2/D1 cells via a previously unidentified reduction pathway. Both the binding affinities for curcuminoids and their reductive metabolic pathways varied in other cell lines. These results suggest that curcuminoids interact with cellular binding sites, thereby activating signal transduction pathways that initiate a variety of biological responses. The dose-dependent effects of these responses further imply that distinct cellular pathways are sequentially activated and that this activation is dependent on the affinity of curcuminoids for the respective binding sites. Defined serum-solubilized curcuminoids used in cell culture media are thus suitable for further investigating the differential activation of signal transduction pathways.	SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Quitschke, WW (corresponding author), SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA.	wolfgang.quitschke@sbumed.org			American Health Assistance Foundation [A2009342]; National Institutes of Health/National Center for Research Resources (NIH/NCRR) through the Proteomics Center of the State University of New York at Stony Brook [1 S10 RR023680-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health/National Center for Research Resources (NIH/NCRR) through the Proteomics Center of the State University of New York at Stony Brook; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grant A2009342 from the American Health Assistance Foundation (http://www.ahaf.org/). Additionally, support for mass spectrometry was provided by the shared instrumentation grant National Institutes of Health/National Center for Research Resources (NIH/NCRR) 1 S10 RR023680-1 through the Proteomics Center of the State University of New York at Stony Brook. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas F, 2006, Z NATURFORSCH C, V61, P625; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; ANDREWS PW, 1984, LAB INVEST, V50, P147; Anuchapreeda S, 2006, ACTA PHARMACOL SIN, V27, P360, DOI 10.1111/j.1745-7254.2006.00291.x; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Balstad TR, 2011, MOL NUTR FOOD RES, V55, P185, DOI 10.1002/mnfr.201000204; Bangaru MLY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009893; Bartik L, 2010, J NUTR BIOCHEM, V21, P1153, DOI 10.1016/j.jnutbio.2009.09.012; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Bielak-Zmijewska A, 2010, CELL PROLIFERAT, V43, P354, DOI 10.1111/j.1365-2184.2010.00684.x; Blasius R, 2004, ANN NY ACAD SCI, V1030, P442, DOI 10.1196/annals.1329.055; Braga MEM, 2003, J AGR FOOD CHEM, V51, P6604, DOI 10.1021/jf0345550; Cen L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-99; Charoensuk L, 2011, INT J PARASITOL; Chen CC, 2010, INT J MOL SCI, V11, P2839, DOI 10.3390/ijms11082839; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Delmas D, 2011, MOL NUTR FOOD RES, V55, P1142, DOI 10.1002/mnfr.201100065; Demirovic D, 2011, BIOGERONTOLOGY; Dempe JS, 2008, MOL NUTR FOOD RES, V52, P1074, DOI 10.1002/mnfr.200800029; Deters M, 2008, PHARM RES-DORDR, V25, P1822, DOI 10.1007/s11095-008-9579-2; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding ZS, 2008, MOLECULES, V13, P220, DOI 10.3390/molecules13020220; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Dujic J, 2007, J INVEST DERMATOL, V127, P1992, DOI 10.1038/sj.jid.5700801; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Friedman L, 2009, ANTI-CANCER DRUG, V20, P444, DOI 10.1097/CAD.0b013e32832afc04; Gautam SC, 1998, BIOCHEM PHARMACOL, V55, P1333, DOI 10.1016/S0006-2952(98)00019-7; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Heng MCY, 2010, INT J DERMATOL, V49, P608, DOI 10.1111/j.1365-4632.2010.04468.x; Hiserodt R, 1996, J CHROMATOGR A, V740, P51, DOI 10.1016/0021-9673(96)00103-3; Hoehle SI, 2006, J AGR FOOD CHEM, V54, P756, DOI 10.1021/jf058146a; HUANG MT, 1995, CARCINOGENESIS, V16, P2493, DOI 10.1093/carcin/16.10.2493; Huang TY, 2010, J AGR FOOD CHEM, V58, P10639, DOI 10.1021/jf1016303; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Jaruga E, 1998, FEBS LETT, V433, P287, DOI 10.1016/S0014-5793(98)00919-3; Jayaprakasha GK, 2002, J AGR FOOD CHEM, V50, P3668, DOI 10.1021/jf025506a; Johnson SM, 2009, ANTICANCER RES, V29, P3185; Kim AN, 2010, FREE RADICAL BIO MED, V49, P323, DOI 10.1016/j.freeradbiomed.2010.04.015; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Knower KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017751; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Leung MHM, 2009, LANGMUIR, V25, P5773, DOI 10.1021/la804215v; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Lin L, 2011, BIOCHEM BIOPH RES CO, V416, P246, DOI 10.1016/j.bbrc.2011.10.112; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P603, DOI 10.1111/j.1745-7254.2005.00081.x; Liu Q, 2009, PHYTOMEDICINE, V16, P916, DOI 10.1016/j.phymed.2009.04.008; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; Lu CW, 2010, CURR EYE RES, V35, P352, DOI 10.3109/02713680903521944; Lu JJ, 2012, MOL CELL BIOCHEM, V360, P253, DOI 10.1007/s11010-011-1064-2; Lunenburger H, 2010, ANTI-CANCER DRUG, V21, P514, DOI 10.1097/CAD.0b013e3283375d5c; Magalska A, 2006, ACTA BIOCHIM POL, V53, P531; Malik M, 2009, FERTIL STERIL, V91, P2177, DOI 10.1016/j.fertnstert.2008.03.045; Marczylo TH, 2007, CANCER CHEMOTH PHARM, V60, P171, DOI 10.1007/s00280-006-0355-x; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Moiseeva EP, 2007, MOL CANCER THER, V6, P3071, DOI 10.1158/1535-7163.MCT-07-0117; Nangia AK, 2007, J UROLOGY, V178, P1092, DOI 10.1016/j.juro.2007.05.009; Natarajan VT, 2010, J INVEST DERMATOL; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Peret-Almeida L, 2005, FOOD RES INT, V38, P1039, DOI 10.1016/j.foodres.2005.02.021; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Piwocka K, 1999, EXP CELL RES, V249, P299, DOI 10.1006/excr.1999.4480; Premanand C, 2006, INVEST OPHTH VIS SCI, V47, P2179, DOI 10.1167/iovs.05-0580; Purkayastha S, 2009, BRAIN RES; Quitschke WW, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-84; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Reddy ACP, 1999, LIPIDS, V34, P1025, DOI 10.1007/s11745-999-0453-x; Sahu A, 2008, ACTA BIOMATER, V4, P1752, DOI 10.1016/j.actbio.2008.04.021; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Scapagnini G, 2011, MOL NEUROBIOL; Schaaf C, 2010, NEUROENDOCRINOLOGY, V91, P200, DOI 10.1159/000287236; Shen GX, 2006, MOL CANCER THER, V5, P39, DOI 10.1158/1535-7163.MCT-05-0293; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Shu JC, 2009, BRAZ J MED BIOL RES, V42, P1173, DOI 10.1590/S0100-879X2009005000041; Sikora E, 2006, MOL CANCER THER, V5, P927, DOI 10.1158/1535-7163.MCT-05-0360; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Singh M, 2010, MED ONCOL, V27, P1096, DOI 10.1007/s12032-009-9341-6; Siwak DR, 2005, CANCER-AM CANCER SOC, V104, P879, DOI 10.1002/cncr.21216; Skommer J, 2006, EXP HEMATOL, V34, P463, DOI 10.1016/j.exphem.2005.12.015; Staal J, 2011, CELL RES, V21, P40, DOI 10.1038/cr.2010.168; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tayyem RR, 2006, NUTR CANCER, V55, P126, DOI 10.1207/s15327914nc5502_2; Teiten MH, 2011, INT J ONCOL, V38, P603, DOI 10.3892/ijo.2011.905; Thangapazham RL, 2006, AAPS J, V8, pE443, DOI 10.1208/aapsj080352; Tripathi R, 2011, MOL CANCER THER, V10, P255, DOI 10.1158/1535-7163.MCT-10-0606; Verghese J., 1993, Flavour and Fragrance Journal, V8, P315, DOI 10.1002/ffj.2730080605; Villegas I, 2008, MOL NUTR FOOD RES, V52, P1040, DOI 10.1002/mnfr.200700280; Walters DK, 2008, INVEST NEW DRUG, V26, P289, DOI 10.1007/s10637-007-9099-7; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Wu JY, 2007, BIOL PHARM BULL, V30, P1336, DOI 10.1248/bpb.30.1336; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P62, DOI 10.1016/j.bcp.2006.03.022; Yue GGL, 2010, FOOD CHEM TOXICOL, V48, P2011, DOI 10.1016/j.fct.2010.04.039; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou QM, 2011, ACTA PHARMACOL SIN, V32, P1402, DOI 10.1038/aps.2011.97	112	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39568	10.1371/journal.pone.0039568	http://dx.doi.org/10.1371/journal.pone.0039568			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22768090	Green Published, Green Submitted, gold			2022-12-25	WOS:000305808700035
J	Guo, SJ; Li, XB; Gao, M; Kong, H; Li, YQ; Gu, ML; Dong, XQ; Niu, WQ				Guo, Shujie; Li, Xiaobo; Gao, Min; Kong, Hong; Li, Yuqiong; Gu, Mingliang; Dong, Xiaoqun; Niu, Wenquan			Synergistic Association of PTGS2 and CYP2E1 Genetic Polymorphisms with Lung Cancer Risk in Northeastern Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; INCREASED EXPRESSION; CYCLOOXYGENASE-2; SURVIVAL; ASIANS	Background: Lung cancer is the most common cause of cancer-related deaths worldwide. The aim of this study was to investigate the association of five extensively-studied polymorphisms in PTGS2 (rs689466, rs5275, rs20417) and CYP2E1 (rs2031920, rs6413432) genes with lung cancer risk in a large northeastern Chinese population. Methodology/Principal Findings: This is a hospital-based case-control study involving 684 patients with lung cancer and 604 cancer-free controls. Genotyping was performed using the PCR-LDR method. Data were analyzed using Haplo.stats and MDR programs. There were significant differences between patients and controls in allele/genotype distributions of rs5275 (P = 0.002/0.003) and rs6413432 (P = 0.037/0.044), as well as in genotype distributions of rs689466 (P = 0.02). The risk for lung cancer associated with the rs5275-C mutant allele was decreased by 60% (95% CI [confidence interval]: 0.21-0.74; P = 0.004) under the recessive model. Carriers of rs689466-G mutant allele had a 28% (95% CI: 0.57-0.92; P = 0.008) reduced risk of developing lung cancer relative to the AA genotype carriers. In haplotype analysis, haplotype G-C-C-T (in order of rs689466, rs5275, rs2031920 and rs6413432) decreased the odds of lung cancer by 28% (95% CI: 0.51-0.93; P = 0.019) after adjusting for confounding factors, whereas haplotype A-T-T-T had 1.49-fold (95% CI: 1.21-1.79; P = 0.012) increased risk for lung cancer. Using MDR method, the overall best model including rs5275, rs689466 and rs6413432 polymorphisms was identified with a maximal testing accuracy of 66.1% and a maximal cross-validation consistency of 10 out of 10 (P = 0.003). Conclusions/Significance: Our findings demonstrated a potentially synergistic association of PTGS2 and CYP2E1 polymorphisms with the underlying cause of lung cancer in northeastern Chinese.	[Guo, Shujie; Li, Xiaobo; Kong, Hong; Li, Yuqiong; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Gao, Min] Harbin Med Univ, Affiliated Hosp 1, Dept Resp Med, Harbin, Heilongjiang, Peoples R China; [Gu, Mingliang] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Gu, Mingliang] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Dong, Xiaoqun] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Harbin Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Rhode Island	Guo, SJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	xiaoqun_dong@mail.uri.edu; niuwenquan@yahoo.cn			Shanghai Rising Star Program [11QA1405500]; National Natural Science Foundation of China [30900808]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising Star Program (11QA1405500), and the National Natural Science Foundation of China (30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Haque AK, 2004, APPL IMMUNOHISTO M M, V12, P315, DOI 10.1097/00129039-200412000-00005; Hida T, 1998, CANCER RES, V58, P3761; Koch A, 2011, DIAGN CYTOPATHOL, V39, P188, DOI 10.1002/dc.21366; Liao Zhongxing, 2004, Expert Rev Anticancer Ther, V4, P543, DOI 10.1586/14737140.4.4.543; Liu F, 2010, ASIAN PAC J CANCER P, V11, P1257; Michaud V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015666; Micu AL, 2003, J PHARMACOL EXP THER, V306, P941, DOI 10.1124/jpet.103.052183; Mineo TC, 2010, EUR J CARDIO-THORAC, V38, P245, DOI 10.1016/j.ejcts.2010.02.012; Moore JH, 2010, ADV GENET, V72, P101, DOI [10.1016/B978-0-12-380862-2.00005-9, 10.1016/S0065-2660(10)72005-8]; Neafsey P, 2009, J TOXICOL ENV HEAL B, V12, P362, DOI 10.1080/10937400903158359; Niu WQ, 2010, CLIN CHIM ACTA, V411, P1491, DOI 10.1016/j.cca.2010.06.004; Pankratz VS, 2011, J THORAC ONCOL, V6, P1488, DOI 10.1097/JTO.0b013e318223bf05; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Peng WJ, 2011, MOL BIOL REP; Salgia R, 2011, SEMIN ONCOL, V38, P274, DOI 10.1053/j.seminoncol.2011.01.012; Salmenkivi K, 2001, J CLIN ENDOCR METAB, V86, P5615, DOI 10.1210/jc.86.11.5615; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Subramanian J, 2008, LANCET ONCOL, V9, P676, DOI 10.1016/S1470-2045(08)70174-8; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Wang YD, 2010, EUR J CANCER, V46, P758, DOI 10.1016/j.ejca.2009.12.010; Wolff H, 1998, CANCER RES, V58, P4997; Zhan P, 2010, LUNG CANCER, V69, P19, DOI 10.1016/j.lungcan.2009.09.001	27	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39814	10.1371/journal.pone.0039814	http://dx.doi.org/10.1371/journal.pone.0039814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761909	Green Published, gold			2022-12-25	WOS:000305781700069
J	Bourens, M; Dabir, DV; Tienson, HL; Sorokina, I; Koehler, CM; Barrientos, A				Bourens, Myriam; Dabir, Deepa V.; Tienson, Heather L.; Sorokina, Irina; Koehler, Carla M.; Barrientos, Antoni			Role of Twin Cys-Xaa(9)-Cys Motif Cysteines in Mitochondrial Import of the Cytochrome c Oxidase Biogenesis Factor Cmc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; INTERMEMBRANE SPACE; PROTEIN IMPORT; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; MIA40; PATHWAY; ERV1; RECOGNITION; OXIDATION	The Mia40 import pathway facilitates the import and oxidative folding of cysteine-rich protein substrates into the mitochondrial intermembrane space. Here we describe the in vitro and in organello oxidative folding of Cmc1, a twin CX9C-containing substrate, which contains an unpaired cysteine. In vitro, Cmc1 can be oxidized by the import receptor Mia40 alone when in excess or at a lower rate by only the sulfhydryl oxidase Erv1. However, physiological and efficient Cmc1 oxidation requires Erv1 and Mia40. Cmc1 forms a stable intermediate with Mia40 and is released from this interaction in the presence of Erv1. The three proteins are shown to form a ternary complex in mitochondria. Our results suggest that this mechanism facilitates efficient formation of multiple disulfides and prevents the formation of non-native disulfide bonds.	[Bourens, Myriam; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Dabir, Deepa V.; Tienson, Heather L.; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sorokina, Irina] Midwest Bio Serv LLC, Overland Pk, KS 66211 USA	University of Miami; University of Miami; University of California System; University of California Los Angeles	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.maimi.edu		Sorokina, Irina/0000-0003-1531-1832	National Institutes of Health [GM071775A, GM061721, GM07185, 1F32GM084568-01A1]; Muscular Dysthrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R01GM071775, F32GM084568, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dysthrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071775A (to A. B.), GM061721 (to C. M. K.), GM07185 (to H. L. T.), and 1F32GM084568-01A1 (to D. V. D.). This work was also supported by a Muscular Dysthrophy Association Research Grant (to A. B.).	Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Herrmann JM, 2009, BBA-MOL CELL RES, V1793, P71, DOI 10.1016/j.bbamcr.2008.05.001; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horn D, 2010, J BIOL CHEM, V285, P15088, DOI 10.1074/jbc.M110.104786; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Stuart R.A., 2007, CURRENT PROTOCOLS CE; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Tie JK, 2004, J BIOL CHEM, V279, P54079, DOI 10.1074/jbc.M408945200; Tienson HL, 2009, MOL BIOL CELL, V20, P3481, DOI 10.1091/mbc.E08-10-1062	30	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31258	31269		10.1074/jbc.M112.383562	http://dx.doi.org/10.1074/jbc.M112.383562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22767599	hybrid, Green Published			2022-12-25	WOS:000308791300038
J	Domashevskiy, AV; Miyoshi, H; Goss, DJ				Domashevskiy, Artem V.; Miyoshi, Hiroshi; Goss, Dixie J.			Inhibition of Pokeweed Antiviral Protein (PAP) by Turnip Mosaic Virus Genome-linked Protein (VPg)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; CAP-INDEPENDENT TRANSLATION; TOBACCO ETCH VIRUS; RICIN-A-CHAIN; INITIATION-FACTORS; MESSENGER-RNA; VIRAL RNAS; SARCIN/RICIN LOOP; BINDING; POTYVIRUS	Pokeweed antiviral protein (PAP) from Phytolacca americana is a ribosome-inactivating protein (RIP) and an RNA N-glycosidase that removes specific purine residues from the sarcin/ricin loop of large rRNA, arresting protein synthesis at the translocation step. PAP is also a cap-binding protein and is a potent antiviral agent against many plant, animal, and human viruses. To elucidate the mechanism of RNA depurination, and to understand how PAP recognizes and targets various RNAs, the interactions between PAP and turnip mosaic virus genome-linked protein (VPg) were investigated. VPg can function as a cap analog in cap-independent translation and potentially target PAP to uncapped IRES-containing RNA. In this work, fluorescence spectroscopy and HPLC techniques were used to quantitatively describe PAP depurination activity and PAP-VPg interactions. PAP binds to VPg with high affinity (29.5 nM); the reaction is enthalpically driven and entropically favored. Further, VPg is a potent inhibitor of PAP depurination of RNA in wheat germ lysate and competes with structured RNA derived from tobacco etch virus for PAP binding. VPg may confer an evolutionary advantage by suppressing one of the plant defense mechanisms and also suggests the possible use of this protein against the cytotoxic activity of ribosome-inactivating proteins.	[Domashevskiy, Artem V.; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Domashevskiy, Artem V.; Goss, Dixie J.] CUNY Grad Ctr, New York, NY 10065 USA; [Domashevskiy, Artem V.] CUNY John Jay Coll Criminal Justice, Dept Sci, New York, NY 10019 USA; [Domashevskiy, Artem V.] CUNY Grad Ctr, New York, NY 10019 USA; [Miyoshi, Hiroshi] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa 2168511, Japan	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Saint Marianna University	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Domashevskiy, Artem/0000-0001-7511-8191; Miyoshi, Hiroshi/0000-0002-0489-9848	National Science Foundation [MCB 0814051, MCB 1118320]; PSC-CUNY Faculty Awards; CUNY Collaborative Award; Ministry of Education, Science and Culture of Japan [2368042]; Div Of Molecular and Cellular Bioscience [1118320] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); PSC-CUNY Faculty Awards; CUNY Collaborative Award; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB 0814051 and MCB 1118320 (to D. J. G.) and MCB 0919626 (to D. E. F.). This work was also supported by PSC-CUNY Faculty Awards (to D. J. G. and D. E. F.), a CUNY Collaborative Award (to D. J. G. and D. E. F.), and Grant-in-aid for Scientific Research 2368042 from the Ministry of Education, Science and Culture of Japan (to H. M.).	ARON GM, 1980, ANTIMICROB AGENTS CH, V17, P1032, DOI 10.1128/AAC.17.6.1032; Baldwin AE, 2009, BBA-GENE REGUL MECH, V1789, P109, DOI 10.1016/j.bbagrm.2008.09.001; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; BONNESS MS, 1994, PLANT J, V5, P173, DOI 10.1046/j.1365-313X.1994.05020173.x; BRIGOTTI M, 1989, BIOCHEM J, V257, P723, DOI 10.1042/bj2570723; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P6977, DOI 10.1021/bi00242a024; CHEN ZC, 1993, PHYSIOL MOL PLANT P, V42, P249, DOI 10.1006/pmpp.1993.1023; DALLAL JA, 1978, FEBS LETT, V89, P257, DOI 10.1016/0014-5793(78)80230-0; DUGGAR B. M., 1925, Ann. Mo. Bot. Gdn., V12, P359, DOI 10.2307/2394061; Firpo MA, 1996, J BIOL CHEM, V271, P4693; GALLIE DR, 1991, MOL GEN GENET, V228, P258, DOI 10.1007/BF00282474; GOSS DJ, 1984, BIOCHEMISTRY-US, V23, P6522, DOI 10.1021/bi00321a038; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hudak KA, 2000, RNA, V6, P369, DOI 10.1017/S1355838200991337; Hudak KA, 1999, J BIOL CHEM, V274, P3859, DOI 10.1074/jbc.274.6.3859; Hudak KA, 2002, RNA, V8, P1148, DOI 10.1017/S1355838202026638; Hudak KA, 2001, VIROLOGY, V279, P292, DOI 10.1006/viro.2000.0647; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; KIM KS, 1969, VIROLOGY, V37, P297, DOI 10.1016/0042-6822(69)90213-X; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, p[52, 277, 530]; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Leonard S, 2004, J GEN VIROL, V85, P1055, DOI 10.1099/vir.0.19706-0; LEVINE RL, 1977, CLIN CHEM, V23, P2292; Mansouri S, 2006, RNA, V12, P1683, DOI 10.1261/rna.70306; MIURA K, 1991, ANAL BIOCHEM, V196, P84, DOI 10.1016/0003-2697(91)90121-9; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; MURPHY JF, 1991, J VIROL, V65, P511, DOI 10.1128/JVI.65.1.511-513.1991; Nielsen K, 2001, ANNU REV PLANT PHYS, V52, P785, DOI 10.1146/annurev.arplant.52.1.785; Niepel M, 1999, J VIROL, V73, P9080, DOI 10.1128/JVI.73.11.9080-9088.1999; OBRIG TG, 1973, ARCH BIOCHEM BIOPHYS, V155, P278, DOI 10.1016/0003-9861(73)90116-1; OSBORN RW, 1990, EUR J BIOCHEM, V193, P401, DOI 10.1111/j.1432-1033.1990.tb19353.x; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Picard D, 2005, J BIOL CHEM, V280, P20069, DOI 10.1074/jbc.M413452200; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; READY MP, 1986, P NATL ACAD SCI USA, V83, P5053, DOI 10.1073/pnas.83.14.5053; Ren JH, 1996, NUCLEIC ACIDS RES, V24, P3629, DOI 10.1093/nar/24.18.3629; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; TOMLINSON JA, 1974, J GEN VIROL, V22, P225, DOI 10.1099/0022-1317-22-2-225; Tumer NE, 1999, CURR TOP MICROBIOL, V240, P139; Tumer NE, 1998, J VIROL, V72, P1036, DOI 10.1128/JVI.72.2.1036-1042.1998; USSERY MA, 1977, ANN NY ACAD SCI, V284, P431, DOI 10.1111/j.1749-6632.1977.tb21979.x; Vivanco JM, 2003, PHYTOPATHOLOGY, V93, P588, DOI 10.1094/PHYTO.2003.93.5.588; Wang M, 2006, NUCLEIC ACIDS RES, V34, P1174, DOI 10.1093/nar/gkj520; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; ZAMBONI M, 1989, BIOCHEM J, V259, P639, DOI 10.1042/bj2590639; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200; ZHANG Y, 1991, AM J PHYSIOL, V260, pG658, DOI 10.1152/ajpgi.1991.260.4.G658	52	16	16	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29729	29738		10.1074/jbc.M112.367581	http://dx.doi.org/10.1074/jbc.M112.367581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773840	Green Published, hybrid			2022-12-25	WOS:000308286900049
J	Ayna, G; Krysko, DV; Kaczmarek, A; Petrovski, G; Vandenabeele, P; Fesus, L				Ayna, Gizem; Krysko, Dmitri V.; Kaczmarek, Agnieszka; Petrovski, Goran; Vandenabeele, Peter; Fesues, Laszlo			ATP Release from Dying Autophagic Cells and Their Phagocytosis Are Crucial for Inflammasome Activation in Macrophages	PLOS ONE			English	Article							CALRETICULIN EXPOSURE; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; P2X(7) RECEPTOR; MECHANISMS; IL-1-BETA; APOPTOSIS; DANGER; DEATH; RECOGNITION	Pathogen-activated and damage-associated molecular patterns activate the inflammasome in macrophages. We report that mouse macrophages release IL-1 beta while co-incubated with pro-B (Ba/F3) cells dying, as a result of IL-3 withdrawal, by apoptosis with autophagy, but not when they are co-incubated with living, apoptotic, necrotic or necrostatin-1 treated cells. NALP3-deficient macrophages display reduced IL-1b secretion, which is also inhibited in macrophages deficient in caspase-1 or pre-treated with its inhibitor. This finding demonstrates that the inflammasome is activated during phagocytosis of dying autophagic cells. We show that activation of NALP3 depends on phagocytosis of dying cells, ATP release through pannexin-1 channels of dying autophagic cells, P2X7 purinergic receptor activation, and on consequent potassium efflux. Dying autophagic Ba/F3 cells injected intraperitoneally in mice recruit neutrophils and thereby induce acute inflammation. These findings demonstrate that NALP3 performs key upstream functions in inflammasome activation in mouse macrophages engulfing dying autophagic cells, and that these functions lead to pro-inflammatory responses.	[Ayna, Gizem; Vandenabeele, Peter; Fesues, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Debrecen, Hungary; [Krysko, Dmitri V.; Kaczmarek, Agnieszka; Vandenabeele, Peter] VIB, Dept Mol Biomed Res, Mol Signalling & Cell Death Unit, Ghent, Belgium; [Krysko, Dmitri V.; Kaczmarek, Agnieszka; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Fesues, Laszlo] Univ Debrecen, Hungarian Acad Sci, Med & Hlth Sci Ctr, Apoptosis & Genom Res Grp, Debrecen, Hungary	University of Debrecen; Flanders Institute for Biotechnology (VIB); Ghent University; Hungarian Academy of Sciences; University of Debrecen	Ayna, G (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Debrecen, Hungary.	fesus@med.unideb.hu	Krysko, Dmitri V./AAE-9368-2019; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Krysko, Dmitri V./0000-0002-9692-2047; Vandenabeele, Peter/0000-0002-6669-8822; Ayna Duran, Assist. Prof. Dr. Gizem/0000-0002-2168-753X; Petrovski, Goran/0000-0003-2905-9252	Hungarian Scientific Research Fund [OTKA NI 67877, K 61868]; European Social Fund [TAMOP-4.2.2-08/1/2008-0015, TAMOP 4.2.1./B-09/1/KONV-2010-0007]; ETT (Egeszsegugyi Tudomanyos Tanacs) from Hungarian Ministry of Health; EU [MRTNCT-2006-036032, MRTN-CT 2006-035624]; Fund for Scientific Research Flanders (FWO [Het Fonds Wetenschappelijk Onderzoek - Vlaanderen]-Vlaanderen) [3G072810]; FWO-Vlaanderen [31507110]; VIB; Ghent University (GROUP-ID consortium of the UGent MRP initiative); FWO Vlaanderen [G.0875.11, G.0973.11]; Federal Research Program [IAP 6/18]; European Research Program [MRTN-CT-035624, Apo-Sys 200767]; Euregional PACTII (Euregional PACT II - Euregional Platform for Advancing Cancer Treatment II); Flemish Government [BOF09/01M00709]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Social Fund(European Social Fund (ESF)); ETT (Egeszsegugyi Tudomanyos Tanacs) from Hungarian Ministry of Health; EU(European Commission); Fund for Scientific Research Flanders (FWO [Het Fonds Wetenschappelijk Onderzoek - Vlaanderen]-Vlaanderen)(FWO); FWO-Vlaanderen(FWO); VIB; Ghent University (GROUP-ID consortium of the UGent MRP initiative); FWO Vlaanderen(FWO); Federal Research Program; European Research Program(European Commission); Euregional PACTII (Euregional PACT II - Euregional Platform for Advancing Cancer Treatment II); Flemish Government(European Commission)	This work has been supported by grants from the Hungarian Scientific Research Fund (OTKA NI 67877, K 61868), TAMOP-4.2.2-08/1/2008-0015 and TAMOP 4.2.1./B-09/1/KONV-2010-0007 project implemented through the New Hungary Development Plan, co-financed by the European Social Fund, an ETT (Egeszsegugyi Tudomanyos Tanacs) grant from the Hungarian Ministry of Health, EU MRTNCT-2006-036032 and MRTN-CT 2006-035624, Fund for Scientific Research Flanders (FWO [Het Fonds Wetenschappelijk Onderzoek - Vlaanderen]-Vlaanderen, 3G072810 to D.V.K.) and by an individual research grant from FWO-Vlaanderen (31507110 to D.V.K.). D.V.K. is a postdoctoral fellow and A.K. is a doctoral fellow, both paid by fellowships from FWO-Vlaanderen. Peter Vandenabeele's group is supported by VIB, Ghent University (GROUP-ID consortium of the UGent MRP initiative), FWO Vlaanderen (G.0875.11 and G.0973.11), Federal Research Program (IAP 6/18), European Research Program FP6 ApopTrain (MRTN-CT-035624), FP7 Apo-Sys 200767, and the Euregional PACTII (Euregional PACT II - Euregional Platform for Advancing Cancer Treatment II). P.V. holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; D'hondt C, 2011, CELL SIGNAL, V23, P305, DOI 10.1016/j.cellsig.2010.07.018; ELLIOTT JA, 1986, INFECT IMMUN, V51, P31, DOI 10.1128/IAI.51.1.31-36.1986; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fesus L, 2011, ANTIOXID REDOX SIGN, V14, P2233, DOI 10.1089/ars.2010.3485; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krysko DV, 2011, CELL DEATH DIFFER, V18, P1316, DOI 10.1038/cdd.2011.4; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Krysko DV, 2010, APOPTOSIS, V15, P995, DOI 10.1007/s10495-010-0524-6; Krysko O, 2010, APOPTOSIS, V15, P1137, DOI 10.1007/s10495-010-0504-x; Majai G, 2006, IMMUNOL LETT, V104, P94, DOI 10.1016/j.imlet.2005.11.016; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McDonald B, 2011, SCIENCE, V331, P1517; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, SWISS MED WKLY, V137, p28S; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Petrovski G, 2007, CELL DEATH DIFFER, V14, P1117, DOI 10.1038/sj.cdd.4402112; Petrovski G, 2011, AUTOPHAGY, V7, P321, DOI 10.4161/auto.7.3.14583; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Prietzsch H, 2002, CELL SIGNAL, V14, P751, DOI 10.1016/S0898-6568(02)00023-2; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	56	88	92	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40069	10.1371/journal.pone.0040069	http://dx.doi.org/10.1371/journal.pone.0040069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768222	Green Published, gold			2022-12-25	WOS:000305892100194
J	Hejda, M				Hejda, Martin			What Is the Impact of Impatiens parviflora on Diversity and Composition of Herbal Layer Communities of Temperate Forests?	PLOS ONE			English	Article							SPECIES RICHNESS; INVASION; VEGETATION; PLANTS; SIZE; DC.	The aim was to estimate the impacts of invasive Impatiens parviflora on forests' herbal layer communities. A replicated Before-After-Control-Impact field experiment and comparisons with adjacent uninvaded plots were used. The alien's impact on species richness was tested using hierarchical generalized mixed effect models with Poisson error structure. Impact on species composition was tested using multivariate models (DCA, CCA, RDA) and Monte-Carlo permutation tests. Removal plots did not differ in native species richness from neither invaded nor adjacent uninvaded plots, both when the treatment's main effect or its interaction with sampling time was tested (Chi(2) = 0.4757, DF = 2, p = 0.7883; Chi(2) = 7.229, DF = 8, p = 0.5121 respectively). On the contrary, ordination models revealed differences in the development of plots following the treatments (p = 0.034) with the invaded plots differing from the adjacent uninvaded (p = 0.002). Impatiens parviflora is highly unlikely to impact native species richness of invaded communities, which may be associated with its limited ability to create a dense canopy, a modest root system or the fact the I. parviflora does not represent a novel and distinctive dominant to the invaded communities. Concerning its potential impacts on species composition, the presence of native clonal species (Athyrium filix-femina, Dryopteris filix-mas, Fragaria moschata, Luzula luzuloides, Poa nemoralis) on the adjacent uninvaded plots likely makes them different from the invaded plots. However, these competitive and strong species are more likely to prevent the invasion of I. parviflora on the adjacent uninvaded plots rather than being themselves eliminated from the invaded communities.	Acad Sci Czech Republic, Dept Invas Ecol, Inst Bot, Pruhonice, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Hejda, M (corresponding author), Acad Sci Czech Republic, Dept Invas Ecol, Inst Bot, Pruhonice, Czech Republic.	martinhejda@seznam.cz	Hejda, Martin/H-1589-2014		Grant Agency of the Czech Republic [P505/11/1112, 206/070668]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The work on this manuscript was funded by grants no. P505/11/1112 and 206/070668 from the Grant Agency of the Czech Republic (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chmura D, 2007, FOREST ECOL MANAG, V242, P487, DOI 10.1016/j.foreco.2007.01.083; Chmura D, 2006, POL J ECOL, V54, P417; Crawley MJ., 2007, R BOOK; CSONTOS P, 1986, Studia Botanica Hungarica, V19, P115; ELIAS P, 1992, EKOL CSFR, V11, P299; Godefroid S, 2010, PLANT ECOL EVOL, V143, P119, DOI 10.5091/plecevo.2010.397; Hejda M, 2006, BIOL CONSERV, V132, P143, DOI 10.1016/j.biocon.2006.03.025; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Hughes AP, 1964, NEW PHYTOL, V64, P48; Klimko Malgorzata, 2003, Ecological Questions, V3, P63; Kwiatkowska AJ, 1997, PLANT ECOL, V129, P1, DOI 10.1023/A:1009708317294; Leps J., 2000, MULTIVARIATE ANAL EC; Obidzinski T, 2000, ACTA SOC BOT POL, V69, P311, DOI 10.5586/asbp.2000.041; PEACE WJH, 1982, NEW PHYTOL, V90, P127, DOI 10.1111/j.1469-8137.1982.tb03247.x; PERRINS J, 1993, J BIOGEOGR, V20, P33, DOI 10.2307/2845737; Piskorz R, 2006, ACTA SOC BOT POL, V75, P51; Piskorz R, 2007, SYLWAN, V151, P43; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sadlo J, 2007, PRESLIA, V79, P303; Schmitz G, 1998, PLANT INVASIONS: ECOLOGICAL MECHANISMS AND HUMAN RESPONSES, P335; Schmitz Gregor, 1999, Zeitschrift fuer Oekologie und Naturschutz, V7, P193; Swies F, 1982, BIOLOGIA, V37, P351; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Trepl L, 1982, DISSERTATIONES BOT, V73; UHERCIKOVA E, 1991, Preslia (Prague), V63, P227	25	35	39	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39571	10.1371/journal.pone.0039571	http://dx.doi.org/10.1371/journal.pone.0039571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768091	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100061
J	Keating, MA; Hamela, G; Miller, WC; Moses, A; Hoffman, IF; Hosseinipour, MC				Keating, Maria A.; Hamela, Gloria; Miller, William C.; Moses, Agnes; Hoffman, Irving F.; Hosseinipour, Mina C.			High HIV Incidence and Sexual Behavior Change among Pregnant Women in Lilongwe, Malawi: Implications for the Risk of HIV Acquisition	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; INFECTION; ZIMBABWE; PREVENTION; PREVALENCE; ABSTINENCE; EXPRESSION; INSIGHTS; AFRICA; PERIOD	Background: HIV incidence is higher among pregnant women than their non-pregnant counterparts in some sub-Saharan African settings. Our aims were (1) to estimate HIV incidence during pregnancy and (2) to compare sexual activity between pregnant, postpartum, and non-pregnant women. Methods: We examined a retrospective cohort of 1087 women to identify seroconverters using antenatal and labor ward HIV test results. We also conducted a cross-sectional survey, including a quantitative questionnaire (n = 200) and in-depth interviews (n = 20) among women in early pregnancy, late pregnancy, postpartum, and non-pregnancy. Outcomes included measures of sexual activity, reported spouse's risky behavior, and beliefs about abstinence. Results: 11 of 1087 women seroconverted during pregnancy yielding a 1% seroconversion risk and an incidence rate of 4.0/100 person years (95% CI 2.2-7.2). The reported sexual activity of the early pregnancy and non-pregnancy groups was similar, but significantly higher than the late pregnancy and postpartum groups (p < 0.001). During pregnancy, sex acts decreased as gestation increased (p = 0.001). There was no reported difference in the spouse's risky behavior. Most women believed that sex should cease between the 6th and 8th month of pregnancy and should not resume until 6 months postpartum. Some talked about conflict between their cultural obligation to abstain and fear of HIV infection if their spouses find other partners. Conclusions: HIV incidence is high among pregnant women in Malawi, and sexual activity decreases during pregnancy and postpartum. Pregnant women need to be informed of their increased risk for HIV and the importance of using condoms throughout pregnancy and the postpartum period.	[Keating, Maria A.; Hamela, Gloria; Moses, Agnes; Hosseinipour, Mina C.] Univ N Carolina Project, Lilongwe, Malawi; [Keating, Maria A.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Miller, William C.; Hoffman, Irving F.; Hosseinipour, Mina C.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	Drexel University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Keating, MA (corresponding author), Univ N Carolina Project, Lilongwe, Malawi.	mina_hosseinipour@med.unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	Doris Duke Charitable Foundation through the University of North Carolina; Elizabeth Glaser Pediatric AIDS Foundation [MQ-00-9-200-01205-0-00]; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health [P30 AI50410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation through the University of North Carolina; Elizabeth Glaser Pediatric AIDS Foundation; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was upported by (1) the Doris Duke Charitable Foundation through the University of North Carolina to fund Clinical Research Fellow Maria Keating, (2) the Elizabeth Glaser Pediatric AIDS Foundation Operation Research Grant #MQ-00-9-200-01205-0-00, and (3) the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health funded program #P30 AI50410. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER EM, 1989, BAILLIERE CLIN OB GY, V3, P805, DOI 10.1016/S0950-3552(89)80066-5; Awusabo-Asare K, 1997, Health Transit Rev, V7 Suppl, P257; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Cleland JG, 1999, AIDS, V13, P125, DOI 10.1097/00002030-199901140-00017; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Government of Malawi Ministry of Health, 2007, PREV MOTH CHILD TRAN; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Kinuthia J, 2010, CURR HIV RES, V8, P510, DOI 10.2174/157016210793499213; Lawoyin TO, 2002, J BIOSOC SCI, V34, P51, DOI 10.1017/S0021932002000512; Makanani B, 2010, INT J GYNECOL OBSTET, V108, P26, DOI 10.1016/j.ijgo.2009.08.014; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Morrison CS, 2007, AIDS, V21, P1027, DOI 10.1097/QAD.0b013e3280f00fc4; Munjoma MW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-668; Patterson BK, 1998, AM J PATHOL, V153, P481, DOI 10.1016/S0002-9440(10)65591-5; PIWOWARMANNING EM, 2010, AIDS CARE, V9, P170; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Sheffield JS, 2009, REPROD SCI, V16, P20, DOI 10.1177/1933719108325510; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; Tavengwa NV, 2007, TROP MED INT HEALTH, V12, P97, DOI 10.1111/j.1365-3156.2006.01758.x; UNAIDS, 2010, GLOB REP UNAIDS REP; Urassa W, 2006, SCAND J PUBLIC HEALT, V34, P272, DOI 10.1080/14034940500434871	25	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39109	10.1371/journal.pone.0039109	http://dx.doi.org/10.1371/journal.pone.0039109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768063	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100033
J	Libeu, CAP; Descamps, O; Zhang, Q; John, V; Bredesen, DE				Libeu, Clare A. Peters; Descamps, Olivier; Zhang, Qiang; John, Varghese; Bredesen, Dale E.			Altering APP Proteolysis: Increasing sAPPalpha Production by Targeting Dimerization of the APP Ectodomain	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BOVINE SERUM ALBUMIN; A-BETA; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; ALZHEIMER-DISEASE; ALPHA-SECRETASE; BINDING; CLEAVAGE; COMMON	One of the events associated with Alzheimer's disease is the dysregulation of alpha- versus beta-cleavage of the amyloid precursor protein (APP). The product of a-cleavage (sAPP alpha) has neuroprotective properties, while A beta 1-42 peptide, a product of beta-cleavage, is neurotoxic. Dimerization of APP has been shown to influence the relative rate of alpha- and beta-cleavage of APP. Thus finding compounds that interfere with dimerization of the APP ectodomain and increase the alpha-cleavage of APP could lead to the development of new therapies for Alzheimer's disease. Examining the intrinsic fluorescence of a fragment of the ectodomain of APP, which dimerizes through the E2 and A beta-cognate domains, revealed significant changes in the fluorescence of the fragment upon binding of A beta oligomers-which bind to dimers of the ectodomain- and A beta fragments-which destabilize dimers of the ectodomain. This technique was extended to show that RERMS-containing peptides (APP(695) 328-332), disulfiram, and sulfiram also inhibit dimerization of the ectodomain fragment. This activity was confirmed with small angle x-ray scattering. Analysis of the activity of disulfiram and sulfiram in an AlphaLISA assay indicated that both compounds significantly enhance the production of sAPP alpha by 7W-CHO and B103 neuroblastoma cells. These observations demonstrate that there is a class of compounds that modulates the conformation of the APP ectodomain and influences the ratio of alpha- to beta-cleavage of APP. These compounds provide a rationale for the development of a new class of therapeutics for Alzheimer's disease.	[Libeu, Clare A. Peters; Descamps, Olivier; Zhang, Qiang; John, Varghese; Bredesen, Dale E.] Buck Inst Res Aging, Novato, CA USA	Buck Institute for Research on Aging	Libeu, CAP (corresponding author), Buck Inst Res Aging, Novato, CA USA.	clibeu@buckinstitute.org	Zhang, Qiang/C-3317-2018	Zhang, Qiang/0000-0002-4746-0392	Stephen D. Bechtel, Jr. Foundation; Joseph Drown Foundation; Douglas and Ellen Rosenberg Foundation; National Institutes of Health [AG034427]; NATIONAL INSTITUTE ON AGING [R01AG034427] Funding Source: NIH RePORTER	Stephen D. Bechtel, Jr. Foundation; Joseph Drown Foundation; Douglas and Ellen Rosenberg Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Stephen D. Bechtel, Jr. Foundation, the Joseph Drown Foundation, the Douglas and Ellen Rosenberg Foundation, and the National Institutes of Health (AG034427- D. Bredesen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; Butterfield DA, 2003, CURR MED CHEM, V10, P2651, DOI 10.2174/0929867033456422; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Ferrao-Gonzales AD, 2005, J BIOL CHEM, V280, P34747, DOI 10.1074/jbc.M501651200; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Haas C, 1997, BIOCHEM J, V325, P169, DOI 10.1042/bj3250169; Hass S, 1998, J BIOL CHEM, V273, P13892; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; JIN LW, 1994, J NEUROSCI, V14, P5461; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Libeu CP, 2011, J ALZHEIMERS DIS, V25, P547, DOI 10.3233/JAD-2011-101938; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MULTHAUP G, 1994, BIOCHIMIE, V76, P304, DOI 10.1016/0300-9084(94)90163-5; Multhaup G, 2006, NEURODEGENER DIS, V3, P270, DOI 10.1159/000095266; Neve RL, 2008, AMYLOID, V15, P1, DOI 10.1080/13506120701814608; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Oh SY, 2005, J NEUROSCI RES, V82, P32, DOI 10.1002/jnr.20625; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WEBER G, 1966, BIOCHEMISTRY-US, V5, P1900, DOI 10.1021/bi00870a017; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	56	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40027	10.1371/journal.pone.0040027	http://dx.doi.org/10.1371/journal.pone.0040027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768208	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100180
J	Overman, EL; Rivier, JE; Moeser, AJ				Overman, Elizabeth L.; Rivier, Jean E.; Moeser, Adam J.			CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-alpha	PLOS ONE			English	Article							INDUCED VISCERAL HYPERSENSITIVITY; NEONATAL MATERNAL SEPARATION; STRESS-RELATED ALTERATIONS; PARACELLULAR PERMEABILITY; SIGNALING PATHWAYS; COLONIC DISTENSION; RECTAL DISTENSION; SUBSTANCE-P; DYSFUNCTION; TIGHT	Background and Aims: Psychological stress is a predisposing factor in the onset and exacerbation of important gastrointestinal diseases including irritable bowel syndrome (IBS) and the inflammatory bowel diseases (IBD). The pathophysiology of stress-induced intestinal disturbances is known to be mediated by corticotropin releasing factor (CRF) but the precise signaling pathways remain poorly understood. Utilizing a porcine ex vivo intestinal model, the aim of this study was to investigate the mechanisms by which CRF mediates intestinal epithelial barrier disturbances. Methodology: Ileum was harvested from 6-8 week-old pigs, mounted on Ussing Chambers, and exposed to CRF in the presence or absence of various pharmacologic inhibitors of CRF-mediated signaling pathways. Mucosal-to-serosal flux of 4 kDa-FITC dextran (FD4) and transepithelial electrical resistance (TER) were recorded as indices of intestinal epithelial barrier function. Results: Exposure of porcine ileum to 0.05-0.5 mu M CRF increased (p < 0.05) paracellular flux compared with vehicle controls. CRF treatment had no deleterious effects on ileal TER. The effects of CRF on FD4 flux were inhibited with pre-treatment of tissue with the non-selective CRF1/2 receptor antagonist Astressin B and the mast cell stabilizer sodium cromolyn (10(-4) M). Furthermore, anti-TNF-alpha neutralizing antibody (p < 0.01), protease inhibitors (p < 0.01) and the neural blocker tetrodotoxin (TTX) inhibited CRF-mediated intestinal barrier dysfunction. Conclusion: These data demonstrate that CRF triggers increases in intestinal paracellular permeability via mast cell dependent release of TNF-alpha and proteases. Furthermore, CRF-mast cell signaling pathways and increases in intestinal permeability require critical input from the enteric nervous system. Therefore, blocking the deleterious effects of CRF may address the enteric signaling of mast cell degranulation, TNF alpha release, and protease secretion, hallmarks of IBS and IBD.	[Overman, Elizabeth L.; Moeser, Adam J.] N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Rivier, Jean E.] Salk Inst Biol Studies, La Jolla, CA USA	University of North Carolina; North Carolina State University; Salk Institute	Overman, EL (corresponding author), N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	ajmoeser@ncsu.edu		Moeser, Adam/0000-0003-3068-627X	National Institutes of Health [NIH P30 DK34987, K08 DK084313, DKPO1026741]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084313, P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grant NIH P30 DK34987 (UNC Chapel Hill Center for Gastrointestinal Biology and Disease) and K08 DK084313 (AJM) and DKPO1026741 (JER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Agelaki S, 2002, INFECT IMMUN, V70, P6068, DOI 10.1128/IAI.70.11.6068-6074.2002; AGGARWAL A, 1994, GASTROENTEROLOGY, V106, P945, DOI 10.1016/0016-5085(94)90753-6; Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; ARGENZIO RA, 1990, AM J VET RES, V51, P747; ARGENZIO RA, 1988, AM J PHYSIOL, V255, pG62, DOI 10.1152/ajpgi.1988.255.1.G62; Asadi S, 2012, J INVEST DERMATOL, V132, P324, DOI 10.1038/jid.2011.334; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Buhner S, 2011, BIOCH BIOPHYS ACTA; Cao J, 2006, MOL PHARMACOL, V69, P998, DOI 10.1124/mol.105.019539; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Delvaux M M, 1999, Can J Gastroenterol, V13 Suppl A, p32A; Farhadi A, 2005, AM J GASTROENTEROL, V100, P1796, DOI 10.1111/j.1572-0241.2005.50071.x; Gareau MG, 2007, AM J PHYSIOL-GASTR L, V293, pG198, DOI 10.1152/ajpgi.00392.2006; Gareau MG, 2006, PEDIATR RES, V59, P83, DOI 10.1203/01.pdr.0000190577.62426.45; Gebhardt T, 2005, EUR J IMMUNOL, V35, P1124, DOI 10.1002/eji.200425869; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Gue M, 1997, NEUROGASTROENT MOTIL, V9, P271, DOI 10.1046/j.1365-2982.1997.d01-63.x; Hart A, 2002, ALIMENT PHARM THER, V16, P2017, DOI 10.1046/j.1365-2036.2002.01359.x; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Johnson David A, 2006, Methods Mol Biol, V315, P193; Keita A V, 2010, Neurogastroenterol Motil, V22, P770, DOI 10.1111/j.1365-2982.2010.01471.x; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Nozu T, 2006, J GASTROENTEROL, V41, P740, DOI 10.1007/s00535-006-1848-4; Park CH, 2003, J KOREAN MED SCI, V18, P204, DOI 10.3346/jkms.2003.18.2.204; Raithel M, 1999, SCAND J GASTROENTERO, V34, P496, DOI 10.1080/003655299750026236; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; SAUNDERS PR, 1994, AM J PHYSIOL-GASTR L, V267, pG794, DOI 10.1152/ajpgi.1994.267.5.G794; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Tjong YW, 2010, NEUROENDOCRINOL LETT, V31, P215; Venihaki M, 1997, ENDOCRINOLOGY, V138, P698, DOI 10.1210/en.138.2.698; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Yuan PQ, 2007, NEUROGASTROENT MOTIL, V19, P923, DOI 10.1111/j.1365-2982.2007.00978.x; Zhao JH, 2011, EUR J PHARMACOL, V654, P289, DOI 10.1016/j.ejphar.2010.12.032; Zoumakis E, 2001, GYNECOL ENDOCRINOL, V15, P98, DOI 10.1080/713602800	51	138	146	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39935	10.1371/journal.pone.0039935	http://dx.doi.org/10.1371/journal.pone.0039935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768175	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100145
J	Schuch, AP; Lago, JC; Yagura, T; Menck, CFM				Schuch, Andre Passaglia; Lago, Juliana Carvalhaes; Yagura, Teiti; Martins Menck, Carlos Frederico			DNA Dosimetry Assessment for Sunscreen Genotoxic Photoprotection	PLOS ONE			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; SUN PROTECTION FACTOR; HUMAN SKIN; ULTRAVIOLET-RADIATION; HUMAN KERATINOCYTES; UVA RADIATION; DAMAGE; CELLS; REPAIR; PHOTOCARCINOGENESIS	Background: Due to the increase of solar ultraviolet radiation (UV) incidence over the last few decades, the use of sunscreen has been widely adopted for skin protection. However, considering the high efficiency of sunlight-induced DNA lesions, it is critical to improve upon the current approaches that are used to evaluate protection factors. An alternative approach to evaluate the photoprotection provided by sunscreens against daily UV radiation-induced DNA damage is provided by the systematic use of a DNA dosimeter. Methodology/Principal Findings: The Sun Protection Factor for DNA (DNA-SPF) is calculated by using specific DNA repair enzymes, and it is defined as the capacity for inhibiting the generation of cyclobutane pyrimidine dimers (CPD) and oxidised DNA bases compared with unprotected control samples. Five different commercial brands of sunscreen were initially evaluated, and further studies extended the analysis to include 17 other products representing various formulations and Sun Protection Factors (SPF). Overall, all of the commercial brands of SPF 30 sunscreens provided sufficient protection against simulated sunlight genotoxicity. In addition, this DNA biosensor was useful for rapidly screening the biological protection properties of the various sunscreen formulations. Conclusions/Significance: The application of the DNA dosimeter is demonstrated as an alternative, complementary, and reliable method for the quantification of sunscreen photoprotection at the level of DNA damage.	[Schuch, Andre Passaglia; Yagura, Teiti; Martins Menck, Carlos Frederico] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Lago, Juliana Carvalhaes] Nat Inovacao & Tecnol Prod LTDA, Sao Paulo, Brazil	Universidade de Sao Paulo	Schuch, AP (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.	cfmmenck@usp.br	Schuch, André/AAY-8946-2020; Menck, Carlos FM/G-6321-2011	Menck, Carlos FM/0000-0003-1941-0694	Natura Inovacao e Tecnologia de Produtos LTDA (Sao Paulo, Brazil); FAPESP (Sao Paulo, Brazil); CNPq (Brasilia, Brazil); Natura Inovacao e Tecnologia de Produtos LTDA	Natura Inovacao e Tecnologia de Produtos LTDA (Sao Paulo, Brazil); FAPESP (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natura Inovacao e Tecnologia de Produtos LTDA	This work was funded by Natura Inovacao e Tecnologia de Produtos LTDA (Sao Paulo, Brazil), FAPESP (Sao Paulo, Brazil), and CNPq (Brasilia, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, Juliana Carvalhaes Lago, is a researcher at the company Natura Inovacao e Tecnologia de Produtos LTDA, a funder of this research. However, he confirms that this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Bernerd F, 2003, EUR J DERMATOL, V13, P242; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet J, 2011, J INVEST DERMATOL, V131, P1005, DOI 10.1038/jid.2011.51; COLIPA, 2006, INT SUN PROT FACT SP; Courdavault S, 2005, DNA REPAIR, V4, P836, DOI 10.1016/j.dnarep.2005.05.001; Dahle J, 2008, CANCER LETT, V267, P18, DOI 10.1016/j.canlet.2008.03.002; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Duale N, 2010, TOXICOL SCI, V114, P272, DOI 10.1093/toxsci/kfq005; Goulart JM, 2010, PHOTOCH PHOTOBIO SCI, V9, P432, DOI 10.1039/b9pp00122k; Gulston M, 1999, MUTAT RES-GEN TOX EN, V444, P49, DOI 10.1016/S1383-5718(99)00091-1; Horiki S, 2000, ARCH DERMATOL RES, V292, P511, DOI 10.1007/s004030000164; Kozmin S, 2005, P NATL ACAD SCI USA, V102, P13538, DOI 10.1073/pnas.0504497102; Lejeune F, 2008, PHOTODERMATOL PHOTO, V24, P249, DOI 10.1111/j.1600-0781.2008.00370.x; Liardet S, 2001, J INVEST DERMATOL, V117, P1437, DOI 10.1046/j.0022-202x.2001.01580.x; Marrot L, 2008, J AM ACAD DERMATOL, V58, pS139, DOI 10.1016/j.jaad.2007.12.007; Mouret S, 2008, DNA REPAIR, V7, P704, DOI 10.1016/j.dnarep.2008.01.005; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Mouret S, 2011, PHOTOCHEM PHOTOBIOL, V87, P109, DOI 10.1111/j.1751-1097.2010.00834.x; PIETTE J, 1986, PHOTOCHEM PHOTOBIOL, V44, P793, DOI 10.1111/j.1751-1097.1986.tb05539.x; RIBEIRO DT, 1992, PHOTOCHEM PHOTOBIOL, V55, P39, DOI 10.1111/j.1751-1097.1992.tb04207.x; Runger TM, 2007, J INVEST DERMATOL, V127, P2103, DOI 10.1038/sj.jid.5700988; Schuch AP, 2012, ENVIRON MOL MUTAGEN, V53, P198, DOI 10.1002/em.21678; Schuch AP, 2010, J PHOTOCH PHOTOBIO B, V99, P111, DOI 10.1016/j.jphotobiol.2010.03.004; Schuch AP, 2009, PHOTOCH PHOTOBIO SCI, V8, P111, DOI 10.1039/b810085c; Tewari A, 2011, J INVEST DERMATOL, V131, pS103; Yagura T, 2011, SENSORS-BASEL, V11, P4277, DOI 10.3390/s110404277; Young AR, 2010, J INVEST DERMATOL, V130, P2457, DOI 10.1038/jid.2010.144	30	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40344	10.1371/journal.pone.0040344	http://dx.doi.org/10.1371/journal.pone.0040344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768281	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100255
J	Thomas, CM; Wood, RC; Wyatt, JE; Pendleton, MH; Torrenegra, RD; Rodriguez, OE; Harirforoosh, S; Ballester, M; Lightner, J; Krishnan, K; Ramsauer, VP				Thomas, Christan M.; Wood, Robert C., III; Wyatt, Jarrett E.; Pendleton, Morgan H.; Torrenegra, Ruben D.; Rodriguez, Oscar E.; Harirforoosh, Sam; Ballester, Maria; Lightner, Janet; Krishnan, Koyamangalath; Ramsauer, Victoria P.			Anti-Neoplastic Activity of Two Flavone Isomers Derived from Gnaphalium elegans and Achyrocline bogotensis	PLOS ONE			English	Article							CANCER STEM-CELLS; IN-VITRO; APOPTOSIS; ESTABLISHMENT; APIGENIN; PLANTS; LINE	Over 4000 flavonoids have been identified so far and among these, many are known to have antitumor activities. The basis of the relationships between chemical structures, type and position of substituent groups and the effects these compounds exert specifically on cancer cells are not completely elucidated. Here we report the differential cytotoxic effects of two flavone isomers on human cancer cells from breast (MCF7, SK-BR-3), colon (Caco-2, HCT116), pancreas (MIA PaCa, Panc 28), and prostate (PC3, LNCaP) that vary in differentiation status and tumorigenic potential. These flavones are derived from plants of the family Asteraceae, genera Gnaphalium and Achyrocline reputed to have anti-cancer properties. Our studies indicate that 5,7-dihydroxy-3,6,8-trimethoxy-2-phenyl-4H-chromen-4-one (5,7-dihydroxy-3,6,8-trimethoxy flavone) displays potent activity against more differentiated carcinomas of the colon (Caco-2), and pancreas (Panc28), whereas 3,5-dihydroxy-6,7,8-trimethoxy-2-phenyl-4H-chromen-4-one (3,5-dihydroxy-6,7,8-trimethoxy flavone) cytototoxic action is observed on poorly differentiated carcinomas of the colon (HCT116), pancreas (Mia PaCa), and breast (SK-BR3). Both flavones induced cell death (>50%) as proven by MTT cell viability assay in these cancer cell lines, all of which are regarded as highly tumorigenic. At the concentrations studied (5-80 mu M), neither flavone demonstrated activity against the less tumorigenic cell lines, breast cancer MCF-7 cells, androgen-responsive LNCaP human prostate cancer line, and androgen-unresponsive PC3 prostate cancer cells. 5,7-dihydroxy-3,6,8-trimethoxy-2-phenyl-4H-chromen-4-one (5,7-dihydroxy-3,6,8-trimethoxy flavone) displays activity against more differentiated carcinomas of the colon and pancreas, but minimal cytotoxicity on poorly differentiated carcinomas of these organs. On the contrary, 3,5-dihydroxy-6,7,8-trimethoxy-2-phenyl-4H-chromen-4-one (3,5-dihydroxy-6,7,8-trimethoxy flavone) is highly cytotoxic to poorly differentiated carcinomas of the colon, pancreas, and breast with minimal activity against more differentiated carcinomas of the same organs. These differential effects suggest activation of distinct apoptotic pathways. In conclusion, the specific chemical properties of these two flavone isomers dictate mechanistic properties which may be relevant when evaluating biological responses to flavones.	[Harirforoosh, Sam; Ramsauer, Victoria P.] E Tennessee State Univ, Bill Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA; [Torrenegra, Ruben D.; Rodriguez, Oscar E.] Univ Ciencias Aplicadas & Ambientales, Bogota, Colombia; [Ballester, Maria] Nova SE Univ, Farquhar Coll Arts & Sci, Div Math Sci & Technol, Ft Lauderdale, FL 33314 USA; [Lightner, Janet; Krishnan, Koyamangalath; Ramsauer, Victoria P.] E Tennessee State Univ, James Quillen Coll Med, Dept Internal Med, Div Hematol Oncol, Johnson City, TN 37614 USA	East Tennessee State University; Nova Southeastern University; East Tennessee State University	Thomas, CM (corresponding author), E Tennessee State Univ, Bill Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA.	ramsauer@mail.etsu.edu	GUERRERO, RUBEN D TORRENEGRA/W-9018-2019; Palau, Victoria E/F-3520-2012; Harirforoosh, Sam/J-9493-2013; RODRIGUEZ AGUIRRE, OSCAR EDUARDO/A-2907-2015	Palau, Victoria E/0000-0003-2761-7003; Harirforoosh, Sam/0000-0002-2631-3756; U.D.C.A, Universidad de Ciencias Aplicadas y Ambientales/0000-0002-2291-5354; RODRIGUEZ AGUIRRE, OSCAR EDUARDO/0000-0002-5934-0451; Torrenegra G., Ruben Dario/0000-0002-5473-5315	Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy; Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales	Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy; Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales	Funds were provided by the Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy, and the Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi EJ, 2009, ONCOL REP, V22, P1533, DOI 10.3892/or_00000598; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Dandawate PR, 2012, PHARM RES; Erhart LM, 2005, APOPTOSIS, V10, P611, DOI 10.1007/s10495-005-1895-y; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; Garca-Barriga H, 1975, FLORA MED COLOMBIA B; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; HANSEL R, 1972, PHYTOCHEMISTRY, V11, P2632, DOI 10.1016/S0031-9422(00)88566-0; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Javed H, 2012, NEUROSCIENCE; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kale A, 2008, PHYTOTHER RES, V22, P567, DOI 10.1002/ptr.2283; Kanadaswami C, 2005, IN VIVO, V19, P895; Karna P, 2011, CARCINOGENESIS, V32, P1872, DOI 10.1093/carcin/bgr215; Le Marchand L, 2002, BIOMED PHARMACOTHER, V56, P296, DOI 10.1016/S0753-3322(02)00186-5; Lee SH, 2008, CANCER LETT, V259, P39, DOI 10.1016/j.canlet.2007.09.015; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; Lin L, 2011, BRIT J CANCER, V105, P212, DOI 10.1038/bjc.2011.200; Liu HL, 2010, RECENT PAT ANTI-CANC, V5, P152, DOI 10.2174/157489210790936261; Lopez-Lazaro M, 2002, Curr Med Chem Anticancer Agents, V2, P691; Menter DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028813; Middleton E, 2000, PHARMACOL REV, V52, P673; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Moghaddam G, 2011, PHYTOTHER RES; Neumeister V, 2010, AM J PATHOL, V176, P2131, DOI 10.2353/ajpath.2010.090712; Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8; Schumacher M, 2011, CANCER INVEST, V29, P396, DOI 10.3109/07357907.2011.587071; Sclabas Guido M, 2003, Int J Gastrointest Cancer, V33, P15, DOI 10.1385/IJGC:33:1:15; Shin SY, 2011, TOXICOL APPL PHARM, V254, P288, DOI 10.1016/j.taap.2011.05.003; Singh M, 2011, J BIOMED NANOTECHNOL, V7, P202, DOI 10.1166/jbn.2011.1268; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Suzgec S, 2005, FITOTERAPIA, V76, P269, DOI 10.1016/j.fitote.2004.12.006; TOMASLORENTE F, 1989, PHYTOCHEMISTRY, V28, P1613, DOI 10.1016/S0031-9422(00)97809-9; TORRENEGRA RD, 1980, PHYTOCHEMISTRY, V19, P2795, DOI 10.1016/S0031-9422(00)83978-3; Torrenegra RD, 1982, REV LATINOAM QUIM, V13, P75; Torrenegra RD, 1987, REV LATINOAMERICANA, V18, P116; Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619; Tseng Tsui-Hwa, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P347, DOI 10.2174/187152006777698150; VANPUYVELDE L, 1989, J NAT PROD, V52, P629, DOI 10.1021/np50063a025; Visus C, 2011, CLIN CANCER RES, V17, P6174, DOI 10.1158/1078-0432.CCR-11-1111; Wang HK, 2000, EXPERT OPIN INV DRUG, V9, P2103, DOI 10.1517/13543784.9.9.2103; Wang S, 2009, EUR J PHARMACOL, V624, P31, DOI 10.1016/j.ejphar.2009.10.001; Xiong HP, 2009, ACTA CRYSTALLOGR E, V65, pO3277, DOI 10.1107/S1600536809050715	43	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39806	10.1371/journal.pone.0039806	http://dx.doi.org/10.1371/journal.pone.0039806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768128	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100098
J	Zhang, CZ; Pan, YH; Cao, Y; Lai, PBS; Liu, LL; Chen, GG; Yun, JP				Zhang, Chris Zhiyi; Pan, Yinghua; Cao, Yun; Lai, Paul B. S.; Liu, Lili; Chen, George Gong; Yun, Jingping			Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis in Liver Cancer In Vitro and In Vivo	PLOS ONE			English	Article							SIGNALING PATHWAY; PHASE-II; C-MYC; CELLS; PROTEIN; ERK; DEGRADATION; VORINOSTAT; ACTIVATION; EXPRESSION	Liver cancer ranks in prevalence and mortality among top five cancers worldwide. Accumulating interests have been focused in developing new strategies for liver cancer treatment. We have previously showed that dihydroartemisinin (DHA) exhibited antitumor activity towards liver cancer. In this study, we demonstrated that histone deacetylase inhibitors (HDACi) significantly augmented the antineoplastic effect of DHA via increasing apoptosis in vitro and in vivo. Inhibition of ERK phosphorylation contributed to DHA-induced apoptosis, due to the fact that inhibitor of ERK phosphorylation (PD98059) increased DHA-induced apoptosis. Compared with DHA alone, the combined treatment with DHA and HDACi reduced mitochondria membrane potential, released cytochrome c into cytoplasm, increased p53 and Bak, decreased Mcl-1 and p-ERK, activated caspase 3 and PARP, and induced apoptotic cells. Furthermore, we showed that HDACi pretreatment facilitated DHA-induced apoptosis. In Hep G2-xenograft carrying nude mice, the intraperitoneal injection of DHA and SAHA resulted in significant inhibition of xenograft tumors. Results of TUNEL and H&E staining showed more apoptosis induced by combined treatment. Immunohistochemistry data revealed the activation of PARP, and the decrease of Ki-67, p-ERK and Mcl-1. Taken together, our data suggest that the combination of HDACi and DHA offers an antitumor effect on liver cancer, and this combination treatment should be considered as a promising strategy for chemotherapy.	[Zhang, Chris Zhiyi; Cao, Yun; Liu, Lili; Yun, Jingping] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chris Zhiyi; Cao, Yun; Liu, Lili; Yun, Jingping] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Yinghua] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Lai, Paul B. S.; Chen, George Gong] Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital	Zhang, CZ (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	gchen@cuhk.edu.hk; yunjp@mail.sysu.edu.cn	Liu, Lili/HHC-6357-2022; Chen, George Gong/I-2757-2016; Lai, Paul BS/K-8556-2015; Zhang, Chris Zhiyi/F-9862-2013	Lai, Paul BS/0000-0002-9469-6728; 	National Natural Science Foundation of China [81172345, 30973506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81172345 and No. 30973506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilano K, 2009, BIOCHEM PHARMACOL, V77, P337, DOI 10.1016/j.bcp.2008.10.034; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Breous E, 2011, J HEPATOL, V54, P830, DOI 10.1016/j.jhep.2010.10.013; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Erichsen R, 2008, EUR J GASTROEN HEPAT, V20, P104, DOI 10.1097/MEG.0b013e3282f17517; Gould JJ, 2010, J UROLOGY, V183, P2395, DOI 10.1016/j.juro.2010.02.004; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim HM, 2011, BREAST CANCER RES TR, V130, P365, DOI 10.1007/s10549-010-1310-4; Konopleva M, 2011, LEUKEMIA; Kretzner L, 2011, CANCER RES, V71, P3912, DOI 10.1158/0008-5472.CAN-10-2259; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Lu JJ, 2010, BIOCHEM PHARMACOL, V80, P22, DOI 10.1016/j.bcp.2010.02.016; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Reeves MB, 2012, P NATL ACAD SCI USA, V109, P588, DOI 10.1073/pnas.1114966108; Rosato RR, 2008, MOL CANCER THER, V7, P3285, DOI 10.1158/1535-7163.MCT-08-0385; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Sun HL, 2009, CLIN CANCER RES, V15, P4904, DOI 10.1158/1078-0432.CCR-09-0269; Nguyen T, 2011, CLIN CANCER RES, V17, P3219, DOI 10.1158/1078-0432.CCR-11-0234; Tsochatzis EA, 2010, SEMIN ONCOL, V37, P89, DOI 10.1053/j.seminoncol.2010.03.007; Wagner S, 2005, BIOCHEM PHARMACOL, V69, P1059, DOI 10.1016/j.bcp.2004.12.017; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yuen HF, 2012, CLIN CANCER RES, V18, P380, DOI 10.1158/1078-0432.CCR-11-2035; Zhang CZY, 2012, CELL CYCLE, V11, P322, DOI 10.4161/cc.11.2.18758; Zhang CZY, 2011, APOPTOSIS, V16, P683, DOI 10.1007/s10495-011-0597-x; Zhang CZ, BIOCH PHARM	38	30	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39870	10.1371/journal.pone.0039870	http://dx.doi.org/10.1371/journal.pone.0039870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761917	gold, Green Published, Green Submitted			2022-12-25	WOS:000305826400043
J	Yang, CH; Liu, XM; Si, JJ; Shi, HS; Xue, YX; Liu, JF; Luo, YX; Chen, C; Li, P; Yang, JL; Wu, P; Lu, L				Yang, Cheng-Hao; Liu, Xiang-Ming; Si, Ji-Jian; Shi, Hai-Shui; Xue, Yan-Xue; Liu, Jian-Feng; Luo, Yi-Xiao; Chen, Chen; Li, Peng; Yang, Jian-Li; Wu, Ping; Lu, Lin			Role of IKK/NF-kappa B Signaling in Extinction of Conditioned Place Aversion Memory in Rats	PLOS ONE			English	Article							LONG-TERM-MEMORY; ANTAGONIST MK-801 BLOCKS; TRANSCRIPTION FACTOR; BASOLATERAL AMYGDALA; SODIUM-BUTYRATE; IMPAIRS RECONSOLIDATION; HISTONE MODIFICATION; SYNAPTIC PLASTICITY; FEAR EXTINCTION; SPATIAL MEMORY	The inhibitor kB protein kinase/nuclear factor kB (IKK/NF-kB) signaling pathway is critical for synaptic plasticity. However, the role of IKK/NF-kB in drug withdrawal-associated conditioned place aversion (CPA) memory is unknown. Here, we showed that inhibition of IKK/NF-kB by sulphasalazine (SSZ; 10 mM, i.c.v.) selectively blocked the extinction but not acquisition or expression of morphine-induced CPA in rats. The blockade of CPA extinction induced by SSZ was abolished by sodium butyrate, an inhibitor of histone deacetylase. Thus, the IKK/NF-kB signaling pathway might play a critical role in the extinction of morphine-induced CPA in rats and might be a potential pharmacotherapy target for opiate addiction.	[Yang, Cheng-Hao; Si, Ji-Jian] Tianjin Med Univ, Tianjin, Peoples R China; [Liu, Xiang-Ming] Tianjin Med Univ, Dept Thorac Oncol, Tianjin Canc Inst & Hosp, Tianjin, Peoples R China; [Shi, Hai-Shui; Xue, Yan-Xue; Liu, Jian-Feng; Luo, Yi-Xiao; Chen, Chen; Li, Peng; Wu, Ping; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Yang, Cheng-Hao; Si, Ji-Jian; Yang, Jian-Li] Tianjin Mental Hlth Ctr, Tianjin Inst Mental Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Peking University	Yang, CH (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.	yangjianli0722@sohu.com; wuping@bjmu.edu.cn		Yang, Chenghao/0000-0002-3424-6004; Liu, Jianfeng/0000-0002-3464-6462	National Natural Science Foundation of China [30870895, 81071085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30870895 and and No. 81071085 to JLY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Azar MR, 2003, PSYCHOPHARMACOLOGY, V170, P42, DOI 10.1007/s00213-003-1514-y; Baker JD, 1996, BEHAV NEUROSCI, V110, P618, DOI 10.1037/0735-7044.110.3.618; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Boccia M, 2007, J NEUROSCI, V27, P13436, DOI 10.1523/JNEUROSCI.4430-07.2007; COX J, 1994, Q J EXP PSYCHOL-B, V47, P187; Dash PK, 2005, J NEUROCHEM, V93, P269, DOI 10.1111/j.1471-4159.2004.03016.x; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; de la Fuente V, 2011, J NEUROSCI, V31, P5562, DOI 10.1523/JNEUROSCI.6066-10.2011; De Vries TJ, 2002, J NEUROSCI, V22, P3321; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ear T, 2005, J IMMUNOL, V175, P1834, DOI 10.4049/jimmunol.175.3.1834; Federman N, 2009, LEARN MEMORY, V16, P600, DOI 10.1101/lm.1537009; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Glezer I, 2003, NEUROPHARMACOLOGY, V45, P1120, DOI 10.1016/S0028-3908(03)00279-X; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; He YY, 2011, NEUROPSYCHOPHARMACOL, V36, P1972, DOI 10.1038/npp.2011.63; Hou YY, 2009, J NEUROSCI, V29, P12244, DOI 10.1523/JNEUROSCI.1970-09.2009; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Lattal KM, 2006, BIOL PSYCHIAT, V60, P344, DOI 10.1016/j.biopsych.2006.05.038; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Lu L, 2005, PSYCHOPHARMACOLOGY, V181, P90, DOI 10.1007/s00213-005-2207-5; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Lubin FD, 2011, NEUROSCIENTIST, V17, P616, DOI 10.1177/1073858411386967; Madrigal JLM, 2001, J NEUROCHEM, V76, P532, DOI 10.1046/j.1471-4159.2001.00108.x; Massa PE, 2005, J BIOL CHEM, V280, P14057, DOI 10.1074/jbc.M414401200; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Merlo E, 2002, NEUROSCIENCE, V112, P161, DOI 10.1016/S0306-4522(02)00049-0; Merlo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003687; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nestler H P, 2001, IDrugs, V4, P1365; PRASAD KN, 1976, IN VITRO CELL DEV B, V12, P125; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Stafford JM, 2012, BIOL PSYCHIAT; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wang XY, 2008, J NEUROSCI, V28, P5602, DOI 10.1523/JNEUROSCI.0750-08.2008; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; White DA, 2005, PHARMACOL BIOCHEM BE, V81, P451, DOI 10.1016/j.pbb.2005.04.002; Yang JL, 2011, BEHAV BRAIN RES, V216, P592, DOI 10.1016/j.bbr.2010.08.047; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhai HF, 2008, BEHAV PHARMACOL, V19, P211, DOI 10.1097/FBP.0b013e3282fe88a0	58	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39696	10.1371/journal.pone.0039696	http://dx.doi.org/10.1371/journal.pone.0039696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761874	gold, Green Published, Green Submitted			2022-12-25	WOS:000305808700045
J	Stevens, M; Peigneur, S; Dyubankova, N; Lescrinier, E; Herdewijn, P; Tytgat, J				Stevens, Marijke; Peigneur, Steve; Dyubankova, Natalia; Lescrinier, Eveline; Herdewijn, Piet; Tytgat, Jan			Design of Bioactive Peptides from Naturally Occurring mu-Conotoxin Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; WATER SUPPRESSION; POTENT INHIBITOR; CONUS-STRIATUS; TETRODOTOXIN; KIIIA; BLOCK; EPILEPSY; GIIIA; PIIIA	To date, cone snail toxins ("conotoxins") are of great interest in the pursuit of novel subtype-selective modulators of voltage-gated sodium channels (Na(v)s). Na(v)s participate in a wide range of electrophysiological processes. Consequently, their malfunctioning has been associated with numerous diseases. The development of subtype-selective modulators of Na(v)s remains highly important in the treatment of such disorders. In current research, a series of novel, synthetic, and bioactive compounds were designed based on two naturally occurring mu-conotoxins that target Na(v)s. The initial designed peptide contains solely 13 amino acids and was therefore named "Mini peptide." It was derived from the mu-conotoxins KIIIA and BuIIIC. Based on this Mini peptide, 10 analogues were subsequently developed, comprising 12-16 amino acids with two disulfide bridges. Following appropriate folding and mass verification, blocking effects on Na(v)s were investigated. The most promising compound established an IC50 of 34.1 +/- 0.01 nM (R2-Midi on Na(v)1.2). An NMR structure of one of our most promising compounds was determined. Surprisingly, this structure does not reveal an alpha-helix. We prove that it is possible to design small peptides based on known pharmacophores of mu-conotoxins without losing their potency and selectivity. These data can provide crucial material for further development of conotoxin- based therapeutics.	[Stevens, Marijke; Peigneur, Steve; Tytgat, Jan] Katholieke Univ KU Leuven, Toxicol Lab, B-3000 Louvain, Belgium; [Dyubankova, Natalia; Lescrinier, Eveline; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium	KU Leuven; KU Leuven	Tytgat, J (corresponding author), Katholieke Univ KU Leuven, Toxicol Lab, Campus Gasthuisberg O & N2,Herestr 49,Box 922, B-3000 Louvain, Belgium.	Jan.Tytgat@pharm.kuleuven.be	Lescrinier, Eveline/G-9339-2016	Lescrinier, Eveline/0000-0001-7066-4329; Herdewijn, Piet/0000-0003-3589-8503; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0257.08, G.0433.12]; KU Leuven Grant [OT/12/081]; Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy Grant [IUAP 7/12]	Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); KU Leuven Grant; Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy Grant	This work was supported in part by Fonds Wetenschappelijk Onderzoek Vlaanderen Grants G.0257.08 and G.0433.12, KU Leuven Grant OT/12/081, and Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy Grant IUAP 7/12.	Buczek O, 2007, BIOCHEMISTRY-US, V46, P9929, DOI 10.1021/bi700797f; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Chen R, 2012, BIOPHYS J, V102, P483, DOI 10.1016/j.bpj.2011.12.041; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Clark RJ, 2012, TOXICON, V59, P446, DOI 10.1016/j.toxicon.2010.12.003; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Ekberg J, 2008, INT J BIOCHEM CELL B, V40, P2363, DOI 10.1016/j.biocel.2007.08.017; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Favreau P, 2012, BRIT J PHARMACOL, V166, P1654, DOI 10.1111/j.1476-5381.2012.01837.x; French RJ, 2010, MAR DRUGS, V8, P2153, DOI 10.3390/md8072153; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Han TS, 2009, CHEMMEDCHEM, V4, P406, DOI 10.1002/cmdc.200800292; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jurkat-Rott K, 2010, PFLUG ARCH EUR J PHY, V460, P239, DOI 10.1007/s00424-010-0814-4; Keller R., 2004, THESIS SWISS FEDERAL; Khoo KK, 2011, J MED CHEM, V54, P7558, DOI 10.1021/jm200839a; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; Leipold E, 2011, NEUROPHARMACOLOGY, V61, P105, DOI 10.1016/j.neuropharm.2011.03.008; Lewis RJ, 2007, MOL PHARMACOL, V71, P676, DOI 10.1124/mol.106.028225; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; McArthur JR, 2011, MOL PHARMACOL, V80, P573, DOI 10.1124/mol.111.073460; McArthur JR, 2011, MOL PHARMACOL, V80, P219, DOI 10.1124/mol.111.071779; McArthur JR, 2011, BIOCHEMISTRY-US, V50, P116, DOI 10.1021/bi101316y; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Schroeder CI, 2008, J BIOL CHEM, V283, P21621, DOI 10.1074/jbc.M802852200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; Shon KJ, 1998, J NEUROSCI, V18, P4473; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SPENCE I, 1977, LIFE SCI, V21, P1759, DOI 10.1016/0024-3205(77)90156-4; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; STEPHAN MM, 1994, J MEMBRANE BIOL, V137, P1; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; Walewska A, 2008, J AM CHEM SOC, V130, P14280, DOI 10.1021/ja804303p; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j; Zuliani V, 2012, CURR TOP MED CHEM, V12, P962, DOI 10.2174/156802612800229206	55	25	26	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31382	31392		10.1074/jbc.M112.375733	http://dx.doi.org/10.1074/jbc.M112.375733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22773842	Green Published, hybrid			2022-12-25	WOS:000308791300049
J	Rama, N; Goldschneider, D; Corset, V; Lambert, J; Pays, L; Mehlen, P				Rama, Nicolas; Goldschneider, David; Corset, Veronique; Lambert, Jeremy; Pays, Laurent; Mehlen, Patrick			Amyloid Precursor Protein Regulates Netrin-1-mediated Commissural Axon Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER DCC; ADENOSINE A2B RECEPTOR; NETRIN RECEPTOR; SURVIVAL FACTOR; SONIC HEDGEHOG; GUIDANCE; GENE; ACTIVATION; APOPTOSIS; FAMILY	The multifunctional protein netrin-1 was initially discovered as the main attractive cue for commissural axon guidance by acting through its receptor DCC. Recently, we have shown that netrin-1 also interacts with the orphan transmembrane receptor amyloid precursor protein (APP). APP is cleaved by proteases, generating amyloid-beta peptide, the main component of the amyloid plaques that are associated with Alzheimer disease. Our previous work demonstrated that via its interaction with APP, netrin-1 is a negative regulator of amyloid-beta production in adult brain, but the biological relevance of APP/netrin-1 interaction under non-pathological conditions was unknown. We show here that during commissural axon navigation, APP, expressed at the growth cone, is part of the DCC receptor complex mediating netrin-1-dependent axon guidance. APP interacts with DCC in the presence of netrin-1 and enhances netrin-1-mediated DCC intracellular signaling, such as MAPK activation. Inactivation of APP in mice is associated with reduced commissural axon outgrowth. Thus, APP functionally acts as a co-receptor for DCC to mediate axon guidance.	[Rama, Nicolas; Goldschneider, David; Corset, Veronique; Lambert, Jeremy; Pays, Laurent; Mehlen, Patrick] Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,INSERM CNRS UMR5286 U105, Equipe Labellisee La Ligue,Ctr Cancerol Lyon, F-69008 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Mehlen, P (corresponding author), Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,INSERM CNRS UMR5286 U105, Equipe Labellisee La Ligue,Ctr Cancerol Lyon, F-69008 Lyon, France.	patrick.mehlen@lyon.unicancer.fr		Pays, Laurent/0000-0003-0720-2273; Rama, Nicolas/0000-0003-1614-7755	CNRS, University of Lyon, Centre Leon Berard; Ligue contre le Cancer, L'Institut National du Cancer (INCa); L'Agence Nationale de la Recherche (ANR)	CNRS, University of Lyon, Centre Leon Berard; Ligue contre le Cancer, L'Institut National du Cancer (INCa); L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by an institutional grant from CNRS, University of Lyon, Centre Leon Berard, and by the Ligue contre le Cancer, L'Institut National du Cancer (INCa), and L'Agence Nationale de la Recherche (ANR).	Castets M, 2010, CELL CYCLE, V9, P1466, DOI 10.4161/cc.9.8.11197; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; Hansen LA, 1997, NEUROBIOL AGING, V18, pS71, DOI 10.1016/S0197-4580(97)00073-0; Heber S, 2000, J NEUROSCI, V20, P7951; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320	38	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					30014	30023		10.1074/jbc.M111.324780	http://dx.doi.org/10.1074/jbc.M111.324780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782894	Green Published, hybrid			2022-12-25	WOS:000308286900074
J	Ling, JQ; Peterson, KM; Simonovic, I; Soll, D; Simonovic, M				Ling, Jiqiang; Peterson, Kaitlyn M.; Simonovic, Ivana; Soell, Dieter; Simonovic, Miljan			The Mechanism of Pre-transfer Editing in Yeast Mitochondrial Threonyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISTRANSLATION; RECOGNITION; TRANSLATION; PRETRANSFER; HYDROLYSIS; ADENYLATES; DOMAIN	Accurate translation of mRNA into protein is a fundamental biological process critical for maintaining normal cellular functions. To ensure translational fidelity, aminoacyl-tRNA synthetases (aaRSs) employ pre-transfer and post-transfer editing activities to hydrolyze misactivated and mischarged amino acids, respectively. Whereas post-transfer editing, which requires either a specialized domain in aaRS or a trans-protein factor, is well described, the mechanism of pre-transfer editing is less understood. Here, we show that yeast mitochondrial threonyl-tRNA synthetase (MST1), which lacks an editing domain, utilizes pre-transfer editing to discriminate against serine. MST1 misactivates serine and edits seryl adenylate (Ser-AMP) in a tRNA-independent manner. MST1 hydrolyzes 80% of misactivated Ser-AMP at a rate 4-fold higher than that for the cognate threonyl adenylate (Thr-AMP) while releasing 20% of Ser-AMP into the solution. To understand the mechanism of pre-transfer editing, we solved the crystal structure of MST1 complexed with an analog of Ser-AMP. The binding of the Ser-AMP analog to MST1 induces conformational changes in the aminoacylation active site, and it positions a potential hydrolytic water molecule more favorably for nucleophilic attack. In addition, inhibition results reveal that the Ser-AMP analog binds the active site 100-fold less tightly than the Thr-AMP analog. In conclusion, we propose that the plasticity of the aminoacylation site in MST1 allows binding of Ser-AMP and the appropriate positioning of the hydrolytic water molecule.	[Ling, Jiqiang; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Peterson, Kaitlyn M.; Simonovic, Ivana; Simonovic, Miljan] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114, New Haven, CT 06520 USA.	dieter.soll@yale.edu; msimon5@uic.edu	Ling, Jiqiang/AAU-1097-2021; Ling, Jiqiang/B-2885-2009	Ling, Jiqiang/0000-0003-4466-8304; Ling, Jiqiang/0000-0003-4466-8304; Simonovic, Miljan/0000-0002-1576-2222	National Institutes of Health through the NIGMS [GM22854]; American Cancer Society, Illinois Division, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM022854, R01GM097042] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society, Illinois Division, Inc.(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM22854 through the NIGMS (to D. S.). This work was also supported by the American Cancer Society, Illinois Division, Inc. and by National Institutes of Health through the NIGMS (to M. S.). Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guo M, 2012, CURR OPIN STRUC BIOL, V22, P119, DOI 10.1016/j.sbi.2011.11.008; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1978, FEBS LETT, V95, P235, DOI 10.1016/0014-5793(78)81001-1; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Mascarenhas A. P., 2008, PROTEIN ENG, P153; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Sarkar J, 2011, J AM CHEM SOC, V133, P18510, DOI 10.1021/ja2048122; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Su D, 2011, NUCLEIC ACIDS RES, V39, P4866, DOI 10.1093/nar/gkr073; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	45	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28518	28525		10.1074/jbc.M112.372920	http://dx.doi.org/10.1074/jbc.M112.372920			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773845	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000308074600027
J	Boncompagni, S; Thomas, M; Lopez, JR; Allen, PD; Yuan, QY; Kranias, EG; Franzini-Armstrong, C; Perez, CF				Boncompagni, Simona; Thomas, Monique; Lopez, Jose R.; Allen, Paul D.; Yuan, Qunying; Kranias, Evangelia G.; Franzini-Armstrong, Clara; Perez, Claudio F.			Triadin/Junctin Double Null Mouse Reveals a Differential Role for Triadin and Junctin in Anchoring CASQ to the jSR and Regulating Ca2+ Homeostasis	PLOS ONE			English	Article							RABBIT SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM VESICLES; CALCIUM-BINDING PROTEIN; RYANODINE RECEPTOR; MOLECULAR-CLONING; STORE DEPLETION; CARDIAC-MUSCLE; RELEASE UNITS; CALSEQUESTRIN; MEMBRANE	Triadin (Tdn) and Junctin (Jct) are structurally related transmembrane proteins thought to be key mediators of structural and functional interactions between calsequestrin (CASQ) and ryanodine receptor (RyRs) at the junctional sarcoplasmic reticulum (jSR). However, the specific contribution of each protein to the jSR architecture and to excitation-contraction (e-c) coupling has not been fully established. Here, using mouse models lacking either Tdn (Tdn-null), Jct (Jct-null) or both (Tdn/Jct-null), we identify Tdn as the main component of periodically located anchors connecting CASQ to the RyR-bearing jSR membrane. Both proteins proved to be important for the structural organization of jSR cisternae and retention of CASQ within them, but with different degrees of impact. Our results also suggest that the presence of CASQ is responsible for the wide lumen of the jSR cisternae. Using Ca2+ imaging and Ca2+ selective microelectrodes we found that changes in e-c coupling, SR Ca2+ content and resting [Ca2+] in Jct, Tdn and Tdn/Jct-null muscles are directly correlated to the effect of each deletion on CASQ content and its organization within the jSR. These data suggest that in skeletal muscle the disruption of Tdn/CASQ link has a more profound effect on jSR architecture and myoplasmic Ca2+ regulation than Jct/CASQ association.	[Boncompagni, Simona] Univ G DAnnunzio, CeSI Ctr Res Ageing, DNI Dept Neurosci & Imaging, Chieti, Italy; [Boncompagni, Simona; Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Yuan, Qunying; Kranias, Evangelia G.] Acad Athens, Biomed Res Fdn, Div Mol Biol, Athens, Greece; [Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Thomas, Monique; Lopez, Jose R.; Allen, Paul D.; Perez, Claudio F.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA	G d'Annunzio University of Chieti-Pescara; University of Pennsylvania; Academy of Athens; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital	Boncompagni, S (corresponding author), Univ G DAnnunzio, CeSI Ctr Res Ageing, DNI Dept Neurosci & Imaging, Chieti, Italy.	s.boncompagni@unich.it			National Institutes of Health [5K01AR054818, P01AR052354, P01AR47605, AR055104, HL26057, HL64018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL026057, R01HL026057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054818, R03AR047605, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health, Grants 5K01AR054818 to Dr. Perez, P01AR052354 to Dr. Allen and Dr. Franzini-Armstrong, P01AR47605 to Dr. Allen, AR055104 KG Beam subcontract to Dr. Franzini-Armstrong and HL26057, HL64018 to Dr. Kranias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Boncompagni S, 2011, AGE DORDR; Boncompagni S, 2007, P NATL ACAD SCI USA, V104, P19339, DOI 10.1073/pnas.0709061104; CAMPBELL KP, 1980, BIOCHIM BIOPHYS ACTA, V602, P97, DOI 10.1016/0005-2736(80)90293-X; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Danieli-Betto D, 2005, AM J PHYSIOL-REG I, V289, pR1328, DOI 10.1152/ajpregu.00673.2004; Dinchuk JE, 2000, J BIOL CHEM, V275, P39543, DOI 10.1074/jbc.M006753200; Divet A, 2007, J CELL PHYSIOL, V213, P464, DOI 10.1002/jcp.21121; Eltit JM, 2011, CELL CALCIUM, V49, P128, DOI 10.1016/j.ceca.2011.01.005; Eltit JM, 2010, J BIOL CHEM, V285, P38453, DOI 10.1074/jbc.M110.164525; ENGEL AG, 2004, MYOLOGY, P749; FAN HR, 1995, BIOCHEMISTRY-US, V34, P14902, DOI 10.1021/bi00045a035; Fodor J, 2008, J PHYSIOL-LONDON, V586, P5803, DOI 10.1113/jphysiol.2008.160457; FRANZINI.C, 1970, J CELL BIOL, V47, P488, DOI 10.1083/jcb.47.2.488; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Froemming GR, 1999, BBA-BIOMEMBRANES, V1418, P197, DOI 10.1016/S0005-2736(99)00024-3; Gergs U, 2007, AM J PHYSIOL-HEART C, V293, pH728, DOI 10.1152/ajpheart.01187.2006; Gu W, 1996, SOC GEN PHY, V51, P19; Guido AN, 2010, ANAT REC, V293, P1722, DOI 10.1002/ar.21224; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hong CS, 2002, FASEB J, V16, P1310, DOI 10.1096/fj.01-0908fje; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; JORGENSEN AO, 1984, J CELL BIOL, V98, P1597, DOI 10.1083/jcb.98.4.1597; Kirchhefer U, 2006, CELL CALCIUM, V39, P131, DOI 10.1016/j.ceca.2005.10.004; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lee KW, 2012, J BIOL CHEM, V287, P1679, DOI 10.1074/jbc.M111.254045; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MARTY I, 1995, BIOCHEM J, V307, P769, DOI 10.1042/bj3070769; McFarland TP, 2010, J MOL CELL CARDIOL, V49, P556, DOI 10.1016/j.yjmcc.2010.05.012; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; Milstein ML, 2009, EXP CELL RES, V315, P523, DOI 10.1016/j.yexcr.2008.11.006; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; O'Reilly FM, 2002, BIOPHYS J, V82, P145, DOI 10.1016/S0006-3495(02)75381-2; Oddoux S, 2009, J BIOL CHEM, V284, P34918, DOI 10.1074/jbc.M109.022442; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Takekura H, 1996, J MUSCLE RES CELL M, V17, P391, DOI 10.1007/BF00123356; TAKEKURA H, 1995, P NATL ACAD SCI USA, V92, P3381, DOI 10.1073/pnas.92.8.3381; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Treves S, 2004, J CELL BIOL, V166, P537, DOI 10.1083/jcb.200404079; Treves S, 2000, J BIOL CHEM, V275, P39555, DOI 10.1074/jbc.M005473200; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Wei L, 2009, INT J BIOCHEM CELL B, V41, P2214, DOI 10.1016/j.biocel.2009.04.017; Wetzel GT, 2000, MOL GENET METAB, V69, P252, DOI 10.1006/mgme.2000.2966; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	64	44	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39962	10.1371/journal.pone.0039962	http://dx.doi.org/10.1371/journal.pone.0039962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768324	Green Published, gold, Green Submitted			2022-12-25	WOS:000305966500037
J	Perise-Barrios, AJ; Munoz-Fernandez, MA; Pion, M				Judith Perise-Barrios, Ana; Angeles Munoz-Fernandez, Maria; Pion, Marjorie			Direct Phenotypical and Functional Dysregulation of Primary Human B Cells by Human Immunodeficiency Virus (HIV) Type 1 In Vitro	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; POLYCLONAL ACTIVATION; CD40 LIGAND; T-CELLS; MEMORY; INFECTION; LYMPHOCYTES; HYPERGAMMAGLOBULINEMIA; DIFFERENTIATION; MAINTENANCE	Background: Human immunodeficiency virus type 1 (HIV-1) induces a general dysregulation of immune system. Dysregulation of B cell compartment is generally thought to be induced by HIV-related immune activation and lymphopenia. However, a direct influence of HIV-1 particles on B cells was recently proposed as the third pathway of B cells dysregulation. Methods/Principal Findings: We evaluated the direct and specific consequences of HIV-1 contact on activation, survival, proliferation and phenotype of primary B cells in vitro. Moreover, we examined expression of activation-induced cytidine deaminase (AID) mRNA that is responsible for class switch recombination (CSR) and somatic hypermutation (SHM). Here, we report that changes observed in cellular proliferation, phenotypes and activation of B cells could be caused by direct contact between HIV-1 particles and primary B cells in vitro. Finally, direct HIV-1-derived B cells activation led to the increase of AID mRNA expression and its subsequent CSR function was detected in vitro. Conclusion/Significance: We showed that HIV-1 could directly induce primary B cells dysregulation triggering phenotypical and functional abilities of B cells in vitro that could explain in some extent early B-cell abnormalities in HIV disease.	[Judith Perise-Barrios, Ana; Angeles Munoz-Fernandez, Maria; Pion, Marjorie] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain; [Angeles Munoz-Fernandez, Maria] Red Temat Invest Cooperat Sanitaria Inst Salud Ca, HIV Vaccine Grp, Madrid, Spain	General University Gregorio Maranon Hospital	Perise-Barrios, AJ (corresponding author), Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain.	marjorie.pion@salud.madrid.org	Barrios, Ana Judith Perisé/AAY-5670-2020; Pion, Marjorie/AAB-5812-2022; Pion, Marjorie/D-8139-2012; Barrios, Ana Judith Perisé/A-4007-2019; Pion, Marjorie/D-8139-2012	Barrios, Ana Judith Perisé/0000-0002-0136-3968; Pion, Marjorie/0000-0003-1828-4745; Barrios, Ana Judith Perisé/0000-0002-0136-3968; Munoz-Fernandez/0000-0002-0813-4500; Pion, Marjorie/0000-0002-6406-747X	Fondos de Investigacion Sanitaria [FIS PS09/02523]; Subprogramma Ramon y Cajal [RYC-2009-05486]; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RETIC RD06/0006/0035]; Fundacion para la Investigacion y Prevencion del SIDA en Espana [FIPSE 240800/09]; INTRASALUD [PI09/02029]; Fondo de Investigacion Sanitaria [CP07/00117]	Fondos de Investigacion Sanitaria(Instituto de Salud Carlos III); Subprogramma Ramon y Cajal; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII; Fundacion para la Investigacion y Prevencion del SIDA en Espana; INTRASALUD; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by Fondos de Investigacion Sanitaria (FIS PS09/02523), Subprogramma Ramon y Cajal (RYC-2009-05486), Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RETIC RD06/0006/0035), Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE 240800/09). AJPB was supported by INTRASALUD (PI09/02029). The authors thank Dr. Rafael Correa Rocha (Fondo de Investigacion Sanitaria (CP07/00117)) who provided statistical analysis support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Epeldegui M, 2010, IMMUNOL RES; Epeldegui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011448; French MA, 2007, HIV MED, V8, P148, DOI 10.1111/j.1468-1293.2007.00445.x; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Jacobson MA, 2002, JAIDS, V31, P472, DOI 10.1097/00126334-200212150-00003; Jakubik JJ, 2000, J VIROL, V74, P552, DOI 10.1128/JVI.74.1.552-555.2000; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Maddaly R, 2010, FEBS LETT, V584, P4883, DOI 10.1016/j.febslet.2010.08.022; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; Malaspina A, 2002, J VIROL, V76, P8855, DOI 10.1128/JVI.76.17.8855-8863.2002; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Martinez-Maza O, 2002, CURR OPIN ONCOL, V14, P528, DOI 10.1097/00001622-200209000-00009; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Redgrave BE, 2005, HIV MED, V6, P307, DOI 10.1111/j.1468-1293.2005.00312.x; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; Seidl T, 2011, IMMUNOLOGY; Shen Xiaoying, 2011, Curr HIV/AIDS Rep, V8, P23, DOI 10.1007/s11904-010-0064-2; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; STRONG DM, 1974, J IMMUNOL, V113, P1429; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; WRIGHT DN, 1990, J ALLERGY CLIN IMMUN, V85, P445, DOI 10.1016/0091-6749(90)90154-V	44	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39472	10.1371/journal.pone.0039472	http://dx.doi.org/10.1371/journal.pone.0039472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768302	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000305966500015
J	Tsvirkun, D; Bourreau, J; Mieuset, A; Garo, F; Vinogradova, O; Larina, I; Navasiolava, N; Gauquelin-Koch, G; Gharib, C; Custaud, MA				Tsvirkun, Darya; Bourreau, Jennifer; Mieuset, Aurelie; Garo, Florian; Vinogradova, Olga; Larina, Irina; Navasiolava, Nastassia; Gauquelin-Koch, Guillemette; Gharib, Claude; Custaud, Marc-Antoine			Contribution of Social Isolation, Restraint, and Hindlimb Unloading to Changes in Hemodynamic Parameters and Motion Activity in Rats	PLOS ONE			English	Article							NERVOUS-SYSTEM; BLOOD-PRESSURE; ANTIORTHOSTATIC RESTRAINT; CARDIOVASCULAR CHANGES; CIRCADIAN-RHYTHMS; HEART-RATE; MICROGRAVITY; HYPERTENSION; RECOVERY; EXERCISE	The most accepted animal model for simulation of the physiological and morphological consequences of microgravity on the cardiovascular system is one of head-down hindlimb unloading. Experimental conditions surrounding this model include not only head-down tilting of rats, but also social and restraint stresses that have their own influences on cardiovascular system function. Here, we studied levels of spontaneous locomotor activity, blood pressure, and heart rate during 14 days under the following experimental conditions: cage control, social isolation in standard rat housing, social isolation in special cages for hindlimb unloading, horizontal attachment (restraint), and head-down hindlimb unloading. General activity and hemodynamic parameters were continuously monitored in conscious rats by telemetry. Heart rate and blood pressure were both evaluated during treadmill running to reveal cardiovascular deconditioning development as a result of unloading. The main findings of our work are that: social isolation and restraint induced persistent physical inactivity, while unloading in rats resulted in initial inactivity followed by normalization and increased locomotion after one week. Moreover, 14 days of hindlimb unloading showed significant elevation of blood pressure and slight elevation of heart rate. Hemodynamic changes in isolated and restrained rats largely reproduced the trends observed during unloading. Finally, we detected no augmentation of tachycardia during moderate exercise in rats after 14 days of unloading. Thus, we concluded that both social isolation and restraint, as an integral part of the model conditions, contribute essentially to cardiovascular reactions during head-down hindlimb unloading, compared to the little changes in the hydrostatic gradient.	[Tsvirkun, Darya; Bourreau, Jennifer; Mieuset, Aurelie; Garo, Florian; Custaud, Marc-Antoine] Univ Angers, CNRS, INSERM 1083, Fac Med Angers,UMR 6214, Angers, France; [Tsvirkun, Darya] Moscow MV Lomonosov State Univ, Dept Human & Anim Physiol, Moscow, Russia; [Gauquelin-Koch, Guillemette] Ctr Natl Etud Spatiales, Paris, France; [Gharib, Claude] ISOSTEO LYON Inst Super Osteopathie, Limonest, France; [Gharib, Claude] Fac Med Lyon Est, Lyon, France; [Larina, Irina; Navasiolava, Nastassia; Custaud, Marc-Antoine] Associated French Russia Lab CaDyWEC, Angers, France; [Vinogradova, Olga; Larina, Irina; Navasiolava, Nastassia] Russian Acad Sci SSC, Inst Biomed Problems, Moscow, Russia; [Custaud, Marc-Antoine] CHU Angers, Angers, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Tsvirkun, D (corresponding author), Univ Angers, CNRS, INSERM 1083, Fac Med Angers,UMR 6214, Angers, France.	macustaud@chu-angers.fr	Navasiolava, Nastassia/AAU-8149-2020; Custaud, Marc-Antoine/K-1376-2015; Tsvirkun, Darya/AAH-7043-2020; Vinogradova, Olga/E-6494-2014	Tsvirkun, Darya/0000-0002-6599-6844; Vinogradova, Olga/0000-0002-4622-0522	Centre National d'Etudes Spatiales (CNES); Centre National de la Recherche Scientifique (CNRS); Region des Pays de la Loire; French Embassy in Russia	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region des Pays de la Loire(Region Pays de la Loire); French Embassy in Russia	This work was supported by the Centre National d'Etudes Spatiales (CNES, www.cnes.fr), the Centre National de la Recherche Scientifique (CNRS, www.cnrs.fr, LIA CaDyWEC), and the Region des Pays de la Loire (www.paysdelaloire.fr, project DCVACE). Post-doctoral study grants are from the French Embassy in Russia and CNES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SH, 1995, PSYCHOPHARMACOLOGY, V117, P116, DOI 10.1007/BF02245106; Assenmacher I, 1995, ACTA ASTRONAUT, V36, P545, DOI 10.1016/0094-5765(95)00141-7; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; Basset A, 2004, J HYPERTENS, V22, P727, DOI 10.1097/00004872-200404000-00015; BENNETT T, 1979, BRIT J PHARMACOL, V65, P205, DOI 10.1111/j.1476-5381.1979.tb07820.x; Bouzeghrane F, 1996, J APPL PHYSIOL, V80, P1993, DOI 10.1152/jappl.1996.80.6.1993; CARLIER PG, 1988, J HYPERTENS, V6, pS112, DOI 10.1097/00004872-198812040-00032; Dehority W, 1999, AM J PHYSIOL-ENDOC M, V276, pE62; DELP MD, 1995, J APPL PHYSIOL, V78, P2079, DOI 10.1152/jappl.1995.78.6.2079; Dupont E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017564; FELL RD, 1985, AM J PHYSIOL, V249, pR308, DOI 10.1152/ajpregu.1985.249.3.R308; Fluckey JD, 2002, ACTA PHYSIOL SCAND, V176, P293, DOI 10.1046/j.1365-201X.2002.01040.x; Fujita N, 2009, ARCH HISTOL CYTOL, V72, P151, DOI 10.1679/aohc.72.151; GARDINER SM, 1977, MED BIOL, V55, P325; GAUQUELIN G, 1987, BIOCHEM BIOPH RES CO, V148, P582, DOI 10.1016/0006-291X(87)90916-8; Greene Adrianne N., 2007, Journal of Pharmacological and Toxicological Methods, V56, P218, DOI 10.1016/j.vascn.2007.04.006; Grippo AJ, 2003, PHYSIOL BEHAV, V78, P703, DOI 10.1016/S0031-9384(03)00050-7; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Hargens AR., 1984, PHYSIOLOGIST, V27, pS37; Hasser EM, 2001, ANN NY ACAD SCI, V940, P454; Henze M, 2008, AM J PHYSIOL-HEART C, V295, pH29, DOI 10.1152/ajpheart.01373.2007; Itai Y, 2004, ACTA PHYSIOL SCAND, V181, P217, DOI 10.1111/j.1365-201X.2004.01271.x; JANKOWSKA E, 1991, BEHAV BRAIN RES, V43, P155, DOI 10.1016/S0166-4328(05)80065-8; Makino M, 1997, CIRCULATION, V96, P1667, DOI 10.1161/01.CIR.96.5.1667; Maurel D, 1996, BRAIN RES, V736, P165, DOI 10.1016/0006-8993(96)00676-2; MCDONALD KS, 1992, J APPL PHYSIOL, V72, P2210, DOI 10.1152/jappl.1992.72.6.2210; Moffitt JA, 2008, J APPL PHYSIOL, V105, P1049, DOI 10.1152/japplphysiol.90535.2008; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Morey E R, 1979, Physiologist, V22, pS23; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mueller PJ, 2008, AM J PHYSIOL-REG I, V295, pR727, DOI 10.1152/ajpregu.00144.2008; Mueller PJ, 2010, AM J PHYSIOL-REG I, V298, pR1468, DOI 10.1152/ajpregu.00101.2010; Musacchia X J, 1997, J Gravit Physiol, V4, P49; Narayanan R, 2004, BONE, V35, P134, DOI 10.1016/j.bone.2004.02.014; Navasiolava NM, 2011, EUR J APPL PHYSIOL, V111, P1235, DOI 10.1007/s00421-010-1750-x; Ohira T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021044; OVERTON JM, 1989, J APPL PHYSIOL, V66, P653, DOI 10.1152/jappl.1989.66.2.653; Raffai G, 2009, PHYSIOL RES, V58, P57, DOI 10.33549/physiolres.931264; Ray CA, 2001, J APPL PHYSIOL, V91, P1207, DOI 10.1152/jappl.2001.91.3.1207; Sabban EL, 2009, NEUROENDOCRINOLOGY, V89, P98, DOI 10.1159/000150099; Schuenke MD, 2009, EUR J APPL PHYSIOL, V106, P885, DOI 10.1007/s00421-009-1091-9; SHELLOCK FG, 1985, AVIAT SPACE ENVIR MD, V56, P791; Shen S, 1999, CLIN EXP HYPERTENS, V21, P275, DOI 10.3109/10641969909068667; Shibata S, 2010, J APPL PHYSIOL, V108, P1177, DOI 10.1152/japplphysiol.01408.2009; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Watenpaugh DE, 2000, J APPL PHYSIOL, V89, P218, DOI 10.1152/jappl.2000.89.1.218; Wright RC, 2003, NEUROPEPTIDES, V37, P127, DOI 10.1016/S0143-4179(03)00024-6; Xue JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019775; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2008, J APPL PHYSIOL, V105, P1134, DOI 10.1152/japplphysiol.00184.2008	50	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39923	10.1371/journal.pone.0039923	http://dx.doi.org/10.1371/journal.pone.0039923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768322	Green Published, gold			2022-12-25	WOS:000305966500035
J	Hosoi, T; Korematsu, K; Horie, N; Suezawa, T; Okuma, Y; Nomura, Y; Ozawa, K				Hosoi, Toru; Korematsu, Kenta; Horie, Naohiro; Suezawa, Takahiro; Okuma, Yasunobu; Nomura, Yasuyuki; Ozawa, Koichiro			Inhibition of Casein Kinase 2 Modulates XBP1-GRP78 Arm of Unfolded Protein Responses in Cultured Glial Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; CANCER-THERAPY; MESSENGER-RNA; CK2; XBP-1; TRANSLATION; ACTIVATION; EXPRESSION	Stress signals cause abnormal proteins to accumulate in the endoplasmic reticulum (ER). Such stress is known as ER stress, which has been suggested to be involved in neurodegenerative diseases, diabetes, obesity and cancer. ER stress activates the unfolded protein response (UPR) to reduce levels of abnormal proteins by inducing the production of chaperon proteins such as GRP78, and to attenuate translation through the phosphorylation of eIF2 alpha. However, excessive stress leads to apoptosis by generating transcription factors such as CHOP. Casein kinase 2 (CK2) is a serine/threonine kinase involved in regulating neoplasia, cell survival and viral infections. In the present study, we investigated a possible linkage between CK2 and ER stress using mouse primary cultured glial cells. 4,5,6,7-tetrabromobenzotriazole (TBB), a CK2-specific inhibitor, attenuated ER stress-induced XBP-1 splicing and subsequent induction of GRP78 expression, but was ineffective against ER stress-induced eIF2 alpha phosphorylation and CHOP expression. Similar results were obtained when endogenous CK2 expression was knocked-down by siRNA. Immunohistochemical analysis suggested that CK2 was present at the ER. These results indicate CK2 to be linked with UPR and to resist ER stress by activating the XBP-1-GRP78 arm of UPR.	[Hosoi, Toru; Korematsu, Kenta; Suezawa, Takahiro; Ozawa, Koichiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacotherapy, Hiroshima, Japan; [Horie, Naohiro] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Chiba, Japan; [Nomura, Yasuyuki] Yokohama Coll Pharm, Dept Pharmacotherapeut, Yokohama, Kanagawa, Japan	Hiroshima University; Hokkaido University	Hosoi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacotherapy, Hiroshima, Japan.	toruh@hiroshima-u.ac.jp; ozawak@hiroshima-u.ac.jp	Hosoi, Toru/A-7954-2018	Hosoi, Toru/0000-0003-4831-487X	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23790088]; Takeda Science Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; Nakajima Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; Nakajima Foundation	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23790088); Takeda Science Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; and The Nakajima Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHAUHAN A, 1993, BRAIN RES, V629, P47, DOI 10.1016/0006-8993(93)90479-7; Faust M, 2001, MOL CELL BIOCHEM, V227, P73, DOI 10.1023/A:1013129410551; Gerber DA, 2000, J BIOL CHEM, V275, P23919, DOI 10.1074/jbc.M002697200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hosoi T, 2000, BIOCHEM BIOPH RES CO, V273, P312, DOI 10.1006/bbrc.2000.2937; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hosoi T, 2010, J PHARMACOL SCI, V114, P230, DOI 10.1254/jphs.10082SC; Hosoi T, 2010, BRIT J PHARMACOL, V159, P428, DOI 10.1111/j.1476-5381.2009.00544.x; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Hosoi T, 2009, NEUROCHEM INT, V54, P1, DOI 10.1016/j.neuint.2008.09.017; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	34	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40144	10.1371/journal.pone.0040144	http://dx.doi.org/10.1371/journal.pone.0040144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768244	gold, Green Published			2022-12-25	WOS:000305892100217
J	Jia, KZ; Zhang, YP; Li, Y				Jia, Kaizhi; Zhang, Yanping; Li, Yin			Identification and Characterization of Two Functionally Unknown Genes Involved in Butanol Tolerance of Clostridium acetobutylicum	PLOS ONE			English	Article							PROTEIN-KINASE-C; INCREASED SOLVENT PRODUCTION; TRANSCRIPTIONAL ANALYSIS; ESCHERICHIA-COLI; ATCC 824; DSM 1731; ALCOHOLS; MOTILITY; STRAIN; OVEREXPRESSION	Solvents toxicity is a major limiting factor hampering the cost-effective biotechnological production of chemicals. In Clostridium acetobutylicum, a functionally unknown protein (encoded by SMB_G1518) with a hypothetical alcohol interacting domain was identified. Disruption of SMB_G1518 and/or its downstream gene SMB_G1519 resulted in increased butanol tolerance, while overexpression of SMB_G1518-1519 decreased butanol tolerance. In addition, SMB_G1518-1519 also influences the production of pyruvate: ferredoxin oxidoreductase (PFOR) and flagellar protein hag, the maintenance of cell motility. We conclude that the system of SMB_G1518-1519 protein plays a role in the butanol sensitivity/tolerance phenotype of C. acetobutylicum, and can be considered as potential targets for engineering alcohol tolerance.	[Jia, Kaizhi; Zhang, Yanping; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Jia, KZ (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	yli@im.ac.cn	Zhang, Yanping/C-7114-2009; Li, Yin/C-6644-2009	Li, Yin/0000-0003-0995-3070	National Science Foundation of China [31000024]; National Basic Research Program of China (973 Project) [2011CBA00807]; Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Science Foundation of China (31000024), National Basic Research Program of China (973 Project, 2011CBA00807), and Hundreds Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaker KV, 2004, J BACTERIOL, V186, P1959, DOI 10.1128/JB.186.7.1959-1971.2004; Bao GH, 2011, J BACTERIOL, V193, P5007, DOI 10.1128/JB.05596-11; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Das J, 2006, PROTEIN SCI, V15, P2107, DOI 10.1110/ps.062237606; Dong HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009038; Ezeji TC, 2005, BIOPROC BIOSYST ENG, V27, P207, DOI 10.1007/s00449-005-0403-7; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Ezeji TC, 2007, CURR OPIN BIOTECH, V18, P220, DOI 10.1016/j.copbio.2007.04.002; Faulds-Pain A, 2011, J BACTERIOL, V193, P2695, DOI 10.1128/JB.01172-10; FRANKS NP, 1982, NATURE, V300, P487, DOI 10.1038/300487a0; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; INGRAM LO, 1986, TRENDS BIOTECHNOL, V4, P40, DOI 10.1016/0167-7799(86)90152-6; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Jia KZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016693; Jia KZ, 2010, ENG LIFE SCI, V10, P422, DOI 10.1002/elsc.201000076; Lai S, 2009, ENVIRON MICROBIOL, V11, P126, DOI 10.1111/j.1462-2920.2008.01747.x; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; LIN YL, 1983, APPL ENVIRON MICROB, V45, P966, DOI 10.1128/AEM.45.3.966-973.1983; Mao SM, 2010, J PROTEOME RES, V9, P3046, DOI 10.1021/pr9012078; Mendez M, 2008, J BACTERIOL, V190, P48, DOI 10.1128/JB.01407-07; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; RICHARDS CD, 1978, NATURE, V276, P775, DOI 10.1038/276775a0; Sengupta S, 2008, NUCLEIC ACIDS RES, V36, P4310, DOI 10.1093/nar/gkn355; Shi Z, 2008, APPL ENVIRON MICROB, V74, P7709, DOI 10.1128/AEM.01948-08; Slater SJ, 1997, J BIOL CHEM, V272, P6167, DOI 10.1074/jbc.272.10.6167; SLATER SJ, 1993, NATURE, V364, P82, DOI 10.1038/364082a0; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Tang Y, 2004, MOL MICROBIOL, V51, P1817, DOI 10.1111/j.1365-2958.2003.03954.x; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; Tomas CA, 2003, APPL ENVIRON MICROB, V69, P4951, DOI 10.1128/AEM.69.8.4951-4965.2003; Wong J, 1996, CURR MICROBIOL, V32, P349, DOI 10.1007/s002849900062; Yakhnin H, 2007, MOL MICROBIOL, V64, P1605, DOI 10.1111/j.1365-2958.2007.05765.x; Zhao YS, 2003, APPL ENVIRON MICROB, V69, P2831, DOI 10.1128/AEM.69.5.2831-2841.2003	38	24	26	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38815	10.1371/journal.pone.0038815	http://dx.doi.org/10.1371/journal.pone.0038815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768047	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100018
J	Koga, H; Tsedensodnom, O; Tomimaru, Y; Walker, EJ; Lee, HC; Kim, KM; Yano, H; Wands, JR; Kim, M				Koga, Hironori; Tsedensodnom, Orkhontuya; Tomimaru, Yoshito; Walker, Evan J.; Lee, Han Chu; Kim, Kang Mo; Yano, Hirohisa; Wands, Jack R.; Kim, Miran			Loss of the SxxSS Motif in a Human T-Cell Factor-4 Isoform Confers Hypoxia Resistance to Liver Cancer: An Oncogenic Switch in Wnt Signaling	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BETA-CATENIN; COLORECTAL-CANCER; INDUCIBLE FACTORS; TUMOR HYPOXIA; GROWTH-FACTOR; C-MYC; IDENTIFICATION; TRANSCRIPTION; ACTIVATION	Purpose: Aberrantly activated Wnt/beta-catenin signaling is important in hepatocellular carcinoma (HCC) development. Downstream gene expressions involving the Wnt/b-catenin cascade occur through T-cell factor (TCF) proteins. Here, we show the oncogenic potential of human TCF-4 isoforms based on the expression of a single conserved SxxSS motif. Methods: We investigated the TCF-4J and K isoform pair characterized by the presence (K) or absence (J) of the SxxSS motif. The mRNA expression profiles were examined in 47 pairs of human HCCs and adjacent non-cancerous liver tissues by RT-PCR. Proliferation, sphere assays and immunoblot analysis were performed under normoxia and hypoxia conditions. The ability of HCC cells overexpressing TCF-4J (J cells) and K (K cells) to grow as solid tumors in nude mice was explored. Results: TCF-4J expression was significantly upregulated in HCC tumors compared to corresponding peritumor and normal liver and was preferentially expressed in poorly differentiated HCCs. In contrast, TCF-4K was downregulated in those same HCC tumors. TCF-4J-overexpressing HCC cells (J cells) revealed a survival advantage under hypoxic conditions, high proliferation rate and formation of aggregates/spheres compared to overexpression of TCF-4K (K cells). The hypoxic J cells had high expression levels of HIF-2 alpha and EGFR as possible mechanisms to promote tumorigenesis. Increased stability of HIF-2 alpha under hypoxia in J cells was associated with a decreased level of von Hippel-Lindau (VHL) protein, a known E3 ligase for HIF-alpha s. In a xenograft model, the J cells rapidly developed tumors compared to K cells. Tumor tissues derived from J cells exhibited high expression levels of HIF-2 alpha and EGFR compared to the slow developing and small K cell derived tumors. Conclusions: Our results suggest that the specific TCF-4J isoform, which lacks a regulatory SxxSS motif, has robust tumor-initiating potential under hypoxic conditions.	[Koga, Hironori; Tsedensodnom, Orkhontuya; Tomimaru, Yoshito; Walker, Evan J.; Wands, Jack R.; Kim, Miran] Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA; [Koga, Hironori; Tsedensodnom, Orkhontuya; Tomimaru, Yoshito; Walker, Evan J.; Wands, Jack R.; Kim, Miran] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Lee, Han Chu; Kim, Kang Mo] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; [Yano, Hirohisa] Kurume Univ, Dept Pathol, Kurume, Fukuoka 830, Japan	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University of Ulsan; Kurume University	Koga, H (corresponding author), Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA.	Miran_Kim@brown.edu		Walker, Evan/0000-0002-3081-190X	National Institutes of Health [CA-123544]; NATIONAL CANCER INSTITUTE [R01CA123544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA-123544 to JRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Choi H, 2010, CANCER RES, V70, P10101, DOI 10.1158/0008-5472.CAN-10-0505; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Deng Y, 2010, J CANCER RES CLIN, V136, P1161, DOI 10.1007/s00432-010-0763-5; Duval A, 2000, CANCER RES, V60, P3872; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kojiro M, 2004, INTERVIROLOGY, V47, P179, DOI 10.1159/000078470; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Maeyama M, 2008, CANCER, V113, P2823, DOI 10.1002/cncr.23900; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakamura K, 2007, HUM PATHOL, V38, P1532, DOI 10.1016/j.humpath.2007.03.002; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pukrop T, 2001, J BIOL CHEM, V276, P8968, DOI 10.1074/jbc.M007533200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsedensodnom O, 2011, EXP CELL RES, V317, P920, DOI 10.1016/j.yexcr.2011.01.015; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338; YANO H, 1993, HEPATOLOGY, V18, P320, DOI 10.1016/0270-9139(93)90015-F; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Yoneda N, 2011, LAB INVEST, V91, P262, DOI 10.1038/labinvest.2010.161	45	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39981	10.1371/journal.pone.0039981	http://dx.doi.org/10.1371/journal.pone.0039981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768190	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100162
J	Kuhns, M; Zautner, AE; Rabsch, W; Zimmermann, O; Weig, M; Bader, O; Gross, U				Kuhns, Martin; Zautner, Andreas E.; Rabsch, Wolfgang; Zimmermann, Ortrud; Weig, Michael; Bader, Oliver; Gross, Uwe			Rapid Discrimination of Salmonella enterica Serovar Typhi from Other Serovars by MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; BLOOD-STREAM INFECTIONS; BACTEREMIA; FEVER; IDENTIFICATION; EPIDEMIOLOGY; RESISTANCE; CHILDREN; KENYA; ADMISSIONS	Systemic infections caused by Salmonella enterica are an ongoing public health problem especially in Sub-Saharan Africa. Essentially typhoid fever is associated with high mortality particularly because of the increasing prevalence of multidrug-resistant strains. Thus, a rapid blood-culture based bacterial species diagnosis including an immediate sub-differentiation of the various serovars is mandatory. At present, MALDI-TOF based intact cell mass spectrometry (ICMS) advances to a widely used routine identification tool for bacteria and fungi. In this study, we investigated the appropriateness of ICMS to identify pathogenic bacteria derived from Sub-Saharan Africa and tested the potential of this technology to discriminate S. enterica subsp. enterica serovar Typhi (S. Typhi) from other serovars. Among blood culture isolates obtained from a study population suffering from febrile illness in Ghana, no major misidentifications were observed for the species identification process, but serovars of Salmonella enterica could not be distinguished using the commercially available Biotyper database. However, a detailed analysis of the mass spectra revealed several serovar-specific biomarker ions, allowing the discrimination of S. Typhi from others. In conclusion, ICMS is able to identify isolates from a sub-Saharan context and may facilitate the rapid discrimination of the clinically and epidemiologically important serovar S. Typhi and other non-S. Typhi serovars in future implementations.	[Kuhns, Martin; Zautner, Andreas E.; Zimmermann, Ortrud; Weig, Michael; Bader, Oliver; Gross, Uwe] Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany; [Kuhns, Martin; Zautner, Andreas E.; Zimmermann, Ortrud; Weig, Michael; Bader, Oliver; Gross, Uwe] Univ Med Ctr Gottingen, Int Hlth Network Gottingen, Gottingen, Germany; [Rabsch, Wolfgang] Robert Koch Inst, German Natl Reference Ctr Salmonella & Enter Path, Wernigerode, Germany	University of Gottingen; University of Gottingen; Robert Koch Institute	Kuhns, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany.	obader@medizin.uni-goettingen.de	Zautner, Andreas Erich/AAE-7425-2019; Bader, Oliver/C-7650-2015; Zautner, Andreas Erich/ABA-9655-2020	Zautner, Andreas Erich/0000-0003-0984-013X; Bader, Oliver/0000-0002-1534-440X; Zautner, Andreas Erich/0000-0003-0984-013X	German Research Foundation; University of Gottingen Publication Foundation	German Research Foundation(German Research Foundation (DFG)); University of Gottingen Publication Foundation	Publication costs were covered by the open-access support program of the German Research Foundation and the University of Gottingen Publication Foundation.	Akinyemi KO, 2005, PUBLIC HEALTH, V119, P321, DOI 10.1016/j.puhe.2004.04.009; Archibald LK, 2003, J INFECT DIS, V188, P202, DOI 10.1086/376507; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Browne NK, 2010, J APPL MICROBIOL, V108, P1828, DOI 10.1111/j.1365-2672.2009.04588.x; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Conway GC, 2001, J MOL MICROB BIOTECH, V3, P103; Cooke VM, 1999, APPL ENVIRON MICROB, V65, P807; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; English M, 2003, B WORLD HEALTH ORGAN, V81, P166; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gross U, 2011, EMERG INFECT DIS, V17, P1879, DOI [10.3201/edi1710.110327, 10.3201/eid1710.110327]; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Kodaka H, 2000, J FOOD PROTECT, V63, P1643, DOI 10.4315/0362-028X-63.12.1643; Kothari A, 2008, J INFECT DEV COUNTR, V2, P253; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Mengo DM, 2010, J INFECT DEV COUNTR, V4, P393, DOI 10.3855/jidc.503; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pien BC, 2010, AM J MED, V123, P819, DOI 10.1016/j.amjmed.2010.03.021; Rabsch W, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P25; Rabsch Wolfgang, 2007, V394, P177, DOI 10.1007/978-1-59745-512-1_10; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shears P, 2001, T ROY SOC TROP MED H, V95, P127, DOI 10.1016/S0035-9203(01)90134-8; Sparbier K, 2012, EUR J CLIN MICROBIOL, V31, P767, DOI 10.1007/s10096-011-1373-0; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Wain J, 2008, J INFECT DEV COUNTR, V2, P421, DOI 10.3855/jidc.164; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405	35	66	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40004	10.1371/journal.pone.0040004	http://dx.doi.org/10.1371/journal.pone.0040004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768195	Green Published, gold			2022-12-25	WOS:000305892100167
J	Menezes, SP; dos Santos, JL; Cardoso, THS; Pirovani, CP; Micheli, F; Noronha, FSM; Alves, AC; Faria, AMC; Gesteira, AD				Menezes, Sara Pereira; dos Santos, Jane Lima; Santana Cardoso, Thyago Hermylly; Pirovani, Carlos Priminho; Micheli, Fabienne; Motta Noronha, Fatima Soares; Alves, Andrea Catao; Caetano Faria, Ana Maria; Gesteira, Abelmon da Silva			Evaluation of the Allergenicity Potential of TcPR-10 Protein from Theobroma cacao	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; MAJOR CHERRY ALLERGEN; BET V 1; MUTATIONAL EPITOPE ANALYSIS; SITE-DIRECTED MUTAGENESIS; PLANT FOOD ALLERGENS; CROSS-REACTIVITY; BIRCH POLLEN; PRU AV-1; MOLECULAR-CLONING	Background: The pathogenesis related protein PR10 (TcPR-10), obtained from the Theobroma cacao-Moniliophthora perniciosa interaction library, presents antifungal activity against M. perniciosa and acts in vitro as a ribonuclease. However, despite its biotechnological potential, the TcPR-10 has the P-loop motif similar to those of some allergenic proteins such as Bet v 1 (Betula verrucosa) and Pru av 1 (Prunus avium). The insertion of mutations in this motif can produce proteins with reduced allergenic power. The objective of the present work was to evaluate the allergenic potential of the wild type and mutant recombinant TcPR-10 using bioinformatics tools and immunological assays. Methodology/Principal Findings: Mutant substitutions (T10P, I30V, H45S) were inserted in the TcPR-10 gene by site-directed mutagenesis, cloned into pET28a and expressed in Escherichia coli BL21(DE3) cells. Changes in molecular surface caused by the mutant substitutions was evaluated by comparative protein modeling using the three-dimensional structure of the major cherry allergen, Pru av 1 as a template. The immunological assays were carried out in 8-12 week old female BALB/c mice. The mice were sensitized with the proteins (wild type and mutants) via subcutaneous and challenged intranasal for induction of allergic airway inflammation. Conclusions/Significance: We showed that the wild TcPR-10 protein has allergenic potential, whereas the insertion of mutations produced proteins with reduced capacity of IgE production and cellular infiltration in the lungs. On the other hand, in vitro assays show that the TcPR-10 mutants still present antifungal and ribonuclease activity against M. perniciosa RNA. In conclusion, the mutant proteins present less allergenic potential than the wild TcPR-10, without the loss of interesting biotechnological properties.	[Menezes, Sara Pereira; Santana Cardoso, Thyago Hermylly; Pirovani, Carlos Priminho; Micheli, Fabienne] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil; [dos Santos, Jane Lima] Univ Estadual Santa Cruz, Ctr Microscopia Eletron, Ilheus, BA, Brazil; [Micheli, Fabienne] CIRAD, UMAR AGAP, Montpellier, France; [Motta Noronha, Fatima Soares; Alves, Andrea Catao; Caetano Faria, Ana Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Gesteira, Abelmon da Silva] Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; CIRAD; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Menezes, SP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	Abelmon.Gesteira@embrapa.br	Pirovani, Carlos Priminho/N-1153-2019; Faria, Ana Maria/AAK-8688-2021; Micheli, Fabienne/AAL-9895-2021; Pirovani, Carlos P/J-3426-2017; da Silva Gesteira, Abelmon/I-2136-2013	Pirovani, Carlos Priminho/0000-0002-6176-4069; Pirovani, Carlos P/0000-0002-6176-4069; da Silva Gesteira, Abelmon/0000-0002-7590-0455; Micheli, Fabienne/0000-0002-9031-362X; Faria, Ana Maria/0000-0002-0604-8510	Research Support Foundation of the State of Bahia (FAPESB); FAPESB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471849/2004-9]	Research Support Foundation of the State of Bahia (FAPESB); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work of SPM was supported by the Research Support Foundation of the State of Bahia (FAPESB). This research was supported by FAPESB and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - 471849/2004-9, http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2001, EV ALL GEN MOD FOODS; Asensio T, 2004, J ALLERGY CLIN IMMUN, V114, P896, DOI 10.1016/j.jaci.2004.06.014; AYRES M, 2005, BIOESTAT APLICACOES; Bahramnejad B, 2010, PLANT CELL REP, V29, P1235, DOI 10.1007/s00299-010-0909-6; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; Breiteneder H, 2005, BIOTECHNOL ADV, V23, P395, DOI 10.1016/j.biotechadv.2005.05.004; Chapman HD, 2000, WORLD POULTRY SCI J, V56, P7, DOI 10.1079/WPS20000002; Chapman JA, 2006, ANN ALLERG ASTHMA IM, V96, pS1, DOI 10.1016/S1081-1206(10)60926-X; Cressman RF, 2009, REGUL TOXICOL PHARM, V54, pS20, DOI 10.1016/j.yrtph.2008.11.006; Dearman RJ, 2003, FOOD CHEM TOXICOL, V41, P1509, DOI 10.1016/S0278-6915(03)00167-4; Ebner C, 2001, ALLERGY, V56, P43, DOI 10.1034/j.1398-9995.2001.00913.x; Fernandes H, 2009, FEBS J, V276, P1596, DOI 10.1111/j.1742-4658.2009.06892.x; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Filho DF, 2006, CURR MICROBIOL, V52, P407, DOI 10.1007/s00284-005-0405-3; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gallo M, 2009, CURR OPIN BIOTECH, V20, P191, DOI 10.1016/j.copbio.2009.03.005; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hoffmann-Sommergruber K, 2002, BIOCHEM SOC T, V30, P930, DOI 10.1042/BST0300930; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Ivanciuc O, 2002, BIOINFORMATICS, V18, P1358, DOI 10.1093/bioinformatics/18.10.1358; Ivanciuc O, 2009, MOL IMMUNOL, V46, P559, DOI 10.1016/j.molimm.2008.07.034; Ivanciuc O, 2009, REGUL TOXICOL PHARM, V54, pS11, DOI 10.1016/j.yrtph.2008.11.007; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lebel S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-184; Liu JJ, 2005, PLANTA, V221, P159, DOI 10.1007/s00425-004-1428-x; Ma Y, 2006, INT ARCH ALLERGY IMM, V139, P53, DOI 10.1159/000089756; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Midoro-Horiuti T, 2001, ANN ALLERG ASTHMA IM, V87, P261, DOI 10.1016/S1081-1206(10)62238-7; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Motulsky H.J., 2003, PRISM 4 STAT GUIDE S; Neudecker P, 2000, J BIOMOL NMR, V18, P71, DOI 10.1023/A:1008357100592; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Peters S, 2011, TRANSGENIC RES, V20, P547, DOI 10.1007/s11248-010-9435-0; Puehringer HM, 2003, GENE, V321, P173, DOI 10.1016/S0378-1119(03)00822-9; Schenk MF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-168; Scheurer S, 1999, MOL IMMUNOL, V36, P155, DOI 10.1016/S0161-5890(99)00033-4; Selgrade MK, 2009, TOXICOL SCI, V110, P31, DOI 10.1093/toxsci/kfp075; Silvanovich A, 2009, REGUL TOXICOL PHARM, V54, pS26, DOI 10.1016/j.yrtph.2009.02.004; Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; SWOBODA I, 1995, PLANT CELL ENVIRON, V18, P865, DOI 10.1111/j.1365-3040.1995.tb00595.x; Thomas K, 2008, FOOD CHEM TOXICOL, V46, P3219, DOI 10.1016/j.fct.2008.06.078; Thomas WR, 2011, J ALLERGY CLIN IMMUN, V127, P855, DOI 10.1016/j.jaci.2010.12.1084; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Montagu M, 2011, ANNU REV PLANT BIOL, V62, P1, DOI 10.1146/annurev-arplant-042110-103906; Veluthakkal R, 2010, TREES-STRUCT FUNCT, V24, P993, DOI 10.1007/s00468-010-0489-7; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; Wangorsch A, 2007, MOL IMMUNOL, V44, P2518, DOI 10.1016/j.molimm.2006.12.023; Wiche R, 2005, BIOCHEM J, V385, P319, DOI 10.1042/BJ20040842; Xie YR, 2010, J PLANT PHYSIOL, V167, P121, DOI 10.1016/j.jplph.2009.07.004; Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543	63	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37969	10.1371/journal.pone.0037969	http://dx.doi.org/10.1371/journal.pone.0037969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768037	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100008
J	Perot, G; Croce, S; Ribeiro, A; Lagarde, P; Velasco, V; Neuville, A; Coindre, JM; Stoeckle, E; Floquet, A; MacGrogan, G; Chibon, F				Perot, Gaelle; Croce, Sabrina; Ribeiro, Agnes; Lagarde, Pauline; Velasco, Valerie; Neuville, Agnes; Coindre, Jean-Michel; Stoeckle, Eberhard; Floquet, Anne; MacGrogan, Gaetan; Chibon, Frederic			MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; X-CHROMOSOME INACTIVATION; BETA-CATENIN EXPRESSION; BROAD LIGAMENT; CLONAL ORIGINS; LEIOMYOSARCOMA; LEIOMYOMA; ABERRATIONS; NEOPLASMS; MEDIATOR	The relationship between benign uterine leiomyomas and their malignant counterparts, i.e. leiomyosarcomas and smooth muscle tumors of uncertain malignant potential (STUMP), is still poorly understood. The idea that a leiomyosarcoma could derive from a leiomyoma is still controversial. Recently MED12 mutations have been reported in uterine leiomyomas. In this study we asked whether such mutations could also be involved in leiomyosarcomas and STUMP oncogenesis. For this purpose we examined 33 uterine mesenchymal tumors by sequencing the hot-spot mutation region of MED12. We determined that MED12 is altered in 66.6% of typical leiomyomas as previously reported but also in 11% of STUMP and 20% of leiomyosarcomas. The mutated allele is predominantly expressed in leiomyomas and STUMP. Interestingly all classical leiomyomas exhibit MED12 protein expression while 40% of atypical leiomyomas, 50% of STUMP and 80% of leiomyosarcomas (among them the two mutated ones) do not express MED12. All these tumors without protein expression exhibit complex genomic profiles. No mutations and no expression loss were identified in an additional series of 38 non-uterine leiomyosarcomas. MED12 mutations are not exclusive to leiomyomas but seem to be specific to uterine malignancies. A previous study has suggested that MED12 mutations in leiomyomas could lead to Wnt/beta-catenin pathway activation however our immunohistochemistry results show that there is no association between MED12 status and beta-catenin nuclear/cytoplasmic localization. Collectively, our results show that subgroups of benign and malignant tumors share a common genetics. We propose here that MED12 alterations could be implicated in the development of smooth muscle tumor and that its expression could be inhibited in malignant tumors.	[Perot, Gaelle; Lagarde, Pauline; Coindre, Jean-Michel; MacGrogan, Gaetan; Chibon, Frederic] Inst Bergonie, Inst Canc, INSERM U916, Bordeaux, France; [Croce, Sabrina; Ribeiro, Agnes; Velasco, Valerie; Neuville, Agnes; Coindre, Jean-Michel; MacGrogan, Gaetan; Chibon, Frederic] Inst Bergonie, Inst Canc, Dept Pathol, Bordeaux, France; [Ribeiro, Agnes; Velasco, Valerie; Chibon, Frederic] Inst Bergonie, Inst Canc, Dept Mol Pathol, Bordeaux, France; [Coindre, Jean-Michel] Univ Victor Segalen, Bordeaux, France; [Stoeckle, Eberhard] Inst Bergonie, Inst Canc, Dept Surg, Bordeaux, France; [Floquet, Anne] Inst Bergonie, Inst Canc, Dept Med Oncol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie	Perot, G (corresponding author), Inst Bergonie, Inst Canc, INSERM U916, Bordeaux, France.	f.chibon@bordeaux.unicancer.fr	Pérot, Gaëlle/W-8038-2019; chibon, frederic/A-2651-2013; Pérot, Gaëlle/J-3912-2014	chibon, Frederic/0000-0002-6548-2181; MacGrogan, Gaetan/0000-0002-3483-9758	Institut National Du Cancer (INCa); La Ligue Nationale Contre le Cancer; Institut Bergonie	Institut National Du Cancer (INCa)(Institut National du Cancer (INCA) France); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut Bergonie	Institut National Du Cancer (INCa): http://www.e-cancer.fr/; La Ligue Nationale Contre le Cancer: http://www.ligue-cancer.net/; and Institut Bergonie:http://www.bergonie.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL SW, 1994, AM J SURG PATHOL, V18, P535, DOI 10.1097/00000478-199406000-00001; Canevari RA, 2005, AM J OBSTET GYNECOL, V193, P1395, DOI 10.1016/j.ajog.2005.02.097; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Cho YL, 2005, GYNECOL ONCOL, V99, P545, DOI 10.1016/j.ygyno.2005.07.017; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; D'Angelo E, 2011, GYNECOL ONCOL, V121, P328, DOI 10.1016/j.ygyno.2011.01.022; Doring B, 2006, J CELL SCI, V119, P1715, DOI 10.1242/jcs.02892; Fletcher CDM, 2002, WHO CLASSIFICATION T; HAN KJ, 1994, CANCER GENET CYTOGEN, V74, P19, DOI 10.1016/0165-4608(94)90023-X; HART WR, 1978, CANCER, V41, P1902, DOI 10.1002/1097-0142(197805)41:5<1902::AID-CNCR2820410535>3.0.CO;2-K; HASHIMOTO K, 1995, GYNECOL OBSTET INVES, V40, P204, DOI 10.1159/000292336; HERBOLD DR, 1983, AM J SURG PATHOL, V7, P285, DOI 10.1097/00000478-198304000-00007; Hodge JC, 2007, HUM MOL GENET, V16, pR7, DOI 10.1093/hmg/ddm043; Hostetter G, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp881; Je EM, 2012, INT J CANCER, V131, pE1044, DOI 10.1002/ijc.27610; Jung CK, 2008, MODERN PATHOL, V21, P756, DOI 10.1038/modpathol.2008.53; Kildal W, 2009, EUR J CANCER, V45, P2412, DOI 10.1016/j.ejca.2009.06.017; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kir G, 2003, EUR J GYNAECOL ONCOL, V24, P505; Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; LOWELL DM, 1968, OBSTET GYNECOL, V32, P107; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Markowski DN, 2012, INT J CANCER, V131, P1528, DOI 10.1002/ijc.27424; MASHAL RD, 1994, GENE CHROMOSOME CANC, V11, P1, DOI 10.1002/gcc.2870110102; McGuire MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033251; Mittal K, 2000, HUM PATHOL, V31, P398, DOI 10.1016/S0046-8177(00)80258-0; Mittal K, 2007, GYNECOL ONCOL, V104, P362, DOI 10.1016/j.ygyno.2006.08.034; Mittal KR, 2009, MODERN PATHOL, V22, P1303, DOI 10.1038/modpathol.2009.96; Morey C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002212; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Oliva E., 2009, GYNECOLOGIC PATHOLOG, V1st; Pelmus M, 2009, INT J GYNECOL CANCER, V19, P385, DOI 10.1111/IGC.0b013e3181a1bfbc; Qiao QL, 2001, INT J CANCER, V95, P194, DOI 10.1002/1097-0215(20010520)95:3<194::AID-IJC1033>3.3.CO;2-D; Robboy SJ, 2000, ENVIRON HEALTH PERSP, V108, P779, DOI 10.2307/3454306; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Salas S, 2010, GENE CHROMOSOME CANC, V49, P560, DOI 10.1002/gcc.20766; SCURRY J, 1990, GYNECOL ONCOL, V39, P381, DOI 10.1016/0090-8258(90)90271-L; Szymanska J, 1997, CANCER GENET CYTOGEN, V99, P14, DOI 10.1016/S0165-4608(96)00436-0; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tavassoli F, 2003, WHO CLASSIFICATION T, V5, P223; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; Yanai H, 2010, PATHOL INT, V60, P506, DOI 10.1111/j.1440-1827.2010.02549.x; Zavadil J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012362; Zhang P, 2006, HUM PATHOL, V37, P1350, DOI 10.1016/j.humpath.2006.05.005	48	100	103	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40015	10.1371/journal.pone.0040015	http://dx.doi.org/10.1371/journal.pone.0040015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768200	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100172
J	Reinders, AATS; Willemsen, ATM; Vos, HPJ; den Boer, JA; Nijenhuis, ERS				Reinders, A. A. T. Simone; Willemsen, Antoon T. M.; Vos, Herry P. J.; den Boer, Johan A.; Nijenhuis, Ellert R. S.			Fact or Factitious? A Psychobiological Study of Authentic and Simulated Dissociative Identity States	PLOS ONE			English	Article							ANIMAL DEFENSIVE REACTIONS; FANTASY PRONENESS; MULTIPLE PERSONALITY; COGNITIVE-PROCESSES; SOMATOFORM DISSOCIATION; SOCIOCOGNITIVE MODEL; DISORDER; PERSISTENCE; TRAUMA; BRAIN	Background: Dissociative identity disorder (DID) is a disputed psychiatric disorder. Research findings and clinical observations suggest that DID involves an authentic mental disorder related to factors such as traumatization and disrupted attachment. A competing view indicates that DID is due to fantasy proneness, suggestibility, suggestion, and role-playing. Here we examine whether dissociative identity state-dependent psychobiological features in DID can be induced in high or low fantasy prone individuals by instructed and motivated role-playing, and suggestion. Methodology/Principal Findings: DID patients, high fantasy prone and low fantasy prone controls were studied in two different types of identity states (neutral and trauma-related) in an autobiographical memory script-driven (neutral or trauma-related) imagery paradigm. The controls were instructed to enact the two DID identity states. Twenty-nine subjects participated in the study: 11 patients with DID, 10 high fantasy prone DID simulating controls, and 8 low fantasy prone DID simulating controls. Autonomic and subjective reactions were obtained. Differences in psychophysiological and neural activation patterns were found between the DID patients and both high and low fantasy prone controls. That is, the identity states in DID were not convincingly enacted by DID simulating controls. Thus, important differences regarding regional cerebral bloodflow and psychophysiological responses for different types of identity states in patients with DID were upheld after controlling for DID simulation. Conclusions/Significance: The findings are at odds with the idea that differences among different types of dissociative identity states in DID can be explained by high fantasy proneness, motivated role-enactment, and suggestion. They indicate that DID does not have a sociocultural (e. g., iatrogenic) origin.	[Reinders, A. A. T. Simone] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Reinders, A. A. T. Simone] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Reinders, A. A. T. Simone] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Willemsen, Antoon T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [den Boer, Johan A.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands; [Nijenhuis, Ellert R. S.] Top Referent Trauma Ctr Mental Hlth Care Drenthe, Assen, Netherlands	University of London; King's College London; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Reinders, AATS (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England.	a.a.t.s.reinders@gmail.com		Nijenhuis, Ellert/0000-0003-4710-474X	Netherlands Organization for Scientific Research, NWO-VENI [451-07-009]	Netherlands Organization for Scientific Research, NWO-VENI(Netherlands Organization for Scientific Research (NWO))	AATSR is supported by the Netherlands Organization for Scientific Research (www.nwo.nl), NWO-VENI grant no. 451-07-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Armony JL, 1997, ANN NY ACAD SCI, V821, P259, DOI 10.1111/j.1749-6632.1997.tb48285.x; Association AP DSM- IV APATF, 2000, DIAGN STAT MAN MENT; Braffman W, 1999, J PERS SOC PSYCHOL, V77, P578, DOI 10.1037/0022-3514.77.3.578; Bremner JD, 2010, PSYCHOL BULL, V136, P1, DOI 10.1037/a0018021; Brett M., 2006, MNI BRAIN TALAIRACH; Brown D., 1998, MEMORY TRAUMA TREATM; Brown D, 1999, J PSYCHIAT LAW, V27, P549, DOI DOI 10.1177/009318539902700308; Camm AJ, 1996, EUR HEART J, V17, P354; Casada JH, 1998, BIOL PSYCHIAT, V44, P1037, DOI 10.1016/S0006-3223(98)00182-6; Coons PM, 2005, CAN J PSYCHIAT, V50, P813, DOI 10.1177/070674370505001217; Draijer N, 1999, J PSYCHIAT L, V27, P423; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Elzinga BM, 2003, J ABNORM PSYCHOL, V112, P237, DOI 10.1037/0021-843X.112.2.237; Elzinga BM, 1998, CLIN PSYCHOL PSYCHOT, V5, P13, DOI 10.1002/(SICI)1099-0879(199803)5:1<13::AID-CPP148>3.0.CO;2-J; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, TRENDS COGN SCI, V1, P21, DOI 10.1016/S1364-6613(97)01001-2; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giesbrecht T, 2008, E COMMUNICATION 0211; Giesbrecht T, 2008, PSYCHOL BULL, V134, P617, DOI 10.1037/0033-2909.134.5.617; Giesbrecht T, 2007, J NERV MENT DIS, V195, P812, DOI 10.1097/NMD.0b013e3181568137; Giesbrecht T, 2006, PERS INDIV DIFFER, V41, P697, DOI 10.1016/j.paid.2006.02.015; Giesbrecht T, 2010, PSYCHOL BULL, V136, P7, DOI 10.1037/a0018068; Gleaves DH, 1996, PSYCHOL BULL, V120, P42, DOI 10.1037/0033-2909.120.1.42; Goebel R, 2011, BRAIN INNOVATION HOM; Haaksma J, 1994, HEART RATE DEPENDENT, P45; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Huntjens RJC, 2007, BEHAV RES THER, V45, P775, DOI 10.1016/j.brat.2006.07.001; Huntjens RJC, 2006, PSYCHOL MED, V36, P857, DOI 10.1017/S0033291706007100; Huntjens RJC, 2005, CONSCIOUS COGN, V14, P377, DOI 10.1016/j.concog.2004.10.001; Huntjens RJC, 2005, BEHAV RES THER, V43, P243, DOI 10.1016/j.brat.2004.01.007; Huntjens RJC, 2003, J ABNORM PSYCHOL, V112, P290, DOI 10.1037/0021-843X.112.2.290; Huntjens RJC, 2002, MEM COGNITION, V30, P1033, DOI 10.3758/BF03194321; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levin R, 2004, ASSESSMENT, V11, P160, DOI 10.1177/1073191103256377; Lilienfeld SO, 1999, PSYCHOL BULL, V125, P507, DOI 10.1037/0033-2909.125.5.507; Loewenstein RJ., 2007, TRAUMATIC DISSOCIATI, P275; Mai J.K., 1997, ATLAS HUMAN BRAIN; Merckelbach H, 2000, J NERV MENT DIS, V188, P428, DOI 10.1097/00005053-200007000-00006; Merckelbach H, 2006, PERS INDIV DIFFER, V40, P365, DOI 10.1016/j.paid.2005.07.007; Merckelbach H, 2001, PERS INDIV DIFFER, V31, P987, DOI 10.1016/S0191-8869(00)00201-4; Merckelbach H, 2002, CLIN PSYCHOL REV, V22, P481, DOI 10.1016/S0272-7358(01)00115-5; Merckelbach H, 2001, BEHAV RES THER, V39, P245, DOI 10.1016/S0005-7967(99)00181-3; Merskey H, 2009, REMOVING DID MPD DSM; Nijenhuis ERS, 2011, DISSOCIATION AND THE DISSOCIATIVE DISORDERS: DSM-V AND BEYOND, P337; Nijenhuis ERS, 2011, J TRAUMA DISSOCIATIO, V12, P416, DOI 10.1080/15299732.2011.570592; Nijenhuis ERS, 1998, J TRAUMA STRESS, V11, P243, DOI 10.1023/A:1024447003022; Nijenhuis ERS, 1996, J NERV MENT DIS, V184, P688, DOI 10.1097/00005053-199611000-00006; Nijenhuis ERS, 1998, J ABNORM PSYCHOL, V107, P63, DOI 10.1037/0021-843X.107.1.63; Nijenhuis ERS, 2004, AUST NZ J PSYCHIAT, V38, P678, DOI 10.1080/j.1440-1614.2004.01441.x; Nijenhuis ERS, 2002, CLIN PSYCHOL PSYCHOT, V9, P200, DOI 10.1002/cpp.332; Nijenhuis ERS, 1997, ACTA PSYCHIAT SCAND, V96, P311, DOI 10.1111/j.1600-0447.1997.tb09922.x; O'Neil, 2009, DISSOCIATION DISSOCI; Pavani F, 2003, TRENDS COGN SCI, V7, P407, DOI 10.1016/S1364-6613(03)00189-X; Piper A, 2005, CAN J PSYCHIAT, V50, P814, DOI 10.1177/070674370505001220; Piper A, 2004, CAN J PSYCHIAT, V49, P678, DOI 10.1177/070674370404901005; Piper A, 2004, CAN J PSYCHIAT, V49, P592, DOI 10.1177/070674370404900904; Pope HG, 2006, PSYCHOTHER PSYCHOSOM, V75, P19, DOI 10.1159/000089223; Poulsen B. C., 2003, CONT HYPNOSIS, V20, P198, DOI DOI 10.1002/CH.278; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Price CJ, 1997, HUM BRAIN MAPP, V5, P264, DOI 10.1002/(SICI)1097-0193(1997)5:4<264::AID-HBM11>3.0.CO;2-E; PUTNAM FW, 1992, BRIT J PSYCHIAT, V161, P415, DOI 10.1192/bjp.161.3.415b; Rassin E, 2001, J NERV MENT DIS, V189, P478, DOI 10.1097/00005053-200107000-00010; RAUSCHENBERGER SL, 1995, J ABNORM PSYCHOL, V104, P373, DOI 10.1037/0021-843X.104.2.373; Reinders AATS, 2008, NEUROCASE, V14, P44, DOI 10.1080/13554790801992768; Reinders AATS, 2006, BIOL PSYCHIAT, V60, P730, DOI 10.1016/j.biopsych.2005.12.019; Reinders AATS, 2005, EUR J NEUROSCI, V22, P524, DOI 10.1111/j.1460-9568.2005.04212.x; Reinders AATS, 2003, NEUROIMAGE, V20, P2119, DOI 10.1016/j.neuroimage.2003.08.021; Reinders AATS, 2002, NEUROIMAGE, V17, P1844, DOI 10.1006/nimg.2002.1318; Sar V, 2001, J TRAUMA DISSOCIATIO, V1, P67, DOI DOI 10.1300/J229v01n04_04; Sar V, 2005, CAN J PSYCHIAT, V50, P813, DOI 10.1177/070674370505001218; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; SILVA CE, 1992, J PERS SOC PSYCHOL, V63, P847, DOI 10.1037/0022-3514.63.5.847; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Spanos N.P., 1996, MULTIPLE IDENTITIES; SPANOS NP, 1994, PSYCHOL BULL, V116, P143, DOI 10.1037/0033-2909.116.1.143; Spiegel D, 2006, AM J PSYCHIAT, V163, P566, DOI 10.1176/appi.ajp.163.4.566; SPIEGEL D, 1984, PSYCHIAT CLIN N AM, V7, P101; Steinberg M, 1993, STRUCTURED CLIN INTE; Talairach J., 1988, COPLANAR STEREOTAXIC; van der Hart O, 2006, HAUNTED SELF STRUCTU; White NM, 2009, BEHAV BRAIN RES, V199, P3, DOI 10.1016/j.bbr.2008.12.003; Xiao ZP, 2006, AM J PSYCHIAT, V163, P1388, DOI 10.1176/appi.ajp.163.8.1388; [No title captured]	91	54	54	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39279	10.1371/journal.pone.0039279	http://dx.doi.org/10.1371/journal.pone.0039279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768068	gold, Green Published			2022-12-25	WOS:000305892100039
J	Sawitzky, M; Zeissler, A; Langhammer, M; Bielohuby, M; Stock, P; Hammon, HM; Gors, S; Metges, CC; Stoehr, BJM; Bidlingmaier, M; Fromm-Dornieden, C; Baumgartner, BG; Christ, B; Brenig, B; Binder, G; Metzger, F; Renne, U; Hoeflich, A				Sawitzky, Mandy; Zeissler, Anja; Langhammer, Martina; Bielohuby, Maximilian; Stock, Peggy; Hammon, Harald M.; Goers, Solvig; Metges, Cornelia C.; Stoehr, Barbara J. M.; Bidlingmaier, Martin; Fromm-Dornieden, Carolin; Baumgartner, Bernhard G.; Christ, Bruno; Brenig, Bertram; Binder, Gerhard; Metzger, Friedrich; Renne, Ulla; Hoeflich, Andreas			Phenotype Selection Reveals Coevolution of Muscle Glycogen and Protein and PTEN as a Gate Keeper for the Accretion of Muscle Mass in Adult Female Mice	PLOS ONE			English	Article							LONG-TERM SELECTION; BREAST-CANCER CELLS; GROWTH FACTOR-I; STRAIN FZT-DU; KINASE-B; SYNTHASE KINASE-3; IGF-II; MYOTUBE HYPERTROPHY; SKELETAL; AKT	We have investigated molecular mechanisms for muscle mass accretion in a non-inbred mouse model (DU6P mice) characterized by extreme muscle mass. This extreme muscle mass was developed during 138 generations of phenotype selection for high protein content. Due to the repeated trait selection a complex setting of different mechanisms was expected to be enriched during the selection experiment. In muscle from 29-week female DU6P mice we have identified robust increases of protein kinase B activation (AKT, Ser-473, up to 2-fold) if compared to 11- and 54-week DU6P mice or controls. While a number of accepted effectors of AKT activation, including IGF-I, IGF-II, insulin/IGF-receptor, myostatin or integrin-linked kinase (ILK), were not correlated with this increase, phosphatase and tensin homologue deleted on chromosome 10 (PTEN) was down-regulated in 29-week female DU6P mice. In addition, higher levels of PTEN phosphorylation were found identifying a second mechanism of PTEN inhibition. Inhibition of PTEN and activation of AKT correlated with specific activation of p70S6 kinase and ribosomal protein S6, reduced phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha) and higher rates of protein synthesis in 29-week female DU6P mice. On the other hand, AKT activation also translated into specific inactivation of glycogen synthase kinase 3 beta (GSK3 beta) and an increase of muscular glycogen. In muscles from 29-week female DU6P mice a significant increase of protein/DNA was identified, which was not due to a reduction of protein breakdown or to specific increases of translation initiation. Instead our data support the conclusion that a higher rate of protein translation is contributing to the higher muscle mass in mid-aged female DU6P mice. Our results further reveal coevolution of high protein and high glycogen content during the selection experiment and identify PTEN as gate keeper for muscle mass in mid-aged female DU6P mice.	[Sawitzky, Mandy; Zeissler, Anja; Langhammer, Martina; Renne, Ulla; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol FBN, Lab Mouse Genet Res Unit Genet & Biometry, Dummerstorf, Germany; [Bielohuby, Maximilian; Stoehr, Barbara J. M.; Bidlingmaier, Martin] Univ Munich, Endocrine Res Unit, Med Klin, Munich, Germany; [Bielohuby, Maximilian; Stoehr, Barbara J. M.; Bidlingmaier, Martin] Univ Munich, Poliklin 4, Munich, Germany; [Stock, Peggy; Christ, Bruno] Univ Halle Wittenberg, ZAMED, Halle, Germany; [Hammon, Harald M.; Goers, Solvig; Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol, Dummerstorf, Germany; [Fromm-Dornieden, Carolin; Baumgartner, Bernhard G.; Brenig, Bertram] Inst Vet Med, Gottingen, Germany; [Binder, Gerhard] Univ Childrens Hosp, Tubingen, Germany; [Metzger, Friedrich] F Hoffmann La Roche Ltd, CNS Discovery Res, Basel, Switzerland	Forschungsinstitut fur Nutztierbiologie (FBN); University of Munich; University of Munich; Martin Luther University Halle Wittenberg; Forschungsinstitut fur Nutztierbiologie (FBN); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Roche Holding	Sawitzky, M (corresponding author), Leibniz Inst Farm Anim Biol FBN, Lab Mouse Genet Res Unit Genet & Biometry, Dummerstorf, Germany.	hoeflich@fbn-dummerstorf.de	Hammon, Harald/AAD-9990-2020; Bielohuby, Maximilian/A-2304-2015	Bielohuby, Maximilian/0000-0002-9859-8156; Christ, Bruno/0000-0001-8213-9548; Brenig, Bertram/0000-0002-7635-9656; Hoeflich, Andreas/0000-0003-2018-2836; Bidlingmaier, Martin/0000-0002-4681-6668; Stock, Peggy/0000-0002-9208-8411	H. Wilhelm Schaumann Foundation; Eli Lilly Foundation; German Research Council (DFG)	H. Wilhelm Schaumann Foundation; Eli Lilly Foundation(Eli Lilly); German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the H. Wilhelm Schaumann Foundation, Eli Lilly Foundation, and by the German Research Council (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Bielohuby M, 2009, ENDOCRINOLOGY, V150, P1269, DOI 10.1210/en.2008-1055; Binder G, 2006, J CLIN ENDOCR METAB, V91, P4709, DOI 10.1210/jc.2006-1127; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Boppart MD, 2011, BBA-MOL BASIS DIS, V1812, P439, DOI 10.1016/j.bbadis.2011.01.002; Bunger L, 1998, GENET RES, V72, P93, DOI 10.1017/S0016672398003401; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cassano M, 2009, J MUSCLE RES CELL M, V30, P243, DOI 10.1007/s10974-010-9204-y; Cid VJ, 2008, ONCOGENE, V27, P5431, DOI 10.1038/onc.2008.240; Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dietl G, 2004, ARCH TIERZUCHT, V47, P595, DOI 10.5194/aab-47-595-2004; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gardner S, 2011, MOL ENDOCRINOL, V25, P128, DOI 10.1210/me.2010-0292; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hamilton DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011624; Hoeflich A, 2002, FEBS LETT, V523, P63, DOI 10.1016/S0014-5793(02)02935-6; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kromer JO, 2005, ANAL BIOCHEM, V340, P171, DOI 10.1016/j.ab.2005.01.027; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Liao Y, 2010, AM J TRANSL RES, V2, P19; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P433, DOI 10.1210/endo-123-1-433; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendez R, 1996, FASEB J, V10, P1378; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Morris DR, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-215; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Parent R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r19; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; REHFELDT C, 1990, ARCH TIERZUCHT, V33, P507; Renne U, 2003, J EXP ANIM SCI, V42, P218, DOI 10.1016/S0939-8600(03)80004-4; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHULER L, 1985, ARCH TIERZUCHT, V28, P357; Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wan XL, 2003, ONCOGENE, V22, P8205, DOI 10.1038/sj.onc.1206878; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Xu Z, 2003, BIOCHEM BIOPH RES CO, V312, P388, DOI 10.1016/j.bbrc.2003.10.130; Zhang Y, 2010, DEV GROWTH DIFFER, V52, P725, DOI 10.1111/j.1440-169X.2010.01209.x	63	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39711	10.1371/journal.pone.0039711	http://dx.doi.org/10.1371/journal.pone.0039711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768110	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100080
J	Strasser, K; Bloomfield, G; MacWilliams, A; Ceccarelli, A; MacWilliams, H; Tsang, A				Strasser, Kimchi; Bloomfield, Gareth; MacWilliams, Asa; Ceccarelli, Adriano; MacWilliams, Harry; Tsang, Adrian			A Retinoblastoma Orthologue Is a Major Regulator of S-Phase, Mitotic, and Developmental Gene Expression in Dictyostelium	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-REPLICATION; TRANSCRIPTIONAL REPRESSION; PHYSARUM POLYCEPHALUM; SLIME MOLD; DISCOIDEUM; CANCER; DIFFERENTIATION; PROTEINS; E2F	Background: The retinoblastoma tumour suppressor, Rb, has two major functions. First, it represses genes whose products are required for S-phase entry and progression thus stabilizing cells in G1. Second, Rb interacts with factors that induce cell-cycle exit and terminal differentiation. Dictyostelium lacks a G1 phase in its cell cycle but it has a retinoblastoma orthologue, rblA. Methodology/Principal Findings: Using microarray analysis and mRNA-Seq transcriptional profiling, we show that RblA strongly represses genes whose products are involved in S phase and mitosis. Both S-phase and mitotic genes are upregulated at a single point in late G2 and again in mid-development, near the time when cell cycling is reactivated. RblA also activates a set of genes unique to slime moulds that function in terminal differentiation. Conclusions: Like its mammalian counterpart Dictyostelium, RblA plays a dual role, regulating cell-cycle progression and transcriptional events leading to terminal differentiation. In the absence of a G1 phase, however, RblA functions in late G2 controlling the expression of both S-phase and mitotic genes.	[Strasser, Kimchi; Tsang, Adrian] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Strasser, Kimchi; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Bloomfield, Gareth] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Bloomfield, Gareth] Wellcome Trust Sanger Inst, Hinxton, S Cambs, England; [MacWilliams, Asa] Siemens Corp Technol, Munich, Germany; [Ceccarelli, Adriano] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy; [MacWilliams, Harry] Univ Munich, Biozentrum, Munich, Germany	Concordia University - Canada; Concordia University - Canada; MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; Siemens AG; Siemens Germany; University of Turin; University of Munich	Strasser, K (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	kimchi@gene.concordia.ca		Bloomfield, Gareth/0000-0003-4269-8059	Natural Sciences and Engineering Research Council of Canada; MRC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Charles David, John Bonner, Richard Kessin, and John Stiller for helpful comments on the manuscript, and are especially grateful to the DictyBase team for support in all aspects of this project. HKM thanks his colleagues Angelika Boettger and Heinrich Leonhardt for encouragement and Dietfried Molter for IT expertise; he is particularly indebted to Barbara Goldstein-Muller whose intervention at a crucial juncture made it possible for him to complete this work. KS thanks Vineet Dua for preparing RNA from the cell-cycle experiment, Nadeeza Ismael for coordinating sample shipment, Marc Champagne for sharing his knowledge on qPCR, and Ian Reid for handling the sequence submission. GB wishes to thank Rob Kay and Al Ivens for their support, and Jason Skelton and the rest of the Sanger Pathogen Microarrays group for help with the array experiment.; This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada, http://NSERC.ca. GB was supported by MRC core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAND RN, 1973, J PROTOZOOL, V20, P654, DOI 10.1111/j.1550-7408.1973.tb03592.x; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Bonner JT, 1952, J EXPT ZOOLOGY, P561; BRAUN R, 1965, P NATL ACAD SCI USA, V53, P924, DOI 10.1073/pnas.53.5.924; Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Date DA, 2007, CELL BIOL INT, V31, P1470, DOI 10.1016/j.cellbi.2007.06.013; de Jager SM, 2009, PLANT MOL BIOL, V71, P345, DOI 10.1007/s11103-009-9527-5; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; DURSTON AJ, 1978, EXP CELL RES, V115, P454, DOI 10.1016/0014-4827(78)90308-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escalante R, 2004, EUKARYOT CELL, V3, P564, DOI 10.1128/EC.3.2.564-566.2004; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gaudet P, 2011, NUCLEIC ACIDS RES, V39, pD620, DOI 10.1093/nar/gkq1103; Hallows JL, 1998, J NEUROSCI, V18, P5682; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; JANTZEN H, 1988, J CELL SCI, V91, P389; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; KESSLER D, 1967, EXP CELL RES, V45, P676, DOI 10.1016/0014-4827(67)90170-X; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Kollmar M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-47; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Li H, 2008, EUKARYOT CELL, V7, P894, DOI 10.1128/EC.00422-07; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MacWilliams H, 2006, DEVELOPMENT, V133, P1287, DOI 10.1242/dev.02287; MacWilliams H, 2001, DIFFERENTIATION, V67, P12, DOI 10.1046/j.1432-0436.2001.067001012.x; Maeda Y, 1986, J GEN MICROBIOL, P1189; Magyar Z, 2000, FEBS LETT, V486, P79, DOI 10.1016/S0014-5793(00)02238-9; Markey MP, 2002, CANCER RES, V62, P6587; Miyagishima SY, 2008, P NATL ACAD SCI USA, V105, P15202, DOI 10.1073/pnas.0802412105; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Nag Dilip K, 2008, BMC Cell Biol, V9, P21, DOI 10.1186/1471-2121-9-21; NYGAARD OF, 1960, BIOCHIM BIOPHYS ACTA, V38, P298, DOI 10.1016/0006-3002(60)91245-2; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Ramirez-Parra E, 2003, PLANT J, V33, P801, DOI 10.1046/j.1365-313X.2003.01662.x; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeki M, 2006, BIOCHEM BIOPH RES CO, V342, P568, DOI 10.1016/j.bbrc.2006.02.009; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Vicente JJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-1; WEIJER CJ, 1984, J CELL SCI, V70, P111; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; ZADAHAMES IM, 1978, J CELL SCI, V32, P1; ZADAHAMES IM, 1978, DEV BIOL, V63, P307, DOI 10.1016/0012-1606(78)90136-7; ZIMMERMAN W, 1993, DEV BIOL, V160, P178, DOI 10.1006/dbio.1993.1296	64	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39914	10.1371/journal.pone.0039914	http://dx.doi.org/10.1371/journal.pone.0039914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768168	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100137
J	Uhalte, EC; Kirchner, M; Hellwig, N; Allen, JJ; Donat, S; Shokat, KM; Selbach, M; Abdelilah-Seyfried, S				Uhalte, Elena Cibrian; Kirchner, Marieluise; Hellwig, Nicole; Allen, Jasmina J.; Donat, Stefan; Shokat, Kevan M.; Selbach, Matthias; Abdelilah-Seyfried, Salim			In Vivo Conditions to Identify Prkci Phosphorylation Targets Using the Analog-Sensitive Kinase Method in Zebrafish	PLOS ONE			English	Article							CELL POLARITY; EPITHELIAL POLARITY; APKC; COMPLEX; MORPHOGENESIS; HEART; PAR-3; MECHANISMS; DIVISION; POSITION	Protein kinase C iota is required for various cell biological processes including epithelial tissue polarity and organ morphogenesis. To gain mechanistic insight into different roles of this kinase, it is essential to identify specific substrate proteins in their cellular context. The analog-sensitive kinase method provides a powerful tool for the identification of kinase substrates under in vivo conditions. However, it has remained a major challenge to establish screens based on this method in multicellular model organisms. Here, we report the methodology for in vivo conditions using the analog-sensitive kinase method in a genetically-tractable vertebrate model organism, the zebrafish. With this approach, kinase substrates can uniquely be labeled in the developing zebrafish embryo using bulky ATP gamma S analogs which results in the thiophosphorylation of substrates. The labeling of kinase substrates with a thiophosphoester epitope differs from phosphoesters that are generated by all other kinases and allows for an enrichment of thiophosphopeptides by immunoaffinity purification. This study provides the foundation for using the analog-sensitive kinase method in the context of complex vertebrate development, physiology, or disease.	[Uhalte, Elena Cibrian; Kirchner, Marieluise; Hellwig, Nicole; Donat, Stefan; Selbach, Matthias; Abdelilah-Seyfried, Salim] Max Delbruck Ctr Mol Med, Berlin, Germany; [Allen, Jasmina J.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Allen, Jasmina J.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Uhalte, EC (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge, England.	seyfried@mdc-berlin.de	Selbach, Matthias/C-5988-2008	Donat, Stefan/0000-0003-3901-3733; Cibrian Uhalte, Elena/0000-0002-0987-9862	Deutsche Forschungsgemeinschaft (DFG) [SE106/5-1]; Helmholtz Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Society(Helmholtz Association)	S.A.-S. is supported by a Heisenberg fellowship of the Deutsche Forschungsgemeinschaft (DFG). This work was supported by DFG grant SE106/5-1 and a Helmholtz Society re-entry grant to N.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Bakkers J, 2009, DEV BIOL, V330, P213, DOI 10.1016/j.ydbio.2009.04.011; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Cravatt BF, 2005, NAT METHODS, V2, P411, DOI 10.1038/nmeth0605-411; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Galli M, 2011, NAT CELL BIOL, V13, P1132, DOI 10.1038/ncb2315; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Rohr S, 2006, DEVELOPMENT, V133, P107, DOI 10.1242/dev.02182; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Westerfield M, 1994, ZEBRAFISH BOOK; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	36	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40000	10.1371/journal.pone.0040000	http://dx.doi.org/10.1371/journal.pone.0040000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768194	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100166
J	Wada, M; Takano, K; Ikegami, S; Ora, H; Spence, C; Kansaku, K				Wada, Makoto; Takano, Kouji; Ikegami, Shiro; Ora, Hiroki; Spence, Charles; Kansaku, Kenji			Spatio-Temporal Updating in the Left Posterior Parietal Cortex	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENT; EVENT-RELATED FMRI; PERCEPTION; HANDEDNESS; LOBE; HAND; JUNCTION; PATHWAY; POSTURE; BODY	Adopting an unusual posture can sometimes give rise to paradoxical experiences. For example, the subjective ordering of successive unseen tactile stimuli delivered to the two arms can be affected when people cross them. A growing body of evidence now highlights the role played by the parietal cortex in spatio-temporal information processing when sensory stimuli are delivered to the body or when actions are executed; however, little is known about the neural basis of such paradoxical feelings resulting from such unusual limb positions. Here, we demonstrate increased fMRI activation in the left posterior parietal cortex when human participants adopted a crossed hands posture with their eyes closed. Furthermore, by assessing tactile temporal order judgments (TOJs) in the same individuals, we observed a positive association between activity in this area and the degree of reversal in TOJs resulting from crossing arms. The strongest positive association was observed in the left intraparietal sulcus. This result implies that the left posterior parietal cortex may be critically involved in monitoring limb position and in spatio-temporal binding when serial events are delivered to the limbs.	[Wada, Makoto; Takano, Kouji; Ikegami, Shiro; Ora, Hiroki; Kansaku, Kenji] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Brain Funct, Syst Neurosci Sect, Tokorozawa, Saitama, Japan; [Spence, Charles] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	University of Oxford	Wada, M (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Brain Funct, Syst Neurosci Sect, Tokorozawa, Saitama, Japan.	kansaku-kenji@rehab.go.jp	Ora, Hiroki/B-2407-2008; Ikegami, Shiro/GLS-7614-2022	Ora, Hiroki/0000-0001-8393-8982; 	Ministry of Education, Culture, Sports Science and Technology (MEXT) [21650062, 23300151]	Ministry of Education, Culture, Sports Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by Ministry of Education, Culture, Sports Science and Technology (MEXT) grants (#21650062 and #23300151) to K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bohlhalter S, 2009, CEREB CORTEX, V19, P1256, DOI 10.1093/cercor/bhn168; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Cadieux ML, 2010, EXP BRAIN RES, V204, P431, DOI 10.1007/s00221-010-2268-5; Davis B, 2009, J NEUROSCI, V29, P3182, DOI 10.1523/JNEUROSCI.5793-08.2009; Desmurget M, 2001, J NEUROSCI, V21, P2919, DOI 10.1523/JNEUROSCI.21-08-02919.2001; EFRON R, 1963, BRAIN, V86, P261, DOI 10.1093/brain/86.2.261; Fridman EA, 2006, NEUROIMAGE, V29, P417, DOI 10.1016/j.neuroimage.2005.07.026; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jacquin-Ciourtois S, 2011, SYSTEMS NEUROSCIENCE AND REHABILITATION, P81, DOI 10.1007/978-4-431-54008-3_6; Kitazawa S, 2007, REVERSAL SUBJECTIVE; Kroliczak G, 2009, CEREB CORTEX, V19, P2396, DOI 10.1093/cercor/bhn261; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Rusconi E, 2010, BRAIN, V133, P320, DOI 10.1093/brain/awp281; Rusconi E, 2009, ANN NEUROL, V66, P654, DOI 10.1002/ana.21776; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; SIRIGU A, 1995, CORTEX, V31, P41, DOI 10.1016/S0010-9452(13)80104-9; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Spierer L, 2009, J NEUROSCI, V29, P8630, DOI 10.1523/JNEUROSCI.2111-09.2009; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Woo SH, 2009, BRAIN COGNITION, V69, P337, DOI 10.1016/j.bandc.2008.08.006; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	30	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39800	10.1371/journal.pone.0039800	http://dx.doi.org/10.1371/journal.pone.0039800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768126	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100096
J	Karan, R; DeLeon, T; Biradar, H; Subudhi, PK				Karan, Ratna; DeLeon, Teresa; Biradar, Hanamareddy; Subudhi, Prasanta K.			Salt Stress Induced Variation in DNA Methylation Pattern and Its Influence on Gene Expression in Contrasting Rice Genotypes	PLOS ONE			English	Article							ORYZA-SATIVA L.; CYTOSINE METHYLATION; ARABIDOPSIS-THALIANA; ENVIRONMENTAL-STRESS; PLANTS; TOLERANCE; STAGE; POLYMORPHISMS; DEMETHYLATION; TRANSCRIPTION	Background: Salinity is a major environmental factor limiting productivity of crop plants including rice in which wide range of natural variability exists. Although recent evidences implicate epigenetic mechanisms for modulating the gene expression in plants under environmental stresses, epigenetic changes and their functional consequences under salinity stress in rice are underexplored. DNA methylation is one of the epigenetic mechanisms regulating gene expression in plant's responses to environmental stresses. Better understanding of epigenetic regulation of plant growth and response to environmental stresses may create novel heritable variation for crop improvement. Methodology/Principal Findings: Methylation sensitive amplification polymorphism (MSAP) technique was used to assess the effect of salt stress on extent and patterns of DNA methylation in four genotypes of rice differing in the degree of salinity tolerance. Overall, the amount of DNA methylation was more in shoot compared to root and the contribution of fully methylated loci was always more than hemi-methylated loci. Sequencing of ten randomly selected MSAP fragments indicated gene-body specific DNA methylation of retrotransposons, stress responsive genes, and chromatin modification genes, distributed on different rice chromosomes. Bisulphite sequencing and quantitative RT-PCR analysis of selected MSAP loci showed that cytosine methylation changes under salinity as well as gene expression varied with genotypes and tissue types irrespective of the level of salinity tolerance of rice genotypes. Conclusions/Significance: The gene body methylation may have an important role in regulating gene expression in organ and genotype specific manner under salinity stress. Association between salt tolerance and methylation changes observed in some cases suggested that many methylation changes are not "directed''. The natural genetic variation for salt tolerance observed in rice germplasm may be independent of the extent and pattern of DNA methylation which may have been induced by abiotic stress followed by accumulation through the natural selection process.	[Karan, Ratna; DeLeon, Teresa; Biradar, Hanamareddy; Subudhi, Prasanta K.] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Karan, R (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	psubudhi@agcenter.lsu.edu		Karan, Ratna/0000-0002-1737-2682	United States Department of Agriculture-CSREES; Louisiana Rice Research Board	United States Department of Agriculture-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Louisiana Rice Research Board	United States Department of Agriculture-CSREES and Louisiana Rice Research Board funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Berken A, 2006, CELL MOL LIFE SCI, V63, P2446, DOI 10.1007/s00018-006-6197-1; Berr A, 2009, PLANT PHYSIOL, V151, P1476, DOI 10.1104/pp.109.143941; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Karan R, 2009, FUNCT INTEGR GENOMIC, V9, P411, DOI 10.1007/s10142-009-0119-x; Kashkush K, 2007, GENETICS, V177, P1975, DOI 10.1534/genetics.107.080234; Kim J, 2002, PLANT PHYSIOL, V128, P95, DOI 10.1104/pp.101801; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Kurek I, 1999, PLANT PHYSIOL, V119, P693, DOI 10.1104/pp.119.2.693; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lee KS, 2003, PLANTA, V216, P1043, DOI 10.1007/s00425-002-0958-3; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; MURRAY HG, 1980, NUCLEIC ACIDS RES, V8, P4321; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Subudhi PK, 1998, THEOR APPL GENET, V96, P941, DOI 10.1007/s001220050824; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takata M, 2005, BREEDING SCI, V55, P57, DOI 10.1270/jsbbs.55.57; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Yan HH, 2010, PLANT J, V63, P353, DOI 10.1111/j.1365-313X.2010.04246.x; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zemach A, 2007, TRENDS PLANT SCI, V12, P80, DOI 10.1016/j.tplants.2006.12.004; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong L, 2009, AFR J BIOTECHNOL, V8, P6201; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	51	184	203	11	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40203	10.1371/journal.pone.0040203	http://dx.doi.org/10.1371/journal.pone.0040203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761959	gold, Green Submitted, Green Published			2022-12-25	WOS:000305826400060
J	Sanz-Ramos, M; Rodriguez-Calvo, T; Sevilla, N				Sanz-Ramos, Marta; Rodriguez-Calvo, Teresa; Sevilla, Noemi			Mutagenesis-Mediated Decrease of Pathogenicity as a Feature of the Mutant Spectrum of a Viral Population	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOTIDE-SEQUENCE HETEROGENEITY; DEPENDENT RNA-POLYMERASE; LETHAL MUTAGENESIS; ERROR CATASTROPHE; RIBAVIRIN; FITNESS; REPLICATION; POLIOVIRUS	Background: RNA virus populations are heterogeneous ensembles of closely related genomes termed quasispecies. This highly complex distribution of variants confers important properties to RNA viruses and influences their pathogenic behavior. It has been hypothesized that increased mutagenesis of viral populations, by treatment with mutagenic agents, can induce alterations in the pathogenic potential of a virus population. In this work we investigate whether mutagenized foot-and-mouth disease virus (FMDV) populations display changes in their virulence in mice. Methodology and Principal Findings: FMDV C-S8c1 was passaged in BHK cells in the presence of the mutagenic agent ribavirin. Decline in viral titer and viral RNA progeny was observed in the first passage, fluctuating around a constant value thereafter. Hence, the specific infectivity remained stable during the passages. The viral population harvested from passage 9 (P9 R) showed decreased virulence in mice, with a lethal dose 50 (LD50) > 10(4) PFU, as compared with LD50 of 50 PFU of the parental population FMDV C-S8c1. This decrease in virulence was associated to a 20-fold increase in the mutation frequency of the P9 R population with respect to C-S8c1. Interestingly, individual biological clones isolated from the attenuated population P9 R were as virulent as the parental virus C-S8c1. Furthermore, a mixed population of C-S8c1 and P9 R was inoculated into mice and showed decreased virulence as compared to C-S8c1, suggesting that population P9 R is able to suppress the virulent phenotype of C-S8c1. Conclusion: Ribavirin-mediated mutagenesis of an FMDV population resulted in attenuation in vivo, albeit a large proportion of its biological clones displayed a highly virulent phenotype. These results, together with the suppression of C-S8c1 by mutagenized P9 R population, document a suppressive effect of mutagenized viral quasispecies in vivo, and suggest novel approaches to the treatment and prevention of viral diseases.	[Sanz-Ramos, Marta; Rodriguez-Calvo, Teresa; Sevilla, Noemi] INIA, CISA, Madrid, Spain; [Sanz-Ramos, Marta] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz-Ramos, M (corresponding author), Natl Inst Med Res, Div Virol, London NW7 1AA, England.	sevilla@inia.es	Sevilla, Noemi/K-8648-2014; Rodriguez-Calvo, Teresa/AAH-2365-2019	Sevilla, Noemi/0000-0003-0118-0376; 	CISA-INIA Centro de Investigacion en Sanidad Animal from Ministerio de Ciencia e Innovacion (MCINN) [AGL2007-61374, AGL2009-07353]; Activities 7th EU program [228394-NADIR-Integrating]; CBMSO Centro de Biologia Molecular from Ministerio de Ciencia e Innovacion and Fundacion R. Areces [BFU2008-02816/BMC]	CISA-INIA Centro de Investigacion en Sanidad Animal from Ministerio de Ciencia e Innovacion (MCINN); Activities 7th EU program; CBMSO Centro de Biologia Molecular from Ministerio de Ciencia e Innovacion and Fundacion R. Areces	Work at CISA-INIA Centro de Investigacion en Sanidad Animal was supported by grants AGL2007-61374 and AGL2009-07353 from Ministerio de Ciencia e Innovacion (MCINN) and 228394-NADIR-Integrating Activities 7th EU program. Work at CBMSO Centro de Biologia Molecular was supported by grants BFU2008-02816/BMC from Ministerio de Ciencia e Innovacion and Fundacion R. Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Arias A, 2005, J MOL BIOL, V353, P1021, DOI 10.1016/j.jmb.2005.09.022; Arias A, 2001, J GEN VIROL, V82, P1049, DOI 10.1099/0022-1317-82-5-1049; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; BORREGO B, 1993, J VIROL, V67, P6071, DOI 10.1128/JVI.67.10.6071-6079.1993; CHUMAKOV KM, 1991, P NATL ACAD SCI USA, V88, P199, DOI 10.1073/pnas.88.1.199; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crowder S, 2005, NAT GENET, V37, P701, DOI 10.1038/ng1583; DELATORRE JC, 1990, J VIROL, V64, P6278, DOI 10.1128/JVI.64.12.6278-6281.1990; Domingo E, 2005, VIRUS RES, V107, P115, DOI 10.1016/j.virusres.2004.11.001; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; DOMINGO E, 1980, GENE, V11, P333, DOI 10.1016/0378-1119(80)90073-6; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P87, DOI 10.1016/B978-0-12-374153-0.00004-7; DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; Eigen M, 1988, RNA GENETICS, V3; Eigen M, 1979, THE HYPERCYCLE, P60; Escarmis C, 1999, J MOL BIOL, V285, P495, DOI 10.1006/jmbi.1998.2366; Escarmis C, 2008, J MOL BIOL, V376, P367, DOI 10.1016/j.jmb.2007.11.042; Ferrer-Orta C, 2010, J VIROL, V84, P6188, DOI 10.1128/JVI.02420-09; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Gonzalez-Lopez Claudia, 2005, Infection Genetics and Evolution, V5, P366, DOI 10.1016/j.meegid.2005.05.001; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Harris KS, 2005, ANTIVIR RES, V67, P1, DOI 10.1016/j.antiviral.2005.03.004; Lancaster KZ, 2011, J VIROL, V85, P9778, DOI 10.1128/JVI.00355-11; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mahy BWJ, 2005, CURR TOP MICROBIOL, V288, P1; Martin V, 2010, J GEN VIROL, V91, P990, DOI 10.1099/vir.0.017053-0; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; Moreno H, 2011, J VIROL, V85, P7246, DOI 10.1128/JVI.00614-11; Ojosnegros S, 2010, P NATL ACAD SCI USA, V107, P2108, DOI 10.1073/pnas.0909787107; Ojosnegros S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-207; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; Pawlotsky JM, 1998, J MED VIROL, V54, P256, DOI 10.1002/(SICI)1096-9071(199804)54:4<256::AID-JMV4>3.3.CO;2-K; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perales C, 2010, FUTURE VIROL, V5, P679, DOI 10.2217/FVL.10.61; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; Pfeiffer JK, 2006, P NATL ACAD SCI USA, V103, P5520, DOI 10.1073/pnas.0600834103; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Rowlands DJ, 2003, VIRUS RES, V91, P1, DOI 10.1016/S0168-1702(02)00264-2; Salguero FJ, 2005, VIROLOGY, V332, P384, DOI 10.1016/j.virol.2004.11.005; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; SOBRINO F, 2004, FOOT AND MOUTH DIS C; Teng MN, 1996, J VIROL, V70, P8438, DOI 10.1128/JVI.70.12.8438-8443.1996; Toja M, 1999, VIRUS RES, V64, P161, DOI 10.1016/S0168-1702(99)00089-1; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Vignuzzi M, 2010, PICORNAVIRU IN PRESS; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Volkenstein MV., 1994, PHYS APPROACHES BIOL, DOI [10.1007/978-3-642-78788-1, DOI 10.1007/978-3-642-78788-1]	64	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39941	10.1371/journal.pone.0039941	http://dx.doi.org/10.1371/journal.pone.0039941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761933	Green Submitted, Green Published, gold			2022-12-25	WOS:000305826400049
J	Zhang, DL; Xiong, W; Chu, S; Sun, C; Albensi, BC; Parkinson, FE				Zhang, Dali; Xiong, Wei; Chu, Stephanie; Sun, Chao; Albensi, Benedict C.; Parkinson, Fiona E.			Inhibition of Hippocampal Synaptic Activity by ATP, Hypoxia or Oxygen-Glucose Deprivation Does Not Require CD73	PLOS ONE			English	Article							ADENOSINE A(1) RECEPTORS; NUCLEOSIDE TRANSPORTER 1; RAT HIPPOCAMPUS; ADENINE-NUCLEOTIDES; ISCHEMIC CONDITIONS; MOUSE NEURONS; AREA CA1; TRANSMISSION; RELEASE; ECTO-5'-NUCLEOTIDASE	Adenosine, through activation of its A(1) receptors, has neuroprotective effects during hypoxia and ischemia. Recently, using transgenic mice with neuronal expression of human equilibrative nucleoside transporter 1 (hENT1), we reported that nucleoside transporter-mediated release of adenosine from neurons was not a key mechanism facilitating the actions of adenosine at A(1) receptors during hypoxia/ischemia. The present study was performed to test the importance of CD73 (ecto-5'-nucleotidase) for basal and hypoxic/ischemic adenosine production. Hippocampal slice electrophysiology was performed with CD73(+/+) and CD73(-/-) mice. Adenosine and ATP had similar inhibitory effects in both genotypes, with IC50 values of approximately 25 mu M. In contrast, ATP was a less potent inhibitor (IC50 = 100 mu M) in slices from mice expressing hENT1 in neurons. The inhibitory effects of ATP in CD73(+/+) and CD73(-/-) slices were blocked by the adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and were enhanced by the nucleoside transport inhibitor S-(4-nitrobenzyl)-6-thioinosine (NBTI), consistent with effects that are mediated by adenosine after metabolism of ATP. AMP showed a similar inhibitory effect to ATP and adenosine, indicating that the response to ATP was not mediated by P2 receptors. In comparing CD73(-/-) and CD73(+/+) slices, hypoxia and oxygen-glucose deprivation produced similar depression of synaptic transmission in both genotypes. An inhibitor of tissue non-specific alkaline phosphatase (TNAP) was found to attenuate the inhibitory effects of AMP and ATP, increase basal synaptic activity and reduce responses to oxygen-glucose deprivation selectively in slices from CD73(-/-) mice. These results do not support an important role for CD73 in the formation of adenosine in the CA1 area of the hippocampus during basal, hypoxic or ischemic conditions, but instead point to TNAP as a potential source of extracellular adenosine when CD73 is absent.	[Zhang, Dali; Xiong, Wei; Chu, Stephanie; Sun, Chao; Albensi, Benedict C.; Parkinson, Fiona E.] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada; [Zhang, Dali; Albensi, Benedict C.] St Boniface Gen Hosp, Res Ctr, Div Neurodegenerat Disorders, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Zhang, DL (corresponding author), Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada.	parkins@cc.umanitoba.ca	Albensi, Benedict Charles/AAJ-2359-2021	Albensi, Benedict Charles/0000-0002-7884-9261	Canadian Institutes for Health Research; Heart and Stroke Foundation of Manitoba; St. Boniface General Hospital Research Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Manitoba; St. Boniface General Hospital Research Foundation	This research was funded by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html), the Heart and Stroke Foundation of Manitoba (http://www.heartandstroke.mb.ca/site/c.lgLSIVOyGpF/b.4951313/k.F6E0/Heart_Disease_Stroke_and_Healthy_Living.htm), and the St. Boniface General Hospital Research Foundation (http://www.stbhf.org/english/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Brust TB, 2006, J NEUROSCI, V26, P12427, DOI 10.1523/JNEUROSCI.4052-06.2006; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Coppi E, 2007, PURINERG SIGNAL, V3, P203, DOI 10.1007/s11302-006-9049-4; Cunha RA, 1996, BRIT J PHARMACOL, V119, P253, DOI 10.1111/j.1476-5381.1996.tb15979.x; Cunha RA, 1998, J NEUROSCI, V18, P1987; CUNHA RA, 1992, J NEUROCHEM, V59, P657, DOI 10.1111/j.1471-4159.1992.tb09420.x; Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s; Diez-Zaera M, 2011, MOL BIOL CELL, V22, P1014, DOI 10.1091/mbc.E10-09-0740; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; GRIBKOFF VK, 1992, J NEUROPHYSIOL, V68, P620, DOI 10.1152/jn.1992.68.2.620; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Klyuch BP, 2011, J PHYSIOL-LONDON, V589, P283, DOI 10.1113/jphysiol.2010.198986; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lucchi R, 1996, BRAIN RES, V732, P261, DOI 10.1016/0006-8993(96)00748-2; Martin ED, 2007, GLIA, V55, P36, DOI 10.1002/glia.20431; Masino SA, 2002, J PHARMACOL EXP THER, V303, P356, DOI 10.1124/jpet.102.036731; Parkinson FE, 2005, NEUROL RES, V27, P153, DOI 10.1179/016164105X21878; Parkinson FE, 2009, J NEUROCHEM, V109, P562, DOI 10.1111/j.1471-4159.2009.05991.x; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pearson T, 2000, EUR J NEUROSCI, V12, P3064, DOI 10.1046/j.1460-9568.2000.00201.x; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; SCHRADER J, 1976, PFLUG ARCH EUR J PHY, V367, P129, DOI 10.1007/BF00585148; Sowa NA, 2010, J NEUROSCI, V30, P2235, DOI 10.1523/JNEUROSCI.5324-09.2010; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Zamzow CR, 2008, J NEUROSCI RES, V86, P2641, DOI 10.1002/jnr.21718; Zernecke A, 2006, CIRCULATION, V113, P2120, DOI 10.1161/CIRCULATIONAHA.105.595249; Zhang DL, 2011, J NEUROCHEM, V118, P4, DOI 10.1111/j.1471-4159.2011.07242.x; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	32	65	67	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39772	10.1371/journal.pone.0039772	http://dx.doi.org/10.1371/journal.pone.0039772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761898	Green Published, Green Submitted, gold			2022-12-25	WOS:000305781700065
J	Alli, AA; Song, JZ; Al-Khalili, O; Bao, HF; Ma, HP; Alli, AA; Eaton, DC				Alli, Abdel A.; Song, John Z.; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Alli, Alia A.; Eaton, Douglas C.			Cathepsin B Is Secreted Apically from Xenopus 2F3 Cells and Cleaves the Epithelial Sodium Channel (ENaC) to Increase Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE RECEPTOR; TUMOR-NECROSIS-FACTOR; LIDDLES-SYNDROME; PLASMA-MEMBRANE; GAMMA-SUBUNIT; PROTEOLYTIC ACTIVATION; CYTOCHROME-C; ION CHANNELS; PROTEASE; APOPTOSIS	The epithelial sodium channel (ENaC) plays an important role in regulating sodium balance, extracellular volume, and blood pressure. Evidence suggests the alpha and gamma subunits of ENaC are cleaved during assembly before they are inserted into the apical membranes of epithelial cells, and maximal activity of ENaC depends on cleavage of the extracellular loops of alpha and gamma subunits. Here, we report that Xenopus 2F3 cells apically express the cysteine protease cathepsin B, as indicated by two-dimensional gel electrophoresis and mass spectrometry analysis. Recombinant GST ENaC alpha, beta, and gamma subunit fusion proteins were expressed in Escherichia coli and then purified and recovered from bacterial inclusion bodies. In vitro cleavage studies revealed the full-length ENaC alpha subunit fusion protein was cleaved by active cathepsin B but not the full-length beta or alpha subunit fusion proteins. Both single channel patch clamp studies and short circuit current experiments show ENaC activity decreases with the application of a cathepsin B inhibitor directly onto the apical side of 2F3 cells. We suggest a role for the proteolytic cleavage of ENaC by cathepsin B, and we suggest two possible mechanisms by which cathepsin B could regulate ENaC. Cathepsin B may cleave ENaC extracellularly after being secreted or intracellularly, while ENaC is present in the Golgi or in recycling endosomes.	Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30345 USA; Ctr Cell & Mol Signaling, Atlanta, GA 30345 USA	Emory University	Alli, AA (corresponding author), Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA.	aalli@emory.edu		Eaton, Douglas/0000-0002-2686-6692	National Institutes of Health [F32 DK093255-01, T32 DK007771, 5R01 DK067110, R37 DK037963]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093255, T32DK007771, R01DK067110, R37DK037963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 DK093255-01 (to Abdel A. Alli), T32 DK007771 (to C. A. Parkos), 5R01 DK067110 (to H.-P. M.), and R37 DK037963 (to D. C. E.).	Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Alli A. A., 2012, AM J PHYSL IN PRESS; Alli AA, 2010, J CELL BIOCHEM, V110, P985, DOI 10.1002/jcb.22612; Alli AA, 2009, AM J PHYSIOL-CELL PH, V297, pC1157, DOI 10.1152/ajpcell.00219.2009; Bertog M, 2008, J PHYSIOL-LONDON, V586, P459, DOI 10.1113/jphysiol.2007.140459; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Eykelbosh AJ, 2010, COMP BIOCHEM PHYS A, V156, P218, DOI 10.1016/j.cbpa.2010.02.005; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Foghsgaard L, 2002, J BIOL CHEM, V277, P39499, DOI 10.1074/jbc.M206669200; Furukawa T, 2007, PHARMACOL THERAPEUT, V115, P106, DOI 10.1016/j.pharmthera.2007.04.008; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Grant Andrew, 2007, P421; GUENETTE RS, 1994, EUR J BIOCHEM, V226, P311, DOI 10.1111/j.1432-1033.1994.tb20055.x; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Haddock RE, 2002, J PHYSIOL-LONDON, V545, P615, DOI 10.1113/jphysiol.2002.027904; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Konstas AA, 2000, PFLUG ARCH EUR J PHY, V441, P341, DOI 10.1007/s004240000430; Korbmacher C, 2009, J MED INVESTIG, V56, P306, DOI 10.2152/jmi.56.306; Krusek J, 2004, PHYSIOL RES, V53, pS103; Lester H A, 1995, Harvey Lect, V91, P79; Lohmuller T, 2003, BIOL CHEM, V384, P899, DOI 10.1515/BC.2003.101; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; MARTELPELLETIER J, 1990, J ORTHOPAED RES, V8, P336, DOI 10.1002/jor.1100080305; Mort J S, 1985, Prog Clin Biol Res, V180, P243; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; PALMER LG, 1989, BIOPHYS J, V55, P779, DOI 10.1016/S0006-3495(89)82876-0; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Schild L, 1996, NEPHROLOGIE, V17, P395; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	49	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30073	30083		10.1074/jbc.M111.338574	http://dx.doi.org/10.1074/jbc.M111.338574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22782900	Green Published, hybrid			2022-12-25	WOS:000308579800003
J	Geng, YY; Monajembashi, S; Shao, AW; Cui, D; He, WY; Chen, ZZ; Hemmerich, P; Tang, J				Geng, Yunyun; Monajembashi, Shamci; Shao, Anwen; Cui, Di; He, Weiyong; Chen, Zhongzhou; Hemmerich, Peter; Tang, Jun			Contribution of the C-terminal Regions of Promyelocytic Leukemia Protein (PML) Isoforms II and V to PML Nuclear Body Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E4 ORF3 PROTEIN; ND10; BODIES; DOMAINS; TRANSCRIPTION; DISRUPTION; MECHANISMS; REPRESSION; INFECTION; SEQUENCE	Promyelocytic leukemia protein (PML) nuclear bodies are dynamic and heterogeneous nuclear protein complexes implicated in various important functions, most notably tumor suppression. PML is the structural component of PML nuclear bodies and has several nuclear splice isoforms that share a common N-terminal region but differ in their C termini. Previous studies have suggested that the coiled-coil motif within the N-terminal region is sufficient for PML nuclear body formation by mediating homo/multi-dimerization of PML molecules. However, it has not been investigated whether any of the C-terminal variants of PML may contribute to PML body assembly. Here we report that the unique C-terminal domains of PML-II and PML-V can target to PML-NBs independent of their N-terminal region. Strikingly, both domains can form nuclear bodies in the absence of endogenous PML. The C-terminal domain of PML-II interacts transiently with unknown binding sites at PML nuclear bodies, whereas the C-terminal domain of PML-V exhibits hyperstable binding to PML bodies via homo-dimerization. This strong interaction is mediated by a putative alpha-helix in the C terminus of PML-V. Moreover, nuclear bodies assembled from the C-terminal domain of PML-V also recruit additional PML body components, including Daxx and Sp100. These observations establish the C-terminal domain of PML-V as an additional important contributor to the assembly mechanism(s) of PML bodies.	[Geng, Yunyun; Shao, Anwen; Cui, Di; He, Weiyong; Tang, Jun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Geng, Yunyun; Cui, Di; Chen, Zhongzhou; Tang, Jun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Monajembashi, Shamci; Hemmerich, Peter] Leibniz Inst Age Res, D-07743 Jena, Germany; [Chen, Zhongzhou] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); China Agricultural University	Tang, J (corresponding author), China Agr Univ, Coll Vet Med, Rm 213,2 Yuanmingyuan W Rd, Beijing 100193, Peoples R China.	jtang@cau.edu.cn	耿, 云云/GSJ-0054-2022; chen, zhong/E-3900-2015; Shao, Anwen/L-4860-2019	chen, zhong/0000-0003-1319-9664; Shao, Anwen/0000-0001-5616-0394	Chinese Universities Scientific Fund [2012RC002]	Chinese Universities Scientific Fund	This work was supported by Chinese Universities Scientific Fund 2012RC002 (to J. T.).	Beech SJ, 2005, EXP CELL RES, V307, P109, DOI 10.1016/j.yexcr.2005.03.012; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Boichuk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025814; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Cantrell SR, 2006, J VIROL, V80, P6188, DOI 10.1128/JVI.02676-05; Chung I, 2011, J CELL SCI, V124, P3603, DOI 10.1242/jcs.084681; Condemine W, 2007, J CELL SCI, V120, P3219, DOI 10.1242/jcs.007492; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Cuchet D, 2011, J CELL SCI, V124, P280, DOI 10.1242/jcs.075390; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Ebrahimian M, 2010, CELLS TISSUES ORGANS, V192, P374, DOI 10.1159/000319466; Everett RD, 1999, J CELL SCI, V112, P4581; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Fagioli M, 1998, ONCOGENE, V16, P2905, DOI 10.1038/sj.onc.1201811; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; Guccione E, 2004, ONCOGENE, V23, P4662, DOI 10.1038/sj.onc.1207631; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; ISHOV AM, 1999, J CELL BIOL, V147, P221, DOI [10.1083/jcb.147.2.221, DOI 10.1083/JCB.147.2.221]; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jul-Larsen A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-89; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Leppard KN, 2009, J GEN VIROL, V90, P95, DOI 10.1099/vir.0.005512-0; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Negorev D, 2001, J CELL SCI, V114, P59; Nguyen LA, 2005, BLOOD, V105, P292, DOI 10.1182/blood-2004-03-1185; Oh W, 2009, J CELL SCI, V122, P2613, DOI 10.1242/jcs.048066; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Pandolfi PP, 2001, ONCOGENE, V20, P5726, DOI 10.1038/sj.onc.1204600; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tang J, 2005, CANCER BIOL THER, V4, P645, DOI 10.4161/cbt.4.6.1729; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Wu Q, 2009, J BIOL CHEM, V284, P8738, DOI 10.1074/jbc.M807590200; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	59	32	35	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30729	30742		10.1074/jbc.M112.374769	http://dx.doi.org/10.1074/jbc.M112.374769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773875	hybrid, Green Published			2022-12-25	WOS:000308579800062
J	Siekierska, A; De Baets, G; Reumers, J; Gallardo, R; Rudyak, S; Broersen, K; Couceiro, J; Van Durme, J; Schymkowitz, J; Rousseau, F				Siekierska, Aleksandra; De Baets, Greet; Reumers, Joke; Gallardo, Rodrigo; Rudyak, Stanislav; Broersen, Kerensa; Couceiro, Jose; Van Durme, Joost; Schymkowitz, Joost; Rousseau, Frederic			alpha-Galactosidase Aggregation Is a Determinant of Pharmacological Chaperone Efficacy on Fabry Disease Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; LYSOSOMAL STORAGE; ENDOPLASMIC-RETICULUM; GAUCHER-DISEASE; FORCE-FIELD; TRAFFICKING; PREDICTION; DEFECT; 1-DEOXYGALACTONOJIRIMYCIN; POLYMORPHISMS	Fabry disease is a lysosomal storage disorder caused by loss of alpha-galactosidase function. More than 500 Fabry disease mutants have been identified, the majority of which are structurally destabilized. A therapeutic strategy under development for lysosomal storage diseases consists of using pharmacological chaperones to stabilize the structure of the mutant protein, thereby promoting lysosomal delivery over retrograde degradation. The substrate analog 1-deoxygalactonojirimycin (DGJ) has been shown to restore activity of mutant alpha-galactosidase and is currently in clinical trial for treatment of Fabry disease. However, only similar to 65% of tested mutants respond to treatment in cultured patient fibroblasts, and the structural underpinnings of DGJ response remain poorly explained. Using computational modeling and cell culture experiments, we show that the DGJ response is negatively affected by protein aggregation of alpha-galactosidase mutants, revealing a qualitative difference between misfolding-associated and aggregation-associated loss of function. A scoring function combining predicted thermodynamic stability and intrinsic aggregation propensity of mutants captures well their aggregation behavior under overexpression in HeLa cells. Interestingly, the same classifier performs well on DGJ response data of patient-derived cultured lymphoblasts, showing that protein aggregation is an important determinant of chemical chaperone efficiency under endogenous expression levels as well. Our observations reinforce the idea that treatment of aggregation-associated loss of function observed for the more severe alpha-galactosidase mutants could be enhanced by combining pharmacological chaperone treatment with the suppression of mutant aggregation, e. g. via proteostatic regulator compounds that increase cellular chaperone expression.	[Siekierska, Aleksandra; De Baets, Greet; Reumers, Joke; Rudyak, Stanislav; Broersen, Kerensa; Van Durme, Joost] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Siekierska, Aleksandra; De Baets, Greet; Reumers, Joke; Gallardo, Rodrigo; Rudyak, Stanislav; Broersen, Kerensa; Couceiro, Jose; Van Durme, Joost; Schymkowitz, Joost; Rousseau, Frederic] VIB SWITCH Lab, Brussels, Belgium; [Siekierska, Aleksandra; De Baets, Greet; Gallardo, Rodrigo; Couceiro, Jose; Van Durme, Joost; Schymkowitz, Joost; Rousseau, Frederic] Univ Louvain, Dept Cellular & Mol Med, B-3000 Louvain, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Schymkowitz, J (corresponding author), Univ Louvain, Dept Mol Cell Biol, SWITCH Lab, B-3000 Louvain, Belgium.	joost.schymkowitz@switch.vib-kuleuven.be; frederic.rousseau@switch.vib-kuleuven.be	Schymkowitz, Joost/AAV-3680-2021; Rudyak, Stanislav/U-1781-2017; Rodríguez Couceiro, Jose/F-1497-2016; Bustelo, Xose R./A-9526-2010; De Baets, Greet/J-1881-2014; Rousseau, Frederic/J-9044-2016; Schymkowitz, Joost/K-7764-2016	Rodríguez Couceiro, Jose/0000-0002-5742-1071; Bustelo, Xose R./0000-0001-9398-6072; De Baets, Greet/0000-0001-8844-800X; Rousseau, Frederic/0000-0002-9189-7399; Schymkowitz, Joost/0000-0003-2020-0168; Siekierska, Aleksandra/0000-0003-4907-605X; Reumers, Joke/0000-0001-5434-6515; Gallardo, Rodrigo/0000-0003-1584-3564	Funds for Scientific Research of Flanders (FWO); Federal Office for Scientific Affairs, Belgium [IUAP P6/43]	Funds for Scientific Research of Flanders (FWO)(FWO); Federal Office for Scientific Affairs, Belgium	This work was supported by the Funds for Scientific Research of Flanders (FWO) and the Federal Office for Scientific Affairs, Belgium, Grant IUAP P6/43 (to the SWITCH Laboratory).	Andreotti G, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-66; Andreotti G, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-36; Asano N, 2000, EUR J BIOCHEM, V267, P4179, DOI 10.1046/j.1432-1327.2000.01457.x; Benjamin ER, 2009, J INHERIT METAB DIS, V32, P424, DOI 10.1007/s10545-009-1077-0; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Bruni S, 2007, Acta Myol, V26, P87; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; ENG CM, 1994, HUM MUTAT, V3, P103, DOI 10.1002/humu.1380030204; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Fan JQ, 2007, FEBS J, V274, P4962, DOI 10.1111/j.1742-4658.2007.06041.x; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, MOL GENET METAB, V77, P3, DOI 10.1016/S1096-7192(02)00151-8; Hamanaka R, 2008, BBA-MOL BASIS DIS, V1782, P408, DOI 10.1016/j.bbadis.2008.03.001; Ishii S, 1996, BIOCHEM BIOPH RES CO, V220, P812, DOI 10.1006/bbrc.1996.0486; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LEMANSKY P, 1987, J BIOL CHEM, V262, P2062; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shin SH, 2008, PHARMACOGENET GENOM, V18, P773, DOI 10.1097/FPC.0b013e32830500f4; Sugawara K, 2008, J HUM GENET, V53, P812, DOI 10.1007/s10038-008-0316-9; Sugawara K, 2009, J HUM GENET, V54, P324, DOI 10.1038/jhg.2009.32; TAMURA G, 1968, J ANTIBIOT, V21, P160, DOI 10.7164/antibiotics.21.160; Yam GHF, 2007, BIOCHEM BIOPH RES CO, V360, P375, DOI 10.1016/j.bbrc.2007.06.048; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671	46	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28386	28397		10.1074/jbc.M112.351056	http://dx.doi.org/10.1074/jbc.M112.351056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773828	hybrid, Green Published			2022-12-25	WOS:000308074600015
J	Ahn, M; Ghaemmaghami, S; Huang, Y; Phuan, PW; May, BCH; Giles, K; DeArmond, SJ; Prusiner, SB				Ahn, Misol; Ghaemmaghami, Sina; Huang, Yong; Phuan, Puay-Wah; May, Barnaby C. H.; Giles, Kurt; DeArmond, Stephen J.; Prusiner, Stanley B.			Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION DISEASES; CELL-DEATH; ACCUMULATION; BARRIER; DRUGS; P53; DERIVATIVES; INHIBITOR; ACRIDINE	The lipophilic cationic compound quinacrine has been used as an antimalarial drug for over 75 years but its pharmacokinetic profile is limited. Here, we report on the pharmacokinetic properties of quinacrine in mice. Following an oral dose of 40 mg/kg/day for 30 days, quinacrine concentration in the brain of wild-type mice was maintained at a concentration of similar to 1 mu M. As a substrate of the P-glycoprotein (P-gp) efflux transporter, quinacrine is actively exported from the brain, preventing its accumulation to levels that may show efficacy in some disease models. In the brains of P-gp-deficient Mdr1(0/0) mice, we found quinacrine reached concentrations of similar to 80 mu M without any signs of acute toxicity. Additionally, we examined the distribution and metabolism of quinacrine in the wild-type and Mdr1(0/0) brains. In wild-type mice, the co-administration of cyclosporin A, a known P-gp inhibitor, resulted in a 6-fold increase in the accumulation of quinacrine in the brain. Our findings argue that the inhibition of the P-gp efflux transporter should improve the poor pharmacokinetic properties of quinacrine in the CNS.	[Ahn, Misol; Ghaemmaghami, Sina; May, Barnaby C. H.; Giles, Kurt; DeArmond, Stephen J.; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Huang, Yong] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; [Ahn, Misol; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Phuan, Puay-Wah] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Ghaemmaghami, Sina; May, Barnaby C. H.; Giles, Kurt; Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ahn, M (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	stanley@ind.ucsf.edu		Ghaemmaghami, Sina/0000-0002-8696-2950; May, Barnaby/0000-0001-9855-018X; Ahn, Misol/0000-0002-6088-8481	National Institutes of Health [AG021601, AG031220]; NATIONAL INSTITUTE ON AGING [R37AG031220, P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (AG021601 and AG031220) as well as by gifts from the Sherman Fairchild Foundation, Fight for Mike Homer Program, Schott Foundation for Public Education, and Lincy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito-Leon J, 2004, CLIN NEUROPHARMACOL, V27, P201, DOI 10.1097/01.wnf.0000134853.36429.0e; BERMAN JD, 1983, AM J TROP MED HYG, V32, P947, DOI 10.4269/ajtmh.1983.32.947; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; CONNELLY MC, 1984, BIOCHEM BIOPH RES CO, V121, P931, DOI 10.1016/0006-291X(84)90766-6; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P205, DOI 10.1023/B:CEMN.0000018617.21378.95; Dolphin GT, 2008, CHEMBIOCHEM, V9, P952, DOI 10.1002/cbic.200700602; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Gao JT, 2009, CELL BIOL INT, V33, P874, DOI 10.1016/j.cellbi.2009.04.021; Gayrard V, 2005, BRIT J PHARMACOL, V144, P386, DOI 10.1038/sj.bjp.0706072; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Goodman L., 1975, PHARM BASIS THERAPEU; Gorbachev AV, 2007, EUR J IMMUNOL, V37, P2257, DOI 10.1002/eji.200636708; Guo C, 2009, ONCOGENE, V28, P1151, DOI 10.1038/onc.2008.460; Huang Y, 2006, DRUG METAB DISPOS, V34, P1136, DOI 10.1124/dmd.105.008664; Jonker JW, 1999, BRIT J PHARMACOL, V127, P43, DOI 10.1038/sj.bjp.0702497; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Nakajima M, 2004, DEMENT GERIATR COGN, V17, P158, DOI 10.1159/000076350; Neznanov N, 2009, CELL CYCLE, V8, P3960, DOI 10.4161/cc.8.23.10179; Pardridge William M, 2005, NeuroRx, V2, P3; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; WALLACE DJ, 1989, SEMIN ARTHRITIS RHEU, V18, P282, DOI 10.1016/0049-0172(89)90050-4; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134; Yung L, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-53; Zipper J, 2003, INT J GYNECOL OBSTET, V83, pS7, DOI 10.1016/S0020-7292(03)90084-1	29	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39112	10.1371/journal.pone.0039112	http://dx.doi.org/10.1371/journal.pone.0039112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768295	Green Submitted, Green Published, gold			2022-12-25	WOS:000305966500008
J	Knight, AJ; Johnson, NM; Behm, CA				Knight, Alison J.; Johnson, Nicholas M.; Behm, Carolyn A.			VHA-19 Is Essential in Caenorhabditis elegans Oocytes for Embryogenesis and Is Involved in Trafficking in Oocytes	PLOS ONE			English	Article							C-ELEGANS; GERM-LINE; CHONDROITIN PROTEOGLYCANS; MEIOTIC MATURATION; CELL-DIVISION; GENE; EXPRESSION; PROTEIN; IDENTIFICATION; REQUIREMENT	There is an urgent need to develop new drugs against parasitic nematodes, which are a significant burden on human health and agriculture. Information about the function of essential nematode-specific genes provides insight to key nematode-specific processes that could be targeted with drugs. We have characterized the function of a novel, nematode-specific Caenorhabditis elegans protein, VHA-19, and show that VHA-19 is essential in the germline and, specifically, the oocytes, for the completion of embryogenesis. VHA-19 is also involved in trafficking the oocyte receptor RME-2 to the oocyte plasma membrane and is essential for osmoregulation in the embryo, probably because VHA-19 is required for proper eggshell formation via exocytosis of cortical granules or other essential components of the eggshell. VHA-19 may also have a role in cytokinesis, either directly or as an indirect effect of its role in osmoregulation. Critically, VHA-19 is expressed in the excretory cell in both larvae and adults, suggesting that it may have a role in osmoregulation in C. elegans more generally, probably in trafficking or secretion pathways. This is the first time a role for VHA-19 has been described.	[Knight, Alison J.; Johnson, Nicholas M.; Behm, Carolyn A.] Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia	Australian National University	Knight, AJ (corresponding author), Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	Carolyn.Behm@anu.edu.au	Behm, Carolyn A/A-2102-2008	Behm, Carolyn A/0000-0002-0603-221X	Meat and Livestock Australia; Australian Government; NIH National Center for Research Resources (NCRR)	Meat and Livestock Australia(Meat and Livestock Australia); Australian Government(Australian GovernmentCGIAR); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	AK was supported in part by a Junior Research Fellowship from Meat and Livestock Australia and by an Australian Government Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nicole Norris for critical reading of this manuscript and Daryl Webb from the Centre for Advanced Microscopy (Australian National University) for assistance with confocal microscopy. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; BRENNER S, 1974, GENETICS, V77, P71; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; Choe KP, 2007, AM J PHYSIOL-CELL PH, V293, pC915, DOI 10.1152/ajpcell.00126.2007; Choi KY, 2003, GENE, V311, P13, DOI 10.1016/S0378-1119(03)00561-4; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Fritz JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005117; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hall DH., 2008, C ELEGANS ATLAS; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Johnston WL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-35; Johnston WL, 2012, GENESIS, V50, P333, DOI 10.1002/dvg.20823; Kaitna S, 2002, J CELL SCI, V115, P2293; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kelly WG, 1997, GENETICS, V146, P227; Koenning SR, 1999, J NEMATOL, V31, P587; Kosinski M, 2005, DEVELOPMENT, V132, P3357, DOI 10.1242/dev.01916; Kuwabara PE, 2000, GENE DEV, V14, P1933; LAMUNYON CW, 1995, EXPERIENTIA, V51, P817, DOI 10.1007/BF01922436; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Oka T, 2000, J BIOL CHEM, V275, P29556, DOI 10.1074/jbc.M002756200; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; SCHEDL T, 1988, GENETICS, V119, P43; SHARROCK WJ, 1990, J BIOL CHEM, V265, P14422; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Xu XZ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-114	50	2	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40317	10.1371/journal.pone.0040317	http://dx.doi.org/10.1371/journal.pone.0040317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768351	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500064
J	Anel, JA; Blanco-Duran, M; Gimeno, L; de la Torre, L				Anel, Juan A.; Blanco-Duran, Marcos; Gimeno, Luis; de la Torre, Laura			Recovery of Meteorological Data for the Observatory of A Guarda, Spain	PLOS ONE			English	Article							SURFACE OZONE; PRECIPITATION; ATLANTIC; 20TH-CENTURY; WIND	We herein describe the recovery of a series of data on temperature, humidity, precipitation, evaporation, wind, and local weather conditions from documentary sources obtained from the Jesuit observatory of A Guarda (Galicia, Spain) for the period 1881-1896. The data were digitized and made available in accessible electronic formats. Comparisons were made with present-day meteorological data obtained from two nearby stations. We further believe that the discovery of some new complementary documentary sources made during the present research could be a basis for future data recovery efforts. Among these new results, early ozone data from the period are of outstanding importance to meteorologists.	[Anel, Juan A.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England; [Anel, Juan A.; Blanco-Duran, Marcos; Gimeno, Luis; de la Torre, Laura] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Galicia, Spain	University of Oxford; Universidade de Vigo	Anel, JA (corresponding author), Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England.	juan.anel@smithschool.ox.ac.uk	, Juan Antonio Añel Cabanelas/N-1866-2019; de la Torre, Laura/Y-3723-2019; GIMENO, LUIS/B-8137-2008	, Juan Antonio Añel Cabanelas/0000-0003-2448-4647; de la Torre, Laura/0000-0001-5305-6946; GIMENO, LUIS/0000-0002-0778-3605	Ministerio de Medio Ambiente y Medio Rural y Marino (Spanish Ministry of Environment and Rural and Marine Areas) through the Salva-Sinobas Project [20080050083542]; European Regional Development Fund	Ministerio de Medio Ambiente y Medio Rural y Marino (Spanish Ministry of Environment and Rural and Marine Areas) through the Salva-Sinobas Project; European Regional Development Fund(European Commission)	This study was partially funded by the Ministerio de Medio Ambiente y Medio Rural y Marino (Spanish Ministry of Environment and Rural and Marine Areas) through the Salva-Sinobas Project (Ref. 20080050083542) and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ACRE, 2010, ACRE IN INT ATM CIRC; Blanco-Duran M, 2008, HIST METEROLOXIA CLI; Bronnimann S, 2006, CLIM PAST, V2, P137; CARTALIS C, 1994, ATMOS ENVIRON, V28, P3, DOI 10.1016/1352-2310(94)90018-3; Eisenberg JD, 2005, OASIS OPENDOCUMENT E; Garcia NO, 2005, ATMOSFERA, V18, P25; Herrera RG, 2003, B AM METEOROL SOC, V84, P1025, DOI 10.1175/BAMS-84-8-1025; Hurrell J, 2003, CLIMATE VARIABILITY, V2, P439; Iribarne JV, 1996, TERMODINAMICA ATMOSF, P296; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; LINVILL DE, 1980, MON WEATHER REV, V108, P1883, DOI 10.1175/1520-0493(1980)108<1883:OIME>2.0.CO;2; Merino B, 1897, OBSERVATORIO METEORO; Merino B, 1894, OBSERVATORIO METEORO; Merino B, 1893, ESTUDIO BORRASCAS CO, V65; Merino Baltasar, 1891, RESUMEN OBSERVACIONE; OASIS, 2005, OP DOC FORM OFF APPL; Rodrigo FS, 2008, GLOBAL PLANET CHANGE, V63, P243, DOI 10.1016/j.gloplacha.2007.09.004; Servicio Meteorologico Nacional, 1943, SER MAS LARG OBS P D; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Trigo RM, 2008, ANN NY ACAD SCI, V1146, P212, DOI 10.1196/annals.1446.014; Trigo RM, 2004, INT J CLIMATOL, V24, P925, DOI 10.1002/joc.1048; Udias A, 2003, SEARCHING HEAVENS EA, P369; Udias A, 1996, B AM METEOROL SOC, V7, P2307; VAROTSOS C, 1994, TOXICOL ENVIRON CHEM, V44, P233, DOI 10.1080/02772249409358062; WMO, 2008, MEDARE P INT WORKSH; WMO, 2004, 1210 WMOTD, V1210, P1210	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39281	10.1371/journal.pone.0039281	http://dx.doi.org/10.1371/journal.pone.0039281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768069	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100040
J	Hussain, AR; Ahmed, SO; Ahmed, M; Khan, OS; Al AbdulMohsen, S; Platanias, LC; Al-Kuraya, KS; Uddin, S				Hussain, Azhar R.; Ahmed, Saeeda O.; Ahmed, Maqbool; Khan, Omar S.; Al AbdulMohsen, Sally; Platanias, Leonidas C.; Al-Kuraya, Khawla S.; Uddin, Shahab			Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis	PLOS ONE			English	Article							KAPPA-B ACTIVATION; SARCOMA-ASSOCIATED HERPESVIRUS; KINASE PROTEIN-2 DEGRADATION; FATTY-ACID SYNTHASE; CONSTITUTIVE ACTIVATION; EXPRESSION; INHIBITION; BAX; PROLIFERATION; SUPPRESSION	Background: A number of constitutively activated signaling pathways play critical roles in the survival and growth of primary effusion lymphoma cells (PELs) including NFkB and PI3/AKT kinase cascades. NFkB is constitutively activated in a number of malignancies, including multiple myeloma, Burkitt's lymphoma and diffuse large cell B-cell lymphoma. However, its role in primary effusion lymphoma has not been fully explored. Methodology/Principal Findings: We used pharmacological inhibition and gene silencing to define the role of NFkB in growth and survival of PEL cells. Inhibition of NFkB activity by Bay11-7085 resulted in decreased expression of p65 in the nuclear compartment as detected by EMSA assays. In addition, Bay11-7085 treatment caused de-phosphorylation of AKT and its downstream targets suggesting a cross-talk between NFkB and the PI3-kinase/AKT pathway. Importantly, treatment of PEL cells with Bay11-7085 led to inhibition of cell viability and induced apoptosis in a dose dependent manner. Similar apoptotic effects were found when p65 was knocked down using specific small interference RNA. Finally, co-treatment of PEL cells with suboptimal doses of Bay11-7085 and LY294002 led to synergistic apoptotic responses in PEL cells. Conclusion/Significance: These data support a strong biological-link between NFkB and the PI3-kinase/AKT pathway in the modulation of anti-apoptotic effects in PEL cells. Synergistic targeting of these pathways using NFKB- and PI3-kinase/AKT-inhibitors may have a therapeutic potential for the treatment of PEL and possibly other malignancies with constitutive activation of these pathways.	[Hussain, Azhar R.; Ahmed, Saeeda O.; Ahmed, Maqbool; Khan, Omar S.; Al AbdulMohsen, Sally; Al-Kuraya, Khawla S.; Uddin, Shahab] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia; [Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	King Faisal Specialist Hospital & Research Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Hussain, AR (corresponding author), King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia.	Shahab@kfshrc.edu.sa		Khan, Omar/0000-0002-4998-1693; Uddin, Shahab/0000-0003-1886-6710				An J, 2004, LEUKEMIA, V18, P1699, DOI 10.1038/sj.leu.2403460; Ansari MQ, 1996, AM J CLIN PATHOL, V105, P221; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Aoki Y, 2001, BLOOD, V97, P2173, DOI 10.1182/blood.V97.7.2173; Arora Anita, 2007, Cancer Treat Res, V133, P21; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Boulanger E, 2008, AM J TRANSPLANT, V8, P707, DOI 10.1111/j.1600-6143.2007.02110.x; Brimo F, 2007, CANCER CYTOPATHOL, V111, P224, DOI 10.1002/cncr.22691; Carbone A, 2008, BRIT J HAEMATOL, V140, P13, DOI 10.1111/j.1365-2141.2007.06879.x; Chen JH, 2004, BIOCHEM PHARMACOL, V67, P1337, DOI 10.1016/j.bcp.2003.12.015; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cras A, 2011, CLIN CANC RES; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fisher RI, 2003, LEUKEMIA, V17, P1948, DOI 10.1038/sj.leu.2403096; Ganem D, 2007, KSHV INDUCED ONCOGEN; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Grossmann C, 2008, VIROLOGY, V375, P94, DOI 10.1016/j.virol.2007.12.044; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Hussain AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024703; Hussain AR, 2009, LEUKEMIA LYMPHOMA, V50, P1204, DOI 10.1080/10428190902951799; Jones KD, 1999, BLOOD, V94, P2871; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Keller SA, 2000, BLOOD, V96, P2537; Kim SW, 2008, BLOOD, V111, P1644, DOI 10.1182/blood-2007-05-088591; Melo NCV, 2008, AM J TRANSPLANT, V8, P906, DOI 10.1111/j.1600-6143.2008.02156.x; Rahman MA, 2010, NUTR CANCER, V62, P973, DOI 10.1080/01635581.2010.509538; Raskatov JA, 2011, P NATL ACAD SCI US; Rossi D, 2003, HAEMATOLOGICA, V88, P212; Scheid MP, 2000, CURR BIOL, V10, pR191, DOI 10.1016/S0960-9822(00)00349-3; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Smolewski P, 2011, CURR MOL MED, V11, P633, DOI 10.2174/156652411797536723; Uddin S, 2005, ONCOGENE, V24, P7022, DOI 10.1038/sj.onc.1208864; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Uddin S, 2008, J CLIN ENDOCR METAB, V93, P4088, DOI 10.1210/jc.2008-0503; Uddin S, 2008, CANCER RES, V68, P3379, DOI 10.1158/0008-5472.CAN-07-6109; Uddin S, 2009, AM J GASTROENTEROL, V104, P1790, DOI 10.1038/ajg.2009.230; Wu SJ, 2009, J CLIN VIROL, V44, P81, DOI 10.1016/j.jcv.2008.08.015; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	49	114	120	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39945	10.1371/journal.pone.0039945	http://dx.doi.org/10.1371/journal.pone.0039945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768179	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100149
J	Julien, C; Marcouiller, F; Bretteville, A; El Khoury, NB; Baillargeon, J; Hebart, SS; Planel, E				Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel			Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation	PLOS ONE			English	Article							NEURONAL CELL-DEATH; COLD-WATER STRESS; ALZHEIMERS-DISEASE; IN-VIVO; NEUROFIBRILLARY PATHOLOGY; PROTEIN PHOSPHATASE-2A; PHOSPHORYLATION SITES; INHIBITION; HYPOTHERMIA; KINASE	Dimethyl sulfoxide (DMSO) is widely used as a solvent or vehicle for biological studies, and for treatment of specific disorders, including traumatic brain injury and several forms of amyloidosis. As Alzheimer's disease (AD) brains are characterized by deposits of beta-amyloid peptides, it has been suggested that DMSO could be used as a treatment for this devastating disease. AD brains are also characterized by aggregates of hyperphosphorylated tau protein, but the effect of DMSO on tau phosphorylation is unknown. We thus investigated the impact of DMSO on tau phosphorylation in vitro and in vivo. One hour following intraperitoneal administration of 1 or 2 ml/kg DMSO in mice, no change was observed in tau phosphorylation. However, at 4 ml/kg, tau was hyperphosphorylated at AT8 (Ser(202)/Thr(205)), PHF-1 (Ser(396)/Ser(404)) and AT180 (Thr(231)) epitopes. At this dose, we also noticed that the animals were hypothermic. When the mice were maintained normothermic, the effect of 4 ml/kg DMSO on tau hyperphosphorylation was prevented. On the other hand, in SH-SY5Y cells, 0.1% DMSO induced tau hyperphosphorylation at AT8 and AT180 phosphoepitopes in normothermic conditions. Globally, these findings demonstrate that DMSO can induce tau hyperphosphorylation indirectly via hypothermia in vivo, and directly in vitro. These data should caution researchers working with DMSO as it can induce artifactual results both in vivo and in vitro.	[Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada; [Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Quebec, Ctr Hosp, Ctr Rech, Axe Neurosci, Quebec City, PQ, Canada	Laval University; Laval University; University of Quebec	Julien, C (corresponding author), Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada.	carl.julien@crchul.ulaval.ca; emmanuel@planel.org	Hébert, Sébastien S./Q-2729-2017; Julien, Carl/AAU-5309-2021	Planel, Emmanuel/0000-0001-5128-0565; Hebert, Sebastien/0000-0002-0391-9325	Canadian Institute of Health Research [MOP-106423, PCN-102993]; Natural Sciences and Engineering Research Council of Canada [354722]; Fonds de la recherche en sante du Quebec [16205, 20048]; Alzheimer Society of Canada; Alzheimer Society of Saskatchewan	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Alzheimer Society of Canada; Alzheimer Society of Saskatchewan	This work was supported by grants to EP from the Canadian Institute of Health Research (MOP-106423, PCN-102993) (www.cihr-irsc.gc.ca), the Natural Sciences and Engineering Research Council of Canada (354722) (www.nserc-crsng.gc.ca), the Fonds de la recherche en sante du Quebec (16205, 20048) (www.frsq.gouv.qc.ca). CJ was supported by Postdoctoral Awards from the Alzheimer Society of Canada and the Alzheimer Society of Saskatchewan (www.alzheimer.ca). NBEK was supported by a Doctoral Award from the Alzheimer Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTLAND PD, 1966, P SOC EXP BIOL MED, V123, P853; ASHWOODS.MJ, 1967, ANN NY ACAD SCI, V141, P45, DOI 10.1111/j.1749-6632.1967.tb34865.x; Balakin KV, 2006, CURR MED CHEM, V13, P223, DOI 10.2174/092986706775197917; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; CAUJOLLE F, 1964, CR HEBD ACAD SCI, V258, P2224; de Oliveira ACP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-2; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; FARRANT J, 1964, J PHARM PHARMACOL, V16, P472, DOI 10.1111/j.2042-7158.1964.tb07496.x; Feng Q, 2005, NEUROSCI LETT, V388, P13, DOI 10.1016/j.neulet.2005.06.022; Goedert M, 1996, ANN NY ACAD SCI, V777, P121, DOI 10.1111/j.1749-6632.1996.tb34410.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Goldbaum O, 2002, GLIA, V40, P271, DOI 10.1002/glia.10119; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; KORNEYEV A, 1995, NEUROSCI LETT, V191, P19, DOI 10.1016/0304-3940(95)11546-3; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Mailliot C, 2000, ANN NY ACAD SCI, V920, P107; Martins DF, 2011, J PAIN, V12, P315, DOI 10.1016/j.jpain.2010.06.007; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Pegg David E, 2007, Methods Mol Biol, V368, P39; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Pohjanvirta R, 2002, FOOD CHEM TOXICOL, V40, P1023, DOI 10.1016/S0278-6915(02)00067-4; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Regelson W, 1997, ANN NY ACAD SCI, V826, P348, DOI 10.1111/j.1749-6632.1997.tb48485.x; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Roller J, 2010, LANGENBECK ARCH SURG, V395, P387, DOI 10.1007/s00423-010-0603-8; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Villarreal JS, 2006, NEUROBIOL LEARN MEM, V85, P44, DOI 10.1016/j.nlm.2005.08.005; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Watanabe E, 2000, BIOL PHARM BULL, V23, P838; Whittington RA, 2010, CURR ALZHEIMER RES, V7, P717; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; WOOD DC, 1975, ANN NY ACAD SCI, V243, P7, DOI 10.1111/j.1749-6632.1975.tb25339.x; Zhu GC, 2006, TRANSPLANT P, V38, P3307, DOI 10.1016/j.transproceed.2006.10.114	50	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40020	10.1371/journal.pone.0040020	http://dx.doi.org/10.1371/journal.pone.0040020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768202	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100174
J	Liu, ZJ; Kumari, S; Zhang, LF; Zheng, YL; Ware, D				Liu, Zhijie; Kumari, Sunita; Zhang, Lifang; Zheng, Yonglian; Ware, Doreen			Characterization of miRNAs in Response to Short-Term Waterlogging in Three Inbred Lines of Zea mays	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; DNA-BINDING SPECIFICITY; ZINC-FINGER PROTEIN; LOOP RT-PCR; TRANSCRIPTION FACTORS; ABSCISIC-ACID; SMALL RNAS; MOLECULAR CHARACTERIZATION; AERENCHYMA FORMATION; ENDOGENOUS SIRNAS	Waterlogging of plants leads to low oxygen levels (hypoxia) in the roots and causes a metabolic switch from aerobic respiration to anaerobic fermentation that results in rapid changes in gene transcription and protein synthesis. Our research seeks to characterize the microRNA-mediated gene regulatory networks associated with short-term waterlogging. MicroRNAs (miRNAs) are small non-coding RNAs that regulate many genes involved in growth, development and various biotic and abiotic stress responses. To characterize the involvement of miRNAs and their targets in response to short-term hypoxia conditions, a quantitative real time PCR (qRT-PCR) assay was used to quantify the expression of the 24 candidate mature miRNA signatures (22 known and 2 novel mature miRNAs, representing 66 miRNA loci) and their 92 predicted targets in three inbred Zea mays lines (waterlogging tolerant Hz32, mid-tolerant B73, and sensitive Mo17). Based on our studies, miR159, miR164, miR167, miR393, miR408 and miR528, which are mainly involved in root development and stress responses, were found to be key regulators in the post-transcriptional regulatory mechanisms under short-term waterlogging conditions in three inbred lines. Further, computational approaches were used to predict the stress and development related cis-regulatory elements on the promoters of these miRNAs; and a probable miRNA-mediated gene regulatory network in response to short-term waterlogging stress was constructed. The differential expression patterns of miRNAs and their targets in these three inbred lines suggest that the miRNAs are active participants in the signal transduction at the early stage of hypoxia conditions via a gene regulatory network; and crosstalk occurs between different biochemical pathways.	[Liu, Zhijie; Zheng, Yonglian] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Liu, Zhijie; Kumari, Sunita; Zhang, Lifang; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ware, Doreen] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Huazhong Agricultural University; Cold Spring Harbor Laboratory; United States Department of Agriculture (USDA)	Liu, ZJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	yonglianzheng@gmail.com; ware@cshl.edu			USDA [1907-21000-030]; project 111, Ministry of Education of China and State Administration of Foreign Experts Affairs of China [B07041]	USDA(United States Department of Agriculture (USDA)); project 111, Ministry of Education of China and State Administration of Foreign Experts Affairs of China	This work was supported by a USDA grant (1907-21000-030, www.usda.gov), and project 111 (B07041, Ministry of Education of China and State Administration of Foreign Experts Affairs of China) (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Hernandez GJ, 2005, PLANT J, V43, P506, DOI 10.1111/j.1365-313X.2005.02468.x; Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Colasanti J, 2000, TRENDS BIOCHEM SCI, V25, P236, DOI 10.1016/S0968-0004(00)01542-5; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Colmer TD, 2006, NEW PHYTOL, V170, P767, DOI 10.1111/j.1469-8137.2006.01725.x; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; DENNIS ES, 1988, J MOL BIOL, V202, P759, DOI 10.1016/0022-2836(88)90556-6; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Gomez-Cadenas A, 2001, PLANT CELL, V13, P667, DOI 10.1105/tpc.13.3.667; GUAN LQ, 1993, PLANT J, V3, P527, DOI 10.1046/j.1365-313X.1993.03040527.x; Gubler F, 1999, PLANT J, V17, P1, DOI 10.1046/j.1365-313X.1999.00346.x; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; He CJ, 1996, PLANT PHYSIOL, V112, P1679, DOI 10.1104/pp.112.4.1679; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; HUANG H, 1995, PLANT MOL BIOL, V28, P549, DOI 10.1007/BF00020401; HUANG H, 1993, NUCLEIC ACIDS RES, V21, P4769, DOI 10.1093/nar/21.20.4769; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jia H, 2007, CROP SCI, V47, pS45, DOI 10.2135/cropsci2006-00025tpg; Johannesson H, 2001, PLANT MOL BIOL, V45, P63, DOI 10.1023/A:1006423324025; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Katiyar-Agarwal S, 2007, METHOD ENZYMOL, V427, P215, DOI 10.1016/S0076-6879(07)27012-0; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kozaki A, 2004, NUCLEIC ACIDS RES, V32, P1710, DOI 10.1093/nar/gkh337; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee TG, 2007, PHYSIOL PLANTARUM, V129, P375, DOI 10.1111/j.1399-3054.2006.00828.x; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu YZ, 2010, AGR SCI CHINA, V9, P362, DOI 10.1016/S1671-2927(09)60105-X; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Maltby E, 1991, PLANT LIFE OXYGEN DE, P3; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Martinez-Garcia JF, 1998, PLANT J, V13, P489, DOI 10.1046/j.1365-313X.1998.00050.x; Meng YJ, 2010, BIOCHEM BIOPH RES CO, V393, P345, DOI 10.1016/j.bbrc.2010.01.129; MEYER WS, 1987, IRRIGATION SCI, V8, P257, DOI 10.1007/BF00257510; Moldovan D, 2010, J EXP BOT, V61, P165, DOI 10.1093/jxb/erp296; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Niu XP, 1999, PLANT MOL BIOL, V41, P1, DOI 10.1023/A:1006206011502; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Qiu FZ, 2007, ANN BOT-LONDON, V99, P1067, DOI 10.1093/aob/mcm055; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Ritter W, 1969, ASAE T, V12, P46; SACHS MM, 1980, CELL, V20, P761, DOI 10.1016/0092-8674(80)90322-0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sato N, 1998, PLANT CELL, V10, P859, DOI 10.1105/tpc.10.5.859; Savelieff MG, 2008, P NATL ACAD SCI USA, V105, P7919, DOI 10.1073/pnas.0711316105; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; SHEN QX, 1995, PLANT CELL, V7, P295, DOI 10.1105/tpc.7.3.295; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang WH, 2005, SCI CHINA SER C, V48, P337, DOI 10.1360/062004-27; Tree JJ, 2007, ENVIRON MICROBIOL, V9, P2110, DOI 10.1111/j.1462-2920.2007.01320.x; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; vanderZaal BJ, 1996, PLANT PHYSIOL, V110, P79, DOI 10.1104/pp.110.1.79; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Waypa GB, 2005, J APPL PHYSIOL, V98, P404, DOI 10.1152/japplphysiol.00722.2004; Webster CI, 1997, PLANT J, V11, P703, DOI 10.1046/j.1365-313X.1997.11040703.x; Webster CI, 2001, EUR J BIOCHEM, V268, P3154, DOI 10.1046/j.1432-1327.2001.02191.x; West AG, 1998, NUCLEIC ACIDS RES, V26, P5277, DOI 10.1093/nar/26.23.5277; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yang YZ, 2003, PLANT J, V33, P47, DOI 10.1046/j.0960-7412.2003.01473.x; Yao XZ, 2009, FEBS LETT, V583, P3711, DOI 10.1016/j.febslet.2009.10.076; Yokoyama A, 2007, PLANT CELL PHYSIOL, V48, P84, DOI 10.1093/pcp/pcl040; Zentella R, 2002, PLANT CELL, V14, P2289, DOI 10.1105/tpc.003376; Zhai L, 2012, PHYSL PLANTARUM, P9999; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhong Ke-Ya, 2006, Yichuan, V28, P249; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	122	59	61	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39786	10.1371/journal.pone.0039786	http://dx.doi.org/10.1371/journal.pone.0039786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768123	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305892100093
J	Singh, S; Chitkara, D; Mehrazin, R; Behrman, SW; Wake, RW; Mahato, RI				Singh, Saurabh; Chitkara, Deepak; Mehrazin, Reza; Behrman, Stephen W.; Wake, Robert W.; Mahato, Ram I.			Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway	PLOS ONE			English	Article							P-GLYCOPROTEIN ABCB1; STEM-LIKE CELLS; SIDE POPULATION; MULTIDRUG-RESISTANCE; LUNG-CANCER; LINES; CYCLOPAMINE; METASTASIS; EXPRESSION; DOCETAXEL	Many prostate cancers relapse due to the generation of chemoresistance rendering first-line treatment drugs like paclitaxel (PTX) ineffective. The present study aims to determine the role of miRNAs and Hedgehog (Hh) pathway in chemoresistant prostate cancer and to evaluate the combination therapy using Hh inhibitor cyclopamine (CYA). Studies were conducted on PTX resistant DU145-TXR and PC3-TXR cell lines and clinical prostate tissues. Drug sensitivity and apoptosis assays showed significantly improved cytotoxicity with combination of PTX and CYA. To distinguish the presence of cancer stem cell like side populations (SP), Hoechst 33342 flow cytometry method was used. PTX resistant DU145 and PC3 cells, as well as human prostate cancer tissue possess a distinct SP fraction. Nearly 75% of the SP cells are in the G0/G1 phase compared to 62% for non-SP cells and have higher expression of stem cell markers as well. SP cell fraction was increased following PTX monotherapy and treatment with CYA or CYA plus PTX effectively reduced their numbers suggesting the effectiveness of combination therapy. SP fraction cells were allowed to differentiate and reanalyzed by Hoechst staining and gene expression analysis. Post differentiation, SP cells constitute 15.8% of total viable cells which decreases to 0.6% on treatment with CYA. The expression levels of P-gp efflux protein were also significantly decreased on treatment with PTX and CYA combination. MicroRNA profiling of DU145-TXR and PC3-TXR cells and prostate cancer tissue from the patients showed decreased expression of tumor suppressor miRNAs such as miR34a and miR200c. Treatment with PTX and CYA combination restored the expression of miR200c and 34a, confirming their role in modulating chemoresistance. We have shown that supplementing mitotic stabilizer drugs such as PTX with Hh-inhibitor CYA can reverse PTX chemoresistance and eliminate SP fraction in androgen independent, metastatic prostate cancer cell lines.	[Singh, Saurabh; Chitkara, Deepak; Mahato, Ram I.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Chitkara, Deepak] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Sas Nagar, Punjab, India; [Mehrazin, Reza; Wake, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Urol, Memphis, TN 38163 USA; [Behrman, Stephen W.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Singh, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	rmahato@uthsc.edu	Jackson, Benjamin L/C-4297-2012; Chitkara, Deepak/K-5545-2017		Idea Award from Department of Defense Prostate Cancer Research Program [W81XWH-10-1-0969]; Kosten Foundation	Idea Award from Department of Defense Prostate Cancer Research Program; Kosten Foundation	This work is supported by an Idea Award (W81XWH-10-1-0969) from the Department of Defense Prostate Cancer Research Program. Financial support by Kosten Foundation (www.kostenfoundation.com) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Baumert C, 2009, ANTI-CANCER AGENT ME, V9, P415, DOI 10.2174/1871520610909040415; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chearwae W, 2004, BIOCHEM PHARMACOL, V68, P2043, DOI 10.1016/j.bcp.2004.07.009; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; Chung MK, 2010, CLIN EXP MED, V10, P51, DOI 10.1007/s10238-009-0068-7; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Colabufo NA, 2011, TOXICOL IN VITRO, V25, P222, DOI 10.1016/j.tiv.2010.11.004; Coley HM, 2010, METHODS MOL BIOL, V596, P341, DOI 10.1007/978-1-60761-416-6_15; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Danquah M, 2009, PHARM RES-DORDR, V26, P2081, DOI 10.1007/s11095-009-9903-5; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gandellini P, 2010, DISCOV MED, V9, P212; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Han J, 2012, CANC LETT; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Komuro H, 2007, J PEDIATR SURG, V42, P2040, DOI 10.1016/j.jpedsurg.2007.08.026; Li F, 2011, DRUG DELIV TRANSL RE, V1, P420, DOI 10.1007/s13346-011-0042-2; Limtrakul P, 2007, MOL CELL BIOCHEM, V296, P85, DOI 10.1007/s11010-006-9302-8; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Nadendla SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020271; Nguyen NP, 2010, CANCER TREAT REV, V36, P485, DOI 10.1016/j.ctrv.2010.02.016; PAZDUR R, 1993, CANCER TREAT REV, V19, P351, DOI 10.1016/0305-7372(93)90010-O; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Ruiz IAA, 2011, SCI SIGNAL, V4, ppt9; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Shaw G, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-3; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shukla S, 2010, CURR DRUG TARGETS; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; van Brussel JR, 2003, ONKOLOGIE, V26, P175, DOI 10.1159/000071510; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zhou Y, 2012, BIOMATERIALS, V33, P1863, DOI 10.1016/j.biomaterials.2011.11.029	52	82	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40021	10.1371/journal.pone.0040021	http://dx.doi.org/10.1371/journal.pone.0040021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768203	gold, Green Published			2022-12-25	WOS:000305892100175
J	Wei, CC; Chen, YW; Powell, LC; Zheng, JY; Shi, K; Bradley, WE; Powell, PC; Ahmad, S; Ferrario, CM; Dell'Italia, LJ				Wei, Chih-Chang; Chen, Yuanwen; Powell, Lindsay C.; Zheng, Junying; Shi, Ke; Bradley, Wayne E.; Powell, Pamela C.; Ahmad, Sarfaraz; Ferrario, Carlos M.; Dell'Italia, Louis J.			Cardiac Kallikrein-Kinin System Is Upregulated in Chronic Volume Overload and Mediates an Inflammatory Induced Collagen Loss	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MAST-CELLS; BRADYKININ; HEART; RECEPTOR; RATS; HYPERTROPHY	Background: The clinical problem of a "pure volume overload'' as in isolated mitral or aortic regurgitation currently has no documented medical therapy that attenuates collagen loss and the resultant left ventricular (LV) dilatation and failure. Here, we identify a potential mechanism related to upregulation of the kallikrein - kinin system in the volume overload of aortocaval fistula (ACF) in the rat. Methodology/Principal Findings: LV interstitial fluid (ISF) collection, hemodynamics, and echocardiography were performed in age - matched shams and 4 and 15 wk ACF rats. ACF rats had LV dilatation and a 2 - fold increase in LV end-diastolic pressure, along with increases in LV ISF bradykinin, myocardial kallikrein and bradykinin type - 2 receptor (BK2R) mRNA expression. Mast cell numbers were increased and interstitial collagen was decreased at 4 and 15 wk ACF, despite increases in LV ACE and chymase activities. Treatment with the kallikrein inhibitor aprotinin preserved interstitial collagen, prevented the increase in mast cells, and improved LV systolic function at 4 wk ACF. To establish a cause and effect between ISF bradykinin and mast cell - mediated collagen loss, direct LV interstitial bradykinin infusion in vivo for 24 hrs produced a 2 - fold increase in mast cell numbers and a 30% decrease in interstitial collagen, which were prevented by BK2R antagonist. To further connect myocardial stretch with cellular kallikrein - kinin system upregulation, 24 hrs cyclic stretch of adult cardiomyocytes and fibroblasts produced increased kallikrein, BK2R mRNA expressions, bradykinin protein and gelatinase activity, which were all decreased by the kallikrein inhibitor - aprotinin. Conclusions/Significance: A pure volume overload is associated with upregulation of the kallikrein - kinin system and ISF bradykinin, which mediates mast cell infiltration, extracellular matrix loss, and LV dysfunction - all of which are improved by kallikrein inhibition. The current investigation provides important new insights into future potential medical therapies for the volume overload of aortic and mitral regurgitation.	[Wei, Chih-Chang; Dell'Italia, Louis J.] Univ Alabama Birmingham, Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Wei, Chih-Chang; Powell, Lindsay C.; Zheng, Junying; Shi, Ke; Bradley, Wayne E.; Powell, Pamela C.; Dell'Italia, Louis J.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Dell'Italia, Louis J.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Chen, Yuanwen] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Ahmad, Sarfaraz; Ferrario, Carlos M.] Wake Forest Univ, Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27109 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Shanghai Jiao Tong University; Wake Forest University	Wei, CC (corresponding author), Univ Alabama Birmingham, Birmingham Vet Affairs Med Ctr, Birmingham, AL USA.	chih@uab.edu	Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020; Chen, Yuanwen/AAL-6421-2020	Ferrario, Carlos/0000-0003-0792-6239; 	American Heart Association [0130306N]; Department of Veteran Affairs [84781]; National Institutes of Health for the SCCOR (Specialized Centers of Clinically Oriented Research) in Cardiac Dysfunction [P50-HL077100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952, P50HL077100] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veteran Affairs(US Department of Veterans Affairs); National Institutes of Health for the SCCOR (Specialized Centers of Clinically Oriented Research) in Cardiac Dysfunction; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association for National Scientist Development Grant Program [Grant 0130306N to CCW], by the Department of Veteran Affairs for Merit Review [Grant 84781 to CCW], and by the National Institutes of Health for the SCCOR (Specialized Centers of Clinically Oriented Research) in Cardiac Dysfunction [Grant P50-HL077100 to LJD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax JJ, 2006, J AM COLL CARDIOL, V48, P754, DOI 10.1016/j.jacc.2006.04.077; Behr TM, 2000, CIRCULATION, V102, P1315, DOI 10.1161/01.CIR.102.11.1315; Bledsoe G, 2003, AM J PHYSIOL-HEART C, V285, pH1479, DOI 10.1152/ajpheart.01129.2002; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; Borer JS, 2003, CIRCULATION, V108, P2432, DOI 10.1161/01.CIR.0000096400.00562.A3; Brower GL, 2002, AM J PHYSIOL-HEART C, V283, pH518, DOI 10.1152/ajpheart.00218.2000; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Chandrashekhar Y, 2007, J AM COLL CARDIOL, V49, P822, DOI 10.1016/j.jacc.2006.11.025; CHAO J, 1988, BIOCHIM BIOPHYS ACTA, V964, P329, DOI 10.1016/0304-4165(88)90033-5; Chen YW, 2011, AM J PHYSIOL-HEART C, V300, pH2251, DOI 10.1152/ajpheart.01104.2010; Cross LJM, 1997, INFLAMM RES, V46, P306, DOI 10.1007/s000110050192; Dolgilevich SM, 2001, AM J PHYSIOL-HEART C, V281, pH207, DOI 10.1152/ajpheart.2001.281.1.H207; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Forteza R, 1999, AM J RESP CELL MOL, V21, P666, DOI 10.1165/ajrcmb.21.6.3651; Hsieh HL, 2004, CELL SIGNAL, V16, P1163, DOI 10.1016/j.cellsig.2004.03.021; Kim NN, 1999, J MOL CELL CARDIOL, V31, P457, DOI 10.1006/jmcc.1998.0887; Li HJ, 2007, CARDIOVASC RES, V73, P130, DOI 10.1016/j.cardiores.2006.10.014; Li P, 1997, HYPERTENSION, V29, P394, DOI 10.1161/01.HYP.29.1.394; Lopez B, 2006, J AM COLL CARDIOL, V48, P89, DOI 10.1016/j.jacc.2006.01.077; Nolly H, 1997, IMMUNOPHARMACOLOGY, V36, P185, DOI 10.1016/S0162-3109(97)00020-9; Okada H, 2004, J AM SOC NEPHROL, V15, P2404, DOI 10.1097/01.ASN.0000136132.20189.95; Pat B, 2010, J CARD FAIL, V16, P769, DOI 10.1016/j.cardfail.2010.05.005; Ryan TD, 2007, J AM COLL CARDIOL, V49, P811, DOI 10.1016/j.jacc.2006.06.083; Sancho-Bru P, 2007, GASTROENTEROLOGY, V133, P2019, DOI 10.1053/j.gastro.2007.09.023; Santos DR, 2003, BRIT J PHARMACOL, V139, P271, DOI 10.1038/sj.bjp.0705236; Shigematsu S, 2002, AM J PHYSIOL-HEART C, V283, pH2676, DOI 10.1152/ajpheart.00538.2002; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tyagi SC, 1998, J CELL PHYSIOL, V176, P374, DOI 10.1002/(SICI)1097-4652(199808)176:2<374::AID-JCP16>3.0.CO;2-3; Wang M, 2011, PLOS ONE, V6; Wei CC, 2003, AM J PHYSIOL-HEART C, V285, pH784, DOI 10.1152/ajpheart.00793.2001; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; Yayama K, 2003, BIOCHEM PHARMACOL, V65, P1017, DOI 10.1016/S0006-2952(03)00008-X; Yayama K, 2000, BBA-MOL CELL RES, V1495, P69, DOI 10.1016/S0167-4889(99)00154-8; Zaczynska E, 2003, INFLAMMATION, V27, P307, DOI 10.1023/A:1026080527573	35	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40110	10.1371/journal.pone.0040110	http://dx.doi.org/10.1371/journal.pone.0040110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768235	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100207
J	Zhang, WS; Edwards, A; Fan, W; Flemington, EK; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Fan, Wei; Flemington, Erik K.; Zhang, Kun			miRNA-mRNA Correlation-Network Modules in Human Prostate Cancer and the Differences between Primary and Metastatic Tumor Subtypes	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; HUMAN BRAIN-CELLS; REGULATORY MODULES; EXPRESSION PROFILES; MICRORNA EXPRESSION; IDENTIFICATION; ACTIVATION; GENOMICS; TOOLS	Recent studies have shown the contribution of miRNAs to cancer pathogenesis. Prostate cancer is the most commonly diagnosed cancer in men. Unlike other major types of cancer, no single gene has been identified as being mutated in the majority of prostate tumors. This implies that the expression profiling of genes, including the non-coding miRNAs, may substantially vary across individual cases of this cancer. The within-class variability makes it possible to reconstruct or infer disease-specific miRNA-mRNA correlation and regulatory modular networks using high-dimensional microarray data of prostate tumor samples. Furthermore, since miRNAs and tumor suppressor genes are usually tissue specific, miRNA-mRNA modules could potentially differ between primary prostate cancer (PPC) and metastatic prostate cancer (MPC). We herein performed an in silico analysis to explore the miRNA-mRNA correlation network modules in the two tumor subtypes. Our analysis identified 5 miRNA-mRNA module pairs (MPs) for PPC and MPC, respectively. Each MP includes one positive-connection (correlation) module and one negative-connection (correlation) module. The number of miRNAs or mRNAs (genes) in each module varies from 2 to 8 or from 6 to 622. The modules discovered for PPC are more informative than those for MPC in terms of the implicated biological insights. In particular, one negative-connection module in PPC fits well with the popularly recognized miRNA-mediated post-transcriptional regulation theory. That is, the 3'UTR sequences of the involved mRNAs (similar to 620) are enriched with the target site motifs of the 7 modular miRNAs, has-miR-106b, -191, -19b, -92a, -92b, -93, and -141. About 330 GO terms and KEGG pathways, including TGF-beta signaling pathway that maintains tissue homeostasis and plays a crucial role in the suppression of the proliferation of cancer cells, are over-represented (adj. p<0.05) in the modular gene list. These computationally identified modules provide remarkable biological evidence for the interference of miRNAs in the development of prostate cancers and warrant additional follow-up in independent laboratory studies.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Fan, Wei] IBM TJ Watson Res, Hawthorne, NY USA; [Flemington, Erik K.] Tulane Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70118 USA; [Flemington, Erik K.] Tulane Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; International Business Machines (IBM); Tulane University; Tulane University	Zhang, WS (corresponding author), Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA.	kzhang@xula.edu	Jackson, Benjamin L/C-4297-2012		National Institutes of Health [NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-03]; Louisiana BOR award [LEQSF(2008-11)-RD-A-32]; US Department of Army [W911NF-12-1-0066]; NSF [EPS-1006891]; NATIONAL CANCER INSTITUTE [R01CA138268] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana BOR award; US Department of Army; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by National Institutes of Health grants (NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-03), a Louisiana BOR award (LEQSF(2008-11)-RD-A-32), an US Department of Army grant (W911NF-12-1-0066) and an NSF grant (EPS-1006891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonnet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010162; Bueno MJ, 2010, MOL CELL BIOL, V30, P2983, DOI 10.1128/MCB.01372-09; Bunz F., 2008, PRINCIPLES CANC GENE; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Figel S, 2011, ANTICANCER AGENTS ME; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-426; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Kulp DC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-125; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu B, 2010, BIOINFORMATICS, V26, P3105, DOI 10.1093/bioinformatics/btq576; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wall ME, 2001, BIOINFORMATICS, V17, P566, DOI 10.1093/bioinformatics/17.6.566; Wang D., 2010, PLOS ONE, V5; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031429; Zhang WS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-338	39	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40130	10.1371/journal.pone.0040130	http://dx.doi.org/10.1371/journal.pone.0040130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768240	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100212
J	Kenney, JW; Poole, RL; Adoff, MD; Logue, SF; Gould, TJ				Kenney, Justin W.; Poole, Rachel L.; Adoff, Michael D.; Logue, Sheree F.; Gould, Thomas J.			Learning and Nicotine Interact to Increase CREB Phosphorylation at the jnk1 Promoter in the Hippocampus	PLOS ONE			English	Article							LONG-TERM-MEMORY; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR CREB; SYNAPTIC PLASTICITY; C57BL/6J MICE; HISTONE ACETYLTRANSFERASE; ACETYLCHOLINE-RECEPTOR; GLUTAMATE RECEPTORS; CBP; NEURONS	Nicotine is known to enhance long-term hippocampus dependent learning and memory in both rodents and humans via its activity at nicotinic acetylcholinergic receptors (nAChRs). However, the molecular basis for the nicotinic modulation of learning is incompletely understood. Both the mitogen activated protein kinases (MAPKs) and cAMP response element binding protein (CREB) are known to be integral to the consolidation of long-term memory and the disruption of MAPKs and CREB are known to abrogate some of the cognitive effects of nicotine. In addition, the acquisition of contextual fear conditioning in the presence of nicotine is associated with a beta 2-subunit containing nAChR-dependent increase in jnk1 (mapk8) transcription in the hippocampus. In the present study, chromatin immunoprecipitation (ChIP) was used to examine whether learning and nicotine interact to alter transcription factor binding or histone acetylation at the jnk1 promoter region. The acquisition of contextual fear conditioning in the presence of nicotine resulted in an increase in phosphorylated CREB (pCREB) binding to the jnk1 promoter in the hippocampus in a beta 2-subunit containing nAChR dependent manner, but had no effect on CREB binding; neither fear conditioning alone nor nicotine administration alone altered transcription factor binding to the jnk1 promoter. In addition, there were no changes in histone H3 or H4 acetylation at the jnk1 promoter following fear conditioning in the presence of nicotine. These results suggest that contextual fear learning and nicotine administration act synergistically to produce a unique pattern of protein activation and gene transcription in the hippocampus that is not individually generated by fear conditioning or nicotine administration alone.	[Kenney, Justin W.; Poole, Rachel L.; Adoff, Michael D.; Logue, Sheree F.; Gould, Thomas J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kenney, JW (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	tgould@temple.edu	Kenney, Justin/AAG-8291-2020	Kenney, Justin/0000-0001-8790-5184	National Institutes of Health [DA017949, DA024787, DA07237, CA143187]; Temple University; NATIONAL CANCER INSTITUTE [P50CA143187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024787, R01DA017949, T32DA007237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (DA017949, DA024787, TJG; DA07237, JWK; CA143187, PI Caryn Lerman) and the Temple University Thomas E. Shipley Jr. Memorial Award (Justin W. Kenney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Andre JM, 2011, NEUROPHARMACOLOGY, V60, P617, DOI 10.1016/j.neuropharm.2010.12.004; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Davis JA, 2006, NEUROSCI LETT, V394, P202, DOI 10.1016/j.neulet.2005.10.026; Davis JA, 2007, J NEUROSCI, V27, P10870, DOI 10.1523/JNEUROSCI.3242-07.2007; Davis JA, 2007, PSYCHOPHARMACOLOGY, V190, P343, DOI 10.1007/s00213-006-0624-8; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Gass P, 1998, LEARN MEMORY, V5, P274; Gould TJ, 2003, NEUROBIOL LEARN MEM, V80, P147, DOI 10.1016/S1074-7427(03)00057-1; Graves L, 2002, HIPPOCAMPUS, V12, P18, DOI 10.1002/hipo.10003; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Herman AI, 2010, ADDICT BIOL, V15, P250, DOI 10.1111/j.1369-1600.2010.00213.x; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Kenney JW, 2008, BEHAV NEUROSCI, V122, P1158, DOI 10.1037/a0012807; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Kenney JW, 2011, PSYCHOPHARMACOLOGY, V217, P353, DOI 10.1007/s00213-011-2283-7; Kenney JW, 2010, NEUROPSYCHOPHARMACOL, V35, P483, DOI 10.1038/npp.2009.153; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; KURINO M, 1995, J NEUROCHEM, V65, P1282; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mayall TP, 1997, GENE DEV, V11, P887, DOI 10.1101/gad.11.7.887; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Melichercik AM, 2012, NEUROPHARMACOLOGY, V62, P2096, DOI 10.1016/j.neuropharm.2012.01.008; Nakayama H, 2001, J NEUROCHEM, V79, P489, DOI 10.1046/j.1471-4159.2001.00602.x; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Oliveira AMM, 2011, LEARN MEMORY, V18, P161, DOI 10.1101/lm.1939811; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Picciotto MR, 2008, FRONT BIOSCI-LANDMRK, V13, P492, DOI 10.2741/2695; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Portugal GS, 2012, BEHAV GENET, V42, P133, DOI 10.1007/s10519-011-9489-7; Quinn JJ, 2005, HIPPOCAMPUS, V15, P665, DOI 10.1002/hipo.20088; Raybuck JD, 2010, NEUROBIOL LEARN MEM, V94, P353, DOI 10.1016/j.nlm.2010.08.001; Raybuck JD, 2007, BEHAV NEUROSCI, V121, P1119, DOI 10.1037/0735-7044.121.5.1119; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Steiner RC, 2007, J NEUROCHEM, V103, P666, DOI 10.1111/j.1471-4159.2007.04799.x; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wehner JM, 2004, NEUROSCIENCE, V129, P11, DOI 10.1016/j.neuroscience.2004.07.016; Woodruff-Pak Diana S, 2002, Behav Cogn Neurosci Rev, V1, P5, DOI 10.1177/1534582302001001002; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	69	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39939	10.1371/journal.pone.0039939	http://dx.doi.org/10.1371/journal.pone.0039939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761932	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305826400048
J	Khemiri, L; Guterstam, J; Franck, J; Jayaram-Lindstrom, N				Khemiri, Lotfi; Guterstam, Joar; Franck, Johan; Jayaram-Lindstrom, Nitya			Alcohol Dependence Associated with Increased Utilitarian Moral Judgment: A Case Control Study	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; EMOTIONAL FACIAL EXPRESSION; DECISION-MAKING; PERSONAL/IMPERSONAL DISTINCTION; PROBLEM GAMBLERS; DEFICITS; ADDICTION; INDIVIDUALS; IMPULSIVITY; COGNITION	Recent studies indicate that emotional processes, mediated by the ventromedial prefrontal cortex (VMPC), are of great importance for moral judgment. Neurological patients with VMPC dysfunction have been shown to generate increased utilitarian moral judgments, i.e. are more likely to endorse emotionally aversive actions in order to maximize aggregate welfare, when faced with emotionally salient personal moral dilemmas. Patients with alcohol dependence (AD) also exhibit impairments in functions mediated by the prefrontal cortex, but whether they exhibit increased utilitarian moral reasoning has not previously been investigated. The aim of this study was to investigate moral judgment in AD patients (n = 20) compared to healthy controls (n = 20) matched by sex, age and education years. Each subject responded to a battery of 50 hypothetical dilemmas categorized as non-moral, moral impersonal and moral personal. They also responded to a questionnaire evaluating explicit knowledge of social and moral norms. Results confirmed our hypothesis that AD patients generated increased utilitarian moral judgment compared to controls when faced with moral personal dilemmas. Crucially, there was no difference in their responses to non-moral or impersonal moral dilemmas, nor knowledge of explicit social and moral norms. One possible explanation is that damage to the VMPC, caused by long term repeated exposure to alcohol results in emotional dysfunction, predisposing to utilitarian moral judgment. This work elucidates a novel aspect of the neuropsychological profile of AD patients, namely a tendency to generate utilitarian moral judgment when faced with emotionally salient moral personal dilemmas.	[Khemiri, Lotfi; Guterstam, Joar; Franck, Johan; Jayaram-Lindstrom, Nitya] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Khemiri, L (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	lotfi.khemiri@stud.ki.se	Jayaram-Lindström, Nitya/AAQ-4268-2021; Guterstam, Joar/T-8883-2019	Jayaram-Lindström, Nitya/0000-0002-2678-3782; Guterstam, Joar/0000-0002-2643-4291	Swedish Science Research Council (VR)	Swedish Science Research Council (VR)(Swedish Research Council)	The study was supported by a public grant from the Swedish Science Research Council (VR). This grant was given to support research on alcoholism. None of the authors are in any way affiliated or employed by the funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTERMAN AI, 1978, J CLIN PSYCHOL, V34, P790, DOI 10.1002/1097-4679(197807)34:3<790::AID-JCLP2270340346>3.0.CO;2-P; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bentham J, 2007, INTRO PRINCIPLES MOR; CERMAK LS, 1989, ALCOHOL CLIN EXP RES, V13, P611, DOI 10.1111/j.1530-0277.1989.tb00391.x; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Clark US, 2007, NEUROPSYCHOLOGY, V21, P346, DOI 10.1037/0894-4105.21.3.346; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Damasio, 2005, DESCARTES ERROR EMOT, P101; Darwin Charles, 1998, DESCENT MAN; Foisy ML, 2007, ALCOHOL CLIN EXP RES, V31, P404, DOI 10.1111/j.1530-0277.2006.00321.x; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, J EXP SOC PSYCHOL, V45, P581, DOI 10.1016/j.jesp.2009.01.003; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HARPER CG, 1987, BRIT J ADDICT, V82, P1349; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Kant I., 2005, FUNDAMENTAL PRINCIPL; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1973, J PHILOS, V70, P630, DOI [10.2307/2025030, DOI 10.2307/2025030]; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2011, CURR TOP BEHAV NEURO; Kril JJ, 1999, PROG NEUROBIOL, V58, P381, DOI 10.1016/S0301-0082(98)00091-4; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; MANN K, 1995, J NEURAL TRANSM-GEN, V99, P145, DOI 10.1007/BF01271475; McGuire J, 2009, J EXP SOC PSYCHOL, V45, P577, DOI 10.1016/j.jesp.2009.01.002; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Monnot M, 2001, ALCOHOL CLIN EXP RES, V25, P362, DOI 10.1111/j.1530-0277.2001.tb02222.x; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1097/00000374-199906000-00010; Thomson Judith J, 1976, Monist, V59, P204; Uekermann J, 2007, ADDICTION, V102, P232, DOI 10.1111/j.1360-0443.2006.01656.x; Uekermann J, 2008, ADDICTION, V103, P726, DOI 10.1111/j.1360-0443.2008.02157.x; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Waal F, 2009, PRIMATES PHILOS MORA; Young L, 2007, BRIT MED BULL, V84, P69, DOI 10.1093/bmb/ldm031	43	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39882	10.1371/journal.pone.0039882	http://dx.doi.org/10.1371/journal.pone.0039882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761922	Green Submitted, gold, Green Published			2022-12-25	WOS:000305826400044
J	Cevik, MO; Erden, A				Cevik, Munire Ozlem; Erden, Ahmet			The Course of Habituation of the Proboscis Extension Reflex Can Be Predicted by Sucrose Responsiveness in Drosophila	PLOS ONE			English	Article							TASTE; BEHAVIOR; FLY; DISHABITUATION; MUTATIONS; LABELLAR	The proboscis extension reflex (PER) is triggered when insects' gustatory receptors contact appetitive stimuli, so it provides a behavioral readout for perceptual encoding of tastants. Research on the experience dependent modulation of PER in Drosophila has been hindered by the difficulty of obtaining reliable measures of memory-driven change in PER probability in the background of larger changes induced by physiological state. In this study, we showed that the course of PER habituation can be predicted by the degree of sucrose responsiveness in Drosophila. We assessed early response parameters, including the number of proboscis extensions and labellar movements in the first five trials, the trial to start responding, and the trial to make the first stop to quantify responsiveness, which predicted the upcoming pattern of both the short-term and 1 hour memory of PER habituation for individual flies. The cAMP signaling pathway mutant rutabaga displayed deficits in attunement of perceptual salience of sucrose to physiological demands and stimulus-driven sensitization.	[Cevik, Munire Ozlem; Erden, Ahmet] Abant Izzet Baysal Univ, Bolu, Turkey	Abant Izzet Baysal University	Cevik, MO (corresponding author), Dogus Univ, Istanbul, Turkey.	mcevik@dogus.edu.tr	Cevik, Munire Ozlem/O-7757-2019	Cevik, Munire Ozlem/0000-0002-7151-9630	Turkish Institute of Scientific and Technological Research [TUBITAK-SBAG 2534]; Turkish Academy of Science Young Investigator Award (TUBA-GEBIP); Abant Izzet Baysal Universitesi Scientific Research Grants (AIBU-BAP)	Turkish Institute of Scientific and Technological Research(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish Academy of Science Young Investigator Award (TUBA-GEBIP)(Turkish Academy of Sciences); Abant Izzet Baysal Universitesi Scientific Research Grants (AIBU-BAP)(Abant Izzet Baysal University)	This research was supported by research grants to Munire Ozlem Cevik from the following institutions: The Turkish Institute of Scientific and Technological Research (TUBITAK-SBAG 2534), www.tubitak.gov.tr, The Turkish Academy of Science Young Investigator Award (TUBA-GEBIP), www.tuba.gov.tr, and Abant Izzet Baysal Universitesi Scientific Research Grants (AIBU-BAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, LEARN MEMORY, V14, P376, DOI 10.1101/lm.566007; Bullock TH, 1959, INTRO NERVOUS SYSTEM; Bullock TH, 1957, PHYSL TRIGGERS DISCO; Chabaud MA, 2006, J COMP PHYSIOL A, V192, P1335, DOI 10.1007/s00359-006-0160-3; CORFAS G, 1990, J NEUROSCI, V10, P491; CORFAS G, 1989, J NEUROSCI, V9, P56; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dethier V, 1974, EXPT ANAL INSECT BEH; DETHIER VG, 1952, BIOL BULL, V103, P178, DOI 10.2307/1538444; Dethier VG, 1976, HUNGRY FLY; DOMJAN M, 1980, LEARN MOTIV, V11, P522, DOI 10.1016/0023-9690(80)90031-4; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; EDGECOMB RS, 1987, J EXP BIOL, V127, P79; Engel JE, 2009, NEUROBIOL LEARN MEM, V92, P166, DOI 10.1016/j.nlm.2008.08.003; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; LUBOW RE, 1959, J COMP PHYSIOL PSYCH, V52, P415, DOI 10.1037/h0046700; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Martin F, 2001, J COMP PHYSIOL A, V187, P359, DOI 10.1007/s003590100208; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Motosaka K, 2007, J COMP PHYSIOL A, V193, P279, DOI 10.1007/s00359-006-0200-z; Muller U, 2002, J NEUROSCI, V22, P8739; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; POLLACK GS, 1977, J COMP PHYSIOL, V121, P115, DOI 10.1007/BF00614184; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; SUDLOW LC, 1987, J EXP BIOL, V130, P219; TULLY T, 1983, BEHAV NEUROSCI, V97, P146, DOI 10.1037/0735-7044.97.1.146; Ueda A, 2009, J NEUROGENET, V23, P185, DOI 10.1080/01677060802471726; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; VARGO M, 1982, J COMP PHYSIOL PSYCH, V96, P452, DOI 10.1037/h0077899; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001	35	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39863	10.1371/journal.pone.0039863	http://dx.doi.org/10.1371/journal.pone.0039863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761915	Green Submitted, gold, Green Published			2022-12-25	WOS:000305808700051
J	Lausberg, F; Fleckenstein, S; Kreutzenbeck, P; Frobel, J; Rose, P; Muller, M; Freudl, R				Lausberg, Frank; Fleckenstein, Stefan; Kreutzenbeck, Peter; Froebel, Julia; Rose, Patrick; Mueller, Matthias; Freudl, Roland			Genetic Evidence for a Tight Cooperation of TatB and TatC during Productive Recognition of Twin-Arginine (Tat) Signal Peptides in Escherichia coli	PLOS ONE			English	Article							PRECURSOR PROTEINS BIND; TRANSLOCATION PATHWAY; SUBSTRATE-BINDING; SECRETION; MEMBRANE; TRANSPORT; COMPLEX; SYSTEM; EXPORT; MOTIF	The twin arginine translocation (Tat) pathway transports folded proteins across the cytoplasmic membrane of bacteria. Tat signal peptides contain a consensus motif (S/T-R-R-X-F-L-K) that is thought to play a crucial role in substrate recognition by the Tat translocase. Replacement of the phenylalanine at the +2 consensus position in the signal peptide of a Tat-specific reporter protein (TorA-MalE) by aspartate blocked export of the corresponding TorA(D+2)-MalE precursor, indicating that this mutation prevents a productive binding of the TorA(D+2) signal peptide to the Tat translocase. Mutations were identified in the extreme amino-terminal regions of TatB and TatC that synergistically suppressed the export defect of TorA(D+2)-MalE when present in pairwise or triple combinations. The observed synergistic suppression activities were even more pronounced in the restoration of membrane translocation of another export-defective precursor, TorA(KQ)-MalE, in which the conserved twin arginine residues had been replaced by lysine-glutamine. Collectively, these findings indicate that the extreme amino-terminal regions of TatB and TatC cooperate tightly during recognition and productive binding of Tat-dependent precursor proteins and, furthermore, that TatB and TatC are both involved in the formation of a specific signal peptide binding site that reaches out as far as the end of the TatB transmembrane segment.	[Lausberg, Frank; Fleckenstein, Stefan; Kreutzenbeck, Peter; Freudl, Roland] Forschungszentrum Julich, Inst Bio & Geowissensch 1, D-52425 Julich, Germany; [Froebel, Julia; Rose, Patrick; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79106 Freiburg, Germany; [Froebel, Julia; Rose, Patrick] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Helmholtz Association; Research Center Julich; University of Freiburg; University of Freiburg	Freudl, R (corresponding author), Forschungszentrum Julich, Inst Bio & Geowissensch 1, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279	Commission of the European Union (CEU) [LSHG-CT-2004-005257]	Commission of the European Union (CEU)(European Commission)	This research was supported by the Commission of the European Union (CEU) project LSHG-CT-2004-005257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jaeger KE, 2001, APPL MICROBIOL BIOT, V55, P519, DOI 10.1007/s002530100643; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; KNECHT DA, 1984, ANAL BIOCHEM, V136, P180, DOI 10.1016/0003-2697(84)90321-X; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Li HM, 2006, FEMS MICROBIOL LETT, V255, P268, DOI 10.1111/j.1574-6968.2005.00081.x; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Meissner D, 2007, APPL MICROBIOL BIOT, V76, P633, DOI 10.1007/s00253-007-0934-8; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Rusch SL, 2007, BIOCHEMISTRY-US, V46, P9665, DOI 10.1021/bi7010064; Sambrook J, 2001, MOL CLONING LAB MANU; Sargent F, 2006, FEMS MICROBIOL LETT, V254, P198, DOI 10.1111/j.1574-6968.2005.00049.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zoufaly S, 2012, J BIOL CHEM IN PRESS	44	37	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39867	10.1371/journal.pone.0039867	http://dx.doi.org/10.1371/journal.pone.0039867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761916	Green Submitted, gold, Green Published			2022-12-25	WOS:000305808700052
J	Tanaka, M; Mroz, P; Dai, TH; Huang, LY; Morimoto, Y; Kinoshita, M; Yoshihara, Y; Nemoto, K; Shinomiya, N; Seki, S; Hamblin, MR				Tanaka, Masamitsu; Mroz, Pawel; Dai, Tianhong; Huang, Liyi; Morimoto, Yuji; Kinoshita, Manabu; Yoshihara, Yasuo; Nemoto, Koichi; Shinomiya, Nariyoshi; Seki, Suhji; Hamblin, Michael R.			Photodynamic Therapy Can Induce a Protective Innate Immune Response against Murine Bacterial Arthritis via Neutrophil Accumulation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; KAPPA-B ACTIVATION; IN-VIVO; CHOROIDAL NEOVASCULARIZATION; ANTITUMOR IMMUNITY; INFECTIONS; CELLS; VITRO; MICE; PHOTOSENSITIZER	Background: Local microbial infections induced by multiple-drug-resistant bacteria in the orthopedic field can be intractable, therefore development of new therapeutic modalities is needed. Photodynamic therapy (PDT) is a promising alternative modality to antibiotics for intractable microbial infections, and we recently reported that PDT has the potential to accumulate neutrophils into the infected site which leads to resolution of the infection. PDT for cancer has long been known to be able to stimulate the innate and adaptive arms of the immune system. Methodology/Principal Findings: In the present study, a murine methicillin-resistant Staphylococcus aureus (MRSA) arthritis model using bioluminescent MRSA and polystyrene microparticles was established, and both the therapeutic (Th-PDT) and preventive (Pre-PDT) effects of PDT using methylene blue as photosensitizer were examined. Although Th-PDT could not demonstrate direct bacterial killing, neutrophils were accumulated into the infectious joint space after PDT and MRSA arthritis was reduced. With the preconditioning Pre-PDT regimen, neutrophils were quickly accumulated into the joint immediately after bacterial inoculation and bacterial growth was suppressed and the establishment of infection was inhibited. Conclusions/Significance: This is the first demonstration of a protective innate immune response against a bacterial pathogen produced by PDT.	[Tanaka, Masamitsu; Mroz, Pawel; Dai, Tianhong; Huang, Liyi; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Tanaka, Masamitsu; Mroz, Pawel; Dai, Tianhong; Huang, Liyi; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Tanaka, Masamitsu; Yoshihara, Yasuo; Nemoto, Koichi] Natl Def Med Coll, Dept Orthoped Surg, Tokorozawa, Saitama 359, Japan; [Morimoto, Yuji; Shinomiya, Nariyoshi] Natl Def Med Coll, Dept Integrated Physiol & Bionano Med, Tokorozawa, Saitama 359, Japan; [Kinoshita, Manabu; Seki, Suhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; Harvard University; Massachusetts Institute of Technology (MIT)	Tanaka, M (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	moyan@ndmc.ac.jp; hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Dai, Tianhong/P-5961-2018; Shinomiya, Nariyoshi/I-9666-2014; Mroz, Pawel/P-1258-2019; Hamblin, Mike/AAB-2511-2022; MORIMOTO, YUJI/F-2912-2019	Hamblin, Michael R/0000-0001-6431-4605; Dai, Tianhong/0000-0001-8960-8896; Mroz, Pawel/0000-0003-3838-4743; MORIMOTO, YUJI/0000-0001-6494-413X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23659628]; U.S. National Institutes of Health [R01AI050875]; Airlift Research Foundation Extremity Trauma Research Grant [109421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Airlift Research Foundation Extremity Trauma Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (23659628) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Yuji Morimoto. Liyi Huang and Michael R. Hamblin were supported by U.S. National Institutes of Health grant R01AI050875 to Michael R. Hamblin, and Tianhong Dai by an Airlift Research Foundation Extremity Trauma Research Grant (grant 109421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHIAUME F, 1994, BIO-TECHNOL, V12, P703, DOI 10.1038/nbt0794-703; Biel MA, 2010, METHODS MOL BIOL, V635, P175, DOI 10.1007/978-1-60761-697-9_13; Bisland SK, 2006, PHOTOCH PHOTOBIO SCI, V5, P31, DOI 10.1039/b507082a; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Cecic I, 2001, PHOTOCHEM PHOTOBIOL, V74, P712, DOI 10.1562/0031-8655(2001)074<0712:IOSNRI>2.0.CO;2; Chang CJ, 1999, LASER SURG MED, V24, P178, DOI 10.1002/(SICI)1096-9101(1999)24:3<178::AID-LSM2>3.3.CO;2-N; Dai TH, 2010, LASER SURG MED, V42, P38, DOI 10.1002/lsm.20887; deVree WJA, 1996, CANCER RES, V56, P2908; Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038; DRISCOLL KE, 1993, AM J RESP CELL MOL, V8, P311, DOI 10.1165/ajrcmb/8.3.311; Fontana CR, 2009, J PERIODONTAL RES, V44, P751, DOI 10.1111/j.1600-0765.2008.01187.x; Gad F, 2004, PHOTOCH PHOTOBIO SCI, V3, P451, DOI 10.1039/b311901g; Gallo Jiri, 2003, Biomedical Papers (Olomouc), V147, P27; Garg AD, 2011, PHOTOCH PHOTOBIO SCI, V10, P670, DOI 10.1039/c0pp00294a; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Granville DJ, 2000, BLOOD, V95, P256; Hamblin MR, 2002, PHOTOCHEM PHOTOBIOL, V75, P51, DOI 10.1562/0031-8655(2002)075<0051:RCOWIB>2.0.CO;2; HAYATA Y, 1982, CHEST, V81, P269, DOI 10.1378/chest.81.3.269; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x; HSIANG YN, 1994, CAN J SURG, V37, P148; Kielian T, 2000, AM J PATHOL, V157, P647, DOI 10.1016/S0002-9440(10)64575-0; Kinoshita M, 2011, INFECT IMMUN, V79, P2670, DOI 10.1128/IAI.01298-10; KONIG K, 1987, J CANCER RES CLIN, V113, P301, DOI 10.1007/BF00396390; Korbelik M, 1999, CANCER RES, V59, P1941; Kousis PC, 2007, CANCER RES, V67, P10501, DOI 10.1158/0008-5472.CAN-07-1778; Kramer M, 1996, OPHTHALMOLOGY, V103, P427; Lambrechts SAG, 2005, PHOTOCH PHOTOBIO SCI, V4, P503, DOI 10.1039/b502125a; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328; Massey E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005341.pub2; MONTEFORT S, 1994, J CLIN INVEST, V93, P1411, DOI 10.1172/JCI117118; Mroz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015194; NAKAGAWA Y, 1993, CANCER IMMUNOL IMMUN, V37, P157, DOI 10.1007/BF01525429; Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Obana A, 1999, LASER SURG MED, V24, P209, DOI 10.1002/(SICI)1096-9101(1999)24:3<209::AID-LSM6>3.0.CO;2-L; Oleinick NL, 1998, RADIAT RES, V150, pS146, DOI 10.2307/3579816; Patel A, 2008, J BONE JOINT SURG BR, V90B, P1401, DOI 10.1302/0301-620X.90B11.20771; Peng Q, 1997, PHOTOCHEM PHOTOBIOL, V65, P235, DOI 10.1111/j.1751-1097.1997.tb08549.x; Preise D, 2009, CANCER IMMUNOL IMMUN, V58, P71, DOI 10.1007/s00262-008-0527-0; RYTER SW, 1993, PHOTOCHEM PHOTOBIOL, V58, P753, DOI 10.1111/j.1751-1097.1993.tb04964.x; Street CN, 2010, PHOTOMED LASER SURG, V28, pS61, DOI 10.1089/pho.2009.2622; Tanaka M, 2012, PHOTOCHEM PHOTOBIOL, V88, P227, DOI 10.1111/j.1751-1097.2011.01005.x; Tanaka M, 2011, LASER SURG MED, V43, P221, DOI 10.1002/lsm.21037; Tanaka M, 2010, PHOTOCHEM PHOTOBIOL, V86, P403, DOI 10.1111/j.1751-1097.2009.00658.x; TANG G, 1993, NEUROSURGERY, V32, P438, DOI 10.1227/00006123-199303000-00016; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; Volanti C, 2002, PHOTOCHEM PHOTOBIOL, V75, P36, DOI 10.1562/0031-8655(2002)075<0036:IOOSIN>2.0.CO;2; Zolfaghari PS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-27	52	44	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39823	10.1371/journal.pone.0039823	http://dx.doi.org/10.1371/journal.pone.0039823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761911	Green Published, Green Submitted, gold			2022-12-25	WOS:000305808700049
J	Yao, YF; Li, X; Jiang, HE; Ferguson, DK; Hueber, F; Ghosh, R; Bera, S; Li, CS				Yao, Yi-Feng; Li, Xiao; Jiang, Hong-En; Ferguson, David K.; Hueber, Francis; Ghosh, Ruby; Bera, Subir; Li, Cheng-Sen			Pollen and Phytoliths from Fired Ancient Potsherds as Potential Indicators for Deciphering Past Vegetation and Climate in Turpan, Xinjiang, NW China	PLOS ONE			English	Article							YANGHAI TOMBS; PALEOENVIRONMENTAL INDICATORS; ENVIRONMENTAL-CONDITIONS; QUANTITATIVE INDICATORS; GRASSES; L.; RECONSTRUCTION; ASSEMBLAGES; CANNABIS; HISTORY	It is demonstrated that palynomorphs can occur in fired ancient potsherds when the firing temperature was under 350 degrees C. Pollen and phytoliths recovered from incompletely fired and fully fired potsherds (ca. 2700 yrs BP) from the Yanghai Tombs, Turpan, Xinjiang, NW China can be used as potential indicators for reconstructing past vegetation and corresponding climate in the area. The results show a higher rate of recovery of pollen and phytoliths from incompletely fired potsherds than from fully fired ones. Charred phytoliths recovered from both fully fired and incompletely fired potsherds prove that degree and condition of firing result in a permanent change in phytolith color. The palynological data, together with previous data of macrobotanical remains from the Yanghai Tombs, suggest that temperate vegetation and arid climatic conditions dominated in the area ca. 2700 yrs BP.	[Yao, Yi-Feng; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, Xiao] Renmin Univ China, Sch Guoxue, Beijing, Peoples R China; [Jiang, Hong-En] Chinese Acad Sci, Grad Univ, Dept Sci Hist & Archaeometry, Beijing, Peoples R China; [Ferguson, David K.] Univ Vienna, Dept Paleontol, Vienna, Austria; [Hueber, Francis] US Natl Museum, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC USA; [Ghosh, Ruby] Birbal Sahni Inst Paleobot, Lucknow, Uttar Pradesh, India; [Ghosh, Ruby; Bera, Subir] Univ Calcutta, Dept Bot, Kolkata, India	Chinese Academy of Sciences; Institute of Botany, CAS; Renmin University of China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Vienna; Smithsonian Institution; Smithsonian National Museum of Natural History; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); University of Calcutta	Yao, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	lics@ibcas.ac.cn		Bera, Subir/0000-0002-1075-7846	National Natural Science Foundation of China [30990241, 40701191, 41102114]; Graduate University of Chinese Academy of Sciences [Y05101PY00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate University of Chinese Academy of Sciences(Chinese Academy of Sciences)	This study is financially supported by the National Natural Science Foundation of China (Nos. 30990241, 40701191, 41102114) and the Presidential Fund of the Graduate University of Chinese Academy of Sciences (Y05101PY00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[阿布都热合曼·哈力克 Abdirahman·Halik], 2009, [水文, Hydrology], V29, P50; [Anonymous], [No title captured]; Barboni D, 1999, PALAEOGEOGR PALAEOCL, V152, P87, DOI 10.1016/S0031-0182(99)00045-0; Boyd M, 2005, J ARID ENVIRON, V61, P357, DOI 10.1016/j.jaridenv.2004.09.015; BROWN DA, 1984, J ARCHAEOL SCI, V11, P345, DOI 10.1016/0305-4403(84)90016-5; Bryant VM, 2003, SCIENCE, V299, P1029, DOI 10.1126/science.1081624; Comprehensive Expedition of Xinjiang Chinese Academy of Sciences Institute of Botany CAS (CEXCAS IBCAS), 1978, XINJ VEG ITS UT; Elbaum R, 2003, J ARCHAEOL SCI, V30, P217, DOI 10.1006/jasc.2002.0828; Erdtman G., 1952, INTRO PALYNOLOGY, VI; Faegri K, 1975, TXB POLLEN ANAL; Fici S, 2004, PLANT BIOSYST, V138, P125, DOI 10.1080/11263500412331283753; FREDLUND GG, 1994, J BIOGEOGR, V21, P321, DOI 10.2307/2845533; Ghosh R, 2006, J ARCHAEOL SCI, V33, P1445, DOI 10.1016/j.jas.2006.01.015; Gu YS, 2008, J BIOGEOGR, V35, P325, DOI 10.1111/j.1365-2699.2007.01763.x; Hu YQ, 2007, J ARCHAEOL SCI, V34, P1153, DOI 10.1016/j.jas.2006.10.026; IBCAS (Institute of Botany Chinese Academy of Sciences), 1976, SPOR PTER SIN; IBSCIBCAS (Institute of Botany and South China Institute of Botany Chinese Academy of Sciences), 1982, ANG POLL FLOR TROP S; JACOBS M., 1965, Blumea, V12, P385; Jiang H, 2007, J PALAEOGEOGR, V5, P551; Jiang HE, 2006, THESIS CHINESE ACAD; Jiang HE, 2007, J ETHNOPHARMACOL, V113, P409, DOI 10.1016/j.jep.2007.06.020; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Jiang HE, 2007, J ARCHAEOL SCI, V34, P167, DOI 10.1016/j.jas.2006.04.003; Jiang HE, 2009, J ARCHAEOL SCI, V36, P1458, DOI 10.1016/j.jas.2009.02.010; Kenny JB, 1976, COMPLETE BOOK POTTER; KONDO R, 1981, Research Bulletin of Obihiro University Series I, V12, P217; Kondo R, 1978, SOIL SCI PLANT NUTR, V49, P138; Kondo R., 1994, OPAL PHYTOLITHS NZ; Lu HY, 2007, QUATERNARY SCI REV, V26, P759, DOI 10.1016/j.quascirev.2006.10.006; Lu HY, 2006, QUATERNARY SCI REV, V25, P945, DOI 10.1016/j.quascirev.2005.07.014; Lu HY, 2005, HOLOCENE, V15, P965, DOI 10.1191/0959683605hl870ra; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; MULHOLLAND SC, 1989, J ARCHAEOL SCI, V16, P489, DOI 10.1016/0305-4403(89)90070-8; Parr JF, 2006, GEOARCHAEOLOGY, V21, P171, DOI 10.1002/gea.20102; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno D. R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1998, SMITHSONIAN CONTRIBU, P1, DOI [10.5479/si.0081024X.85, DOI 10.5479/SI.0081024X.85]; Russo EB, 2008, J EXP BOT, V59, P4171, DOI 10.1093/jxb/ern260; SASE T, 1974, Research Bulletin of Obihiro University Series I, V8, P465; SENGUPTA S, 1977, REV PALAEOBOT PALYNO, V24, P239, DOI 10.1016/0034-6667(77)90037-9; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Wallis LA, 2001, QUATERN INT, V83-5, P103, DOI 10.1016/S1040-6182(01)00033-7; Wang F.X., 1995, POLLEN FLORA CHINA; Wang YJ, 1993, STUDY PHYTOLITHS THE; Xi Y.Z., 1994, YUSHANIA, V11, P119; XICRA-BCRTP (Xinjiang Institute of Cultural Relics and Archaeology Bureau of Cultural Relics of Turpan Prefecture), 2004, TURFANOLOGICAL RES, V1, P1	49	10	10	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39780	10.1371/journal.pone.0039780	http://dx.doi.org/10.1371/journal.pone.0039780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761901	Green Published, Green Submitted, gold			2022-12-25	WOS:000305781700067
J	Gallo, LA; Tran, M; Moritz, KM; Jefferies, AJ; Wlodek, ME				Gallo, Linda A.; Tran, Melanie; Moritz, Karen M.; Jefferies, Andrew J.; Wlodek, Mary E.			Pregnancy in aged rats that were born small: cardiorenal and metabolic adaptations and second-generation fetal growth	FASEB JOURNAL			English	Article						growth restriction; maternal age; gestational; blood pressure; glucose tolerance	MATERNAL PROTEIN RESTRICTION; REDUCING LITTER SIZE; UTEROPLACENTAL INSUFFICIENCY; BLOOD-PRESSURE; GLUCOSE-TOLERANCE; BARKER HYPOTHESIS; PRENATAL EXPOSURE; UTERINE ARTERY; RENAL-FUNCTION; BIRTH-WEIGHT	Uteroplacental insufficiency is associated with adult cardiorenal and metabolic diseases, particularly in males. Pregnancy is the greatest physiological challenge facing women, and those born small are at increased risk of gestational hypertension and diabetes and delivering smaller babies. Increased maternal age is associated with exacerbated pregnancy complications. We hypothesized that pregnancy in aged, growth-restricted females unmasks an underlying predisposition to cardiorenal and metabolic dysfunction and compromises fetal growth. Uteroplacental insufficiency was induced by bilateral uterine vessel ligation (restricted group) or sham surgery (control group) on d 18 of gestation in Wistar Kyoto rats. At 12 mo, growth-restricted F1 female offspring were mated with a normal male. F1 restricted females had elevated systolic blood pressure, before and during pregnancy (+10 mmHg) but normal renal and metabolic pregnancy adaptations. F2 fetal weight was not different between groups. In control and restricted females, advanced maternal age (12 vs. 4 mo) was associated with a reduction in the hypoglycemic response to pregnancy and reduced F2 fetal litter size and body weight. Aged rats born small exhibited mostly normal pregnancy adaptations, although they had elevated blood pressure. Advanced maternal age was associated with poorer fetal outcomes that were not exacerbated by low maternal birth weight.-Gallo, L. A., Tran, M., Moritz, K. M., Jefferies, A. J., Wlodek, M. E. Pregnancy in aged rats that were born small: cardiorenal and metabolic adaptations and second-generation fetal growth. FASEB J. 26, 4337-4347 (2012). www.fasebj.org	[Gallo, Linda A.; Tran, Melanie; Jefferies, Andrew J.; Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia; [Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Melbourne; University of Queensland	Wlodek, ME (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia.	m.wlodek@unimelb.edu.au	Dalton-O'Reilly, Jessica/AAM-8569-2021; wlodek, Mary/A-8939-2019; Gallo, Linda A/M-3197-2014; Moritz, Karen/G-2508-2015	wlodek, Mary/0000-0002-8490-9099; Gallo, Linda A/0000-0002-0471-8517; Moritz, Karen/0000-0002-8085-0034; Tran, Melanie/0000-0003-1427-841X	National Health and Medical Research Council of Australia [400004]; Heart Foundation of Australia [G 08M 3698]; March of Dimes Birth Defects Foundation, USA [6-FY08-269]; National Heart Foundation Biomedical Scholarship; University of Melbourne Faculty Research Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia(National Heart Foundation of Australia); March of Dimes Birth Defects Foundation, USA(March of Dimes); National Heart Foundation Biomedical Scholarship; University of Melbourne Faculty Research Scholarship	The authors acknowledge the technical assistance of Kerryn Westcott and Jordanna Master. This work was funded by the National Health and Medical Research Council of Australia (grant 400004), the Heart Foundation of Australia (G 08M 3698), and the March of Dimes Birth Defects Foundation, USA (grant 6-FY08-269). L.A.G. was supported by a National Heart Foundation Biomedical Scholarship and a University of Melbourne Faculty Research Scholarship.	BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Black MJ, 2012, AM J PHYSIOL-REG I, V302, pR1101, DOI 10.1152/ajpregu.00030.2012; Blondeau B, 1999, ENDOCRINOLOGY, V140, P4208, DOI 10.1210/en.140.9.4208; Caluwaerts S, 2006, METABOLISM, V55, P409, DOI 10.1016/j.metabol.2005.10.001; Gallo LA, 2012, CELL TISSUE RES, V349, P863, DOI 10.1007/s00441-012-1411-y; Gallo LA, 2012, HYPERTENSION, V60, P206, DOI 10.1161/HYPERTENSIONAHA.112.195578; Gallo LA, 2012, J PHYSIOL-LONDON, V590, P617, DOI 10.1113/jphysiol.2011.219147; Haavaldsen C, 2011, BJOG-INT J OBSTET GY, V118, P1470, DOI 10.1111/j.1471-0528.2011.03053.x; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harrison M, 2009, BRIT J NUTR, V101, P1020, DOI 10.1017/S0007114508057607; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Henriksen T, 2002, ACTA OBSTET GYN SCAN, V81, P112, DOI 10.1034/j.1600-0412.2002.810204.x; Hoppe CC, 2009, PHYSIOL RES, V58, P69, DOI 10.33549/physiolres.931390; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Klebanoff MA, 1999, ARCH INTERN MED, V159, P1607, DOI 10.1001/archinte.159.14.1607; Laker RC, 2011, AM J PHYSIOL-ENDOC M, V301, pE931, DOI 10.1152/ajpendo.00114.2011; Langley-Evans SC, 2005, MATERN CHILD NUTR, V1, P142, DOI 10.1111/j.1740-8709.2005.00015.x; Mazzuca MQ, 2010, J PHYSIOL-LONDON, V588, P1997, DOI 10.1113/jphysiol.2010.187849; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Moritz KM, 2009, J PHYSIOL-LONDON, V587, P2635, DOI 10.1113/jphysiol.2009.170407; Nicolaides KH, 2005, SEMIN PERINATOL, V29, P190, DOI 10.1053/j.semperi.2005.06.001; Nybo, 2000, West J Med, V173, P331, DOI 10.1136/ewjm.173.5.331; O'Dowd R, 2008, AM J PHYSIOL-REG I, V294, pR539, DOI 10.1152/ajpregu.00628.2007; Odibo AO, 2006, AM J PERINAT, V23, P325, DOI 10.1055/s-2006-947164; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Paulson RJ, 2002, JAMA-J AM MED ASSOC, V288, P2320, DOI 10.1001/jama.288.18.2320; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; REFSAL KR, 1984, DOMEST ANIM ENDOCRIN, V1, P225, DOI 10.1016/0739-7240(84)90003-1; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Schreuder MF, 2007, J PHYSIOL BIOCHEM, V63, P213, DOI 10.1007/BF03165784; Schreuder M, 2006, KIDNEY BLOOD PRESS R, V29, P108, DOI 10.1159/000094538; Seghieri G, 2002, DIABETES CARE, V25, P1761, DOI 10.2337/diacare.25.10.1761; Siebel AL, 2008, ENDOCRINOLOGY, V149, P3067, DOI 10.1210/en.2008-0128; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Taricco E, 2003, PLACENTA, V24, P343, DOI 10.1053/plac.2002.0913; Toner JP, 2002, FERTIL STERIL, V78, P1038, DOI 10.1016/S0015-0282(02)03371-X; Torgersen CKL, 2006, CRIT CARE NURS Q, V29, P2, DOI 10.1097/00002727-200601000-00002; Torrens C, 2008, BRIT J NUTR, V100, P760, DOI 10.1017/S0007114508921747; van der Heijden OWH, 2004, J SOC GYNECOL INVEST, V11, P304, DOI 10.1016/j.jsgi.2004.02.004; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wadley GD, 2008, AM J PHYSIOL-ENDOC M, V294, pE861, DOI 10.1152/ajpendo.00037.2008; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wight E, 2000, J SOC GYNECOL INVEST, V7, P106, DOI 10.1016/S1071-5576(00)00036-8; Wlodek ME, 2008, KIDNEY INT, V74, P187, DOI 10.1038/ki.2008.153; Wlodek ME, 2007, J AM SOC NEPHROL, V18, P1688, DOI 10.1681/ASN.2007010015; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462	50	21	21	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4337	4347		10.1096/fj.12-210401	http://dx.doi.org/10.1096/fj.12-210401			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22772163	Bronze			2022-12-25	WOS:000309704000038
J	Li, Y; Chen, L; Kass, RS; Dessauer, CW				Li, Yong; Chen, Lei; Kass, Robert S.; Dessauer, Carmen W.			The A-kinase Anchoring Protein Yotiao Facilitates Complex Formation between Adenylyl Cyclase Type 9 and the I-Ks Potassium Channel in Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; SIGNALING COMPLEX; REGULATORY PROPERTIES; MESSENGER-RNA; CAMP; INHIBITION; ISOFORMS; CELLS; PHOSPHORYLATION; IDENTIFICATION	The scaffolding protein Yotiao is a member of a large family of protein A-kinase anchoring proteins with important roles in the organization of spatial and temporal signaling. In heart, Yotiao directly associates with the slow outward potassium ion current (I-Ks) and recruits both PKA and PP1 to regulate I-Ks phosphorylation and gating. Human mutations that disrupt I-Ks-Yotiao interaction result in reduced PKA-dependent phosphorylation of the I-Ks subunit KCNQ1 and inhibition of sympathetic stimulation of I-Ks, which can give rise to long-QT syndrome. We have previously identified a subset of adenylyl cyclase (AC) isoforms that interact with Yotiao, including AC1-3 and AC9, but surprisingly, this group did not include the major cardiac isoforms AC5 and AC6. We now show that either AC2 or AC9 can associate with KCNQ1 in a complex mediated by Yotiao. In transgenic mouse heart expressing KCNQ1-KCNE1, AC activity was specifically associated with the I-Ks-Yotiao complex and could be disrupted by addition of the AC9 N terminus. A survey of all AC isoforms by RT-PCR indicated expression of AC4-6 and AC9 in adult mouse cardiac myocytes. Of these, the only Yotiao-interacting isoform was AC9. Furthermore, the endogenous I-Ks-Yotiao complex from guinea pig also contained AC9. Finally, AC9 association with the KCNQ1-Yotiao complex sensitized PKA phosphorylation of KCNQ1 to beta-adrenergic stimulation. Thus, in heart, Yotiao brings together PKA, PP1, PDE4D3, AC9, and the I-Ks channel to achieve localized temporal regulation of beta-adrenergic stimulation.	[Li, Yong; Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Chen, Lei; Kass, Robert S.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, Ctr Mol Cardiol, New York, NY 10032 USA; [Chen, Lei; Kass, Robert S.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	University of Texas System; University of Texas Health Science Center Houston; Columbia University; Columbia University	Dessauer, CW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St,MSB 4-202, Houston, TX 77030 USA.	carmen.w.dessauer@uth.tmc.edu	Dessauer, Carmen/N-6933-2018	Dessauer, Carmen/0000-0003-1210-4280	National Institutes of Health [GM60419, HL044365]; American Heart Association [GRNT2200034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 (to C. W. D.) and HL044365 (to R. S. K.). This work was also supported by American Heart Association Grant GRNT2200034 (to C. W. D.).	Antoni FA, 2006, NEUROCHEM RES, V31, P287, DOI 10.1007/s11064-005-9019-1; ANTONI FA, 1995, J BIOL CHEM, V270, P28055; Baragli A, 2008, CELL SIGNAL, V20, P480, DOI 10.1016/j.cellsig.2007.10.033; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Chen-Goodspeed M, 2005, J BIOL CHEM, V280, P1808, DOI 10.1074/jbc.M409172200; Ciampa EJ, 2011, J BIOL CHEM, V286, P4141, DOI 10.1074/jbc.M110.158865; Cui H, 2001, BIOCHEM BIOPH RES CO, V283, P107, DOI 10.1006/bbrc.2001.4725; Cumbay MG, 2005, BIOCHEM PHARMACOL, V69, P1247, DOI 10.1016/j.bcp.2005.02.001; Cumbay MG, 2004, J PHARMACOL EXP THER, V310, P108, DOI 10.1124/jpet.104.065748; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dessauer CW, 2002, METHOD ENZYMOL, V345, P112; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Hacker BM, 1998, GENOMICS, V50, P97, DOI 10.1006/geno.1998.5293; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; KASS RS, 1982, J PHYSIOL-LONDON, V322, P541, DOI 10.1113/jphysiol.1982.sp014054; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; Kurokawa J, 2001, J MOL CELL CARDIOL, V33, P873, DOI 10.1006/jmcc.2001.1377; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lin JW, 1998, J NEUROSCI, V18, P2017; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Ostrom RS, 2003, J BIOL CHEM, V278, P24461, DOI 10.1074/jbc.M212659200; Paterson JM, 2000, J NEUROCHEM, V75, P1358, DOI 10.1046/j.1471-4159.2000.0751358.x; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Sampson KJ, 2010, HEART RHYTHM, V7, P1151, DOI 10.1016/j.hrthm.2010.02.013; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	52	73	74	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29815	29824		10.1074/jbc.M112.380568	http://dx.doi.org/10.1074/jbc.M112.380568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778270	Green Published, hybrid			2022-12-25	WOS:000308286900056
J	Nakatogawa, H; Ohbayashi, S; Sakoh-Nakatogawa, M; Kakuta, S; Suzuki, SW; Kirisako, H; Kondo-Kakuta, C; Noda, NN; Yamamoto, H; Ohsumi, Y				Nakatogawa, Hitoshi; Ohbayashi, Shiran; Sakoh-Nakatogawa, Machiko; Kakuta, Soichiro; Suzuki, Sho W.; Kirisako, Hiromi; Kondo-Kakuta, Chika; Noda, Nobuo N.; Yamamoto, Hayashi; Ohsumi, Yoshinori			The Autophagy-related Protein Kinase Atg1 Interacts with the Ubiquitin-like Protein Atg8 via the Atg8 Family Interacting Motif to Facilitate Autophagosome Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; STRUCTURAL BASIS; COMPLEX; YEAST; ORGANIZATION; BIOGENESIS; INDUCTION; TRANSPORT; SYSTEM	In autophagy, a cup-shaped membrane called the isolation membrane is formed, expanded, and sealed to complete a double membrane-bound vesicle called the autophagosome that encapsulates cellular constituents to be transported to and degraded in the lysosome/vacuole. The formation of the autophagosome requires autophagy-related (Atg) proteins. Atg8 is a ubiquitin-like protein that localizes to the isolation membrane; a subpopulation of this protein remains inside the autophagosome and is transported to the lysosome/vacuole. In the budding yeast Saccharomyces cerevisiae, Atg1 is a serine/threonine kinase that functions in the initial step of autophagosome formation and is also efficiently transported to the vacuole via autophagy. Here, we explore the mechanism and significance of this autophagic transport of Atg1. In selective types of autophagy, receptor proteins recognize degradation targets and also interact with Atg8, via the Atg8 family interacting motif ( AIM), to link the targets to the isolation membrane. We find that Atg1 contains an AIM and directly interacts with Atg8. Mutations in the AIM disrupt this interaction and abolish vacuolar transport of Atg1. These results suggest that Atg1 associates with the isolation membrane by binding to Atg8, resulting in its incorporation into the autophagosome. We also show that mutations in the Atg1 AIM cause a significant defect in autophagy, without affecting the functions of Atg1 implicated in triggering autophagosome formation. We propose that in addition to its essential function in the initial stage, Atg1 also associates with the isolation membrane to promote its maturation into the autophagosome.	[Nakatogawa, Hitoshi; Ohbayashi, Shiran; Sakoh-Nakatogawa, Machiko; Kakuta, Soichiro; Suzuki, Sho W.; Kirisako, Hiromi; Kondo-Kakuta, Chika; Yamamoto, Hayashi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Noda, Nobuo N.] Inst Microbial Chem, Tokyo 1410021, Japan	Tokyo Institute of Technology	Nakatogawa, H (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan.	hnakatogawa@iri.titech.ac.jp	Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166; Suzuki, Sho/0000-0002-6563-5387; Noda, Nobuo/0000-0002-6940-8069	Funding Program for Next Generation World-Leading Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Funding Program for Next Generation World-Leading Researchers (to H. N.) and grants-in-aid for scientific research (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566	24	78	87	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28503	28507		10.1074/jbc.C112.387514	http://dx.doi.org/10.1074/jbc.C112.387514			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22778255	hybrid, Green Published			2022-12-25	WOS:000308074600025
J	Groeneveld, LF; Atencia, R; Garriga, RM; Vigilant, L				Groeneveld, Linn Fenna; Atencia, Rebeca; Garriga, Rosa M.; Vigilant, Linda			High Diversity at PRDM9 in Chimpanzees and Bonobos	PLOS ONE			English	Article							AMINO-ACID SITES; MEIOTIC RECOMBINATION HOTSPOTS; HISTONE H3 METHYLTRANSFERASE; POLYMERASE-CHAIN-REACTION; HOT-SPOTS; NUCLEOTIDE SUBSTITUTION; MOLECULAR EVOLUTION; POSITIVE SELECTION; MALE-STERILITY; GENE	Background: The PRDM9 locus in mammals has increasingly attracted research attention due to its role in mediating chromosomal recombination and possible involvement in hybrid sterility and hence speciation processes. The aim of this study was to characterize sequence variation at the PRDM9 locus in a sample of our closest living relatives, the chimpanzees and bonobos. Methodology/Principal Findings: PRDM9 contains a highly variable and repetitive zinc finger array. We amplified this domain using long-range PCR and determined the DNA sequences using conventional Sanger sequencing. From 17 chimpanzees representing three subspecies and five bonobos we obtained a total of 12 alleles differing at the nucleotide level. Based on a data set consisting of our data and recently published Pan PRDM9 sequences, we found that at the subspecies level, diversity levels did not differ among chimpanzee subspecies or between chimpanzee subspecies and bonobos. In contrast, the sample of chimpanzees harbors significantly more diversity at PRDM9 than samples of humans. Pan PRDM9 shows signs of rapid evolution including no alleles or ZnFs in common with humans as well as signals of positive selection in the residues responsible for DNA binding. Conclusions and Significance: The high number of alleles specific to the genus Pan, signs of positive selection in the DNA binding residues, and reported lack of conservation of recombination hotspots between chimpanzees and humans suggest that PRDM9 could be active in hotspot recruitment in the genus Pan. Chimpanzees and bonobos are considered separate species and do not have overlapping ranges in the wild, making the presence of shared alleles at the amino acid level between the chimpanzee and bonobo species interesting in view of the hypothesis that PRDM9 plays a universal role in interspecific hybrid sterility.	[Groeneveld, Linn Fenna; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Garriga, Rosa M.] Tacugama Chimpanzee Sanctuary, Freetown, Sierra Leone; [Atencia, Rebeca] Jane Goodall Inst, Pointe Noire, Rep Congo	Max Planck Society	Groeneveld, LF (corresponding author), Univ Gottingen, Courant Res Ctr Geobiol, Gottingen, Germany.	linn.groeneveld@geo.uni-goettingen.de; vigilant@eva.mpg.de		Groeneveld, Linn Fenna/0000-0002-1290-9436; Garriga, Rosa M./0000-0002-5442-7523	Max Planck Society; Ministry of Forest of the Republic of Congo	Max Planck Society(Max Planck Society); Ministry of Forest of the Republic of Congo	This project was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Roger Mundry for help with the permutation tests, Kathrin Kohler for preparing DNA extracts and the MPI-EVA Sequencing Group for sequencing services and Kay Prufer and Svante Paabo for helpful discussions. We are grateful to Ngamba Island Chimpanzee Sanctuary/Chimpanzee Sanctuary & Wildlife Conservation Trust, Uganda and Lola ya Bonobo Sanctuary, Democratic Republic of Congo for granting access to samples, as well as A. Fischer and M. Halbwax for sample acquisition efforts. The Ministry of Forest of the Republic of Congo is thanked for their authorization and support of this study.	Adams DC, 1996, ANIM BEHAV, V51, P733, DOI 10.1006/anbe.1996.0077; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Cheung VG, 2010, SCIENCE, V327, P791, DOI 10.1126/science.1187155; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; ENNIS PD, 1990, P NATL ACAD SCI USA, V87, P2833, DOI 10.1073/pnas.87.7.2833; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Goldman N, 2002, MOL BIOL EVOL, V19, P1821, DOI 10.1093/oxfordjournals.molbev.a004007; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Goodstadt L, 2011, HEREDITY, V106, P710, DOI 10.1038/hdy.2010.88; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hochwagen A, 2010, CURR BIOL, V20, pR271, DOI 10.1016/j.cub.2010.01.048; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Jeffreys AJ, 2009, NAT GENET, V41, P625, DOI 10.1038/ng.346; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; LABBE D, 1992, IMMUNOGENETICS, V35, P395; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Longeri M, 2002, EUR J IMMUNOGENET, V29, P517, DOI 10.1046/j.1365-2370.2002.00356.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; McVean G, 2010, NAT GENET, V42, P821, DOI 10.1038/ng1010-821; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nielsen R, 1998, GENETICS, V148, P929; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; PAABO S, 1990, J BIOL CHEM, V265, P4718; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Sandovici Ionel, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-37; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zwickl D.J., 2006, THESIS U TEXAS AUSTI; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	61	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39064	10.1371/journal.pone.0039064	http://dx.doi.org/10.1371/journal.pone.0039064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768294	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500007
J	Trindade-Silva, AE; Rua, C; Silva, GGZ; Dutilh, BE; Moreira, APB; Edwards, RA; Hajdu, E; Lobo-Hajdu, G; Vasconcelos, AT; Berlinck, RGS; Thompson, FL				Trindade-Silva, Amaro E.; Rua, Cintia; Silva, Genivaldo G. Z.; Dutilh, Bas E.; Moreira, Ana Paula B.; Edwards, Robert A.; Hajdu, Eduardo; Lobo-Hajdu, Gisele; Vasconcelos, Ana Tereza; Berlinck, Roberto G. S.; Thompson, Fabiano L.			Taxonomic and Functional Microbial Signatures of the Endemic Marine Sponge Arenosclera brasiliensis	PLOS ONE			English	Article							TRIPARTITE TRICARBOXYLATE TRANSPORTER; ELECTRON-MICROSCOPE; GENOME; BACTERIA; DIVERSITY; SEQUENCE; DEHYDROGENASE; BIOSYNTHESIS; METAGENOMES; ASSOCIATION	The endemic marine sponge Arenosclera brasiliensis (Porifera, Demospongiae, Haplosclerida) is a known source of secondary metabolites such as arenosclerins A-C. In the present study, we established the composition of the A. brasiliensis microbiome and the metabolic pathways associated with this community. We used 454 shotgun pyrosequencing to generate approximately 640,000 high-quality sponge-derived sequences (similar to 150 Mb). Clustering analysis including sponge, seawater and twenty-three other metagenomes derived from marine animal microbiomes shows that A. brasiliensis contains a specific microbiome. Fourteen bacterial phyla (including Proteobacteria, Cyanobacteria, Actinobacteria, Bacteroidetes, Firmicutes and Cloroflexi) were consistently found in the A. brasiliensis metagenomes. The A. brasiliensis microbiome is enriched for Betaproteobacteria (e.g., Burkholderia) and Gammaproteobacteria (e.g., Pseudomonas and Alteromonas) compared with the surrounding planktonic microbial communities. Functional analysis based on Rapid Annotation using Subsystem Technology (RAST) indicated that the A. brasiliensis microbiome is enriched for sequences associated with membrane transport and one-carbon metabolism. In addition, there was an overrepresentation of sequences associated with aerobic and anaerobic metabolism as well as the synthesis and degradation of secondary metabolites. This study represents the first analysis of sponge-associated microbial communities via shotgun pyrosequencing, a strategy commonly applied in similar analyses in other marine invertebrate hosts, such as corals and algae. We demonstrate that A. brasiliensis has a unique microbiome that is distinct from that of the surrounding planktonic microbes and from other marine organisms, indicating a species-specific microbiome.	[Trindade-Silva, Amaro E.; Berlinck, Roberto G. S.] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Trindade-Silva, Amaro E.; Rua, Cintia; Moreira, Ana Paula B.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Silva, Genivaldo G. Z.; Dutilh, Bas E.; Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Edwards, Robert A.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Hajdu, Eduardo] Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Rio De Janeiro, Brazil; [Lobo-Hajdu, Gisele] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil; [Vasconcelos, Ana Tereza] Lab Nacl Comp Cient, Petropolis, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; California State University System; San Diego State University; Radboud University Nijmegen; United States Department of Energy (DOE); Argonne National Laboratory; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Laboratorio Nacional de Computacao Cientifica (LNCC)	Trindade-Silva, AE (corresponding author), Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil.	fabiano.thompson@biologia.ufrj.br	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Lobo-Hajdu, Gisele/A-6709-2008; Moreira, Ana Paula B./J-8442-2013; Hajdu, Eduardo/C-3863-2009; Fapesp, Biota/F-8655-2017; Trindade-Silva, Amaro/AAO-5685-2020; Dutilh, Bas E./B-9719-2011; Berlinck, Roberto G. S./G-4756-2010; Moreira, Ana Paula B./ABE-5912-2020; Edwards, Robert/Q-1691-2019; Vasconcelos, Ana Tereza R/I-1011-2012	Lobo-Hajdu, Gisele/0000-0001-7792-9609; Moreira, Ana Paula B./0000-0001-9757-1317; Hajdu, Eduardo/0000-0002-8760-9403; Fapesp, Biota/0000-0002-9887-8449; Trindade-Silva, Amaro/0000-0003-4321-065X; Dutilh, Bas E./0000-0003-2329-7890; Berlinck, Roberto G. S./0000-0003-0118-2523; Moreira, Ana Paula B./0000-0001-9757-1317; Edwards, Robert/0000-0001-8383-8949; Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Rua, Cintia/0000-0002-1872-2963; Thompson, Fabiano/0000-0002-7562-1683	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAPESP [2009/11612-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Dutch Science foundation (NWO) Veni grant [016.111.075]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Dutch Science foundation (NWO) Veni grant	The authors thank the financial support provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to RGSB, by FAPESP scholarship 2009/11612-1 to AETS, by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to FLT, and by Dutch Science foundation (NWO) Veni grant: 016.111.075 to BED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Bluman AG., 2007, ELEMENTARY STAT STEP; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; de Oliveira JHHL, 2007, J NAT PROD, V70, P538, DOI 10.1021/np060450q; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Dutilh BE, 2007, BIOINFORMATICS, V23, P815, DOI 10.1093/bioinformatics/btm015; Dutilh BE, 2004, J MOL EVOL, V58, P527, DOI 10.1007/s00239-003-2575-6; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Fontana A., 2006, MOLLUSCS CHEMOECOLOG, P304; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Korbel JO, 2002, TRENDS GENET, V18, P158, DOI 10.1016/S0168-9525(01)02597-5; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lobo-Hadju G., 2004, B MUS I BIOL U GEN, V68, P413; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Mahenthiralingam E, 2011, CHEM BIOL, V18, P665, DOI 10.1016/j.chembiol.2011.01.020; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muricy Guilherme, 1999, Beaufortia, V49, P83; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; O'Sullivan LA, 2007, ENVIRON MICROBIOL, V9, P1017, DOI 10.1111/j.1462-2920.2006.01228.x; Ollagnier-de Choudens S, 2005, FEBS LETT, V579, P3737, DOI 10.1016/j.febslet.2005.05.065; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Raaijmakers H, 2002, STRUCTURE, V10, P1261, DOI 10.1016/S0969-2126(02)00826-2; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Rohm B, 2010, ORG BIOMOL CHEM, V8, P1520, DOI 10.1039/b925483h; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sipkema D, 2009, MICROB ECOL, V58, P903, DOI 10.1007/s00248-009-9534-8; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stankevicins L, 2008, TOXICOL IN VITRO, V22, P1869, DOI 10.1016/j.tiv.2008.09.003; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thompson FL, 2011, ARCH MICROBIOL, V193, P105, DOI 10.1007/s00203-010-0644-y; Torres YR, 2002, TOXICON, V40, P885, DOI 10.1016/S0041-0101(01)00286-0; Torres YR, 2000, J NAT PROD, V63, P1098, DOI 10.1021/np9905618; Turque AS, 2008, MAR BIOL, V155, P135, DOI 10.1007/s00227-008-1008-x; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; WOOTTERS WK, 1981, PHYS REV D, V23, P357, DOI 10.1103/PhysRevD.23.357	57	43	43	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39905	10.1371/journal.pone.0039905	http://dx.doi.org/10.1371/journal.pone.0039905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768320	Green Submitted, Green Published, gold			2022-12-25	WOS:000305966500033
J	Bowlby, SC; Thomas, MJ; D'Agostino, RB; Kridel, SJ				Bowlby, Sarah C.; Thomas, Michael J.; D'Agostino, Ralph B., Jr.; Kridel, Steven J.			Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; PROSTATE-CANCER; LIFE-SPAN; PHASE-I; SIRT1; INHIBITION; PHOSPHORYLATION; OVEREXPRESSION; ACETYLATION; CHS-828	Tumor cells have increased metabolic requirements to maintain rapid growth. In particular, a highly lipogenic phenotype is a hallmark of many tumor types, including prostate. Cancer cells also have increased turnover of nicotinamide adenine dinucleotide (NAD(+)), a coenzyme involved in multiple metabolic pathways. However, a specific role for NAD(+) in tumor cell lipogenesis has yet to be described. Our studies demonstrate a novel role for the NAD(+)-biosynthetic enzyme Nicotinamide phosphoribosyltransferase (Nampt) in maintaining de novo lipogenesis in prostate cancer (PCa) cells. Inhibition of Nampt reduces fatty acid and phospholipid synthesis. In particular, short chain saturated fatty acids and the phosphatidylcholine (PC) lipids into which these fatty acids are incorporated were specifically reduced by Nampt inhibition. Nampt blockade resulted in reduced ATP levels and concomitant activation of AMP-activated protein kinase (AMPK) and phosphorylation of acetyl-CoA carboxylase (ACC). In spite of this, pharmacological inhibition of AMPK was not sufficient to fully restore fatty acid synthesis. Rather, Nampt blockade also induced protein hyperacetylation in PC-3, DU145, and LNCaP cells, which correlated with the observed decreases in lipid synthesis. Moreover, the sirtuin inhibitor Sirtinol, and the simultaneous knockdown of SIRT1 and SIRT3, phenocopied the effects of Nampt inhibition on fatty acid synthesis. Altogether, these data reveal a novel role for Nampt in the regulation of de novo lipogenesis through the modulation of sirtuin activity in PCa cells.	[Bowlby, Sarah C.; Kridel, Steven J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA; [Thomas, Michael J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA; [D'Agostino, Ralph B., Jr.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Thomas, Michael J.; D'Agostino, Ralph B., Jr.; Kridel, Steven J.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Bowlby, SC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA.	skridel@wakehealth.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	National Institutes of Health/National Cancer Institute (NIH/NCI) [T32 CA079448-10, CA114104]; Department of Defense Prostate Cancer Research Program [W81XWH-10-1-0538, W81XWH-11-1-0168]; NATIONAL CANCER INSTITUTE [R01CA114104, T32CA079448] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health/National Cancer Institute (NIH/NCI) T32 CA079448-10; Department of Defense Prostate Cancer Research Program W81XWH-10-1-0538, W81XWH-11-1-0168; and National Institutes of Health/National Cancer Institute (NIH/NCI) CA114104. The Nampt inhibitor FK866 was provided by the National Institute of Mental Health Chemical Synthesis and Drug Supply Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bae SK, 2006, FEBS LETT, V580, P4105, DOI 10.1016/j.febslet.2006.06.052; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2009, AGING CELL, V8, P100, DOI 10.1111/j.1474-9726.2009.00453.x; Chalkiadaki A, 2012, NAT REV ENDOCRINOL A; DeLong CJ, 2001, J LIPID RES, V42, P1959; Fleischer TC, 2010, CHEM BIOL, V17, P659, DOI 10.1016/j.chembiol.2010.05.008; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hasmann M, 2003, CANCER RES, V63, P7436; Hirschey MD, 2011, COLD SPRING HARBOR S; Ho C, 2009, FEBS LETT, V583, P3081, DOI 10.1016/j.febslet.2009.08.031; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hovstadius P, 2002, CLIN CANCER RES, V8, P2843; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Kim DH, 2011, J NUTR BIOCH; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; KOSAKA A, 1971, J BIOL CHEM, V246, P3277; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nakane K, 2012, INT J UROL, V19, P71, DOI 10.1111/j.1442-2042.2011.02888.x; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pittelli M, 2010, J BIOL CHEM; Pizer ES, 1998, CANCER RES, V58, P4611; PREISS J, 1957, J BIOL CHEM, V225, P759; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Ravaud A, 2005, EUR J CANCER, V41, P702, DOI 10.1016/j.ejca.2004.12.023; Reddy PS, 2008, CANCER BIOL THER, V7, P663, DOI 10.4161/cbt.7.5.5663; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Scott KEN, 2012, PLOS ONE IN PRESS; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; WITTERS LA, 1990, BIOCHEM BIOPH RES CO, V169, P369, DOI 10.1016/0006-291X(90)90341-J; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	60	44	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40195	10.1371/journal.pone.0040195	http://dx.doi.org/10.1371/journal.pone.0040195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768255	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100228
J	Oh, JH; Wong, HP; Wang, XW; Deasy, JO				Oh, Jung Hun; Wong, Harry P.; Wang, Xiaowei; Deasy, Joseph O.			A Bioinformatics Filtering Strategy for Identifying Radiation Response Biomarker Candidates	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BREAST-CANCER PATIENTS; SQUAMOUS-CELL CARCINOMA; DNA-REPAIR GENES; DIFFERENTIALLY EXPRESSED GENES; ADENOVIRUS-MEDIATED EXPRESSION; THERAPY FOLLOWING LUMPECTOMY; NORMAL TISSUE COMPLICATIONS; HUMAN TUMOR-CELLS; QUALITY-OF-LIFE	The number of biomarker candidates is often much larger than the number of clinical patient data points available, which motivates the use of a rational candidate variable filtering methodology. The goal of this paper is to apply such a bioinformatics filtering process to isolate a modest number (<10) of key interacting genes and their associated single nucleotide polymorphisms involved in radiation response, and to ultimately serve as a basis for using clinical datasets to identify new biomarkers. In step 1, we surveyed the literature on genetic and protein correlates to radiation response, in vivo or in vitro, across cellular, animal, and human studies. In step 2, we analyzed two publicly available microarray datasets and identified genes in which mRNA expression changed in response to radiation. Combining results from Step 1 and Step 2, we identified 20 genes that were common to all three sources. As a final step, a curated database of protein interactions was used to generate the most statistically reliable protein interaction network among any subset of the 20 genes resulting from Steps 1 and 2, resulting in identification of a small, tightly interacting network with 7 out of 20 input genes. We further ranked the genes in terms of likely importance, based on their location within the network using a graph-based scoring function. The resulting core interacting network provides an attractive set of genes likely to be important to radiation response.	[Oh, Jung Hun; Deasy, Joseph O.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Wong, Harry P.] Washington Univ, Sch Med, Dept Infect Dis, St Louis, MO USA; [Wang, Xiaowei] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA	Memorial Sloan Kettering Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Oh, JH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA.	deasyj@mskcc.org	Wang, Xiaowei/T-7452-2019	Oh, Jung Hun/0000-0001-8791-2755; Deasy, Joseph/0000-0002-9437-266X	Memorial Sloan-Kettering Cancer Center	Memorial Sloan-Kettering Cancer Center	The research did not receive any external funding. This work was funded by an internal grant from Memorial Sloan-Kettering Cancer Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadeh F, 2010, J MED GENET, V47, P176, DOI 10.1136/jmg.2009.068866; Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1; Ambrosone CB, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1526; Andreassen CN, 2006, INT J RADIAT BIOL, V82, P577, DOI 10.1080/09553000600876637; Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Appleby JM, 1997, BRIT J CANCER, V76, P1546, DOI 10.1038/bjc.1997.593; Azria D, 2008, CLIN CANCER RES, V14, P6284, DOI 10.1158/1078-0432.CCR-08-0700; Badie C, 2008, BRIT J CANCER, V98, P1845, DOI 10.1038/sj.bjc.6604381; Barahmani N, 2009, NEURO-ONCOLOGY, V11, P292, DOI 10.1215/15228517-2008-089; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Bonner JA, 2009, RADIOTHER ONCOL, V92, P339, DOI 10.1016/j.radonc.2009.06.022; Borgmann K, 2002, RADIOTHER ONCOL, V64, P141, DOI 10.1016/S0167-8140(02)00167-6; Brem R, 2006, CARCINOGENESIS, V27, P2469, DOI 10.1093/carcin/bgl114; Brigl B, 2006, METHOD INFORM MED, V45, P216; Brunner TB, 2005, CANCER RES, V65, P8433, DOI 10.1158/0008-5472.CAN-05-0158; Burns TF, 2001, ONCOGENE, V20, P4601, DOI 10.1038/sj.onc.1204484; Burri RJ, 2008, RADIAT RES, V170, P49, DOI 10.1667/RR1219.1; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Cecchin E, 2011, PHARMACOGENOMICS J, V11, P214, DOI 10.1038/tpj.2010.25; Cengel KA, 2005, CRIT REV ONCOL HEMAT, V55, P103, DOI 10.1016/j.critrevonc.2005.02.001; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V380, P236, DOI 10.1016/j.bbrc.2009.01.040; Chang JTC, 2007, MOL CANCER THER, V6, P2271, DOI 10.1158/1535-7163.MCT-06-0801; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Chen T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S20; Chen WS, 2010, INT J RADIAT ONCOL, V77, P566, DOI 10.1016/j.ijrobp.2009.12.013; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Chiani F, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap007; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Chorna IV, 2005, EXP ONCOL, V27, P196; Chung HJ, 2006, J CELL PHYSIOL, V209, P131, DOI 10.1002/jcp.20714; Clark AJ, 2007, J NEURO-ONCOL, V83, P163, DOI 10.1007/s11060-006-9317-8; Clarke R A, 2002, Australas Radiol, V46, P329, DOI 10.1046/j.1440-1673.2002.01072.x; Correa CR, 2004, AM J HUM GENET, V75, P885, DOI 10.1086/425221; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; De Ruyck K, 2005, RADIAT RES, V164, P237, DOI 10.1667/RR3417.1; De Ruyck K, 2005, INT J RADIAT ONCOL, V62, P1140, DOI 10.1016/j.ijrobp.2004.12.027; Demizu Y, 2008, ANTIOXID REDOX SIGN, V10, P951, DOI 10.1089/ars.2007.1871; Dexter TJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-127; Ding KK, 2009, RADIAT ENVIRON BIOPH, V48, P205, DOI 10.1007/s00411-009-0213-4; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Djuzenova C, 2004, BRIT J CANCER, V90, P2356, DOI 10.1038/sj.bjc.6601878; Du XL, 2009, CROAT MED J, V50, P143, DOI 10.3325/cmj.2009.50.143; Edvardsen H, 2007, INT J RADIAT ONCOL, V67, P1163, DOI 10.1016/j.ijrobp.2006.11.009; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; Ernestos B, 2010, INT J RADIAT ONCOL, V76, P1199, DOI 10.1016/j.ijrobp.2009.10.020; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Fernet M, 2004, DNA REPAIR, V3, P1237, DOI 10.1016/j.dnarep.2004.03.019; Fernet M, 2000, INT J RADIAT BIOL, V76, P1621, DOI 10.1080/09553000050201118; Firat E, 2009, CANCER RES, V69, P3325, DOI 10.1158/0008-5472.CAN-08-3269; Fogarty GB, 2010, INT J RADIAT ONCOL, V77, P1486, DOI 10.1016/j.ijrobp.2009.07.1690; Gaffney DK, 1998, RADIOTHER ONCOL, V47, P129, DOI 10.1016/S0167-8140(98)00023-1; Giagkousiklidis S, 2007, ONCOGENE, V26, P7006, DOI 10.1038/sj.onc.1210502; Giotopoulos G, 2007, BRIT J CANCER, V96, P1001, DOI 10.1038/sj.bjc.6603637; Guo WF, 2007, INT J ONCOL, V30, P1447; Guo WF, 2005, RADIAT RES, V164, P27, DOI 10.1667/RR3401; Hadchity E, 2009, MOL THER, V17, P1387, DOI 10.1038/mt.2009.90; Haffty BG, 2003, ONCOGENE, V22, P5915, DOI 10.1038/sj.onc.1206704; Guan HT, 2006, WORLD J GASTROENTERO, V12, P2901, DOI 10.3748/wjg.v12.i18.2901; Hall EJ, 1998, CANCER J, V4, P385; Hamilton J, 2009, CANCER BIOL THER, V8, P1577, DOI 10.4161/cbt.8.16.8962; Hehlgans S, 2009, RADIOTHER ONCOL, V92, P362, DOI 10.1016/j.radonc.2009.07.004; Hendry JH, 2002, INT J RADIAT BIOL, V78, P559, DOI 10.1080/09553000210132333; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Hixon JA, 2001, BIOL BLOOD MARROW TR, V7, P136, DOI 10.1053/bbmt.2001.v7.pm11302547; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Iannuzzi CM, 2002, INT J RADIAT ONCOL, V52, P606, DOI 10.1016/S0360-3016(01)02684-0; Ishigami T, 2008, BRIT J CANCER, V98, P1357, DOI 10.1038/sj.bjc.6604290; Isomura M, 2008, CLIN CANCER RES, V14, P6683, DOI 10.1158/1078-0432.CCR-07-4389; Javvadi P, 2010, CANCER RES, V70, P1941, DOI 10.1158/0008-5472.CAN-09-3025; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Jia LJ, 2010, CLIN CANCER RES, V16, P814, DOI 10.1158/1078-0432.CCR-09-1592; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kassem HS, 2002, INT J CANCER, V101, P454, DOI 10.1002/ijc.10631; Kim DW, 2007, J ORTHOP RES, V25, P820, DOI 10.1002/jor.20377; Kim D, 2010, CYTOKINE, V50, P37, DOI 10.1016/j.cyto.2009.12.013; Kim JS, 2010, PROTEOMICS, V10, P2589, DOI 10.1002/pmic.200900523; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kornguth DG, 2005, INT J RADIAT ONCOL, V62, P665, DOI 10.1016/j.ijrobp.2004.11.026; Kuo ML, 2003, CANCER J, V9, P277, DOI 10.1097/00130404-200307000-00010; Kuptsova N, 2008, INT J CANCER, V122, P1333, DOI 10.1002/ijc.23138; Langsenlehner T, 2008, INT J RADIAT ONCOL, V71, P960, DOI 10.1016/j.ijrobp.2008.02.029; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Leong T, 2000, INT J RADIAT ONCOL, V48, P959, DOI 10.1016/S0360-3016(00)00728-8; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Li XM, 2010, ONCOL REP, V23, P345, DOI 10.3892/or_00000642; Li XL, 2009, ACTA PHARMACOL SIN, V30, P458, DOI 10.1038/aps.2009.18; Liu Li, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1551; Lu HR, 2006, CELL CYCLE, V5, P2364, DOI 10.4161/cc.5.20.3355; Mao JH, 2008, ONCOGENE, V27, P6596, DOI 10.1038/onc.2008.280; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Meyer A, 2009, WORLD J UROL, V27, P371, DOI 10.1007/s00345-008-0354-0; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; Moore J, 2007, INT J RADIAT ONCOL, V69, pS7, DOI 10.1016/j.ijrobp.2007.07.014; Moretti L, 2007, AUTOPHAGY, V3, P142, DOI 10.4161/auto.3607; Moullan N, 2003, CANCER EPIDEM BIOMAR, V12, P1168; Moussavi-Harami F, 2006, BIOCHEM BIOPH RES CO, V346, P379, DOI 10.1016/j.bbrc.2006.05.158; Moussay E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-115; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Negroni A, 2008, INT J RADIAT BIOL, V84, P265, DOI 10.1080/09553000801953318; O'Malley BW, 2003, LARYNGOSCOPE, V113, P1588, DOI 10.1097/00005537-200309000-00034; Ogawa K, 2007, CANCER RES, V67, P4016, DOI 10.1158/0008-5472.CAN-06-4498; Oh JH, 2011, J PROTEOME RES, V10, P1406, DOI 10.1021/pr101226q; Park JJ, 2009, INT J RADIAT ONCOL, V73, P1196, DOI 10.1016/j.ijrobp.2008.10.070; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; PATERSON MC, 1979, CANCER RES, V39, P3725; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Pazzaglia S, 2006, ONCOGENE, V25, P1165, DOI 10.1038/sj.onc.1209032; Pena LA, 2000, CANCER RES, V60, P321; Peng YL, 2002, CANCER RES, V62, P6400; Peter Y, 2001, EMBO J, V20, P1538, DOI 10.1093/emboj/20.7.1538; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Pietras RJ, 1999, CANCER RES, V59, P1347; Popanda O, 2006, CANCER EPIDEM BIOMAR, V15, P1048, DOI 10.1158/1055-9965.EPI-06-0046; Popanda O, 2009, MUTAT RES-FUND MOL M, V667, P58, DOI 10.1016/j.mrfmmm.2008.10.014; Prevo R, 2008, CANCER RES, V68, P5915, DOI 10.1158/0008-5472.CAN-08-0757; Price EA, 1997, SOMAT CELL MOLEC GEN, V23, P237, DOI 10.1007/BF02674415; Pugh TJ, 2009, CLIN CANCER RES, V15, P5008, DOI 10.1158/1078-0432.CCR-08-3357; Raaphorst GP, 2005, ANTICANCER RES, V25, P53; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Rieger KE, 2004, P NATL ACAD SCI USA, V101, P6635, DOI 10.1073/pnas.0307761101; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; Sak SC, 2005, CLIN CANCER RES, V11, P6205, DOI 10.1158/1078-0432.CCR-05-0045; Sakata Koh-Ichi, 2007, Radiat Med, V25, P433, DOI 10.1007/s11604-007-0161-3; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Shan B, 2003, J BIOL CHEM, V278, P44009, DOI 10.1074/jbc.M302671200; Shankar S, 2004, INT J ONCOL, V24, P1133; Shanley S, 2006, CLIN CANCER RES, V12, P7025, DOI 10.1158/1078-0432.CCR-06-1244; Sheen JH, 2002, MOL CELL BIOL, V22, P1819, DOI 10.1128/MCB.22.6.1819-1833.2002; Shi Hua-Shan, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1977; Singhal SS, 2010, INT J CANCER, V126, P1327, DOI 10.1002/ijc.24767; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Sterpone S, 2010, MUTAT RES-FUND MOL M, V684, P43, DOI 10.1016/j.mrfmmm.2009.11.009; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suga T, 2008, INT J RADIAT ONCOL, V72, P808, DOI 10.1016/j.ijrobp.2008.01.029; Suga T, 2007, INT J RADIAT ONCOL, V69, P685, DOI 10.1016/j.ijrobp.2007.06.021; Tan WH, 2006, J IMMUNOL, V176, P6186, DOI 10.4049/jimmunol.176.10.6186; Taniguchi K, 2008, ANTICANCER RES, V28, P1559; Templin T, 2011, INT J RADIAT ONCOL, V80, P549, DOI 10.1016/j.ijrobp.2010.12.061; Terry SYA, 2009, MUTAT RES-FUND MOL M, V663, P40, DOI 10.1016/j.mrfmmm.2009.01.003; Thurfjell N, 2005, INT J MOL MED, V16, P1065; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Turtoi A, 2009, INT J RADIAT BIOL, V85, P403, DOI 10.1080/09553000902838541; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urano M, 2010, INT J RADIAT ONCOL, V77, P877, DOI 10.1016/j.ijrobp.2009.12.062; Valdagni R, 2009, INT J RADIAT ONCOL, V74, P1431, DOI 10.1016/j.ijrobp.2008.10.021; Vandersickel V, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-30; Vandersickel V, 2010, INT J RADIAT BIOL, V86, P114, DOI 10.3109/09553000903419940; Vens C, 2002, NUCLEIC ACIDS RES, V30, P2995, DOI 10.1093/nar/gkf403; Wachsberger PR, 1999, RADIAT RES, V151, P398, DOI 10.2307/3579826; Wang R, 2009, AURIS NASUS LARYNX, V36, P332, DOI 10.1016/j.anl.2008.08.006; Wang X, 2006, ONCOGENE, V25, P1980, DOI 10.1038/sj.onc.1209212; Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591; Welsh JW, 2009, INT J RADIAT ONCOL, V74, P1251, DOI 10.1016/j.ijrobp.2009.03.018; Werbrouck J, 2009, INT J RADIAT ONCOL, V73, P1187, DOI 10.1016/j.ijrobp.2008.08.073; Wiebalk K, 2007, INT J CANCER, V121, P2340, DOI 10.1002/ijc.22981; Wischhusen J, 2002, CANCER RES, V62, P2592; Worgul BV, 2002, P NATL ACAD SCI USA, V99, P9836, DOI 10.1073/pnas.162349699; Xiang DB, 2008, CANCER GENE THER, V15, P625, DOI 10.1038/cgt.2008.30; Xiang GA, 2010, SURGERY, V147, P553, DOI 10.1016/j.surg.2009.10.033; Xiao Z, 2005, ONCOGENE, V24, P1403, DOI 10.1038/sj.onc.1208309; Xu QY, 2008, CHINESE MED J-PEKING, V121, P1830, DOI 10.1097/00029330-200809020-00014; Xu W, 2010, ANTI-CANCER AGENT ME, V10, P152, DOI 10.2174/187152010790909362; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1628, DOI 10.1111/j.1745-7254.2007.00647.x; Yavari K, 2010, ACTA ONCOL, V49, P70, DOI 10.3109/02841860903334429; Yokomakura N, 2007, ONCOL REP, V18, P561; Yoshida K, 2004, CANCER RES, V64, P4131, DOI 10.1158/0008-5472.CAN-03-2566; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763; Zhang B, 2010, MED ONCOL; Zhang B, 2008, BIOCHEM PHARMACOL, V75, P660, DOI 10.1016/j.bcp.2007.09.016; Zhang M, 2008, CLIN CANCER RES, V14, P1868, DOI 10.1158/1078-0432.CCR-07-1894; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632; Zhou T, 2006, ENVIRON HEALTH PERSP, V114, P553, DOI 10.1289/ehp.8026; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016	190	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38870	10.1371/journal.pone.0038870	http://dx.doi.org/10.1371/journal.pone.0038870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768051	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100021
J	Ringler, E; Ringler, M; Jehle, R; Hodl, W				Ringler, Eva; Ringler, Max; Jehle, Robert; Hoedl, Walter			The Female Perspective of Mating in A. femoralis, a Territorial Frog with Paternal Care - A Spatial and Genetic Analysis	PLOS ONE			English	Article							DART-POISON FROG; MATE CHOICE; KIN RECOGNITION; INBREEDING AVOIDANCE; EPIPEDOBATES-FEMORALIS; SEQUENTIAL POLYANDRY; SEXUAL SELECTION; BEHAVIOR; WILD; RELATEDNESS	The adaptive significance of sequential polyandry is a challenging question in evolutionary and behavioral biology. Costs and benefits of different mating patterns are shaped by the spatial distribution of individuals and by genetic parameters such as the pairwise relatedness between potential mating partners. Thus, females should become less choosy as costs of mating and searching for mates increase. We used parentage assignments to investigate spatial and genetic patterns of mating across a natural population of the Neotropical frog Allobates femoralis, a species characterized by male territoriality and care and female iteroparity. There was no correlation between genetic and spatial distances between adult individuals across the population. In 72% of cases, females mated with males available within a radius of 20 m. Mean pairwise relatedness coefficients of successful reproducers did not differ from random mating but had a lower variance than expected by chance, suggesting maximal reproductive output at intermediate genetic divergence. We also found evidence for selection in favor of more heterozygous individuals between the embryo and adult stage. The level of sequential polyandry significantly increased with the number of spatially available males. Females that had more candidate males also produced more adult progeny. We hypothesize that the benefits associated with female multiple mating outweigh the costs of in-and outbreeding depression, and consequently precluded the evolution of 'choosy' mate selection in this species.	[Ringler, Eva; Ringler, Max; Hoedl, Walter] Univ Vienna, Dept Evolutionary Biol, Vienna, Austria; [Jehle, Robert] Univ Salford, Ctr Environm Syst & Wildlife Res, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England	University of Vienna; University of Salford	Ringler, E (corresponding author), Univ Vienna, Dept Evolutionary Biol, Vienna, Austria.	eva.ringler@univie.ac.at	Ringler, Max/J-4821-2012; , Eva/F-9064-2014	Ringler, Max/0000-0002-4530-4919; , Eva/0000-0003-3273-6568	University of Vienna; French Centre National de la Recherche Scientifique (CNRS); Austrian Science Fund (FWF) [P18811]; DOC-fFORTE scholarship; Austrian Academy of Sciences	University of Vienna; French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); DOC-fFORTE scholarship; Austrian Academy of Sciences	This work was supported by the University of Vienna ('Forschungsstipendium' and 'Forderstipendium', http://www.univie.ac.at), the 'Nouragues Grant 2009' (PI Max Ringler) from the French Centre National de la Recherche Scientifique (CNRS, http://www.guyane.cnrs.fr), and the Austrian Science Fund (FWF): P18811 (PI Walter Hodl, http://www.fwf.ac.at). Eva Ringler was supported by a DOC-fFORTE scholarship and a L'OREAL Austria fellowship 'For Women in Science' from the Austrian Academy of Sciences (http://www.oeaw.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; [Anonymous], 2010, R LANG ENV STAT COMP; Arct A, 2010, BIOL LETTERS, V6, P762, DOI 10.1098/rsbl.2010.0417; BLAUSTEIN AR, 1992, ANIM BEHAV, V44, P207, DOI 10.1016/0003-3472(92)90027-7; Bleu J, 2012, ANIM BEHAV, V83, P131, DOI 10.1016/j.anbehav.2011.10.017; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Bonachea LA, 2011, ETHOLOGY, V117, P56, DOI 10.1111/j.1439-0310.2010.01843.x; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Byrne PG, 2012, BIOL REV, V87, P209, DOI 10.1111/j.1469-185X.2011.00191.x; Byrne PG, 2009, P R SOC B, V276, P115, DOI 10.1098/rspb.2008.0794; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; Colegrave N, 2002, EVOL ECOL RES, V4, P911; CORNELL TJ, 1989, OECOLOGIA, V78, P312, DOI 10.1007/BF00379103; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Data East, 2021, XTOOLS PRO ARCGIS DE; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Ficetola GF, 2011, EVOL APPL, V4, P30, DOI 10.1111/j.1752-4571.2010.00130.x; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Gottsberger B, 2004, J TROP ECOL, V20, P271, DOI 10.1017/S0266467403001172; HALLIDAY TR, 1988, J HERPETOL, V22, P253, DOI 10.2307/1564148; Halverson MA, 2006, J HERED, V97, P499, DOI 10.1093/jhered/esl019; Hettyey A, 2010, ETHOLOGY, V116, P1, DOI 10.1111/j.1439-0310.2009.01704.x; Hodl W, 2004, J COMP PHYSIOL A, V190, P823, DOI 10.1007/s00359-004-0536-1; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kokko H, 2002, AM NAT, V160, P468, DOI 10.1086/342074; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Konovalov DA, 2008, MOL ECOL RESOUR, V8, P256, DOI 10.1111/j.1471-8286.2007.01940.x; Lampert KP, 2006, BEHAV ECOL SOCIOBIOL, V59, P796, DOI 10.1007/s00265-005-0125-5; Lotters S., 2007, POISON FROGS BIOL SP; MANTEL N, 1967, CANCER RES, V27, P209; Mays HL, 2008, GENETICA, V134, P147, DOI 10.1007/s10709-007-9219-5; Milinski M, 2003, J FISH BIOL, V63, P1, DOI 10.1111/j.1095-8649.2003.00215.x; Montanarin A, 2011, ETHOL ECOL EVOL, V23, P141, DOI 10.1080/03949370.2011.554884; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Part T, 1996, EVOLUTION, V50, P1625, DOI 10.1111/j.1558-5646.1996.tb03934.x; Prohl H, 2005, J HERPETOL, V39, P354, DOI 10.1670/162-04A.1; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Richard M, 2009, P ROY SOC B-BIOL SCI, V276, P2779, DOI 10.1098/rspb.2009.0319; Ringler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025844; Ringler M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1281, DOI 10.1007/s00265-009-0793-7; Rioux-Paquette E, 2010, ANIM BEHAV, V80, P865, DOI 10.1016/j.anbehav.2010.08.006; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; ROITHMAIR ME, 1994, HERPETOL J, V4, P77; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Summers K, 1997, BEHAV ECOL, V8, P260, DOI 10.1093/beheco/8.3.260; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; TOFT CA, 1980, OECOLOGIA, V45, P131, DOI 10.1007/BF00346717; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Ursprung E, 2011, HERPETOL J, V21, P83; Ursprung E, 2011, MOL ECOL, V20, P1759, DOI 10.1111/j.1365-294X.2011.05056.x; Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9; Voronoi G., 1907, J REINE ANGEW MATH, V133, P97, DOI DOI 10.1515/CRLL.1908.133.97; Wagner AP, 2007, MOL ECOL, V16, P4356, DOI 10.1111/j.1365-294X.2007.03470.x; WALDMAN B, 1992, AM ZOOL, V32, P18; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Weygoldt P., 1980, Salamandra, V16, P215; [No title captured]	68	37	37	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40237	10.1371/journal.pone.0040237	http://dx.doi.org/10.1371/journal.pone.0040237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768260	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305892100233
J	Taqi, MM; Warmlander, SKTS; Yamskova, O; Madani, F; Bazov, I; Luo, JH; Zubarev, R; Verbeek, D; Graslund, A; Bakalkin, G				Taqi, Malik Mumtaz; Warmlander, Sebastian K. T. S.; Yamskova, Olga; Madani, Fatemeh; Bazov, Igor; Luo, Jinghui; Zubarev, Roman; Verbeek, Dineke; Graslund, Astrid; Bakalkin, Georgy			Conformation Effects of CpG Methylation on Single-Stranded DNA Oligonucleotides: Analysis of the Opioid Peptide Dynorphin-Coding Sequences	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; IN-VIVO; CYTOSINE METHYLATION; HAIRPIN CONFORMATION; DYNAMIC IMPACT; G-QUADRUPLEX; TRANSCRIPTION; RECOMBINATION; RECOGNITION; GUANINE	Single-stranded DNA (ssDNA) is characterized by high conformational flexibility that allows these molecules to adopt a variety of conformations. Here we used native polyacrylamide gel electrophoresis (PAGE), circular dichroism (CD) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy to show that cytosine methylation at CpG sites affects the conformational flexibility of short ssDNA molecules. The CpG containing 37-nucleotide PDYN (prodynorphin) fragments were used as model molecules. The presence of secondary DNA structures was evident from differences in oligonucleotide mobilities on PAGE, from CD spectra, and from formation of A-T, G-C, and non-canonical G-T base pairs observed by NMR spectroscopy. The oligonucleotides displayed secondary structures at 4 degrees C, and some also at 37 degrees C. Methylation at CpG sites prompted sequence-dependent formation of novel conformations, or shifted the equilibrium between different existing ssDNA conformations. The effects of methylation on gel mobility and base pairing were comparable in strength to the effects induced by point mutations in the DNA sequences. The conformational effects of methylation may be relevant for epigenetic regulatory events in a chromatin context, including DNA-protein or DNA-DNA recognition in the course of gene transcription, and DNA replication and recombination when double-stranded DNA is unwinded to ssDNA.	[Warmlander, Sebastian K. T. S.; Madani, Fatemeh; Luo, Jinghui; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Zubarev, Roman] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Verbeek, Dineke] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [Taqi, Malik Mumtaz; Yamskova, Olga; Bazov, Igor; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Stockholm University; Karolinska Institutet; University of Groningen; Uppsala University	Taqi, MM (corresponding author), Quaid I Azam Univ, Dept Pharm, Islamabad, Pakistan.	Georgy.Bakalkin@farmbio.uu.se	Zubarev, Roman A/W-7891-2018	Zubarev, Roman A/0000-0001-9839-2089; Bazov, Igor/0000-0003-4388-1656; Luo, Jinghui/0000-0002-7014-8153; Bakalkin, Georgy/0000-0002-8074-9833	Swedish Science Research Council; Swedish Council for Working Life and Social Research	Swedish Science Research Council; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by grants from the Swedish Science Research Council, and Swedish Council for Working Life and Social Research to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Silva C, 2010, J PHYS CHEM B, V114, P10217, DOI 10.1021/jp103850h; Bakalkin G, 2010, 2010 NEUR M PLANN; Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Biyani M, 2005, J BIOCHEM, V138, P363, DOI 10.1093/jb/mvi149; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Derreumaux S, 2001, NUCLEIC ACIDS RES, V29, P2314, DOI 10.1093/nar/29.11.2314; DIEKMANN S, 1987, NUCLEIC ACIDS RES, V15, P5765, DOI 10.1093/nar/15.14.5765; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; Geahigan KB, 2000, BIOCHEMISTRY-US, V39, P4939, DOI 10.1021/bi9917636; Gohler T, 2002, J BIOL CHEM, V277, P41192, DOI 10.1074/jbc.M202344200; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Hernandez M, 2007, BIOCHEM BIOPH RES CO, V355, P1075, DOI 10.1016/j.bbrc.2007.02.079; HODGESGARCIA Y, 1992, BIOCHEMISTRY-US, V31, P7595, DOI 10.1021/bi00148a022; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Krasilnikov AS, 1999, J MOL BIOL, V292, P1149, DOI 10.1006/jmbi.1999.3117; Lada AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024848; Laporte L, 1998, J MOL BIOL, V281, P261, DOI 10.1006/jmbi.1998.1938; Liang XG, 2006, BIOPHYS J, V90, P2877, DOI 10.1529/biophysj.105.074104; Masai H, 1997, CELL, V89, P897, DOI 10.1016/S0092-8674(00)80275-5; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mayer-Jung C, 1998, EMBO J, V17, P2709, DOI 10.1093/emboj/17.9.2709; Meints GA, 2001, BIOCHEMISTRY-US, V40, P12436, DOI 10.1021/bi0102555; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Napierala M, 2002, J BIOL CHEM, V277, P34087, DOI 10.1074/jbc.M202128200; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; NISHIGAKI K, 1986, J BIOCHEM-TOKYO, V99, P663, DOI 10.1093/oxfordjournals.jbchem.a135525; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Patel SS, 2011, CURR OPIN CHEM BIOL; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Severin P, 2011, NUCL ACIDS RES; SHEA RG, 1990, NUCLEIC ACIDS RES, V18, P4859, DOI 10.1093/nar/18.16.4859; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Skolakova P, 2010, BIOCHEM BIOPH RES CO, V399, P203, DOI 10.1016/j.bbrc.2010.07.055; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Swamynathan SK, 1998, FASEB J, V12, P515, DOI 10.1096/fasebj.12.7.515; Tomasko M, 2009, BIOCHIMIE, V91, P171, DOI 10.1016/j.biochi.2008.07.012; Vondruskova J, 2008, INT J BIOL MACROMOL, V43, P463, DOI 10.1016/j.ijbiomac.2008.08.013; Warmlander S, 2000, BIOCHEMISTRY-US, V39, P607, DOI 10.1021/bi991863b; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wright BE, 2011, CARCINOGENESIS, V32, P1559, DOI 10.1093/carcin/bgr177; YU AD, 1995, NUCLEIC ACIDS RES, V23, P2706, DOI 10.1093/nar/23.14.2706; ZACHARIAS W, 1990, J BACTERIOL, V172, P3278, DOI 10.1128/jb.172.6.3278-3283.1990; Zhuang XY, 2007, J MOL RECOGNIT, V20, P386, DOI 10.1002/jmr.847; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39605	10.1371/journal.pone.0039605	http://dx.doi.org/10.1371/journal.pone.0039605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768096	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100066
J	Zhou, Y; Fang, L; Jiang, L; Wen, P; Cao, HD; He, WC; Dai, CS; Yang, JW				Zhou, Yang; Fang, Li; Jiang, Lei; Wen, Ping; Cao, Hongdi; He, Weichun; Dai, Chunsun; Yang, Junwei			Uric Acid Induces Renal Inflammation via Activating Tubular NF-kappa B Signaling Pathway	PLOS ONE			English	Article							CELL-PROLIFERATION; EPITHELIAL-CELLS; URATE CRYSTALS; KIDNEY-DISEASE; EXPRESSION; MICE; HYPERTENSION; INCREASES; FIBROSIS	Inflammation is a pathologic feature of hyperuricemia in clinical settings. However, the underlying mechanism remains unknown. Here, infiltration of T cells and macrophages were significantly increased in hyperuricemia mice kidneys. This infiltration of inflammatory cells was accompanied by an up-regulation of TNF-alpha, MCP-1 and RANTES expression. Further, infiltration was largely located in tubular interstitial spaces, suggesting a role for tubular cells in hyperuricemia-induced inflammation. In cultured tubular epithelial cells (NRK-52E), uric acid, probably transported via urate transporter, induced TNF-alpha, MCP-1 and RANTES mRNA as well as RANTES protein expression. Culture media of NRK-52E cells incubated with uric acid showed a chemo-attractive ability to recruit macrophage. Moreover uric acid activated NF-kappa B signaling. The uric acid-induced up-regulation of RANTES was blocked by SN 50, a specific NF-kappa B inhibitor. Activation of NF-kappa B signaling was also observed in tubule of hyperuricemia mice. These results suggest that uric acid induces renal inflammation via activation of NF-kappa B signaling.	[Zhou, Yang; Fang, Li; Jiang, Lei; Wen, Ping; Cao, Hongdi; He, Weichun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			National Science Foundation of China [30871201/31171093]; Ministry of Science and Technology, China [2011CB504005]; Jiangsu Province's Outstanding Medical Academic Leader Program [SWKJ 2006-50]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by National Science Foundation of China Grants 30871201/31171093, "973'' Science Program of the Ministry of Science and Technology, China (2011CB504005), and Jiangsu Province's Outstanding Medical Academic Leader Program (SWKJ 2006-50) to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen GL, 2006, AM J CHINESE MED, V34, P77, DOI 10.1142/S0192415X06003655; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; DIGIOVINE FS, 1991, J CLIN INVEST, V87, P1375, DOI 10.1172/JCI115142; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Han HJ, 2007, AM J PHYSIOL-RENAL, V292, pF373, DOI 10.1152/ajprenal.00104.2006; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Lai KN, 2007, KIDNEY INT, V71, P526, DOI 10.1038/sj.ki.5002091; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mene P, 2008, J HYPERTENS, V26, P2085, DOI 10.1097/HJH.0b013e32830e4945; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Roson MI, 2006, KIDNEY INT, V70, P1439, DOI 10.1038/sj.ki.5001831; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wang Y, 2004, BASIC CLIN PHARMACOL, V94, P232, DOI 10.1111/j.1742-7843.2004.pto940506.x; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zhou Y, 2010, AM J PHYSIOL-RENAL, V299, pF336, DOI 10.1152/ajprenal.00053.2010; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	28	131	143	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39738	10.1371/journal.pone.0039738	http://dx.doi.org/10.1371/journal.pone.0039738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761883	Green Submitted, gold, Green Published			2022-12-25	WOS:000305781700061
J	Zhang, X; Cruz, FD; Terry, M; Remotti, F; Matushansky, I				Zhang, X.; Cruz, F. D.; Terry, M.; Remotti, F.; Matushansky, I.			Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming	ONCOGENE			English	Article						sarcoma; stem cells; induced pluripotent stem cells	MESENCHYMAL STEM-CELLS; RED-BLOOD-CELLS; HEMATOPOIETIC STEM; DIRECTED DIFFERENTIATION; HUMAN FIBROBLASTS; COPY NUMBER; IN-VITRO; GENES; GENOME; CLASSIFICATION	Pluripotent cells can be derived from various types of somatic cells by nuclear reprogramming using defined transcription factors. It is, however, unclear whether human cancer cells can be similarly reprogrammed and subsequently terminally differentiated with abrogation of tumorigenicity. Here, using sarcomas we show that human-derived complex karyotype solid tumors: (1) can be reprogrammed into a pluripotent-like state as defined by all in vitro criteria used to define pluripotent stem cells generated from somatic cells; (2) can be terminally differentiated into mature connective tissue and red blood cells; and (3) terminal differentiation is accompanied with loss of both proliferation and tumorigenicity. We go on to perform the first global DNA promoter methylation and gene expression analyses comparing human cancers to their reprogrammed counterparts and report that reprogramming/differentiation results in significant epigenetic remodeling of oncogenes and tumor suppressors, while not significantly altering the differentiation status of the reprogrammed cancer cells, in essence dedifferentiating them to a state slightly before the mesenchymal stem cell differentiation stage. Our data demonstrate that direct nuclear reprogramming can restore terminal differentiation potential to human-derived cancer cells, with simultaneous loss of tumorigenicity, without the need to revert to an embryonic state. We anticipate that our models would serve as a starting point to more fully assess how nuclear reprogramming overcomes the multitude of genetic and epigenetic aberrancies inherent in human cancers to restore normal terminal differentiation pathways. Finally, these findings suggest that nuclear reprogramming may be a broadly applicable therapeutic strategy for the treatment of cancer.	[Zhang, X.; Cruz, F. D.; Terry, M.; Remotti, F.; Matushansky, I.] Columbia Univ, Med Ctr, Dept Med, Div Med Oncol, New York, NY 10032 USA	Columbia University	Matushansky, I (corresponding author), Columbia Univ, Med Ctr, Dept Med, Div Med Oncol, 1130 St Nicholas Ave Rm 208C, New York, NY 10032 USA.	im17@columbia.edu			NCI; Gerstner CDA; Damon Runyon Cancer Research Fund; NATIONAL CANCER INSTITUTE [K08CA132986] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gerstner CDA; Damon Runyon Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank: Timothy C Wang MD for critical discussions and manuscript review; Sara Siddiqi and Gannie Tzonove for general technical assistance; Carlos Cordo-Cardo MD PhD for assistance with solid tumor pathological review and discussion; Benjamin Tycko MD PhD for assistance with DNA methylation analysis; Bachir Alobeid MD for assistance with hematological pathological review; Pavel Sumazin PhD for bioniformatic analysis. IM receives funding from NCI, Gerstner CDA and the Damon Runyon Cancer Research Fund.; XZ performed all experiments and assisted with experimental design. MT assisted with experiments and data interpretation. FDC assisted with experiments and data interpretation. FR reviewed and interpreted all histopathology outlined. IM designed the concept and experiments, interpreted the data and wrote the manuscript. IM receives funding from NCI, Gerstner CDA and the Damon Runyon Cancer Research Fund.	BARRIOS C, 1994, AM J CLIN ONCOL-CANC, V17, P273, DOI 10.1097/00000421-199406000-00019; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Chang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010320; Charytonowicz E, 2012, J CLIN INVEST, V122, P886, DOI 10.1172/JCI60015; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Giebel B, 2008, BIOL CHEM, V389, P813, DOI 10.1515/BC.2008.092; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012297; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krause U, 2011, METHODS MOL BIOL, V698, P215, DOI 10.1007/978-1-60761-999-4_17; Lai RC, 2011, METHODS MOL BIOL, V698, P141, DOI 10.1007/978-1-60761-999-4_11; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lengner CJ, 2010, ANN NY ACAD SCI, V1192, P38, DOI 10.1111/j.1749-6632.2009.05213.x; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lu SJ, 2010, METHODS MOL BIOL, V636, P105, DOI 10.1007/978-1-60761-691-7_7; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Matushansky I, 2008, AM J PATHOL, V172, P1069, DOI 10.2353/ajpath.2008.070284; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mills J, 2011, MOL CANCER THER, V10, P313, DOI 10.1158/1535-7163.MCT-10-0724; Mills J, 2009, HUM CELL, V22, P85, DOI 10.1111/j.1749-0774.2009.00073.x; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; OGAWA M, 1983, BLOOD, V61, P823; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Pitha-Rowe I, 2003, LEUKEMIA, V17, P1723, DOI 10.1038/sj.leu.2403065; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Siddiqi S, 2010, CURR STEM CELL RES T, V5, P63, DOI 10.2174/157488810790442859; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang Y, 2005, CANCER RES, V65, P8324, DOI 10.1158/0008-5472.CAN-05-0027; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; West FD, 2008, STEM CELLS, V26, P2768, DOI 10.1634/stemcells.2008-0124; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015336	58	83	88	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2013	32	18					2249	2260		10.1038/onc.2012.237	http://dx.doi.org/10.1038/onc.2012.237			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22777357	Green Accepted			2022-12-25	WOS:000318683600002
J	Kashef, F; Li, JD; Wright, P; Snyder, J; Suliman, F; Kilic, A; Higgins, RSD; Anderson, ME; Binkley, PF; Hund, TJ; Mohler, PJ				Kashef, Farshid; Li, Jingdong; Wright, Patrick; Snyder, Jedidiah; Suliman, Faroug; Kilic, Ahmet; Higgins, Robert S. D.; Anderson, Mark E.; Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.			Ankyrin-B Protein in Heart Failure IDENTIFICATION OF A NEW COMPONENT OF METAZOAN CARDIOPROTECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; CARDIAC-ARRHYTHMIA; MOLECULAR-BASIS; MEMBRANE; REQUIRES; PROTEOLYSIS; STABILITY; SPECTRIN; NODES; BETA(2)-SPECTRIN	Ankyrins (ankyrin-R, -B, and -G) are adapter proteins linked with defects in metazoan physiology. Ankyrin-B (encoded by ANK2) loss-of-function mutations are directly associated with human cardiovascular phenotypes including sinus node disease, atrial fibrillation, ventricular tachycardia, and sudden cardiac death. Despite the link between ankyrin-B dysfunction and monogenic disease, there are no data linking ankyrin-B regulation with common forms of human heart failure. Here, we report that ankyrin-B levels are altered in both ischemic and non-ischemic human heart failure. Mechanistically, we demonstrate that cardiac ankyrin-B levels are tightly regulated downstream of reactive oxygen species, intracellular calcium, and the calcium-dependent protease calpain, all hallmarks of human myocardial injury and heart failure. Surprisingly, beta(II)-spectrin, previously thought to mediate ankyrin-dependent modulation in the nervous system and heart, is not coordinately regulated with ankyrin-B or its downstream partners. Finally, our data implicate ankyrin-B expression as required for vertebrate myocardial protection as hearts deficient in ankyrin-B show increased cardiac damage and impaired function relative to wild-type mouse hearts following ischemia reperfusion. In summary, our findings provide the data of ankyrin-B regulation in human heart failure, provide insight into candidate pathways for ankyrin-B regulation in acquired human cardiovascular disease, and surprisingly, implicate ankyrin-B as a molecular component for cardioprotection following ischemia.	[Kashef, Farshid; Li, Jingdong; Wright, Patrick; Snyder, Jedidiah; Kilic, Ahmet; Higgins, Robert S. D.; Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Coll Engn, Columbus, OH 43210 USA; [Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dept Internal Med, Coll Engn, Div Cardiovasc Med, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Coll Engn, Columbus, OH 43210 USA; [Kilic, Ahmet; Higgins, Robert S. D.] Ohio State Univ, Comprehens Transplant Ctr, Coll Engn, Columbus, OH 43210 USA; [Hund, Thomas J.] Ohio State Univ, Ohio State Univ Med Ctr, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Suliman, Faroug; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA 52242 USA; [Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa; University of Iowa	Mohler, PJ (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Coll Engn, 473 W 12th Ave,DHLRI 110G, Columbus, OH 43210 USA.	peter.mohler@osumc.edu	Hund, Thomas/C-9222-2012; Higgins, Robert/AGZ-7064-2022		National Institutes of Health [HL084583, HL083422, HL096805]; Saving Tiny Hearts Society; Pew Scholars Trust; American Heart Association Established Investigator Award; Fondation Leducq (Alliance for Calmodulin Kinase Signaling in Heart Disease); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113001, R01HL083422, K99HL096805, R01HL084583, R00HL096805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saving Tiny Hearts Society; Pew Scholars Trust; American Heart Association Established Investigator Award(American Heart Association); Fondation Leducq (Alliance for Calmodulin Kinase Signaling in Heart Disease)(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.) and HL096805 (to T. J. H.). This work was also supported by grants from the Saving Tiny Hearts Society (to P. J. M.), Pew Scholars Trust (to P. J. M.), American Heart Association Established Investigator Award (to P. J. M.), and Fondation Leducq (Alliance for Calmodulin Kinase Signaling in Heart Disease (to P. J. M. and M. E. A.).	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; BENNETT V, 1978, J BIOL CHEM, V253, P2292; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Brundel BJJM, 2002, CARDIOVASC RES, V54, P380, DOI 10.1016/S0008-6363(02)00289-4; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gumina RJ, 2003, AM J PHYSIOL-HEART C, V284, pH2106, DOI 10.1152/ajpheart.00057.2003; Haruna T, 1998, CIRCULATION, V98, P2905, DOI 10.1161/01.CIR.98.25.2905; Hashemi SM, 2009, J MOL CELL CARDIOL, V47, P203, DOI 10.1016/j.yjmcc.2009.04.010; Healy JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000771; Hund TJ, 2011, AM J PHYSIOL-HEART C, V300, pH33, DOI 10.1152/ajpheart.01088.2010; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Inserte J, 2005, CIRC RES, V97, P465, DOI 10.1161/01.RES.0000181170.87738.f3; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Liu XL, 2003, J PHARMACOL EXP THER, V304, P63, DOI 10.1124/jpet.102.043406; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Ma WL, 2011, J CLIN INVEST, V121, P4548, DOI 10.1172/JCI57734; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2006, J CARDIOVASC ELECTR, V17, P1153, DOI 10.1111/j.1540-8167.2006.00540.x; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Monceau V, 2004, CARDIOVASC RES, V64, P496, DOI 10.1016/j.cardiores.2004.08.003; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Schwartz SM, 2003, PEDIATR RES, V54, P91, DOI 10.1203/01.PDR.0000065730.79610.7D; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	52	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30268	30281		10.1074/jbc.M112.368415	http://dx.doi.org/10.1074/jbc.M112.368415			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778271	Green Published, hybrid			2022-12-25	WOS:000308579800020
J	Costa, B; Kean, MJ; Ast, V; Knight, JDR; Mett, A; Levy, Z; Ceccarelli, DF; Badillo, BG; Eils, R; Konig, R; Gingras, AC; Fainzilber, M				Costa, Barbara; Kean, Michelle J.; Ast, Volker; Knight, James D. R.; Mett, Alice; Levy, Zehava; Ceccarelli, Derek F.; Badillo, Beatriz Gonzalez; Eils, Roland; Koenig, Rainer; Gingras, Anne-Claude; Fainzilber, Mike			STK25 Protein Mediates TrkA and CCM2 Protein-dependent Death in Pediatric Tumor Cells of Neural Origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; RECENT INSIGHTS; RECEPTORS; KINASE; GOLGI; PURIFICATION; INTERACTS; PATHWAY; COMPLEX; GROWTH	The TrkA receptor tyrosine kinase induces death in medulloblastoma cells via an interaction with the cerebral cavernous malformation 2 (CCM2) protein. We used affinity proteomics to identify the germinal center kinase class III (GCKIII) kinases STK24 and STK25 as novel CCM2 interactors. Down-modulation of STK25, but not STK24, rescued medulloblastoma cells from NGF-induced TrkA-dependent cell death, suggesting that STK25 is part of the death-signaling pathway initiated by TrkA and CCM2. CCM2 can be phosphorylated by STK25, and the kinase activity of STK25 is required for death signaling. Finally, STK25 expression in tumors is correlated with positive prognosis in neuroblastoma patients. These findings delineate a death-signaling pathway downstream of neurotrophic receptor tyrosine kinases that may provide targets for therapeutic intervention in pediatric tumors of neural origin.	[Costa, Barbara; Mett, Alice; Levy, Zehava; Fainzilber, Mike] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kean, Michelle J.; Knight, James D. R.; Ceccarelli, Derek F.; Badillo, Beatriz Gonzalez; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kean, Michelle J.; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Ast, Volker; Eils, Roland; Koenig, Rainer] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Genom, Bioquant, D-69120 Heidelberg, Germany; [Ast, Volker; Eils, Roland; Koenig, Rainer] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany	Weizmann Institute of Science; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Costa, B (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	barbara.costa@weizmann.ac.il; mike.fainzilber@weizmann.ac.il	Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020; Eils, Roland/B-6121-2009	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Eils, Roland/0000-0002-0034-4036; Fainzilber, Mike/0000-0001-8173-8557; Ceccarelli, Derek/0000-0002-2674-9234; Costa, Barbara/0000-0001-5958-5099	European Union (Endocyte Network); German-Israeli Cooperation in Cancer Research [CA 140]; Canadian Institutes of Health Research, Nationales Genom-Forschungs-Netz (NGFN+) project ENGINE [01GS0898]; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie CancerSys-Verbundprojekt: MYCNET [0316076C]; Lombroso postdoctoral fellowship; Banting and Best Canada Graduate Scholarship	European Union (Endocyte Network); German-Israeli Cooperation in Cancer Research; Canadian Institutes of Health Research, Nationales Genom-Forschungs-Netz (NGFN+) project ENGINE(Canadian Institutes of Health Research (CIHR)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie CancerSys-Verbundprojekt: MYCNET(Federal Ministry of Education & Research (BMBF)); Lombroso postdoctoral fellowship; Banting and Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by the European Union (Endocyte Network), the German-Israeli Cooperation in Cancer Research (CA 140), the Canadian Institutes of Health Research, Nationales Genom-Forschungs-Netz (NGFN+) project ENGINE (01GS0898), and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie CancerSys-Verbundprojekt: MYCNET (0316076C), a Lombroso postdoctoral fellowship (to B. C.), and a Banting and Best Canada Graduate Scholarship (to M. J. K.).	Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Dunham WH, 2011, PROTEOMICS, V11, P2603, DOI 10.1002/pmic.201000571; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Harel L, 2010, DEV NEUROBIOL, V70, P298, DOI 10.1002/dneu.20769; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Hothorn T, 2003, COMPUT STAT DATA AN, V43, P121, DOI 10.1016/S0167-9473(02)00225-6; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Muragaki Y, 1997, J NEUROSCI, V17, P530; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9	20	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29285	29289		10.1074/jbc.C112.345397	http://dx.doi.org/10.1074/jbc.C112.345397			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782892	hybrid, Green Published			2022-12-25	WOS:000308286900008
J	Smith, SD; Enge, M; Bao, WJ; Thullberg, M; Costa, TDF; Olofsson, H; Gashi, B; Selivanova, G; Stromblad, S				Smith, Stephen D.; Enge, Martin; Bao, Wenjie; Thullberg, Minna; Costa, Tania D. F.; Olofsson, Helene; Gashi, Behxhet; Selivanova, Galina; Stromblad, Staffan			Protein Kinase C alpha (PKC alpha) Regulates p53 Localization and Melanoma Cell Survival Downstream of Integrin alpha v in Three-dimensional Collagen and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; WILD-TYPE P53; CYTOPLASMIC SEQUESTRATION; BCL2 PHOSPHORYLATION; MALIGNANT-MELANOMA; PHORBOL ESTER; DNA-DAMAGE; GROWTH; APOPTOSIS; SUPPRESSION	Protein kinase C alpha (PKC alpha) is overexpressed in numerous types of cancer. Importantly, PKC alpha has been linked to metastasis of malignant melanoma in patients. However, it has been unclear how PKC alpha may be regulated and how it exerts its role in melanoma. Here, we identified a role for PKC alpha in melanoma cell survival in a three-dimensional collagen model mimicking the in vivo pathophysiology of the dermis. A pathway was identified that involved integrin alpha v-mediated up-regulation of PKC alpha and PKC alpha-dependent regulation of p53 localization, which was connected to melanoma cell survival. Melanoma survival and growth in three-dimensional microenvironments requires the expression of integrin alpha v, which acts to suppress p53 activity. Interestingly, microarray analysis revealed that PKC alpha was up-regulated by integrin alpha v in a three-dimensional microenvironment-dependent manner. Integrin alpha v was observed to promote a relocalization of endogenous p53 from the nucleus to the cytoplasm upon growth in three-dimensional collagen as well as in vivo, whereas stable knockdown of PKC alpha inhibited the integrin alpha v-mediated relocalization of p53. Importantly, knockdown of PKC alpha also promoted apoptosis in three-dimensional collagen and in vivo, resulting in reduced tumor growth. This indicates that PKC alpha constitutes a crucial component of the integrin alpha v-mediated pathway(s) that promote p53 relocalization and melanoma survival.	[Smith, Stephen D.; Enge, Martin; Bao, Wenjie; Thullberg, Minna; Costa, Tania D. F.; Olofsson, Helene; Gashi, Behxhet; Stromblad, Staffan] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Enge, Martin; Bao, Wenjie; Selivanova, Galina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Stromblad, S (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden.	staffan.stromblad@ki.se	Enge, Martin/GYQ-5073-2022	Stromblad, Staffan/0000-0002-1236-6339; Selivanova, Galina/0000-0002-8698-4332; Enge, Martin/0000-0001-8748-8931	Swedish Cancer Society; EU [p53]; Swedish Research Council; Center of Biosciences; Foundation for Allergy and Cancer in Sweden; Portuguese Foundation for Science and Technology [SFRH/BD/47330/2008]	Swedish Cancer Society(Swedish Cancer Society); EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Center of Biosciences; Foundation for Allergy and Cancer in Sweden; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Swedish Cancer Society, EU-FP6-Active p53, and the Swedish Research Council (to S. S. and G. S.) and from the Center of Biosciences and the Foundation for Allergy and Cancer in Sweden (to S. S.).; Supported by the Portuguese Foundation for Science and Technology (SFRH/BD/47330/2008).	ALBELDA SM, 1990, CANCER RES, V50, P6757; Bao WJ, 2011, CELL CYCLE, V10, P301, DOI 10.4161/cc.10.2.14538; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Byers HR, 2010, MELANOMA RES, V20, P171, DOI 10.1097/CMR.0b013e32832f1581; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Chernov MV, 2001, J BIOL CHEM, V276, P31819, DOI 10.1074/jbc.M103170200; Coutinho I, 2009, FEBS LETT, V583, P3582, DOI 10.1016/j.febslet.2009.10.030; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DANG CV, 1989, J BIOL CHEM, V264, P18019; Delphin C, 1997, EUR J BIOCHEM, V245, P684, DOI 10.1111/j.1432-1033.1997.t01-1-00684.x; DELPHIN C, 1994, J BIOL CHEM, V269, P29579; Dennis JU, 1998, CANCER LETT, V128, P65, DOI 10.1016/S0304-3835(98)00052-4; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Haller D, 2010, ONCOGENE, V29, P3079, DOI 10.1038/onc.2010.61; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; Jorgensen K, 2005, BIOCHEM BIOPH RES CO, V329, P266, DOI 10.1016/j.bbrc.2005.01.143; Komlodi-Pasztor E, 2009, ONCOGENE, V28, P3111, DOI 10.1038/onc.2009.166; Koren R, 2004, ONCOL REP, V11, P321; Lahn MM, 2004, MELANOMA RES, V14, P85, DOI 10.1097/00008390-200404000-00002; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Luu Y, 2003, ANTICANCER RES, V23, P99; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Petitclerc E, 1999, CANCER RES, V59, P2724; PRICE BD, 1993, ONCOGENE, V8, P3055; Putnam AJ, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-10; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tsubaki M, 2007, CLIN EXP METASTAS, V24, P431, DOI 10.1007/s10585-007-9080-z; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wu CC, 2004, BIOINFORMATICS, V20, P3691, DOI 10.1093/bioinformatics/bth428; Youmell M, 1998, BIOCHEM BIOPH RES CO, V245, P514, DOI 10.1006/bbrc.1998.8471; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	50	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29336	29347		10.1074/jbc.M112.341917	http://dx.doi.org/10.1074/jbc.M112.341917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773839	hybrid, Green Published			2022-12-25	WOS:000308286900013
J	Falcone, R; Brunamonti, E; Genovesio, A				Falcone, Rossella; Brunamonti, Emiliano; Genovesio, Aldo			Vicarious Learning from Human Models in Monkeys	PLOS ONE			English	Article							RHESUS-MONKEYS; IMITATION	We examined whether monkeys can learn by observing a human model, through vicarious learning. Two monkeys observed a human model demonstrating an object-reward association and consuming food found underneath an object. The monkeys observed human models as they solved more than 30 learning problems. For each problem, the human models made a choice between two objects, one of which concealed a piece of apple. In the test phase afterwards, the monkeys made a choice of their own. Learning was apparent from the first trial of the test phase, confirming the ability of monkeys to learn by vicarious observation of human models.	[Falcone, Rossella; Brunamonti, Emiliano; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	Sapienza University Rome	Falcone, R (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	aldo.genovesio@uniroma1.it		FALCONE, ROSSELLA/0000-0001-5068-2984; Genovesio, Aldo/0000-0003-2521-143X; Brunamonti, Emiliano/0000-0002-5119-6950	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie [P288/09]	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie	This work was supported by the 'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie (Protocol number: P288/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1971, SOCIAL LEARNING THEO; Bonnie KE, 2007, ANIM COGN, V10, P283, DOI 10.1007/s10071-006-0069-9; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Chang SWC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00027; DARBY CL, 1959, J COMP PHYSIOL PSYCH, V52, P94, DOI 10.1037/h0046068; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032209; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; HEYES CM, 1993, ANIM LEARN BEHAV, V21, P221, DOI 10.3758/BF03197985; Kumashiro M, 2003, INT J PSYCHOPHYSIOL, V50, P81, DOI 10.1016/S0167-8760(03)00126-0; Meunier M, 2007, NEUROBIOL LEARN MEM, V88, P243, DOI 10.1016/j.nlm.2007.04.015; Miklosi A, 1999, BIOL REV, V74, P347, DOI 10.1017/S000632319900537X; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Monfardini E, 2008, NEUROIMAGE, V42, P1207, DOI 10.1016/j.neuroimage.2008.05.043; MYERS WA, 1970, J EXP ANAL BEHAV, V14, P225, DOI 10.1901/jeab.1970.14-225; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Snowdon CT, 2003, J COMP PSYCHOL, V117, P142, DOI 10.1037/0735-7036.117.2.142; Subiaul F, 2007, ANIM COGN, V10, P369, DOI 10.1007/s10071-006-0070-3; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	25	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40283	10.1371/journal.pone.0040283	http://dx.doi.org/10.1371/journal.pone.0040283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768347	Green Submitted, Green Published, gold			2022-12-25	WOS:000305966500060
J	Jordan, F; Gjata, N; Mei, S; Yule, CM				Jordan, Ferenc; Gjata, Nerta; Mei, Shu; Yule, Catherine M.			Simulating Food Web Dynamics along a Gradient: Quantifying Human Influence	PLOS ONE			English	Article							ECOLOGY; CONSERVATION; CHALLENGES; COMPLEXITY; KEYSTONES; STREAMS; INDEX; QUEST	Realistically parameterized and dynamically simulated food-webs are useful tool to explore the importance of the functional diversity of ecosystems, and in particular relations between the dynamics of species and the whole community. We present a stochastic dynamical food web simulation for the Kelian River (Borneo). The food web was constructed for six different locations, arrayed along a gradient of increasing human perturbation (mostly resulting from gold mining activities) along the river. Along the river, the relative importance of grazers, filterers and shredders decreases with increasing disturbance downstream, while predators become more dominant in governing eco-dynamics. Human activity led to increased turbidity and sedimentation which adversely impacts primary productivity. Since the main difference between the study sites was not the composition of the food webs (structure is quite similar) but the strengths of interactions and the abundance of the trophic groups, a dynamical simulation approach seemed to be useful to better explain human influence. In the pristine river (study site 1), when comparing a structural version of our model with the dynamical model we found that structurally central groups such as omnivores and carnivores were not the most important ones dynamically. Instead, primary consumers such as invertebrate grazers and shredders generated a greater dynamical response. Based on the dynamically most important groups, bottom-up control is replaced by the predominant top-down control regime as distance downstream and human disturbance increased. An important finding, potentially explaining the poor structure to dynamics relationship, is that indirect effects are at least as important as direct ones during the simulations. We suggest that our approach and this simulation framework could serve systems-based conservation efforts. Quantitative indicators on the relative importance of trophic groups and the mechanistic modeling of eco-dynamics could greatly contribute to understanding various aspects of functional diversity.	[Jordan, Ferenc; Gjata, Nerta] Univ Trent, Ctr Computat & Syst Biol, Microsoft Res, Trento, Italy; [Mei, Shu; Yule, Catherine M.] Monash Univ, Sch Sci, Selangor Darulehsan, Malaysia	University of Trento	Jordan, F (corresponding author), Univ Trent, Ctr Computat & Syst Biol, Microsoft Res, Trento, Italy.	jordan.ferenc@gmail.com	Jordan, Ferenc/A-9940-2009; YULE, Catherine/F-9733-2015	Jordan, Ferenc/0000-0002-0224-6472; YULE, CATHERINE/0000-0002-1085-2798				Abrams Peter A., 1996, P371; Baptista DF, 2007, HYDROBIOLOGIA, V575, P83, DOI 10.1007/s10750-006-0286-x; Boyero L, 2012, GLOBAL ECOL BIOGEOGR, V21, P134, DOI 10.1111/j.1466-8238.2011.00673.x; Dematte L, 2008, THEOR COMPUT SCI, V408, P83, DOI 10.1016/j.tcs.2008.07.013; Dudgeon D, 2010, CURRENT OPINION ENV, V2, P1; Feest A, 2010, ECOL INDIC, V10, P1077, DOI 10.1016/j.ecolind.2010.04.002; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; Green JL, 2005, BIOSCIENCE, V55, P501, DOI 10.1641/0006-3568(2005)055[0501:CIEACM]2.0.CO;2; Guariento RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022205; Harary F., 1961, GEN SYST, V6, P41; Hurlbert SH, 1997, AUST J ECOL, V22, P369, DOI 10.1111/j.1442-9993.1997.tb00687.x; Jordan F, 2006, COMMUNITY ECOL, V7, P81, DOI 10.1556/ComEc.7.2006.1.8; Jordan F., 2004, Physics of Life Reviews, V1, DOI 10.1016/j.plrev.2004.08.001; Jordan F, 2003, COMMUNITY ECOL, V4, P79, DOI 10.1556/ComEc.4.2003.1.12; Jordan F, 1999, OIKOS, V86, P453, DOI 10.2307/3546650; Jordan F, 2011, ECOL COMPLEX, V8, P357, DOI 10.1016/j.ecocom.2011.07.006; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; KERANS BL, 1994, ECOL APPL, V4, P768, DOI 10.2307/1942007; Livi CM, 2011, ECOL MODEL, V222, P2542, DOI 10.1016/j.ecolmodel.2010.09.025; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pascual M, 2005, PLOS COMPUT BIOL, V1, P101, DOI 10.1371/journal.pcbi.0010018; PATTEN BC, 1991, THEORETICAL STUDIES, P117; Pimm SL, 1991, BALANCE NATURE ECOLO; Powell CR, 2009, J THEOR BIOL, V257, P170, DOI 10.1016/j.jtbi.2008.11.006; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Priami C, 2009, COMMUN ACM, V52, P80, DOI 10.1145/1506409.1506427; Seth AK, 2007, PHILOS T R SOC B, V362, P1545, DOI 10.1098/rstb.2007.2052; Valentini R, 2010, ENVIRON MODELL SOFTW, V25, P886, DOI 10.1016/j.envsoft.2010.02.001; Wassermann S., 1994, SOCIAL NETWORK ANAL, Vfirst; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Yule C.M., 1995, TROPICAL LIMNOLOGY, V3, P61; Yule CM, 2010, MAR FRESHWATER RES, V61, P204, DOI 10.1071/MF09065; Yule CM, 2009, J N AM BENTHOL SOC, V28, P404, DOI 10.1899/07-161.1	39	9	9	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40280	10.1371/journal.pone.0040280	http://dx.doi.org/10.1371/journal.pone.0040280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768346	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500059
J	Ke, LP; Liu, RE; Chu, BJ; Yu, XS; Sun, J; Jones, B; Pan, G; Cheng, XF; Wang, HZ; Zhu, SJ; Sun, YQ				Ke, Liping; Liu, RuiE; Chu, Bijue; Yu, Xiushuang; Sun, Jie; Jones, Brian; Pan, Gang; Cheng, Xiaofei; Wang, Huizhong; Zhu, Shuijin; Sun, Yuqiang			Cell Suspension Culture-Mediated Incorporation of the Rice Bel Gene into Transgenic Cotton	PLOS ONE			English	Article							PLANT CYTOCHROME-P450; GOSSYPIUM-HIRSUTUM; SOMATIC HYBRIDS; METABOLISM; TOBACCO; HYDROXYLATION; RESISTANCE; BENTAZON; CLONING; YEAST	Cotton plants engineered for resistance to the herbicides, glyphosate or glufosinate have made a considerable impact on the production of the crop worldwide. In this work, embryogenic cell cultures derived from Gossypium hirsutum L. cv Coker 312 hypocotyl callus were transformed via Agrobacterium tumefaciens with the rice cytochrome P450 gene, CYP81A6 (bel). In rice, bel has been shown to confer resistance to both bentazon and sulfanylurea herbicides. Transformed cells were selected on a liquid medium supplemented alternately or simultaneously with kanamycin (50mg/L) and bentazon (4.2 mu mol). A total of 17 transgenic cotton lines were recovered, based on the initial resistance to bentazon and on PCR detection of the bel transgene. Bel integration into the cotton genome was confirmed by Southern blot and expression of the transgene was verified by RT-PCR. In greenhouse and experimental plot trials, herbicide (bentazon) tolerance of up to 1250mg/L was demonstrated in the transgenic plants. Transgenic lines with a single copy of the bel gene showed normal Mendelian inheritance of the characteristic. Importantly, resistance to bentazon was shown to be stably incorporated in the T1, T2 and T3 generations of self-fertilised descendents and in plants outcrossed to another upland cotton cultivar. Engineering resistance to bentazon in cotton through the heterologous expression of bel opens the possibility of incorporating this trait into elite cultivars, a strategy that would give growers a more flexible alternative to weed management in cotton crops.	[Ke, Liping; Liu, RuiE; Chu, Bijue; Yu, Xiushuang; Cheng, Xiaofei; Wang, Huizhong; Sun, Yuqiang] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Sun, Jie] Shihezi Univ, Coll Agron, Shihezi, Xinjiang, Peoples R China; [Jones, Brian] Univ Sydney, Fac Agr Food & Nat Resources, Sydney, NSW 2006, Australia; [Pan, Gang; Zhu, Shuijin] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; Shihezi University; University of Sydney; Zhejiang University	Sun, YQ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	yqsun@hznu.edu.cn	Cheng, Xiaofei/AAT-2600-2020; Jones, Brian m/E-8848-2016; Cheng, Xiaofei/M-6239-2014	Cheng, Xiaofei/0000-0002-9771-9059; Sun, Jie/0000-0002-8068-8102	Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (FANEDD) [201175]; National Natural Science foundation of China [31101417]; National Program on Research and Development of Transgenic Plants	Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Research and Development of Transgenic Plants	This research was funded by a Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (FANEDD, 201175), the National Natural Science foundation of China (Grant No. 31101417) and the National Program on Research and Development of Transgenic Plants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLEY C, 1992, THEOR APPL GENET, V83, P645, DOI 10.1007/BF00226910; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BOLWELL GP, 1994, PHYTOCHEMISTRY, V37, P1491, DOI 10.1016/S0031-9422(00)89567-9; Bowyer P., 2001, MOL CELLULAR BIOL FI, P33; BROWN HM, 1990, PESTIC SCI, V29, P263, DOI 10.1002/ps.2780290304; BURTON JD, 1992, PESTIC BIOCHEM PHYS, V44, P40, DOI 10.1016/0048-3575(92)90007-M; Cabello-Hurtado F, 1998, J BIOL CHEM, V273, P7260, DOI 10.1074/jbc.273.13.7260; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Chou WM, 1998, PLANT J, V15, P289, DOI 10.1046/j.1365-313X.1998.00220.x; Deng F, 2002, PESTIC BIOCHEM PHYS, V74, P102, DOI 10.1016/S0048-3575(02)00151-7; Didierjean L, 2002, PLANT PHYSIOL, V130, P179, DOI 10.1104/pp.005801; Durst Francis, 1995, Drug Metabolism and Drug Interactions, V12, P171; FIROOZABADY E, 1987, PLANT MOL BIOL, V10, P105, DOI 10.1007/BF00016148; Forthoffer N, 2001, EUR J DRUG METAB PH, V26, P9, DOI 10.1007/BF03190370; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Hooykaas PJJ, 1988, PLANT MOL BIOL MANUA, pA4; Keller G, 1997, TRANSGENIC RES, V6, P385, DOI 10.1023/A:1018483300902; KOEPPE MK, 1995, AGRO FOOD IND HI TEC, V6, P9; Lamb SB, 1998, FEBS LETT, V431, P343, DOI 10.1016/S0014-5793(98)00771-6; LEAH JM, 1991, PESTIC BIOCHEM PHYS, V39, P232, DOI 10.1016/0048-3575(91)90118-6; MCFADDEN JJ, 1990, BIOCHEM BIOPH RES CO, V168, P206, DOI 10.1016/0006-291X(90)91695-O; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PIERREL MA, 1994, EUR J BIOCHEM, V224, P835, DOI 10.1111/j.1432-1033.1994.00835.x; Robineau T, 1998, PLANT PHYSIOL, V118, P1049, DOI 10.1104/pp.118.3.1049; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAWAHEL WA, 1992, BIOTECHNOL ADV, V10, P393, DOI 10.1016/0734-9750(92)90302-P; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Siminszky B, 1999, P NATL ACAD SCI USA, V96, P1750, DOI 10.1073/pnas.96.4.1750; Stalker David M., 1996, P93; Sun YQ, 2005, PLANT CELL TISS ORG, V83, P303, DOI 10.1007/s11240-005-7770-2; Sun YQ, 2005, PLANT CELL TISS ORG, V82, P309, DOI 10.1007/s11240-005-1837-y; Sun YQ, 2004, THEOR APPL GENET, V109, P472, DOI 10.1007/s00122-004-1663-3; Wilkins TA, 2000, CRIT REV PLANT SCI, V19, P511, DOI 10.1016/S0735-2689(01)80007-1; Wilkins TA, 2004, J FOOD AGRIC ENVIRON, V2, P179; Yamada T, 2000, PESTIC BIOCHEM PHYS, V68, P11, DOI 10.1006/pest.2000.2496	37	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39974	10.1371/journal.pone.0039974	http://dx.doi.org/10.1371/journal.pone.0039974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768325	Green Submitted, Green Published, gold			2022-12-25	WOS:000305966500038
J	Bendezu, FO; Vincenzetti, V; Martin, SG				Bendezu, Felipe O.; Vincenzetti, Vincent; Martin, Sophie G.			Fission Yeast Sec3 and Exo70 Are Transported on Actin Cables and Localize the Exocyst Complex to Cell Poles	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; FORMIN FOR3P; POLARIZED SECRETION; SUBUNIT SEC3; GTPASE RHO3; V MYOSINS; IN-VIVO; EXOCYTOSIS	The exocyst complex is essential for many exocytic events, by tethering vesicles at the plasma membrane for fusion. In fission yeast, polarized exocytosis for growth relies on the combined action of the exocyst at cell poles and myosin-driven transport along actin cables. We report here the identification of fission yeast Schizosaccharomyces pombe Sec3 protein, which we identified through sequence homology of its PH-like domain. Like other exocyst subunits, sec3 is required for secretion and cell division. Cells deleted for sec3 are only conditionally lethal and can proliferate when osmotically stabilized. Sec3 is redundant with Exo70 for viability and for the localization of other exocyst subunits, suggesting these components act as exocyst tethers at the plasma membrane. Consistently, Sec3 localizes to zones of growth independently of other exocyst subunits but depends on PIP2 and functional Cdc42. FRAP analysis shows that Sec3, like all other exocyst subunits, localizes to cell poles largely independently of the actin cytoskeleton. However, we show that Sec3, Exo70 and Sec5 are transported by the myosin V Myo52 along actin cables. These data suggest that the exocyst holocomplex, including Sec3 and Exo70, is present on exocytic vesicles, which can reach cell poles by either myosin-driven transport or random walk.	[Bendezu, Felipe O.; Vincenzetti, Vincent; Martin, Sophie G.] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Lausanne	Bendezu, FO (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland.	Sophie.Martin@unil.ch		Bendezu, Felipe/0000-0003-4324-2993; Martin, Sophie/0000-0002-5317-2557	Swiss National Science Foundation (SNF) [PP00A_114936]; SNF [31003A_138177]; HFSP [CDA0016/2008]; European Research Council [260493]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF; HFSP(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission)	This work was supported by a Swiss National Science Foundation (SNF) Professorship grant (PP00A_114936) and a SNF Research grant (31003A_138177) to S.G.M. Research in S.G.M.'s lab is also supported by a HFSP Career Development Award (CDA0016/2008) and a European Research Council Starting Grant (260493). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Aghamohammadzadeh S, 2009, NAT CELL BIOL, V11, P1039, DOI 10.1038/ncb1918; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Baek K, 2010, J BIOL CHEM, V285, P10424, DOI 10.1074/jbc.M109.096966; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; EauClaire S, 2003, NEURON, V37, P369, DOI 10.1016/S0896-6273(03)00059-X; Estravis M, 2011, TRAFFIC, V12, P1744, DOI 10.1111/j.1600-0854.2011.01275.x; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2012, EXORCISING EXOCYST C; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Lo Presti L, 2011, CURR BIOL, V21, P2064, DOI 10.1016/j.cub.2011.10.033; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Mulvihill DP, 2006, CELL MOTIL CYTOSKEL, V63, P149, DOI 10.1002/cm.20113; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Nakano K, 2011, TRAFFIC, V12, P726, DOI 10.1111/j.1600-0854.2011.01190.x; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Roumanie O, 2005, J CELL BIOL, V170, P583, DOI 10.1083/jcb.200504108; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Snaith HA, 2011, J CELL SCI, V124, P2187, DOI 10.1242/jcs.084038; Tang X, 2011, YEAST, V28, P205, DOI 10.1002/yea.1831; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Win TZ, 2001, J CELL SCI, V114, P69; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yamashita M, 2010, NAT STRUCT MOL BIOL, V17, P180, DOI 10.1038/nsmb.1722; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	55	46	49	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40248	10.1371/journal.pone.0040248	http://dx.doi.org/10.1371/journal.pone.0040248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768263	Green Published, gold			2022-12-25	WOS:000305892100237
J	Chang, M; Alsaigh, T; Kistler, EB; Schmid-Schonbein, GW				Chang, Marisol; Alsaigh, Tom; Kistler, Erik B.; Schmid-Schoenbein, Geert W.			Breakdown of Mucin as Barrier to Digestive Enzymes in the Ischemic Rat Small Intestine	PLOS ONE			English	Article							CYCLOHEXANE CARBOXYLIC ACID; TOLL-LIKE RECEPTOR; MUCUS GEL LAYER; GASTROINTESTINAL MUCUS; ALPHA-AMYLASE; SECRETION; SHOCK; EXPRESSION; GLYCOPROTEINS; DISRUPTION	Loss of integrity of the epithelial/mucosal barrier in the small intestine has been associated with different pathologies that originate and/or develop in the gastrointestinal tract. We showed recently that mucin, the main protein in the mucus layer, is disrupted during early periods of intestinal ischemia. This event is accompanied by entry of pancreatic digestive enzymes into the intestinal wall. We hypothesize that the mucin-containing mucus layer is the main barrier preventing digestive enzymes from contacting the epithelium. Mucin breakdown may render the epithelium accessible to pancreatic enzymes, causing its disruption and increased permeability. The objective of this study was to investigate the role of mucin as a protection for epithelial integrity and function. A rat model of 30 min splanchnic arterial occlusion (SAO) was used to study the degradation of two mucin isoforms (mucin 2 and 13) and two epithelial membrane proteins (E-cadherin and toll-like receptor 4, TLR4). In addition, the role of digestive enzymes in mucin breakdown was assessed in this model by luminal inhibition with acarbose, tranexamic acid, or nafamostat mesilate. Furthermore, the protective effect of the mucin layer against trypsin-mediated disruption of the intestinal epithelium was studied in vitro. Rats after SAO showed degradation of mucin 2 and fragmentation of mucin 13, which was not prevented by protease inhibition. Mucin breakdown was accompanied by increased intestinal permeability to FITC-dextran as well as degradation of E-cadherin and TLR4. Addition of mucin to intestinal epithelial cells in vitro protected against trypsin-mediated degradation of E-cadherin and TLR4 and reduced permeability of FITC-dextran across the monolayer. These results indicate that mucin plays an important role in the preservation of the mucosal barrier and that ischemia but not digestive enzymes disturbs mucin integrity, while digestive enzymes actively mediate epithelial cell disruption.	[Chang, Marisol; Alsaigh, Tom; Kistler, Erik B.; Schmid-Schoenbein, Geert W.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kistler, Erik B.] Univ Calif San Diego, Med Ctr, Dept Anesthesiol & Crit Care, San Diego, CA 92103 USA; [Schmid-Schoenbein, Geert W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Chang, M (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	gwss@ucsd.edu		Kistler, Erik/0000-0002-6512-4798	National Institutes of Health (NIH) [HL76180, GM85072]; UC San Diego Interfaces Graduate Training Program in Interdisciplinary Specialization in Multiscale Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085072] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC San Diego Interfaces Graduate Training Program in Interdisciplinary Specialization in Multiscale Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) Grants HL76180 and GM85072 and the UC San Diego Interfaces Graduate Training Program in Interdisciplinary Specialization in Multiscale Biology http://interfaces.ucsd.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANESE CT, 1994, SURGERY, V116, P76; ALLEN A, 1972, GUT, V13, P666, DOI 10.1136/gut.13.8.666; ANDERSSON L, 1965, SCAND J HAEMATOL, V2, P230; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; BOUNOUS G, 1966, ANN SURG, V164, P13, DOI 10.1097/00000658-196607000-00002; Chang M, 2011, SHOCK; Chang M, 2012, SHOCK, V37, P297, DOI 10.1097/SHK.0b013e318240b59b; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Corfield AP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1321, DOI 10.2741/Corfield; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; DUBBER AHC, 1965, BRIT J HAEMATOL, V11, P237, DOI 10.1111/j.1365-2141.1965.tb06583.x; Epstein FH, 1994, NEW ENGL J MED, V330, P1580; Faure M, 2005, J NUTR, V135, P486, DOI 10.1093/jn/135.3.486; FORSTNER JF, 1981, AM J PHYSIOL, V240, pG10, DOI 10.1152/ajpgi.1981.240.1.G10; FUJII S, 1981, BIOCHIM BIOPHYS ACTA, V661, P342, DOI 10.1016/0005-2744(81)90023-1; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; GREEN GM, 1980, GASTROENTEROLOGY, V79, P695; Gum JR, 1995, BIOCHEM SOC T, V23, P795, DOI 10.1042/bst0230795; Guzman K, 1996, AM J PHYSIOL-LUNG C, V270, pL846, DOI 10.1152/ajplung.1996.270.5.L846; HAGLUND U, 1976, EUR SURG RES, V8, P435, DOI 10.1159/000127888; Helgason CD, 2005, CULTURE PRIMARY ADHE; HENKEL E, 1984, J CLIN CHEM CLIN BIO, V22, P489; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; KEMPER AC, 1991, ANAT REC, V229, P219, DOI 10.1002/ar.1092290209; Kim MJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P277, DOI 10.1006/abbi.1999.1423; LAMONT JT, 1983, AM J PHYSIOL, V245, pG92, DOI 10.1152/ajpgi.1983.245.1.G92; LAMONT JT, 1992, ANN NY ACAD SCI, V664, P190, DOI 10.1111/j.1749-6632.1992.tb39760.x; LICHTENBERGER LM, 1995, ANNU REV PHYSIOL, V57, P565, DOI 10.1146/annurev.ph.57.030195.003025; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lu P, 2011, INFLAMM BOWEL DIS, V17, P2047, DOI 10.1002/ibd.21592; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; MAXSON RT, 1994, J SURG RES, V57, P682, DOI 10.1006/jsre.1994.1201; MERLIN D, 1994, J MEMBRANE BIOL, V137, P137; MIYASAKA K, 1984, GASTROENTEROLOGY, V86, P114; Moses T, 2009, J LEUKOCYTE BIOL, V86, P971, DOI 10.1189/jlb.0708396; NIMMERFALL F, 1980, BIOCHEM BIOPH RES CO, V94, P960, DOI 10.1016/0006-291X(80)91328-5; Rong M, 2005, J CELL PHYSIOL, V202, P275, DOI 10.1002/jcp.20121; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Sodhi C, 2011, AM J PHYSIOL-GASTR L, V300, pG862, DOI 10.1152/ajpgi.00373.2010; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yu Q, 2000, GENE DEV, V14, P163; ZIMMERMAN M, 1977, ANAL BIOCHEM, V78, P47, DOI 10.1016/0003-2697(77)90006-9	48	78	86	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40087	10.1371/journal.pone.0040087	http://dx.doi.org/10.1371/journal.pone.0040087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768227	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100199
J	Dauvilliers, Y; Jaussent, I; Krams, B; Scholz, S; Lado, S; Levy, P; Pepin, JL				Dauvilliers, Yves; Jaussent, Isabelle; Krams, Benjamin; Scholz, Sabine; Lado, Stephane; Levy, Patrick; Pepin, Jean Louis			Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; PERIODIC LEG MOVEMENTS; ENDOTHELIAL DYSFUNCTION; SLEEP; MORTALITY; HYPERTENSION; OREXINS; ASSOCIATION; NUCLEUS; RATS	Background: Patients with narcolepsy-cataplexy (NC) mostly exhibit undetectable hypocretin levels. Hypocretin system is one of the key players in the complex interaction between sleep and the cardiovascular system. We tested the hypothesis that hypocretin deficiency affects cardiovascular risk factors by measuring nighttime and daytime ambulatory blood pressure (BP) and the night-to-day BP ratio as well as endothelial dysfunction by the digital pulse amplitude response in drug-free patients with NC compared to controls. Methodology: Sleep, clinical and biological cardiovascular risk factors, fingertip peripheral arterial tonometry, and 24-hour ambulatory BP monitoring were recorded in 50 drug-free patients with NC and 42 healthy control subjects, except for BP monitoring available in all controls but in 36 patients with NC. Principal Findings: More patients than controls were smokers, obese and with dyslipidemia. One-third of patients with NC were "non-dippers" (defined as,10% drop in BP during sleep) compared to only 3% of controls. The diastolic non-dipper BP profile had up to 12-fold higher odds of being associated with NC. We noted negative correlations between mean diastolic BP fall during night, REM sleep percentage and number of sleep onset REM periods, and a positive correlation with mean sleep latency on the MSLT. The digital pulse amplitude response measured by fingertip was similar between NC and controls. Conclusion: We found a high percentage of non-dippers in patients with NC with association with REM sleep dysregulation. The blunted sleep-related BP dip in NC may be of clinical relevance, as it may indicate increased risk for cardiovascular events.	[Dauvilliers, Yves; Krams, Benjamin; Scholz, Sabine; Lado, Stephane] CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy,Sleep Unit, Montpellier, France; [Dauvilliers, Yves; Jaussent, Isabelle] INSERM, U1061, Montpellier, France; [Dauvilliers, Yves; Jaussent, Isabelle] Univ Montpellier I, Montpellier, France; [Lado, Stephane; Levy, Patrick; Pepin, Jean Louis] Univ Grenoble 1, Univ Hosp Grenoble, Sleep Lab, Hypoxia PathoPhysiol Lab HP2,INSERM 1042, Grenoble, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Dauvilliers, Y (corresponding author), CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy,Sleep Unit, Montpellier, France.	ydauvilliers@yahoo.fr	Lévy, Patrick/M-6903-2014; PEPIN, Jean-Louis/M-6549-2014; LEVY, Patrick/AAX-2802-2020	Lévy, Patrick/0000-0003-3632-1327; LEVY, Patrick/0000-0003-3174-7935; Jaussent, Isabelle/0000-0002-8205-7590; Pepin, Jean Louis/0000-0003-3832-2358; Dauvilliers, yves/0000-0003-0683-6506	UCB Pharma; Cephalon; Novartis; Bioprojet	UCB Pharma(UCB Pharma SA); Cephalon; Novartis(Novartis); Bioprojet	This was not an industry-supported study. Prs Levy and Pepin, Drs Krams and Lado report no disclosures. Isabelle Jaussent and Sabine Scholz report no disclosures. Prof. Dauvilliers has received speaker's honoraria and funding for travel to conferences from UCB Pharma, Cephalon, Novartis, and Bioprojet. Prof. Dauvilliers has participated in advisory boards of UCB and Bioprojet. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Baguet JP, 2009, J HUM HYPERTENS, V23, P431, DOI 10.1038/jhh.2008.147; Bastianini S, 2011, SLEEP, V34, P213, DOI 10.1093/sleep/34.2.213; Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Chen CT, 2000, AM J PHYSIOL-REG I, V278, pR692, DOI 10.1152/ajpregu.2000.278.3.R692; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Dauvilliers Y, 2011, SLEEP, V34, P219, DOI 10.1093/sleep/34.2.219; de Oliveira CVR, 2003, AM J PHYSIOL-HEART C, V284, pH1369, DOI 10.1152/ajpheart.00877.2002; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Grimaldi D, 2012, SLEEP, V35, P519, DOI 10.5665/sleep.1738; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Iber C., 2007, AASM MANUAL SCORING; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MIDDELKOOP HAM, 1995, PSYCHOPHYSIOLOGY, V32, P286, DOI 10.1111/j.1469-8986.1995.tb02957.x; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; National Cholesterol Education Program Adult Treatment Panel III criteria, 2001, JAMA, V285, P486; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Plazzi G, 2008, SLEEP MED REV, V12, P109, DOI 10.1016/j.smrv.2007.08.010; Poli F, 2009, SLEEP, V32, P1491, DOI 10.1093/sleep/32.11.1491; Quinaglia T, 2011, J HUM HYPERTENS, V25, P656, DOI 10.1038/jhh.2011.43; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Samson WK, 2005, SLEEP MED REV, V9, P243, DOI 10.1016/j.smrv.2004.07.006; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Shirasaka T, 2002, REGUL PEPTIDES, V104, P91, DOI 10.1016/S0167-0115(01)00352-4; Smith PM, 2002, BRAIN RES, V950, P261, DOI 10.1016/S0006-8993(02)03048-2; Smolensky MH, 2007, SLEEP MED, V8, P668, DOI 10.1016/j.sleep.2006.11.011; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yoshimoto M, 2011, SLEEP, V34, P1093, DOI 10.5665/SLEEP.1168; Zucconi M, 2006, SLEEP MED, V7, P175, DOI 10.1016/j.sleep.2006.01.001	36	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38977	10.1371/journal.pone.0038977	http://dx.doi.org/10.1371/journal.pone.0038977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768053	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100023
J	Jacob, D; Sauer, U; Housley, R; Washington, C; Sannes-Lowery, K; Ecker, DJ; Sampath, R; Grunow, R				Jacob, Daniela; Sauer, Uschi; Housley, Roberta; Washington, Cicely; Sannes-Lowery, Kristin; Ecker, David J.; Sampath, Rangarajan; Grunow, Roland			Rapid and High-Throughput Detection of Highly Pathogenic Bacteria by Ibis PLEX-ID Technology	PLOS ONE			English	Article							BIOTERRORISM AGENTS; UNIVERSAL BIOSENSOR; MASS-SPECTROMETRY; IDENTIFICATION; SURVEILLANCE	In this manuscript, we describe the identification of highly pathogenic bacteria using an assay coupling biothreat group-specific PCR with electrospray ionization mass spectrometry (PCR/ESI-MS) run on an Ibis PLEX-ID high-throughput platform. The biothreat cluster assay identifies most of the potential bioterrorism-relevant microorganisms including Bacillus anthracis, Francisella tularensis, Yersinia pestis, Burkholderia mallei and pseudomallei, Brucella species, and Coxiella burnetii. DNA from 45 different reference materials with different formulations and different concentrations were chosen and sent to a service screening laboratory that uses the PCR/ESI-MS platform to provide a microbial identification service. The standard reference materials were produced out of a repository built up in the framework of the EU funded project "Establishment of Quality Assurances for Detection of Highly Pathogenic Bacteria of Potential Bioterrorism Risk" (EQADeBa). All samples were correctly identified at least to the genus level.	[Jacob, Daniela; Sauer, Uschi; Grunow, Roland] Robert Koch Inst, Berlin, Germany; [Housley, Roberta; Ecker, David J.; Sampath, Rangarajan] Abbott Co, Ibis Biosci Inc, Carlsbad, CA USA; [Washington, Cicely; Sannes-Lowery, Kristin] Athogen Inc, Irvine, CA USA	Robert Koch Institute	Jacob, D (corresponding author), Robert Koch Inst, Berlin, Germany.	GrunowR@rki.de		Ecker, David/0000-0003-4350-9037	European Commission's Executive Agency for Health and Consumers (EAHC)	European Commission's Executive Agency for Health and Consumers (EAHC)	This publication has been produced with the support of the European Commission's Executive Agency for Health and Consumers (EAHC). Its content is the sole responsibility of Robert Koch-Institut, Centre for Biological Security, and can in no way be taken to reflect the views of the EAHC or any other body of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda JA, 2002, AM J CLIN PATHOL, V117, P116; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Ecker D, 2006, J ASS LAB AUTOM, P341; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; He J, 2009, VIRUSES-BASEL, V1, P441, DOI 10.3390/v1030441; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Horn Jan K, 2003, Surg Infect (Larchmt), V4, P281, DOI 10.1089/109629603322419625; Janse I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-314; Lasch P, 2010, ANAL CHEM, V82, P8464, DOI 10.1021/ac101036s; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Pappas Georgios, 2009, J Infect Public Health, V2, P55, DOI 10.1016/j.jiph.2009.03.002; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036528; Wagar EA, 2010, ARCH PATHOL LAB MED, V134, P1490, DOI 10.1043/2010-0098-CP.1	17	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39928	10.1371/journal.pone.0039928	http://dx.doi.org/10.1371/journal.pone.0039928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768173	gold, Green Published			2022-12-25	WOS:000305892100143
J	Masaki, S; Masutani, H; Yoshihara, E; Yodoi, J				Masaki, So; Masutani, Hiroshi; Yoshihara, Eiji; Yodoi, Junji			Deficiency of Thioredoxin Binding Protein-2 (TBP-2) Enhances TGF-beta Signaling and Promotes Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							UP-REGULATED PROTEIN-1; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CELL-GROWTH; VDUP1; TRANSCRIPTION; INHIBITOR; ARRESTIN; SMURF2; SNAIL	Background: Transforming growth factor beta (TGF-beta) has critical roles in regulating cell growth, differentiation, apoptosis, invasion and epithelial-mesenchymal transition (EMT) of various cancer cells. TGF-beta-induced EMT is an important step during carcinoma progression to invasion state. Thioredoxin binding protein-2 (TBP-2, also called Txnip or VDUP1) is downregulated in various types of human cancer, and its deficiency results in the earlier onset of cancer. However, it remains unclear how TBP-2 suppresses the invasion and metastasis of cancer. Principal Findings: In this study, we demonstrated that TBP-2 deficiency increases the transcriptional activity in response to TGF-beta and also enhances TGF-beta-induced Smad2 phosphorylation levels. Knockdown of TBP-2 augmented the TGF-beta-responsive expression of Snail and Slug, transcriptional factors related to TGF-beta-mediated induction of EMT, and promoted TGF-beta-induced spindle-like morphology consistent with the depletion of E-Cadherin in A549 cells. Conclusions/Significance: Our results indicate that TBP-2 deficiency enhances TGF-beta signaling and promotes TGF-beta-induced EMT. The control of TGF-beta-induced EMT is critical for the inhibition of the invasion and metastasis. Thus TBP-2, as a novel regulatory molecule of TGF-beta signaling, is likely to be a prognostic indicator or a potential therapeutic target for preventing tumor progression.	[Masaki, So; Masutani, Hiroshi; Yoshihara, Eiji; Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Infect & Prevent, Kyoto 606, Japan; [Yodoi, Junji] Ewha Womans Univ, Ctr Cell Signaling Res, Dept Bioinspired Sci, Seoul, South Korea	Kyoto University; Ewha Womans University	Masaki, S (corresponding author), Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Infect & Prevent, Kyoto 606, Japan.	yodoi@virus.kyoto-u.ac.jp	Masutani, Hiroshi/B-5114-2014	Masutani, Hiroshi/0000-0001-7633-2827; Yoshihara, Eiji/0000-0001-6324-6495	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); World Class University [R31-10010]; Grants-in-Aid for Scientific Research [23126512] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); World Class University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and partly by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). This work was also supported by World Class University Grant R31-10010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MK, 2006, ONCOGENE, V25, P2181, DOI 10.1038/sj.onc.1209256; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Arai RJ, 2008, TOXICOL APPL PHARM, V233, P227, DOI 10.1016/j.taap.2008.07.023; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen Z, 2011, LEUKEMIA, V25, P440, DOI 10.1038/leu.2010.286; Goldberg SF, 2003, CANCER RES, V63, P432; Hajra KM, 2002, CANCER RES, V62, P1613; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Kuljaca S, 2009, CARCINOGENESIS, V30, P1865, DOI 10.1093/carcin/bgp225; Kwon HJ, 2011, J HEPATOL, V54, P1168, DOI 10.1016/j.jhep.2010.09.025; Kwon HJ, 2010, J IMMUNOL, V185, P3980, DOI 10.4049/jimmunol.1000990; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishizawa K, 2011, CARCINOGENESIS, V32, P1459, DOI 10.1093/carcin/bgr137; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Son A, 2008, EUR J IMMUNOL, V38, P1358, DOI 10.1002/eji.200737939; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	42	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39900	10.1371/journal.pone.0039900	http://dx.doi.org/10.1371/journal.pone.0039900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768160	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100129
J	Moriishi, T; Fukuyama, R; Ito, M; Miyazaki, T; Maeno, T; Kawai, Y; Komori, H; Komori, T				Moriishi, Takeshi; Fukuyama, Ryo; Ito, Masako; Miyazaki, Toshihiro; Maeno, Takafumi; Kawai, Yosuke; Komori, Hisato; Komori, Toshihisa			Osteocyte Network; a Negative Regulatory System for Bone Mass Augmented by the Induction of Rankl in Osteoblasts and Sost in Osteocytes at Unloading	PLOS ONE			English	Article							SCLEROSTIN; WNT; APOPTOSIS; DENSITY; EXPRESSION; MATURATION; RESORPTION; PROTEIN-1; DELETION; STRAIN	Reduced mechanical stress is a major cause of osteoporosis in the elderly, and the osteocyte network, which comprises a communication system through processes and canaliculi throughout bone, is thought to be a mechanosensor and mechanotransduction system; however, the functions of osteocytes are still controversial and remain to be clarified. Unexpectedly, we found that overexpression of BCL2 in osteoblasts eventually caused osteocyte apoptosis. Osteoblast and osteoclast differentiation were unaffected by BCL2 transgene in vitro. However, the cortical bone mass increased due to enhanced osteoblast function and suppressed osteoclastogenesis at 4 months of age, when the frequency of TUNEL-positive lacunae reached 75%. In the unloaded condition, the trabecular bone mass decreased in both wild-type and BCL2 transgenic mice at 6 weeks of age, while it decreased due to impaired osteoblast function and enhanced osteoclastogenesis in wild-type mice but not in BCL2 transgenic mice at 4 months of age. Rankl and Opg were highly expressed in osteocytes, but Rankl expression in osteoblasts but not in osteocytes was increased at unloading in wild-type mice but not in BCL2 transgenic mice at 4 months of age. Sost was locally induced at unloading in wild-type mice but not in BCL2 transgenic mice, and the dissemination of Sost was severely interrupted in BCL2 transgenic mice, showing the severely impaired osteocyte network. These findings indicate that the osteocyte network is required for the upregulation of Rankl in osteoblasts and Sost in osteocytes in the unloaded condition. These findings suggest that the osteocyte network negatively regulate bone mass by inhibiting osteoblast function and activating osteoclastogenesis, and these functions are augmented in the unloaded condition at least partly through the upregulation of Rankl expression in osteoblasts and that of Sost in osteocytes, although it cannot be excluded that low BCL2 transgene expression in osteoblasts contributed to the enhanced osteoblast function.	[Moriishi, Takeshi; Miyazaki, Toshihiro; Maeno, Takafumi; Kawai, Yosuke; Komori, Hisato; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Fukuyama, Ryo] Hiroshima Int Univ, Pharmacol Lab, Kure, Japan; [Ito, Masako] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Radiat Biol, Nagasaki 852, Japan; [Maeno, Takafumi] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka 558, Japan; [Kawai, Yosuke] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Osaka Metropolitan University; Nagasaki University	Moriishi, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan.	komorit@nagasaki-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Ground-based Research Program for Space Utilization; Nakatomi Foundation; Nagasaki University, Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ground-based Research Program for Space Utilization; Nakatomi Foundation; Nagasaki University, Japan	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the "Ground-based Research Program for Space Utilization'' promoted by the Japan Space Forum, the Nakatomi Foundation, and the President's Discretionary Fund of Nagasaki University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Hedgecock NL, 2007, BONE, V40, P627, DOI 10.1016/j.bone.2006.10.006; Heino TJ, 2002, J CELL BIOCHEM, V85, P185, DOI 10.1002/jcb.10109; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; LAZENBY RA, 1990, AM J PHYS ANTHROPOL, V82, P473, DOI 10.1002/ajpa.1330820408; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MAROTTI G, 1995, BONE, V16, P125, DOI 10.1016/S8756-3282(94)00019-0; Martin RB, 2000, BONE, V26, P71, DOI 10.1016/S8756-3282(99)00242-2; Martin RB, 1998, SKELETAL TISSUE MECH; Metz LN, 2003, BONE, V33, P753, DOI 10.1016/S8756-3282(03)00245-X; Moriishi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027487; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Mueller RJ, 2004, J MATER SCI-MATER M, V15, P367, DOI 10.1023/B:JMSM.0000021103.39114.cd; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Qiu S, 2002, BONE, V31, P709, DOI 10.1016/S8756-3282(02)00907-9; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Russo CR, 2006, BONE, V38, P112, DOI 10.1016/j.bone.2005.07.025; Sakai A., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P387; Schulze C, 2008, AUTOIMMUN REV, V8, P5, DOI 10.1016/j.autrev.2008.07.049; Schwab P, 2008, CURR OPIN RHEUMATOL, V20, P213, DOI 10.1097/BOR.0b013e3282f3cbd3; Seeman E, 2001, CALCIFIED TISSUE INT, V69, P205, DOI 10.1007/s00223-001-1040-z; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Wang YY, 2012, BONE, V50, P409, DOI 10.1016/j.bone.2011.07.012; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wolff J., 2010, GESETZ TRANSFORMATIO; Wu YL, 2008, AUTOIMMUNITY, V41, P183, DOI 10.1080/08916930701693180; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	53	65	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40143	10.1371/journal.pone.0040143	http://dx.doi.org/10.1371/journal.pone.0040143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768243	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100216
J	Sinke, CBA; Van den Stock, J; Goebel, R; de Gelder, B				Sinke, Charlotte B. A.; Van den Stock, Jan; Goebel, Rainer; de Gelder, Beatrice			The Constructive Nature of Affective Vision: Seeing Fearful Scenes Activates Extrastriate Body Area	PLOS ONE			English	Article							ANTICIPATION; PERCEPTION; CONTEXT; BRAIN	It is part of basic emotions like fear or anger that they prepare the brain to act adaptively. Hence scenes representing emotional events are normally associated with characteristic adaptive behavior. Normally, face and body representation areas in the brain are modulated by these emotions when presented in the face or body. Here, we provide neuroimaging evidence (using functional magnetic resonance imaging) that the extrastriate body area (EBA) is highly responsive when subjects observe isolated faces presented in emotional scenes. This response of EBA to threatening scenes in which no body is present gives rise to speculation about its function. We discuss the possibility that the brain reacts proactively to the emotional meaning of the scene.	[Sinke, Charlotte B. A.; Van den Stock, Jan; de Gelder, Beatrice] Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands; [Sinke, Charlotte B. A.; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands; [de Gelder, Beatrice] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Martinos Ctr Biomed Imaging, Charlestown, MA USA	Tilburg University; Maastricht University; Harvard University; Massachusetts General Hospital	Sinke, CBA (corresponding author), Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands.	b.degelder@uvt.nl	Van den Stock, J./F-1906-2014	Van den Stock, J./0000-0001-5756-3195; Goebel, Rainer/0000-0003-1780-2467	TANGO grant; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open [249858]	TANGO grant; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open	This work was supported by the TANGO grant. The project TANGO acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open (grant number 249858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bar M, 1996, PERCEPTION, V25, P343, DOI 10.1068/p250343; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; De Ridder D, 2007, NEW ENGL J MED, V357, P1829, DOI 10.1056/NEJMoa070010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Esterman M, 2010, CEREB CORTEX, V20, P1245, DOI 10.1093/cercor/bhp188; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349; Frijda NH, 2010, BIOL PSYCHOL, V84, P570, DOI 10.1016/j.biopsycho.2010.01.005; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kuhn S, 2011, J COGNITIVE NEUROSCI, V23, P214, DOI 10.1162/jocn.2010.21418; Lamm C, 2008, CEREB CORTEX, V18, P2369, DOI 10.1093/cercor/bhn006; Lundqvist D., 1998, KAROLINSKA DIRECTED; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; Sabatinelli D, 2001, PSYCHOPHYSIOLOGY, V38, P719, DOI 10.1111/1469-8986.3840719; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065	24	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38118	10.1371/journal.pone.0038118	http://dx.doi.org/10.1371/journal.pone.0038118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768039	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100010
J	Stellari, FF; Franceschi, V; Capocefalo, A; Ronchei, M; Facchinetti, F; Villetti, G; Donofrio, G				Stellari, Fabio Franco; Franceschi, Valentina; Capocefalo, Antonio; Ronchei, Marcello; Facchinetti, Fabrizio; Villetti, Gino; Donofrio, Gaetano			In Vivo Imaging of Transiently Transgenized Mice with a Bovine Interleukin 8 (CXCL8) Promoter/Luciferase Reporter Construct	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ALVEOLAR MACROPHAGES; MOLECULAR-CLONING; MESSENGER-RNA; CDNA CLONING; EXPRESSION; NEUTROPHIL; CELLS	One of the most remarkable properties of interleukin 8 (CXCL8/IL-8), a chemokine with known additional functions also in angiogenesis and tissue remodeling, is the variation of its expression levels. In healthy tissues, IL-8 is barely detectable, but it is rapidly induced by several folds in response to proinflammatory cytokines, bacterial or viral products, and cellular stress. Although mouse cells do not bear a clear homologous IL-8 gene, the murine transcriptional apparatus may well be capable of activating or repressing a heterologous IL-8 gene promoter driving a reporter gene. In order to induce a transient transgenic expression, mice were systemically injected with a bovine IL-8 promoter-luciferase construct. Subsequently mice were monitored for luciferase expression in the lung by in vivo bioluminescent image analysis over an extended period of time (up to 60 days). We demonstrate that the bovine IL-8 promoter-luciferase construct is transiently and robustly activated 3-5 hours after LPS and TNF-alpha instillation into the lung, peaking at 35 days after construct delivery. Bovine IL-8 promoter-luciferase activation correlates with white blood cell and neutrophil infiltration into the lung. This study demonstrates that a small experimental rodent model can be utilized for non-invasively monitoring, through a reporter gene system, the activation of an IL-8 promoter region derived from a larger size animal (bovine). This proof of principle study has the potential to be utilized also for studying primate IL-8 promoter regions.	[Stellari, Fabio Franco; Franceschi, Valentina; Capocefalo, Antonio; Ronchei, Marcello; Donofrio, Gaetano] Univ Parma, Dipartimento Salute Anim, Sez Malattie Infett Anim, I-43100 Parma, Italy; [Stellari, Fabio Franco; Facchinetti, Fabrizio; Villetti, Gino] Chiesi Farmaceut SpA, Parma, Italy	University of Parma; Chiesi Pharmaceuticals Inc	Stellari, FF (corresponding author), Univ Parma, Dipartimento Salute Anim, Sez Malattie Infett Anim, I-43100 Parma, Italy.	gaetano.donofrio@unipr.it	Capocefalo, Antonio/O-3027-2017; franceschi, valentina/AAR-5566-2020	Capocefalo, Antonio/0000-0002-4215-4265; Donofrio, Gaetano/0000-0002-8984-0377; franceschi, valentina/0000-0003-3945-2285	Chiesi Farmaceutici; Italian Ministry of University and Scientific Research	Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This study received financial support from Chiesi Farmaceutici and the Italian Ministry of University and Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bette M, 2003, J COMP NEUROL, V465, P417, DOI 10.1002/cne.10877; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; DEHBI M, 1992, MOL CELL BIOL, V12, P1490, DOI 10.1128/MCB.12.4.1490; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Donofrio G, 2010, BIOL REPROD, V83, P919, DOI 10.1095/biolreprod.110.086074; Doyle TC, 2004, CELL MICROBIOL, V6, P303, DOI 10.1111/j.1462-5822.2004.00378.x; Gesser B, 1996, J LEUKOCYTE BIOL, V59, P407, DOI 10.1002/jlb.59.3.407; Golden JM, 2008, IMMUNOL LETT, V118, P30, DOI 10.1016/j.imlet.2008.02.011; Harada A, 1996, MOL MED TODAY, V2, P482; JORENS PG, 1992, AM J PHYSIOL, V263, pL708, DOI 10.1152/ajplung.1992.263.6.L708; Koay MA, 2002, AM J RESP CELL MOL, V26, P572, DOI 10.1165/ajrcmb.26.5.4748; KUKIELKA GL, 1995, J CLIN INVEST, V95, P89, DOI 10.1172/JCI117680; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; LEGASTELOIS I, 1994, GENE, V150, P367, DOI 10.1016/0378-1119(94)90454-5; LIN GF, 1994, J BIOL CHEM, V269, P77; Luscinskas FW, 2000, ANN NY ACAD SCI, V902, P288; Malazdrewich C, 2001, VET PATHOL, V38, P297, DOI 10.1354/vp.38-3-297; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; Meade KG, 2012, MOL IMMUNOL, V50, P108, DOI 10.1016/j.molimm.2011.12.011; MINNERLY JC, 1995, INFLAMMATION, V19, P313, DOI 10.1007/BF01534390; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Morsey MA, 1996, MICROB PATHOGENESIS, V20, P203, DOI 10.1006/mpat.1996.0019; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Murugan V, 2009, EXP LUNG RES, V35, P439, DOI 10.1080/01902140902759290; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; Srinivasan S, 2003, CIRC RES, V92, P371, DOI 10.1161/01.RES.0000061714.74668.5C; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; VILLINGER F, 1995, J IMMUNOL, V155, P3946; YOSHIMURA T, 1991, J IMMUNOL, V146, P3483; YOSHIMURA T, 1993, J IMMUNOL, V150, P5025; Zhao XX, 2010, PULM PHARMACOL THER, V23, P22, DOI 10.1016/j.pupt.2009.09.001; Zhao XX, 2009, J IMMUNOL, V182, P3213, DOI 10.4049/jimmunol.0800551	35	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39716	10.1371/journal.pone.0039716	http://dx.doi.org/10.1371/journal.pone.0039716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761878	Green Published, gold, Green Submitted			2022-12-25	WOS:000305826400030
J	Lam, M; Carmichael, AR; Griffiths, HR				Lam, Matt; Carmichael, Amtul R.; Griffiths, Helen R.			An Aqueous Extract of Fagonia cretica Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Breast Cancer Cells via FOXO3a and p53 Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; SURVIVAL; REPAIR; CHECKPOINTS; PROMOTES; G(1); DIFFERENTIATION; ACTIVATION; PATHWAY	Background: Plants have proved to be an important source of anti-cancer drugs. Here we have investigated the cytotoxic action of an aqueous extract of Fagonia cretica, used widely as a herbal tea-based treatment for breast cancer. Methodology/Principal Findings: Using flow cytometric analysis of cells labeled with cyclin A, annexin V and propidium iodide, we describe a time and dose-dependent arrest of the cell cycle in G0/G1 phase of the cell cycle and apoptosis following extract treatment in MCF-7 (WT-p53) and MDA-MB-231 (mutant-p53) human breast cancer cell lines with a markedly reduced effect on primary human mammary epithelial cells. Analysis of p53 protein expression and of its downstream transcription targets, p21 and BAX, revealed a p53 associated growth arrest within 5 hours of extract treatment and apoptosis within 24 hours. DNA double strand breaks measured as gamma-H2AX were detected early in both MCF-7 and MDA-MB-231 cells. However, loss of cell viability was only partly due to a p53-driven response; as MDA-MB-231 and p53-knockdown MCF-7 cells both underwent cell cycle arrest and death following extract treatment. p53-independent growth arrest and cytotoxicity following DNA damage has been previously ascribed to FOXO3a expression. Here, in MCF-7 and MDA-MB-231 cells, FOXO3a expression was increased significantly within 3 hours of extract treatment and FOXO3 siRNA reduced the extract-induced loss of cell viability in both cell lines. Conclusions/Significance: Our results demonstrate for the first time that an aqueous extract of Fagonia cretica can induce cell cycle arrest and apoptosis via p53-dependent and independent mechanisms, with activation of the DNA damage response. We also show that FOXO3a is required for activity in the absence of p53. Our findings indicate that Fagonia cretica aqueous extract contains potential anti-cancer agents acting either singly or in combination against breast cancer cell proliferation via DNA damage-induced FOXO3a and p53 expression.	[Lam, Matt; Griffiths, Helen R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Carmichael, Amtul R.] Dudley Grp Hosp, Dudley, England	Aston University	Lam, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	h.r.griffiths@aston.ac.uk	Griffiths, Helen R./E-3453-2013	Griffiths, Helen R./0000-0002-2666-2147; Carmichael, Amtul R/0000-0002-3003-8486				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Al-Mohanna MA, 2001, CARCINOGENESIS, V22, P573, DOI 10.1093/carcin/22.4.573; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Aristotle L, 2004, ANTICANCER RES, V24, P987; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Ben Sahra I, 2008, INT J OBESITY, V32, pS17; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cheng WL, 2011, PLANTA MED, V77, P164, DOI 10.1055/s-0030-1250177; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Gao JC, 2012, INT J ONCOL, V40, P1203, DOI 10.3892/ijo.2011.1293; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Habashy HO, 2011, BREAST CANCER RES TR, V129, P11, DOI 10.1007/s10549-010-1161-z; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ichikawa A, 2008, HUM CELL, V21, P28, DOI 10.1111/j.1749-0774.2008.00048.x; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SH, 2010, CANCER PREV RES, V3, P718, DOI 10.1158/1940-6207.CAPR-10-0048; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lei H, 2009, MOL CANCER RES, V7, P1294, DOI 10.1158/1541-7786.MCR-08-0531; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; McNamee LM, 2009, GENETICS, V182, P423, DOI 10.1534/genetics.109.102327; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Moll UM, 2003, MOL CANCER RES, V1, P1001; Pellegata NS, 1996, P NATL ACAD SCI USA, V93, P15209, DOI 10.1073/pnas.93.26.15209; Said HM, 1969, HAMDARD PHARMACOPOEI; Shah Manish A, 2003, Cancer Chemother Biol Response Modif, V21, P145; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Thompson T, 2010, CANCER BIOL THER, V10, P344, DOI 10.4161/cbt.10.4.12366; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Yoshida K, 2010, CANCER SCI, V101, P831, DOI 10.1111/j.1349-7006.2010.01488.x; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	46	70	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40152	10.1371/journal.pone.0040152	http://dx.doi.org/10.1371/journal.pone.0040152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761954	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305825800090
J	Rossi, B; Ogden, D; Llano, I; Tan, YP; Marty, A; Collin, T				Rossi, Benedicte; Ogden, David; Llano, Isabel; Tan, Yusuf P.; Marty, Alain; Collin, Thibault			Current and Calcium Responses to Local Activation of Axonal NMDA Receptors in Developing Cerebellar Molecular Layer Interneurons	PLOS ONE			English	Article							PURKINJE CELL SYNAPSES; ENHANCES GABA RELEASE; D-ASPARTATE RECEPTORS; LONG-TERM DEPRESSION; PRESYNAPTIC NMDA; STELLATE CELLS; RAT CEREBELLUM; PARALLEL FIBER; SOMATIC DEPOLARIZATION; SYNAPTIC PLASTICITY	In developing cerebellar molecular layer interneurons (MLIs), NMDA increases spontaneous GABA release. This effect had been attributed to either direct activation of presynaptic NMDA receptors (preNMDARs) or an indirect pathway involving activation of somato-dendritic NMDARs followed by passive spread of somatic depolarization along the axon and activation of axonal voltage dependent Ca2+ channels (VDCCs). Using Ca2+ imaging and electrophysiology, we searched for preNMDARs by uncaging NMDAR agonists either broadly throughout the whole field or locally at specific axonal locations. Releasing either NMDA or glutamate in the presence of NBQX using short laser pulses elicited current transients that were highly sensitive to the location of the spot and restricted to a small number of varicosities. The signal was abolished in the presence of high Mg2+ or by the addition of APV. Similar paradigms yielded restricted Ca2+ transients in interneurons loaded with a Ca2+ indicator. We found that the synaptic effects of NMDA were not inhibited by blocking VDCCs but were impaired in the presence of the ryanodine receptor antagonist dantrolene. Furthermore, in voltage clamped cells, bath applied NMDA triggers Ca2+ elevations and induces neurotransmitter release in the axonal compartment. Our results suggest the existence of preNMDARs in developing MLIs and propose their involvement in the NMDA-evoked increase in GABA release by triggering a Ca2+-induced Ca2+ release process mediated by presynaptic Ca2+ stores. Such a mechanism is likely to exert a crucial role in various forms of Ca2+-mediated synaptic plasticity.	[Rossi, Benedicte; Ogden, David; Llano, Isabel; Tan, Yusuf P.; Marty, Alain; Collin, Thibault] Univ Paris Diderot, Univ Paris Descartes, CNRS UMR 8118, Lab Physiol Cerebrale, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Rossi, B (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	thibault.collin@parisdescartes.fr			Agence Nationale de la Recherche [BLAN08-2_31083]; EU Strep 'Photolysis' [LSHM-CT-2007-037765]; Fondation pour la Recherche Medicale (FRM Team); Medical Research Council [U117512659] Funding Source: researchfish	Agence Nationale de la Recherche(French National Research Agency (ANR)); EU Strep 'Photolysis'; Fondation pour la Recherche Medicale (FRM Team)(Fondation pour la Recherche Medicale); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Agence Nationale de la Recherche (contract BLAN08-2_31083), the EU Strep 'Photolysis' (LSHM-CT-2007-037765), and Fondation pour la Recherche Medicale (FRM Team, A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bidoret C, 2009, P NATL ACAD SCI USA, V106, P14126, DOI 10.1073/pnas.0904284106; Bouhours B, 2011, J NEUROSCI, V31, P5804, DOI 10.1523/JNEUROSCI.5127-10.2011; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Duguid IC, 2007, J NEUROSCI, V27, P12464, DOI 10.1523/JNEUROSCI.0178-07.2007; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Duguid IC, 2009, BIOL NMDA RECEPTOR; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Glitsch M, 1999, J NEUROSCI, V19, P511; Glitsch MD, 2008, NEUROSCIENCE, V151, P403, DOI 10.1016/j.neuroscience.2007.10.024; Huang H, 2004, J NEUROSCI, V24, P5659, DOI 10.1523/JNEUROSCI.1338-04.2004; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Lonchamp E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030180; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pugh JR, 2011, J NEUROSCI, V31, P16550, DOI 10.1523/JNEUROSCI.3910-11.2011; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Rodrigo J, 2001, BRAIN RES, V909, P20, DOI 10.1016/S0006-8993(01)02613-0; Rossi B, 2008, J PHYSIOL-LONDON, V586, P5129, DOI 10.1113/jphysiol.2008.159921; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032	46	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39983	10.1371/journal.pone.0039983	http://dx.doi.org/10.1371/journal.pone.0039983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761940	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800084
J	Fattorini, S; Dennis, RLH; Cook, LM				Fattorini, Simone; Dennis, Roger L. H.; Cook, Laurence M.			Use of Cross-Taxon Congruence for Hotspot Identification at a Regional Scale	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIPS; BIODIVERSITY HOTSPOTS; INDICATOR GROUPS; PRIORITY AREAS; SPATIAL SCALE; CONSERVATION; DIVERSITY; RICHNESS; COMPLEMENTARITY; CONCORDANCE	One of the most debated problems in conservation biology is the use of indicator (surrogate) taxa to predict spatial patterns in other taxa. Cross-taxon congruence in species richness patterns is of paramount importance at regional scales to disclose areas of high conservation value that are significant in a broader biogeographical context but yet placed in the finer, more practical, political context of decision making. We analysed spatial patterns of diversity in six arthropod taxa from the Turkish fauna as a regional case study relevant to global conservation of the Mediterranean basin. Although we found high congruence in cross-taxon comparisons of species richness (0.241<r<0.645), hotspots of different groups show limited overlap, generally less than 50 per cent. The ability of a given taxon to capture diversity of other taxa was usually modest (on average, 50 percent of diversity of non-target taxa), limiting the use of hotspots for effective conservation of non-target groups. Nevertheless, our study demonstrates that a given group may partially stand in for another with similar ecological needs and biogeographical histories. We therefore advocate the use of multiple sets of taxa, chosen so as to be representative of animals with different ecological needs and biogeographical histories.	[Fattorini, Simone] Univ Milano Bicocca, Dept Biosci & Biotechnol, Water Ecol Team, Milan, Italy; [Fattorini, Simone] Univ Acores, Dept Ciencias Agr CITA A, Azorean Biodivers Grp, Pico Da Urze, Angra Do Herois, Portugal; [Dennis, Roger L. H.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Dennis, Roger L. H.] Staffordshire Univ, Inst Environm Sustainabil & Regenerat, Stoke On Trent ST4 2DE, Staffs, England; [Cook, Laurence M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Milano-Bicocca; Universidade dos Acores; Oxford Brookes University; Staffordshire University; University of Manchester	Fattorini, S (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Water Ecol Team, Milan, Italy.	simone_fattorini@virgilio.it	Fattorini, Simone/AAR-8028-2020; Fattorini, Simone/E-7075-2012	Fattorini, Simone/0000-0002-4517-2135; Fattorini, Simone/0000-0002-4517-2135				Anand M, 2005, CONSERV BIOL, V19, P955, DOI 10.1111/j.1523-1739.2005.00571.x; Atalay I, 2010, J ENVIRON BIOL, V31, P61; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Cplak B., 2008, INSECT ECOLOGY CONSE, P135; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Fattorini S, 2009, ANIM CONSERV, V12, P313, DOI 10.1111/j.1469-1795.2009.00251.x; Fattorini S, 2007, BIODIVERS CONSERV, V16, P2531, DOI 10.1007/s10531-006-9029-6; Fattorini S, 2006, CONSERV BIOL, V20, P1169, DOI 10.1111/j.1523-1739.2006.00418.x; Fattorini S, 2011, BIOL CONSERV, V144, P1690, DOI 10.1016/j.biocon.2011.03.002; Flather CH, 1997, ECOL APPL, V7, P531, DOI 10.1890/1051-0761(1997)007[0531:IGICNO]2.0.CO;2; Gaspar C, 2010, BIOL CONSERV, V143, P1287, DOI 10.1016/j.biocon.2010.03.007; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Guclu K, 2004, BIODIVERS CONSERV, V13, P1373, DOI 10.1023/B:BIOC.0000019399.35427.64; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Isaac NJB, 2004, DIVERS DISTRIB, V10, P275, DOI 10.1111/j.1366-9516.2004.00092.x; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Lund MP, 2002, ANIM CONSERV, V5, P163, DOI 10.1017/S1367943002002226; Maes D, 2005, BIODIVERS CONSERV, V14, P1345, DOI 10.1007/s10531-004-9662-x; Martin HG, 2006, P NATL ACAD SCI USA, V103, P10310, DOI 10.1073/pnas.0510605103; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pearson DL, 1999, J BIOGEOGR, V26, P1079, DOI 10.1046/j.1365-2699.1999.00337.x; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; Qian H, 2007, CONSERV BIOL, V21, P937, DOI 10.1111/j.1523-1739.2007.00692.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Reyers B, 2000, P ROY SOC B-BIOL SCI, V267, P505, DOI 10.1098/rspb.2000.1029; Rodrigues ASL, 2007, NATURE, V450, pE19, DOI 10.1038/nature06374; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; RYTI RT, 1992, ECOL APPL, V2, P404, DOI 10.2307/1941875; Sekercioglu CH, 2011, BIOL CONSERV, V144, P2752, DOI 10.1016/j.biocon.2011.06.025; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Toranza Carolina, 2010, BMC Ecology, V10, P18, DOI 10.1186/1472-6785-10-18; Ulrich W, 2005, BIODIVERS CONSERV, V14, P1977, DOI 10.1007/s10531-004-2526-6; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Veech JA, 2000, CONSERV BIOL, V14, P140, DOI 10.1046/j.1523-1739.2000.99064.x; Vessby K, 2002, CONSERV BIOL, V16, P430, DOI 10.1046/j.1523-1739.2002.00198.x; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Wolters V, 2006, ECOLOGY, V87, P1886, DOI 10.1890/0012-9658(2006)87[1886:RATSRO]2.0.CO;2	48	18	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e40018	10.1371/journal.pone.0040018	http://dx.doi.org/10.1371/journal.pone.0040018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761947	Green Submitted, Green Published, gold			2022-12-25	WOS:000305808700056
J	Spijkerman, J; Prevaes, SMPJ; van Gils, EJM; Veenhoven, RH; Bruin, JP; Bogaert, D; Wijmenga-Monsuur, AJ; van den Dobbelsteen, GPJM; Sanders, EAM				Spijkerman, Judith; Prevaes, Sabine M. P. J.; van Gils, Elske J. M.; Veenhoven, Reinier H.; Bruin, Jacob P.; Bogaert, Debby; Wijmenga-Monsuur, Alienke J.; van den Dobbelsteen, Germie P. J. M.; Sanders, Elisabeth A. M.			Long-Term Effects of Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; INFANT IMMUNIZATION; CO-COLONIZATION; NASAL CARRIAGE; CHILDREN; EPIDEMIOLOGY; IMPACT	Background: Shifts in pneumococcal serotypes following introduction of 7-valent pneumococcal conjugate vaccine (PCV-7) may alter the presence of other bacterial pathogens co-inhabiting the same nasopharyngeal niche. Methodology/Principal Findings: Nasopharyngeal prevalence rates of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis were investigated before, 3 and 4.5 years after introduction of PCV-7 in the national immunisation program in children at 11 and 24 months of age, and parents of 24-month-old children (n approximate to 330/group) using conventional culture methods. Despite a virtual disappearance of PCV-7 serotypes over time, similar overall pneumococcal rates were observed in all age groups, except for a significant reduction in the 11-month-old group (adjusted Odds Ratio after 4.5 years 0.48, 95% Confidence Interval 0.34-0.67). Before, 3 and 4.5 years after PCV-7 implementation, prevalence rates of S. aureus were 5%, 9% and 14% at 11 months of age (3.59, 1.90-6.79) and 20%, 32% and 34% in parents (1.96, 1.36-2.83), but remained similar at 24 months of age, respectively. Prevalence rates of H. influenzae were 46%, 65% and 65% at 11 months (2.22, 1.58-3.13), 52%, 73% and 76% at 24 months of age (2.68, 1.88-3.82) and 23%, 30% and 40% in parents (2.26, 1.58-3.33), respectively. No consistent changes in M. catarrhalis carriage rates were observed over time. Conclusions/Significance: In addition to large shifts in pneumococcal serotypes, persistently higher nasopharyngeal prevalence rates of S. aureus and H. influenzae were observed among young children and their parents after PCV-7 implementation. These findings may have implications for disease incidence and antibiotic treatment in the post-PCV era.	[Spijkerman, Judith; Prevaes, Sabine M. P. J.; van Gils, Elske J. M.; Bogaert, Debby; Sanders, Elisabeth A. M.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands; [Spijkerman, Judith; Prevaes, Sabine M. P. J.; van Gils, Elske J. M.; Veenhoven, Reinier H.] Spaarne Hosp, Linnaeus Inst, Res Ctr, Hoofddorp, Netherlands; [Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands; [Wijmenga-Monsuur, Alienke J.; van den Dobbelsteen, Germie P. J. M.] Natl Inst Publ Hlth & Environm, Vaccinol Unit, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; Netherlands National Institute for Public Health & the Environment	Spijkerman, J (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands.	l.sanders@umcutrecht.nl		Bogaert, Debby/0000-0003-2651-7000	Dutch Ministry of Health the Netherlands; Wyeth-Pfizer Vaccines [WS847078/GIPIHP_RG_20101022T1552, 0887X1-4598]; GlaxoSmithKline; Pfizer-Wyeth; Pfizer; Baxter	Dutch Ministry of Health the Netherlands; Wyeth-Pfizer Vaccines; GlaxoSmithKline(GlaxoSmithKline); Pfizer-Wyeth(WyethPfizer); Pfizer(Pfizer); Baxter	This work was supported by the Dutch Ministry of Health the Netherlands. Grant support for pneumococcal surveillance and serotyping was provided by Wyeth-Pfizer Vaccines (grant number WS847078/GIPIHP_RG_20101022T1552, 0887X1-4598). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: RHV has received research support from GlaxoSmithKline and Pfizer-Wyeth for vaccine studies and consulting fees for GlaxoSmithKline. BD declares to have received consulting fees from Pfizer. EAMS has received unrestricted grant support for research from Pfizer-Wyeth and Baxter, consulting fees for Pfizer-Wyeth and GlaxoSmithKline, lecturing fees from Pfizer-Wyeth and GlaxoSmithKline and grant support for vaccine studies from Pfizer-Wyeth and GlaxoSmithKline. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Cohen R, 2007, CLIN INFECT DIS, V45, P1583, DOI 10.1086/523734; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Enright MC, 1997, J MED MICROBIOL, V46, P360, DOI 10.1099/00222615-46-5-360; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; Gerber JS, 2009, CLIN INFECT DIS, V49, P65, DOI 10.1086/599348; Grijalva CG, 2008, EXPERT REV VACCINES, V7, P83, DOI 10.1586/14760584.7.1.83; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Kilpi T, 2003, CLIN INFECT DIS, V37, P1155, DOI 10.1086/378744; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lebon A, 2008, J CLIN MICROBIOL, V46, P3517, DOI 10.1128/JCM.00641-08; Lee GM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-110; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; Margolis E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-59; McNally LM, 2006, J INFECT DIS, V194, P385, DOI 10.1086/505076; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Ray GT, 2012, J CLIN MICROBIOL; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Regev-Yochay G, 2008, CLIN INFECT DIS, V47, P289, DOI 10.1086/589573; Regev-Yochay G, 2009, CLIN INFECT DIS, V48, P760, DOI 10.1086/597040; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Rose M, 2009, EXPERT REV VACCINES, V8, P1351, DOI [10.1586/erv.09.78, 10.1586/ERV.09.78]; Shrestha NK, 2002, J CLIN MICROBIOL, V40, P2659, DOI 10.1128/JCM.40.7.2659-2661.2002; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; van Gils EJ, 2011, VACCINE; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	42	105	105	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39730	10.1371/journal.pone.0039730	http://dx.doi.org/10.1371/journal.pone.0039730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761879	Green Submitted, gold, Green Published			2022-12-25	WOS:000305781700060
J	Satomi-Kobayashi, S; Kinugasa, M; Kobayashi, R; Hatakeyama, K; Kurogane, Y; Ishida, T; Emoto, N; Asada, Y; Takai, Y; Hirata, K; Rikitake, Y				Satomi-Kobayashi, Seimi; Kinugasa, Mitsuo; Kobayashi, Reiko; Hatakeyama, Kinta; Kurogane, Yusuke; Ishida, Tatsuro; Emoto, Noriaki; Asada, Yujiro; Takai, Yoshimi; Hirata, Ken-ichi; Rikitake, Yoshiyuki			Osteoblast-like Differentiation of Cultured Human Coronary Artery Smooth Muscle Cells by Bone Morphogenetic Protein Endothelial Cell Precursor-derived Regulator (BMPER)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR RISK; CALCIFICATION; CROSSVEINLESS-2; ACTIVATION; INHIBITION	Differentiation of vascular smooth muscle cells (SMCs) into osteoblast-like cells is considered to be a mechanism of vascular calcification. However, regulators of osteoblast-like differentiation of vascular SMCs are not fully elucidated. Here, we investigated the expression of bone morphogenetic protein (BMP)binding endothelial cell precursor-derived regulator (BMPER), a vertebrate homologue of Drosophila crossveinless-2, in vascular SMCs and the role and mode of action of BMPER in osteoblast-like differentiation of human coronary artery SMCs (HCASMCs). BMPER was expressed in cultured human vascula SMCs, including HCASMCs. Silencing of endogenous BMPER expression by an RNA interference technique inhibited osteoblast-like differentiation of HCASMCs, as evaluated by up-regulation of osteoblast markers such as alkaline phosphatase (ALP) and runt-related transcription factor 2 (Runx2), by down-regulation of a SMC marker alpha-smooth muscle actin (alpha SMA), and by mineralization. Treatment with recombinant BMPER enhanced, whereas BMP-2 reduced osteoblast-like differentiation. BMPER antagonized BMP-2-induced phosphorylation of Smad 1/5/8, suggesting that the effect of BMPER was mediated by antagonizing the action of BMP. BMPER increased I kappa B alpha phosphorylation and NF-kappa B activity and specific NF-kappa B decoy oligonucleotides deteriorated osteoblast-like differentiation of HCASMCs by BMPER. In human coronary artery with atherosclerotic plaque containing calcification, the BMPER-positive signals were observed in the neointimal and medial SMCs in the vicinity of the plaque. These findings indicate that BMPER is a novel regulator of the osteoblast-like differentiation of HCASMCs.	[Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct,Chou Ku, Kobe, Hyogo 6500017, Japan; [Satomi-Kobayashi, Seimi; Kinugasa, Mitsuo; Kurogane, Yusuke; Ishida, Tatsuro; Emoto, Noriaki; Hirata, Ken-ichi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chou Ku, Kobe, Hyogo 6500017, Japan; [Kobayashi, Reiko; Takai, Yoshimi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chou Ku, Kobe, Hyogo 6500017, Japan; [Hatakeyama, Kinta; Asada, Yujiro] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki 8891692, Japan; [Emoto, Noriaki] Kobe Pharmaceut Univ, Dept Clin Pharm, Kobe, Hyogo 6588558, Japan	Kobe University; Kobe University; Kobe University; University of Miyazaki; Kobe Pharmaceutical University	Rikitake, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct,Chou Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	rikitake@med.kobe-u.ac.jp		Emoto, Noriaki/0000-0001-6673-2616	Japan Society for the Promotion of Science; Global Center of Excellence; Takeda Science Foundation; Mitsui Life Social Welfare Foundation; Grants-in-Aid for Scientific Research [22590828] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsui Life Social Welfare Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (to Y. R.), and grants from the Global Center of Excellence (to Y. R. and K. H.), Takeda Science Foundation, and Mitsui Life Social Welfare Foundation (to Y. R.).	Armstrong ZB, 2011, CARDIOVASC RES, V90, P165, DOI 10.1093/cvr/cvq391; Ashique AM, 2002, DEVELOPMENT, V129, P4647; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Conley CA, 2000, DEVELOPMENT, V127, P3947; Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434; Helbing T, 2011, BLOOD, V118, P5040, DOI 10.1182/blood-2011-03-339762; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kikumori T, 1998, ENDOCRINOLOGY, V139, P1715, DOI 10.1210/en.139.4.1715; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Nakano-Kurimoto R, 2009, AM J PHYSIOL-HEART C, V297, pH1673, DOI 10.1152/ajpheart.00455.2009; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Shimizu H, 2006, GENE THER, V13, P933, DOI 10.1038/sj.gt.3302711; van der Zee S, 2009, NAT REV CARDIOL, V6, P580, DOI 10.1038/nrcardio.2009.121; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017	26	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30336	30345		10.1074/jbc.M111.329110	http://dx.doi.org/10.1074/jbc.M111.329110			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778264	Green Published, hybrid			2022-12-25	WOS:000308579800026
J	Penniston, JT; Caride, AJ; Strehler, EE				Penniston, John T.; Caride, Ariel J.; Strehler, Emanuel E.			Alternative Pathways for Association and Dissociation of the Calmodulin-binding Domain of Plasma Membrane Ca2+-ATPase Isoform 4b (PMCA4b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ PUMP; CALCIUM-PUMP; ACTIVATION; DYNAMICS; MECHANISM; RECOGNITION; REGION; SLOW	The calmodulin (CaM)-binding domain of isoform 4b of the plasma membrane Ca2+-ATPase (PMCA) pump is represented by peptide C28. CaM binds to either PMCA or C28 by a mechanism in which the primary anchor residue Trp-1093 binds to the C-terminal lobe of the extended CaM molecule, followed by collapse of CaM with the N-terminal lobe binding to the secondary anchor Phe-1110 (Juranic, N., Atanasova, E., Filoteo, A. G., Macura, S., Prendergast, F. G., Penniston, J. T., and Strehler, E. E. (2010) J. Biol. Chem. 285, 4015-4024). This is a relatively rapid reaction, with an apparent half-time of similar to 1 s. The dissociation of CaM from PMCA4b or C28 is much slower, with an overall half-time of similar to 10 min. Using targeted molecular dynamics, we now show that dissociation of Ca2+-CaM from C28 may occur by a pathway in which Trp-1093, although deeply embedded in a pocket in the C-terminal lobe of CaM, leaves first. The dissociation begins by relatively rapid release of Trp-1093, followed by very slow release of Phe-1110, removal of C28, and return of CaM to its conformation in the free state. Fluorescence measurements and molecular dynamics calculations concur in showing that this alternative path of release of the PMCA4b CaM-binding domain is quite different from that of binding. The intermediate of dissociation with exposed Trp-1093 has a long lifetime (minutes) and may keep the PMCA primed for activation.	[Caride, Ariel J.; Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Penniston, John T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Mayo Clinic; Harvard University; Massachusetts General Hospital	Strehler, EE (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	strehler.emanuel@mayo.edu			National Institutes of Health [NS51769]; Mayo Foundation for Medical Research and Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation for Medical Research and Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769 ( to E. E. S.). This work was also supported by the Mayo Foundation for Medical Research and Education.	Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Caride AJ, 2001, CELL CALCIUM, V30, P49, DOI 10.1054/ceca.2001.0212; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; Carlsson P, 2006, BIOPHYS J, V91, P3151, DOI 10.1529/biophysj.106.082917; Chocholousova J, 2006, J COMPUT CHEM, V27, P719, DOI 10.1002/jcc.20387; GUERINI D, 1984, J BIOL CHEM, V259, P5172; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kranz JK, 2002, BIOCHEMISTRY-US, V41, P2599, DOI 10.1021/bi011818f; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Ovchinnikov V, 2012, J PHYS CHEM B, V116, P8584, DOI 10.1021/jp212634z; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Penheiter AR, 2002, J BIOL CHEM, V277, P17728, DOI 10.1074/jbc.M111608200; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; Slaughter BD, 2007, BIOCHEMISTRY-US, V46, P4045, DOI 10.1021/bi602481u; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Sun HY, 2000, J BIOL CHEM, V275, P1731, DOI 10.1074/jbc.275.3.1731; Swift RV, 2008, BIOCHEMISTRY-US, V47, P4102, DOI 10.1021/bi8000209; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; VERMA AK, 1994, J BIOL CHEM, V269, P1687	30	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29664	29671		10.1074/jbc.M112.377556	http://dx.doi.org/10.1074/jbc.M112.377556			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767601	Green Published, hybrid			2022-12-25	WOS:000308286900042
J	Beeharry, N; Rattner, JB; Bellacosa, A; Smith, MR; Yen, TJ				Beeharry, Neil; Rattner, Jerome B.; Bellacosa, Alfonso; Smith, Mitchell R.; Yen, Timothy J.			Dose Dependent Effects on Cell Cycle Checkpoints and DNA Repair by Bendamustine	PLOS ONE			English	Article							HYDROCHLORIDE; APOPTOSIS; EFFICACY	Bendamustine (BDM) is an active chemotherapeutic agent approved in the U. S. for treating chronic lymphocytic leukemia and non-Hodgkin lymphoma. Its chemical structure suggests it may have alkylator and anti-metabolite activities; however the precise mechanism of action is not well understood. Here we report the concentration-dependent effects of BDM on cell cycle, DNA damage, checkpoint response and cell death in HeLa cells. Low concentrations of BDM transiently arrested cells in G2, while a 4-fold higher concentration arrested cells in S phase. DNA damage at 50, but not 200 mu M, was efficiently repaired after 48 h treatment, suggesting a difference in DNA repair efficiency at the two concentrations. Indeed, perturbing base-excision repair sensitized cells to lower concentrations of BDM. Timelapse studies of the checkpoint response to BDM showed that inhibiting Chk1 caused both the S- and G2-arrested cells to prematurely enter mitosis. However, whereas the cells arrested in G2 (low dose BDM) entered mitosis, segregated their chromosomes and divided normally, the S-phase arrested cells (high dose BDM) exhibited a highly aberrant mitosis, whereby EM images showed highly fragmented chromosomes. The vast majority of these cells died without ever exiting mitosis. Inhibiting the Chk1-dependent DNA damage checkpoint accelerated the time of killing by BDM. Our studies suggest that BDM may affect different biological processes depending on drug concentration. Sensitizing cells to killing by BDM can be achieved by inhibiting base-excision repair or disrupting the DNA damage checkpoint pathway.	[Beeharry, Neil; Bellacosa, Alfonso; Smith, Mitchell R.; Yen, Timothy J.] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA; [Rattner, Jerome B.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada	Fox Chase Cancer Center; University of Calgary	Beeharry, N (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Neil.Beeharry@fccc.edu; Timothy.Yen@fccc.edu		Yen, Tim/0000-0003-2159-0997; Smith, Mitchell/0000-0003-1428-8765	Commonwealth of Pennsylvania; Greenberg Fund; NATIONAL CANCER INSTITUTE [R01CA078412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086877] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania; Greenberg Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following sources: R01-GM86877, an appropriation from the Commonwealth of Pennsylvania, and the Greenberg Fund (to TJY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5; Gaul L, 2008, J CANCER RES CLIN, V134, P245, DOI 10.1007/s00432-007-0278-x; Heider A, 2001, ANTI-CANCER DRUG, V12, P725, DOI 10.1097/00001813-200110000-00003; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Konstantinov SM, 2002, J CANCER RES CLIN, V128, P271, DOI 10.1007/s00432-002-0331-8; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; Leoni LM, 2011, SEMIN HEMATOL, V48, pS12, DOI 10.1053/j.seminhematol.2011.03.003; LIUZZI M, 1985, J BIOL CHEM, V260, P5252; Ogura M, 2011, CANCER SCI, V102, P1687, DOI 10.1111/j.1349-7006.2011.01994.x; Ogura M, 2010, CANCER SCI, V101, P2054, DOI 10.1111/j.1349-7006.2010.01633.x; Owen JS, 2010, CANCER CHEMOTH PHARM, V66, P1039, DOI 10.1007/s00280-010-1254-8; RATTNER JB, 1992, J CELL SCI, V103, P1039; Roue G, 2008, CLIN CANCER RES, V14, P6907, DOI 10.1158/1078-0432.CCR-08-0388; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schwanen C, 2002, LEUKEMIA, V16, P2096, DOI 10.1038/sj.leu.2402651; Stevens JB, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-20; Strumberg D, 1996, ANTI-CANCER DRUG, V7, P415, DOI 10.1097/00001813-199606000-00007	22	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40342	10.1371/journal.pone.0040342	http://dx.doi.org/10.1371/journal.pone.0040342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768280	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100254
J	Billeskov, R; Elvang, TT; Andersen, PL; Dietrich, J				Billeskov, Rolf; Elvang, Tara T.; Andersen, Peter L.; Dietrich, Jes			The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; TUBERCULOSIS INFECTION; T-CELLS; ANTIGEN 85B; ENVIRONMENTAL MYCOBACTERIA; FUSION PROTEIN; MICE; CORRELATE; EFFICACY; ESAT-6	Background: The current vaccine against tuberculosis (TB), BCG, has failed to control TB worldwide and the protective efficacy is moreover limited to 10-15 years. A vaccine that could efficiently boost a BCG-induced immune response and thus prolong protective immunity would therefore have a significant impact on the global TB-burden. Methods/Findings: In the present study we show that the fusion protein HyVac4 (H4), consisting of the mycobacterial antigens Ag85B and TB10.4, given in the adjuvant IC31 (R) or DDA/MPL effectively boosted and prolonged immunity induced by BCG, leading to improved protection against infection with virulent M. tuberculosis (M.tb). Increased protection correlated with an increased percentage of TB10.4 specific IFN gamma/TNF alpha/IL-2 or TNF alpha/IL-2 producing CD4 T cells at the site of infection. Moreover, this vaccine strategy did not compromise the use of ESAT-6 as an accurate correlate of disease development/vaccine efficacy. Indeed both CD4 and CD8 ESAT-6 specific T cells showed significant correlation with bacterial levels. Conclusions/Significance: H4-IC31 (R) can efficiently boost BCG-primed immunity leading to an increased protective anti-M.tb immune response dominated by IFN gamma/TNF alpha/IL-2 or TNF alpha/IL2 producing CD4 T cells. H4 in the CD4 T cell inducing adjuvant IC31 (R) is presently in clinical trials.	[Billeskov, Rolf; Elvang, Tara T.; Andersen, Peter L.; Dietrich, Jes] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Billeskov, R (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	ROB@ssi.dk; JDI@ssi.dk		Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304	Danish Graduate School of Immunology	Danish Graduate School of Immunology	TE and RB are recipients of PhD scholarships from the Danish Graduate School of Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; ANDERSEN P, 1991, INFECT IMMUN, V59, P1558, DOI 10.1128/IAI.59.4.1558-1563.1991; ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Billeskov R, 2010, EUR J IMMUNOL, V40, P1342, DOI 10.1002/eji.200939830; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; Brooks JV, 2001, INFECT IMMUN, V69, P2714, DOI 10.1128/IAI.69.4.2714-2717.2001; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dourado I, 2003, INT J TUBERC LUNG D, V7, P399; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flaherty DK, 2006, J LEUKOCYTE BIOL, V80, P1262, DOI 10.1189/jlb.0606407; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; HUBBARD RD, 1992, CLIN EXP IMMUNOL, V87, P94; Junqueira-Kipnis AP, 2004, INFECT IMMUN, V72, P570, DOI 10.1128/IAI.72.1.570-575.2004; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Lillebaek T, 2002, J INFECT DIS, V185, P401, DOI 10.1086/338342; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Ottenhoff TH, 2010, HUM VACCINES, V6, P1007, DOI 10.4161/hv.6.12.13143; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Thom M, 2008, TUBERCULOSIS, V88, P324, DOI 10.1016/j.tube.2007.12.002; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; WHO, 2010, GLOB TUB CONTR SUIRV	44	73	79	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39909	10.1371/journal.pone.0039909	http://dx.doi.org/10.1371/journal.pone.0039909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768165	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100134
J	Schramm, F; Kern, A; Barthel, C; Nadaud, S; Meyer, N; Jaulhac, B; Boulanger, N				Schramm, Frederic; Kern, Aurelie; Barthel, Cathy; Nadaud, Sophie; Meyer, Nicolas; Jaulhac, Benoit; Boulanger, Nathalie			Microarray Analyses of Inflammation Response of Human Dermal Fibroblasts to Different Strains of Borrelia burgdorferi Sensu Stricto	PLOS ONE			English	Article							ACRODERMATITIS CHRONICA ATROPHICANS; LYME-DISEASE SPIROCHETE; HUMAN DENDRITIC CELLS; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; ERYTHEMA MIGRANS; SKIN; SALIVA; TICKS; OSPC	In Lymeborreliosis, the skin is the key site of bacterial inoculation by the infected tick, and of cutaneous manifestations, erythema migrans and acrodermatitis chronica atrophicans. We explored the role of fibroblasts, the resident cells of the dermis, in the development of the disease. Using microarray experiments, we compared the inflammation of fibroblasts induced by three strains of Borrelia burgdorferi sensu stricto isolated from different environments and stages of Lyme disease: N40 (tick), Pbre (erythema migrans) and 1408 (acrodermatitis chronica atrophicans). The three strains exhibited a similar profile of inflammation with strong induction of chemokines (CXCL1 and IL-8) and IL-6 cytokine mainly involved in the chemoattraction of of immune cells. Molecules such as TNF-alpha and NF-kappa B factors, metalloproteinases (MMP-1, -3 and -12) and superoxide dismutase (SOD2), also described in inflammatory and cellular events, were up-regulated. In addition, we showed that tick salivary gland extracts induce a cytotoxic effect on fibroblasts and that OspC, essential in the transmission of Borrelia to the vertebrate host, was not responsible for the secretion of inflammatory molecules by fibroblasts. Tick saliva components could facilitate the early transmission of the disease to the site of injury creating a feeding pit. Later in the development of the disease, Borrelia would intensively multiply in the skin and further disseminate to distant organs.	[Schramm, Frederic; Kern, Aurelie; Barthel, Cathy; Jaulhac, Benoit; Boulanger, Nathalie] Univ Strasbourg, Fac Med & Pharm, EA 4438, Strasbourg, France; [Nadaud, Sophie] UPMC Univ Paris 06, INSERM, UMR S 956, Paris, France; [Meyer, Nicolas] Univ Strasbourg, Fac Med, Lab Biostat & Informat Med, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schramm, F (corresponding author), Univ Strasbourg, Fac Med & Pharm, EA 4438, Strasbourg, France.	nboulanger@unistra.fr	Nadaud, Sophie/GXV-0505-2022; Nadaud, Sophie/A-7063-2013; Schramm, Frédéric/M-8166-2015; Boulanger, Nathalie/ABF-1353-2020; Schramm, Frédéric/R-9953-2019	Nadaud, Sophie/0000-0002-1452-6009; Schramm, Frédéric/0000-0002-6889-515X; Schramm, Frédéric/0000-0002-6889-515X	Conseil Regional d'Alsace and Direction Generale de l'Armement [2009.60.053]; Pasteur Institute [PTR 309]	Conseil Regional d'Alsace and Direction Generale de l'Armement(Region Grand-Est); Pasteur Institute	Aurelie Kern was supported by grant 2009.60.053 from the Conseil Regional d'Alsace and Direction Generale de l'Armement. Part of the research project was supported by the Pasteur Institute, PTR 309 (Programme Transversal de Recherche, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERER E, 1991, AM J DERMATOPATH, V13, P334, DOI 10.1097/00000372-199108000-00003; Antonara S, 2010, INFECT IMMUN, V78, P4723, DOI 10.1128/IAI.00464-10; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; Behera AK, 2004, INFECT IMMUN, V72, P2864, DOI 10.1128/IAI.72.5.2864-2871.2004; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Castelli E, 2008, AM J DERMATOPATH, V30, P241, DOI 10.1097/DAD.0b013e3181676b60; CINCO M, 1994, FEMS MICROBIOL LETT, V122, P187, DOI 10.1111/j.1574-6968.1994.tb07163.x; Deban L, 2011, CELL TISSUE RES, V343, P237, DOI 10.1007/s00441-010-1018-0; DEKONING J, 1995, J CUTAN PATHOL, V22, P23; DEKONING J, 1993, CLIN DERMATOL, V11, P377, DOI 10.1016/0738-081X(93)90093-R; Diegmann J, 2005, EUR J CANCER, V41, P1794, DOI 10.1016/j.ejca.2005.05.005; Ebnet K, 1997, J IMMUNOL, V158, P3285; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Fikrig E, 2006, MICROBES INFECT, V8, P1390, DOI 10.1016/j.micinf.2005.12.022; Filgueira L, 1996, J IMMUNOL, V157, P2998; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Hajnicka V, 2011, INT J PARASITOL, V41, P213, DOI 10.1016/j.ijpara.2010.09.005; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Hovius JWR, 2009, J INVEST DERMATOL, V129, P2337, DOI 10.1038/jid.2009.202; Hu LT, 2001, ARTHRITIS RHEUM-US, V44, P1401, DOI 10.1002/1529-0131(200106)44:6<1401::AID-ART234>3.0.CO;2-S; JONES NC, 1994, MICROB PATHOGENESIS, V16, P261, DOI 10.1006/mpat.1994.1027; Kern A, 2011, VECTOR-BORNE ZOONOT, V11, P1343, DOI 10.1089/vbz.2010.0197; LaFrance ME, 2011, INFECT IMMUN, V79, P3249, DOI 10.1128/IAI.05122-11; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Lin B, 2001, J INFECT DIS, V184, P174, DOI 10.1086/322000; Marchal C, 2011, INFECT IMMUN, V79, P774, DOI 10.1128/IAI.00482-10; Marchal CMP, 2009, J INVEST DERMATOL, V129, P2515, DOI 10.1038/jid.2009.73; Mullegger RR, 2008, AM J CLIN DERMATOL, V9, P355, DOI 10.2165/0128071-200809060-00002; Mullegger RR, 2007, INFECT IMMUN, V75, P4621, DOI 10.1128/IAI.00263-07; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pancewicz S A, 2001, Med Sci Monit, V7, P1230; Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Picken RN, 1998, J INVEST DERMATOL, V110, P211, DOI 10.1046/j.1523-1747.1998.00130.x; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Saalbach A, 2007, J IMMUNOL, V178, P4966, DOI 10.4049/jimmunol.178.8.4966; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Skaleric U, 2000, EUR J ORAL SCI, V108, P130, DOI 10.1034/j.1600-0722.2000.90771.x; Smetanick MT, 2010, CUTIS, V85, P247; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Suhonen J, 2000, J INFECT DIS, V181, P195, DOI 10.1086/315195; Talkington J, 1999, INFECT IMMUN, V67, P1107, DOI 10.1128/IAI.67.3.1107-1115.1999; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10	59	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40046	10.1371/journal.pone.0040046	http://dx.doi.org/10.1371/journal.pone.0040046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768217	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100189
J	Zhou, B; Wang, JL; Ressom, HW				Zhou, Bin; Wang, Jinlian; Ressom, Habtom W.			MetaboSearch: Tool for Mass-Based Metabolite Identification Using Multiple Databases	PLOS ONE			English	Article								Searching metabolites against databases according to their masses is often the first step in metabolite identification for a mass spectrometry-based untargeted metabolomics study. Major metabolite databases include Human Metabolome DataBase (HMDB), Madison Metabolomics Consortium Database (MMCD), Metlin, and LIPID MAPS. Since each one of these databases covers only a fraction of the metabolome, integration of the search results from these databases is expected to yield a more comprehensive coverage. However, the manual combination of multiple search results is generally difficult when identification of hundreds of metabolites is desired. We have implemented a web-based software tool that enables simultaneous mass-based search against the four major databases, and the integration of the results. In addition, more complete chemical identifier information for the metabolites is retrieved by cross-referencing multiple databases. The search results are merged based on IUPAC International Chemical Identifier (InChI) keys. Besides a simple list of m/z values, the software can accept the ion annotation information as input for enhanced metabolite identification. The performance of the software is demonstrated on mass spectrometry data acquired in both positive and negative ionization modes. Compared with search results from individual databases, MetaboSearch provides better coverage of the metabolome and more complete chemical identifier information. Availability: The software tool is available at http://omics.georgetown.edu/MetaboSearch.html.	[Zhou, Bin; Wang, Jinlian; Ressom, Habtom W.] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Zhou, B (corresponding author), Georgetown Univ, Dept Oncol, Washington, DC 20057 USA.	hwr@georgetown.edu	Zhou, Bin/N-3454-2014		National Cancer Institute [R21CA153176]; NATIONAL CANCER INSTITUTE [R21CA153176] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Grant R21CA153176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown M, 2011, BIOINFORMATICS; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Draper J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-227; Scheltema RA, 2009, BIOANALYSIS, V1, P1551, DOI [10.4155/bio.09.146, 10.4155/BIO.09.146]; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tautenhahn R, 2007, LECT NOTES COMPUT SC, V4414, P371; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wohlgemuth G, 2010, BIOINFORMATICS, V26, P2647, DOI 10.1093/bioinformatics/btq476	11	11	12	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40096	10.1371/journal.pone.0040096	http://dx.doi.org/10.1371/journal.pone.0040096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768229	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100201
J	Nieto, K; Weghofer, M; Sehr, P; Ritter, M; Sedlmeier, S; Karanam, B; Seitz, H; Muller, M; Kellner, M; Horer, M; Michaelis, U; Roden, RBS; Gissmann, L; Kleinschmidt, JA				Nieto, Karen; Weghofer, Margit; Sehr, Peter; Ritter, Mirko; Sedlmeier, Sebastian; Karanam, Balasubramanyam; Seitz, Hanna; Mueller, Martin; Kellner, Markus; Hoerer, Markus; Michaelis, Uwe; Roden, Richard B. S.; Gissmann, Lutz; Kleinschmidt, Juergen A.			Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; HUMAN-PAPILLOMAVIRUS VACCINES; ADENOASSOCIATED VIRUS TYPE-2; CROSS-NEUTRALIZING EPITOPE; HEPARAN-SULFATE; N-TERMINUS; L2; VECTORS; ANTIBODIES; GENERATION	The human papillomavirus (HPV) minor capsid protein L2 is a promising candidate for a broadly protective HPV vaccine yet the titers obtained in most experimental systems are rather low. Here we examine the potential of empty AAV2 particles (AAVLPs), assembled from VP3 alone, for display of L2 epitopes to enhance their immunogenicity. Insertion of a neutralizing epitope (amino acids 17-36) from L2 of HPV16 and HPV31 into VP3 at positions 587 and 453, respectively, permitted assembly into empty AAV particles (AAVLP(HPV16/31L2)). Intramuscularly vaccination of mice and rabbits with AAVLP(HPV16/31L2)s in montanide adjuvant, induced high titers of HPV16 L2 antibodies as measured by ELISA. Sera obtained from animals vaccinated with the AAVLP(HPV16/31L2) s neutralized infections with several HPV types in a pseudovirion infection assay. Lyophilized AAVLP(HPV16/31L2) particles retained their immunogenicity upon reconstitution. Interestingly, vaccination of animals that were pre-immunized with AAV2 - simulating the high prevalence of AAV2 antibodies in the population - even increased cross neutralization against HPV31, 45 and 58 types. Finally, passive transfer of rabbit antisera directed against AAVLP(HPV16/31L2) s protected naive mice from vaginal challenge with HPV16 pseudovirions. In conclusion, AAVLP(HPV16/31L2) particles have the potential as a broadly protective vaccine candidate regardless of prior exposure to AAV.	[Nieto, Karen; Seitz, Hanna; Mueller, Martin; Gissmann, Lutz; Kleinschmidt, Juergen A.] German Canc Res Ctr, Res Program Infect & Canc, D-6900 Heidelberg, Germany; [Weghofer, Margit; Ritter, Mirko; Sedlmeier, Sebastian; Kellner, Markus; Hoerer, Markus; Michaelis, Uwe] MediGene AG, Planegg Martinsried, Germany; [Sehr, Peter] European Mol Biol Lab, Chem Biol Core Facil, Heidelberg, Germany; [Karanam, Balasubramanyam; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Johns Hopkins University	Nieto, K (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, D-6900 Heidelberg, Germany.	k.nieto@dkfz.de	Gissmann, Lutz/H-4688-2011	Sehr, Peter/0000-0002-4348-5066	PHS [P50 CA098252, RC2 CA148499]; Deutsche Krebshilfe [109653]; NATIONAL CANCER INSTITUTE [P50CA098252, RC2CA148499] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RBSR and BK were funded by grants from the PHS (P50 CA098252 and RC2 CA148499), JAK and MM were supported by the Deutsche Krebshilfe, grant 109653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Aucoin Marc G., 2007, V388, P281; Bartel M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00204; Boucas J, 2009, J GENE MED, V11, P1103, DOI 10.1002/jgm.1392; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Calcedo R, 2011, CLIN VACCINE IMMUNOL, V18, P1586, DOI 10.1128/CVI.05107-11; Campo MS, 1997, VIROLOGY, V234, P261, DOI 10.1006/viro.1997.8649; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Girod A, 1999, NAT MED, V5, P1052, DOI 10.1038/12491; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Guyard-Dangremont V, 1999, PROTEIN SCI, V8, P2392; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Kuck D, 2006, J VIROL, V80, P2621, DOI 10.1128/JVI.80.6.2621-2630.2006; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Michelfelder S, 2009, ADV GENET, V67, P29, DOI 10.1016/S0065-2660(09)67002-4; Mitchell AM, 2010, CURR GENE THER, V10, P319; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Muzyczka N, 2005, HUM GENE THER, V16, P408, DOI 10.1089/hum.2005.16.408; Naumer M, 2011, HUM GENE THER; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Rubio I, 2009, VACCINE, V27, P1949, DOI 10.1016/j.vaccine.2009.01.102; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Sonntag F, 2011, J VIROL, V85, P12686, DOI 10.1128/JVI.05359-11; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Zur Hausen H., 2006, INFECT CAUSING HUMAN, P1	41	59	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39741	10.1371/journal.pone.0039741	http://dx.doi.org/10.1371/journal.pone.0039741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761884	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800064
J	Yanpallewar, SU; Barrick, CA; Buckley, H; Becker, J; Tessarollo, L				Yanpallewar, Sudhirkumar U.; Barrick, Colleen A.; Buckley, Hannah; Becker, Jodi; Tessarollo, Lino			Deletion of the BDNF Truncated Receptor TrkB.T1 Delays Disease Onset in a Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; NEUROTROPHIN RECEPTOR; IN-VIVO; TRANSGENIC MICE; NERVOUS-SYSTEM; SPINAL-CORDS; FULL-LENGTH; CELL-DEATH; EXPRESSION; GENE	Brain Derived Neurotrophic Factor (BDNF) exerts strong pro-survival effects on developing and injured motoneurons. However, in clinical trials, BDNF has failed to benefit patients with amyotrophic lateral sclerosis (ALS). To date, the cause of this failure remains unclear. Motoneurons express the TrkB kinase receptor but also high levels of the truncated TrkB. T1 receptor isoform. Thus, we investigated whether the presence of this receptor may affect the response of diseased motoneurons to endogenous BDNF. We deleted TrkB. T1 in the hSOD1(G93A) ALS mouse model and evaluated the impact of this mutation on motoneuron death, muscle weakness and disease progression. We found that TrkB. T1 deletion significantly slowed the onset of motor neuron degeneration. Moreover, it delayed the development of muscle weakness by 33 days. Although the life span of the animals was not affected we observed an overall improvement in the neurological score at the late stage of the disease. To investigate the effectiveness of strategies aimed at bypassing the TrkB. T1 limit to BDNF signaling we treated SOD1 mutant mice with the adenosine A2A receptor agonist CGS21680, which can activate motoneuron TrkB receptor signaling independent of neurotrophins. We found that CGS21680 treatment slowed the onset of motor neuron degeneration and muscle weakness similarly to TrkB. T1 removal. Together, our data provide evidence that endogenous TrkB. T1 limits motoneuron responsiveness to BDNF in vivo and suggest that new strategies such as Trk receptor transactivation may be used for therapeutic intervention in ALS or other neurodegenerative disorders.	[Yanpallewar, Sudhirkumar U.; Barrick, Colleen A.; Buckley, Hannah; Becker, Jodi; Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yanpallewar, SU (corresponding author), NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA.	tessarol@mail.nih.gov			National Cancer Institute, Center for Cancer Research, NIH; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendoerfer KL, 1994, J NEUROSCIENCE; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Beers DR, 2001, J NEUROCHEM, V79, P499, DOI 10.1046/j.1471-4159.2001.00582.x; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Carim-Todd L, 2009, J NEUROSCI, V29, P678, DOI 10.1523/JNEUROSCI.5060-08.2009; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; De Wit J, 2006, J NEUROSCI, V26, P1516, DOI 10.1523/JNEUROSCI.4543-05.2006; Domeniconi M, 2010, HISTOL HISTOPATHOL, V25, P1207, DOI 10.14670/HH-25.1207; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gomes JR, 2012, J NEUROSCI, V32, P4610, DOI 10.1523/JNEUROSCI.0374-12.2012; Guatteo E, 2007, NEUROBIOL DIS, V28, P90, DOI 10.1016/j.nbd.2007.07.002; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hemendinger R, 2005, EXP NEUROL, V196, P235, DOI 10.1016/j.expneurol.2005.07.025; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kawamoto Y, 1998, J NEUROPATH EXP NEUR, V57, P822, DOI 10.1097/00005072-199809000-00003; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Mutoh T, 2000, NEUROCHEM RES, V25, P239, DOI 10.1023/A:1007575504321; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Palko ME, 1999, J NEUROSCI, V19, P775; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saarelainen T, 2000, MOL CELL NEUROSCI, V16, P87, DOI 10.1006/mcne.2000.0863; Sebastiao AM, 2009, BRIT J PHARMACOL, V158, P15, DOI 10.1111/j.1476-5381.2009.00157.x; SEEBURGER JL, 1993, BRAIN RES, V621, P111, DOI 10.1016/0006-8993(93)90304-6; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Vidaurre OG, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.143; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Zhai JB, 2011, HUM MOL GENET, V20, P4116, DOI 10.1093/hmg/ddr335	48	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39946	10.1371/journal.pone.0039946	http://dx.doi.org/10.1371/journal.pone.0039946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761934	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800080
J	Mise, N; Savai, R; Yu, HY; Schwarz, J; Kaminski, N; Eickelberg, O				Mise, Nikica; Savai, Rajkumar; Yu, Haiying; Schwarz, Johannes; Kaminski, Naftali; Eickelberg, Oliver			Zyxin Is a Transforming Growth Factor-beta (TGF-beta)/Smad3 Target Gene That Regulates Lung Cancer Cell Motility via Integrin alpha 5 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA; ACTIN-POLYMERIZATION; TUMOR-SUPPRESSOR; ALPHA-ACTININ; II RECEPTOR; PROTEIN; ADHESION; TRANSDIFFERENTIATION; SMAD3	Although TGF-beta acts as a tumor suppressor in normal tissues and in early carcinogenesis, these tumor suppressor effects are lost in advanced malignancies. Single cell migration and epithelial-mesenchymal transition (EMT), both of which are regulated by TGF-beta, are critical steps in mediating cancer progression. Here, we sought to identify novel direct targets of TGF-beta signaling in lung cancer cells and have indentified the zyxin gene as a target of Smad3-mediated TGF-beta 1 signaling. Zyxin concentrates at focal adhesions and along the actin cytoskeleton; as such, we hypothesized that cytoskeletal organization, motility, and EMT in response to TGF-beta 1 might be regulated by zyxin expression. We show that TGF-beta 1 treatment of lung cancer cells caused rapid phospho-Smad3-dependent expression of zyxin. Zyxin expression was critical for the formation and integrity of cell adherens junctions. Silencing of zyxin decreased expression of the focal adhesion protein vasodilator-activated phosphoprotein (VASP), although the formation and morphology of focal adhesions remained unchanged. Zyxin-depleted cells displayed significantly increased integrin alpha 5 beta 1 levels, accompanied by enhanced adhesion to fibronectin and acquisition of a mesenchymal phenotype in response to TGF-beta 1. Zyxin silencing led to elevated integrin alpha 5 beta 1-dependent single cell motility. Importantly, these features are mirrored in the K-ras-driven mouse model of lung cancer. Here, lung tumors revealed decreased levels of both zyxin and phospho-Smad3 when compared with normal tissues. Our data thus demonstrate that zyxin is a novel functional target and effector of TGF-beta signaling in lung cancer. By regulating cell-cell junctions, integrin alpha 5 beta 1 expression, and cell-extracellular matrix adhesion, zyxin may regulate cancer cell motility and EMT during lung cancer development and progression.	[Mise, Nikica; Yu, Haiying; Schwarz, Johannes; Eickelberg, Oliver] Univ Munich, Univ Hosp, CPC, D-81377 Munich, Germany; [Mise, Nikica; Yu, Haiying; Schwarz, Johannes; Eickelberg, Oliver] Helmholtz Zentrum Munich, D-81377 Munich, Germany; [Savai, Rajkumar] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Kaminski, Naftali] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mise, N (corresponding author), Univ Munich, Univ Hosp, CPC, Max Lebsche Pl 31, D-81377 Munich, Germany.	nikica.mise@helmholtz-muenchen.de; oliver.eickelberg@helmholtz-muenchen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360; Kaminski, Naftali/0000-0001-5917-4601	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by the Helmholtz Association.	Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; Beckerle MC, 1998, CELL, V95, P741, DOI 10.1016/S0092-8674(00)81697-9; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Chan CB, 2007, CELL DEATH DIFFER, V14, P1688, DOI 10.1038/sj.cdd.4402179; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Daly AC, 2010, J BIOL CHEM, V285, P6489, DOI 10.1074/jbc.M109.043877; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Han XS, 2001, ONCOGENE, V20, P7976, DOI 10.1038/sj.onc.1204996; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Malkoski SP, 2012, CLIN CANCER RES, V18, P2173, DOI 10.1158/1078-0432.CCR-11-2557; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Mori M, 2009, MOL BIOL CELL, V20, P3115, DOI 10.1091/mbc.E09-01-0046; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Piek E, 1999, J CELL SCI, V112, P4557; Portella G, 1998, CELL GROWTH DIFFER, V9, P393; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Sperry RB, 2010, J CELL PHYSIOL, V222, P612, DOI 10.1002/jcp.21977; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Yu YP, 2011, ONCOGENE, V30, P4855, DOI 10.1038/onc.2011.200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang YH, 2011, INT J ORAL SCI, V3, P1, DOI 10.4248/IJOS11003	48	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31393	31405		10.1074/jbc.M112.357624	http://dx.doi.org/10.1074/jbc.M112.357624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22778267	hybrid, Green Published			2022-12-25	WOS:000308791300050
J	Hehemann, JH; Correc, G; Thomas, F; Bernard, T; Barbeyron, T; Jam, M; Helbert, W; Michel, G; Czjzek, M				Hehemann, Jan-Hendrik; Correc, Gaelle; Thomas, Francois; Bernard, Thomas; Barbeyron, Tristan; Jam, Murielle; Helbert, William; Michel, Gurvan; Czjzek, Mirjam			Biochemical and Structural Characterization of the Complex Agarolytic Enzyme System from the Marine Bacterium Zobellia galactanivorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT SYMBIONT; BETA-AGARASE; CELL-WALLS; RED ALGA; BINDING; STARCH; NOMENCLATURE; EXPRESSION; PORPHYRAN; EVOLUTION	Zobellia galactanivorans is an emerging model bacterium for the bioconversion of algal biomass. Notably, this marine Bacteroidetes possesses a complex agarolytic system comprising four beta-agarases and five beta-porphyranases, all belonging to the glycoside hydrolase family 16. Although beta-agarases are specific for the neutral agarobiose moieties, the recently discovered beta-porphyranases degrade the sulfated polymers found in various quantities in natural agars. Here, we report the biochemical and structural comparison of five beta-porphyranases and beta-agarases from Z. galactanivorans. The respective degradation patterns of two beta-porphyranases and three beta-agarases are analyzed by their action on defined hybrid oligosaccharides. In light of the high resolution crystal structures, the biochemical results allowed a detailed mapping of substrate specificities along the active site groove of the enzymes. Although PorA displays a strict requirement for C6-sulfate in the -2- and + 1-binding subsites, PorB tolerates the presence of 3-6-anhydro-L-galactose in subsite -2. Both enzymes do not accept methylation of the galactose unit in the -1 subsite. The beta-agarase AgaD requires at least four consecutive agarose units (DP8) and is highly intolerant to modifications, whereas for AgaB oligosaccharides containing C6-sulfate groups at the -4, +1, and +3 positions are still degraded. Together with a transcriptional analysis of the expression of these enzymes, the structural and biochemical results allow proposition of a model scheme for the agarolytic system of Z. galactanivorans.	[Hehemann, Jan-Hendrik; Correc, Gaelle; Thomas, Francois; Barbeyron, Tristan; Jam, Murielle; Helbert, William; Michel, Gurvan; Czjzek, Mirjam] Univ Paris 06, F-29682 Roscoff, France; [Correc, Gaelle; Thomas, Francois; Barbeyron, Tristan; Jam, Murielle; Helbert, William; Michel, Gurvan; Czjzek, Mirjam] CNRS, Vegetaux Marins & Biomol UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, France; [Hehemann, Jan-Hendrik] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Bernard, Thomas] Swiss Inst Bioinformat, Vital IT Grp, CH-1015 Lausanne, Switzerland	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Victoria; Swiss Institute of Bioinformatics	Michel, G (corresponding author), Univ Paris 06, F-29682 Roscoff, France.	gurvan@sb-roscoff.fr; czjzek@sb-roscoff.fr		MICHEL, Gurvan/0000-0002-3009-6205; Hehemann, Jan-Hendrik/0000-0002-8700-2564; Thomas, Francois/0000-0003-1896-0774; Bernard, Thomas/0000-0003-3736-1507	Region Bretagne; CNRS; European Marie Curie Ph.D. grant	Region Bretagne(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Marie Curie Ph.D. grant	This work was supported in part by the Region Bretagne and the CNRS.; Supported by a European Marie Curie Ph.D. grant.	Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; ANDERSON KL, 1989, J BACTERIOL, V171, P3199, DOI 10.1128/jb.171.6.3199-3204.1989; ANDERSON NS, 1965, J CHEM SOC, P5880, DOI 10.1039/jr9650005880; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dong JH, 2006, APPL ENVIRON MICROB, V72, P6399, DOI 10.1128/AEM.00935-06; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flament D, 2007, APPL ENVIRON MICROB, V73, P4691, DOI 10.1128/AEM.00496-07; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hehemann JH, 2010, ACTA CRYSTALLOGR F, V66, P413, DOI 10.1107/S174430911000429X; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Karlsson EN, 2004, FEMS MICROBIOL LETT, V241, P233, DOI 10.1016/j.femsle.2004.10.026; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; KNUTSEN SH, 1994, BOT MAR, V37, P163, DOI 10.1515/botm.1994.37.2.163; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; LAHAYE M, 1989, CARBOHYD RES, V190, P249, DOI 10.1016/0008-6215(89)84129-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lechat H, 2000, J PHYCOL, V36, P891, DOI 10.1046/j.1529-8817.2000.00056.x; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Starr CM, 1996, J CHROMATOGR A, V720, P295, DOI 10.1016/0021-9673(95)00749-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; van de Velde F, 2002, TRENDS FOOD SCI TECH, V13, P73, DOI 10.1016/S0924-2244(02)00066-3; Vandenbussche S, 2008, CHEM-EUR J, V14, P7570, DOI 10.1002/chem.200800247; Zobell CE, 1941, J MAR RES, V4, P42	52	89	100	1	89	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30571	30584		10.1074/jbc.M112.377184	http://dx.doi.org/10.1074/jbc.M112.377184			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778272	Green Published, hybrid			2022-12-25	WOS:000308579800049
J	Pescatore, LA; Bonatto, D; Forti, FL; Sadok, A; Kovacic, H; Laurindo, FRM				Pescatore, Luciana A.; Bonatto, Diego; Forti, Fabio L.; Sadok, Amine; Kovacic, Herve; Laurindo, Francisco R. M.			Protein Disulfide Isomerase Is Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Migration, Nox1 NADPH Oxidase Expression, and RhoGTPase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; INTERACTION NETWORKS; BINDING PROTEIN; BALLOON INJURY; RHO; LOCALIZATION; ASSOCIATION; INTERACTOME; ADHESION; SURFACE	Vascular Smooth Muscle Cell (VSMC) migration into vessel neointima is a therapeutic target for atherosclerosis and postinjury restenosis. Nox1 NADPH oxidase-derived oxidants synergize with growth factors to support VSMC migration. We previously described the interaction between NADPH oxidases and the endoplasmic reticulum redox chaperone protein disulfide isomerase (PDI) in many cell types. However, physiological implications, as well as mechanisms of such association, are yet unclear. We show here that platelet-derived growth factor (PDGF) promoted subcellular redistribution of PDI concomitant to Nox1-dependent reactive oxygen species production and that siRNA-mediated PDI silencing inhibited such reactive oxygen species production, while nearly totally suppressing the increase in Nox1 expression, with no change in Nox4. Furthermore, PDI silencing inhibited PDGF-induced VSMC migration assessed by distinct methods, whereas PDI overexpression increased spontaneous basal VSMC migration. To address possible mechanisms of PDI effects, we searched for PDI interactome by systems biology analysis of physical protein-protein interaction networks, which indicated convergence with small GTPases and their regulator RhoGDI. PDI silencing decreased PDGF-induced Rac1 and RhoA activities, without changing their expression. PDI co-immunoprecipitated with RhoGDI at base line, whereas such association was decreased after PDGF. Also, PDI co-immunoprecipitated with Rac1 and RhoA in a PDGF-independent way and displayed detectable spots of perinuclear co-localization with Rac1 and RhoGDI. Moreover, PDI silencing promoted strong cytoskeletal changes: disorganization of stress fibers, decreased number of focal adhesions, and reduced number of RhoGDI-containing vesicular recycling adhesion structures. Overall, these data suggest that PDI is required to support Nox1/redox and GTPase-dependent VSMC migration.	[Pescatore, Luciana A.; Laurindo, Francisco R. M.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Vasc Biol Lab, BR-05403000 Sao Paulo, Brazil; [Bonatto, Diego] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, BR-91509900 Porto Alegre, RS, Brazil; [Forti, Fabio L.] Univ Sao Paulo, Inst Chem, BR-05508000 Sao Paulo, Brazil; [Sadok, Amine; Kovacic, Herve] Univ Aix Marseille 1, INSERM, UMR 911, CRO2, F-13385 Marseille, France	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Laurindo, FRM (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Vasc Biol Lab, Av Eneas Carvalho Aguiar 44,Annex 2,9th Floor, BR-05403000 Sao Paulo, Brazil.	francisco.laurindo@incor.usp.br	FORTI, FABIO LUIS/F-8085-2012; Pescatore, Luciana/P-1986-2014; kovacic, hervé/ABF-2451-2020; Bonatto, Diego/F-5893-2010	FORTI, FABIO LUIS/0000-0002-2278-6396; Bonatto, Diego/0000-0001-8679-2448; Kovacic, Herve/0000-0001-6509-4210				Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Azevedo LCP, 2000, CARDIOVASC RES, V47, P436, DOI 10.1016/S0008-6363(00)00091-2; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; Clissold PM, 2003, BIOESSAYS, V25, P603, DOI 10.1002/bies.10287; Custodis F, 2006, CARDIOVASC RES, V71, P342, DOI 10.1016/j.cardiores.2006.04.005; Delom F, 2001, J BIOL CHEM, V276, P21337, DOI 10.1074/jbc.M101086200; Di-Poi N, 2001, BIOCHEMISTRY-US, V40, P10014, DOI 10.1021/bi010289c; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Fae KC, 2008, J AUTOIMMUN, V31, P136, DOI 10.1016/j.jaut.2008.04.023; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fernandes DC, 2009, ARCH BIOCHEM BIOPHYS, V484, P197, DOI 10.1016/j.abb.2009.01.022; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Haefliger S, 2011, BLOOD, V117, P5931, DOI 10.1182/blood-2010-08-304485; Hashida T, 2011, J TOXICOL SCI, V36, P1, DOI 10.2131/jts.36.1; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; Kost B, 2008, TRENDS CELL BIOL, V18, P119, DOI 10.1016/j.tcb.2008.01.003; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Laurindo FRM, 2002, METHOD ENZYMOL, V352, P432; Leite PF, 2003, ARTERIOSCL THROM VAS, V23, P2197, DOI 10.1161/01.ATV.0000093980.46838.41; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maruri-Avidal L, 2008, J VIROL, V82, P5368, DOI 10.1128/JVI.02751-07; Moissoglu K, 2009, CANCER RES, V69, P2838, DOI 10.1158/0008-5472.CAN-08-1397; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Ramirez-Rangel I, 2011, MOL CELL BIOL, V31, P1657, DOI 10.1128/MCB.00824-10; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Santos CXC, 2009, J LEUKOCYTE BIOL, V86, P989, DOI 10.1189/jlb.0608354; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Souza HP, 2000, FREE RADICAL BIO MED, V28, P1232, DOI 10.1016/S0891-5849(00)00240-9; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Zhou M, 2008, CRIT CARE, V12, DOI 10.1186/cc6977; Zimmerman MC, 2011, HYPERTENSION, V58, P446, DOI 10.1161/HYPERTENSIONAHA.111.177006; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	70	56	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29290	29300		10.1074/jbc.M112.394551	http://dx.doi.org/10.1074/jbc.M112.394551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773830	Green Published, hybrid			2022-12-25	WOS:000308286900009
J	Kandala, PK; Srivastava, SK				Kandala, Prabodh K.; Srivastava, Sanjay K.			Diindolylmethane-mediated Gli1 Protein Suppression Induces Anoikis in Ovarian Cancer Cells in Vitro and Blocks Tumor Formation Ability in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; ANIMAL DEVELOPMENT; PANCREATIC-CANCER; INDUCED APOPTOSIS; DOWN-REGULATION; 3,3'-DIINDOLYLMETHANE; ACTIVATION; PROLIFERATION; METASTASIS; RESISTANCE	Anoikis is a cell death that occurs due to detachment of a cell from the extracellular matrix (ECM). Resistance to anoikis is a primary feature of a cell that undergoes metastasis. In this study for the first time, we demonstrated the potential role of Gli1 in anoikis resistance. Treatment of various ovarian cancer cells by different concentrations of diindolylmethane (DIM), an active ingredient of cruciferous vegetables, reduced the anoikis resistance in a concentration-dependent manner. Reduction in anoikis resistance was associated with a decrease in the expression of Gli1 and an increase in the cleavage of poly(ADP-ribose) polymerase (PARP). Sonic hedgehog (Shh) treatment not only increased the expression of Gli1, but also blocked anoikis induced by DIM and abrogated the change in the expression of Gli1 and cleaved PARP by DIM. To confirm the role of Gli1, hedgehog inhibitor cyclopamine, Gli1 siRNA and Gli1(-/-) mouse embryonic fibroblasts (MEFs) were used. Cyclopamine treatment alone significantly reduced anoikis resistance in A2780 and OVCAR-429 cells. Cyclopamine-mediated reduction in anoikis resistance was associated with reduced expression of Gli1 and induction of cleaved PARP. Shh treatment blocked cyclopamine-induced anoikis. Silencing Gli1 expression induced anoikis and cleavage of PARP in A2780 and OVCAR-429 cells. Furthermore, Gli1(-/-) MEFs were more sensitive to anoikis compared with Gli1(+/+) MEFs. Our in vivo studies established that DIM-or cyclopamine-treated ovarian cancer cells under suspension culture conditions drastically lost their ability of tumor formation in vivo in mice. Taken together, our results establish that Gli1 is a critical player in anoikis resistance in ovarian cancer.	[Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX 79106 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Srivastava, SK (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Suite 1103,1406 Coulter, Amarillo, TX 79106 USA.	sanjay.srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020		National Institutes of Health through the NCI [R01 CA106953, CA129038]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA106953 and CA129038 (to S. K. S.) through the NCI.	Banerjee S, 2011, MUTAT RES-REV MUTAT, V728, P47, DOI 10.1016/j.mrrev.2011.06.001; Banerjee S, 2009, CANCER RES, V69, P5592, DOI 10.1158/0008-5472.CAN-09-0838; Bhatnagar N, 2009, CANCER PREV RES, V2, P581, DOI 10.1158/1940-6207.CAPR-08-0142; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; BUCK RC, 1973, CANCER RES, V33, P3181; Chen XL, 2008, WORLD J GASTROENTERO, V14, P582, DOI 10.3748/wjg.14.582; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cho HJ, 2011, MOL CARCINOGEN, V50, P100, DOI 10.1002/mc.20698; Coates JM, 2010, J SURG RES, V164, P301, DOI 10.1016/j.jss.2009.07.011; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Donahue JK, 2006, GENE THER, V13, P998, DOI 10.1038/sj.gt.3302748; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Elamin MH, 2010, MOL CARCINOGEN, V49, P302, DOI 10.1002/mc.20604; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; He XP, 2010, CANCER RES, V70, P3109, DOI 10.1158/0008-5472.CAN-09-3557; Hu WG, 2007, ACTA PHARMACOL SIN, V28, P1224, DOI 10.1111/j.1745-7254.2007.00620.x; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jin YC, 2011, MOL CELL BIOCHEM, V358, P345, DOI 10.1007/s11010-011-0985-0; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kandala PK, 2012, ONCOTARGET, V3, P435; Kandala PK, 2012, DRUG DISCOV THER, V6, P94, DOI 10.5582/ddt.2012.v6.2.94; Kandala PK, 2012, J PHARMACOL EXP THER, V341, P24, DOI 10.1124/jpet.111.188706; Kandala PK, 2010, MOL PHARMACOL, V78, P297, DOI 10.1124/mol.110.063750; Kaur M, 2006, MOL CANCER THER, V5, P1265, DOI 10.1158/1535-7163.MCT-06-0014; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Mawji IA, 2007, J NATL CANCER I, V99, P811, DOI 10.1093/jnci/djk182; Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Altaba ARI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002540; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Vestergaard J, 2008, DNA CELL BIOL, V27, P251, DOI 10.1089/dna.2007.0625; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338	47	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28745	28754		10.1074/jbc.M112.351379	http://dx.doi.org/10.1074/jbc.M112.351379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773833	Green Published, hybrid			2022-12-25	WOS:000308074600048
J	Tesfay, L; Huhn, AJ; Hatcher, H; Torti, FM; Torti, SV				Tesfay, Lia; Huhn, Annissa J.; Hatcher, Heather; Torti, Frank M.; Torti, Suzy V.			Ferritin Blocks Inhibitory Effects of Two-Chain High Molecular Weight Kininogen (HKa) on Adhesion and Survival Signaling in Endothelial Cells	PLOS ONE			English	Article							H-FERRITIN; ANGIOGENESIS; PROLIFERATION; BRADYKININ; RECEPTOR; KININOSTATIN; MACROPHAGES; EXPRESSION; MIGRATION; PATHWAYS	Angiogenesis is tightly regulated through complex crosstalk between pro- and anti-angiogenic signals. High molecular weight kininogen (HK) is an endogenous protein that is proteolytically cleaved in plasma and on endothelial cell surfaces to HKa, an anti-angiogenic protein. Ferritin binds to HKa and blocks its anti-angiogenic activity. Here, we explore mechanisms underlying the cytoprotective effect of ferritin in endothelial cells exposed to HKa. We observe that ferritin promotes adhesion and survival of HKa-treated cells and restores key survival and adhesion signaling pathways mediated by Erk, Akt, FAK and paxillin. We further elucidate structural motifs of both HKa and ferritin that are required for effects on endothelial cells. We identify an histidine-glycine-lysine (HGK) -rich antiproliferative region within domain 5 of HK as the target of ferritin, and demonstrate that both ferritin subunits of the H and L type regulate HKa activity. We further demonstrate that ferritin reduces binding of HKa to endothelial cells and restores the association of uPAR with alpha 5 beta 1 integrin. We propose that ferritin blocks the anti-angiogenic activity of HKa by reducing binding of HKa to UPAR and interfering with anti-adhesive and anti-proliferative signaling of HKa.	[Tesfay, Lia; Hatcher, Heather; Torti, Frank M.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Huhn, Annissa J.; Torti, Suzy V.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Torti, Frank M.; Torti, Suzy V.] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University	Tesfay, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA.	storti@uchc.edu		Huhn, Annissa/0000-0002-8543-2229	National Institutes of Health [R01DK71892, R37 DK42421]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071892, R01DK042421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01DK71892; R37 DK42421). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; CADENA RAD, 1991, TRENDS PHARMACOL SCI, V12, P272, DOI 10.1016/0165-6147(91)90569-E; Cao DJ, 2004, CIRC RES, V94, P1227, DOI 10.1161/01.RES.0000126567.75232.46; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Coffman LG, 2008, AM J PHYSIOL-LUNG C, V294, pL505, DOI 10.1152/ajplung.00347.2007; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Colman RW, 2006, CURR PHARM DESIGN, V12, P2599, DOI 10.2174/138161206777698710; Colman RW, 2000, BLOOD, V95, P543, DOI 10.1182/blood.V95.2.543; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; FARGION S, 1991, CURR STUD HEMATOL BL, V58, P164; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Guo YL, 2005, J THROMB HAEMOST, V3, P670, DOI 10.1111/j.1538-7836.2005.01218.x; Guo YL, 2003, J CELL BIOCHEM, V89, P622, DOI 10.1002/jcb.10536; Guo YL, 2001, ARTERIOSCL THROM VAS, V21, P1427, DOI 10.1161/hq0901.095277; HASAN AAK, 1995, J BIOL CHEM, V270, P19256, DOI 10.1074/jbc.270.33.19256; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Kawasaki M, 2003, J BIOL CHEM, V278, P49301, DOI 10.1074/jbc.M308790200; Kelly RJ, 2010, CANCER J, V16, P635, DOI 10.1097/PPO.0b013e3181ff37cf; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Leimberg MJ, 2008, J CELL BIOCHEM, V103, P1211, DOI 10.1002/jcb.21499; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Liu YC, 2008, AM J PHYSIOL-CELL PH, V295, pC257, DOI 10.1152/ajpcell.00569.2007; MATZNER Y, 1979, BRIT J HAEMATOL, V42, P345, DOI 10.1111/j.1365-2141.1979.tb01142.x; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McCrae KR, 2005, CURR CANCER DRUG TAR, V5, P519, DOI 10.2174/156800905774574039; Parthasarathy N, 2002, BIOCHEM J, V365, P279, DOI 10.1042/BJ20011637; Peerschke EIB, 2007, IMMUNOBIOLOGY, V212, P333, DOI 10.1016/j.imbio.2006.11.011; Rajappa M, 2010, ADV CLIN CHEM, V50, P103, DOI 10.1016/S0065-2423(10)50006-4; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Schmaier AH, 1998, THROMB RES, V92, P293, DOI 10.1016/S0049-3848(98)00142-X; SIBILLE JC, 1988, HEPATOLOGY, V8, P296, DOI 10.1002/hep.1840080218; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Zins SR, 2010, ANGIOGENESIS, V13, P293, DOI 10.1007/s10456-010-9186-9	44	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40030	10.1371/journal.pone.0040030	http://dx.doi.org/10.1371/journal.pone.0040030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768328	gold, Green Published, Green Submitted			2022-12-25	WOS:000305966500041
J	Wang, J; Chen, GY; Gong, HL; Huang, W; Long, D; Tang, WF				Wang, Jia; Chen, Guangyuan; Gong, Hanlin; Huang, Wei; Long, Dan; Tang, Wenfu			Amelioration of Experimental Acute Pancreatitis with Dachengqi Decoction via Regulation of Necrosis-Apoptosis Switch in the Pancreatic Acinar Cell	PLOS ONE			English	Article							CHENG-QI DECOCTION; NITRIC-OXIDE; NECROTIZING PANCREATITIS; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; DEATH; RATS; CYTOKINES; SEVERITY; RADICALS	Severity of acute pancreatitis contributes to the modality of cell death. Pervious studies have demonstrated that the herb medicine formula "Dachengqi Decoction" (DCQD) could ameliorate the severity of acute pancreatitis. However, the biological mechanisms governing its action of most remain unclear. The role of apoptosis/necrosis switch within acute pancreatitis has attracted much interest, because the induction of apoptosis within injured cells might suppress inflammation and ameliorate the disease. In this study, we used cerulein (10(-8) M)-stimulated AR42J cells as an in vitro model of acute pancreatitis and retrograde perfusion into the biliopancreatic duct of 3.5% sodium taurocholate as an in vivo rat model. After the treatment of DCQD, cell viability, levels of apoptosis and necrosis, reactive oxygen species positive cells, serum amylase, concentration of nitric oxide and inducible nitric oxide syntheses, pancreatic tissue pathological score and inflammatory cell infiltration were tested. Pretreatment with DCQD increased cell viability, induced apoptosis, decreased necrosis and reduced the severity of pancreatitis tissue. Moreover, treatment with DCQD reduced the generation of reactive oxygen species in AR42J cells but increased the concentration of nitric oxide of pancreatitis tissues. Therefore, the regulation of apoptosis/necrosis switch by DCQD might contribute to ameliorating the pancreatic inflammation and pathological damage. Further, the different effect on reactive oxygen species and nitric oxide may play an important role in DCQD-regulated apoptosis/necrosis switch in acute pancreatitis.	[Wang, Jia; Chen, Guangyuan; Gong, Hanlin; Tang, Wenfu] Sichuan Univ, Dept Integrated Tradit Chinese & Western Med, W China Hosp, Chengdu 610064, Peoples R China; [Huang, Wei] Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England; [Long, Dan] Sichuan Univ, Dept Lab Transplant Engn & Immunol, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University; University of Liverpool; Sichuan University	Wang, J (corresponding author), Sichuan Univ, Dept Integrated Tradit Chinese & Western Med, W China Hosp, Chengdu 610064, Peoples R China.	wftang900@gmail.com			Natural Science Foundation of China [30400576, 30973711, 30672588]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the grants of Natural Science Foundation of China (No: 30400576, 30973711 and 30672588). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif L, 2006, J GEN VIROL, V87, P2539, DOI 10.1099/vir.0.81915-0; Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bhatia M, 2004, J CELL MOL MED, V8, P402, DOI 10.1111/j.1582-4934.2004.tb00330.x; Bhatia M, 2009, FRONT BIOSCI-LANDMRK, V14, P2042, DOI 10.2741/3362; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Cevikel MH, 2003, PANCREATOLOGY, V3, P329, DOI 10.1159/000071772; Chang YC, 2011, EVID BASED COMPLEMEN; Chvanov M, 2005, PHILOS T R SOC B, V360, P2273, DOI 10.1098/rstb.2005.1757; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Dobosz M, 2005, PHYSIOL RES, V54, P363, DOI 10.33549/physiolres.930637; Gong HL, 2009, WORLD J GASTROENTERO, V15, P5992, DOI 10.3748/wjg.15.5992; HIETARANTA AJ, 1995, J SURG RES, V59, P271, DOI 10.1006/jsre.1995.1164; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Katakai Masumi, 2002, Yakushigaku Zasshi, V37, P28; Kim H, 2000, FREE RADICAL BIO MED, V29, P674, DOI 10.1016/S0891-5849(00)00368-3; Leindler L, 2004, PANCREAS, V29, P157, DOI 10.1097/00006676-200408000-00011; Liu BB, 2011, FREE RADICAL RES, V45, P835, DOI 10.3109/10715762.2011.580343; Lu GH, 2008, CHINESE ARCH TRADITI, V27, P260; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mofidi R, 2006, BRIT J SURG, V93, P738, DOI 10.1002/bjs.5290; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Rahman SH, 2003, GUT, V52, P270, DOI 10.1136/gut.52.2.270; Rakonczay Z, 2002, PANCREAS, V24, P83, DOI 10.1097/00006676-200201000-00011; RUBANYI GM, 1991, BIOCHEM BIOPH RES CO, V181, P1392, DOI 10.1016/0006-291X(91)92093-Y; Shang D, 2002, CHINESE J SURG INTEG, V8, P70; Tang WF, 2007, BIOMED CHROMATOGR, V21, P1186, DOI 10.1002/bmc.873; Tang Wenfu, 2008, Chin Med, V3, P5, DOI 10.1186/1749-8546-3-5; Tsai K, 1998, GUT, V42, P850, DOI 10.1136/gut.42.6.850; Um SH, 2003, J KOREAN MED SCI, V18, P520, DOI 10.3346/jkms.2003.18.4.520; Wan MH, 2011, CHIN J INTEGR MED, V17, P141, DOI 10.1007/s11655-011-0630-5; Weber H, 2000, DIGEST DIS SCI, V45, P2252, DOI 10.1023/A:1026459001195; Xia Q, 2001, CHIN J BASES CLIN GE, V8, P131; Xia Q, 2006, CHIN J TCM WM CRIT C, V13, P131; Yu JH, 2007, INT J BIOCHEM CELL B, V39, P2063, DOI 10.1016/j.biocel.2007.05.021; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	36	25	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40160	10.1371/journal.pone.0040160	http://dx.doi.org/10.1371/journal.pone.0040160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768339	Green Published, gold, Green Submitted			2022-12-25	WOS:000305966500052
J	Abe, S; Kurata, M; Suzuki, S; Yamamoto, K; Aisaki, K; Kanno, J; Kitagawa, M				Abe, Shinya; Kurata, Morito; Suzuki, Shiho; Yamamoto, Kouhei; Aisaki, Ken-ichi; Kanno, Jun; Kitagawa, Masanobu			Minichromosome Maintenance 2 Bound with Retroviral Gp70 Is Localized to Cytoplasm and Enhances DNA-Damage-Induced Apoptosis	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; VIRUS-INDUCED LEUKEMOGENESIS; STRAND BREAK REPAIR; S-PHASE; PHOSPHATASE 2A; MCM2-7 COMPLEX; GENE FAMILY; REPLICATION; CELLS; P53	The interaction of viral proteins with host-cellular proteins elicits the activation of cellular signal transduction pathways and possibly leads to viral pathogenesis as well as cellular biological events. Apoptotic signals induced by DNA-damage are remarkably up-regulated by Friend leukemia virus (FLV) exclusively in C3H hosts; however, the mechanisms underlying the apoptosis enhancement and host-specificity are unknown. Here, we show that C3H mouse-derived hematopoietic cells originally express higher levels of the minichromosome maintenance (MCM) 2 protein than BALB/c- or C57BL/6-deriverd cells, and undergo more frequent apoptosis following doxorubicin-induced DNA-damage in the presence of the FLV envelope protein gp70. Dual transfection with gp70/Mcm2 reproduced doxorubicin-induced apoptosis even in BALB/c-derived 3T3 cells. Immunoprecipitation assays using various deletion mutants of MCM2 revealed that gp70 bound to the nuclear localization signal (NLS) 1 (amino acids 18-24) of MCM2, interfered with the function of NLS2 (amino acids 132-152), and suppressed the normal nuclear-import of MCM2. Cytoplasmic MCM2 reduced the activity of protein phosphatase 2A (PP2A) leading to the subsequent hyperphosphorylation of DNA-dependent protein kinase (DNA-PK). Phosphorylated DNA-PK exhibited elevated kinase activity to phosphorylate P53, thereby up-regulating p53-dependent apoptosis. An apoptosis-enhancing domain was identified in the C-terminal portion (amino acids 703-904) of MCM2. Furthermore, simultaneous treatment with FLV and doxorubicin extended the survival of SCID mice bearing 8047 leukemia cells expressing high levels of MCM2. Thus, depending on its subcellular localization, MCM2 plays different roles. It participates in DNA replication in the nucleus as shown previously, and enhances apoptosis in the cytoplasm.	[Abe, Shinya; Kurata, Morito; Suzuki, Shiho; Yamamoto, Kouhei; Kitagawa, Masanobu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan; [Aisaki, Ken-ichi; Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Health Sciences - Japan	Abe, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan.	masa.pth2@tmd.ac.jp	Kurata, Morito/AAD-3172-2019	Kurata, Morito/0000-0002-1242-6709	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21590432]; Ministry of Health, Labour and Welfare of Japan [H18-Kagaku-001]; Grants-in-Aid for Scientific Research [23790392] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid (21590432) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Health Sciences Research Grant H18-Kagaku-001 from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi RO, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001141; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Dudderidge TJ, 2005, CLIN CANCER RES, V11, P2510, DOI 10.1158/1078-0432.CCR-04-1776; Feng PH, 2007, PLOS PATHOG, V3, P1849, DOI 10.1371/journal.ppat.0030174; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Going JJ, 2002, GUT, V50, P373, DOI 10.1136/gut.50.3.373; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hasegawa M, 2005, LEUKEMIA RES, V29, P933, DOI 10.1016/j.leukres.2005.01.016; Hasegawa M, 2009, LEUKEMIA RES, V33, P1100, DOI 10.1016/j.leukres.2008.10.025; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 2001, J BIOL CHEM, V276, P42744, DOI 10.1074/jbc.M106861200; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Kanai R, 2012, JNCI-J NATL CANCER I, V104, P42, DOI 10.1093/jnci/djr509; Kanno J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-64; Kennedy AL, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-16; Kitagawa M, 1998, LEUKEMIA, V12, P486, DOI 10.1038/sj.leu.2400980; Kitagawa M, 2002, J VIROL, V76, P7790, DOI 10.1128/JVI.76.15.7790-7798.2002; KITAGAWA M, 1986, CANCER RES, V46, P3034; KITAGAWA M, 1995, BLOOD, V86, P1557, DOI 10.1182/blood.V86.4.1557.bloodjournal8641557; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Madine MA, 2000, J STRUCT BIOL, V129, P198, DOI 10.1006/jsbi.2000.4218; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Meng MV, 2001, CLIN CANCER RES, V7, P2712; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Qian ZK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000814; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708; Tanaka K, 2004, INT J RADIAT BIOL, V80, P673, DOI 10.1080/09553000400005502; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Wang QH, 2009, NEOPLASIA, V11, P1012, DOI 10.1593/neo.09720; Woo RA, 2002, EMBO J, V21, P3000, DOI 10.1093/emboj/cdf307; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Yamaguchi S, 2005, LEUKEMIA RES, V29, P307, DOI 10.1016/j.leukres.2004.07.003; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	60	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40129	10.1371/journal.pone.0040129	http://dx.doi.org/10.1371/journal.pone.0040129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768239	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100211
J	Chen, L; Ge, XC; Wang, XJ; Patel, JR; Xu, P				Chen, Lei; Ge, Xiuchun; Wang, Xiaojing; Patel, Jenishkumar R.; Xu, Ping			SpxA1 Involved in Hydrogen Peroxide Production, Stress Tolerance and Endocarditis Virulence in Streptococcus sanguinis	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL CONTROL; BACILLUS-SUBTILIS; INFECTIVE ENDOCARDITIS; RNA-POLYMERASE; PYRUVATE OXIDASE; COMPETENCE DEVELOPMENT; LACTOCOCCUS-LACTIS; BIOFILM FORMATION; OXIDATIVE STRESS; TERMINAL DOMAIN	Streptococcus sanguinis is one of the most common agents of infective endocarditis. Spx proteins are a group of global regulators that negatively or positively control global transcription initiation. In this study, we characterized the spxA1 gene in S. sanguinis SK36. The spxA1 null mutant displayed opaque colony morphology, reduced hydrogen peroxide (H2O2) production, and reduced antagonistic activity against Streptococcus mutans UA159 relative to the wild type strain. The Delta spxA1 mutant also demonstrated decreased tolerance to high temperature, acidic and oxidative stresses. Further analysis revealed that Delta spxA1 also exhibited a similar to 5-fold reduction in competitiveness in an animal model of endocarditis. Microarray studies indicated that expression of several oxidative stress genes was downregulated in the Delta spxA1 mutant. The expression of spxB and nox was significantly decreased in the Delta spxA1 mutant compared with the wild type. These results indicate that spxA1 plays a major role in H2O2 production, stress tolerance and endocarditis virulence in S. sanguinis SK36. The second spx gene, spxA2, was also found in S. sanguinis SK36. The spxA2 null mutant was found to be defective for growth under normal conditions and showed sensitivity to high temperature, acidic and oxidative stresses.	[Chen, Lei; Ge, Xiuchun; Wang, Xiaojing; Patel, Jenishkumar R.; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA USA	Virginia Commonwealth University	Chen, L (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	pxu@vcu.edu			National Institutes of Health [R01DE018138]; Virginia Commonwealth University Presidential Research Incentive Program (PRIP) [144602-3]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University Presidential Research Incentive Program (PRIP); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE018138 from the National Institutes of Health (PX) and in part, by Virginia Commonwealth University Presidential Research Incentive Program (PRIP) 144602-3 (PX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Caufield PW, 2000, INFECT IMMUN, V68, P4018, DOI 10.1128/IAI.68.7.4018-4023.2000; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Frees D, 2001, MOL MICROBIOL, V41, P93, DOI 10.1046/j.1365-2958.2001.02503.x; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; HERZBERG MC, 1992, INFECT IMMUN, V60, P4809, DOI 10.1128/IAI.60.11.4809-4818.1992; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; KILIAN M, 1981, INFECT IMMUN, V31, P868, DOI 10.1128/IAI.31.3.868-873.1981; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Liu JJ, 2000, MOL MICROBIOL, V37, P885, DOI 10.1046/j.1365-2958.2000.02053.x; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Nakano MM, 2000, MOL MICROBIOL, V37, P869, DOI 10.1046/j.1365-2958.2000.02052.x; Nakano MM, 2002, MOL MICROBIOL, V44, P1341, DOI 10.1046/j.1365-2958.2002.02963.x; Nakano MM, 2001, MOL MICROBIOL, V42, P383, DOI 10.1046/j.1365-2958.2001.02639.x; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Prabhu RM, 2005, EUR J CLIN MICROBIOL, V24, P832, DOI 10.1007/s10096-005-0037-3; Ramos-Montanez S, 2008, MOL MICROBIOL, V67, P729, DOI 10.1111/j.1365-2958.2007.06082.x; Reyes DY, 2008, MOL MICROBIOL, V69, P765, DOI 10.1111/j.1365-2958.2008.06330.x; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Turlan C, 2009, MOL MICROBIOL, V73, P492, DOI 10.1111/j.1365-2958.2009.06789.x; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Turner LS, 2009, MICROBIOL-SGM, V155, P2573, DOI 10.1099/mic.0.024513-0; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	41	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40034	10.1371/journal.pone.0040034	http://dx.doi.org/10.1371/journal.pone.0040034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768210	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100182
J	Chou, SD; Prince, T; Gong, JL; Calderwood, SK				Chou, Shiuh-Dih; Prince, Thomas; Gong, Jianlin; Calderwood, Stuart K.			mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; PHOSPHOPROTEOMIC ANALYSIS; BINDING PROTEIN; DNA-BINDING; PHOSPHORYLATION; FACTOR-1; THERMOTOLERANCE; AUTOPHAGY; KINASE; CELLS	The target of rapamycin (TOR) is a high molecular weight protein kinase that regulates many processes in cells in response to mitogens and variations in nutrient availability. Here we have shown that mTOR in human tissue culture cells plays a key role in responses to proteotoxic stress and that reduction in mTOR levels by RNA interference leads to increase sensitivity to heat shock. This effect was accompanied by a drastic reduction in ability to synthesize heat shock proteins (HSP), including Hsp70, Hsp90 and Hsp110. As HSP transcription is regulated by heat shock transcription factor 1 (HSF1), we examined whether mTOR could directly phosphorylate this factor. Indeed, we determined that mTOR could directly phosphorylate HSF1 on serine 326, a key residue in transcriptional activation. HSF1 was phosphorylated on S326 immediately after heat shock and was triggered by other cell stressors including proteasome inhibitors and sodium arsenite. Null mutation of S326 to alanine led to loss of ability to activate an HSF1-regulated promoter-reporter construct, indicating a direct role for mTOR and S326 in transcriptional regulation of HSP genes during stress. As mTOR is known to exist in at least two intracellular complexes, mTORC1 and mTOR2 we examined which complex might interact with HSF1. Indeed mTORC1 inhibitor rapamycin prevented HSF1-S326 phosphorylation, suggesting that this complex is involved in HSF1 regulation in stress. Our experiments therefore suggest a key role for mTORC1 in transcriptional responses to proteotoxic stress.	[Chou, Shiuh-Dih; Prince, Thomas; Calderwood, Stuart K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA; [Gong, Jianlin] Boston Univ, Med Ctr, Dept Hematol & Med Oncol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Chou, SD (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA.	scalderw@bidmc.harvard.edu		Gong, Jianlin/0000-0003-0910-014X	National Institutes of Health [RO-1CA047407, R01CA119045, RO-1CA094397]; NATIONAL CANCER INSTITUTE [R01CA047407, R01CA119045, R01CA094397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health research grants RO-1CA047407, R01CA119045 and RO-1CA094397. The funders had no role in study design. data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Calderwood S K, 2010, Sign Transduct Insights, V2, P13; Calderwood SK, 2012, J CELL BIOCHEM, V113, P1096, DOI 10.1002/jcb.23461; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Clemens MJ, 2001, PROG MOLEC, V27, P57; CRAIG EA, 1985, SCIENCE, V230, P800, DOI 10.1126/science.230.4727.800-a; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hayashida N, 2010, EMBO J, V29, P3459, DOI 10.1038/emboj.2010.225; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; LANKS KW, 1986, J CELL PHYSIOL, V129, P385, DOI 10.1002/jcp.1041290317; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; Li GC, 2009, INT J HYPERTHER, V25, P258, DOI 10.1080/02656730902862106; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Petroulakis E, 2007, Br J Cancer, V96 Suppl, pR11; SANDERS MM, 1991, J CELL PHYSIOL, V146, P180, DOI 10.1002/jcp.1041460123; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028950; Zhang Y, 2011, METHODS MOL BIOL, V787, P21, DOI 10.1007/978-1-61779-295-3_2; Zhang Y, 2011, INT J HYPERTHER, V27, P409, DOI 10.3109/02656736.2011.552087	36	154	156	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39679	10.1371/journal.pone.0039679	http://dx.doi.org/10.1371/journal.pone.0039679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768106	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100076
J	Hirschhausen, N; Schlesier, T; Peters, G; Heilmann, C				Hirschhausen, Nina; Schlesier, Tim; Peters, Georg; Heilmann, Christine			Characterization of the Modular Design of the Autolysin/Adhesin Aaa from Staphylococcus Aureus	PLOS ONE			English	Article							FIBRONECTIN-BINDING-PROTEINS; WALL-ASSOCIATED PROTEIN; LISTERIA-MONOCYTOGENES; EUKARYOTIC CELLS; SURFACE PROTEIN; BACTERIAL; DOMAIN; GENE; EPIDERMIDIS; INFECTIONS	Background: Staphylococcus aureus is a frequent cause of serious and life-threatening infections, such as endocarditis, osteomyelitis, pneumonia, and sepsis. Its adherence to various host structures is crucial for the establishment of diseases. Adherence may be mediated by a variety of adhesins, among them the autolysin/adhesins Atl and Aaa. Aaa is composed of three N-terminal repeated sequences homologous to a lysin motif (LysM) that can confer cell wall attachment and a C-terminally located cysteine, histidine-dependent amidohydrolase/peptidase (CHAP) domain having bacteriolytic activity in many proteins. Methodology/Principal Findings: Here, we show by surface plasmon resonance that the LysM domain binds to fibrinogen, fibronectin, and vitronectin respresenting a novel adhesive function for this domain. Moreover, we demonstrated that the CHAP domain not only mediates the bacteriolytic activity, but also adherence to fibrinogen, fibronectin, and vitronectin, thus demonstrating for the first time an adhesive function for this domain. Adherence of an S. aureus aaa mutant and the complemented aaa mutant is slightly decreased and increased, respectively, to vitronectin, but not to fibrinogen and fibronectin, which might at least in part result from an increased expression of atl in the aaa mutant. Furthermore, an S. aureus atl mutant that showed enhanced adherence to fibrinogen, fibronectin, and endothelial cells also demonstrated increased aaa expression and production of Aaa. Thus, the redundant functions of Aaa and Atl might at least in part be interchangeable. Lastly, RT-PCR and zymographic analysis revealed that aaa is negatively regulated by the global virulence gene regulators agr and SarA. Conclusions/Significance: We identified novel functions for two widely distributed protein domains, LysM and CHAP, i.e. the adherence to the extracellular matrix proteins fibrinogen, fibronectin, and vitronectin. The adhesive properties of Aaa might promote S. aureus colonization of host extracellular matrix and tissue, suggesting a role for Aaa in the pathogenesis of S. aureus infections.	[Hirschhausen, Nina; Schlesier, Tim; Peters, Georg; Heilmann, Christine] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Peters, Georg; Heilmann, Christine] Univ Hosp Munster, Interdisciplinary Ctr Clin Res, Munster, Germany	University of Munster; University of Munster	Hirschhausen, N (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	heilmac@uni-muenster.de			German National Research Foundation (DFG) [He 3546/2-1]; Graduate School (Munster, Germany) of the DFG [GRK 1409]	German National Research Foundation (DFG)(German Research Foundation (DFG)); Graduate School (Munster, Germany) of the DFG	This study was supported by a grant of the German National Research Foundation (DFG) (http://www.dfg.de) to C. H. (He 3546/2-1) and (in part) by the Graduate School GRK 1409 (Munster, Germany) of the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allignet J, 2002, FEMS MICROBIOL LETT, V213, P193, DOI 10.1016/S0378-1097(02)00813-3; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; BRUCKNER R, 1993, J BACTERIOL, V175, P851; BUBERT A, 1992, J BACTERIOL, V174, P8166, DOI 10.1128/JB.174.24.8166-8171.1992; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; CHEUNG AL, 1994, INFECT IMMUN, V62, P1719, DOI 10.1128/IAI.62.5.1719-1725.1994; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; Gibson T. J., 1984, THESIS CAMBRIDGE U C; GOTZ F, 1987, FEMS MICROBIOL LETT, V40, P285, DOI 10.1016/0378-1097(87)90391-0; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gotz F, 2000, INFECT ASS INDWELLIN, P55; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Hayashi Masao, 1994, Journal of Tissue Culture Methods, V16, P193, DOI 10.1007/BF01540649; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Heilmann C, 2005, INFECT IMMUN, V73, P4793, DOI 10.1128/IAI.73.8.4793-4802.2005; Heilmann C., 2010, BACTERIAL SIGNALING, P7; Hell W, 1998, MOL MICROBIOL, V29, P871, DOI 10.1046/j.1365-2958.1998.00983.x; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Milohanic E, 2001, MOL MICROBIOL, V39, P1212, DOI 10.1046/j.1365-2958.2001.02208.x; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLEIFER KH, 1982, INT J SYST BACTERIOL, V32, P153, DOI 10.1099/00207713-32-2-153; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Ziebuhr W, 2001, Contrib Microbiol, V8, P102; Zou YM, 2010, COMPUT BIOL CHEM, V34, P251, DOI 10.1016/j.compbiolchem.2010.07.001	52	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40353	10.1371/journal.pone.0040353	http://dx.doi.org/10.1371/journal.pone.0040353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768285	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100259
J	Leal, E; Casseb, J; Hendry, M; Busch, MP; Diaz, RS				Leal, Elcio; Casseb, Jorge; Hendry, Michael; Busch, Michael P.; Diaz, Ricardo Sobhie			Relaxation of Adaptive Evolution during the HIV-1 Infection Owing to Reduction of CD4+T Cell Counts	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; CORECEPTOR USAGE; ENVELOPE; PHENOTYPE; GENE; NEUTRALIZATION; TRANSMISSION; VARIANTS; TROPISM	Background: The first stages of HIV-1 infection are essential to establish the diversity of virus population within host. It has been suggested that adaptation to host cells and antibody evasion are the leading forces driving HIV evolution at the initial stages of AIDS infection. In order to gain more insights on adaptive HIV-1 evolution, the genetic diversity was evaluated during the infection time in individuals contaminated by the same viral source in an epidemic cluster. Multiple sequences of V3 loop region of the HIV-1 were serially sampled from four individuals: comprising a single blood donor, two blood recipients, and another sexually infected by one of the blood recipients. The diversity of the viral population within each host was analyzed independently in distinct time points during HIV-1 infection. Results: Phylogenetic analysis identified multiple HIV-1 variants transmitted through blood transfusion but the establishing of new infections was initiated by a limited number of viruses. Positive selection (d(N)/d(S)>1) was detected in the viruses within each host in all time points. In the intra-host viruses of the blood donor and of one blood recipient, X4 variants appeared respectively in 1993 and 1989. In both patients X4 variants never reached high frequencies during infection time. The recipient, who X4 variants appeared, developed AIDS but kept narrow and constant immune response against HIV-1 during the infection time. Conclusion: Slowing rates of adaptive evolution and increasing diversity in HIV-1 are consequences of the CD4+ T cells depletion. The dynamic of R5 to X4 shift is not associated with the initial amplitude of humoral immune response or intensity of positive selection.	[Leal, Elcio] Fed Univ Para, Inst Biotechnol, BR-66059 Belem, Para, Brazil; [Casseb, Jorge] Univ Sao Paulo, Inst Trop Med, Sao Paulo, SP, Brazil; [Hendry, Michael] CDC, Ctr Dis Control & Prevent, Branch Lab, Atlanta, GA 30333 USA; [Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Busch, Michael P.] Blood Syst Inc, San Francisco, CA USA; [Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; Vitalant; Universidade Federal de Sao Paulo (UNIFESP)	Leal, E (corresponding author), Fed Univ Para, Inst Biotechnol, BR-66059 Belem, Para, Brazil.	elcioleal@gmail.br	Leal, Elcio/J-6236-2016; casseb, jorge/X-5219-2019; Leal, Elcio/M-5275-2019; Diaz, Ricardo/K-3978-2012	Leal, Elcio/0000-0003-3463-0492; casseb, jorge/0000-0002-4553-2559; Leal, Elcio/0000-0003-3463-0492; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Foundation for the Support of Research in the State of Sao Paulo) [07/52841-8]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Foundation for the Support of Research in the State of Sao Paulo; grant no. 07/52841-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Bunnik EM, 2007, J VIROL, V81, P525, DOI 10.1128/JVI.01983-06; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Davenport MP, 2002, TRENDS MICROBIOL, V10, P275, DOI 10.1016/S0966-842X(02)02370-3; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Diaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014; Diaz RS, 1997, AIDS, V11, P415, DOI 10.1097/00002030-199704000-00003; English S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-54; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KOOT M, 1993, J INFECT DIS, V168, P733, DOI 10.1093/infdis/168.3.733; Leal ED, 2004, VIROLOGY, V325, P181, DOI 10.1016/j.virol.2004.04.004; Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Lemey P, 2005, J VIROL, V79, P11981, DOI 10.1128/JVI.79.18.11981-11989.2005; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Rij RP, 2003, VIROLOGY, V314, P451, DOI 10.1016/S0042-6822(03)00454-9; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Yang ZH, 2000, GENETICS, V155, P431; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	40	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39776	10.1371/journal.pone.0039776	http://dx.doi.org/10.1371/journal.pone.0039776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768122	Green Published, gold			2022-12-25	WOS:000305892100092
J	Lipschutz-Powell, D; Woolliams, JA; Bijma, P; Doeschl-Wilson, AB				Lipschutz-Powell, Debby; Woolliams, John A.; Bijma, Piter; Doeschl-Wilson, Andrea B.			Indirect Genetic Effects and the Spread of Infectious Disease: Are We Capturing the Full Heritable Variation Underlying Disease Prevalence?	PLOS ONE			English	Article							BIOLOGICAL GROUPS; SELECTION; RESISTANCE; PARAMETERS; EVOLUTION; HUMANS; MODELS; ORIGIN	Reducing disease prevalence through selection for host resistance offers a desirable alternative to chemical treatment. Selection for host resistance has proven difficult, however, due to low heritability estimates. These low estimates may be caused by a failure to capture all the relevant genetic variance in disease resistance, as genetic analysis currently is not taylored to estimate genetic variation in infectivity. Host infectivity is the propensity of transmitting infection upon contact with a susceptible individual, and can be regarded as an indirect effect to disease status. It may be caused by a combination of physiological and behavioural traits. Though genetic variation in infectivity is difficult to measure directly, Indirect Genetic Effect (IGE) models, also referred to as associative effects or social interaction models, allow the estimation of this variance from more readily available binary disease data (infected/non-infected). We therefore generated binary disease data from simulated populations with known amounts of variation in susceptibility and infectivity to test the adequacy of traditional and IGE models. Our results show that a conventional model fails to capture the genetic variation in infectivity inherent in populations with simulated infectivity. An IGE model, on the other hand, does capture some of the variation in infectivity. Comparison with expected genetic variance suggests that there is scope for further methodological improvement, and that potential responses to selection may be greater than values presented here. Nonetheless, selection using an index of estimated direct and indirect breeding values was shown to have a greater genetic selection differential and reduced future disease risk than traditional selection for resistance only. These findings suggest that if genetic variation in infectivity substantially contributes to disease transmission, then breeding designs which explicitly incorporate IGEs might help reduce disease prevalence.	[Lipschutz-Powell, Debby; Woolliams, John A.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Lipschutz-Powell, Debby; Woolliams, John A.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Bijma, Piter] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Wageningen University & Research	Lipschutz-Powell, D (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	debby.powell@roslin.ed.ac.uk	Lipschutz-Powell, Debby/I-3154-2012	Wilson, Andrea/0000-0002-2658-6973; Lipschutz-Powell, Debby/0000-0003-2845-3557	Biotechnology and Biological Sciences Research Council (BBSRC); Cobb-Vantress Incorporated; Cobb-Vantress Incorporated as part of the BioScience KTN CASE PhD studentship award; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/D/05191133] Funding Source: researchfish; BBSRC [BBS/E/D/05191133, BBS/E/D/20211554] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cobb-Vantress Incorporated; Cobb-Vantress Incorporated as part of the BioScience KTN CASE PhD studentship award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk; BioScience KTN CASE PhD studentship award) and Cobb-Vantress Incorporated (http://www.cobb-vantress.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partly funded by Cobb-Vantress Incorporated as part of the BioScience KTN CASE PhD studentship award. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDERSON RM, 2006, INFECT DIS HUMANS; Bergsma R, 2008, GENETICS, V178, P1559, DOI 10.1534/genetics.107.084236; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Bijma P, 2010, GENETICS, V186, P1013, DOI 10.1534/genetics.110.120493; Bishop SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008940; Chen J, 2010, MICROB ECOL, V60, P479, DOI 10.1007/s00248-010-9634-5; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Demeler J, 2010, VET PARASITOL, V174, P58, DOI 10.1016/j.vetpar.2010.08.020; DEMPSTER ER, 1950, GENETICS, V35, P212; Denison RF, 2003, Q REV BIOL, V78, P145, DOI 10.1086/374951; Doeschl-Wilson AB, 2011, GENETICS, V188, P683, DOI 10.1534/genetics.110.125625; Doeschl-Wilson AB, 2008, GENET SEL EVOL, V40, P241, DOI 10.1051/gse:2008001; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gilmour A., 2006, ASREML USER GUIDE RE; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; GRIFFING B, 1976, GENETICS, V82, P723; Houston RD, 2010, HEREDITY, V105, P318, DOI 10.1038/hdy.2009.171; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Keeling, 2008, MODELLING INFECT DIS; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Muir WM, 1998, POULTRY SCI, V77, P1781, DOI 10.1093/ps/77.12.1781; Nath M, 2004, J ANIM SCI, V82, P384; Pullinger GD, 2010, INFECT IMMUN, V78, P372, DOI 10.1128/IAI.01203-09; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Ramirez-Valverde R, 2001, J ANIM SCI, V79, P333; Van Dyken JD, 2011, AM NAT, V177, P288, DOI 10.1086/658365; Vazquez AI, 2009, J DAIRY SCI, V92, P739, DOI 10.3168/jds.2008-1325; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yates A, 2006, P ROY SOC B-BIOL SCI, V273, P3075, DOI 10.1098/rspb.2006.3681	33	30	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39551	10.1371/journal.pone.0039551	http://dx.doi.org/10.1371/journal.pone.0039551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768088	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100059
J	Slanina, H; Hebling, S; Hauck, CR; Schubert-Unkmeir, A				Slanina, Heiko; Hebling, Sabrina; Hauck, Christoph R.; Schubert-Unkmeir, Alexandra			Cell Invasion by Neisseria meningitidis Requires a Functional Interplay between the Focal Adhesion Kinase, Src and Cortactin	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; TYROSINE-KINASE; ESCHERICHIA-COLI; YERSINIA-PSEUDOTUBERCULOSIS; ARP2/3 COMPLEX; F-ACTIN; INTEGRIN; PROTEIN; FIBRONECTIN	Entry of Neisseria meningitidis (the meningococcus) into human brain microvascular endothelial cells (HBMEC) is mediated by fibronectin or vitronectin bound to the surface protein Opc forming a bridge to the respective integrins. This interaction leads to cytoskeletal rearrangement and uptake of meningococci. In this study, we determined that the focal adhesion kinase (FAK), which directly associates with integrins, is involved in integrin-mediated internalization of N. meningitidis in HBMEC. Inhibition of FAK activity by the specific FAK inhibitor PF 573882 reduced Opc-mediated invasion of HBMEC more than 90%. Moreover, overexpression of FAK mutants that were either impaired in the kinase activity or were not capable of autophosphorylation or overexpression of the dominant-negative version of FAK (FRNK) blocked integrin-mediated internalization of N. meningitidis. Importantly, FAK-deficient fibroblasts were significantly less invaded by N. meningitidis. Furthermore, N. meningitidis induced tyrosine phosphorylation of several host proteins including the FAK/Src complex substrate cortactin. Inhibition of cortactin expression by siRNA silencing and mutation of critical amino acid residues within cortactin, that encompass Arp2/3 association and dynamin binding, significantly reduced meningococcal invasion into eukaryotic cells suggesting that both domains are critical for efficient uptake of N. meningitidis into eukaryotic cells. Together, these results indicate that N. meningitidis exploits the integrin signal pathway for its entry and that FAK mediates the transfer of signals from activated integrins to the cytoskeleton. A cooperative interplay between FAK, Src and cortactin then enables endocytosis of N. meningitidis into host cells.	[Slanina, Heiko; Hebling, Sabrina; Schubert-Unkmeir, Alexandra] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany; [Hauck, Christoph R.] Univ Konstanz, Dept Cell Biol, Constance, Germany	University of Wurzburg; University of Konstanz	Slanina, H (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany.	aunkmeir@hygiene.uni-wuerzburg.de			German Research Foundation (DFG) [SCHU 2394/1-2]; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by grants from the German Research Foundation (DFG) (SCHU 2394/1-2) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1995, TRENDS MICROBIOL, V3, P186, DOI 10.1016/S0966-842X(00)88918-0; Agerer F, 2004, J MICROBIOL METH, V59, P23, DOI 10.1016/j.mimet.2004.05.008; Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Cantarelli VV, 2002, INFECT IMMUN, V70, P2206, DOI 10.1128/IAI.70.4.2206-2209.2002; Cantarelli VV, 2000, INFECT IMMUN, V68, P382, DOI 10.1128/IAI.68.1.382-386.2000; Chen XM, 2003, GASTROENTEROLOGY, V125, P216, DOI 10.1016/S0016-5085(03)00662-0; Cho BA, 2010, INFECT IMMUN, V78, P1915, DOI 10.1128/IAI.01316-09; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kriz P, 1995, EPIDEMIOL INFECT, V115, P411, DOI 10.1017/S0950268800058568; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; SAWAYA R, 1985, NEUROSURGERY, V16, P161, DOI 10.1227/00006123-198502000-00006; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schmitt C, 2007, J BACTERIOL, V189, P7968, DOI 10.1128/JB.00851-07; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Selbach M, 2005, TRENDS MICROBIOL, V13, P181, DOI 10.1016/j.tim.2005.02.007; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Slanina H, 2010, INFECT IMMUN, V78, P1905, DOI 10.1128/IAI.01267-09; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; VIRJI M, 1992, MOL MICROBIOL, V6, P2785, DOI 10.1111/j.1365-2958.1992.tb01458.x; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WHALEN CM, 1995, JAMA-J AM MED ASSOC, V273, P390, DOI 10.1001/jama.273.5.390; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 2001, J CELL SCI, V114, P3583; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	72	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39613	10.1371/journal.pone.0039613	http://dx.doi.org/10.1371/journal.pone.0039613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768099	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100069
J	van der Werff, SD; Polman, K; Ponce, MC; Twisk, JWR; Diaz, RJ; Gorbea, MB; Van der Stuyft, P				van der Werff, Suzanne D.; Polman, Katja; Ponce, Maiza Campos; Twisk, Jos W. R.; Junco Diaz, Raquel; Bonet Gorbea, Mariano; Van der Stuyft, Patrick			Childhood Atopic Diseases and Early Life Circumstances: An Ecological Study in Cuba	PLOS ONE			English	Article							ECONOMIC-CRISIS; CARDIOVASCULAR-DISEASE; WORLDWIDE VARIATIONS; PRENATAL EXPOSURE; DUTCH FAMINE; HEALTH-CARE; ASTHMA; IMPACT; PREVALENCE; ALLERGIES	Background: Children are especially vulnerable during periods of resource shortage such as economic embargoes. They are likely to suffer most from poor nutrition, infectious diseases, and other ensuing short-term threats. Moreover, early life circumstances can have important consequences for long-term health. We examined the relationship between early childhood exposure to the Cuban economic situation in the nineties and the occurrence of atopic diseases later in childhood. Methodology/Principal Findings: A cross-sectional study of 1321 primary schoolchildren aged 4-14 was conducted in two Cuban municipalities. Asthma, allergic rhinoconjunctivitis and atopic dermatitis were diagnosed using the International Study of Asthma and Allergies in Childhood questionnaire. Children were divided into three groups of exposure to the economic situation in the nineties according to birth date: (1) unexposed; (2) exposed during infancy; (3) exposed during infancy and early childhood. Associations were assessed using multiple logistic regression models. Exposure during infancy had a significant inverse association with the occurrence of asthma (OR 0.56, 95% CI 0.33-0.94) and allergic rhinoconjunctivitis (OR 0.46, 95% CI 0.25-0.85). The associations were stronger after longer exposure, i.e. during infancy and early childhood, for asthma (OR 0.40, 95% CI 0.17-0.95) and allergic rhinoconjunctivitis (OR 0.29, 95% CI 0.11-0.77). No significant associations were found for atopic dermatitis. Conclusions/Significance: Exposure to the economic situation in the nineties during infancy and early childhood was inversely associated with asthma and allergic rhinoconjunctivitis occurrence later in childhood. We hypothesize that factors related to this period, such as infectious diseases and undernutrition, may have an attenuating effect on atopic disease development. The exact cause and underlying mechanisms need to be further elucidated.	[van der Werff, Suzanne D.; Polman, Katja; Ponce, Maiza Campos; Twisk, Jos W. R.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [van der Werff, Suzanne D.; Polman, Katja] Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Junco Diaz, Raquel; Bonet Gorbea, Mariano] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Van der Stuyft, Patrick] Prince Leopold Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Vrije Universiteit Amsterdam; Institute of Tropical Medicine (ITM); Vrije Universiteit Amsterdam; Institute of Tropical Medicine (ITM); Ghent University	van der Werff, SD (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.	suzanne.vander.werff@vu.nl	van der Werff, Suzanne D./ABF-8976-2021	van der Werff, Suzanne D./0000-0001-7162-3844; Campos Ponce, Maiza/0000-0003-1700-4756	Directorate-General for Development Cooperation (DGDC) [ITM-DGD FA2 920501]	Directorate-General for Development Cooperation (DGDC)	This work was supported by a grant of the Directorate-General for Development Cooperation (DGDC) within the Framework Agreement 2 (2003-2007) DGDC-ITM 'IPK/INHEM/CUBA' project [ITM-DGD FA2 920501]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel-Smith B, 1986, Health Policy Plan, V1, P202, DOI 10.1093/heapol/1.3.202; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barker D. J. P., 2004, Public health nutrition, P302; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P189; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P189; De Vos P, 2005, INT J HEALTH SERV, V35, P189, DOI 10.2190/M72R-DBKD-2XWV-HJWB; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Eisenbarth SC, 2004, CURR OPIN PEDIATR, V16, P659, DOI 10.1097/01.mop.0000145920.00101.e4; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Garfield R, 1997, AM J PUBLIC HEALTH, V87, P15, DOI 10.2105/AJPH.87.1.15; Garfield R, 1997, J Am Med Womens Assoc (1972), V52, P181; Garfield R, 1995, B NEW YORK ACAD MED, V72, P454; Garfield R, 1997, J AM MED WOMEN ASSOC, V52, P198; Hedges TR, 1997, SURV OPHTHALMOL, V41, P341, DOI 10.1016/S0039-6257(96)00008-2; Hopkins S, 2006, HEALTH POLICY, V75, P347, DOI 10.1016/j.healthpol.2005.04.002; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Koski KG, 2001, ANNU REV NUTR, V21, P297, DOI 10.1146/annurev.nutr.21.1.297; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P36, DOI 10.1053/j.spid.2006.01.002; Lopuhaa CE, 2000, THORAX, V55, P555, DOI 10.1136/thorax.55.7.555; Ministerio de Salud Publica, 2000, AN EST SAL CUB 2000; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nayeri K, 2005, INT J HEALTH SERV, V35, P797, DOI 10.2190/C1QG-6Y0X-CJJA-863H; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Rodriguez-Ojea A, 2002, PUBLIC HEALTH NUTR, V5, P129, DOI 10.1079/PHN2001284; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Scrimshaw NS, 2003, J NUTR, V133, p316S, DOI 10.1093/jn/133.1.316S; Shaheen SO, 1999, THORAX, V54, P396, DOI 10.1136/thx.54.5.396; Shore SA, 2006, PHARMACOL THERAPEUT, V110, P83, DOI 10.1016/j.pharmthera.2005.10.002; Sonis J, 1998, Fam Med, V30, P584; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Von Mutius E, 1998, CLIN EXP ALLERGY, V28, P45; Waters H, 2004, INT J EPIDEMIOL, V33, P589, DOI 10.1093/ije/dyh074; Waters H, 2003, HEALTH POLICY PLANN, V18, P172, DOI 10.1093/heapol/czg022; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x; Wordemann M, 2006, ALLERGY, V61, P1125, DOI 10.1111/j.1398-9995.2006.01129.x	44	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39892	10.1371/journal.pone.0039892	http://dx.doi.org/10.1371/journal.pone.0039892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768156	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100125
J	Wang, L; Weng, XC; He, S				Wang, Lan; Weng, Xuchu; He, Sheng			Perceptual Grouping without Awareness: Superiority of Kanizsa Triangle in Breaking Interocular Suppression	PLOS ONE			English	Article							BINOCULAR-RIVALRY; CORTICAL RESPONSES; SALIENT REGIONS; ATTENTION; CONSCIOUSNESS; EXPRESSIONS; INFORMATION; CONTOURS; FEARFUL; VISION	Much information could be processed unconsciously. However, there is no direct evidence on whether perceptual grouping could occur without awareness. To answer this question, we investigated whether a Kanizsa triangle (an example of perceptual grouping) is processed differently from stimuli with the same local components but are ungrouped or weakly grouped. Specifically, using a suppression time paradigm we tested whether a Kanizsa triangle would emerge from interocular continuous flash suppression sooner than control stimuli. Results show a significant advantage of the Kanizsa triangle: the Kanizsa triangle emerged from suppression noise significantly faster than the control stimulus with the local Pacmen randomly rotated (t(9) = -2.78, p = 0.02); and also faster than the control stimulus with all Pacmen rotated 180 degrees (t(11) = -3.20, p<0.01). Additional results demonstrated that the advantage of the grouped Kanizsa triangle could not be accounted for by the faster detection speed at the conscious level for the Kanizsa figures on a dynamic noise background. Our results indicate that certain properties supporting perceptual grouping could be processed in the absence of awareness.	[Wang, Lan; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Wang, Lan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Weng, Xuchu; He, Sheng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wang, Lan; He, Sheng] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hangzhou Normal University; University of Minnesota System; University of Minnesota Twin Cities	Wang, L (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	wengxc@psych.ac.cn; sheng@umn.edu			Natural Science Foundation of China [31070905]; U.S. National Science Foundation [BCS-0818588]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from the Natural Science Foundation of China (31070905) (http://www.nsfc.gov.cn/Portal0/default124.htm) and U.S. National Science Foundation (BCS-0818588) (http://www.nsf.gov/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar A, 2008, HUM BRAIN MAPP, V29, P1313, DOI 10.1002/hbm.20464; Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; BENAV MB, 1992, PERCEPT PSYCHOPHYS, V52, P277, DOI 10.3758/BF03209145; BRAUN J, 1990, PERCEPT PSYCHOPHYS, V48, P45, DOI 10.3758/BF03205010; Conci M, 2007, PERCEPT PSYCHOPHYS, V69, P32, DOI 10.3758/BF03194451; Conci M, 2009, NEUROPSYCHOLOGIA, V47, P726, DOI 10.1016/j.neuropsychologia.2008.11.029; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Meng M, 2007, J VISION, V7, DOI 10.1167/7.13.8; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Moutoussis K, 2005, VISION RES, V45, P2231, DOI 10.1016/j.visres.2005.02.007; Murray SO, 2004, NEURAL NETWORKS, V17, P695, DOI 10.1016/j.neunet.2004.03.010; Pearson J, 2005, CURR BIOL, V15, P2142, DOI 10.1016/j.cub.2005.10.066; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Sobel KV, 2003, VISION RES, V43, P1533, DOI 10.1016/S0042-6989(03)00178-0; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; VANDERZWAN R, 1994, VISUAL NEUROSCI, V11, P823, DOI 10.1017/S0952523800003114; Watanabe M, 2011, SCIENCE, V334, P829, DOI 10.1126/science.1203161; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8	38	44	45	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40106	10.1371/journal.pone.0040106	http://dx.doi.org/10.1371/journal.pone.0040106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768232	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100204
J	Xiang, YT; Wang, G; Hu, C; Guo, T; Ungvari, GS; Kilbourne, AM; Lai, KYC; Si, TM; Zheng, QW; Chen, DF; Fang, YR; Lu, Z; Yang, HC; Hu, J; Chen, ZY; Huang, Y; Sun, J; Wang, XP; Li, HC; Zhang, JB; Chiu, HFK				Xiang, Yu-Tao; Wang, Gang; Hu, Chen; Guo, Tong; Ungvari, Gabor S.; Kilbourne, Amy M.; Lai, Kelly Y. C.; Si, Tian-Mei; Zheng, Qi-Wen; Chen, Da-Fang; Fang, Yi-Ru; Lu, Zheng; Yang, Hai-Chen; Hu, Jian; Chen, Zhi-Yu; Huang, Yi; Sun, Jing; Wang, Xiao-Ping; Li, Hui-Chun; Zhang, Jin-Bei; Chiu, Helen F. K.			Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with the Melancholic Subtype of Major Depressive Disorder in China	PLOS ONE			English	Article							NIGELLA-SATIVA SEEDS; 1ST 3 YEARS; OPIOID RECEPTOR; FOOD ALLERGY; MAST-CELLS; DOUBLE-BLIND; PHARMACOLOGICAL CHARACTERIZATION; MOUSE MODEL; THYMOQUINONE; MU	Background: Little has been known about the demographic and clinical features of the melancholic subtype of major depressive disorder (MDD) in Chinese patients. This study examined the frequency of melancholia in Chinese MDD patients and explored its demographic and clinical correlates and prescribing patterns of psychotropic drugs. Methods: A consecutively collected sample of 1,178 patients with MDD were examined in 13 psychiatric hospitals or psychiatric units of general hospitals in China nationwide. The cross-sectional data of patients' demographic and clinical characteristics and prescriptions of psychotropic drugs were recorded using a standardized protocol and data collection procedure. The diagnosis of the melancholic subtype was established using the Mini International Neuropsychiatric Interview (MINI). Medications ascertained included antidepressants, mood stabilizers, antipsychotics and benzodiazepines. Results: Six hundred and twenty nine (53.4%) of the 1,178 patients fulfilled criteria for melancholia. In multiple logistic regression analyses, compared to non-melancholic counterparts, melancholic MDD patients were more likely to be male and receive benzodiazepines, had more frequent suicide ideations and attempts and seasonal depressive episodes, while they were less likely to be employed and receive antidepressants and had less family history of psychiatric disorders and lifetime depressive episodes. Conclusions: The demographic and clinical features of melancholic MDD in Chinese patients were not entirely consistent with those found in Western populations. Compared to non-melancholic MDD patients, melancholic patients presented with different demographic and clinical features, which have implications for treatment decisions.	[Xiang, Yu-Tao; Lai, Kelly Y. C.; Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Xiang, Yu-Tao; Wang, Gang; Hu, Chen; Guo, Tong] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Kilbourne, Amy M.] Vet Adm Ann Arbor Ctr Clin Management Res, Ann Arbor, MI USA; [Kilbourne, Amy M.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; [Si, Tian-Mei] Minist Mental Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Si, Tian-Mei] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Zheng, Qi-Wen; Chen, Da-Fang] Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Fang, Yi-Ru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Lu, Zheng] Tongji Univ, Shanghai Tongji Hosp, Sch Med, Shanghai 200092, Peoples R China; [Yang, Hai-Chen] Shenzhen Mental Hlth Ctr, Div Mood Disorders, Shenzhen, Guangdong, Peoples R China; [Hu, Jian] Harbin Med Univ, First Hosp, Harbin, Heilongjiang Pr, Peoples R China; [Chen, Zhi-Yu] Hangzhou Seventh Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Huang, Yi] Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Sun, Jing] Nanjing Med Univ, Affiliated Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Xiao-Ping] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Li, Hui-Chun] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jin-Bei] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Capital Medical University; University of Notre Dame Australia; University of Michigan System; University of Michigan; Peking University; Peking University; Shanghai Jiao Tong University; Tongji University; Harbin Medical University; Sichuan University; Nanjing Medical University; Central South University; Zhejiang University; Sun Yat Sen University	Xiang, YT (corresponding author), Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	xyutly@gmail.com; gangwangdoc@gmail.com		Zheng, Qiwen/0000-0001-6921-6254	Ministry of Science and Technology of China [2007BAI17B05]; AstraZeneca China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); AstraZeneca China(AstraZeneca)	This study was funded by the National Key Scientific and Technological Projects for the 11th Five-Year from the Ministry of Science and Technology of China (Project Title: Early Diagnostic Assessment and Standardized Treatment Approach for Depression; No. 2007BAI17B05). The study was initiated by the Chinese Society of Psychiatry (CSP) with support from AstraZeneca China. AstraZeneca China had no role in the study design, generating or interpreting the results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Ayman Talatt, 2005, Egypt J Immunol, V12, P95; Abdel-Fattah AFM, 2000, EUR J PHARMACOL, V400, P89, DOI 10.1016/S0014-2999(00)00340-X; Badary OA, 2001, CANCER DETECT PREV, V25, P362; Banerjee S, 2010, NUTR CANCER, V62, P938, DOI 10.1080/01635581.2010.509832; BARBEZAT GO, 1979, S AFR MED J, V55, P502; BOCK SA, 1987, PEDIATRICS, V79, P683; Boskabady MH, 2010, PHYTOMEDICINE, V17, P707, DOI 10.1016/j.phymed.2010.01.002; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Butt MS, 2010, CRIT REV FOOD SCI, V50, P654, DOI 10.1080/10408390902768797; Buyukozturk S, 2005, J ETHNOPHARMACOL, V100, P295, DOI 10.1016/j.jep.2005.03.007; CHAKRAVARTY N, 1993, ANN ALLERGY, V70, P237; El Gazzar M, 2006, BBA-GEN SUBJECTS, V1760, P1088, DOI 10.1016/j.bbagen.2006.03.006; El Gazzar M, 2006, INT IMMUNOPHARMACOL, V6, P1135, DOI 10.1016/j.intimp.2006.02.004; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P583, DOI 10.1007/s10719-010-9302-5; Garcia-Careaga Manuel Jr, 2005, Nutr Clin Pract, V20, P526, DOI 10.1177/0115426505020005526; Gerez IFA, 2010, EXPERT REV CLIN IMMU, V6, P279, DOI 10.1586/ECI.09.82; Ghosheh OA, 1999, J PHARMACEUT BIOMED, V19, P757, DOI 10.1016/S0731-7085(98)00300-8; GUPTA S, 1979, INDIAN J MED RES, V69, P981; Hosseinzadeh H, 2005, MED SCI MONITOR, V11, pBR106; Hosseinzadeh H, 2004, PHYTOMEDICINE, V11, P56, DOI 10.1078/0944-7113-00376; HOUGHTON PJ, 1995, PLANTA MED, V61, P33, DOI 10.1055/s-2006-957994; Isik F, 2011, DIGEST DIS SCI, V56, P721, DOI 10.1007/s10620-010-1333-z; JAFFE G, 1977, J INT MED RES, V5, P195, DOI 10.1177/030006057700500309; Kanter M, 2006, ARCH TOXICOL, V80, P217, DOI 10.1007/s00204-005-0037-1; Lee DKC, 2003, CLIN EXP ALLERGY, V33, P882, DOI 10.1046/j.1365-2222.2003.01705.x; Luccioli S, 2008, PEDIATRICS, V122, pS105, DOI 10.1542/peds.2008-1315n; Lutterodt H, 2010, LWT-FOOD SCI TECHNOL, V43, P1409, DOI 10.1016/j.lwt.2010.04.009; Mainardi T, 2009, J ALLERGY CLIN IMMUN, V123, P283, DOI 10.1016/j.jaci.2008.12.023; Mansour M, 2004, J ENZYM INHIB MED CH, V19, P431, DOI 10.1080/14756360400002072; MENG F, 1993, P NATL ACAD SCI USA, V90, P9954, DOI 10.1073/pnas.90.21.9954; Nikakhlagh S, 2011, AM J OTOLARYNG, V32, P402, DOI 10.1016/j.amjoto.2010.07.019; Padhye Subhash, 2008, Cancer Ther, V6, P495; Perrier C, 2010, CLIN EXP ALLERGY, V40, P153, DOI 10.1111/j.1365-2222.2009.03329.x; Philippe D, 2003, J CLIN INVEST, V111, P1329, DOI 10.1172/JCI200316750; Poonyachoti S, 2001, J NEUROIMMUNOL, V112, P89, DOI 10.1016/S0165-5728(00)00387-8; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Ramadan MF, 2002, AID FOOD240 3 0 CO, P2; Ramesh S, 2008, CLIN REV ALLERG IMMU, V34, P217, DOI 10.1007/s12016-007-8034-1; Rogers TJ, 2003, TRENDS IMMUNOL, V24, P116, DOI 10.1016/S1471-4906(03)00003-6; Schempp CA, 2003, PHYTOMEDICINE, V10, P31, DOI 10.1078/1433-187X-00306; Shahbazian A, 2002, BRIT J PHARMACOL, V135, P741, DOI 10.1038/sj.bjp.0704527; SHOOK JE, 1989, J PHARMACOL EXP THER, V249, P83; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; SIMONIN F, 1994, MOL PHARMACOL, V46, P1015; Sirohi S, 2007, J PHARMACOL EXP THER, V323, P701, DOI 10.1124/jpet.107.127019; STEAD RH, 1989, GASTROENTEROLOGY, V97, P575, DOI 10.1016/0016-5085(89)90627-6; Stead RH, 2006, AUTON NEUROSCI-BASIC, V125, P53, DOI 10.1016/j.autneu.2006.01.002; Vaillancourt F, 2011, J CELL BIOCHEM, V112, P107, DOI 10.1002/jcb.22884; Venkatachallam SKT, 2010, J FOOD SCI TECH MYS, V47, P598, DOI 10.1007/s13197-010-0109-y; Venter C, 2008, ALLERGY, V63, P354, DOI 10.1111/j.1398-9995.2007.01570.x; Verma-Gandhu M, 2007, AM J PHYSIOL-GASTR L, V292, pG344, DOI 10.1152/ajpgi.00318.2006; WANG JB, 1994, FEBS LETT, V338, P217, DOI 10.1016/0014-5793(94)80368-4; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Wood JD, 2004, NEUROGASTROENT MOTIL, V16, P17, DOI 10.1111/j.1743-3150.2004.00554.x; Zuercher AW, 2010, CLIN EXP ALLERGY, V40, P942, DOI 10.1111/j.1365-2222.2010.03460.x; Zuercher AW, 2006, CURR OPIN BIOTECH, V17, P198, DOI 10.1016/j.copbio.2006.01.010	57	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39840	10.1371/journal.pone.0039840	http://dx.doi.org/10.1371/journal.pone.0039840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768140	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100110
J	Fischer, S; Maier, LK; Stoll, B; Brendel, J; Fischer, E; Pfeiffer, F; Dyall-Smith, M; Marchfelder, A				Fischer, Susan; Maier, Lisa-Katharina; Stoll, Britta; Brendel, Jutta; Fischer, Eike; Pfeiffer, Friedhelm; Dyall-Smith, Mike; Marchfelder, Anita			An Archaeal Immune System Can Detect Multiple Protospacer Adjacent Motifs (PAMs) to Target Invader DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOFERAX-VOLCANII; CRISPR RNA; ACQUIRED-RESISTANCE; DYNAMIC PROPERTIES; BACTERIA; DEFENSE; SEQUENCE; REPEATS; GENOME; GENES	The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system provides adaptive and heritable immunity against foreign genetic elements in most archaea and many bacteria. Although this system is widespread and diverse with many subtypes, only a few species have been investigated to elucidate the precise mechanisms for the defense of viruses or plasmids. Approximately 90% of all sequenced archaea encode CRISPR/Cas systems, but their molecular details have so far only been examined in three archaeal species: Sulfolobus solfataricus, Sulfolobus islandicus, and Pyrococcus furiosus. Here, we analyzed the CRISPR/Cas system of Haloferax volcanii using a plasmid-based invader assay. Haloferax encodes a type I-B CRISPR/Cas system with eight Cas proteins and three CRISPR loci for which the identity of protospacer adjacent motifs (PAMs) was unknown until now. We identified six different PAM sequences that are required upstream of the protospacer to permit target DNA recognition. This is only the second archaeon for which PAM sequences have been determined, and the first CRISPR group with such a high number of PAM sequences. Cells could survive the plasmid challenge if their CRISPR/Cas system was altered or defective, e. g. by deletion of the cas gene cassette. Experimental PAM data were supplemented with bioinformatics data on Haloferax and Haloquadratum.	[Fischer, Susan; Maier, Lisa-Katharina; Stoll, Britta; Brendel, Jutta; Fischer, Eike; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany; [Pfeiffer, Friedhelm] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Dyall-Smith, Mike] Charles Sturt Univ, Sch Biomed Sci, Sydney, NSW 2678, Australia	Ulm University; Max Planck Society; Charles Sturt University	Marchfelder, A (corresponding author), Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246; Marchfelder, Anita/0000-0002-1382-1794	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft in the frame of Research Group 1680, "Unravelling the prokaryotic immune system."	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Burns DG, 2004, APPL ENVIRON MICROB, V70, P5258, DOI 10.1128/AEM.70.9.5258-5265.2004; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dyall-Smith M. L., 2008, HALOHANDBOOK; Dyall-Smith ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020968; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett RA, 2011, TRENDS MICROBIOL, V19, P549, DOI 10.1016/j.tim.2011.08.002; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Greve Bo, 2004, Archaea, V1, P231, DOI 10.1155/2004/151926; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nieuwlandt D. T., 1995, P161; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Sambrook J, 2001, MOL CLONING LAB MANU, P633; Santos F, 2010, ENVIRON MICROBIOL, V12, P2965, DOI 10.1111/j.1462-2920.2010.02273.x; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	49	85	109	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33351	33363		10.1074/jbc.M112.377002	http://dx.doi.org/10.1074/jbc.M112.377002			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22767603	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000309602100023
J	Miyajima, D; Hayata, T; Suzuki, T; Hemmi, H; Nakamoto, T; Notomi, T; Amagasa, T; Bottcher, RT; Costell, M; Fassler, R; Ezura, Y; Noda, M				Miyajima, Daisuke; Hayata, Tadayoshi; Suzuki, Takafumi; Hemmi, Hiroaki; Nakamoto, Tetsuya; Notomi, Takuya; Amagasa, Teruo; Boettcher, Ralph T.; Costell, Mercedes; Faessler, Reinhard; Ezura, Yoichi; Noda, Masaki			Profilin1 Regulates Sternum Development and Endochondral Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; SKELETAL DEVELOPMENT; CELL-DIVISION; MICE LACKING; CHONDROCYTES; EXPRESSION; MOUSE; CARTILAGE; GROWTH; PROLIFERATION	Bone development is a dynamic process that requires cell motility and morphological adaptation under the control of actin cytoskeleton. This actin cytoskeleton system is regulated by critical modulators including actin-binding proteins. Among them, profilin1 (Pfn1) is a key player to control actin fiber structure, and it is involved in a number of cellular activities such as migration. During the early phase of body development, skeletal stem cells and osteoblastic progenitor cells migrate to form initial rudiments for future skeletons. During this migration, these cells extend their process based on actin cytoskeletal rearrangement to locate themselves in an appropriate location within microenvironment. However, the role of Pfn1 in regulation of mesenchymal progenitor cells (MPCs) during skeletal development is incompletely understood. Here we examined the role of Pfn1 in skeletal development using a genetic ablation of Pfn1 in MPCs by using Prx1-Cre recombinase. We found that Pfn1 deficiency in MPCs caused complete cleft sternum. Notably, Pfn1-deficient mice exhibited an absence of trabecular bone in the marrow space of appendicular long bone. This phenotype is location-specific, as Pfn1 deficiency did not largely affect osteoblasts in cortical bone. Pfn1 deficiency also suppressed longitudinal growth of long bone. In vitro, Pfn1 deficiency induced retardation of osteoblastic cell migration. These observations revealed that Pfn1 is a critical molecule for the skeletal development, and this could be at least in part associated with the retardation of cell migration	[Hayata, Tadayoshi; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan; [Miyajima, Daisuke; Suzuki, Takafumi; Nakamoto, Tetsuya; Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Tokyo 1138510, Japan; [Miyajima, Daisuke; Amagasa, Teruo] Tokyo Med & Dent Univ, Dept Maxillofacial Surg, Tokyo 1138510, Japan; [Boettcher, Ralph T.; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Costell, Mercedes] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Valencia, Spain	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Max Planck Society; University of Valencia	Hayata, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, 5-45 Yushima 1 Chome, Tokyo 1138510, Japan.	thayata.mph@mri.tmd.ac.jp; ezura.mph@mri.tmd.ac.jp; noda.mph@mri.tmd.ac.jp	Costell, Mercedes/H-7850-2015; Ezura, Yoichi/L-9485-2016; Hayata, Tadayoshi/AAE-9712-2021	Costell, Mercedes/0000-0001-6146-996X; 	Grants-in-Aid for Scientific Research [22591680] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aizawa T, 2001, J ORTHOP RES, V19, P785, DOI 10.1016/S0736-0266(00)00078-4; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; CHEN JM, 1952, J ANAT, V86, P373; CHEN JM, 1952, J ANAT, V86, P387; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Durland JL, 2008, J ANAT, V212, P590, DOI 10.1111/j.1469-7580.2008.00879.x; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; GALOTTO M, 1994, J BONE MINER RES, V9, P1239; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawaguchi J, 2002, BIOTECHNIQUES, V32, P66, DOI 10.2144/02321st02; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2007, ANN NY ACAD SCI, V1116, P59, DOI 10.1196/annals.1402.059; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Modder UI, 2008, J CELL BIOCHEM, V103, P393, DOI 10.1002/jcb.21423; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Roach HI, 1996, CONNECT TISSUE RES, V35, P85, DOI 10.3109/03008209609029178; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Torre M, 2012, EUR J CARDIO-THORAC, V41, P4, DOI 10.1016/j.ejcts.2011.05.049; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; YANG F, 1991, BONE, V12, P7, DOI 10.1016/8756-3282(91)90048-N	36	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33545	33553		10.1074/jbc.M111.329938	http://dx.doi.org/10.1074/jbc.M111.329938			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22773831	Green Published, hybrid			2022-12-25	WOS:000309602100040
J	Nagano, T; Kojima, K; Hisabori, T; Hayashi, H; Morita, EH; Kanamori, T; Miyagi, T; Ueda, T; Nishiyama, Y				Nagano, Takanori; Kojima, Kouji; Hisabori, Toru; Hayashi, Hidenori; Morita, Eugene Hayato; Kanamori, Takashi; Miyagi, Tomoko; Ueda, Takuya; Nishiyama, Yoshitaka			Elongation Factor G Is a Critical Target during Oxidative Damage to the Translation System of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP PCC 6803; PROTEIN-SYNTHESIS; PHOTOSYSTEM-II; CUMENE HYDROPEROXIDE; IN-VITRO; STRESS; THIOREDOXIN; CELLS; IDENTIFICATION; INTERMEDIATE	Elongation factor G (EF-G), a key protein in translational elongation, is known to be particularly susceptible to oxidation in Escherichia coli. However, neither the mechanism of the oxidation of EF-G nor the influence of its oxidation on translation is fully understood. In the present study, we investigated the effects of oxidants on the chemical properties and function of EF-G using a translation system in vitro derived from E. coli. Treatment of EF-G with 0.5 mM H2O2 resulted in the complete loss of translational activity. The inactivation of EF-G by H2O2 was attributable to the oxidation of two specific cysteine residues, namely, Cys(114) and Cys(266), and subsequent formation of an intramolecular disulfide bond. Replacement of Cys(114) by serine rendered EF-G insensitive to oxidation and inactivation by H2O2. Furthermore, generation of the translation system in vitro with the mutated EF-G protected the entire translation system from oxidation, suggesting that EF-G might be a primary target of oxidation within the translation system. Oxidized EF-G was reactivated via reduction of the disulfide bond by thioredoxin, a ubiquitous protein that mediates dithiol-disulfide exchange. Our observations indicate that the translational machinery in E. coli is regulated, in part, by the redox state of EF-G, which might depend on the balance between the supply of reducing power and the degree of oxidative stress.	[Nagano, Takanori; Kojima, Kouji; Nishiyama, Yoshitaka] Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, Saitama 3388570, Japan; [Nishiyama, Yoshitaka] Saitama Univ, Grad Sch Sci & Engn, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Hayashi, Hidenori] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Hayashi, Hidenori] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Morita, Eugene Hayato] Ehime Univ, Fac Agr, Dept Bioresources, Matsuyama, Ehime 7908566, Japan; [Kanamori, Takashi; Miyagi, Tomoko; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan	Saitama University; Saitama University; Tokyo Institute of Technology; Ehime University; Ehime University; Ehime University; University of Tokyo	Nishiyama, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	nishiyama@molbiol.saitama-u.ac.jp	Kojima, Kouji/L-8180-2013; Ueda, Takuya/K-5217-2014; Nishiyama, Yoshitaka/K-3825-2012; Hisabori, Toru/E-5205-2014	Ueda, Takuya/0000-0002-7760-8271; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science and Technology of Japan [21570033, 24570039]; Asahi Glass Foundation; Network Joint Research Center for Materials and Devices	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Network Joint Research Center for Materials and Devices	This work was supported, in part, by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21570033 and 24570039) (to Y. N.), the Asahi Glass Foundation (to Y. N.), and the Cooperative Research Program of the Network Joint Research Center for Materials and Devices (to Y. N. and T. H.).	Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Ejima K, 2012, FEBS LETT, V586, P778, DOI 10.1016/j.febslet.2012.01.042; Ezure T, 2009, J BIOTECHNOL, V144, P287, DOI 10.1016/j.jbiotec.2009.09.017; Hirose T, 1996, EMBO J, V15, P1687, DOI 10.1002/j.1460-2075.1996.tb00514.x; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; INOUEYOKOSAWA N, 1974, J BIOL CHEM, V249, P4321; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kojima K, 2009, J BIOL CHEM, V284, P18685, DOI 10.1074/jbc.M109.015131; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; NILSSON A, 1995, BBA-GENE STRUCT EXPR, V1260, P200, DOI 10.1016/0167-4781(94)00198-C; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Nishiyama Y, 2009, ADV BOT RES, V52, P187, DOI 10.1016/S0065-2296(10)52007-X; POOT M, 1988, MECH AGEING DEV, V43, P1, DOI 10.1016/0047-6374(88)90093-0; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Starosta AL, 2009, CHEM BIOL, V16, P1087, DOI 10.1016/j.chembiol.2009.09.016; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vlamis-Gardikas A, 2002, J BIOL CHEM, V277, P10861, DOI 10.1074/jbc.M111024200; Yokoyama T, 2012, EMBO J, V31, P1836, DOI 10.1038/emboj.2012.22	31	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28697	28704		10.1074/jbc.M112.378067	http://dx.doi.org/10.1074/jbc.M112.378067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773838	hybrid, Green Published			2022-12-25	WOS:000308074600043
J	Xu, YM; Pempe, EH; Liu, J				Xu, Yongmei; Pempe, Elizabeth H.; Liu, Jian			Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED THROMBOCYTOPENIA; ANTITHROMBIN-III; TERNARY COMPLEX; SULFATE; ANTICOAGULANT; BINDING; BIOSYNTHESIS; REPLACEMENT; SPECIFICITY; REVEALS	Heparan sulfate (HS) and heparin are highly sulfated polysaccharides. Heparin is a commonly used anticoagulant drug that inhibits the activities of factors Xa and IIa (also known as thrombin) to prevent blood clot formation. Here, we report the synthesis of a series of size-defined oligosaccharides to probe the minimum size requirement for an oligosaccharide with anti-IIa activity. The synthesis was completed by a chemoenzymatic approach involving glycosyltransferases, HS sulfotransferases, and C-5-epimerase. We demonstrate the ability to synthesize highly purified N-sulfo-oligosaccharides having up to 21 saccharide residues. The results from anti-Xa and anti-IIa activity measurements revealed that an oligosaccharide longer than 19 saccharide residues is necessary to display anti-IIa activity. The oligosaccharides also exhibit low binding toward platelet factor 4, raising the possibility of preparing a synthetic heparin with a reduced effect of heparin-induced thrombocytopenia. The results from this study demonstrate the ability to synthesize large HS oligosaccharides and provide a unique tool to probe the structure and function relationships of HS that require the use of large HS fragments.	[Xu, Yongmei; Pempe, Elizabeth H.; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Beard Hall,Rm 303, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu		Chappell, Elizabeth/0000-0003-4491-0631	National Institutes of Health [R01 HL094463, R01 AI050050, F31 AG040927-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL094463 and R01 AI050050 (to J. L.) and F31 AG040927-01 (to E. H. P.).	Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Corbett TL, 2010, J THROMB THROMBOLYS, V30, P375, DOI 10.1007/s11239-010-0494-0; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Duncan MB, 2004, BBA-GEN SUBJECTS, V1671, P34, DOI 10.1016/j.bbagen.2003.12.010; Herbert JM, 2001, THROMB HAEMOSTASIS, V85, P852; Hu YP, 2011, NAT CHEM, V3, P557, DOI 10.1038/nchem.1073; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725; Lassen MR, 2008, J AM COLL CARDIOL, V51, P1498, DOI 10.1016/j.jacc.2008.03.007; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271; OOSTA GM, 1981, P NATL ACAD SCI-BIOL, V78, P829, DOI 10.1073/pnas.78.2.829; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Spinler SA, 2006, J THROMB THROMBOLYS, V21, P17, DOI 10.1007/s11239-006-5571-z; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; YAMADA SH, 1993, J BIOL CHEM, V268, P4780; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	31	39	42	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29054	29061		10.1074/jbc.M112.358523	http://dx.doi.org/10.1074/jbc.M112.358523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773834	Green Published, hybrid			2022-12-25	WOS:000308074600072
J	Ammar, FF; Abdel-Azeim, S; Zargarian, L; Hobaika, Z; Maroun, RG; Fermandjian, S				Ammar, Farah F.; Abdel-Azeim, Safwat; Zargarian, Loussinee; Hobaika, Zeina; Maroun, Richard G.; Fermandjian, Serge			Unprocessed Viral DNA Could Be the Primary Target of the HIV-1 Integrase Inhibitor Raltegravir	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRAND TRANSFER INHIBITORS; NUCLEIC-ACID INTERACTIONS; MOLECULAR-DYNAMICS; EXPERIENCED PATIENTS; CATALYTIC DOMAIN; FREE-ENERGIES; ACTIVE-SITE; FORCE-FIELD; IN-VITRO	Integration of HIV DNA into host chromosome requires a 3'-processing (3'-P) and a strand transfer (ST) reactions catalyzed by virus integrase (IN). Raltegravir (RAL), commonly used in AIDS therapy, belongs to the family of IN ST inhibitors (INSTIs) acting on IN-viral DNA complexes (intasomes). However, studies show that RAL fails to bind IN alone, but nothing has been reported on the behaviour of RAL toward free viral DNA. Here, we assessed whether free viral DNA could be a primary target for RAL, assuming that the DNA molecule is a receptor for a huge number of pharmacological agents. Optical spectroscopy, molecular dynamics and free energy calculations, showed that RAL is a tight binder of both processed and unprocessed LTR (long terminal repeat) ends. Complex formation involved mainly van der Waals forces and was enthalpy driven. Dissociation constants (Kds) revealed that RAL affinity for unbound LTRs was stronger than for bound LTRs. Moreover, Kd value for binding of RAL to LTRs and IC50 value (half concentration for inhibition) were in same range, suggesting that RAL binding to DNA and ST inhibition are correlated events. Accommodation of RAL into terminal base-pairs of unprocessed LTR is facilitated by an extensive end fraying that lowers the RAL binding energy barrier. The RAL binding entails a weak damping of fraying and correlatively of 3'-P inhibition. Noteworthy, present calculated RAL structures bound to free viral DNA resemble those found in RAL-intasome crystals, especially concerning the contacts between the fluorobenzyl group and the conserved 5'C(4)pA(3)3' step. We propose that RAL inhibits IN, in binding first unprocessed DNA. Similarly to anticancer drug poisons acting on topoisomerases, its interaction with DNA does not alter the cut, but blocks the subsequent joining reaction. We also speculate that INSTIs having viral DNA rather IN as main target could induce less resistance.	[Ammar, Farah F.; Abdel-Azeim, Safwat; Zargarian, Loussinee; Fermandjian, Serge] Ecole Normale Super, LBPA, UMR8113, CNRS, Cachan, France; [Ammar, Farah F.; Hobaika, Zeina; Maroun, Richard G.] Univ St Joseph, Unite Biochim, Dept SVT, Fac Sci, Cst Mar Roukoz, Beyrouth, Lebanon	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Saint Joseph University Beirut	Ammar, FF (corresponding author), Ecole Normale Super, LBPA, UMR8113, CNRS, Cachan, France.	serge.fermandjian@lbpa.ens-cachan.fr	Maroun, Richard/ABG-6613-2020; Abdel-azeim, Safwat/R-8096-2019	Maroun, Richard/0000-0002-0697-2535; abdel-Azeim, Safwat sayed/0000-0001-8611-1251	French-Lebanese program CEDRE [05 SF21/L14]	French-Lebanese program CEDRE	This work was supported by a grant from the French-Lebanese program CEDRE [05 SF21/L14 to Dr. Fermandjian and Dr. Maroun] (L'accord de cooperation pour l'evaluation et le developpement de la recherche). http://www.enseignementsup-recherche.gouv.fr/cid21216/programme-cedre-cooperation-franco-libanaise.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapkina J, 2004, EUR J BIOCHEM, V271, P205, DOI 10.1046/j.1432-1033.2003.03921.x; Berova N., 2000, CIRCULAR DICHROISM P, DOI DOI 10.1038/natrevmats.2016.21; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BUJALOWSKI W, 1987, BIOCHEMISTRY-US, V26, P3099, DOI 10.1021/bi00385a023; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CALLADINE CR, 1992, UNDERSTANDING DNA MO; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; da Silva D, 2010, J ANTIMICROB CHEMOTH, V65, P1262, DOI 10.1093/jac/dkq099; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; DOUGHERTY G, 1982, CRC CR REV BIOCH MOL, V12, P103, DOI 10.3109/10409238209108704; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Fasman G.D., 1996, CIRCULAR DICHROISM C; Fitzkee NC, 2010, J BIOL CHEM, V285, P18072, DOI 10.1074/jbc.M110.113407; GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Harris SA, 2001, J AM CHEM SOC, V123, P12658, DOI 10.1021/ja016233n; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill JJ, 1997, METHOD ENZYMOL, V278, P390; Hobaika Z, 2010, NEUROCHEM RES, V35, P888, DOI 10.1007/s11064-009-0098-2; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Johns B., 2010, 17 C RETR OPP INF SA; Johnson BC, 2012, ANTIMICROB AGENTS CH, V56, P411, DOI 10.1128/AAC.05292-11; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; Katz RA, 2011, J BIOL CHEM, V286, P25710, DOI 10.1074/jbc.M111.229179; Koelsch KK, 2009, CURR OPIN HIV AIDS, V4, P518, DOI 10.1097/COH.0b013e328331b526; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Langley DR, 2008, BIOCHEMISTRY-US, V47, P13481, DOI 10.1021/bi801372d; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Marinello J, 2008, BIOCHEMISTRY-US, V47, P9345, DOI 10.1021/bi800791q; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; McColl DJ, 2010, ANTIVIR RES, V85, P101, DOI 10.1016/j.antiviral.2009.11.004; Metifiot M, 2011, ANTIMICROB AGENTS CH, V55, P5127, DOI 10.1128/AAC.05288-11; Metifiot M, 2010, VIRUSES-BASEL, V2, P1347, DOI 10.3390/v2071347; MONNOT M, 1991, J BIOL CHEM, V266, P1820; MONNOT M, 1992, EUR J BIOCHEM, V204, P1035, DOI 10.1111/j.1432-1033.1992.tb16725.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rassolov VA, 2001, J COMPUT CHEM, V22, P976, DOI 10.1002/jcc.1058; Reigadas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010311; Renisio JG, 2005, NUCLEIC ACIDS RES, V33, P1970, DOI 10.1093/nar/gki346; ROOTHAAN CCJ, 1951, REV MOD PHYS, V23, P69, DOI 10.1103/RevModPhys.23.69; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; Smith GF, 2009, PROGR MED CHEM, V48, P1, DOI 10.1016/S0079-6468(09)04801-2; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Treesuwan W, 2009, PHYS CHEM CHEM PHYS, V11, P10682, DOI 10.1039/b910574c; Vacca J, 2007, 4 IAS C HIV PATH TRE; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WILSON WD, 1990, ANTI-CANCER DRUG DES, V5, P31; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Zargarian L, 2003, J BIOL CHEM, V278, P19966, DOI 10.1074/jbc.M211711200	73	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40223	10.1371/journal.pone.0040223	http://dx.doi.org/10.1371/journal.pone.0040223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768342	Green Submitted, gold, Green Published			2022-12-25	WOS:000305966500055
J	Chang, TC; Liu, CC; Hsing, EW; Liang, SM; Chi, YH; Sung, LY; Lin, SP; Shen, TL; Ko, BS; Yen, BLJ; Yet, SF; Wu, KK; Liou, JY				Chang, Tzu-Ching; Liu, Chia-Chia; Hsing, En-Wei; Liang, Shu-Man; Chi, Ya-Hui; Sung, Li-Ying; Lin, Shau-Ping; Shen, Tang-Long; Ko, Bor-Sheng; Yen, B. Linju; Yet, Shaw-Fang; Wu, Kenneth K.; Liou, Jun-Yang			14-3-3 sigma Regulates beta-Catenin-Mediated Mouse Embryonic Stem Cell Proliferation by Sequestering GSK-3 beta	PLOS ONE			English	Article							EFFICIENT TRANSFECTION METHOD; NEURAL DIFFERENTIATION; STRUCTURAL BASIS; RETINOIC ACID; ACTIVATION; PHOSPHORYLATION; KINASE; CANCER; PROTEINS; PLURIPOTENCY	Background: Pluripotent embryonic stem cells are considered to be an unlimited cell source for tissue regeneration and cell-based therapy. Investigating the molecular mechanism underlying the regulation of embryonic stem cell expansion is thus important. 14-3-3 proteins are implicated in controlling cell division, signaling transduction and survival by interacting with various regulatory proteins. However, the function of 14-3-3 in embryonic stem cell proliferation remains unclear. Methodology and Principal Findings: In this study, we show that all seven 14-3-3 isoforms were detected in mouse embryonic stem cells. Retinoid acid suppressed selectively the expression of 14-3-3 sigma isoform. Knockdown of 14-3-3 sigma with siRNA reduced embryonic stem cell proliferation, while only 14-3-3 sigma transfection increased cell growth and partially rescued retinoid acid-induced growth arrest. Since the growth-enhancing action of 14-3-3s was abrogated by beta-catenin knockdown, we investigated the influence of 14-3-3 sigma overexpression on beta-catenin/GSK-3 beta. 14-3-3 sigma bound GSK-3 beta and increased GSK-3 beta phosphorylation in a PI-3K/Akt-dependent manner. It disrupted beta-catenin binding by the multiprotein destruction complex. 14-3-3 sigma overexpression attenuated beta-catenin phosphorylation and rescued the decline of beta-catenin induced by retinoid acid. Furthermore, 14-3-3 sigma enhanced Wnt3a-induced beta-catenin level and GSK-3 beta phosphorylation. DKK, an inhibitor of Wnt signaling, abolished Wnt3a-induced effect but did not interfere GSK-3b/14-3-3 sigma binding. Significance: Our findings show for the first time that 14-3-3 sigma plays an important role in regulating mouse embryonic stem cell proliferation by binding and sequestering phosphorylated GSK-3 beta and enhancing Wnt-signaled GSK-3 beta inactivation. 14-3-3 sigma is a novel target for embryonic stem cell expansion.	[Chang, Tzu-Ching; Liu, Chia-Chia; Hsing, En-Wei; Liang, Shu-Man; Chi, Ya-Hui; Ko, Bor-Sheng; Yen, B. Linju; Yet, Shaw-Fang; Wu, Kenneth K.; Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Liu, Chia-Chia; Sung, Li-Ying; Lin, Shau-Ping] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Ko, Bor-Sheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chang, TC (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	kkgo@nhri.org.tw; jliou@nhri.org.tw	Yet, Shaw-Fang/B-1067-2010; Yen, B. Lin-Ju/B-1088-2010; Chi, Ya-Hui/B-1080-2010; Yet, Shaw-Fang/O-8583-2019; Chi, Ya-Hui/ABE-8550-2020; Liou, Jun-Yang/B-1065-2010; Wu, Kenneth Kun-Yu/B-1070-2010	Chi, Ya-Hui/0000-0002-9216-0938; SUNG, LI-YING/0000-0003-1221-2476; Yet, Shaw-Fang/0000-0001-9097-3962; KO, BOR-SHENG/0000-0002-7965-7579; Lin, Shau-Ping/0000-0003-3423-991X; Shen, Tang-Long/0000-0001-6264-3608	National Science Council [99-3111-B-400-001, 100-2321-B-400-021, 99-3111-B-400-005, 100-2321-B-400-020]; National Health Research Institutes of Taiwan [00A1-CSPP08-014]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by The National Science Council (99-3111-B-400-001, 100-2321-B-400-021, 99-3111-B-400-005 and 100-2321-B-400-020) and The National Health Research Institutes (00A1-CSPP08-014) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; Chang TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009187; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Ko BS, 2009, GENE THER, V16, P154, DOI 10.1038/gt.2008.125; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liou JY, 2007, STEM CELLS, V25, P1096, DOI 10.1634/stemcells.2006-0505; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Liou JY, 2010, METHODS MOL BIOL, V650, P145, DOI 10.1007/978-1-60761-769-3_12; Liu N, 2007, J CELL PHYSIOL, V211, P279, DOI 10.1002/jcp.20978; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin-Ibanez R, 2007, J NEUROSCI RES, V85, P2686, DOI 10.1002/jnr.21228; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mwangi S, 2006, NEUROSCIENCE, V143, P241, DOI 10.1016/j.neuroscience.2006.07.050; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Sakurai H, 2008, STEM CELLS, V26, P1865, DOI 10.1634/stemcells.2008-0173; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shumway SD, 2003, J BIOL CHEM, V278, P2089, DOI 10.1074/jbc.C200499200; Su YW, 2011, P NATL ACAD SCI USA, V108, P1555, DOI 10.1073/pnas.1017729108; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Welsh GI, 1996, TRENDS CELL BIOL, V6, P274, DOI 10.1016/0962-8924(96)10023-4; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yan WL, 2006, J PHARMACOL EXP THER, V317, P267, DOI 10.1124/jpet.105.096826; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40193	10.1371/journal.pone.0040193	http://dx.doi.org/10.1371/journal.pone.0040193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768254	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100227
J	Goatley, CHR; Hoey, AS; Bellwood, DR				Goatley, Christopher H. R.; Hoey, Andrew S.; Bellwood, David R.			The Role of Turtles as Coral Reef Macroherbivores	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CHELONIA-MYDAS; PHASE-SHIFTS; COMMUNITY STRUCTURE; HAWKSBILL TURTLES; KANEOHE BAY; HOME-RANGE; RESILIENCE; HERBIVORY; CONSERVATION	Herbivory is widely accepted as a vital function on coral reefs. To date, the majority of studies examining herbivory in coral reef environments have focused on the roles of fishes and/or urchins, with relatively few studies considering the potential role of macroherbivores in reef processes. Here, we introduce evidence that highlights the potential role of marine turtles as herbivores on coral reefs. While conducting experimental habitat manipulations to assess the roles of herbivorous reef fishes we observed green turtles (Chelonia mydas) and hawksbill turtles (Eretmochelys imbricata) showing responses that were remarkably similar to those of herbivorous fishes. Reducing the sediment load of the epilithic algal matrix on a coral reef resulted in a forty-fold increase in grazing by green turtles. Hawksbill turtles were also observed to browse transplanted thalli of the macroalga Sargassum swartzii in a coral reef environment. These responses not only show strong parallels to herbivorous reef fishes, but also highlight that marine turtles actively, and intentionally, remove algae from coral reefs. When considering the size and potential historical abundance of marine turtles we suggest that these potentially valuable herbivores may have been lost from many coral reefs before their true importance was understood.	[Goatley, Christopher H. R.; Hoey, Andrew S.; Bellwood, David R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Goatley, Christopher H. R.; Hoey, Andrew S.; Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Hoey, Andrew S.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	James Cook University; James Cook University; King Abdullah University of Science & Technology	Goatley, CHR (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	christopher.goatley@jcu.edu.au	Goatley, Christopher/C-1492-2016; Hoey, Andrew S/B-5457-2015	Goatley, Christopher/0000-0002-2930-5591; Hoey, Andrew/0000-0002-4261-5594	Australian Research Council; PADI Foundation; Lizard Island Doctoral Fellowship; Ian Potter Doctoral Fellowship at Lizard Island	Australian Research Council(Australian Research Council); PADI Foundation; Lizard Island Doctoral Fellowship; Ian Potter Doctoral Fellowship at Lizard Island	This work was funded by the Australian Research Council (DRB), the PADI Foundation, a Lizard Island Doctoral Fellowship (CHRG) and an Ian Potter Doctoral Fellowship at Lizard Island (ASH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MS, 2007, CORAL REEFS, V26, P959, DOI 10.1007/s00338-007-0234-x; Alvarez BLA, 2000, P 18 INT SEA TURTL S; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bjorndal KA, 2003, CRC MAR BIOL SER, P259; Bjorndal Karen A., 1997, P199; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Carrion-Cortez JA, 2010, J MAR BIOL ASSOC UK, V90, P1005, DOI 10.1017/S0025315410000226; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Choat J.H., 1991, P120; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; FORBES G.A., 1994, P 13 ANN S SEA TURTL, P57; Fourqurean JW, 2010, MAR ECOL PROG SER, V419, P223, DOI 10.3354/meps08853; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Fuentes MMPB, 2010, AQUAT CONSERV, V20, P132, DOI 10.1002/aqc.1088; GBRMPA, 2009, GREAT BARR REEF OUTL GREAT BARR REEF OUTL; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUNTER CL, 1995, B MAR SCI, V57, P501; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Leon YM, 2002, MAR ECOL PROG SER, V245, P249, DOI 10.3354/meps245249; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Luschi P, 1996, J COMP PHYSIOL A, V178, P447; Marsh H, 2005, ECOL APPL, V15, P481, DOI 10.1890/04-0673; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; Mayor PA, 1998, P 17 ANN SEA TURTL S, P244; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; MEYLAN A, 1988, SCIENCE, V239, P393, DOI 10.1126/science.239.4838.393; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; Obura DO, 2010, CORAL REEFS, V29, P759, DOI 10.1007/s00338-010-0611-8; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Pike DA, 2007, OECOLOGIA, V153, P471, DOI 10.1007/s00442-007-0732-0; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Read Mark A., 2002, Memoirs of the Queensland Museum, V48, P207; Russell DF, 2009, PAC SCI, V63, P181, DOI 10.2984/049.063.0202; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Sheppard C., 1995, MAR POLL B, V30, P766; Stampar Sergio N., 2007, Marine Turtle Newsletter, V117, P3; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Wabnitz CCC, 2010, MAR ECOL PROG SER, V420, P27, DOI 10.3354/meps08846; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; [No title captured]	64	31	31	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39979	10.1371/journal.pone.0039979	http://dx.doi.org/10.1371/journal.pone.0039979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768189	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305892100161
J	Hartel, C; Faust, K; Avenarius, S; Bohnhorst, B; Emeis, M; Gebauer, C; Groneck, P; Heitmann, F; Hoehn, T; Hubert, M; Kribs, A; Kuster, H; Laux, R; Mogel, M; Muller, D; Olbertz, D; Roll, C; Siegel, J; Stein, A; Vochem, M; Weller, U; von der Wense, A; Wieg, C; Wintgens, J; Hemmelmann, C; Simon, A; Herting, E; Goopel, W				Haertel, Christoph; Faust, Kirstin; Avenarius, Stefan; Bohnhorst, Bettina; Emeis, Michael; Gebauer, Corinna; Groneck, Peter; Heitmann, Friedhelm; Hoehn, Thomas; Hubert, Mechthild; Kribs, Angela; Kuester, Helmut; Laux, Reinhard; Moegel, Michael; Mueller, Dirk; Olbertz, Dirk; Roll, Claudia; Siegel, Jens; Stein, Anja; Vochem, Matthias; Weller, Ursula; von der Wense, Axel; Wieg, Christian; Wintgens, Juergen; Hemmelmann, Claudia; Simon, Arne; Herting, Egbert; Goepel, Wolfgang		German Neonatal Network GNN	Epidemic Microclusters of Blood-Culture Proven Sepsis in Very-Low-Birth Weight Infants: Experience of the German Neonatal Network	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; GRAM-NEGATIVE BACILLI; LATE-ONSET SEPSIS; STREAM INFECTIONS; SURVEILLANCE SYSTEM; ENTEROBACTER-CLOACAE; PATHOGEN	Introduction: We evaluated blood culture-proven sepsis episodes occurring in microclusters in very-low-birth-weight infants born in the German Neonatal Network (GNN) during 2009-2010. Methods: Thirty-seven centers participated in GNN; 23 centers enrolled >= 50 VLBW infants in the study period. Data quality was approved by on-site monitoring. Microclusters of sepsis were defined as occurrence of at least two blood-culture proven sepsis events in different patients of one center within 3 months with the same bacterial species. For microcluster analysis, we selected sepsis episodes with typically cross-transmitted bacteria of high clinical significance including gram-negative rods and Enterococcus spp. Results: In our cohort, 12/2110 (0.6%) infants were documented with an early-onset sepsis and 235 late-onset sepsis episodes (>= 72 h of age) occurred in 203/2110 (9.6%) VLBW infants. In 182/235 (77.4%) late-onset sepsis episodes gram-positive bacteria were documented, while coagulase negative staphylococci were found to be the most predominant pathogens (48.5%, 95%CI: 42.01-55.01). Candida spp. and gram-negative bacilli caused 10/235 (4.3%, 95%CI: 1.68% -6.83%) and 43/235 (18.5%) late-onset sepsis episodes, respectively. Eleven microclusters of blood-culture proven sepsis were detected in 7 hospitals involving a total 26 infants. 16/26 cluster patients suffered from Klebsiella spp. sepsis. The median time interval between the first patient's Klebsiella spp. sepsis and cluster cases was 14.1 days (interquartile range: 1-27 days). First patients in the cluster, their linked cases and sporadic sepsis events did not show significant differences in short term outcome parameters. Discussion: Microclusters of infection are an important phenomenon for late-onset sepsis. Most gram-negative cluster infections occur within 30 days after the first patient was diagnosed and Klebsiella spp. play a major role. It is essential to monitor epidemic microclusters of sepsis in surveillance networks to adapt clinical practice, inform policy and further improve quality of care.	[Haertel, Christoph; Faust, Kirstin; Herting, Egbert; Goepel, Wolfgang] Univ Lubeck, Dept Pediat, Lubeck, Germany; [Avenarius, Stefan] Univ Magdeburg, Dept Pediat, D-39106 Magdeburg, Germany; [Bohnhorst, Bettina] Med Sch Hanover, Dept Pediat, Hannover, Germany; [Emeis, Michael] Vivantes Klinikum Neukolln, Dept Neonatol, Berlin, Germany; [Gebauer, Corinna] Univ Leipzig, Dept Pediat, Leipzig, Germany; [Groneck, Peter] Klinikum Leverkusen, Dept Neonatol, Leverkusen, Germany; [Heitmann, Friedhelm] Klinikum Dortmund, Dept Neonatol, Dortmund, Germany; [Hoehn, Thomas] Univ Dusseldorf, Dept Pediat, D-40225 Dusseldorf, Germany; [Hubert, Mechthild] Klinikum Siegen, Dept Neonatol, Siegen, Germany; [Kribs, Angela] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany; [Kuester, Helmut] Univ Gottingen, Dept Pediat, D-3400 Gottingen, Germany; [Laux, Reinhard] Asclepios Klin Barmbek, Dept Neonatol, Hamburg, Germany; [Moegel, Michael] Univ Dresden, Dept Pediat, Dresden, Germany; [Mueller, Dirk] Klinikum Kassel, Dept Neonatol, Kassel, Germany; [Olbertz, Dirk] Sudtstadt Klin Rostock, Dept Neonatol, Rostock, Germany; [Roll, Claudia] Vest Klin, Dept Neonatol, Datteln, Germany; [Siegel, Jens] Krankenhaus Aud Bult, Dept Neonatol, Hanover, NH USA; [Stein, Anja] Univ Essen Gesamthsch, Dept Pediat, Essen, Germany; [Vochem, Matthias] Olga Hosp, Dept Neonatol, Stuttgart, Germany; [Weller, Ursula] Klinikum Bielefeld, Dept Neonatol, Bielefeld, Germany; [von der Wense, Axel] Altonaer Kinderkrankenhaus, Dept Neonatol, Hamburg, Germany; [Wieg, Christian] Klinikum Aschaffenburg, Dept Neonatol, Aschaffenburg, Germany; [Wintgens, Juergen] Stadt Klinikum Rheydt, Dept Neonatol, Monchengladbach, Germany; [Hemmelmann, Claudia] Univ Lubeck, Inst Biometry & Med Stat, Lubeck, Germany; [Simon, Arne] Saarland Univ Hosp, Dept Pediat Hematol & Oncol, Homburg, Germany	University of Lubeck; Otto von Guericke University; VIivantes Klinikum Neukolln; Leipzig University; Klinikum Dortmund; Heinrich Heine University Dusseldorf; University of Cologne; University of Gottingen; Technische Universitat Dresden; Klinikum Kassel; University of Duisburg Essen; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Universitatsklinikum des Saarlandes	Hartel, C (corresponding author), Univ Lubeck, Dept Pediat, Lubeck, Germany.	haertel@paedia.ukl.mu-luebeck.de	Härtel, Christoph/ABD-8841-2020	Stein, Anja/0000-0002-0497-4609	German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)	German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly H, 2005, PEDIATRICS, V115, P1513, DOI 10.1542/peds.2004-1785; Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Aziz Khalid, 2005, BMC Pediatr, V5, P22, DOI 10.1186/1471-2431-5-22; Benjamin Daniel K, 2004, J Perinatol, V24, P175, DOI 10.1038/sj.jp.7211068; Cimiotti JP, 2006, ARCH PEDIAT ADOL MED, V160, P832, DOI 10.1001/archpedi.160.8.832; Cordero L, 2004, AM J INFECT CONTROL, V32, P189, DOI 10.1016/j.ajic.2003.07.004; Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1542/peds.2005-2677; Curry S, 2009, NEONATAL NETW, V28, P151, DOI 10.1891/0730-0832.28.3.151; Daley AJ, 2004, PEDIATR INFECT DIS J, V23, P630, DOI 10.1097/01.inf.0000128782.20060.79; Faust K, 2011, CHEMOTHERAPIE J, V20, P1; Gastmeier P, 2007, AM J INFECT CONTROL, V35, P172, DOI 10.1016/j.ajic.2006.07.007; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Graham PL, 2007, PEDIATR INFECT DIS J, V26, P1153, DOI 10.1097/INF.0b013e31814619d4; Graham PL, 2004, AM J INFECT CONTROL, V32, P232, DOI 10.1016/j.ajic.2003.07.008; Harbarth S, 1999, INFECT CONT HOSP EP, V20, P598, DOI 10.1086/501677; Makhoul IR, 2005, CLIN INFECT DIS, V40, P218, DOI 10.1086/426444; Reiss I, 2000, LANCET, V356, P310, DOI 10.1016/S0140-6736(00)02509-5; Schwab F, 2007, J HOSP INFECT, V65, P319, DOI 10.1016/j.jhin.2006.12.020; Schwab F, 2012, J HOSP INFECT, V80, P133, DOI 10.1016/j.jhin.2011.11.014; Smith A, 2010, PEDIATR INFECT DIS J, V29, P831, DOI 10.1097/INF.0b013e3181e7884f; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Talon D, 2004, J HOSP INFECT, V57, P119, DOI 10.1016/j.jhin.2004.01.023; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798	24	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38304	10.1371/journal.pone.0038304	http://dx.doi.org/10.1371/journal.pone.0038304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768043	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100014
J	Lijavetzky, D; Carbonell-Bejerano, P; Grimplet, J; Bravo, G; Flores, P; Fenoll, J; Hellin, P; Oliveros, JC; Martinez-Zapater, JM				Lijavetzky, Diego; Carbonell-Bejerano, Pablo; Grimplet, Jerome; Bravo, Gema; Flores, Pilar; Fenoll, Jose; Hellin, Pilar; Carlos Oliveros, Juan; Martinez-Zapater, Jose M.			Berry Flesh and Skin Ripening Features in Vitis vinifera as Assessed by Transcriptional Profiling	PLOS ONE			English	Article							LIPID TRANSFER PROTEIN; GRAPE MUSCAT HAMBURG; GENE-EXPRESSION; ANTHOCYANIN BIOSYNTHESIS; CABERNET-SAUVIGNON; WINE GRAPE; XYLOGLUCAN ENDOTRANSGLUCOSYLASE/HYDROLASE; PLANT DEVELOPMENT; ABC TRANSPORTER; MOLECULAR-BASIS	Background: Ripening of fleshy fruit is a complex developmental process involving the differentiation of tissues with separate functions. During grapevine berry ripening important processes contributing to table and wine grape quality take place, some of them flesh- or skin-specific. In this study, transcriptional profiles throughout flesh and skin ripening were followed during two different seasons in a table grape cultivar 'Muscat Hamburg' to determine tissue-specific as well as common developmental programs. Methodology/Principal Findings: Using an updated GrapeGen Affymetrix GeneChip (R) annotation based on grapevine 126v1 gene predictions, 2188 differentially accumulated transcripts between flesh and skin and 2839 transcripts differentially accumulated throughout ripening in the same manner in both tissues were identified. Transcriptional profiles were dominated by changes at the beginning of veraison which affect both pericarp tissues, although frequently delayed or with lower intensity in the skin than in the flesh. Functional enrichment analysis identified the decay on biosynthetic processes, photosynthesis and transport as a major part of the program delayed in the skin. In addition, a higher number of functional categories, including several related to macromolecule transport and phenylpropanoid and lipid biosynthesis, were over-represented in transcripts accumulated to higher levels in the skin. Functional enrichment also indicated auxin, gibberellins and bHLH transcription factors to take part in the regulation of pre-veraison processes in the pericarp, whereas WRKY and C2H2 family transcription factors seems to more specifically participate in the regulation of skin and flesh ripening, respectively. Conclusions/Significance: A transcriptomic analysis indicates that a large part of the ripening program is shared by both pericarp tissues despite some components are delayed in the skin. In addition, important tissue differences are present from early stages prior to the ripening onset including tissue-specific regulators. Altogether, these findings provide key elements to understand berry ripening and its differential regulation in flesh and skin.	[Lijavetzky, Diego; Carbonell-Bejerano, Pablo; Bravo, Gema; Carlos Oliveros, Juan; Martinez-Zapater, Jose M.] CSIC, Dept Genet Mol Plantas, CNB, Madrid, Spain; [Carbonell-Bejerano, Pablo; Grimplet, Jerome; Martinez-Zapater, Jose M.] Univ La Rioja Gobierno La Rioja, ICVV, Consejo Super Invest Cient, Logrono, La Rioja, Spain; [Flores, Pilar; Fenoll, Jose; Hellin, Pilar] Inst Murciano Invest & Desarrollo Agr & Alimentar, Area Biotecnol, Estac Sericicola, Murcia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	Lijavetzky, D (corresponding author), Univ Nacl Cuyo, Inst Biol Agr Mendoza, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Agr, Chacras De Coria, Argentina.	pablo.carbonell@icvv.es	Flores, Pilar/H-5432-2015; Lijavetzky, Diego/AAF-1557-2020; Grimplet, Jérôme/M-4589-2019; FENOLL, JOSE/L-8098-2014; Carbonell-Bejerano, Pablo/L-6699-2017; Carbonell-Bejerano, Pablo/AAX-3509-2021; Grimplet, Jerome/A-3422-2011; Hellin, Pilar/M-4436-2018; Martinez Zapater, Jose/I-4892-2012	Flores, Pilar/0000-0002-0493-8720; Grimplet, Jérôme/0000-0002-3265-4012; FENOLL, JOSE/0000-0002-9568-1122; Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Grimplet, Jerome/0000-0002-3265-4012; Hellin, Pilar/0000-0002-5130-7008; Martinez Zapater, Jose/0000-0001-7217-4454; Oliveros, Juan Carlos/0000-0002-4520-0853; Lijavetzky, Diego/0000-0003-4207-3067	Genoma Espana; Ministerio de Ciencia e Innovacion [BIO2008-03892]; Argentina [AR2009-0021]; GrapeGen Project	Genoma Espana; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Argentina; GrapeGen Project	This study was financially supported by GrapeGen Project funded by Genoma Espana within a collaborative agreement with Genome Canada. The authors also thank The Ministerio de Ciencia e Innovacion for project BIO2008-03892 and a bilateral collaborative grant with Argentina (AR2009-0021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afoufa-Bastien D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-245; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ali MB, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Battilana J, 2011, J EXP BOT, V62, P5497, DOI 10.1093/jxb/err231; Battilana J, 2009, THEOR APPL GENET, V118, P653, DOI 10.1007/s00122-008-0927-8; BERNSTEIN Z, 1981, VITIS, V20, P15; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Cantos E, 2002, J AGR FOOD CHEM, V50, P5691, DOI 10.1021/jf0204102; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Castellarin SD, 2007, PLANT CELL ENVIRON, V30, P1381, DOI 10.1111/j.1365-3040.2007.01716.x; Castellarin SD, 2011, J EXP BOT, V62, P4345, DOI 10.1093/jxb/err150; CAWTHON DL, 1982, J AM SOC HORTIC SCI, V107, P1097; Chen J, 2011, CARBOHYD RES, V346, P1684, DOI 10.1016/j.carres.2011.05.003; Chira K, 2009, J AGR FOOD CHEM, V57, P545, DOI 10.1021/jf802301g; Cohen SD, 2008, ANAL CHIM ACTA, V621, P57, DOI 10.1016/j.aca.2007.11.029; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Commenil P, 1997, J EXP BOT, V48, P1599, DOI 10.1093/jexbot/48.313.1599; Conde C, 2007, FOOD, V22, DOI DOI 10.1186/S12864-016-2660-Z; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; COOMBE BG, 1987, AM J ENOL VITICULT, V38, P120; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; COOMBE BG, 1973, PLANT PHYSIOL, V51, P629, DOI 10.1104/pp.51.4.629; CRAVERO MC, 1994, VITIS, V33, P75; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Deluc LG, 2011, J AGR FOOD CHEM, V59, P289, DOI 10.1021/jf1024888; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Deytieux-Belleau C, 2008, PLANT PHYSIOL BIOCH, V46, P638, DOI 10.1016/j.plaphy.2008.04.008; Diakou P, 2001, PROTOPLASMA, V218, P225, DOI 10.1007/BF01306611; Duchene E, 2009, THEOR APPL GENET, V118, P541, DOI 10.1007/s00122-008-0919-8; Emanuelli F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-241; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; Esteban MA, 1999, AM J ENOL VITICULT, V50, P418; Fenoll J, 2009, FOOD CHEM, V114, P420, DOI 10.1016/j.foodchem.2008.09.060; Ford CM, 1998, J BIOL CHEM, V273, P9224, DOI 10.1074/jbc.273.15.9224; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Fournand D, 2006, J AGR FOOD CHEM, V54, P7331, DOI 10.1021/jf061467h; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Garcia-Gago JA, 2009, PLANT SIGNAL BEHAV, V4, P766, DOI 10.1104/pp.109.138297; Gatto P, 2008, J AGR FOOD CHEM, V56, P11773, DOI 10.1021/jf8017707; Gholami M., 1995, Australian Journal of Grape and Wine Research, V1, P19, DOI 10.1111/j.1755-0238.1995.tb00073.x; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Grimplet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008365; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guillaumie S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-165; HALE CR, 1970, PLANT PHYSIOL, V45, P620, DOI 10.1104/pp.45.5.620; Hardie W. J., 1996, Australian Journal of Grape and Wine Research, V2, P97, DOI 10.1111/j.1755-0238.1996.tb00101.x; HARDIE WJ, 1988, AUST J BOT, V36, P107, DOI 10.1071/BT9880107; Hayasaka Y, 2003, RAPID COMMUN MASS SP, V17, P9, DOI 10.1002/rcm.869; Hayes MA, 2007, J EXP BOT, V58, P1985, DOI 10.1093/jxb/erm061; Helliwell CA, 1999, PLANT PHYSIOL, V119, P507, DOI 10.1104/pp.119.2.507; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hollenbach B, 1997, PLANTA, V203, P9, DOI 10.1007/s004250050159; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Martinez-Esteso MJ, 2011, J EXP BOT, V62, P2521, DOI 10.1093/jxb/erq434; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P5348, DOI 10.1021/jf010758h; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KLIEWER WM, 1972, AM J ENOL VITICULT, V23, P71; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kossmann J, 1999, PLANTA, V208, P503, DOI 10.1007/s004250050587; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; KRIEDEMANN PE, 1968, AUST J BIOL SCI, V21, P907, DOI 10.1071/BI9680907; Laquitaine L, 2006, MOL PLANT MICROBE IN, V19, P1103, DOI 10.1094/MPMI-19-1103; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; Liu YB, 2007, PLANTA, V226, P1547, DOI 10.1007/s00425-007-0591-2; Luan F, 2002, PHYTOCHEMISTRY, V60, P451, DOI 10.1016/S0031-9422(02)00147-4; Lund ST, 2006, SCIENCE, V311, P804, DOI 10.1126/science.1118962; Lund ST, 2008, PLANT MOL BIOL, V68, P301, DOI 10.1007/s11103-008-9371-z; Maris A, 2009, J EXP BOT, V60, P3959, DOI 10.1093/jxb/erp229; Mateo JJ, 2000, J CHROMATOGR A, V881, P557, DOI 10.1016/S0021-9673(99)01342-4; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Miedes E, 2011, J PLANT PHYSIOL, V168, P196, DOI 10.1016/j.jplph.2010.06.029; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Muganu M, 2011, AM J ENOL VITICULT, V62, P91, DOI 10.5344/ajev.2010.10012; Nunan KJ, 1998, PLANT PHYSIOL, V118, P783, DOI 10.1104/pp.118.3.783; Nunan KJ, 2001, PLANTA, V214, P257, DOI 10.1007/s004250100609; PANDEY RM, 1977, VITIS, V16, P106; Panikashvili D, 2010, MOL PLANT, V3, P563, DOI 10.1093/mp/ssp103; PARK SK, 1991, J AGR FOOD CHEM, V39, P514, DOI 10.1021/jf00003a017; Pastore C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-631; Peng FY, 2007, GENE, V402, P40, DOI 10.1016/j.gene.2007.07.016; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Polaskova P, 2008, CHEM SOC REV, V37, P2478, DOI 10.1039/b714455p; Pontin MA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-224; POSSNER DRE, 1985, VITIS, V24, P229; Prasanna V, 2007, CRIT REV FOOD SCI, V47, P1, DOI 10.1080/10408390600976841; Quesada MA, 2009, PLANT PHYSIOL, V150, P1022, DOI 10.1104/pp.109.138297; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; RIBEREAUGAYON P, 1975, J AGR FOOD CHEM, V23, P1042, DOI 10.1021/jf60202a050; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; ROSENQUIST JK, 1989, AM J ENOL VITICULT, V40, P241; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; RUFFNER HP, 1982, VITIS, V21, P346; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Schlosser J, 2008, PROTOPLASMA, V232, P255, DOI 10.1007/s00709-008-0280-9; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Swift J. G., 1973, Vitis, V12, P38; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Thomas TR, 2008, PLANTA, V228, P1067, DOI 10.1007/s00425-008-0808-z; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vicens A, 2009, J AGR FOOD CHEM, V57, P2955, DOI 10.1021/jf803416w; Vidal S, 2003, J SCI FOOD AGR, V83, P564, DOI 10.1002/jsfa.1394; Wada H, 2009, J EXP BOT, V60, P1773, DOI 10.1093/jxb/erp050; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Wheeler S, 2009, AUST J GRAPE WINE R, V15, P195, DOI 10.1111/j.1755-0238.2008.00045.x; Yang H. Y., 1955, AM J ENOL VITICULT, V6, P32; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang XY, 2006, PLANT PHYSIOL, V142, P220, DOI 10.1104/pp.106.081430	133	105	105	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39547	10.1371/journal.pone.0039547	http://dx.doi.org/10.1371/journal.pone.0039547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768087	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100058
J	Long, DP; Zhao, AC; Chen, XJ; Zhang, Y; Lu, WJ; Guo, Q; Handler, AM; Xiang, ZH				Long, Ding-Pei; Zhao, Ai-Chun; Chen, Xue-Jiao; Zhang, Yang; Lu, Wei-Jian; Guo, Qing; Handler, Alfred M.; Xiang, Zhong-Huai			FLP Recombinase-Mediated Site-Specific Recombination in Silkworm, Bombyx mori	PLOS ONE			English	Article							GERMLINE TRANSFORMATION; TRANSGENIC SILKWORMS; PHI-C31 INTEGRASE; DROSOPHILA-MELANOGASTER; ENHANCER DETECTION; CASSETTE EXCHANGE; 2-MU CIRCLE; CELL-LINES; GENE; TRANSPOSON	A comprehensive understanding of gene function and the production of site-specific genetically modified mutants are two major goals of genetic engineering in the post-genomic era. Although site-specific recombination systems have been powerful tools for genome manipulation of many organisms, they have not yet been established for use in the manipulation of the silkworm Bombyx mori genome. In this study, we achieved site-specific excision of a target gene at predefined chromosomal sites in the silkworm using a FLP/FRT site-specific recombination system. We first constructed two stable transgenic target silkworm strains that both contain a single copy of the transgene construct comprising a target gene expression cassette flanked by FRT sites. Using pre-blastoderm microinjection of a FLP recombinase helper expression vector, 32 G3 site-specific recombinant transgenic individuals were isolated from five of 143 broods. The average frequency of FLP recombinase-mediated site-specific excision in the two target strains genome was approximately 3.5%. This study shows that it is feasible to achieve site-specific recombination in silkworms using the FLP/FRT system. We conclude that the FLP/FRT system is a useful tool for genome manipulation in the silkworm. Furthermore, this is the first reported use of the FLP/FRT system for the genetic manipulation of a lepidopteran genome and thus provides a useful reference for the establishment of genome manipulation technologies in other lepidopteran species.	[Long, Ding-Pei; Zhao, Ai-Chun; Chen, Xue-Jiao; Zhang, Yang; Lu, Wei-Jian; Guo, Qing; Xiang, Zhong-Huai] Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Handler, Alfred M.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	Southwest University - China; United States Department of Agriculture (USDA)	Long, DP (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zhaoaichun@hotmail.com	Zhao, Aichun/T-4308-2018	Zhao, Aichun/0000-0001-6140-0102; Long, Dingpei/0000-0002-2907-6901	Chongqing Science & Technology Commission [CSTC, 2011BA1005, CSTC, 2009AA1024]; Fundamental Research Funds for the Central Universities [XDJK2010B015]	Chongqing Science & Technology Commission(Natural Science Foundation Project of CQ CSTC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Chongqing Science & Technology Commission (No. CSTC, 2011BA1005 and CSTC, 2009AA1024) and the Fundamental Research Funds for the Central Universities (No. XDJK2010B015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BJ, 1985, CELL, V40, P795, DOI 10.1016/0092-8674(85)90339-3; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Czeh M, 2010, ONCOGENE, V29, P6591, DOI 10.1038/onc.2010.388; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; Gao G, 2008, P NATL ACAD SCI USA, V105, P13999, DOI 10.1073/pnas.0805843105; Gimond C, 1998, J CELL BIOL, V143, P253, DOI 10.1083/jcb.143.1.253; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Golic KG, 1996, GENETICS, V144, P1693; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; Horn C, 2003, GENETICS, V163, P647; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Hu Q, 2008, PLANT BIOTECHNOL J, V6, P176, DOI 10.1111/j.1467-7652.2007.00310.x; Ishikawa Y, 2006, J GENE MED, V8, P646, DOI 10.1002/jgm.891; JAYARAM M, 1985, P NATL ACAD SCI USA, V82, P5875, DOI 10.1073/pnas.82.17.5875; Kanginakudru S, 2007, INSECT MOL BIOL, V16, P635, DOI 10.1111/j.1365-2583.2007.00753.x; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Li B, 2010, J BIOTECHNOL, V145, P206, DOI 10.1016/j.jbiotec.2009.11.010; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Mange A, 1997, J MOL BIOL, V265, P266, DOI 10.1006/jmbi.1996.0734; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; MORRIS AC, 1991, NUCLEIC ACIDS RES, V19, P5895, DOI 10.1093/nar/19.21.5895; Nakayama G, 2006, MOL GENET GENOMICS, V275, P1, DOI 10.1007/s00438-005-0026-3; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Siegal ML, 2000, METH MOL B, V136, P487; SONTI RV, 1995, PLANT MOL BIOL, V28, P1127, DOI 10.1007/BF00032673; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Tomita S, 1999, APPL ENTOMOL ZOOL, V34, P371, DOI 10.1303/aez.34.371; Turakainen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004341; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; Vazquez-Manrique RP, 2010, GENOMICS, V95, P37, DOI 10.1016/j.ygeno.2009.09.001; Wong AC, 2011, TRANSGENIC RES, V20, P409, DOI 10.1007/s11248-010-9410-9; Woo HJ, 2009, TRANSGENIC RES, V18, P455, DOI 10.1007/s11248-008-9236-x; Wu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008054; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xiang Z.H., 2005, BIOL SERICULTURE, P1; Zhao AC, 2012, INSECT SCI, V19, P172, DOI 10.1111/j.1744-7917.2011.01422.x; Zhao Ai-chun, 2004, Acta Genetica Sinica, V31, P787; Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7; Zuber ME, 2012, GENESIS, V50, P325, DOI 10.1002/dvg.22006	60	51	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40150	10.1371/journal.pone.0040150	http://dx.doi.org/10.1371/journal.pone.0040150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768245	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100218
J	Petrus, AK; Swithers, KS; Ranjit, C; Wu, S; Brewer, HM; Gogarten, JP; Pasa-Tolic, L; Noll, KM				Petrus, Amanda K.; Swithers, Kristen S.; Ranjit, Chaman; Wu, Si; Brewer, Heather M.; Gogarten, J. Peter; Pasa-Tolic, Ljiljana; Noll, Kenneth M.			Genes for the Major Structural Components of Thermotogales Species' Togas Revealed by Proteomic and Evolutionary Analyses of OmpA and OmpB Homologs	PLOS ONE			English	Article							CARBOXY-TERMINAL PHENYLALANINE; SEQUENCE ALIGNMENT; COILED-COIL; CELL-WALL; PROTEIN; ALPHA; BACTERIA; SPECTRA; CLONING; MODEL	The unifying structural characteristic of members of the bacterial order Thermotogales is their toga, an unusual cell envelope that includes a loose-fitting sheath around each cell. Only two toga-associated structural proteins have been purified and characterized in Thermotoga maritima: the anchor protein OmpA1 (or Omp alpha) and the porin OmpB (or Omp beta). The gene encoding OmpA1 (ompA1) was cloned and sequenced and later assigned to TM0477 in the genome sequence, but because no peptide sequence was available for OmpB, its gene (ompB) was not annotated. We identified six porin candidates in the genome sequence of T. maritima. Of these candidates, only one, encoded by TM0476, has all the characteristics reported for OmpB and characteristics expected of a porin including predominant beta-sheet structure, a carboxy terminus porin anchoring motif, and a porin-specific amino acid composition. We highly enriched a toga fraction of cells for OmpB by sucrose gradient centrifugation and hydroxyapatite chromatography and analyzed it by LC/MS/MS. We found that the only porin candidate that it contained was the TM0476 product. This cell fraction also had beta-sheet character as determined by circular dichroism, consistent with its enrichment for OmpB. We conclude that TM0476 encodes OmpB. A phylogenetic analysis of OmpB found orthologs encoded in syntenic locations in the genomes of all but two Thermotogales species. Those without orthologs have putative isofunctional genes in their place. Phylogenetic analyses of OmpA1 revealed that each species of the Thermotogales has one or two OmpA homologs. T. maritima has two OmpA homologs, encoded by ompA1 (TM0477) and ompA2 (TM1729), both of which were found in the toga protein-enriched cell extracts. These annotations of the genes encoding toga structural proteins will guide future examinations of the structure and function of this unusual lineage-defining cell sheath.	[Petrus, Amanda K.; Swithers, Kristen S.; Ranjit, Chaman; Gogarten, J. Peter; Noll, Kenneth M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06340 USA; [Wu, Si; Brewer, Heather M.; Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Washington, DC USA	University of Connecticut; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Petrus, AK (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06340 USA.	kenneth.noll@uconn.edu		Gogarten, Johann Peter/0000-0001-6459-6518	US Department of Energy Office of Basic Science program [DE-FG02-08ER64687]; NASA Exobiology program [NNX08AQ10G]; Environmental Molecular Sciences Laboratory of Pacific Northwest National Laboratory [39965]; U. S. Department of Energy (DOE) Office of Biological and Environmental Research; Direct For Biological Sciences [0830024] Funding Source: National Science Foundation	US Department of Energy Office of Basic Science program(United States Department of Energy (DOE)); NASA Exobiology program(National Aeronautics & Space Administration (NASA)); Environmental Molecular Sciences Laboratory of Pacific Northwest National Laboratory; U. S. Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by grants from the US Department of Energy Office of Basic Science program (DE-FG02-08ER64687), NASA Exobiology program (NNX08AQ10G), and the Environmental Molecular Sciences Laboratory of Pacific Northwest National Laboratory (ID # 39965). Portions of this work were supported by the U. S. Department of Energy (DOE) Office of Biological and Environmental Research and performed in the Environmental Molecular Science Laboratory (EMSL), a DOE national scientific user facility located on the campus of Pacific Northwest National Laboratory (PNNL) in Richland, Washington. The aforementioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Beveridge TJ, 2001, BIOTECH HISTOCHEM, V76, P111, DOI 10.1080/714028139; BOLLA JM, 1995, J BACTERIOL, V177, P4266, DOI 10.1128/jb.177.15.4266-4271.1995; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; deCock H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/jmbi.1997.1069; Do CB, 2008, METHODS MOL BIOL, V484, P379, DOI 10.1007/978-1-59745-398-1_25; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ENGEL AM, 1993, FEMS MICROBIOL LETT, V109, P231, DOI 10.1016/0378-1097(93)90025-W; ENGEL AM, 1992, EMBO J, V11, P4369, DOI 10.1002/j.1460-2075.1992.tb05537.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liebl WG, 2008, J BACTERIOL, V190, P1350, DOI 10.1128/JB.01149-07; Lim WJ, 2003, RES MICROBIOL, V154, P681, DOI 10.1016/j.resmic.2003.09.005; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; LUPAS A, 1995, J MOL BIOL, V248, P180, DOI 10.1006/jmbi.1995.0210; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Nanavati D, 2002, MICROBIOL-SGM, V148, P3531, DOI 10.1099/00221287-148-11-3531; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nesbo CL, 2012, EXTREMOPHILES, V16, P387, DOI 10.1007/s00792-012-0437-0; Park JS, 2012, FASEB J, V26, P219, DOI 10.1096/fj.11-188425; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; RACHEL R, 1990, FEBS LETT, V262, P64, DOI 10.1016/0014-5793(90)80155-C; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SCHUMANN J, 1991, FEBS LETT, V282, P122, DOI 10.1016/0014-5793(91)80459-G; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stenkova AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020546; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Taboada B, 2011, NUCLEIC ACIDS RES, V40, P1; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilkins MR, 1999, METH MOL B, V112, P531; WINTERHALTER C, 1995, APPL ENVIRON MICROB, V61, P1810, DOI 10.1128/AEM.61.5.1810-1815.1995	46	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40236	10.1371/journal.pone.0040236	http://dx.doi.org/10.1371/journal.pone.0040236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768259	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100232
J	Xu, JQ; Sun, YD; Huang, X; Luan, WZ				Xu, Jianqiang; Sun, Yongdong; Huang, Xin; Luan, Wenzhong			Management of Symptomatic Sacral Perineural Cysts	PLOS ONE			English	Article							FIBRIN GLUE THERAPY; MENINGEAL CYSTS; DRAINAGE	Background: There has been no consensus on the optimal treatment of symptomatic sacral perineural cysts. Most previous reports concerning the management methods were either sporadic case reports or a series of limited cases. This study is to further optimize the management for patients with symptomatic sacral perineural cysts by analyzing the outcomes of a cohort of patients who were treated with different strategies. Methods and Findings: We reviewed the outcomes of 15 patients with symptomatic sacral perineural cysts who were managed by three different modalities from 1998 through 2010. Six patients underwent microsurgical cyst fenestration and cyst wall imbrication. Seven patients underwent a modified surgical procedure, during which the cerebrospinal fluid leak aperture was located and repaired. Two patients were treated with medication and physical therapy. Outcomes of the patients were assessed by following up (13 months to 10 years). All of the six patients treated with microsurgical cyst fenestration and cyst wall imbrication experienced complete or substantial relief of their preoperative symptoms. However, the symptoms of one patient reappeared eight months after the operation. Another patient experienced a postoperative cerebrospinal fluid leakage. Six of the seven patients treated with the modified surgical operation experienced complete or substantial resolution of their preoperative symptoms, with only one patient who experienced temporary worsening of his preoperative urine incontinence, which disappeared gradually one month later. No new postoperative neurological deficits, no cerebrospinal fluid leaks and no recurrence were observed in the seven patients. The symptoms of the two patients treated with conservative measures aggravated with time. Conclusions: Microsurgical operation should be a treatment consideration in patients with symptomatic sacral perineural cysts. Furthermore, the surgical procedure with partial cyst removal and aperture repair for prevention of cerebrospinal fluid leakage seemed to be more simple and effective.	[Xu, Jianqiang; Sun, Yongdong; Huang, Xin] Gen Hosp, Fengfeng Grp, Dept Neurosurg, Handan, Peoples R China; [Luan, Wenzhong] Peking Univ, Peoples Hosp, Dept Neurosurg, Beijing 100871, Peoples R China	Peking University	Xu, JQ (corresponding author), Gen Hosp, Fengfeng Grp, Dept Neurosurg, Handan, Peoples R China.	wzh_luan@163.com						Acosta Frank L Jr, 2003, Neurosurg Focus, V15, pE15; Bartels RHMA, 1997, NEUROSURGERY, V40, P861, DOI 10.1097/00006123-199704000-00044; Caspar W, 2003, SURG NEUROL, V59, P101, DOI 10.1016/S0090-3019(02)00981-3; Guo DS, 2007, NEUROSURGERY, V60, P1059, DOI 10.1227/01.NEU.0000255457.12978.78; Kunz U, 1999, EUR SPINE J, V8, P218, DOI 10.1007/s005860050161; Lucantoni C, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11221; Morio Y, 2001, SPINE, V26, P451, DOI 10.1097/00007632-200102150-00025; Mummaneni PV, 2000, NEUROSURGERY, V47, P74, DOI 10.1097/00006123-200007000-00016; NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366; Neulen A, 2011, ACTA NEUROCHIR, V153, P1427, DOI 10.1007/s00701-011-1043-0; Patel MR, 1997, AM J ROENTGENOL, V168, P367, DOI 10.2214/ajr.168.2.9016209; PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293; Prashad Bhagwat, 2007, Indian J Orthop, V41, P401, DOI 10.4103/0019-5413.37007; Smith Zachary A, 2011, Surg Neurol Int, V2, P129, DOI 10.4103/2152-7806.85469; Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025; Zhang T, 2007, J NEUROSURG-SPINE, V7, P145, DOI 10.3171/SPI-07/08/145	16	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39958	10.1371/journal.pone.0039958	http://dx.doi.org/10.1371/journal.pone.0039958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768183	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100155
J	Ying, JM; Shan, L; Li, JS; Zhong, L; Xue, LY; Zhao, H; Li, LL; Langford, C; Guo, L; Qiu, T; Lu, N; Tao, Q				Ying, Jianming; Shan, Ling; Li, Jisheng; Zhong, Lan; Xue, Liyan; Zhao, Hong; Li, Lili; Langford, Cordelia; Guo, Lei; Qiu, Tian; Lu, Ning; Tao, Qian			Genome-Wide Screening for Genetic Alterations in Esophageal Cancer by aCGH Identifies 11q13 Amplification Oncogenes Associated with Nodal Metastasis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA MICROARRAYS; BLADDER-CANCER; CTTN EMS1; OVEREXPRESSION; EXPRESSION; HYBRIDIZATION; ARRAY; EPIDEMIOLOGY; CCND1	Background: Esophageal squamous cell carcinoma (ESCC) is highly prevalent in China and other Asian countries, as a major cause of cancer-related mortality. ESCC displays complex chromosomal abnormalities, including multiple structural and numerical aberrations. Chromosomal abnormalities, such as recurrent amplifications and homozygous deletions, directly contribute to tumorigenesis through altering the expression of key oncogenes and tumor suppressor genes. Methodology/Principle Findings: To understand the role of genetic alterations in ESCC pathogenesis and identify critical amplification/deletion targets, we performed genome-wide 1-Mb array comparative genomic hybridization (aCGH) analysis for 10 commonly used ESCC cell lines. Recurrent chromosomal gains were frequently detected on 3q26-27, 5p15-14, 8p12, 8p22-24, 11q13, 13q21-31, 18p11 and 20q11-13, with frequent losses also found on 8p23-22, 11q22, 14q32 and 18q11-23. Gain of 11q13.3-13.4 was the most frequent alteration in ESCC. Within this region, CCND1 oncogene was identified with high level of amplification and overexpression in ESCC, while FGF19 and SHANK2 was also remarkably over-expressed. Moreover, a high concordance (91.5%) of gene amplification and protein overexpression of CCND1 was observed in primary ESCC tumors. CCND1 amplification/overexpression was also significantly correlated with the lymph node metastasis of ESCC. Conclusion: These findings suggest that genomic gain of 11q13 is the major mechanism contributing to the amplification. Novel oncogenes identified within the 11q13 amplicon including FGF19 and SHANK2 may play important roles in ESCC tumorigenesis.	[Ying, Jianming; Shan, Ling; Xue, Liyan; Guo, Lei; Qiu, Tian; Lu, Ning] Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China; [Ying, Jianming; Shan, Ling; Xue, Liyan; Zhao, Hong; Guo, Lei; Qiu, Tian; Lu, Ning] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Ying, Jianming; Li, Jisheng; Zhong, Lan; Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, State Key Lab Oncol S China, Canc Epigenet Lab,Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Ying, Jianming; Li, Jisheng; Zhong, Lan; Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Jisheng] Shandong Univ, Qilu Hosp, Ctr Canc, Dept Chemotherapy, Jinan 250100, Peoples R China; [Zhao, Hong] Peking Union Med Coll, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China; [Langford, Cordelia] Wellcome Trust Sanger Inst, Microarray Facil, Cambridge, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese University of Hong Kong; Chinese University of Hong Kong; Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wellcome Trust Sanger Institute	Ying, JM (corresponding author), Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China.	jmying@hotmail.com; nlu03@126.com; qtao@cuhk.edu.hk	Li, Lili/Q-5750-2018; Tao, Qian/T-4743-2018; Guo, Lei/AEU-0178-2022	Li, Lili/0000-0002-0292-5889; Tao, Qian/0000-0001-5383-4808; 	National Natural Science Foundation of China [30801344, 30928012]; Beijing Nova Program [2009A70]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This study was supported by grants from the National Natural Science Foundation of China (#30801344, #30928012) and the Beijing Nova Program (No. 2009A70). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 1997, SURG ONCOL, V6, P193, DOI 10.1016/S0960-7404(98)00003-6; Arai H, 2003, CANCER GENET CYTOGEN, V146, P16, DOI 10.1016/S0165-4608(03)00106-7; Bass AJ, NAT GENE, V41, P1238; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brown J, 2011, WORLD J GASTROENTERO, V17, P2909, DOI 10.3748/wjg.v17.i24.2909; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; Chi B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-13; Chiang PW, 1999, CLIN CANCER RES, V5, P1381; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Hibberts NA, 1999, CLIN CANCER RES, V5, P2133; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Janssen JWG, 2002, J HUM GENET, V47, P460, DOI 10.1007/s100380200065; JIANG W, 1992, CANCER RES, V52, P2980; Kunisaki C, 2004, HEPATO-GASTROENTEROL, V51, P736; Lambert R, 2007, BEST PRACT RES CL GA, V21, P921, DOI 10.1016/j.bpg.2007.10.001; Law FB, 2007, ONCOGENE, V26, P7490; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Liu GY, 2008, WORLD J GASTROENTERO, V14, P7199, DOI 10.3748/wjg.14.7199; Luo ML, 2007, CELL RES, V17, P298, DOI 10.1038/cr.2007.17; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Maesawa C, 1997, JPN J CANCER RES, V88, P340, DOI 10.1111/j.1349-7006.1997.tb00386.x; Miller CT, 2003, CANCER RES, V63, P4136; Nagasawa S, 2001, J SURG ONCOL, V78, P208, DOI 10.1002/jso.1152; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Park HL, 2008, INT J CANCER, V122, P2498, DOI 10.1002/ijc.23434; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 1993, INT J CANCER, V19, P594; Peng Hui, 2009, Ai Zheng, V28, P38; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Rodrigo JP, 2009, J PATHOL, V217, P516, DOI 10.1002/path.2462; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Thompson SK, 2008, ANN SURG ONCOL, V15, P3447, DOI 10.1245/s10434-008-0155-0; Wang XX, 2006, CELL RES, V16, P356, DOI 10.1038/sj.cr.7310046; Yang ZQ, 2000, CANCER RES, V60, P4735; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zheng M, 2004, AM J PATHOL, V165, P63, DOI 10.1016/S0002-9440(10)63275-0	45	28	36	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39797	10.1371/journal.pone.0039797	http://dx.doi.org/10.1371/journal.pone.0039797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761904	Green Published, gold, Green Submitted			2022-12-25	WOS:000305781700068
J	Jacque, E; Billot, K; Authier, H; Bordereaux, D; Baud, V				Jacque, E.; Billot, K.; Authier, H.; Bordereaux, D.; Baud, V.			RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation	ONCOGENE			English	Article						RelB; NF-kappa B; cell proliferation; p53	NF-KAPPA-B; NUCLEAR-FACTOR; KINASE-ALPHA; MULTIPLE-MYELOMA; GENE-EXPRESSION; PROMOTES; PATHWAYS; DEATH; CARCINOMAS; SUPPRESSOR	The alternative nuclear factor-kappaB (NF-kappa B) - activation pathway proceeds via inducible p100 processing, leading to the activation of RelB-containing dimers. This pathway is aberrantly activated in several types of tumors; however, a direct role for RelB in the control of cell proliferation is still largely unexplored. Here, we demonstrate that RelB provides cell proliferation-inhibitory signals in murine fibroblasts. In agreement with these results, RelB ectopic expression inhibits xenograft tumor growth in vivo, whereas RelB knockdown enhances it. Significantly, we show that RelB inhibits cell proliferation and tumor growth in a p53-dependent manner. Mechanistic studies indicate that RelB regulates the transcription of the p53 tumor-suppressor gene through direct recruitment to the p53 promoter, thus increasing both p53 protein levels and expression of p53 target genes such as p21. Our findings define a novel link between NF-kappa B and growth-inhibitory pathways involving the RelB-dependent transcriptional upregulation of p53. Furthermore, they suggest that inhibition of RelB in some tumor types that retain wild-type p53 may diminish rather than improve therapeutic responses.	[Jacque, E.; Billot, K.; Authier, H.; Bordereaux, D.; Baud, V.] INSERM, Dept Immunol Hematol, Inst Cochin, U1016, F-75014 Paris, France; [Jacque, E.; Billot, K.; Authier, H.; Bordereaux, D.; Baud, V.] CNRS, UMR 8104, Paris, France; [Jacque, E.; Billot, K.; Authier, H.; Bordereaux, D.; Baud, V.] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Baud, V (corresponding author), INSERM, Dept Immunol Hematol, Inst Cochin, U1016, 123 Blvd Port Royal, F-75014 Paris, France.	veronique.baud@inserm.fr	Baud, Veronique/F-7699-2013; Baud, Veronique/AAL-3950-2020	Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X; authier, helene/0000-0002-5556-4570	Agence Nationale pour la Recherche (ANR); Association pour la Recherche sur le Cancer; Belgian InterUniversity Attraction Pole; Canceropole Ile-deFrance and Universite Paris Descartes,; Ministere de la Recherche et des Technologies; Ligue Nationale contre le Cancer; Societe Francaise du Cancer; Bettencourt-Schueller Fundation	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Belgian InterUniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-deFrance and Universite Paris Descartes,; Ministere de la Recherche et des Technologies; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Societe Francaise du Cancer; Bettencourt-Schueller Fundation	D Reisman, G Kroemer, JL Perfettini, M Korner, LA Martinez, T Tchenio, J Browning and I Verma for valuable material; G Piton for technical assistance; N Boggetto for cell sorting (ImagoSeine, Institut Monod, France, Region Ile-de-France grant no. E539); and LL Pritchard for critically reading the manuscript. This work was supported by grants to VB from Agence Nationale pour la Recherche (ANR), Association pour la Recherche sur le Cancer, Belgian InterUniversity Attraction Pole, Canceropole Ile-deFrance and Universite Paris Descartes, post-doctoral funding from ANR (HA and KB), doctoral fellowships from Ministere de la Recherche et des Technologies, Ligue Nationale contre le Cancer, and Societe Francaise du Cancer (EJ), and an award from the Bettencourt-Schueller Fundation (EJ).	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Chen F, 2006, J BIOL CHEM, V281, P37142, DOI 10.1074/jbc.M603631200; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hellin AC, 1998, ONCOGENE, V16, P1187, DOI 10.1038/sj.onc.1201638; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu BG, 2006, P NATL ACAD SCI USA, V103, P17202, DOI 10.1073/pnas.0604481103; Maeda G, 2007, CLIN CANCER RES, V13, P5041, DOI 10.1158/1078-0432.CCR-07-0463; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Mise N, 2006, ONCOGENE, V25, P6637, DOI 10.1038/sj.onc.1209669; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Park E, 2007, CANCER RES, V67, P9158, DOI 10.1158/0008-5472.CAN-07-0590; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Roy B, 1996, ONCOGENE, V13, P2359; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	45	20	21	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 23	2013	32	21					2661	2669		10.1038/onc.2012.282	http://dx.doi.org/10.1038/onc.2012.282			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FH	22777360				2022-12-25	WOS:000319806700007
J	Agarwal, NK; Chen, CH; Cho, H; Boulbes, DR; Spooner, E; Sarbassov, DD				Agarwal, N. K.; Chen, C-H; Cho, H.; Boulbes, D. R.; Spooner, E.; Sarbassov, D. D.			Rictor regulates cell migration by suppressing RhoGDI2	ONCOGENE			English	Article						rictor (rapamycin-insensitive companion of mTOR); cell migration; Rho proteins; RhoGDI2	GDP-DISSOCIATION INHIBITOR; ENDOPLASMIC-RETICULUM; AKT PHOSPHORYLATION; MTOR COMPLEX; CANCER; METASTASIS; ACTIVATION; GROWTH; SITE; DICTYOSTELIUM	Rictor and its binding partner Sin1 are indispensable components of mTORC2 (mammalian target of rapamycin complex 2). The mTORC2 signaling complex functions as the regulatory kinase of the distinct members of AGC kinase family known to regulate cell proliferation and survival. In the early chemotaxis studies in Dictyostelium, the rictor's ortholog has been identified as a regulator of cell migration. How rictor regulates cell migration is poorly characterized. Here we show that rictor regulates cell migration by controlling a potent inhibitor of Rho proteins known as the Rho-GDP dissociation inhibitor 2 (RhoGDI2). On the basis of on our proteomics study we identified that the rictor-dependent deficiency in cell migration is caused by upregulation of RhoGDI2 leading to a low activity of Rac and Cdc42. We found that a suppression of RhoGDI2 by rictor is not related to the Sin1 or raptor function that excludes a role of mTORC2 or mTORC1 in regulation of RhoGDI2. Our study reveals that rictor by suppressing RhoGDI2 promotes activity of the Rho proteins and cell migration.	[Agarwal, N. K.; Chen, C-H; Cho, H.; Boulbes, D. R.; Sarbassov, D. D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, C-H; Cho, H.; Sarbassov, D. D.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX USA; [Spooner, E.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Massachusetts Institute of Technology (MIT); Whitehead Institute	Sarbassov, DD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dsarbass@mdanderson.org	Sarbassov, Dos/AAS-4950-2020	Sarbassov, Dos/0000-0002-6848-1133	MD Anderson Metastasis Research Program; NIH [CA133522]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA133522] Funding Source: NIH RePORTER	MD Anderson Metastasis Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank MA Magnuson for providing the immortalized rictor null MEFs, David A Guertin and David M Sabatini for providing the rictor null primary MEFs, and Bin Su for providing Sin1 null MEFs. This study was supported by the MD Anderson Metastasis Research Program and the NIH grant CA133522 (DDS).	Aimbetov R, 2012, ONCOGENE, V31, P2115, DOI 10.1038/onc.2011.404; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gildea JJ, 2002, CANCER RES, V62, P6418; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Imai K, 2002, BIOCHEM BIOPH RES CO, V296, P305, DOI 10.1016/S0006-291X(02)00861-6; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Khyrul WAKM, 2004, J BIOL CHEM, V279, P54131, DOI 10.1074/jbc.M410051200; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Moissoglu K, 2009, CANCER RES, V69, P2838, DOI 10.1158/0008-5472.CAN-08-1397; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Said N, 2009, CANCER METAST REV, V28, P327, DOI 10.1007/s10555-009-9197-4; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Zhang YQ, 2009, J BIOL CHEM, V284, P12956, DOI 10.1074/jbc.M807845200; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	33	46	48	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 16	2013	32	20					2521	2526		10.1038/onc.2012.287	http://dx.doi.org/10.1038/onc.2012.287			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	148UY	22777355	Green Accepted			2022-12-25	WOS:000319274300003
J	Kuhse, J; Kalbouneh, H; Schlicksupp, A; Mukusch, S; Nawrotzki, R; Kirsch, J				Kuhse, Jochen; Kalbouneh, Heba; Schlicksupp, Andrea; Muekusch, Susanne; Nawrotzki, Ralph; Kirsch, Joachim			Phosphorylation of Gephyrin in Hippocampal Neurons by Cyclin-dependent Kinase CDK5 at Ser-270 Is Dependent on Collybistin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE RECEPTOR; INHIBITORY SYNAPSES; SYNAPTIC PLASTICITY; GABAERGIC SYNAPSES; PROTEIN GEPHYRIN; SPLICE VARIANTS; BINDING; SUBUNITS; TRANSMISSION; CYTOSKELETON	Gephyrin is a scaffold protein essential for the postsynaptic clustering of inhibitory glycine and different subtypes of GABA(A) receptors. The cellular and molecular mechanisms involved in gephyrin-mediated receptor clustering are still not well understood. Here we provide evidence that the gephyrin-binding protein collybistin is involved in regulating the phosphorylation of gephyrin. We demonstrate that the widely used monoclonal antibody mAb7a is a phospho-specific antibody that allows the cellular and biochemical analysis of gephyrin phosphorylation at Ser-270. In addition, another neighbored epitope determinant was identified at position Thr-276. Analysis of the double mutant gephyrin(T276A,S277A) revealed significant reduction in gephyrin cluster formation and altered oligomerization behavior of gephyrin. Moreover, pharmacological inhibition of cyclin-dependent kinases in hippocampal neurons reduced postsynaptic gephyrin mAb7a immunoreactivities. In vitro phosphorylation assays and phosphopeptide competition experiments revealed a phosphorylation at Ser-270 depending on enzyme activities of cyclin-dependent kinases CDK1, -2, or -5. These data indicate that collybistin and cyclin-dependent kinases are involved in regulating the phosphorylation of gephyrin at postsynaptic membrane specializations.	[Kuhse, Jochen] Univ Heidelberg, Inst Anat & Zellbiol, Lehrstuhl 2, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kuhse, J (corresponding author), Univ Heidelberg, Inst Anat & Zellbiol, Lehrstuhl 2, Dept Anat & Cell Biol, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kuhse, Jochen/T-3864-2019; Kalbouneh, Heba/P-4801-2015	Kalbouneh, Heba/0000-0002-0956-9223				Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; Bluem R, 2007, J BIOL CHEM, V282, P37783, DOI 10.1074/jbc.M708301200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Korber C, 2012, MOL CELL NEUROSCI, V50, P250, DOI 10.1016/j.mcn.2012.05.006; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; LANGOSCH D, 1992, FEBS LETT, V298, P113, DOI 10.1016/0014-5793(92)80034-E; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nawrotzki R, 2012, HISTOCHEM CELL BIOL, V137, P471, DOI 10.1007/s00418-012-0914-7; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Shimojima K, 2011, J HUM GENET, V56, P561, DOI 10.1038/jhg.2011.58; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	36	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30952	30966		10.1074/jbc.M112.349597	http://dx.doi.org/10.1074/jbc.M112.349597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22778260	hybrid, Green Published			2022-12-25	WOS:000308791300009
J	Balyasnikova, IV; Wainwright, DA; Solomaha, E; Lee, G; Han, Y; Thaci, B; Lesniak, MS				Balyasnikova, Irina V.; Wainwright, Derek A.; Solomaha, Elena; Lee, Gina; Han, Yu; Thaci, Bart; Lesniak, Maciej S.			Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor alpha 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS EXOTOXIN; CANCER; CELLS; GLIOMA; GLYCOSYLATION; PROTEIN; CHAIN; EXPRESSION; CYTOTOXIN; CLONING	The high affinity interleukin-13 receptor alpha 2 (IL13R alpha 2) is selectively expressed at a high frequency by glioblastoma multiforme (GBM) as well as several other tumor types. One approach for targeting this tumor-specific receptor utilizes the cognate ligand, IL-13, conjugated to cytotoxic molecules. However, this approach lacks specificity because the lower affinity receptor for IL-13, IL13R alpha 1, is widely expressed by normal tissues. Here, we aimed to develop and characterize a novel monoclonal antibody (mAb) specific to IL13R alpha 2 for the therapeutic purpose of targeting IL13R alpha 2-expressing tumors. Hybridoma cell lines were generated and compared for binding affinities to recombinant human IL13R alpha 2 (rhIL13R alpha 2). Clone 47 demonstrated binding to the native conformation of IL13R alpha 2 and was therefore chosen for further studies. Clone 47 bound specifically and with high affinity (K-D = 1.39 x 10(-9) M) to rhIL13R alpha 2 but not to rhIL13R alpha 1 or murine IL13R alpha 2. Furthermore, clone 47 specifically recognized wild-type IL13R alpha 2 expressed on the surface of CHO and HEK cells as well as several glioma cell lines. Competitive binding assays revealed that clone 47 also significantly inhibited the interaction between human soluble IL-13 and IL13R alpha 2 receptor. Moreover, we found that N-linked glycosylation of IL13R alpha 2 contributes in part to the interaction of the antibody to IL13R alpha 2. In vivo, the IL13R alpha 2 mAb improved the survival of nude mice intracranially implanted with a human U251 glioma xenograft. Collectively, these data warrant further investigation of this novel IL13R alpha 2 mAb with an emphasis on translational implications for therapeutic use.	[Balyasnikova, Irina V.; Wainwright, Derek A.; Lee, Gina; Han, Yu; Thaci, Bart; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA; [Solomaha, Elena] Univ Chicago, Biophys Core Facil, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Balyasnikova, IV (corresponding author), Univ Chicago, Brain Tumor Ctr, 5841 S Maryland Ave,MC 3026, Chicago, IL 60637 USA.	ibalyasn@surgery.bsd.uchicago.edu	Han, Yu/GZA-9220-2022	Wainwright, Derek/0000-0001-7232-4264; Thaci, Bart/0000-0001-5392-7174	National Institutes of Health [R01 CA138587, R01 CA122930, R01 NS077388, U01 NS069997, F32 NS073366]; Elsa U. Pardee Foundation; American Cancer Society (ACS) Illinois Division; ACS [RSG-07-276-01]; NATIONAL CANCER INSTITUTE [R01CA122930, R01CA138587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS073366, U01NS069997, R01NS077388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elsa U. Pardee Foundation; American Cancer Society (ACS) Illinois Division(American Cancer Society); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA138587 (to M. S. L.), R01 CA122930 (to M. S. L.), R01 NS077388 (to M. S. L.), U01 NS069997 (to M. S. L.), and F32 NS073366 (to D. A. W.). This work was also supported by the Elsa U. Pardee Foundation (to I. V. B.), American Cancer Society (ACS) Illinois Division (to I. V. B.), and ACS Grant RSG-07-276-01 (to M. S. L.).	Akaiwa M, 2001, CYTOKINE, V13, P75, DOI 10.1006/cyto.2000.0814; Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Debinski W, 1998, NAT BIOTECHNOL, V16, P449, DOI 10.1038/nbt0598-449; Debinski W, 1995, CLIN CANCER RES, V1, P1253; Debinski W, 2000, J NEURO-ONCOL, V48, P103, DOI 10.1023/A:1006446426611; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Gauchat JF, 1997, EUR J IMMUNOL, V27, P971, DOI 10.1002/eji.1830270425; HANSEN HJ, 1993, CANCER, V71, P3478, DOI 10.1002/1097-0142(19930601)71:11<3478::AID-CNCR2820711104>3.0.CO;2-A; Hsu YF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-139; Husain SR, 2000, BLOOD, V95, P3506, DOI 10.1182/blood.V95.11.3506.011k47_3506_3513; Husain SR, 1997, CLIN CANCER RES, V3, P151; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Joshi BH, 2000, CANCER RES, V60, P1168; Joshi BH, 2003, CROAT MED J, V44, P455; Kawakami K, 2006, CANCER RES, V66, P4434, DOI 10.1158/0008-5472.CAN-05-1265; Kawakami M, 2003, CLIN CANCER RES, V9, P6381; Kawakami M, 2002, MOL CANCER THER, V1, P999; Kioi M, 2008, MOL CANCER THER, V7, P1579, DOI 10.1158/1535-7163.MCT-07-2131; Kioi M, 2006, FASEB J, V20, P2378, DOI 10.1096/fj.06-5995fje; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kuan CT, 2000, INT J CANCER, V88, P962, DOI 10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Pini A, 2000, CURR PROTEIN PEPT SC, V1, P155, DOI 10.2174/1389203003381397; Puri RK, 1996, BLOOD, V87, P4333, DOI 10.1182/blood.V87.10.4333.bloodjournal87104333; Rich T, 1996, GENE, V180, P125, DOI 10.1016/S0378-1119(96)00431-3; Ross JS, 2003, AM J CLIN PATHOL, V119, P472, DOI 10.1309/Y6LPC0LR726L9DX9; Sampson JH, 2000, P NATL ACAD SCI USA, V97, P7503, DOI 10.1073/pnas.130166597; Shimamura T, 2010, CLIN CANCER RES, V16, P577, DOI 10.1158/1078-0432.CCR-09-2015; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Souriau C, 2003, EXPERT OPIN BIOL TH, V3, P305, DOI 10.1517/eobt.3.2.305.21159; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990	45	37	40	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30215	30227		10.1074/jbc.M112.370015	http://dx.doi.org/10.1074/jbc.M112.370015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778273	Green Published, hybrid			2022-12-25	WOS:000308579800016
J	Raskin, A; Lange, S; Banares, K; Lyon, RC; Zieseniss, A; Lee, LK; Yamazaki, KG; Granzier, HL; Gregorio, CC; McCulloch, AD; Omens, JH; Sheikh, F				Raskin, Anna; Lange, Stephan; Banares, Katherine; Lyon, Robert C.; Zieseniss, Anke; Lee, Leonard K.; Yamazaki, Katrina G.; Granzier, Henk L.; Gregorio, Carol C.; McCulloch, Andrew D.; Omens, Jeffrey H.; Sheikh, Farah			A Novel Mechanism Involving Four-and-a-half LIM Domain Protein-1 and Extracellular Signal-regulated Kinase-2 Regulates Titin Phosphorylation and Mechanics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; PASSIVE TENSION; SKELETAL-MUSCLE; HEART-MUSCLE; EXPRESSION; STIFFNESS; SEQUENCE; COLLAGEN; ACCELERATION; INVOLVEMENT	Understanding mechanisms underlying titin regulation in cardiac muscle function is of critical importance given recent compelling evidence that highlight titin mutations as major determinants of human cardiomyopathy. We previously identified a cardiac biomechanical stress-regulated complex at the cardiac-specific N2B region of titin that includes four-and-a-half LIM domain protein-1 (Fhl1) and components of the mitogen-activated protein signaling cascade, which impacted muscle compliance in Fhl1 knock-out cardiac muscle. However, direct regulation of these molecular components in mediating titin N2B function remained unresolved. Here we identify Fhl1 as a novel negative regulator of titin N2B levels and phosphorylation-mediated mechanics. We specifically identify titin N2B as a novel substrate of extracellular signal regulated-kinase-2 (Erk2) and demonstrate that Fhl1 directly interferes with Erk2-mediated titin-N2B phosphorylation. We highlight the critical region in titin-N2B that interacts with Fhl1 and residues that are dependent on Erk2-mediated phosphorylation in situ. We also propose a potential mechanism for a known titin-N2B cardiomyopathy-causing mutation that involves this regulatory complex. These studies shed light on a novel mechanism regulating titin-N2B mechano-signaling as well as suggest that dysfunction of these pathways could be important in cardiac disease states affecting muscle compliance.	[Raskin, Anna; Lange, Stephan; Banares, Katherine; Lyon, Robert C.; Lee, Leonard K.; Yamazaki, Katrina G.; Omens, Jeffrey H.; Sheikh, Farah] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Raskin, Anna; Lee, Leonard K.; McCulloch, Andrew D.; Omens, Jeffrey H.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Granzier, Henk L.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Arizona	Sheikh, F (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	fasheikh@ucsd.edu	Lange, Stephan/A-1422-2010	Lange, Stephan/0000-0001-9361-6602	National Institutes of Health [5P01HL46345, 1R01HL095780-01, K99/R00]; MDA Development Grant [MDA68929, K99HL107744-01]; University of California-San Diego Cardiovascular Scholarship awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103566, T32HL007444, R01HL095780, K99HL107744, P01HL046345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA Development Grant; University of California-San Diego Cardiovascular Scholarship awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P01HL46345 (to A. D. M.) and 1R01HL095780-01 (to F. S.).; Supported by MDA Development Grant MDA68929, National Institutes of Health K99/R00 pathway to independence Grant K99HL107744-01, and University of California-San Diego Cardiovascular Scholarship awards.	Asher Craig R, 2002, Cardiol Rev, V10, P218, DOI 10.1097/00045415-200207000-00007; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Betocchi S, 2000, Heart Fail Rev, V5, P333, DOI 10.1023/A:1026559113044; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chu PH, 2000, MECH DEVELOP, V95, P259, DOI 10.1016/S0925-4773(00)00341-5; Fukuda N, 2005, J GEN PHYSIOL, V125, P257, DOI 10.1085/jgp.200409177; Garcia RA, 2005, AM J PHYSIOL-HEART C, V288, pH1080, DOI 10.1152/ajpheart.00860.2004; Gough NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002601; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hwang DM, 2000, GENOMICS, V66, P1, DOI 10.1006/geno.2000.6171; Hwang DM, 1997, CIRCULATION, V96, P4146; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Komuro I, 1996, FASEB J, V10, P631, DOI 10.1096/fasebj.10.5.8621062; Kruger M, 2006, J MUSCLE RES CELL M, V27, P435, DOI 10.1007/s10974-006-9090-5; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Lee SMY, 1998, GENE, V216, P163, DOI 10.1016/S0378-1119(98)00302-3; LeWinter MM, 2007, CLIN CHIM ACTA, V375, P1, DOI 10.1016/j.cca.2006.06.035; LeWinter MM, 2004, CIRCULATION, V110, P109, DOI 10.1161/01.CIR.0000137284.17083.93; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lim DS, 2001, J AM COLL CARDIOL, V38, P1175, DOI 10.1016/S0735-1097(01)01509-1; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Matsumoto Y, 2005, J MUSCLE RES CELL M, V26, P367, DOI 10.1007/s10974-005-9018-5; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Warren CM, 2003, CARDIOVASC RES, V59, P86, DOI 10.1016/S0008-6363(03)00328-6; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Yamada S, 2007, ANAL BIOCHEM, V360, P160, DOI 10.1016/j.ab.2006.10.005; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Yamazaki T, 1996, MOL CELL BIOCHEM, V164, P197, DOI 10.1007/BF00408658; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	49	73	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29273	29284		10.1074/jbc.M112.372839	http://dx.doi.org/10.1074/jbc.M112.372839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778266	hybrid, Green Published			2022-12-25	WOS:000308286900007
J	Kalwa, H; Sartoretto, JL; Sartoretto, SM; Michel, T				Kalwa, Hermann; Sartoretto, Juliano L.; Sartoretto, Simone M.; Michel, Thomas			Angiotensin-II and MARCKS A HYDROGEN PEROXIDE- AND RAC1-DEPENDENT SIGNALING PATHWAY IN VASCULAR ENDOTHELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RESONANCE ENERGY-TRANSFER; INDUCED NEURITE OUTGROWTH; REACTIVE OXYGEN; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; SH-SY5Y CELLS; PC12 CELLS; ACTIVATION; MEMBRANE	MARCKS is an actin-binding protein that modulates vascular endothelial cell migration and cytoskeleton signaling (Kalwa, H., and Michel, T. (2011) J. Biol. Chem. 286, 2320-2330). Angiotensin-II is a vasoactive peptide implicated in vascular physiology as well as pathophysiology; the pathways connecting angiotensin-II and cytoskeletal remodeling are incompletely understood. Here we show that MARCKS is expressed in intact arterial preparations, with prominent staining of the endothelium. In endothelial cells, angiotensin-II-promoted MARCKS phosphorylation is abrogated by PEG-catalase, implicating endogenous H2O2 in the angiotensin-II response. Studies using the H2O2 biosensor HyPer2 reveal that angiotensin-II promotes increases in intracellular H2O2. We used a Rac1 FRET biosensor to show that angiotensin-II promotes Rac1 activation that is attenuated by PEG-catalase. siRN-mediated Rac1 knockdown blocks angiotensin-II-stimulated MARCKS phosphorylation. Cell imaging studies using a phosphoinositide 4,5-bisphosphate (PIP2) biosensor revealed that angiotensin-II PIP2 regulation depends on MARCKS and H2O2. siRN-mediated knockdown of MARCKS or Rac1 attenuates receptor-mediated activation of the tyrosine kinase c-Abl and disrupts actin fiber formation. These studies establish a critical role for H2O2 in angiotensin-II signaling to the endothelial cytoskeleton in a novel pathway that is critically dependent on MARCKS, Rac1, and c-Abl.	[Kalwa, Hermann; Sartoretto, Juliano L.; Sartoretto, Simone M.; Michel, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, 75 Francis St, Boston, MA 02115 USA.	thomas_michel@harvard.edu	Sartoretto, Simone/F-5622-2014; Kalwa, Hermann/ABG-2323-2021	Sartoretto, Simone/0000-0002-0771-233X; sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [HL46457, HL48743, GM36259]; Fonds National de la Recherche, Luxembourg; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R29HL046457, R01HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, HL48743, and GM36259 (to T. M.).; Supported by a postdoctoral fellowship from the Fonds National de la Recherche, Luxembourg.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Amanso Angelica M, 2012, Front Biosci (Schol Ed), V4, P1044; Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Aoki K, 2008, PHILOS T R SOC B, V363, P2143, DOI 10.1098/rstb.2008.2267; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; ARNOLD TP, 1993, BIOCHEM J, V295, P155, DOI 10.1042/bj2950155; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Blackshear PJ, 1996, DEV BRAIN RES, V96, P62, DOI 10.1016/S0165-3806(96)00097-1; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396; Desideri G, 2003, ARTERIOSCL THROM VAS, V23, P1218, DOI 10.1161/01.ATV.0000078521.51319.65; Dietrich U, 2009, BBA-BIOMEMBRANES, V1788, P1474, DOI 10.1016/j.bbamem.2009.04.001; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Finlayson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007833; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Hussain RJ, 2006, HIPPOCAMPUS, V16, P495, DOI 10.1002/hipo.20177; Itoh RE, 2005, EXP CELL RES, V307, P142, DOI 10.1016/j.yexcr.2005.02.026; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Lu D, 1998, J CELL BIOL, V142, P217, DOI 10.1083/jcb.142.1.217; Markvicheva KN, 2011, BIOORGAN MED CHEM, V19, P1079, DOI 10.1016/j.bmc.2010.07.014; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Monahan TS, 2009, FASEB J, V23, P557, DOI 10.1096/fj.08-114173; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Sechi AS, 2000, J CELL SCI, V113, P3685; Shiraishi M, 2006, J CELL PHYSIOL, V209, P1029, DOI 10.1002/jcp.20814; Tanabe A, 2012, J CELL PHYSIOL, V227, P618, DOI 10.1002/jcp.22763; Tzlil S, 2008, BIOPHYS J, V95, P1745, DOI 10.1529/biophysj.108.132522; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822; Yang HJ, 2010, CANCER INVEST, V28, P127, DOI 10.3109/07357900903147184; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452	48	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29147	29158		10.1074/jbc.M112.381517	http://dx.doi.org/10.1074/jbc.M112.381517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773836	hybrid, Green Published			2022-12-25	WOS:000308074600080
J	Ambur, OH; Frye, SA; Nilsen, M; Hovland, E; Tonjum, T				Ambur, Ole Herman; Frye, Stephan A.; Nilsen, Mariann; Hovland, Eirik; Tonjum, Tone			Restriction and Sequence Alterations Affect DNA Uptake Sequence-Dependent Transformation in Neisseria meningitidis	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MODIFICATION SYSTEMS; HOMOLOGOUS RECOMBINATION; NATURAL TRANSFORMATION; EXTRACELLULAR DNA; BIOFILM FORMATION; GONORRHOEAE; BACTERIA; COMPETENCE; IDENTIFICATION	Transformation is a complex process that involves several interactions from the binding and uptake of naked DNA to homologous recombination. Some actions affect transformation favourably whereas others act to limit it. Here, meticulous manipulation of a single type of transforming DNA allowed for quantifying the impact of three different mediators of meningococcal transformation: NlaIV restriction, homologous recombination and the DNA Uptake Sequence (DUS). In the wildtype, an inverse relationship between the transformation frequency and the number of NlaIV restriction sites in DNA was observed when the transforming DNA harboured a heterologous region for selection (ermC) but not when the transforming DNA was homologous with only a single nucleotide heterology. The influence of homologous sequence in transforming DNA was further studied using plasmids with a small interruption or larger deletions in the recombinogenic region and these alterations were found to impair transformation frequency. In contrast, a particularly potent positive driver of DNA uptake in Neisseria sp. are short DUS in the transforming DNA. However, the molecular mechanism(s) responsible for DUS specificity remains unknown. Increasing the number of DUS in the transforming DNA was here shown to exert a positive effect on transformation. Furthermore, an influence of variable placement of DUS relative to the homologous region in the donor DNA was documented for the first time. No effect of altering the orientation of DUS was observed. These observations suggest that DUS is important at an early stage in the recognition of DNA, but does not exclude the existence of more than one level of DUS specificity in the sequence of events that constitute transformation. New knowledge on the positive and negative drivers of transformation may in a larger perspective illuminate both the mechanisms and the evolutionary role(s) of one of the most conserved mechanisms in nature: homologous recombination.	[Ambur, Ole Herman; Frye, Stephan A.; Nilsen, Mariann; Hovland, Eirik; Tonjum, Tone] Ctr Mol Biol & Neurosci, Oslo, Norway; [Frye, Stephan A.; Nilsen, Mariann; Tonjum, Tone] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol, N-0027 Oslo, Norway; [Ambur, Ole Herman; Hovland, Eirik; Tonjum, Tone] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Ambur, OH (corresponding author), Ctr Mol Biol & Neurosci, Oslo, Norway.	o.h.ambur@medisin.uio.no	Tønjum, Tone/J-4581-2014; Ambur, Ole/G-6641-2016; Ambur, Ole Herman/O-5342-2019	Ambur, Ole/0000-0001-9870-6375; Ambur, Ole Herman/0000-0001-9870-6375; Frye, Stephan/0000-0002-0786-8481; Tonjum, Tone/0000-0002-1709-6921	Medical Research Curriculum at the University of Oslo; Research Council of Norway; FUGE platform Consortium for Microbial Science Technology (CAMST)	Medical Research Curriculum at the University of Oslo; Research Council of Norway(Research Council of Norway); FUGE platform Consortium for Microbial Science Technology (CAMST)	This work was supported by The Medical Research Curriculum at the University of Oslo to EH, a Centre of Excellence grant from the Research Council of Norway to Centre for Molecular Biology and Neuroscience (CMBN) and the FUGE platform Consortium for Microbial Science Technology (CAMST) to OHA, SAF, MN and TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2002, MOL MICROBIOL, V46, P1441, DOI 10.1046/j.1365-2958.2002.03265.x; Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BISWAS GD, 1981, J BACTERIOL, V145, P638, DOI 10.1128/JB.145.1.638-640.1981; BoyleVavra S, 1996, MICROBIOL-SGM, V142, P2839, DOI 10.1099/13500872-142-10-2839; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Chaussee MS, 1999, MICROBIOL-UK, V145, P389, DOI 10.1099/13500872-145-2-389; Chaussee MS, 1998, J BACTERIOL, V180, P5117, DOI 10.1128/JB.180.19.5117-5122.1998; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2001, J BACTERIOL, V183, P3160, DOI 10.1128/JB.183.10.3160-3168.2001; Chmiel AA, 2005, PROTEIN ENG DES SEL, V18, P181, DOI 10.1093/protein/gzi019; Claus H, 2000, J BACTERIOL, V182, P1296, DOI 10.1128/JB.182.5.1296-1303.2000; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; Davidsen T, 2004, NUCLEIC ACIDS RES, V32, P1050, DOI 10.1093/nar/gkh255; DOUGHERTY TJ, 1979, BIOCHEM BIOPH RES CO, V86, P97, DOI 10.1016/0006-291X(79)90386-3; Duffin PM, 2010, J BACTERIOL, V192, P4436, DOI 10.1128/JB.00442-10; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; FROHOLM LO, 1973, ACTA PATH MICRO IM B, VB 81, P525; GOODGAL SH, 1990, J BACTERIOL, V172, P5924, DOI 10.1128/jb.172.10.5924-5928.1990; GOODMAN SD, 1991, J BACTERIOL, V173, P5921, DOI 10.1128/jb.173.18.5921-5923.1991; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; GRAVES JF, 1982, J BACTERIOL, V152, P1071; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hill SA, 1999, GENE, V240, P175, DOI 10.1016/S0378-1119(99)00414-X; JYSSUM K, 1965, ACTA PATHOL MIC SC, V63, P306, DOI 10.1111/apm.1965.63.2.306; JYSSUM S, 1970, ACTA PATHOLOG MICROB, VB 78, P140; Kaplan JB, 2002, APPL ENVIRON MICROB, V68, P4943, DOI 10.1128/AEM.68.10.4943-4950.2002; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; KOOMEY JM, 1987, J BACTERIOL, V169, P790, DOI 10.1128/jb.169.2.790-795.1987; LABBE D, 1990, MOL GEN GENET, V224, P101; Lang E, 2009, MICROBIOL-SGM, V155, P852, DOI 10.1099/mic.0.022640-0; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; LAU PCK, 1994, MOL GEN GENET, V243, P24, DOI 10.1007/BF00283872; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; MICHOD RE, 1988, GENETICS, V118, P31; Michod RE, 2008, INFECT GENET EVOL, V8, P267, DOI 10.1016/j.meegid.2008.01.002; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; NISHIGAKI K, 1985, NUCLEIC ACIDS RES, V13, P5747, DOI 10.1093/nar/13.16.5747; QIANG BQ, 1986, NUCLEIC ACIDS RES, V14, P1991, DOI 10.1093/nar/14.5.1991; RITCHOT N, 1990, GENE, V86, P103, DOI 10.1016/0378-1119(90)90120-G; Roberts Michael S., 1993, Genetics, V134, P401; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Seifert HS, 1997, GENE, V188, P215, DOI 10.1016/S0378-1119(96)00810-4; Smith HO, 1999, RES MICROBIOL, V150, P603, DOI 10.1016/S0923-2508(99)00130-8; Snyder LAS, 2007, MOL BIOL EVOL, V24, P2802, DOI 10.1093/molbev/msm215; SOX TE, 1979, J BACTERIOL, V138, P510, DOI 10.1128/JB.138.2.510-518.1979; SPARLING PF, 1966, J BACTERIOL, V92, P1364, DOI 10.1128/JB.92.5.1364-1371.1966; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stefanelli P, 2001, J ANTIMICROB CHEMOTH, V47, P219, DOI 10.1093/jac/47.2.219; STEIN DC, 1988, INFECT IMMUN, V56, P112, DOI 10.1128/IAI.56.1.112-116.1988; STEIN DC, 1995, GENE, V157, P19, DOI 10.1016/0378-1119(94)00649-D; Szollosi GJ, 2006, GENETICS, V174, P2173, DOI 10.1534/genetics.106.063412; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Treangen TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r60; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x	63	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39742	10.1371/journal.pone.0039742	http://dx.doi.org/10.1371/journal.pone.0039742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768309	gold, Green Published, Green Submitted			2022-12-25	WOS:000305966500022
J	Ciupe, SM; Hews, S				Ciupe, Stanca M.; Hews, Sarah			Mathematical Models of E-Antigen Mediated Immune Tolerance and Activation following Prenatal HBV Infection	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; REGULATORY T-CELLS; NATURAL-HISTORY; ANTIVIRAL THERAPY; VIRAL CLEARANCE; CORE PROMOTER; SEROCONVERSION; DYNAMICS; KINETICS; PRECORE	We develop mathematical models for the role of hepatitis B e-antigen in creating immunological tolerance during hepatitis B virus infection and propose mechanisms for hepatitis B e-antigen clearance, subsequent emergence of a potent cellular immune response, and the effect of these on liver damage. We investigate the dynamics of virus-immune cells interactions, and derive parameter regimes that allow for viral persistence. We modify the model to account for mechanisms responsible for hepatitis B e-antigen loss, such as seroconversion and virus mutations that lead to emergence of cellular immune response to the mutant virus. Our models demonstrate that either seroconversion or mutations can induce immune activation and that instantaneous loss of e-antigen by either mechanism is associated with least liver damage and is therefore more beneficial for disease outcomes.	[Ciupe, Stanca M.] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Hews, Sarah] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA	Virginia Polytechnic Institute & State University	Ciupe, SM (corresponding author), Virginia Tech, Dept Math, Blacksburg, VA 24061 USA.	stanca@math.vt.edu			National Science Foundation [DMS-1022865]	National Science Foundation(National Science Foundation (NSF))	SMC acknowledges support from National Science Foundation grant DMS-1022865. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Bertoletti A, 2003, HEPATOLOGY, V38, P4, DOI 10.1053/jhep.2003.50310; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; Carman W, 1989, LANCET, V334, P588; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chang MH, 1998, J GASTROEN HEPATOL, V13, P541, DOI 10.1111/j.1440-1746.1998.tb00685.x; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Ciupe SM, 2007, J THEOR BIOL, V247, P23, DOI 10.1016/j.jtbi.2007.02.017; Ciupe SM, 2007, P NATL ACAD SCI USA, V104, P5050, DOI 10.1073/pnas.0603626104; Ciupe SM, 2011, MATH POPUL STUD, V18, P87, DOI 10.1080/08898480.2011.564563; Colombatto P, 2006, ANTIVIR THER, V11, P197; FATTOVICH G, 1986, HEPATOLOGY, V6, P167, DOI 10.1002/hep.1840060203; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Lau GK, 2007, ANTIVIR THER, V12, P705; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li XF, 2010, CELL IMMUNOL, V264, P42, DOI 10.1016/j.cellimm.2010.04.009; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P246, DOI 10.1046/j.1440-1746.2003.02976.x; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Mason WS, 2005, P NATL ACAD SCI USA, V102, P1139, DOI 10.1073/pnas.0409332102; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Milich DR, 1998, J IMMUNOL, V160, P2013; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; OKAMOTO H, 1994, J VIROL, V68, P8102, DOI 10.1128/JVI.68.12.8102-8110.1994; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perelson AS, 2004, SEMIN LIVER DIS, V24, P11, DOI 10.1055/s-2004-828673; REALDI G, 1980, GASTROENTEROLOGY, V79, P195; Ribeiro RM, 2002, MICROBES INFECT, V4, P829, DOI 10.1016/S1286-4579(02)01603-9; STEVENS CE, 1985, JAMA-J AM MED ASSOC, V253, P1740, DOI 10.1001/jama.253.12.1740; Tsiang M, 1999, HEPATOLOGY, V29, P1863, DOI 10.1002/hep.510290626; Wright TL, 2006, AM J GASTROENTEROL, V101, pS1, DOI 10.1111/j.1572-0241.2006.00469.x; Zhao L, 2010, J DIGEST DIS, V11, P126, DOI 10.1111/j.1751-2980.2010.00428.x	40	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39591	10.1371/journal.pone.0039591	http://dx.doi.org/10.1371/journal.pone.0039591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768303	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500016
J	Arnusch, CJ; Pieters, RJ; Breukink, E				Arnusch, Christopher J.; Pieters, Roland J.; Breukink, Eefjan			Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides	PLOS ONE			English	Article							LIPID-II; NISIN; ANTIBIOTICS; MAGAININS; EXPRESSION; PRECURSOR; DEFENSE; MODE	Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can be modified with a high-affinity targeting module, which enables membrane permeabilization at low concentration. Magainin 2 and a truncated peptide analog were conjugated to vancomycin using click chemistry, and could be directed towards specific membrane embedded receptors both in model membrane systems and whole cells. Compared with untargeted vesicles, a gain in permeabilization efficacy of two orders of magnitude was reached with large unilamellar vesicles that included lipid II, the target of vancomycin. The truncated vancomycin-peptide conjugate showed an increased activity against vancomycin resistant Enterococci, whereas the full-length conjugate was more active against a targeted eukaryotic cell model: lipid II containing erythrocytes. This study highlights that AMPs can be made more selective and more potent against biological membranes that contain structures that can be targeted.	[Arnusch, Christopher J.; Breukink, Eefjan] Univ Utrecht, Dept Membrane Biochem & Biophys, Utrecht, Netherlands; [Arnusch, Christopher J.; Pieters, Roland J.] Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht, Netherlands	Utrecht University; Utrecht University	Arnusch, CJ (corresponding author), Ben Gurion Univ Negev, Dept Desalinat & Water Treatment, Sede Boqer Campus, IL-84105 Beer Sheva, Israel.	r.j.pieters@uu.nl; e.j.breukink@uu.nl	Arnusch, Christopher/F-4069-2012; Pieters, Roland J/A-9254-2008; Breukink, Eefjan/I-3039-2016	Pieters, Roland J/0000-0003-4723-3584; Breukink, Eefjan/0000-0002-7311-0660	council for Chemical Sciences of the Netherlands, Organization for Scientific Research	council for Chemical Sciences of the Netherlands, Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by the council for Chemical Sciences of the Netherlands, Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Richard, 1994, US Patent, Patent No. 5912231; Arnusch CJ, 2007, BIOCHEMISTRY-US, V46, P13437, DOI 10.1021/bi7015553; Arnusch CJ, 2008, BIOCHEMISTRY-US, V47, P12661, DOI 10.1021/bi801597b; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Breukink E, 1999, BBA-BIOMEMBRANES, V1462, P223, DOI 10.1016/S0005-2736(99)00208-4; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Chamorro C, 2012, BBA-BIOMEMBRANES, V1818, P2171, DOI 10.1016/j.bbamem.2012.04.004; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153; Fernandez DI, 2009, BBA-BIOMEMBRANES, V1788, P1630, DOI 10.1016/j.bbamem.2008.10.007; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; HO SB, 1993, CANCER RES, V53, P641; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Oren Z, 1998, BIOPOLYMERS, V47, P451; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; UTSUGI T, 1991, CANCER RES, V51, P3062; Wiedemann I, 2004, J BACTERIOL, V186, P3259, DOI 10.1128/JB.186.10.3259-3261.2004; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	28	45	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39768	10.1371/journal.pone.0039768	http://dx.doi.org/10.1371/journal.pone.0039768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768121	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100091
J	Bray, TC; Bloomer, P; O'Riain, MJ; Bennett, NC				Bray, Timothy C.; Bloomer, Paulette; O'Riain, M. Justin; Bennett, Nigel C.			How Attractive Is the Girl Next Door? An Assessment of Spatial Mate Acquisition and Paternity in the Solitary Cape Dune Mole-Rat, Bathyergus suillus	PLOS ONE			English	Article							MALE REPRODUCTIVE SUCCESS; CRYPTOMYS-HOTTENTOTUS; BURROW ARCHITECTURE; MULTIPLE PATERNITY; SEXUAL-DIMORPHISM; GENETIC-STRUCTURE; COMPUTER-PROGRAM; MATING SYSTEM; RODENTIA; FAMILY	Behavioural observations of reproduction and mate choice in wild fossorial rodents are extremely limited and consequently indirect methods are typically used to infer mating strategies. We use a combination of morphological, reproductive, spatial, and genetic data to investigate the reproductive strategy of a solitary endemic species, the Cape dune mole-rat Bathyergus suillus. These data provide the first account on the population dynamics of this species. Marked sexual dimorphism was apparent with males being both significantly larger and heavier than females. Of all females sampled 36% had previously reproduced and 12% were pregnant at the time of capture. Post-partum sex ratio was found to be significantly skewed in favour of females. The paternity of fifteen litters (n = 37) was calculated, with sires assigned to progeny using both categorical and full probability methods, and including a distance function. The maximum distance between progeny and a putative sire was determined as 2149 m with males moving between sub-populations. We suggest that above-ground movement should not be ignored in the consideration of mate acquisition behaviour of subterranean mammals. Estimated levels of multiple paternity were shown to be potentially as high as 26%, as determined using sibship and sire assignment methods. Such high levels of multiple paternity have not been found in other solitary mole-rat species. The data therefore suggest polyandry with no evidence as yet for polygyny.	[Bray, Timothy C.; Bennett, Nigel C.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Bloomer, Paulette] Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa; [O'Riain, M. Justin] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa	University of Pretoria; University of Pretoria; University of Cape Town	Bray, TC (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	tim_c_bray@zoology.up.ac.za	Bloomer, Paulette/F-5501-2010; Bennett, Nigel/E-4238-2010	Bloomer, Paulette/0000-0002-6357-0153; Bennett, Nigel/0000-0001-9748-2947; O'Riain, M. Justin/0000-0001-5233-8327	Department of Science and Technology from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; National Research Foundation from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; University of Pretoria; National Research Foundation	Department of Science and Technology from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; National Research Foundation from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; University of Pretoria; National Research Foundation	The authors are grateful to the Department of Science and Technology and the National Research Foundation for funding from the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology awarded to NB. Funding was also provided by the University of Pretoria in provision of TB's postdoctoral fellowship. This work is based upon research supported by the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RJ, 1999, MOL ECOL, V8, P107, DOI 10.1046/j.1365-294X.1999.00541.x; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1988, J ZOOL, V214, P95, DOI 10.1111/j.1469-7998.1988.tb04989.x; Bishop JM, 2007, BIOL LETTERS, V3, P176, DOI 10.1098/rsbl.2006.0607; Bishop JM, 2004, MOL ECOL, V13, P1217, DOI 10.1111/j.1365-294X.2004.02131.x; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Bray TC, 2011, CONSERV GENET RESOUR, V3, P221, DOI 10.1007/s12686-010-9327-x; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; Burland TM, 2001, MOL ECOL NOTES, V1, P311, DOI 10.1046/j.1471-8278 .2001.00121.x; CHARNOV E L, 1982; Choate JR, 1998, J MAMMAL, V79, P1416; Ciuti S, 2011, ETHOLOGY, V117, P133, DOI 10.1111/j.1439-0310.2010.01862.x; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Coker CR, 2002, AUK, V119, P403, DOI 10.1642/0004-8038(2002)119[0403:IOMATS]2.0.CO;2; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DAVIES KC, 1986, J ZOOL, V209, P125, DOI 10.1111/j.1469-7998.1986.tb03570.x; Eberle M, 2004, BEHAV ECOL SOCIOBIOL, V57, P91, DOI [10.1007/s00265-004-0823-4, 10.1007/s00265-004-0826-1]; ESRI, 2011, ARCGIS DESKT REL 10; Faulkes CG, 1997, MOL ECOL, V6, P615, DOI 10.1046/j.1365-294X.1997.00227.x; Fisher R.A., 1930, GENETICAL THEORY NAT; FRALEY C, 2006, 504 U WASH DEP STAT; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hart L, 2006, J MAMMAL, V87, P1078, DOI 10.1644/05-MAMM-A-411R2.1; Hart L, 2007, J MAMMAL, V88, P657, DOI 10.1644/06-MAMM-A-058R1.1; Herbst M, 2006, J ZOOL, V270, P420, DOI 10.1111/j.1469-7998.2006.00151.x; Herbst M, 2004, J ZOOL, V263, P259, DOI 10.1017/S0952836904005114; HETH G, 1989, J ZOOL, V217, P39, DOI 10.1111/j.1469-7998.1989.tb02473.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Ingram CM, 2005, THESIS TEXAS A M U; Jacobs DS, 1996, BEHAV ECOL SOCIOBIOL, V39, P401, DOI 10.1007/s002650050307; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Katsushima K, 2010, MOL ECOL RESOUR, V10, P222, DOI 10.1111/j.1755-0998.2009.02742.x; Kinahan AA, 2007, EVOL ECOL, V21, P201, DOI 10.1007/s10682-006-0022-z; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; LEUTENEGGER W, 1987, AM J PRIMATOL, V13, P171, DOI 10.1002/ajp.1350130207; LOVEGROVE BG, 1989, PHYSIOL ZOOL, V62, P449, DOI 10.1086/physzool.62.2.30156179; Malik A, 2011, POPUL ECOL, V53, P501, DOI 10.1007/s10144-011-0264-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McEachern MB, 2009, ANIM BEHAV, V77, P449, DOI 10.1016/j.anbehav.2008.10.024; NARINS PM, 1992, J COMP PHYSIOL A, V170, P13; Nemec P, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P129, DOI 10.1007/978-3-540-69276-8_11; Nielsen CLR, 2007, J MAMMAL, V88, P441, DOI 10.1644/06-MAMM-A-126R2.1; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Patzenhauerova H, 2010, BEHAV ECOL SOCIOBIOL, V64, P757, DOI 10.1007/s00265-009-0893-4; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; Randall JA, 2002, ANIM BEHAV, V64, P11, DOI 10.1006/anbe.2002.3029; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RUTBERG AT, 1983, J THEOR BIOL, V104, P93, DOI 10.1016/0022-5193(83)90403-4; Schradin C, 2012, MOL ECOL, V21, P541, DOI 10.1111/j.1365-294X.2011.05256.x; Schradin C, 2011, J ANIM ECOL, V80, P908, DOI 10.1111/j.1365-2656.2011.01831.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Solmsen N, 2011, MOL ECOL, V20, P1624, DOI 10.1111/j.1365-294X.2011.05042.x; STACEY PB, 1982, AM NAT, V120, P51, DOI 10.1086/283969; Steinberg EK, 2000, LIFE UNDERGROUND BIO, P257; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Thomas HG, 2009, J ZOOL, V279, P277, DOI 10.1111/j.1469-7998.2009.00616.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waser PM, 2011, MOL ECOL, V20, P1277, DOI 10.1111/j.1365-294X.2011.05002.x; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Zenuto RR, 2004, J CHEM ECOL, V30, P2111, DOI 10.1023/B:JOEC.0000048777.42945.e4	70	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39866	10.1371/journal.pone.0039866	http://dx.doi.org/10.1371/journal.pone.0039866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768149	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100118
J	Frid, A; Marliave, J; Heithaus, MR				Frid, Alejandro; Marliave, Jeff; Heithaus, Michael R.			Interspecific Variation in Life History Relates to Antipredator Decisions by Marine Mesopredators on Temperate Reefs	PLOS ONE			English	Article							COMPETITION; PREDATION; BEHAVIOR; FISHES; RISK	As upper-level predatory fishes become overfished, mesopredators rise to become the new 'top' predators of over-exploited marine communities. To gain insight into ensuing mechanisms that might alter indirect species interactions, we examined how behavioural responses to an upper-level predatory fish might differ between mesopredator species with different life histories. In rocky reefs of the northeast Pacific Ocean, adult lingcod (Ophiodon elongatus) are upper-level predators that use a sit-and-wait hunting mode. Reef mesopredators that are prey to adult lingcod include kelp greenling (Hexagrammos decagrammus), younger lingcod, copper rockfish (Sebastes caurinus) and quillback rockfish (S. maliger). Across these mesopredators species, longevity and age at maturity increases and, consequently, the annual proportion of lifetime reproductive output decreases in the order just listed. Therefore, we hypothesized that the level of risk taken to acquire resources would vary interspecifically in that same order. During field experiments we manipulated predation risk with a model adult lingcod and used fixed video cameras to quantify interactions between mesopredators and tethered prey (Pandalus shrimps). We predicted that the probabilities of inspecting and attacking tethered prey would rank from highest to lowest and the timing of these behaviours would rank from earliest to latest as follows: kelp greenling, lingcod, copper rockfish, and quillback rockfish. We also predicted that responses to the model lingcod, such as avoidance of interactions with tethered prey, would rank from weakest to strongest in the same order. Results were consistent with our predictions suggesting that, despite occupying similar trophic levels, longer-lived mesopredators with late maturity have stronger antipredator responses and therefore experience lower foraging rates in the presence of predators than mesopredators with faster life histories. The corollary is that the fishery removal of top predators, which relaxes predation risk, could potentially lead to stronger increases in foraging rates for mesopredators with slower life histories.	[Frid, Alejandro; Marliave, Jeff] Vancouver Aquarium, Vancouver, BC, Canada; [Heithaus, Michael R.] Florida Int Univ, Sch Environm Arts & Soc, Dept Biol Sci, N Miami, FL USA	State University System of Florida; Florida International University	Frid, A (corresponding author), Vancouver Aquarium, Vancouver, BC, Canada.	alejfrid@gmail.com	Heithaus, Michael/AAF-9914-2020	Heithaus, Michael/0000-0002-3219-1003	Florida International University Division of Research	Florida International University Division of Research	The study was funded in its entirety through a Seed Funds Award to Michael R Heithaus from the The Florida International University Division of Research. See http://research.fiu.edu/funding/internalFunding/seedFunds.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 1996, ECOLOGY, V77, P1116, DOI 10.2307/2265580; Beaudreau A. H., 2009, THESIS U WASHINGTON; Beaudreau AH, 2007, T AM FISH SOC, V136, P1438, DOI 10.1577/T06-236.1; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; CASS AJ, 1990, CAN SPEC PUBL FISH A, V109; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Frid A, 2010, BIOL LETTERS, V6, P533, DOI 10.1098/rsbl.2010.0034; FROESE R., 2012, FISHBASE; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; KING J., 2000, 2000164 CAN STOCK AS; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Love M. S., 2002, ROCKFISHES NE PACIFI; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Murie DJ, 1995, MAR BIOL, V124, P341, DOI 10.1007/BF00363908; Nemeth DH, 1997, J EXP BIOL, V200, P2145; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Shanks AL, 2005, ECOL MONOGR, V75, P505, DOI 10.1890/05-0309; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Strong DR, 2010, ANNU REV ENV RESOUR, V35, P1, DOI 10.1146/annurev-environ-031809-133103; Warner RR, 1998, J FISH BIOL, V53, P82, DOI 10.1111/j.1095-8649.1998.tb01019.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Zar JH., 1999, BIOSTAT ANAL	25	18	18	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40083	10.1371/journal.pone.0040083	http://dx.doi.org/10.1371/journal.pone.0040083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768226	Green Published, gold			2022-12-25	WOS:000305892100198
J	Giladi, M; Sasson, Y; Fang, XY; Hiller, R; Buki, T; Wang, YX; Hirsch, JA; Khananshvili, D				Giladi, Moshe; Sasson, Yehezkel; Fang, Xianyang; Hiller, Reuben; Buki, Tal; Wang, Yun-Xing; Hirsch, Joel A.; Khananshvili, Daniel			A Common Ca2+-Driven Interdomain Module Governs Eukaryotic NCX Regulation	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGE; CA2+ BINDING DOMAINS; NA+-CA2+ EXCHANGER; NA+/CA2+ EXCHANGER; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; CA2+-BINDING DOMAIN; CONSURF; SENSOR; IDENTIFICATION	Na+/Ca2+ exchanger (NCX) proteins mediate Ca2+-fluxes across the cell membrane to maintain Ca2+ homeostasis in many cell types. Eukaryotic NCX contains Ca2+-binding regulatory domains, CBD1 and CBD2. Ca2+ binding to a primary sensor (Ca3-Ca4 sites) on CBD1 activates mammalian NCXs, whereas CALX, a Drosophila NCX ortholog, displays an inhibitory response to regulatory Ca2+. To further elucidate the underlying regulatory mechanisms, we determined the 2.7 angstrom crystal structure of mammalian CBD12-E454K, a two-domain construct that retains wild-type properties. In conjunction with stopped-flow kinetics and SAXS (small-angle X-ray scattering) analyses of CBD12 mutants, we show that Ca2+ binding to Ca3-Ca4 sites tethers the domains via a network of interdomain salt-bridges. This Ca2+-driven interdomain switch controls slow dissociation of "occluded" Ca2+ from the primary sensor and thus dictates Ca2+ sensing dynamics. In the Ca2+-bound conformation, the interdomain angle of CBD12 is very similar in NCX and CALX, meaning that the interdomain distances cannot account for regulatory diversity in NCX and CALX. Since the two-domain interface is nearly identical among eukaryotic NCXs, including CALX, we suggest that the Ca2+-driven interdomain switch described here represents a general mechanism for initial conduction of regulatory signals in NCX variants.	[Giladi, Moshe; Hiller, Reuben; Buki, Tal; Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Sasson, Yehezkel; Hirsch, Joel A.] Tel Aviv Univ, Dept Biochem & Mol Biol, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Fang, Xianyang; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, NIH, Frederick, MD 21701 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giladi, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	jhirsch@post.tau.ac.il; dhanan@post.tau.ac.il	Hirsch, Joel/AAC-8000-2021	Hirsch, Joel/0000-0001-7544-8668; Fang, Xianyang/0000-0001-9432-9736; Giladi, Moshe/0000-0002-8589-6920; Khananshvili, Daniel/0000-0002-4202-9966	Israeli Ministry of Health [2010-3-6266]; USA-Israel Binational Foundation Research [2009-334]; Israel Science Foundation [23/10]; DIP-DFG	Israeli Ministry of Health; USA-Israel Binational Foundation Research(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); DIP-DFG	This work was partially funded by the Israeli Ministry of Health Grant # 2010-3-6266, the USA-Israel Binational Foundation Research Grant # 2009-334, the Israel Science Foundation Grant # 23/10 to DK and a DIP-DFG grant to JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baumgartner W, 2003, J NEUROSCI, V23, P11008; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	41	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39985	10.1371/journal.pone.0039985	http://dx.doi.org/10.1371/journal.pone.0039985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768191	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100163
J	Joeris, T; Schmidt, N; Ermert, D; Krienke, P; Visekruna, A; Kuckelkorn, U; Kaufmann, SHE; Steinhoff, U				Joeris, Thorsten; Schmidt, Nicole; Ermert, David; Krienke, Petra; Visekruna, Alexander; Kuckelkorn, Ulrike; Kaufmann, Stefan H. E.; Steinhoff, Ulrich			The Proteasome System in Infection: Impact of beta 5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes	PLOS ONE			English	Article							MAMMALIAN 20S PROTEASOMES; SUBUNITS; IMMUNOPROTEASOMES; DEGRADATION; EXPRESSION; COMPLETION; MECHANISM; COLITIS; TISSUES; CELLS	Proteasomes are the major enzyme complexes for non-lysosomal protein degradation in eukaryotic cells. Mammals express two sets of catalytic subunits: the constitutive subunits beta 1, beta 2 and beta 5 and the immunosubunits LMP2 (beta 1i), MECL-1 (beta 2i) and LMP7 (beta 5i). The LMP7-propeptide (proLMP7) is required for optimal maturation of LMP2/MECL-1-containing precursors to mature immunoproteasomes, but can also mediate efficient integration into mixed proteasomes containing beta 1 and beta 2. In contrast, the beta 5-propeptide (pro beta 5) has been suggested to promote preferential integration into beta 1/beta 2-containing precursors, consequently favouring the formation of constitutive proteasomes. Here, we show that pro beta 5 predominantly promotes integration into LMP2/MECL-1-containing precursors in IFN gamma-stimulated, LMP7-deficient cells and infected LMP7-deficient mice. This demonstrates that pro beta 5 does not direct preferential integration into beta 1/beta 2-containing precursors, but instead promotes the formation of mixed LMP2/MECL-1/beta 5 proteasomes under inflammatory conditions. Moreover, the propeptides substantially differ in their capacity to promote proteasome maturation, with proLMP7 showing a significantly higher chaperone activity as compared to pro beta 5. Increased efficiency of proteasome maturation mediated by proLMP7 is required for optimal MHC class I cell surface expression and is equally important as the catalytic activity of immunoproteasomes. Intriguingly, induction of LMP7 by infection not only results in rapid exchange of constitutive by immunosubunits, as previously suggested, but also increases the total proteasome abundance within the infected tissue. Hence our data identify a novel LMP7-dependend mechanism to enhance the activity of the proteasome system in infection, which is based on the high chaperone activity of proLMP7 and relies on accelerated maturation of active proteasome complexes.	[Joeris, Thorsten; Schmidt, Nicole; Krienke, Petra; Kaufmann, Stefan H. E.; Steinhoff, Ulrich] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Ermert, David] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Visekruna, Alexander; Steinhoff, Ulrich] Univ Marburg, Inst Microbiol & Hyg, Marburg, Germany; [Kuckelkorn, Ulrike] Charite, Inst Biochem, Berlin, Germany	Max Planck Society; Max Planck Society; Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Joeris, T (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	ulrich.steinhoff@staff.uni-marburg.de	Ermert, David/I-5879-2013; Kaufmann, Stefan HE/I-5454-2014	Ermert, David/0000-0003-4600-9070; Visekruna, Alexander/0000-0002-5207-9545; Steinhoff, Ulrich/0000-0003-2141-7756; Kaufmann, Stefan HE/0000-0001-9866-8268; Kuckelkorn, Ulrike/0000-0002-3085-9161	German Research Foundation [KU1261/1, SFB650 TP18]; Charite Berlin; Sonnenfeld-Stiftung; IMPRS-IDI	German Research Foundation(German Research Foundation (DFG)); Charite Berlin; Sonnenfeld-Stiftung; IMPRS-IDI	Funding was provided by the following sources: German Research Foundation, projects KU1261/1 and SFB650 TP18 (htt://www.dfg.de), and a PhD grant of the Charite Berlin (http://www.charite.de); a PhD grant of the Sonnenfeld-Stiftung (http://www.sonnenfeld-stiftung.de); and a PhD grant of the IMPRS-IDI (http://www.zibi-graduateschool-berlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guillaume B, 2010, P NATL ACAD SCI US; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kingsbury DJ, 2000, J BIOL CHEM, V275, P24156, DOI 10.1074/jbc.M001742200; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Li X, 2007, EMBO J; Muchamuel T, 2009, NAT MED; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Ramos PC, 2004, J BIOL CHEM, V279, P14323, DOI 10.1074/jbc.M308757200; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schmidt M, 1999, J MOL BIOL, V288, P117, DOI 10.1006/jmbi.1999.2660; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Visekruna A, 2009, INFLAMM BOWEL DIS, V15, P526, DOI 10.1002/ibd.20805; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39827	10.1371/journal.pone.0039827	http://dx.doi.org/10.1371/journal.pone.0039827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768135	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100105
J	Louie, JK; Yang, S; Yen, C; Acosta, M; Schechter, R; Uyeki, TM				Louie, Janice K.; Yang, Samuel; Yen, Cynthia; Acosta, Meileen; Schechter, Robert; Uyeki, Timothy M.			Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09	PLOS ONE			English	Article							VIRUS-INFECTION; A H1N1; CHILDREN; OSELTAMIVIR; CALIFORNIA	Oral antiviral agents to treat influenza are challenging to administer in the intensive care unit (ICU). We describe 57 critically ill patients treated with the investigational intravenous neuraminidase inhibitor drug peramivir for influenza A (H1N1)pdm09 [pH1N1]. Most received late peramivir treatment following clinical deterioration in the ICU on enterically-administered oseltamivir therapy. The median age was 40 years (range 5 months-81 years). Common clinical complications included pneumonia or acute respiratory distress syndrome requiring mechanical ventilation (54; 95%), sepsis requiring vasopressor support (34/53; 64%), acute renal failure requiring hemodialysis (19/53; 36%) and secondary bacterial infection (14; 25%). Over half (29; 51%) died. When comparing the 57 peramivir-treated cases with 1627 critically ill cases who did not receive peramivir, peramivir recipients were more likely to be diagnosed with pneumonia/acute respiratory distress syndrome (p = 0.0002) or sepsis (p = <0.0001), require mechanical ventilation (p = <0.0001) or die (p = <0.0001). The high mortality could be due to the pre-existing clinical severity of cases prior to request for peramivir, but also raises questions about peramivir safety and effectiveness in hospitalized and critically ill patients. The use of peramivir merits further study in randomized controlled trials, or by use of methods such as propensity scoring and matching, to assess clinical effectiveness and safety.	[Louie, Janice K.; Yang, Samuel; Yen, Cynthia; Acosta, Meileen; Schechter, Robert] Calif Dept Publ Hlth, Richmond, CA 94804 USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	California Department of Public Health; Centers for Disease Control & Prevention - USA	Louie, JK (corresponding author), Calif Dept Publ Hlth, Richmond, CA 94804 USA.	Janice.louie@cdph.ca.gov						[Anonymous], 2010, WHO GUID PHARM MAN P; Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fry AM, 2011, JAMA-J AM MED ASSOC, V306, P160, DOI 10.1001/jama.2011.950; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hernandez JE, 2011, CLIN INFECT DIS, V52, P695, DOI 10.1093/cid/cir001; Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P5267, DOI 10.1128/AAC.00360-11; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Petersen E, 2011, SCAND J INFECT DIS, V43, P495, DOI 10.3109/00365548.2011.556144; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11; *US FDA, EM US AUTH PER 4 FAC; US Food and Drug Administration, PER 4 QUEST ANSW HLT	15	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40261	10.1371/journal.pone.0040261	http://dx.doi.org/10.1371/journal.pone.0040261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768265	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100239
J	Blanco-Pastor, JL; Vargas, P; Pfeil, BE				Luis Blanco-Pastor, Jose; Vargas, Pablo; Pfeil, Bernard E.			Coalescent Simulations Reveal Hybridization and Incomplete Lineage Sorting in Mediterranean Linaria	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SPECIES TREES; GENE TREES; EVOLUTIONARY HISTORY; BAYESIAN-INFERENCE; MOSAIC STRUCTURE; NUCLEAR; RECOMBINATION; CHLOROPLAST; SYSTEMATICS	We examined the phylogenetic history of Linaria with special emphasis on the Mediterranean sect. Supinae (44 species). We revealed extensive highly supported incongruence among two nuclear (ITS, AGT1) and two plastid regions (rpl32-trnL(UAG), trnS-trnG). Coalescent simulations, a hybrid detection test and species tree inference in *BEAST revealed that incomplete lineage sorting and hybridization may both be responsible for the incongruent pattern observed. Additionally, we present a multilabelled *BEAST species tree as an alternative approach that allows the possibility of observing multiple placements in the species tree for the same taxa. That permitted the incorporation of processes such as hybridization within the tree while not violating the assumptions of the *BEAST model. This methodology is presented as a functional tool to disclose the evolutionary history of species complexes that have experienced both hybridization and incomplete lineage sorting. The drastic climatic events that have occurred in the Mediterranean since the late Miocene, including the Quaternary-type climatic oscillations, may have made both processes highly recurrent in the Mediterranean flora.	[Luis Blanco-Pastor, Jose; Vargas, Pablo] Real Jardin Bot RJB CSIC, Dept Biodiversidad & Conservac, Madrid, Spain; [Pfeil, Bernard E.] Gothenburg Univ, Dept Biol & Environm Sci, Gothenburg, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Gothenburg	Blanco-Pastor, JL (corresponding author), Real Jardin Bot RJB CSIC, Dept Biodiversidad & Conservac, Madrid, Spain.	jlblanco@rjb.csic.es	Pfeil, Bernard E/C-1108-2008; Blanco-Pastor, José Luis/R-2075-2018	Pfeil, Bernard E/0000-0001-8179-2270; Blanco-Pastor, José Luis/0000-0002-7708-1342	Spanish National Research Council grant (CSIC: JAEpre); VR (Swedish Research Council); KVA (Royal Swedish Academy of Sciences); Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund	Spanish National Research Council grant (CSIC: JAEpre); VR (Swedish Research Council)(Swedish Research Council); KVA (Royal Swedish Academy of Sciences); Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund	JLB-P received support from a Spanish National Research Council grant (CSIC: JAEpre). This work is framed within a project from the Spanish Ministry of Environment, reference 005/2008. BEP is supported by grants from VR (Swedish Research Council), KVA (Royal Swedish Academy of Sciences), Lars Hiertas Minne fund, The Royal Physiographic Society in Lund, Helge Ax:son Johnsons fund and the Lundgrenska fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2010, TAXON, V59, P1375, DOI 10.1002/tax.595005; Albaladejo RG, 2005, TAXON, V54, P987, DOI 10.2307/25065483; Ane C, 2007, MOL BIOL EVOL, V24, P412; Barres L, 2011, TAXON, V60, P705, DOI 10.1002/tax.603007; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bentham G, 1846, PRODROMUS SISTEMATIS, P266; Bloomquist EW, 2010, SYST BIOL, V59, P27, DOI 10.1093/sysbio/syp076; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Chavannes E, 1833, MONOGRAPHIE ANTIRRHI; Comes HP, 2001, EVOLUTION, V55, P1943, DOI 10.1111/j.0014-3820.2001.tb01312.x; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; del Campo P, 1855, REV PROGRESOS CIENCI, V5, P55; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Druce GC, 1925, BOT SOC EXCHANGE CLU, V7, P998; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Emadzade K, 2010, TAXON, V59, P809, DOI 10.1002/tax.593011; Excoffier Laurent, 2003, Human Genomics, V1, P7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan HH, 2011, MOL PHYLOGENET EVOL, V59, P354, DOI 10.1016/j.ympev.2011.02.019; Fernandez- Mazuecos M, 2011, PLOS ONE, P6; Fiz-Palacios O, 2010, ANN BOT-LONDON, V106, P871, DOI 10.1093/aob/mcq184; Fournier P, 1946, 4 FLORES FRANCE; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Gossmann TI, 2010, MOL BIOL EVOL, V27, P1822, DOI 10.1093/molbev/msq079; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo YP, 2004, TAXON, V53, P657, DOI 10.2307/4135441; Guzman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006362; Hamilton MB, 1999, MOL ECOL, V8, P521; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Holland BR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-202; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Link-Perez MA, 2011, TAXON, V60, P1255, DOI 10.1002/tax.605003; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Liu ZW, 2010, TAXON, V59, P1690, DOI 10.1002/tax.596004; Lo Presti RM, 2010, TAXON, V59, P1441, DOI 10.1002/tax.595010; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mansion G, 2005, TAXON, V54, P931, DOI 10.2307/25065479; Postigo-Mijarra JM, 2010, REV PALAEOBOT PALYNO, V162, P416, DOI 10.1016/j.revpalbo.2010.02.015; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martin-Bravo S, 2010, TAXON, V59, P466, DOI 10.1002/tax.592012; Martinez-Azorin M, 2011, ANN BOT-LONDON, V107, P1, DOI 10.1093/aob/mcq207; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; Meerow AW, 2006, SYST BOT, V31, P42, DOI 10.1600/036364406775971787; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Pirie MD, 2009, SYST BIOL, V58, P612, DOI 10.1093/sysbio/syp068; Poke FS, 2006, MOL PHYLOGENET EVOL, V39, P160, DOI 10.1016/j.ympev.2005.11.016; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, TRACER V1 6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rothmaler W., 1943, FEDDES REPERTORIUM S, V52, P16, DOI [10.1002/fedr.19430520103, DOI 10.1002/FEDR.19430520103]; Rouy G, 1909, FLORE FRANCE DESCRIP; Saez L, 2005, BOT J LINN SOC, V148, P229, DOI 10.1111/j.1095-8339.2005.00404.x; Saez L, 2009, FLORA IBERICA, V13, P232; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Scheen AC, 2012, MOL ECOL RESOUR, V12, P128, DOI 10.1111/j.1755-0998.2011.03070.x; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SMITH JM, 1992, J MOL EVOL, V34, P126; Steele PR, 2010, AM J BOT, V97, P156, DOI 10.3732/ajb.0900192; Stone RD, 2010, TAXON, V59, P83, DOI 10.1002/tax.591009; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sutton D. A., 1988, REVISION TRIBE ANTIR; Valcarcel V, 2006, TAXON, V55, P297, DOI 10.2307/25065579; Valdes B, 1970, B REAL SOC ESPANOLA, V67, P243; Valdes B., 1970, REVISION ESPECIES EU; Valdes B, 1970, ACTA PHYTOTAXONOMICA, V4; Valente LM, 2010, P ROY SOC B-BIOL SCI, V277, P1489, DOI 10.1098/rspb.2009.2163; van der Niet T, 2008, MOL PHYLOGENET EVOL, V47, P154, DOI 10.1016/j.ympev.2007.12.008; Vargas P, 2004, PLANT SYST EVOL, V249, P151, DOI 10.1007/s00606-004-0216-1; Vargas P, 2009, J BIOGEOGRAPHY; VIANO J, 1978, CARYOLOGIA, V31, P383, DOI 10.1080/00087114.1978.10796761; VIANO J, 1978, Candollea, V33, P209; Viano J, 1978, CANDOLLEA, V33, P33; Vilatersana R, 2010, SYST BOT, V35, P907, DOI 10.1600/036364410X539952; Wendel J. F, 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10; Wettstein Von Westersheim R., 1895, NATURL PFLANZ, P39; White TJ., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/B978-0-12-372180-8.50042-1, DOI 10.1016/B978-0-12-372180-8.50042-1]; Wilson Y, 2011, PLANT J, V66, P1032, DOI 10.1111/j.1365-313X.2011.04563.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wong SY, 2010, TAXON, V59, P117, DOI 10.1002/tax.591012; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084	119	94	95	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39089	10.1371/journal.pone.0039089	http://dx.doi.org/10.1371/journal.pone.0039089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768061	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100031
J	Neogi, U; Bontell, I; Shet, A; De Costa, A; Gupta, S; Diwan, V; Laishram, RS; Wanchu, A; Ranga, U; Banerjea, AC; Sonnerborg, A				Neogi, Ujjwal; Bontell, Irene; Shet, Anita; De Costa, Ayesha; Gupta, Soham; Diwan, Vishal; Laishram, Ranbir S.; Wanchu, Ajay; Ranga, Udaykumar; Banerjea, Akhil C.; Sonnerborg, Anders			Molecular Epidemiology of HIV-1 Subtypes in India: Origin and Evolutionary History of the Predominant Subtype C	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NORTH-INDIA; STRAINS; RECOMBINANTS; GENOMES	Background: India has the third largest HIV-1 epidemic with 2.4 million infected individuals. Molecular epidemiological analysis has identified the predominance of HIV-1 subtype C (HIV-1C). However, the previous reports have been limited by sample size, and uneven geographical distribution. The introduction of HIV-1C in India remains uncertain due to this lack of structured studies. To fill the gap, we characterised the distribution pattern of HIV-1 subtypes in India based on data collection from nationwide clinical cohorts between 2007 and 2011. We also reconstructed the time to the most recent common ancestor (tMRCA) of the predominant HIV-1C strains. Methodology/Principal Findings: Blood samples were collected from 168 HIV-1 seropositive subjects from 7 different states. HIV-1 subtypes were determined using two or three genes, gag, pol, and env using several methods. Bayesian coalescent-based approach was used to reconstruct the time of introduction and population growth patterns of the Indian HIV-1C. For the first time, a high prevalence (10%) of unique recombinant forms (BC and A1C) was observed when two or three genes were used instead of one gene (p<0.01; p = 0.02, respectively). The tMRCA of Indian HIV-1C was estimated using the three viral genes, ranged from 1967 (gag) to 1974 (env). Pol-gene analysis was considered to provide the most reliable estimate [1971, (95% CI: 1965-1976)]. The population growth pattern revealed an initial slow growth phase in the mid-1970s, an exponential phase through the 1980s, and a stationary phase since the early 1990s. Conclusions/Significance: The Indian HIV-1C epidemic originated around 40 years ago from a single or few genetically related African lineages, and since then largely evolved independently. The effective population size in the country has been broadly stable since the 1990s. The evolving viral epidemic, as indicated by the increase of recombinant strains, warrants a need for continued molecular surveillance to guide efficient disease intervention strategies.	[Neogi, Ujjwal; Bontell, Irene; Sonnerborg, Anders] Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden; [Neogi, Ujjwal; Gupta, Soham] St Johns Med Coll, Dept Microbiol, Div Clin Virol, Bangalore, Karnataka, India; [Shet, Anita; De Costa, Ayesha] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden; [Shet, Anita] St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India; [Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Laishram, Ranbir S.] Reg Inst Med Sci, Dept Pediat, Imphal, Manipur, India; [Wanchu, Ajay] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Wanchu, Ajay] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Ranga, Udaykumar] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India; [Banerjea, Akhil C.] Natl Inst Immunol, New Delhi 110067, India; [Sonnerborg, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Virol, Stockholm, Sweden	Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's Medical College; Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's Medical College; Regional Institute of Medical Sciences, Imphal; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Oregon Health & Science University; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Karolinska Institutet; Karolinska University Hospital	Neogi, U (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden.	ujjwal.neogi@ki.se	Gupta, Soham/ABC-4407-2021; Neogi, Ujjwal/E-4274-2012; Neogi, Ujjwal/ABF-1172-2021; Sönnerborg, Anders/W-2011-2019	Neogi, Ujjwal/0000-0002-0844-3338; Sönnerborg, Anders/0000-0001-8928-3374; Gupta, Soham/0000-0003-1136-3010; Diwan, Vishal/0000-0001-7948-8579; De Costa, Ayesha/0000-0003-1869-5990; Shet, Anita/0000-0002-7204-8164	European Union; Swedish Physicians against AIDS fund [FOa2011-0014]; Marie Curie ERG (GlobalART) [246599]; Karolinska Institutet [2010Fobi0044]; Department of Biotechnology, Government of India; Swedish Research Council; Lars Hierta Memorial Foundation; Manipur Network of Positive People in northeast India	European Union(European Commission); Swedish Physicians against AIDS fund; Marie Curie ERG (GlobalART); Karolinska Institutet(Karolinska Institutet); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lars Hierta Memorial Foundation; Manipur Network of Positive People in northeast India	This study has been funded by grants from European Union FP7 and Swedish Physicians against AIDS fund (FOa2011-0014), Marie Curie ERG (GlobalART #246599), Karolinska Institutet (2010Fobi0044), Department of Biotechnology, Government of India, Swedish Research Council and EU FP7 CHAIN (European Union 7th Framework Programme). Dr. Neogi and Dr. Shet acknowledge Erasmus Mundus External Co-operation Window 13 (India) scholarship. Dr. Bontell acknowledges grant received from Lars Hierta Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank staff of the respective sites for their support in patient recruitment and sample collection. Authors would like to thank National AIDS Control Organization (NACO) and Karnataka AIDS Prevention Society (KSAPS) for their generous support. A special thanks to The Manipur Network of Positive People in northeast India for their support.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gadkari DA, 1998, INDIAN J MED RES, V107, P1; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; Lakhashe S, 2008, AIDS RES HUM RETROV, V24, P229, DOI 10.1089/aid.2007.0229; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mandal D, 2002, AIDS RES HUM RETROV, V18, P1219, DOI 10.1089/08892220260387968; Neogi U, 2008, ARCH VIROL, V153, P1961, DOI 10.1007/s00705-008-0210-y; Neogi U, 2012, JAIDS-J ACQ IMM DEF, V59, P347, DOI 10.1097/QAI.0b013e3182405c7b; Neogi U, 2011, INDIAN J MED RES, V134, P769, DOI 10.4103/0971-5916.92624; Neogi U, 2010, AIDS RES HUM RETROV, V26, P1097, DOI 10.1089/aid.2010.0092; Neogi U, 2009, INDIAN J EXP BIOL, V47, P424; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sahni AK, 2002, INT J STD AIDS, V13, P115, DOI 10.1258/0956462021924749; Sengupta S, 2005, ARCH VIROL, V150, P2117, DOI 10.1007/s00705-005-0562-5; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Travers SAA, 2004, J VIROL, V78, P10501, DOI 10.1128/JVI.78.19.10501-10506.2004; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1	30	53	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39819	10.1371/journal.pone.0039819	http://dx.doi.org/10.1371/journal.pone.0039819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768132	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000305892100102
J	Singh, N; Zaidi, D; Shyam, H; Sharma, R; Balapure, AK				Singh, Neetu; Zaidi, Deeba; Shyam, Hari; Sharma, Ramesh; Balapure, Anil Kumar			Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to Centchroman	PLOS ONE			English	Article							BREAST-CANCER CELLS; APOPTOSIS INDUCTION; CURCUMIN; RESVERATROL; PHYTOESTROGENS; ACTIVATION; KINASES; PHASE; CYCLE; ANTICANCER	Polyphenols as "sensitizers" together with cytotoxic drugs as "inducers" cooperate to trigger apoptosis in various cancer cells. Hence, their combination having similar mode of mechanism may be a novel approach to enhance the efficacy of inducers. Additionally, this will also enable to achieve the physiological concentrations facilitating significant increase in the activity at concentrations which the compound can individually provide. Here we propose that polyphenols (Resveratrol (RES) and Curcumin (CUR)) pre-treatment may sensitize MCF-7/MDA MB-231 (Human Breast Cancer Cells, HBCCs) to Centchroman (CC, antineoplastic agent). 6 h pre-treated cells with 10 mu M RES/CUR and 100 mu M RES/30 mu M CUR doses, followed by 10 mu M CC for 18 h were investigated for Ser-167 ER-phosphorylation, cell cycle arrest, redox homeostasis, stress activated protein kinase (SAPKs: JNK and p38 MAPK) pathways and downstream apoptosis effectors. Low dose RES/CUR enhances the CC action through ROS mediated JNK/p38 as well as mitochondrial pathway in MCF-7 cells. However, RES/CUR sensitization enhanced apoptosis in p53 mutant MDA MB-231 cells without/with involvement of ROS mediated JNK/p38 adjunct to Caspase-9. Contrarily, through high dose sensitization in CC treated cells, the parameters remained unaltered as in polyphenols alone. We conclude that differential sensitization of HBCCs with low dose polyphenol augments apoptotic efficacy of CC. This may offer a novel approach to achieve enhanced action of CC with concomitant reduction of side effects enabling improved management of hormone-dependent breast cancer.	[Singh, Neetu; Zaidi, Deeba; Shyam, Hari; Sharma, Ramesh; Balapure, Anil Kumar] CSIR, CSIR Cent Drug Res Inst, TCCU, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, N (corresponding author), CSIR, CSIR Cent Drug Res Inst, TCCU, Lucknow, Uttar Pradesh, India.	neetuaashi@yahoo.com	Singh, Neetu/V-4997-2019	Singh, Neetu/0000-0002-5919-655X; Shyam, Hari/0000-0002-5240-3149; BALAPURE, ANIL/0000-0003-1213-4586	Department of Science & Technology (DST) [SR/FT/LS-063/2008]; University Grant Commission (U.G.C) [10-2(5)/2005(i)-E.U.II, CMM-0018]; MOH, New Delhi	Department of Science & Technology (DST)(Department of Science & Technology (India)); University Grant Commission (U.G.C)(University Grants Commission, India); MOH, New Delhi	The work has been supported by funds from Department of Science & Technology (DST) (SR/FT/LS-063/2008), University Grant Commission (U.G.C)(10-2(5)/2005(i)-E.U.II), CMM-0018 and MOH, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Beutler E., 1975, RED CELL METABOLISM, P89; Blesson CS, 2006, STEROIDS, V71, P993, DOI 10.1016/j.steroids.2006.08.001; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; D'Archivio M, 2008, INT J MOL SCI, V9, P213, DOI 10.3390/ijms9030213; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Filomeni G, 2007, GENES NUTR, V2, P295, DOI 10.1007/s12263-007-0059-9; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fulda S, 2010, DRUG DISCOV TODAY, V15, P757, DOI 10.1016/j.drudis.2010.07.005; Gosslau A, 2004, NUTRITION, V20, P95, DOI 10.1016/j.nut.2003.09.017; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Howells LM, 2007, ACTA PHARMACOL SIN, V28, P1274, DOI 10.1111/j.1745-7254.2007.00690.x; Kelkel M, 2010, MOLECULES, V15, P7035, DOI 10.3390/molecules15107035; Lal J, 2010, CONTRACEPTION, V81, P275, DOI 10.1016/j.contraception.2009.11.007; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lopez-Lazaro M, 2008, MOL NUTR FOOD RES, V52, pS103, DOI 10.1002/mnfr.200700238; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Martin KR, 2010, NUTR DIET SUPPL, V2, P1; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mense SM, 2008, ENVIRON HEALTH PERSP, V116, P426, DOI 10.1289/ehp.10538; MISRA NC, 1989, INT J CANCER, V43, P781, DOI 10.1002/ijc.2910430506; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Murias M, 2008, TOXICOL IN VITRO, V22, P1361, DOI 10.1016/j.tiv.2008.03.002; Nakagawa-Goto K, 2007, BIOORG MED CHEM LETT, V17, P5204, DOI 10.1016/j.bmcl.2007.06.083; Nigam M, 2008, LIFE SCI, V82, P577, DOI 10.1016/j.lfs.2007.11.028; Nigam M, 2010, LIFE SCI, V87, P750, DOI 10.1016/j.lfs.2010.10.015; Pozo-Guisado E, 2002, BIOCHEM PHARMACOL, V64, P1375, DOI 10.1016/S0006-2952(02)01296-0; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Renoir JM, 2008, J MOL ENDOCRINOL, V40, P101, DOI 10.1677/JME-07-0143; Rice S, 2006, ENDOCR-RELAT CANCER, V13, P995, DOI 10.1677/erc.1.01159; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; She QB, 2002, MOL CARCINOGEN, V33, P244, DOI 10.1002/mc.10041; Singh N, 2011, CANCER SCI, V102, P1059, DOI 10.1111/j.1349-7006.2011.01893.x; Singh N, 2009, J PHARMACOL SCI, V109, P473, DOI 10.1254/jphs.08173FP; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Torres M, 2003, FRONT BIOSCI, V8, pD369, DOI 10.2741/999; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Yallapu MM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-11	45	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37736	10.1371/journal.pone.0037736	http://dx.doi.org/10.1371/journal.pone.0037736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768036	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100007
J	Stuetz, W; Carrara, VI; McGready, R; Lee, SJ; Biesalski, HK; Nosten, FH				Stuetz, Wolfgang; Carrara, Verena Ilona; McGready, Rose; Lee, Sue Jean; Biesalski, Hans Konrad; Nosten, Francois Henry			Thiamine Diphosphate in Whole Blood, Thiamine and Thiamine Monophosphate in Breast-Milk in a Refugee Population	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CEREBROSPINAL-FLUID; PHOSPHATE-ESTERS; FOLIC-ACID; SERUM; RIBOFLAVIN; POSTPARTUM; VITAMINS; HPLC	Background: The provision of high doses of thiamine may prevent thiamine deficiency in the post-partum period of displaced persons. Methodology/Principal Findings: The study aimed to evaluate a supplementation regimen of thiamine mononitrate (100 mg daily) at the antenatal clinics in Maela refugee camp. Women were enrolled during antenatal care and followed after delivery. Samples were collected at 12 weeks post partum. Thiamine diphosphate (TDP) in whole blood and thiamine in breast-milk of 636 lactating women were measured. Thiamine in breast-milk consisted of thiamine monophosphate (TMP) in addition to thiamine, with a mean TMP to total thiamine ratio of 63%. Mean whole blood TDP (130 nmol/L) and total thiamine in breast-milk (755 nmol/L) were within the upper range reported for well-nourished women. The prevalence of women with low whole blood TDP (<65 nmol/L) was 5% and with deficient breast-milk total thiamine (<300 nmol/L) was 4%. Whole blood TDP predicted both breast-milk thiamine and TMP (R-2 = 0.36 and 0.10, p<0.001). A ratio of TMP to total thiamine >= 63% was associated with a 7.5 and 4-fold higher risk of low whole blood TDP and deficient total breast-milk thiamine, respectively. Routine provision of daily 100 mg of thiamine mononitrate post-partum compared to the previous weekly 10 mg of thiamine hydrochloride resulted in significantly higher total thiamine in breast-milk. Conclusions/Significance: Thiamine supplementation for lactating women in Maela refugee camp is effective and should be continued. TMP and its ratio to total thiamine in breast-milk, reported for the first time in this study, provided useful information on thiamine status and should be included in future studies of breast-milk thiamine.	[Stuetz, Wolfgang] Univ Jena, Inst Nutr, Jena, Germany; [Stuetz, Wolfgang; Biesalski, Hans Konrad] Univ Hohenheim, Inst Biol Chem & Nutr, D-7000 Stuttgart, Germany; [Carrara, Verena Ilona; McGready, Rose; Nosten, Francois Henry] Shoklo Malaria Res Unit, Mae Sot, Thailand; [McGready, Rose; Lee, Sue Jean; Nosten, Francois Henry] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [McGready, Rose; Lee, Sue Jean; Nosten, Francois Henry] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England	Friedrich Schiller University of Jena; University Hohenheim; Mahidol University; Mahidol University; University of Oxford	Stuetz, W (corresponding author), Univ Jena, Inst Nutr, Jena, Germany.	wolfgang.stuetz@uni-jena.de	Carrara, Verena/R-6492-2019; McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019	Carrara, Verena/0000-0002-2758-0872; McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Stuetz, Wolfgang/0000-0002-8011-5849	Wellcome Trust of Great Britain; Eiselen Foundation in Ulm, Germany	Wellcome Trust of Great Britain(Wellcome Trust); Eiselen Foundation in Ulm, Germany	This work was financially supported by the Wellcome Trust of Great Britain and the Eiselen Foundation in Ulm, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlOthman AA, 1996, ECOL FOOD NUTR, V34, P327, DOI 10.1080/03670244.1996.9991469; [Anonymous], 2001, WHO TECHN REP SER; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; DAVIS RE, 1982, CLIN CHIM ACTA, V123, P321, DOI 10.1016/0009-8981(82)90177-2; Food and Agriculture Organization [FAO], 2001, HUM VIT MIN REQ; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Gerrits J, 1997, METHOD ENZYMOL, V279, P74; HERVE C, 1995, CLIN CHIM ACTA, V234, P91, DOI 10.1016/0009-8981(94)05980-7; Ihara HHA, 2005, J ANAL BIO SCI, V28, P241; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; Lynch PLM, 2000, J CHROMATOGR A, V881, P267, DOI 10.1016/S0021-9673(00)00089-3; McGready R, 2001, AM J CLIN NUTR, V74, P808; Molina JA, 2002, J NEURAL TRANSM, V109, P1035, DOI 10.1007/s007020200087; NAIL PA, 1980, AM J CLIN NUTR, V33, P198, DOI 10.1093/ajcn/33.2.198; Ortega RM, 2004, BRIT J NUTR, V92, P129, DOI 10.1079/BJN20041153; RINDI G, 1981, EXPERIENTIA, V37, P975, DOI 10.1007/BF01971788; Stuetz W, 2012, EUR J NUTR, V51, P425, DOI 10.1007/s00394-011-0226-z; TALLAKSEN CME, 1991, J CHROMATOGR-BIOMED, V564, P127, DOI 10.1016/0378-4347(91)80075-N; TALLAKSEN CME, 1992, AM J CLIN NUTR, V56, P559, DOI 10.1093/ajcn/56.3.559; Talwar D, 2000, CLIN CHEM, V46, P704; THOMAS MR, 1980, AM J CLIN NUTR, V33, P2151, DOI 10.1093/ajcn/33.10.2151; VIMOKESANT SL, 1975, AM J CLIN NUTR, V28, P1458, DOI 10.1093/ajcn/28.12.1458; WIELDERS JPM, 1983, J CHROMATOGR, V277, P145, DOI 10.1016/S0378-4347(00)84831-8; World Health Organization (WHO), 1999, SCURV ITS PREV CONTR; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001	27	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e36280	10.1371/journal.pone.0036280	http://dx.doi.org/10.1371/journal.pone.0036280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768031	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100002
J	Fan, L; McElroy, K; Thomas, T				Fan, Lu; McElroy, Kerensa; Thomas, Torsten			Reconstruction of Ribosomal RNA Genes from Metagenomic Data	PLOS ONE			English	Article							MICROBIAL DIVERSITY; PHYLOGENETIC CLASSIFICATION; DNA-SEQUENCES; ACCURATE; BACTERIA; MICROORGANISMS; PROGRAM	Direct sequencing of environmental DNA (metagenomics) has a great potential for describing the 16S rRNA gene diversity of microbial communities. However current approaches using this 16S rRNA gene information to describe community diversity suffer from low taxonomic resolution or chimera problems. Here we describe a new strategy that involves stringent assembly and data filtering to reconstruct full-length 16S rRNA genes from metagenomicpyrosequencing data. Simulations showed that reconstructed 16S rRNA genes provided a true picture of the community diversity, had minimal rates of chimera formation and gave taxonomic resolution down to genus level. The strategy was furthermore compared to PCR-based methods to determine the microbial diversity in two marine sponges. This showed that about 30% of the abundant phylotypes reconstructed from metagenomic data failed to be amplified by PCR. Our approach is readily applicable to existing metagenomic datasets and is expected to lead to the discovery of new microbial phylotypes.	[Fan, Lu] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Fan, L (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	t.thomas@unsw.edu.au	McElroy, Kerensa E/G-1695-2013; Fan, Lu/AAS-5490-2020; Fan, Lu/J-7706-2017	Fan, Lu/0000-0002-4184-7211; Fan, Lu/0000-0002-4184-7211; Thomas, Torsten/0000-0001-9557-3001	Australian Research Council; Gordon and Betty Moore Foundation; Centre for Marine Bio-Innovation	Australian Research Council(Australian Research Council); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Centre for Marine Bio-Innovation	This work was funded by the Australian Research Council, the Gordon and Betty Moore Foundation and the Centre for Marine Bio-Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Bengtsson J, 2011, ANTON LEEUW INT J G, V100, P471, DOI 10.1007/s10482-011-9598-6; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fan L, 2012, PROCNATLACA IN PRESS; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Liu M, 2012, ISME J, V6, P1515, DOI 10.1038/ismej.2012.1; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saeed I, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1204; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Siqueira Jose F Jr, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10743; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yung PY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp746	53	37	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39948	10.1371/journal.pone.0039948	http://dx.doi.org/10.1371/journal.pone.0039948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761935	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800081
J	Awuah, PK; Rhieu, BH; Singh, S; Misse, A; Monga, SPS				Awuah, Prince Kwaku; Rhieu, Byung Han; Singh, Sucha; Misse, Amalea; Monga, Satdarshan P. S.			beta-Catenin Loss in Hepatocytes Promotes Hepatocellular Cancer after Diethylnitrosamine and Phenobarbital Administration to Mice	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; THERAPEUTIC TARGET; SIGNALING PATHWAY; TUMOR PROMOTION; MOUSE-LIVER; WNT; HEPATOCARCINOGENESIS; MUTATIONS; CARCINOMA; ALPHA	Hepatocellular Carcinoma (HCC) is the fifth most common cancer worldwide. beta-Catenin, the central orchestrator of the canonical Wnt pathway and a known oncogene is paramount in HCC pathogenesis. Administration of phenobarbital (PB) containing water (0.05% w/v) as tumor promoter following initial injected intraperitoneal (IP) diethylnitrosamine (DEN) injection (5 mu g/gm body weight) as a tumor inducer is commonly used model to study HCC in mice. Herein, nine fifteen-day male beta-catenin knockout mice (KO) and fifteen wild-type littermate controls (WT) underwent DEN/PB treatment and were examined for hepatic tumorigenesis at eight months. Paradoxically, a significantly higher tumor burden was observed in KO (p<0.05). Tumors in KO were beta-catenin and glutamine synthetase negative and HGF/Met, EGFR & IGFR signaling was unremarkable. A significant increase in PDGFR alpha and its ligand PDGF-CC leading to increased phosphotyrosine-720-PDGFR alpha was observed in tumor-bearing KO mice (p<0.05). Simultaneously, these livers displayed increased cell death, stellate cell activation, hepatic fibrosis and cell proliferation. Further, PDGF-CC significantly induced hepatoma cell proliferation especially following beta-catenin suppression. Our studies also demonstrate that the utilized DEN/PB protocol in the WT C57BL/6 mice did not select for beta-catenin gene mutations during hepatocarcinogenesis. Thus, DEN/PB enhanced HCC in mice lacking beta-catenin in the liver may be due to their ineptness at regulating cell survival, leading to enhanced fibrosis and regeneration through PDGFR alpha activation. beta-Catenin downregulation also made hepatoma cells more sensitive to receptor tyrosine kinases and thus may be exploited for therapeutics.	[Awuah, Prince Kwaku; Rhieu, Byung Han; Singh, Sucha; Misse, Amalea; Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Awuah, PK (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	smonga@pitt.edu		Monga, Satdarshan/0000-0002-8437-3378	National Institutes of Health [1R01DK62277, 1R01CA124414]; Rango's Fund for the Enhancement of Pathology Research; National Institute of Biomedical Imaging and Bioengineering [T32 EB001026]; NATIONAL CANCER INSTITUTE [R01CA124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rango's Fund for the Enhancement of Pathology Research; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants 1R01DK62277 (National Institute of Digestive Diseases and Kidney) and 1R01CA124414 (National Cancer Institute) to S. P. S. M. and by Rango's Fund for the Enhancement of Pathology Research. P. K. A. was funded in part by T32 EB001026 (National Institute of Biomedical Imaging and Bioengineering). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydinlik H, 2001, ONCOGENE, V20, P7812, DOI 10.1038/sj.onc.1204982; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Cadoret A, 2001, CANCER RES, V61, P3245; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DIWAN BA, 1976, CANCER LETT, V1, P249; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; GOLDFARB S, 1983, ENVIRON HEALTH PERSP, V50, P149, DOI 10.2307/3429545; Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123; Harada N, 2002, CANCER RES, V62, P1971; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kudo M, 2011, DIGEST DIS, V29, P289, DOI 10.1159/000327562; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Liu S, 2011, HEPATOLOGY; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; Miyoshi H, 2009, CANCER SCI, V100, P2046, DOI 10.1111/j.1349-7006.2009.01284.x; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ogawa K, 1999, CANCER RES, V59, P1830; Oseini AM, 2009, EXPERT OPIN THER TAR, V13, P443, DOI [10.1517/14728220902719233, 10.1517/14728220902719233 ]; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Rignall B, 2011, CARCINOGENESIS, V32, P52, DOI 10.1093/carcin/bgq226; Sekine S, 2011, CARCINOGENESIS, V32, P622, DOI 10.1093/carcin/bgr002; Stock P, 2007, MOL CANCER THER, V6, P1932, DOI 10.1158/1535-7163.MCT-06-0720; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Thompson MD, 2011, HEPATOLOGY, V54, P1333, DOI 10.1002/hep.24506; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang EY, 2011, P NATL ACAD SCI USA, V108, P18384, DOI 10.1073/pnas.1116386108; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zhang T, 2005, CLIN CANCER RES, V11, P8557, DOI 10.1158/1078-0432.CCR-05-0944; Zhang XF, 2010, HEPATOLOGY, V52, P954, DOI 10.1002/hep.23747	41	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39771	10.1371/journal.pone.0039771	http://dx.doi.org/10.1371/journal.pone.0039771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761897	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305781700064
J	Huang, ZM; Jiang, HM; Liu, XY; Chen, YY; Wong, JM; Wang, Q; Huang, WK; Shi, T; Zhang, J				Huang, Zhimin; Jiang, Haiming; Liu, Xinyi; Chen, Yingyi; Wong, Jiemin; Wang, Qi; Huang, Wenkang; Shi, Ting; Zhang, Jian			HEMD: An Integrated Tool of Human Epigenetic Enzymes and Chemical Modulators for Therapeutics	PLOS ONE			English	Article							DNA METHYLATION; DATABASE; CANCER; IMPACT	Background: Epigenetic mechanisms mainly include DNA methylation, post-translational modifications of histones, chromatin remodeling and non-coding RNAs. All of these processes are mediated and controlled by enzymes. Abnormalities of the enzymes are involved in a variety of complex human diseases. Recently, potent natural or synthetic chemicals are utilized to establish the quantitative contributions of epigenetic regulation through the enzymes and provide novel insight for developing new therapeutics. However, the development of more specific and effective epigenetic therapeutics requires a more complete understanding of the chemical epigenomic landscape. Description: Here, we present a human epigenetic enzyme and modulator database (HEMD), the database which provides a central resource for the display, search, and analysis of the structure, function, and related annotation for human epigenetic enzymes and chemical modulators focused on epigenetic therapeutics. Currently, HEMD contains 269 epigenetic enzymes and 4377 modulators in three categories (activators, inhibitors, and regulators). Enzymes are annotated with detailed description of epigenetic mechanisms, catalytic processes, and related diseases, and chemical modulators with binding sites, pharmacological effect, and therapeutic uses. Integrating the information of epigenetic enzymes in HEMD should allow for the prediction of conserved features for proteins and could potentially classify them as ideal targets for experimental validation. In addition, modulators curated in HEMD can be used to investigate potent epigenetic targets for the query compound and also help chemists to implement structural modifications for the design of novel epigenetic drugs. Conclusions: HEMD could be a platform and a starting point for biologists and medicinal chemists for furthering research on epigenetic therapeutics. HEMD is freely available at http://mdl.shsmu.edu.cn/HEMD/.	[Huang, Zhimin; Jiang, Haiming; Liu, Xinyi; Chen, Yingyi; Wang, Qi; Huang, Wenkang; Shi, Ting; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol, Shanghai 200030, Peoples R China; [Huang, Zhimin; Jiang, Haiming; Liu, Xinyi; Chen, Yingyi; Wang, Qi; Huang, Wenkang; Shi, Ting; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China; [Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University; East China Normal University; Shanghai Jiao Tong University	Huang, ZM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn	liu, xinyi/GWZ-8739-2022; huang, zhimin o/R-4712-2018; Zhang, Jian/GXA-1303-2022; huang, zhimin/H-7878-2013	huang, zhimin o/0000-0001-9230-6039; Zhang, Jian/0000-0002-6558-791X; Wong, Jiemin/0000-0002-5311-842X	National Basic Research Program of China (973 Program) [2011CB504001]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201083]; National Natural Science Foundation of China [21002062]; Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program [10PJ406800]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program	This work was supported in part by grants from National Basic Research Program of China (973 Program) (2011CB504001), A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201083), National Natural Science Foundation of China (21002062), Innovative Research Team of Shanghai Municipal Education Commission, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program (10PJ406800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Best JD, 2010, DRUG DISCOV TODAY, V15, P1008, DOI 10.1016/j.drudis.2010.10.006; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Copeland RA, 2010, CURR OPIN CHEM BIOL, V14, P505, DOI 10.1016/j.cbpa.2010.06.174; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Enzyme Nomenclature Committee, 1992, REC NOM COMM INT U S; Fingerman IM, 2011, NUCLEIC ACIDS RES, V39, pD908, DOI 10.1093/nar/gkq1146; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gaulton A, NUCL ACIDS IN PRESS; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Hamm CA, 2011, DRUG DISCOV TODAY, V16, P626, DOI 10.1016/j.drudis.2011.04.007; He XM, 2008, NUCLEIC ACIDS RES, V36, pD836, DOI 10.1093/nar/gkm730; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Pray L, 2008, CHEM BIOL, V15, P640, DOI 10.1016/j.chembiol.2008.07.003; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Shipra A, 2006, BIOINFORMATICS, V22, P2940, DOI 10.1093/bioinformatics/btl509; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sullivan S, 2002, NUCLEIC ACIDS RES, V30, P341, DOI 10.1093/nar/30.1.341; Turinsky AL, 2011, NUCLEIC ACIDS RES, V39, pD889, DOI 10.1093/nar/gkq857; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, pD149, DOI 10.1093/nar/gkp968; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120; Zhou HH, 2010, BIOL CELL, V102, P645, DOI 10.1042/BC20100029	40	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39917	10.1371/journal.pone.0039917	http://dx.doi.org/10.1371/journal.pone.0039917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761927	Green Published, Green Submitted, gold			2022-12-25	WOS:000305781700073
J	Lee, VHY; Lam, IPY; Choi, HS; Chow, BKC; Lee, LTO				Lee, Vien H. Y.; Lam, Ian P. Y.; Choi, Hueng-Sik; Chow, Billy K. C.; Lee, Leo T. O.			The Estrogen-Related Receptor Alpha Upregulates Secretin Expressions in Response to Hypertonicity and Angiotensin II Stimulation	PLOS ONE			English	Article							INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ERR-ALPHA; GENE-EXPRESSION; SUBFORNICAL ORGAN; MULTIPLE ACTIONS; VASOPRESSIN; WATER; MICE; IDENTIFICATION; FLUID	Osmoregulation via maintenance of water and salt homeostasis is a vital process. In the brain, a functional secretin (SCT) and secretin receptor (SCTR) axis has recently been shown to mediate central actions of angiotensin II (ANGII), including initiation of water intake and stimulation of vasopressin (VP) expression and release. In this report, we provide evidence that estrogen-related receptor alpha (ERR alpha, NR3B1), a transcription factor mainly involved in metabolism, acts as an upstream activator of the SCT gene. In vitro studies using mouse hypothalamic cell line N-42 show that ERR alpha upregulates SCT promoter and gene expression. More importantly, knockdown of endogenous ERR alpha abolishes SCT promoter activation in response to hypertonic and ANGII stimulations. In mouse brain, ERR alpha coexpresses with SCT in various osmoregulatory brain regions, including the lamina terminalis and the paraventricular nucleus of the hypothalamus, and its expression is induced by hyperosmotic and ANGII treatments. Based on our data, we propose that both the upregulation of ERR alpha and/or the increased binding of ERR alpha to the mouse SCT promoter are two possible mechanisms for the elevated SCT expression upon hyperosmolality and central ANGII stimulation.	[Lee, Vien H. Y.; Lam, Ian P. Y.; Chow, Billy K. C.; Lee, Leo T. O.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea	University of Hong Kong; Chonnam National University	Lee, VHY (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	ltolee2@hku.hk	Chow, Billy/D-3064-2009; Lee, Leo T.O./AAB-1581-2021	Chow, Billy/0000-0003-3390-0307; 	Research Grants Council (GRF) [GRF768608]; Committee on Research and Conference Grants (CRCG) [CRCG1159084, GRF764510]	Research Grants Council (GRF); Committee on Research and Conference Grants (CRCG)	This work was supported by research grants from Research Grants Council (GRF), GRF768608 and Committee on Research and Conference Grants (CRCG), CRCG1159084 to LTOL and GRF764510 to BKCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2002, CANCER RES, V62, P6510; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bolbecker AR, 2009, AM J PSYCHIAT, V166, P460, DOI 10.1176/appi.ajp.2008.08040597; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Cheng CYY, 2011, NEUROPSYCHOPHARMACOL, V36, P459, DOI 10.1038/npp.2010.178; CHOW BKC, 1991, J BIOL CHEM, V266, P18927; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Crews EC, 2005, AM J PHYSIOL-REG I, V288, pR638, DOI 10.1152/ajpregu.00525.2004; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Franklin K, 1997, SAN DIEGO MOUSE BRAI; GARDINER TW, 1985, AM J PHYSIOL, V249, pR681, DOI 10.1152/ajpregu.1985.249.6.R681; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Huang ZB, 2004, J PHYSIOL-LONDON, V558, P181, DOI 10.1113/jphysiol.2004.065540; Johnson RF, 2003, AM J PHYSIOL-REG I, V285, pR394, DOI 10.1152/ajpregu.00130.2003; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Lam IPY, 2008, INT REV CYTOL, V265, P159, DOI 10.1016/S0074-7696(07)65004-9; Lam IPY, 2009, AM J PHYSIOL-GASTR L, V297, pG90, DOI 10.1152/ajpgi.00094.2009; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lee LTO, 2005, J NEUROCHEM, V93, P339, DOI 10.1111/j.1471-4159.2005.03018.x; Lee LTO, 2004, MOL ENDOCRINOL, V18, P1740, DOI 10.1210/me.2003-0461; Lee SMY, 2005, NEUROSCIENCE, V134, P377, DOI 10.1016/j.neuroscience.2005.04.009; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Lee VHY, 2009, GENE, V443, P55, DOI 10.1016/j.gene.2009.05.003; LIND RW, 1984, PHYSIOL BEHAV, V32, P69; LINDHEIMER MD, 1989, AM J PHYSIOL, V257, pF159, DOI 10.1152/ajprenal.1989.257.2.F159; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ng SSM, 2002, MOL NEUROBIOL, V26, P97, DOI 10.1385/MN:26:1:097; Ray SK, 2007, MOL CELL BIOL, V27, P7839, DOI 10.1128/MCB.00438-07; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Somponpun SJ, 2007, J NEUROENDOCRINOL, V19, P809, DOI 10.1111/j.1365-2826.2007.01587.x; Somponpun SJ, 2004, AM J PHYSIOL-REG I, V287, pR661, DOI 10.1152/ajpregu.00136.2004; SPRUCE BA, 1985, CLIN ENDOCRINOL, V22, P37, DOI 10.1111/j.1365-2265.1985.tb01062.x; Stachenfeld NS, 2001, J APPL PHYSIOL, V91, P1893, DOI 10.1152/jappl.2001.91.4.1893; Sun Peng-ming, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P544; TANAKA J, 1988, NEUROSCI RES, V6, P45, DOI 10.1016/0168-0102(88)90005-3; Teyssier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007942; Tremblay AM, 2010, MOL ENDOCRINOL, V24, P22, DOI 10.1210/me.2009-0254; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Voisin DL, 1997, NEUROSCIENCE, V78, P215, DOI 10.1016/S0306-4522(96)00551-9; WHEELER MB, 1992, MOL CELL BIOL, V12, P3531, DOI 10.1128/MCB.12.8.3531; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; Yung WH, 2001, J NEUROSCI, V21, P7063, DOI 10.1523/JNEUROSCI.21-18-07063.2001	56	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39913	10.1371/journal.pone.0039913	http://dx.doi.org/10.1371/journal.pone.0039913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761926	Green Published, gold			2022-12-25	WOS:000305781700072
J	Bai, F; Smith, MD; Chan, HL; Pei, XH				Bai, F.; Smith, M. D.; Chan, H. L.; Pei, X-H			Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation	ONCOGENE			English	Article						Brca1; luminal progenitor; basal-like tumor	SUPPRESSOR GENE BRCA1; BREAST-CANCER; ESTROGEN-RECEPTOR; CDK INHIBITORS; EPITHELIAL PROGENITORS; MOLECULAR ANALYSIS; P18(INK4C); EXPRESSION; CYCLE; DIFFERENTIATION	Breast cancer developed in familial BRCA1 mutation carriers bears striking similarities to sporadic basal-like breast tumors. The mechanism underlying the function of BRCA1 in suppressing basal-like breast cancer remains unclear. We previously reported that the deletion of p18(Ink4c) (p18), an inhibitor of G1 cyclin Ds-dependent CDK4 and CDK6, stimulates mammary luminal progenitor cell proliferation and leads to spontaneous luminal tumor development. We report here that germline mutation of Brca1 in p18-deficient mice blocks the increase of luminal progenitor cells, impairs luminal gene expression and promotes malignant transformation of mammary tumors. Instead of the luminal mammary tumors developed in p18 single-mutant mice, mammary tumors developed in the p18; Brca1 mice, similar to breast cancer developed in familial BRCA1 carriers, exhibited extensive basal-like features and lost the remaining wild-type allele of Brca1. These results reveal distinct functions of the RB and BRCA1 pathways in suppressing luminal and basal-like mammary tumors, respectively. These results also suggest a novel mechanism-causing luminal-to-basal transformation-for the development of basal-like breast cancer in familial BRCA1 carriers and establish a unique mouse model for developing therapeutic strategies to target both luminal and basal-like breast cancers.	[Bai, F.; Chan, H. L.; Pei, X-H] Univ Miami, Miller Sch Med, Dept Surg, Mol Oncol Program, Miami, FL 33136 USA; [Smith, M. D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Pei, X-H] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of North Carolina; University of North Carolina Chapel Hill; University of Miami	Pei, XH (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Mol Oncol Program, 1550 NW 10th Ave, Miami, FL 33136 USA.	xhpei@med.miami.edu	Pei, Xin-Hai/P-1812-2014	Chan, Ho Lam/0000-0001-9799-0618; pei, xin-hai/0000-0001-6441-1691	DOD Idea Award [W81XWH-101-0302]; University of Miami Miller School of Medicine	DOD Idea Award; University of Miami Miller School of Medicine	This project was initiated at the Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill. We thank Dr Yue Xiong for his invaluable support, discussion and critical reading of the manuscript, Dr Beverly Koller for providing Brca1 germline mutant mice and Drs Anthony Capobianco and Xiangxi Xu for discussions. This study was supported in part by a DOD Idea Award (W81XWH-101-0302) and startup funds from the University of Miami Miller School of Medicine to XHP.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Arnes JB, 2005, CLIN CANCER RES, V11, P4003, DOI 10.1158/1078-0432.CCR-04-2064; Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Bai F, 2007, MOL CELL BIOL, V27, P1495, DOI 10.1128/MCB.01764-06; Bai F, 2006, MOL CELL BIOL, V26, P4564, DOI 10.1128/MCB.00266-06; Bennett LM, 2000, CANCER RES, V60, P3461; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Buckley NE, 2012, STEM CELL REV REP, V8, P982, DOI 10.1007/s12015-012-9354-y; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Cao L, 2006, EMBO J, V25, P2167, DOI 10.1038/sj.emboj.7601115; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Drost RM, 2009, BRIT J CANCER, V101, P1651, DOI 10.1038/sj.bjc.6605350; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Honrado E, 2005, MODERN PATHOL, V18, P1305, DOI 10.1038/modpathol.3800453; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; Lapointe J, 1996, CANCER RES, V56, P4586; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lee YH, 2011, GENE DEV, V25, P176, DOI 10.1101/gad.1975811; Leone PE, 2008, CLIN CANCER RES, V14, P6033, DOI 10.1158/1078-0432.CCR-08-0347; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Ramsey MR, 2007, CANCER RES, V67, P4732, DOI 10.1158/0008-5472.CAN-06-3437; Ribeiro-Silva A, 2005, HISTOPATHOLOGY, V47, P458, DOI 10.1111/j.1365-2559.2005.02249.x; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smart CE, 2011, ONCOGENE, V30, P1597, DOI 10.1038/onc.2010.538; Smart CE, 2008, BREAST CANCER RES TR, V112, P237, DOI 10.1007/s10549-007-9859-2; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Spirin KS, 1997, INT J ONCOL, V11, P737; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Suspitsin EN, 2011, BREAST CANCER-TOKYO, V18, P137, DOI 10.1007/s12282-009-0105-0; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Williamson EA, 2006, ONCOGENE, V25, P1391, DOI 10.1038/sj.onc.1209170; Wright MH, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-29; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109; Zarkowska T, 1997, ONCOGENE, V14, P249, DOI 10.1038/sj.onc.1200824; Zindy F, 2003, CANCER RES, V63, P5420	70	31	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2715	2725		10.1038/onc.2012.293	http://dx.doi.org/10.1038/onc.2012.293			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22777348				2022-12-25	WOS:000319808000003
J	Furcht, CM; Rojas, ARM; Nihalani, D; Lazzara, MJ				Furcht, C. M.; Rojas, A. R. Munoz; Nihalani, D.; Lazzara, M. J.			Diminished functional role and altered localization of SHP2 in non-small cell lung cancer cells with EGFR-activating mutations	ONCOGENE			English	Article						extracellular signal-regulated kinase (ERK); gefitinib; endocytosis; GRB2-associated binder 1 (GAB1)	SIGNAL-REGULATED KINASE; MOLECULAR-MECHANISM; TYROSINE KINASE; GEFITINIB; PHOSPHATASE; SENSITIVITY; MET; PHOSPHORYLATION; RESISTANCE; INHIBITORS	Non-small cell lung cancer (NSCLC) cells harboring activating mutations of the epidermal growth factor receptor (EGFR) tend to display elevated activity of several survival signaling pathways. Surprisingly, these mutations also correlate with reduced phosphorylation of ERK and SHP2, a protein tyrosine phosphatase required for complete ERK activation downstream of most receptor tyrosine kinases. As ERK activity influences cellular response to EGFR inhibition, altered SHP2 function could have a role in the striking response to gefitinib witnessed with EGFR mutation. Here, we demonstrate that impaired SHP2 phosphorylation correlates with diminished SHP2 function in NSCLC cells expressing mutant, versus wild-type, EGFR. In NSCLC cells expressing wild-type EGFR, SHP2 knockdown decreased ERK phosphorylation, basally and in response to gefitinib, and increased cellular sensitivity to gefitinib. In cells expressing EGFR mutants, these effects of SHP2 knockdown were less substantial, but the expression of constitutively active SHP2 reduced cellular sensitivity to gefitinib. In cells expressing EGFR mutants, which do not undergo efficient ligand-mediated endocytosis, SHP2 was basally associated with GRB2-associated binder 1 (GAB1) and EGFR, and SHP2's presence in membrane fractions was dependent on EGFR activity. Whereas EGF promoted a more uniform intracellular distribution of initially centrally localized SHP2 in cells expressing wild-type EGFR, SHP2 was basally evenly distributed and did not redistribute in response to EGF in cells with EGFR mutation. Thus, EGFR mutation may promote association of a fraction of SHP2 at the plasma membrane with adapters that promote SHP2 activity. Consistent with this, SHP2 immunoprecipitated from cells with EGFR mutation was active, and EGF treatment did not change this activity. Overall, our data suggest that a fraction of SHP2 is sequestered at the plasma membrane in cells with EGFR mutation in a way that impedes SHP2's ability to promote ERK activity and identify SHP2 as a potential target for co-inhibition with EGFR in NSCLC.	[Furcht, C. M.; Lazzara, M. J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Rojas, A. R. Munoz; Lazzara, M. J.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Nihalani, D.] Univ Penn, Dept Med, Renal Electrolyde & Hypertens Div, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazzara, MJ (corresponding author), Univ Penn, Dept Chem & Biomol Engn, 311A Towne Bldg,220 South 33rd St, Philadelphia, PA 19104 USA.	mlazzara@seas.upenn.edu	nihalani, deepak/AAK-9453-2020	Munoz-Rojas, Andres R./0000-0002-1251-723X; Furcht, Christopher/0000-0002-5403-4914	University of Pennsylvania Cell and Molecular Biology Training Grant [T32 GM-07229]; National Cancer Institute [R25 CA101871-07]; Ashton Foundation; University of Pennsylvania Institute for Regenerative Medicine; Pennsylvania Department of Health; National Institutes of Health through the NIDDK [1R01DK087956]; University of Pennsylvania; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	University of Pennsylvania Cell and Molecular Biology Training Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ashton Foundation; University of Pennsylvania Institute for Regenerative Medicine; Pennsylvania Department of Health; National Institutes of Health through the NIDDK; University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CMF was supported in part by the University of Pennsylvania Cell and Molecular Biology Training Grant (T32 GM-07229), grant R25 CA101871-07 from the National Cancer Institute and a fellowship from the Ashton Foundation. AMR received support from the University of Pennsylvania Institute for Regenerative Medicine. This project was funded, in part, under a grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. Support for DN was provided by the National Institutes of Health Grant 1R01DK087956 through the NIDDK. This work was also supported in part by laboratory startup funds from the University of Pennsylvania. We thank Dr Ben Neel, Dr Eric Haura, Dr Pasi Janne, Dr Tyler Jacks, Dr Marilyn Farquhar, Dr Gary Nolan, Dr Anil Rustgi and Dr Susan Margulies for generously providing reagents and access to instrumentation. We also thank Ms Gladys Gray Lawrence, Dr Ranganath Parthasarathy, Mr Calixte Monast and Ms Alice Macdonald Walsh for technical assistance.	Akca H, 2006, LUNG CANCER, V54, P25, DOI 10.1016/j.lungcan.2006.06.007; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hendriks BS, 2006, IEE P SYST BIOL, V153, P457, DOI 10.1049/ip-syb:20050108; Hendriks BS, 2003, CANCER RES, V63, P1130; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lazzara MJ, 2010, CANCER RES, V70, P3843, DOI 10.1158/0008-5472.CAN-09-3421; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Ren Yuan, 2010, Genes Cancer, V1, P994, DOI 10.1177/1947601910395582; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200	31	32	35	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2013	32	18					2346	2355		10.1038/onc.2012.240	http://dx.doi.org/10.1038/onc.2012.240			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22777356	Green Accepted			2022-12-25	WOS:000318683600011
J	Pin, AL; Houle, F; Fournier, P; Guillonneau, M; Paquet, ER; Simard, MJ; Royal, I; Huot, J				Pin, Anne-Laure; Houle, Francois; Fournier, Patrick; Guillonneau, Maeva; Paquet, Eric R.; Simard, Martin J.; Royal, Isabelle; Huot, Jacques			Annexin-1-mediated Endothelial Cell Migration and Angiogenesis Are Regulated by Vascular Endothelial Growth Factor (VEGF)-induced Inhibition of miR-196a Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-ASSOCIATED PROTEINS; ANNEXIN A1; PHOSPHORYLATION; ACTIVATION; KINASE; RECEPTOR; IDENTIFICATION; MEMBRANE; MOUSE; LIPOCORTIN-1	Endothelial cell migration induced in response to vascular endothelial growth factor (VEGF) is an essential step of angiogenesis. It depends in part on the activation of the p38/MAP-KAP kinase-2/LIMK1/annexin-A1 (ANXA1) signaling axis. In the present study, we obtained evidence indicating that miR-196a specifically binds to the 3'-UTR region of ANXA1 mRNA to repress its expression. In accordance with the role of ANXA1 in cell migration and angiogenesis, the ectopic expression of miR-196a is associated with decreased cell migration in wound closure assays, and the inhibitory effect of miR-196a is rescued by overexpressing ANXA1. This finding highlights the fact that ANXA1 is a required mediator of VEGF-induced cell migration. miR-196a also reduces the formation of lamellipodia in response to VEGF suggesting that ANXA1 regulates cell migration by securing the formation of lamellipodia at the leading edge of the cell. Additionally, in line with the fact that cell migration is an essential step of angiogenesis, the ectopic expression of miR-196a impairs the formation of capillary-like structures in a tissue-engineered model of angiogenesis. Here again, the effect of miR-196a is rescued by overexpressing ANXA1. Moreover, the presence of miR-196a impairs the VEGF-induced in vivo neo-vascularization in the Matrigel Plug assay. Interestingly, VEGF reduces the expression of miR-196a, which is associated with an increased level of ANXA1. Similarly, the inhibition of miR-196a with an antagomir results in an increased level of ANXA1. We conclude that the VEGF-induced decrease of miR-196a expression may participate to the angiogenic switch by maintaining the expression of ANXA1 to levels required to enable p38-ANXA1-dependent endothelial cell migration and angiogenesis in response to VEGF.	[Pin, Anne-Laure; Houle, Francois; Guillonneau, Maeva; Paquet, Eric R.; Simard, Martin J.; Huot, Jacques] Univ Laval, Le Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada; [Pin, Anne-Laure; Houle, Francois; Guillonneau, Maeva; Paquet, Eric R.; Simard, Martin J.; Huot, Jacques] Hop Hotel Dieu, Ctr Rech CHUQ, Quebec City, PQ G1R 2J6, Canada; [Fournier, Patrick; Royal, Isabelle] CRCHUM Ctr Hosp Univ Montreal, Montreal, PQ H2L 4M1, Canada; [Fournier, Patrick; Royal, Isabelle] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada	Laval University; Laval University; Universite de Montreal; Universite de Montreal	Huot, J (corresponding author), Univ Laval, Le Ctr Rech Cancerol, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	Jacques.Huot@fmed.ulaval.ca		Paquet, Eric/0000-0001-9194-1655; Royal, Isabelle/0000-0002-7548-1182; Simard, Martin/0000-0002-3189-9309	Canadian Institutes for Health Research (CIHR); Heart Stroke Foundation of Canada (HSFC); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR; CRCHUQ	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); CRCHUQ	This study was supported by grants (to J. H.) from the Canadian Institutes for Health Research (CIHR), The Heart Stroke Foundation of Canada (HSFC), and The Natural Sciences and Engineering Research Council of Canada (NSERC) and by CIHR grants (to M. J. S. and I. R.).; Received a studentship from CRCHUQ.	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Aslam MI, 2009, BRIT J SURG, V96, P702, DOI 10.1002/bjs.6628; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; CAMPOSGONZALEZ R, 1990, CELL MOTIL CYTOSKEL, V15, P34, DOI 10.1002/cm.970150106; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Feige JJ, 2010, B CANCER, V97, P1305, DOI 10.1684/bdc.2010.1208; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Garnier D, 2010, CANCER METAST BIOL T, V14, P243, DOI 10.1007/978-90-481-8833-8_9; Gibot L, 2010, TISSUE ENG PT A, V16, P3199, DOI [10.1089/ten.tea.2010.0189, 10.1089/ten.TEA.2010.0189]; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Liao SH, 2009, PROTEOMICS, V9, P3901, DOI 10.1002/pmic.200800922; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Longatto Filho Adhemar, 2010, J Oncol, V2010, DOI 10.1155/2010/576384; Lu JI, 2005, BIOCHEM BIOPH RES CO, V334, P319, DOI 10.1016/j.bbrc.2005.05.206; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Madhyastha R, 2012, INT WOUND J, V9, P355, DOI 10.1111/j.1742-481X.2011.00890.x; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Oklu R, 2010, J VASC INTERV RADIOL, V21, P1791, DOI 10.1016/j.jvir.2010.08.009; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pin AL, 2012, ANGIOGENESIS, V15, P593, DOI 10.1007/s10456-012-9283-z; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Roviezzo F, 2002, J PHYSIOL PHARMACOL, V53, P541; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Skouteris GG, 1996, J BIOL CHEM, V271, P27266, DOI 10.1074/jbc.271.44.27266; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Traverso V, 1998, J CELL SCI, V111, P1405; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106	50	53	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30541	30551		10.1074/jbc.M112.393561	http://dx.doi.org/10.1074/jbc.M112.393561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773844	hybrid, Green Published			2022-12-25	WOS:000308579800046
J	Wu, F; Li, YP; Wang, FX; Noda, NN; Zhang, H				Wu, Fan; Li, Yuping; Wang, Fuxin; Noda, Nobuo N.; Zhang, Hong			Differential Function of the Two Atg4 Homologues in the Aggrephagy Pathway in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P GRANULE COMPONENTS; C. ELEGANS; AUTOPHAGOSOME BIOGENESIS; DEGRADATION; MICE; LC3; MECHANISMS; PROTEASE; GABARAP; BALANCE	The presence of multiple homologues of the same yeast Atg protein endows an additional layer of complexity on the autophagy pathway in higher eukaryotes. The physiological function of the individual genes, however, remains largely unknown. Here we investigated the role of the two Caenorhabditis elegans homologues of the cysteine protease Atg4 in the pathway responsible for degradation of protein aggregates. Loss of atg-4.1 activity causes defective degradation of a variety of protein aggregates, whereas atg-4.2 mutants remove these substrates normally. LGG-1 precursors accumulate in atg-4.1 mutants, but not atg-4.2 mutants. LGG-1 puncta, formation of which depends on lipidation of LGG-1, are present in atg-4.1 and atg-4.2 single mutants, but are completely absent in atg-4.1; atg-4.2 double mutants. In vitro enzymatic analysis revealed that ATG-4.1 processes LGG-1 precursors about 100-fold more efficiently than ATG-4.2. Expression of a mutant form LGG-1, which mimics the processed precursor, rescues the defective autophagic degradation of protein aggregates in atg-4.1 mutants and, to a lesser extent, in atg-4.1; atg-4.2 double mutants. Our study reveals that ATG-4.1 and ATG-4.2 are functionally redundant yet display differential LGG-1 processing and deconjugating activity in the aggrephagy pathway in C. elegans.	[Wu, Fan; Li, Yuping; Wang, Fuxin; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Wu, Fan] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Wu, Fan] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Hong] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China; [Noda, Nobuo N.] Inst Microbial Chem, Tokyo 1410021, Japan	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, H (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhanghong@nibs.ac.cn	Li, Yuping/AAL-6956-2020; Noda, Nobuo/P-1397-2015	Li, Yuping/0000-0003-2057-3271; Wang, wangfuxin/0000-0003-4497-3667; Noda, Nobuo/0000-0002-6940-8069	National Basic Research Program of China [2011CB910100, 2010CB835201]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23687012]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the National Basic Research Program of China (2011CB910100, 2010CB835201) (to H. Z.) and Grant-in-Aid for Young Scientists (A) (23687012) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. N. N).	Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Cabrera S, 2010, AUTOPHAGY, V6, P961, DOI 10.4161/auto.6.7.13065; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Huang XX, 2011, DEVELOPMENT, V138, P2059, DOI 10.1242/dev.057109; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kovacs AL, 2010, FEBS LETT, V584, P1335, DOI 10.1016/j.febslet.2010.02.002; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Lu Q, 2011, DEV CELL, V21, P343, DOI 10.1016/j.devcel.2011.06.024; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tian E, 2009, AUTOPHAGY, V5, P608, DOI 10.4161/auto.5.5.8624; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhao Y, 2009, AUTOPHAGY, V5, P717, DOI 10.4161/auto.5.5.8552	35	35	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29457	29467		10.1074/jbc.M112.365676	http://dx.doi.org/10.1074/jbc.M112.365676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767594	hybrid, Green Published			2022-12-25	WOS:000308286900023
J	Huijsmans, CJJ; Poodt, J; Damen, J; van der Linden, JC; Savelkoul, PHM; Pruijt, JFM; Hilbink, M; Hermans, MHA				Huijsmans, Cornelis J. J.; Poodt, Jeroen; Damen, Jan; van der Linden, Johannes C.; Savelkoul, Paul H. M.; Pruijt, Johannes F. M.; Hilbink, Mirrian; Hermans, Mirjam H. A.			Single Nucleotide Polymorphism (SNP)-Based Loss of Heterozygosity (LOH) Testing by Real Time PCR in Patients Suspect of Myeloproliferative Disease	PLOS ONE			English	Article							JAK2 617V-GREATER-THAN-F MUTATION; JAK2(V617F) ALLELE BURDEN; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; CHROMOSOME 18Q; PRIMARY MYELOFIBROSIS; COLON-CANCER; WILD-TYPE; V617F	During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an oncogene activating mutation, the mutant allele may be further potentiated if the wild-type allele is lost or inactivated. In myeloproliferative neoplasms (MPN) somatic acquisition of JAK2V617F may be followed by LOH resulting in loss of the wild type allele. The occurrence of LOH in MPN and other proliferative diseases may lead to a further potentiating the mutant allele and thereby increasing morbidity. A real time PCR based SNP profiling assay was developed and validated for LOH detection of the JAK2 region (JAK2LOH). Blood of a cohort of 12 JAK2V617F-positive patients (n = 6 25-50% and n = 6>50% JAK2V617F) and a cohort of 81 patients suspected of MPN was stored with EDTA and subsequently used for validation. To generate germ-line profiles, non-neoplastic formalin-fixed paraffin-embedded tissue from each patient was analyzed. Results of the SNP assay were compared to those of an established Short Tandem Repeat (STR) assay. Both assays revealed JAK2LOH in 1/6 patients with 25-50% JAK2V617F. In patients with >50% JAK2V617F, JAK2LOH was detected in 6/6 by the SNP assay and 5/6 patients by the STR assay. Of the 81 patients suspected of MPN, 18 patients carried JAK2V617F. Both the SNP and STR assay demonstrated the occurrence of JAK2LOH in 5 of them. In the 63 JAK2V617F-negative patients, no JAK2LOH was observed by SNP and STR analyses. The presented SNP assay reliably detects JAK2LOH and is a fast and easy to perform alternative for STR analyses. We therefore anticipate the SNP approach as a proof of principle for the development of LOH SNP-assays for other clinically relevant LOH loci.	[Huijsmans, Cornelis J. J.; Poodt, Jeroen; Hermans, Mirjam H. A.] Jeroen Bosch Hosp, Lab Mol Diagnost, Shertogenbosch, Netherlands; [Damen, Jan; van der Linden, Johannes C.] Jeroen Bosch Hosp, Pathol Lab, Shertogenbosch, Netherlands; [Savelkoul, Paul H. M.] Vrije Univ VU Univ Med Ctr, Amsterdam, Netherlands; [Pruijt, Johannes F. M.] Jeroen Bosch Hosp, Dept Internal Med, Shertogenbosch, Netherlands; [Hilbink, Mirrian] Jeroen Bosch Hosp, Jeroen Bosch Acad, Shertogenbosch, Netherlands	Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis	Huijsmans, CJJ (corresponding author), Jeroen Bosch Hosp, Lab Mol Diagnost, Shertogenbosch, Netherlands.	r.huysmans@jbz.nl						Antonioli E, 2007, HAEMATOLOGICA, V93, P41, DOI 10.3324/haematol.11653; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Huijsmans CJJ, 2011, J MOL DIAGN, V13, P558, DOI 10.1016/j.jmoldx.2011.04.002; Huijsmans R, 2007, J MOL DIAGN, V9, P205, DOI 10.2353/jmoldx.2007.060059; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Kissel HD, 2009, CANCER BIOMARK, V5, P143, DOI 10.3233/CBM-2009-0618; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lanza G, 1998, INT J CANCER, V79, P390, DOI 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.3.CO;2-M; Larsen TS, 2007, EUR J HAEMATOL, V79, P508, DOI 10.1111/j.1600-0609.2007.00960.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ogunbiyi OA, 1998, J CLIN ONCOL, V16, P427, DOI 10.1200/JCO.1998.16.2.427; Passamonti F, 2009, HAEMATOL-HEMATOL J, V94, P7, DOI 10.3324/haematol.2008.001271; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Steensma DP, 2006, J MOL DIAGN, V8, P397, DOI 10.2353/jmoldx.2006.060007; Tefferi A, 2006, CANCER-AM CANCER SOC, V106, P631, DOI 10.1002/cncr.21645; Vannucchi AM, 2007, LEUKEMIA, V21, P1952, DOI 10.1038/sj.leu.2404854; Vannucchi AM, 2007, BLOOD, V110, P840, DOI 10.1182/blood-2006-12-064287; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; WATLING CJ, 1995, CAN J NEUROL SCI, V22, P17, DOI 10.1017/S0317167100040440; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e38362	10.1371/journal.pone.0038362	http://dx.doi.org/10.1371/journal.pone.0038362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768290	Green Published, gold, Green Submitted			2022-12-25	WOS:000305966500003
J	Brockson, ME; Novotny, LA; Jurcisek, JA; McGillivary, G; Bowers, MR; Bakaletz, LO				Brockson, M. Elizabeth; Novotny, Laura A.; Jurcisek, Joseph A.; McGillivary, Glen; Bowers, Martha R.; Bakaletz, Lauren O.			Respiratory Syncytial Virus Promotes Moraxella catarrhalis-Induced Ascending Experimental Otitis Media	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; OUTER-MEMBRANE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; CHINCHILLA MODEL; MIDDLE-EAR; BRANHAMELLA-CATARRHALIS; NONABORIGINAL CHILDREN; BACTERIAL-COLONIZATION; PASSIVE-IMMUNIZATION; BETA-LACTAMASE	Otitis media (OM) is a polymicrobial disease wherein prior or concurrent infection with an upper respiratory tract virus plays an essential role, predisposing the middle ear to bacterial invasion. In episodes of acute bacterial OM, respiratory syncytial virus (RSV) is the most commonly isolated virus and thus serves as an important co-pathogen. Of the predominant bacterial agents of OM, the pathogenesis of disease due to Moraxella catarrhalis is the least well understood. Rigorous study of M. catarrhalis in the context of OM has been significantly hindered by lack of an animal model. To bridge this gap, we assessed whether co-infection of chinchillas with M. catarrhalis and RSV would facilitate ascension of M. catarrhalis from the nasopharynx into the middle ear. Chinchillas were challenged intranasally with M. catarrhalis followed 48 hours later by intranasal challenge with RSV. Within 7 days, 100% of nasopharynges were colonized with M. catarrhalis and homogenates of middle ear mucosa were also culture-positive. Moreover, within the middle ear space, the mucosa exhibited hemorrhagic foci, and a small volume of serosanguinous effusion was present in one of six ears. To improve upon this model, and based on epidemiologic data, nontypeable Haemophilus influenzae (NTHI) was included as an additional bacterial co-pathogen via intranasal administration four days before M. catarrhalis challenge. With this latter protocol, M. catarrhalis was cultured from the nasopharynx and middle ear homogenates of a maximum of 88% and 79% animals, respectively, for up to 17 days after intranasal challenge with M. catarrhalis. Additionally, hemorrhagic foci were observed in 79% of middle ears upon sacrifice. Thus, these data demonstrated that co-infection with RSV and NTHI predisposed to M. catarrhalis-induced ascending experimental OM. This model can be used both in studies of pathogenesis as well as to investigate strategies to prevent or treat OM due to M. catarrhalis.	[Brockson, M. Elizabeth] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Brockson, ME (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	Lauren.Bakaletz@NationwideChildrens.org	Bakaletz, Lauren/GMW-8490-2022		NIH/NIDCD [R01 DC006468]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006468] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIH/NIDCD R01 DC006468 to L.O.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 2011, ADV EXP MED BIOL, V697, P107, DOI 10.1007/978-1-4419-7185-2_9; Alsarraf R, 1999, ARCH OTOLARYNGOL, V125, P12, DOI 10.1001/archotol.125.1.12; APPELL LH, 1971, AM J VET RES, V32, P1835; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Armengol CE, 2011, PEDIATR INFECT DIS J, V30, P518, DOI 10.1097/INF.0b013e3182044930; Bakaletz LO, 2010, J LEUKOCYTE BIOL, V87, P213, DOI 10.1189/jlb.0709518; BAKALETZ LO, 1993, J INFECT DIS, V168, P865, DOI 10.1093/infdis/168.4.865; Bakaletz LO, 1999, INFECT IMMUN, V67, P2746, DOI 10.1128/IAI.67.6.2746-2762.1999; BAKALETZ LO, 1995, INFECT IMMUN, V63, P4188, DOI 10.1128/IAI.63.10.4188-4190.1995; BAKALETZ LO, 1988, INFECT IMMUN, V56, P331, DOI 10.1128/IAI.56.2.331-335.1988; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; BALDWIN RL, 1993, AM J OTOL, V14, P601; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Binks MJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-161; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Broides A, 2009, CLIN INFECT DIS, V49, P1641, DOI 10.1086/647933; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Cassell GH, 1997, NEW REEMERGING INFEC; El Ahmer OR, 2003, J MED MICROBIOL, V52, P853, DOI 10.1099/jmm.0.05124-0; Embers ME, 2011, VET MICROBIOL, V147, P367, DOI 10.1016/j.vetmic.2010.06.029; Gibney Katherine B, 2005, BMC Pediatr, V5, P16, DOI 10.1186/1471-2431-5-16; Giebink GS, 1999, MICROB DRUG RESIST, V5, P57, DOI 10.1089/mdr.1999.5.57; GIEBINK GS, 1980, INFECT IMMUN, V30, P445; Gitiban N, 2005, J VIROL, V79, P6035, DOI 10.1128/JVI.79.10.6035-6042.2005; Grieves JL, 2010, COMPARATIVE MED, V60, P225; Heikkinen T, 2000, VACCINE, V19, pS51, DOI 10.1016/S0264-410X(00)00278-4; Hirano T, 1999, OTOLARYNG HEAD NECK, V121, P616, DOI 10.1016/S0194-5998(99)70068-9; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; HUNTER LL, 1994, ANN OTO RHINOL LARYN, V103, P59, DOI 10.1177/00034894941030S516; INFANTERIVARD C, 1993, EPIDEMIOL REV, V15, P444, DOI 10.1093/oxfordjournals.epirev.a036129; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kaplan B, 1997, PEDIATR INFECT DIS J, V16, pS9, DOI 10.1097/00006454-199702001-00003; Karalus R, 2000, MICROBES INFECT, V2, P547, DOI 10.1016/S1286-4579(00)00314-2; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Klemens JJ, 2006, LARYNGOSCOPE, V116, P1236, DOI 10.1097/01.mlg.0000224526.43698.52; Kotikoski MJ, 2003, INT J PEDIATR OTORHI, V67, P165, DOI 10.1016/S0165-5876(02)00366-X; Krishnamurthy A, 2009, MICROBES INFECT, V11, P545, DOI 10.1016/j.micinf.2009.03.001; Kyd JM, 2003, INFECT IMMUN, V71, P4691, DOI 10.1128/IAI.71.8.4691-4699.2003; Labout JAM, 2011, EUR J EPIDEMIOL, V26, P61, DOI 10.1007/s10654-010-9500-2; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Luke NR, 2004, INFECT IMMUN, V72, P6262, DOI 10.1128/IAI.72.11.6262-6270.2004; Luke NR, 1999, INFECT IMMUN, V67, P681, DOI 10.1128/IAI.67.2.681-687.1999; Martinez-Marin C, 2005, J ANTIMICROB CHEMOTH, V56, P783, DOI 10.1093/jac/dki322; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; Meek RB, 1999, ANN OTO RHINOL LARYN, V108, P31, DOI 10.1177/000348949910800105; Miyamoto N, 1997, MICROB PATHOGENESIS, V23, P119, DOI 10.1006/mpat.1997.0140; Moore HC, 2010, PEDIATR INFECT DIS J, V29, P540, DOI 10.1097/INF.0b013e3181d067cb; Morton DJ, 2004, MICROB PATHOGENESIS, V36, P25, DOI 10.1016/j.micpath.2003.08.007; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Novotny LA, 2006, VACCINE, V24, P4804, DOI 10.1016/j.vaccine.2006.03.021; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Ponte C, 1999, J ANTIMICROB CHEMOTH, V44, P85, DOI 10.1093/jac/44.1.85; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Sakkou Z, 2011, VACCINE, V29, P1167, DOI 10.1016/j.vaccine.2010.12.014; Schaar V, 2011, ANTIMICROB AGENTS CH, V55, P3845, DOI 10.1128/AAC.01772-10; Short KR, 2011, J INFECT DIS; SIRAKOVA T, 1994, INFECT IMMUN, V62, P2002, DOI 10.1128/IAI.62.5.2002-2020.1994; Skoner DP, 2010, CURR ALLERGY ASTHM R, V10, P389, DOI 10.1007/s11882-010-0145-8; STOOL SE, 1994, OTITIS MEDIA EFFUSIO; SUZUKI K, 1994, INFECT IMMUN, V62, P1710, DOI 10.1128/IAI.62.5.1710-1718.1994; Tan TT, 2007, J INFECT DIS, V195, P1661, DOI 10.1086/517611; TEELE DW, 1990, J INFECT DIS, V162, P685, DOI 10.1093/infdis/162.3.685; Thornton RB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-94; VANDEWOUDE SJ, 1991, LAB ANIM SCI, V41, P401; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68	70	29	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40088	10.1371/journal.pone.0040088	http://dx.doi.org/10.1371/journal.pone.0040088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768228	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100200
J	Chauhan, BC; Stevens, KT; Levesque, JM; Nuschke, AC; Sharpe, GP; O'Leary, N; Archibald, ML; Wang, X				Chauhan, Balwantray C.; Stevens, Kelly T.; Levesque, Julie M.; Nuschke, Andrea C.; Sharpe, Glen P.; O'Leary, Neil; Archibald, Michele L.; Wang, Xu			Longitudinal In Vivo Imaging of Retinal Ganglion Cells and Retinal Thickness Changes Following Optic Nerve Injury in Mice	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPY; COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE; RODENT RETINA; ADULT-RATS; FIELD LOSS; HIGH-SPEED; GLAUCOMA; AXOTOMY; DAMAGE	Background: Retinal ganglion cells (RGCs) die in sight-threatening eye diseases. Imaging RGCs in humans is not currently possible and proof of principle in experimental models is fundamental for future development. Our objective was to quantify RGC density and retinal thickness following optic nerve transection in transgenic mice expressing cyan fluorescent protein (CFP) under control of the Thy1 promoter, expressed by RGCs and other neurons. Methodology/Principal Findings: A modified confocal scanning laser ophthalmoscopy (CSLO)/spectral-domain optical coherence tomography (SD-OCT) camera was used to image and quantify CFP+ cells in mice from the B6.Cg-Tg(Thy1-CFP)23Jrs/J line. SD-OCT circle (1 B-scan), raster (37 B-scans) and radial (24 B-scans) scans of the retina were also obtained. CSLO was performed at baseline (n = 11) and 3 (n = 11), 5 (n = 4), 7 (n = 10), 10 (n = 6), 14 (n = 7) and 21 (n = 5) days post-transection, while SD-OCT was performed at baseline and 7, 14 and 35 days (n = 9) post-transection. Longitudinal change in CFP+ cell density and retinal thickness were computed. Compared to baseline, the mean (SD) percentage CFP+ cells remaining at 3, 5, 7, 10, 14 and 21 days post-transection was 86 (9)%, 63 (11)%, 45 (11)%, 31 (9)%, 20 (9)% and 8 (4)%, respectively. Compared to baseline, the mean (SD) retinal thickness at 7 days post-transection was 97 (3)%, 98 (2)% and 97 (4)% for the circle, raster and radial scans, respectively. The corresponding figures at 14 and 35 days post-transection were 96 (3)%, 97 (2)% and 95 (3)%; and 93 (3)%, 94 (3)% and 92 (3)%. Conclusions/Significance: Longitudinal imaging showed an exponential decline in CFP+ cell density and a small (<= 8%) reduction in SD-OCT measured retinal thickness post-transection. SD-OCT is a promising tool for detecting structural changes in experimental optic neuropathy. These results represent an important step towards translation for clinical use.	[Chauhan, Balwantray C.; Stevens, Kelly T.; Levesque, Julie M.; Nuschke, Andrea C.; Archibald, Michele L.; Wang, Xu] Dalhousie Univ, Retina & Opt Nerve Res Lab, Halifax, NS, Canada; [Chauhan, Balwantray C.; Stevens, Kelly T.; Levesque, Julie M.; Nuschke, Andrea C.; Archibald, Michele L.; Wang, Xu] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Chauhan, Balwantray C.; Sharpe, Glen P.; O'Leary, Neil] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Chauhan, BC (corresponding author), Dalhousie Univ, Retina & Opt Nerve Res Lab, Halifax, NS, Canada.	bal@dal.ca		O'Leary, Neil/0000-0002-2765-7016; Chauhan, Balwantray/0000-0002-7936-6907	Canadian Institutes of Health Research [MOP-89808]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by Grant MOP-89808 from the Canadian Institutes of Health Research (cihr.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; DABIN I, 1995, GLIA, V14, P23, DOI 10.1002/glia.440140105; Dowling J. E., 1987, RETINA APPROACHABLE; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2250, DOI 10.1167/iovs.10-6311; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Guo L, 2010, INVEST OPHTH VIS SCI, V51, P6504, DOI 10.1167/iovs.10-5551; HOYT WF, 1973, INVEST OPHTH VISUAL, V12, P814; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P1380; Komaromy AM, 2003, J GLAUCOMA, V12, P307; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Leung CKS, 2009, BRIT J OPHTHALMOL, V93, P964, DOI 10.1136/bjo.2008.150482; Leung CKS, 2008, J NEUROSCI METH, V168, P475, DOI 10.1016/j.jneumeth.2007.10.018; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Mohammadi K, 2004, AM J OPHTHALMOL, V138, P592, DOI 10.1016/j.ajo.2004.05.072; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Murphy JA, 2007, MOL CELL NEUROSCI, V36, P280, DOI 10.1016/j.mcn.2007.07.006; Nickells RW, 2007, VET OPHTHALMOL, V10, P88, DOI 10.1111/j.1463-5224.2007.00564.x; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; PERRY VH, 1984, J NEUROCYTOL, V13, P809, DOI 10.1007/BF01148495; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Raymond ID, 2008, MOL VIS, V14, P1559; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Schuman J S, 1995, Curr Opin Ophthalmol, V6, P89; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; THANOS S, 1994, TRENDS NEUROSCI, V17, P177, DOI 10.1016/0166-2236(94)90098-1; van Velthoven MEJ, 2007, PROG RETIN EYE RES, V26, P57, DOI 10.1016/j.preteyeres.2006.10.002; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wang X, 2010, NEUROSCI LETT, V468, P110, DOI 10.1016/j.neulet.2009.10.077; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008	36	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40352	10.1371/journal.pone.0040352	http://dx.doi.org/10.1371/journal.pone.0040352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768284	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100258
J	De Pourcq, K; Tiels, P; Van Hecke, A; Geysens, S; Vervecken, W; Callewaert, N				De Pourcq, Karen; Tiels, Petra; Van Hecke, Annelies; Geysens, Steven; Vervecken, Wouter; Callewaert, Nico			Engineering Yarrowia lipolytica to Produce Glycoproteins Homogeneously Modified with the Universal Man(3)GlcNAc(2) N-Glycan Core	PLOS ONE			English	Article							II BETA-SUBUNIT; SACCHAROMYCES-CEREVISIAE MUTANT; RETICULUM GLUCOSIDASE-II; ENDOPLASMIC-RETICULUM; ALG3 GENE; HETERODIMERIC STRUCTURE; SUBSTRATE-SPECIFICITY; PROTEIN EXPRESSION; MOLECULAR-CLONING; MRH DOMAIN	Yarrowia lipolytica is a dimorphic yeast that efficiently secretes various heterologous proteins and is classified as "generally recognized as safe." Therefore, it is an attractive protein production host. However, yeasts modify glycoproteins with non-human high mannose-type N-glycans. These structures reduce the protein half-life in vivo and can be immunogenic in man. Here, we describe how we genetically engineered N-glycan biosynthesis in Yarrowia lipolytica so that it produces Man(3)GlcNAc(2) structures on its glycoproteins. We obtained unprecedented levels of homogeneity of this glycanstructure. This is the ideal starting point for building human-like sugars. Disruption of the ALG3 gene resulted in modification of proteins mainly with Man(5)GlcNAc(2) and GlcMan(5)GlcNAc(2) glycans, and to a lesser extent with Glc(2)Man(5)GlcNAc(2) glycans. To avoid underoccupancy of glycosylation sites, we concomitantly overexpressed ALG6. We also explored several approaches to remove the terminal glucose residues, which hamper further humanization of N-glycosylation; overexpression of the heterodimeric Apergillus niger glucosidase II proved to be the most effective approach. Finally, we overexpressed an alpha-1,2-mannosidase to obtain Man(3)GlcNAc(2) structures, which are substrates for the synthesis of complex-type glycans. The final Yarrowia lipolytica strain produces proteins glycosylated with the trimannosyl core N-glycan (Man(3)GlcNAc(2)), which is the common core of all complex-type N-glycans. All these glycans can be constructed on the obtained trimannosyl N-glycan using either in vivo or in vitro modification with the appropriate glycosyltransferases. The results demonstrate the high potential of Yarrowia lipolytica to be developed as an efficient expression system for the production of glycoproteins with humanized glycans.	[De Pourcq, Karen; Tiels, Petra; Van Hecke, Annelies; Geysens, Steven; Vervecken, Wouter; Callewaert, Nico] VIB, Dept Mol Biomed Res, Unit Med Biotechnol, Ghent, Belgium; [Tiels, Petra; Callewaert, Nico] Univ Ghent, Dept Biochem & Microbiol, L Probe, B-9000 Ghent, Belgium; [De Pourcq, Karen; Van Hecke, Annelies; Geysens, Steven; Vervecken, Wouter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Geysens, Steven; Vervecken, Wouter] Oxyrane Belgium, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	De Pourcq, K (corresponding author), VIB, Dept Mol Biomed Res, Unit Med Biotechnol, Ghent, Belgium.	Nico.Callewaert@dmbr.vib-UGent.be		Callewaert, Nico/0000-0003-2069-6917; Van Hecke, Annelies/0000-0002-3010-8034	EU [MEXT-014292]; Oxyrane UK Ltd. (Manchester UK); Fund for Scientific Research Flanders [FWO-G.0.541.08.N.10]	EU(European Commission); Oxyrane UK Ltd. (Manchester UK); Fund for Scientific Research Flanders(FWO)	This work was supported by Marie Curie Excellence Grant MEXT-014292 under EU Framework Program 6, Oxyrane UK Ltd. (Manchester UK) and the Fund for Scientific Research Flanders grant (FWO-G.0.541.08.N.10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Alonzi DS, 2006, BIOCHEM J, V409, P571; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; BAUSE E, 1993, EUR J BIOCHEM, V217, P535, DOI 10.1111/j.1432-1033.1993.tb18274.x; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; Callewaert N, 2001, FEBS LETT, V503, P173, DOI 10.1016/S0014-5793(01)02676-X; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cipollo JF, 2000, J BIOL CHEM, V275, P4267, DOI 10.1074/jbc.275.6.4267; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; Davidson RC, 2004, GLYCOBIOLOGY, V14, P399, DOI 10.1093/glycob/cwh023; De Pourcq K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-53; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fickers P, 2005, FUNGAL GENET BIOL, V42, P264, DOI 10.1016/j.fgb.2004.12.003; Fickers P, 2003, J MICROBIOL METH, V55, P727, DOI 10.1016/j.mimet.2003.07.003; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; Henquet M, 2008, PLANT CELL, V20, P1652, DOI 10.1105/tpc.108.060731; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jolivet P, 2007, FEMS YEAST RES, V7, P1317, DOI 10.1111/j.1567-1364.2007.00293.x; Jones D, 2004, BIOCHEM SOC T, V32, P766, DOI 10.1042/BST0320766; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; Kainz E, 2008, APPL ENVIRON MICROB, V74, P1076, DOI 10.1128/AEM.01058-07; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Madzak C, 2000, J MOL MICROB BIOTECH, V2, P207; MICHAEL JM, 1980, ARCH BIOCHEM BIOPHYS, V199, P249, DOI 10.1016/0003-9861(80)90278-7; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; Oh Doo-Byoung, 2008, Biotechnology Journal, V3, P659, DOI 10.1002/biot.200700252; Pelletier MF, 2000, GLYCOBIOLOGY, V10, P815, DOI 10.1093/glycob/10.8.815; Pignede G, 2000, J BACTERIOL, V182, P2802, DOI 10.1128/JB.182.10.2802-2810.2000; Quinn RP, 2009, GLYCOBIOLOGY, V19, P1408, DOI 10.1093/glycob/cwp087; SAUNIER B, 1982, J BIOL CHEM, V257, P4155; Sharma CB, 2001, BIOL CHEM, V382, P321, DOI 10.1515/BC.2001.039; Song Y, 2007, APPL ENVIRON MICROB, V73, P4446, DOI 10.1128/AEM.02058-06; SPIRO MJ, 1979, J BIOL CHEM, V254, P7668; SPIRO RG, 1979, J BIOL CHEM, V254, P7659; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1998, GLYCOBIOLOGY, V8, P585, DOI 10.1093/glycob/8.6.585; Treml K, 2000, GLYCOBIOLOGY, V10, P493, DOI 10.1093/glycob/10.5.493; TRIMBLE RB, 1995, TRENDS GLYCOSCI GLYC, V7, P1, DOI 10.4052/tigg.7.1; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; VEROSTEK MF, 1993, J BIOL CHEM, V268, P12104; VEROSTEK MF, 1993, J BIOL CHEM, V268, P12095; VEROSTEK MF, 1991, J BIOL CHEM, V266, P5547; Watanabe T, 2009, GLYCOBIOLOGY, V19, P834, DOI 10.1093/glycob/cwp061; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	56	35	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39976	10.1371/journal.pone.0039976	http://dx.doi.org/10.1371/journal.pone.0039976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768188	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100160
J	Jin, HR; Jin, SZ; Cai, XF; Li, DH; Wu, X; Nan, JX; Lee, JJ; Jin, XJ				Jin, Hong Ri; Jin, Song Zhu; Cai, Xing Fu; Li, Donghao; Wu, Xue; Nan, Ji Xing; Lee, Jung Joon; Jin, Xuejun			Cryptopleurine Targets NF-kappa B Pathway, Leading to Inhibition of Gene Products Associated with Cell Survival, Proliferation, Invasion, and Angiogenesis	PLOS ONE			English	Article							CANCER DEVELOPMENT; DRUG DEVELOPMENT; P65 SUBUNIT; KINASE; ACTIVATION; TRANSCRIPTION; INFLAMMATION; EXPRESSION; ALPHA; PROGRESSION	Background: Cryptopleurine, a phenanthroquinolizidine alkaloid, was known to exhibit anticancer activity; however, the underlying mechanism is poorly understood. Because the nuclear factor-kappa B (NF-kappa B) transcription factors control many physiological processes including inflammation, immunity, and development and progression of cancer, we investigated the effects of cryptopleurine on tumor necrosis factor alpha (TNF-alpha)-induced NF-kappa B activation pathway and on the expression of NF-kappa B-regulated gene products associated with many pathophysiological processes. Methodology and Principal Finding: MDA-MB231, MDA-MB435, MCF-7, HEK293, RAW264.7 and Hep3B cells were used to examine cryptopleurine's effect on the NF-kappa B activation pathway. Major assays were promoter-reporter gene assay, electrophoretic mobility shift assay (EMSA), in vitro immune complex kinase assay, real-time PCR, Western blot analysis, and Matrigel invasion assay. Experiments documenting cell proliferation and apoptosis were analyzed by MTT method and flow cytometry, respectively. The results indicated that cryptopleurine suppressed the NF-kappa B activation through the inhibition of I kappa B kinase (IKK) activation, thereby blocking the phosphorylation and degradation of the inhibitor of NF-kappa B alpha (I kappa B alpha) and the nuclear translocation and DNA-binding activity of p65. The suppression of NF-kappa B by cryptopleurine led to the down-regulation of gene products involved in inflammation, cell survival, proliferation, invasion, and angiogenesis. Conclusions and Significance: Our results show that cryptopleurine inhibited NF-kappa B activation pathway, which leads to inhibition of inflammation, proliferation, and invasion, as well as potentiation of apoptosis. Our findings provide a new insight into the molecular mechanisms and a potential application of cryptopleurine for inflammatory diseases as well as certain cancers associated with abnormal NF-kappa B activation.	[Li, Donghao; Wu, Xue; Nan, Ji Xing; Lee, Jung Joon; Jin, Xuejun] Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Jilin, Peoples R China; [Jin, Song Zhu] Yanbian Univ, Coll Basic Med, Dept Immunol & Pathogen Biol, Yanji, Jilin, Peoples R China; [Jin, Hong Ri; Cai, Xing Fu; Lee, Jung Joon] Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Ochang, Chungbuk, South Korea	Yanbian University; Yanbian University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Jin, HR (corresponding author), Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Jilin, Peoples R China.	jjlee@kribb.re.kr; xjjin0224@yahoo.com.cn	nan, ji-xing/H-5604-2018	nan, ji-xing/0000-0002-6221-4309	National Natural Science Foundation of China [81160250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by National Natural Science Foundation of China, No. 81160250. This study also received assistance from the China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Cai XF, 2006, J NAT PROD, V69, P1095, DOI 10.1021/np060081y; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chemler Sherry R, 2009, Curr Bioact Compd, V5, P2; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Jin XJ, 2010, J BIOL CHEM, V285, P30539, DOI 10.1074/jbc.M110.129551; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lin Y, 2003, MOL CELL BIOL, V23, P5849, DOI 10.1128/MCB.23.16.5849-5856.2003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.M700890200; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Polsky D, 2003, ONCOGENE, V22, P3087, DOI 10.1038/sj.onc.1206449; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang J, 2000, J CELL SCI, V113, P753; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	43	48	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40355	10.1371/journal.pone.0040355	http://dx.doi.org/10.1371/journal.pone.0040355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768286	gold, Green Published			2022-12-25	WOS:000305892100260
J	Khosravi-Hashemi, N; Chacron, MJ				Khosravi-Hashemi, Navid; Chacron, Maurice J.			Bursts and Isolated Spikes Code for Opposite Movement Directions in Midbrain Electrosensory Neurons	PLOS ONE			English	Article							LATERAL GENICULATE NEURONS; ELECTRIC FISH; IN-VIVO; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC DYNAMICS; RECEPTIVE-FIELDS; MOTION ANALYSIS; OPTIC TECTUM; PREY-CAPTURE; INFORMATION	Directional selectivity, in which neurons respond strongly to an object moving in a given direction but weakly or not at all to the same object moving in the opposite direction, is a crucial computation that is thought to provide a neural correlate of motion perception. However, directional selectivity has been traditionally quantified by using the full spike train, which does not take into account particular action potential patterns. We investigated how different action potential patterns, namely bursts (i.e. packets of action potentials followed by quiescence) and isolated spikes, contribute to movement direction coding in a mathematical model of midbrain electrosensory neurons. We found that bursts and isolated spikes could be selectively elicited when the same object moved in opposite directions. In particular, it was possible to find parameter values for which our model neuron did not display directional selectivity when the full spike train was considered but displayed strong directional selectivity when bursts or isolated spikes were instead considered. Further analysis of our model revealed that an intrinsic burst mechanism based on subthreshold T-type calcium channels was not required to observe parameter regimes for which bursts and isolated spikes code for opposite movement directions. However, this burst mechanism enhanced the range of parameter values for which such regimes were observed. Experimental recordings from midbrain neurons confirmed our modeling prediction that bursts and isolated spikes can indeed code for opposite movement directions. Finally, we quantified the performance of a plausible neural circuit and found that it could respond more or less selectively to isolated spikes for a wide range of parameter values when compared with an interspike interval threshold. Our results thus show for the first time that different action potential patterns can differentially encode movement and that traditional measures of directional selectivity need to be revised in such cases.	[Khosravi-Hashemi, Navid; Chacron, Maurice J.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Khosravi-Hashemi, Navid; Chacron, Maurice J.] McGill Univ, Ctr Appl Math Biol & Med, Montreal, PQ, Canada; [Chacron, Maurice J.] McGill Univ, Dept Phys, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Khosravi-Hashemi, N (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	maurice.chacron@mcgill.ca		Chacron, Maurice/0000-0002-3032-452X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Canada Research Chairs	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR)	This research was supported by the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council, and the Canada Research Chairs (M.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Akerberg OA, 2011, J COMPUT NEUROSCI, V31, P369, DOI 10.1007/s10827-011-0313-4; Avila-Akerberg O, 2010, NEUROSCIENCE, V168, P300, DOI 10.1016/j.neuroscience.2010.03.012; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1982, J COMP PHYSIOL, V147, P287, DOI 10.1007/BF00609662; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Borst A, 2007, PHILOS T R SOC B, V362, P369, DOI 10.1098/rstb.2006.1964; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; Carr C.E., 1986, P319; CARR CE, 1985, J COMP NEUROL, V235, P207, DOI 10.1002/cne.902350206; Carver S, 2005, BIOL CYBERN, V92, P147, DOI 10.1007/s00422-004-0535-x; Carver S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040032; Chacron MJ, 2008, J NEUROPHYSIOL, V99, P1825, DOI 10.1152/jn.01266.2007; Chacron MJ, 2007, J COMPUT NEUROSCI, V23, P301, DOI 10.1007/s10827-007-0033-y; Chacron MJ, 2011, CURR OPIN NEUROBIOL, V21, P752, DOI 10.1016/j.conb.2011.05.016; Chacron MJ, 2010, J NEUROPHYSIOL, V104, P449, DOI 10.1152/jn.01113.2009; Chacron MJ, 2009, J NEUROPHYSIOL, V102, P3270, DOI 10.1152/jn.00645.2009; Chacron MJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051917; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; Chacron MJ, 2005, J NEUROSCI, V25, P5521, DOI 10.1523/JNEUROSCI.0445-05.2005; Chacron MJ, 2004, J COMPUT NEUROSCI, V17, P127, DOI 10.1023/B:JCNS.0000037677.58916.6b; Chacron MJ, 2001, NEUROCOMPUTING, V38, P129, DOI 10.1016/S0925-2312(01)00549-5; Chance FS, 1998, J NEUROSCI, V18, P4785; Cowan NJ, 2007, J NEUROSCI, V27, P1123, DOI 10.1523/JNEUROSCI.4198-06.2007; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; Deemyad T, 2011, J NEUROPHYSIOL, V105, P1276, DOI 10.1152/jn.00792.2010; Derrington AM, 2004, ANNU REV PSYCHOL, V55, P181, DOI 10.1146/annurev.psych.55.090902.141903; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Edwards CJ, 2008, J NEUROPHYSIOL, V100, P3407, DOI 10.1152/jn.90921.2008; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Eyherabide HG, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.003.2008; Frank K, 1964, PHYS TECHNIQUES BIOL, P23, DOI DOI 10.1016/B978-0-12-514105-5.50009-5; Frye MA, 2001, J EXP BIOL, V204, P3683; Gabbiani F, 1996, NEURAL COMPUT, V8, P44, DOI 10.1162/neco.1996.8.1.44; Gaudry KS, 2008, NETWORK-COMP NEURAL, V19, P69, DOI 10.1080/09548980701819198; George AA, 2011, J NEUROSCI, V31, P14721, DOI 10.1523/JNEUROSCI.1424-11.2011; Green DM, 1966, SIGNAL DETECTION THE; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Harvey-Girard E, 2010, J NEUROSCI, V30, P6152, DOI 10.1523/JNEUROSCI.0303-10.2010; HEILIGENBERG W, 1987, NEUROSCIENCE, V22, P331, DOI 10.1016/0306-4522(87)90224-7; Hitschfeld EM, 2009, ILAR J, V50, P361, DOI 10.1093/ilar.50.4.361; Hock HS, 2009, ACTA PSYCHOL, V132, P1, DOI 10.1016/j.actpsy.2009.06.006; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horak F, 1996, HDB PHYSIOL 12, V12, P255; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Kepecs A, 2002, J NEUROSCI, V22, P9053; Khosravi-Hashemi N, 2011, J NEUROPHYSIOL, V106, P1954, DOI 10.1152/jn.00116.2011; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Krahe R, 2008, J NEUROPHYSIOL, V100, P852, DOI 10.1152/jn.90300.2008; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Leary CJ, 2008, J NEUROSCI, V28, P5481, DOI 10.1523/JNEUROSCI.5041-07.2008; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lewis JE, 2004, J NEUROPHYSIOL, V91, P1064, DOI 10.1152/jn.00856.2003; Lewis JE, 2002, J NEUROPHYSIOL, V88, P1695, DOI 10.1152/jn.2002.88.4.1695; Lindner B, 2009, J NEUROSCI, V29, P2076, DOI 10.1523/JNEUROSCI.3702-08.2009; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MacIver MA, 2001, J EXP BIOL, V204, P543; MAEX R, 1991, P NATL ACAD SCI USA, V88, P3549, DOI 10.1073/pnas.88.9.3549; Manwani A, 1999, NEURAL COMPUT, V11, P1797, DOI 10.1162/089976699300015972; Marsat G, 2004, J NEUROPHYSIOL, V92, P939, DOI 10.1152/jn.00111.2004; Marsat G, 2010, J NEUROPHYSIOL, V104, P2543, DOI 10.1152/jn.00256.2010; Marsat G, 2010, J COMP PHYSIOL A, V196, P315, DOI 10.1007/s00359-010-0514-8; Marsat G, 2009, J NEUROPHYSIOL, V102, P714, DOI 10.1152/jn.91366.2008; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; McGillivray P, 2012, J NEUROSCI, V32, P5510, DOI 10.1523/JNEUROSCI.0478-12.2012; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; Nelson ME, 1999, J EXP BIOL, V202, P1195; Oswald AMM, 2004, J NEUROSCI, V24, P4351, DOI 10.1523/JNEUROSCI.0459-04.2004; Oswald AMM, 2007, J NEUROPHYSIOL, V97, P2731, DOI 10.1152/jn.00987.2006; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Ramcharitar JU, 2006, J NEUROPHYSIOL, V96, P2319, DOI 10.1152/jn.00311.2006; Ramcharitar JU, 2005, J COMP PHYSIOL A, V191, P865, DOI 10.1007/s00359-005-0008-2; REICHARDT W, 1987, J COMP PHYSIOL A, V161, P533, DOI 10.1007/BF00603660; REICHARDT W, 1969, NATURWISSENSCHAFTEN, V56, P424, DOI 10.1007/BF00593644; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rose GJ, 1996, NEUROSCI RES, V26, P89, DOI 10.1016/S0168-0102(96)01074-7; ROSE GJ, 1993, J NEUROSCI, V13, P1178; RUSH ME, 1994, BIOL CYBERN, V71, P281, DOI 10.1007/BF00239616; Samengo I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009669; SAUNDERS J, 1984, J COMP PHYSIOL, V154, P199, DOI 10.1007/BF00604985; Sherman, 2006, EXPLORING THALAMUS I, P357; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; Srinivasan MV, 1999, VISION RES, V39, P2749, DOI 10.1016/S0042-6989(99)00002-4; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Toporikova N, 2009, J NEUROPHYSIOL, V102, P2273, DOI 10.1152/jn.00282.2009; Turner RW, 1999, J EXP BIOL, V202, P1255; Vonderschen K, 2011, J NEUROPHYSIOL, V106, P3102, DOI 10.1152/jn.00588.2011; Vonderschen K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-S1-O3; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	102	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40339	10.1371/journal.pone.0040339	http://dx.doi.org/10.1371/journal.pone.0040339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768279	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100253
J	Liu, D; Trojanowicz, B; Ye, LY; Li, C; Zhang, LQ; Li, XW; Li, GG; Zheng, YX; Chen, L				Liu, Daren; Trojanowicz, Bogusz; Ye, Longyun; Li, Chao; Zhang, Luqing; Li, Xiaowen; Li, Guogang; Zheng, Yixiong; Chen, Li			The Invasion and Metastasis Promotion Role of CD97 Small Isoform in Gastric Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; PREMETASTATIC NICHE; TUMOR INVASION; EXPRESSION; RECEPTOR; EGF-TM7; CD55; MOLECULES; PROTEIN; BONE	CD97 is over-expressed in the majority of gastric adenocarcinomas and is associated with its dedifferentiation and aggressiveness. Our previous results demonstrated that out of three CD97 isoforms tested, only the small one was able to promote increased invasiveness in vitro. Based on these data we further aimed to investigate the role of CD97 small isoform in gastric cancer progression in vivo by employing the cells with a stable CD97 small isoform knock-down and an orthotopic gastric cancer mouse model. We could demonstrate that the knock down of CD97/EGF1,2,5, led to a significant decrease in the number of cells penetrating the gelatin coated membrane as compared with control cells. In the gastric cancer mouse model, both the hypodermic and the orthotopic yielded tumor masses of the CD97/EGF1,2,5kd group and were significantly smaller than the control. Metastatic tumor cell number in early metastatic regional lymph nodes on post-operative day 42 was distinctly decreased in the CD97/EGF1,2,5kd group as compared with the SGC-NS group, and was accompanied with the downregulation of CD44, VEGFR, CD31 and CD97. We concluded in this study that CD97 small isoform not only supported gastric cancer local growth, but also promoted metastatic spread in orthotopically implanted mouse model suggesting involvement of the CD97 small isoform in the preparation of (pre) metastatic niche.	[Liu, Daren; Ye, Longyun; Li, Chao; Zhang, Luqing; Li, Xiaowen; Li, Guogang; Zheng, Yixiong; Chen, Li] Zhejiang Univ, Dept Surg, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Trojanowicz, Bogusz] Universitatklinikum Halle Saale, Klin Innere Med 2, Halle, Saale, Germany	Zhejiang University	Liu, D (corresponding author), Zhejiang Univ, Dept Surg, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	chenli@mail.hz.zj.cn	Trojanowicz, Bogusz/I-3042-2019	Trojanowicz, Bogusz/0000-0001-7429-381X	National Natural Science Foundation of China [81101837, 81071959]; Research Fund for the Doctoral Program of Higher Education of China [20110101120129]; Science Technology Department of Zhejiang Province [2010C34001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Technology Department of Zhejiang Province	This study was funded by the National Natural Science Foundation of China (No. 81101837 and No. 81071959), the Research Fund for the Doctoral Program of Higher Education of China (No. 20110101120129) and the Science Technology Department of Zhejiang Province (No. 2010C34001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust G, 1997, CANCER RES, V57, P1798; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Chidambaram A, 2012, J NEUROSURG, V116, P843, DOI 10.3171/2011.11.JNS111455; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Gray JX, 1996, J IMMUNOL, V157, P5438; Hamann J, 1996, GENOMICS, V32, P144, DOI 10.1006/geno.1996.0092; Hensel F, 2001, LAB INVEST, V81, P1553, DOI 10.1038/labinvest.3780369; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoang-Vu C, 1999, J CLIN ENDOCR METAB, V84, P1104, DOI 10.1210/jc.84.3.1104; Inoue T, 2002, J CLIN PATHOL-MOL PA, V55, P193, DOI 10.1136/mp.55.3.193; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Jaspars LH, 2001, TISSUE ANTIGENS, V57, P325, DOI 10.1034/j.1399-0039.2001.057004325.x; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Liu DR, 2010, INT J ONCOL, V36, P1401, DOI 10.3892/ijo_00000625; Liu Y, 2005, ONCOL REP, V14, P1413; Liu Yong, 2005, J Zhejiang Univ Sci B, V6, P913, DOI 10.1631/jzus.2005.B0913; MARTENS GJM, 1992, PROG BRAIN RES, V92, P201, DOI 10.1016/S0079-6123(08)61176-0; McKnight AJ, 1996, IMMUNOL TODAY, V17, P283, DOI 10.1016/0167-5699(96)80546-9; Mikesch JH, 2006, CELL ONCOL, V28, P223; Nakanishi Y, 2001, CANCER, V91, P1114, DOI 10.1002/1097-0142(20010315)91:6<1114::AID-CNCR1107>3.0.CO;2-Y; Nie D, 2011, FRONT BIOSCI, V2, P184; Park KJ, 2005, DIS COLON RECTUM, V48, P1597, DOI 10.1007/s10350-005-0060-6; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Spendlove I, 2006, CANCER IMMUNOL IMMUN, V55, P987, DOI 10.1007/s00262-006-0136-8; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; vanLier RAW, 1996, IMMUNOL LETT, V54, P185, DOI 10.1016/S0165-2478(96)02670-3; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; WEISS L, 1982, BRIT J CANCER, V45, P44, DOI 10.1038/bjc.1982.6; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	38	28	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39989	10.1371/journal.pone.0039989	http://dx.doi.org/10.1371/journal.pone.0039989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768192	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100164
J	Long, T; Vanderstraete, M; Cailliau, K; Morel, M; Lescuyer, A; Gouignard, N; Grevelding, CG; Browaeys, E; Dissous, C				Long, Thavy; Vanderstraete, Mathieu; Cailliau, Katia; Morel, Marion; Lescuyer, Arlette; Gouignard, Nadege; Grevelding, Christoph G.; Browaeys, Edith; Dissous, Colette			SmSak, the Second Polo-Like Kinase of the Helminth Parasite Schistosoma mansoni: Conserved and Unexpected Roles in Meiosis	PLOS ONE			English	Article							CENTROSOME DUPLICATION; CENTRIOLE DUPLICATION; TYROSINE KINASE; SAK; GROWTH; GENE; EXPRESSION; MUTANT; OVERDUPLICATION; PRAZIQUANTEL	Polo-like kinases (Plks) are a family of conserved regulators of a variety of events throughout the cell cycle, expanded from one Plk in yeast to five Plks in mammals (Plk1-5). Plk1 is the best characterized member of the Plk family, homolog to the founding member Polo of Drosophila, and plays a major role in cell cycle progression by triggering G2/M transition. Plk4/Sak (for Snk (Serum-inducible kinase) akin kinase) is a unique member of the family, structurally distinct from other Plk members, with essential functions in centriole duplication. The genome of the trematode parasite Schistosoma mansoni contains only two Plk genes encoding SmPlk1 and SmSak. SmPlk1 has been shown already to be required for gametogenesis and parasite reproduction. In this work, in situ hybridization indicated that the structurally conserved Plk4 protein, SmSak, was largely expressed in schistosome female ovary and vitellarium. Expression of SmSak in Xenopus oocytes confirmed its Plk4 conserved function in centriole amplification. Moreover, analysis of the function of SmSak in meiosis progression of G2-blocked Xenopus oocytes indicated that, in contrast to SmPlk1, SmSak cannot induce G2/M transition in the absence of endogenous Plk1 (Plx1). Unexpectedly, meiosis progression was spontaneously observed in Plx1-depleted oocytes co-expressing SmSak and SmPlk1. Molecular interaction between SmSak and SmPlk1 was confirmed by co-immunoprecipitation of both proteins. These data indicate that Plk1 and Plk4 proteins have the potential to interact and cross-activate in cells, thus attributing for the first time a potential role of Plk4 proteins in meiosis/mitosis entry. This unexpected role of SmSak in meiosis could be relevant to further consider the function of this novel Plk in schistosome reproduction.	[Long, Thavy; Vanderstraete, Mathieu; Morel, Marion; Gouignard, Nadege; Dissous, Colette] Univ Lille Nord France, CNRS, UMR 8204, Inst Pasteur,Inserm,U1019,Ctr Infect & Immun Lill, Lille, France; [Cailliau, Katia; Lescuyer, Arlette; Browaeys, Edith] Univ Lille 1 Sci & Technol, IFR 147, EA 4479, Villeneuve Dascq, France; [Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, Giessen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Justus Liebig University Giessen	Long, T (corresponding author), Univ Lille Nord France, CNRS, UMR 8204, Inst Pasteur,Inserm,U1019,Ctr Infect & Immun Lill, Lille, France.	colette.dissous@pasteur-lille.fr	Morel, Marion/X-4104-2019	cailliau, katia/0000-0003-1772-1034; Cailliau, Katia/0000-0001-7993-8437; Gouignard, Nadege/0000-0001-8787-2503; Morel, Marion/0000-0002-1439-5360; Dissous, Colette/0000-0002-5003-8205	Institut de la Sante et de la Recherche Medicale; Universite Lille Nord de France; Ministere de l'Education Nationale et de la Recherche, France	Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Lille Nord de France; Ministere de l'Education Nationale et de la Recherche, France	This research was supported by the Institut de la Sante et de la Recherche Medicale and Universite Lille Nord de France. TL, MV, and NG have fellowships through the Ministere de l'Education Nationale et de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; Beckmann S, 2011, J BIOL CHEM, V286, P42325, DOI 10.1074/jbc.M110.210336; Beckmann S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000769; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bonni S, 2008, CELL CYCLE, V7, P545, DOI 10.4161/cc.7.4.5387; Browaeys-Poly E, 2000, EUR J BIOCHEM, V267, P6256, DOI 10.1046/j.1432-1327.2000.01710.x; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; de Carcer G, 2011, MOL CELL BIOL, V31, P1225, DOI 10.1128/MCB.00607-10; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; DISSOUS C, 1981, MOL BIOCHEM PARASIT, V3, P215, DOI 10.1016/0166-6851(81)90053-0; Dissous C, 2011, AN ACAD BRAS CIENC, V83, P627, DOI 10.1590/S0001-37652011000200022; Dissous C, 2011, TRENDS PARASITOL, V27, P59, DOI 10.1016/j.pt.2010.09.001; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fode C, 1996, MOL CELL BIOL, V16, P4665; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gouignard N, 2012, EXP PARASITOL, V132, P32, DOI 10.1016/j.exppara.2011.05.007; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Harris RM, 2011, ENDOCRINOLOGY, V152, P3975, DOI 10.1210/en.2011-1106; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hudson JW, 2000, GENE, V241, P65, DOI 10.1016/S0378-1119(99)00467-9; Karn T, 1997, ONCOL REP, V4, P505; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Lane HA, 1997, TRENDS CELL BIOL, V7, P63, DOI 10.1016/S0962-8924(96)10051-9; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long T, 2010, INT J PARASITOL, V40, P1075, DOI 10.1016/j.ijpara.2010.03.002; LoVerde PT, 2009, CURR OPIN MICROBIOL, V12, P422, DOI 10.1016/j.mib.2009.06.005; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Pearson Chad G, 2010, F1000 Biol Rep, V2, P58, DOI 10.3410/B2-58; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Peters N, 2010, J CELL SCI, V123, P795, DOI 10.1242/jcs.050682; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; SCHALLIG HDFH, 1992, PARASITOLOGY, V104, P309, DOI 10.1017/S0031182000061758; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; SUNKEL CE, 1988, J CELL SCI, V89, P25; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Yan Y, 2007, INT J PARASITOL, V37, P1539, DOI 10.1016/j.ijpara.2007.06.001	66	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40045	10.1371/journal.pone.0040045	http://dx.doi.org/10.1371/journal.pone.0040045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768216	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100188
J	Peterson, GJ; Presse, S; Peterson, KS; Dill, KA				Peterson, G. Jack; Presse, Steve; Peterson, Kristin S.; Dill, Ken A.			Simulated Evolution of Protein-Protein Interaction Networks with Realistic Topology	PLOS ONE			English	Article							GENE DUPLICATION; YEAST; MODULARITY; GENOMES; NEOFUNCTIONALIZATION; DIVERGENCE; PREDICTION; DROSOPHILA; LANDSCAPE; BIOLOGY	We model the evolution of eukaryotic protein-protein interaction (PPI) networks. In our model, PPI networks evolve by two known biological mechanisms: (1) Gene duplication, which is followed by rapid diversification of duplicate interactions. (2) Neofunctionalization, in which a mutation leads to a new interaction with some other protein. Since many interactions are due to simple surface compatibility, we hypothesize there is an increased likelihood of interacting with other proteins in the target protein's neighborhood. We find good agreement of the model on 10 different network properties compared to high-confidence experimental PPI networks in yeast, fruit flies, and humans. Key findings are: (1) PPI networks evolve modular structures, with no need to invoke particular selection pressures. (2) Proteins in cells have on average about 6 degrees of separation, similar to some social networks, such as human-communication and actor networks. (3) Unlike social networks, which have a shrinking diameter (degree of maximum separation) over time, PPI networks are predicted to grow in diameter. (4) The model indicates that evolutionarily old proteins should have higher connectivities and be more centrally embedded in their networks. This suggests a way in which present-day proteomics data could provide insights into biological evolution.	[Peterson, G. Jack] Univ Calif San Francisco, Biophys Grad Grp, San Francisco, CA 94143 USA; [Presse, Steve] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Peterson, Kristin S.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Dill, Ken A.] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Peterson, GJ (corresponding author), Univ Calif San Francisco, Biophys Grad Grp, San Francisco, CA 94143 USA.	jack@tinybike.net			Department of Defense; Sandler Blue Sky Award; National Science Foundation; National Institutes of Health [GM 34993]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034993] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Sandler Blue Sky Award; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GJP was funded by a National Defense Science and Engineering Graduate Fellowship from the Department of Defense, SP was funded by a Sandler Blue Sky Award, KSP was funded by a Long Term Ecological Research grant from the National Science Foundation, and KAD was funded by the National Science Foundation and National Institutes of Health GM 34993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2002, FEBS LETT, V530, P253, DOI 10.1016/S0014-5793(02)03427-0; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beltrao P, 2007, PLOS COMPUTATIONAL B, V3; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cotton J, 2005, P ROYAL SOC B, V272; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Deeds EJ, 2006, P NATL ACAD SCI USA, V103, P311, DOI 10.1073/pnas.0509715102; Dutkowski J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-393; ERDOS P, 1960, B INT STATIST INST, V38, P343; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Espinosa-Soto C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000719; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Gibson TA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000252; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gomez SM, 2003, BIOINFORMATICS, V19, P1875, DOI 10.1093/bioinformatics/btg352; Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hallinan J, 2004, BIOSYSTEMS, V74, P51, DOI 10.1016/j.biosystems.2004.02.004; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Heo MY, 2011, P NATL ACAD SCI USA, V108, P4258, DOI 10.1073/pnas.1009392108; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Hughes D, 2003, NAT REV GENET, V4, P432, DOI 10.1038/nrg1084; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jothi R, 2005, BIOINFORMATICS, V21, pI241, DOI 10.1093/bioinformatics/bti1009; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; KOCH AL, 1972, GENETICS, V72, P297; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; Krapivsky PL, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066123; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Leskovec J., 2005, KNOWLEDGE DISCOVERY; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; Lipson H, 2002, EVOLUTION, V56, P1549, DOI 10.1111/j.0014-3820.2002.tb01466.x; Liu Y, 2005, BIOINFORMATICS, V21, P3279, DOI 10.1093/bioinformatics/bti492; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch Michael, 1998; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Marcotte E, 1999, NATURE, V402, P86; Maslov S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-9; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ohno S., 1970, P1; Osada N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000305; Pan D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r158; Patil A, 2011, NUCLEIC ACIDS RES, V39, pD744, DOI 10.1093/nar/gkq897; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Qin H, 2003, P NATL ACAD SCI USA, V100, P12820, DOI 10.1073/pnas.2235584100; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Sole RV, 2008, J R SOC INTERFACE, V5, P129, DOI 10.1098/rsif.2007.1108; Soyer OS, 2010, EVOLUTION AFTER GENE DUPLICATION, P215; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Ting CT, 2004, P NATL ACAD SCI USA, V101, P12232, DOI 10.1073/pnas.0401975101; Tovchigrechko A, 2001, PROTEIN SCI, V10, P1572, DOI 10.1110/ps.8701; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Vinogradov AE, 2009, GENOMICS, V93, P534, DOI 10.1016/j.ygeno.2009.02.004; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; WALSH JB, 1995, GENETICS, V139, P421; Wan X, 2010, CHAOS, V20, DOI 10.1063/1.3517107; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu F, 2007, IEEE INT C BIOINF BI; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao D, 2007, CHINESE PHYS LETT, V24, P2766, DOI 10.1088/0256-307X/24/10/015; Zhu GM, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-21019-2	91	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39052	10.1371/journal.pone.0039052	http://dx.doi.org/10.1371/journal.pone.0039052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768057	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100027
J	Rogers, MS; Cryan, LM; Habeshian, KA; Bazinet, L; Caldwell, TP; Ackroyd, PC; Christensen, KA				Rogers, Michael S.; Cryan, Lorna M.; Habeshian, Kaiane A.; Bazinet, Lauren; Caldwell, Thomas P.; Ackroyd, P. Christine; Christensen, Kenneth A.			A FRET-Based High Throughput Screening Assay to Identify Inhibitors of Anthrax Protective Antigen Binding to Capillary Morphogenesis Gene 2 Protein	PLOS ONE			English	Article							INDUCED SKIN TUMORIGENESIS; TUMOR ENDOTHELIAL MARKERS; TANNIC-ACID; POLYVALENT INHIBITORS; MONOCLONAL-ANTIBODY; TOXIN; ANGIOGENESIS; THERAPY; RECEPTOR; CANCER	Anti-angiogenic therapies are effective for the treatment of cancer, a variety of ocular diseases, and have potential benefits in cardiovascular disease, arthritis, and psoriasis. We have previously shown that anthrax protective antigen (PA), a nonpathogenic component of anthrax toxin, is an inhibitor of angiogenesis, apparently as a result of interaction with the cell surface receptors capillary morphogenesis gene 2 (CMG2) protein and tumor endothelial marker 8 (TEM8). Hence, molecules that bind the anthrax toxin receptors may be effective to slow or halt pathological vascular growth. Here we describe development and testing of an effective homogeneous steady-state fluorescence resonance energy transfer (FRET) high throughput screening assay designed to identify molecules that inhibit binding of PA to CMG2. Molecules identified in the screen can serve as potential lead compounds for the development of anti-angiogenic and anti-anthrax therapies. The assay to screen for inhibitors of this protein-protein interaction is sensitive and robust, with observed Z' values as high as 0.92. Preliminary screens conducted with a library of known bioactive compounds identified tannic acid and cisplatin as inhibitors of the PA-CMG2 interaction. We have confirmed that tannic acid both binds CMG2 and has anti-endothelial properties. In contrast, cisplatin appears to inhibit PA-CMG2 interaction by binding both PA and CMG2, and observed cisplatin antiangiogenic effects are not mediated by interaction with CMG2. This work represents the first reported high throughput screening assay targeting CMG2 to identify possible inhibitors of both angiogenesis and anthrax intoxication.	[Rogers, Michael S.; Cryan, Lorna M.; Habeshian, Kaiane A.; Bazinet, Lauren] Harvard Univ, Sch Med, Dept Surg, Vasc Biol Program,Childrens Hosp Boston, Boston, MA 02115 USA; [Caldwell, Thomas P.; Ackroyd, P. Christine; Christensen, Kenneth A.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Clemson University	Rogers, MS (corresponding author), Harvard Univ, Sch Med, Dept Surg, Vasc Biol Program,Childrens Hosp Boston, Boston, MA 02115 USA.	kchris@clemson.edu	Rogers, Michael S/A-9814-2009; Christensen, Kenneth/S-1670-2019; Rogers, Michael/AAE-2217-2019	Rogers, Michael S/0000-0002-5250-8434; Christensen, Kenneth/0000-0002-3736-5500; Rogers, Michael/0000-0002-5250-8434; Cryan, Lorna/0000-0002-2604-7996	National Institutes of Health [1R03NS053690-01, 1R01EY018829-01]; Department of Defense [W81XWH-08-1-0710]; NATIONAL EYE INSTITUTE [R01EY018829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS053690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants 1R03NS053690-01 to KAC and 1R01EY018829-01 to MSR), and the Department of Defense (grant W81XWH-08-1-0710 to MSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; Alvarez Z, 2007, EXPERT REV ANTI-INFE, V5, P783, DOI 10.1586/14787210.5.5.783; Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Bashat S, 2006, P NATL ACAD SCI USA, V103, P13509, DOI 10.1073/pnas.0509870103; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Bell SE, 2001, J CELL SCI, V114, P2755; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Chen X, 2003, CLIN CANCER RES, V9, P3115; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cui XZ, 2005, J INFECT DIS, V191, P422, DOI 10.1086/427189; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; DAMATO RJ, 1995, OPHTHALMOLOGY, V102, P1261, DOI 10.1016/S0161-6420(95)30876-7; DAS M, 1989, INT J CANCER, V43, P468, DOI 10.1002/ijc.2910430321; Davies G, 2006, INT J ONCOL, V29, P1311; Dowling O, 2003, AM J HUM GENET, V73, P957, DOI 10.1086/378781; ENGERMAN RL, 1967, LAB INVEST, V17, P738; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1975, ANN INTERN MED, V82, P96, DOI 10.7326/0003-4819-82-1-96; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Galoyan AA, 2006, NEUROCHEM RES, V31, P795, DOI 10.1007/s11064-006-9082-2; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gubbins MJ, 2006, FEMS IMMUNOL MED MIC, V47, P436, DOI 10.1111/j.1574-695X.2006.00114.x; Gujraty KV, 2006, BIOMACROMOLECULES, V7, P2082, DOI 10.1021/bm060210p; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kamei H, 1999, CANCER BIOTHER RADIO, V14, P135, DOI 10.1089/cbr.1999.14.135; Karginov VA, 2004, FEMS IMMUNOL MED MIC, V40, P71, DOI 10.1016/S0928-8244(03)00302-X; Koide T, 1999, CANCER BIOTHER RADIO, V14, P231, DOI 10.1089/cbr.1999.14.231; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Marienfeld C, 2003, HEPATOLOGY, V37, P1097, DOI 10.1053/jhep.2003.50192; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Michaelson I.C., 1948, T OPHTHALMOL SOC, V68, P137; Moayeri M, 2006, ANTIMICROB AGENTS CH, V50, P2658, DOI 10.1128/AAC.01412-05; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; MUKHTAR H, 1988, CANCER RES, V48, P2361; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Peters DE, 2012, BIOCHEM BIOPH RES CO, V422, P393, DOI 10.1016/j.bbrc.2012.04.160; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Reeves CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034862; REYNOLDS LP, 1992, FASEB J, V6, P886, DOI 10.1096/fasebj.6.3.1371260; Rmali KA, 2005, WORLD J GASTROENTERO, V11, P1283, DOI 10.3748/wjg.v11.i9.1283; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; Rmali KA, 2004, EJSO-EUR J SURG ONC, V30, P948, DOI 10.1016/j.ejso.2004.07.023; Rogers MS, 2007, CANCER RES, V67, P9980, DOI 10.1158/0008-5472.CAN-07-0829; Rogers MS, 2006, EXP CELL RES, V312, P561, DOI 10.1016/j.yexcr.2005.10.021; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schneemann A, 2009, FUTURE MICROBIOL, V4, P35, DOI 10.2217/17460913.4.1.35; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Scorpio A, 2008, ANTIMICROB AGENTS CH, V52, P1014, DOI 10.1128/AAC.00741-07; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; St Croix B, 2000, SCIENCE, V289, P1197; Vitale L, 2006, INFECT IMMUN, V74, P5840, DOI 10.1128/IAI.00712-06; Vuyisich M, 2008, PROTEIN J, V27, P292, DOI 10.1007/s10930-008-9137-0; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Xiong YS, 2006, BIOORG MED CHEM LETT, V16, P964, DOI 10.1016/j.bmcl.2005.10.088; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	68	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39911	10.1371/journal.pone.0039911	http://dx.doi.org/10.1371/journal.pone.0039911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768167	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100136
J	Jung, HJ; Lim, JS; Choi, HJ; Lee, MS; Kim, JH; Kim, SY; Kim, S; Kim, E; Kwon, TH				Jung, Hyun Jun; Lim, Jung-Suk; Choi, Hyo-Jung; Lee, Mi Suk; Kim, Jong-Ho; Kim, Sang-Yeob; Kim, Soyoun; Kim, Eunjung; Kwon, Tae-Hwan			Vasopressin V2R-Targeting Peptide Carrier Mediates siRNA Delivery into Collecting Duct Cells	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; DE-NOVO PEPTIDE; STRUCTURE PREDICTION; TYPE-2 RECEPTOR; ANGIOTENSIN-II; AQP2; INTERNALIZATION; AQUAPORIN-2; KIDNEY; INVOLVEMENT	Internalization of receptor proteins after interacting with specific ligands has been proposed to facilitate siRNA delivery into the target cells via receptor-mediated siRNA transduction. In this study, we demonstrated a novel method of vasopressin V2 receptor (V2R)-mediated siRNA delivery against AQP2 in primary cultured inner medullary collecting duct (IMCD) cells of rat kidney. We synthesized the dDAVP conjugated with nine D-arginines (dDAVP-9r) as a peptide carrier for siRNA delivery. The structure of synthetic peptide carrier showed two regions (i.e., ligand domain to V2R (dDAVP) and siRNA carrying domain (nine D-arginine)) bisected with a spacer of four glycines. The results revealed that 1) synthesized dDAVP-9r peptides formed a stable polyplex with siRNA; 2) siRNA/dDAVP-9r polyplex could bind to the V2R of IMCD cells and induced AQP2 phosphorylation (Ser 256); 3) siRNA/dDAVP-9r polyplex was stable in response to the wide range of different osmolalities, pH levels, or to the RNases; 4) fluorescein-labeled siRNA was delivered into V2R-expressing MDCK and LLC-PK1 cells by siRNA/dDAVP-9r polyplex, but not into the V2R-negative Cos-7 cells; and 5) AQP2-siRNA/dDAVP-9r polyplex effectively delivered siRNA into the IMCD cells, resulting in the significant decrease of protein abundance of AQP2, but not AQP4. Therefore, for the first time to our knowledge, we demonstrated that V2R-mediated siRNA delivery could be exploited to deliver specific siRNA to regulate abnormal expression of target proteins in V2R-expressing kidney cells. The methods could be potentially used in vivo to regulate abnormal expression of proteins associated with disease conditions in the V2R-expressing kidney cells.	[Jung, Hyun Jun; Lim, Jung-Suk; Choi, Hyo-Jung; Lee, Mi Suk; Kim, Jong-Ho; Kim, Sang-Yeob; Kim, Soyoun; Kim, Eunjung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea; [Kim, Jong-Ho] Kyung Hee Univ, Coll Pharm, Dept Pharmaceut Sci, Seoul, South Korea	Kyungpook National University; Kyung Hee University	Jung, HJ (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea.	thkwon@knu.ac.kr	Kim, Soyoun/Y-1276-2018; Kwon, Tae-Hwan/ABA-1981-2020	Jung, Hyun Jun/0000-0003-0519-5858	National Research Foundation [2010-0008225, 2010-0019393]; Ministry of Education, Science and Technology (MEST), Korea; Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Korea [A100617, A111345]	National Research Foundation; Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by National Research Foundation grant (2010-0008225 and 2010-0019393) funded by the Ministry of Education, Science and Technology (MEST), Korea; the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Korea (A100617 and A111345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Bartz R, 2011, BIOCHEM J, V435, P475, DOI 10.1042/BJ20101021; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Bouley R, 2003, AM J PHYSIOL-CELL PH, V285, pC750, DOI 10.1152/ajpcell.00477.2002; Chen Jianmeizi, 2011, J RNAi Gene Silencing, V7, P449; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Fisher O, 2009, PHARM RES-DORDR, V26, P51, DOI 10.1007/s11095-008-9704-2; Gao J, 2012, BIOMATERIALS, V33, P270, DOI 10.1016/j.biomaterials.2011.09.035; Gewirtz AM, 2007, J CLIN INVEST, V117, P3612, DOI 10.1172/JCI34274; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Laufer SD, 2008, CURR PHARM DESIGN, V14, P3637, DOI 10.2174/138161208786898806; Lee YJ, 2007, AM J PHYSIOL-RENAL, V292, pF340, DOI 10.1152/ajprenal.00090.2006; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Robben JH, 2004, MOL BIOL CELL, V15, P5693, DOI 10.1091/mbc.E04-04-0337; Rudolph C, 2003, J BIOL CHEM, V278, P11411, DOI 10.1074/jbc.M211891200; Seyhan AA, 2011, HUM GENET, V130, P583, DOI 10.1007/s00439-011-0995-8; SIMMONS NL, 1992, PFLUG ARCH EUR J PHY, V421, P503, DOI 10.1007/BF00370263; STOKES JB, 1987, AM J PHYSIOL, V253, pF251, DOI 10.1152/ajprenal.1987.253.2.F251; Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08; Tagalakis AD, 2011, BIOMATERIALS, V32, P6302, DOI 10.1016/j.biomaterials.2011.05.022; van Rossenberg SMW, 2004, GENE THER, V11, P457, DOI 10.1038/sj.gt.3302183; Zhang KX, 2008, RNA, V14, P577, DOI 10.1261/rna.739308	35	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40010	10.1371/journal.pone.0040010	http://dx.doi.org/10.1371/journal.pone.0040010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761946	Green Submitted, gold, Green Published			2022-12-25	WOS:000305826400053
J	Peng, QS; O'Loughlin, JL; Humphrey, MB				Peng, Qisheng; O'Loughlin, Jason L.; Humphrey, Mary Beth			DOK3 Negatively Regulates LPS Responses and Endotoxin Tolerance	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CBL-B; TYROSINE KINASES; LIPOPOLYSACCHARIDE; INTERLEUKIN-1-BETA; DEGRADATION; ACTIVATION; PHOSPHORYLATION; PHOSPHATASE; CROSSTALK	Innate immune activation via Toll-like receptors (TLRs), although critical for host defense against infection, must be regulated to prevent sustained cell activation that can lead to cell death. Cells repeatedly stimulated with lipopolysaccharide (LPS) develop endotoxin tolerance making the cells hypo-responsive to additional TLR stimulation. We show here that DOK3 is a negative regulator of TLR signaling by limiting LPS-induced ERK activation and cytokine responses in macrophages. LPS induces ubiquitin-mediated degradation of DOK3 leading to SOS1 degradation and inhibition of ERK activation. DOK3 mice are hypersensitive to sublethal doses of LPS and have altered cytokine responses in vivo. During endotoxin tolerance, DOK3 expression remains stable, and it negatively regulates the expression of SHIP1, IRAK-M, SOCS1, and SOS1. As such, DOK3-deficient macrophages are more sensitive to LPS-induced tolerance becoming tolerant at lower levels of LPS than wild type cells. Taken together, the absence of DOK3 increases LPS signaling, contributing to LPS-induced tolerance. Thus, DOK3 plays a role in TLR signaling during both naive and endotoxin-induced tolerant conditions.	[Peng, Qisheng; O'Loughlin, Jason L.; Humphrey, Mary Beth] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA; [Peng, Qisheng] Jilin Univ, Key Lab Zoonosis Res, Minist Educ, Changchun 130023, Peoples R China; [Humphrey, Mary Beth] Dept Vet Affairs, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Jilin University	Peng, QS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA.	marybeth-humphrey@ouhsc.edu			National Institutes of Health [RO1 DE019398]; Veteran's Affairs Career Development Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Career Development Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (RO1 DE019398 to M. B. H.) and Veteran's Affairs Career Development Award (to M. B. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Alves-Rosa F, 2002, CLIN EXP IMMUNOL, V128, P221, DOI 10.1046/j.1365-2249.2002.01828.x; An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; BURRELL R, 1994, CIRC SHOCK, V43, P137; Cong F, 1999, MOL CELL BIOL, V19, P8314; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; FRANKENBERGER M, 1995, J INFLAMM, V45, P56; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Honma M, 2006, GENES CELLS, V11, P143, DOI 10.1111/j.1365-2443.2006.00926.x; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Janas JA, 2011, MOL CELL BIOL, V31, P2552, DOI 10.1128/MCB.05045-11; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keck S, 2010, J IMMUNOL, V184, P5809, DOI 10.4049/jimmunol.0901423; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Ng CH, 2007, BLOOD, V110, P259, DOI 10.1182/blood-2006-10-055194; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Pierre S, 2011, BIOCHEM PHARMACOL, V82, P1049, DOI 10.1016/j.bcp.2011.07.072; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Robson JD, 2004, MOL CELL BIOL, V24, P2332, DOI 10.1128/MCB.24.6.2332-2343.2004; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Senis YA, 2009, J THROMB HAEMOST, V7, P1718, DOI 10.1111/j.1538-7836.2009.03565.x; Shimauchi H, 1999, INFECT IMMUN, V67, P2153, DOI 10.1128/IAI.67.5.2153-2159.1999; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanabe SI, 2008, J PERIODONTAL RES, V43, P372, DOI 10.1111/j.1600-0765.2007.01049.x	39	26	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39967	10.1371/journal.pone.0039967	http://dx.doi.org/10.1371/journal.pone.0039967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761938	Green Submitted, Green Published, gold			2022-12-25	WOS:000305825800083
J	Zhang, X; Wang, W; Wang, H; Wang, MH; Xu, W; Zhang, R				Zhang, X.; Wang, W.; Wang, H.; Wang, M-H; Xu, W.; Zhang, R.			Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop	ONCOGENE			English	Article						RPS25; p53; MDM2; ribosomal stress	EMBRYONIC LETHALITY; P53 UBIQUITINATION; ONCOPROTEIN MDM2; STABILIZES P53; C-MYC; ACTIVATION; TRANSLATION; DEGRADATION; L11; INHIBITION	There is an increasing interest in determining the role of ribosomal proteins (RPs) in the regulation of MDM2-p53 pathway in coordinating cellular response to stress. Herein, we report a novel regulatory role of ribosomal protein S25 (RPS25) in MDM2-mediated p53 degradation and a feedback regulation of S25 by p53. We demonstrated that S25 interacted with MDM2 and inhibited its E3 ligase activity, resulting in the reduction of MDM2-mediated p53 ubiquitination and the stabilization and activation of p53. S25, MDM2 and p53 formed a ternary complex following ribosomal stress. The nucleolar localization and MDM2-binding domains of S25 were critical for its role in MDM2-mediated p53 regulation. Knockdown of S25 by siRNA attenuated the induction and activation of p53 following ribosomal stress. S25 stabilized and cooperated with MDMX to regulate MDM2 E3 ligase activity. Furthermore, S25 was identified to be a transcriptional target of p53; p53 directly bound to S25 promoter and suppressed S25 expression. Our results suggest that there is a S25-MDM2-p53 regulatory feedback loop, which may have an important role in cancer development and progression.	[Zhang, X.; Wang, W.; Zhang, R.] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA; [Zhang, X.; Xu, W.] Jiangsu Univ, Affiliated Hosp, Ctr Clin Lab, Sch Med Sci & Lab Med, Zhenjiang, Peoples R China; [Wang, W.; Wang, M-H; Zhang, R.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Sch Pharm, Amarillo, TX 79106 USA; [Wang, H.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Wang, M-H] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX 79106 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Jiangsu University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Zhang, R (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, 1300 Coulter Dr, Amarillo, TX 79106 USA.	ruiwen.zhang@ttuhsc.edu			NIH/NCI [R01 CA112029, R01 CA121211]; Susan G Komen Foundation [BCTR0707731]; NIH grant [R01 CA91980]; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; Science and Technology Commission of Shanghai Municipality [08391910800, 10391902100]; National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program' [2009ZX09102-114, 2009ZX09301-011]; NATIONAL CANCER INSTITUTE [R01CA112029, R01CA121211, R01CA091980] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program'; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr J Chen for the kind gift of the MDMX plasmid; Dr G Lozano for the mdmx<SUP>-/-</SUP>p53<SUP>-/-</SUP> and mdm2<SUP>-/-</SUP>p53<SUP>-/-</SUP> MEF cell lines; and Drs G Jin, D Chen, Z Zhang, L Ao, X Yang, J Qin and S Voruganti for helpful discussions and excellent technical support. This work was supported in part by NIH/NCI grants R01 CA112029, R01 CA121211 and a Susan G Komen Foundation grant BCTR0707731 (to RZ). MW was supported by NIH grant R01 CA91980. HW was supported by the One Hundred Talents Program, Chinese Academy of Sciences, grants from National Nature Science Foundation (30870513, 31070680, 91029715 and 81025017) and Ministry of Science and Technology of China (2007CB947100), the Science and Technology Commission of Shanghai Municipality (08391910800, 10391902100), National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program' (2009ZX09102-114, 2009ZX09301-011).	Adilakshmi T, 2002, J BIOL CHEM, V277, P4147, DOI 10.1074/jbc.M109785200; Argentini M, 2001, ONCOGENE, V20, P1267, DOI 10.1038/sj.onc.1204241; Artero-Castro A, 2011, HUM PATHOL, V42, P194, DOI 10.1016/j.humpath.2010.04.020; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Castro ME, 2008, CARCINOGENESIS, V29, P1343, DOI 10.1093/carcin/bgm302; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen D, 2009, EMBO REP, V10, P166, DOI 10.1038/embor.2008.231; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Golomb L, 2012, MOL CELL, V45, P222, DOI 10.1016/j.molcel.2011.11.022; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LAINE RO, 1994, J BIOL CHEM, V269, P9693; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; LI ML, 1992, FEBS LETT, V298, P142, DOI 10.1016/0014-5793(92)80041-E; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Mancini F, 2010, INT J BIOCHEM CELL B, V42, P1080, DOI 10.1016/j.biocel.2010.04.010; Mancini F, 2009, EMBO J, V28, P1926, DOI 10.1038/emboj.2009.154; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	55	63	63	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2782	2791		10.1038/onc.2012.289	http://dx.doi.org/10.1038/onc.2012.289			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22777350	Green Accepted			2022-12-25	WOS:000319808000009
J	Koripella, RK; Chen, Y; Peisker, K; Koh, CS; Selmer, M; Sanyal, S				Koripella, Ravi Kiran; Chen, Yang; Peisker, Kristin; Koh, Cha San; Selmer, Maria; Sanyal, Suparna			Mechanism of Elongation Factor-G-mediated Fusidic Acid Resistance and Fitness Compensation in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-G; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; RNA MOVEMENT; RIBOSOME; SENSITIVITY; TRANSLOCATION; MUTATIONS; EVOLUTION	Antibiotic resistance in bacteria is often associated with fitness loss, which is compensated by secondary mutations. Fusidic acid (FA), an antibiotic used against pathogenic bacteria Staphylococcus aureus, locks elongation factor-G (EF-G) to the ribosome after GTP hydrolysis. To clarify the mechanism of fitness loss and compensation in relation to FA resistance, we have characterized three S. aureus EF-G mutants with fast kinetics and crystal structures. Our results show that a significantly slower tRNA translocation and ribosome recycling, plus increased peptidyl-tRNA drop-off, are the causes for fitness defects of the primary FA-resistant mutant F88L. The double mutant F88L/M16I is three to four times faster than F88L in both reactions and showed no tRNA drop-off, explaining its fitness compensatory phenotype. The M16I mutation alone showed hypersensitivity to FA, higher activity, and somewhat increased affinity to GTP. The crystal structures demonstrate that Phe-88 in switch II is a key residue for FA locking and also for triggering interdomain movements in EF-G essential for its function, explaining functional deficiencies in F88L. The mutation M16I loosens the hydrophobic core in the G domain and affects domain I to domain II contact, resulting in improved activity both in the wild-type and F88L background. Thus, FA-resistant EF-G mutations causing fitness loss and compensation operate by affecting the conformational dynamics of EF-G on the ribosome.	[Koripella, Ravi Kiran; Chen, Yang; Peisker, Kristin; Koh, Cha San; Selmer, Maria; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Uppsala University	Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden.	maria.selmer@icm.uu.se; suparna.sanyal@icm.uu.se		Selmer, Maria/0000-0001-9079-2774	Swedish Research Council; Uppsala RNA Research Centre (URRC); Knut and Alice Wallenberg Foundation (RiboCORE); Wenner-Gren Foundation; Swedish Foundation for Strategic Research; Hagbergs Foundation; Ake Wibergs Foundation; Vinnova/Department of Biotechnology, India; LEO Pharma; Carl Tryggers Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala RNA Research Centre (URRC); Knut and Alice Wallenberg Foundation (RiboCORE); Wenner-Gren Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Hagbergs Foundation; Ake Wibergs Foundation; Vinnova/Department of Biotechnology, India; LEO Pharma(LEO Pharma); Carl Tryggers Foundation	This work was supported by the research grants from Swedish Research Council (individual project grants and through the Uppsala RNA Research Centre (URRC), Knut and Alice Wallenberg Foundation (RiboCORE), Wenner-Gren Foundation, and the Swedish Foundation for Strategic Research (to M. S. and S. S.); from the Hagbergs Foundation and the Ake Wibergs Foundation (to M. S.); and from Vinnova/Department of Biotechnology, India, LEO Pharma, and Carl Tryggers Foundation (to S. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; Brown EM, 2002, LANCET, V359, P803, DOI 10.1016/S0140-6736(02)07869-8; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2010, FEBS J, V277, P3789, DOI 10.1111/j.1742-4658.2010.07780.x; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2010, ANNU REV BIOCHEM, V79, P381, DOI 10.1146/annurev-biochem-060408-173330; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo XH, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120016; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; Johanson U, 1996, J MOL BIOL, V258, P420, DOI 10.1006/jmbi.1996.0259; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Johansson M, 2011, P NATL ACAD SCI USA, V108, P79, DOI 10.1073/pnas.1012612107; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Khade PK, 2011, NAT STRUCT MOL BIOL, V18, P1300, DOI 10.1038/nsmb.2140; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Levin BR, 2000, GENETICS, V154, P985; Li MM, 2011, J HAZARD MATER, V186, P2031, DOI 10.1016/j.jhazmat.2010.12.101; Mandava CS, 2012, NUCLEIC ACIDS RES, V40, P2054, DOI 10.1093/nar/gkr1031; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ticu C, 2011, J BIOL CHEM, V286, P21697, DOI 10.1074/jbc.M110.214056; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WILLIE GR, 1975, BIOCHEMISTRY-US, V14, P1713, DOI 10.1021/bi00679a025; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	51	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30257	30267		10.1074/jbc.M112.378521	http://dx.doi.org/10.1074/jbc.M112.378521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22767604	Green Published, hybrid			2022-12-25	WOS:000308579800019
J	Fukushima, T; Nakamura, Y; Yamanaka, D; Shibano, T; Chida, K; Minami, S; Asano, T; Hakuno, F; Takahashi, SI				Fukushima, Toshiaki; Nakamura, Yusaku; Yamanaka, Daisuke; Shibano, Takashi; Chida, Kazuhiro; Minami, Shiro; Asano, Tomoichiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro			Phosphatidylinositol 3-Kinase (PI3K) Activity Bound to Insulin-like Growth Factor-I (IGF-I) Receptor, which Is Continuously Sustained by IGF-I Stimulation, Is Required for IGF-I-induced Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID SYNTHESIS; EPITHELIAL-CELLS; FRTL-5 CELLS; TYROSINE PHOSPHORYLATION; DNA-SYNTHESIS; CYCLIN D1; ACTIVATION; DEGRADATION; SUBSTRATE-2; PATHWAY	Continuous stimulation of cells with insulin-like growth factors (IGFs) in G(1) phase is a well established requirement for IGF-induced cell proliferation; however, the molecular components of this prolonged signaling pathway that is essential for cell cycle progression from G(1) to S phase are unclear. IGF-I activates IGF-I receptor (IGF-IR) tyrosine kinase, followed by phosphorylation of substrates such as insulin receptor substrates (IRS) leading to binding of signaling molecules containing SH2 domains, including phosphatidylinositol 3-kinase (PI3K) to IRS and activation of the downstream signaling pathways. In this study, we found prolonged (>9 h) association of PI3K with IGF-IR induced by IGF-I stimulation. PI3K activity was present in this complex in thyrocytes and fibroblasts, although tyrosine phosphorylation of IRS was not yet evident after 9 h of IGF-I stimulation. IGF-I withdrawal in mid-G(1) phase impaired the association of PI3K with IGF-IR and suppressed DNA synthesis the same as when PI3K inhibitor was added. Furthermore, we demonstrated that Tyr(1316)-X-X-Met of IGF-IR functioned as a PI3K binding sequence when this tyrosine is phosphorylated. We then analyzed IGF signaling and proliferation of IGF-IR-/- fibroblasts expressing exogenous mutant IGF-IR in which Tyr(1316) was substituted with Phe (Y1316F). In these cells, IGF-I stimulation induced tyrosine phosphorylation of IGF-IR and IRS-1/2, but mutated IGF-IR failed to bind PI3K and to induce maximal phosphorylation of GSK3 beta and cell proliferation in response to IGF-I. Based on these results, we concluded that PI3K activity bound to IGF-IR, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.	[Takahashi, Shin-Ichiro] Univ Tokyo, Lab Cell Regulat, Dept Anim Sci, Grad Sch Agr & Life Sci,Bunkyo Ku, Tokyo 1138657, Japan; [Fukushima, Toshiaki; Nakamura, Yusaku; Shibano, Takashi; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Fukushima, Toshiaki; Asano, Tomoichiro] Hiroshima Univ, Lab Biomed Chem, Inst Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Yamanaka, Daisuke; Minami, Shiro] Nippon Med Sch, Dept Bioregulat, Kawasaki, Kanagawa 2118533, Japan	University of Tokyo; University of Tokyo; Hiroshima University; Nippon Medical School	Takahashi, SI (corresponding author), Univ Tokyo, Lab Cell Regulat, Dept Anim Sci, Grad Sch Agr & Life Sci,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp	柴野, 卓志/AHB-7015-2022	Takahashi, Shin-Ichiro/0000-0002-2323-2010; Hakuno, Fumihiko/0000-0002-4447-6225	Japan Society for the Promotion of Science (JSPS) [16208028, 22248030]; JSPS Core-to-Core Program; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [24790928] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS) ((A) (2) 16208028 and (A) 22248030), the JSPS Core-to-Core Program, and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to S.- I. T.).	AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Blakesley VA, 1996, ENDOCRINOLOGY, V137, P410, DOI 10.1210/en.137.2.410; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; FARIA TN, 1994, J BIOL CHEM, V269, P13922; Fukushima T, 2008, ENDOCRINOLOGY, V149, P3729, DOI 10.1210/en.2007-1443; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V404, P767, DOI 10.1016/j.bbrc.2010.12.045; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hongo A, 1996, ONCOGENE, V12, P1231; Ito Y, 1997, BIOCHEM J, V324, P379, DOI 10.1042/bj3240379; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; KATO H, 1994, MOL ENDOCRINOL, V8, P40, DOI 10.1210/me.8.1.40; Kim B, 2005, ENDOCRINOLOGY, V146, P5350, DOI 10.1210/en.2005-0356; LEOF EB, 1982, EXP CELL RES, V141, P107, DOI 10.1016/0014-4827(82)90073-8; LEVYTOLEDANO R, 1994, J BIOL CHEM, V269, P31178; LI SW, 1994, J BIOL CHEM, V269, P32558; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Ness JK, 2002, MOL CELL NEUROSCI, V20, P476, DOI 10.1006/mcne.2002.1149; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Qureshi FG, 1997, J SURG RES, V69, P354, DOI 10.1006/jsre.1997.5080; Ristow HJ, 1996, GROWTH REGULAT, V6, P96; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Rose DW, 1998, ONCOGENE, V17, P889, DOI 10.1038/sj.onc.1201997; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; SEELY BL, 1995, J BIOL CHEM, V270, P19151, DOI 10.1074/jbc.270.32.19151; Shao JH, 2002, DIABETES, V51, P19, DOI 10.2337/diabetes.51.1.19; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Stull MA, 2002, ENDOCRINOLOGY, V143, P1872, DOI 10.1210/en.143.5.1872; STURANI E, 1988, MOL CELL BIOL, V8, P1345, DOI 10.1128/MCB.8.3.1345; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736, DOI 10.1210/endo-126-2-736; TartareDeckert S, 1996, ENDOCRINOLOGY, V137, P1019, DOI 10.1210/en.137.3.1019; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; VANHORN DJ, 1994, J BIOL CHEM, V269, P29; Yam A, 2001, J BIOL CHEM, V276, P24409, DOI 10.1074/jbc.M102358200; YAMAMOTO K, 1992, ENDOCRINOLOGY, V130, P1490, DOI 10.1210/en.130.3.1490; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	43	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29713	29721		10.1074/jbc.M112.393074	http://dx.doi.org/10.1074/jbc.M112.393074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767591	hybrid, Green Published			2022-12-25	WOS:000308286900047
J	Xu, KQ; Wu, XL; Tompkins, JD; Her, CT				Xu, Keqian; Wu, Xiling; Tompkins, Joshua D.; Her, Chengtao			Assessment of Anti-recombination and Double-strand Break-induced Gene Conversion in Human Cells by a Chromosomal Reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MISMATCH REPAIR; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; MITOTIC RECOMBINATION; MICROSATELLITE INSTABILITY; MEIOTIC RECOMBINATION; HIGH-FREQUENCY; MRE11 COMPLEX; PROTEIN HMLH1	Gene conversion is one of the frequent end results of homologous recombination, and it often underlies the inactivation of tumor suppressor genes in cancer cells. Here, we have developed an integrated assay system that allows simultaneous examination of double-strand break (DSB)-induced gene conversion events at the site of a DSB (proximal region) and at a surrounding region similar to 1 kb away from the break (distal region). Utilizing this assay system, we find that gene conversion events at the proximal and distal regions are relatively independent of one another. The results also indicate that synthesis-dependent strand annealing (SDSA) plays a major role in DSB-induced gene conversion. In addition, our current study has demonstrated that hMLH1 plays an essential role in anti-recombination and gene conversion. Specifically, the anti-recombination activity of hMLH1 is partially dependent on its interaction with hMRE11. Our data suggests that the role of hMLH1 and hMRE11 in the process of gene conversion is complex, and these proteins play different roles in DSB-induced proximal and distal gene conversions. In particular, the involvement of hMLH1 and hMRE11 in the distal gene conversion requires both hMSH2 and heteroduplex formation.	[Xu, Keqian; Wu, Xiling; Tompkins, Joshua D.; Her, Chengtao] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Her, CT (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	cher@wsu.edu			National Institutes of Health, USPHS Grant, NIGMS [GM084353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084353] Funding Source: NIH RePORTER	National Institutes of Health, USPHS Grant, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health, USPHS Grant GM084353 (to C. H.) from the NIGMS.	Auclair J, 2007, HUM MUTAT, V28, P1084, DOI 10.1002/humu.20569; Bannister LA, 2004, DNA REPAIR, V3, P465, DOI 10.1016/j.dnarep.2004.01.001; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen WL, 1999, GENETICS, V151, P1299; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Datta A, 1997, P NATL ACAD SCI USA, V94, P9757, DOI 10.1073/pnas.94.18.9757; David P, 1997, J NEUROSCI, V17, P8711; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; FANG WH, 1993, J BIOL CHEM, V268, P11838; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Her CT, 2002, DNA REPAIR, V1, P719, DOI 10.1016/S1568-7864(02)00079-4; HUGHES MJ, 1992, J BIOL CHEM, V267, P23876; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kirkpatrick DT, 1998, GENETICS, V149, P1693; Li F, 2009, J BIOL CHEM, V284, P33056, DOI 10.1074/jbc.M109.049874; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Neuwirth EAH, 2007, MOL CELL BIOL, V27, P5261, DOI 10.1128/MCB.01852-06; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Owen BAL, 2009, NAT STRUCT MOL BIOL, V16, P550, DOI 10.1038/nsmb.1596; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Papadakis MN, 1999, HUM GENET, V104, P117, DOI 10.1007/s004390050923; Qin J, 2002, J HERED, V93, P201, DOI 10.1093/jhered/93.3.201; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Saparbaev M, 1996, GENETICS, V142, P727; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shao CS, 2004, ONCOGENE, V23, P9017, DOI 10.1038/sj.onc.1208148; Siehler SY, 2009, DNA REPAIR, V8, P242, DOI 10.1016/j.dnarep.2008.10.011; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Surtees JA, 2004, CYTOGENET GENOME RES, V107, P146, DOI 10.1159/000080593; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Taghian DG, 1997, MOL CELL BIOL, V17, P6386, DOI 10.1128/MCB.17.11.6386; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vo AT, 2005, EMBO REP, V6, P438, DOI 10.1038/sj.embor.7400392; Wang Q, 2006, MUTAT RES-FUND MOL M, V594, P189, DOI 10.1016/j.mrfmmm.2005.09.005; Wang Y, 2000, GENE DEV, V14, P927; Wu XL, 2011, MOL CANCER RES, V9, P1443, DOI 10.1158/1541-7786.MCR-11-0322; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan T, 2009, CLIN CANCER RES, V15, P6912, DOI 10.1158/1078-0432.CCR-09-1698; Zhang J, 2006, CANCER RES, V66, P659, DOI 10.1158/0008-5472.CAN-05-4043; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhao N, 2008, BIOCHEM BIOPH RES CO, V370, P338, DOI 10.1016/j.bbrc.2008.03.082; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444	51	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29543	29553		10.1074/jbc.M112.352302	http://dx.doi.org/10.1074/jbc.M112.352302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773873	hybrid, Green Published			2022-12-25	WOS:000308286900030
J	Ben Mohamed, F; Garcia-Verdugo, I; Medina, M; Balloy, V; Chignard, M; Ramphal, R; Touqui, L				Ben Mohamed, Fatima; Garcia-Verdugo, Ignacio; Medina, Mathieu; Balloy, Viviane; Chignard, Michel; Ramphal, Reuben; Touqui, Lhousseine			A Crucial Role of Flagellin in the Induction of Airway Mucus Production by Pseudomonas aeruginosa	PLOS ONE			English	Article							MUCIN GENE-EXPRESSION; INTERLEUKIN-8 PRODUCTION; BACTERIAL FLAGELLIN; EPITHELIAL-CELLS; INNATE IMMUNITY; LUNG-DISEASE; RECOGNITION; RECEPTOR; MACROPHAGES; LIPOPOLYSACCHARIDE	Pseudomonas aeruginosa is an opportunistic pathogen involved in nosocomial infections. Flagellin is a P. aeruginosa virulence factor involved in host response to this pathogen. We examined the role of flagellin in P. aeruginosa-induced mucus secretion. Using a mouse model of pulmonary infection we showed that PAK, a wild type strain of P. aeruginosa, induced airway mucus secretion and mucin muc5ac expression at higher levels than its flagellin-deficient mutant (Delta FliC). PAK induced expression of MUC5AC and MUC2 in both human airway epithelial NCI-H292 cell line and in primary epithelial cells. In contrast, Delta FliC infection had lower to no effect on MUC5AC and MUC2 expressions. A purified P. aeruginosa flagellin induced MUC5AC expression in parallel to IL-8 secretion in NCI-H292 cells. Accordingly, Delta FliC mutant stimulated IL-8 secretion at significantly lower levels compared to PAK. Incubation of NCI-H292 cells with exogenous IL-8 induced MUC5AC expression and pre-incubation of these cells with an anti-IL-8 antibody abrogated flagellin-mediated MUC5AC expression. Silencing of TLR5 and Naip, siRNA inhibited both flagellin-induced MUC5AC expression and IL-8 secretion. Finally, inhibition of ERK abolished the expression of both PAK- and flagellin-induced MUC5AC. We conclude that: (i) flagellin is crucial in P. aeruginosa-induced mucus hyper-secretion through TLR5 and Naip pathways; (ii) this process is mediated by ERK and amplified by IL-8. Our findings help understand the mechanisms involved in mucus secretion during pulmonary infectious disease induced by P. aeruginosa, such as in cystic fibrosis.	[Ben Mohamed, Fatima; Garcia-Verdugo, Ignacio; Medina, Mathieu; Balloy, Viviane; Chignard, Michel; Touqui, Lhousseine] Inst Pasteur, Unite Def Innee & Inflammat, Paris, France; [Ben Mohamed, Fatima; Garcia-Verdugo, Ignacio; Medina, Mathieu; Balloy, Viviane; Chignard, Michel; Touqui, Lhousseine] INSERM, U874, Paris, France; [Ramphal, Reuben] Univ Florida, Dept Med, Gainesville, FL USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; State University System of Florida; University of Florida	Ben Mohamed, F (corresponding author), Inst Pasteur, Unite Def Innee & Inflammat, Paris, France.	fatima.ben-mohamed@pasteur.fr	Garcia-Verdugo, Ignacio/J-3584-2017; Balloy, Viviane/B-8551-2014; Chignard, Michel/B-4351-2008	Garcia-Verdugo, Ignacio/0000-0003-4535-8316; Balloy, Viviane/0000-0001-9093-9676; Chignard, Michel/0000-0003-3810-6575	Vaincre la Mucoviscidose; Foundation "Legs Poix"; Vaincre la ucoviscidose [RIF20110600609]	Vaincre la Mucoviscidose; Foundation "Legs Poix"; Vaincre la ucoviscidose	This work was supported by "Vaincre la Mucoviscidose", and the Foundation "Legs Poix". Vaincre la ucoviscidose (grant number RIF20110600609). Website:http://www.vaincrelamuco.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora SK, 2000, INFECT IMMUN, V68, P1474, DOI 10.1128/IAI.68.3.1474-1479.2000; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; Bautista MV, 2009, J IMMUNOL, V183, P2159, DOI 10.4049/jimmunol.0803022; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Burgel PR, 2001, J IMMUNOL, V167, P5948, DOI 10.4049/jimmunol.167.10.5948; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dif F, 2010, EUR RESPIR J, V36, P1120, DOI 10.1183/09031936.00183409; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finzi L, 2006, AM J PATHOL, V169, P2031, DOI 10.2353/ajpath.2006.060146; Garcia-Verdugo I, 2012, EUR RESP J IN PRESS; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HO SB, 1993, CANCER RES, V53, P641; Kim S, 2011, EXP CELL RES, V317, P2650, DOI 10.1016/j.yexcr.2011.08.023; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Rivas-Santiago B, 2007, REV INVEST CLIN, V59, P481; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Song KS, 2009, AM J RESP CELL MOL, V41, P40, DOI 10.1165/rcmb.2008-0280OC; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V284, pL260, DOI 10.1152/ajplung.00226.2002; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vestbo Jorgen, 2002, Ugeskr Laeger, V164, P5510; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	41	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39888	10.1371/journal.pone.0039888	http://dx.doi.org/10.1371/journal.pone.0039888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768318	gold, Green Published, Green Submitted			2022-12-25	WOS:000305966500031
J	Malmhall, C; Bossios, A; Radinger, M; Sjostrand, M; Lu, Y; Lundback, B; Lotvall, J				Malmhall, Carina; Bossios, Apostolos; Radinger, Madeleine; Sjostrand, Margareta; Lu, You; Lundback, Bo; Lotvall, Jan			Immunophenotyping of Circulating T Helper Cells Argues for Multiple Functions and Plasticity of T Cells In Vivo in Humans - Possible Role in Asthma	PLOS ONE			English	Article							CLUSTER-ANALYSIS; IDENTIFICATION; TRANSCRIPTION; INFLAMMATION; PHENOTYPES; DIVERSITY; PRODUCE; MEMORY; GAMMA; LUNG	In Background: The immune process driving eosinophilic and non-eosinophilic asthma is likely driven by different subsets of T helper (Th) cells. Recently, in vitro studies and animal studies suggest that Th cell subsets displays plasticity by changing their transcription factor or by expressing multiple transcription factors. Our aim was to determine whether individuals with asthma and elevated circulating eosinophils express signs of different regulatory immune mechanisms compared with asthmatics with low blood eosinophils and non-asthmatic control subjects. In addition, determine the relationship between eosinophilia and circulating Th cell subsets. Methodology/Principal findings: Participants were selected from a random epidemiological cohort, the West Sweden Asthma Study. Immunophenotypes of fresh peripheral blood cells obtained from stable asthmatics, with and without elevated eosinophilic inflammation (EOS high and EOS low respectively) and control subjects, were determined by flow cytometry. No differences in the number of Th1 (T-bet), Th2 (GATA-3), Th17 (ROR gamma t) or Treg (FOXP3) cells were observed between the groups when analysing each subset separately. However, in all groups, each of the Th subsets showed expression of additional canonical transcription factors T-bet, GATA-3, ROR gamma t and FOXP3. Furthermore, by in vitro stimulation with anti-CD3/anti-CD28 there was a significant increase of single expressing GATA-3(+) and co-expressing T-bet(+)GATA-3(+) cells in the EOS high asthmatics in comparison with control subjects. In addition, T-bet(-)GATA-3(+)ROR gamma t(+)FOXP3(+) were decreased in comparison to the EOS low asthmatics. Finally, in a group of control subjects we found that the majority of proliferating Th cells (CD4(+)CD25(+)Ki67(+)) expressed three or four transcription factors. Conclusions: The ability of human Th cells to express several regulatory transcription factors suggests that these cells may display plasticity in vivo.	[Malmhall, Carina; Bossios, Apostolos; Radinger, Madeleine; Sjostrand, Margareta; Lu, You; Lundback, Bo; Lotvall, Jan] Univ Gothenburg, Krefting Res Ctr, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Malmhall, C (corresponding author), Univ Gothenburg, Krefting Res Ctr, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden.	jan.lotvall@gu.se	Bossios, Apostolos/ABH-8262-2020	Bossios, Apostolos/0000-0002-0494-2690; Radinger, Madeleine/0000-0002-0652-7378; Lotvall, Jan/0000-0001-9195-9249	VBG-GROUP Centre for Asthma and Allergy Research; Herman Krefting Foundation against Asthma and Allergy; Swedish Research Council [K2011-56X-20676-04-6]; Swedish Heart and Lung Foundation; Swedish Asthma- and Allergy Foundation; GlaxoSmithKline; University of Gothenburg	VBG-GROUP Centre for Asthma and Allergy Research; Herman Krefting Foundation against Asthma and Allergy; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma- and Allergy Foundation; GlaxoSmithKline(GlaxoSmithKline); University of Gothenburg	This study was funded by VBG-GROUP Centre for Asthma and Allergy Research, Herman Krefting Foundation against Asthma and Allergy, the Swedish Research Council (K2011-56X-20676-04-6), the Swedish Heart and Lung Foundation, the Swedish Asthma- and Allergy Foundation and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist related to this paper. Krefting Research Centre has financial support from the University of Gothenburg structure called "VBG-GROUP Centre for Asthma and Allergy Research", through a long-term agreement between University of Gothenburg and the donors, Herman Krefting Foundation against Asthma/Allergy. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No commercial entity is involved in the decision or analysis of this study.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akdis M, 2010, CURR OPIN ALLERGY CL, V10, P443, DOI 10.1097/ACI.0b013e32833d7d48; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Durrant DM, 2010, IMMUNOL INVEST, V39, P526, DOI 10.3109/08820131003615498; Finotto S, 2004, SPRINGER SEMIN IMMUN, V25, P281, DOI 10.1007/s00281-003-0143-1; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lotvall J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-94; Matsumoto K, 2009, RESPIROLOGY, V14, P187, DOI 10.1111/j.1440-1843.2008.01472.x; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Provoost S, 2009, ALLERGY, V64, P1539, DOI 10.1111/j.1398-9995.2009.02056.x; Raymond M, 2011, J ALLERGY CLIN IMMUN, V128, P192, DOI 10.1016/j.jaci.2011.04.029; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Simon D, 2009, ALLERGY, V64, P1681, DOI 10.1111/j.1398-9995.2009.02097.x; Smyth LJC, 2010, CHEST, V138, P905, DOI 10.1378/chest.09-3079; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	29	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40012	10.1371/journal.pone.0040012	http://dx.doi.org/10.1371/journal.pone.0040012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768198	gold, Green Submitted, Green Published			2022-12-25	WOS:000305892100170
J	Nguyen, AD; Mitchell, NF; Lin, S; Macia, L; Yulyaningsih, E; Baldock, PA; Enriquez, RF; Zhang, L; Shi, YC; Zolotukhin, S; Herzog, H; Sainsbury, A				Nguyen, Amy D.; Mitchell, Natalie F.; Lin, Shu; Macia, Laurence; Yulyaningsih, Ernie; Baldock, Paul A.; Enriquez, Ronaldo F.; Zhang, Lei; Shi, Yan-Chuan; Zolotukhin, Serge; Herzog, Herbert; Sainsbury, Amanda			Y1 and Y5 Receptors Are Both Required for the Regulation of Food Intake and Energy Homeostasis in Mice	PLOS ONE			English	Article							NEUROPEPTIDE-Y; FEEDING-BEHAVIOR; TRANSGENIC MICE; WEIGHT-LOSS; RAT-BRAIN; OBESITY; EXPRESSION; HYPOTHALAMUS; NPY; APPETITE	Neuropeptide Y (NPY) acting in the hypothalamus is one of the most powerful orexigenic agents known. Of the five known Y receptors, hypothalamic Y1 and Y5 have been most strongly implicated in mediating hyperphagic effects. However, knockout of individual Y1 or Y5 receptors induces late-onset obesity - and Y5 receptor knockout also induces hyperphagia, possibly due to redundancy in functions of these genes. Here we show that food intake in mice requires the combined actions of both Y1 and Y5 receptors. Germline Y1Y5 ablation in Y1Y5(-/-) mice results in hypophagia, an effect that is at least partially mediated by the hypothalamus, since mice with adult-onset Y1Y5 receptor dual ablation targeted to the paraventricular nucleus (PVN) of the hypothalamus (Y1Y5(Hyp/Hyp)) also exhibit reduced spontaneous or fasting-induced food intake when fed a high fat diet. Interestingly, despite hypophagia, mice with germline or hypothalamus-specific Y1Y5 deficiency exhibited increased body weight and/or increased adiposity, possibly due to compensatory responses to gene deletion, such as the decreased energy expenditure observed in male Y1Y5(-/-) animals relative to wildtype values. While Y1 and Y5 receptors expressed in other hypothalamic areas besides the PVN - such as the dorsomedial nucleus and the ventromedial hypothalamus - cannot be excluded from having a role in the regulation of food intake, these studies demonstrate the pivotal, combined role of both Y1 and Y5 receptors in the mediation of food intake.	[Nguyen, Amy D.; Mitchell, Natalie F.; Lin, Shu; Macia, Laurence; Yulyaningsih, Ernie; Zhang, Lei; Shi, Yan-Chuan; Herzog, Herbert; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia; [Baldock, Paul A.; Enriquez, Ronaldo F.] Garvan Inst Med Res, Bone & Mineral Res Program, Sydney, NSW, Australia; [Zolotukhin, Serge] Univ Florida, Div Cell & Mol Therapy, Gainesville, FL USA; [Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; State University System of Florida; University of Florida; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Nguyen, AD (corresponding author), Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia.	amanda.sainsbury-salis@sydney.edu.au	/A-4361-2010; Baldock, Paul/B-3840-2012; Macia, laurence/D-5983-2016; Herzog, Herbert/B-8294-2008; Salis, Amanda/A-3187-2011; Shi, Yanchuan/H-5608-2012; Nguyen, Amy D/K-2588-2019; Yulyaningsih, Ernie/A-6021-2011	Macia, laurence/0000-0003-0835-851X; Salis, Amanda/0000-0001-9176-1574; Shi, Yanchuan/0000-0002-8368-6735; Nguyen, Amy D/0000-0003-4603-564X; lin, shu/0000-0002-4239-2028; , Herbert/0000-0002-1713-1029; Yulyaningsih, Ernie/0000-0003-2110-2017	National Health and Medical Research Council of Australia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research is supported by the National Health and Medical Research Council of Australia with a research grant, a Postgraduate Scholarship (ADN and EY), Career Development Awards (PAB and AS) and a Research Fellowship (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; BERNARDIS L L, 1970, Journal of Neuro-Visceral Relations, V31, P387, DOI 10.1007/BF02312740; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Cahill F, 2011, AM J CLIN NUTR, V93, P741, DOI 10.3945/ajcn.110.003624; Chance WT, 2007, PEPTIDES, V28, P295, DOI 10.1016/j.peptides.2006.10.018; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Doucet E, 2000, INT J OBESITY, V24, P906, DOI 10.1038/sj.ijo.0801251; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Herzog H, 1997, GENOMICS, V41, P315, DOI 10.1006/geno.1997.4684; Higuchi H, 2008, WORLD J GASTROENTERO, V14, P6312, DOI 10.3748/wjg.14.6312; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Kask A, 2000, CAN J PHYSIOL PHARM, V78, P143, DOI 10.1139/cjpp-78-2-143; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kishi T, 2005, J COMP NEUROL, V482, P217, DOI 10.1002/cne.20432; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; Lin S, 2005, NEUROPEPTIDES, V39, P21, DOI 10.1016/j.npep.2004.10.002; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Majdic G, 2009, ACTA CHIM SLOV, V56, P289; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Oberto A, 2007, EUR J NEUROSCI, V26, P155, DOI 10.1111/j.1460-9568.2007.05631.x; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pasman WJ, 1999, OBES RES, V7, P43, DOI 10.1002/j.1550-8528.1999.tb00389.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Pittner R, 2004, INT J OBESITY, P1; Raposinho PD, 2004, ENDOCRINOLOGY, V145, P304, DOI 10.1210/en.2003-0914; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; STANLEY BG, 1986, PEPTIDES, V7, P1189; Weinberg DH, 1996, J BIOL CHEM, V271, P16435, DOI 10.1074/jbc.271.28.16435; Wisialowski T, 2000, J CLIN INVEST, V105, P1253, DOI 10.1172/JCI8695; Wittmann W, 2005, NEUROSCIENCE, V136, P241, DOI 10.1016/j.neuroscience.2005.07.047; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	44	67	69	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40191	10.1371/journal.pone.0040191	http://dx.doi.org/10.1371/journal.pone.0040191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768253	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100226
J	Stegger, JG; Schmidt, EB; Tjonneland, A; Kopp, TI; Sorensen, TIA; Vogel, U; Overvad, K				Stegger, Jakob Gerhard; Schmidt, Erik Berg; Tjonneland, Anne; Kopp, Tine Iskov; Sorensen, Thorkild I. A.; Vogel, Ulla; Overvad, Kim			Single Nucleotide Polymorphisms in IL1B and the Risk of Acute Coronary Syndrome: A Danish Case-Cohort Study	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; MYOCARDIAL-INFARCTION; MULTIPLE-MYELOMA; GENE AFFECT; YOUNG AGE; NSAID USE; ATHEROSCLEROSIS; DISEASE; MECHANISMS; IL-1-BETA	Background: Interleukin-1B (IL-1B) is a key pro-inflammatory cytokine that has been associated with the development of atherosclerosis and myocardial infarction. However, the prospective associations between functional single nucleotide polymorphisms (SNPs) in IL1B and incident acute coronary syndrome (ACS) have not been thoroughly investigated. The aims of this study were to examine the associations between individual SNPs in and SNP haplotypes of the promoter region of IL1B and incident ACS in a prospective study. Furthermore, we wanted to explore potential interactions with other risk factors for ACS on an additive scale. Methodology/Principal Findings: The present study was based on the Danish prospective study Diet, Cancer and Health comprising more than 57 000 participants aged 50-64 at baseline. During a median follow-up of 7.2 years we identified 989 cases of incident ACS (755 men and 234 women). All cases were validated by review of medical records, and information on covariates was collected by study technicians. The study was conducted according to a case-cohort study design including ACS cases and a sex-stratified sub cohort of 1663 participants drawn randomly from the entire cohort. Weighted Cox proportional hazard models with age as time axis were used in the statistical analyses. Individual IL1B SNPs, SNP haplotypes, or haplotype combinations were not significantly associated with incident ACS, and, likewise, we found no evidence of interaction on an additive scale between IL1B haplotypes and risk factors, respectively. Conclusions/Significance: Genetic variation in the promoter region of IL1B may not be associated with incident ACS in men or women above the age of 50 years.	[Stegger, Jakob Gerhard; Schmidt, Erik Berg; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Kopp, Tine Iskov] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Inst Prevent Med, Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; Danish Cancer Society; Technical University of Denmark; University of Copenhagen; National Research Centre for the Working Environment; Aarhus University	Stegger, JG (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark.	Jakob.Stegger@rn.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Overvad, Kim/0000-0001-6429-7921; Kopp, Tine/0000-0003-3729-4420; Tjonneland, Anne/0000-0003-4385-2097	Danish Cancer Society; Danish Heart Foundation [08-10-R68-A2176-B994-22514, 09-4-R72-A2346-22544]; Danish Obesity Research Centre; Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome	Danish Cancer Society(Danish Cancer Society); Danish Heart Foundation; Danish Obesity Research Centre; Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome	The authors would like to thank the Danish Cancer Society (www.cancer.dk) for the funding of the Diet, Cancer and Health study. The present study was funded by the Danish Heart Foundation (www.hjerteforeningen.dk) (08-10-R68-A2176-B994-22514 and 09-4-R72-A2346-22544) as well as the Danish Obesity Research Centre (www.DanORC.dk) and the Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (www.HEPADIP.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bhaskar V, 2011, ATHEROSCLEROSIS, V216, P313, DOI 10.1016/j.atherosclerosis.2011.02.026; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrel F.E., 2001, REGRESSION MODELING; Iacoviello L, 2005, ARTERIOSCL THROM VAS, V25, P222, DOI 10.1161/01.ATV.0000150039.60906.02; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Latella MC, 2009, IMMUNOL INVEST, V38, P203, DOI 10.1080/08820130902766142; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Ridker PM, 2003, CLIN CARDIOL, V26, P39, DOI 10.1002/clc.4960261508; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman K., 1998, MODERN EPIDEMIOLOGY; Stegger JG, 2011, INT J OBES LOND; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vangsted AJ, 2009, BONE MARROW TRANSPL, V43, P539, DOI 10.1038/bmt.2008.351; Vangsted AJ, 2011, ANN HEMATOL; Vangsted AJ, 2009, HAEMATOL-HEMATOL J, V94, P1274, DOI 10.3324/haematol.2008.004572; Vogel U, 2011, ATHEROSCLEROSIS; Vogel U, 2008, MUTAT RES-FUND MOL M, V639, P89, DOI 10.1016/j.mrfmmm.2007.11.004; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006	28	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e36829	10.1371/journal.pone.0036829	http://dx.doi.org/10.1371/journal.pone.0036829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768033	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100004
J	Wang, XD; Zhang, N; Glorieux, S; Holtappels, G; Vaneechoutte, M; Krysko, O; Zhang, L; Han, DM; Nauwynck, HJ; Bachert, C				Wang, XiangDong; Zhang, Nan; Glorieux, Sarah; Holtappels, Gabriele; Vaneechoutte, Mario; Krysko, Olga; Zhang, Luo; Han, Demin; Nauwynck, Hans J.; Bachert, Claus			Herpes Simplex Virus Type 1 Infection Facilitates Invasion of Staphylococcus aureus into the Nasal Mucosa and Nasal Polyp Tissue	PLOS ONE			English	Article							EPITHELIAL-CELLS; ORGAN-CULTURE; ENTEROTOXIN-B; PROTEIN-A; RHINOVIRUS; SEROPREVALENCE; ASTHMA; MODEL; REPLICATION; ASSOCIATION	Background: Staphylococcus aureus (S. aureus) plays an important role in the pathogenesis of severe chronic airway disease, such as nasal polyps. However the mechanisms underlying the initiation of damage and/or invasion of the nasal mucosa by S. aureus are not clearly understood. The aim of this study was to investigate the interaction between S. aureus and herpes simplex virus type 1 (HSV1) in the invasion of the nasal mucosa and nasal polyp tissue. Methodology/Principal Findings: Inferior turbinate and nasal polyp samples were cultured and infected with either HSV1 alone, S. aureus alone or a combination of both. Both in turbinate mucosa and nasal polyp tissue, HSV1, with or without S. aureus incubation, led to focal infection of outer epithelial cells within 48 h, and loss or damage of the epithelium and invasion of HSV1 into the lamina propria within 72 h. After pre-infection with HSV1 for 24 h or 48 h, S. aureus was able to pass the basement membrane and invade the mucosa. Epithelial damage scores were significantly higher for HSV1 and S. aureus co-infected explants compared with control explants or S. aureus only-infected explants, and significantly correlated with HSV1-invasion scores. The epithelial damage scores of nasal polyp tissues were significantly higher than those of inferior turbinate tissues upon HSV1 infection. Consequently, invasion scores of HSV1 of nasal polyp tissues were significantly higher than those of inferior turbinate mucosa in the HSV1 and co-infection groups, and invasion scores of S. aureus of nasal polyp tissues were significantly higher than those of inferior turbinate tissues in the co-infection group. Conclusions/Significance: HSV1 may lead to a significant damage of the nasal epithelium and consequently may facilitate invasion of S. aureus into the nasal mucosa. Nasal polyp tissue is more susceptible to the invasion of HSV1 and epithelial damage by HSV1 compared with inferior turbinate mucosa.	[Wang, XiangDong; Zhang, Nan; Holtappels, Gabriele; Krysko, Olga; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium; [Wang, XiangDong; Zhang, Luo; Han, Demin] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Glorieux, Sarah; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Virol Lab, B-9000 Ghent, Belgium; [Vaneechoutte, Mario] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Zhang, Luo; Han, Demin] Capital Med Univ, Beijing Inst Otolaryngol, Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Ghent University; Ghent University Hospital; Capital Medical University; Ghent University; Ghent University; Capital Medical University	Wang, XD (corresponding author), Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium.	Luozhang@trhos.com; handm@trhos.com	Krysko, Olga/C-2481-2009; Zhang, Nan/AAQ-3944-2020; Vaneechoutte, Mario/A-6189-2009; Bachert, Claus/J-8825-2012	Krysko, Olga/0000-0001-5019-0752; Vaneechoutte, Mario/0000-0002-4586-203X; Nauwynck, Hans/0000-0001-5470-0713; Zhang, Luo/0000-0002-0910-9884	European Commission [260895]; Flemish Scientific Research Board, FWO [A12/5-HB-KH3, G.0436.04, 3G.0489, G.0642.10N]; National Science Fund for Distinguished Young Scholars; National Natural Science Foundation of China [30872846, 30973282]; Beijing Natural Science Foundation [7072017]; Beijing Ke-Ji-Xin-Xing Project [2006A67]; Project of Beijing Senior Scholar of Health; Project of Liu-Xue-Gui-Guo Scholar; Global Allergy and Asthma European Network (GA2LEN); Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy [IAP P6/35]	European Commission(European CommissionEuropean Commission Joint Research Centre); Flemish Scientific Research Board, FWO(FWO); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Ke-Ji-Xin-Xing Project; Project of Beijing Senior Scholar of Health; Project of Liu-Xue-Gui-Guo Scholar; Global Allergy and Asthma European Network (GA2LEN); Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by grants to Claus Bachert from the European Commission's Seventh Framework programme under grant agreement No 260895 (PREDICTA); by the Flemish Scientific Research Board, FWO, Nr. A12/5-HB-KH3, project G.0436.04, 3G.0489, G.0642.10N; by National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China (30872846 and 30973282) and Beijing Natural Science Foundation (7072017) to Luo Zhang; Beijing Ke-Ji-Xin-Xing Project grant (2006A67), Project of Beijing Senior Scholar of Health and Project of Liu-Xue-Gui-Guo Scholar to XiangDong Wang; and to Claus Bachert by the Global Allergy and Asthma European Network (GA2LEN), and the Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy, Nr. IAP P6/35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Becker S, 1997, AM J PHYSIOL-LUNG C, V272, pL512, DOI 10.1152/ajplung.1997.272.3.L512; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Bunzli D, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-10; Chacko J, 2009, INDIAN J MED MICROBI, V27, P146, DOI 10.4103/0255-0857.49429; Chen TS, 2006, MODERN PATHOL, V19, P726, DOI 10.1038/modpathol.3800584; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cheung AL, 1998, INFECT IMMUN, V66, P5988, DOI 10.1128/IAI.66.12.5988-5993.1998; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corriveau MN, 2009, AM J RHINOL ALLERGY, V23, P461, DOI 10.2500/ajra.2009.23.3367; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Doi Y, 2009, J EPIDEMIOL, V19, P56, DOI 10.2188/jea.JE20080061; DUPUIT F, 1995, HUM GENE THER, V6, P1185, DOI 10.1089/hum.1995.6.9-1185; EDWARDS KM, 1986, J INFECT DIS, V153, P41, DOI 10.1093/infdis/153.1.41; Engelbert M, 2005, INVEST OPHTH VIS SCI, V46, P2479, DOI 10.1167/iovs.04-1139; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Glorieux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022160; Glorieux S, 2009, VET MICROBIOL, V136, P341, DOI 10.1016/j.vetmic.2008.11.005; Hollams EM, 2010, EUR RESPIR J, V36, P509, DOI 10.1183/09031936.00184109; Jang YJ, 2005, J VIROL METHODS, V125, P41, DOI 10.1016/j.jviromet.2004.12.004; Kowalski ML, 2011, ALLERGY, V66, P32, DOI 10.1111/j.1398-9995.2010.02379.x; Larkin EA, 2009, CURR MED CHEM, V16, P4003, DOI 10.2174/092986709789352321; Mongodin E, 2000, J HISTOCHEM CYTOCHEM, V48, P523, DOI 10.1177/002215540004800410; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Novo CAP, 2010, CLIN EXP ALLERGY, V40, P1323, DOI 10.1111/j.1365-2222.2010.03577.x; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Pitkaranta A, 1997, J CLIN MICROBIOL, V35, P1791; Rabenau HF, 2002, MED MICROBIOL IMMUN, V190, P153, DOI 10.1007/s00430-001-0102-1; Read RC, 1999, INFECT IMMUN, V67, P3082, DOI 10.1128/IAI.67.6.3082-3086.1999; ROLLINS BS, 1993, ANTIVIR RES, V21, P357, DOI 10.1016/0166-3542(93)90013-9; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Spear PG, 2002, DEV CELL, V3, P462, DOI 10.1016/S1534-5807(02)00298-8; Steukers L, 2011, KINETICS BO IN PRESS; Suptawiwat O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012973; THOMAS, 2007, CHEM IMMUNOL ALLERGY, V93, P24; Van Zele T, 2007, CLIN EXP ALLERGY, V37, P1840, DOI 10.1111/j.1365-2222.2007.02838.x; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Vandekerckhove AP, 2010, J GEN VIROL, V91, P2019, DOI 10.1099/vir.0.019257-0; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang JH, 2007, AM J RHINOL, V21, P670, DOI 10.2500/ajr.2007.21.3101; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yeo NK, 2010, LARYNGOSCOPE, V120, P346, DOI 10.1002/lary.20764; Zaravinos A, 2009, J MED VIROL, V81, P1613, DOI 10.1002/jmv.21534; Zhang N, 2006, AM J RHINOL, V20, P445, DOI 10.2500/ajr.2006.20.2887	51	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39875	10.1371/journal.pone.0039875	http://dx.doi.org/10.1371/journal.pone.0039875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768151	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100120
J	Chu, YH; Tzeng, SL; Lin, CW; Chien, MH; Chen, MK; Yang, SF				Chu, Yin-Hung; Tzeng, Shu-Ling; Lin, Chiao-Wen; Chien, Ming-Hsien; Chen, Mu-Kuan; Yang, Shun-Fa			Impacts of MicroRNA Gene Polymorphisms on the Susceptibility of Environmental Factors Leading to Carcinogenesis in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PRE-MICRORNAS; RISK; INVASION; DIFFERENTIATION; MIR-146A; CONTRIBUTES; POPULATION; METASTASIS; VARIANTS	Background: MicroRNAs (miRNAs) have been regarded as a critical factor in targeting oncogenes or tumor suppressor genes in tumorigenesis. The genetic predisposition of miRNAs-signaling pathways related to the development of oral squamous cell carcinoma (OSCC) remains unresolved. This study examined the associations of polymorphisms with four miRNAs with the susceptibility and clinicopathological characteristics of OSCC. Methodology/Principal Findings: A total of 895 male subjects, including 425 controls and 470 male oral cancer patients, were selected. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and real-time PCR were used to analyze miRNA146a, miRNA196, miRNA499 and miRNA149 genetic polymorphisms between the control group and the case group. This study determined that a significant association of miRNA499 with CC genotype, as compared to the subjects with TT genotype, had a higher risk (AOR = 4.52, 95% CI = 1.24-16.48) of OSCC. Moreover, an impact of those four miRNAs gene polymorphism on the susceptibility of betel nut and tobacco consumption leading to oral cancer was also revealed. We found a protective effect between clinical stage development (AOR = 0.58, 95% CI = 0.36-0.94) and the tumor size growth (AOR = 0.47, 95% CI = 0.28-0.79) in younger patients (age, 60). Conclusions: Our results suggest that genetic polymorphism of miRNA499 is associated with oral carcinogenesis, and the interaction of the miRNAs genetic polymorphism and environmental carcinogens is also related to an increased risk of oral cancer in Taiwanese.	[Chu, Yin-Hung; Tzeng, Shu-Ling; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Chiao-Wen; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Changhua Christian Hospital	Chu, YH (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	53780@cch.org.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biolchini F, 2005, Minerva Stomatol, V54, P405; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Liu Xiqiang, 2009, Cancer Genomics & Proteomics, V6, P131; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu SY, 2006, CARCINOGENESIS, V27, P1273, DOI 10.1093/carcin/bgi357; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Reis PP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-238; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Starczynowski DT, 2011, EXP HEMATOL, V39, P167, DOI 10.1016/j.exphem.2010.09.011; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Weng CJ, 2012, J DENT RES, V91, P358, DOI 10.1177/0022034512438402; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zavras AI, 2011, ANN SURG ONCOL, V18, P1478, DOI 10.1245/s10434-010-1431-3; Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou B, 2010, CLIN CHIM ACTA, V411, P1287, DOI 10.1016/j.cca.2010.05.010	40	57	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39777	10.1371/journal.pone.0039777	http://dx.doi.org/10.1371/journal.pone.0039777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761899	Green Submitted, Green Published, gold			2022-12-25	WOS:000305826400038
J	Dvorak, P; Hasler, P; Poulickova, A				Dvorak, Petr; Hasler, Petr; Poulickova, Aloisie			Phylogeography of the Microcoleus vaginatus (Cyanobacteria) from Three Continents - A Spatial and Temporal Characterization	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PHYLOGENETIC ANALYSES; DIVERSITY; RECOMBINATION; BIOGEOGRAPHY; PHORMIDIUM; DISPERSAL; REVISION; BACTERIA; ORIGINS	It has long been assumed that cyanobacteria have, as with other free-living microorganisms, a ubiquitous occurrence. Neither the geographical dispersal barriers nor allopatric speciation has been taken into account. We endeavoured to examine the spatial and temporal patterns of global distribution within populations of the cyanobacterium Microcoleus vaginatus, originated from three continents, and to evaluate the role of dispersal barriers in the evolution of free-living cyanobacteria. Complex phylogeographical approach was applied to assess the dispersal and evolutionary patterns in the cyanobacterium Microcoleus vaginatus (Oscillatoriales). We compared the 16S rRNA and 16S-23S ITS sequences of strains which had originated from three continents (North America, Europe, and Asia). The spatial distribution was investigated using a phylogenetic tree, network, as well as principal coordinate analysis (PCoA). A temporal characterization was inferred using molecular clocks, calibrated from fossil DNA. Data analysis revealed broad genetic diversity within M. vaginatus. Based on the phylogenetic tree, network, and PCoA analysis, the strains isolated in Europe were spatially separated from those which originated from Asia and North America. A chronogram showed a temporal limitation of dispersal barriers on the continental scale. Dispersal barriers and allopatric speciation had an important role in the evolution of M. vaginatus. However, these dispersal barriers did not have a permanent character; therefore, the genetic flow among populations on a continental scale was only temporarily present. Furthermore, M. vaginatus is a recently evolved species, which has been going through substantial evolutionary changes.	[Dvorak, Petr; Hasler, Petr; Poulickova, Aloisie] Palacky Univ Olomouc, Dept Bot, Olomouc, Czech Republic	Palacky University Olomouc	Dvorak, P (corresponding author), Palacky Univ Olomouc, Dept Bot, Olomouc, Czech Republic.	p.dvorak@upol.cz	Hasler, Petr/ABD-9747-2020; Dvorak, Petr/AAC-7610-2020	Hasler, Petr/0000-0003-4658-1114; Dvorak, Petr/0000-0003-0101-9566	Czech Science Foundation [206/07/0115, 206/08/0389]; Internal Grant Agency of Palacky University, Olomouc [PrF_2012_001]; T. Bata Foundation	Czech Science Foundation(Grant Agency of the Czech Republic); Internal Grant Agency of Palacky University, Olomouc; T. Bata Foundation	This study was supported by Czech Science Foundation grants 206/07/0115 and 206/08/0389; and grant PrF_2012_001 from the Internal Grant Agency of Palacky University, Olomouc; as well as the T. Bata Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andersen R. A., 2005, ALGAL CULTURING TECH; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Becking L.G.M.B, 1934, GEOBIOLOGIE INLEIDIN; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bock C, 2011, FOTTEA, V11, P293, DOI 10.5507/fot.2011.028; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Coesel PFM, 2008, BIODIVERS CONSERV, V17, P381, DOI 10.1007/s10531-007-9256-5; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hasler P, 2012, FOTTEA, V12, P341, DOI 10.5507/fot.2012.024; Hay WW, 1999, GEOL S AM S, P1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iteman I, 2000, MICROBIOL-SGM, V146, P1275, DOI 10.1099/00221287-146-6-1275; Johansen J. R., 2005, ALGOLOGICAL STUDIES, V116, P71, DOI [DOI 10.1127/1864-1318/2005/0117-0071, 10.1127/1864-1318/2005/0117-0071]; Jungblut AD, 2010, ISME J, V4, P191, DOI 10.1038/ismej.2009.113; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komarek J, 2005, SUSSWASSERFLORA MITT, V1; Komarek J, 2010, HYDROBIOLOGIA, V639, P245, DOI 10.1007/s10750-009-0031-3; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Miller SR, 2007, APPL ENVIRON MICROB, V73, P4751, DOI 10.1128/AEM.02945-06; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Neustupa J, 2011, HYDROBIOLOGIA, V667, P223, DOI 10.1007/s10750-011-0650-3; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Panieri G, 2010, GEOBIOLOGY, V8, P101, DOI 10.1111/j.1472-4669.2009.00230.x; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poulickova A, 2010, PROTIST, V161, P353, DOI 10.1016/j.protis.2009.12.003; Rambaut A, 2004, TRACER V1 5; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Schwartz, 2010, P GAT COMP ENV WORKS; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; STAUB R., 1961, SCHWEIZ Z HYDROL, V23, P83; Strunecky O, 2011, FOTTEA, V11, P57, DOI 10.5507/fot.2011.007; Strunecky O, 2010, POLAR BIOL, V33, P1419, DOI 10.1007/s00300-010-0834-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taton A, 2006, J PHYCOL, V42, P1257, DOI 10.1111/j.1529-8817.2006.00278.x; Telford RJ, 2007, SCIENCE, V316, DOI 10.1126/science.1137697; Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; Vanormelingen P, 2008, PROTIST, V159, P73, DOI 10.1016/j.protis.2007.08.004; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Whitaker RJ, 2006, PHILOS T R SOC B, V361, P1975, DOI 10.1098/rstb.2006.1927; Whitton B.A., 2000, ECOLOGY CYANOBACTERI, P669, DOI DOI 10.1007/0-306-4685507; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Wiley EO, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P70	68	34	34	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40153	10.1371/journal.pone.0040153	http://dx.doi.org/10.1371/journal.pone.0040153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761955	Green Submitted, Green Published, gold			2022-12-25	WOS:000305825800091
J	Francis, RW; Thompson-Wicking, K; Carter, KW; Anderson, D; Kees, UR; Beesley, AH				Francis, Richard W.; Thompson-Wicking, Katherine; Carter, Kim W.; Anderson, Denise; Kees, Ursula R.; Beesley, Alex H.			FusionFinder: A Software Tool to Identify Expressed Gene Fusion Candidates from RNA-Seq Data	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BREAST-CANCER; TRANSCRIPT; IDENTIFICATION; TRANSLOCATION; DISCOVERY; PATIENT; ABL	The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, which may lead to gene fusions. Recently, next-generation sequencing techniques at the transcriptome level (RNA-Seq) have been used to verify known and discover novel transcribed gene fusions. We present FusionFinder, a Perl-based software designed to automate the discovery of candidate gene fusion partners from single-end (SE) or paired-end (PE) RNA-Seq read data. FusionFinder was applied to data from a previously published analysis of the K562 chronic myeloid leukaemia (CML) cell line. Using FusionFinder we successfully replicated the findings of this study and detected additional previously unreported fusion genes in their dataset, which were confirmed experimentally. These included two isoforms of a fusion involving the genes BRK1 and VHL, whose co-deletion has previously been associated with the prevalence and severity of renal-cell carcinoma. FusionFinder is made freely available for non-commercial use and can be downloaded from the project website (http://bioinformatics.childhealthresearch.org.au/software/fusionfinder/).	[Francis, Richard W.; Carter, Kim W.; Anderson, Denise] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Bioinformat & Biostat, Perth, WA 6009, Australia; [Thompson-Wicking, Katherine; Kees, Ursula R.; Beesley, Alex H.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Childrens Leukaemia & Canc Res, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; Telethon Kids Institute; University of Western Australia	Francis, RW (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Bioinformat & Biostat, Perth, WA 6009, Australia.	rfrancis@ichr.uwa.edu.au	Beesley, Alex H/K-5805-2013; Francis, Richard/K-2812-2019	Beesley, Alex H/0000-0002-5742-7270; Francis, Richard/0000-0003-1580-7934; Anderson, Denise/0000-0003-0643-4136	WA State Government Centres of Excellence Program; Children's Leukaemia and Cancer Research Foundation, Perth; Mike Schon-Hegrad Memorial Fund	WA State Government Centres of Excellence Program; Children's Leukaemia and Cancer Research Foundation, Perth; Mike Schon-Hegrad Memorial Fund	The study was funded by the WA State Government Centres of Excellence Program, the Children's Leukaemia and Cancer Research Foundation, Perth and the Mike Schon-Hegrad Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne JL, 1998, BRIT J HAEMATOL, V103, P791, DOI 10.1046/j.1365-2141.1998.01043.x; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Escobar B, 2010, CANCER RES, V70, P9349, DOI 10.1158/0008-5472.CAN-09-4491; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Ge H, 2011, BIOINFORMATICS; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, BIOINFORMATICS, V27, P1708, DOI 10.1093/bioinformatics/btr265; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Maranchie JK, 2004, HUM MUTAT, V23, P40, DOI 10.1002/humu.10302; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROWLEY JD, 1973, ANN GENET-PARIS, V16, P109; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Smit A, 1996, REPEATMASKER OPEN 30; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Takahashi T, 2001, GENE CHROMOSOME CANC, V30, P196, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1078>3.0.CO;2-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Zhao Q, 2009, P NATL ACAD SCI USA, V106, P1886, DOI 10.1073/pnas.0812945106	34	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39987	10.1371/journal.pone.0039987	http://dx.doi.org/10.1371/journal.pone.0039987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761941	Green Submitted, Green Published, gold			2022-12-25	WOS:000305825800085
J	Li, R; Ackerman, WE; Mihai, C; Volakis, LI; Ghadiali, S; Kniss, DA				Li, Ruth; Ackerman, William E.; Mihai, Cosmin; Volakis, Leonithas I.; Ghadiali, Samir; Kniss, Douglas A.			Myoferlin Depletion in Breast Cancer Cells Promotes Mesenchymal to Epithelial Shape Change and Stalls Invasion	PLOS ONE			English	Article							DYSFERLIN; GROWTH; REPAIR; TUMOR; GENE; METALLOPROTEINASES; IDENTIFICATION; TRANSITIONS; ENDOCYTOSIS; EXPRESSION	Myoferlin (MYOF) is a mammalian ferlin protein with homology to ancestral Fer-1, a nematode protein that regulates spermatic membrane fusion, which underlies the amoeboid-like movements of its sperm. Studies in muscle and endothelial cells have reported on the role of myoferlin in membrane repair, endocytosis, myoblast fusion, and the proper expression of various plasma membrane receptors. In this study, using an in vitro human breast cancer cell model, we demonstrate that myoferlin is abundantly expressed in invasive breast tumor cells. Depletion of MYOF using lentiviral-driven shRNA expression revealed that MDA-MB-231 cells reverted to an epithelial morphology, suggesting at least some features of mesenchymal to epithelial transition (MET). These observations were confirmed by the down-regulation of some mesenchymal cell markers (e.g., fibronectin and vimentin) and coordinate up-regulation of the E-cadherin epithelial marker. Cell invasion assays using Boyden chambers showed that loss of MYOF led to a significant diminution in invasion through Matrigel or type I collagen, while cell migration was unaffected. PCR array and screening of serum-free culture supernatants from shRNA(MYOF) transduced MDA-MB-231 cells indicated a significant reduction in the steady-state levels of several matrix metalloproteinases. These data when considered in toto suggest a novel role of MYOF in breast tumor cell invasion and a potential reversion to an epithelial phenotype upon loss of MYOF.	[Li, Ruth; Ackerman, William E.; Kniss, Douglas A.] Ohio State Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Lab Perinatal Res, Columbus, OH 43210 USA; [Volakis, Leonithas I.; Ghadiali, Samir; Kniss, Douglas A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Ghadiali, Samir] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Mihai, Cosmin] Pacific NW Natl Lab, Richland, WA 99352 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Li, R (corresponding author), Ohio State Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Lab Perinatal Res, Columbus, OH 43210 USA.	kniss.1@osu.edu	Ackerman, William/E-2612-2011; Ghadiali, Samir N./C-5463-2012; Ghadiali, Samir/AAN-7772-2020	Ghadiali, Samir N./0000-0002-6845-774X; Ghadiali, Samir/0000-0002-6845-774X; Ackerman, William/0000-0001-7366-3903	Ohio State University; NIH [K08 HD49628]; National Science Foundation Nanoscience Science and Engineering Center [EEC-0425626]; Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [1134201]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD049628] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; Directorate For Engineering [1134201] Funding Source: National Science Foundation	Ohio State University(Ohio State University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Nanoscience Science and Engineering Center; Chemical, Bioengineering, Environmental, and Transport Systems (CBET); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Ohio State University Perinatal Research and Development Fund (DAK), NIH K08 HD49628 (WEA), and the National Science Foundation Nanoscience Science and Engineering Center grant #EEC-0425626 (RL) and Chemical, Bioengineering, Environmental, and Transport Systems (CBET) #1134201 (LV, DAK, SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 1997, J CELL SCI, V110, P1073; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; American Cancer Society, 2009, BREAST CANC SOURCEBO; ARGON Y, 1980, GENETICS, V96, P413; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Caldieri G, 2010, TRENDS CELL BIOL, V20, P64, DOI 10.1016/j.tcb.2009.10.006; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Cipta S, 2009, AM J PHYSIOL-CELL PH, V297, pC481, DOI 10.1152/ajpcell.00288.2009; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Fletcher SJ, 2009, BIOCHEM SOC T, V37, P1072, DOI 10.1042/BST0371072; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horner MJ, 2009, SEER CANC STAT REV 1; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Mills GB, 2009, J CLIN INVEST, V119, P2123, DOI 10.1172/JCI40256; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; SOULE HD, 1990, CANCER RES, V50, P6075; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yu C, 2011, VASCUL PHARM	54	33	33	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39766	10.1371/journal.pone.0039766	http://dx.doi.org/10.1371/journal.pone.0039766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761893	gold, Green Submitted, Green Published			2022-12-25	WOS:000305825800067
J	Martos, A; Monterroso, B; Zorrilla, S; Reija, B; Alfonso, C; Mingorance, J; Rivas, G; Jimenez, M				Martos, Ariadna; Monterroso, Begona; Zorrilla, Silvia; Reija, Belen; Alfonso, Carlos; Mingorance, Jesus; Rivas, German; Jimenez, Mercedes			Isolation, Characterization and Lipid-Binding Properties of the Recalcitrant FtsA Division Protein from Escherichia coli	PLOS ONE			English	Article							MEMBRANE TARGETING SEQUENCE; ACTIN-LIKE FTSA; CELL-DIVISION; INORGANIC-PHOSPHATE; Z-RING; VESICLES; ASSAY; ZIPA; PHOSPHOLIPIDS; DOMAIN	We have obtained milligram amounts of highly pure Escherichia coli division protein FtsA from inclusion bodies with an optimized purification method that, by overcoming the reluctance of FtsA to be purified, surmounts a bottleneck for the analysis of the molecular basis of FtsA function. Purified FtsA is folded, mostly monomeric and interacts with lipids. The apparent affinity of FtsA binding to the inner membrane is ten-fold higher than to phospholipids, suggesting that inner membrane proteins could modulate FtsA-membrane interactions. Binding of FtsA to lipids and membranes is insensitive to ionic strength, indicating that a net contribution of hydrophobic interactions is involved in the association of FtsA to lipid/membrane structures.	[Martos, Ariadna; Monterroso, Begona; Alfonso, Carlos; Rivas, German; Jimenez, Mercedes] CSIC, Ctr Invest Biol, Madrid, Spain; [Zorrilla, Silvia; Reija, Belen] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Mingorance, Jesus] IdiPAZ, Hosp Univ La Paz, Microbiol Serv, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Hospital Universitario La Paz	Martos, A (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	grivas@cib.csic.es; enoe@cib.csic.es	Monterroso, Begoña/J-9748-2014; Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Rivas, German/AFL-7528-2022; Mingorance, Jesus/B-7562-2009; Jimenez Sarmiento, Mercedes/K-2691-2014; Zorrilla, Silvia/J-9771-2014	Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Rivas, German/0000-0003-3450-7478; Mingorance, Jesus/0000-0001-6173-5711; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903; Zorrilla, Silvia/0000-0002-6309-9058	Spanish Government [BIO2008-04478-C03, BIO2011-28941-C03-03, BFU2010-14910, CSIC PIE-201020I001]; European Commission [HEALTH-F3-2009-223431]; Human Frontier Science Program [RGP0050/2010-C102]	Spanish Government(Spanish GovernmentEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the Spanish Government through Grants BIO2008-04478-C03 and BIO2011-28941-C03-03 (to G.R.), BFU2010-14910 (to S.Z.), CSIC PIE-201020I001 (to C.A.), by the European Commission through Contract HEALTH-F3-2009-223431, and by the Human Frontier Science Program through Grant RGP0050/2010-C102 (both to G.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Carettoni D, 2003, PROTEINS, V50, P192, DOI 10.1002/prot.10244; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DEVAUX PF, 1985, BIOCHIM BIOPHYS ACTA, V822, P63, DOI 10.1016/0304-4157(85)90004-8; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Paradis-Bleau C, 2005, PROTEIN ENG DES SEL, V18, P85, DOI 10.1093/protein/gzi008; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; PLA J, 1990, J BACTERIOL, V172, P5097, DOI 10.1128/jb.172.9.5097-5102.1990; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiomi D, 2008, MOL MICROBIOL, V67, P558, DOI 10.1111/j.1365-2958.2007.06085.x; Shiomi D, 2007, MOL MICROBIOL, V66, P1396, DOI 10.1111/j.1365-2958.2007.05998.x; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; van Holde KE, 1985, SEDIMENTATION PHYS B; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	36	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39829	10.1371/journal.pone.0039829	http://dx.doi.org/10.1371/journal.pone.0039829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761913	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800075
J	Jiang, J; Lu, CM; Peng, DL; Zhu, CZ; Howell, P				Jiang, Jing; Lu, Chunming; Peng, Danling; Zhu, Chaozhe; Howell, Peter			Classification of Types of Stuttering Symptoms Based on Brain Activity	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; RESONANCE-IMAGING FMRI; FUNCTIONAL SEGREGATION; ACTIVATION PATTERNS; SPEECH PRODUCTION; NEURAL SYSTEMS; INITIAL STATUS; BASAL GANGLIA; LANGUAGE; FLUENT	Among the non-fluencies seen in speech, some are more typical (MT) of stuttering speakers, whereas others are less typical (LT) and are common to both stuttering and fluent speakers. No neuroimaging work has evaluated the neural basis for grouping these symptom types. Another long-debated issue is which type (LT, MT) whole-word repetitions (WWR) should be placed in. In this study, a sentence completion task was performed by twenty stuttering patients who were scanned using an event-related design. This task elicited stuttering in these patients. Each stuttered trial from each patient was sorted into the MT or LT types with WWR put aside. Pattern classification was employed to train a patient-specific single trial model to automatically classify each trial as MT or LT using the corresponding fMRI data. This model was then validated by using test data that were independent of the training data. In a subsequent analysis, the classification model, just established, was used to determine which type the WWR should be placed in. The results showed that the LT and the MT could be separated with high accuracy based on their brain activity. The brain regions that made most contribution to the separation of the types were: the left inferior frontal cortex and bilateral precuneus, both of which showed higher activity in the MT than in the LT; and the left putamen and right cerebellum which showed the opposite activity pattern. The results also showed that the brain activity for WWR was more similar to that of the LT and fluent speech than to that of the MT. These findings provide a neurological basis for separating the MT and the LT types, and support the widely-used MT/LT symptom grouping scheme. In addition, WWR play a similar role as the LT, and thus should be placed in the LT type.	[Jiang, Jing; Lu, Chunming; Peng, Danling; Zhu, Chaozhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Howell, Peter] UCL, Div Psychol & Language Sci, London, England	Beijing Normal University; University of London; University College London	Jiang, J (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	luchunming@bnu.edu.cn; p.howell@ucl.ac.uk		Jiang, Jing/0000-0002-2991-2076	National Natural Science Foundation of China (NSFC) [30900393]; State Key Laboratory of Cognitive Neuroscience and Learning	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cognitive Neuroscience and Learning	This work was supported by a grant from the National Natural Science Foundation of China (NSFC) (30900393) and Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Anderson JD, 2007, J SPEECH LANG HEAR R, V50, P229, DOI 10.1044/1092-4388(2007/018); Beal DS, 2011, NEUROIMAGE, V54, P2994, DOI 10.1016/j.neuroimage.2010.11.026; BINDER JR, 1995, ARCH NEUROL-CHICAGO, V52, P593, DOI 10.1001/archneur.1995.00540300067015; BLOODSTEIN O, 1981, J SPEECH HEAR RES, V24, P298, DOI 10.1044/jshr.2402.298; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Chang SE, 2011, CEREB CORTEX; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Conture E. G., 2001, STUTTERING ITS NATUR; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cunnington R, 1996, HUM MOVEMENT SCI, V15, P627, DOI 10.1016/0167-9457(96)00018-8; Cykowski MD, 2010, NEUROIMAGE; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; Deng Y, 2008, NEUROPSYCHOLOGIA, V46, P1864, DOI 10.1016/j.neuropsychologia.2007.09.010; DENIL LF, 1991, BRAIN, V114, P2145, DOI 10.1093/brain/114.5.2145; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Foundas AL, 2001, NEUROLOGY, V57, P207, DOI 10.1212/WNL.57.2.207; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Giraud AL, 2008, BRAIN LANG, V104, P190, DOI 10.1016/j.bandl.2007.04.005; Groussard M, 2010, NEUROIMAGE, V49, P2764, DOI 10.1016/j.neuroimage.2009.10.039; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Howell P, 1999, J SPEECH LANG HEAR R, V42, P345, DOI 10.1044/jslhr.4202.345; Howell P, 2011, J DEV BEHAV PEDIAT; Howell P, 2010, CLIN LINGUIST PHON; Howell P., 2002, CURRENT ISSUES LINGU, P95, DOI [10.1075/cilt.227.09how, DOI 10.1075/CILT.227.09HOW]; Howell P, 2007, HUM MOVEMENT SCI, V26, P728, DOI 10.1016/j.humov.2007.07.004; Hulvershorn J, 2005, HUM BRAIN MAPP, V25, P247, DOI 10.1002/hbm.20094; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Ingham RJ, 2000, BRAIN LANG, V75, P163, DOI 10.1006/brln.2000.2351; JOHNSON W, 1959, ONSET STUTTERING RES; KADIHANIFI K, 1992, J FLUENCY DISORD, V17, P151, DOI 10.1016/0094-730X(92)90008-E; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Kikuchi Y, 2011, NEUROIMAGE, V55, P891, DOI 10.1016/j.neuroimage.2010.12.083; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kolk H. H. J., 1997, NATURE TREATMENT STU, P182; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Lieberman P, 2003, LANGUAGE EVOLUTION S; Lu C, 2009, NEUROSCIENCE, V161, P1008, DOI 10.1016/j.neuroscience.2009.04.020; Lu CM, 2010, EXP NEUROL, V221, P146, DOI 10.1016/j.expneurol.2009.10.016; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mestres-Misse A, 2010, NEUROIMAGE, V49, P2826, DOI 10.1016/j.neuroimage.2009.10.018; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Neumann K, 2005, J FLUENCY DISORD, V30, P23, DOI 10.1016/j.jfludis.2004.12.002; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paden EP, 1999, J SPEECH LANG HEAR R, V42, P1113, DOI 10.1044/jslhr.4205.1113; Papoutsi M, 2009, CEREB CORTEX, V19, P2156, DOI 10.1093/cercor/bhn239; Preston JL, 2010, BRAIN, V133, P2185, DOI 10.1093/brain/awq163; RATNER NB, 1997, NATURE TREATMENT STU, P99; Riley G., 1994, STUTTERING SEVERITY; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schnur TT, 2009, P NATL ACAD SCI USA, V106, P322, DOI 10.1073/pnas.0805874106; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; STRICK PL, 1985, BEHAV BRAIN RES, V18, P107, DOI 10.1016/0166-4328(85)90067-1; Toyomura A, 2011, NEUROIMAGE, V57, P1507, DOI 10.1016/j.neuroimage.2011.05.039; Ujihira A, 2011, COMMUN D ACROSS LANG, P139; Van Opstal F, 2009, NEUROIMAGE, V47, P367, DOI 10.1016/j.neuroimage.2009.04.035; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Watkins RV, 1999, J SPEECH LANG HEAR R, V42, P1125, DOI 10.1044/jslhr.4205.1125; Wingate M. E., 2002, FDN STUTTERING; Wingate ME, 2001, J SPEECH LANG HEAR R, V44, P381, DOI 10.1044/1092-4388(2001/031); WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097; Yaruss JS, 2006, J FLUENCY DISORD, V31, P90, DOI 10.1016/j.jfludis.2006.02.002; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	84	34	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39747	10.1371/journal.pone.0039747	http://dx.doi.org/10.1371/journal.pone.0039747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965QG	22761887	gold, Green Published, Green Submitted			2022-12-25	WOS:000305781700062
J	Bandyopadhyay, BC; Swaim, WD; Sarkar, A; Liu, XB; Ambudkar, IS				Bandyopadhyay, Bidhan C.; Swaim, William D.; Sarkar, Ankana; Liu, Xibao; Ambudkar, Indu S.			Extracellular Ca2+ Sensing in Salivary Ductal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-TRANSPORT; EPITHELIAL-CELLS; TRPC3 CHANNELS; PLASMA-MEMBRANE; FLUID SECRETION; CATION CHANNEL; AMINO-ACIDS; RECEPTOR; GLAND; LOCALIZATION	Ca2+ is secreted from the salivary acinar cells as an ionic constituent of primary saliva. Ions such as Na+ and Cl- get reabsorbed whereas primary saliva flows through the salivary ductal system. Although earlier studies have shown that salivary [Ca2+] decreases as it flows down the ductal tree into the oral cavity, ductal reabsorption of Ca2+ remains enigmatic. Here we report a potential role for the G protein-coupled receptor, calcium-sensing receptor (CSR), in the regulation of Ca2+ reabsorption by salivary gland ducts. Our data show that CSR is present in the apical region of ductal cells where it is co-localized with transient receptor potential canonical 3 (TRPC3). CSRis activated in isolated salivary gland ducts as well as a ductal cell line (SMIE) by altering extracellular [Ca2+] or by aromatic amino acid, L-phenylalanine (L-Phe, endogenous component of saliva), as well as neomycin. CSR activation leads to Ca2+ influx that, in polarized cells grown on a filter support, is initiated in the luminal region. Weshow that TRPC3 contributes to Ca2+ entry triggered by CSR activation. Further, stimulation of CSR in SMIE cells enhances the CSR-TRPC3 association as well as surface expression of TRPC3. Together our findings suggest that CSR could serve as a Ca2+ sensor in the luminal membrane of salivary gland ducts and regulate reabsorption of [Ca2+] from the saliva via TRPC3, thus contributing to maintenance of salivary [Ca2+]. CSR could therefore be a potentially important protective mechanism against formation of salivary gland stones (sialolithiasis) and infection (sialoadenitis).	[Bandyopadhyay, Bidhan C.] Vet Affairs Med Ctr, Res Serv, Calcium Signaling Lab, Washington, DC 20422 USA; [Bandyopadhyay, Bidhan C.; Sarkar, Ankana] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Swaim, William D.; Liu, Xibao; Ambudkar, Indu S.] NIDCR, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bandyopadhyay, BC (corresponding author), DVA Med Ctr, Calcium Signaling Lab, Res Serv 151, 50 Irving St NW, Washington, DC 20422 USA.	bidhan.bandyopadhyay@va.gov	Bandyopadhyay, Bidhan/AAC-6828-2022	Bandyopadhyay, Bidhan/0000-0003-2364-8945	National Institutes of Health through NIDCR [DE 019524]; NIDCR Intramural Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER	National Institutes of Health through NIDCR; NIDCR Intramural Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported, in whole or in part, by National Institutes of Health Grant DE 019524 through the NIDCR ( to B. C. B) and by NIDCR Intramural Research ( to I. S. A.).	Ambudkar IS, 2006, CELL CALCIUM, V40, P495, DOI 10.1016/j.ceca.2006.08.011; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Bandyopadhyay BC, 2011, J LEUKOCYTE BIOL, V89, P57, DOI 10.1189/jlb.0610381; Bandyopadhyay S, 2010, J NEUROSCI RES, V88, P2073, DOI 10.1002/jnr.22391; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Conigrave AD, 2007, BIOCHEM SOC T, V35, P1195, DOI 10.1042/BST0351195; Conigrave AD, 2007, J NUTR, V137, p1524S, DOI 10.1093/jn/137.6.1524S; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Feng SL, 2011, BIOCHEM BIOPH RES CO, V406, P278, DOI 10.1016/j.bbrc.2011.02.033; Futakuchi S, 2009, PFLUG ARCH EUR J PHY, V459, P215, DOI 10.1007/s00424-009-0731-6; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; Grases F, 2003, CLIN CHIM ACTA, V334, P131, DOI 10.1016/S0009-8981(03)00227-4; Grases F, 2002, CLIN CHIM ACTA, V322, P29, DOI 10.1016/S0009-8981(02)00063-3; He XJ, 1998, PFLUG ARCH EUR J PHY, V435, P375, DOI 10.1007/s004240050526; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Homann V, 2006, HISTOCHEM CELL BIOL, V125, P583, DOI 10.1007/s00418-005-0100-2; Kasaboglu O, 2004, J ORAL MAXIL SURG, V62, P1253, DOI 10.1016/j.joms.2003.11.018; Khanal RC, 2008, CLIN EXP PHARMACOL P, V35, P1277, DOI 10.1111/j.1440-1681.2008.05053.x; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; KNAUF H, 1982, AM J PHYSIOL, V242, pF132, DOI 10.1152/ajprenal.1982.242.2.F132; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; MANGOS JA, 1978, J DENT RES, V57, P818, DOI 10.1177/00220345780570071101; MANGOS JA, 1981, J DENT RES, V60, P91, DOI 10.1177/00220345810600011801; Nakamura Y, 2010, IN VIVO, V24, P837; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; PAPANAYOTOU PH, 1973, J DENT RES, V52, P418, DOI 10.1177/00220345730520030301; Rey O, 2006, J BIOL CHEM, V281, P38730, DOI 10.1074/jbc.M605956200; Rey O, 2010, J CELL PHYSIOL, V225, P73, DOI 10.1002/jcp.22198; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; Romanenko VG, 2008, AM J PHYSIOL-GASTR L, V295, pG1058, DOI 10.1152/ajpgi.90384.2008; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Su YX, 2010, ARCH ORAL BIOL, V55, P15, DOI 10.1016/j.archoralbio.2009.11.006; Tanida T, 2003, J ORAL PATHOL MED, V32, P586, DOI 10.1034/j.1600-0714.2003.00015.x; TANNENBAUM PJ, 1976, J DENT RES, V55, P997, DOI 10.1177/00220345760550065201; Thongon N, 2008, AM J PHYSIOL-CELL PH, V294, pC1158, DOI 10.1152/ajpcell.00020.2008; Tran SD, 2005, TISSUE ENG, V11, P172, DOI 10.1089/ten.2005.11.172; VanHouten JN, 2007, ENDOCRINOLOGY, V148, P5943, DOI 10.1210/en.2007-0850; Venza M, 2001, J CHROMATOGR B, V757, P111, DOI 10.1016/S0378-4347(01)00130-X; WESTHOFEN M, 1984, VIRCHOWS ARCH A, V402, P425, DOI 10.1007/BF00734639; Zentner MD, 1998, J BIOL CHEM, V273, P30770, DOI 10.1074/jbc.273.46.30770; ZHAO H, 1995, J BIOL CHEM, V270, P19599, DOI 10.1074/jbc.270.33.19599	50	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30305	30316		10.1074/jbc.M112.394122	http://dx.doi.org/10.1074/jbc.M112.394122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778254	Green Published, hybrid			2022-12-25	WOS:000308579800023
J	Huang, XJ; Fruen, B; Farrington, DT; Wagenknecht, T; Liu, Z				Huang, Xiaojun; Fruen, Bradley; Farrington, Dinah T.; Wagenknecht, Terence; Liu, Zheng			Calmodulin-binding Locations on the Skeletal and Cardiac Ryanodine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; 3-DIMENSIONAL RECONSTRUCTION; CRYOELECTRON MICROSCOPY; ELECTRON-MICROSCOPY; RYR1; APOCALMODULIN; LOCALIZATION; ACTIVATION; VISUALIZATION; INHIBITION	Ryanodine receptor types 1 (RyR1) and 2 (RyR2) are calcium release channels that are highly enriched in skeletal and cardiac muscle, respectively, where they play an essential role in excitation-contraction coupling. Apocalmodulin (apo-CaM) weakly activates RyR1 but inhibits RyR2, whereas Ca2+-calmodulin inhibits both isoforms. Previous cryo-EM studies showed distinctly different binding locations on RyR1 for the two states of CaM. However, recent studies employing FRET appear to challenge these findings. Here, using cryo-EM, we have determined that a CaM mutant that is incapable of binding calcium binds to RyR1 at the apo site, regardless of the calcium concentration. We have also re-determined the location of RyR1-bound Ca2+-CaM using uniform experimental conditions. Our results show the existence of the two overlapping but distinct binding sites for CaM in RyR1 and imply that the binding location switch is due to Ca2+ binding to CaM, as opposed to direct effects of Ca2+ on RyR1. We also discuss explanations that could resolve the apparent conflict between the cryo-EM and FRET results. Interestingly, apo-CaM binds to RyR2 at a similar binding location to that of Ca2+-CaM on RyR1, in seeming agreement with the inhibitory effects of these two forms of CaM on their respective receptors.	[Huang, Xiaojun; Farrington, Dinah T.; Wagenknecht, Terence; Liu, Zheng] SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Huang, Xiaojun; Wagenknecht, Terence] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Fruen, Bradley] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Minnesota System; University of Minnesota Twin Cities	Wagenknecht, T (corresponding author), SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	terry@wadsworth.org; liuz@wadsworth.org		Liu, Zheng/0000-0001-6952-3406	National Institutes of Health [R01 HL095541, R01 AR040615, R01 HL076433]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092097, R01HL076433, R01HL095541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL095541 (to Z. L.), R01 AR040615 (to T. W.), and R01 HL076433 (to B. F.).	Aracena P, 2005, DEV CARDIOVASC MED, V254, P163; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; BURATTI R, 1995, BIOCHEM BIOPH RES CO, V213, P1082, DOI 10.1006/bbrc.1995.2238; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Damiani E, 2000, J MUSCLE RES CELL M, V21, P1, DOI 10.1023/A:1005635330773; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J., 2006, 3 DIMENSIONAL ELECT, P58; FRANK J, 2006, 3 DIMENSIONAL ELECT, P145; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; INUI M, 1987, J BIOL CHEM, V262, P1740; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; Prosser BL, 2011, CELL CALCIUM, V50, P323, DOI 10.1016/j.ceca.2011.06.001; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wagenknecht TC, 2010, CURR TOP MEMBR, V66, P27, DOI 10.1016/S1063-5823(10)66002-4; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200	35	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30328	30335		10.1074/jbc.M112.383109	http://dx.doi.org/10.1074/jbc.M112.383109			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773841	Green Published, hybrid			2022-12-25	WOS:000308579800025
J	Yin, XM; Jin, NN; Gu, JL; Shi, JH; Zhou, JH; Gong, CX; Iqbal, K; Grundke-Iqbal, I; Liu, F				Yin, Xiaomin; Jin, Nana; Gu, Jianlan; Shi, Jianhua; Zhou, Jianhua; Gong, Cheng-Xin; Iqbal, Khalid; Grundke-Iqbal, Inge; Liu, Fei			Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Modulates Serine/Arginine-rich Protein 55 (SRp55)-promoted Tau Exon 10 Inclusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SPLICING FACTORS; SR PROTEINS; DOWN-SYNDROME; NEURODEGENERATIVE DISEASE; MICROTUBULE DYNAMICS; ALZHEIMERS-DISEASE; CONSERVED FAMILY; INCREASED DOSAGE; LOCALIZATION; EXPRESSION	Tau exon 10, which encodes the second microtubule-binding repeat, is regulated by alternative splicing. Its alternative splicing generates Tau isoforms with three-or four-microtubule-binding repeats, named 3R-tau and 4R-tau. Adult human brain expresses equal levels of 3R-tau and 4R-tau. Imbalance of 3R-tau and 4R-tau causes Tau aggregation and neurofibrillary degeneration. In the present study, we found that splicing factor SRp55 (serine/arginine-rich protein 55) promoted Tau exon 10 inclusion. Knockdown of SRp55 significantly promoted Tau exon 10 exclusion. The promotion of Tau exon 10 inclusion by SRp55 required the arginine/serine-rich region, which was responsible for the subnucleic speckle localization. Dyrk1A (dual specificity tyrosine-phosphorylated and regulated kinase 1A) interacted with SRp55 and mainly phosphorylated its proline-rich domain. Phosphorylation of SRp55 by Dyrk1A suppressed its ability to promote Tau exon 10 inclusion. Up-regulation of Dyrk1A as in Down syndrome could lead to neurofibrillary degeneration by shifting the alternative splicing of Tau exon 10 to an increase in the ratio of 3R-tau/4R-tau.	[Gong, Cheng-Xin; Iqbal, Khalid; Grundke-Iqbal, Inge; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Yin, Xiaomin; Gu, Jianlan; Shi, Jianhua] Nantong Univ, Sch Med, Dept Biochem & Mol Biol, Nantong 226001, Jiangsu, Peoples R China; [Yin, Xiaomin; Jin, Nana; Gu, Jianlan; Shi, Jianhua; Zhou, Jianhua; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Sch Med, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Institute for Basic Research in Developmental Disabilities; Nantong University; Nantong University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com	Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X	National Natural Science Foundation of China [30973143, 81030059]; Chinese Natural Science Foundation of Jiangsu Province [BK2009159]; U.S. Alzheimer's Association [IIRG-08-91126]; Basic Research Program of Jiangsu Education Department [10KJA310040]; Priority Academic Program Development of Jiangsu Higher Education Institution	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); U.S. Alzheimer's Association(Alzheimer's Association); Basic Research Program of Jiangsu Education Department; Priority Academic Program Development of Jiangsu Higher Education Institution	This work was supported by National Natural Science Foundation of China Grants 30973143 and 81030059 (to F. L.), Chinese Natural Science Foundation of Jiangsu Province Grant BK2009159 (to F. L.), U.S. Alzheimer's Association Grant IIRG-08-91126 (to F. L.), Basic Research Program of Jiangsu Education Department Grant 10KJA310040 (to F. L.), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Carter JG, 2011, CURR EYE RES, V36, P328, DOI 10.3109/02713683.2010.548892; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Deshpande A, 2008, FASEB J, V22, P2357, DOI 10.1096/fj.07-096909; Ding SH, 2012, NEUROBIOL AGING, V33, P1389, DOI 10.1016/j.neurobiolaging.2010.11.021; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Jiang CC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.48; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; MAYEDA A, 1992, P NATL ACAD SCI USA, V89, P1301, DOI 10.1073/pnas.89.4.1301; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Panda D, 1999, P NATL ACAD SCI USA, V96, P12459, DOI 10.1073/pnas.96.22.12459; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Tranell A, 2011, VIRUS RES, V157, P82, DOI 10.1016/j.virusres.2011.02.010; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	45	65	69	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30497	30506		10.1074/jbc.M112.355412	http://dx.doi.org/10.1074/jbc.M112.355412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22767602	hybrid, Green Published			2022-12-25	WOS:000308579800042
J	Aziz, MH; Shen, H; Maki, CG				Aziz, Moammir H.; Shen, Hong; Maki, Carl G.			Glucocorticoid Receptor Activation Inhibits p53-induced Apoptosis of MCF10Amyc Cells via Induction of Protein Kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PKC-EPSILON; MAPK ACTIVATION; BREAST-CANCER; P53-DEPENDENT APOPTOSIS; P53 PATHWAY; EXPRESSION; GENE; CHEMOSENSITIVITY; PHOSPHORYLATION; TRANSCRIPTION	Glucocorticoid receptor (GR) is a ligand-dependent transcription factor that can promote apoptosis or survival in a cell-specific manner. Activated GR has been reported to inhibit apoptosis in mammary epithelial cells and breast cancer cells by increasing pro-survival gene expression. In this study, activated GR inhibited p53-dependent apoptosis in MCF10A cells and human mammary epithelial cells that overexpress the MYC oncogene. Specifically, GR agonists hydrocortisone or dexamethasone inhibited p53-dependent apoptosis induced by cisplatin, ionizing radiation, or the MDM2 antagonist Nutlin-3. In contrast, the GR antagonist RU486 sensitized the cells to apoptosis by these agents. Apoptosis inhibition was associated with maintenance of mitochondrial membrane potential, diminished caspase-3 and -7 activation, and increased expression at both the mRNA and protein level of the anti-apoptotic PKC family member PKC epsilon. Knockdown of PKC epsilon via siRNA targeting reversed the protective effect of dexamethasone and restored apoptosis sensitivity. These data provide evidence that activated GR can inhibit p53-dependent apoptosis through induction of the anti-apoptotic factor PKC epsilon.	[Aziz, Moammir H.; Shen, Hong; Maki, Carl G.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Med Ctr, Chicago, IL 60612 USA.	Carl_Maki@rush.edu			National Institutes of Health from NCI [1RO1CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1CA137598-01A1 from NCI (to C. G. M.).	Aziz MH, 2010, ONCOGENE, V29, P3100, DOI 10.1038/onc.2010.63; Aziz MH, 2009, J INVEST DERMATOL, V129, P2011, DOI 10.1038/jid.2008.458; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Baines CP, 2001, BASIC RES CARDIOL, V96, P207, DOI 10.1007/s003950170051; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Cohen MV, 2000, ANNU REV PHYSIOL, V62, P79, DOI 10.1146/annurev.physiol.62.1.79; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Dwivedi Y, 1999, J NEUROCHEM, V72, P380, DOI 10.1046/j.1471-4159.1999.0720380.x; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herr I, 2003, CANCER RES, V63, P3112; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Impicciatore G, 2010, CURR PHARM DESIGN, V16, P1427, DOI 10.2174/138161210791033932; Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maddali KK, 2005, VASC PHARMACOL, V42, P153, DOI 10.1016/j.vph.2004.11.008; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Moran TJ, 2000, CANCER RES, V60, P867; Ni Chonghaile T, 2006, APOPTOSIS, V11, P1247, DOI 10.1007/s10495-006-7233-1; OConnor PM, 1997, CANCER RES, V57, P4285; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Petiti JP, 2008, MOL CELL ENDOCRINOL, V289, P77, DOI 10.1016/j.mce.2008.04.015; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Sengupta S, 2001, GENE DEV, V15, P2367, DOI 10.1101/gad.202201; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Tennis M, 2006, CANCER EPIDEM BIOMAR, V15, P80, DOI 10.1158/1055-9965.EPI-05-0444; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Webster JC, 1997, J BIOL CHEM, V272, P9287; Wu GS, 1996, CLIN CANCER RES, V2, P623; Wu GS, 2002, ONCOGENE, V21, P1, DOI 10.1038/sj.onc.1205020; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	53	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29825	29836		10.1074/jbc.M112.393256	http://dx.doi.org/10.1074/jbc.M112.393256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773829	Green Published, hybrid			2022-12-25	WOS:000308286900057
J	Rajgor, D; Mellad, JA; Autore, F; Zhang, QP; Shanahan, CM				Rajgor, Dipen; Mellad, Jason A.; Autore, Flavia; Zhang, Qiuping; Shanahan, Catherine M.			Multiple Novel Nesprin-1 and Nesprin-2 Variants Act as Versatile Tissue-Specific Intracellular Scaffolds	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE ARCHITECTURE; MEMBRANE PROTEIN; TRANSLATION INITIATION; SUSCEPTIBILITY LOCUS; N-MYRISTOYLATION; PLASMA-MEMBRANE; PROGERIA CELLS; BINDING; LOCALIZATION	Background: Nesprins (Nuclear envelope spectrin-repeat proteins) are a novel family of giant spectrin-repeat containing proteins. The nesprin-1 and nesprin-2 genes consist of 146 and 116 exons which encode proteins of similar to 1mDa and similar to 800 kDa is size respectively when all the exons are utilised in translation. However emerging data suggests that the nesprins have multiple alternative start and termination sites throughout their genes allowing the generation of smaller isoforms. Results: In this study we set out to identify novel alternatively transcribed nesprin variants by screening the EST database and by using RACE analysis to identify cDNA ends. These two methods provided potential hits for alternative start and termination sites that were validated by PCR and DNA sequencing. We show that these alternative sites are not only expressed in a tissue specific manner but by combining different sites together it is possible to create a wide array of nesprin variants. By cloning and expressing small novel nesprin variants into human fibroblasts and U2OS cells we show localization to actin stress-fibres, focal adhesions, microtubules, the nucleolus, nuclear matrix and the nuclear envelope (NE). Furthermore we show that the sub-cellular localization of individual nesprin variants can vary depending on the cell type, suggesting any single nesprin variant may have different functions in different cell types. Conclusions: These studies suggest nesprins act as highly versatile tissue specific intracellular protein scaffolds and identify potential novel functions for nesprins beyond cytoplasmic-nuclear coupling. These alternate functions may also account for the diverse range of disease phenotypes observed when these genes are mutated.	[Rajgor, Dipen; Mellad, Jason A.; Zhang, Qiuping; Shanahan, Catherine M.] Kings Coll London, James Black Ctr, Cardiovasc Div, London WC2R 2LS, England; [Autore, Flavia] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Rajgor, D (corresponding author), Kings Coll London, James Black Ctr, Cardiovasc Div, London WC2R 2LS, England.	cathy.shanahan@kcl.ac.uk	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Shanahan, Catherine/0000-0002-8352-8171	Medical Research Council; British Heart Foundation; British Heart Foundation [NH/12/2/29427, RG/11/14/29056, PG/11/58/29004] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Medical Research Council and the British Heart Foundation provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eldad N, 2008, NUCLEIC ACIDS RES, V36, P6728, DOI 10.1093/nar/gkn754; Fabian M.R., 2007, CURR PROTOC MICROBIO, V6, p16E. 11.11, DOI [10.1002/9780471729259.mc16e01s6, DOI 10.1002/9780471729259.MC16E01S6]; Fairley EAL, 1999, J CELL SCI, V112, P2571; Gough LL, 2004, BBA-MOL CELL RES, V1693, P29, DOI 10.1016/j.bbamcr.2004.04.004; Gough LL, 2003, MOL BIOL CELL, V14, P2410, DOI 10.1091/mbc.E02-07-0446; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Kandert S, 2007, HUM MOL GENET, V16, P2944, DOI 10.1093/hmg/ddm255; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kobayashi Y, 2006, EXP CELL RES, V312, P3152, DOI 10.1016/j.yexcr.2006.06.026; Koutelou E, 2008, J BIOL CHEM, V283, P3846, DOI 10.1074/jbc.M706974200; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Marme A, 2008, INT J CANCER, V123, P2048, DOI 10.1002/ijc.23763; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; MELEFORS O, 1993, BLOOD REV, V7, P251, DOI 10.1016/0268-960X(93)90012-S; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Nikolova-Krstevski V, 2011, J MOL CELL CARDIOL, V50, P479, DOI 10.1016/j.yjmcc.2010.12.001; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Pecci A, 2001, J BIOL CHEM, V276, P21062, DOI 10.1074/jbc.M008665200; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; QUELLE DE, 1995, CELL, V83, P993; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Tanguay RL, 1996, MOL CELL BIOL, V16, P146; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; VAGNER S, 1995, J BIOL CHEM, V270, P20376, DOI 10.1074/jbc.270.35.20376; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhen YY, 2002, J CELL SCI, V115, P3207	51	78	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40098	10.1371/journal.pone.0040098	http://dx.doi.org/10.1371/journal.pone.0040098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768332	Green Submitted, gold, Green Published			2022-12-25	WOS:000305966500045
J	Senturia, R; Laganowsky, A; Barr, I; Scheidemantle, BD; Guo, F				Senturia, Rachel; Laganowsky, Arthur; Barr, Ian; Scheidemantle, Brooke D.; Guo, Feng			Dimerization and Heme Binding Are Conserved in Amphibian and Starfish Homologues of the microRNA Processing Protein DGCR8	PLOS ONE			English	Article							CRITICAL REGION 8; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; PREFRONTAL CORTEX; BIOGENESIS; RNA; SOFTWARE; DEFICITS; PHASER; DOMAIN	Human DiGeorge Critical Region 8 (DGCR8) is an essential microRNA (miRNA) processing factor that is activated via direct interaction with Fe(III) heme. In order for DGCR8 to bind heme, it must dimerize using a dimerization domain embedded within its heme-binding domain (HBD). We previously reported a crystal structure of the dimerization domain from human DGCR8, which demonstrated how dimerization results in the formation of a surface important for association with heme. Here, in an attempt to crystallize the HBD, we search for DGCR8 homologues and show that DGCR8 from Patiria miniata (bat star) also binds heme. The extinction coefficients (epsilon) of DGCR8-heme complexes are determined; these values are useful for biochemical analyses and allow us to estimate the heme occupancy of DGCR8 proteins. Additionally, we present the crystal structure of the Xenopus laevis dimerization domain. The structure is very similar to that of human DGCR8. Our results indicate that dimerization and heme binding are evolutionarily conserved properties of DGCR8 homologues not only in vertebrates, but also in at least some invertebrates.	[Senturia, Rachel; Barr, Ian; Scheidemantle, Brooke D.; Guo, Feng] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA; [Laganowsky, Arthur] Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Senturia, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA.	fguo@mbi.ucla.edu		Barr, Ian/0000-0003-1805-1415; Barr, Ian/0000-0002-7351-418X; Laganowsky, Arthur/0000-0001-5012-5547	National Institutes of Health (NIH) [GM080563]; UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080563] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM080563 to F.G. and by UCLA Dissertation Year Fellowship to R.S. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barr I, 2012, P NATL ACAD SCI USA, V109, P1919, DOI 10.1073/pnas.1114514109; Barr I, 2011, J BIOL CHEM, V286, P16716, DOI 10.1074/jbc.M110.180844; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Gong M, 2012, PROTEIN SCI, V21, P797, DOI 10.1002/pro.2062; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Schofield CM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-11; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; SUDOL M, 2005, MODULAR PROTEIN DOMA, P59; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yankura KA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-143; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zhang ZD, 2003, J MOL BIOL, V332, P127, DOI 10.1016/S0022-2836(03)00858-1	39	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39688	10.1371/journal.pone.0039688	http://dx.doi.org/10.1371/journal.pone.0039688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768307	gold, Green Submitted, Green Published			2022-12-25	WOS:000305966500020
J	Bloes, DA; Otto, M; Peschel, A; Kretschmer, D				Bloes, Dominik Alexander; Otto, Michael; Peschel, Andreas; Kretschmer, Dorothee			Enterococcus faecium Stimulates Human Neutrophils via the Formyl-Peptide Receptor 2	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; VIRULENCE DETERMINANTS; ACTIVATES NEUTROPHILS; SENSING SYSTEM; SEX-PHEROMONES; FAECALIS; INFECTIONS; RESISTANCE; PLASMID; IDENTIFICATION	The human formyl-peptide receptor 2 (FPR2/ALX) senses phenol-soluble modulin (PSM) peptide toxins produced by pathogenic staphylococcal species and plays a crucial role in directing neutrophil influx during staphylococcal infection. However, it has remained unclear if FPR2 responds also to molecules from other bacterial pathogens. Here we analyzed a variety of Gram-positive and Gram-negative pathogens and found that apart from staphylococci only certain enterococcal strains have the capacity to stimulate FPR2/ALX. Most of the analyzed Enterococcus faecium but only sporadic Enterococcus faecalis strains released FPR2/ALX-stimulating molecules leading to neutrophil calcium ion fluxes, chemotaxis, and complement receptor upregulation. Among ten test strains vancomycin-resistant E. faecium had a significantly higher capacity to stimulate FPR2/ALX than vancomycin-susceptible strains, suggesting an association of strong FPR2/ALX activation with health-care associated strains. The enterococcal FPR2/ALX agonists were found to be peptides or proteins, which appear, however, to be unrelated to staphylococcal PSMs in sequence and physicochemical properties. Enterococci are among the most frequent invasive bacterial pathogens but the basis of enterococcal virulence and immune activation has remained incompletely understood. Our study indicates that previously unrecognized proteinaceous agonists contribute to Enterococcus-host interaction and underscores the importance of FPR2/ALX in host defense against major endogenous bacterial pathogens.	[Bloes, Dominik Alexander; Peschel, Andreas; Kretschmer, Dorothee] Univ Tubingen, Cellular & Mol Microbiol Sect, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, US NIH, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bloes, DA (corresponding author), Univ Tubingen, Cellular & Mol Microbiol Sect, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	andreas.peschel@uni-tuebingen.de		Otto, Michael/0000-0002-2222-4115	German Research Foundation [SFB685, TRR34]; German Ministry of Education and Research (SkinStaph, Menage); University of Tubingen Medical Faculty; National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research (SkinStaph, Menage)(Federal Ministry of Education & Research (BMBF)); University of Tubingen Medical Faculty; National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financed by the German Research Foundation grants SFB685 and TRR34 and the German Ministry of Education and Research (SkinStaph, Menage) to AP; the Fortune program of the University of Tubingen Medical Faculty to DK; and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Clewell DB, 1993, BACTERIAL CONJUGATIO, P349; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; EMBER JA, 1989, AM J PATHOL, V134, P797; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; Holtfreter S, 2011, EUR J CLIN MICROBIOL, V30, P707, DOI 10.1007/s10096-010-1136-3; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Mader D, 2010, MICROBES INFECT, V12, P415, DOI 10.1016/j.micinf.2010.01.014; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Nanamori M, 2004, MOL PHARMACOL, V66, P1213, DOI 10.1124/mol.104.004309; Passerini R, 2011, ECANCERMEDICALSCIENC, V5, DOI 10.3332/ecancer.2011.191; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Prat C, 2009, J IMMUNOL, V183, P6569, DOI 10.4049/jimmunol.0801523; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; SANNOMIYA P, 1990, P NATL ACAD SCI USA, V87, P66, DOI 10.1073/pnas.87.1.66; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Schulte B, 2008, EPIDEMIOL INFECT, V136, P1131, DOI 10.1017/S0950268807009508; TSUBOKURA M, 1993, ZBL BAKT-INT J MED M, V278, P500; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; WIRTH R, 1994, EUR J BIOCHEM, V222, P235, DOI 10.1111/j.1432-1033.1994.tb18862.x; WISEMAN GM, 1975, BACTERIOL REV, V39, P317, DOI 10.1128/MMBR.39.4.317-344.1975; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	44	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39910	10.1371/journal.pone.0039910	http://dx.doi.org/10.1371/journal.pone.0039910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768166	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100135
J	Bondue, B; De Henau, O; Luangsay, S; Devosse, T; de Nadai, P; Springael, JY; Parmentier, M; Vosters, O				Bondue, Benjamin; De Henau, Olivier; Luangsay, Souphalone; Devosse, Thalie; de Nadai, Patricia; Springael, Jean-Yves; Parmentier, Marc; Vosters, Olivier			The Chemerin/ChemR23 System Does Not Affect the Pro-Inflammatory Response of Mouse and Human Macrophages Ex Vivo	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RECEPTOR; CHEMR23; ADIPOKINE; ADIPOGENESIS; TRAFFICKING; METABOLISM; ACTIVATION; RESOLUTION; INDUCTION	Macrophages constitute a major component of innate immunity and play an essential role in defense mechanisms against external aggressions and in inflammatory responses. Chemerin, a chemoattractant protein, is generated in inflammatory conditions, and recruits cells expressing the G protein-coupled receptor ChemR23, including macrophages. Chemerin was initially expected to behave as a pro-inflammatory agent. However, recent data described more complex activities that are either pro-or anti-inflammatory, according to the disease model investigated. In the present study, peritoneal macrophages were generated from WT or ChemR23(-/-) mice, stimulated with lipopolyssaccharide in combination or not with IFN-gamma and the production of pro- (TNF-alpha, IL-1 beta and IL-6) and anti-inflammatory (IL-10) cytokines was evaluated using qRT-PCR and ELISA. Human macrophages generated from peripheral blood monocytes were also tested in parallel. Peritoneal macrophages from WT mice, recruited by thioglycolate or polyacrylamide beads, functionally expressed ChemR23, as assessed by flow cytometry, binding and chemotaxis assays. However, chemerin had no effect on the strong upregulation of cytokine release by these cells upon stimulation by LPS or LPS/IFN-gamma, whatever the concentration tested. Similar data were obtained with human macrophages. In conclusion, our results rule out the direct anti-inflammatory effect of chemerin on macrophages ex vivo, described previously in the literature, despite the expression of a functional ChemR23 receptor in these cells.	[Bondue, Benjamin; De Henau, Olivier; Luangsay, Souphalone; Devosse, Thalie; de Nadai, Patricia; Springael, Jean-Yves; Parmentier, Marc; Vosters, Olivier] Univ Libre Brussels, Fac Med, IRIBHM, Brussels, Belgium; [Luangsay, Souphalone] Euroscreen SA, Brussels, Belgium; [Bondue, Benjamin] Univ Libre Brussels, Hop Erasme, Serv Pneumol, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Bondue, B (corresponding author), Univ Libre Brussels, Fac Med, IRIBHM, Brussels, Belgium.	mparment@ulb.ac.be		Parmentier, Marc/0000-0001-8081-4685; de NADAI, Patricia/0000-0001-6084-7447	European Union [LSHB-CT-2005-518167/INNOCHEM]; Interuniversity Attraction Poles Programme (P6/14) - Belgian State - Belgian Science Policy; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Fonds de la Recherche Scientifique Medicale of Belgium; Walloon Region (Programme d'excellence "CIBLES''); Fonds Ithier; Fonds Alice and David Van Buuren, Televie; Fondation Medicale Reine Elisabeth	European Union(European Commission); Interuniversity Attraction Poles Programme (P6/14) - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Actions de Recherche Concertees of the Communaute Francaise de Belgique; Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Walloon Region (Programme d'excellence "CIBLES''); Fonds Ithier; Fonds Alice and David Van Buuren, Televie; Fondation Medicale Reine Elisabeth	This work was supported by the Interuniversity Attraction Poles Programme (P6/14) - Belgian State - Belgian Science Policy, the Actions de Recherche Concertees of the Communaute Francaise de Belgique, the European Union (LSHB-CT-2005-518167/INNOCHEM), the Fonds de la Recherche Scientifique Medicale of Belgium, the Walloon Region (Programme d'excellence "CIBLES''), the Fonds Ithier, the Fonds Alice and David Van Buuren, Televie and the Fondation Medicale Reine Elisabeth. B.B. and O.D.H. were aspirant of the Belgian National Fund for Scientific Research (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Otero K, 2010, BLOOD, V116, P2942, DOI 10.1182/blood-2009-12-259903; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Samson M, 1998, EUR J IMMUNOL, V28, P1689, DOI 10.1002/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300	22	28	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40043	10.1371/journal.pone.0040043	http://dx.doi.org/10.1371/journal.pone.0040043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768214	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100186
J	Hu, R; Zhou, P; Peng, YB; Xu, XJ; Ma, J; Liu, Q; Zhang, L; Wen, XD; Qi, LW; Gao, N; Li, P				Hu, Rong; Zhou, Ping; Peng, Yong-Bo; Xu, Xiaojun; Ma, Jiang; Liu, Qun; Zhang, Lei; Wen, Xiao-Dong; Qi, Lian-Wen; Gao, Ning; Li, Ping			6-Shogaol Induces Apoptosis in Human Hepatocellular Carcinoma Cells and Exhibits Anti-Tumor Activity In Vivo through Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SELECTIVE-INHIBITION; CASPASE ACTIVATION; OXIDATIVE STRESS; DEATH; KINASE; PHOSPHORYLATION; INGREDIENTS; ATTENUATION; INDUCTION	6-Shogaol is an active compound isolated from Ginger (Zingiber officinale Rosc). In this work, we demonstrated that 6-shogaol induces apoptosis in human hepatocellular carcinoma cells in relation to caspase activation and endoplasmic reticulum (ER) stress signaling. Proteomic analysis revealed that ER stress was accompanied by 6-shogaol-induced apoptosis in hepatocellular carcinoma cells. 6-shogaol affected the ER stress signaling by regulating unfolded protein response (UPR) sensor PERK and its downstream target eIF2 alpha. However, the effect on the other two UPR sensors IRE1 and ATF6 was not obvious. In prolonged ER stress, 6-shogaol inhibited the phosphorylation of eIF2 alpha and triggered apoptosis in SMMC-7721 cells. Salubrinal, an activator of the PERK/eIF2 alpha pathway, strikingly enhanced the phosphorylation of eIF2 alpha in SMMC-7721 cells with no toxicity. However, combined treatment with 6-shogaol and salubrinal resulted in significantly increase of apoptosis and dephosphorylation of eIF2 alpha. Overexpression of eIF2 alpha prevented 6-shogaol-mediated apoptosis in SMMC-7721 cells, whereas inhibition of eIF2 alpha by small interfering RNA markedly enhanced 6-shogaol-mediated cell death. Furthermore, 6-shogaol-mediated inhibition of tumor growth of mouse SMMC-7721 xenograft was associated with induction of apoptosis, activation of caspase-3, and inactivation of eIF2 alpha. Altogether our results indicate that the PERK/eIF2 alpha pathway plays an important role in 6-shogaol-mediated ER stress and apoptosis in SMMC-7721 cells in vitro and in vivo.	[Hu, Rong; Zhou, Ping; Peng, Yong-Bo; Xu, Xiaojun; Ma, Jiang; Liu, Qun; Zhang, Lei; Wen, Xiao-Dong; Qi, Lian-Wen; Li, Ping] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Gao, Ning] 3rd Mil Med Univ, Dept Pharmacognosy, Coll Pharm, Chongqing, Peoples R China	China Pharmaceutical University; Army Medical University	Hu, R (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	gaoning59@yahoo.com.cn; liping2004@126.com	Li, Ping/GYV-4914-2022; Peng, Yong-bo/ADE-0574-2022; LianWen, Qi/H-5020-2014; Li, Ping/A-2615-2013	Peng, Yong-bo/0000-0003-4861-7184; Li, Ping/0000-0002-9669-0231	Program for Changjiang Scholars and Innovative Research Team in University [IRT0868]; National Science and Technology Major Project 'Creation of Major New Drugs' from China [2009ZX09502-020]; National Science Foundation of China [81001618]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science and Technology Major Project 'Creation of Major New Drugs' from China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Program for Changjiang Scholars and Innovative Research Team in University (No. IRT0868), National Science and Technology Major Project 'Creation of Major New Drugs' from China (No. 2009ZX09502-020), and the National Science Foundation of China (No. 81001618). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bollo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011925; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Drexler HCA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004161; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Gao N, 2006, BLOOD, V107, P241, DOI 10.1182/blood-2005-06-2409; Gao N, 2005, ONCOGENE, V24, P3797, DOI 10.1038/sj.onc.1208530; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hannun YA, 1997, BLOOD, V89, P1845, DOI 10.1182/blood.V89.6.1845; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Ishiguro K, 2007, BIOCHEM BIOPH RES CO, V362, P218, DOI 10.1016/j.bbrc.2007.08.012; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; KURODA Y, 1982, SCIENCE, V215, P415, DOI 10.1126/science.7058326; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Pan MH, 2008, MOL NUTR FOOD RES, V52, P527, DOI 10.1002/mnfr.200700157; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Sang SM, 2009, J AGR FOOD CHEM, V57, P10645, DOI 10.1021/jf9027443; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Sharathchandra RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014708; Shieh PC, 2010, J AGR FOOD CHEM, V58, P3847, DOI 10.1021/jf904563c; Soboloff J, 2002, J BIOL CHEM, V277, P13812, DOI 10.1074/jbc.M112129200; Surh YJ, 2002, FOOD CHEM TOXICOL, V40, P1091, DOI 10.1016/S0278-6915(02)00037-6; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com	32	75	77	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39664	10.1371/journal.pone.0039664	http://dx.doi.org/10.1371/journal.pone.0039664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768104	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100074
J	Kuo, KL; Zhu, HN; McNamara, PJ; Leggas, M				Kuo, Kuei-Ling; Zhu, Haining; McNamara, Patrick J.; Leggas, Markos			Localization and Functional Characterization of the Rat Oatp4c1 Transporter in an In Vitro Cell System and Rat Tissues	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTER; CANCER RESISTANCE PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; PH-DEPENDENT TRANSPORT; DRUG DISPOSITION; APICAL MEMBRANE; SHOTGUN PROTEOMICS; PROXIMAL TUBULE; RENAL-CORTEX; KIDNEY-CELLS	The organic anion transporting polypeptide 4c1 (Oatp4c1) was previously identified as a novel uptake transporter predominantly expressed at the basolateral membrane in the rat kidney proximal tubules. Its functional role was suggested to be a vectorial transport partner of an apically-expressed efflux transporter for the efficient translocation of physiological substrates into urine, some of which were suggested to be uremic toxins. However, our in vitro studies with MDCKII cells showed that upon transfection rat Oatp4c1 polarizes to the apical membrane. In this report, we validated the trafficking and function of Oatp4c1 in polarized cell systems as well as its subcellular localization in rat kidney. Using several complementary biochemical, molecular and proteomic methods as well as antibodies amenable to immunohistochemistry, immunofluorescence, and immunobloting we investigated the expression pattern of Oatp4c1 in polarized cell systems and in the rat kidney. Collectively, these data demonstrate that rat Oatp4c1 traffics to the apical cell surface of polarized epithelium and localizes primarily in the proximal straight tubules, the S3 fraction of the nephron. Drug uptake studies in Oatp4c1-overexpressing cells demonstrated that Oatp4c1-mediated estrone-3-sulfate (E3S) uptake was pH-dependent and ATP-independent. These data definitively demonstrate the subcellular localization and histological location of Oatp4c1 and provide additional functional evidence that reconciles expression-function reports found in the literature.	[Kuo, Kuei-Ling; McNamara, Patrick J.; Leggas, Markos] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Zhu, Haining] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Kentucky	Kuo, KL (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA.	mark.leggas@uky.edu	Leggas, Markos/E-6618-2011; Zhu, Haining/A-6076-2008	Leggas, Markos/0000-0003-4314-4533; Zhu, Haining/0000-0001-5498-6694	National Center for Research Resources [5P20RR020171-09]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103486-09]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were partially supported by grants from the National Center for Research Resources (5P20RR020171-09) and the National Institute of General Medical Sciences (8 P20 GM103486-09) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395; Bao Y, 2002, AM J PHYSIOL-RENAL, V282, pF1103, DOI 10.1152/ajprenal.00152.2001; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; Bindels R J, 1991, Contrib Nephrol, V91, P7; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Breedveld P, 2007, MOL PHARMACOL, V71, P240, DOI 10.1124/mol.106.028167; BUERKERT J, 1983, AM J PHYSIOL, V244, pF442, DOI 10.1152/ajprenal.1983.244.4.F442; Chu XY, 2007, J PHARMACOL EXP THER, V321, P673, DOI 10.1124/jpet.106.116517; Deguchi T, 2005, J PHARMACOL EXP THER, V314, P932, DOI 10.1124/jpet.105.085613; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; DUBOSE TD, 1979, J CLIN INVEST, V64, P476, DOI 10.1172/JCI109485; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Evers R, 1996, J CLIN INVEST, V97, P1211, DOI 10.1172/JCI118535; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Goh LB, 2002, BIOCHEM PHARMACOL, V64, P1569, DOI 10.1016/S0006-2952(02)01355-2; GOLDINGER JM, 1984, AM J PHYSIOL, V247, pC217, DOI 10.1152/ajpcell.1984.247.3.C217; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Hoque MT, 2009, BIOCHEM BIOPH RES CO, V379, P60, DOI 10.1016/j.bbrc.2008.12.014; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Ito K, 2005, PHARM RES-DORDR, V22, P1559, DOI 10.1007/s11095-005-6810-2; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Lai LQ, 2002, BIOCHEM J, V361, P497, DOI 10.1042/0264-6021:3610497; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Leuthold S, 2009, AM J PHYSIOL-CELL PH, V296, pC570, DOI 10.1152/ajpcell.00436.2008; Li L, 2011, DRUG METAB DISPOS, V39, P1478, DOI 10.1124/dmd.111.039370; Liu BL, 1997, J NATL CANCER I, V89, P1524, DOI 10.1093/jnci/89.20.1524; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MALNIC G, 1972, AM J PHYSIOL, V222, P147, DOI 10.1152/ajplegacy.1972.222.1.147; Masuda S, 1999, MOL PHARMACOL, V55, P743; Masuda S, 1997, FEBS LETT, V407, P127, DOI 10.1016/S0014-5793(97)00314-1; Meier-Abt F, 2004, BBA-BIOMEMBRANES, V1664, P64, DOI 10.1016/j.bbamem.2004.04.004; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; MURER H, 1986, KIDNEY INT, V30, P171, DOI 10.1038/ki.1986.169; Mutsaers HAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018438; Nies AT, 2008, EXPERT OPIN DRUG MET, V4, P545, DOI [10.1517/17425255.4.5.545, 10.1517/17425255.4.5.545 ]; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Piepenhagen PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1417, DOI 10.1152/ajpcell.1995.269.6.C1417; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; SABOLIC I, 1992, AM J PHYSIOL, V263, pC1225, DOI 10.1152/ajpcell.1992.263.6.C1225; Saito H, 1996, J BIOL CHEM, V271, P20719, DOI 10.1074/jbc.271.34.20719; Satlin LM, 1997, J BIOL CHEM, V272, P26340, DOI 10.1074/jbc.272.42.26340; SCALERA V, 1981, MEMBRANE BIOCHEM, V4, P49, DOI 10.3109/09687688109065422; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; VIEIRA FL, 1968, AM J PHYSIOL, V214, P710, DOI 10.1152/ajplegacy.1968.214.4.710; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Wierdl M, 2003, MOL PHARMACOL, V64, P279, DOI 10.1124/mol.64.2.279; Yamaguchi H, 2010, DRUG METAB PHARMACOK, V25, P314, DOI 10.2133/dmpk.25.314; Yang CH, 2009, TOXICOL LETT, V190, P163, DOI 10.1016/j.toxlet.2009.07.011; Zhai JJ, 2009, FEBS J, V276, P3308, DOI 10.1111/j.1742-4658.2009.07057.x	53	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39641	10.1371/journal.pone.0039641	http://dx.doi.org/10.1371/journal.pone.0039641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768102	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100072
J	Mittal, RA; Hammel, M; Schwarz, J; Heschl, KM; Bretschneider, N; Flemmer, AW; Herber-Jonat, S; Konigshoff, M; Eickelberg, O; Holzinger, A				Mittal, Rashmi A.; Hammel, Markus; Schwarz, Johannes; Heschl, Katharina M.; Bretschneider, Nancy; Flemmer, Andreas W.; Herber-Jonat, Susanne; Koenigshoff, Melanie; Eickelberg, Oliver; Holzinger, Andreas			SFTA2-A Novel Secretory Peptide Highly Expressed in the Lung-Is Modulated by Lipopolysaccharide but Not Hyperoxia	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; PULMONARY SURFACTANT; EPITHELIAL-CELLS; DEFICIENT MICE; SP-A; TRANSCRIPTION; PREDICTION; SEQUENCE; DISEASE; PU.1	Tissue-specific transcripts are likely to be of importance for the corresponding organ. While attempting to define the specific transcriptome of the human lung, we identified the transcript of a yet uncharacterized protein, SFTA2. In silico analyses, biochemical methods, fluorescence imaging and animal challenge experiments were employed to characterize SFTA2. Human SFTA2 is located on Chr. 6p21.33, a disease-susceptibility locus for diffuse panbronchiolitis. RT-PCR verified the abundance of SFTA2-specific transcripts in human and mouse lung. SFTA2 is synthesized as a hydrophilic precursor releasing a 59 amino acid mature peptide after cleavage of an N-terminal secretory signal. SFTA2 has no recognizable homology to other proteins while orthologues are present in all mammals. SFTA2 is a glycosylated protein and specifically expressed in nonciliated bronchiolar epithelium and type II pneumocytes. In accordance with other hydrophilic surfactant proteins, SFTA2 did not colocalize with lamellar bodies but colocalized with golgin97 and clathrin-labelled vesicles, suggesting a classical secretory pathway for its expression and secretion. In the mouse lung, Sfta2 was significantly downregulated after induction of an inflammatory reaction by intratracheal lipopolysaccharides paralleling surfactant proteins B and C but not D. Hyperoxia, however, did not alter SFTA2 mRNA levels. We have characterized SFTA2 and present it as a novel unique secretory peptide highly expressed in the lung.	[Mittal, Rashmi A.; Hammel, Markus; Heschl, Katharina M.; Flemmer, Andreas W.; Herber-Jonat, Susanne; Holzinger, Andreas] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Schwarz, Johannes; Koenigshoff, Melanie; Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Inst Expt Pneumol, Munich, Germany; [Schwarz, Johannes; Koenigshoff, Melanie; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Bretschneider, Nancy] Genomatix Software GmbH, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Mittal, RA (corresponding author), Univ Munich, Dr Von Haunerschen Kinderspital, Lindwurmstr 4, D-80337 Munich, Germany.	andreas.holzinger@med.uni-muenchen.de	W., Andreas Flemmer/AAQ-5654-2021; Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360	foundation Kindness for Kids, Munich, Germany; German Federal Ministry of Education and Research [GOLD.net 01GM0858]	foundation Kindness for Kids, Munich, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding was received from the foundation Kindness for Kids, Munich, Germany (http://www.kindness-for-kids.de) and the German Federal Ministry of Education and Research (GOLD.net 01GM0858), website: http://www.bmbf.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Diaz J, 2000, SHOCK, V14, P300, DOI 10.1097/00024382-200014030-00010; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Garcia-Verdugo I, 2010, INT J BIOCHEM CELL B, V42, P1779, DOI 10.1016/j.biocel.2010.08.003; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Hijikata M, 2011, HUM GENET, V129, P117, DOI 10.1007/s00439-010-0906-4; Jain D, 2007, AM J PHYSIOL-LUNG C, V292, pL861, DOI 10.1152/ajplung.00145.2006; Keicho N, 2000, AM J HUM GENET, V66, P501, DOI 10.1086/302786; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Leth-Larsen R, 2004, MOL HUM REPROD, V10, P149, DOI 10.1093/molehr/gah022; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Muller S, 1999, BIOCHEM BIOPH RES CO, V259, P364, DOI 10.1006/bbrc.1999.0677; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Sato Atsuyasu, 2010, Am J Respir Crit Care Med, V181, P1098, DOI 10.1164/rccm.200912-1818OC; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Sorokina EM, 2009, AM J PHYSIOL-LUNG C, V297, pL871, DOI 10.1152/ajplung.00052.2009; Stahlman MT, 1996, J HISTOCHEM CYTOCHEM, V44, P673, DOI 10.1177/44.7.8675988; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; White JA, 1997, GENOMICS, V45, P468, DOI 10.1006/geno.1997.4979; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	26	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40011	10.1371/journal.pone.0040011	http://dx.doi.org/10.1371/journal.pone.0040011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768197	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100169
J	Pilot, M; Jedrzejewski, W; Sidorovich, VE; Meier-Augenstein, W; Hoelzel, AR				Pilot, Malgorzata; Jedrzejewski, Wlodzimierz; Sidorovich, Vadim E.; Meier-Augenstein, Wolfram; Hoelzel, A. Rus			Dietary Differentiation and the Evolution of Population Genetic Structure in a Highly Mobile Carnivore	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; WOLVES CANIS-LUPUS; HABITAT SPECIALIZATION; FORAGING ECOLOGY; DISPERSAL; FOREST; ECOSYSTEMS; PREDATION; HISTORY; CARBON	Recent studies on highly mobile carnivores revealed cryptic population genetic structures correlated to transitions in habitat types and prey species composition. This led to the hypothesis that natal-habitat-biased dispersal may be responsible for generating population genetic structure. However, direct evidence for the concordant ecological and genetic differentiation between populations of highly mobile mammals is rare. To address this we analyzed stable isotope profiles (delta C-13 and delta N-15 values) for Eastern European wolves (Canis lupus) as a quantifiable proxy measure of diet for individuals that had been genotyped in an earlier study (showing cryptic genetic structure), to provide a quantitative assessment of the relationship between individual foraging behavior and genotype. We found a significant correlation between genetic distances and dietary differentiation (explaining 46% of the variation) in both the marginal test and crucially, when geographic distance was accounted for as a co-variable. These results, interpreted in the context of other possible mechanisms such as allopatry and isolation by distance, reinforce earlier studies suggesting that diet and associated habitat choice are influencing the structuring of populations in highly mobile carnivores.	[Pilot, Malgorzata; Hoelzel, A. Rus] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Pilot, Malgorzata] Polish Acad Sci, Museum Zool, Warsaw, Poland; [Pilot, Malgorzata] Polish Acad Sci, Inst Zool, Warsaw, Poland; [Jedrzejewski, Wlodzimierz] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Jedrzejewski, Wlodzimierz] Ctr Ecol, IVIC, Caracas, Venezuela; [Sidorovich, Vadim E.] Natl Acad Sci Belarus, Inst Zool, Minsk, BELARUS; [Meier-Augenstein, Wolfram] James Hutton Inst, Stable Isotope Lab, Dundee, Scotland	Durham University; Polish Academy of Sciences; Polish Academy of Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Venezuelan Institute Science Research; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; James Hutton Institute	Pilot, M (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	a.r.hoelzel@durham.ac.uk	Meier-Augenstein, Wolfram/F-1895-2011	Meier-Augenstein, Wolfram/0000-0002-9498-5837; Pilot, Malgorzata/0000-0002-6057-5768	British Ecological Society; Foundation for Polish Science; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	British Ecological Society; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	This study was funded by a Small Ecological Project Grant from the British Ecological Society. M. Pilot was supported by a postdoctoral fellowship from the Foundation for Polish Science. SCRI gratefully acknowledges the financial support by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson M.J., 2004, DISTLM V5 FORTRAN CO; Andersone A, 2004, ACTA THERIOL, V49, P357, DOI 10.1007/BF03192534; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Filonov K, 1989, UNGULATES LARGE PRED; Fox-Dobbs K, 2007, CAN J ZOOL, V85, P458, DOI 10.1139/Z07-018; Gade-Jorgensen I, 2000, ACTA THERIOL, V45, P537, DOI 10.4098/AT.arch.00-52; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; Hoelzel A. Rus, 2009, V17, P294; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Jedrzejewski Wlodzimierz, 2010, P207; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kielland K, 2001, ALCES-N AM MOOSE CON, V37, P329; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Mattioli L, 2004, J ZOOL, V264, P249, DOI 10.1017/S095283690400576X; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mech L. David, 2003, P131; Migli Despoina, 2005, Journal of Biological Research (Thessaloniki), V4, P217; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Okarma H, 1995, ACTA THERIOL, V40, P335, DOI 10.4098/AT.arch.95-35; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rueness EK, 2003, NATURE, V425, P69, DOI 10.1038/nature01942; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Sacks BN, 2005, MOL ECOL, V14, P1241, DOI 10.1111/j.1365-294X.2005.02473.x; Sidorovich VE, 2003, WILDLIFE BIOL, V9, P103, DOI 10.2981/wlb.2003.032; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stevens RE, 2006, OECOLOGIA, V149, P12, DOI 10.1007/s00442-006-0416-1; Urton EJM, 2005, OECOLOGIA, V145, P317, DOI 10.1007/s00442-005-0124-2; Van Treuren R, 1999, MOL ECOL, V8, P181, DOI 10.1046/j.1365-294X.1999.00548.x; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Wellenreuther M, 2009, EVOL ECOL, V23, P557, DOI 10.1007/s10682-008-9255-3; Zunna Agrita, 2009, Estonian Journal of Ecology, V58, P141, DOI 10.3176/eco.2009.2.07	49	34	34	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39341	10.1371/journal.pone.0039341	http://dx.doi.org/10.1371/journal.pone.0039341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768075	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100046
J	Teramoto, W; Sakamoto, S; Furune, F; Gyoba, J; Suzuki, Y				Teramoto, Wataru; Sakamoto, Shuichi; Furune, Fumimasa; Gyoba, Jiro; Suzuki, Yoiti			Compression of Auditory Space during Forward Self-Motion	PLOS ONE			English	Article							RAPID HEAD TURNS; SOUND LOCALIZATION; DISTANCE PERCEPTION; VISUAL SPACE; MOVEMENTS; DIRECTION; LATERALIZATION; LISTENERS; ILLUSION; CORTEX	Background: Spatial inputs from the auditory periphery can be changed with movements of the head or whole body relative to the sound source. Nevertheless, humans can perceive a stable auditory environment and appropriately react to a sound source. This suggests that the inputs are reinterpreted in the brain, while being integrated with information on the movements. Little is known, however, about how these movements modulate auditory perceptual processing. Here, we investigate the effect of the linear acceleration on auditory space representation. Methodology/Principal Findings: Participants were passively transported forward/backward at constant accelerations using a robotic wheelchair. An array of loudspeakers was aligned parallel to the motion direction along a wall to the right of the listener. A short noise burst was presented during the self-motion from one of the loudspeakers when the listener's physical coronal plane reached the location of one of the speakers (null point). In Experiments 1 and 2, the participants indicated which direction the sound was presented, forward or backward relative to their subjective coronal plane. The results showed that the sound position aligned with the subjective coronal plane was displaced ahead of the null point only during forward self-motion and that the magnitude of the displacement increased with increasing the acceleration. Experiment 3 investigated the structure of the auditory space in the traveling direction during forward self-motion. The sounds were presented at various distances from the null point. The participants indicated the perceived sound location by pointing a rod. All the sounds that were actually located in the traveling direction were perceived as being biased towards the null point. Conclusions/Significance: These results suggest a distortion of the auditory space in the direction of movement during forward self-motion. The underlying mechanism might involve anticipatory spatial shifts in the auditory receptive field locations driven by afferent signals from vestibular system.	[Teramoto, Wataru; Sakamoto, Shuichi; Furune, Fumimasa; Suzuki, Yoiti] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Teramoto, Wataru; Gyoba, Jiro] Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Teramoto, W (corresponding author), Muroran Inst Technol, Dept Comp Sci & Syst Engn, Muroran, Hokkaido 050, Japan.	teraw@ais.riec.tohoku.ac.jp	Suzuki, Yoiti/AAC-3765-2019	Gyoba, Jiro/0000-0003-4198-6323	Ministry of Education, Culture, Sports, Science and Technology [19001004, 21730585]; Grants-in-Aid for Scientific Research [23730693] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Specially Promoted Research (No. 19001004) and Young Scientists (B) (No. 21730585) from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOULT MD, 1950, AM J PSYCHOL, V63, P229, DOI 10.2307/1418926; ASHMEAD DH, 1995, J EXP PSYCHOL HUMAN, V21, P239, DOI 10.1037/0096-1523.21.2.239; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Clark B, 1949, J PSYCHOL, V28, P235, DOI 10.1080/00223980.1949.9916005; Cooper J, 2008, EXP BRAIN RES, V191, P209, DOI 10.1007/s00221-008-1516-4; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; DiZio P, 2001, J NEUROPHYSIOL, V85, P2455, DOI 10.1152/jn.2001.85.6.2455; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Gray R, 2000, CURR BIOL, V10, P587, DOI 10.1016/S0960-9822(00)00493-0; GRAYBIEL A, 1951, J EXP PSYCHOL, V42, P227, DOI 10.1037/h0059186; Hazelhoff F, 1924, Z PSYCHOL, V96, P171; Kim HY, 2001, APPL ACOUST, V62, P245, DOI 10.1016/S0003-682X(00)00023-2; Lackner JR, 2010, EXP BRAIN RES, V202, P513, DOI 10.1007/s00221-009-2149-y; LACKNER JR, 1974, Q J EXP PSYCHOL, V26, P235, DOI 10.1080/14640747408400409; LESTER G, 1970, AM J PSYCHOL, V83, P554, DOI 10.2307/1420689; Leung J, 2008, P NATL ACAD SCI USA, V105, P6492, DOI 10.1073/pnas.0710837105; Lewald J, 2000, J NEUROPHYSIOL, V84, P1107, DOI 10.1152/jn.2000.84.2.1107; Lewald J, 2002, EUR J NEUROSCI, V16, P761, DOI 10.1046/j.1460-9568.2002.02117.x; Lewald J, 2001, EUR J NEUROSCI, V13, P2268, DOI 10.1046/j.0953-816x.2001.01608.x; MacKay DM, 1961, SENS COMMUN, P339; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Munsterberg H, 1894, PSYCHOL REV, V1, P461; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Neuhoff JG, 2009, J EXP PSYCHOL HUMAN, V35, P225, DOI 10.1037/a0013159; Nijhawan R, 2002, TRENDS COGN SCI, V6, P387, DOI 10.1016/S1364-6613(02)01963-0; Perrett S, 1997, PERCEPT PSYCHOPHYS, V59, P1018, DOI 10.3758/BF03205517; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Speigle J. M., 1993, Proceedings IEEE 1993 Symposium on Research Frontiers in Virtual Reality (Cat. No.93TH0585-0), P92, DOI 10.1109/VRAIS.1993.378257; Stecker GC, 2000, J ACOUST SOC AM, V107, P3358, DOI 10.1121/1.429407; TEUBER HL, 1956, AM PSYCHOL, V11, P430; THURLOW WR, 1967, J ACOUST SOC AM, V42, P480, DOI 10.1121/1.1910604; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; Wightman FL, 1999, J ACOUST SOC AM, V105, P2841, DOI 10.1121/1.426899; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409	37	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39402	10.1371/journal.pone.0039402	http://dx.doi.org/10.1371/journal.pone.0039402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768076	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100047
J	Zhang, L; Wang, XM; Qian, H; Chi, S; Liu, C; Liu, T				Zhang, Lei; Wang, Xumin; Qian, Hao; Chi, Shan; Liu, Cui; Liu, Tao			Complete Sequences of the Mitochondrial DNA of the Wild Gracilariopsis lemaneiformis and Two Mutagenic Cultivated Breeds (Gracilariaceae, Rhodophyta)	PLOS ONE			English	Article							GENE CONTENT; NUCLEOTIDE-SEQUENCE; CHONDRUS-CRISPUS; GENOME; EVOLUTION; RED; GENERATION; VULGARIS; INSIGHTS	The complete mitochondrial DNA (mtDNA) of Gracilariopsis lemaneiformis was sequenced (25883 bp) and mapped to a circular model. The A+T composition was 72.5%. Forty six genes and two potentially functional open reading frames were identified. They include 24 protein-coding genes, 2 rRNA genes, 20 tRNA genes and 2 ORFs (orf60, orf142). There is considerable sequence synteny across the five red algal mtDNAs falling into Florideophyceae including Gr. lemaneiformis in this study and previously sequenced species. A long stem-loop and a hairpin structure were identified in intergenic regions of mt genome of Gr. lemaneiformis, which are believed to be involved with transcription and replication. In addition, the mtDNAs of two mutagenic cultivated breeds ("981" and "07-2") were also sequenced. Compared with the mtDNA of wild Gr. lemaneiformis, the genome size and gene length and order of three strains were completely identical except nine base mutations including eight in the protein-coding genes and one in the tRNA gene. None of the base mutations caused frameshift or a premature stop codon in the mtDNA genes. Phylogenetic analyses based on mitochondrial protein-coding genes and rRNA genes demonstrated Gracilariopsis andersonii had closer phylogenetic relationship with its parasite Gracilariophila oryzoides than Gracilariopsis lemaneiformis which was from the same genus of Gracilariopsis.	[Zhang, Lei; Qian, Hao; Chi, Shan; Liu, Cui; Liu, Tao] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China; [Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, L (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China.	liutao@ouc.edu.cn	wang, xumin/HII-8627-2022		Province Science and Technology in the Guangdong Project [2010B060200010, 2010B020201015]; National Public Benefit Research Foundation of China [201203063]	Province Science and Technology in the Guangdong Project; National Public Benefit Research Foundation of China	This work was supported by Province Science and Technology in the Guangdong Project (2010B060200010, 2010B020201015) and the National Public Benefit Research Foundation of China (201203063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOYEN C, 1994, NUCLEIC ACIDS RES, V22, P1400, DOI 10.1093/nar/22.8.1400; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burger G, 1999, PLANT CELL, V11, P1675, DOI 10.1105/tpc.11.9.1675; BURGER G, 1995, J MOL BIOL, V245, P522, DOI 10.1006/jmbi.1994.0043; CHANG DD, 1986, MOL CELL BIOL, V6, P1446, DOI 10.1128/MCB.6.5.1446; [陈伟洲 CHEN Wei-Zhou], 2009, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V39, P437; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Conklin KY, 2009, J APPL PHYCOL, V21, P691, DOI 10.1007/s10811-009-9404-2; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Hancock L, 2010, GENOME BIOL EVOL, V2, P897, DOI 10.1093/gbe/evq075; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; LEBLANC C, 1995, J MOL BIOL, V250, P484, DOI 10.1006/jmbi.1995.0392; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Meng L, 2009, PERIOD OCEAN U CHINA, V39, P94; NOSEK J, 2004, J APPL BIOMED, V2, P71; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; SANTELICES B, 1989, AQUACULTURE, V78, P95, DOI 10.1016/0044-8486(89)90026-4; Smith DR, 2010, CURR GENET, V56, P427, DOI 10.1007/s00294-010-0311-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sui ZH, 2002, ACTA BOT SIN, V44, P557; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Turmel M, 2002, P NATL ACAD SCI USA, V99, P11275, DOI 10.1073/pnas.162203299; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van der Meer J P, 1990, BIOL RED ALGAE, P103, DOI [10.1046/j.1420-9101.1992.5030533.x, DOI 10.1046/J.1420-9101.1992.5030533.X]; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WOLFF G, 1994, J MOL BIOL, V237, P75, DOI 10.1006/jmbi.1994.1210; Xia BM, 1999, FLORA ALGARUM MARINA, P55; Xu JT, 2008, J APPL PHYCOL, V20, P681, DOI 10.1007/s10811-007-9247-7; ZHANG XC, 1987, BOT MAR, V30, P309, DOI 10.1515/botm.1987.30.4.309	38	17	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40241	10.1371/journal.pone.0040241	http://dx.doi.org/10.1371/journal.pone.0040241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768261	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100235
J	Zhang, SB; Guan, ZJ; Sun, M; Zhang, JJ; Cao, KF; Hu, H				Zhang, Shi-Bao; Guan, Zhi-Jie; Sun, Mei; Zhang, Juan-Juan; Cao, Kun-Fang; Hu, Hong			Evolutionary Association of Stomatal Traits with Leaf Vein Density in Paphiopedilum, Orchidaceae	PLOS ONE			English	Article							ANATOMICAL CHARACTERISTICS; HYDRAULIC CONDUCTANCE; WATER TRANSPORT; GENOME SIZE; PLANTS; CAPACITY; VENATION; DROUGHT; PHOTOSYNTHESIS; RESPONSES	Background: Both leaf attributes and stomatal traits are linked to water economy in land plants. However, it is unclear whether these two components are associated evolutionarily. Methodology/Principal Findings: In characterizing the possible effect of phylogeny on leaf attributes and stomatal traits, we hypothesized that a correlated evolution exists between the two. Using a phylogenetic comparative method, we analyzed 14 leaf attributes and stomatal traits for 17 species in Paphiopedilum. Stomatal length (SL), stomatal area (SA), upper cuticular thickness (UCT), and total cuticular thickness (TCT) showed strong phylogenetic conservatism whereas stomatal density (SD) and stomatal index (SI) were significantly convergent. Leaf vein density was correlated with SL and SD whether or not phylogeny was considered. The lower epidermal thickness (LET) was correlated positively with SL, SA, and stomatal width but negatively with SD when phylogeny was not considered. When this phylogenetic influence was factored in, only the significant correlation between SL and LET remained. Conclusion/Significance: Our results support the hypothesis for correlated evolution between stomatal traits and vein density in Paphiopedilum. However, they do not provide evidence for an evolutionary association between stomata and leaf thickness. These findings lend insight into the evolution of traits related to water economy for orchids under natural selection.	[Zhang, Shi-Bao; Guan, Zhi-Jie; Zhang, Juan-Juan; Hu, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China; [Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang] Chinese Acad Sci, Key Lab Trop Plant Ecol, Kunming, Yunnan, Peoples R China; [Guan, Zhi-Jie] China Agr Univ, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Guan, Zhi-Jie] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; China Agricultural University; China Agricultural University	Zhang, SB (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China.	huhong@mail.kib.ac.cn	Cao, Kun-Fang/D-2157-2009; Zhang, Juan/GRX-2638-2022	Cao, Kun-Fang/0000-0002-2253-7189; 	National Natural Science Foundation of China [31170315, 30770226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Natural Science Foundation of China (31170315, 30770226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasamaa K, 2001, AUST J PLANT PHYSIOL, V28, P765, DOI 10.1071/PP00157; Ackerly DD, 1998, AM NAT, V152, P767, DOI 10.1086/286208; ASHTON PMS, 1992, NEW PHYTOL, V121, P587, DOI 10.1111/j.1469-8137.1992.tb01130.x; ASSMANN SM, 1985, PLANT PHYSIOL, V77, P461, DOI 10.1104/pp.77.2.461; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Beerling DJ, 1996, NEW PHYTOL, V134, P35, DOI 10.1111/j.1469-8137.1996.tb01144.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Bussis D, 2006, FUNCT PLANT BIOL, V33, P1037, DOI 10.1071/FP06078; Carins Murphy MR, 2012, PLANT CELL ENVIRON, V35, P1407, DOI 10.1111/j.1365-3040.2012.02498.x; Caruso CM, 2005, EVOLUTION, V59, P826; Cox AV, 1997, PLANT SYST EVOL, V208, P197, DOI 10.1007/BF00985442; Cribb PJ, 1998, GENUS PAPHIOPEDILUM; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Franks PJ, 2009, GEOBIOLOGY, V7, P227, DOI 10.1111/j.1472-4669.2009.00193.x; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Gentry GL, 2006, ENTOMOL EXP APPL, V121, P115, DOI 10.1111/j.1570-8703.2006.00472.x; Gratani L, 1999, PHOTOSYNTHETICA, V37, P573, DOI 10.1023/A:1007171525298; Guan ZJ, 2011, J PLANT RES, V124, P289, DOI 10.1007/s10265-010-0372-z; Helbsing S, 2000, ANN BOT-LONDON, V86, P765, DOI 10.1006/anbo.2000.1239; Hodgson JG, 2010, ANN BOT-LONDON, V105, P573, DOI 10.1093/aob/mcq011; James SA, 2001, AUST J BOT, V49, P259, DOI 10.1071/BT99044; Jimenez MS, 2000, FLORA, V195, P228; Karasawa K, 1982, B HIROSHIMA BOT GARD, V5, P1; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019992; Kerstiens G, 2006, J EXP BOT, V57, P2493, DOI 10.1093/jxb/erl017; MANETAS Y, 1997, PLANT ECOL, V128, P101, DOI DOI 10.1023/A:1009706806427; MUCHOW RC, 1989, PLANT CELL ENVIRON, V12, P425, DOI 10.1111/j.1365-3040.1989.tb01958.x; Nardini A, 2008, PHYSIOL PLANTARUM, V133, P755, DOI 10.1111/j.1399-3054.2008.01087.x; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Pittermann J, 2010, GEOBIOLOGY, V8, P112, DOI 10.1111/j.1472-4669.2010.00232.x; R Core Team, 2016, R FDN STAT COMP; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2003, PLANT ECOL, V168, P139, DOI 10.1023/A:1024423820136; Schluter U, 2003, J EXP BOT, V54, P867, DOI 10.1093/jxb/erg087; Schreiber L, 1996, OECOLOGIA, V107, P426, DOI 10.1007/BF00333931; Scoffoni C, 2011, PLANT PHYSIOL, V156, P832, DOI 10.1104/pp.111.173856; TURNER IM, 1994, FUNCT ECOL, V8, P669, DOI 10.2307/2390225; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Wang RZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026209; Watkins JE, 2007, NEW PHYTOL, V176, P708, DOI 10.1111/j.1469-8137.2007.02194.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Willson CJ, 2008, AM J BOT, V95, P299, DOI 10.3732/ajb.95.3.299; Woodward FI, 1998, J EXP BOT, V49, P471, DOI 10.1093/jexbot/49.suppl_1.471; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; Xu Z, 2008, J EXP BOT, V59, P3317, DOI 10.1093/jxb/ern185; Zhang SB, 2011, PHYSIOL PLANTARUM, V142, P118, DOI 10.1111/j.1399-3054.2011.01448.x	56	54	73	11	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40080	10.1371/journal.pone.0040080	http://dx.doi.org/10.1371/journal.pone.0040080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768224	Green Submitted, gold, Green Published			2022-12-25	WOS:000305892100196
J	Baloucoune, GA; Chun, L; Zhang, WH; Xu, CJ; Huang, SL; Sun, Q; Wang, YY; Tu, HJ; Liu, JF				Baloucoune, Guillaume A.; Chun, Lei; Zhang, Wenhua; Xu, Chanjuan; Huang, Siluo; Sun, Qian; Wang, Yunyun; Tu, Haijun; Liu, Jianfeng			GABA(B) Receptor Subunit GB1 at the Cell Surface Independently Activates ERK1/2 through IGF-1R Transactivation	PLOS ONE			English	Article							TISSUE DISTRIBUTION; SPLICE VARIANTS; B RECEPTOR; PROTEIN; EXPRESSION; TRAFFICKING; CLONING; BRAIN; MICE; HETERODIMERIZATION	Background: Functional GABA(B) receptor is believed to require hetero-dimerization between GABA(B1) (GB1) and GABA(B2) (GB2) subunits. The GB1 extracellular domain is required for ligand binding, and the GB2 trans-membrane domain is responsible for coupling to G proteins. Atypical GABA(B) receptor responses observed in GB2-deficient mice suggested that GB1 may have activity in the absence of GB2. However the underlying mechanisms remain poorly characterized. Methodology/Principal Findings: Here, by using cells overexpressing a GB1 mutant (GB1asa) with the ability to translocate to the cell surface in the absence of GB2, we show that GABA(B) receptor agonists, such as GABA and Baclofen, can induce ERK1/2 phosphorylation in the absence of GB2. Furthermore, we demonstrate that GB1asa induces ERK1/2 phosphorylation through Gi/o proteins and PLC dependent IGF-1R transactivation. Conclusions/Significance: Our data suggest that GB1 may form a functional receptor at the cell surface in the absence of GB2.	[Baloucoune, Guillaume A.; Chun, Lei; Zhang, Wenhua; Xu, Chanjuan; Huang, Siluo; Sun, Qian; Wang, Yunyun; Tu, Haijun; Liu, Jianfeng] Huazhong Univ Sci & Technol, Sinofrance Lab Drug Screening, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Baloucoune, GA (corresponding author), Huazhong Univ Sci & Technol, Sinofrance Lab Drug Screening, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	jfliu@mail.hust.edu.cn	Sun, Qian/AAU-8410-2020; Liu, Jianfeng/E-2786-2012	Sun, Qian/0000-0002-9532-3042; 	Ministry of Science and Technology [2012CB51800, 2010DFA32140]; National Natural Science Foundation of China (NSFC) [31130028, 30973514]; Ministry of Education [B08029]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Education	This work was supported by grants from Ministry of Science and Technology (Grant 2012CB51800 and 2010DFA32140). ULR: http://www.973.gov.cn/AreaAppl.aspx), National Natural Science Foundation of China (NSFC) (Grant 31130028 and 30973514. URL: http://www.nsfc.gov.cn/Portal0/default152.htm), Program of Introducing Talents of Discipline to Universities of Ministry of Education (B08029. URL: http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Calver AR, 2001, J NEUROSCI, V21, P1203; Cao JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-67; Clark JA, 2000, BRAIN RES, V860, P41, DOI 10.1016/S0006-8993(00)01958-2; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; David M, 2006, CELL SIGNAL, V18, P2172, DOI 10.1016/j.cellsig.2006.05.014; Dong AQ, 2007, CELL BIOL INT, V31, P500, DOI 10.1016/j.cellbi.2006.11.017; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Giorelli M, 2001, J INTERF CYTOK RES, V21, P809, DOI 10.1089/107999001753238042; Isomoto S, 1998, BIOCHEM BIOPH RES CO, V253, P10, DOI 10.1006/bbrc.1998.9706; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Laviv T, J NEUROSCI, V31, P12523; Lin X, 2012, BIOCHEM J, V443, P627, DOI 10.1042/BJ20120188; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Nakamura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020167; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Richer M, 2009, J MOL NEUROSCI, V38, P67, DOI 10.1007/s12031-008-9163-6; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Tu HJ, 2010, J NEUROSCI, V30, P749, DOI 10.1523/JNEUROSCI.2343-09.2010; Vanhoose AM, 2002, J BIOL CHEM, V277, P9049, DOI 10.1074/jbc.M108309200; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Wei KR, 2001, NEUROREPORT, V12, P833, DOI 10.1097/00001756-200103260-00042; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	36	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39698	10.1371/journal.pone.0039698	http://dx.doi.org/10.1371/journal.pone.0039698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761875	Green Submitted, Green Published, gold			2022-12-25	WOS:000305826400029
J	Galeotti, C; Lahlou, Z; Goullon, D; Sarda-Thibault, H; Cahen-Varsaux, J; Bignon-Topalovic, J; Bashamboo, A; McElreavey, K; Brauner, R				Galeotti, Caroline; Lahlou, Zineb; Goullon, Domitille; Sarda-Thibault, Helene; Cahen-Varsaux, Juliette; Bignon-Topalovic, Joelle; Bashamboo, Anu; McElreavey, Ken; Brauner, Raja			Longitudinal Evaluation of the Hypothalamic-Pituitary-Testicular Function in 8 Boys with Adrenal Hypoplasia Congenita (AHC) Due to NR0B1 Mutations	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; SERUM INHIBIN-B; INCOMPLETE HYPOGONADOTROPIC HYPOGONADISM; NONSENSE MUTATION; GONADAL-FUNCTION; DAX-1 GENE; INSUFFICIENCY; MEN; SPERMATOGENESIS; EXPERIENCE	Background: Boys carrying mutations in the NR0B1 gene develop adrenal hypoplasia congenita (AHC) and impaired sexual development due to the combination of hypogonadotropic hypogonadism (HH) and primary defects in spermatogenesis. Methods: We analysed the evolution of hypothalamic-pituitary-testicular function of 8 boys with AHC due to NR0B1 mutations. Our objective was to characterize and monitor the progressive deterioration of this function. Results: The first symptoms appeared in the neonatal period (n = 5) or between 6 months and 8.7 years (n = 3). Basal plasma adrenocorticotrophic hormone (ACTH) concentrations increased in all boys, whilst cortisol levels decreased in one case. The natremia was equal or below 134 mmol/L and kaliemia was over 5 mmol/L. All had increased plasma renin. In 3 of 4 patients diagnosed in the neonatal period and evaluated during the first year, the basal plasma gonadotropins concentrations, and their response to gonadotropin releasing hormone (GnRH) test (n = 2), and those of testosterone were normal. The plasma inhibin B levels were normal in the first year of life. With the exception of two cases these concentrations decreased to below the normal for age. Anti-Mullerian hormone concentrations were normal for age in all except one case, which had low concentrations before the initiation of testosterone treatment. In 3 of the 8 cases the gene was deleted and the remaining 5 cases carried frameshift mutations that are predicted to introduce a downstream nonsense mutation resulting in a truncated protein. Conclusions: The decreases in testosterone and inhibin B levels indicated a progressive loss of testicular function in boys carrying NR0B1 mutations. These non-invasive examinations can help to estimate the age of the testicular degradation and cryopreservation of semen may be considered in these cases as investigational procedure with the aim of restoring fertility.	[Galeotti, Caroline; Lahlou, Zineb; Goullon, Domitille; Brauner, Raja] Univ Paris 05, Sorbonne Paris Cite, France; [Galeotti, Caroline; Lahlou, Zineb; Goullon, Domitille; Brauner, Raja] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Sarda-Thibault, Helene] Ctr Hosp Rene Dubos, Serv Pediat, Pontoise, France; [Cahen-Varsaux, Juliette] Ctr Hosp Victor Dupuy, Serv Diabetol Endocrinol, Argenteuil, France; [Bignon-Topalovic, Joelle; Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Human Dev Genet Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier Rene Dubos, Pontoise; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Galeotti, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, France.	raja.brauner@wanadoo.fr						Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P2873, DOI 10.1210/jc.2003-032148; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bergada I, 2008, CLIN ENDOCRINOL, V68, P240, DOI 10.1111/j.1365-2265.2007.03026.x; Bergada I, 2006, J CLIN ENDOCR METAB, V91, P4092, DOI 10.1210/jc.2006-1079; Binder G, 2000, CLIN ENDOCRINOL, V53, P249, DOI 10.1046/j.1365-2265.2000.01038.x; Brown P, 2003, J CLIN ENDOCR METAB, V88, P1341, DOI 10.1210/jc.2002-021560; Crofton PM, 1997, CLIN ENDOCRINOL, V46, P109, DOI 10.1046/j.1365-2265.1997.d01-1744.x; FOREST MG, 1974, J CLIN INVEST, V53, P819, DOI 10.1172/JCI107621; Frapsauce C, HUM REPROD, V26, P724; GUO WW, 1995, JAMA-J AM MED ASSOC, V274, P324, DOI 10.1001/jama.274.4.324; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; Jeffs B, 2001, ENDOCRINOLOGY, V142, P4486, DOI 10.1210/en.142.10.4486; Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059; Kaiserman KB, 1998, J PEDIATR-US, V133, P300, DOI 10.1016/S0022-3476(98)70242-2; Landau Z, 2001, CLIN ENDOCRINOL OXF, V72, P448; Li N, 2001, J CLIN ENDOCR METAB, V95, pe104; Lin L, 2006, J CLIN ENDOCR METAB, V91, P3048, DOI 10.1210/jc.2006-0603; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P44, DOI 10.1210/jc.87.1.44; Meeks JJ, 2003, DEVELOPMENT, V130, P1029, DOI 10.1242/dev.00316; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Ozisik G, 2003, J CLIN ENDOCR METAB, V88, P417, DOI 10.1210/jc.2002-021034; Peter M, 1998, J CLIN ENDOCR METAB, V83, P2666, DOI 10.1210/jc.83.8.2666; Pierik FH, 1998, J CLIN ENDOCR METAB, V83, P3110, DOI 10.1210/jc.83.9.3110; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Shulman DI, 2007, PEDIATRICS, V119, pE484, DOI 10.1542/peds.2006-1612; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tabarin A, 2000, J CLIN INVEST, V105, P321, DOI 10.1172/JCI7212; Takahashi T, 1997, J PEDIATR-US, V130, P485, DOI 10.1016/S0022-3476(97)70217-8; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	32	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39828	10.1371/journal.pone.0039828	http://dx.doi.org/10.1371/journal.pone.0039828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761912	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800074
J	Fenina, M; Simon-Chazottes, D; Vandormael-Pournin, S; Soueid, J; Langa, F; Cohen-Tannoudji, M; Bernard, BA; Panthier, JJ				Fenina, Myriam; Simon-Chazottes, Dominique; Vandormael-Pournin, Sandrine; Soueid, Jihane; Langa, Francina; Cohen-Tannoudji, Michel; Bernard, Bruno A.; Panthier, Jean-Jacques			I-SceI-Mediated Double-Strand Break Does Not Increase the Frequency of Homologous Recombination at the Dct Locus in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; MAMMALIAN-CELLS; TRANSGENE EXPRESSION; GENE; REPAIR; MELANOCYTES; PROMOTER; VECTOR; MODEL; DIFFERENTIATION	Targeted induction of double-strand breaks (DSBs) at natural endogenous loci was shown to increase the rate of gene replacement by homologous recombination in mouse embryonic stem cells. The gene encoding dopachrome tautomerase (Dct) is specifically expressed in melanocytes and their precursors. To construct a genetic tool allowing the replacement of Dct gene by any gene of interest, we generated an embryonic stem cell line carrying the recognition site for the yeast I-SceI meganuclease embedded in the Dct genomic segment. The embryonic stem cell line was electroporated with an I-SceI expression plasmid, and a template for the DSB-repair process that carried sequence homologies to the Dct target. The I-SceI meganuclease was indeed able to introduce a DSB at the Dct locus in live embryonic stem cells. However, the level of gene targeting was not improved by the DSB induction, indicating a limited capacity of I-SceI to mediate homologous recombination at the Dct locus. These data suggest that homologous recombination by meganuclease-induced DSB may be locus dependent in mammalian cells.	[Fenina, Myriam; Simon-Chazottes, Dominique; Vandormael-Pournin, Sandrine; Soueid, Jihane; Cohen-Tannoudji, Michel; Panthier, Jean-Jacques] Inst Pasteur, CNRS, URA 2578, Paris, France; [Langa, Francina] Inst Pasteur, Mouse Genet Engn Ctr, Paris, France; [Fenina, Myriam; Bernard, Bruno A.] LOreal Rech & Innovat, Dept Life Sci, Clichy, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group	Panthier, JJ (corresponding author), Inst Pasteur, CNRS, URA 2578, Paris, France.	panthier@pasteur.fr	PANTHIER, Jean-Jacques/I-4366-2014	PANTHIER, Jean-Jacques/0000-0002-7966-0663; Cohen-Tannoudji, Michel/0000-0002-6405-2657; Soueid, Jihane/0000-0002-1973-8705	Association Nationale de la Recherche et de la Technologie (ANRT) [C080052]; L'Oreal Recherche; Fondation pour la Recherche Medicale	Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); L'Oreal Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from the Association Nationale de la Recherche et de la Technologie (ANRT), research contract C080052, and L'Oreal Recherche. MF was awarded fellowships from the ANRT, L'Oreal Recherche and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120; Besaratinia A, 2009, METHODS, V48, P35, DOI 10.1016/j.ymeth.2009.02.008; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; CHOULIKA A, 1994, CR ACAD SCI III-VIE, V317, P1013; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Daboussi F, 2012, NUCL ACIDS IN PRESS; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Dunn KJ, 2005, PIGM CELL RES, V18, P167, DOI 10.1111/j.1600-0749.2005.00226.x; Egidy G, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-34; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Guyonneau L, 2002, PIGM CELL RES, V15, P305, DOI 10.1034/j.1600-0749.2002.02039.x; Izmiryan A, 2011, NUCLEIC ACIDS RES, V39, P7610, DOI 10.1093/nar/gkr524; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lanning JL, 2005, J INVEST DERMATOL, V125, P805, DOI 10.1111/j.0022-202X.2005.23819.x; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; LUKACSOVICH T, 1994, NUCLEIC ACIDS RES, V22, P5649, DOI 10.1093/nar/22.25.5649; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Serrano L, 2011, STEM CELLS DEV, V20, P363, DOI 10.1089/scd.2010.0159; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Stambrook PJ, 2010, ADV EXP MED BIOL, V695, P59, DOI 10.1007/978-1-4419-7037-4_5; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Ward CM, 2002, STEM CELLS, V20, P472, DOI 10.1634/stemcells.20-5-472; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Woods SL, 2011, TRANSGENIC RES, V20, P421, DOI 10.1007/s11248-010-9421-6; Zhao SL, 1999, DEV BIOL, V216, P154, DOI 10.1006/dbio.1999.9480	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39895	10.1371/journal.pone.0039895	http://dx.doi.org/10.1371/journal.pone.0039895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761925	Green Published, Green Submitted, gold			2022-12-25	WOS:000305808700054
J	Macheda, ML; Sun, WW; Kugathasan, K; Hogan, BM; Bower, NI; Halford, MM; Zhang, YF; Jacques, BE; Lieschke, GJ; Dabdoub, A; Stacker, SA				Macheda, Maria L.; Sun, Willy W.; Kugathasan, Kumudhini; Hogan, Benjamin M.; Bower, Neil I.; Halford, Michael M.; Zhang, You Fang; Jacques, Bonnie E.; Lieschke, Graham J.; Dabdoub, Alain; Stacker, Steven A.			The Wnt Receptor Ryk Plays a Role in Mammalian Planar Cell Polarity Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EXTENSION; AXON GUIDANCE; VANGL2; GROWTH; DIFFERENTIATION; SPECIFICATION; SILBERBLICK; MOVEMENTS; DEFECTS; RHOA	Wnts are essential for a wide range of developmental processes, including cell growth, division, and differentiation. Some of these processes signal via the planar cell polarity (PCP) pathway, which is a beta-catenin-independent Wnt signaling pathway. Previous studies have shown that Ryk, a member of the receptor tyrosine kinase family, can bind to Wnts. Ryk is required for normal axon guidance and neuronal differentiation during development. Here, we demonstrate that mammalian Ryk interacts with the Wnt/PCP pathway. In vitro analysis showed that the Wnt inhibitory factor domain of Ryk was necessary for Wnt binding. Detailed analysis of two vertebrate model organisms showed Ryk phenotypes consistent with PCP signaling. In zebrafish, gene knockdown using morpholinos revealed a genetic interaction between Ryk and Wnt11 during the PCP pathway-regulated process of embryo convergent extension. Ryk-deficient mouse embryos displayed disrupted polarity of stereociliary hair cells in the cochlea, a characteristic of disturbed PCP signaling. This PCP defect was also observed in mouse embryos that were double heterozygotes for Ryk and Looptail (containing a mutation in the core Wnt/PCP pathway gene Vangl2) but not in either of the single heterozygotes, suggesting a genetic interaction between Ryk and Vangl2. Co-immunoprecipitation studies demonstrated that RYK and VANGL2 proteins form a complex, whereas RYK also activated RhoA, a downstream effector of PCP signaling. Overall, our data suggest an important role for Ryk in Wnt/planar cell polarity signaling during vertebrate development via the Vangl2 signaling pathway, as demonstrated in the mouse cochlea.	[Macheda, Maria L.; Halford, Michael M.; Zhang, You Fang; Stacker, Steven A.] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, Melbourne, Vic 3002, Australia; [Macheda, Maria L.; Kugathasan, Kumudhini; Hogan, Benjamin M.; Halford, Michael M.; Zhang, You Fang; Lieschke, Graham J.; Stacker, Steven A.] Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Sun, Willy W.; Jacques, Bonnie E.; Dabdoub, Alain] Univ Calif San Diego, Sch Med, Dept Surg, Div Otolaryngol, La Jolla, CA 92093 USA; [Hogan, Benjamin M.; Bower, Neil I.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Stacker, Steven A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia	Peter Maccallum Cancer Center; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Queensland; Peter Maccallum Cancer Center; University of Melbourne	Stacker, SA (corresponding author), Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	steven.stacker@petermac.org	Hogan, Benjamin M/J-1807-2014; Hogan, Benjamin/AAD-7410-2022; Bower, Neil/K-1478-2014	Hogan, Benjamin M/0000-0002-0651-7065; Hogan, Benjamin/0000-0002-0651-7065; Lieschke, Graham/0000-0003-0325-798X; Dabdoub, Alain/0000-0002-4259-2425; /0000-0003-1282-9695; Stacker, Steven/0000-0003-4096-9273; Macheda, Maria/0000-0002-8460-2046; Bower, Neil/0000-0002-6764-6063	National Health and Medical Research Council of Australia; National Institutes of Health [R01DC011104]; Pfizer Australia; National Institutes of Health NS/NINDS HHS [P30-NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011104] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Australia(PfizerPfizer Australia); National Institutes of Health NS/NINDS HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by a program grant (to S. A. S.) from the National Health and Medical Research Council of Australia and Grant R01DC011104 (to A. D.) from the National Institutes of Health.; Supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia and a Pfizer Australia Fellowship. To whom correspondence should be addressed: Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., Melbourne, Victoria 8006, Australia. Tel.: 61-3-9656-5263; Fax: 61-3-9656-1411; E-mail: steven.stacker@petermac.org.; We thank R. Moon for the super TOP-FLASH and super FOP-FLASH plasmids; A. McMahon for the Wnt3a and Wnt11 plasmids; R. Habas for the pGEX-RBD plasmid; Y. Zou for the anti-Ryk antibodies; S. Jane for providing the Vangl2<SUP>Lp</SUP> mice; A. Naughton and staff at the Biological Resource Facility at the Ludwig Institute for Cancer Research, Melbourne, Australia, for assistance with mouse experiments; S. Cody for assistance with imaging; S. Paquet-Fifield for assistance with photography; and M. Achen for critical reading of the manuscript. Fluorescent images were generated at the University of California, San Diego, Neuroscience Microscopy Shared Facility supported by National Institutes of Health NS/NINDS HHS Grant P30-NS047101.	Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Kamitori K, 2005, BIOCHEM BIOPH RES CO, V330, P446, DOI 10.1016/j.bbrc.2005.02.177; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Lindqvist M, 2010, J CELL SCI, V123, P472, DOI 10.1242/jcs.048074; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Reynolds A, 2010, MECH DEVELOP, V127, P385, DOI 10.1016/j.mod.2009.12.002; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; STACKER SA, 1993, ONCOGENE, V8, P1347; STEIN KF, 1953, J HERED, V44, P59, DOI 10.1093/oxfordjournals.jhered.a106356; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Tada M, 2000, DEVELOPMENT, V127, P2227; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu G, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-66; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Zhong JY, 2011, DEVELOPMENT, V138, P409, DOI 10.1242/dev.061051	44	71	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29312	29323		10.1074/jbc.M112.362681	http://dx.doi.org/10.1074/jbc.M112.362681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773843	Green Published, hybrid			2022-12-25	WOS:000308286900011
J	Liu, YJ; Peng, LR; Seto, E; Huang, SM; Qiu, Y				Liu, Yuanjing; Peng, Lirong; Seto, Edward; Huang, Suming; Qiu, Yi			Modulation of Histone Deacetylase 6 (HDAC6) Nuclear Import and Tubulin Deacetylase Activity through Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 CATALYTIC DOMAINS; NONHISTONE PROTEINS; RECEPTOR; YEAST; TRANSCRIPTION; COMPONENTS; INTERACTS; COMPLEX; FAMILY; CANCER	The reversible acetylation of histones and non-histone proteins by histone acetyltransferases and deacetylases (HDACs) plays a critical role in many cellular processes in eukaryotic cells. HDAC6 is a unique histone deacetylase with two deacetylase domains and a C-terminal zinc finger domain. HDAC6 resides mainly in the cytoplasm and regulates many important biological processes, including cell migration and degradation of misfold proteins. HDAC6 has also been shown to localize in the nucleus to regulate transcription. However, how HDAC6 shuttles between the nucleus and cytoplasm is largely unknown. In addition, it is not clear how HDAC6 enzymatic activity is modulated. Here, we show that HDAC6 can be acetylated by p300 on five clusters of lysine residues. One cluster (site B) of acetylated lysine is in the N-terminal nuclear localization signal region. These lysine residues in site B were converted to glutamine to mimic acetylated lysines. The mutations significantly reduced HDAC6 tubulin deacetylase activity and further impaired cell motility, but had no effect on histone deacetylase activity. More interestingly, these mutations retained HDAC6 in the cytoplasm by blocking the interaction with the nuclear import protein importin-alpha. The retention of HDAC6 in the cytoplasm by acetylation eventually affects histone deacetylation. Thus, we conclude that acetylation is an important post-translational modification that regulates HDAC6 tubulin deacetylase activity and nuclear import.	[Liu, Yuanjing; Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Coll Med, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Dept Biochem & Mol Biol, Coll Med, Gainesville, FL 32610 USA; [Peng, Lirong; Seto, Edward] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute	Qiu, Y (corresponding author), Univ Florida, Dept Anat & Cell Biol, Coll Med, Rm 356,2033 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu		, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674, 5R01 GM081650, R01 HL091929, R01091929-01A1S1, R01 HL090589]; Florida Bankhead Coley Research Foundation; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090589, R01HL095674, R01HL091929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead Coley Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL095674 (to Y. Q.); Grant 5R01 GM081650 (to E. S.); and Grants R01 HL091929, R01091929-01A1S1 (ARRA Administrative Supplement), and R01 HL090589 (to S. H.). This work was also supported by the Florida Bankhead Coley Research Foundation (to Y. Q.).	Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Han Y, 2009, BIOCHEM BIOPH RES CO, V383, P88, DOI 10.1016/j.bbrc.2009.03.147; Han Y, 2008, BIOCHEM BIOPH RES CO, V375, P576, DOI 10.1016/j.bbrc.2008.08.042; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	30	87	91	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29168	29174		10.1074/jbc.M112.371120	http://dx.doi.org/10.1074/jbc.M112.371120			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22778253	hybrid, Green Published			2022-12-25	WOS:000308074600082
J	Maruyama, K; Kawagoe, T; Kondo, T; Akira, S; Takeuchi, O				Maruyama, Kenta; Kawagoe, Tatsukata; Kondo, Takeshi; Akira, Shizuo; Takeuchi, Osamu			TRAF Family Member-associated NF-kappa B Activator (TANK) Is a Negative Regulator of Osteoclastogenesis and Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE INTERLEUKIN-1; DC-STAMP; C-FOS; DIFFERENTIATION; KINASE; MICE; OSTEOPETROSIS; PROTEIN; RANKL; RECOGNITION	The differentiation of bone-resorbing osteoclasts is induced by RANKL signaling, and leads to the activation of NF-kappa B via TRAF6 activation. TRAF family member-associated NF-kappa B activator (TANK) acts as a negative regulator of Toll-like receptors (TLRs) and B-cell receptor (BCR) signaling by inhibiting TRAF6 activation. Tank(-/-) mice spontaneously develop autoimmune glomerular nephritis in an IL-6-dependent manner. Despite its importance in the TCRs and BCR-activated TRAF6 inhibition, the involvement of TANK in RANKL signaling is poorly understood. Here, we report that TANK is a negative regulator of osteoclast differentiation. The expression levels of TANK mRNA and protein were up-regulated during RANKL-induced osteoclastogenesis, and overexpression of TANK in vitro led to a decrease in osteoclast formation. The in vitro osteoclastogenesis of Tank(-/-) cells was significantly increased, accompanied by increased ubiquitination of TRAF6 and enhanced canonical NF-kappa B activation in response to RANKL stimulation. Tank(-/-) mice showed severe trabecular bone loss, but increased cortical bone mineral density, because of enhanced bone erosion and formation. TANK mRNA expression was induced during osteoblast differentiation and Tank(-/-) osteoblasts exhibited enhaced NF-kappa B activation, IL-11 expression, and bone nodule formation than wild-type control cells. Finally, wild-type mice transplanted with bone marrow cells from Tank(-/-) mice showed trabecular bone loss analogous to that in Tank(-/-) mice. These findings demonstrate that TANK is critical for osteoclastogenesis by regulating NF-kappa B, and is also important for proper bone remodeling.	[Maruyama, Kenta; Kawagoe, Tatsukata; Kondo, Takeshi; Akira, Shizuo; Takeuchi, Osamu] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan; [Kondo, Takeshi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; Osaka University; Kyoto University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp; otake@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; KONDO, Takeshi/AGV-4963-2022; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare in Japan; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [22689016] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science, and Technology, grants from the Ministry of Health, Labour, and Welfare in Japan, the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), and a research fellowship from the JSPS for the Promotion of Science for Young Scientists.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Almerigogna F, 2002, J EUR ACAD DERMATOL, V16, P214, DOI 10.1046/j.1468-3083.2002.00458.x; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chin AID, 1999, MOL CELL BIOL, V19, P6665; de Koning HD, 2007, SEMIN ARTHRITIS RHEU, V37, P137, DOI 10.1016/j.semarthrit.2007.04.001; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Li HM, 2005, J EXP MED, V201, P1169, DOI 10.1084/jem.20041444; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maruyama T, 2010, J BONE MINER RES, V25, P1058, DOI 10.1359/jbmr.091032; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Taguchi Y, 1998, P ASSOC AM PHYSICIAN, V110, P559; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200	33	33	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29114	29124		10.1074/jbc.M112.347799	http://dx.doi.org/10.1074/jbc.M112.347799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773835	hybrid, Green Published			2022-12-25	WOS:000308074600077
J	Getlik, M; Simard, JR; Termathe, M; Grutter, C; Rabiller, M; van Otterlo, WAL; Rauh, D				Getlik, Matthaeus; Simard, Jeffrey R.; Termathe, Martin; Gruetter, Christian; Rabiller, Matthias; van Otterlo, Willem A. L.; Rauh, Daniel			Fluorophore Labeled Kinase Detects Ligands That Bind within the MAPK Insert of p38 alpha Kinase	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; PROTEIN-KINASES; INHIBITORS; SITE; ATP; PATHWAYS; ABL	The vast majority of small molecules known to modulate kinase activity, target the highly conserved ATP-pocket. Consequently, such ligands are often less specific and in case of inhibitors, this leads to the inhibition of multiple kinases. Thus, selective modulation of kinase function remains a major hurdle. One of the next great challenges in kinase research is the identification of ligands which bind to less conserved sites and target the non-catalytic functions of protein kinases. However, approaches that allow for the unambiguous identification of molecules that bind to these less conserved sites are few in number. We have previously reported the use of fluorescent labels in kinases (FLiK) to develop direct kinase binding assays that exclusively detect ligands which stabilize inactive (DFG-out) kinase conformations. Here, we present the successful application of the FLiK approach to develop a high-throughput binding assay capable of directly monitoring ligand binding to a remote site within the MAPK insert of p38 alpha mitogen-activated protein kinase (MAPK). Guided by the crystal structure of an initially identified hit molecule in complex with p38 alpha, we developed a tight binding ligand which may serve as an ideal starting point for further investigations of the biological function of the MAPK insert in regulating the p38 alpha signaling pathway.	[Getlik, Matthaeus; Simard, Jeffrey R.; Termathe, Martin; Gruetter, Christian; Rabiller, Matthias; Rauh, Daniel] Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany; [Gruetter, Christian; Rauh, Daniel] Tech Univ Dortmund, Fak Chem, Dortmund, Germany; [van Otterlo, Willem A. L.] Univ Stellenbosch, Dept Chem & Polymer Sci, ZA-7600 Stellenbosch, South Africa; [Getlik, Matthaeus; Simard, Jeffrey R.; Termathe, Martin; Gruetter, Christian; Rabiller, Matthias; Rauh, Daniel] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany	Max Planck Society; Dortmund University of Technology; Stellenbosch University; Max Planck Society	Getlik, M (corresponding author), Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany.	daniel.rauh@tu-dortmund.de	van Otterlo, Willem A.L./AAJ-8542-2021; Rauh, Daniel/G-1595-2013	van Otterlo, Willem/0000-0002-3300-6463; Termathe, Martin/0000-0002-5618-4633; Rauh, Daniel/0000-0002-1970-7642	German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus) [BMBF 01GS08104]; MSD; Bayer HealthCare; Merck-Serono; Bayer CropScience	German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus)(Federal Ministry of Education & Research (BMBF)); MSD; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Merck-Serono(Merck & Company); Bayer CropScience(Bayer AG)	The work was supported by the German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus) (Grant No. BMBF 01GS08104 to DR). MSD, Bayer HealthCare, Merck-Serono and Bayer CropScience are thanked for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Comess KM, 2011, ACS CHEM BIOL, V6, P234, DOI 10.1021/cb1002619; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabbro D, 2010, BBA-PROTEINS PROTEOM, V1804, P454, DOI 10.1016/j.bbapap.2009.12.009; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Laskowski R.A., 1993, J APPL CRYSTALLOGR, V26, P263; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Michelotti EL, 2005, BIOORG MED CHEM LETT, V15, P5274, DOI 10.1016/j.bmcl.2005.08.038; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perry JJP, 2009, J MOL BIOL, V391, P1, DOI 10.1016/j.jmb.2009.06.005; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sanz V, 2000, FEBS LETT, V474, P169, DOI 10.1016/S0014-5793(00)01598-2; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Simard JR, 2010, J AM CHEM SOC, V132, P4152, DOI 10.1021/ja908083e; Simard JR, 2009, J AM CHEM SOC, V131, P13286, DOI 10.1021/ja902010p; Simard JR, 2009, NAT CHEM BIOL, V5, P394, DOI 10.1038/nchembio.162; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	32	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39713	10.1371/journal.pone.0039713	http://dx.doi.org/10.1371/journal.pone.0039713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768308	gold, Green Published, Green Submitted			2022-12-25	WOS:000305966500021
J	Beynon, V; Quintana, FJ; Weiner, HL				Beynon, Vanessa; Quintana, Francisco J.; Weiner, Howard L.			Activated Human CD4+CD45RO+Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; DIFFERENTIATION; CYTOKINES	Inflammasomes are multi-protein complexes that control the production of pro-inflammatory cytokines such as IL-1 beta. Inflammasomes play an important role in the control of immunity to tumors and infections, and also in autoimmune diseases, but the mechanisms controlling the activation of human inflammasomes are largely unknown. We found that human activated CD4+CD45RO+ memory T-cells specifically suppress P2X7R-mediated NLRP3 inflammasome activation, without affecting P2X7R-independent NLRP3 or NLRP1 inflammasome activation. The concomitant increase in pro-IL-1 beta production induced by activated memory T-cells concealed this effect. Priming with IFN beta decreased pro-IL-1 beta production in addition to NLRP3 inflammasome inhibition and thus unmasked the inhibitory effect on NLRP3 inflammasome activation. IFN beta suppresses NLRP3 inflammasome activation through an indirect mechanism involving decreased P2X7R signaling. The inhibition of pro-IL-1 beta production and suppression of NLRP3 inflammasome activation by IFN beta-primed human CD4+CD45RO+ memory T-cells is partly mediated by soluble FasL and is associated with down-regulated P2X7R mRNA expression and reduced response to ATP in monocytes. CD4+CD45RO+ memory T-cells from multiple sclerosis (MS) patients showed a reduced ability to suppress NLRP3 inflammasome activation, however their suppressive ability was recovered following in vivo treatment with IFN beta. Thus, our data demonstrate that human P2X7R-mediated NLRP3 inflammasome activation is regulated by activated CD4+CD45RO+ memory T cells, and provide new information on the mechanisms mediating the therapeutic effects of IFN beta in MS.	[Beynon, Vanessa; Quintana, Francisco J.; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Beynon, V (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		National Multiple Sclerosis Society [RG 4151-A-12]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by the National Multiple Sclerosis Society, RG 4151-A-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Furlan R, 1999, J IMMUNOL, V163, P2403; Genc K, 1997, J CLIN INVEST, V99, P2664, DOI 10.1172/JCI119455; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Graber JJ, 2007, J NEUROIMMUNOL, V185, P168, DOI 10.1016/j.jneuroim.2007.01.011; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Huang WX, 2004, MULT SCLER J, V10, P482, DOI 10.1191/1352458504ms1071oa; Ichinohe T, 2011, P NATL ACAD SCI US; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; JIANG H, 1995, J NEUROIMMUNOL, V61, P17, DOI 10.1016/0165-5728(95)00072-A; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Latz E, 2010, CURRENT OPINION IMMU, P1; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Ming X, 2002, J NEUROL SCI, V197, P9, DOI 10.1016/S0022-510X(02)00030-8; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rudick RA, 1998, NEUROLOGY, V50, P1294, DOI 10.1212/WNL.50.5.1294; Rudick RA, 1997, NEW ENGL J MED, V337, P1604, DOI 10.1056/NEJM199711273372207; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; STONE LA, 1995, ANN NEUROL, V37, P611, DOI 10.1002/ana.410370511; Vallittu AM, 2007, NEUROL RES, V29, P763, DOI 10.1179/016164107X228633; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zhang X, 2010, CLIN NEUROL NEUROSUR, V112, P641, DOI 10.1016/j.clineuro.2010.04.020	46	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39576	10.1371/journal.pone.0039576	http://dx.doi.org/10.1371/journal.pone.0039576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768094	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100064
J	Bougard, C; Espie, S; Larnaudie, B; Moussay, S; Davenne, D				Bougard, Clement; Espie, Stephane; Larnaudie, Bruno; Moussay, Sebastien; Davenne, Damien			Effects of Time of Day and Sleep Deprivation on Motorcycle-Driving Performance	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; MANUAL DEXTERITY; ROAD ACCIDENTS; SEVERITY; INJURIES; DRIVERS; ALCOHOL; CONSEQUENCES; TEMPERATURE; IMPAIRMENT	The aim of this study was to investigate whether motorcycle handling capabilities - measured by means of the efficiency of emergency manoeuvres - were dependent on prior sleep deprivation and time of day. Twelve male participants voluntarily took part in four test sessions, starting at 6 a. m., 10 a. m., 2 p. m., and 6 p. m., following a night either with or without sleep. Each test session comprised temperature and sleepiness measurements, before three different types of motorcycling tests were initiated: (1) stability in straight ahead riding at low speed (in "slow motion' mode and in "brakes and clutch" mode), (2) emergency braking and (3) crash avoidance tasks performed at 20 kph and 40 kph. The results indicate that motorcycle control at low speed depends on time of day, with an improvement in performance throughout the day. Emergency braking performance is affected at both speeds by time of day, with poorer performance (longer total stopping distance, reaction time and braking distance) in the morning, and also by sleep deprivation, from measurements obtained at 40 kph (incorrect initial speed). Except for a tendency observed after the sleepless night to deviate from the initial speed, it seems that crash avoidance capabilities are quite unaffected by the two disturbance factors. Consequently, some motorcycle handling capabilities (stability at low speed and emergency braking) change in the same way as the diurnal fluctuation observed in body temperature and sleepiness, whereas for others (crash avoidance) the participants were able to maintain their initial performance level despite the high levels of sleepiness recorded after a sleepless night. Motorcycle riders have to be aware that their handling capabilities are limited in the early morning and/or after sleep deprivation. Both these situations can increase the risk of falls and of being involved in a road accident.	[Bougard, Clement; Moussay, Sebastien; Davenne, Damien] Univ Caen, INSERM ERI27, F-14032 Caen, France; [Bougard, Clement; Espie, Stephane] IFSTTAR IM, Paris, France; [Bougard, Clement] IRBA Dept Environm Operat, Bretigny Sur Orge, France; [Larnaudie, Bruno] Univ Paris 11, CNRS UMR 8622, IEF AXIS, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Universite Gustave-Eiffel; UDICE-French Research Universities; Universite Paris Saclay	Bougard, C (corresponding author), Univ Caen, INSERM ERI27, F-14032 Caen, France.	clementbougard@aol.com	Davenne, Damien/K-2959-2015; Davenne, Damien/K-2432-2019	Davenne, Damien/0000-0002-9399-9970; Davenne, Damien/0000-0002-9399-9970; Bougard, Clement/0000-0001-6293-0041	Conseil Regional de Basse-Normandie (Regional council of Lower Normandy); Institut National de Recherche sur les Transports et leur Securite (The French National Institute for Transport and Safety Research); University of Caen/Basse-Normandie	Conseil Regional de Basse-Normandie (Regional council of Lower Normandy)(Region Normandie); Institut National de Recherche sur les Transports et leur Securite (The French National Institute for Transport and Safety Research); University of Caen/Basse-Normandie(Region Normandie)	This research was supported by a grant from the Conseil Regional de Basse-Normandie (Regional council of Lower Normandy), the Institut National de Recherche sur les Transports et leur Securite (The French National Institute for Transport and Safety Research) and the University of Caen/Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEM, 2009, MAIDS DEPTH INV ACC; Amans B, 2005, PROJET RIDER RAPPORT; [Anonymous], 2001, P INT MOT SAF C ORL; Association des Constructeurs Europeens de Motocydes (ACEM), 2006, GUID PTW SAF ROAD DE; Bastos Yara Gerber Lima, 2005, Cad. Saúde Pública, V21, P815, DOI 10.1590/S0102-311X2005000300015; Baxter C, 1983, Br J Sports Med, V17, P122; Bellamy N, 2002, ANN RHEUM DIS, V61, P1075, DOI 10.1136/ard.61.12.1075; BELLAMY N, 1991, ANN RHEUM DIS, V50, P243, DOI 10.1136/ard.50.4.243; Borbely AA, 2009, J SLEEP RES, V18, P1, DOI 10.1111/j.1365-2869.2009.00750.x; Bougard C, 2009, CHRONOBIOL INT, V26, P307, DOI 10.1080/07420520902774532; Bougard C, 2008, ACCIDENT ANAL PREV, V40, P635, DOI 10.1016/j.aap.2007.09.002; Bougard C, 2012, EUR J APPL PHYSIOL, V112, P59, DOI 10.1007/s00421-011-1948-6; Casagrande M, 1997, ERGONOMICS, V40, P613, DOI 10.1080/001401397187919; Cirera E, 2001, EUR J EPIDEMIOL, V17, P201, DOI 10.1023/A:1017961921607; Conrad P, 1996, ACCIDENT ANAL PREV, V28, P193, DOI 10.1016/0001-4575(95)00056-9; Corno M, 2008, CONTROL ENG PRACT, V16, P644, DOI 10.1016/j.conengprac.2007.08.001; Cossalter V, 2004, 20044305 SAE INT; Cossalter V., 2002, MOTORCYCLE DYNAMICS; Creaser JI, 2009, ACCIDENT ANAL PREV, V41, P906, DOI 10.1016/j.aap.2009.04.007; Crundall D, 2008, ACCIDENT ANAL PREV, V40, P983, DOI 10.1016/j.aap.2007.11.004; Dahms P, 1996, Wien Med Wochenschr, V146, P287; Davenne, 2006, RECHERCHE TRANSPORTS, V91, P137, DOI 10.3166/rts.91.137-151; de Lapparent M, 2006, ACCIDENT ANAL PREV, V38, P260, DOI 10.1016/j.aap.2005.09.001; de Rome L., 2002, MCC SURVEY MOTORCYCL; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ecker H, 2001, P INT MOT SAF C 1 4; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Filou C, 1994, P ESV C MUN GERM; Fitzgerald RM, 1976, PHOTOGRAPHIC ANAL CO; Fondation Promocycle, 2003, 0154 FMQTRF FOND PRO; Gillberg M, 1998, PHYSIOL BEHAV, V64, P599, DOI 10.1016/S0031-9384(98)00063-8; Guyot R, 2008, GISEMENT SECURITE RO; Harrison WA, 1997, J SAFETY RES, V28, P105, DOI 10.1016/S0022-4375(96)00042-4; Haworth N., 2005, REV MOTORCYCLE LICEN; Himashree Gidugu, 2002, Indian Journal of Physiology and Pharmacology, V46, P6; Hockey GRJ, 1998, HUM FACTORS, V40, P233, DOI 10.1518/001872098779480479; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hurt H, 1981, 805862 DOT HS NAT HI; Hurt H, 1984, 28 P HUM FACT SOC SA; Italian National Institute of Statistics (ISTAT), 2003, TRAFF ACC STAT YEAR; Jain A, 2009, J FORENSIC LEG MED, V16, P130, DOI 10.1016/j.jflm.2008.08.019; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kasantikul V, 2005, ACCIDENT ANAL PREV, V37, P357, DOI 10.1016/j.aap.2004.07.006; Klarica AJ, 2001, BRIT J SPORT MED, V35, P290, DOI 10.1136/bjsm.35.5.290; Kraemer S, 2000, BIOL PSYCHIAT, V48, P1069, DOI 10.1016/S0006-3223(00)00908-2; Larnaudie B, 2006, EXPT STUDY MOTORCYCL; Lavie P., 1985, ULTRADIAN RHYTHMS PH, V12, P148, DOI DOI 10.1007/978-3-642-70483-3_11; Limpert R, 2008, ACCIDENT INVESTIGATI, V18, P15; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; Millar K., 1992, SLEEP AROUSAL PERFOR, P31; Miyata S, 2010, NEUROSCI LETT, V469, P229, DOI 10.1016/j.neulet.2009.12.001; MONK TH, 1982, CHRONOBIOLOGIA, V9, P49; Nakahara S, 2005, ACCIDENT ANAL PREV, V37, P833, DOI 10.1016/j.aap.2005.04.001; ONISR, 2007, SEC ROUT FRANC BIL A SEC ROUT FRANC BIL A; Orzel-Gryglewska J, 2010, INT J OCCUP MED ENV, V23, P95, DOI 10.2478/v10001-010-0004-9; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Prem H, 1984, MOTORCYCLE RIDER SKI; Quddus MA, 2002, J SAFETY RES, V33, P445, DOI 10.1016/S0022-4375(02)00051-8; REILLY T, 1990, CRIT REV BIOMED ENG, V18, P165; Reilly T, 2003, BIOL RHYTHM RES, V34, P321, DOI 10.1076/brhm.34.4.321.26229; Reilly T, 2007, CHRONOBIOL INT, V24, P507, DOI 10.1080/07420520701420709; Reilly T, 2009, EUR J APPL PHYSIOL, V106, P321, DOI 10.1007/s00421-009-1066-x; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Schmidt R. A., 2008, MOTOR LEARNING PERFO; Sexton BF, 2004, 607 TRL LTD; Sharp RS, 2004, MULTIBODY SYST DYN, V12, P251, DOI 10.1023/B:MUBO.0000049195.60868.a2; SHARP RS, 1971, J MECH ENG SCI, V13, P316, DOI 10.1243/JMES_JOUR_1971_013_051_02; Shuman K, 2006, DO I BRAKE DO I SWER; Simoncic M, 2001, ACCIDENT ANAL PREV, V33, P147, DOI 10.1016/S0001-4575(00)00025-7; Tetard C, 1994, INRETS CONV ARC FRAN; Valent F, 2002, ACCIDENT ANAL PREV, V34, P71, DOI 10.1016/S0001-4575(00)00104-4; vanElslande P., 2002, ANAL APPROFONDIE ACC ANAL APPROFONDIE ACC; Watanabe Y, 1973, P 2 INT C AUT SAF SA; Welford A.T., 1968, FUNDAMENTALS SKILL; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wong T W, 1990, Asia Pac J Public Health, V4, P34; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Yokomori M, 2000, JSAE REV, V21, P61, DOI 10.1016/S0389-4304(99)00078-8	79	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39735	10.1371/journal.pone.0039735	http://dx.doi.org/10.1371/journal.pone.0039735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761881	Green Published, gold			2022-12-25	WOS:000305826400032
J	Theurel, A; Frileux, S; Hatwell, Y; Gentaz, E				Theurel, Anne; Frileux, Stephanie; Hatwell, Yvette; Gentaz, Edouard			The Haptic Recognition of Geometrical Shapes in Congenitally Blind and Blindfolded Adolescents: Is There a Haptic Prototype Effect?	PLOS ONE			English	Article							VISUAL EXPERIENCE; CANONICAL VIEWS; OBJECT; CLASSIFICATION; FORM; REPRESENTATION; PERCEPTION; JUDGMENTS; DRAWINGS; PICTURES	Background: It has been shown that visual geometrical shape categories (rectangle and triangle) are graded structures organized around a prototype as demonstrated by perception and production tasks in adults as well as in children. The visual prototypical shapes are better recognized than other exemplars of the categories. Their existence could emerge from early exposure to these prototypical shapes that are present in our visual environment. The present study examined the role of visual experience in the existence of prototypical shapes by comparing the haptic recognition of geometrical shapes in congenitally blind and blindfolded adolescents. Methodology/Principal Findings: To determine whether the existence of a prototype effect (higher recognition of prototypical shapes than non prototypical shapes) depended on visual experience, congenitally blind and blindfolded sighted adolescents were asked to recognize in the haptic modality three categories of correct shapes (square, rectangle, triangle) varying in orientation (prototypical/canonical orientation vs. non prototypical/canonical orientation rotated by 45 degrees) among a set of other shapes. A haptic prototype effect was found in the blindfolded sighted whereas no difference between prototypical and non prototypical correct shapes was observed in the congenitally blind. A control experiment using a similar visual recognition task confirmed the existence of a visual prototype effect in a group of sighted adolescents. Conclusion/Significance: These findings show that the prototype effect is not intrinsic to the haptic modality but depends on visual experience. This suggests that the occurrence of visual and haptic prototypical shapes in the recognition of geometrical shape seems to depend on visual exposure to these prototypical shapes existing in our environment.	[Theurel, Anne; Hatwell, Yvette; Gentaz, Edouard] Univ Pierre Mendes France, Lab Psychol & NeuroCognit, CNRS, UMR 5105, Grenoble, France; [Frileux, Stephanie] Inst Natl Super Format & Rech Educat Jeunes Handi, Suresnes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Theurel, A (corresponding author), Univ Pierre Mendes France, Lab Psychol & NeuroCognit, CNRS, UMR 5105, Grenoble, France.	Edouard.Gentaz@upmf-grenoble.fr		Theurel, Anne/0000-0001-7372-3195				Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; APPELLE S, 1980, CAN J PSYCHOL, V34, P161, DOI 10.1037/h0081027; CUTZU F, 1994, VISION RES, V34, P3037, DOI 10.1016/0042-6989(94)90277-1; EDELMAN S, 1991, BIOL CYBERN, V64, P209, DOI 10.1007/BF00201981; EWART AG, 1963, AM J PSYCHOL, V76, P488, DOI 10.2307/1419794; Feldman J, 2000, J EXP PSYCHOL HUMAN, V26, P152, DOI 10.1037/0096-1523.26.1.152; Gentaz E., 2008, REV FRANCAISE PEDAGO, V162, P1; Gentaz E, 2008, EXP BRAIN RES, V187, P331, DOI 10.1007/s00221-008-1382-0; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; HATWELL Y, 1959, J Psychol Norm Pathol (Paris), V56, P187; HATWELL Y, 1994, TRAITE PSYCHOL EXPT, P543; Hatwell Y, 1990, DEV EYE HAND COORDIN, P99; HATWELL Y, 2003, TOUCHING KNOWING; HATWELL Y, 1978, HDB SENSORY PHYSL, V7; Hatwell Y, 1985, PRIVATION SENSORIELL; Heller M., 1991, PSYCHOL TOUCH, P239; Heller MA, 1996, PERCEPTION, V25, P321, DOI 10.1068/p250321; HELLER MA, 1993, PERCEPT PSYCHOPHYS, V53, P422, DOI 10.3758/BF03206785; Kalenine S, BRIT J PSYC IN PRESS; Kalenine S, 2011, INT J BEHAV DEV, V35, P18, DOI 10.1177/0165025410367443; KARMILOFFSMITH A, 1990, COGNITION, V34, P57, DOI 10.1016/0010-0277(90)90031-E; Kennedy JM, 2002, PERCEPTION, V31, P1013, DOI 10.1068/p3259; Lange-Kuttner C., 2007, DEV DRAWING NONVERBA; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; LEDERMAN SJ, 1993, ACTA PSYCHOL, V84, P29, DOI 10.1016/0001-6918(93)90070-8; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEDERMAN SJ, 1990, COGNITIVE PSYCHOL, V22, P421, DOI 10.1016/0010-0285(90)90009-S; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Millar Susanna, 1994, UNDERSTANDING REPRES, DOI 10.1093/acprof:oso/9780198521426.001.0001; MORRONGIELLO BA, 1994, PERCEPTION, V23, P833, DOI 10.1068/p230833; Newell FN, 2001, PSYCHOL SCI, V12, P37, DOI 10.1111/1467-9280.00307; Noordzij ML, 2007, PERCEPTION, V36, P101, DOI 10.1068/p5390; NOSOFSKY RM, 1988, J EXP PSYCHOL LEARN, V14, P700, DOI 10.1037/0278-7393.14.4.700; Piaget Jean, 1947, REPRESENTATION ESPAC; Picard D, 2005, J EXP CHILD PSYCHOL, V90, P48, DOI 10.1016/j.jecp.2004.09.002; Pick AD, 1966, PSYCHON SCI, V6, P367; Pick HL, 1974, PERCEPTION ESSAYS HO, P317; Pinet L., 2007, GRAND N, V80, P17; Postma A, 2008, PERCEPT PSYCHOPHYS, V70, P1197, DOI 10.3758/PP.70.7.1197; Revesz Geza, 1950, PSYCHOL ART BLIND; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P532, DOI 10.1016/0010-0285(75)90021-3; Sunanto J, 1998, PERCEPT MOTOR SKILL, V86, P383, DOI 10.2466/pms.1998.86.2.383; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; UNGAR S, 1995, PERCEPTION, V24, P891, DOI 10.1068/p240891; Van Sommers P, 1984, DRAWING COGNITION DE; VERFAILLIE K, 1995, PERCEPT PSYCHOPHYS, V57, P925, DOI 10.3758/BF03205454; Wijntjes MWA, 2008, PERCEPTION, V37, P602, DOI 10.1068/p5714; Woods AT, 2008, PERCEPTION, V37, P1867, DOI 10.1068/p6038; Worchel P., 1951, PSYCHOL MONOGRAPH, V65	50	16	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40251	10.1371/journal.pone.0040251	http://dx.doi.org/10.1371/journal.pone.0040251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761961	gold, Green Submitted, Green Published			2022-12-25	WOS:000305826400062
J	Lin, CH; Paulson, A; Abmayr, SM; Workman, JL				Lin, Chia-Hui; Paulson, Ariel; Abmayr, Susan M.; Workman, Jerry L.			HP1a Targets the Drosophila KDM4A Demethylase to a Subset of Heterochromatic Genes to Regulate H3K36me3 Levels	PLOS ONE			English	Article							HISTONE H3; PROTEIN-1 HP1; CHROMOSOMAL-PROTEIN; MSL COMPLEX; LYSINE 36; MELANOGASTER; METHYLATION; TRIMETHYLATION; TRANSCRIPTION; EXPRESSION	The KDM4 subfamily of JmjC domain-containing demethylases mediates demethylation of histone H3K36me3/me2 and H3K9me3/me2. Several studies have shown that human and yeast KDM4 proteins bind to specific gene promoters and regulate gene expression. However, the genome-wide distribution of KDM4 proteins and the mechanism of genomic-targeting remain elusive. We have previously identified Drosophila KDM4A (dKDM4A) as a histone H3K36me3 demethylase that directly interacts with HP1a. Here, we performed H3K36me3 ChIP-chip analysis in wild type and dkdm4a mutant embryos to identify genes regulated by dKDM4A demethylase activity in vivo. A subset of heterochromatic genes that show increased H3K36me3 levels in dkdm4a mutant embryos overlap with HP1a target genes. More importantly, binding to HP1a is required for dKDM4A-mediated H3K36me3 demethylation at a subset of heterochromatic genes. Collectively, these results show that HP1a functions to target the H3K36 demethylase dKDM4A to heterochromatic genes in Drosophila.	[Lin, Chia-Hui; Paulson, Ariel; Abmayr, Susan M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO USA; [Abmayr, Susan M.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Lin, CH (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	jlw@stowers.org			National Institute of General Medical Sciences [GM047867]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867, R01GM047867] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM047867 from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/), and funding from the Stowers Institute for Medical Research (http://www.stowers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; Cryderman DE, 1999, NUCLEIC ACIDS RES, V27, P3364, DOI 10.1093/nar/27.16.3364; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; de Wit E, 2005, GENOME RES, V15, P1265, DOI 10.1101/gr.3198905; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012339; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johansson AM, 2007, PLOS GENET, V3, P2235, DOI 10.1371/journal.pgen.0030209; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Liang CY, 2011, NUCL ACIDS RES; Lin CH, 2008, MOL CELL, V32, P696, DOI 10.1016/j.molcel.2008.11.008; Lloret-Llinares M, 2008, NUCLEIC ACIDS RES, V36, P2852, DOI 10.1093/nar/gkn098; Lorbeck MT, 2010, GENE, V450, P8, DOI 10.1016/j.gene.2009.09.007; Lu BY, 2000, GENETICS, V155, P699; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Schwaiger M, 2010, GENOME RES, V20, P771, DOI 10.1101/gr.101790.109; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005	62	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39758	10.1371/journal.pone.0039758	http://dx.doi.org/10.1371/journal.pone.0039758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761891	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800066
J	Bangsgaard, N; Houtkamp, M; Schuurhuis, DH; Parren, PWHI; Baadsgaard, O; Niessen, HWM; Skov, L				Bangsgaard, Nannie; Houtkamp, Mischa; Schuurhuis, Danita H.; Parren, Paul W. H. I.; Baadsgaard, Ole; Niessen, Hans W. M.; Skov, Lone			Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE-KINASE INHIBITORS; TUMOR-NECROSIS-FACTOR; EGF RECEPTOR; CHEMOKINE EXPRESSION; MONOCLONAL-ANTIBODY; ACNEIFORM ERUPTION; COLORECTAL-CANCER; SKIN INFLAMMATION; SOLID TUMORS	Epidermal growth factor receptor (EGFR) inhibitors are widely used in the treatment of cancer. EGFR-targeted treatment is known to be associated with a high incidence of dermatological adverse reactions, including papulopustular rash, which can be dose-limiting and may affect compliance to treatment. Currently, the pathways involved in EGFR inhibitor-induced rash are poorly understood and few treatment options for this adverse event are available. Here, we developed a model for induction of papulopustular rash in healthy human volunteers by subcutaneous injection of the anti-EGFR monoclonal antibody zalutumumab. The injection sites and surrounding skin were evaluated by a dermatologist for the presence or absence of papulopustular rash and skin biopsies were taken to confirm the macroscopical findings by immunohistochemistry. Locally injected zalutumumab induced a papulopustular rash, characterized by acute follicular neutrophil-rich hair follicle inflammation, and thus mimicked adverse events induced by systemic administration of EGFR inhibitors. In this model, we tested the hypothesis that neutrophils, attracted by IL-8, play a central role in the observed rash. Indeed, concomitant local repeat dose treatment with HuMab-10F8, a neutralizing human antibody against IL-8, reduced the rash. Inhibition of IL-8 can therefore ameliorate dermatological adverse events induced by treatment with EGFR inhibitors.	[Bangsgaard, Nannie; Skov, Lone] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Hellerup, Denmark; [Houtkamp, Mischa; Schuurhuis, Danita H.; Parren, Paul W. H. I.] Genmab, Utrecht, Netherlands; [Baadsgaard, Ole] Genmab, Copenhagen, Denmark; [Niessen, Hans W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands	University of Copenhagen; Herlev & Gentofte Hospital; Genmab; Genmab; Vrije Universiteit Amsterdam	Bangsgaard, N (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Hellerup, Denmark.	Nanban01@geh.regionh.dk	Skov, Lone/W-3575-2018	Skov, Lone/0000-0002-4784-9680; Niessen, Hans/0000-0001-9404-9822; Parren, Paul/0000-0002-4365-3859				Agero ALC, 2006, J AM ACAD DERMATOL, V55, P657, DOI 10.1016/j.jaad.2005.10.010; Alexandrescu DT, 2007, CLIN EXP DERMATOL, V32, P71, DOI 10.1111/j.1365-2230.2006.02285.x; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Bleeker WK, 2004, J IMMUNOL, V173, P4699, DOI 10.4049/jimmunol.173.7.4699; Busam KJ, 2001, BRIT J DERMATOL, V144, P1169, DOI 10.1046/j.1365-2133.2001.04226.x; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; GUSTERSON B, 1984, CELL BIOL INT REP, V8, P649, DOI 10.1016/0309-1651(84)90045-6; Han SS, 2010, BRIT J DERMATOL, V162, P371, DOI 10.1111/j.1365-2133.2009.09536.x; Hansen LA, 2000, CANCER RES, V60, P3328; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Ho C, 2011, INVEST NEW DRUG, V29, P680, DOI 10.1007/s10637-010-9396-4; Hoffmann TK, 2009, INT J CANCER, V124, P2589, DOI 10.1002/ijc.24269; Hu JC, 2007, J AM ACAD DERMATOL, V56, P317, DOI 10.1016/j.jaad.2006.09.005; Jacot W, 2004, BRIT J DERMATOL, V151, P238, DOI 10.1111/j.1365-2133.2004.06026.x; Jost M, 2000, EUR J DERMATOL, V10, P505; Journagan S, 2006, J AM ACAD DERMATOL, V54, P358, DOI 10.1016/j.jaad.2005.08.033; Kimyai-Asadi A, 2002, ARCH DERMATOL, V138, P129, DOI 10.1001/archderm.138.1.129; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; LARSEN CG, 1989, IMMUNOLOGY, V68, P31; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; Machiels JP, 2011, LANCET ONCOL, V12, P333, DOI 10.1016/S1470-2045(11)70034-1; Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1; Mimeault M, 2004, SKIN PHARMACOL PHYS, V17, P153, DOI 10.1159/000078818; Molinari E, 2005, DERMATOLOGY, V211, P330, DOI 10.1159/000088502; NANNEY LB, 1990, J INVEST DERMATOL, V94, P742, DOI 10.1111/1523-1747.ep12874601; NANNEY LB, 1984, J INVEST DERMATOL, V83, P385, DOI 10.1111/1523-1747.ep12264708; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; PEREZSOLER R, 1994, J CLIN ONCOL, V12, P730, DOI 10.1200/JCO.1994.12.4.730; Pinto C, 2011, ONCOLOGIST, V16, P228, DOI 10.1634/theoncologist.2010-0298; Robert C, 2005, LANCET ONCOL, V6, P491, DOI 10.1016/S1470-2045(05)70243-6; Rodeck U, 1997, J CELL SCI, V110, P113; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Salcedo R, 2002, CLIN CANCER RES, V8, P2655; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; Segaert S, 2005, ANN ONCOL, V16, P1425, DOI 10.1093/annonc/mdi279; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Surguladze D, 2009, CANCER RES, V69, P5643, DOI 10.1158/0008-5472.CAN-09-0487; TAKEMATSU H, 1990, TOHOKU J EXP MED, V162, P1, DOI 10.1620/tjem.162.1; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Vivanco I, 2010, CURR OPIN ONCOL, V22, P573, DOI 10.1097/CCO.0b013e32833edbdf	43	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39706	10.1371/journal.pone.0039706	http://dx.doi.org/10.1371/journal.pone.0039706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761877	gold, Green Published			2022-12-25	WOS:000305781700059
J	Lopez-de los Santos, Y; Chan, H; Cantu, VA; Rettner, R; Sanchez, F; Zhang, ZG; Saier, MH; Soberon, X				Lopez-de los Santos, Yossef; Chan, Henry; Cantu, Vito A.; Rettner, Rachael; Sanchez, Filiberto; Zhang, Zhongge; Saier, Milton H., Jr.; Soberon, Xavier			Genetic Engineering of the Phosphocarrier Protein NPr of the Escherichia coli Phosphotransferase System Selectively Improves Sugar Uptake Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER CLASSIFICATION DATABASE; PHOSPHORYL TRANSFER COMPLEX; ENZYME IIA(NTR); DIHYDROXYACETONE KINASE; GLYCOGEN-PHOSPHORYLASE; SUBSTRATE-SPECIFICITY; TIGHT REGULATION; PHOSPHOENOLPYRUVATE; EXPRESSION; K-12	The Escherichia coli phosphoenolpyruvate: sugar phosphotransferase system (PTS) in prokaryotes mediates the uptake and phosphorylation of its numerous substrates through a phosphoryl transfer chain where a phosphoryl transfer protein, HPr, transfers its phosphoryl group to any of several sugar-specific Enzyme IIA proteins in preparation for sugar transport. A phosphoryl transfer protein of the PTS, NPr, homologous to HPr, functions to regulate nitrogen metabolism and shows virtually no enzymatic cross-reactivity with HPr. Here we describe the genetic engineering of a "chimeric" HPr/NPr protein, termed CPr14 because 14 amino acid residues of the interface were replaced. CPr14 shows decreased activity with most PTS permeases relative to HPr, but increases activity with the broad specificity mannose permease. The results lead to the proposal that HPr is not optimal for most PTS permeases but instead represents a compromise with suboptimal activity for most PTS permeases. The evolutionary implications are discussed.	[Chan, Henry; Zhang, Zhongge; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Soberon, Xavier] Inst Nacl Med Genom, Mexico City 14610, DF, Mexico; [Lopez-de los Santos, Yossef; Cantu, Vito A.; Sanchez, Filiberto; Soberon, Xavier] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62210, Morelos, Mexico	University of California System; University of California San Diego; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	msaier@ucsd.edu; soberon@ibt.unam.mx		, Adrian/0000-0002-3168-5140	National Institutes of Health from the NIGMS [GM077402]; CONACyT [83039]; University of California Institute for Mexico [060021]; United States-CONACyT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico; United States-CONACyT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077402 from the NIGMS (to M. H. S.). This work was also supported by Grant 83039 from CONACyT and by the sabbatical Grant 060021 from University of California Institute for Mexico and the United States-CONACyT.	Aboulwafa M, 2004, J BACTERIOL, V186, P8453, DOI 10.1128/JB.186.24.8453-8462.2004; Aboulwafa M, 2002, RES MICROBIOL, V153, P667, DOI 10.1016/S0923-2508(02)01376-1; Alonso-Casajus N, 2006, J BACTERIOL, V188, P5266, DOI 10.1128/JB.01566-05; Bachler C, 2005, EMBO J, V24, P283, DOI 10.1038/sj.emboj.7600517; Bahr T, 2011, J BACTERIOL, V193, P2013, DOI 10.1128/JB.01459-10; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Cases I, 2001, J BACTERIOL, V183, P5128, DOI 10.1128/JB.183.17.5128-5133.2001; Chung YJ, 2002, J BACTERIOL, V184, P2543, DOI 10.1128/JB.184.9.2543-2545.2002; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dozot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012679; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FELDHEIM DA, 1990, J BACTERIOL, V172, P5459, DOI 10.1128/jb.172.9.5459-5469.1990; Gorke B, 1999, EMBO J, V18, P3370, DOI 10.1093/emboj/18.12.3370; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Houot L, 2010, J BACTERIOL, V192, P3055, DOI 10.1128/JB.00213-10; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Kim HJ, 2011, BIOCHEM BIOPH RES CO, V409, P556, DOI 10.1016/j.bbrc.2011.05.044; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; LENGELER J, 1975, J BACTERIOL, V124, P26, DOI 10.1128/JB.124.1.26-38.1975; Li X, 2008, AMINO ACIDS, V35, P531, DOI 10.1007/s00726-008-0079-9; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; NGUYEN T, 2006, PHARM PRAC, V22, P11; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Rabus R, 1999, MICROBIOL-SGM, V145, P3431, DOI 10.1099/00221287-145-12-3431; REPHAELI AW, 1980, J BIOL CHEM, V255, P8585; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sutrina SL, 2002, MICROBIOL-SGM, V148, P3857, DOI 10.1099/00221287-148-12-3857; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; THOMPSON J, 1985, J BACTERIOL, V162, P224, DOI 10.1128/JB.162.1.224-234.1985; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Zimmer B, 2008, FEMS MICROBIOL LETT, V286, P96, DOI 10.1111/j.1574-6968.2008.01262.x	46	3	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29931	29939		10.1074/jbc.M112.345660	http://dx.doi.org/10.1074/jbc.M112.345660			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767600	hybrid, Green Published			2022-12-25	WOS:000308286900066
J	Mazzuoli, G; Schemann, M				Mazzuoli, Gemma; Schemann, Michael			Mechanosensitive Enteric Neurons in the Myenteric Plexus of the Mouse Intestine	PLOS ONE			English	Article							RHYTHMIC MOTOR PATTERN; GUINEA-PIG ILEUM; SENSORY NEURONS; NERVOUS-SYSTEM; DISTAL COLON; MOVEMENTS; STRETCH	Background: Within the gut the autonomous enteric nervous system (ENS) is able to sense mechanical stimuli and to trigger gut reflex behaviour. We previously proposed a novel sensory circuit in the ENS which consists of multifunctional rapidly adapting mechanosensitive enteric neurons (RAMEN) in the guinea pig. The aim of this study was to validate this concept by studying its applicability to other species or gut regions. Methodology/Principal Findings: We deformed myenteric ganglia in the mouse small and large intestine and recorded spike discharge using voltage sensitive dye imaging. We also analysed expression of markers hitherto proposed to label mouse sensory myenteric neurons in the ileum (NF145kD) or colon (calretinin). RAMEN constituted 22% and 15% of myenteric neurons per ganglion in the ileum and colon, respectively. They encoded dynamic rather than sustained deformation. In the colon, 7% of mechanosensitive neurons fired throughout the sustained deformation, a behaviour typical for slowly adapting echanosensitive neurons (SAMEN). RAMEN and SAMEN responded directly to mechanical deformation as their response remained unchanged after synaptic blockade in low Ca++/high Mg++. Activity levels of RAMEN increased with the degree of ganglion deformation. Recruitment of more RAMEN with stronger stimuli may suggest low and high threshold RAMEN. The majority of RAMEN were cholinergic but most lacked expression of NF145kD or calretinin. Conclusions/Significance: We showed for the first time that fundamental properties of mechanosensitive enteric neurons, such as firing pattern, encoding of dynamic deformation, cholinergic phenotype and their proportion, are conserved across species and regions. We conclude that RAMEN are important for mechanotransduction in the ENS. They directly encode dynamic changes in force as their firing frequency is proportional to the degree of deformation of the ganglion they reside in. The additional existence of SAMEN in the colon is likely an adaptation to colonic motor patterns which consist of phasic and tonic contractions.	[Mazzuoli, Gemma; Schemann, Michael] Tech Univ Munich, Freising Weihenstephan, Germany	Technical University of Munich	Mazzuoli, G (corresponding author), Tech Univ Munich, Freising Weihenstephan, Germany.	gemma.mazzuoli@wzw.tum.de	mazzuoli-weber, gemma/L-2020-2015	mazzuoli-weber, gemma/0000-0001-7803-3556; Schemann, Michael/0000-0003-1007-9843	German Research Council (DFG) [Ma 5202/1-1]	German Research Council (DFG)(German Research Foundation (DFG))	Grant support came from the German Research Council (DFG, Ma 5202/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss W M, 1899, J Physiol, V24, P99; Bayliss WM, 1900, J PHYSIOL-LONDON, V26, P107; Bian XC, 2003, J PHYSIOL-LONDON, V551, P309, DOI 10.1113/jphysiol.2003.044172; Blackshaw LA, 2007, NEUROGASTROENT MOTIL, V19, P1, DOI 10.1111/j.1365-2982.2006.00871.x; BROOKES SJH, 1987, J PHYSIOL-LONDON, V390, P305, DOI 10.1113/jphysiol.1987.sp016702; Brown DR, 2004, NEUROGASTROENT MOTIL, V16, P50, DOI 10.1111/j.1743-3150.2004.00475.x; Bush TG, 2000, AUTON NEUROSCI-BASIC, V84, P162, DOI 10.1016/S1566-0702(00)00201-0; DESAI KM, 1991, NATURE, V351, P477, DOI 10.1038/351477a0; Dogiel AS, 1895, ARCH ANAT PHYS, P130; Fida R, 1997, NEUROGASTROENT MOTIL, V9, P99, DOI 10.1046/j.1365-2982.1997.d01-25.x; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; Furness JB, 1998, PROG NEUROBIOL, V54, P1, DOI 10.1016/S0301-0082(97)00051-8; FURUKAWA K, 1986, J NEUROPHYSIOL, V55, P1395, DOI 10.1152/jn.1986.55.6.1395; HIRST GDS, 1974, J PHYSIOL-LONDON, V236, P303, DOI 10.1113/jphysiol.1974.sp010436; KIRCHGESSNER AL, 1992, J NEUROSCI, V12, P235; Kunze WAA, 1998, J PHYSIOL-LONDON, V506, P827, DOI 10.1111/j.1469-7793.1998.827bv.x; Langley JN, 1905, J PHYSIOL-LONDON, V33, P34; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; MAYER CJ, 1975, PFLUG ARCH EUR J PHY, V357, P35, DOI 10.1007/BF00584543; Mazzuoli G, 2009, J PHYSIOL-LONDON, V587, P4681, DOI 10.1113/jphysiol.2009.177105; Neunlist M, 1999, NEUROGASTROENT MOTIL, V11, P393; Nurgali K, 2004, J COMP NEUROL, V468, P112, DOI 10.1002/cne.10948; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; SCHEMANN M, 1989, J PHYSIOL-LONDON, V417, P501, DOI 10.1113/jphysiol.1989.sp017815; Schemann M, 2010, AUTON NEUROSCI-BASIC, V153, P21, DOI 10.1016/j.autneu.2009.08.003; Spencer NJ, 2004, J PHYSIOL-LONDON, V558, P577, DOI 10.1113/jphysiol.2004.063586; Spencer NJ, 2002, J PHYSIOL-LONDON, V545, P629, DOI 10.1113/jphysiol.2002.028647; Trendelenburg P, 1917, ARCH EXP PATHOL PHAR, V81, P55, DOI 10.1007/BF01862644; Wood J. D., 1974, P 4 INT S GASTR MOT, P387	30	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39887	10.1371/journal.pone.0039887	http://dx.doi.org/10.1371/journal.pone.0039887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768317	Green Published, gold, Green Submitted			2022-12-25	WOS:000305966500030
J	Akle, V; Guelin, E; Yu, LL; Brassard-Giordano, H; Slack, BE; Zhdanova, IV				Akle, Veronica; Guelin, Emmanuel; Yu, Lili; Brassard-Giordano, Helena; Slack, Barbara E.; Zhdanova, Irina V.			F-Spondin/spon1b Expression Patterns in Developing and Adult Zebrafish	PLOS ONE			English	Article							ROSTRAL MIGRATORY STREAM; F-SPONDIN; EXTRACELLULAR-MATRIX; OPTIC TECTUM; TELEOST FISH; FLOOR PLATE; HABENULAR COMPLEX; MIDBRAIN TARGET; GENE-EXPRESSION; NERVOUS-SYSTEM	F-spondin, an extracellular matrix protein, is an important player in embryonic morphogenesis and CNS development, but its presence and role later in life remains largely unknown. We generated a transgenic zebrafish in which GFP is expressed under the control of the F-spondin (spon1b) promoter, and used it in combination with complementary techniques to undertake a detailed characterization of the expression patterns of F-spondin in developing and adult brain and periphery. We found that F-spondin is often associated with structures forming long neuronal tracts, including retinal ganglion cells, the olfactory bulb, the habenula, and the nucleus of the medial longitudinal fasciculus (nMLF). F-spondin expression coincides with zones of adult neurogenesis and is abundant in CSF-contacting secretory neurons, especially those in the hypothalamus. Use of this new transgenic model also revealed F-spondin expression patterns in the peripheral CNS, notably in enteric neurons, and in peripheral tissues involved in active patterning or proliferation in adults, including the endoskeleton of zebrafish fins and the continuously regenerating pharyngeal teeth. Moreover, patterning of the regenerating caudal fin following fin amputation in adult zebrafish was associated with F-spondin expression in the blastema, a proliferative region critical for tissue reconstitution. Together, these findings suggest major roles for F-spondin in the CNS and periphery of the developing and adult vertebrate.	[Akle, Veronica; Guelin, Emmanuel; Yu, Lili; Brassard-Giordano, Helena; Zhdanova, Irina V.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Slack, Barbara E.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Akle, V (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	zhdanova@bu.edu	akle, veronica/AAD-7577-2019; Slack, Barbara/AAU-9917-2021	Akle, Veronica/0000-0002-2050-5511; Slack, Barbara/0000-0002-7619-410X; Zhdanova, Irina/0000-0002-8401-9571	Chaikin-Wile Foundation	Chaikin-Wile Foundation	The work was supported by a grant from the Chaikin-Wile Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; Benard C, 2009, CURR TOP DEV BIOL, V87, P175, DOI 10.1016/S0070-2153(09)01206-X; Burstyn-Cohen T, 1998, J NEUROSCI, V18, P8875; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Colognato H, 2011, DEV NEUROBIOLOGY; de Borsetti NH, 2011, DEV BIOL; Debby-Brafman A, 1999, NEURON, V22, P475, DOI 10.1016/S0896-6273(00)80703-5; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Feinstein Y, 2004, INT J BIOCHEM CELL B, V36, P975, DOI 10.1016/j.biocel.2004.01.002; Folgueira N, 2007, COMP GEN PHARMACOL, V370, P348, DOI [10.1002/cne, DOI 10.1002/CNE]; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Geisler S, 2003, J COMP NEUROL, V458, P78, DOI 10.1002/cne.10566; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hadzhiev Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-75; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2008, MOL NEUROBIOL, V37, P64, DOI 10.1007/s12035-008-8017-0; Hoffman GE, 2008, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301; Huysseune A, 2006, INT J DEV BIOL, V50, P637, DOI 10.1387/ijdb.052098ah; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita M, 2006, J COMP NEUROL, V499, P546, DOI 10.1002/cne.21080; Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Kuan YS, 2007, J EXP ZOOL PART B, V308B, P669, DOI 10.1002/jez.b.21184; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; Marta W, 2011, GEN COMP ENDOCR, V172, P173, DOI 10.1016/j.ygcen.2011.03.018; MEEK J, 1978, J COMP NEUROL, V182, P89, DOI 10.1002/cne.901820107; Meiniel O, 2008, J MOL EVOL, V66, P1, DOI 10.1007/s00239-007-9055-3; Mueller T, 2009, BRAIN BEHAV EVOLUT, V74, P30, DOI 10.1159/000229011; Mueller T, 2009, J COMP NEUROL, V516, P553, DOI 10.1002/cne.22122; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Nishida E, 2007, GENE, V404, P70, DOI 10.1016/j.gene.2007.09.009; Norton WHJ, 2008, J COMP NEUROL, V511, P521, DOI 10.1002/cne.21831; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Peterziel H, 2010, MOL CELLULAR NEUROSC; Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027; Rodriguez F, 2002, BRAIN RES BULL, V57, P499, DOI 10.1016/S0361-9230(01)00682-7; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Sankrithi NS, 2010, NEUROSCIENCE, V166, P970, DOI 10.1016/j.neuroscience.2010.01.003; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Schubert D, 2006, J NEUROCHEM, V96, P444, DOI 10.1111/j.1471-4159.2005.03563.x; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tzarfaty-Majar V, 2001, J BIOL CHEM, V276, P28233, DOI 10.1074/jbc.M102585200; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Vigh B, 2004, MED HYPOTHESES RES, P77; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Woo WM, 2008, DEVELOPMENT, V135, P2747, DOI 10.1242/dev.015289; Wullimann MF, 2002, BRAIN RES BULL, V57, P363, DOI 10.1016/S0361-9230(01)00666-9; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; Zisman S, 2007, J CELL BIOL, V178, P1237, DOI 10.1083/jcb.200702184; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182	71	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37593	10.1371/journal.pone.0037593	http://dx.doi.org/10.1371/journal.pone.0037593			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768035	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100006
J	Gostring, L; Malm, M; Hoiden-Guthenberg, I; Frejd, FY; Stahl, S; Lofblom, J; Gedda, L				Gostring, Lovisa; Malm, Magdalena; Hoiden-Guthenberg, Ingmarie; Frejd, Fredrik Y.; Stahl, Stefan; Lofblom, John; Gedda, Lars			Cellular Effects of HER3-Specific Affibody Molecules	PLOS ONE			English	Article							ONCOGENE PRODUCT; EGF RECEPTOR; HUMAN BREAST; CANCER; KINASE; LIGAND; ERBB2; FAMILY; DIFFERENTIATION; TRASTUZUMAB	Recent studies have led to the recognition of the epidermal growth factor receptor HER3 as a key player in cancer, and consequently this receptor has gained increased interest as a target for cancer therapy. We have previously generated several Affibody molecules with subnanomolar affinity for the HER3 receptor. Here, we investigate the effects of two of these HER3-specific Affibody molecules, Z05416 and Z05417, on different HER3-overexpressing cancer cell lines. Using flow cytometry and confocal microscopy, the Affibody molecules were shown to bind to HER3 on three different cell lines. Furthermore, the receptor binding of the natural ligand heregulin (HRG) was blocked by addition of Affibody molecules. In addition, both molecules suppressed HRG-induced HER3 and HER2 phosphorylation in MCF-7 cells, as well as HER3 phosphorylation in constantly HER2-activated SKBR-3 cells. Importantly, Western blot analysis also revealed that HRG-induced downstream signalling through the Ras-MAPK pathway as well as the PI3K-Akt pathway was blocked by the Affibody molecules. Finally, in an in vitro proliferation assay, the two Affibody molecules demonstrated complete inhibition of HRG-induced cancer cell growth. Taken together, our findings demonstrate that Z05416 and Z05417 exert an anti-proliferative effect on two breast cancer cell lines by inhibiting HRG-induced phosphorylation of HER3, suggesting that the Affibody molecules are promising candidates for future HER3-targeted cancer therapy.	[Gostring, Lovisa; Frejd, Fredrik Y.; Gedda, Lars] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Malm, Magdalena; Stahl, Stefan; Lofblom, John] AlbaNova Univ Ctr, Royal Inst Technol KTH, Sch Biotechnol, Dept Mol Biotechnol, Stockholm, Sweden; [Hoiden-Guthenberg, Ingmarie; Frejd, Fredrik Y.] Affibody AB, Solna, Sweden	Uppsala University; Royal Institute of Technology	Gostring, L (corresponding author), Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden.	lofblom@kth.se		Gedda, Lars/0000-0002-3746-6811; Lofblom, John/0000-0001-9423-0541; Malm, Magdalena/0000-0003-1763-9073	Swedish Research Council (VR) [2009-5758]; Governmental Agency for Innovation Systems (excellence center for protein technology, ProNova) [2009-00179]; Swedish Cancer Society [2011/473]; Swedish Foundation for Strategic Research [RBa08-0067]	Swedish Research Council (VR)(Swedish Research Council); Governmental Agency for Innovation Systems (excellence center for protein technology, ProNova); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by the Swedish Research Council (VR) [2009-5758], Governmental Agency for Innovation Systems [2009-00179; the excellence center for protein technology, ProNova], The Swedish Cancer Society [2011/473] and Swedish Foundation for Strategic Research [RBa08-0067]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; BACUS SS, 1992, CELL GROWTH DIFFER, V3, P401; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Clark AS, 2002, MOL CANCER THER, V1, P707; Ekerljung L, 2006, TUMOR BIOL, V27, P201, DOI 10.1159/000093023; Friedman M, 2009, BIOTECHNOL APPL BIOC, V54, P121, DOI 10.1042/BA20090096; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Guerra-Vladusic FK, 1999, INT J ONCOL, V15, P883; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist N, 2011, PROTEIN ENG DES SEL, V24, P385, DOI 10.1093/protein/gzq118; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; LUPU R, 1990, SCIENCE, V249, P1552, DOI 10.1126/science.2218496; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P412, DOI 10.1016/j.ccr.2010.03.014; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; Tolmachev V, 2009, J NUCL MED, V50, P274, DOI 10.2967/jnumed.108.055525; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yakes FM, 2002, CANCER RES, V62, P4132; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zielinski R, 2011, CLIN CANCER RES, V17, P5071, DOI 10.1158/1078-0432.CCR-10-2887	37	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40023	10.1371/journal.pone.0040023	http://dx.doi.org/10.1371/journal.pone.0040023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768204	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100176
J	Guo, X; Li, HG; Xu, H; Halim, V; Zhang, WY; Wang, H; Ong, KT; Woo, SL; Walzem, RL; Mashek, DG; Dong, H; Lu, FE; Wei, L; Huo, YQ; Wu, CD				Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Zhang, Weiyu; Wang, Huan; Ong, Kuok Teong; Woo, Shih-Lung; Walzem, Rosemary L.; Mashek, Douglas G.; Dong, Hui; Lu, Fuer; Wei, Lai; Huo, Yuqing; Wu, Chaodong			Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice	PLOS ONE			English	Article							SYSTEMIC INSULIN-RESISTANCE; FATTY LIVER; ADIPOSE-TISSUE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; DIABETES-MELLITUS; DISEASE; ACID; ACTIVATION; OBESITY; HEPATOCYTES	The interaction between fat deposition and inflammation during obesity contributes to the development of non-alcoholic fatty liver disease (NAFLD). The present study examined the effects of palmitoleate, a monounsaturated fatty acid (16:1n7), on liver metabolic and inflammatory responses, and investigated the mechanisms by which palmitoleate increases hepatocyte fatty acid synthase (FAS) expression. Male wild-type C57BL/6J mice were supplemented with palmitoleate and subjected to the assays to analyze hepatic steatosis and liver inflammatory response. Additionally, mouse primary hepatocytes were treated with palmitoleate and used to analyze fat deposition, the inflammatory response, and sterol regulatory element-binding protein 1c (SREBP1c) activation. Compared with controls, palmitoleate supplementation increased the circulating levels of palmitoleate and improved systemic insulin sensitivity. Locally, hepatic fat deposition and SREBP1c and FAS expression were significantly increased in palmitoleate-supplemented mice. These pro-lipogenic events were accompanied by improvement of liver insulin signaling. In addition, palmitoleate supplementation reduced the numbers of macrophages/Kupffer cells in livers of the treated mice. Consistently, supplementation of palmitoleate decreased the phosphorylation of nuclear factor kappa B (NF-kappa B, p65) and the expression of proinflammatory cytokines. These results were recapitulated in primary mouse hepatocytes. In terms of regulating FAS expression, treatment of palmitoleate increased the transcription activity of SREBP1c and enhanced the binding of SREBP1c to FAS promoter. Palmitoleate also decreased the phosphorylation of NF-kappa B p65 and the expression of proinflammatory cytokines in cultured macrophages. Together, these results suggest that palmitoleate acts through dissociating liver inflammatory response from hepatic steatosis to play a unique role in NAFLD.	[Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Woo, Shih-Lung; Walzem, Rosemary L.; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, Intercollegiate Fac Nutr, College Stn, TX 77843 USA; [Zhang, Weiyu; Wang, Huan] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ong, Kuok Teong; Mashek, Douglas G.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA; [Dong, Hui; Lu, Fuer] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Integrated Chinese & Western Med, Wuhan 430074, Peoples R China; [Wei, Lai] Peking Univ, Hlth Sci Ctr, Inst Hepatol, Beijing 100871, Peoples R China; [Huo, Yuqing] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA USA	Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Huazhong University of Science & Technology; Peking University; University System of Georgia; Augusta University	Guo, X (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, Intercollegiate Fac Nutr, College Stn, TX 77843 USA.	YHUO@georgiahealth.edu; cdwu@tamu.edu	Ong, Kuok Teong/H-8274-2015; Mashek, Douglas/ABD-6844-2021	Ong, Kuok Teong/0000-0001-8605-375X; Mashek, Douglas/0000-0001-7033-3386	American Diabetes Association (ADA) [1-10-BS-76, 1-10-JF-54]; National Institutes of Health (NIH) [HL78679, HL080569]; American Heart Association (AHA) [12BGIA9050003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078679, R01HL080569, R01HL095556, R21HL108922] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Diabetes Association (ADA) grant 1-10-BS-76, National Institutes of Health (NIH) HL78679, NIH HL080569, ADA grant 1-10-JF-54, and American Heart Association (AHA) 12BGIA9050003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Angulo P, 2006, GASTROENTEROLOGY, V130, P1848, DOI 10.1053/j.gastro.2006.03.041; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Huo Y, 2012, J BIOL CHEM; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Lonardo A, 2006, J HEPATOL, V44, P190, DOI 10.1016/j.jhep.2005.06.018; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Neuschwander-Tetri BA, 2010, NAT REV GASTRO HEPAT, V7, P243, DOI 10.1038/nrgastro.2010.50; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Petit JM, 2012, CLIN NUTR; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Tauriainen E, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/525094; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wendel AA, 2008, J LIPID RES, V49, P98, DOI 10.1194/jlr.M700195-JLR200; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	38	93	93	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39286	10.1371/journal.pone.0039286	http://dx.doi.org/10.1371/journal.pone.0039286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768070	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100041
J	Janssen, S; Laermans, J; Iwakura, H; Tack, J; Depoortere, I				Janssen, Sara; Laermans, Jorien; Iwakura, Hiroshi; Tack, Jan; Depoortere, Inge			Sensing of Fatty Acids for Octanoylation of Ghrelin Involves a Gustatory G-Protein	PLOS ONE			English	Article							IN-VIVO; DIETARY LIPIDS; TASTE; CELLS; SECRETION; RECEPTOR; PEPTIDE; GPR120; ACYL; IDENTIFICATION	Background: Ghrelin is an important regulator of energy - and glucose homeostasis. The octanoylation at Ser(3) is essential for ghrelin's biological effects but the mechanisms involved in the octanoylation are unknown. We investigated whether the gustatory G-protein, alpha-gustducin, and the free fatty acid receptors GPR40 and GPR120 are involved in the fatty acid sensing mechanisms of the ghrelin cell. Methods: Wild-type (WT) and alpha-gustducin knockout (gust(-/-)) mice were fed a glyceryl trioctanoate-enriched diet (OD) during 2 weeks. Ghrelin levels and gastric emptying were determined. Co-localization between GPR40, GPR120 and ghrelin or alpha-gustducin/alpha-transducin was investigated by immunofluorescence staining. The role of GPR120 in the effect of medium and long chain fatty acids on the release of ghrelin was studied in the ghrelinoma cell line, MGN3-1. The effect of the GPR40 agonist, MEDICA16, and the GPR120 agonist, grifolic acid, on ghrelin release was studied both in vitro and in vivo. Results: Feeding an OD specifically increased octanoyl ghrelin levels in the stomach of WT mice but not of gust(-/-) mice. Gastric emptying was accelerated in WT but not in gust(-/-) mice. GPR40 was colocalized with desoctanoyl but not with octanoyl ghrelin, alpha-gustducin or alpha-transducin positive cells in the stomach. GPR120 only colocalized with ghrelin in the duodenum. Addition of octanoic acid or alpha-linolenic acid to MGN3-1 cells increased and decreased octanoyl ghrelin levels, respectively. Both effects could not be blocked by GPR120 siRNA. MEDICA16 and grifolic acid did not affect ghrelin secretion in vitro but oral administration of grifolic acid increased plasma ghrelin levels. Conclusion: This study provides the first evidence that alpha-gustducin is involved in the octanoylation of ghrelin and shows that the ghrelin cell can sense long- and medium-chain fatty acids directly. GPR120 but not GPR40 may play a role in the lipid sensing cascade of the ghrelin cell.	[Janssen, Sara; Laermans, Jorien; Tack, Jan; Depoortere, Inge] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium; [Iwakura, Hiroshi] Kyoto Univ, Kyoto Univ Hosp, Grad Sch Med, Translat Res Ctr,Dept Med, Kyoto, Japan; [Iwakura, Hiroshi] Kyoto Univ, Kyoto Univ Hosp, Grad Sch Med, Translat Res Ctr,Dept Clin Sci, Kyoto, Japan; [Iwakura, Hiroshi] Kyoto Univ, Kyoto Univ Hosp, Grad Sch Med, Translat Res Ctr,Dept Endocrinol & Metab, Kyoto, Japan	KU Leuven; Kyoto University; Kyoto University; Kyoto University	Janssen, S (corresponding author), Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium.	inge.depoortere@med.kuleuven.be	Depoortere, Inge/I-5019-2013	Depoortere, Inge/0000-0002-0289-2175; Iwakura, Hiroshi/0000-0001-8033-0736; Laermans, Jorien/0000-0002-6695-6019; Tack, Jan/0000-0002-3206-6704	Flemish Foundation for Scientific Research [FWO G. 0670.10]; University of Leuven	Flemish Foundation for Scientific Research(FWO); University of Leuven(KU Leuven)	This work was supported by grants from the Flemish Foundation for Scientific Research (contract FWO G. 0670.10) and by a Methusalem grant from the University of Leuven for research on "The Brain-Gut Axis in Health and Disease: from Mucosal Integrity to Cortical Processing''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Callahan HS, 2004, J CLIN ENDOCR METAB, V89, P1319, DOI 10.1210/jc.2003-031267; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Choi KC, 2003, ENDOCRINOLOGY, V144, P754, DOI 10.1210/en.2002-220783; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Depoortere I, 2005, EUR J PHARMACOL, V515, P160, DOI 10.1016/j.ejphar.2005.04.008; Depoortere I, 2009, REGUL PEPTIDES, V156, P13, DOI 10.1016/j.regpep.2009.04.002; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Foster-Schubert KE, 2008, J CLIN ENDOCR METAB, V93, P1971, DOI 10.1210/jc.2007-2289; Fukuda H, 2004, SCAND J GASTROENTERO, V39, P1209, DOI 10.1080/00365520410007908; FUKUWATARI T, 1997, FEBS LETT, V414, P461; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hass N, 2007, HISTOCHEM CELL BIOL, V128, P457, DOI 10.1007/s00418-007-0325-3; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kitazawa T, 2005, GUT, V54, P1078, DOI 10.1136/gut.2005.065896; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Overduin J, 2005, ENDOCRINOLOGY, V146, P845, DOI 10.1210/en.2004-0609; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Shah BP, 2012, AM J PHYSIOL-CELL PH, V302, pC210, DOI 10.1152/ajpcell.00209.2011; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P515, DOI 10.1007/s00210-007-0250-y; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Verhulst PJ, 2008, GASTROENTEROLOGY, V135, P1267, DOI 10.1053/j.gastro.2008.06.044; Widmayer P, 2011, INT J OBES LOND; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P15868, DOI 10.1073/pnas.1011116107	46	76	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40168	10.1371/journal.pone.0040168	http://dx.doi.org/10.1371/journal.pone.0040168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768248	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100221
J	Lange, J; Barz, T; Ekkernkamp, A; Wilke, B; Kloting, I; Follak, N				Lange, Joern; Barz, Thomas; Ekkernkamp, Axel; Wilke, Barbara; Kloeting, Ingrid; Follak, Niels			Phenotypic and Gene Expression Differences between DA, BN and WOKW Rats	PLOS ONE			English	Article							METABOLIC SYNDROME; BODY-FAT; OBESITY; INSULIN; GENOME; MOUSE; LOCI; FEATURES; DISEASE; LINKAGE	Background: Because inbred rat strains are widely used as laboratory models, knowledge of phenotypic and genetic variations between strains will be useful to obtain insight into the relationship between different strains. Methods and Results: We studied phenotypic traits: of each strain - BN/K, DA/K and WOKW -10 male rats were studied for body weight and serum constituents at an age of 10 and 30 weeks. In addition, a total of 95 rats were studied for life expectancy. At an age of 30 weeks, these male rats were killed by an overdose of anesthetic (Sevofluran, Abbott), and the subcutaneous and visceral adipose tissue as well as bone tissue were removed to study the expression of 20 genes. There were significant differences in body weight, serum lipids and leptin at an age of 30 weeks between strains. Regarding life expectancy, BN rats lived longest (1072 +/- 228d). The highest gene expression was found in bone of BN rats. In adipose tissues, Nfkb1 is only expressed in subcutaneous adipocytes, and 5 genes, Col2a1, Mmp9, Tnfa, Ins1 and Cyp24a1, are not expressed in adipocytes. The ranking BN = DA>WOKW was observed in only one gene in subcutaneous (Fto) and visceral adipocytes (Col6a1). There were no significant differences in gene expression of one gene in subcutaneous adipocytes and of 3 genes in visceral adipocytes. Comparing the gene expression in visceral and subcutaneous adipocytes, only one gene showed a comparable behavior (Bmp1). Conclusion: From these results, it can be concluded that obvious phenotypic differences are caused by genetic differences between three rat strains, BN, DA and WOKW, as supported by gene expression studies in bone and adipose tissues. Especially BN rats can be used to study the genetic basis of long life.	[Lange, Joern; Ekkernkamp, Axel] Ernst Moritz Arndt Univ Greifswald, Fac Med, Dept Trauma & Reconstruct Surg, Greifswald, Germany; [Barz, Thomas] Asklepios Clin Uckermark, Dept Orthoped Surg, Schwedt, Germany; [Wilke, Barbara; Kloeting, Ingrid] Ernst Moritz Arndt Univ Greifswald, Fac Med, Dept Lab Anim Sci, Greifswald, Germany; [Follak, Niels] Pfeiffersche Stiftungen, Orthoped Clin, Magdeburg, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Lange, J (corresponding author), Ernst Moritz Arndt Univ Greifswald, Fac Med, Dept Trauma & Reconstruct Surg, Greifswald, Germany.	kloeting@uni-greifswald.de			Deutsche Forschungsgemeinschaft [KL 771/11-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research is partially supported by Grant No. KL 771/11-2 of the Deutsche Forschungsgemeinschaft. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Baguhl R, 2009, OBESITY, V17, P1215, DOI 10.1038/oby.2008.658; Bosse Y, 2005, INT J OBESITY, V29, P1338, DOI 10.1038/sj.ijo.0803010; Cheung MC, 2002, BBA-MOL BASIS DIS, V1587, P53, DOI 10.1016/S0925-4439(02)00054-6; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; HENRY GA, 1988, CLIN IMMUNOL IMMUNOP, V49, P187, DOI 10.1016/0090-1229(88)90109-2; Jukema JW, 1999, ACTA CARDIOL, V54, P163; Kaser S, 2001, DIABETOLOGIA, V44, P1111, DOI 10.1007/s001250100630; Kloting I, 2001, BIOCHEM BIOPH RES CO, V284, P150, DOI 10.1006/bbrc.2001.4932; Kloting N, 2006, DIABETES-METAB RES, V22, P146, DOI 10.1002/dmrr.582; Kloting N, 2005, DIABETES-METAB RES, V21, P281, DOI 10.1002/dmrr.526; Kovacs P, 2000, BIOCHEM BIOPH RES CO, V269, P660, DOI 10.1006/bbrc.2000.2352; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; Murdoch SJ, 2003, J LIPID RES, V44, P1705, DOI 10.1194/jlr.M300073-JLR200; Napolioni V, 2011, CYTOKINE, V56, P481, DOI 10.1016/j.cyto.2011.07.023; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Pawelec G, 2008, EXP GERONTOL, V43, P34, DOI 10.1016/j.exger.2007.09.609; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Turner CH, 2001, J BONE MINER RES, V16, P1532, DOI 10.1359/jbmr.2001.16.8.1532; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; Vaarhorst AAM, 2011, AGE, V33, P219, DOI 10.1007/s11357-010-9172-6; van den Brandt J, 2000, INT J OBESITY, V24, P1618, DOI 10.1038/sj.ijo.0801444; van den Brandt J, 2000, METABOLISM, V49, P1140, DOI 10.1053/meta.2000.8610; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015	32	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38981	10.1371/journal.pone.0038981	http://dx.doi.org/10.1371/journal.pone.0038981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768054	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100024
J	Prabakaran, T; Nielsen, R; Satchell, SC; Mathieson, PW; Feldt-Rasmussen, U; Sorensen, SS; Christensen, EI				Prabakaran, Thaneas; Nielsen, Rikke; Satchell, Simon C.; Mathieson, Peter W.; Feldt-Rasmussen, Ulla; Sorensen, Soren S.; Christensen, Erik I.			Mannose 6-Phosphate Receptor and Sortilin Mediated Endocytosis of alpha-Galactosidase A in Kidney Endothelial Cells	PLOS ONE			English	Article							FABRY-DISEASE; LYSOSOMAL-ENZYME; CEREBRAL HYPERPERFUSION; REPLACEMENT THERAPY; PROTEIN; ACCUMULATION; NEPHROPATHY; DYSFUNCTION; EXPRESSION; CHILDREN	Prominent vasculopathy in Fabry disease patients is caused by excessive intracellular accumulation of globotriaosylceramide (GL-3) throughout the vascular endothelial cells causing progressive cerebrovascular, cardiac and renal impairments. The vascular lesions lead to myocardial ischemia, atherogenesis, stroke, aneurysm, thrombosis, and nephropathy. Hence, injury to the endothelial cells in the kidney is a key mechanism in human glomerular disease and endothelial cell repair is an important therapeutic target. We investigated the mechanism of uptake of alpha-galactosidase A (alpha-Gal A) in renal endothelial cells, in order to clarify if the recombinant enzyme is targeted to the lysosomes via the universal mannose 6-phosphate receptor (M6PR) and possibly other receptors. Immunohistochemical localization of infused recombinant alpha-Gal A in a renal biopsy from a classic Fabry disease patient showed that recombinant protein localize in the endothelial cells of the kidney. Affinity purification studies using alpha-Gal A resins identified M6PR and sortilin as alpha-Gal A receptors in cultured glomerular endothelial cells. Immunohistochemical analyses of normal human kidney with anti-sortilin and anti-M6PR showed that sortilin and M6PR were expressed in the endothelium of smaller and larger vessels. Uptake studies in cultured glomerular endothelial cells of alpha-Gal A labeled with fluorescence and I-125 showed by inhibition with RAP and M6P that sortilin and M6PR mediated uptake of alpha-Gal A. Biacore studies revealed that alpha-Gal A binds to human M6PR with very high affinity, but M6PR also binds to sortilin in a way that prevents alpha-Gal A binding to sortilin. Taken together, our data provide evidence that sortilin is a new alpha-Gal A receptor expressed in renal endothelial cells and that this receptor together with the M6PR is able to internalize circulating alpha-Gal A during enzyme replacement therapy in patients with Fabry disease.	[Prabakaran, Thaneas; Nielsen, Rikke; Christensen, Erik I.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Satchell, Simon C.; Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Feldt-Rasmussen, Ulla] Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Sorensen, Soren S.] Rigshosp, Dept Nephrol P, DK-2100 Copenhagen, Denmark	Aarhus University; University of Bristol; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Prabakaran, T (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	eic@ana.au.dk	Prabakaran, Thaneas/K-3021-2019; Feldt-Rasmussen, Ulla/AAB-9218-2021	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Prabakaran, Thaneas/0000-0002-4698-7563; Nielsen, Rikke/0000-0003-3105-3474	Danish Medical Research Council; Novo Nordisk Foundation; Arvid Nilsson's Foundation; European Commission EUNEFRON [201590]; Aarhus University; Genzyme Corporation; Genzyme Corporation, Framingham, Massachusetts; Genzyme; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilsson's Foundation; European Commission EUNEFRON(European Commission); Aarhus University; Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Genzyme Corporation, Framingham, Massachusetts(Sanofi-AventisGenzyme Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Danish Medical Research Council, Novo Nordisk Foundation, Arvid Nilsson's Foundation, the European Commission EUNEFRON (FP7, GA#201590), Aarhus University, and Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A PhD-grant for T. Prabakaran is in part paid by Genzyme Corporation, Framingham, Massachusetts. U. Feldt-Rasmussen has received unrestricted research grants form Genzyme and serves at the Fabry Registry Advisory Board. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Altarescu G, 2001, STROKE, V32, P1559, DOI 10.1161/01.STR.32.7.1559; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Christensen EI, 2007, J AM SOC NEPHROL, V18, P698, DOI 10.1681/ASN.2006080822; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; Desnick RJ, 2006, METABOLIC MOL BASES, P3733; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fervenza FC, 2008, BIOL-TARGETS THER, V2, P823; Gelderman MP, 2007, ARTERIOSCL THROM VAS, V27, pE138, DOI 10.1161/ATVBAHA.107.143511; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Goligorsky MS, 2001, HYPERTENSION, V37, P744, DOI 10.1161/01.HYP.37.2.744; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Heare T, 2007, J INHERIT METAB DIS, V30, P79, DOI 10.1007/s10545-006-0473-y; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Mitsias P, 1996, ANN NEUROL, V40, P8, DOI 10.1002/ana.410400105; Moore DF, 2007, J NEUROL SCI, V257, P258, DOI 10.1016/j.jns.2007.01.053; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; Moore DF, 2004, J MAGN RESON IMAGING, V20, P674, DOI 10.1002/jmri.20162; Ojo A, 2000, TRANSPLANTATION, V69, P2337, DOI 10.1097/00007890-200006150-00020; OKA Y, 1985, J BIOL CHEM, V260, P9435; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; SANDO GN, 1977, CELL, V12, P619, DOI 10.1016/0092-8674(77)90262-8; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Shen JS, 2007, MOL GENET METAB, V92, P137, DOI 10.1016/j.ymgme.2007.06.003; Tauris J, 1998, FEBS LETT, V429, P27, DOI 10.1016/S0014-5793(98)00559-6; Thadhani R, 2002, KIDNEY INT, V61, P249, DOI 10.1046/j.1523-1755.2002.00097.x; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2008, AM J KIDNEY DIS, V51, P767, DOI 10.1053/j.ajkd.2007.12.032; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Vinge L, 2010, NEPHROL DIAL TRANSPL, V25, P2458, DOI 10.1093/ndt/gfq044; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516	45	20	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39975	10.1371/journal.pone.0039975	http://dx.doi.org/10.1371/journal.pone.0039975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768187	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100159
J	Sloane, PA; Shastry, S; Wilhelm, A; Courville, C; Tang, LP; Backer, K; Levin, E; Raju, SV; Li, Y; Mazur, M; Byan-Parker, S; Grizzle, W; Sorscher, EJ; Dransfield, MT; Rowe, SM				Sloane, Peter A.; Shastry, Suresh; Wilhelm, Andrew; Courville, Clifford; Tang, Li Ping; Backer, Kyle; Levin, Elina; Raju, S. Vamsee; Li, Yao; Mazur, Marina; Byan-Parker, Suzanne; Grizzle, William; Sorscher, Eric J.; Dransfield, Mark T.; Rowe, Steven M.			A Pharmacologic Approach to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Smoking Related Lung Disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CFTR GENE-MUTATIONS; AIRWAY INFLAMMATION; ADENOSINE RECEPTORS; CHLORIDE SECRETION; DELTA-F508 CFTR; IN-VITRO; MUCUS; EXPRESSION; CLEARANCE	Background: Mucus stasis in chronic obstructive pulmonary disease (COPD) is a significant contributor to morbidity and mortality. Potentiators of cystic fibrosis transmembrane conductance regulator (CFTR) activity pharmacologically enhance CFTR function; ivacaftor is one such agent approved to treat CF patients with the G551D-CFTR gating mutation. CFTR potentiators may also be useful for other diseases of mucus stasis, including COPD. Methods and Findings: In primary human bronchial epithelial cells, exposure to cigarette smoke extract diminished CFTR-mediated anion transport (65.8 +/- 0.2% of control, P<0.005) and mucociliary transport (0.17 +/- 0.05 mu m/sec vs. 2.4 +/- 0.47 mu m/sec control, P<0.05) by reducing airway surface liquid depth (7.3 +/- 0.6 mu m vs. 13.0 +/- 0.6 mu m control, P<0.005) and augmenting mucus expression (by 64%, P<0.05) without altering transepithelial resistance. Smokers with or without COPD had reduced CFTR activity measured by nasal potential difference compared to age-matched non-smokers (-6.3 +/- 1.4 and -8.0 +/- 2.0 mV, respectively vs. -15.2 +/- 2.7 mV control, each P<0.005, n = 12-14/group); this CFTR decrement was associated with symptoms of chronic bronchitis as measured by the Breathlessness Cough and Sputum Score (r = 0.30, P<0.05) despite controlling for smoking (r = 0.31, P<0.05). Ivacaftor activated CFTR-dependent chloride transport in non-CF epithelia and ameliorated the functional CFTR defect induced by smoke to 185 +/- 36% of non-CF control (P<0.05), thereby increasing airway surface liquid (from 7.3 +/- 0.6 mu m to 10.1 +/- 0.4 mu m, P<0.005) and mucociliary transport (from 0.27 +/- 0.11 mu m/s to 2.7 +/- 0.28 mu m/s, P<0.005). Conclusions: Cigarette smoking reduces CFTR activity and is causally related to reduced mucus transport in smokers due to inhibition of CFTR dependent fluid transport. These effects are reversible by the CFTR potentiator ivacaftor, representing a potential therapeutic strategy to augment mucociliary clearance in patients with smoking related lung disease.	[Sloane, Peter A.; Shastry, Suresh; Tang, Li Ping; Backer, Kyle; Levin, Elina; Raju, S. Vamsee; Li, Yao; Mazur, Marina; Sorscher, Eric J.; Dransfield, Mark T.; Rowe, Steven M.] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA; [Wilhelm, Andrew; Courville, Clifford; Sorscher, Eric J.; Dransfield, Mark T.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rowe, Steven M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Sorscher, Eric J.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Byan-Parker, Suzanne; Grizzle, William] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Dransfield, Mark T.; Rowe, Steven M.] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sloane, PA (corresponding author), Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA.	smrowe@uab.edu		Sorscher, Eric J./0000-0001-9341-3354	National Institutes of Health (NIH) [1R01 HL105487, K23 DK075788, P30 DK072482, 5UL1 RR025777]; Cystic Fibrosis Foundation [R464-CF, CLANCY09Y0]; Vertex Pharmaceuticals; GlaxoSmithKline; Boehringer Ingelheim; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473, R01HL105487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075788, P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Vertex Pharmaceuticals(Vertex Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was sponsored by National Institutes of Health (NIH) (1R01 HL105487 to Dr. Rowe, K23 DK075788 to Dr. Rowe, P30 DK072482 to Dr. Sorscher and 5UL1 RR025777) and the Cystic Fibrosis Foundation (R464-CF to Dr. Sorscher and CLANCY09Y0 to Dr. Rowe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Rowe served as a consultant for Vertex Pharmaceuticals for the design of CF clinical trials and also served as site PI for CF Clinical Trials sponsored by Vertex Pharmaceuticals. Dr. Dransfield has served on COPD-related advisory boards for Forest, GlaxoSmithKline and Boehringer Ingelheim. Dr. Dransfield has served as site PI for contracted COPD clinical trials sponsored by GlaxoSmithKline and Boehringer Ingelheim. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Barnes PJ, 2004, NEW ENGL J MED, V350, P2635, DOI 10.1056/NEJMp048102; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Cobb BR, 2003, AM J RESP CELL MOL, V29, P410, DOI 10.1165/rcmb.2002-0247OC; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Girodon E, 1997, EUR J HUM GENET, V5, P149, DOI 10.1159/000484750; Guimbellot JS, 2008, AM J RESP CELL MOL, V39, P514, DOI 10.1165/rcmb.2007-0452OC; Hogg JC, 2007, AM J RESP CRIT CARE, V176, P454, DOI 10.1164/rccm.200612-1772OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Kasai A, 2006, CANCER RES, V66, P7143, DOI 10.1158/0008-5472.CAN-05-4541; Kellermayer R, 2006, J INVEST DERMATOL, V126, P229, DOI 10.1038/sj.jid.5700031; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Knowles MR, 2002, NEW ENGL J MED, V347, P439, DOI 10.1056/NEJMe020070; Koblizek V, 2011, RHINOLOGY, V49, P397, DOI 10.4193/Rhino11.051; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Leidy NK, 2003, CHEST, V124, P2182, DOI 10.1378/chest.124.6.2182; Marchand E, 2001, CHEST, V119, P762, DOI 10.1378/chest.119.3.762; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Miller PW, 1996, AM J HUM GENET, V59, P45; Mortaz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004946; Pignatti PF, 1996, AM J HUM GENET, V58, P889; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rennolds J, 2010, TOXICOL SCI, V116, P349, DOI 10.1093/toxsci/kfq101; Rollins BM, 2008, AM J RESP CELL MOL, V39, P190, DOI 10.1165/rcmb.2007-0450OC; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2010, J CYST FIBROS, VS20; Rowe SM, 2007, AM J RESP CELL MOL, V37, P347, DOI 10.1165/rcmb.2006-0176OC; Rowe SM, 2010, PEDIATR PULM, P216; Sarir H, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-12; Savitski AN, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-120; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vestbo J, 2002, NOVART FDN SYMP, V248, P3; WELSH MJ, 1983, J CLIN INVEST, V71, P1614, DOI 10.1172/JCI110917; Wilschanski M, 2006, AM J RESP CRIT CARE, V174, P787, DOI 10.1164/rccm.200509-1377OC; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7	54	133	155	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39809	10.1371/journal.pone.0039809	http://dx.doi.org/10.1371/journal.pone.0039809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768130	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100100
J	Sudfeld, CR; Wang, ML; Aboud, S; Giovannucci, EL; Mugusi, FM; Fawzi, WW				Sudfeld, Christopher R.; Wang, Molin; Aboud, Said; Giovannucci, Edward L.; Mugusi, Ferdinand M.; Fawzi, Wafaie W.			Vitamin D and HIV Progression among Tanzanian Adults Initiating Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; DISEASE PROGRESSION; REGRESSION-MODELS; IMMUNE-SYSTEM; ASSOCIATION; PREVALENCE; MORTALITY; RISK	Background: There is growing evidence of an association between low vitamin D and HIV disease progression; however, no prospective studies have been conducted among adults receiving antiretroviral therapy (ART) in sub-Saharan Africa. Methods: Serum 25-hydroxyvitamin D (25(OH)D) levels were assessed at ART initiation for a randomly selected cohort of HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania during 2006-2010. Participants were prospectively followed at monthly clinic visits for a median of 20.6 months. CD4 T-cell measurements were obtained every 4 months. Proportional hazard models were utilized for mortality analyses while generalized estimating equations were used for CD4 T-cell counts. Results: Serum 25(OH)D was measured in 1103 adults 9.2% were classified as vitamin D deficient (<20 ng/ml), 43.6% insufficient (20-30 ng/mL), and 47.2% as sufficient (>30 ng/mL). After multivariate adjustment, vitamin D deficiency was significantly associated with increased mortality as compared to vitamin D sufficiency (HR: 2.00; 95% CI: 1.19-3.37; p = 0.009), whereas no significant association was found for vitamin D insufficiency (HR: 1.24; 95% CI: 0.87-1.78; p = 0.24). No effect modification by ART regimen or change in the associations over time was detected. Vitamin D status was not associated with change in CD4 T-cell count after ART initiation. Conclusions: Deficient vitamin D levels may lead to increased mortality in individuals receiving ART and this relationship does not appear to be due to impaired CD4 T-cell reconstitution. Randomized controlled trials are needed to determine the safety and efficacy of vitamin D supplementation for individuals receiving ART.	[Sudfeld, Christopher R.; Giovannucci, Edward L.; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Molin] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Giovannucci, Edward L.; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mugusi, Ferdinand M.] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Giovannucci, Edward L.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Harvard University; Brigham & Women's Hospital	Sudfeld, CR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	csudfeld@hsph.harvard.edu	Sudfeld, Christopher/AAW-3856-2021	Sudfeld, Christopher/0000-0002-3203-3638	National Institute of Child Health and Human development [R01 HD32257]; National Institute of Allergy and Infectious Diseases [T32AI007358]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007358] Funding Source: NIH RePORTER	National Institute of Child Health and Human development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Child Health and Human development (Grant Number R01 HD32257). C.R. Sudfeld was supported by Award Number T32AI007358 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; [Anonymous], 1985, THEORETICAL EPIDEMIO; Arpadi SM, 2009, PEDIATRICS, V123, pE121, DOI 10.1542/peds.2008-0176; BARSHAVIT Z, 1981, CALCIFIED TISSUE INT, V33, P673, DOI 10.1007/BF02409507; BHALLA AK, 1984, J IMMUNOL, V133, P1748; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Boonstra A, 2001, J IMMUNOL, V169, P4974; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; COX DR, 1972, J R STAT SOC B, V34, P187; Cozzolino M, 2003, AIDS, V17, P513, DOI 10.1097/00002030-200303070-00006; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Deeks Steven G, 2009, Top HIV Med, V17, P118; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fox J, 2011, AIDS RES HUM RETROV, V27, P29, DOI 10.1089/aid.2010.0081; Global HIV/AIDS Response, 2011, EP UPD HLTH SECT PRO; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; Hansen KE, 2008, J BONE MINER RES, V23, P1052, DOI 10.1359/JBMR.080230; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; Haug CJ, 1998, J CLIN ENDOCR METAB, V83, P3832, DOI 10.1210/jc.83.11.3832; Heaney RP, 2004, AM J CLIN NUTR, V80, p1706S, DOI 10.1093/ajcn/80.6.1706S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Institute of Medicine, 2011, DIETARY REFERENCE IN; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kakalia S, 2011, J PEDIATR-US, V159, P951, DOI 10.1016/j.jpeds.2011.06.010; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Kovesdy CP, 2008, ARCH INTERN MED, V168, P397, DOI 10.1001/archinternmed.2007.110; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Mehta S, 2011, AIDS PATIENT CARE ST, V25, P579, DOI 10.1089/apc.2011.0182; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Overbergh L, 2000, DIABETES, V49, P1301, DOI 10.2337/diabetes.49.8.1301; Overton Edgar Turner, 2011, Curr Infect Dis Rep, V13, P83, DOI 10.1007/s11908-010-0144-x; Realegeno S, 2011, P NATL ACAD SCI USA, V108, P18861, DOI 10.1073/pnas.1116513108; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ross AC, 2011, ANTIVIR THER, V16, P555, DOI 10.3851/IMP1784; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stein EM, 2011, OSTEOPOROSIS INT, V22, P477, DOI 10.1007/s00198-010-1299-x; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Terrier B, 2011, J HEPATOL, V55, P756, DOI 10.1016/j.jhep.2011.01.041; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; Vescini F, 2011, JAIDS-J ACQ IMM DEF, V58, P163, DOI 10.1097/QAI.0b013e31822e57e9; Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7; Villamor E, 2006, NUTR REV, V64, P226, DOI 10.1111/j.1753-4887.2006.tb00205.x; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; World Health Organization, 2004, SCAL ANT THER RES LT; YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260; Yin M, 2011, CLIN INFECT DIS, V52, P406, DOI 10.1093/cid/ciq169; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	66	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40036	10.1371/journal.pone.0040036	http://dx.doi.org/10.1371/journal.pone.0040036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768212	Green Published, gold			2022-12-25	WOS:000305892100184
J	Mir, M; Babacan, SD; Bednarz, M; Do, MN; Golding, I; Popescu, G				Mir, Mustafa; Babacan, S. Derin; Bednarz, Michael; Do, Minh N.; Golding, Ido; Popescu, Gabriel			Visualizing Escherichia coli Sub-Cellular Structure Using Sparse Deconvolution Spatial Light Interference Tomography	PLOS ONE			English	Article							PHASE MICROSCOPY; QUANTITATIVE PHASE; DIFFRACTION TOMOGRAPHY; CELL-CYCLE; RESOLUTION; DIVISION; LIMIT; IMPROVEMENT; PROTEINS; DYNAMICS	Studying the 3D sub-cellular structure of living cells is essential to our understanding of biological function. However, tomographic imaging of live cells is challenging mainly because they are transparent, i.e., weakly scattering structures. Therefore, this type of imaging has been implemented largely using fluorescence techniques. While confocal fluorescence imaging is a common approach to achieve sectioning, it requires fluorescence probes that are often harmful to the living specimen. On the other hand, by using the intrinsic contrast of the structures it is possible to study living cells in a non-invasive manner. One method that provides high-resolution quantitative information about nanoscale structures is a broadband interferometric technique known as Spatial Light Interference Microscopy (SLIM). In addition to rendering quantitative phase information, when combined with a high numerical aperture objective, SLIM also provides excellent depth sectioning capabilities. However, like in all linear optical systems, SLIM's resolution is limited by diffraction. Here we present a novel 3D field deconvolution algorithm that exploits the sparsity of phase images and renders images with resolution beyond the diffraction limit. We employ this label-free method, called deconvolution Spatial Light Interference Tomography (dSLIT), to visualize coiled sub-cellular structures in E. coli cells which are most likely the cytoskeletal MreB protein and the division site regulating MinCDE proteins. Previously these structures have only been observed using specialized strains and plasmids and fluorescence techniques. Our results indicate that dSLIT can be employed to study such structures in a practical and non-invasive manner.	[Mir, Mustafa; Do, Minh N.; Popescu, Gabriel] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Mir, Mustafa; Babacan, S. Derin; Do, Minh N.; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Bednarz, Michael; Golding, Ido] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL USA; [Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine	Mir, M (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.	mmir2@illinois.edu	N., Minh/AAX-8498-2020	N., Minh/0000-0001-5132-4986; Mir, Mustafa/0000-0001-8280-2821	National Science Foundation (NSF) under the Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) [CBET-0939511]; NSF [CBET 1040462 MRI, CBET 08-46660 CAREER, 082265, CCF-0916953]; National Institutes of Health [R01GM082837]; Human Frontier Science Program [RGY 70/2008]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER	National Science Foundation (NSF) under the Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation (NSF) under the Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) Grant No. CBET-0939511 to G. P. This work was supported in part by NSF Grants CBET 1040462 MRI and CBET 08-46660 CAREER to G. P. Work in the I. G. laboratory is supported by National Institutes of Health Grant R01GM082837, Human Frontier Science Program Grant RGY 70/2008 and NSF Grant 082265 (Physics Frontiers Center: Center for the Physics of Living Cells). M.N.D. is supported by NSF grant CCF-0916953. S. D. B. is supported by the Beckman Institute Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E, 1873, ARCH MIKROSK ANAT, P9; Allain M, 2006, IEEE T IMAGE PROCESS, V15, P1130, DOI 10.1109/TIP.2005.864173; [Anonymous], [No title captured]; Babacan SD, 2011, BIOMED OPT EXPRESS, V2, P1815, DOI 10.1364/BOE.2.001815; Babacan SD, 2010, IEEE INT C IM PROC I; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Charriere F, 2006, OPT LETT, V31, P178, DOI 10.1364/OL.31.000178; Charriere F, 2006, OPT EXPRESS, V14, P7005, DOI 10.1364/OE.14.007005; Chen BQ, 1998, APPL OPTICS, V37, P2996, DOI 10.1364/AO.37.002996; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Cotte Y, 2010, OPT EXPRESS, V18, P19462, DOI 10.1364/OE.18.019462; Debailleul M, 2009, OPT LETT, V34, P79, DOI 10.1364/OL.34.000079; Ding H, 2008, PRL, P101; DONACHIE WD, 1993, ANNU REV MICROBIOL, V47, P199, DOI 10.1146/annurev.mi.47.100193.001215; Donachie WD, 2001, MOL MICROBIOL, V40, P779, DOI 10.1046/j.1365-2958.2001.02439.x; Donoho D, 2004, MOST LARGE UNDERDETE; Fiolka R, 2009, OPT EXPRESS, V17, P12407, DOI 10.1364/OE.17.012407; Gbur G, 2001, J OPT SOC AM A, V18, P2132, DOI 10.1364/JOSAA.18.002132; Ghosh AS, 2005, J BACTERIOL, V187, P1913, DOI 10.1128/JB.187.6.1913-1922.2005; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Haldar JP, 2011, IEEE T BIO-MED ENG, V58, P2489, DOI 10.1109/TBME.2011.2158003; HELL S, 1992, OPT COMMUN, V93, P277, DOI 10.1016/0030-4018(92)90185-T; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2007, BIOPHYS J, p419A; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Ikeda T, 2005, OPT LETT, V30, P1165, DOI 10.1364/OL.30.001165; Joo C, 2005, OPT LETT, V30, P2131, DOI 10.1364/OL.30.002131; Maire G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213905; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Nikolova M, 2005, SIAM J SCI COMPUT, V27, P937, DOI 10.1137/030600862; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G, 2004, OPT LETT, V29, P2503, DOI 10.1364/OL.29.002503; Popescu G., 2011, QUANTITATIVE PHASE I; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rockward WS, 2008, APPL OPTICS, V47, P1684, DOI 10.1364/AO.47.001684; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sarder P, 2006, IEEE SIGNAL PROC MAG, V23, P32, DOI 10.1109/MSP.2006.1628876; Shechtman Y, 2011, OPT EXPRESS, V19, P14807, DOI 10.1364/OE.19.014807; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Sridharan S, 2011, BIOMED OPT EXPRESS, V2, P2815, DOI 10.1364/BOE.2.002815; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Szameit A, 2012, NAT MAT; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Van Aert S, 2006, OPT EXPRESS, V14, P3830, DOI 10.1364/OE.14.003830; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Wang R, 2011, OPT EXPRESS, V19, P20571, DOI 10.1364/OE.19.020571; Wang Z, 2011, J BIOMED OPT, V16; Wang Z., 2011, J BIOMEDICAL OPTICS, V16; Wang Z, 2011, OPT EXPRESS, V19, P19907, DOI 10.1364/OE.19.019907; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Wang Z, 2010, OPT LETT, V35, P208, DOI 10.1364/OL.35.000208; Wright SJ, 2002, METHOD CELL BIOL, V70, P1; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345; Zysk AM, 2003, OPT LETT, V28, P701, DOI 10.1364/OL.28.000701	57	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39816	10.1371/journal.pone.0039816	http://dx.doi.org/10.1371/journal.pone.0039816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761910	Green Published, gold, Green Submitted			2022-12-25	WOS:000305826400041
J	Yeh, JR; Zhang, XF; Nagano, MC				Yeh, Jonathan R.; Zhang, Xiangfan; Nagano, Makoto C.			Indirect Effects of Wnt3a/beta-Catenin Signalling Support Mouse Spermatogonial Stem Cells In Vitro	PLOS ONE			English	Article							SELF-RENEWAL; STEM/PROGENITOR CELLS; BETA-CATENIN; EXPRESSION; SPERMATOGENESIS; ACTIVATION; PATHWAY; EMBRYOS; NOTCH; ASSAY	Proper regulation of spermatogonial stem cells (SSCs) is crucial for sustaining steady-state spermatogenesis. Previous work has identified several paracrine factors involved in this regulation, in particular, glial cell line-derived neurotrophic factor and fibroblast growth factor 2, which promote long-term SSC self-renewal. Using a SSC culture system, we have recently reported that Wnt5a promotes SSC self-renewal through a beta-catenin-independent Wnt mechanism whereas the beta-catenin-dependent Wnt pathway is not active in SSCs. In contrast, another study has reported that Wnt3a promotes SSC self-renewal through the beta-catenin-dependent pathway, as it can stimulate the proliferation of a spermatogonia cell line. To reconcile these two contradictory reports, we assessed Wnt3a effects on SSCs and progenitor cells, rather than a cell line, in vitro. We observed that Wnt3a induced beta-catenin-dependent signalling in a large subset of germ cells and increased SSC numbers. However, further investigation revealed that cell populations with greater beta-catenin-signalling activity contained fewer SSCs. The increased maintenance of SSCs by Wnt3a coincided with more active cell cycling and the formation of germ cell aggregates, or communities, under feeder-free conditions. Therefore, the results of this study suggest that Wnt3a selectively stimulates proliferation of progenitors that are committed to differentiation or are in the process of exiting the SSC state, leading to enhanced formation of germ cell communities, which indirectly support SSCs and act as an in vitro niche.	[Yeh, Jonathan R.; Zhang, Xiangfan; Nagano, Makoto C.] McGill Univ, Dept Obstet & Gynecol, Div Expt Med, Montreal, PQ H3A 2T5, Canada	McGill University	Yeh, JR (corresponding author), McGill Univ, Dept Obstet & Gynecol, Div Expt Med, Montreal, PQ H3A 2T5, Canada.	makoto.nagano@muhc.mcgill.ca			Canadian Institutes of Health Research [MOP-86532]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Financial support was from the Canadian Institutes of Health Research (MOP-86532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ebata KT, 2011, EXP CELL RES, V317, P1319, DOI 10.1016/j.yexcr.2011.03.013; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Holowacz T, 2011, EUR J NEUROSCI, V33, P1366, DOI 10.1111/j.1460-9568.2011.07632.x; JEN J, 1990, MOL REPROD DEV, V25, P14, DOI 10.1002/mrd.1080250104; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kuehl Michael, 2008, V469, P467, DOI 10.1007/978-1-60327-469-29; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lin YF, 2001, DEV DYNAM, V222, P26, DOI 10.1002/dvdy.1164; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marcon L, 2010, BIOL REPROD, V83, P228, DOI 10.1095/biolreprod.110.083568; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Morimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007909; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Yeh JR, 2007, BIOL REPROD, V77, P897, DOI 10.1095/biolreprod.107.063057; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang XF, 2003, BIOL REPROD, V69, P1872, DOI 10.1095/biolreprod.103.019273	39	44	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40002	10.1371/journal.pone.0040002	http://dx.doi.org/10.1371/journal.pone.0040002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761943	Green Published, gold, Green Submitted			2022-12-25	WOS:000305826400052
J	Luzi, E; Marini, F; Giusti, F; Galli, G; Cavalli, L; Brandi, ML				Luzi, Ettore; Marini, Francesca; Giusti, Francesca; Galli, Gianna; Cavalli, Loredana; Brandi, Maria Luisa			The Negative Feedback-Loop between the Oncomir Mir-24-1 and Menin Modulates the Men1 Tumorigenesis by Mimicking the "Knudson's Second Hit"	PLOS ONE			English	Article							MICRORNAS; CANCER; NOISE; ACCUMULATION; EXPRESSION; NETWORKS; MUTATION; REGIONS	Multiple endocrine neoplasia type 1 (MEN1) syndrome is a rare hereditary cancer disorder characterized by tumors of the parathyroids, of the neuroendocrine cells, of the gastro-entero-pancreatic tract, of the anterior pituitary, and by non-endocrine neoplasms and lesions. MEN1 gene, a tumor suppressor gene, encodes menin protein. Loss of heterozygosity at 11q13 is typical of MEN1 tumors, in agreement with the Knudson's two-hit hypothesis. In silico analysis with Target Scan, Miranda and Pictar-Vert softwares for the prediction of miRNA targets indicated miR-24-1 as capable to bind to the 3'UTR of MEN1 mRNA. We investigated this possibility by analysis of miR-24-1 expression profiles in parathyroid adenomatous tissues from MEN1 gene mutation carriers, in their sporadic non-MEN1 counterparts, and in normal parathyroid tissue. Interestingly, the MEN1 tumorigenesis seems to be under the control of a "negative feedback loop" between miR-24-1 and menin protein, that mimics the second hit of Knudson's hypothesis and that could buffer the effect of the stochastic factors that contribute to the onset and progression of this disease. Our data show an alternative way to MEN1 tumorigenesis and, probably, to the "two-hit dogma". The functional significance of this regulatory mechanism in MEN1 tumorigenesis is also the basis for opening future developments of RNA antagomir(s)-based strategies in the in vivo control of tumorigenesis in MEN1 carriers.	[Luzi, Ettore; Marini, Francesca; Giusti, Francesca; Galli, Gianna; Cavalli, Loredana; Brandi, Maria Luisa] Univ Florence, Bone Metab Unit, Dept Internal Med, Florence, Italy	University of Florence	Luzi, E (corresponding author), Univ Florence, Bone Metab Unit, Dept Internal Med, Florence, Italy.	m.brandi@dmi.unifi.it	L, E/AAG-9596-2019	Luzi, Ettore/0000-0002-8896-241X; Marini, Francesca/0000-0002-3678-4922; Cavalli, Loredana/0000-0003-4075-933X; Giusti, Francesca/0000-0002-8576-9606	Fondazione Raffaella Becagli; Osservatorio Nazionale Salute Donna	Fondazione Raffaella Becagli; Osservatorio Nazionale Salute Donna	EL, PhD was supported by a grant of the Fondazione Raffaella Becagli. FM, PhD was recipient of a fellowship, from Osservatorio Nazionale Salute Donna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2007, NEOPLASIA, V9, P101, DOI 10.1593/neo.06706; Anlauf M, 2007, PATHOBIOLOGY, V74, P279, DOI 10.1159/000105810; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Falchetti A, 2009, GENET MED, V11, P825, DOI 10.1097/GIM.0b013e3181be5c97; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Galasso M, 2010, GENOME MED, V2, DOI 10.1186/gm133; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Keene JD, 2010, ENDOCRINOLOGY, V151, P1391, DOI 10.1210/en.2009-1250; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Luzi E, 2010, CANCER GENE THER, V17, P814, DOI 10.1038/cgt.2010.39; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Michael MZ, 2003, MOL CANCER RES, V1, P882; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ogino Shuji, 2007, J Genet Couns, V16, P29, DOI 10.1007/s10897-006-9040-9; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sonnenschein C, 2009, MOL CARCINOG, V29, P205; Soto AM, 2004, BIOESSAYS, V26, P1097, DOI 10.1002/bies.20087; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009	33	66	70	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39767	10.1371/journal.pone.0039767	http://dx.doi.org/10.1371/journal.pone.0039767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761894	Green Submitted, gold, Green Published			2022-12-25	WOS:000305825800068
J	Thi, VLD; Granier, C; Zeisel, MB; Guerin, M; Mancip, J; Granio, O; Penin, F; Lavillette, D; Bartenschlager, R; Baumert, TF; Cosset, FL; Dreux, M				Viet Loan Dao Thi; Granier, Christelle; Zeisel, Mirjam B.; Guerin, Maryse; Mancip, Jimmy; Granio, Ophelia; Penin, Francois; Lavillette, Dimitri; Bartenschlager, Ralf; Baumert, Thomas F.; Cosset, Francois-Loic; Dreux, Marlene			Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; NONSTRUCTURAL PROTEIN 5A; CELL ENTRY; APOLIPOPROTEIN-E; SR-BI; NEUTRALIZING ANTIBODIES; HUMAN HEPATOCYTES; E2 GLYCOPROTEIN; MEMBRANE-FUSION; MEDIATED ENDOCYTOSIS	Hepatitis C virus (HCV) particles assemble along the very low density lipoprotein pathway and are released from hepatocytes as entities varying in their degree of lipid and apolipoprotein (apo) association as well as buoyant densities. Little is known about the cell entry pathway of these different HCV particle subpopulations, which likely occurs by regulated spatiotemporal processes involving several cell surface molecules. One of these molecules is the scavenger receptor BI (SR-BI), a receptor for high density lipoprotein that can bind to the HCV glycoprotein E2. By studying the entry properties of infectious virus subpopulations differing in their buoyant densities, we show that these HCV particles utilize SR-BI in a manifold manner. First, SR-BI mediates primary attachment of HCV particles of intermediate density to cells. These initial interactions involve apolipoproteins, such as apolipoprotein E, present on the surface of HCV particles, but not the E2 glycoprotein, suggesting that lipoprotein components in the virion act as host-derived ligands for important entry factors such as SR-BI. Second, we found that in contrast to this initial attachment, SR-BI mediates entry of HCV particles independent of their buoyant density. This function of SR-BI does not depend on E2/SR-BI interaction but relies on the lipid transfer activity of SR-BI, probably by facilitating entry steps along with other HCV entry co-factors. Finally, our results underscore a third function of SR-BI governed by specific residues in hypervariable region 1 of E2 leading to enhanced cell entry and depending on SR-BI ability to bind to E2.	[Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] INSERM, U758, Human Virol Lab, EVIR Team, F-69007 Lyon, France; [Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] Ecole Normale Super Lyon, F-69007 Lyon, France; [Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] Univ Lyon, UCB Lyon1, F-69007 Lyon, France; [Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Penin, Francois; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] Univ Lyon, LabEx Ecofect, F-69007 Lyon, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] INSERM, U748, F-67000 Strasbourg, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] Univ Strasbourg, F-67000 Strasbourg, France; [Guerin, Maryse] INSERM, UMRS939, Paris, France; [Penin, Francois] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon, France; [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Baumert, Thomas F.] Hop Univ Strasbourg, F-67000 Strasbourg, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ruprecht Karls University Heidelberg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cosset, FL (corresponding author), ENS Lyon, INSERM, U758, Human Virol Dept, 46 Allee Italie, F-69364 Lyon 07, France.	flcosset@ens-lyon.fr; marlene.dreux@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019; Dreux, Marlene/M-7295-2014; Zeisel, Mirjam B/E-9205-2016; Guerin, Maryse/N-5794-2017; Baumert, Thomas/ABF-4718-2020; Bartenschlager, Ralf/L-2582-2015	Cosset, François-Loïc/0000-0001-8842-3726; Dreux, Marlene/0000-0002-6607-4796; Zeisel, Mirjam B/0000-0003-1606-0131; Baumert, Thomas/0000-0002-8864-2168; Christelle, GRANIER/0000-0001-8987-0632; GUERIN, Maryse/0000-0003-0150-1360; Lavillette, Dimitri/0000-0002-4706-1519; Bartenschlager, Ralf/0000-0001-5601-9307; Dao Thi, Viet Loan/0000-0003-2293-3592	European Research Council [ERC-2008-AdG-233130-HEPCENT]; European Union [PCIG11-GA-2012-322377]; Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS); Region Rhone-Alpes; EU INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Ne; Laboratoire d'excellence HEPSYS [ANR-10-LAB-28]; Agence Nationale pour la Recherche contre le SIDA post-doctoral fellowship	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); EU INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Ne; Laboratoire d'excellence HEPSYS; Agence Nationale pour la Recherche contre le SIDA post-doctoral fellowship(French National Research Agency (ANR))	This work was supported by the European Research Council (ERC-2008-AdG-233130-HEPCENT to F.-L. C.), the European Union (PCIG11-GA-2012-322377 "HepATG," to M. D.), and the Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS).r Supported by a predoctoral fellowship from Region Rhone-Alpes.r Supported by EU INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009 and the Laboratoire d'excellence HEPSYS (ANR-10-LAB-28).r Supported by an Agence Nationale pour la Recherche contre le SIDA post-doctoral fellowship.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Catalano G, 2008, J LIPID RES, V49, P635, DOI 10.1194/jlr.M700510-JLR200; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chroni A, 2005, BIOCHEMISTRY-US, V44, P13132, DOI 10.1021/bi051029o; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Iro M, 2009, ANTIVIR RES, V83, P148, DOI 10.1016/j.antiviral.2009.04.007; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; MOYA MD, 1994, ARTERIOSCLER THROMB, V14, P1056; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nieland TJF, 2005, BBA-MOL CELL BIOL L, V1734, P44, DOI 10.1016/j.bbalip.2005.02.007; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Parathath S, 2004, J BIOL CHEM, V279, P24976, DOI 10.1074/jbc.M402435200; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schwarz AK, 2009, J VIROL, V83, P12407, DOI 10.1128/JVI.01552-09; Sharma NR, 2011, J BIOL CHEM, V286, P30361, DOI 10.1074/jbc.M111.263350; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Viet LDT, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001785; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	96	88	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31242	31257		10.1074/jbc.M112.365924	http://dx.doi.org/10.1074/jbc.M112.365924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22767607	Green Published, hybrid			2022-12-25	WOS:000308791300037
J	Sharma, N; Medikayala, S; Defour, A; Rayavarapu, S; Brown, KJ; Hathout, Y; Jaiswal, JK				Sharma, Nimisha; Medikayala, Sushma; Defour, Aurelia; Rayavarapu, Sree; Brown, Kristy J.; Hathout, Yetrib; Jaiswal, Jyoti K.			Use of Quantitative Membrane Proteomics Identifies a Novel Role of Mitochondria in Healing Injured Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC IDENTIFICATION; CELL-SURFACE PROTEINS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHIES; REPAIR; REGENERATION; SARCOLEMMA; DYSFERLIN; FIBERS; DIFFERENTIATION	Skeletal muscles are proficient at healing from a variety of injuries. Healing occurs in two phases, early and late phase. Early phase involves healing the injured sarcolemma and restricting the spread of damage to the injured myofiber. Late phase of healing occurs a few days postinjury and involves interaction of injured myofibers with regenerative and inflammatory cells. Of the two phases, cellular and molecular processes involved in the early phase of healing are poorly understood. We have implemented an improved sarcolemmal proteomics approach together with in vivo labeling of proteins with modified amino acids in mice to study acute changes in the sarcolemmal proteome in early phase of myofiber injury. We find that a notable early phase response to muscle injury is an increased association of mitochondria with the injured sarcolemma. Real-time imaging of live myofibers during injury demonstrated that the increased association of mitochondria with the injured sarcolemma involves translocation of mitochondria to the site of injury, a response that is lacking in cultured myoblasts. Inhibiting mitochondrial function at the time of injury inhibited healing of the injured myofibers. This identifies a novel role of mitochondria in the early phase of healing injured myofibers.	[Sharma, Nimisha; Medikayala, Sushma; Defour, Aurelia; Rayavarapu, Sree; Brown, Kristy J.; Hathout, Yetrib; Jaiswal, Jyoti K.] Childrens Natl Med Ctr, Ctr Genet Med Res, Washington, DC 20010 USA; [Rayavarapu, Sree] George Washington Univ, Inst Biomed Sci, Washington, DC 20010 USA; [Jaiswal, Jyoti K.] George Washington Univ, Dept Integrat Syst Biol, Washington, DC 20010 USA	Children's National Health System; George Washington University; George Washington University	Jaiswal, JK (corresponding author), Childrens Natl Med Ctr, Ctr Genet Med Res, 111 Michigan Ave NW, Washington, DC 20010 USA.	jkjaiswal@cnmcresearch.org	Jaiswal, Jyoti/AAD-5386-2020; Jaiswal, Jyoti/ABI-1666-2020; Jaiswal, JK/M-5891-2013	Jaiswal, Jyoti/0000-0002-5992-5185; Jaiswal, JK/0000-0002-5992-5185; Brown, Kristy/0000-0002-1047-4328; Rayavarapu, Sree/0000-0002-5833-4711; defour, aurelia/0000-0002-9114-0054	National Institutes of Health [RO1AR055686, P50AR060836, P30HD040677, R24HD050846]; National Institutes of Health, NCRR [UL1RR031988]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060836, R01AR055686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AR055686 and P50AR060836 (to J. K. J.). The mass spectrometry and microscopy facilities used are supported by National Institutes of Health Grants P30HD040677 (Intellectual and Developmental Disabilities Research Center) and R24HD050846 (National Center for Medical Rehabilitation Research) and National Institutes of Health, NCRR, Grant UL1RR031988 (George Washington University Children's National Medical Center, Clinical and Translational Science Institute).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Brewis IA, 2010, ADV PROTEIN CHEM STR, V80, P1, DOI [10.1016/S1876-1623(10)80001-X, 10.1016/B978-0-12-381264-3.00001-1]; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; CARPENTER S, 1989, J NEUROPATH EXP NEUR, V48, P154, DOI 10.1097/00005072-198903000-00003; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; CHARUK JHM, 1989, BIOCHEM J, V264, P885, DOI 10.1042/bj2640885; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Donoghue P, 2010, J PROTEOMICS, V73, P1441, DOI 10.1016/j.jprot.2010.01.014; Doran P, 2006, PROTEOMICS, V6, P4610, DOI 10.1002/pmic.200600082; Elia G, 2008, PROTEOMICS, V8, P4012, DOI 10.1002/pmic.200800097; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; FAULKNER JA, 1993, PHYS THER, V73, P911, DOI 10.1093/ptj/73.12.911; Gelfi C, 2011, J PROTEOMICS, V74, P774, DOI 10.1016/j.jprot.2011.02.028; Ghosh D, 2004, J PROTEOME RES, V3, P841, DOI 10.1021/pr049937f; GROUNDS MD, 1991, PATHOL RES PRACT, V187, P1; Gundry RL, 2009, MOL CELL PROTEOMICS, V8, P2555, DOI 10.1074/mcp.M900195-MCP200; HONSCHA W, 1993, BIOCHIM BIOPHYS ACTA, V1153, P175, DOI 10.1016/0005-2736(93)90403-M; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Huber LA, 2003, CIRC RES, V92, P962, DOI 10.1161/01.RES.0000071748.48338.25; Jarrold B, 2005, ELECTROPHORESIS, V26, P2269, DOI 10.1002/elps.200410367; Kim BW, 2010, PROTEOMICS, V10, P2498, DOI 10.1002/pmic.200900826; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; Kline KG, 2010, ANNU REV BIOPHYS, V39, P291, DOI 10.1146/annurev.biophys.093008.131339; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Lewis C, 2010, ANAL BIOCHEM, V404, P197, DOI 10.1016/j.ab.2010.05.017; McClatchy DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016039; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Mellgren RL, 2010, J BIOL CHEM, V285, P36597, DOI 10.1074/jbc.M110.110015; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Nagaraj N, 2008, J PROTEOME RES, V7, P5028, DOI 10.1021/pr800412j; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Ohlendieck K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-6; PAPADIMITRIOU JM, 1990, J STRUCT BIOL, V103, P124, DOI 10.1016/1047-8477(90)90016-6; Peirce Matthew J., 2009, V528, P135, DOI 10.1007/978-1-60327-310-7_10; Raddatz K, 2008, PROTEOMICS, V8, P1885, DOI 10.1002/pmic.200700902; SEILER S, 1982, J BIOL CHEM, V257, P13862; SEILER S, 1988, METHOD ENZYMOL, V157, P26; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Tannu NS, 2004, MOL CELL PROTEOMICS, V3, P1065, DOI 10.1074/mcp.M400020-MCP200; Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06; Vitorino R, 2007, ANAL BIOCHEM, V366, P156, DOI 10.1016/j.ab.2007.04.009; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Weekes Michael P, 2010, J Biomol Tech, V21, P108; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Zanivan S, 2011, METHODS MOL BIOL, V757, P435, DOI 10.1007/978-1-61779-166-6_25; Zhang ZY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-206; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	54	36	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30455	30467		10.1074/jbc.M112.354415	http://dx.doi.org/10.1074/jbc.M112.354415			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778268	Green Published, hybrid			2022-12-25	WOS:000308579800038
J	Thom, SR; Bhopale, VM; Milovanova, TN; Yang, M; Bogush, M				Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina			Thioredoxin Reductase Linked to Cytoskeleton by Focal Adhesion Kinase Reverses Actin S-Nitrosylation and Restores Neutrophil beta(2) Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERBARIC-OXYGEN THERAPY; MYOCARDIAL-INFARCTION; REDOX REGULATION; NITRIC-OXIDE; INHIBITION; REPERFUSION; ADHERENCE; INJURY; BETA(2)-INTEGRIN; PHOSPHORYLATION	The investigation goal was to identify mechanisms for reversal of actin S-nitrosylation in neutrophils after exposure to high oxygen partial pressures. Prior work has shown that hyperoxia causes S-nitrosylated actin (SNO-actin) formation, which mediates beta(2) integrin dysfunction, and these changes can be reversed by formylmethionylleucylphenylalanine or 8-bromo-cyclic GMP. Herein we show that thioredoxin reductase (TrxR) is responsible for actin denitrosylation. Approximately 80% of cellular TrxR is localized to the cytosol, divided between the G-actin and short filamentous actin (sF-actin) fractions based on Triton solubility of cell lysates. TrxR linkage to sF-actin requires focal adhesion kinase (FAK) based on immunoprecipitation studies. S-Nitrosylation accelerates actin filament turnover (by mechanisms described previously (Thom, S. R., Bhopale, V. M., Yang, M., Bogush, M., Huang, S., and Milovanova, T. (2011) Neutrophil beta(2) integrin inhibition by enhanced interactions of vasodilator stimulated phosphoprotein with S-nitrosylated actin. J. Biol. Chem. 286, 32854-32865), which causes FAK to disassociate from sF-actin. TrxR subsequently dissociates from FAK, and the physical separation from actin impedes denitrosylation. If SNO-actin is photochemically reduced with UV light or if actin filament turnover is impeded by incubations with cytochalasin D, latrunculin B, 8-bromo-cGMP, or formylmethionylleucylphenylalanine, FAK and TrxR reassociate with sF-actin and cause SNO-actin removal. FAK-TrxR association can also be demonstrated using isolated enzymes in ex vivo preparations. Uniquely, the FAK kinase domain is the site of TrxR linkage. We conclude that through its scaffold function, FAK influences TrxR activity and actin S-nitrosylation.	[Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina] Univ Penn, Med Ctr, Inst Environm Med, Philadelphia, PA 19104 USA; [Thom, Stephen R.] Univ Penn, Med Ctr, Dept Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thom, SR (corresponding author), Univ Penn, Inst Environm, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	sthom@mail.med.upenn.edu			Office of Naval Research; National Institutes of Health [P30CA016520, ES013508-04]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the Office of Naval Research.; Mass spectrometry analysis was provided by the Proteomics Core Facility, University of Pennsylvania, supported by National Institutes of Health Grants P30CA016520 (to the Abramson Cancer Center) and ES013508-04 (to the Center of Excellence in Environmental Toxicology).	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; Buras JA, 2006, CRIT CARE MED, V34, P2624, DOI 10.1097/01.CCM.0000239438.22758.E0; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Du P, 2005, PROTEIN EXPRES PURIF, V44, P121, DOI 10.1016/j.pep.2005.04.018; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373; ILLC D, 1995, NATURE, V377, P539; Juttner B, 2003, UNDERSEA HYPERBAR M, V30, P305; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; MILESKI WJ, 1990, SURGERY, V108, P206; MILESKI WJ, 1993, J SURG RES, V54, P349, DOI 10.1006/jsre.1993.1056; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; ROSS RM, 1965, LANCET, V1, P579; Sada K, 1997, EUR J BIOCHEM, V248, P827, DOI 10.1111/j.1432-1033.1997.00827.x; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shandling AH, 1997, AM HEART J, V134, P544, DOI 10.1016/S0002-8703(97)70093-0; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Sharifi Mohsen, 2002, Cardiovasc Radiat Med, V3, P124, DOI 10.1016/S1522-1865(03)00104-5; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sroka J, 2007, BIOL CELL, V99, P677, DOI 10.1042/BC20070024; Stavitsky Y, 1998, CARDIOLOGY, V90, P131, DOI 10.1159/000006832; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tabassam FH, 1999, CELL IMMUNOL, V193, P179, DOI 10.1006/cimm.1999.1472; Tahepold P, 2003, J THORAC CARDIOV SUR, V125, P650, DOI 10.1067/mtc.2003.36; Tahepold P, 2001, LIFE SCI, V68, P1629, DOI 10.1016/S0024-3205(01)00964-X; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Thom SR, 1997, AM J PHYSIOL-CELL PH, V272, pC770, DOI 10.1152/ajpcell.1997.272.3.C770; THOM SR, 1986, J INFECT DIS, V154, P504, DOI 10.1093/infdis/154.3.504; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Wang XG, 2010, ANTIOXID REDOX SIGN, V13, P565, DOI 10.1089/ars.2009.2833; Wang XD, 2008, FREE RADICAL BIO MED, V44, P1362, DOI 10.1016/j.freeradbiomed.2007.12.032; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wong Howard P., 1996, Surgical Forum, V47, P705; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; Zheng DH, 2009, BIOCHEM BIOPH RES CO, V388, P301, DOI 10.1016/j.bbrc.2009.07.156	63	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30346	30357		10.1074/jbc.M112.355875	http://dx.doi.org/10.1074/jbc.M112.355875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778269	hybrid, Green Published			2022-12-25	WOS:000308579800027
J	Cheng, Q; Sohl, CD; Yoshimoto, FK; Guengerich, FP				Cheng, Qian; Sohl, Christal D.; Yoshimoto, Francis K.; Guengerich, F. Peter			Oxidation of Dihydrotestosterone by Human Cytochromes P450 19A1 and 3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLACENTAL AROMATASE; HUMAN-LIVER; ESTROGEN 2-HYDROXYLASE; DRUG-METABOLISM; STEROID 5-ALPHA-REDUCTASE; STRUCTURAL BASIS; MODEL REACTION; IN-VITRO; AROMATIZATION; MICROSOMES	Dihydrotestosterone is a more potent androgen than testosterone and plays an important role in endocrine function. We demonstrated that, like testosterone, dihydrotestosterone can be oxidized by human cytochrome P450 (P450) 19A1, the steroid aromatase. The products identified include the 19-hydroxy- and 19-oxo derivatives and the resulting Delta(1,10)-, Delta(5,10)-, and Delta(9,10)-dehydro 19-norsteroid products (loss of 19-methyl group). The overall catalytic efficiency of oxidation was similar to 10-fold higher than reported for 3 alpha-reduction by 3 alpha-hydroxysteroid dehydrogenase, the major enzyme known to deactivate dihydrotestosterone. These and other studies demonstrate the flexibility of P450 19A1 in removing the 1- and 2-hydrogens from 19-norsteroids, the 2-hydrogen from estrone, and (in this case) the 1-, 5 beta-, and 9 beta-hydrogens of dihydrotestosterone. Incubation of dihydrotestosterone with human liver microsomes and NADPH yielded the 18- and 19-hydroxy products plus the Delta(1,10)-dehydro 19-nor product identified in the P450 19A1 reaction. The 18- and 19-hydroxylation reactions were attributed to P450 3A4, and 18- and 19-hydroxydihydrotestosterone were identified in human plasma and urine samples. The change in the pucker of the A ring caused by reduction of the Delta(4,5) bond is remarkable in shifting the course of hydroxylation from the 6 beta-, 2 beta-, 1 beta-, and 15 beta-methylene carbons (testosterone) to the axial methyl groups (18, 19) in dihydrotestosterone and demonstrates the sensitivity of P450 3A4, even with its large active site, to small changes in substrate structure.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Yoshimoto, Francis/0000-0002-2308-2999	National Institutes of Health [R37 CA090426, R01 GM069970, T32 ES007028, P30 ES000267]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426, R01 GM069970, T32 ES007028, and P30 ES000267.	AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Almadhidi J, 1996, J STEROID BIOCHEM, V59, P55, DOI 10.1016/S0960-0760(96)00085-4; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200; BRODIE AMH, 1993, PHARMACOL THERAPEUT, V60, P501, DOI 10.1016/0163-7258(93)90033-A; Carey F. A., 1990, ADV ORGANIC CHEM A, P12; Carruba G, 2009, ANN NY ACAD SCI, V1155, P187, DOI 10.1111/j.1749-6632.2009.03706.x; COLE PA, 1988, J AM CHEM SOC, V110, P1284, DOI 10.1021/ja00212a043; CONNEY AH, 1967, PHARMACOL REV, V19, P317; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Frye SV, 2006, CURR TOP MED CHEM, V6, P405, DOI 10.2174/156802606776743101; GAILLARD JL, 1987, J BIOL CHEM, V262, P5717; GED C, 1989, BRIT J CLIN PHARMACO, V28, P373, DOI 10.1111/j.1365-2125.1989.tb03516.x; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P363, DOI 10.1021/tx00016a015; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; HAMBURGERBAR R, 1977, ACTA ENDOCRINOL-COP, V84, P813, DOI 10.1530/acta.0.0840813; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Harada N, 1998, J CLIN ENDOCR METAB, V83, P697, DOI 10.1210/jc.83.2.697; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106, DOI 10.1093/oxfordjournals.jbchem.a122213; HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; KERR JA, 1966, CHEM REV, V66, P465, DOI 10.1021/cr60243a001; KNOX LH, 1965, J ORG CHEM, V30, P2198, DOI 10.1021/jo01018a019; Krauser JA, 2005, J BIOL CHEM, V280, P19496, DOI 10.1074/jbc.M501854200; Krauser JA, 2004, EUR J BIOCHEM, V271, P3962, DOI 10.1111/j.1432-1033.2004.04339.x; LESCHBER G, 1989, ANDROLOGIA, V21, P529; MILLER JA, 1970, CANCER RES, V30, P559; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; OH SS, 1994, J CHEM SOC PERK T 1, P2237, DOI 10.1039/p19940002237; OKAZAKI O, 1993, J BIOL CHEM, V268, P1546; Okubo K, 1996, ENDOCR J, V43, P363, DOI 10.1507/endocrj.43.363; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; RYAN KJ, 1958, BIOCHIM BIOPHYS ACTA, V27, P658, DOI 10.1016/0006-3002(58)90408-6; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; SMUK M, 1977, J CLIN ENDOCR METAB, V45, P1009, DOI 10.1210/jcem-45-5-1009; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Tang ZM, 2010, ANAL CHEM, V82, P7706, DOI 10.1021/ac1015497; TOWNSLEY JD, 1968, BIOCHEMISTRY-US, V7, P33, DOI 10.1021/bi00841a005; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	57	20	20	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29554	29567		10.1074/jbc.M112.390047	http://dx.doi.org/10.1074/jbc.M112.390047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773874	Green Published, hybrid			2022-12-25	WOS:000308286900031
J	Feng, HZ; Chen, XQ; Hossain, MM; Jin, JP				Feng, Han-Zhong; Chen, Xuequn; Hossain, M. Moazzem; Jin, Jian-Ping			Toad Heart Utilizes Exclusively Slow Skeletal Muscle Troponin T AN EVOLUTIONARY ADAPTATION WITH POTENTIAL FUNCTIONAL BENEFITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILITY; EXTENSION; ISOFORMS; FIBERS	The three isoforms of vertebrate troponin T (TnT) are normally expressed in a muscle type-specific manner. Here we report an exception that the cardiac muscle of toad (Bufo) expresses exclusively slow skeletal muscle TnT(ssTnT) together with cardiac forms of troponin I and myosin as determined using immunoblotting, cDNA cloning, and/or LC-MS/MS. Using RT-PCR and 3'- and 5'-rapid amplification of cDNA ends on toad cardiac mRNA, we cloned full-length cDNAs encoding two alternatively spliced variants of ssTnT. Expression of the cloned cDNAs in Escherichia coli confirmed that the toad cardiac muscle expresses solely ssTnT, predominantly the low molecular weight variant with the exon 5-encoded NH2-terminal segment spliced out. Functional studies were performed in ex vivo working toad hearts and compared with the frog (Rana) hearts. The results showed that toad hearts had higher contractile and relaxation velocities and were able to work against a significantly higher afterload than that of frog hearts. Therefore, the unique evolutionary adaptation of utilizing exclusively ssTnT in toad cardiac muscle corresponded to a fitness value from improving systolic function of the heart. The data demonstrated a physiological importance of the functional diversity of TnT isoforms. The structure-function relationship of TnT may be explored for the development of new treatment of heart failure.	[Feng, Han-Zhong; Chen, Xuequn; Hossain, M. Moazzem; Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), 540 E Canfield St,Scott Hall 5374, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063	National Institutes of Health [AR048816, HL098945]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR048816 and HL098945 (to J. P. J.).	Barton PJR, 2004, MOL CELL BIOCHEM, V263, P91, DOI 10.1023/B:MCBI.0000041851.53074.72; BORAL M C, 1970, Proceedings of the Indian National Science Academy Part B Biological Sciences, V36, P369; Brotto MA, 2006, AM J PHYSIOL-CELL PH, V290, pC567, DOI 10.1152/ajpcell.00422.2005; CHATTERI.CD, 1974, AM J PHYSIOL, V226, P408, DOI 10.1152/ajplegacy.1974.226.2.408; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Feng HZ, 2011, J APPL PHYSIOL, V111, P834, DOI 10.1152/japplphysiol.00031.2011; Feng HZ, 2009, J BIOL CHEM, V284, P31798, DOI 10.1074/jbc.M109.020826; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HILLMAN SS, 1988, J COMP PHYSIOL B, V157, P807, DOI 10.1007/BF00691012; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2000, AM J PHYSIOL-CELL PH, V279, pC1067, DOI 10.1152/ajpcell.2000.279.4.C1067; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Mazza R, 2008, AM J PHYSIOL-HEART C, V295, pH113, DOI 10.1152/ajpheart.00172.2008; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Perry SV, 2008, BIOCHEM BIOPH RES CO, V369, P43, DOI 10.1016/j.bbrc.2007.11.185; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; SCHADT JC, 1991, AM J PHYSIOL, V260, pH305; SIMONS JR, 1957, J PHYSIOL-LONDON, V137, P12, DOI 10.1113/jphysiol.1957.sp005793; Wei B, 2011, ARCH BIOCHEM BIOPHYS, V505, P144, DOI 10.1016/j.abb.2010.10.013; Yu ZB, 2007, AM J PHYSIOL-CELL PH, V292, pC1192, DOI 10.1152/ajpcell.00462.2006	27	12	12	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29753	29764		10.1074/jbc.M112.373191	http://dx.doi.org/10.1074/jbc.M112.373191			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778265	hybrid, Green Published			2022-12-25	WOS:000308286900051
J	Zhang, L; Huang, M; Blair, IA; Penning, TM				Zhang, Li; Huang, Meng; Blair, Ian A.; Penning, Trevor M.			Detoxication of Benzo[a]pyrene-7,8-dione by Sulfotransferases (SULTs) in Human Lung Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PAH O-QUINONES; ALDO-KETO REDUCTASE; HUMAN DIHYDRODIOL DEHYDROGENASE; FORM PHENOL SULFOTRANSFERASES; REACTIVE OXYGEN; CYTOSOLIC SULFOTRANSFERASES; MOLECULAR-CLONING; DNA-ADDUCTS; A549 CELLS	Polycyclic aromatic hydrocarbons (PAH) are environmental and tobacco carcinogens. Human aldo-keto reductases catalyze the metabolic activation of proximate carcinogenic PAH trans-dihydrodiols to yield electrophilic and redox-active o-quinones. Benzo[a]pyrene-7,8-dione a representative PAH o-quinone is reduced back to the corresponding catechol to generate a futile redox-cycle. We investigated whether sulfonation of PAH catechols by human sulfotransferases (SULT) could intercept the catechol in human lung cells. RT-PCR identified SULT1A1, -1A3, and -1E1 as the isozymes expressed in four human lung cell lines. The corresponding recombinant SULTs were examined for their substrate specificity. Benzo[a] pyrene-7,8-dione was reduced to benzo[a] pyrene-7,8-catechol by dithiothreitol under anaerobic conditions and then further sulfonated by the SULTs in the presence of 3'-[S-35]phosphoadenosine 5'-phosphosulfate as the sulfonate group donor. The human SULTs catalyzed the sulfonation of benzo[a] pyrene-7,8-catechol and generated two isomeric benzo[a] pyrene-7,8-catechol O-monosulfate products that were identified by reversed phase HPLC and by LC-MS/MS. The various SULT isoforms produced the two isomers in different proportions. Two-dimensional H-1 and C-13 NMR assigned the two regioisomers of benzo[a] pyrene-7,8-catechol monosulfate as 8-hydroxy-benzo[a]pyrene-7-O-sulfate (M1) and 7-hydroxy-benzo[a]pyrene-8-O-sulfate (M2), respectively. The kinetic profiles of three SULTs were different. SULT1A1 gave the highest catalytic efficiency (k(cat)/K-m) and yielded a single isomeric product corresponding to M1. By contrast, SULT1E1 showed distinct substrate inhibition and formed both M1 and M2. Based on expression levels, catalytic efficiency, and the fact that the lung cells only produce M1, it is concluded that the major isoform that can intercept benzo[a] pyrene-7,8-catechol is SULT1A1.	Univ Penn, Perelman Sch Med, Dept Pharmacol, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Dept Pharmacol, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Penning, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu	Zhang, Li/F-9782-2013	Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [P30-ES-013508, R01-CA39504, PA-DOH4100038714]; NATIONAL CANCER INSTITUTE [P30CA016520, R01CA039504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-ES-013508, R01-CA39504, and PA-DOH4100038714 (to T. M. P.).	Adjei AA, 2002, BIOCHEM BIOPH RES CO, V292, P402, DOI 10.1006/bbrc.2002.6658; Balu N, 2006, ANAL BIOCHEM, V355, P213, DOI 10.1016/j.ab.2006.05.023; Burczynski ME, 1998, BIOCHEMISTRY-US, V37, P6781, DOI 10.1021/bi972725u; Burczynski ME, 1999, CANCER RES, V59, P607; CAPPIELLO M, 1989, EUR J CLIN PHARMACOL, V37, P317, DOI 10.1007/BF00679793; Carlini EJ, 2001, PHARMACOGENETICS, V11, P57, DOI 10.1097/00008571-200102000-00007; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; CAVALIERI EL, 1995, XENOBIOTICA, V25, P677, DOI 10.3109/00498259509061885; CONNEY AH, 1982, CANCER RES, V42, P4875; Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8; Ebmeier CC, 2004, J CLIN ENDOCR METAB, V89, P5597, DOI 10.1210/jc.2003-031939; Falany CN, 1995, ANN NY ACAD SCI, V774, P59, DOI 10.1111/j.1749-6632.1995.tb17372.x; FOLDES A, 1973, BIOCHIM BIOPHYS ACTA, V327, P365, DOI 10.1016/0005-2744(73)90419-1; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Glatt H, 2004, N-S ARCH PHARMACOL, V369, P55, DOI 10.1007/s00210-003-0826-0; GRIMMER G, 1975, J ASSOC OFF ANA CHEM, V58, P725; Harvey RG, 2004, J ORG CHEM, V69, P2024, DOI 10.1021/jo030348n; Hildebrandt HAT, 2004, BIOCHEM BIOPH RES CO, V321, P870, DOI 10.1016/j.bbrc.2004.07.038; Huang M, 2012, CHEM RES TOXICOL, V25, P993, DOI 10.1021/tx200463s; Hui Y, 2008, BIOL PHARM BULL, V31, P769, DOI 10.1248/bpb.31.769; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; KOREEDA M, 1978, SCIENCE, V199, P778, DOI 10.1126/science.622566; Liu MC, 2000, J BIOL CHEM, V275, P13460, DOI 10.1074/jbc.275.18.13460; MALAVEILLE C, 1977, MUTAT RES, V44, P313, DOI 10.1016/0027-5107(77)90091-4; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; MURTY VS, 1992, CHEM-BIOL INTERACT, V84, P169, DOI 10.1016/0009-2797(92)90077-X; MURTY VS, 1992, BIOCONJUGATE CHEM, V3, P218, DOI 10.1021/bc00015a003; Nagar S, 2006, MOL PHARMACOL, V69, P2084, DOI 10.1124/mol.105.019240; Negishi M, 2001, ARCH BIOCHEM BIOPHYS, V390, P149, DOI 10.1006/abbi.2001.2368; Nesnow S, 1995, TOXICOLOGY, V105, P403, DOI 10.1016/0300-483X(95)03238-B; Pai TG, 2002, BBA-GEN SUBJECTS, V1573, P165, DOI 10.1016/S0304-4165(02)00416-6; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palackal NT, 2001, BIOCHEMISTRY-US, V40, P10901, DOI 10.1021/bi010872t; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Raftogianis RB, 1999, BIOCHEM PHARMACOL, V58, P605, DOI 10.1016/S0006-2952(99)00145-8; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Sakakibara Y, 1998, J BIOL CHEM, V273, P6242, DOI 10.1074/jbc.273.11.6242; Shen YM, 2006, CHEM RES TOXICOL, V19, P1441, DOI 10.1021/tx0601206; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Shimada T, 1996, CANCER RES, V56, P2979; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Shultz CA, 2011, CHEM RES TOXICOL, V24, P2153, DOI 10.1021/tx200294c; Somers GI, 2007, DRUG METAB DISPOS, V35, P1797, DOI 10.1124/dmd.107.015966; Stanley EL, 2005, MOL CELL ENDOCRINOL, V240, P32, DOI 10.1016/j.mce.2005.06.003; Taskinen J, 2003, DRUG METAB DISPOS, V31, P1187, DOI 10.1124/dmd.31.9.1187; Wang YF, 2002, LUNG CANCER, V35, P137, DOI 10.1016/S0169-5002(01)00406-8; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zhang L, 2011, J BIOL CHEM, V286, P25644, DOI 10.1074/jbc.M111.240739	50	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29909	29920		10.1074/jbc.M112.386052	http://dx.doi.org/10.1074/jbc.M112.386052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782890	Green Published, hybrid			2022-12-25	WOS:000308286900064
J	Korcekova, D; Gombitova, A; Raska, I; Cmarko, D; Lanctot, C				Korcekova, Darina; Gombitova, Adriana; Raska, Ivan; Cmarko, Dusan; Lanctot, Christian			Nucleologenesis in the Caenorhabditis elegans Embryo	PLOS ONE			English	Article							RIBOSOMAL-RNA; C-ELEGANS; NUCLEOLAR RNA; POLYMERASE-I; CELL-CYCLE; TRANSCRIPTION; PROTEIN; LOCALIZATION; FIBRILLARIN; DYNAMICS	In the Caenorhabditis elegans nematode, the oocyte nucleolus disappears prior to fertilization. We have now investigated the re-formation of the nucleolus in the early embryo of this model organism by immunostaining for fibrillarin and DAO-5, a putative NOLC1/Nopp140 homolog involved in ribosome assembly. We find that labeled nucleoli first appear in somatic cells at around the 8-cell stage, at a time when transcription of the embryonic genome begins. Quantitative analysis of radial positioning showed the nucleolus to be localized at the nuclear periphery in a majority of early embryonic nuclei. At the ultrastructural level, the embryonic nucleolus appears to be composed of a relatively homogenous core surrounded by a crescent-shaped granular structure. Prior to embryonic genome activation, fibrillarin and DAO-5 staining is seen in numerous small nucleoplasmic foci. This staining pattern persists in the germline up to the similar to 100-cell stage, until the P4 germ cell divides to give rise to the Z2/Z3 primordial germ cells and embryonic transcription is activated in this lineage. In the ncl-1 mutant, which is characterized by increased transcription of rDNA, DAO-5-labeled nucleoli are already present at the 2-cell stage. Our results suggest a link between the activation of transcription and the initial formation of nucleoli in the C. elegans embryo.	[Korcekova, Darina; Gombitova, Adriana; Raska, Ivan; Cmarko, Dusan; Lanctot, Christian] Charles Univ Prague, Inst Cellular Biol & Pathol, Fac Med 1, Prague, Czech Republic	Charles University Prague	Korcekova, D (corresponding author), Charles Univ Prague, Inst Cellular Biol & Pathol, Fac Med 1, Prague, Czech Republic.	christian.lanctot@lf1.cuni.cz	Cmarko, Dusan/G-3712-2017; Raska, Ivan/H-2326-2017; Majovská, Darina/AAS-3786-2021	Cmarko, Dusan/0000-0002-7467-8565; Raska, Ivan/0000-0002-2583-5595; Lanctot, Christian/0000-0003-3211-3061	Charles University in Prague [UNCE 204022, Prvouk/1LF/1]; Czech Science Foundation [P302/11/1262]; NICHD; NIH National Center for Research Resources (NCRR, USA)	Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH National Center for Research Resources (NCRR, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded in part by programs of the Charles University in Prague (UNCE 204022 and Prvouk/1LF/1) as well as by the Czech Science Foundation (grant no. P302/11/1262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Thomas Cremer for providing the eADS program, Jens Nagel for help in using it, Jana Smigova for help with high pressure freezing and cryo-embedding, and Dr. Susan Strome for the kind gift of the PGL-1 antiserum. The DAO-5 antibody, developed by M. L. Nonet, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology at the University of Iowa (USA). The ncl-1(e1865) strain was provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR, USA).	ALBERTSON DG, 1984, EMBO J, V3, P1227, DOI 10.1002/j.1460-2075.1984.tb01957.x; Angelier N, 2005, MOL BIOL CELL, V16, P2862, DOI 10.1091/mbc.e05-01-0041; Baran V, 2001, MOL REPROD DEV, V59, P277, DOI 10.1002/mrd.1032; BARAN V, 1995, MOL REPROD DEV, V40, P305, DOI 10.1002/mrd.1080400306; CAIRNS C, 1995, J CELL SCI, V108, P3339; Cheutin T, 2002, J CELL SCI, V115, P3297; Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437; DiMario PJ, 2004, INT REV CYTOL, V239, P99, DOI 10.1016/S0074-7696(04)39003-0; Duerr Janet S, 2006, WormBook, P1; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Dundr M, 1997, CHROMOSOMA, V105, P407, DOI 10.1007/BF02510477; EDGAR LG, 1994, DEVELOPMENT, V120, P443; ELLIS RE, 1986, NUCLEIC ACIDS RES, V14, P2345, DOI 10.1093/nar/14.5.2345; FERREIRA J, 1995, DEVELOPMENT, V121, P601; Flechon JE, 1998, ZYGOTE, V6, P183, DOI 10.1017/S0967199498000112; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; FRASER RSS, 1976, J CELL SCI, V21, P497; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; HEDGECOCK EM, 1995, GENETICS, V141, P989; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Huang ZP, 2007, GENOMICS, V89, P490, DOI 10.1016/j.ygeno.2006.12.002; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; Kupper K, 2007, RADIAL CHROMATIN POS; McCain J, 2006, CELL TISSUE RES, V323, P105, DOI 10.1007/s00441-005-0044-9; MEDINA FJ, 1995, EXP CELL RES, V221, P111, DOI 10.1006/excr.1995.1358; MEIER UT, 1992, CELL, V70, P127; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Olson MOJ, 2002, INT REV CYTOL, V219, P199; PAI CY, 1995, J CELL SCI, V108, P1911; RASKA I, 1990, J STRUCT BIOL, V104, P120, DOI 10.1016/1047-8477(90)90066-L; RASKA I, 1995, J CELL BIOCHEM, V59, P11, DOI 10.1002/jcb.240590103; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Sasano Y, 2008, BIOCHIMIE, V90, P898, DOI 10.1016/j.biochi.2008.02.001; Seydoux G, 1997, DEVELOPMENT, V124, P2191; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Seydoux G, 2001, INT REV CYTOL, V203, P139; Stiernagle Theresa, 2006, WormBook, P1; Thiry M, 2005, TRENDS CELL BIOL, V15, P194, DOI 10.1016/j.tcb.2005.02.007; Thiry M, 2009, HISTOCHEM CELL BIOL, V132, P129, DOI 10.1007/s00418-009-0599-8; Vancoppenolle B, 2000, MICROSC RES TECHNIQ, V49, P212, DOI 10.1002/(SICI)1097-0029(20000415)49:2<212::AID-JEMT15>3.0.CO;2-1; Verheggen C, 1998, J CELL BIOL, V142, P1167, DOI 10.1083/jcb.142.5.1167; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Walker AK, 2007, DEV BIOL, V304, P382, DOI 10.1016/j.ydbio.2006.12.039; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210; Zatsepina O, 2003, DEV BIOL, V253, P66, DOI 10.1006/dbio.2002.0865; Zatsepina OV, 2000, DEV BIOL, V223, P354, DOI 10.1006/dbio.2000.9762	49	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40290	10.1371/journal.pone.0040290	http://dx.doi.org/10.1371/journal.pone.0040290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768349	Green Published, Green Submitted, gold			2022-12-25	WOS:000305966500062
J	Abu Dawud, R; Schreiber, K; Schomburg, D; Adjaye, J				Abu Dawud, Raed; Schreiber, Kerstin; Schomburg, Dietmar; Adjaye, James			Human Embryonic Stem Cells and Embryonal Carcinoma Cells Have Overlapping and Distinct Metabolic Signatures	PLOS ONE			English	Article							SELF-RENEWAL; COMPLEX-III; ES CELLS; EC CELLS; DIFFERENTIATION; PATHWAY; LINE; IDENTIFICATION; PLURIPOTENCY; EXPRESSION	While human embryonic stem cells (hESCs) and human embryonal carcinoma cells (hECCs) have been studied extensively at the levels of the genome, transcriptome, proteome and epigenome our knowledge of their corresponding metabolomes is limited. Here, we present the metabolic signatures of hESCs and hESCs obtained by untargeted gas chromatography coupled to mass spectrometry (GC-MS). Whilst some metabolites are common to both cell types, representing the self-renewal and house-keeping signatures, others were either higher (e. g., octadecenoic acid, glycerol-3-phosphate, 4-hydroxyproline) or lower (e. g., glutamic acid, mannitol, malic acid, GABA) in hESCs (H9) compared to hECCs (NTERA2), these represent cell type specific signatures. Further, our combined results of GC-MS and microarray based gene expression profiling of undifferentiated and OCT4-depleted hESCs are consistent with the Warburg effect which is increased glycolysis in embryonic cells and tumor cells in the presence of O-2 while oxidative phosphorylation (OXPHOS) is impaired or even shut down. RNAi-based OCT4 knock down mediated differentiation resulted in the activation of the poised OXPHOS machinery by expressing missing key proteins such as NDUFC1, UQCRB and COX, increase in TCA cycle activity and decreased lactate metabolism. These results shed light on the metabolite layer of pluripotent stem cells and could potentially establish novel metabolic markers of self renewal and pluripotency.	[Abu Dawud, Raed; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Abu Dawud, Raed; Adjaye, James] King Saud Univ, Stem Cell Unit, Dept Anat, Riyadh, Saudi Arabia; [Schreiber, Kerstin; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Adjaye, James] Univ Dusseldorf, Fac Med, Inst Stem Cell Res & Regenerat Med, D-40225 Dusseldorf, Germany	Max Planck Society; King Saud University; Braunschweig University of Technology; Heinrich Heine University Dusseldorf	Abu Dawud, R (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	adjaye@molgen.mpg.de		Schomburg, Dietmar/0000-0002-3354-822X	ENFIN, European Network of Excellence; European Commission [LSHG-CT-2005-518254]	ENFIN, European Network of Excellence; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by ENFIN, the European Network of Excellence, funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health", contract number LSHG-CT-2005-518254 (http://www.enfin.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; ANDREWS PW, 1984, LAB INVEST, V50, P147; Avery K, 2008, STEM CELLS DEV, V17, P1195, DOI 10.1089/scd.2008.0063; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Botting NP, 1995, CHEM SOC REV, V24, P401, DOI 10.1039/cs9952400401; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cezar GG, 2007, STEM CELLS DEV, V16, P869, DOI 10.1089/scd.2007.0022; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig Tenneille, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c02s2; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; STONE TW, 1993, PHARMACOL REV, V45, P309; SUZUKI H, 1989, BIOCHEM BIOPH RES CO, V161, P371, DOI 10.1016/0006-291X(89)91607-0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ton C, 1997, BIOCHEM BIOPH RES CO, V241, P589, DOI 10.1006/bbrc.1997.7707; Walsh J, 2003, APMIS, V111, P197, DOI 10.1034/j.1600-0463.2003.1110124.x; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	42	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39896	10.1371/journal.pone.0039896	http://dx.doi.org/10.1371/journal.pone.0039896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768158	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100127
J	Bai, XF; Song, ZG; Fu, YZ; Yu, ZJ; Zhao, L; Zhao, HS; Yao, WF; Huang, DS; Mi, XY; Wang, EH; Zheng, ZH; Wei, MJ				Bai, Xuefeng; Song, Zhiguo; Fu, Yingzi; Yu, Zhaojin; Zhao, Lin; Zhao, Haishan; Yao, Weifan; Huang, Desheng; Mi, Xiaoyi; Wang, Enhua; Zheng, Zhihong; Wei, Minjie			Clinicopathological Significance and Prognostic Value of DNA Methyltransferase 1, 3a, and 3b Expressions in Sporadic Epithelial Ovarian Cancer	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; PROTEIN OVEREXPRESSION; CLINICAL-SIGNIFICANCE; PROMOTER METHYLATION; ABERRANT METHYLATION; BREAST CARCINOMAS; DOWN-REGULATION; POOR-PROGNOSIS; GASTRIC-CANCER	Altered DNA methylation of tumor suppressor gene promoters plays a role in human carcinogenesis and DNA methyltransferases (DNMTs) are responsible for it. This study aimed to determine aberrant expression of DNMT1, DNMT3a, and DNMT3b in benign and malignant ovarian tumor tissues for their association with clinicopathological significance and prognostic value. A total of 142 ovarian cancers and 44 benign ovarian tumors were recruited for immunohistochemical analysis of their expression. The data showed that expression of DNMT1, DNMT3a, and DNMT3b was observed in 76 (53.5%), 92 (64.8%) and 79 (55.6%) of 142 cases of ovarian cancer tissues, respectively. Of the serious tumors, DNMT3a protein expression was significantly higher than that in benign tumor samples (P = 0.001); DNMT3b was marginally significant down regulated in ovarian cancers compared to that of the benign tumors (P = 0.054); DNMT1 expression has no statistical difference between ovarian cancers and benign tumor tissues (P = 0.837). Of the mucious tumors, the expression of DNMT3a, DNMT3b, and DNMT1 was not different between malignant and benign tumors. Moreover, DNMT1 expression was associated with DNMT3b expression (P = 0.020, r = 0.195). DNMT1 expression was associated with age of the patients, menopause status, and tumor localization, while DNMT3a expression was associated with histological types and serum CA125 levels and DNMT3b expression was associated with lymph node metastasis. In addition, patients with DNMT1 or DNMT3b expression had a trend of better survival than those with negative expression. Co-expression of DNMT1 and DNMT3b was significantly associated with better overall survival (P = 0.014). The data from this study provided the first evidence for differential expression of DNMTs proteins in ovarian cancer tissues and their associations with clinicopathological and survival data in sporadic ovarian cancer patients.	[Bai, Xuefeng; Song, Zhiguo; Fu, Yingzi; Yu, Zhaojin; Zhao, Lin; Zhao, Haishan; Yao, Weifan; Wei, Minjie] China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China; [Huang, Desheng] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Liaoning, Peoples R China; [Mi, Xiaoyi; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Dept Pathol, Shenyang, Liaoning, Peoples R China; [Mi, Xiaoyi; Wang, Enhua; Zheng, Zhihong; Wei, Minjie] China Med Univ, Inst Pathophysiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Bai, XF (corresponding author), China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China.	weiminjiecmu@163.com			National Natural Science Foundation of China [30873097, 30973559]; Science and Technology Department of Liaoning Province [2010225001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported in part by grants from the National Natural Science Foundation of China (No. 30873097 and No. 30973559) and the Science and Technology Department of Liaoning Province (No. 2010225001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P299, DOI 10.1006/gyno.2001.6284; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; BESTOR TH, 1988, GENE, V74, P9, DOI 10.1016/0378-1119(88)90238-7; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Bukowski RM, 2007, SEMIN ONCOL, V34, pS1, DOI 10.1053/j.seminoncol.2007.03.012; Chaudhry P, 2009, CANCER INVEST, V27, P877, DOI 10.1080/07357900902849699; Chen Chun-ling, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P770; Chen HY, 2011, CANC SCI; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Ding WJ, 2008, DIGEST DIS SCI, V53, P2083, DOI 10.1007/s10620-007-0145-2; Eads CA, 1999, CANCER RES, V59, P2302; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204; Fu SQ, 2011, CANCER-AM CANCER SOC, V117, P1661, DOI 10.1002/cncr.25701; Fujii S, 2010, DIGESTION, V82, P179, DOI 10.1159/000311064; Girault I, 2003, CLIN CANCER RES, V9, P4415; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2; Klisovic RB, 2008, CLIN CANCER RES, V14, P2444, DOI 10.1158/1078-0432.CCR-07-1320; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Liu XP, 2011, BRAIN RES, V1391, P125, DOI 10.1016/j.brainres.2011.03.042; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; MANETTA A, 1995, AM J CLIN ONCOL-CANC, V18, P156, DOI 10.1097/00000421-199504000-00012; Matei DE, 2010, GYNECOL ONCOL, V116, P195, DOI 10.1016/j.ygyno.2009.09.043; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Oh BK, 2007, INT J MOL MED, V20, P65; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Park HJ, 2006, CANCER LETT, V233, P271, DOI 10.1016/j.canlet.2005.03.017; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Partridge EE, 1999, CA-CANCER J CLIN, V49, P297, DOI 10.3322/canjclin.49.5.297; Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x; Plumb JA, 2000, CANCER RES, V60, P6039; Plummer R, 2009, CLIN CANCER RES, V15, P3177, DOI 10.1158/1078-0432.CCR-08-2859; Pradhan S, 1997, NUCLEIC ACIDS RES, V25, P4666, DOI 10.1093/nar/25.22.4666; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; Rajendran G, 2011, J NEUROONCOL; Ramzy Iman I, 2011, Arab J Gastroenterol, V12, P139, DOI 10.1016/j.ajg.2011.07.002; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; Sawada M, 2007, CANCER LETT, V251, P211, DOI 10.1016/j.canlet.2006.11.023; Shieh YS, 2005, CANCER-AM CANCER SOC, V104, P1013, DOI 10.1002/cncr.21278; Sun L, 1997, JPN J CANCER RES, V88, P1165, DOI 10.1111/j.1349-7006.1997.tb00345.x; Teodoridis JM, 2005, CANCER RES, V65, P8961, DOI 10.1158/0008-5472.CAN-05-1187; Tessema M, 2003, LEUKEMIA, V17, P910, DOI 10.1038/sj.leu.2402891; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Wei SH, 2006, CLIN CANCER RES, V12, P2788, DOI 10.1158/1078-0432.CCR-05-1551; Wu D., 2011, LUNG CANC; Xing J, 2008, BRIT J CANCER, V98, P1716, DOI 10.1038/sj.bjc.6604343; Xu L, 2011, GUT; Yang B., 2011, UROL ONCOL; Yang J, 2011, MOL MED REP, V4, P1139, DOI 10.3892/mmr.2011.578; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Zhou W, 2009, J CANCER RES CLIN, V135, P91, DOI 10.1007/s00432-008-0435-x	59	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40024	10.1371/journal.pone.0040024	http://dx.doi.org/10.1371/journal.pone.0040024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768205	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100177
J	Barra, NG; Chew, MV; Reid, S; Ashkar, AA				Barra, Nicole G.; Chew, Marianne V.; Reid, Sarah; Ashkar, Ali A.			Interleukin-15 Treatment Induces Weight Loss Independent of Lymphocytes	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ADIPOSE-TISSUE; T-CELLS; GLUCOSE-INTOLERANCE; IMMUNE-RESPONSES; POTENTIAL ROLE; NK CELLS; IL-15; OBESITY; INFLAMMATION	Obesity is a chronic inflammatory condition characterized by activation and infiltration of proinflammatory immune cells and a dysregulated production of proinflammatory cytokines. While known as a key regulator of immune natural killer (NK) cell function and development, we have recently demonstrated that reduced expression of the cytokine Interleukin-15 (IL-15) is closely linked with increased body weight and adiposity in mice and humans. Previously, we and others have shown that obese individuals have lower circulating levels of IL-15 and NK cells. Lean IL-15 overexpressing (IL-15 tg) mice had an accumulation in adipose NK cells compared to wildtype and NK cell deficient obese IL-15(-/-) mice. Since IL-15 induces weight loss in IL-15(-/-) and diet induced obese mice and has effects on various lymphocytes, the aim of this paper was to determine if lymphocytes, particularly NK cells, play a role in IL-15 mediated weight loss. Acute IL-15 treatment resulted in an increased accumulation of NK, NKT, and CD3(+) T cells in adipose tissue of B6 mice. Mice depleted of NK and NKT cells had similar weight loss comparable to controls treated with IL-15. Finally, IL-15 treatment induces significant weight loss in lymphocyte deficient RAG2(-/-) gamma c(-/-) mice independent of food intake. Fat pad cross-sections show decreased pad size with cytokine treatment is due to adipocyte shrinkage. These results clearly suggest that IL-15 mediates weight loss independent of lymphocytes.	[Barra, Nicole G.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada; McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Barra, NG (corresponding author), McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	ashkara@mcmaster.ca	Barra, Nicole/ABG-2670-2021	Barra, Nicole/0000-0002-2605-0845; Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro V, 2006, BBA-MOL CELL BIOL L, V1761, P37, DOI 10.1016/j.bbalip.2005.12.006; Almendro V, 2005, INT J MOL MED, V15, P963; Almendro V, 2008, OBESITY, V16, P285, DOI 10.1038/oby.2007.47; Almendro V, 2009, INT J MOL MED, V24, P453, DOI 10.3892/ijmm_00000252; Alvarez B, 2002, BBA-GEN SUBJECTS, V1570, P33, DOI 10.1016/S0304-4165(02)00148-4; Alves NL, 2003, BLOOD, V102, P2541, DOI 10.1182/blood-2003-01-0183; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Carbo N, 2001, BBA-GEN SUBJECTS, V1526, P17, DOI 10.1016/S0304-4165(00)00188-4; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Conde J, 2010, EXPERT REV CLIN IMMU, V6, P801, DOI [10.1586/eci.10.48, 10.1586/ECI.10.48]; Davies E, 2010, J LEUKOCYTE BIOL, V88, P529, DOI 10.1189/jlb.0909648; Dunne J, 2001, J IMMUNOL, V167, P3129, DOI 10.4049/jimmunol.167.6.3129; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fuster G, 2011, LIPIDS, V46, P1033, DOI 10.1007/s11745-011-3594-5; Gill N, 2005, J VIROL, V79, P4470, DOI 10.1128/JVI.79.7.4470-4478.2005; Gill N, 2007, EUR J IMMUNOL, V37, P2529, DOI 10.1002/eji.200636997; Kanegane H, 1996, BLOOD, V88, P230; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Lee GA, 2011, J IMMUNOL, V187, P1212, DOI 10.4049/jimmunol.1100331; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lopez-Soriano J, 2004, INT J MOL MED, V13, P817; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Ohteki Toshiaki, 2002, Current Molecular Medicine (Hilversum), V2, P371, DOI 10.2174/1566524023362519; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Sharif-Askari E, 2001, JNCI-J NATL CANCER I, V93, P1724, DOI 10.1093/jnci/93.22.1724; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	48	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39553	10.1371/journal.pone.0039553	http://dx.doi.org/10.1371/journal.pone.0039553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768089	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100060
J	Gonzalez-Lopez, A; Aguirre, A; Lopez-Alonso, I; Amado, L; Astudillo, A; Fernandez-Garcia, MS; Suarez, MF; Batalla-Solis, E; Colado, E; Albaiceta, GM				Gonzalez-Lopez, Adrian; Aguirre, Alina; Lopez-Alonso, Ines; Amado, Laura; Astudillo, Aurora; Soledad Fernandez-Garcia, Maria; Suarez, Maria F.; Batalla-Solis, Estefania; Colado, Enrique; Albaiceta, Guillermo M.			MMP-8 Deficiency Increases TLR/RAGE Ligands S100A8 and S100A9 and Exacerbates Lung Inflammation during Endotoxemia	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-8; PROTEINS; INJURY; NEUTROPHILS; INHIBITION; MICE	Matrix metalloproteinase-8, released mainly from neutrophils, is a critical regulator of the inflammatory response by its ability to cleave multiple mediators. Herein, we report the results of a model of endotoxemia after intraperitoneal LPS injection in mice lacking MMP-8 and their wildtype counterparts. Control, saline-treated animals showed no differences between genotypes. However, there was an increased lung inflammatory response, with a prominent neutrophilic infiltration in mutant animals after LPS treatment. Using a proteomic approach, we identify alarmins S100A8 and S100A9 as two of the main differences between genotypes. Mice lacking MMP-8 showed a significant increase in these two molecules in lung homogenates, but not in spleen and serum. Mice lacking MMP-8 also showed an increase in MIP-1 alpha levels and a marked activation of the non-canonical NF-kappa B pathway, with no differences in CXC-chemokines such as MIP-2 or LIX. These results show that MMP-8 can modulate the levels of S100A8 and S100A9 and its absence promotes the lung inflammatory response during endotoxemia.	[Gonzalez-Lopez, Adrian; Aguirre, Alina; Lopez-Alonso, Ines; Batalla-Solis, Estefania; Albaiceta, Guillermo M.] Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Biol Func, Oviedo, Spain; [Amado, Laura; Batalla-Solis, Estefania; Albaiceta, Guillermo M.] Hosp Univ Cent Asturias, Serv Med Intens, Oviedo, Spain; [Astudillo, Aurora; Soledad Fernandez-Garcia, Maria] Hosp Univ Cent Asturias, Serv Anat Patol, Oviedo, Spain; [Suarez, Maria F.] Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Bioquim & Biol Mol, Oviedo, Spain; [Colado, Enrique] Hosp Univ Cent Asturias, Serv Hematol & Hemoterapia, Oviedo, Spain; [Albaiceta, Guillermo M.] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Gonzalez-Lopez, A (corresponding author), Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Biol Func, Oviedo, Spain.	Guillermo.muniz@sespa.princast.es	Lopez, Adrian Gonzalez/AAS-9613-2021; Albaiceta, Guillermo/AAU-5069-2020; López-Alonso, Inés/AAQ-4784-2021; Colado, Enrique/Z-6326-2019; Suárez, María Fernanda Valencia/F-8200-2019; Gonzalez, Adrian/AAD-2269-2021; López-Alonso, Inés/ABG-5496-2020	Albaiceta, Guillermo/0000-0002-9276-3253; López-Alonso, Inés/0000-0001-9183-5457; Colado, Enrique/0000-0001-8675-8207; Suárez, María Fernanda Valencia/0000-0001-8987-8431; López-Alonso, Inés/0000-0001-9183-5457; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809; Gonzalez-Lopez, Adrian/0000-0001-5347-278X	Instituto de Salud Carlos III [FIS PI 07-0597, INT 11/14]; Universidad de Oviedo [UNOV-09-pf]; Instituto Universitario de Oncologia del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) [COF-11-40]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Universidad de Oviedo; Instituto Universitario de Oncologia del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT)	Supported by Instituto de Salud Carlos III (FIS PI 07-0597). AGL is the recipient of a grant from Universidad de Oviedo (UNOV-09-pf). A. Aguirre is the recipient of a grant from Instituto Universitario de Oncologia del Principado de Asturias. EBS is the recipient of a grant from Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT, COF-11-40). GMA is the recipient of a grant from Instituto de Salud Carlos III (Intensificacion de la Actividad Investigadora-INT 11/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaiceta GM, 2008, AM J PHYSIOL-LUNG C, V294, pL535, DOI 10.1152/ajplung.00334.2007; Albaiceta GM, 2010, AM J RESP CELL MOL, V43, P555, DOI 10.1165/rcmb.2009-0034OC; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Dejonckheere E, 2011, CYTOKINE GROWTH F R, V22, P73, DOI 10.1016/j.cytogfr.2011.02.002; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Ferguson ND, 2007, CRIT CARE, V11, DOI 10.1186/cc6113; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Greenlee KJ, 2006, J IMMUNOL, V177, P7312, DOI 10.4049/jimmunol.177.10.7312; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hergrueter AH, 2011, AM J PHYSIOL-LUNG C, V300, pL512, DOI 10.1152/ajplung.00023.2011; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Khatwa UA, 2010, J LEUKOCYTE BIOL, V87, P69, DOI 10.1189/jlb.0509361; Lauhio A, 2011, PHARMACOL RES, V64, P590, DOI 10.1016/j.phrs.2011.06.019; Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004; Penzo M, 2010, J IMMUNOL, V184, P4497, DOI 10.4049/jimmunol.0903131; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Solan PD, 2012, CRIT CARE MED, V40, P379, DOI 10.1097/CCM.0b013e318232e404; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Yamakawa N, 2011, AM J PHYSIOL-LUNG C, V300, pL516, DOI 10.1152/ajplung.00118.2010	29	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39940	10.1371/journal.pone.0039940	http://dx.doi.org/10.1371/journal.pone.0039940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768176	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100146
J	Juhas, M; Stark, M; von Mering, C; Lumjiaktase, P; Crook, DW; Valvano, MA; Eberl, L				Juhas, Mario; Stark, Manuel; von Mering, Christian; Lumjiaktase, Puthapoom; Crook, Derrick W.; Valvano, Miguel A.; Eberl, Leo			High Confidence Prediction of Essential Genes in Burkholderia Cenocepacia	PLOS ONE			English	Article							RHAMNOSE-INDUCIBLE PROMOTER; ESCHERICHIA-COLI; COMPARATIVE GENOMICS; TRANSPOSON MUTAGENESIS; TRANSFER-RNA; DATABASE; IDENTIFICATION; EVOLUTION; EXCISION; ISLAND	Background: Essential genes are absolutely required for the survival of an organism. The identification of essential genes, besides being one of the most fundamental questions in biology, is also of interest for the emerging science of synthetic biology and for the development of novel antimicrobials. New antimicrobial therapies are desperately needed to treat multidrug-resistant pathogens, such as members of the Burkholderia cepacia complex. Methodology/Principal Findings: We hypothesize that essential genes may be highly conserved within a group of evolutionary closely related organisms. Using a bioinformatics approach we determined that the core genome of the order Burkholderiales consists of 649 genes. All but two of these identified genes were located on chromosome 1 of Burkholderia cenocepacia. Although many of the 649 core genes of Burkholderiales have been shown to be essential in other bacteria, we were also able to identify a number of novel essential genes present mainly, or exclusively, within this order. The essentiality of some of the core genes, including the known essential genes infB, gyrB, ubiB, and valS, as well as the so far uncharacterized genes BCAL1882, BCAL2769, BCAL3142 and BCAL3369 has been confirmed experimentally in B. cenocepacia. Conclusions/Significance: We report on the identification of essential genes using a novel bioinformatics strategy and provide bioinformatics and experimental evidence that the large majority of the identified genes are indeed essential. The essential genes identified here may represent valuable targets for the development of novel antimicrobials and their detailed study may shed new light on the functions required to support life.	[Juhas, Mario; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, CH-8008 Zurich, Switzerland; [Stark, Manuel; von Mering, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Stark, Manuel; von Mering, Christian] Univ Zurich, Swiss Inst Bioinformat, Zurich, Switzerland; [Lumjiaktase, Puthapoom] Mahidol Univ, Salaya, Nakhon Pathom, Thailand; [Crook, Derrick W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada	University of Zurich; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; Mahidol University; University of Oxford; Western University (University of Western Ontario)	Juhas, M (corresponding author), Univ Zurich, Inst Plant Biol, Dept Microbiol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	mario.juhas@uzh.ch; leo.eberl@uzh.ch	von Mering, Christian/B-3300-2008; Eberl, Leo/A-8380-2012; Valvano, Miguel A/G-8759-2012; Eberl, Leo/AAE-8165-2019	von Mering, Christian/0000-0001-7734-9102; Eberl, Leo/0000-0002-7241-0864; Valvano, Miguel A/0000-0001-8229-3641; 	European Union; MRC [G0400039] Funding Source: UKRI; Medical Research Council [G0400039] Funding Source: researchfish	European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the European Union 7th Framework Program, project NABATIVI. M.A.V. holds Canada Research Chair in Infectious Diseases and Pathogenesis, and is a Zeller's Senior Research Scientist from Cystic Fibrosis Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bohannon J, 2011, SCIENCE, V333, P1236, DOI 10.1126/science.333.6047.1236; Bottacini F, 2010, MICROBIOL-SGM, V156, P3243, DOI 10.1099/mic.0.039545-0; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Carbone A, 2006, J MOL EVOL, V63, P733, DOI 10.1007/s00239-005-0250-9; Cardona ST, 2006, APPL ENVIRON MICROB, V72, P2547, DOI 10.1128/AEM.72.4.2547-2555.2006; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Feher T, 2007, CHEM REV, V107, P3498, DOI 10.1021/cr0683111; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Karberg KA, 2011, P NATL ACAD SCI USA, V108, P20154, DOI 10.1073/pnas.1109451108; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Klein J, 2009, NUCLEIC ACIDS RES, V37, pD494, DOI 10.1093/nar/gkn674; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lechner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-141; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Loutet Slade A, 2011, Front Cell Infect Microbiol, V1, P6, DOI [10.3389/fmicb.2011.00159, 10.3389/fcimb.2011.00006]; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McCutcheon JP, 2010, CURR OPIN MICROBIOL, V13, P73, DOI 10.1016/j.mib.2009.12.002; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moya A, 2009, FEMS MICROBIOL REV, V33, P225, DOI 10.1111/j.1574-6976.2008.00151.x; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Pang ZH, 2005, J BACTERIOL, V187, P7773, DOI 10.1128/JB.187.22.7773-7783.2005; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665; Sentchilo V, 2009, MOL MICROBIOL, V72, P1293, DOI 10.1111/j.1365-2958.2009.06726.x; Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Ussery DW, 2009, GENOME DYNAM, V6, P140, DOI 10.1159/000235768; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Yoo JH, 2008, MOL MICROBIOL, V67, P1012, DOI 10.1111/j.1365-2958.2008.06104.x; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740; Yu Byung Jo, 2008, V416, P261, DOI 10.1007/978-1-59745-321-9_17; Zhang Chun-Ting, 2008, V416, P391, DOI 10.1007/978-1-59745-321-9_27; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	66	44	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40064	10.1371/journal.pone.0040064	http://dx.doi.org/10.1371/journal.pone.0040064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768221	gold, Green Published, Green Accepted			2022-12-25	WOS:000305892100193
J	Meyniel, C; Spelman, T; Jokubaitis, VG; Trojano, M; Izquierdo, G; Grand'Maison, F; Oreja-Guevara, C; Boz, C; Lugaresi, A; Girard, M; Grammond, P; Iuliano, G; Fiol, M; Cabrera-Gomez, JA; Fernandez-Bolanos, R; Giuliani, G; Lechner-Scott, J; Cristiano, E; Herbert, J; Petkovska-Boskova, T; Bergamaschi, R; van Pesch, V; Moore, F; Vella, N; Slee, M; Santiago, V; Barnett, M; Havrdova, E; Young, C; Sirbu, CA; Tanner, M; Rutherford, M; Butzkueven, H				Meyniel, Claire; Spelman, Timothy; Jokubaitis, Vilija G.; Trojano, Maria; Izquierdo, Guillermo; Grand'Maison, Francois; Oreja-Guevara, Celia; Boz, Cavit; Lugaresi, Alessandra; Girard, Marc; Grammond, Pierre; Iuliano, Gerardo; Fiol, Marcela; Antonio Cabrera-Gomez, Jose; Fernandez-Bolanos, Ricardo; Giuliani, Giorgio; Lechner-Scott, Jeannette; Cristiano, Edgardo; Herbert, Joseph; Petkovska-Boskova, Tatjana; Bergamaschi, Roberto; van Pesch, Vincent; Moore, Fraser; Vella, Norbert; Slee, Mark; Santiago, Vetere; Barnett, Michael; Havrdova, Eva; Young, Carolyn; Sirbu, Carmen-Adella; Tanner, Mary; Rutherford, Michelle; Butzkueven, Helmut		MSBasis Study Grp	Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome	PLOS ONE			English	Article							INTERFERON-BETA; ADHERENCE; DEFINITE; CONVERSION; REGISTRY; TRIAL; RISK	Objectives: We conducted a prospective study, MSBASIS, to assess factors leading to first treatment discontinuation in patients with a clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS). Methods: The MSBASIS Study, conducted by MSBase Study Group members, enrols patients seen from CIS onset, reporting baseline demographics, cerebral magnetic resonance imaging (MRI) features and Expanded Disability Status Scale (EDSS) scores. Follow-up visits report relapses, EDSS scores, and the start and end dates of MS-specific therapies. We performed a multivariable survival analysis to determine factors within this dataset that predict first treatment discontinuation. Results: A total of 2314 CIS patients from 44 centres were followed for a median of 2.7 years, during which time 1247 commenced immunomodulatory drug (IMD) treatment. Ninety percent initiated IMD after a diagnosis of MS was confirmed, and 10% while still in CIS status. Over 40% of these patients stopped their first IMD during the observation period. Females were more likely to cease medication than males (HR 1.36, p = 0.003). Patients treated in Australia were twice as likely to cease their first IMD than patients treated in Spain (HR 1.98, p = 0.001). Increasing EDSS was associated with higher rate of IMD cessation (HR 1.21 per EDSS unit, p<0.001), and intramuscular interferon-beta-1a (HR 1.38, p = 0.028) and subcutaneous interferon-beta-1a (HR 1.45, p = 0.012) had higher rates of discontinuation than glatiramer acetate, although this varied widely in different countries. Onset cerebral MRI features, age, time to treatment initiation or relapse on treatment were not associated with IMD cessation. Conclusion: In this multivariable survival analysis, female sex, country of residence, EDSS change and IMD choice independently predicted time to first IMD cessation.	[Meyniel, Claire; Spelman, Timothy; Jokubaitis, Vilija G.; Tanner, Mary; Rutherford, Michelle; Butzkueven, Helmut] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia; [Meyniel, Claire] CHU Nantes, CIC 0004, F-44035 Nantes 01, France; [Trojano, Maria] Univ Bari, Bari, Italy; [Izquierdo, Guillermo] Univ Hosp, Seville, Spain; [Grand'Maison, Francois] Clin Neuro Rive S, Greenfield Pk, PQ, Canada; [Oreja-Guevara, Celia] Univ Hosp La Paz, IdiPAZ, Madrid, Spain; [Boz, Cavit] Karadeniz Tech Univ, Trabzon, Turkey; [Lugaresi, Alessandra] Univ G dAnnunzio, Dept Neurosci & Imaging, MS Ctr, Chieti, Italy; [Girard, Marc; Grammond, Pierre] Hotel Dieu Levis, Dept Neurol, Levis, PQ, Canada; [Iuliano, Gerardo] Osped Riuniti Salerno, Salerno, Italy; [Fiol, Marcela] FLENI, Buenos Aires, DF, Argentina; [Antonio Cabrera-Gomez, Jose] Ctr Int Restaurac Neurol, Havana, Cuba; [Fernandez-Bolanos, Ricardo] Hosp Univ Virgen de Valme, Seville, Spain; [Giuliani, Giorgio] Osped Macerata, Macerata, Italy; [Lechner-Scott, Jeannette] John Hunter Hosp, Newcastle, NSW, Australia; [Cristiano, Edgardo] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Herbert, Joseph] NYU, Hosp Joint Dis, New York, NY USA; [Petkovska-Boskova, Tatjana] Clin Neurol Clin Ctr, Skopje, Macedonia; [Bergamaschi, Roberto] Neurol Inst IRCCS Mondino, Pavia, Italy; [van Pesch, Vincent] Clin Univ St Luc, B-1200 Brussels, Belgium; [Moore, Fraser] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Vella, Norbert] Mater Dei Hosp, Msida, Malta; [Slee, Mark] Flinders Univ & Med Ctr, Adelaide, SA 5001, Australia; [Santiago, Vetere] HIGA Gral, San Martin La Plata, Argentina; [Barnett, Michael] Brain Mind Res Inst, Camperdown, NSW, Australia; [Havrdova, Eva] Gen Teaching Hosp, Prague, Czech Republic; [Young, Carolyn] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Sirbu, Carmen-Adella] Cent Univ Emergency Mil Hosp, Bucharest, Romania; [Butzkueven, Helmut] Univ Melbourne, Melbourne Brain Ctr, Dept Med, Melbourne, Vic 3010, Australia; [Butzkueven, Helmut] Monash Univ, Box Hill Hosp, Dept Neurol, Melbourne, Vic 3004, Australia	Royal Melbourne Hospital; Nantes Universite; CHU de Nantes; Universita degli Studi di Bari Aldo Moro; Hospital Universitario La Paz; Karadeniz Technical University; G d'Annunzio University of Chieti-Pescara; Laval University; Hospital Valme; John Hunter Hospital; Hospital Italiano de Buenos Aires; University of Buenos Aires; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; IRCCS Fondazione Casimiro Mondino; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; McGill University; Flinders University South Australia; University of Sydney; General University Hospital Prague; Walton Centre; University of Melbourne; Box Hill Hospital; Monash University	Meyniel, C (corresponding author), Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia.	butz@unimelb.edu.au	pietrolongo, erika/AAC-5694-2020; Lucchese, Guglielmo/AAL-9860-2020; BOZ, Cavit/V-5127-2017; pucci, eugenio/I-1039-2014; SIRBU, Carmen Adella/AAA-9317-2020; Oreja-Guevara, Celia/N-5151-2019; Havrdova, Eva Kubala/P-4892-2017; Slee, Mark/J-4731-2015; Boz, Cavit/AAR-2268-2020; Jokubaitis, Vilija G./AAD-5949-2019; van Pesch, Vincent/AAK-9506-2020; Lugaresi, Alessandra/C-7743-2012	pietrolongo, erika/0000-0002-6311-5994; Lucchese, Guglielmo/0000-0002-1809-6376; pucci, eugenio/0000-0001-7606-7330; SIRBU, Carmen Adella/0000-0002-1982-1066; Oreja-Guevara, Celia/0000-0002-9221-5716; Havrdova, Eva Kubala/0000-0002-9543-4359; Slee, Mark/0000-0003-4323-2453; Boz, Cavit/0000-0003-0956-3304; Jokubaitis, Vilija G./0000-0002-3942-4340; Lugaresi, Alessandra/0000-0003-2902-5589; Young, Carolyn/0000-0003-1745-7720; Kilpatrick, Trevor/0000-0003-3999-085X; Trojano, Maria/0000-0002-6329-8946; Skibina, Olga/0000-0002-6275-8138; , Carolyn/0000-0001-6971-8203; Butzkueven, Helmut/0000-0003-3940-8727; De Luca, Giovanna/0000-0002-7693-2256; Petersen, Thor/0000-0001-5633-2600; van Pesch, Vincent/0000-0003-2885-9004; Cristiano, Edgardo/0000-0002-6400-8277; Lechner-Scott, Jeannette/0000-0002-3850-447X	MSBase Foundation; Journees de Neurologie de Langue Francaise; National Health and Medical Research Council (NHMRC) [628856]; NHMRC Australia [1032484]; Bayer Schering; Biogen Dompe; Biogen Idec; Merck Serono; Novartis; Sanofi Aventis; Teva; EMD Serono; Genzyme; ONO UBC; Associazione Italiana Sclerosi Multipla; Czech Ministry of Education [MSM 0021620849]; MS Society United Kingdom; MND association United Kingdom; British Polio Fellowship; NHMRC [628856, 566513, 628799, 1009757]; NHMRC Centre of Excellence Award [1001216]; ARC Linkage Grant [LP110100473]; National MS Society (United States of America) [RG3850A3/1]	MSBase Foundation; Journees de Neurologie de Langue Francaise; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); Bayer Schering(Bayer AG); Biogen Dompe(Biogen); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Teva(Teva Pharmaceutical Industries); EMD Serono; Genzyme(Sanofi-AventisGenzyme Corporation); ONO UBC; Associazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); MS Society United Kingdom; MND association United Kingdom; British Polio Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centre of Excellence Award(National Health and Medical Research Council (NHMRC) of Australia); ARC Linkage Grant(Australian Research Council); National MS Society (United States of America)	This study was funded by the MSBase Foundation. CM is supported by the Journees de Neurologie de Langue Francaise. HB is supported by National Health and Medical Research Council (NHMRC) Career Development Fellowship 628856, the work was supported by NHMRC Australia grant 1032484. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research Grants: The following authors have received research grants from Bayer Schering: AL, RB & MB; Biogen Dompe: AL & RB; Biogen Idec: MT, FGM, PG & MB; Merck Serono MT, AL, RB & MB; Novartis: MT, FGM, AL, RB & MB; Sanofi Aventis: AL, PG, RB & MB; Teva: FGM & MB. Travel Grants: The following authors have received travel grants from Bayer Schering: AL, VvP & CAS; Biogen Dompe: AL; Biogen Idec: MG, VvP, NV, CY & HB; EMD Serono: MG; Merck Serono: AL, VvP & CY; Novartis: TS, AL, VvP, NV & HB; Sanofi Aventis: AL, VvP & HB; Teva: AL, CY & CAS. Honoraria: The following authors have received honoraria from Bayer Schering: MT, GIz, AL, PG, JLS, JH, RB & MB; Biogen Dompe: AL & RB; Biogen Idec: MT, GIz, MG, PG, JLS, JH, VvP & MB; EMD Serono: MG, PG & FM; Merck Serono: MT, GIz, AL, JLS, JH, RB, & MB; Novartis: GIz, AL, MG, PG, JLS, RB, NV & MB; Sanofi Aventis: MT, GIz, AL, JLS, RB & MB; Teva: GIz, FGM, AL, MG, PG, JH, MB & CAS. Advisory Board Membership: The following authors report sitting on advisory boards for Bayer Schering: COG, AL, MS & CY; Biogen Dompe: AL; Biogen Idec: COG, MG, VvP, MS, CY & HB; Merck Serono: COG, AL, MS & CY; Novartis: FGM, COG, MS, CY & HB; Sanofi Aventis: MS & HB; Teva: COG, MG & CY. FGM also reports receiving research grants from EMD Serono, Genzyme, ONO & UBC. COG has participated in clinical trials and other research projects promoted by Biogen-Idec, GSK, Teva & Novartis. AL has received travel and research grants from the Associazione Italiana Sclerosi Multipla and is a Consultant of "Fondazione Cesare Serono". FM has participated in MS clinical trials sponsored by EMD Serono and Bayer. NV has received travel support from Eisai & GSK. EH acknowledges financial support from the Czech Ministry of Education (research program MSM 0021620849). CY reports sitting on the scientific advisory board of Lilly. CY participates in clinical trials sponsored by Biogen Idec, Merck Serono, Novartis, Roche, Sanofi Aventis, and Teva. CY holds research grants from the MS Society United Kingdom, the MND association United Kingdom and the British Polio Fellowship. CY is on the steering committee for LiCALS. HB serves on steering committees for trials conducted by Merck Serono, Biogen Idec and Novartis. HB has received research support from Merck Serono, Novartis and Biogen Idec in his capacity as honorary chair of the MSBase Foundation. HB is the recipient of an National Health and Medical Research Council (NHMRC) Career Development Award (628856), NHMRC Project Grants (566513, 628799, 1009757), NHMRC Centre of Excellence Award (1001216), an ARC Linkage Grant (LP110100473)RG & a National MS Society (United States of America) Project Grant (RG3850A3/1). These disclosures do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.	Arbizu T, 2000, ACTA NEUROL SCAND, V102, P209, DOI 10.1034/j.1600-0404.2000.102004209.x; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; BRONNUMHANSEN H, 1994, NEUROLOGY, V44, P1901, DOI 10.1212/WNL.44.10.1901; Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; Costello Kathleen, 2008, Medscape J Med, V10, P225; Filippi M, 2004, LANCET, V364, P1489, DOI 10.1016/S0140-6736(04)17271-1; Giordano A, 2008, J NEUROL SCI, V275, P86, DOI 10.1016/j.jns.2008.07.026; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Hurwitz BJ, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e3182050225; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kleinman Nathan L, 2010, J Med Econ, V13, P633, DOI 10.3111/13696998.2010.527588; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Milanese C, 2003, J NEUROL NEUROSUR PS, V74, P1689, DOI 10.1136/jnnp.74.12.1689; Miller DH, 2004, LANCET, V364, P1463, DOI 10.1016/S0140-6736(04)17285-1; Mohr DC, 1999, MULT SCLER, V5, P192, DOI 10.1191/135245899678846069; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Ross AP, 2008, NEUROLOGY, V71, pS21, DOI 10.1212/WNL.0b013e31818f3dcb; Ruggieri RM, 2003, NEUROL SCI, V24, P361, DOI 10.1007/s10072-003-0190-3; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D	27	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38661	10.1371/journal.pone.0038661	http://dx.doi.org/10.1371/journal.pone.0038661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768046	Green Published, gold			2022-12-25	WOS:000305892100017
J	Moreno-Lopez, L; Stamatakis, EA; Fernandez-Serrano, MJ; Gomez-Rio, M; Rodriguez-Fernandez, A; Perez-Garcia, M; Verdejo-Garcia, A				Moreno-Lopez, Laura; Stamatakis, Emmanuel A.; Jose Fernandez-Serrano, Maria; Gomez-Rio, Manuel; Rodriguez-Fernandez, Antonio; Perez-Garcia, Miguel; Verdejo-Garcia, Antonio			Neural Correlates of the Severity of Cocaine, Heroin, Alcohol, MDMA and Cannabis Use in Polysubstance Abusers: A Resting-PET Brain Metabolism Study	PLOS ONE			English	Article							MOTOR FUNCTION; ACTIVATION; ECSTASY; TASK; DEFICITS; CORTEX	Introduction: Functional imaging studies of addiction following protracted abstinence have not been systematically conducted to look at the associations between severity of use of different drugs and brain dysfunction. Findings from such studies may be relevant to implement specific interventions for treatment. The aim of this study was to examine the association between resting-state regional brain metabolism (measured with 18F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) and the severity of use of cocaine, heroin, alcohol, MDMA and cannabis in a sample of polysubstance users with prolonged abstinence from all drugs used. Methods: Our sample consisted of 49 polysubstance users enrolled in residential treatment. We conducted correlation analyses between estimates of use of cocaine, heroin, alcohol, MDMA and cannabis and brain metabolism (BM) (using Statistical Parametric Mapping voxel-based (VB) whole-brain analyses). In all correlation analyses conducted for each of the drugs we controlled for the co-abuse of the other drugs used. Results: The analysis showed significant negative correlations between severity of heroin, alcohol, MDMA and cannabis use and BM in the dorsolateral prefrontal cortex (DLPFC) and temporal cortex. Alcohol use was further associated with lower metabolism in frontal premotor cortex and putamen, and stimulants use with parietal cortex. Conclusions: Duration of use of different drugs negatively correlated with overlapping regions in the DLPFC, whereas severity of cocaine, heroin and alcohol use selectively impact parietal, temporal, and frontal-premotor/basal ganglia regions respectively. The knowledge of these associations could be useful in the clinical practice since different brain alterations have been associated with different patterns of execution that may affect the rehabilitation of these patients.	[Moreno-Lopez, Laura; Perez-Garcia, Miguel; Verdejo-Garcia, Antonio] Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain; [Stamatakis, Emmanuel A.] Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England; [Jose Fernandez-Serrano, Maria] Univ Jaen, Dept Psychol, Jaen, Spain; [Gomez-Rio, Manuel; Rodriguez-Fernandez, Antonio] Hosp Virgen Nieves Granada, Nucl Med Serv, Granada, Spain; [Perez-Garcia, Miguel] Univ Granada, CIBERSAM, Ctr Invest Biomed Red Salud Mental, Granada, Spain; [Perez-Garcia, Miguel; Verdejo-Garcia, Antonio] Univ Granada, Inst Neurosci Federico Oloriz, Granada, Spain	University of Granada; University of Cambridge; Universidad de Jaen; Hospital Universitario Virgen de las Nieves; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; University of Granada	Moreno-Lopez, L (corresponding author), Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain.	lmoreno@ugr.es	Serrano, M Josefa Fernández/V-3124-2019; Verdejo-Garcia, Antonio/AAV-1147-2021; perez, miguel/GXF-5077-2022; García, Miguel Pérez/F-9630-2010; Rodriguez-Fernandez, Antonio/AAB-3469-2019; Fernandez-Serrano, Maria Jose/AGA-6711-2022; Moreno-López, Laura/K-9568-2015	Serrano, M Josefa Fernández/0000-0002-6158-237X; Verdejo-Garcia, Antonio/0000-0001-8874-9339; García, Miguel Pérez/0000-0003-4775-7556; Moreno-López, Laura/0000-0003-3687-7237; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Spanish Ministry of Education and Science [SEJ2006-08278]; Council of Science and Innovation [P07-HUM-03089]; FPU from the Spanish Ministry of Science and Innovation [AP2007-03583]; MCINN in the Department of Experimental Psychology, University of Cambridge; Queens' College, Cambridge	Spanish Ministry of Education and Science(Spanish Government); Council of Science and Innovation; FPU from the Spanish Ministry of Science and Innovation; MCINN in the Department of Experimental Psychology, University of Cambridge; Queens' College, Cambridge	This study has been supported with funds from the SEJ2006-08278 project from the Spanish Ministry of Education and Science, the P07-HUM-03089 project from the Council of Science and Innovation. Laura Moreno-Lopez is supported by the FPU grant (AP2007-03583) from the Spanish Ministry of Science and Innovation. Antonio Verdejo-Garcia was supported by a MCINN Jose Castillejo grant in the Department of Experimental Psychology, University of Cambridge. Emmanuel A. Stamatakis is supported by the Stephen Erskine Fellowship from Queens' College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron JL, 2007, ADDICTION, V102, P33, DOI 10.1111/j.1360-0443.2006.01778.x; Barros-Loscertales A, 2011, PSYCHIAT RES-NEUROIM, V194, P111, DOI 10.1016/j.pscychresns.2011.05.001; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Bustamante JC, 2011, BRAIN RES, V1375, P111, DOI 10.1016/j.brainres.2010.12.042; de Sola S, 2008, PSYCHOPHARMACOLOGY, V200, P425, DOI 10.1007/s00213-008-1217-5; de Win MML, 2008, BRIT J PSYCHIAT, V193, P289, DOI 10.1192/bjp.bp.106.035089; Fehr C, 2007, PSYCHOPHARMACOLOGY, V191, P975, DOI 10.1007/s00213-006-0696-5; Fernandez-Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377, DOI 10.1016/j.neubiorev.2010.04.008; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Gruber SA, 2007, NEUROPSYCHOL REV, V17, P299, DOI 10.1007/s11065-007-9041-y; Hanson KL, 2011, PSYCHOL ADDICT BEHAV, V25, P127, DOI 10.1037/a0022350; Johnson-Greene D, 2002, CLIN NEUROPSYCHOL, V16, P300, DOI 10.1076/clin.16.3.300.13845; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; King GR, 2011, J NEUROSCI, V31, P17923, DOI 10.1523/JNEUROSCI.4148-11.2011; Kish SJ, 2010, BRAIN, V133, P1779, DOI 10.1093/brain/awq103; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; Pillay SS, 2008, EXP CLIN PSYCHOPHARM, V16, P22, DOI 10.1037/1064-1297.16.1.22; Pitel AL, 2010, PSYCHOL MED, V40, P497, DOI 10.1017/S0033291709990626; Sullivan EV, 2005, BIOL PSYCHIAT, V57, P768, DOI 10.1016/j.biopsych.2004.12.012; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Holst RJ, 2012, DRUG ALCOHO IN PRESS; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zakzanis KK, 2007, HUM PSYCHOPHARM CLIN, V22, P427, DOI 10.1002/hup.873; Zinn S, 2004, ALCOHOL CLIN EXP RES, V28, P1338, DOI 10.1097/01.ALC.0000139814.81811.62; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	32	43	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39830	10.1371/journal.pone.0039830	http://dx.doi.org/10.1371/journal.pone.0039830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768136	Green Published, gold			2022-12-25	WOS:000305892100106
J	Oyarzun, JP; Lopez-Barroso, D; Fuentemilla, L; Cucurell, D; Pedraza, C; Rodriguez-Fornells, A; de Diego-Balaguer, R				Oyarzun, Javiera P.; Lopez-Barroso, Diana; Fuentemilla, Lluis; Cucurell, David; Pedraza, Carmen; Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth			Updating Fearful Memories with Extinction Training during Reconsolidation: A Human Study Using Auditory Aversive Stimuli	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PROTEIN-SYNTHESIS; CONDITIONED FEAR; ANIMAL-MODELS; MECHANISMS; RETRIEVAL; AMYGDALA; REINSTATEMENT; PROPRANOLOL; RESPONSES	Learning to fear danger in the environment is essential to survival, but dysregulation of the fear system is at the core of many anxiety disorders. As a consequence, a great interest has emerged in developing strategies for suppressing fear memories in maladaptive cases. Recent research has focused in the process of reconsolidation where memories become labile after being retrieved. In a behavioral manipulation, Schiller et al., (2010) reported that extinction training, administrated during memory reconsolidation, could erase fear responses. The implications of this study are crucial for the possible treatment of anxiety disorders without the administration of drugs. However, attempts to replicate this effect by other groups have been so far unsuccessful. We sought out to reproduce Schiller et al., (2010) findings in a different fear conditioning paradigm based on auditory aversive stimuli instead of electric shock. Following a within-subject design, participants were conditioned to two different sounds and skin conductance response (SCR) was recorded as a measure of fear. Our results demonstrated that only the conditioned stimulus that was reminded 10 minutes before extinction training did not reinstate a fear response after a reminder trial consisting of the presentation of the unconditioned stimuli. For the first time, we replicated Schiller et al., (2010) behavioral manipulation and extended it to an auditory fear conditioning paradigm.	[Oyarzun, Javiera P.; Lopez-Barroso, Diana; Fuentemilla, Lluis; Cucurell, David; Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth] Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Grp, Barcelona, Spain; [Oyarzun, Javiera P.; Lopez-Barroso, Diana; Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Pedraza, Carmen] Univ Malaga, Fac Psychol, Dept Psychobiol, E-29071 Malaga, Spain; [Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universidad de Malaga; ICREA	Oyarzun, JP (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Grp, Barcelona, Spain.	ruth.dediego@ub.edu	López-Barroso, Diana/AAH-6830-2019; de Diego-Balaguer, Ruth/V-2131-2017; Rodriguez-Fornells, Antoni/L-5878-2014; Benitez, Carmen Pedraza/K-2328-2017; Fuentemilla, Lluís/E-3926-2012	López-Barroso, Diana/0000-0002-8938-1959; de Diego-Balaguer, Ruth/0000-0002-2357-5195; Rodriguez-Fornells, Antoni/0000-0002-3249-6931; Benitez, Carmen Pedraza/0000-0002-0011-2817; Fuentemilla, Lluís/0000-0002-5482-7615; Oyarzun, Javiera/0000-0002-6486-0689	University of Barcelona; Generalitat of Catalunya; MICINN [PSI2008-03901, PSI2008-3885]; Catalan Government (Generalitat de Catalunya) [2009 SGR 93]; ICREA Funding Source: Custom	University of Barcelona; Generalitat of Catalunya(Generalitat de Catalunya); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); ICREA(ICREA)	Pre-doctoral research grant to Dr. Oyarzun from the University of Barcelona (http://www.ub.edu/dyn/cms/continguts_es/estudis/suport_estudi/beques_ajuts/fitxes/adr.html), pre-doctoral grant to Dr. Lopez-Barroso from the Generalitat of Catalunya (http://www10.gencat.net/agaur_web/AppJava/a_beca.jsp?categoria=predoctorals&id_beca=17881), Ramon y Cajal position awarded to Dr. Fuentemilla, Spanish grants MICINN (PSI2008-03901 - Dr. Rodriguez-Fornells and PSI2008-3885 Dr. de Diego-Balaguer) and the Catalan Government (Generalitat de Catalunya, 2009 SGR 93) http://www.micinn.es/portal/site/MICINN/menuitem.00d7c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav Irit, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/30873; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Debiec J, 2011, DEPRESS ANXIETY, V28, P186, DOI 10.1002/da.20803; Dirikx T, 2004, LEARN MEMORY, V11, P549, DOI 10.1101/lm.78004; Dirikx T, 2007, J BEHAV THER EXP PSY, V38, P237, DOI 10.1016/j.jbtep.2006.04.001; Dirikx T, 2009, ACTA PSYCHOL, V130, P175, DOI 10.1016/j.actpsy.2008.12.002; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Galvez R, 1996, NEUROBIOL LEARN MEM, V66, P253, DOI 10.1006/nlme.1996.0067; HOLLAND PC, 1990, COGNITION, V37, P105, DOI 10.1016/0010-0277(90)90020-K; HYGGE S, 1978, J PERS SOC PSYCHOL, V36, P271, DOI 10.1037/0022-3514.36.3.271; Indovina I, 2011, NEURON, V69, P563, DOI 10.1016/j.neuron.2010.12.034; Kindt M, 2011, BIOL PSYCHOL    1008; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LEATON RN, 1990, J EXP PSYCHOL ANIM B, V16, P279, DOI 10.1037/0097-7403.16.3.279; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Mineka S, 2002, BIOL PSYCHIAT, V52, P927, DOI 10.1016/S0006-3223(02)01669-4; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2010, ANN NY ACAD SCI, V1191, P27, DOI 10.1111/j.1749-6632.2010.05443.x; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; O'Donnell T, 2004, NEUROPSYCHOBIOLOGY, V50, P273, DOI 10.1159/000080952; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Pitman RK, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00011; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Rothbaum BO, 2005, J TRAUMA STRESS, V18, P607, DOI 10.1002/jts.20069; Rothbaum BO, 1999, J TRAUMA STRESS, V12, P263, DOI 10.1023/A:1024772308758; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schmajuk NA, 2007, BEHAV BRAIN RES, V177, P242, DOI 10.1016/j.bbr.2006.11.026; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tollenaar MS, 2009, PSYCHOPHARMACOLOGY, V203, P793, DOI 10.1007/s00213-008-1427-x; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Westbrook FR, 2002, J EXP PSYCHOL-ANIM B, V28, P97, DOI 10.1037//0097-7403.28.1.97; Yang CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1992, DOI 10.1038/npp.2011.87	64	88	92	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38849	10.1371/journal.pone.0038849	http://dx.doi.org/10.1371/journal.pone.0038849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768048	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100019
J	Pando, MA; Balan, IC; Marone, R; Dolezal, C; Leu, CS; Squiquera, L; Barreda, V; Fermepin, MR; Vaulet, LG; Rey, J; Picconi, M; Carballo-Dieguez, A; Avila, MM				Pando, Maria A.; Balan, Ivan C.; Marone, Ruben; Dolezal, Curtis; Leu, Cheng-Shiun; Squiquera, Luis; Barreda, Victoria; Rodriguez Fermepin, Marcelo; Vaulet, Lucia Gallo; Rey, Jorge; Picconi, Maria; Carballo-Dieguez, Alex; Avila, Maria M.			HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men Recruited by RDS in Buenos Aires, Argentina: High HIV and HPV Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; ANAL HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; HOMOSEXUAL-MEN; HEPATITIS-C; PREVALENCE; SEROPREVALENCE; EPIDEMIOLOGY; COHORT	Background: The aim of this study was to estimate the prevalence of HIV and other STIs, among MSM from Buenos Aires (2007-2009). Methods: Responding Driven Sampling was used for recruitment of MSM. Participants completed a structured web-based survey and provided biological samples. Results: A total of 496 MSM were studied for HIV, HBV, HCV, and T pallidum infections. Chlamydia and HPV diagnoses were only performed in 98 and 109 participants, respectively. Prevalence of HIV was 17.3%, HBV 22.9%, HCV 7.5%, T pallidum 20.5%, HPV 83.5%, and C trachomatis 1.7%. In the year prior to the evaluation, 71% of the participants had had sex with men and/or trans and women (MMW) while 29% had not had sex with women (MM). Comparing MM to MMW, prevalence of HIV (30.7% vs. 11.9%, p<0.001), HBV (36.4% vs. 17.8%, p<0.001), T pallidum (32.1% vs. 15.7%, p<0.001), and HPV (88.3% vs. 70.4%, p = 0.039) were significantly higher among MM, whereas no significant differences were found for HCV and C trachomatis. The MM group had also significantly higher HIV incidence (5.60 vs. 4.28 per 100 persons-year, p = 0.032). HPV genotypes 16, 6, and 11 were the most frequently found; 40.7% of the MSM had more than one genotype and one high risk genotype was detected in 43.6% of participants. Conclusions: Both MM and MMW are at high risk of infection for HIV and other STIs. Rates of HIV, HBV, T pallidum and HPV infections are higher in the MM group.	[Pando, Maria A.; Avila, Maria M.] Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, Argentina; [Pando, Maria A.; Avila, Maria M.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, Argentina; [Balan, Ivan C.; Dolezal, Curtis; Leu, Cheng-Shiun; Carballo-Dieguez, Alex] Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY USA; [Marone, Ruben; Squiquera, Luis; Barreda, Victoria] Nexo Asociac Civil, Buenos Aires, Argentina; [Rodriguez Fermepin, Marcelo; Vaulet, Lucia Gallo] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Inmunol Clin, Buenos Aires, Argentina; [Rey, Jorge] Univ Buenos Aires, Hosp Clin Jose San Martin, Div Enfermedades Transmis Transfus, Buenos Aires, Argentina; [Picconi, Maria] Inst Nacl Enfermedades Infecciosas ANLIS, Lab Nacl Referencia HPV, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Columbia University; New York State Psychiatry Institute; University of Buenos Aires; University of Buenos Aires; Hospital de Clinicas Jose de San Martin	Pando, MA (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, Argentina.	mpando@fmed.uba.ar	RODRIGUEZ FERMEPIN, Marcelo/AAY-7762-2021	RODRIGUEZ FERMEPIN, Marcelo/0000-0003-2543-4262; Rey, Jorge/0000-0001-6148-9346	US National Institute of Mental Health (NIMH) [R01-MH073410]; NIMH [P30-MH43520]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073410, P30MH043520] Funding Source: NIH RePORTER	US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported with funds from the US National Institute of Mental Health (NIMH) to the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University (R01-MH073410; Principal Investigator: Alex Carballo-Dieguez, Ph.D.). Additional funds came from a grant from NIMH to the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University (P30-MH43520; Principal Investigator: Anke A. Ehrhardt, Ph.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the National Institutes of Health.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], 2011, VAC CONTR VIR PAP HU; Bautista CT, 2004, SEX TRANSM INFECT, V80, P498, DOI 10.1136/sti.2004.013094; Boletin sobre el VIH-SIDA en la Argentina, 2011, B VIH SIDA ARGENTINA, V28; Carballo-Dieguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027447; Centers for Disease Control and Prevention, 2009, GON CHLAM PROP MSM T; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Ciesielski Carol A., 2003, Curr Infect Dis Rep, V5, P145, DOI 10.1007/s11908-003-0051-5; Comite Nacional de Infectologia, 2000, ARCH ARGENT PEDIATR, V98, P138; Dang T, 2009, CLIN INFECT DIS, V49, P1532, DOI 10.1086/644740; Dietz CA, 2011, J AM OSTEOPATH ASSOC, V111, pS19; Farias MSD, 2011, J CLIN VIROL, V51, P96, DOI 10.1016/j.jcv.2011.03.008; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Fermepin MR, 2007, SEX TRANSM DIS, V34, P1041, DOI 10.1097/OLQ.0b013e31815c1bf1; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Jin F, 2007, SEX TRANSM DIS, V34, P488, DOI 10.1097/01.olq.0000245960.52668.e5; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Marcus U, 2011, SEX HEALTH, V8, P184, DOI 10.1071/SH10053; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nicol AF, 2005, DIAGN MOL PATHOL, V14, P39, DOI 10.1097/01.pas.0000143309.81183.6c; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; O'Leary A, 2006, SEX TRANSM DIS, V33, P594, DOI 10.1097/01.olq.0000225280.44538.f6; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky JM, 2010, J ADOLESCENT HEALTH, V46, pS12, DOI 10.1016/j.jadohealth.2010.01.010; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2006, SEX TRANSM DIS, V33, P307, DOI 10.1097/01.olq.0000194578.06795.2d; Pando MD, 2003, INT J EPIDEMIOL, V32, P735, DOI 10.1093/ije/dyg104; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; SAYADA C, 1991, FEMS MICROBIOL LETT, V83, P73; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; UNAIDS, 2008, REP GLOB AIDS EP; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; van der Bij AK, 2005, SEX TRANSM INFECT, V81, P34, DOI 10.1136/sti.2003.007997; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Vignoles M, 2006, JAIDS-J ACQ IMM DEF, V42, P494, DOI 10.1097/01.qai.0000221678.06822.8b	47	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39834	10.1371/journal.pone.0039834	http://dx.doi.org/10.1371/journal.pone.0039834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768137	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100107
J	Davies, ZG; Fuller, RA; Dallimer, M; Loram, A; Gaston, KJ				Davies, Zoe G.; Fuller, Richard A.; Dallimer, Martin; Loram, Alison; Gaston, Kevin J.			Household Factors Influencing Participation in Bird Feeding Activity: A National Scale Analysis	PLOS ONE			English	Article							FOOD SUPPLEMENTATION; BIODIVERSITY CONSERVATION; GREEN SPACE; URBAN; GARDENS; HEALTH; ENVIRONMENTS; ASSOCIATIONS; PATTERNS; BENEFITS	Ameliorating pressures on the ecological condition of the wider landscape outside of protected areas is a key focus of conservation initiatives in the developed world. In highly urbanized nations, domestic gardens can play a significant role in maintaining biodiversity and facilitating human-wildlife interactions, which benefit personal and societal health and wellbeing. The extent to which sociodemographic and socioeconomic factors are associated with engagement in wildlife gardening activities remain largely unresolved. Using two household-level survey datasets gathered from across Britain, we determine whether and how the socioeconomic background of a household influences participation in food provision for wild birds, the most popular and widespread form of human-wildlife interaction. A majority of households feed birds (64% across rural and urban areas in England, and 53% within five British study cities). House type, household size and the age of the head of the household were all important predictors of bird feeding, whereas gross annual household income, the occupation of the head of the household, and whether the house is owned or rented were not. In both surveys, the prevalence of bird feeding rose as house type became more detached and as the age of the head of the household increased. A clear, consistent pattern between households of varying size was less evident. When regularity of food provision was examined in the study cities, just 29% of households provided food at least once a week. The proportion of households regularly feeding birds was positively related to the age of the head of the household, but declined with gross annual income. As concerns grow about the lack of engagement between people and the natural environment, such findings are important if conservation organizations are successfully to promote public participation in wildlife gardening specifically and environmentally beneficial behaviour in society more generally.	[Davies, Zoe G.] Univ Kent, DICE, Canterbury, Kent, England; [Fuller, Richard A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Dallimer, Martin] Univ Copenhagen, Div Econ Policy & Management Planning, Copenhagen, Denmark; [Dallimer, Martin] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Loram, Alison] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Kent; University of Queensland; University of Copenhagen; University of Copenhagen; University of Sheffield; University of Exeter	Davies, ZG (corresponding author), Univ Kent, DICE, Canterbury, Kent, England.	z.g.davies@kent.ac.uk	Dallimer, Martin/I-1547-2019; Fuller, Richard/B-7971-2008	Fuller, Richard/0000-0001-9468-9678; Gaston, Kevin J./0000-0002-7235-7928; Dallimer, Martin/0000-0001-8120-3309	Engineering and Physical Sciences Research Council through the CityForm research consortium; Countryside Council for Wales; Department for Environment, Food and Rural Affairs; Environment and Heritage Service; English Nature; Scotland and Northern Ireland Forum for Environmental Research	Engineering and Physical Sciences Research Council through the CityForm research consortium(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Countryside Council for Wales; Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Environment and Heritage Service; English Nature; Scotland and Northern Ireland Forum for Environmental Research	This work was funded by the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) (through the CityForm research consortium), and the Countryside Council for Wales, the Department for Environment, Food and Rural Affairs, the Environment and Heritage Service, English Nature, and Scotland and Northern Ireland Forum for Environmental Research (through the BUGS II project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Bland RL, 2004, BIRD STUDY, V51, P97, DOI 10.1080/00063650409461340; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; BRITTINGHAM MC, 1992, J FIELD ORNITHOL, V63, P190; Brown C., 2005, BUILD ENVIRON, V31, P326, DOI [10.2148/benv.2005.31.4.326, DOI 10.2148/BENV.2005.31.4.326]; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burton R, 2004, RSPB POCKET BIRDFEED; CABE Space, 2004, VAL PUBL SPAC HIGH Q; Cardiff Biodiversity Partnership, 2008, CARD LOC BIOD ACT PL; Chamberlain DE, 2005, IBIS, V147, P563, DOI 10.1111/j.1474-919x.2005.00430.x; COWIE RJ, 1988, BIRD STUDY, V35, P163, DOI 10.1080/00063658809476985; Crawley MJ., 2007, R BOOK; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; DCLG, 2010, ENGL HOUS SURV DAT S; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Defra, 2002, WORK GRAIN NAT BIOD; Defra, 2011, BIOD STRAT ENGL MEAS; Defra, 2003, MEAS PROGR BAS ASS; Edinburgh Biodiversity Partnership, 2010, ED BIOD ACT PLAN 201; European Commission, 2010, EUR 2010 SURV ATT EU; Fabos JG, 2006, LANDSCAPE URBAN PLAN, V76, P1, DOI 10.1016/j.landurbplan.2004.09.028; Freyfogle ET, 2003, CONSERV BIOL, V17, P354, DOI 10.1046/j.1523-1739.2003.01724.x; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Glasgow Biodiversity Action Plan Steering Group, 2008, GLASG CIT BIOD ACT P; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Good Robert, 2000, British Wildlife, V12, P77; GRUBB TC, 1990, ORNIS SCAND, V21, P277, DOI 10.2307/3676392; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Hedblom M, 2010, J BIOGEOGR, V37, P1302, DOI 10.1111/j.1365-2699.2010.02299.x; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Irvine KN, 2010, FUTURE CITY, V2, P215, DOI 10.1007/978-1-4020-8647-2_10; James P, 2009, URBAN FOR URBAN GREE, V8, P65, DOI 10.1016/j.ufug.2009.02.001; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Kaplan R, 1989, EXPERIENCE NATURE PS; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kinzig AP, 2005, ECOL SOC, V10; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Lepczyk CA, 2004, ENVIRON MANAGE, V33, P110, DOI 10.1007/s00267-003-0036-z; Lin E, 2005, PRODUCTION PROCESSIN; Loram A, 2007, LANDSCAPE ECOL, V22, P601, DOI 10.1007/s10980-006-9051-9; Loram A, 2011, ENVIRON MANAGE, V48, P808, DOI 10.1007/s00267-011-9723-3; Louv R., 2005, LAST CHILD WOODS WHY; Luck GW, 2009, ECOSYSTEMS, V12, P604, DOI 10.1007/s10021-009-9244-6; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Mason J, 2007, LANDSCAPE URBAN PLAN, V80, P153, DOI 10.1016/j.landurbplan.2006.07.002; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Moss S, 2003, GARDEN BIRD HDB ATTR; Naeem S., 2009, BIODIVERSITY ECOSYST; National Centre for Social Research and Department for Transport Local Government and the Regions, 2004, SN5021 DEP TRANSP LO; Natural England, 2010, MON ENG NAT ENV NAT; Newton I., 1998, POPULATION LIMITATIO; Office for National Statistics, 2006, TIM US SURV 2005 WE; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Pretty J. N., 2007, EARTH ONLY ENDURES R; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Ryall Colin, 2003, Environmentalist, V23, P81, DOI 10.1023/A:1022995610486; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Schwartz MW, 2006, CONSERV BIOL, V20, P1550, DOI 10.1111/j.1523-1739.2006.00421.x; Siriwardena GM, 2007, J APPL ECOL, V44, P920, DOI 10.1111/j.1365-2664.2007.01339.x; Soper T, 2006, BIRD TABLE BOOK COMP; Stigsdotter UK, 2010, SCAND J PUBLIC HEALT, V38, P411, DOI 10.1177/1403494810367468; Stilgoe JR, 2001, AM J PREV MED, V20, P243, DOI 10.1016/S0749-3797(00)00319-6; Strohbach MW, 2009, ECOL SOC, V14; Sullivan WC, 2004, ENVIRON BEHAV, V36, P678, DOI 10.1177/0193841x04264945; Sutherland WJ, 2008, J APPL ECOL, V45, P821, DOI 10.1111/j.1365-2664.2008.01474.x; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; The Horticultural Trades Association, 2012, IND FACTS FIG; Toms M. P., 2008, GARDEN BIRDS WILDLIF; Toms MP, 2003, BTO CJ GARDEN BIRDWA; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tyrvainen L, 2001, J ENVIRON MANAGE, V62, P75, DOI 10.1006/jema.2001.0421; UK National Ecosystem Assessment, 2011, UK NAT EC ASS TECHN; UN (United Nations), 2009, WORLD URB PROSP 2009; USFWS, 2006, 2006 NAT SURV FISH H; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Whittingham MJ, 2005, J APPL ECOL, V42, P270, DOI 10.1111/j.1365-2664.2005.01007.x; Wilson WH, 2001, WILSON BULL, V113, P65, DOI 10.1676/0043-5643(2001)113[0065:TEOSFO]2.0.CO;2; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	91	49	52	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39692	10.1371/journal.pone.0039692	http://dx.doi.org/10.1371/journal.pone.0039692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761872	Green Published, Green Accepted, gold			2022-12-25	WOS:000305826400027
J	Gan, L; Ni, PY; Ge, Y; Xiao, YF; Sun, CY; Deng, L; Zhang, W; Wu, SS; Liu, Y; Jiang, W; Xin, HB				Gan, Lu; Ni, Pei-Yan; Ge, Yan; Xiao, Yun-Fei; Sun, Chang-Yan; Deng, Lin; Zhang, Wei; Wu, Si-Si; Liu, Ying; Jiang, Wei; Xin, Hong-Bo			Histone Deacetylases Regulate Gonadotropin-Releasing Hormone I Gene Expression via Modulating Otx2-Driven Transcriptional Activity	PLOS ONE			English	Article							NEURON-SPECIFIC EXPRESSION; HYPOGONADOTROPIC HYPOGONADISM; OTX2 HOMEOPROTEIN; PROMOTER ELEMENT; INHIBITORS; ACETYLATION; CELLS; VIVO; IDENTIFICATION; ACTIVATION	Background: Precise coordination of the hypothalamic-pituitary-gonadal axis orchestrates the normal reproductive function. As a central regulator, the appropriate synthesis and secretion of gonadotropin-releasing hormone I (GnRH-I) from the hypothalamus is essential for the coordination. Recently, emerging evidence indicates that histone deacetylases (HDACs) play an important role in maintaining normal reproductive function. In this study, we identify the potential effects of HDACs on Gnrh1 gene transcription. Methodology/Principal Findings: Inhibition of HDACs activities by trichostatin A (TSA) and valproic acid (VPA) promptly and dramatically repressed transcription of Gnrh1 gene in the mouse immortalized mature GnRH neuronal cells GT1-7. The suppression was connected with a specific region of Gnrh1 gene promoter, which contains two consensus Otx2 binding sites. Otx2 has been known to activate the basal and also enhancer-driven transcription of Gnrh1 gene. The transcriptional activity of Otx2 is negatively modulated by Grg4, a member of the Groucho-related-gene (Grg) family. In the present study, the expression of Otx2 was downregulated by TSA and VPA in GT1-7 cells, accompanied with the opposite changes of Grg4 expression. Chromatin immunoprecipitation and electrophoretic mobility shift assays demonstrated that the DNA-binding activity of Otx2 to Gnrh1 gene was suppressed by TSA and VPA. Overexpression of Otx2 partly abolished the TSA- and VPA-induced downregulation of Gnrh1 gene expression. Conclusions/Significance: Our data indicate that HDAC inhibitors downregulate Gnrh1 gene expression via repressing Otx2-driven transcriptional activity. This study should provide an insight for our understanding on the effects of HDACs in the reproductive system and suggests that HDACs could be potential novel targets for the therapy of GnRH-related diseases.	[Gan, Lu; Ni, Pei-Yan; Ge, Yan; Sun, Chang-Yan; Deng, Lin; Zhang, Wei; Wu, Si-Si; Liu, Ying; Jiang, Wei; Xin, Hong-Bo] Sichuan Univ, W China Hosp, Lab Cardiovasc Dis, Chengdu 610064, Peoples R China; [Gan, Lu; Ni, Pei-Yan; Ge, Yan; Sun, Chang-Yan; Deng, Lin; Zhang, Wei; Wu, Si-Si; Liu, Ying; Jiang, Wei; Xin, Hong-Bo] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Lab Cellular & Mol Biol, Chengdu 610064, Peoples R China; [Xiao, Yun-Fei; Xin, Hong-Bo] Nanchang Univ, Inst Translat Med, Nanchang, Peoples R China	Sichuan University; Sichuan University; Nanchang University	Gan, L (corresponding author), Sichuan Univ, W China Hosp, Lab Cardiovasc Dis, Chengdu 610064, Peoples R China.	xinhb2012@yahoo.com	Gan, Lu/GLU-5032-2022	Gan, Lu/0000-0001-8665-2760	National Natural Science Foundation of China [30770791, 81070095]; National Basic Research Program of China [2007CB512100]; Postgraduate Student Foundation for supervisor in the Ministry of Education of China [20113601110001]; China Postdoctoral Science Foundation [2011M 501416]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Postgraduate Student Foundation for supervisor in the Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (30770791 and 81070095 to HBX), the National Basic Research Program of China (2007CB512100 to HBX), the Postgraduate Student Foundation for supervisor in the Ministry of Education of China (20113601110001 to HBX) and China Postdoctoral Science Foundation (2011M 501416 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley GE, 2010, BRAIN RES, V1364, P62, DOI 10.1016/j.brainres.2010.10.001; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bouligand J, 2010, FRONT HORM RES, V39, P111, DOI 10.1159/000312697; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Daschner M, 2002, KIDNEY INT, V62, P1582, DOI 10.1046/j.1523-1755.2002.00616.x; Diaczok D, 2011, MOL ENDOCRINOL, V25, P833, DOI 10.1210/me.2010-0271; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Fenic I, 2004, J ANDROL, V25, P811; Fernald RD, 1999, FRONT NEUROENDOCRIN, V20, P224, DOI 10.1006/frne.1999.0181; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Ge Y, 2010, BIOCHEM BIOPH RES CO, V399, P167, DOI 10.1016/j.bbrc.2010.07.040; Glaser KB, 2003, MOL CANCER THER, V2, P151; Heider U, 2006, EUR J HAEMATOL, V76, P42, DOI 10.1111/j.1600-0609.2005.00546.x; Jepsen K, 2002, J CELL SCI, V115, P689; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim HH, 2007, SEMIN REPROD MED, V25, P326, DOI 10.1055/s-2007-984738; Kim HH, 2007, SEMIN REPROD MED, V25, P313, DOI 10.1055/s-2007-984737; Kim HH, 2007, MOL ENDOCRINOL, V21, P457, DOI 10.1210/me.2005-0216; Kim HH, 2002, J BIOL CHEM, V277, P5194, DOI 10.1074/jbc.M110535200; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Korkmaz CG, 2004, J ENDOCRINOL, V182, P377, DOI 10.1677/joe.0.1820377; Larder R, 2009, J BIOL CHEM, V284, P16966, DOI 10.1074/jbc.M109.002485; Lee VHY, 2008, FEBS J, V275, P5458, DOI 10.1111/j.1742-4658.2008.06676.x; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Makki MS, 2008, NUCLEIC ACIDS RES, V36, P4067, DOI 10.1093/nar/gkn356; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matheu A, 2005, J BIOL CHEM, V280, P42433, DOI 10.1074/jbc.M508270200; Melamed P, 2008, TRENDS ENDOCRIN MET, V19, P25, DOI 10.1016/j.tem.2007.10.008; Mochizuki T, 2000, DEV BIOL, V224, P470, DOI 10.1006/dbio.2000.9778; Mul D, 2008, EUR J ENDOCRINOL, V159, pS3, DOI 10.1530/EJE-08-0814; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Nelson SB, 2000, MOL ENDOCRINOL, V14, P1509, DOI 10.1210/me.14.9.1509; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Tarlatzis Basil C, 2004, Expert Opin Drug Saf, V3, P39, DOI 10.1517/14740338.3.1.39; Wetsel WC, 2002, PROG BRAIN RES, V141, P221	43	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39770	10.1371/journal.pone.0039770	http://dx.doi.org/10.1371/journal.pone.0039770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761896	Green Submitted, Green Published, gold			2022-12-25	WOS:000305781700063
J	Koo, DH; Park, CY; Lee, ES; Ro, J; Oh, SW				Koo, Dong Hoe; Park, Cheol-Young; Lee, Eun Sook; Ro, Jungsil; Oh, Sang Woo			Progranulin as a Prognostic Biomarker for Breast Cancer Recurrence in Patients Who Had Hormone Receptor-Positive Tumors: A Cohort Study	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR; STIMULATES PROLIFERATION; INSULIN-RESISTANCE; THERAPY; SERUM	Background: Progranulin (PGRN) is considered to play an important role in breast cancer tumorigenesis and in inhibiting tamoxifen-induced apoptosis. We aimed to determine whether PGRN levels are associated with breast cancer recurrence after curative surgery. Methodology/Principal Findings: We evaluated the associations between preoperative serum PGRN levels and breast cancer recurrence in a cohort of 697 newly diagnosed breast cancer patients who underwent curative surgery between April 2001 and December 2004. The mean age +/- standard deviation (SD) was 46 +/- 9.8 years, and all patients with hormone receptor (HR)-positive tumors received adjuvant tamoxifen therapy. At a median follow-up of 62.2 months (range, 2.9-98.2), 89 patients (12.8%) had experienced a recurrence and 51 patients (7.3%) had died. In the HR-positive group, serum PGRN levels were associated with recurrence according to the log-rank test for trend (p for trend = 0.049). There was no association between PGRN levels and recurrence in the HR-negative group (p for trend = 0.658). Adjusted hazard ratios, including possible confounders, revealed a linear relationship between serum PGRN levels and recurrence in the HR-positive group (p for trend = 0.049), and this association was further strengthened after excluding patients who had no lymph node metastasis (p for trend = 0.038). Conclusions/Significance: Serum PGRN levels were clinically significant for predicting recurrence in patients with HR-positive breast cancer during adjuvant tamoxifen therapy.	[Koo, Dong Hoe; Park, Cheol-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Eun Sook; Ro, Jungsil] Natl Canc Ctr, Res Inst & Hosp, Ctr Breast Canc, Goyang Si, Gyeonggi Do, South Korea; [Oh, Sang Woo] Dongguk Univ, Coll Med, Ilsan Hosp, Ctr Obes Nutr & Metab,Dept Family Med, Goyang Si, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Dongguk University; NHIS Ilsan Hospital	Koo, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea.	cydoctor@chol.com; osw6021@yahoo.co.kr	Koo, Dong-Hoe/K-7561-2019; Park, Cheol-Young/C-6690-2018	Koo, Dong-Hoe/0000-0001-9913-8883; Oh, Sang Woo/0000-0002-5623-6720; Park, Cheol-Young/0000-0002-9415-9965	National Research Foundation of Korea; Korean Government [KRF-2008-314-E00201]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This study was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (KRF-2008-314-E00201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Abrhale T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-231; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Cameron DA, 2000, EUR J CANCER, V36, P845, DOI 10.1016/S0959-8049(00)00013-7; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Frampton G, 2012, GUT, V61, P268, DOI 10.1136/gutjnl-2011-300643; Han JJ, 2011, GYNECOL ONCOL, V120, P5, DOI 10.1016/j.ygyno.2010.09.006; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim WE, 2006, CLIN CANCER RES, V12, P4192, DOI 10.1158/1078-0432.CCR-05-2663; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Oh SW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2856; Okura H, 2010, J ATHEROSCLEROSIS TH; Rakha EA, 2008, EUR J CANCER, V44, P73, DOI 10.1016/j.ejca.2007.10.009; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Serrero G, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.22064; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tangkeangsirisin W, 2004, CANCER RES, V64, P1737, DOI 10.1158/0008-5472.CAN-03-2364; Tian Changsheng, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P691; Tkaczuk KR, 2011, BREAST CANCER-BASIC, V5, P155, DOI 10.4137/BCBCR.S7224; Wang M, 2011, IEEE MTT S INT MICR, P1; Wells CA, 2004, VIRCHOWS ARCH, V445, P119, DOI 10.1007/s00428-004-1063-8; Winer EP, 2005, J CLIN ONCOL, V23, P1609, DOI 10.1200/JCO.2005.01.005; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147	27	35	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39880	10.1371/journal.pone.0039880	http://dx.doi.org/10.1371/journal.pone.0039880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761921	Green Published, gold, Green Submitted			2022-12-25	WOS:000305781700071
J	Buga, AM; Vintilescu, R; Balseanu, AT; Pop, OT; Streba, C; Toescu, E; Popa-Wagner, A				Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Toescu, Emil; Popa-Wagner, Aurel			Repeated PTZ Treatment at 25-Day Intervals Leads to a Highly Efficient Accumulation of Doublecortin in the Dorsal Hippocampus of Rats	PLOS ONE			English	Article							ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; ADULT DENTATE GYRUS; NITRIC-OXIDE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CRITICAL PERIOD; SPATIAL MEMORY; DOWN-SYNDROME	Background: Neurogenesis persists throughout life in the adult mammalian brain. Because neurogenesis can only be assessed in postmortem tissue, its functional significance remains undetermined, and identifying an in vivo correlate of neurogenesis has become an important goal. By studying pentylenetetrazole-induced brain stimulation in a rat model of kindling we accidentally discovered that 25+/-1 days periodic stimulation of Sprague-Dawley rats led to a highly efficient increase in seizure susceptibility. Methodology/Principal Findings: By EEG, RT-PCR, western blotting and immunohistochemistry, we show that repeated convulsive seizures with a periodicity of 25+/-1 days led to an enrichment of newly generated neurons, that were BrdU-positive in the dentate gyrus at day 25+/-1 post-seizure. At the same time, there was a massive increase in the number of neurons expressing the migratory marker, doublecortin, at the boundary between the granule cell layer and the polymorphic layer in the dorsal hippocampus. Some of these migrating neurons were also positive for NeuN, a marker for adult neurons. Conclusion/Significance: Our results suggest that the increased susceptibility to seizure at day 25+/-1 post-treatment is coincident with a critical time required for newborn neurons to differentiate and integrate into the existing hippocampal network, and outlines the importance of the dorsal hippocampus for seizure-related neurogenesis. This model can be used as an in vivo correlate of neurogenesis to study basic questions related to neurogenesis and to the neurogenic mechanisms that contribute to the development of epilepsy.	[Buga, Ana-Maria; Balseanu, Adrian Tudor; Popa-Wagner, Aurel] Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Popa-Wagner, Aurel] Univ Med & Pharm, Dept Funct Sci, Craiova, Romania; [Toescu, Emil] Univ Birmingham Edgbaston, Coll Med & Dent Sci, Dept Clin & Expt Med, Birmingham, W Midlands, England	University of Rostock; University of Medicine & Pharmacy of Craiova; University of Birmingham	Buga, AM (corresponding author), Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Popa-Wagner, Aurel/E-2541-2013; Buga, Ana-Maria I/P-1478-2014; Vintilescu, Raluca/A-9499-2018; Streba, Costin Teodor T/C-4196-2011; Balseanu, Tudor Adrian/O-2289-2018; Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/I-2581-2019; Buga, Ana Maria/ABA-8108-2021; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019; Scholz, Claus Jürgen/H-3202-2019	Streba, Costin Teodor T/0000-0001-9590-3197; Balseanu, Tudor Adrian/0000-0002-0047-3436; Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Scholz, Claus Jürgen/0000-0002-6406-7859; Sivanesan, Senthilkumar/0000-0001-5133-7090	Ministry of Research and Education of Germany [0314107]; National Council for Scientific Research of Romania [PN-II-ID-PCE-2011-3-0848]; European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania [8555/2011]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Ministry of Research and Education of Germany; National Council for Scientific Research of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)); European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); ERA-NET FLARE2/UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Ministry of Research and Education of Germany (No 0314107) and from National Council for Scientific Research of Romania (No PN-II-ID-PCE-2011-3-0848). Dr. Ana-Maria Buga and Dr. Toescu were supported by a grant from the European project ERA-NET FLARE2 of United Kingdom and the Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania (No 8555/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Popa-Wagner was supported by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. We also acknowledge the critical reading of the manuscript by Lary Walker.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Babb T L, 1986, Adv Neurol, V44, P949; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Dashtipour K, 2001, BRAIN RES, V890, P261, DOI 10.1016/S0006-8993(00)03119-X; Detour J, 2005, EPILEPSIA, V46, P499, DOI 10.1111/j.0013-9580.2005.38704.x; Devinsky Orrin, 2004, Rev Neurol Dis, V1, P2; ENGEL J, 1993, ELECTROEN CLIN NEURO, V87, P437, DOI 10.1016/0013-4694(93)90158-R; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ferland RJ, 2002, NEUROSCI LETT, V332, P131, DOI 10.1016/S0304-3940(02)00808-X; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Geoghegan D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-2; Hosseini M, 2009, SEIZURE-EUR J EPILEP, V18, P695, DOI 10.1016/j.seizure.2009.09.008; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Junker H, 2005, EPILEPSIA, V46, P339, DOI 10.1111/j.0013-9580.2005.46904.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Parent JM, 1997, J NEUROSCI, V17, P3727; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; Popa-Wagner A, 2007, CURR NEUROVASC RES, V4, P216; PopaWagner A, 1997, EXP NEUROL, V148, P73, DOI 10.1006/exnr.1997.6652; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Scharfman Helen E., 2002, Epilepsy Curr, V2, P63, DOI 10.1046/j.1535-7597.2002.00023.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmoll H, 2003, AM J PATHOL, V162, P1027, DOI 10.1016/S0002-9440(10)63897-7; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	42	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39302	10.1371/journal.pone.0039302	http://dx.doi.org/10.1371/journal.pone.0039302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	23251410	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100042
J	Shiryaev, SA; Thomsen, ER; Cieplak, P; Chudin, E; Cheltsov, AV; Chee, MS; Kozlov, IA; Strongin, AY				Shiryaev, Sergey A.; Thomsen, Elliot R.; Cieplak, Piotr; Chudin, Eugene; Cheltsov, Anton V.; Chee, Mark S.; Kozlov, Igor A.; Strongin, Alex Y.			New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage Assay	PLOS ONE			English	Article							HEPATITIS-C VIRUS; IN-VITRO SELECTION; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; PROTEASE; NS4A; ACTIVATION; DOMAIN; IDENTIFICATION; DETERMINANTS	Background: The hepatitis C virus (HCV) genome encodes a long polyprotein, which is processed by host cell and viral proteases to the individual structural and non-structural (NS) proteins. HCV NS3/4A serine proteinase (NS3/4A) is a non-covalent heterodimer of the N-terminal, similar to 180-residue portion of the 631-residue NS3 protein with the NS4A co-factor. NS3/4A cleaves the polyprotein sequence at four specific regions. NS3/4A is essential for viral replication and has been considered an attractive drug target. Methodology/Principal Findings: Using a novel multiplex cleavage assay and over 2,660 peptide sequences derived from the polyprotein and from introducing mutations into the known NS3/4A cleavage sites, we obtained the first detailed fingerprint of NS3/4A cleavage preferences. Our data identified structural requirements illuminating the importance of both the short-range (P1-P1') and long-range (P6-P5) interactions in defining the NS3/4A substrate cleavage specificity. A newly observed feature of NS3/4A was a high frequency of either Asp or Glu at both P5 and P6 positions in a subset of the most efficient NS3/4A substrates. In turn, aberrations of this negatively charged sequence such as an insertion of a positively charged or hydrophobic residue between the negatively charged residues resulted in inefficient substrates. Because NS5B misincorporates bases at a high rate, HCV constantly mutates as it replicates. Our analysis revealed that mutations do not interfere with polyprotein processing in over 5,000 HCV isolates indicating a pivotal role of NS3/4A proteolysis in the virus life cycle. Conclusions/Significance: Our multiplex assay technology in light of the growing appreciation of the role of proteolytic processes in human health and disease will likely have widespread applications in the proteolysis research field and provide new therapeutic opportunities.	[Shiryaev, Sergey A.; Cieplak, Piotr; Cheltsov, Anton V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA; [Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.] Prognosys Biosci Inc, R&D Dept, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NIH [R43GM085884, R01GM98835, R01CA83017, R01CA157328]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the NIH grants R43GM085884 (IAK), R01GM98835 (PC), and R01CA83017 and R01CA157328 (AYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Case D.A., 2022, AMBER 2020; Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hellen CUT, 1999, J VIRAL HEPATITIS, V6, P79, DOI 10.1046/j.1365-2893.1999.00150.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Koch JO, 1997, VIROLOGY, V237, P78, DOI 10.1006/viro.1997.8760; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Martin MM, 2011, BIOL CHEM, V392, P927, DOI 10.1515/BC.2011.076; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Steinkuhler C, 1996, J VIROL, V70, P6694; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Suzuki R, 1999, INTERVIROLOGY, V42, P145, DOI 10.1159/000024973; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Urbani A, 1997, J BIOL CHEM, V272, P9204; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	48	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35759	10.1371/journal.pone.0035759	http://dx.doi.org/10.1371/journal.pone.0035759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22768327	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000057
J	Malik, SZ; Lewis, M; Isaacs, A; Haskins, M; Van Winkle, T; Vite, CH; Watson, DJ				Malik, Saafan Z.; Lewis, Melissa; Isaacs, Alison; Haskins, Mark; Van Winkle, Thomas; Vite, Charles H.; Watson, Deborah J.			Identification of the Rostral Migratory Stream in the Canine and Feline Brain	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; SUBVENTRICULAR ZONE; STEM-CELLS; OLFACTORY-BULB; PET DOGS; TRANSPLANTATION; DIFFERENTIATION; GLIOBLASTOMA; NEURONS; MODELS	In the adult rodent brain, neural progenitor cells migrate from the subventricular zone of the lateral ventricle towards the olfactory bulb in a track known as the rostral migratory stream (RMS). To facilitate the study of neural progenitor cells and stem cell therapy in large animal models of CNS disease, we now report the location and characteristics of the normal canine and feline RMS. The RMS was found in Nissl-stained sagittal sections of adult canine and feline brains as a prominent, dense, continuous cellular track beginning at the base of the anterior horn of the lateral ventricle, curving around the head of the caudate nucleus and continuing laterally and ventrally to the olfactory peduncle before entering the olfactory tract and bulb. To determine if cells in the RMS were proliferating, the thymidine analog 5-bromo-2-deoxyuridine (BrdU) was administered and detected by immunostaining. BrdU-immunoreactive cells were present throughout this track. The RMS was also immunoreactive for markers of proliferating cells, progenitor cells and immature neurons (Ki-67 and doublecortin), but not for NeuN, a marker of mature neurons. Luxol fast blue and CNPase staining indicated that myelin is closely apposed to the RMS along much of its length and may provide guidance cues for the migrating cells. Identification and characterization of the RMS in canine and feline brain will facilitate studies of neural progenitor cell biology and migration in large animal models of neurologic disease.	[Malik, Saafan Z.; Isaacs, Alison; Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lewis, Melissa; Haskins, Mark; Vite, Charles H.] Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA; [Haskins, Mark; Van Winkle, Thomas] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Malik, SZ (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	djw3@mail.med.upenn.edu		Lewis, Melissa J/0000-0001-6643-191X	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health [DK54481, DK25759, RR02512]; Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054481, R01DK025759] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by University of Pennsylvania Department of Neurosurgery funds (DW), National Institutes of Health DK54481, DK25759 and RR02512 (MH), and the Ara Parseghian Medical Research Foundation (CV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2006, J NEUROSCI METH, V150, P41, DOI 10.1016/j.jneumeth.2005.05.024; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; Berman A.L., 1968, BRAIN STEM CAT CYTOA; Berman AL, 1982, THALAMUS BASAL TELEN; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fitzgerald TC, 1961, VET MED, V56, P38; Gil-Perotin S, 2009, J COMP NEUROL, V514, P533, DOI 10.1002/cne.22026; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Jenkins T, 1972, FUNCATIONAL MAMMALIA; Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792; Klassen H, 2007, VET OPHTHALMOL, V10, P245, DOI 10.1111/j.1463-5224.2007.00547.x; Koestner A, 1999, HISTOLOGIC CLASSIFIC; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipsitz D, 2003, VET PATHOL, V40, P659, DOI 10.1354/vp.40-6-659; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Milward EA, 1997, J NEUROSCI RES, V50, P862, DOI 10.1002/(SICI)1097-4547(19971201)50:5<862::AID-JNR22>3.0.CO;2-1; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Rossignol S, 2002, PROG BRAIN RES, V137, P151; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Smitka M, 2009, NEUROSCIENCE, V162, P482, DOI 10.1016/j.neuroscience.2009.04.058; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Stoica G, 2004, VET PATHOL, V41, P10, DOI 10.1354/vp.41-1-10; Stoica G, 2009, VET PATHOL, V46, P391, DOI 10.1354/vp.08-VP-0218-S-FL; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Thomson SAM, 2005, VET PATHOL, V42, P550, DOI 10.1354/vp.42-5-550; Trojanowski JQ, 2008, ALZHEIMERS DEMENT, V4, P1, DOI 10.1016/j.jalz.2007.09.007; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vite C H, 2006, BRAUNDS CLIN NEUROLO; Walton RM, 2008, J NEUROPATH EXP NEUR, V67, P954, DOI 10.1097/NEN.0b013e3181875b2f; Walton RM, 2008, J NEUROSCI METH, V169, P158, DOI 10.1016/j.jneumeth.2007.12.011; Wang L, 2007, NEUROSCI RES, V59, P327, DOI 10.1016/j.neures.2007.08.011; Waters DJ, 2006, SCI AM, V295, P94, DOI 10.1038/scientificamerican1206-94; WATSON DJ, 2002, VIRAL VECTORS GENE T, P383	43	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36016	10.1371/journal.pone.0036016	http://dx.doi.org/10.1371/journal.pone.0036016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606243	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338200016
J	Zhang, X; Mao, Y; Huang, ZX; Qu, M; Chen, J; Ding, SX; Hong, JN; Sun, TT				Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian			Transcriptome Analysis of the Octopus vulgaris Central Nervous System	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-PERFORMANCE; ENDOTHELIAL-CELLS; MOLECULAR ANATOMY; TISSUES; IDENTIFICATION; SYNAPTOTAGMIN; LOCALIZATION; PERMEABILITY; MICROVESSELS	Background: Cephalopoda are a class of Mollusca species found in all the world's oceans. They are an important model organism in neurobiology. Unfortunately, the lack of neuronal molecular sequences, such as ESTs, transcriptomic or genomic information, has limited the development of molecular neurobiology research in this unique model organism. Results: With high-throughput Illumina Solexa sequencing technology, we have generated 59,859 high quality sequences from 12,918,391 paired-end reads. Using BLASTx/BLASTn, 12,227 contigs have blast hits in the Swissprot, NR protein database and NT nucleotide database with E-value cutoff 1e(-5). The comparison between the Octopus vulgaris central nervous system (CNS) library and the Aplysia californica/Lymnaea stagnalis CNS ESTs library yielded 5.93%/13.45% of O. vulgaris sequences with significant matches (1e(-5)) using BLASTn/tBLASTx. Meanwhile the hit percentage of the recently published Schistocerca gregaria, Tilapia or Hirudo medicinalis CNS library to the O. vulgaris CNS library is 21.03%-46.19%. We constructed the Phylogenetic tree using two genes related to CNS function, Synaptotagmin-7 and Synaptophysin. Lastly, we demonstrated that O. vulgaris may have a vertebrate-like Blood-Brain Barrier based on bioinformatic analysis. Conclusion: This study provides a mass of molecular information that will contribute to further molecular biology research on O. vulgaris. In our presentation of the first CNS transcriptome analysis of O. vulgaris, we hope to accelerate the study of functional molecular neurobiology and comparative evolutionary biology.	[Chen, Jun; Ding, Shaoxiong] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Zhang, Xiang; Qu, Meng; Ding, Shaoxiong] Xiamen Univ, Lab Marine Biodivers & Global Change, Xiamen, Peoples R China; [Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Zhang, X (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	sxding@xmu.edu.cn	Huang, Zixia/AAO-6936-2021; Ding, SX/G-4137-2010; zhang, menghui/Q-3752-2016; Xu, Jia/GSD-6115-2022	Li, Xiaoying/0000-0002-9383-5757; zhang, menghui/0000-0002-9274-487X; Huang, Zixia/0000-0002-1298-0486; Zhang, Xu/0000-0003-2406-9478; Xu, Jia/0000-0002-3341-7668	National fund for oceanography research in Public Interest [201005013]; National Key Technology RD Program [2011BAD13]	National fund for oceanography research in Public Interest; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by the National fund for oceanography research in Public Interest (201005013) and the National Key Technology R&D Program (2011BAD13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT VR, 1987, J BIOL CHEM, V262, P9404; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Gutnick T, 2011, CURR BIOL, V21, P460, DOI 10.1016/j.cub.2011.01.052; HARDEBO JE, 1980, ANN NEUROL, V8, P1, DOI 10.1002/ana.410080102; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hormiga JA, 2010, J BIOTECHNOL, V149, P209, DOI 10.1016/j.jbiotec.2009.12.008; KALARIA RN, 1987, J NEUROCHEM, V49, P856, DOI 10.1111/j.1471-4159.1987.tb00973.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Monteiro A, 2011, HARMFUL ALGAE, V10, P732, DOI 10.1016/j.hal.2011.06.004; Morita T, 2010, MAR POLLUT BULL, V60, P1193, DOI 10.1016/j.marpolbul.2010.03.031; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Perales-Raya C, 2010, FISH RES, V106, P171, DOI 10.1016/j.fishres.2010.05.003; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Prato E, 2010, AQUACULTURE, V309, P203, DOI 10.1016/j.aquaculture.2010.09.036; Quintana D, 2008, AQUACULTURE, V280, P161, DOI 10.1016/j.aquaculture.2008.04.017; Raimundo J, 2010, CHEMOSPHERE, V81, P1314, DOI 10.1016/j.chemosphere.2010.08.029; Raimundo J, 2010, COMP BIOCHEM PHYS C, V152, P139, DOI 10.1016/j.cbpc.2010.03.009; Raimundo J, 2010, ECOTOX ENVIRON SAFE, V73, P1543, DOI 10.1016/j.ecoenv.2010.07.034; Raimundo J, 2010, ENVIRON POLLUT, V158, P2094, DOI 10.1016/j.envpol.2010.03.005; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Seixas P, 2008, AQUACULTURE, V283, P83, DOI 10.1016/j.aquaculture.2008.06.019; Seixas P, 2010, AQUACULTURE, V300, P156, DOI 10.1016/j.aquaculture.2009.12.021; Shih JC, 2004, CURR MED CHEM, V11, P1995, DOI 10.2174/0929867043364757; Shomrat T, 2010, NEUROSCIENCE, V169, P52, DOI 10.1016/j.neuroscience.2010.04.050; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; Sobrino I, 2011, FISH RES, V108, P283, DOI 10.1016/j.fishres.2010.12.022; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ueno M, 2007, CURR MED CHEM, V14, P1199, DOI 10.2174/092986707780597943; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vargas-Yanez M, 2009, FISH RES, V99, P159, DOI 10.1016/j.fishres.2009.05.013; Vazquez-Rowe I, 2012, MAR POLICY, V36, P180, DOI 10.1016/j.marpol.2011.05.002; Villanueva R, 2009, AQUACULTURE, V286, P277, DOI 10.1016/j.aquaculture.2008.09.032; Vorbrodt AW, 2008, BRAIN CELL BIOL, V36, P203, DOI 10.1007/s11068-008-9038-3; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; Weksler BB, 2005, FASEB J; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng J, 2011, PLOS ONE, V6; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	285	298	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40320	10.1371/journal.pone.0040320	http://dx.doi.org/10.1371/journal.pone.0040320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768275	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100249
J	Buga, AM; Scholz, CJ; Kumar, S; Herndon, JG; Alexandru, D; Cojocaru, GR; Dandekar, T; Popa-Wagner, A				Buga, Ana-Maria; Scholz, Claus Juergen; Kumar, Senthil; Herndon, James G.; Alexandru, Dragos; Cojocaru, Gabriel Radu; Dandekar, Thomas; Popa-Wagner, Aurel			Identification of New Therapeutic Targets by Genome-Wide Analysis of Gene Expression in the Ipsilateral Cortex of Aged Rats after Stroke	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; COLONY-STIMULATING FACTOR; CEREBRAL-ISCHEMIA; RECEPTOR; BRAIN; PROTEIN; INHIBITOR; MOUSE; GAMMA; DIFFERENTIATION	Background: Because most human stroke victims are elderly, studies of experimental stroke in the aged rather than the young rat model may be optimal for identifying clinically relevant cellular responses, as well for pinpointing beneficial interventions. Methodology/Principal Findings: We employed the Affymetrix platform to analyze the whole-gene transcriptome following temporary ligation of the middle cerebral artery in aged and young rats. The correspondence, heat map, and dendrogram analyses independently suggest a differential, age-group-specific behaviour of major gene clusters after stroke. Overall, the pattern of gene expression strongly suggests that the response of the aged rat brain is qualitatively rather than quantitatively different from the young, i.e. the total number of regulated genes is comparable in the two age groups, but the aged rats had great difficulty in mounting a timely response to stroke. Our study indicates that four genes related to neuropathic syndrome, stress, anxiety disorders and depression (Acvr1c, Cort, Htr2b and Pnoc) may have impaired response to stroke in aged rats. New therapeutic options in aged rats may also include Calcrl, Cyp11b1, Prcp, Cebpa, Cfd, Gpnmb, Fcgr2b, Fcgr3a, Tnfrsf26, Adam 17 and Mmp14. An unexpected target is the enzyme 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 in aged rats, a key enzyme in the cholesterol synthesis pathway. Post-stroke axonal growth was compromised in both age groups. Conclusion/Significance: We suggest that a multi-stage, multimodal treatment in aged animals may be more likely to produce positive results. Such a therapeutic approach should be focused on tissue restoration but should also address other aspects of patient post-stroke therapy such as neuropathic syndrome, stress, anxiety disorders, depression, neurotransmission and blood pressure.	[Buga, Ana-Maria; Popa-Wagner, Aurel] Univ Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Alexandru, Dragos; Cojocaru, Gabriel Radu] Univ Med, Dept Funct Sci, Craiova, Romania; [Scholz, Claus Juergen] Univ Wurzburg, Lab Microarray Applicat, Interdisciplinary Ctr Clin Res, D-97070 Wurzburg, Germany; [Kumar, Senthil] Iowa State Univ Sci & Technol, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA; [Herndon, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Dandekar, Thomas] Bioctr Hubland, Dept Bioinformat, Wurzburg, Germany	University of Medicine & Pharmacy of Craiova; University of Wurzburg; Iowa State University; Emory University	Popa-Wagner, A (corresponding author), Univ Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Popa-Wagner, Aurel/E-2541-2013; Buga, Ana-Maria I/P-1478-2014; Vintilescu, Raluca/A-9499-2018; Streba, Costin Teodor T/C-4196-2011; Balseanu, Tudor Adrian/O-2289-2018; Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/I-2581-2019; Buga, Ana Maria/ABA-8108-2021; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019; Scholz, Claus Jürgen/H-3202-2019	Streba, Costin Teodor T/0000-0001-9590-3197; Balseanu, Tudor Adrian/0000-0002-0047-3436; Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Scholz, Claus Jürgen/0000-0002-6406-7859; Sivanesan, Senthilkumar/0000-0001-5133-7090	Federal Ministry of Education and Research [01GN0982]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; NIH [OD P51OD11132]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); CNCS-UEFISCDI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-NET FLARE2/UEFISCDI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported financially by the Federal Ministry of Education and Research (Grant No 01GN0982) and by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848 to A. P. W. and by NIH grant OD P51OD11132 to the Yerkes National Primate Research Center. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer HL, 2006, AM J MED GENET A, V140A, P691, DOI 10.1002/ajmg.a.31133; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Badan I, 2003, GERONTOLOGY, V49, P356, DOI 10.1159/000073763; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borday C, 2004, PROG BIOPHYS MOL BIO, V84, P89, DOI 10.1016/j.pbiomolbio.2003.11.002; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Chiou LC, 2007, CURR DRUG TARGETS, V8, P117, DOI 10.2174/138945007779315605; Chnari E, 2006, BIOMACROMOLECULES, V7, P1796, DOI 10.1021/bm0600872; Cruz C, 2010, P NATL ACAD SCI USA, V107, P3564, DOI 10.1073/pnas.1000389107; Deshmukh HS, 2009, AM J RESP CRIT CARE, V180, P834, DOI 10.1164/rccm.200903-0328OC; Deussing JM, 2007, J CEREBR BLOOD F MET, V27, P1476, DOI 10.1038/sj.jcbfm.9600451; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Fischer T, 2011, DEV BIOL, V350, P496, DOI 10.1016/j.ydbio.2010.12.017; Gavioli EC, 2008, PEPTIDES, V29, P1404, DOI 10.1016/j.peptides.2008.04.004; Ghzili H, 2006, REGUL PEPTIDES, V137, P89, DOI 10.1016/j.regpep.2006.06.015; Gierten J, 2008, BRIT J PHARMACOL, V154, P1680, DOI 10.1038/bjp.2008.213; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jang JE, 2012, CIRC RES, V110, P1057, DOI 10.1161/CIRCRESAHA.112.266411; Kagerer SM, 2011, PEPTIDES, V32, P839, DOI 10.1016/j.peptides.2011.01.004; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kennett GA, 1998, NEUROPHARMACOLOGY, V37, P1603, DOI 10.1016/S0028-3908(98)00115-4; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Leitch B, 2009, J COMP NEUROL, V512, P52, DOI 10.1002/cne.21890; Lewis J, 2010, NEURON, V68, P601, DOI 10.1016/j.neuron.2010.11.014; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Lindner MD, 2003, J NEUROSCI, V23, P10913; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Liu RZ, 2004, EUR J BIOCHEM, V271, P339, DOI 10.1046/j.1432-1033.2003.03932.x; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; Martinowich K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-11; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; Mertsch S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-302; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Morikis D, 2002, BIOCHEM SOC T, V30, P1026, DOI 10.1042/BST0301026; Na IK, 2009, J IMMUNOTHER, V32, P907, DOI 10.1097/CJI.0b013e3181b7be60; Papac-Milicevic N, 2012, CIRC RES, V110, pE50, DOI 10.1161/CIRCRESAHA.111.258814; Popa-Wagner A, 1999, J CEREBR BLOOD F MET, V19, P425, DOI 10.1097/00004647-199904000-00008; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Saleh S, 2005, J PHYSIOL-LONDON, V568, P155, DOI 10.1113/jphysiol.2005.090951; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Siehler S, 2008, MOL CELL ENDOCRINOL, V286, P26, DOI 10.1016/j.mce.2007.12.007; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Teronen O, 1997, J DENT RES, V76, P1529, DOI 10.1177/00220345970760090401; Trumbach D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-159; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Yamada Y, 2011, EUR J PHARMACOL, V667, P113, DOI 10.1016/j.ejphar.2011.05.072; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhang GX, 2010, HYPERTENS RES, V33, P478, DOI 10.1038/hr.2010.21; Zhou CY, 2010, J MED CHEM, V53, P7251, DOI 10.1021/jm101013m; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	78	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50985	10.1371/journal.pone.0050985	http://dx.doi.org/10.1371/journal.pone.0050985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251410	Green Published, gold			2022-12-25	WOS:000313236200051
J	Jones, DT; Vemuri, P; Murphy, MC; Gunter, JL; Senjem, ML; Machulda, MM; Przybelski, SA; Gregg, BE; Kantarci, K; Knopman, DS; Boeve, BF; Petersen, RC; Jack, CR				Jones, David T.; Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Machulda, Mary M.; Przybelski, Scott A.; Gregg, Brian E.; Kantarci, Kejal; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.; Jack, Clifford R., Jr.			Non-Stationarity in the "Resting Brain's" Modular Architecture	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; AGE-RELATED-CHANGES; SMALL-WORLD; MRI; ORGANIZATION; FMRI; RECONFIGURATION; DYNAMICS; ADULTS	Task-free functional magnetic resonance imaging (TF-fMRI) has great potential for advancing the understanding and treatment of neurologic illness. However, as with all measures of neural activity, variability is a hallmark of intrinsic connectivity networks (ICNs) identified by TF-fMRI. This variability has hampered efforts to define a robust metric of connectivity suitable as a biomarker for neurologic illness. We hypothesized that some of this variability rather than representing noise in the measurement process, is related to a fundamental feature of connectivity within ICNs, which is their non-stationary nature. To test this hypothesis, we used a large (n = 892) population-based sample of older subjects to construct a well characterized atlas of 68 functional regions, which were categorized based on independent component analysis network of origin, anatomical locations, and a functional meta-analysis. These regions were then used to construct dynamic graphical representations of brain connectivity within a sliding time window for each subject. This allowed us to demonstrate the non-stationary nature of the brain's modular organization and assign each region to a "meta-modular" group. Using this grouping, we then compared dwell time in strong sub-network configurations of the default mode network (DMN) between 28 subjects with Alzheimer's dementia and 56 cognitively normal elderly subjects matched 1: 2 on age, gender, and education. We found that differences in connectivity we and others have previously observed in Alzheimer's disease can be explained by differences in dwell time in DMN sub-network configurations, rather than steady state connectivity magnitude. DMN dwell time in specific modular configurations may also underlie the TF-fMRI findings that have been described in mild cognitive impairment and cognitively normal subjects who are at risk for Alzheimer's dementia.	[Jones, David T.; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Gregg, Brian E.; Kantarci, Kejal; Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Machulda, Mary M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Przybelski, Scott A.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Jones, DT (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	jack.clifford@mayo.edu	Senjem, Matthew L/GRF-6799-2022; Jack, Clifford R/F-2508-2010; Vemuri, Prashanthi/K-7030-2012; Harris, Adrian/ABA-3343-2020; Buffa, Francesca M./D-2574-2013	Senjem, Matthew L/0000-0001-9308-9275; Jack, Clifford R/0000-0001-7916-622X; Lechertier, Tanguy/0000-0002-0202-8424; Kantarci, Kejal/0000-0002-8001-2081; Bicknell, Roy/0000-0002-0941-8919; Harris, Adrian/0000-0003-1376-8409; Jones, J Louise/0000-0003-3880-3274; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Buffa, Francesca M./0000-0003-0409-406X; Mitter, Richard/0000-0002-1279-3760; Jones, David/0000-0002-4807-9833	National Institute on Aging [R01AG11378, P50 AG16574, U01 AG06786, K99AG37573]; Mayo Foundation; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [U01AG006786, P50AG016574, K99AG037573, R01AG011378, R01AG041851] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Foundation; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The National Institute on Aging (R01AG11378, P50 AG16574, U01 AG06786, K99AG37573), the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation, and Alzheimer's Association New Investigator grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; GLOOR P, 1994, ELECTROEN CLIN NEURO, V90, P253, DOI 10.1016/0013-4694(94)90143-0; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2011, ARCH NEUROL-CHICAGO, V68, P1107, DOI 10.1001/archneurol.2011.202; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	47	280	286	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39731	10.1371/journal.pone.0039731	http://dx.doi.org/10.1371/journal.pone.0039731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761880	gold, Green Submitted, Green Published			2022-12-25	WOS:000305826400031
J	Li, XH; Ha, CT; Fu, DD; Xiao, M				Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang			REDD1 Protects Osteoblast Cells from Gamma Radiation-Induced Premature Senescence	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC PROGENITORS; MARROW STROMAL CELLS; NF-KAPPA-B; CELLULAR SENESCENCE; IN-VITRO; DNA-DAMAGE; LIFE-SPAN; P53; MTOR; STRESS	Radiotherapy is commonly used for cancer treatment. However, it often results in side effects due to radiation damage in normal tissue, such as bone marrow (BM) failure. Adult hematopoietic stem and progenitor cells (HSPC) reside in BM next to the endosteal bone surface, which is lined primarily by hematopoietic niche osteoblastic cells. Osteoblasts are relatively more radiation-resistant than HSPCs, but the mechanisms are not well understood. In the present study, we demonstrated that the stress response gene REDD1 (regulated in development and DNA damage responses 1) was highly expressed in human osteoblast cell line (hFOB) cells after gamma irradiation. Knockdown of REDD1 with siRNA resulted in a decrease in hFOB cell numbers, whereas transfection of PCMV6-AC-GFP-REDD1 plasmid DNA into hFOB cells inhibited mammalian target of rapamycin (mTOR) and p21 expression and protected these cells from radiation-induced premature senescence (PS). The PS in irradiated hFOB cells were characterized by significant inhibition of clonogenicity, activation of senescence biomarker SA-beta-gal, and the senescence-associated cytokine secretory phenotype (SASP) after 4 or 8 Gy irradiation. Immunoprecipitation assays demonstrated that the stress response proteins p53 and nuclear factor kappa B (NFkB) interacted with REDD1 in hFOB cells. Knockdown of NFkB or p53 gene dramatically suppressed REDD1 protein expression in these cells, indicating that REDD1 was regulated by both factors. Our data demonstrated that REDD1 is a protective factor in radiation-induced osteoblast cell premature senescence.	[Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Li, XH (corresponding author), Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	xiao@afrri.usuhs.mil			Armed Forces Radiobiology Research Institute [RAB2EI]; American Congressional Grant [G1B2EP]	Armed Forces Radiobiology Research Institute; American Congressional Grant	This study was supported by Armed Forces Radiobiology Research Institute intramural grant (RAB2EI) to MX and an American Congressional Grant (G1B2EP) to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, AGING-US, V1, P1008, DOI 10.18632/aging.100115; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hill R, 2008, CELL CYCLE, V7, P2535; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Singh VK, 2010, INT J RADIAT BIOL, V86, P12, DOI 10.3109/09553000903264515; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Xiao M, 2009, EXP HEMATOL, V37, P52, DOI 10.1016/j.exphem.2008.09.001; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	40	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36604	10.1371/journal.pone.0036604	http://dx.doi.org/10.1371/journal.pone.0036604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22768107	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500020
J	Park, HK; Ha, MH; Park, SG; Kim, MN; Kim, BJ; Kim, W				Park, Hee Kuk; Ha, Myung-Ho; Park, Sang-Gue; Kim, Myeung Nam; Kim, Beom Joon; Kim, Wonyong			Characterization of the Fungal Microbiota (Mycobiome) in Healthy and Dandruff-Afflicted Human Scalps	PLOS ONE			English	Article							HUMAN SKIN; DERMATITIS; ETIOLOGY; YEAST	The human scalp harbors a vast community of microbial mutualists, the composition of which is difficult to elucidate as many of the microorganisms are not culturable using current culture techniques. Dandruff, a common scalp disorder, is known as a causative factor of a mild seborrheic dermatitis as well as pityriasis versicolor, seborrheic dermatitis, and atopic dermatitis. Lipophilic yeast Malassezia is widely accepted to play a role in dandruff, but relatively few comprehensive studies have been reported. In order to investigate fungal biota and genetic resources of dandruff, we amplified the 26S rRNA gene from samples of healthy scalps and dandruff-afflicted scalps. The sequences were analyzed by a high throughput method using a GS-FLX 454 pyrosequencer. Of the 74,811 total sequence reads, Basidiomycota (Filobasidium spp.) was the most common phylum associated with dandruff. In contrast, Ascomycota (Acremonium spp.) was common in the healthy scalps. Our results elucidate the distribution of fungal communities associated with dandruff and provide new avenues for the potential prevention and treatment of dandruff.	[Park, Hee Kuk; Kim, Wonyong] Chung Ang Univ, Dept Microbiol, Seoul 156756, South Korea; [Kim, Myeung Nam; Kim, Beom Joon] Chung Ang Univ, Coll Med, Dept Dermatol, Seoul 156756, South Korea; [Ha, Myung-Ho; Park, Sang-Gue] Chung Ang Univ, Dept Appl Stat, Fac Business & Econ, Seoul 156756, South Korea	Chung Ang University; Chung Ang University; Chung Ang University Hospital; Chung Ang University	Park, HK (corresponding author), Chung Ang Univ, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Park, Heekuk/Y-2097-2019; PARK, Sang-Gue/V-7768-2019; Park, Heekuk/G-5292-2016	Park, Heekuk/0000-0001-5815-9717; Park, Heekuk/0000-0001-5815-9717; FERKO, Boris/0000-0001-5340-4437; Kim, Beom Joon/0000-0003-2320-7621	Ministry for Health & Welfare, Republic of Korea [A085138]	Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare Technology Research & Development Project, Ministry for Health & Welfare, Republic of Korea (A085138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Das S, 2010, MYCOPATHOLOGIA, V170, P361, DOI 10.1007/s11046-010-9334-1; Erchiga VC, 2002, CURR OPIN INFECT DIS, V15, P133, DOI 10.1097/00001432-200204000-00006; Geyer AS, 2006, J AM ACAD DERMATOL, V55, P1095, DOI 10.1016/j.jaad.2006.08.001; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gueho E, 1998, MED MYCOL, V36, P220; Gupta AK, 2004, DERMATOLOGY, V208, P89, DOI 10.1159/000076478; Gupta AK, 2001, MED MYCOL, V39, P199, DOI 10.1080/mmy.39.2.199.206; Gupta M, 2007, INDIAN J DERMATOL VE, V73, P389; Jo JH, 2005, CONTACT DERMATITIS, V52, P142, DOI 10.1111/j.0105-1873.2005.00528.x; 박주희, 2009, [Korean Journal of Dermatology, 대한피부과학회지], V47, P875; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LEYDEN JJ, 1976, ARCH DERMATOL, V112, P333, DOI 10.1001/archderm.112.3.333; MCGINLEY KJ, 1975, J INVEST DERMATOL, V64, P401, DOI 10.1111/1523-1747.ep12512335; Miyazaki J, 1996, J FERMENT BIOENG, V81, P315, DOI 10.1016/0922-338X(96)80583-6; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; PERFECT JR, 2006, FUNGAL PATHOGENESIS, P3; Pierard G E, 1995, Skin Res Technol, V1, P137, DOI 10.1111/j.1600-0846.1995.tb00033.x; Pierard-Franchimont C., 2006, International Journal of Cosmetic Science, V28, P311, DOI 10.1111/j.1467-2494.2006.00326.x; Pierard-Franchimont C, 2000, DERMATOLOGY, V200, P93, DOI 10.1159/000018337; Prohic Asja, 2003, Acta Dermatovenerol Croat, V11, P10; Ranganathan S, 2010, Indian J Dermatol, V55, P130, DOI 10.4103/0019-5154.62734; Ro BI, 2005, J INVEST DERM SYMP P, V10, P194, DOI 10.1111/j.1087-0024.2005.10104.x; Sugita T, 2002, J CLIN MICROBIOL, V40, P1363, DOI 10.1128/JCM.40.4.1363-1367.2002	27	255	268	7	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32847	10.1371/journal.pone.0032847	http://dx.doi.org/10.1371/journal.pone.0032847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22761928	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500109
J	Wang, DH; Hu, JR; Wang, LY; Hu, YJ; Tan, FQ; Zhou, H; Shao, JZ; Yang, WX				Wang, Da-Hui; Hu, Jian-Rao; Wang, Li-Ya; Hu, Yan-Jun; Tan, Fu-Qing; Zhou, Hong; Shao, Jian-Zhong; Yang, Wan-Xi			The Apoptotic Function Analysis of p53, Apaf1, Caspase3 and Caspase7 during the Spermatogenesis of the Chinese Fire-Bellied Newt Cynops orientalis	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; CADMIUM-INDUCED APOPTOSIS; FOLLICLE-STIMULATING-HORMONE; GLUCOSE-METABOLISM; OXIDATIVE STRESS; STRUCTURAL BASIS; DNA-DAMAGE; SPERMATOGONIAL APOPTOSIS; TESTOSTERONE WITHDRAWAL; SIGNALING PATHWAY	Background: Spontaneous and stress-induced germ cell apoptosis during spermatogenesis of multicellular organisms have been investigated broadly in mammals. Spermatogenetic process in urodele amphibians was essentially like that in mammals in spite of morphological differences; however, the mechanism of germ cell apoptosis in urodele amphibians remains unknown. The Chinese fire-belly newt, Cynops orientalis, was an excellent organism for studying germ cell apoptosis due to its sensitiveness to temperature, strong endurance of starvation, and sensitive skin to heavy metal exposure. Methodology/Principal Findings: TUNEL result showed that spontaneous germ cell apoptosis took place in normal newt, and severe stress-induced apoptosis occurred to spermatids and sperm in response to heat shock (40 degrees C 2 h), cold exposure(4 degrees C 12 h), cadmium exposure(Cd 36 h), and starvation stress. Quantitative reverse transcription polymerase chain reactions (qRT-PCR) showed that gene expression of Caspase3 or Caspase7 was obviously elevated after stress treatment. Apaf1 was not altered at its gene expression level, and p53 was significantly decreased after various stress treatment. Caspase assay demonstrated that Caspase-3, -8,-9 enzyme activities in newt testis were significantly elevated after heat shock (40 degrees C 2 h), cold exposure(4 degrees C 12 h), and cadmium exposure(Cd 36 h), while Caspase3 and Caspase8 activities were increased with Caspase9 significantly decreased after starvation treatment. Conclusions/Significance: Severe germ cell apoptosis triggered by heat shock, cold exposure, and cadmium exposure was Caspase3 dependent, which probably involved both extrinsic and intrinsic pathways. Apaf1 may be involved in this process without elevating its gene expression. But starvation-induced germ cell apoptosis was likely mainly through extrinsic pathway. p53 was probably not responsible for stress-induced germ cell apoptosis in newt testis. The intriguing high occurrence of spermatid and sperm apoptosis probably resulted from the sperm morphology and unique reproduction policy of Chinese fire-belly newt, Cynops orientalis.	[Wang, Da-Hui; Zhou, Hong; Shao, Jian-Zhong; Yang, Wan-Xi] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Jian-Rao] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Li-Ya; Hu, Yan-Jun] Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Tan, Fu-Qing] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang University; Zhejiang University	Wang, DH (corresponding author), Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	wang, dahui/0000-0001-6435-5132; Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [31072198, 81100393]; National Basic Research Program of China (973 Program) [2012CB967902]; Zhejiang Provincial Natural Science Foundation of China [Y2100296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the following projects: National Natural Science Foundation of China (No. 31072198 and 81100393), the National Basic Research Program of China (973 Program, Grant number: No. 2012CB967902), Zhejiang Provincial Natural Science Foundation of China (No. Y2100296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE SI, 1994, INT J DEV BIOL, V38, P201; ALLAN DJ, 1992, CELL PROLIFERAT, V25, P241, DOI 10.1111/j.1365-2184.1992.tb01399.x; Allemand I, 1999, ONCOGENE, V18, P6521, DOI 10.1038/sj.onc.1203052; Allsopp TE, 2000, CELL DEATH DIFFER, V7, P984, DOI 10.1038/sj.cdd.4400733; BAKALKIN G, 1994, P NATL ACAD SCI USA, V91, P413, DOI 10.1073/pnas.91.1.413; BARTKE A, 1995, ENDOCRINOLOGY, V136, P3, DOI 10.1210/en.136.1.3; Bernal-Manas CM, 2005, ACTA HISTOCHEM, V107, P365, DOI 10.1016/j.acthis.2005.07.002; Beumer TL, 1997, MOL REPROD DEV, V47, P240, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;240::AID-MRD2&gt;3.0.CO;2-L; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; BILLIG H, 1995, ENDOCRINOLOGY, V136, P5, DOI 10.1210/en.136.1.5; Blanco-Rodriguez J, 2003, REPRODUCTION, V126, P661, DOI 10.1530/reprod/126.5.661; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHOWDHURY AK, 1964, AM J ANAT, V115, P509, DOI 10.1002/aja.1001150307; Ciesielska AS, 2000, TOXICOLOGY, V145, P171; Coureui M, 2006, CELL DEATH DIFFER, V13, P1927, DOI 10.1038/sj.cdd.4401887; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Embree-Ku M, 2002, BIOL REPROD, V66, P1456, DOI 10.1095/biolreprod66.5.1456; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Glander HJ, 2002, ANDROLOGIA, V34, P227, DOI 10.1046/j.1439-0272.2002.00501.x; Gordo S, 2008, P NATL ACAD SCI USA, V105, P16426, DOI 10.1073/pnas.0805658105; Gosden R, 1997, BRIT MED BULL, V53, P644; Hall JL, 2001, DIABETES, V50, P1171, DOI 10.2337/diabetes.50.5.1171; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Hasegawa M, 1998, RADIAT RES, V149, P263, DOI 10.2307/3579959; Hassoun EA, 1996, TOXICOLOGY, V112, P219, DOI 10.1016/0300-483X(96)03404-X; HECKERT L, 1993, RECENT PROG HORM RES, V48, P61; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; HEW KW, 1993, TOXICOL APPL PHARM, V121, P15, DOI 10.1006/taap.1993.1123; Hikim APS, 1997, BIOL REPROD, V57, P1193, DOI 10.1095/biolreprod57.5.1193; Hikim APS, 1999, REV REPROD, V4, P38; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; HIKIM APS, 1995, ENDOCRINOLOGY, V136, P2770, DOI 10.1210/en.136.6.2770; Hikim APS, 1998, J CLIN ENDOCR METAB, V83, P152; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Ji YL, 2010, REPROD TOXICOL, V29, P176, DOI 10.1016/j.reprotox.2009.10.014; Ji Zai-Si, 1994, Zygote, V2, P53; Jimi S, 2004, ANN NY ACAD SCI, V1011, P325, DOI 10.1196/annals.1293.032; Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kilic M, 2002, CELL DEATH DIFFER, V9, P125, DOI 10.1038/sj/cdd/4400968; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kim MS, 2000, TOXICOLOGY, V145, P27, DOI 10.1016/S0300-483X(99)00176-6; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; Lafuente A, 2004, TOXICOL LETT, V146, P175, DOI 10.1016/j.toxlet.2003.10.004; Lafuente A, 2003, BIOMETALS, V16, P243, DOI 10.1023/A:1020658128413; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LASKEY JW, 1991, TOXICOL APPL PHARM, V108, P296, DOI 10.1016/0041-008X(91)90119-Y; Lee J, 1999, ENDOCRINOLOGY, V140, P852, DOI 10.1210/en.140.2.852; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Li LH, 1996, J ANDROL, V17, P538; Li M, 2000, J BIOL CHEM, V275, P39702, DOI 10.1074/jbc.M007369200; Lia MY, 2011, FISH SHELLFISH IMMUN, V30, P910, DOI 10.1016/j.fsi.2011.01.018; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liu J, 2001, LIFE SCI, V69, P1833, DOI 10.1016/S0024-3205(01)01267-X; LOCKSHIN RA, 1964, J INSECT PHYSIOL, V10, P643, DOI 10.1016/0022-1910(64)90034-4; Lomb DJ, 2009, MOL PHARMACOL, V75, P1198, DOI 10.1124/mol.108.053157; Lue Y, 1997, J ANDROL, V18, P166; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Matsui Y, 1998, APMIS, V106, P142, DOI 10.1111/j.1699-0463.1998.tb01329.x; McClure RF, 1999, J BIOL CHEM, V274, P7756, DOI 10.1074/jbc.274.12.7756; MIEUSSET R, 1995, INT J ANDROL, V18, P169, DOI 10.1111/j.1365-2605.1995.tb00408.x; Morissette MR, 2003, J MOL CELL CARDIOL, V35, P1217, DOI 10.1016/S0022-2828(03)00212-8; Nandi S, 1999, BIOL REPROD, V61, P70, DOI 10.1095/biolreprod61.1.70; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; OBEROSLER P, 1993, EMBO J, V12, P2389, DOI 10.1002/j.1460-2075.1993.tb05893.x; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; Ohta H, 2003, BIOL REPROD, V68, P2249, DOI 10.1095/biolreprod.102.014779; Ozawa N, 2002, J CLIN INVEST, V109, P457, DOI [10.1172/JCI0213190, 10.1172/JCI200213190]; Paasch U, 2003, J ANDROL, V24, P246; PACKER AI, 1995, MOL REPROD DEV, V42, P303, DOI 10.1002/mrd.1080420307; Pant N, 2003, REPROD TOXICOL, V17, P447, DOI 10.1016/S0890-6238(03)00036-4; Pareek TK, 2007, APOPTOSIS, V12, P1085, DOI 10.1007/s10495-006-0039-3; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; RAGAN HA, 1990, REV ENVIRON CONTAM T, V114, P1; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Richburg JH, 2000, TOXICOL LETT, V112, P79, DOI 10.1016/S0378-4274(99)00253-2; Ricote M, 2002, MOL REPROD DEV, V63, P202, DOI 10.1002/mrd.10167; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; ROBERTS KP, 1991, ANN NY ACAD SCI, V637, P90, DOI 10.1111/j.1749-6632.1991.tb27303.x; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Said TM, 2004, HUM REPROD UPDATE, V10, P39, DOI 10.1093/humupd/dmh003; Salazar G, 2005, DEV DYNAM, V234, P114, DOI 10.1002/dvdy.20533; Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026; Sen Gupta R, 2004, MOL CELL ENDOCRINOL, V221, P57, DOI 10.1016/j.mce.2004.03.012; Siu ER, 2009, TOXICOL APPL PHARM, V238, P240, DOI 10.1016/j.taap.2009.01.028; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; STOCCO DM, 1993, ENDOCRINOLOGY, V133, P2827, DOI 10.1210/en.133.6.2827; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Thangaraju M, 2000, J BIOL CHEM, V275, P33487, DOI 10.1074/jbc.M005824200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vera Y, 2004, BIOL REPROD, V70, P1534, DOI 10.1095/biolreprod.103.024661; Vera Y, 2006, MOL ENDOCRINOL, V20, P1597, DOI 10.1210/me.2005-0395; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Q, 2010, TOXICOL LETT, V199, P129, DOI 10.1016/j.toxlet.2010.08.014; Wang X, 2003, FERTIL STERIL, V80, P531, DOI 10.1016/S0015-0282(03)00756-8; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984; Wolgemuth DJ, 2003, CYTOGENET GENOME RES, V103, P256, DOI 10.1159/000076811; Woolveridge L, 1999, BIOL REPROD, V60, P461, DOI 10.1095/biolreprod60.2.461; Wu XD, 2002, REPROD TOXICOL, V16, P379, DOI 10.1016/S0890-6238(02)00039-4; Xu CY, 1996, TOXICOLOGY, V107, P1, DOI 10.1016/0300-483X(95)03195-L; Xu GG, 2010, BIOL REPROD, V83, P979, DOI 10.1095/biolreprod.110.085415; Xu Jian, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P25; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yang JM, 2003, REPROD TOXICOL, V17, P553, DOI 10.1016/S0890-6238(03)00100-X; Yazawa T, 1999, GEN COMP ENDOCR, V113, P302, DOI 10.1006/gcen.1998.7207; Yazawa T, 2000, ENDOCRINOLOGY, V141, P2027, DOI 10.1210/en.141.6.2027; Yazawa T, 2003, MOL REPROD DEV, V66, P60, DOI 10.1002/mrd.10328; Yazawa T, 2001, GEN COMP ENDOCR, V122, P296, DOI 10.1006/gcen.2001.7631; Yazawa T, 2001, MOL REPROD DEV, V59, P209, DOI 10.1002/mrd.1024; Yin YZ, 1998, BIOL REPROD, V58, P492, DOI 10.1095/biolreprod58.2.492; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074; Yin YZ, 2002, J ANDROL, V23, P64, DOI 10.1002/jand.2002.23.1.64; Young KA, 1999, ENDOCRINOLOGY, V140, P3133, DOI 10.1210/en.140.7.3133; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZH, 2003, CONTRACEPTION, V68, P297, DOI 10.1016/S0010-7824(03)00176-8; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zheng H, 1996, TOXICOL APPL PHARM, V136, P229, DOI 10.1006/taap.1996.0029; Zhou T, 1999, TOXICOLOGY, V142, P1, DOI 10.1016/S0300-483X(99)00115-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	147	117	120	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39920	10.1371/journal.pone.0039920	http://dx.doi.org/10.1371/journal.pone.0039920			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22808142	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100139
J	Shiryaev, SA; Cheltsov, AV; Strongin, AY				Shiryaev, Sergey A.; Cheltsov, Anton V.; Strongin, Alex Y.			Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; WEST-NILE-VIRUS; SERINE-PROTEASE INHIBITORS; NS4A COFACTOR PEPTIDE; IN-VITRO RESISTANCE; MACROCYCLIC INHIBITORS; POLYMERASE INHIBITORS; ANTIVIRAL THERAPY; DRUG-RESISTANCE; DENGUE-VIRUS	Background: Hepatitis C is a treatment-resistant disease affecting millions of people worldwide. The hepatitis C virus (HCV) genome is a single-stranded RNA molecule. After infection of the host cell, viral RNA is translated into a polyprotein that is cleaved by host and viral proteinases into functional, structural and non-structural, viral proteins. Cleavage of the polyprotein involves the viral NS3/4A proteinase, a proven drug target. HCV mutates as it replicates and, as a result, multiple emerging quasispecies become rapidly resistant to anti-virals, including NS3/4A inhibitors. Methodology/Principal Findings: To circumvent drug resistance and complement the existing anti-virals, NS3/4A inhibitors, which are additional and distinct from the FDA-approved telaprevir and boceprevir alpha-ketoamide inhibitors, are required. To test potential new avenues for inhibitor development, we have probed several distinct exosites of NS3/4A which are either outside of or partially overlapping with the active site groove of the proteinase. For this purpose, we employed virtual ligand screening using the 275,000 compound library of the Developmental Therapeutics Program (NCI/NIH) and the X-ray crystal structure of NS3/4A as a ligand source and a target, respectively. As a result, we identified several novel, previously uncharacterized, nanomolar range inhibitory scaffolds, which suppressed of the NS3/4A activity in vitro and replication of a sub-genomic HCV RNA replicon with a luciferase reporter in human hepatocarcinoma cells. The binding sites of these novel inhibitors do not significantly overlap with those of alpha-ketoamides. As a result, the most common resistant mutations, including V36M, R155K, A156T, D168A and V170A, did not considerably diminish the inhibitory potency of certain novel inhibitor scaffolds we identified. Conclusions/Significance: Overall, the further optimization of both the in silico strategy and software platform we developed and lead compounds we identified may lead to advances in novel anti-virals.	[Shiryaev, Sergey A.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA; [Cheltsov, Anton V.] Q MOL LLC, R&D Dept, San Diego, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA.	anton@q-mol.com; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01CA83017, R01CA157328]; NIAID [HHSN272201000009C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grants R01CA83017 and R01CA157328 to Alex Y. Strongin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Marintha Heil (Southern Research Institute, Birmingham, AL) for performing tests in human hepatocarcinoma cell line Huh7 ET (luc-ubi-neo/ET) that exhibits a sub-genomic HCV RNA replicon with a firefly luciferase reporter (NIAID Contract No. HHSN272201000009C). The authors are also grateful to Drs. Nicholas Cosford and Robert Ardecky (Sanford-Burnham Medical Research Institute, La Jolla, CA) for their expert support in performing our study.	Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chen X, 2002, J CHEM INF COMP SCI, V42, P1407, DOI 10.1021/ci025531g; Chevaliez S., 2006, HEPATITIS C VIRUSES, V1, P5; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Delang L, 2011, ANTIMICROB AGENTS CH, V55, P4103, DOI 10.1128/AAC.00294-11; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Flores MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1441, DOI 10.1016/j.bbapap.2009.06.004; Fonseca-Coronado S, 2012, J CLIN MICROBIOL, V50, P281, DOI 10.1128/JCM.05842-11; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Kwong AD, 1999, ANTIVIR RES, V41, P65; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Llinas-Brunet M, 2004, J MED CHEM, V47, P1605, DOI 10.1021/jm0342414; Ma C, 2011, ACS COMB SCI, V13, P223, DOI 10.1021/co100033m; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Margeridon-Thermet S, 2010, VIRUSES-BASEL, V2, P2696, DOI 10.3390/v2122696; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Nicholls A, 2010, J MED CHEM, V53, P3862, DOI 10.1021/jm900818s; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ortqvist P, 2010, ANTIVIR THER, V15, P841, DOI 10.3851/IMP1655; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Raboisson P, 2008, BIOORG MED CHEM LETT, V18, P4853, DOI 10.1016/j.bmcl.2008.07.088; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Shiryaev SA, 2007, PROTEIN EXPRES PURIF, V52, P334, DOI 10.1016/j.pep.2006.11.009; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309; Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Urbani A, 1999, BIOCHEMISTRY-US, V38, P5206, DOI 10.1021/bi982773u; Venkatraman S, 2009, BIOORG MED CHEM LETT, V19, P180, DOI 10.1016/j.bmcl.2008.10.124; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Vermehren J, 2011, EUR J MED RES, V16, P303, DOI 10.1186/2047-783X-16-7-303; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	75	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40029	10.1371/journal.pone.0040029	http://dx.doi.org/10.1371/journal.pone.0040029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768327	Green Submitted, gold, Green Published			2022-12-25	WOS:000305966500040
J	Liu, YJ; Ding, YC; Alonas, E; Zhao, WL; Santangelo, PJ; Jin, DY; Piper, JA; Teng, JL; Ren, QS; Xi, P				Liu, Yujia; Ding, Yichen; Alonas, Eric; Zhao, Wenli; Santangelo, Philip J.; Jin, Dayong; Piper, James A.; Teng, Junlin; Ren, Qiushi; Xi, Peng			Achieving lambda/10 Resolution CW STED Nanoscopy with a Ti:Sapphire Oscillator	PLOS ONE			English	Article							STIMULATED-EMISSION-DEPLETION; 2-PHOTON EXCITATION; MICROSCOPY; BREAKING; REVEALS; LIMIT	In this report, a Ti: Sapphire oscillator was utilized to realize synchronization-free stimulated emission depletion (STED) microscopy. With pump power of 4.6 W and sample irradiance of 310 mW, we achieved super-resolution as high as 71 nm. With synchronization-free STED, we imaged 200 nm nanospheres as well as all three cytoskeletal elements (microtubules, intermediate filaments, and actin filaments), clearly demonstrating the resolving power of synchronization-free STED over conventional diffraction limited imaging. It also allowed us to discover that, Dylight 650, exhibits improved performance over ATTO647N, a fluorophore frequently used in STED. Furthermore, we applied synchronization-free STED to image fluorescently-labeled intracellular viral RNA granules, which otherwise cannot be differentiated by confocal microscopy. Thanks to the widely available Ti:Sapphire oscillators in multiphoton imaging system, this work suggests easier access to setup super-resolution microscope via the synchronization-free STED.	[Liu, Yujia; Ren, Qiushi] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Liu, Yujia; Ding, Yichen; Ren, Qiushi; Xi, Peng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Alonas, Eric; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Alonas, Eric; Santangelo, Philip J.] Emory Univ, Atlanta, GA 30322 USA; [Jin, Dayong; Piper, James A.] Macquarie Univ, Adv Cytometry Labs, MQphoton Res Ctr, Sydney, NSW 2109, Australia; [Zhao, Wenli; Teng, Junlin] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Shanghai Jiao Tong University; Peking University; University System of Georgia; Georgia Institute of Technology; Emory University; Macquarie University; Peking University	Liu, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	xipeng@pku.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	"973" Major State Basic Research Development Program of China [2011CB809101, 2010CB933901, 2011CB707502]; National Natural Science Foundation of China [61178076]; PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	"973" Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the "973" Major State Basic Research Development Program of China (2011CB809101, 2010CB933901, 2011CB707502), the National Natural Science Foundation of China (61178076), PKU-GT/Emory University BME Seed Grant funded by Wallace H. Coulter Foundation, and seed fund support from Olympus Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Cao YY, 2011, OPT EXPRESS, V19, P19486, DOI 10.1364/OE.19.019486; Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2010, SPRINGER SER CHEM PH, V96, P365, DOI 10.1007/978-3-642-02597-6_19; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hirvonen LM, 2011, AUST J CHEM, V64, P41, DOI 10.1071/CH10333; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hyeon C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364190; Kasper R, 2010, SMALL, V6, P1379, DOI 10.1002/smll.201000203; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Rankin BR, 2009, OPT EXPRESS, V17, P15679, DOI 10.1364/OE.17.015679; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Scheul T, 2011, OPT EXPRESS, V19, P18036, DOI 10.1364/OE.19.018036; Schrof S, 2011, OPT EXPRESS, V19, P8066, DOI 10.1364/OE.19.008066; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang WC, 2010, APPL OPTICS, V49, P6703, DOI 10.1364/AO.49.006703; Westphal V, 2003, APPL PHYS LETT, V82, P3125, DOI 10.1063/1.1571656; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11; Xi P, 2008, OPT COMMUN, V281, P1841, DOI 10.1016/j.optcom.2007.09.066; Xi P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059629	38	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40003	10.1371/journal.pone.0040003	http://dx.doi.org/10.1371/journal.pone.0040003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22615852	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800086
J	Fu, WX; Liu, Y; Lu, X; Niu, XY; Ding, XD; Liu, JF; Zhang, Q				Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin			A Genome-Wide Association Study Identifies Two Novel Promising Candidate Genes Affecting Escherichia coli F4ab/F4ac Susceptibility in Swine	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; POPULATION STRATIFICATION; INTESTINAL RECEPTOR; EPITHELIAL-CELLS; MILK-PRODUCTION; DAIRY-CATTLE; INTEGRIN; BINDING; PROTEIN; F4AC	Enterotoxigenic Escherichia coli (ETEC) expressing F4 fimbria is the major pathogenic bacteria causing diarrhoea in neonatal and post-weaning piglets. Previous studies have revealed that the susceptibility to ETEC F4ab/F4ac is an autosomal Mendelian dominant trait and the loci controlling the F4ab/F4ac receptor are located on SSC13q41, between markers SW207 and S0283. To pinpoint these loci and further validate previous findings, we performed a genome-wide association study (GWAS) using a two generation family-based population, consisting of 301 piglets with phenotypes of susceptibility to ETEC F4ab/F4ac by the vitro adhesion test. The DNA of all piglets and their parents was genotyped using the Illumina PorcineSNP60 BeadChip, and 50,972 and 50,483 SNPs were available for F4ab and F4ac susceptibility, respectively, in the association analysis after quality control. In summary, 28 and 18 significant SNPs (p < 0.05) were detected associated with F4ab and F4ac susceptibility respectively at genome-wide significance level. From these significant findings, two novel candidate genes, HEG1 and ITGB5, were firstly identified as the most promising genes underlying F4ab/F4ac susceptibility in swine according to their functions and positions. Our findings herein provide a novel evidence for unravelling genetic mechanism of diarrhoea risk in piglets.	[Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China; [Lu, Xin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Fu, WX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China.	liujf@cau.edu.cn; qzhang@cau.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Natural Science Foundations of China [30972092, 30800776]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2009ZX08009-146B]; Natural Science Foundations of Beijing [6102016]; New-Century Training Programme Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Natural Science Foundations of Beijing; New-Century Training Programme Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Natural Science Foundations of China (30972092, 30800776), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2009ZX08009-146B), the Natural Science Foundations of Beijing (6102016), New-Century Training Programme Foundation for the Talents by the State Education Commission of China (NETC-10-0783) and Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIJLSMA IGW, 1987, VET RES COMMUN, V11, P509, DOI 10.1007/BF00396368; Billey LO, 1998, VET MICROBIOL, V59, P203, DOI 10.1016/S0378-1135(97)00193-4; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; de Koning DJ, 1999, GENETICS, V152, P1679; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GEORGES M, 1995, GENETICS, V139, P907; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Joller D, 2009, COMP MOL APPROACHES; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kasuga I, 2009, RESP MED, V103, P1672, DOI 10.1016/j.rmed.2009.05.008; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; Li Yuhua, 2007, Journal of Genetics and Genomics, V34, P591, DOI 10.1016/S1673-8527(07)60067-8; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Memmo LM, 1998, J CELL SCI, V111, P425; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Pongpanich M, 2010, BIOINFORMATICS, V26, P1731, DOI 10.1093/bioinformatics/btq272; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Python P, 2005, J ANIM BREED GENET, V122, P5, DOI 10.1111/j.1439-0388.2005.00490.x; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Ren J, 2009, J ANIM BREED GENET, V126, P30, DOI 10.1111/j.1439-0388.2008.00751.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x	46	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32127	10.1371/journal.pone.0032127	http://dx.doi.org/10.1371/journal.pone.0032127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22615852	Green Published, gold, Green Submitted			2022-12-25	WOS:000304046900001
J	Liu, Y; Costa, MB; Gerhardinger, C				Liu, Yang; Costa, Montserrat Biarnes; Gerhardinger, Chiara			IL-1 beta Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1 beta Autostimulation	PLOS ONE			English	Article							PROTEIN-KINASE-C; INTERLEUKIN-1 INDUCES INTERLEUKIN-1; MULLER CELLS; MICROGLIAL ACTIVATION; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; GENE-EXPRESSION; RETINOPATHY; BRAIN; INDUCTION	Many molecular and cellular abnormalities detected in the diabetic retina support a role for IL-1 beta-driven neuroinflammation in the pathogenesis of diabetic retinopathy. IL-1 beta is well known for its role in the induction and, through autostimulation, amplification of neuroinflammation. Upregulation of IL-1 beta has been consistently detected in the diabetic retina; however, the mechanisms and cellular source of IL-1 beta overexpression are poorly understood. The aim of this study was to investigate the effect of high glucose and IL-1 beta itself on IL-1 beta expression in microglial, macroglial (astrocytes and Muller cells) and retinal vascular endothelial cells; and to study the effect of diabetes on the expression of IL-1 beta in isolated retinal vessels and on the temporal pattern of IL-1 beta upregulation and glial reactivity in the retina of streptozotocin-diabetic rats. IL-1 beta was quantified by RealTime RT-PCR and ELISA, glial fibrillar acidic protein, alpha 2-macroglobulin, and ceruloplasmin by immunoblotting. We found that high glucose induced a 3-fold increase of IL-1 beta expression in retinal endothelial cells but not in macroglia and microglia. IL-1 beta induced its own synthesis in endothelial and macroglial cells but not in microglia. In retinal endothelial cells, the high glucose-induced IL-1 beta overexpression was prevented by calphostin C, a protein kinase C inhibitor. The retinal vessels of diabetic rats showed increased IL-1 beta expression as compared to non-diabetic rats. Retinal expression of IL-1 beta increased early after the induction of diabetes, continued to increase with progression of the disease, and was temporally associated with upregulation of markers of glial activation. These findings point to hyperglycemia as the trigger and to the endothelium as the origin of the initial retinal upregulation of IL-1 beta in diabetes; and to IL-1 beta itself, via autostimulation in endothelial and macroglial cells, as the mechanism of sustained IL-1 beta overexpression. Interrupting the vicious circle triggered by IL-1 beta autostimulation could limit the progression of diabetic retinopathy.	[Liu, Yang] Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School	Liu, Y (corresponding author), Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA.	chiara.gerhardinger@schepens.harvard.edu	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Institutes of Health [R01EY016206]; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (R01EY016206). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Asakawa H, 1997, J DIABETES COMPLICAT, V11, P176, DOI 10.1016/S1056-8727(97)00004-4; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; CAGLIERO E, 1991, J BIOL CHEM, V266, P14244; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Chakrabarti S, 2000, DIABETES-METAB RES, V16, P393, DOI 10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; DALTON BJ, 1989, ARTHRITIS RHEUM, V32, P279, DOI 10.1002/anr.1780320309; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; GIULIAN D, 1988, J NEUROSCI, V8, P2485; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; HURME M, 1990, BLOOD, V76, P2198; Ibrahim AS, 2011, DIABETES, V60, P1122, DOI 10.2337/db10-1160; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; LEE SC, 1993, J IMMUNOL, V150, P2659; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Ramsauer M, 2002, FASEB J, V16, P1274, DOI 10.1096/fj.01-0814fje; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHIBA T, 1993, AM J PHYSIOL, V265, pE783, DOI 10.1152/ajpendo.1993.265.5.E783; Sun W, 2005, DIABETES, V54, P3418, DOI 10.2337/diabetes.54.12.3418; Tham CS, 2003, INT J DEV NEUROSCI, V21, P431, DOI 10.1016/j.ijdevneu.2003.09.003; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316; WARNER SJC, 1987, J IMMUNOL, V139, P1911; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang L, 2011, INVEST OPHTH VIS SCI, V50, P2319; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6	52	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36949	10.1371/journal.pone.0036949	http://dx.doi.org/10.1371/journal.pone.0036949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615852	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300046
